<SEC-DOCUMENT>0001093557-20-000029.txt : 20200213
<SEC-HEADER>0001093557-20-000029.hdr.sgml : 20200213
<ACCEPTANCE-DATETIME>20200213171725
ACCESSION NUMBER:		0001093557-20-000029
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		106
CONFORMED PERIOD OF REPORT:	20191231
FILED AS OF DATE:		20200213
DATE AS OF CHANGE:		20200213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DEXCOM INC
		CENTRAL INDEX KEY:			0001093557
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330857544
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51222
		FILM NUMBER:		20612055

	BUSINESS ADDRESS:	
		STREET 1:		6340 SEQUENCE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8582000200

	MAIL ADDRESS:	
		STREET 1:		6340 SEQUENCE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>dxcm-12312019x10kasof1.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:5db812665eee4a1e9154a1e66356aa71,x:a640240837374f389f1edf4cfc737057-->
<!-- Document created using Wdesk  -->
<!-- Copyright 2020 Workiva -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2019-01-31" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2019-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2019-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2019-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2011-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2019-01-31" xmlns:lea="http://fasb.org/dis/lea/2019-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2019-01-31" xmlns:guar="http://fasb.org/dis/guar/2019-01-31" xmlns:ru="http://fasb.org/dis/ru/2019-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:leas="http://fasb.org/dis/leas/2019-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2019-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2019-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2019-01-31" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2017-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:fs-insa="http://fasb.org/dis/fs-insa/2019-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:cce="http://fasb.org/dis/cce/2019-01-31" xmlns:inv="http://fasb.org/dis/inv/2019-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:srt-std="http://fasb.org/srt-std/2019-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2019-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2019-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2019-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2019-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2019-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2019-01-31" xmlns:ceclcalc3l="http://fasb.org/dis/ceclcalc3l/2019-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2019-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:re="http://fasb.org/dis/re/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2019-01-31" xmlns:invco="http://fasb.org/dis/invco/2019-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2019-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2019-01-31" xmlns:currency-ent-dep="http://xbrl.sec.gov/currency-ent-dep/2019-01-31" xmlns:aro="http://fasb.org/dis/aro/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2019-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:srt-all="http://fasb.org/srt-all/2019-01-31" xmlns:codification-part="http://fasb.org/codification-part/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:sec-re="http://fasb.org/dis/sec-re/2019-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2019-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2019-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2019-01-31" xmlns:equity="http://fasb.org/dis/equity/2019-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:se="http://fasb.org/dis/se/2019-01-31" xmlns:crcrb="http://fasb.org/dis/crcrb/2019-01-31" xmlns:edco="http://fasb.org/dis/edco/2019-01-31" xmlns:te="http://fasb.org/dis/te/2019-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2019-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2019-01-31" xmlns:invest-all="http://xbrl.sec.gov/invest-all/2013-01-31" xmlns:hco="http://fasb.org/dis/hco/2019-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:dr="http://fasb.org/dis/dr/2019-01-31" xmlns:ero="http://fasb.org/dis/ero/2019-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2017-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2019-01-31" xmlns:cecl="http://fasb.org/dis/cecl/2019-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2019-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2019-01-31" xmlns:ceclcalc2="http://fasb.org/dis/ceclcalc2/2019-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2019-01-31" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2019-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2019-01-31" xmlns:soi="http://fasb.org/stm/soi/2019-01-31" xmlns:diha="http://fasb.org/dis/diha/2019-01-31" xmlns:debt="http://fasb.org/dis/debt/2019-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:invest-std="http://xbrl.sec.gov/invest-std/2013-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2019-01-31" xmlns:bc="http://fasb.org/dis/bc/2019-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2011-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2019-01-31" xmlns:invest-ent-all="http://xbrl.sec.gov/invest-ent-all/2013-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2019-01-31" xmlns:rd="http://fasb.org/dis/rd/2019-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2019-01-31" xmlns:eui="http://fasb.org/dis/eui/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ap="http://fasb.org/dis/ap/2019-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2019-01-31" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2019-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2019-01-31" xmlns:sr="http://fasb.org/dis/sr/2019-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2019-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2019-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2019-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2019-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2019-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2019-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2019-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2019-01-31" xmlns:oi="http://fasb.org/dis/oi/2019-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2019-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2019-01-31" xmlns:cc="http://fasb.org/dis/cc/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2019-01-31" xmlns:disops="http://fasb.org/dis/disops/2019-01-31" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:cn-part="http://fasb.org/cn-part/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2019-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2017-01-31" xmlns:dxcm="http://www.dexcom.com/20191231" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2019-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2019-01-31" xmlns:ts="http://fasb.org/dis/ts/2019-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2019-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2019-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:ni="http://fasb.org/dis/ni/2019-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2019-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2019-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2019-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2019-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2019-01-31" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2019-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2019-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:ir="http://fasb.org/dis/ir/2019-01-31" xmlns:sheci="http://fasb.org/stm/sheci/2019-01-31" xmlns:foct="http://fasb.org/dis/foct/2019-01-31" xmlns:soc="http://fasb.org/stm/soc/2019-01-31" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2019-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2019-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2019-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2017-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:con="http://fasb.org/dis/con/2019-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2011-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:invest-ent-std="http://xbrl.sec.gov/invest-ent-std/2013-01-31" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2019-01-31" xmlns:eps="http://fasb.org/dis/eps/2019-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:iago="http://fasb.org/dis/iago/2019-01-31" xmlns:pay="http://fasb.org/dis/pay/2019-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:tin-part="http://fasb.org/tin-part/2019-01-31" xmlns:acec="http://fasb.org/dis/acec/2019-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2019-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:nt="http://fasb.org/dis/nt/2019-01-31" xmlns:spc="http://fasb.org/stm/spc/2019-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2019-01-31" xmlns:ides="http://fasb.org/dis/ides/2019-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2019-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2011-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:regop="http://fasb.org/dis/regop/2019-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2019-01-31" xmlns:com="http://fasb.org/stm/com/2019-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2019-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2019-01-31" xmlns:exch-ent-dep="http://xbrl.sec.gov/exch-ent-dep/2019-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ei="http://fasb.org/dis/ei/2019-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
	<head>
		<meta http-equiv="Content-Type" content="text/html" />
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="FD2019Q4YTD" name="dei:AmendmentFlag" id="Fact-9E0865A17F60D9469B55EB34A8521ECF-wk-Fact-9E0865A17F60D9469B55EB34A8521ECF" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="dei:CurrentFiscalYearEndDate" id="Fact-9897DACFA071E366EB970F96EB4A29BD-wk-Fact-9897DACFA071E366EB970F96EB4A29BD">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="dei:DocumentFiscalPeriodFocus" id="Fact-CE1B7A46FE4F8E515F55EB34A8521452-wk-Fact-CE1B7A46FE4F8E515F55EB34A8521452">FY</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="dei:DocumentFiscalYearFocus" id="Fact-A45B79DFD9105FC799D074E310CBAACF-wk-Fact-A45B79DFD9105FC799D074E310CBAACF">2019</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="dei:EntityCentralIndexKey" id="Fact-BF17FEEF0D4A073C171FEB34A8529A46-wk-Fact-BF17FEEF0D4A073C171FEB34A8529A46">0001093557</ix:nonNumeric><ix:nonFraction decimals="INF" unitRef="usd" contextRef="FI2018Q4" name="dxcm:FairValueAssetsLevel3TransfersAmount" id="Fact-F2C3900BC4B45D4164E7B4C32C2338C5-wk-Fact-F2C3900BC4B45D4164E7B4C32C2338C5">0</ix:nonFraction><ix:nonNumeric contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember" name="dxcm:LesseeOperatingLeaseRemainingLeaseTerm" id="Fact-FEA71BEB20744EFED6EE3A3280004FD3-wk-Fact-FEA71BEB20744EFED6EE3A3280004FD3">P1Y</ix:nonNumeric><ix:nonFraction decimals="INF" unitRef="patent" contextRef="D2018Q1Feb28_dxcm_NameOfPlaintiffAxis_dxcm_WaveFormTechnologiesInc.Member" name="dxcm:LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber" id="Fact-FD148B65EF8B43F23A0AB073765ADB59-wk-Fact-FD148B65EF8B43F23A0AB073765ADB59">2</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="patent" contextRef="D2016Q1March28_dxcm_NameOfPlaintiffAxis_dxcm_WaveFormTechnologiesInc.Member" name="dxcm:LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff" id="Fact-05932699E4B6A39079EAB06CCCAD9434-wk-Fact-05932699E4B6A39079EAB06CCCAD9434">3</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="usdPerShare" contextRef="FI2018Q4" name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact-9ADA991B01095821A1F9014EFC4E1E46-wk-Fact-9ADA991B01095821A1F9014EFC4E1E46">0.001</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="usdPerShare" contextRef="FI2019Q4" name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact-8A33731F91A4554FAC0E41DA9604E4B1-wk-Fact-8A33731F91A4554FAC0E41DA9604E4B1">0.001</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2018Q4" name="us-gaap:CommonStockSharesAuthorized" id="Fact-65E3C1D4884E58508A2D8F0F4F156181-wk-Fact-65E3C1D4884E58508A2D8F0F4F156181">200000000</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:CommonStockSharesAuthorized" id="Fact-98F41E524955570E8814040C80BD1644-wk-Fact-98F41E524955570E8814040C80BD1644">200000000</ix:nonFraction><ix:nonFraction decimals="-5" unitRef="shares" contextRef="FI2018Q4" name="us-gaap:CommonStockSharesIssued" id="Fact-A7809165C55F5A73BCACB2B951DA64CA-wk-Fact-A7809165C55F5A73BCACB2B951DA64CA">91100000</ix:nonFraction><ix:nonFraction decimals="-5" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:CommonStockSharesIssued" id="Fact-AF24C46C9B9C516DA07C028C1D1652E0-wk-Fact-AF24C46C9B9C516DA07C028C1D1652E0">92400000</ix:nonFraction><ix:nonFraction decimals="-5" unitRef="shares" contextRef="FI2018Q4" name="us-gaap:CommonStockSharesOutstanding" id="Fact-DC0A363621EE5E75BC5ED5D907F13739-wk-Fact-DC0A363621EE5E75BC5ED5D907F13739">90000000</ix:nonFraction><ix:nonFraction decimals="-5" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:CommonStockSharesOutstanding" id="Fact-38AED5E818BC5247AAD229AC617ABC1F-wk-Fact-38AED5E818BC5247AAD229AC617ABC1F">91600000</ix:nonFraction><ix:nonFraction decimals="7" unitRef="number" contextRef="D2017Q2June_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" id="Fact-98939C21F7C37AAB4AE1EB34A832758B-wk-Fact-98939C21F7C37AAB4AE1EB34A832758B">0.0100918</ix:nonFraction><ix:nonFraction decimals="7" unitRef="number" contextRef="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" id="Fact-7FFEB2573C2E1ED2562CEB34A83211C5-wk-Fact-7FFEB2573C2E1ED2562CEB34A83211C5">0.0060869</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="number" contextRef="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact-747F77BDEE4C5AD898091BEB40211FAD-wk-Fact-747F77BDEE4C5AD898091BEB40211FAD">0.0075</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="usd" contextRef="FI2018Q4" name="us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount" id="Fact-04DA6FCDA578F03514B8B4C2D92D1A14-wk-Fact-04DA6FCDA578F03514B8B4C2D92D1A14">0</ix:nonFraction><ix:nonNumeric contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact-EAC7044633B7864A4F5BC9CD307E0004-wk-Fact-EAC7044633B7864A4F5BC9CD307E0004">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact-117BA70552F5E25DBC2CC9CCC81C472C-wk-Fact-117BA70552F5E25DBC2CC9CCC81C472C">P2Y</ix:nonNumeric><ix:nonFraction decimals="INF" unitRef="patent" contextRef="D2017Q3Sep15_dxcm_NameOfDefendantAxis_dxcm_AgaMatrixMember" name="us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber" id="Fact-6E34E4A5BC18DC5B7F00B06E67E51677-wk-Fact-6E34E4A5BC18DC5B7F00B06E67E51677">2</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="usd" contextRef="FD2017Q4YTD" name="us-gaap:GoodwillAndIntangibleAssetImpairment" id="Fact-2A212D98ED7CED625772C9CDCCB55642-wk-Fact-2A212D98ED7CED625772C9CDCCB55642">0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="usd" contextRef="FD2018Q4YTD" name="us-gaap:GoodwillAndIntangibleAssetImpairment" id="Fact-FE789D10CDBCCECD05CDC9CDC08AE362-wk-Fact-FE789D10CDBCCECD05CDC9CDC08AE362">0</ix:nonFraction><ix:nonNumeric contextRef="FI2019Q4_srt_RangeAxis_srt_MinimumMember" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="Fact-AD2C6A38A7598D502B0F3A31B5D1F516-wk-Fact-AD2C6A38A7598D502B0F3A31B5D1F516">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="FI2019Q4_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="Fact-39ADA2190258692E6C703A3164415D86-wk-Fact-39ADA2190258692E6C703A3164415D86">P5Y</ix:nonNumeric><ix:nonFraction decimals="INF" unitRef="patent" contextRef="D2016Q1March28_dxcm_NameOfPlaintiffAxis_dxcm_AgaMatrixMember" name="us-gaap:LossContingencyPatentsAllegedlyInfringedNumber" id="Fact-54302A1A6E3EA980F599B06BBBC20376-wk-Fact-54302A1A6E3EA980F599B06BBBC20376">3</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="patent" contextRef="D2016Q1March28_dxcm_NameOfPlaintiffAxis_dxcm_WaveFormTechnologiesInc.Member" name="us-gaap:LossContingencyPatentsAllegedlyInfringedNumber" id="Fact-566CB59FD371CE9B83CDB06D118B5B7B-wk-Fact-566CB59FD371CE9B83CDB06D118B5B7B">3</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="usdPerShare" contextRef="FI2018Q4" name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact-848804054CEA571AA991638CE176DB8E-wk-Fact-848804054CEA571AA991638CE176DB8E">0.001</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="usdPerShare" contextRef="FI2019Q4" name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact-5FA5621C72D35E0CAB8DD0627B9F5C65-wk-Fact-5FA5621C72D35E0CAB8DD0627B9F5C65">0.001</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2018Q4" name="us-gaap:PreferredStockSharesAuthorized" id="Fact-D38D3D1F4C2A5A10A2FDB08598EB115A-wk-Fact-D38D3D1F4C2A5A10A2FDB08598EB115A">5000000</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:PreferredStockSharesAuthorized" id="Fact-75DF8DBA38A75373A7743729EDA463F6-wk-Fact-75DF8DBA38A75373A7743729EDA463F6">5000000</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2018Q4" name="us-gaap:PreferredStockSharesIssued" id="Fact-AC7A9090EA011005B626EB34A814E7A7-wk-Fact-AC7A9090EA011005B626EB34A814E7A7">0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:PreferredStockSharesIssued" id="Fact-8D3FF2E61E5A90393B0AEB34A8161A08-wk-Fact-8D3FF2E61E5A90393B0AEB34A8161A08">0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2018Q4" name="us-gaap:PreferredStockSharesOutstanding" id="Fact-E7E877AC818C920B89BFEB34A817A5A9-wk-Fact-E7E877AC818C920B89BFEB34A817A5A9">0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:PreferredStockSharesOutstanding" id="Fact-E61FB2ECC913F2990B65EB34A8150081-wk-Fact-E61FB2ECC913F2990B65EB34A8150081">0</ix:nonFraction><ix:nonNumeric contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact-406AE4B3D55448FDC5D6C9C8A99CFFD4-wk-Fact-406AE4B3D55448FDC5D6C9C8A99CFFD4">P4Y</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Fact-3042733F2ACD97849D62AFEDE4510189-wk-Fact-3042733F2ACD97849D62AFEDE4510189">P4Y</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Fact-490442D4F8688A00EABCAFEDB917B39B-wk-Fact-490442D4F8688A00EABCAFEDB917B39B">P3Y</ix:nonNumeric><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2017Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact-D36A2B56FA0DB61D63CFEB34A8156A97-wk-Fact-D36A2B56FA0DB61D63CFEB34A8156A97">0.0056</ix:nonFraction><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2017Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact-2D333815BA26F3EFC73AEB34A81AF927-wk-Fact-2D333815BA26F3EFC73AEB34A81AF927">0.0033</ix:nonFraction><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2018Q4QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact-20ECAE3947010606AA8EEB34A81AF9AE-wk-Fact-20ECAE3947010606AA8EEB34A81AF9AE">0.0067</ix:nonFraction><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2018Q4QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact-F33F452D4F2C51088AEBEB34A81B1659-wk-Fact-F33F452D4F2C51088AEBEB34A81B1659">0.0050</ix:nonFraction><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact-0F91CAA4CF9ECEE17E59EB34A81BEB95-wk-Fact-0F91CAA4CF9ECEE17E59EB34A81BEB95">0.0051</ix:nonFraction><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact-8A2679F60796A80445ECEB34A81B3C40-wk-Fact-8A2679F60796A80445ECEB34A81B3C40">0.0040</ix:nonFraction><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2017Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact-E9D9E04F471E9FB0DFEAEB34A8177E4B-wk-Fact-E9D9E04F471E9FB0DFEAEB34A8177E4B">0.0112</ix:nonFraction><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2017Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact-FE943925A56C5DCBBFE3EB34A815A976-wk-Fact-FE943925A56C5DCBBFE3EB34A815A976">0.0075</ix:nonFraction><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2018Q4QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact-016B1FE28B89EAA453BDEB34A819D2C8-wk-Fact-016B1FE28B89EAA453BDEB34A819D2C8">0.0225</ix:nonFraction><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2018Q4QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact-B7C2D9EBA585FEECB753EB34A81A8C65-wk-Fact-B7C2D9EBA585FEECB753EB34A81A8C65">0.0155</ix:nonFraction><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact-FC932E3E280565379B4FEB34A8168780-wk-Fact-FC932E3E280565379B4FEB34A8168780">0.0255</ix:nonFraction><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact-1E8D553C6BA0B7863D86EB34A8194E2C-wk-Fact-1E8D553C6BA0B7863D86EB34A8194E2C">0.0172</ix:nonFraction><ix:nonFraction decimals="-5" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:TreasuryStockShares" id="Fact-A955A08A8500E80053D8EB34A81369C1-wk-Fact-A955A08A8500E80053D8EB34A81369C1">800000</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:href="dxcm-20191231.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="FD2019Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q1Feb07">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-02-07</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q2Jun28">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-28</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2016Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201609Member_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201609Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201609Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201609Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerBMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerBMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerCMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerBMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerBMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementInitialPaymentMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-11-20</xbrli:startDate>
			<xbrli:endDate>2018-11-20</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-11-20</xbrli:startDate>
			<xbrli:endDate>2018-11-20</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-11-20</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementInitialPaymentMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-11-20</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementInitialPaymentMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4December28_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementInitialPaymentMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-28</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ProductOrServiceAxis_dxcm_ReceiverProductComponentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dxcm:ReceiverProductComponentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q4Feb01-Dec31">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-02-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_dxcm_ReceiverProductComponentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dxcm:ReceiverProductComponentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4December_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-12-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4December_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-12-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-11-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-11-01</xbrli:startDate>
			<xbrli:endDate>2018-11-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4December_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-12-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4December19_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-19</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4December_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-12-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-11-01</xbrli:startDate>
			<xbrli:endDate>2018-11-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2017Q2June_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2017-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-11-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2017Q2June_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2017-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q1January1">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-01-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">dxcm:LeasedBuildingsMesaArizonaExpiringMarch2028Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_RangeAxis_srt_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q1January1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-01-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">dxcm:LeasedBuildingsMesaArizonaExpiringMarch2028Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_RangeAxis_srt_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2016Q1March28_dxcm_NameOfPlaintiffAxis_dxcm_WaveFormTechnologiesInc.Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:NameOfPlaintiffAxis">dxcm:WaveFormTechnologiesInc.Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-03-28</xbrli:startDate>
			<xbrli:endDate>2016-03-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2016Q1March28_dxcm_NameOfPlaintiffAxis_dxcm_AgaMatrixMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:NameOfPlaintiffAxis">dxcm:AgaMatrixMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-03-28</xbrli:startDate>
			<xbrli:endDate>2016-03-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q1Feb28_dxcm_NameOfPlaintiffAxis_dxcm_WaveFormTechnologiesInc.Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:NameOfPlaintiffAxis">dxcm:WaveFormTechnologiesInc.Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-02-28</xbrli:startDate>
			<xbrli:endDate>2018-02-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2017Q3Sep15_dxcm_NameOfDefendantAxis_dxcm_AgaMatrixMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dxcm:NameOfDefendantAxis">dxcm:AgaMatrixMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-09-15</xbrli:startDate>
			<xbrli:endDate>2017-09-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4QTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_dxcm_SellingGeneralAndAdministrativeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_dxcm_SellingGeneralAndAdministrativeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_dxcm_SellingGeneralAndAdministrativeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_PlanNameAxis_dxcm_A401kPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A401kPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_A401kPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A401kPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2015Q2RSUsharesauthorized">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-05-28</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2016Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q3QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q2QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-04-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q2QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-04-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-10-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q1QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:unit id="number">
		<xbrli:measure>xbrli:pure</xbrli:measure>
	</xbrli:unit><xbrli:unit id="usdPerShare">
		<xbrli:divide>
			<xbrli:unitNumerator>
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unitNumerator>
			<xbrli:unitDenominator>
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unitDenominator>
		</xbrli:divide>
	</xbrli:unit><xbrli:unit id="d">
		<xbrli:measure>utreg:D</xbrli:measure>
	</xbrli:unit><xbrli:unit id="usd">
		<xbrli:measure>iso4217:USD</xbrli:measure>
	</xbrli:unit><xbrli:unit id="shares">
		<xbrli:measure>xbrli:shares</xbrli:measure>
	</xbrli:unit><xbrli:unit id="patent">
		<xbrli:measure>dxcm:number_patents</xbrli:measure>
	</xbrli:unit><xbrli:unit id="segment">
		<xbrli:measure>dxcm:segment</xbrli:measure>
	</xbrli:unit><xbrli:unit id="renewal_term">
		<xbrli:measure>dxcm:renewal_term</xbrli:measure>
	</xbrli:unit><xbrli:unit id="finance_lease">
		<xbrli:measure>dxcm:finance_lease</xbrli:measure>
	</xbrli:unit></ix:resources></ix:header></div><div><a id="sBF7F64218A0755A2B71A1E554AFBDFC5"></a></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">UNITED STATES</span></div><div style="line-height:120%;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="line-height:120%;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">Washington, DC&#160;20549</span></div><div style="line-height:120%;text-align:center;font-size:14pt;"><span style="font-family:inherit;font-size:14pt;font-weight:bold;">FORM </span><span><ix:nonNumeric id="d37371145e547-wk-Fact-A3C625C60B5AF96539080F84D0092DAE" name="dei:DocumentType" contextRef="FD2019Q4YTD"><span style="font-size:14pt;font-weight:bold;">10-K</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:14pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:87.09677419354838%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:2%;"></td><td style="width:98%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><span style="font-family:Arial Unicode MS;font-size:12pt;"><span><ix:nonNumeric id="d37371145e565-wk-Fact-9C5876AA87E5E198801D403877EE29C5" name="dei:DocumentAnnualReport" contextRef="FD2019Q4YTD" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the fiscal year ended</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d37371145e577-wk-Fact-6B5B7E13FAA89D2862B70F856964B175" name="dei:DocumentPeriodEndDate" contextRef="FD2019Q4YTD" format="ixt:datemonthdayyearen">December 31, 2019</ix:nonNumeric></span></span></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:9pt;">&#160;</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:87.09677419354838%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:2%;"></td><td style="width:98%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><span style="font-family:Arial Unicode MS;font-size:12pt;"><span><ix:nonNumeric id="d37371145e596-wk-Fact-C10DABFE8D9E21D5C1C840389878D00A" name="dei:DocumentTransitionReport" contextRef="FD2019Q4YTD" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Commission file number&#160;</span><span><ix:nonNumeric id="d37371145e609-wk-Fact-6DF098CDD9EA27E637880F860F852A46" name="dei:EntityFileNumber" contextRef="FD2019Q4YTD"><span style="font-weight:bold;">000-51222</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;"><img src="dexcomgreenstandalone.jpg" alt="dexcomgreenstandalone.jpg" style="height:28px;width:190px;"></img></div><div style="line-height:120%;text-align:center;font-size:20pt;"><span><ix:nonNumeric id="d37371145e618-wk-Fact-E9B49DB4893B1BFF377A0F958206A159" name="dei:EntityRegistrantName" contextRef="FD2019Q4YTD"><span style="font-size:20pt;font-weight:bold;">DEXCOM, INC.</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:20pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Exact name of Registrant as specified in its charter)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.75627240143369%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:44%;"></td><td style="width:11%;"></td><td style="width:45%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;"><span><ix:nonNumeric id="d37371145e641-wk-Fact-DA692B418DE3AC2242960F86DCD5B791" name="dei:EntityIncorporationStateCountryCode" contextRef="FD2019Q4YTD" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;"><span><ix:nonNumeric id="d37371145e651-wk-Fact-F4450ACAC902E462CC8D0F8700DCBC44" name="dei:EntityTaxIdentificationNumber" contextRef="FD2019Q4YTD">33-0857544</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(State or Other Jurisdiction of Incorporation or Organization)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(I.R.S. Employer Identification No.)</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span><ix:nonNumeric id="d37371145e670-wk-Fact-CAB9573ECBC86EC1A55A678175C7F4DA" name="dei:EntityAddressAddressLine1" contextRef="FD2019Q4YTD"><span style="font-size:9pt;font-weight:bold;">6340 Sequence Drive</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">, </span><span><ix:nonNumeric id="d37371145e675-wk-Fact-0A64F544F649CC0490DC6781B317C448" name="dei:EntityAddressCityOrTown" contextRef="FD2019Q4YTD"><span style="font-size:9pt;font-weight:bold;">San Diego</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:9pt;font-weight:bold;">, </span><span><ix:nonNumeric id="d37371145e680-wk-Fact-050AD23E14DA27BD9B6F6781D6E1D6BB" name="dei:EntityAddressStateOrProvince" contextRef="FD2019Q4YTD"><span style="font-size:9pt;font-weight:bold;">CA</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:9pt;font-weight:bold;"> </span><span><ix:nonNumeric id="d37371145e685-wk-Fact-4C86B40AD99EA73969D16781FB05D3C5" name="dei:EntityAddressPostalZipCode" contextRef="FD2019Q4YTD"><span style="font-size:9pt;font-weight:bold;">92121</span></ix:nonNumeric></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:9pt;">(Address of Principal Executive Offices, including area code)</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;"> (</span><span><ix:nonNumeric id="d37371145e698-wk-Fact-ABC7C113656C9FB6BE2D1C110D6EB76E" name="dei:CityAreaCode" contextRef="FD2019Q4YTD"><span style="font-size:9pt;font-weight:bold;">858</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:9pt;font-weight:bold;">)&#160;</span><span><ix:nonNumeric id="d37371145e703-wk-Fact-A90DAB94CD2B06B493401C11363DDA8D" name="dei:LocalPhoneNumber" contextRef="FD2019Q4YTD"><span style="font-size:9pt;font-weight:bold;">200-0200</span></ix:nonNumeric></span></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(Registrant&#8217;s Telephone Number, including area code) </span></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Securities registered pursuant to Section&#160;12(b) of the Exchange Act:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.75627240143369%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:42%;"></td><td style="width:16%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Title of Each Class</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Trading Symbol(s)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Name of Each Exchange on Which Registered</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span><ix:nonNumeric id="d37371145e742-wk-Fact-1511A9E342CE4C375CCD0F88D998E31C" name="dei:Security12bTitle" contextRef="FD2019Q4YTD">Common Stock, $0.001 Par Value Per Share</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span><ix:nonNumeric id="d37371145e747-wk-Fact-B05E29F818D7CA7DEA0A0F88F7638E5C" name="dei:TradingSymbol" contextRef="FD2019Q4YTD">DXCM</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span><ix:nonNumeric id="d37371145e752-wk-Fact-0EF06584DC36B43A133C0F89148D35D2" name="dei:SecurityExchangeName" contextRef="FD2019Q4YTD" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(Nasdaq Global Select Market)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Securities registered pursuant to Section&#160;12(g) of the Exchange Act: None</span></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37371145e778-wk-Fact-52F4F26C3DB3F4C890860F8F3CF46F6D" name="dei:EntityWellKnownSeasonedIssuer" contextRef="FD2019Q4YTD">Yes</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;">&#160;&#160;</span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9746;</span><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;No&#160;&#160; </span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9744;</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indicate by check mark if the Registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Exchange Act.</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Yes&#160;&#160;</span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9744;</span><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37371145e798-wk-Fact-A7E6ED9D4A106CC14D5A0F8F7422346C" name="dei:EntityVoluntaryFilers" contextRef="FD2019Q4YTD">No</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;">&#160;&#160; </span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9746;</span></div><div style="line-height:120%;padding-top:4px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the Registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.   </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37371145e807-wk-Fact-E44870D6E22F329A1B850F8FB6655421" name="dei:EntityCurrentReportingStatus" contextRef="FD2019Q4YTD">Yes</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;">&#160;&#160;</span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9746;</span><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;No&#160;&#160; </span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9744;</span></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37371145e820-wk-Fact-6CD28FA106906CF265320F8FF2C2E296" name="dei:EntityInteractiveDataCurrent" contextRef="FD2019Q4YTD">Yes</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;">&#160;&#160;</span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9746;</span><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;No&#160;&#160; </span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9744;</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-indent:30px;font-size:10pt;"><span><ix:nonNumeric id="d37371145e834-wk-Fact-C5F5768ED8E112F28A5A0F901DCB8F77" name="dei:EntityFilerCategory" contextRef="FD2019Q4YTD" format="ixt-sec:entityfilercategoryen"><span style="font-size:9pt;">Large accelerated filer</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:9pt;">&#160;</span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9746;</span><span style="font-family:inherit;font-size:9pt;">&#160;&#160;  Accelerated filer&#160;</span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9744;</span><span style="font-family:inherit;font-size:9pt;">&#160;&#160; Non-accelerated filer&#160;</span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9744;</span><span style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160; Smaller reporting company&#160;</span><span><ix:nonNumeric id="d37371145e851-wk-Fact-C363B45E268E96B47DBB0F9054FC5CD2" name="dei:EntitySmallBusiness" contextRef="FD2019Q4YTD" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:Wingdings;font-size:9pt;"> </span><span style="font-family:inherit;font-size:9pt;">Emerging growth company</span><span style="font-family:inherit;font-size:10pt;">&#160;</span><span><ix:nonNumeric id="d37371145e861-wk-Fact-0F94A2D94BE02808BBDA0F907FCE31E2" name="dei:EntityEmergingGrowthCompany" contextRef="FD2019Q4YTD" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:Wingdings;font-size:10pt;"> </span></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160; </span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9744;</span></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes&#160;</span><span><ix:nonNumeric id="d37371145e874-wk-Fact-EB5940767E979D7407DF0F8EE29F2863" name="dei:EntityShellCompany" contextRef="FD2019Q4YTD" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;No&#160;&#160; </span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9746;</span></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">June&#160;28, 2019</span><span style="font-family:inherit;font-size:10pt;">, the last business day of the Registrant&#8217;s most recently completed second fiscal quarter, the aggregate market value of the registrant&#8217;s common stock held by non-affiliates of the registrant was approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37371145e888-wk-Fact-F01D275506541F7A15A2EB34A852A5CC" name="dei:EntityPublicFloat" contextRef="I2019Q2Jun28" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13,556.6</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> based on the closing sales price of </span><span style="font-family:inherit;font-size:10pt;">$149.84</span><span style="font-family:inherit;font-size:10pt;"> per share as reported on the Nasdaq Global Select Market.</span></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date.</span></div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.75627240143369%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:49%;"></td><td style="width:3%;"></td><td style="width:48%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Class</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Outstanding at February 7, 2020</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Common stock, $0.001 par value per share</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span><ix:nonFraction id="d37371145e940-wk-Fact-5E8A04668C055F94BEB1A1ED583A9691" name="dei:EntityCommonStockSharesOutstanding" contextRef="I2020Q1Feb07" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">91,594,142</ix:nonFraction></span></span></div></td></tr></table></div></div><div><br/></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Portions of the Registrant&#8217;s definitive proxy statement relating to its </span><span style="font-family:inherit;font-size:10pt;">2020</span><span style="font-family:inherit;font-size:10pt;"> Annual Meeting of Stockholders (the Proxy Statement) are incorporated by reference in Part&#160;III, Items 10 through 14 of this Annual Report on Form 10-K, as specified in the responses to those item numbers. Except with respect to information specifically incorporated by reference in the Form 10-K, the Proxy Statement is not deemed to be filed as part hereof.</span></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div><br/></div><hr style="page-break-after:always"></hr><div><a id="sC3A8DB824D535821AD8C05BE08495661"></a></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">DexCom, Inc.</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #58a618;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Table of Contents</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:16%;"></td><td style="width:75%;"></td><td style="width:9%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Page</span></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">PART I</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;1.</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Business</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s394B35A74DC95653AEE4F947B4A475EB">3</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;1A.</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Risk Factors </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sB2B2A2FFB5AD59048087F45FF7556428">24</a></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;1B.</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Unresolved Staff Comments</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s5148CF436CD954FEA9B04D4D60A8B424">57</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;2.</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Properties</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s903B427E80075861AE918E170E37E4AF">58</a></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;3.</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Legal Proceedings</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sD537126CD9165A08A9C65F5A611C206F">58</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;4.</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Mine Safety Disclosures</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sC64C48DCFD5D50B28B960A1753D33379">59</a></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">PART&#160;II </span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;5.</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sA8EC57ACEC355957A9CA1FE862822632">60</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;6.</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Selected Financial Data</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sDAEECAAB8B86591391F01122DB44A6A6">62</a></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;7.</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sC3A902C4DAC35550A0BE7005FFA5DC34">63</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;7A.</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Quantitative and Qualitative Disclosures about Market Risk</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s7793CC0CECA051959268354C52BE01F6">72</a></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;8.</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Consolidated Financial Statements and Supplementary Data</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s2243A5FC435652FDB211483B996DF071">73</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;9.</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s0420A6987E7C5A44BC135B263CFAFA0F">73</a></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;9A.</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Controls and Procedures</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s05B0AA515D805DE69D07EDB45A5709E2">73</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;9B.</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Other Information</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s5C4ADD9F0F5058379C3DC991B985B8B1">76</a></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">PART&#160;III</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;10.</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Directors, Executive Officers and Corporate Governance</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s007EADF423D85A59A15561782B2B361B">76</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;11.</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Executive Compensation</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sDE0C49E35FF658F1BA3FD25597E1D08C">76</a></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;12.</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sC0AA1D3BCDA35F3A839C41A2BEBE1A95">76</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;13.</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Certain Relationships and Related Transactions, and Director Independence</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sB8B5251623995FB595E71F7D2D35E43C">76</a></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;14.</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Principal Accountant Fees and Services</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sE12AB1B2DA55597E83FE9964C4A3E1A5">76</a></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">PART IV</span></div></td></tr><tr><td style="vertical-align:top;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM&#160;15.</span></div></td><td style="vertical-align:top;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Exhibits, Financial Statement Schedules</span></div></td><td style="vertical-align:top;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#s4D522FBEBB255F0A9D97052D6D9F5DEA">77</a></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">ITEM 16.</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Form 10-K Summary</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;" href="#sE75A667AD6D15EF9A70E878B597AACD6">80</a></div></td></tr></table></div></div><div><br/></div><hr style="page-break-after:always"></hr><div><a id="sCC41A12F3882577A9F8ABB18704C99A0"></a></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Except for historical financial information contained herein, the matters discussed in this Form 10-K may be considered forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended, and subject to the safe harbor created by the Securities Litigation Reform Act of 1995. Such statements include declarations regarding our intent, belief, or current expectations and those of our management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve a number of risks, uncertainties and other factors, some of which are beyond our control; actual results could differ materially from those indicated by such forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, but are not limited to: (i)&#160;that the information is of a preliminary nature and may be subject to further adjustment; (ii)&#160;those risks and uncertainties identified under &#8220;Risk Factors&#8221;; and (iii)&#160;the other risks detailed from time-to-time in our reports and registration statements filed with the Securities and Exchange Commission, or SEC. Except as required by law, we undertake no obligation to revise or update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">PART I </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><a id="s394B35A74DC95653AEE4F947B4A475EB"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:84px;text-indent:-84px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Item 1 - BUSINESS</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Overview</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for use by people with diabetes and by healthcare providers. We received approval from the United States (U.S.) Food and Drug Administration, or FDA, and commercialized our first product in 2006. We launched our latest generation system, the DexCom G6</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></span><span style="font-family:inherit;font-size:10pt;"> integrated Continuous Glucose Monitoring System, or G6, in 2018. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;DexCom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Products</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">DexCom G6</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup>&#160;</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2018, we obtained marketing authorization from the FDA for the G6 via the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</span><span style="font-family:inherit;font-size:10pt;"> process. The G6 is the first type of CGM system permitted by the FDA to be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. G6 and substantially equivalent devices of this generic type that may later receive marketing authorization are referred to as integrated continuous glucose monitoring systems, or iCGMs, and have been classified as Class II devices by the FDA. Along with this classification, the FDA established criteria, called special controls, which outline requirements for assuring CGM accuracy, reliability and clinical relevance, and which also describe the type of studies and data required to demonstrate acceptable CGM performance. The G6 is designed to allow our transmitter to run an algorithm to generate a glucose value and to communicate directly to a patient&#8217;s compatible mobile device, including iPhone</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></span><span style="font-family:inherit;font-size:10pt;">, iPod touch</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></span><span style="font-family:inherit;font-size:10pt;">, iPad</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></span><span style="font-family:inherit;font-size:10pt;">, and certain Android</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></span><span style="font-family:inherit;font-size:10pt;"> mobile devices. A patient&#8217;s glucose data can also be displayed on wearable devices, like the Apple Watch</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></span><span style="font-family:inherit;font-size:10pt;"> and Wear OS by Google devices. The G6 transmitter has a labeled useful life of three months. Data from the G6 can be integrated with DexCom CLARITY</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></span><span style="font-family:inherit;font-size:10pt;">, our cloud-based reporting software, for personalized, easy-to-understand analysis of trends that may improve diabetes management. In the United States, the G6 is covered by Medicare as well as those commercial insurers that reimburse for the DexCom G5 Mobile Continuous Glucose Monitoring System, subject to satisfaction of certain eligibility and coverage criteria. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2018, we received Conformit&#233; Europ&#233;enne Marking, or CE Mark, approval for the G6, which allows us to market the system in the European Union and the countries in Asia and Latin America that recognize the CE Mark, as well as New Zealand, though certain countries may require compliance with certain local administrative requirements and/or additional marketing authorizations (for example, the inclusion of medical devices on the Australian Register of Therapeutic Goods in Australia).</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In October 2019, we also received marketing authorization from the FDA for the DexCom G6 Pro, or G6 Pro, which allows healthcare professionals to purchase the G6 for use with their patients. The G6 Pro has many of same features as the G6 and is intended for healthcare professionals to use with their patients ages two years and up. The G6 Pro may be used in a blinded or unblinded mode for up to 10 days.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">3</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the G6, the sensor is inserted by the user and is intended to be used continuously for up to 10 days, after which it may be replaced with a new disposable sensor. Our transmitter is reusable until it reaches the end of its use life. Our receiver is also reusable. As we establish an installed base of customers using our products, we expect to generate an increasing portion of our revenues through recurring sales of our disposable sensors.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The G6 carries forward important features of prior generation DexCom CGM systems:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Continuous glucose readings.</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> </span><span style="font-family:inherit;font-size:10pt;">Automatically sends glucose readings to a DexCom receiver or compatible mobile device every five minutes.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Mobile app and sharing.</span><span style="font-family:inherit;font-size:10pt;"> Compatibility with mobile device applications allows for sharing glucose information with other people for added support and care coordination.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Customizable alarms and alerts.</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> </span><span style="font-family:inherit;font-size:10pt;">Personalized alert schedule immediately warns the user of pending dangerous high and low blood sugars.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The G6 also has a number of new or improved features compared to our prior generation devices:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Finger stick elimination.</span><span style="font-family:inherit;font-size:10pt;"> No finger sticks are needed for calibration or diabetes treatment decisions, consistent with the instructions for use.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Easy sensor application.</span><span style="font-family:inherit;font-size:10pt;"> Complete redesign of the sensor applicator allows for one-touch, simple self-insertion.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Discreet and low profile.</span><span style="font-family:inherit;font-size:10pt;"> A redesigned transmitter with a 28% lower profile than the previous generation DexCom CGM system makes the device comfortable and easy to wear under clothing.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Medication blocking.</span><span style="font-family:inherit;font-size:10pt;"> New feature allows for more accurate glucose readings without interference from common medications taken at typical indication doses, such as acetaminophen.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Predictive low alert.</span><span style="font-family:inherit;font-size:10pt;"> New alert feature intended to predict hypoglycemia before it hits to help avoid dangerous low blood sugar events.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Extended 10-day sensor.</span><span style="font-family:inherit;font-size:10pt;"> Up to 10-day sensor use allows for 43% longer wear than previous generation DexCom CGM systems.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other than with respect to the foregoing, the G6 is equivalent to our prior generation CGM systems in its technical capabilities and its indications. Since the G6 is classified by the FDA as a Class II device, it is subject to special controls and modifications of, or revisions to, the device may be made under the 510(k) process.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">DexCom G5</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Mobile</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2015, we received approval from the FDA for the DexCom G5 Mobile Continuous Glucose Monitoring System, also referred to as the G5 Mobile. The G5 Mobile is designed to allow our transmitter to run the Software 505 algorithm, and to communicate directly to a patient&#8217;s compatible mobile device, including iPhone, iPod touch, iPad, and certain Android mobile devices. The G5 Mobile transmitter has a labeled useful life of three months. Data from the G5 Mobile can be integrated with DexCom CLARITY. In September 2015, we launched the G5 Mobile in certain countries in Europe.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Similar to the G6, the disposable sensor is inserted by the user and is intended to be used continuously for up to seven days, after which it may be replaced with a new sensor. The related transmitter is reusable until it reaches the end of its use life, and the related receiver is also reusable. In December 2016, the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> approved the G5 Mobile as the first CGM system in the United States to have a non-adjunctive indication. The non-adjunctive indication expands the lawfully permitted use of the G5 Mobile as a replacement to finger stick glucose testing for diabetes treatment decisions. With the new label indication, the G5 Mobile only requires two finger sticks per day for calibration. In the countries and regions outside of the United States that recognize the CE Mark, as well as the United States and Canada, the G5 Mobile also does not require confirmatory finger sticks when making treatment decisions, although a minimum of two finger sticks a day remain necessary for calibration. Approval of the non-adjunctive indication was also an important and necessary step in enabling people with Medicare to access CGM. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Except with respect to the foregoing, the G5 Mobile is functionally equivalent to our earlier generation CGM systems in its technical capabilities and its regulatory requirements and indications.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">DexCom G4</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> PLATINUM</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The DexCom G4 PLATINUM CGM system, or G4 PLATINUM, replaced our DexCom SEVEN PLUS system beginning in 2012, when it was approved for up to seven days of continuous use by adults with diabetes. Since 2012, we have marketed the G4 PLATINUM under a CE Mark in the European Union, the countries in Asia and Latin America that recognize the CE Mark, New Zealand and Australia, and in the United States with approval from the FDA. We received approvals for a pediatric indication under the CE Mark in February 2013 and from the FDA in February 2014, enabling us to market and sell this system to persons two years old and older who have diabetes. In June 2014, we received approval from the FDA for an expanded indication for the G4 PLATINUM for professional use, which allows healthcare professionals to purchase the G4 PLATINUM system for use with multiple patients. Healthcare professionals can use the insights gained from a G4 PLATINUM professional </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">session to adjust therapy and to educate and motivate patients to modify their behavior after viewing the effects that specific foods, exercise, stress and medications have on their glucose levels. In October 2014, we launched our Software 505 algorithm for the G4 PLATINUM, an algorithm which enabled our systems to achieve a single digit MARD, a measure of the accuracy of continuous glucose monitoring. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">DexCom Share</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup>&#160;</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In 2015, we received approval from the FDA for the G4 PLATINUM with DexCom Share, or Share, and began commercializing this product in the United States in the first quarter of 2015 using a secure wireless connection between a patient&#8217;s G4 PLATINUM receiver and an app. We now offer this feature through the G6 and the G5 Mobile apps as well as the Share2 app, which works with the G4 PLATINUM receiver with Share. The Share remote monitoring system uses an app on the patient&#8217;s iPhone, iPod touch, iPad or Android mobile device to transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, or &#8220;followers,&#8221; who can remotely monitor a patient&#8217;s glucose information and receive alert notifications anywhere they have an Internet or cellular connection. A patient&#8217;s glucose data can also be displayed on a patient&#8217;s or follower&#8217;s wearable device, such as the Apple Watch and Wear OS by Google devices, when used in conjunction with the patient&#8217;s or follower&#8217;s iPhone or Android mobile device.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Data and Insulin Delivery Collaborations</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have entered into multiple collaboration agreements that leverage our technology platform to integrate our CGM products with insulin delivery systems. The general purpose of these development and commercial relationships is to integrate our technology into the insulin pump or pen product offerings of the respective partner, enabling the partner&#8217;s insulin delivery device to receive and display glucose readings from our transmitter and, in some cases, use the glucose readings for semi-automated insulin delivery. Currently, we have announced significant insulin delivery partnerships with Eli Lilly, Insulet, Novo Nordisk and Tandem Diabetes. In addition to these major partners, we are working with other companies that are pursuing varying strategies surrounding semi-automated insulin delivery and data analytics to improve outcomes and ease-of-use in diabetes management. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Verily Collaboration</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On November 20, 2018, we entered into an Amended and Restated Collaboration and License Agreement with Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited (collectively, Verily), which we refer to as the Restated Collaboration Agreement. This replaced our original Collaboration and License Agreement with Verily from August 2015, as amended in October 2016, and eliminated any future royalty obligations under the original agreement. Pursuant to the Restated Collaboration Agreement, we and Verily have agreed to continue to jointly develop a certain next-generation CGM product, and potentially one or more additional CGM products, for which we will have exclusive commercialization rights. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Restated Collaboration Agreement also provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#8217;s other intellectual property rights to develop, manufacture, and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities. The Restated Collaboration Agreement requires us to use commercially reasonable efforts to develop, launch, and commercialize the CGM product(s) that are the subject of the collaboration according to certain timing and other objectives, and provides for one executive sponsor from each of us and Verily to meet periodically and make decisions related to the collaboration (within a limited scope of authority) by consensus.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In consideration of Verily&#8217;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we have made upfront and incentive payments, and will make potential future milestone payments upon the achievement of certain goals, as follows:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On December 28, 2018, we made an initial payment of $250.0 million in shares of our common stock, calculated under the Restated Collaboration Agreement to be 1,840,943 shares of our common stock, allocated between Verily and Onduo, LLC, subject to certain transfer restrictions.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During 2019, we paid </span><span style="font-family:inherit;font-size:10pt;">$3.2 million</span><span style="font-family:inherit;font-size:10pt;"> for the completion of certain development obligations before the agreed-upon deadline.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additional milestone payments of up to </span><span style="font-family:inherit;font-size:10pt;">$275.0 million</span><span style="font-family:inherit;font-size:10pt;"> may become due and payable by us upon the achievement of future product regulatory approval and revenue milestones. At our election, we may make these milestone payments in shares of our common stock, also allocated between Verily and Onduo, LLC, with the number of shares being calculated based on the same share value that was used for purposes of the initial payment, adjusted for stock splits, dividends, and the like, subject to customary closing conditions, including any required antitrust approvals applicable to the issuance of such shares. Alternatively, at our election, we may make any of these milestone payments in cash. Any such cash </span></div></td></tr></table><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">5</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-left:40px;padding-bottom:4px;padding-top:4px;text-align:left;"><span style="font-family:inherit;font-size:10pt;">payment would be equal to the number of shares that would otherwise be issued for the given milestone payment (calculated as described above) multiplied by the value of our stock on the date the relevant milestone is achieved, adjusted for stock splits, dividends, and the like.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Future Products</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We plan to develop future generations of technologies focused on improved performance and convenience and that will enable intelligent insulin administration. We are also exploring how to extend our offerings to other opportunities, including for people with Type 2 diabetes that are non-insulin using, people with pre-diabetes, people who are obese, people who are pregnant, and people in the hospital setting. We will continue to develop a networked platform with open architecture, connectivity and transmitters capable of communicating with other devices and software systems. We also intend to expand our efforts to accumulate CGM patient data and metrics and apply predictive modeling and machine learning to generate interactive CGM insights that can inform patient behavior. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Background</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diabetes is a disease with significant adverse consequences for human health throughout the world. The </span><span style="font-family:inherit;font-size:10pt;">International Diabetes Federation, or IDF</span><span style="font-family:inherit;font-size:10pt;">, estimates that in 2019, 463&#160;million adults (aged 20-79) around the world had diabetes, including 31 million in the United States. </span><span style="font-family:inherit;font-size:10pt;">IDF</span><span style="font-family:inherit;font-size:10pt;"> estimates that by 2045, the worldwide incidence of people suffering from diabetes will reach 700 million. According to the Centers for Disease Control and Prevention&#8217;s National Vital Statistics Reports for 2017, diabetes was the seventh leading cause of death by disease in the United States, excluding comorbidities associated with the disease. According to the Congressional Diabetes Caucus website, diabetes is the leading cause of kidney failure, adult-onset blindness, lower-limb amputations, and a significant cause of heart disease, stroke, high blood pressure and nerve damage. According to the </span><span style="font-family:inherit;font-size:10pt;">IDF</span><span style="font-family:inherit;font-size:10pt;">, there were an estimated 4.2&#160;million deaths attributable to diabetes globally in 2019 between the ages of 20 and 79 years. The </span><span style="font-family:inherit;font-size:10pt;">American Diabetes Association, or ADA</span><span style="font-family:inherit;font-size:10pt;">, Fast Facts, revised in August 2017, states that diabetes is the primary cause of death for more than 80,000 Americans each year, and contributes to the death of more than 250,000 Americans annually. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Among people of all ages, 2017 data indicated the following: An estimated 24.7 million people or 7.6% of the U.S. population had been diagnosed with diabetes. In addition to those newly diagnosed, the Congressional Diabetes Caucus website reports that every 24 hours there are: 238 amputations in people with diabetes, 120 people who enter end-stage kidney disease programs, and 48 people who go blind.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">According to the </span><span style="font-family:inherit;font-size:10pt;">ADA</span><span style="font-family:inherit;font-size:10pt;">, one in every four healthcare dollars was spent on treating people with diabetes in 2017, and the direct medical costs and indirect expenditures attributable to diabetes in the United States were an estimated $327 billion, an inflation-adjusted increase of approximately 26% since 2012. Of the $327 billion in overall expenses, the </span><span style="font-family:inherit;font-size:10pt;">ADA</span><span style="font-family:inherit;font-size:10pt;"> estimated that approximately $237 billion were direct costs associated with diabetes care, chronic complications and excess general medical costs, and $90 billion were indirect costs. The </span><span style="font-family:inherit;font-size:10pt;">ADA</span><span style="font-family:inherit;font-size:10pt;"> also found that in 2017, average medical expenditures among people with diagnosed diabetes were 2.3 times higher than for people without diabetes. According to the </span><span style="font-family:inherit;font-size:10pt;">IDF</span><span style="font-family:inherit;font-size:10pt;">, 2017 expenditures attributable to diabetes were estimated to be $760 billion globally. The </span><span style="font-family:inherit;font-size:10pt;">IDF</span><span style="font-family:inherit;font-size:10pt;"> estimates that expenditures attributable to diabetes will grow to $845 billion globally by 2045. </span></div><div style="line-height:174%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Continuous Glucose Monitoring</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We believe continuous glucose monitoring has the potential to enable more people with diabetes to achieve and sustain tight glycemic control with minimal disruption to their daily lives. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The landmark 1993 </span><span style="font-family:inherit;font-size:10pt;">Diabetes Control and Complications Trial</span><span style="font-family:inherit;font-size:10pt;">, or DCCT, demonstrated that improving blood glucose control lowers the risk of developing diabetes-related complications by up to 50%. The study also demonstrated that people with Type 1 diabetes achieved sustained benefits with intensive management. However, according to an article published in </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">The New England Journal of Medicine</span><span style="font-family:inherit;font-size:10pt;"> in November 2014, in two national registries, only 13% to 15% of people with diabetes met treatment guidelines for good glycemic control, and more than 20% had very poor glycemic control.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Various clinical studies and real world evidence also demonstrate the benefits of continuous glucose monitoring in the management of Type 1 diabetes and insulin-requiring Type-2 diabetes, when compared to regimens relying on self-monitoring of blood glucose. Results of several early clinical trials established that CGM usage was associated with improved glycemic outcomes. For instance, a </span><span style="font-family:inherit;font-size:10pt;">Juvenile Diabetes Research Foundation, or JDRF</span><span style="font-family:inherit;font-size:10pt;">, study published in the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">New England Journal of Medicine</span><span style="font-family:inherit;font-size:10pt;"> in 2008, and the extension phase of the study, published in </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Diabetes Care</span><span style="font-family:inherit;font-size:10pt;"> in 2009, demonstrated that continuous glucose monitoring improved A1c levels and reduced incidence of hypoglycemia for patients over the age of 25 and for all patients of all ages who utilized continuous glucose monitoring regularly. In 2016, the first randomized, controlled study focusing solely on the benefit of continuous glucose monitoring for diabetes patients using multiple daily injections insulin therapy showed DexCom CGM system users on multiple daily injections of insulin therapy achieved a one percent average A1c reduction after 24 weeks of regular use, compared to their baseline. Study participants also increased time spent in their target </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">6</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A1c range and spent less time in hypoglycemia and hyperglycemia when they used a DexCom CGM system compared to those who used only a standard blood glucose meter to monitor their glucose. This DIaMonD (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) study is the first-of-its-kind in demonstrating the impact of CGM only, without insulin pumps or other therapeutic interventions, on A1c and hypoglycemia in participants using a multiple daily injection insulin regimen. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Real-time alerts and multi-device integration further differentiate CGM-based and self-monitoring of blood glucose, or SMBG, based diabetes regimens. Alerts triggered by existing or impending abnormal glucose values are associated with less exposure to hypo- and hyperglycemia in large real-world data sets, and multi-device integration allows some CGM systems to communicate with automated insulin delivery systems. One such automated insulin delivery system that uses the G6 was studied in a large clinical trial that associated its use with numerous quality-of-life and glycemic benefits. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In late 2019, the ADA, in its Standards of Medical Care in Diabetes, recognized CGM as a useful tool in diabetes management, citing level &#8220;A&#8221; evidence in Type 1 diabetes and level &#8220;B&#8221; evidence in Type 2 diabetes and pregnancy. The ADA recommends continued access and use &#8220;as close to daily as possible&#8221; for maximal benefit. We believe Dexcom&#8217;s CGM technology contributes to better glycemic outcomes and improved quality of life by allowing informed diabetes treatment decisions.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A 2019 white paper from IQVIA also outlines the potential benefit offered by use of CGM systems, suggesting that increasing time-in-range to industry standards for Type 1 and Type 2 insulin-using patients would result in significant cost savings to the economic system and the prevention of major complications.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our current target market consists primarily of people with Type 1 and Type 2 diabetes who utilize insulin pump therapy or who utilize multiple daily insulin injections. We continue to target people with Type 2 diabetes on multiple daily injection therapy and expect to expand our target market to include all people with diabetes, people with pre-diabetes, people who are obese, people who are pregnant, and people with diabetes in the hospital setting. Although the majority of our revenue has been generated in the United States, we have expanded our operations to include </span><span style="font-family:inherit;font-size:10pt;">certain countries in Africa, Asia, Europe, Latin America, and the Middle East, as well as Australia, Canada, and New Zealand</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Commercial Operations</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have built a direct sales organization in the United States, Canada and certain countries in Europe to call on healthcare professionals, including endocrinologists, physicians and diabetes educators, who can educate and influence patient adoption of continuous glucose monitoring. We believe that focusing efforts on these participants is important given the instrumental role they each play in the decision-making process for diabetes therapy. To complement our direct sales efforts, we have entered into distribution arrangements in the United States and internationally that allow distributors to sell our products. We believe our direct, highly specialized and focused sales organization and our domestic and international distribution agreements are sufficient for us to support our sales efforts for at least the next twelve months.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Product revenues are generated from the sale of our CGM systems through a direct sales force in the </span><span style="font-family:inherit;font-size:10pt;">United States, Austria, Canada, Germany, Switzerland and the United Kingdom</span><span style="font-family:inherit;font-size:10pt;"> as well as through distribution arrangements in the United States, </span><span style="font-family:inherit;font-size:10pt;">Australia and New Zealand, and certain countries in Africa, Asia, Europe, Latin America, and the Middle East</span><span style="font-family:inherit;font-size:10pt;">.</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.51656920077973%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Market Opportunity</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Diabetes</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diabetes is a chronic, life-threatening disease for which there is no known cure. The disease is caused by the body&#8217;s inability to produce or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. Glucose, the primary source of energy for cells, must be maintained at certain concentrations in the blood in order to permit optimal cell function and health. Normally, the pancreas provides control of blood glucose levels by secreting the hormone insulin to decrease blood glucose levels when concentrations are too high. In people with diabetes, the body does not produce sufficient levels of insulin, or fails to utilize insulin effectively, causing blood glucose levels to rise above normal. This condition is called hyperglycemia and often results in acute complications as well as chronic long-term complications such as heart disease, limb amputations, loss of kidney function and blindness. When blood glucose levels are high, people with diabetes often administer insulin in an effort to decrease blood glucose levels. Unfortunately, insulin administration can drive blood glucose levels below the normal range, resulting in hypoglycemia. In cases of severe hypoglycemia, people with diabetes risk acute complications, such as loss of consciousness or death. Due to the drastic nature of acute complications associated with hypoglycemia, many people with diabetes are reluctant to reduce blood glucose levels. Consequently, these individuals often remain in a hyperglycemic state, increasing their odds of developing long-term chronic complications. Diabetes is typically classified into two major groups: Type 1 and Type 2.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">7</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Type 1 Diabetes</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">According to the ADA, as of 2017 there were an estimated 1.3 million people with Type 1 diabetes in the United States. Type 1 diabetes is an autoimmune disorder that usually develops during childhood and is characterized by an absence of insulin, resulting from destruction of the insulin producing cells of the pancreas. Individuals with Type&#160;1 diabetes must rely on frequent insulin injections in order to regulate and maintain blood glucose levels. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">According to JDRF, 40,000 people are diagnosed with Type 1 diabetes each year in the United States and between the years 2001 and 2009 there was a 21% increase in the prevalence of Type 1 diabetes in people under the age of 20. In addition, according to the ADA in 2019, nearly 18,000 youth are newly diagnosed with Type 1 diabetes every year in the United States.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Type 2 Diabetes</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">According to the ADA, in 2012 there were approximately 27.8 million people in the United States with Type 2 diabetes. Type 2 diabetes is a metabolic disorder which results when the body is unable to produce sufficient amounts of insulin or becomes insulin resistant. Depending on the severity of Type 2 diabetes, individuals may require diet and nutrition management, exercise, oral medications or insulin injections to regulate blood glucose levels. We estimate that approximately 6.0&#160;million Type 2 patients must use insulin to manage their diabetes.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Type 2 diabetes is occurring with increasing frequency in young people, with the increase in prevalence related to an increase in obesity amongst children. According to the Centers for Disease Control and Prevention, as of 2016, approximately 18.5% of children and adolescents aged 2-19 years, or 13.7 million children, in the United States were obese. Childhood obesity has more than doubled in children and quadrupled in adolescents in the past 30 years.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Diabetes and Glucose Management in the Hospital Setting</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There are various subgroups of people with diabetes, including in-hospital patients, who present significant management challenges. According to the ADA, diabetes-related inpatient hospitalizations totaled 40.3&#160;million days and 22.2 million outpatient visits in 2017, with outpatient visits increasing 48% since 2012. Additionally, market research shows that over 1.6&#160;million patients are admitted with hyperglycemia prior to elective surgery, which results in delays and increased length of stay. Once admitted, studies conducted by </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Hospital Health Network </span><span style="font-family:inherit;font-size:10pt;">in 2013 and AACE in 2011 suggest that approximately 28% of patients experience hyperglycemia and 5% of patients experience hypoglycemia, both of which are preventable. After discharge, patients who experienced hyperglycemia or hypoglycemia in the hospital have a higher rate of readmission within 30 days. Approximately 30% of all health care expenditures incurred by people with diabetes come from higher rates of hospital admission and longer average lengths of stay per admission, constituting the single largest contributor to the medical cost of diabetes. Of the $486 billion in national expenditures for hospital inpatient care in 2017, approximately $123 billion is incurred by people who have diabetes, of which $70 billion is directly attributed to their diabetes.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Importance of Glucose Monitoring</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Blood glucose levels can be affected by many factors, including the carbohydrate and fat content of meals, exercise, stress, illness or impending illness, hormonal releases, variability in insulin absorption and changes in the effects of insulin in the body. Given the many factors that affect blood glucose levels, maintaining glucose within a normal range is difficult, resulting in frequent and unpredictable excursions above or below normal blood glucose levels. People with diabetes administer insulin or ingest carbohydrates throughout the day in order to maintain blood glucose levels within normal ranges. People with diabetes frequently overcorrect and fluctuate between hyperglycemic and hypoglycemic states, often multiple times during the same day. As a result, many people with diabetes are routinely outside the normal blood glucose range. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In an attempt to maintain blood glucose levels within the normal range, people with diabetes must first measure their blood glucose levels. Often, after measuring their blood glucose levels, people with diabetes make therapeutic adjustments. As adjustments are made, additional blood glucose measurements may be necessary to gauge the individual&#8217;s response to the adjustments. More frequent testing of blood glucose levels provides people with diabetes with information that can be used to better understand and manage their diabetes. The ADA recommends that most people with Type 1 diabetes test their blood glucose levels at least three or more times per day, and that significantly more frequent testing may be required to reach A1c targets safely without hypoglycemia.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Clinical outcomes data support the notion that an important component of effective diabetes management is frequent monitoring of blood glucose levels. The landmark 1993 DCCT consisting of patients with Type 1 diabetes, and the 1998 UK Prospective Diabetes Study, consisting of patients with Type 2 diabetes, demonstrated that people with diabetes who intensively managed their blood glucose levels delayed the onset and slowed the progression of diabetes-related complications. The DCCT demonstrated that intensive management reduced the risk of complications by 76% for eye disease, 60% for nerve disease and 50% for kidney disease, but also found that it led to a three-fold increase in the frequency of hypoglycemic events. In the December 2005 edition of the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">New England Journal of Medicine</span><span style="font-family:inherit;font-size:10pt;">, the authors of a peer-reviewed study concluded that intensive diabetes therapy has long-term beneficial effects on the risk of cardiovascular disease in patients with Type 1 diabetes. The </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">8</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">study showed that intensive diabetes therapy reduced the risk of cardiovascular disease by 42% and the risk of non-fatal heart attack, stroke or death from cardiovascular disease by 57%.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Limitations of Existing Glucose Monitoring Products</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Single-point finger stick devices are the most prevalent devices for glucose monitoring. These devices require taking a blood sample with a finger stick, placing a drop of blood on a test strip and inserting the strip into a glucose meter that yields a single point in time blood glucose measurement. We believe that these devices suffer from several limitations, including:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Limited Information.</span><span style="font-family:inherit;font-size:10pt;"> Even if people with diabetes test several times each day, each measurement represents a single blood glucose value at a single point in time. Given the many factors that can affect blood glucose levels, excursions above and below the normal range often occur between these discrete measurement points in time. Without the ability to determine whether their blood glucose level is rising, falling or holding constant, and the rate at which their blood glucose level is changing, the individual&#8217;s ability to effectively manage and maintain blood glucose levels within normal ranges is severely limited. Further, people with diabetes cannot test themselves during sleep, when the risk of hypoglycemia is significantly increased.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:40px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following graph shows the limited information provided by four single-point measurements during a single day using a traditional single-point finger stick device, compared to the data provided by our continuous sensor. The data presented in the graph is from a clinical trial we completed in 2003 with a CGM system, where the patient was blinded to the continuous glucose data. The continuous data indicates that, even with four finger sticks in one day, the patient&#8217;s blood glucose levels were above the target range of 80-140 milligrams per deciliter (&#8220;mg/dl&#8221;) for a period of 13.5 hours. </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Single Day Continuous Data</span></div><div style="line-height:120%;padding-top:12px;text-align:center;"><img src="singledaydataa05.jpg" alt="singledaydataa05.jpg" style="height:368px;width:584px;"></img></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Inconvenience.</span><span style="font-family:inherit;font-size:10pt;"> The process of measuring blood glucose levels with single-point finger stick devices can cause significant disruption in the daily activities of people with diabetes and their families. People with diabetes using single-point finger stick devices must stop whatever they are doing several times per day, self-inflict a painful prick and draw blood to measure blood glucose levels. To do so, people with diabetes must always carry a fully supplied kit that may include a spring-loaded needle, or lancet, disposable test strips, cleansing wipes and the meter, and then safely dispose of the used supplies. This process is inconvenient and may cause uneasiness in social situations.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Difficulty of Use.</span><span style="font-family:inherit;font-size:10pt;"> To obtain a sample with single-point finger stick devices, people with diabetes generally prick one of their fingertips or, occasionally, a forearm with a lancet. They then squeeze the area to produce the blood sample and another prick may be required if a sufficient volume of blood is not obtained the first time. The blood sample is then placed on a disposable test strip that is inserted into a blood glucose meter. This task can be difficult for individuals with decreased tactile sensation and visual acuity, which are common complications of diabetes.</span></div></td></tr></table><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">9</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Pain.</span><span style="font-family:inherit;font-size:10pt;"> Although the fingertips are rich in blood flow and provide a good site to obtain a blood sample, they are also densely populated with highly sensitive nerve endings. This makes the lancing and subsequent manipulation of the finger to draw blood painful. The pain and discomfort are compounded by the fact that fingers offer limited surface area, so tests are often performed on areas that are sore from prior tests. People with diabetes may also suffer pain when the finger prick site is disturbed during regular activities.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">The DexCom Solution</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our G4 PLATINUM, G5 Mobile and G6 systems offer the following advantages to people with diabetes:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Improved Outcomes.</span><span style="font-family:inherit;font-size:10pt;"> Results of a major multicenter clinical trial funded by the JDRF demonstrated that patients with Type 1 diabetes who used continuous glucose monitoring devices to help manage their disease experienced significant improvements in glucose control. Data published in a peer-reviewed article based on the pivotal trial for our first-generation system demonstrated that patients using the system showed statistically significant improvements in glucose levels within the target range when compared to patients relying solely on single-point finger stick measurements. Additional peer-reviewed published data has demonstrated that patients with access to seven days of continuous glucose data statistically improved glucose control by further increasing their time spent with glucose levels in the target range, thereby reducing time spent in both hyperglycemic and hypoglycemic ranges. Finally, peer reviewed data published from the DIaMonD study demonstrated that DexCom CGM system users on multiple daily injection insulin regimen achieved a one percent average reduction in hemoglobin A1c levels, a measure of the average amount of glucose in the blood over the prior three months, after 24 weeks of regular use, compared to their baseline. Study participants also increased time spent in their target A1c range and spent less time in hypoglycemia and hyperglycemia when they used a DexCom CGM system compared to those who used only a standard blood glucose meter to monitor their glucose.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Access to Real-Time Values, Trend Information and Alerts.</span><span style="font-family:inherit;font-size:10pt;"> At their fingertips, people with diabetes can view their current glucose value, along with a graphical display of the historical trend information on our receiver or alternate display device. Without continuous monitoring, the individual is often unaware if his or her glucose is rising, declining or remaining constant. Access to continuous real-time glucose measurements provides people with diabetes information that may aid in attaining better glucose control. Additionally, our G4 PLATINUM, G5 Mobile and G6 systems alert people with diabetes when their glucose levels approach inappropriately high or low levels so that they may intervene.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Intuitive User Interface.</span><span style="font-family:inherit;font-size:10pt;"> We have developed a user interface that we believe is intuitive and easy to use. The G5 Mobile and G6 receiver are compact with an easy-to-read color display, simple navigation tools, audible alerts and graphical display of trend information. Similar benefits are available via the interfaces we have made available on compatible mobile devices. These devices can serve as substitutes for our receivers or alternate display units in certain geographies.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Convenience and Comfort.</span><span style="font-family:inherit;font-size:10pt;"> Our G4 PLATINUM, G5 Mobile and G6 systems provide people with diabetes with the benefits of continuous monitoring, without having to perform finger stick tests for every measurement. Additionally, the disposable sensor that is inserted under the skin is a very thin wire, minimizing potential discomfort associated with inserting or wearing the disposable sensor. The external portion of the sensor, attached to the transmitter, is small, has a low profile and is designed to be easily worn under clothing. The wireless receiver is the size of a small smart phone and can be carried discreetly in a pocket or purse. We believe that convenience is an important factor in achieving widespread adoption of a CGM system.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Connectivity to Wearables and Others. </span><span style="font-family:inherit;font-size:10pt;">Patients can monitor their glucose levels and trends on compatible wearable devices, such as Apple Watch and Wear OS by Google devices, when used with a compatible mobile device. Also, our Share remote monitoring systems enable users of our G4 PLATINUM with Share, G5 Mobile and G6 systems to have their sensor glucose information remotely monitored by their family, friends or designated recipient, or follower, by wirelessly transmitting data from the user&#8217;s smart phone to the cloud and then to the follower&#8217;s mobile device. Several followers can remotely monitor a patient&#8217;s glucose information and receive secondary alert notifications from almost anywhere with an Internet connection via each follower&#8217;s mobile device.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">While we believe the G4 PLATINUM, G5 Mobile and G6 systems offer these advantages, people with diabetes may not perceive the benefits of continuous glucose monitoring and may be unwilling to change their current treatment regimens. Furthermore, our G4 PLATINUM, G5 Mobile and G6 systems are only available by prescription in the United States and may not appeal to all types of people with diabetes. Many international jurisdictions do not require a prescription for the dispensing of a specific device to a patient, however, the device must have received necessary regulatory approvals (e.g., Australia, Singapore and Germany). In the United Kingdom and Germany, CGMs and most related supplies do not require a prescription to purchase; however, a prescription is required for coverage. The G4 PLATINUM and G5 Mobile systems prompt the user to replace the sensor no later than the seventh day, and the G6 prompts the user to replace the sensor no later than the tenth day. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The G4 PLATINUM is not indicated as a replacement device for single-point finger stick devices in the United States, must be calibrated initially using measurements from two single-point finger stick tests and thereafter at least every 12 hours </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">using single-point finger stick tests, and may be more costly to use than other glucose measurement devices. In the United States, Canada and the countries and regions outside of the United States that recognize the CE Mark, our G5 Mobile system no longer requires confirmatory finger sticks when making treatment decisions although it does require two single-point finger stick tests each day for calibration. In the United States, Canada and the countries and regions outside of the United States that recognize the CE Mark, our G6 does not require confirmatory finger sticks when making treatment decisions or finger stick tests each day for calibration, although it does require finger stick tests when symptoms do not match readings and when readings are unavailable.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Our Strategy</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our objective is to remain a leading provider of CGM systems and related products to enable people with diabetes to more effectively and conveniently manage their disease. We are also developing and commercializing products that integrate our CGM technologies into the insulin delivery systems or data platforms of our respective partners. In addition, we continue to pursue development partnerships with other insulin delivery companies, including automated insulin delivery systems. To achieve these objectives, we are focusing on the following business strategies:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Establishing and maintaining our technology platform as the leading approach to CGM and leveraging our development expertise to rapidly bring products to market, including for expanded indications.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Driving the adoption of our ambulatory products through a direct sales and marketing effort, as well as key distribution arrangements. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Driving additional adoption through technology integration partnerships such as our current partnerships with Eli Lilly, Insulet, Novo Nordisk, Tandem Diabetes and others.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Seeking broad coverage policies and reimbursement for our products from private third-party payors and national health systems.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Driving increased utilization and adoption of our products through a cloud-based data repository platform that enables people with diabetes to aggregate and analyze data from numerous diabetes devices and share the data with their healthcare providers and other individuals involved in their diabetes management and care.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expanding the use of our products to other patient care settings and patient demographics, including use in the hospital setting, people with Type 2 diabetes and people who are pregnant.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Providing a high level of customer support, service and education.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pursuing the highest safety and quality levels for our products.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Our Technology Platform</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We believe we have a broad technology platform that will support the development of multiple products for continuous glucose monitoring.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Sensor Technology</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The key enabling technologies for our sensors include biomaterials, membrane systems, electrochemistry and low power microelectronics. Our membrane technology consists of multiple polymer layers configured to selectively allow the appropriate mix of glucose and oxygen to travel through the membrane and react with a glucose specific enzyme to create an extremely low electrical signal, measured in pico-amperes. This electrical signal is then translated into glucose values. We believe that the capability to measure very low levels of an electrical signal and to accurately translate those measurements into glucose values is also a unique and distinguishing feature of our technology. We have also developed technology to allow sensitive electronics to be packaged in a small, fully contained, lightweight sealed unit that minimizes inconvenience and discomfort for the user.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Receiver and Transmitter Technology</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">G4 PLATINUM uses proprietary radiofrequency, and G5 Mobile and G6 use Bluetooth, to wirelessly transmit information from the transmitter, which sits in a pod atop the sensor, to our receiver or to a compatible mobile device. We have developed technology for reliable transmission and reception and have consistently demonstrated a high rate of successful transmissions from transmitter to receiver or compatible mobile device in our clinical trials. Our receiver or the mobile device, via our G5 Mobile and G6 apps, then displays both real-time and trended glucose values, and provides alerts and alarms. We have used our extensive database of continuous glucose data to create and refine software, algorithms and other technology for the display of data to customers.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">11</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Products in Development</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have gained our technology expertise by learning to design implants that can withstand the rigors of functioning within the human body for extended periods of time, as well as other issues such as device sealing, miniaturization, durability and sensor geometry.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are leveraging this technology platform to enhance the capabilities of our current products (including obtaining expanded indications of use) and to develop additional CGM products. We plan to develop future generations of technologies focused on improved performance and convenience and that will enable intelligent insulin administration. Over the longer term, we plan to continue to develop and improve networked platforms with open architecture, connectivity and transmitters capable of communicating with other devices. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We also continue to pursue and support development partnerships with insulin pump companies and companies or institutions developing insulin delivery systems, including automated insulin delivery systems.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the future, we intend to seek additional indications for our CGM technology, including applications in pregnancy and hospital monitoring. Eventually, we may apply our technological expertise to products beyond glucose monitoring.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Disposable Sensor&#160;and Reusable Transmitter</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our sensor includes a tiny wire-like electrode coated with our sensing membrane system. This disposable sensor comes packaged with an integrated insertion device and is contained in a small plastic housing platform, or pod. The base of the pod has adhesive that attaches it to the skin. The sensor is intended to be easily and reliably inserted by the user by exposing the adhesive, placing the pod against the surface of the skin of the abdomen or upper buttocks for people ages 2-17, and pushing down on the insertion device. The insertion device first extends a narrow gauge needle containing the sensor into the subcutaneous tissue and then retracts the needle, leaving behind the sensor in the tissue and the pod adhered to the skin. The user then disposes of the insertion device and snaps the transmitter to the pod. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">After a stabilization period with the G6, the user will begin receiving CGM data on his or her mobile device or dedicated receiver through the ten-day usage period. After a stabilization period with the G5 Mobile, the user is required to calibrate the sensor with two measurements from a single-point finger stick device and the disposable sensor begins wirelessly transmitting the continuous glucose data at specific intervals to the handheld receiver or compatible mobile device. Users are prompted by the receiver or mobile app, if using the G5 Mobile, to calibrate the system twice per day with finger stick measurements throughout the use period to ensure reliable operation. Calibration may be accomplished by using any FDA cleared blood glucose meter. Currently, the G4 PLATINUM system is indicated for use as an adjunctive device to complement, not replace, information obtained from standard home blood glucose monitoring devices. Our G6 and G5 Mobile systems both have labeling from the FDA and CE Mark permitting their use as a replacement for finger sticks for making therapeutic adjustments, although the G5 Mobile still requires two daily finger stick calibrations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The disposable sensor contained in the G6 system is intended to function for up to ten days and the G5 Mobile and G4 PLATINUM systems are intended to function for up to seven days, after which the sensor should be replaced. To replace a sensor, the user simply removes the pod and attached sensor from the skin and discards them while retaining the reusable transmitter. A new sensor and pod can then be inserted and used with the same receiver and transmitter for a subsequent use period. We are aware of reports from the field, however, that patients have been able to use the G6 and the G5 Mobile and G4 PLATINUM sensors for periods longer than ten or seven days, respectively.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Handheld Receiver</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our small handheld receiver is carried by the user and wirelessly receives continuous glucose values from the transmitter. Proprietary algorithms and software, developed from our extensive database of continuous glucose data from clinical trials, are programmed into the G4 PLATINUM receiver to process the glucose data from the sensor and display it on a user-friendly graphical user interface. For the G5 Mobile and G6, the algorithm resides on the transmitter, which then sends the processed glucose data to the receiver. With a push of a button, the user can access their current glucose value and one-, three-, six-, twelve- and twenty-four-hour trended data. Additionally, when glucose values are inappropriately high or low, the receiver provides an audible alert or vibrates. The receiver is a self-contained, durable unit with a rechargeable battery.</span></div><div style="line-height:174%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Compatible Mobile Devices</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">With our G5 Mobile and G6 systems, the functionalities of our proprietary receiver can be obtained through the use of a compatible mobile device, such as an iOS or Android device, and our mobile applications, depending on the patient&#8217;s geographic location. A receiver may be required as the primary display device or a backup to the mobile device in some jurisdictions, including the United States.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">12</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Sales and Marketing</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have built a direct sales organization to call on health care professionals, such as endocrinologists, physicians and diabetes educators, who can educate and influence patient adoption of continuous glucose monitoring. We believe that focusing efforts on these participants is important given the instrumental role they each play in the decision-making process for diabetes therapy, and to ensure that health care professionals and patients are knowledgeable about our products and their functionality. We focus on delivering this important information to participants to drive adoption of our G4 PLATINUM, G5 Mobile and G6 systems. We directly market our products in the United States, Austria, Canada, Germany, Ireland, Switzerland, and the United Kingdom primarily to endocrinologists, physicians and diabetes educators. Although the number of diabetes patients is significant, the number of physicians and educators influencing these patients is relatively small. As of 2018, we estimate there were approximately 6,500 clinical endocrinologists who treat diabetes in the United States. As a result, we believe our direct, highly specialized and focused sales organization is sufficient for us to support our sales efforts for the foreseeable future.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We also are increasing our direct to consumer marketing efforts to increase awareness of our CGM systems and drive new patient leads to our website. We target people with Type 1 and insulin intensive Type 2 diabetes. We advertise on television, in print, digital and video media, CRM, offer sponsorships, host or participate in diabetes related events, conduct public relations and maintain a brand ambassador program. Our campaigns target people with diabetes.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We use a variety of marketing tools to drive adoption, ensure continued usage and establish brand loyalty for our continuous glucose monitoring systems by:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">creating awareness of the benefits of continuous glucose monitoring and the advantages of our technology with endocrinologists, physicians, diabetes educators and people with diabetes;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">providing strong and simple educational and training programs to healthcare providers and people with diabetes to ensure easy, safe and effective use of our systems; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">maintaining a readily accessible telephone and web-based technical and customer support infrastructure, which includes clinicians, diabetes educators and reimbursement specialists, to help referring physicians, diabetes educators and people with diabetes as necessary.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our sales organization competes with the experienced and well-funded marketing and sales operations of our competitors. As compared to some of our competitors, we have relatively limited experience maintaining and managing a direct sales organization, and it is a difficult, expensive and time-consuming process. To continue to be successful we must:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">recruit and retain adequate numbers of effective sales personnel;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">effectively train our sales personnel in the benefits of our products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">establish and maintain successful sales, marketing, training and education programs to educate endocrinologists, physicians, diabetes educators and patients about our products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">manage geographically disbursed operations; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">effectively train our sales personnel on the applicable fraud and abuse laws that govern interactions with healthcare practitioners as well as current and prospective patients and maintain active oversight and auditing measures to ensure continued compliance.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Competition</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The market for blood glucose monitoring devices is intensely competitive, subject to rapid change and significantly affected by new product introductions and other market activities of industry participants. In selling the G4 PLATINUM, G5 Mobile and G6 systems, we compete directly with the Diabetes Care division of Abbott Laboratories; Medtronic plc&#8217;s Diabetes Group; Roche Diabetes Care, a division of Roche Diagnostics; privately-held LifeScan, Inc.; and Ascensia Diabetes Care, each of which manufactures and markets products for the single-point finger stick device market. Collectively, these companies currently account for the majority of the worldwide sales of self-monitored glucose testing systems.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Several companies are developing or commercializing products for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin that compete directly with our products. In 2015, Abbott Diabetes Care, Inc. launched a consumer flash or intermittent scan glucose monitoring system, FreeStyle Libre outside the United States. Abbott first received FDA approval for a professional-use version of this system in September 2016 for use in the United States for which readings are only made available to the patient through consultation with their healthcare provider. Abbott first received FDA approval for the consumer version of this system in September 2017 for use in the United States. Medtronic plc&#8217;s Diabetes Group markets and sells a standalone glucose monitoring product called Guardian Connect, which has launched both internationally and in the United States after receiving FDA approval in 2018. </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">13</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Medtronic and other third parties have developed or are developing, insulin pumps integrated with continuous glucose monitoring systems that provide, among other things, the ability to suspend insulin administration while the user&#8217;s glucose levels are low and to automate basal or bolus insulin dosing. Medtronic launched its 670G insulin delivery system in 2017.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We believe that the principal competitive factors in our market include:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">safe, reliable and high-quality performance of products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">cost of products and eligibility for reimbursement;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">comfort and ease of use of products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">effective sales, marketing and distribution networks;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">brand awareness and strong acceptance by healthcare professionals and people with diabetes;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">customer service and support and comprehensive education for people with diabetes and diabetes care providers;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">speed of product innovation and time to market;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">regulatory expertise; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">technological leadership and superiority.</span></div></td></tr></table><div style="line-height:120%;padding-left:4px;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For additional information, see our Risk Factors, including </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">We operate in a highly competitive market and face competition from large, well-established medical device manufacturers with significant resources, and, as a result, we may not be able to compete effectively</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Manufacturing</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We currently manufacture our products at our headquarters in San Diego, California and at our manufacturing facility in Mesa, Arizona. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, our headquarters facilities had approximately </span><span style="font-family:inherit;font-size:10pt;">31,000</span><span style="font-family:inherit;font-size:10pt;"> square feet of laboratory space and approximately </span><span style="font-family:inherit;font-size:10pt;">28,000</span><span style="font-family:inherit;font-size:10pt;"> square feet of controlled environment rooms. Our Mesa, Arizona facility has approximately </span><span style="font-family:inherit;font-size:10pt;">14,000</span><span style="font-family:inherit;font-size:10pt;"> square feet of laboratory space and approximately </span><span style="font-family:inherit;font-size:10pt;">33,000</span><span style="font-family:inherit;font-size:10pt;"> square feet of controlled environment rooms. There are technical challenges to increasing manufacturing capacity, including </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> qualification of new manufacturing facilities, equipment design and automation, material procurement, problems with production yields, and quality control and assurance. We have focused significant effort on continual improvement programs in our manufacturing operations intended to improve quality, yields and throughput. We have made progress in manufacturing to enable us to supply adequate amounts of product to support our commercialization efforts, however we cannot guarantee that supply will not be constrained going forward. Additionally, the production of our continuous glucose monitoring systems must occur in a highly controlled and clean environment to minimize particles and other yield- and quality-limiting contaminants. Developing and maintaining commercial-scale manufacturing facilities has and will continue to require the investment of substantial additional funds and the hiring and retaining of additional management, quality assurance, quality control and technical personnel who have the necessary manufacturing experience.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We manufacture our G4 PLATINUM, G5 Mobile and G6 systems with certain components supplied by outside vendors and other components that we manufacture internally. Key components that we manufacture internally include our wire-based sensors. The remaining components and assemblies are purchased from outside vendors. We then assemble, test, package and ship the finished systems, which may include a reusable transmitter, a receiver and disposable sensors. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We purchase certain components and materials used in manufacturing from single sources due to quality considerations, costs or constraints resulting from regulatory or other requirements. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, those single sources include suppliers of application-specific integrated circuits used in our transmitters, seals used for the applicator and certain polymers used to synthesize polymeric membranes for our sensors. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The advantages of the manufacturing facility in Mesa, Arizona include increasing our capacity to: </span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">mitigate the constraints we anticipated in our headquarters facilities continuing in 2020;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">geographically diversify our manufacturing base to mitigate the risks of having all of our manufacturing located in earthquake and fire-prone California; and </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">help manage certain of our operating expenses by taking advantage of Arizona&#8217;s lower costs and taxes relative to California.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Third-Party Reimbursement</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As a medical device company, reimbursement from Medicare, Medicaid or other governmental healthcare programs or systems, and private third-party healthcare payors is an important element of our success. In January 2017, </span><span style="font-family:inherit;font-size:10pt;">the Centers for Medicare and Medicaid, or CMS</span><span style="font-family:inherit;font-size:10pt;">, established a classification of &#8220;Therapeutic Continuous Glucose Monitors&#8221; as durable medical equipment under Medicare Part B, subject to payment by Medicare under certain coverage conditions to be determined </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">14</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">by CMS, by local Medicare Administrative Contractors or on a patient claim by claim basis. This is a decision we had pursued for many years and which was made possible by the FDA&#8217;s decision in December 2016 to approve a non-adjunctive indication, or use, for our G5 Mobile system, as described further in the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Government Regulation</span><span style="font-family:inherit;font-size:10pt;"> section below. Similarly, in September 2016, Germany&#8217;s Federal Joint Committee agreed to provide reimbursement for continuous glucose monitoring systems under certain conditions which we believe we meet.&#160; </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our G4 PLATINUM system is not classified as a Therapeutic CGM by CMS and thus remains ineligible for reimbursement within the Medicare-eligible population.&#160; Reimbursement of our G4 PLATINUM system, or any future system that does not meet the requirements for Therapeutic CGMs under Medicare Part B or the requirements of another governmental healthcare system, will be limited to those customers covered by third-party payors that have adopted coverage policies for continuous glucose monitoring devices that include our products.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, the seven largest private third-party payors, in terms of the number of covered lives, have issued coverage policies for the category of continuous glucose monitoring devices. In addition, we have negotiated contracted rates with all seven of those third-party payors for the purchase of our G4 PLATINUM, G5 Mobile and G6 systems by their members. Many of these coverage policies reimburse for our products under durable medical equipment benefits, are restrictive in nature and require the patient to comply with extensive documentation and other requirements to demonstrate medical necessity under the policy. Customers who are insured by payors that do not offer coverage for our devices will have to bear the financial cost of the products. We have personnel with reimbursement expertise to assist customers in obtaining reimbursement from private third-party payors. We also maintain a field-based reimbursement team charged with calling on third-party private payors to obtain coverage decisions and contracts. We have continued our efforts to create and liberalize coverage policies with third-party payors, including obtaining reimbursement for our products under pharmacy benefits and for more people with diabetes. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Medicare, Medicaid, other governmental health programs, health maintenance organizations and other third-party payors are increasingly attempting to contain healthcare costs by limiting both coverage and the level of reimbursement of medical devices, and, as a result, their coverage policies may be restrictive, or they may not cover or provide adequate payment for our products. In order to obtain reimbursement arrangements, we may have to agree to a net sales price lower than the net sales price we might charge in other sales channels or that we have charged in the past. Our revenue may be limited by the continuing efforts of government and third-party payors to contain or reduce the costs of healthcare through various increasingly sophisticated means, such as requiring prospective reimbursement and second opinions, purchasing in a bundle, or redesigning benefits. Furthermore, we are unable to predict what effect the current or any future healthcare reform will have on our business, or the effect these matters will have on our customers. Our dependence on the commercial success of the G4 PLATINUM, G5 Mobile and G6 systems makes us particularly susceptible to any cost containment or reduction efforts. Accordingly, unless government and other third-party payors provide adequate coverage and reimbursement for the G4 PLATINUM, G5 Mobile and G6 systems, people without coverage who have diabetes may not use our products.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additionally, Medicare does not cover any items or services that are not &#8220;reasonable and necessary.&#8221; Medicare covers the CGM system, which includes supplies necessary for the use of the device, under the Durable Medical Equipment, or DME, benefit category. In order to be covered under this benefit, one component of the CGM system must meet the criteria for a durable medical device. To date, the receiver satisfied this criteria. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In some foreign markets, pricing and profitability of medical devices are subject to government control. In the United States, we expect that there will continue to be federal and state proposals for similar controls. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Also, the managed care trends and the consolidation in the health care industry in the United States and proposed legislation intended to reduce the cost of government insurance programs could significantly impact the purchase of health care services and products and has resulted in lower prices for our products or the exclusion of our products from certain reimbursement programs. For additional information, see Risk Factors </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Managed care trends and consolidation in the health care industry could have an adverse effect on our revenues and results of operations</span><span style="font-family:inherit;font-size:10pt;">. and </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Health care policy changes, including U.S. health care reform legislation, may have a material adverse effect on our business</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Intellectual Property</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Protection of our intellectual property is a strategic priority for our business. We rely on a combination of patents, copyrights, trademarks, tradenames, trade secrets, nondisclosure agreements and other measures to establish and protect our proprietary rights. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had 516 issued U.S. patents in force, and numerous U.S. published patent applications pending. We believe it will take up to five years, and possibly longer, for our pending U.S. patent applications to result in issued patents. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had 50 granted European patents, and numerous European patent applications and published international applications pending under the Patent Cooperation Treaty. Our patents began expiring in 2017. We also have 31 registered U.S. trademarks, 21 registered European Community trademarks, and many other trademark registrations </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">15</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">and pending trademark applications around other parts of the world.&#160;In addition, we have entered into exclusive and non-exclusive licenses in the ordinary course of business relating to a wide array of technologies or other intellectual property rights or assets. Our Restated Collaboration Agreement with Verily provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#8217;s other intellectual property rights to develop, manufacture and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our patents and patent applications seek to protect aspects of our core membrane and sensor technologies and our product concepts for continuous glucose monitoring. We believe that our patent position provides us with sufficient rights to protect our current and proposed commercial products. However, our patent applications may not result in issued patents, and any patents that have been issued or might be issued may not protect our intellectual property rights. Furthermore, we operate in an industry characterized by extensive patent litigation, and our patents may not be upheld if challenged. Any patents issued to us may be challenged by third parties as being invalid or unenforceable, and patent litigation may result in significant damage awards and injunctions that could prevent the manufacture and sale of affected products or result in significant royalty payments in order to continue selling the products. Third parties may also independently develop similar or competing technology that avoids our patents. The steps we have taken may not prevent the misappropriation of our intellectual property, particularly in foreign countries where the laws may not protect our proprietary rights as fully as in the United States. We also face risks associated with intellectual property infringement. For additional information, see our Risk Factors, including </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">We are subject to claims of infringement or misappropriation of the intellectual property rights of others, which could prohibit us from shipping affected products, require us to obtain licenses from third parties or to develop non-infringing alternatives, and subject us to substantial monetary damages and injunctive relief. We may also be subject to other claims or suits. </span><span style="font-family:inherit;font-size:10pt;">and </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Our inability to adequately protect our intellectual property could allow our competitors and others to produce products based on our technology, which could substantially impair our ability to compete</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We also rely on trade secrets, technical know-how and continuing innovation to develop and maintain our competitive position. We seek to protect our proprietary information and other intellectual property by generally requiring our employees, consultants, contractors, suppliers, outside scientific collaborators and other advisors to execute non-disclosure and assignment of invention agreements on commencement of their employment or engagement. Agreements with our employees also forbid them from bringing the proprietary rights of third parties to us. We also generally require confidentiality or material transfer agreements from third parties that receive our confidential data or materials. We cannot guarantee that employees and third parties will abide by the confidentiality or assignment terms of these agreements. Despite measures taken to protect our intellectual property, unauthorized parties might copy aspects of our products or obtain and use information that we regard as proprietary.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Government Regulation</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The medical devices that we manufacture are subject to regulation by numerous regulatory bodies, including the U.S. FDA and comparable international regulatory agencies. These agencies require manufacturers of medical devices to comply with applicable laws and regulations governing the development, testing, manufacturing, labeling, marketing and distribution of medical devices. Devices are generally subject to varying levels of regulatory control, the most comprehensive of which requires that a clinical evaluation program be conducted before a device receives approval for commercial distribution. In addition, healthcare regulatory bodies in the United States and around the world impose a range of requirements related to the payment for medical devices and the procedures in which they are used, including laws intended to prevent fraud, waste, and abuse of healthcare dollars.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">U.S. Laws and Regulations</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At the U.S. federal level, our products are medical devices subject to extensive and ongoing regulation by the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">. The U.S. </span><span style="font-family:inherit;font-size:10pt;">Federal Food, Drug and Cosmetic Act, referred to as the FDCA,</span><span style="font-family:inherit;font-size:10pt;"> and the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">&#8217;s implementing regulations govern product design and development, pre-clinical and clinical testing, pre-market clearance, authorization or approval, establishment registration and product listing, product manufacturing, product labeling, product storage, advertising and promotion, product sales, distribution, recalls and field actions, servicing and post-market clinical surveillance. A number of U.S. states also impose licensing and compliance regimes on companies that manufacture or distribute prescription devices in the state.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, the delivery of our devices in the U.S market is subject to regulation by the U.S. Department of Health and Human Services and comparable state agencies responsible for reimbursement and regulation of payment for health care items and services. U.S. laws and regulations are imposed primarily in connection with the Medicare and Medicaid programs, as well as the government&#8217;s interest in regulating the quality and cost of health care.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">16</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">FDA</span><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"> Regulation</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unless an exemption applies, each medical device we wish to commercially distribute in the United States will require either prior 510(k) clearance, prior </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</span><span style="font-family:inherit;font-size:10pt;"> down-classification and a related grant of marketing authorization, or prior approval from the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> through the premarket approval, or PMA process. The </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> classifies medical devices into one of three classes. Devices requiring fewer controls because they are deemed to pose lower risk are placed in Class I or II. Class I devices are subject to general controls such as labeling, pre-market notification, and adherence to the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">&#8217;s manufacturing requirements, which are contained in the </span><span style="font-family:inherit;font-size:10pt;">Quality System Regulation, or QSR</span><span style="font-family:inherit;font-size:10pt;">. Class II devices are subject to special controls such as performance standards, post-market surveillance, </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> guidelines, or particularized labeling, as well as general controls. Some Class I and Class II devices are exempted by regulation from the pre-market notification (i.e., 510(k) clearance) requirement, and/or the requirement of compliance with substantially all of the </span><span style="font-family:inherit;font-size:10pt;">QSR</span><span style="font-family:inherit;font-size:10pt;">. As an example, the mobile applications that comprise the Share System were classified by the FDA as Class II exempt. With the mobile applications classified as Class II exempt, we must comply with certain general and special controls required by the FDA but we do not need prior FDA review to commercialize changes to the mobile applications. Some devices are placed in Class III, which requires approval of a </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> application, if they are deemed by the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> to pose the greatest risk, such as life-sustaining, life-supporting or certain implantable devices, or to be &#8220;not substantially equivalent&#8221; either to a previously 510(k) cleared device or to a &#8220;preamendment&#8221; Class III device in commercial distribution before May&#160;28, 1976 for which </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> applications have not been required. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If a previously unclassified new medical device does not qualify for the 510(k) pre-market notification process because no predicate device to which it is substantially equivalent can be identified, the device is automatically classified into Class III. The Food and Drug Administration Modernization Act of 1997 established a new route to market for low to moderate risk medical devices that are automatically placed into Class III due to the absence of a predicate device, called the &#8220;Request for Evaluation of Automatic Class III Designation,&#8221; or the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</span><span style="font-family:inherit;font-size:10pt;"> classification procedure. This procedure allows a manufacturer whose novel device is automatically classified into Class III to request down-classification of its medical device into Class I or Class II on the basis that the device presents low or moderate risk, rather than requiring the submission and approval of a PMA. Prior to the enactment of the Food and Drug Administration Safety and Innovation Act, or FDASIA, in July 2012, a medical device could only be eligible for </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</span><span style="font-family:inherit;font-size:10pt;"> classification if the manufacturer first submitted a 510(k) pre-market notification and received a determination from the FDA that the device was not substantially equivalent. FDASIA streamlined the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</span><span style="font-family:inherit;font-size:10pt;"> classification pathway by permitting (under Section 513(f)(2) of the FDCA) manufacturers to request </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</span><span style="font-family:inherit;font-size:10pt;"> classification directly without first submitting a 510(k) pre-market notification to the FDA and receiving a not substantially equivalent determination. FDASIA sets a review time for FDA of 120 days following receipt of the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</span><span style="font-family:inherit;font-size:10pt;"> application, but FDA does not always meet this timeline and has publicly only committed to a review goal of 150 days for 50% of applications. If the manufacturer seeks reclassification into Class II, the manufacturer must include a draft proposal for special controls that are necessary to provide a reasonable assurance of the safety and effectiveness of the medical device. The FDA may reject the reclassification petition if it identifies a legally marketed predicate device that would be appropriate for a 510(k) or determines that the device is not low to moderate risk or that general controls would be inadequate to control the risks and special controls cannot be developed. If the FDA agrees with the down-classification, the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</span><span style="font-family:inherit;font-size:10pt;"> applicant will then receive authorization to market the device, and a classification regulation will be established for the device type. The device can then be used as a predicate device for future 510(k) submissions by the manufacturer or a competitor. In December 2018, the FDA issued proposed regulations to govern the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo </span><span style="font-family:inherit;font-size:10pt;">classification process, which if finalized would further impact this path to market.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As an alternative to the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo </span><span style="font-family:inherit;font-size:10pt;">process, a company could also file a reclassification petition, or the FDA could initiate such a process, seeking to change the automatic Class III designation of a novel postamendment device under Section 513(f)(3) of the FDCA. The FDA issued a final rule (to take effect March 17, 2019) to clarify the process where the FDA initiates such reclassification (issuance of a proposed reclassification order; optional panel consultation; and final reclassification order published in the Federal Register).</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our G4 PLATINUM and G5 Mobile systems (excluding associated Share System functionalities and mobile applications) have been classified as devices requiring </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> approval. A </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> application must be supported by valid scientific evidence, which typically requires extensive data, including technical, pre-clinical, clinical, manufacturing and labeling data, to demonstrate to the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">&#8217;s satisfaction the safety and efficacy of the device. A </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> application also must include a complete description of the device and its components, a detailed description of the methods, facilities and controls used to manufacture the device, and proposed labeling. After a </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> application is submitted and found to be sufficiently complete, the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> begins an in-depth review of the submitted information. During this review period, the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> may request additional information or clarification of information already provided. Also during the review period, an advisory panel of experts from outside the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> may be convened to review and evaluate the application and provide recommendations to the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">. In addition, the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> generally will conduct a pre-approval inspection of the manufacturing facility to evaluate compliance with </span><span style="font-family:inherit;font-size:10pt;">QSR</span><span style="font-family:inherit;font-size:10pt;">, which requires manufacturers to implement and follow design, testing, control, documentation and other quality assurance procedures. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> review of a </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> application generally takes between one and three years, but may take significantly longer. The </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> can delay, limit or deny approval of a </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> application for many reasons, including:</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">17</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our systems may not be safe or effective to the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">&#8217;s satisfaction;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the data from our pre-clinical studies and clinical trials may be insufficient to support approval;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the manufacturing process or facilities we use may not meet applicable requirements; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">changes in </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> approval policies or adoption of new regulations may require additional data.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If an </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> evaluation of a </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> application or manufacturing facilities is favorable, the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> will either issue an approval letter, or approvable letter, which usually contains a number of conditions which must be met in order to secure final approval of the </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;">. When and if those conditions have been fulfilled to the satisfaction of the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">, the agency will issue a </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> approval letter authorizing commercial marketing of a device, subject to the conditions of approval and the limitations established in the approval letter. If the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">&#8217;s evaluation of a </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> application or manufacturing facilities is not favorable, the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> will deny approval of the </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> or issue a not approvable letter. The </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> may also determine that additional trials are necessary, in which case the </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> approval may be delayed for several months or years while the trials are conducted and data is submitted in an amendment to the </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;">. The </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> process can be expensive, uncertain and lengthy and a number of devices for which </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> approval has been sought by other companies have never been approved by the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> for marketing.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">New </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> applications or </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> supplements may be required for modifications to the manufacturing process, labeling, device specifications, materials or design of a device that is approved through the </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> process. </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> supplements often require submission of the same type of information as an initial </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> application, except that the supplement is limited to information needed to support any changes from the device covered by the approved </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> application and may or may not require as extensive clinical data or the convening of an advisory panel.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Clinical trials are almost always required to support a </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> application and are sometimes required for a 510(k) clearance. These trials generally require submission of an application for an </span><span style="font-family:inherit;font-size:10pt;">investigational device exemption, or IDE</span><span style="font-family:inherit;font-size:10pt;"> to the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">. The </span><span style="font-family:inherit;font-size:10pt;">IDE</span><span style="font-family:inherit;font-size:10pt;"> application must be supported by appropriate data, such as animal and laboratory testing results, showing that it is safe to test the device in humans and that the testing protocol is scientifically sound. The </span><span style="font-family:inherit;font-size:10pt;">IDE</span><span style="font-family:inherit;font-size:10pt;"> application must be approved in advance by the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> for a specified number of patients, unless the product is deemed a non-significant risk device and eligible for abbreviated </span><span style="font-family:inherit;font-size:10pt;">IDE</span><span style="font-family:inherit;font-size:10pt;"> requirements. Generally, clinical trials for a significant risk device may begin once the </span><span style="font-family:inherit;font-size:10pt;">IDE</span><span style="font-family:inherit;font-size:10pt;"> application is approved by the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> and the study protocol and informed consent are approved by appropriate institutional review boards at the clinical trial sites. The </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">&#8217;s approval of an </span><span style="font-family:inherit;font-size:10pt;">IDE</span><span style="font-family:inherit;font-size:10pt;"> allows clinical testing to go forward, but does not bind the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> to accept the results of the trial as sufficient to prove the product&#8217;s safety and efficacy, even if the trial meets its intended success criteria. All clinical trials must be conducted in accordance with the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">&#8217;s </span><span style="font-family:inherit;font-size:10pt;">IDE</span><span style="font-family:inherit;font-size:10pt;"> regulations, which govern investigational device labeling, prohibit promotion, and specify an array of Good Clinical Practice requirements, which include among other things, recordkeeping, reporting and monitoring responsibilities of study sponsors and study investigators. Clinical trials must further comply with the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">&#8217;s regulations for institutional review board approval and for informed consent and other human subject protections. Required records and reports are subject to inspection by the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">. The results of clinical testing may be unfavorable or, even if the intended safety and efficacy success criteria are achieved, may not be considered sufficient for the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> to grant approval or clearance of a product. The commencement or completion of any of our clinical trials may be delayed or halted, or be inadequate to support approval of a </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> application, for numerous reasons, including, but not limited to, the following:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> or other regulatory authorities do not approve a clinical trial protocol or a clinical trial, or place a clinical trial on hold;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">patients do not enroll in clinical trials at the rate we expect;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">patients do not comply with trial protocols;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">patient follow-up is not at the rate we expect;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">patients experience adverse side effects;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">patients die during a clinical trial, even though their death may not be related to our products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">institutional review boards and third-party clinical investigators may delay or reject our trial protocol;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">third-party clinical investigators decline to participate in a trial or do not perform a trial on our anticipated schedule or consistent with the clinical trial protocol, good clinical practices or other </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> requirements;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DexCom or third-party organizations do not perform data collection, monitoring and analysis in a timely or accurate manner or consistent with the clinical trial protocol or investigational or statistical plans;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">third-party clinical investigators have significant financial interests related to DexCom or the study that the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> deems to make the study results unreliable, or DexCom or investigators fail to disclose such interests;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">regulatory inspections of our clinical trials or manufacturing facilities, which may, among other things, require us to undertake corrective action or suspend or terminate our clinical trials;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">changes in governmental regulations or administrative actions applicable to our trial protocols;</span></div></td></tr></table><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">18</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the interim or final results of the clinical trial are inconclusive or unfavorable as to safety or effectiveness; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> concludes that the results from our trial and/or trial design are inadequate to demonstrate safety and effectiveness of the product.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In November 2011, we received 510(k) clearance from the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> to market to clinics a data management service, which helps healthcare providers and patients see, understand and use blood glucose meter data to diagnose and manage diabetes. In 2014, we submitted a request to the FDA via the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</span><span style="font-family:inherit;font-size:10pt;"> process and the FDA agreed that our data management services with CGM data is classified as Class I. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our data transfer service allows researchers to control the transfer of data from certain diabetes devices to research tools and databases according to their own research workflows. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The infrastructure of the data management service is considered &#8220;medical device data systems,&#8221; or MDDS, and does not require 510(k) clearance. MDDS are hardware or software products that transfer, store, convert formats, and display medical device data. An MDDS does not modify the data or modify the display of the data, and it does not by itself control the functions or parameters of any other medical device. MDDS are not intended to be used for active patient monitoring. On February 15, 2011, the FDA issued a regulation down-classifying MDDS from Class III (high-risk) to Class I (low-risk). Since down-classifying MDDS, the FDA gained additional experience with these types of technologies, and determined that these devices pose a low risk to the public. Therefore, the FDA stated in 2014 guidance that it did not intend to enforce compliance with the regulatory controls that apply to MDDS devices, including registration and listing, premarket review, postmarket reporting, and QSR for manufacturers of these types of devices. In 2016, the 21st Century Cures Act amended the Food, Drug, and Cosmetic Act&#8217;s definition of &#8220;device&#8221; to exclude certain software functions, thus products meeting the definition of MDDS are no longer considered devices and thus are not subject to FDA regulatory requirements.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additional functions of, or intended uses for, our software platform may require us to obtain either 510(k) clearance or </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> approval from the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">. To obtain 510(k) clearance, we must submit a pre-market notification demonstrating that the software system is substantially equivalent to a previously cleared 510(k) device or a pre-amendment device that was in commercial distribution before May 28, 1976 for which the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> has not yet called for the submission of a </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> application. The </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">&#8217;s 510(k) clearance pathway generally takes from three to twelve months from the date the application is completed, but can take significantly longer. After a medical device receives 510(k) clearance, any modification that could significantly affect its safety or effectiveness, or that would constitute a significant change in its intended use, requires a new 510(k) clearance.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2018, we obtained marketing authorization for our G6 as an integrated continuous glucose monitoring, iCGM, system for determining glucose (sugar) levels in children aged two and older and adults with diabetes, via the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</span><span style="font-family:inherit;font-size:10pt;"> process.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">After a device is authorized for marketing and placed in commercial distribution, numerous regulatory requirements apply. These include:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">establishment registration and device listing;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">QSR</span><span style="font-family:inherit;font-size:10pt;">, which requires manufacturers to follow design, testing, control, storage, supplier/contractor selection, complaint handling, documentation and other quality assurance procedures;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">labeling regulations, which prohibit the promotion of products for unapproved or off-label uses or indications and impose other restrictions on labeling, advertising and promotion;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">medical device reporting regulations, which require that manufacturers report to the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> if a device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if it were to recur;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">voluntary and mandatory device recalls to address problems when a device is defective and/or could be a risk to health; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">corrections and removal reporting regulations, which require that manufacturers report to the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> field corrections and product recalls or removals if undertaken to reduce a risk to health posed by the device or to remedy a violation of the </span><span style="font-family:inherit;font-size:10pt;">FDCA</span><span style="font-family:inherit;font-size:10pt;"> that may present a risk to health.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Also, the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> may require us to conduct post-market surveillance studies or order us to establish and maintain a system for tracking our products through the chain of distribution to the patient level. The </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> and the Food and Drug Branch of the California Department of Health Services enforce regulatory requirements by conducting periodic, unannounced inspections and market surveillance. Inspections may include the manufacturing facilities of our subcontractors.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Failure to comply with applicable regulatory requirements, including those applicable to the conduct of our clinical trials, can result in enforcement action by the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">, which may lead to any of the following sanctions:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">warning letters or untitled letters that require corrective action;</span></div></td></tr></table><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">19</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">fines and civil penalties;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">unanticipated expenditures;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">delays in approving or refusal to approve our future continuous glucose monitoring systems or other products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> refusal to issue certificates to foreign governments needed to export our products for sale in other countries;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">suspension or withdrawal of </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> approval;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">product recall or seizure;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">interruption of production;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">operating restrictions;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">injunctions; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">criminal prosecution.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We and our contract manufacturers, specification developers, and some suppliers of components or device accessories, are also required to manufacture our products in compliance with current Good Manufacturing Practice requirements set forth in the </span><span style="font-family:inherit;font-size:10pt;">QSR</span><span style="font-family:inherit;font-size:10pt;">. The </span><span style="font-family:inherit;font-size:10pt;">QSR</span><span style="font-family:inherit;font-size:10pt;"> requires a quality system for the design, manufacture, packaging, labeling, storage, installation and servicing of marketed devices, and includes extensive requirements with respect to quality management and organization, device design, buildings, equipment, purchase and handling of components or services, production and process controls, packaging and labeling controls, device evaluation, distribution, installation, complaint handling, servicing, and record keeping. The </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> evaluates compliance with the </span><span style="font-family:inherit;font-size:10pt;">QSR</span><span style="font-family:inherit;font-size:10pt;"> through periodic unannounced inspections that may include the manufacturing facilities of our subcontractors. If the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> believes we or any of our contract manufacturers or regulated suppliers are not in compliance with these requirements, it can shut down our manufacturing operations, require recall of our products, refuse to approve new marketing applications, institute legal proceedings to detain or seize products, enjoin future violations, or assess civil and criminal penalties against us or our officers or other employees. Any such action by the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> would have a material adverse effect on our business. We may be unable to comply with all applicable </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> regulations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">U.S. Fraud and Abuse Laws and Other Compliance Requirements</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The healthcare industry is subject to various U.S. federal and state laws pertaining to healthcare fraud and abuse. Violations of these laws are punishable by criminal and civil sanctions, including, in some instances, exclusion from participation in U.S. federal and state healthcare programs, including Medicare and Medicaid.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Anti-kickback Laws.</span><span style="font-family:inherit;font-size:10pt;"> The federal Anti-Kickback Statute prohibits persons from knowingly and willfully soliciting, receiving, offering or providing remuneration directly or indirectly to induce either the referral of an individual, or the furnishing, recommending, or arranging of a good or service, for which payment may be made under a federal healthcare program such as Medicare and Medicaid. The definition of &#8220;remuneration&#8221; has been broadly interpreted to include anything of value, including such items as gifts, discounts, the furnishing of supplies or equipment, credit arrangements, waiver of payments, and providing anything at less than its fair market value. The Department of Health and Human Services - Office of the Inspector General, or OIG, has issued regulations, commonly known as safe harbors, that set forth certain provisions which, if satisfied in their entirety, will assure healthcare providers and other parties that they will not be prosecuted under the federal Anti-Kickback Statute. The failure of a transaction or arrangement to fit precisely within one or more safe harbors does not necessarily mean that it is illegal or that prosecution will be pursued. However, conduct and business arrangements that do not fully satisfy each applicable safe harbor element may result in increased scrutiny by government enforcement authorities or invite litigation by private citizens under federal whistleblower laws.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The penalties for violating the federal Anti-Kickback Statute include imprisonment for up to ten years, fines of up to $100,000 per violation and possible exclusion from federal healthcare programs such as Medicare and Medicaid. Many states have adopted prohibitions similar to the federal Anti-Kickback Statute, some of which apply to the referral of patients for healthcare services reimbursed by any source, not only by the government programs such as Medicare and Medicaid.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Federal False Claims Act.</span><span style="font-family:inherit;font-size:10pt;"> The federal False Claims Act prohibits knowingly presenting, or causing to be presented a false claim or the knowing use of false statements or records to obtain payment from the federal government. When an entity is determined to have violated the False Claims Act, it must pay three times the actual damages sustained by the government, plus mandatory civil penalties of between $11,181 and $22,363 for each separate false claim. Suits filed under the False Claims Act, known as &#8220;qui tam&#8221; actions, can be brought by any individual on behalf of the government and such individuals (known as &#8220;relators&#8221; or, more commonly, as &#8220;whistleblowers&#8221;) may share in any amounts paid by the entity to the government in fines or settlement. In addition, certain states have enacted laws modeled after the federal False Claims Act. Qui tam actions have increased significantly in recent years, causing greater numbers of healthcare companies to have to defend a false claim action, even before the validity of the claim is established and even if the government decides not to intervene in the lawsuit. Healthcare companies may decide to agree to large settlements with the government and/or whistleblowers to avoid the cost and negative publicity associated with litigation. Federal enforcement agencies also have showed increased interest in </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">20</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">pharmaceutical companies&#8217; product and patient assistance programs, including reimbursement and co-pay support services, and a number of investigations into these programs have resulted in significant civil and criminal settlements. &#160;In addition, the Affordable Care Act amended federal law to provide that the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act. Criminal prosecution is possible for knowingly making or presenting a false or fictitious or fraudulent claim to the federal government.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Federal Physician Self-Referral Law. </span><span style="font-family:inherit;font-size:10pt;">The Federal Physician Self-Referral Law, also referred to as the Stark Law, prohibits a physician (or an immediate family member of a physician) who has a financial relationship with an entity from referring patients to that entity for certain designated health services, including durable medical equipment such as the CGM receiver and supplies,</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> </sup></span><span style="font-family:inherit;font-size:10pt;">payable by Medicare, unless an exception applies.</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> </sup></span><span style="font-family:inherit;font-size:10pt;">The Stark Law also prohibits such an entity from presenting or causing to be presented a claim to the Medicare program for such designated health services provided pursuant to a prohibited referral, and provides that certain collections related to any such claims must be refunded in a timely manner. Because we bill Medicare for DME and related supplies, the company&#8217;s financial relationships with referring physicians are governed by the Stark Law. Exceptions to the Stark Law include, among other things, exceptions for certain financial relationships, including both ownership and compensation arrangements. The Stark Law is a strict liability statute, therefore, to the extent that the statute is implicated and an exception does not apply, the statute is violated. In addition to the Stark Law, many states have implemented similar physician self-referral prohibitions that may extend to Medicaid, third party payors, and self-pay patients. Violations of the Stark Law must be reported and returned to Medicare in order to avoid potential liability under the federal False Claims Act for avoiding a known obligation to return identified overpayments. Violations of the Stark Law, the Anti-Kickback Statute, the Civil Monetary Penalties Law and/or the federal False Claims Act can also form the basis for exclusion from participation in federal and state healthcare programs.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Civil Monetary Penalties Law</span><span style="font-family:inherit;font-size:10pt;">. The Civil Monetary Penalties Law, or CMPL, authorizes the imposition of substantial civil money penalties against an entity that engages in certain prohibited activities including but not limited to violations of the Stark Law or Anti-Kickback Statute, knowing submission of a false or fraudulent claim, employment of an excluded individual, and the provision or offer of anything of value to a Medicare or Medicaid beneficiary that the transferring party knows or should know is likely to influence beneficiary selection of a particular provider for which payment may be made in whole or part by a federal health care program,commonly known as the Beneficiary Inducement CMP. Remuneration is defined under the CMPL as any transfer of items or services for free or for less than fair market value. There are certain exceptions to the definition of remuneration for offerings that meet the Financial Need, Preventative Care, or Promoting Access to Care exceptions. Sanctions for violations of the CMPL include civil monetary penalties and administrative penalties up to and including exclusion from participation in federal health care programs.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">State Analogs of Federal Fraud and Abuse Laws</span><span style="font-family:inherit;font-size:10pt;">. Many U.S. states have their own laws intended to protect against fraud and abuse in the health</span><span style="font-family:inherit;font-size:10pt;color:#0000ff;"> </span><span style="font-family:inherit;font-size:10pt;">care industry and more broadly. In some cases these laws prohibit or regulate additional conduct beyond what federal law affects. Penalties for violating these laws can range from fines to criminal sanctions.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">HIPAA and Other Privacy Laws and Regulations. </span><span style="font-family:inherit;font-size:10pt;">The Health Insurance Portability and Accountability Act of 1996, as amended by the American Recovery and Reinvestment Act of 2009, and implementing regulations, or HIPAA, created two new federal crimes: healthcare fraud and false statements relating to healthcare matters. The healthcare fraud statute prohibits knowingly and willfully executing a scheme to defraud any healthcare benefit program, including private payors. A violation of this statute is a felony and may result in fines, imprisonment or exclusion from government sponsored programs. The false statements statute prohibits knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">HIPAA, as well as a number of other federal and state privacy-related laws, also extensively regulate the use and disclosure of individually identifiable health information, known as &#8220;protected health information,&#8221; and require covered entities, including health plans and most health care providers, to implement administrative, physical and technical safeguards to protect the security of such information. Certain provisions of the security and privacy regulations apply to business associates (entities that handle protected health information on behalf of covered entities), and business associates are subject to direct liability for violation of these provisions. In addition, a covered entity may be subject to criminal and civil penalties as a result of a business associate violating HIPAA, if the business associate is found to be an agent of the covered entity. The HIPAA privacy regulations and security regulations impose and will continue to impose significant costs on us in order to comply with these standards.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, certain states have proposed or enacted legislation that will create new data privacy and security obligations for certain entities, such as the California Consumer Privacy Act that went into effect January 1, 2020.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">FCPA and Other Anti-Bribery and Anti-Corruption Laws. </span><span style="font-family:inherit;font-size:10pt;">The U.S.&#160;</span><span style="font-family:inherit;font-size:10pt;">Foreign Corrupt Practices Act, or FCPA,</span><span style="font-family:inherit;font-size:10pt;"> prohibits U.S. corporations and their representatives from offering, promising, authorizing or making payments to any foreign </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">21</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">government official, government staff member, political party or political candidate in an attempt to obtain or retain business abroad. The scope of the </span><span style="font-family:inherit;font-size:10pt;">FCPA</span><span style="font-family:inherit;font-size:10pt;"> would include interactions with certain healthcare professionals in many countries. Our present and future business has been and will continue to be subject to various other U.S. and foreign laws, rules and/or regulations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Physician Payment Sunshine Act. </span><span style="font-family:inherit;font-size:10pt;">Pursuant to the Patient Protection and Affordable Care Act that was signed into law in March 2010, the federal government enacted the Physician Payment Sunshine Act. As a manufacturer of U.S. FDA&#8209;regulated devices reimbursable by federal healthcare programs, we are subject to this law, which requires us to track and annually report certain payments and other transfers of value we make to U.S.-licensed physicians or U.S. teaching hospitals. We are also required to report certain ownership interests held by physicians and their immediate family members. In 2018 the law was extended to require tracking and reporting of transfers of value to physician assistants, nurse practitioners, and other mid-level practitioners. Reporting requirements will go into effect in 2022 for payments and transfers of value made to these additional practitioner-types in 2021. CMS has the potential to impose penalties of up to $1.15 million per year for violations of the Physician Payment Sunshine Act, depending on the circumstances, and payments reported also have the potential to draw scrutiny on payments to and relationships with physicians, which may have implications under the Anti-Kickback Statute, Stark Law and other healthcare laws. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, there has been a recent trend of increased federal and state regulation of payments and other transfers of value provided to healthcare professionals and entities. Similar to the federal law, certain states also have adopted marketing and/or transparency laws relevant to device manufacturers, some of which are broader in scope. Certain states also mandate that device manufacturers implement compliance programs. Other states impose restrictions on device manufacturer marketing practices and require tracking and reporting of gifts, compensation, and other remuneration to healthcare professionals and entities. The need to build and maintain a robust compliance program with different compliance and/or reporting requirements increases the possibility that a healthcare company may violate one or more of the requirements, resulting in fines and penalties.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">International Regulation</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">International sales of medical devices are subject to foreign government regulations, which may vary substantially from country to country. The time required to obtain approval in a foreign country may be longer or shorter than that required for </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> approval, and the requirements may differ. There is a trend towards harmonization of quality system standards among the European Union, United States, Canada and various other industrialized countries.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The primary regulatory body in Europe is that of the European Union, which includes most of the major countries in Europe. Other countries, such as Switzerland, have voluntarily adopted laws and regulations that mirror those of the European Union with respect to medical devices. The European Union has adopted numerous directives and standards regulating the design, manufacture, clinical trials, labeling and adverse event reporting for medical devices. Devices that comply with the requirements of a relevant directive will be entitled to bear the CE conformity marking, indicating that the device conforms to the essential requirements of the applicable directives and, accordingly, can be commercially distributed throughout Europe. The method of assessing conformity varies depending on the class of the product, but normally involves a combination of self-assessment by the manufacturer and a third-party assessment by a &#8220;Notified Body.&#8221; This third-party assessment may consist of an audit of the manufacturer&#8217;s quality system and specific testing of the manufacturer&#8217;s product. An assessment by a Notified Body of one country within the European Union is required in order for a manufacturer to commercially distribute the product throughout the European Union. Outside of the European Union, regulatory approval needs to be sought on a country-by-country basis in order for us to market our products. The European Union regulatory bodies finalized a new Medical Device Regulation (MDR) in 2017, which replaced the existing Directives and provided three years for transition and compliance. The MDR will change several aspects of the existing regulatory framework. Other countries have adopted medical device regulatory regimes, such as the Classification Rules for Medical Devices published by the Hong Kong Department of Health, the Health Sciences Authority of Singapore regulation of medical devices under the Health Products Act, and Health Canada&#8217;s risk classification system for invasive devices, among others. Each country may have its own processes and requirements for medical device licensing, approval, and regulation, therefore requiring us to seek regulatory approvals on a country-by-country basis.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outside the United States a range of anti-bribery and anti-corruption laws, as well and some industry-specific laws and codes of conduct, apply to the medical device industry and interactions with government officials and entities and healthcare professionals. Laws include the UK Bribery Act of 2010. Further, the EU member countries have emphasized a greater focus on healthcare fraud and abuse and have indicated greater attention to the industry by the European Anti-Fraud Office. MedTech Europe, the medical device industry association, also introduced the Code of Ethical Business Practices, which came into effect on January 1, 2017. Countries in Asia have also become more active in their enforcement of anti-bribery laws and with respect to procurement and supply chain fraud.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the European Union, increasingly stringent data protection and privacy rules that have and will continue to have substantial impact on the use of patient data across the healthcare industry became effective in May 2018. The EU General Data Protection Regulation, or GDPR, applies across the European Union and includes, among other things, a requirement for </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">22</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">prompt notice of data breaches to data subjects and supervisory authorities in certain circumstances and significant fines for non-compliance. The GDPR fine framework can be up to 20 million euros, or up to 4 % of the company&#8217;s total global turnover of the preceding fiscal year, whichever is higher. The GDPR also requires companies processing personal data of individuals residing in the European Union to comply with EU privacy and data protection rules, even if the company itself does not have a physical presence in the European Union. Noncompliance could result in the imposition of fines, penalties, or orders to stop noncompliant activities. Due to the strong consumer protection aspects of the GDPR, companies subject to its purview are allocating substantial legal costs to the development of necessary policies and procedures and overall compliance efforts. We expect continued costs associated with maintaining compliance with GDPR into the future.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Environmental Regulation</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our research and development and clinical processes involve the handling of potentially harmful biological materials as well as hazardous materials. We are subject to federal, state and local laws and regulations governing the use, handling, storage and disposal of hazardous and biological materials and we incur expenses relating to compliance with these laws and regulations. If violations of environmental, health and safety laws occur, we could be held liable for damages, penalties and costs of remedial actions. These expenses or this liability could have a significant negative impact on our financial condition. We may violate environmental, health and safety laws in the future as a result of human error, equipment failure or other causes. Environmental laws could become more stringent over time, imposing greater compliance costs and increasing risks and penalties associated with violations. We are subject to potentially conflicting and changing regulatory agendas of political, business and environmental groups. Changes to or restrictions on permitting requirements or processes, hazardous or biological material storage or handling might require an unplanned capital investment or relocation. Failure to comply with new or existing laws or regulations could harm our business, financial condition and results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Advisory Boards and Consultants</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have relied upon the advice of experts in the development and commercialization of our products. Since 2005, we have used experts in various disciplines on a consulting basis as needed to solve problems or accelerate development pathways. We may continue to engage advisors from the academic, consultancy, governmental or other areas to assist us as necessary. Relationships between manufacturers and physicians, including in consultancy and advisory board roles, is subject to scrutiny under the Stark Law, the federal Anti-Kickback Statute, and their state law equivalents. Due to this scrutiny, we incur legal and consulting fees to ensure our relationships with physicians meet regulatory requirements, including that compensation paid to such physicians is within fair market value.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Employees</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had approximately 3,900 full-time employees and approximately 1,300 contract and temporary employees globally. None of our employees are represented by a labor union or covered by a collective bargaining agreement, except for our employees in our Mainz, Germany location that are represented by a Works Council. We have never experienced any employment-related work stoppages and we consider our employee relations to be good.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Available Information</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our Internet website address is www.dexcom.com. We provide free access to various reports that we file with or furnish to the SEC through our website, as soon as reasonably practicable after they have been filed or furnished. These reports include, but are not limited to, our annual reports on Form&#160;10-K, quarterly reports on Form&#160;10-Q, current reports on Form&#160;8-K, and any amendments to those reports. Our SEC reports can be accessed through the investor relations section of our website, or through www.sec.gov. Also available on our website are printable versions of our Audit Committee charter, Compensation Committee charter, Nominating and Corporate Governance Committee charter, and Code of Conduct and Business Ethics. Information on our website does not constitute part of this Annual Report on Form&#160;10-K or other report we file or furnish with the SEC. Stockholders may request copies of these documents from:</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DexCom, Inc.</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">6340 Sequence Drive</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">San Diego, CA 92121</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(858) 200-0200</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">23</span></div></div><hr style="page-break-after:always"></hr><div><a id="sB2B2A2FFB5AD59048087F45FF7556428"></a></div><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:84px;text-indent:-84px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 1A - RISK FACTORS</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Our short and long-term success is subject to numerous risks and uncertainties, many of which involve factors that are difficult to predict or beyond our control. Before making a decision to invest in, hold or sell our common stock, stockholders and potential stockholders should carefully consider the risks and uncertainties described below, in addition to the other information contained in or incorporated by reference into this Annual Report on Form 10-K, as well as the other information we file with the Securities and Exchange Commission. If any of the following risks are realized, our business, financial condition, results of operations and prospects could be materially and adversely affected. In that case, the value of our common stock could decline and stockholders may lose all or part of their investment. Furthermore, additional risks and uncertainties of which we are currently unaware, or which we currently consider to be immaterial, could have a material adverse effect on our business, financial condition or results of operations. Refer to our disclaimer regarding forward-looking statements at the beginning of our Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Risks Related to Our Business and Operations</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">If our manufacturing capabilities are insufficient to produce an adequate supply of product at appropriate quality levels, our growth could be limited and our business could be harmed.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We currently have limited resources and facilities for manufacturing sufficient quantities of product to meet expected demand. In the past, we have had difficulty scaling our manufacturing operations to provide a sufficient supply of product to support market demand and our commercialization efforts. From time to time, we have also experienced brief periods of backorder and, at times, have had to limit the efforts of our sales force to introduce our products to new customers. We have focused significant effort on continual improvement programs in our manufacturing operations intended to improve quality, yields and throughput. We have made progress in manufacturing to enable us to supply adequate amounts of product to support our commercialization efforts; however, we cannot guarantee that supply will not be constrained in the future. In order to produce our products in the quantities we anticipate will be necessary to meet market demand, we will need to adequately predict the market demand for our products and increase our manufacturing capacity by a significant factor over the current level to meet or exceed the anticipated market demand. In addition, we will have to modify our manufacturing design, reliability and process if and when our next-generation continuous glucose monitoring, or CGM, technologies are approved and commercialized. There are technical challenges to increasing manufacturing capacity, including equipment design and automation, materials procurement, manufacturing site expansion, problems with production yields and quality control and assurance. Continuing to develop commercial-scale manufacturing facilities will require the investment of substantial additional funds and the hiring and retention of additional management, quality assurance, quality control and technical personnel who have the necessary manufacturing experience. The scaling of manufacturing capacity is subject to numerous risks and uncertainties, and may lead to variability in product quality or reliability, increased construction timelines, as well as resources required to design, install and maintain manufacturing equipment, among others, all of which can lead to unexpected delays in manufacturing output. In addition, any changes to our manufacturing processes may trigger the need for submissions or notifications to, and in some cases advance approval from, the FDA or other regulatory authority because of the potential impact of changes on our previously cleared, approved and/or authorized devices. Our facilities are subject to inspections by the FDA and corresponding state agencies on an ongoing basis, and we must comply with Good Manufacturing Practices and FDA Quality Systems Regulations. We may be unable to adequately maintain, develop and expand our manufacturing process and operations or maintain compliance with FDA and state agency requirements, and manufacturing issues could impact our cleared and approved products. If we are unable to manufacture a sufficient supply of our current products or any future products for which we may receive approval or clearance, maintain control over expenses or otherwise adapt to anticipated growth, or if we underestimate growth, we may not have the capability to satisfy market demand, contractual obligations, and our business will suffer.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Manufacturing difficulties and/or any disruption at our facilities may adversely affect our manufacturing operations and related product sales, and increase our expenses.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our products are manufactured at certain facilities, with limited alternate facilities. If an event occurs at one of our facilities that results in damage to, or closure of, one or more of such facilities, we may be unable to manufacture the relevant products at the previous levels or at all. Because of the time required to approve and lease a manufacturing facility, an alternate facility and/or a third-party may not be available on a timely basis to replace production capacity in the event manufacturing capacity is lost.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additionally, the majority of our operations are conducted at facilities located in San Diego, California and Mesa, Arizona. We take precautions to safeguard our facilities, which include manufacturing protocols, insurance, health and safety protocols, and off-site storage of data. However, a natural or man-made disaster, such as fire, flood, earthquake, act of terrorism, cyber-attack or other disruptive event could cause substantial delays in our operations, damage or destroy our </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">24</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">manufacturing equipment, inventory, or records and cause us to incur additional expenses. Earthquakes are of particular significance since our primary manufacturing facilities in California are located in an earthquake-prone area. In the event our existing manufacturing facilities or equipment are affected by man-made or natural disasters, we may be unable to manufacture products for sale or meet customer demands or sales projections. If our manufacturing operations were curtailed or ceased, it would seriously harm our business. The insurance we maintain against fires, floods, earthquakes and other natural disasters and similar events may not be adequate to cover our losses in any particular case.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We depend upon third-party suppliers and outsource to other parties, making us vulnerable to supply disruptions, suboptimal quality, non-compliance and/or price fluctuations, which could harm our business.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We manufacture the majority of our products and procure important third-party services, such as sterilization services, at numerous facilities worldwide. We purchase many of the components, materials and services needed to manufacture these products from numerous suppliers in various countries. We have generally been able to obtain adequate supplies of such materials, components and services. However, we also rely on single and/or sole sources for certain components and materials used in manufacturing, such as for the application-specific integrated circuit that is incorporated into the transmitter and certain polymers used to synthesize the polymeric biointerface membranes for our products. In some cases, our agreements with these and other suppliers can be terminated by either party upon short notice. Our contract manufacturers may also rely on single-or sole- source suppliers to manufacture some of the components used in our products. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Although we work with our suppliers to try to ensure continuity of supply while maintaining quality, timeliness and reliability, the supply of these components, materials and services may be interrupted or insufficient. Our manufacturers and suppliers may also encounter problems during manufacturing for a variety of reasons, including the stringent regulations and requirements of regulatory agencies, including the U.S. FDA which may result in the failure to follow specific protocols and procedures, failure to comply with applicable regulations, failed FDA audit or inspection (for example, failures leading to Form 483 Observations and Warning Letters, or other enforcement actions), as well as equipment malfunction and environmental factors, any of which could delay or impede their ability to meet our demand.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, if our sole- or single-source suppliers shift their manufacturing and assembly sites to other locations, these new sites may require additional FDA approval and inspection. Should any such FDA approval be delayed, or such inspection require corrective action, our supply of critical components may be constrained or eliminated. We may not be able to quickly establish additional or replacement suppliers, particularly for our single-source components, in part because of the FDA inspection and approval process and because of the custom nature of various parts we design. Any interruption or delay in the supply of components or materials, or our inability to obtain components or materials from alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our customers and cause them to cancel orders or switch to competitive products.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our reliance on these outside manufacturers and suppliers also subjects us to other risks that could harm our business, including:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">we may experience a reduction or interruption in supply, and may not be able to obtain adequate supply in a timely manner or on commercially reasonable terms from additional or replacement sources; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our products are technologically complex and it is difficult to develop alternative supply sources; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">we are not a major customer of many of our suppliers, and these suppliers may therefore give other customers&#8217; needs higher priority than ours; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our suppliers may make errors in manufacturing components that could negatively affect the quality, effectiveness or safety of our products or cause delays in shipment of our products; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">we may have difficulty locating and qualifying alternative suppliers for our single-source supplies; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">switching components may require product redesign and submission to the FDA of new applications such as a PMA or 510(k) supplement or possibly a separate PMA or 510(k), either of which could significantly delay production;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our suppliers manufacture products for a range of customers, and fluctuations in demand for the products these suppliers manufacture for others may affect their ability to deliver components to us in a timely manner; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our suppliers may make obsolete components that are critical to our products; and </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our suppliers may encounter financial and/or other hardships unrelated to our demand for components, including those related to changes in global economic conditions and/or disease outbreaks, which could inhibit their ability to fulfill our orders and meet our requirements. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We also outsource certain services to other parties, including inside sales, certain transaction processing, accounting, information technology, manufacturing, and other areas. Outsourcing of services to third parties could expose us to suboptimal quality of service delivery or deliverables and potentially result in repercussions such as missed deadlines or other timeliness </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">25</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">issues, erroneous data, supply disruptions, non-compliance (including with applicable legal or regulatory requirements and industry standards) and/or reputational harm, with potential negative effects on our results. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We also require the suppliers, service providers and business partners of components or services for our products and related services to comply with law and certain of our policies regarding sourcing practices, but we do not control them or their practices. If any supplier, service provider or business partner violates laws or implements unethical practices, there could be disruptions to our supply chain, cancellation of our orders, a termination of the relationship with the partner or damage to our reputation, and the FDA or other regulators could seek to hold us responsible for such violations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Continued expansion of our operations may not be scaled at a pace sufficient to ensure that we can manufacture one or more of our continuous glucose monitoring products in quantities sufficient to meet market demand.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our facility in Mesa, Arizona is designed to manufacture current and next-generation sensors and transmitters, but may not be scaled quickly enough to permit us to manufacture one or more of our CGM systems in quantities sufficient to meet market demand. There are risks associated with continued expansion of our manufacturing capacity in Mesa that include but are not limited to contractor issues and delays, licensing and permitting delays or rejections, limitations and delays on the installation of new or custom-ordered equipment, issues associated with validating such equipment, and processes or other aspects of ensuring we manufacture our products in compliance with current Good Manufacturing Practice and other requirements.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We are subject to cost-containment efforts that could result in reduced product pricing and/or sales of our products and cause a reduction in future revenue.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the United States and other countries, government and private sector access to health care products continues to be a subject of focus, and efforts to reduce health care costs are being made by third-party payors. Most of our customers rely on third-party payors, including government programs and private health insurance plans, to cover the cost of our products. We expect that the continuing cost reduction and containment measures may reduce the cost or utilization of health care products and could lead to patients being unable to obtain approval for coverage or payment from these third-party payors.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have experienced, and anticipate that we will continue to experience, downward pressure on product pricing. To the extent these cost containment efforts are not offset by greater patient access to our products, our future revenue may be reduced and our business may be harmed.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">If we experience decreasing prices for our products and we are unable to reduce our expenses, including the per unit cost of producing our products, there may be a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have experienced, and anticipate that we will continue to experience, decreasing prices for our products due to pricing pressure from managed care organizations and other third-party payors, increased market power of our payors, as the medical device industry consolidates, and increased competition among suppliers, including manufacturing services providers. If the prices for our products and services decrease and we are unable to reduce our expenses, including the cost of sourcing materials, logistics and the cost to manufacture our products, our business, results of operations, financial condition and cash flows will be adversely affected.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We have incurred significant losses in the past and may incur losses in the future. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have incurred significant operating losses in the past, including a net loss of </span><span style="font-family:inherit;font-size:10pt;">$186.3 million</span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> December 31, 2018. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had an accumulated deficit of </span><span style="font-family:inherit;font-size:10pt;">$695.7 million</span><span style="font-family:inherit;font-size:10pt;">. We have financed our operations primarily through private and public offerings of equity securities and debt and the sales of our products. We have devoted substantial resources to:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">research and development relating to our continuous glucose monitoring systems;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">sales and marketing and manufacturing expenses associated with the commercialization of our G4 PLATINUM, G5 Mobile and G6 systems; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">expansion of our workforce.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We expect our research and development expenses to increase in connection with our clinical trials and other development activities related to our products, including our next-generation sensors, transmitters and receivers, as well as other collaborations. We also expect that our general and administrative expenses will continue to increase due, among other things, to the additional operational and regulatory burdens applicable to public healthcare and medical device companies. As a result, it is possible that we could incur operating losses in the future. These losses, among other things, may have an adverse effect on our stockholders&#8217; equity.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">26</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">If we do not successfully optimize and operate our distribution channel or we do not effectively expand and update certain aging and/or outdated infrastructure, our operating results and customer experience may be negatively impacted.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If we do not adequately predict market demand or otherwise optimize and operate our distribution channel successfully, it could result in excess or insufficient inventory or fulfillment capacity, increased costs, immediate shortages in product or component supply, or harm our business in other ways. In addition, if we do not adequately expand and update certain aging and/or outdated infrastructure that help us, among other things, manage our purchasing and inventory, it could negatively impact our operating results and customer experience. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">If we are unable to continue the development of an adequate sales and marketing organization and/or if our direct sales organization is not successful, we may have difficulty achieving market awareness and selling our products in the future. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We must continue to develop and grow our sales and marketing organization and enter into partnerships or other arrangements to market and sell our products and/or collaborate with third parties, including distributors and others, to market and sell our products to maintain the commercial success of our G4 PLATINUM, G5 Mobile and G6 systems and to achieve commercial success for any of our future products. Developing and managing a direct sales organization is a difficult, expensive and time-consuming process. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">To continue to develop our sales and marketing organization to successfully achieve market awareness and sell our products, we must:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">recruit and retain adequate numbers of effective and experienced sales and marketing personnel; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">effectively train our sales and marketing personnel in the benefits and risks of our products; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">establish and maintain successful sales, marketing, training and education programs that educate health care professionals, including endocrinologists, physicians and diabetes educators, so they can appropriately inform their patients about our products; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">manage geographically dispersed sales and marketing operations; and </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">effectively train our sales and marketing personnel on the applicable fraud and abuse laws that govern interactions with healthcare practitioners as well as current and prospective patients and maintain active oversight and auditing measures to ensure continued compliance.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We currently employ sales and marketing personnel for the direct sale and marketing of our products in the United States, Canada and certain countries in Europe. Our direct sales and marketing team calls directly on healthcare providers and people with diabetes throughout the applicable country to initiate sales of our products. Our sales and marketing organization competes with the experienced, larger and well-funded marketing and sales operations of our competitors. We may not be able to successfully manage our dispersed sales force or increase our product sales at acceptable rates. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In some instances, we have also entered into distribution arrangements to leverage existing distributors (including wholesalers) already engaged in the distribution of drugs, devices and/or products in the diabetes marketplace. Our U.S. distribution partnerships include those distributors that are focused on accessing underrepresented regions and, in some instances, third-party payors that contract exclusively with distributors. Our European and other international distribution partners include those distributors that call directly on healthcare providers and patients to market and sell our products in </span><span style="font-family:inherit;font-size:10pt;">Australia and New Zealand, and certain countries in Africa, Asia, Europe, Latin America, and the Middle East</span><span style="font-family:inherit;font-size:10pt;">. Because of the competition for their services, we may&#160;be unable to partner with or retain additional qualified distributors. Further, we may&#160;not be able to enter into agreements with distributors on commercially reasonable terms, if at all. Our distributors might not have the resources to continue to support our recent rapid growth. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">If we are unable to establish and maintain adequate sales, marketing and distribution capabilities or enter into and maintain arrangements with third parties to sell, market and distribute our products, our business may be harmed. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have entered into distribution arrangements to leverage established distributors already engaged in the diabetes marketplace. Our distribution agreements with Byram and affiliates, Cardinal Health and affiliates (including Edgepark Medical Supplies), and AmerisourceBergen, our three most significant distributors, generated approximately </span><span style="font-family:inherit;font-size:10pt;">12%</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">17%</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">10%</span><span style="font-family:inherit;font-size:10pt;">, respectively, of our total revenue during the </span><span style="font-family:inherit;font-size:10pt;">twelve</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">. We cannot guarantee that these relationships will continue or that we will be able to maintain this volume of sales from these relationships in the future. A substantial decrease or loss of these sales could have a material adverse effect on our operating performance. To the extent that we enter into additional arrangements with third parties to perform sales, marketing, distribution and billing services in the United States, Europe or other countries, our product margins could be lower than if we directly marketed and sold our products. To the extent that we enter into co-promotion or other marketing and sales arrangements with other companies, any revenue received will depend on the skills and efforts of others, and we cannot predict whether these efforts will be successful. In addition, market acceptance of our products by physicians and people with diabetes in Europe or other countries will largely depend on our ability to demonstrate their relative safety, effectiveness, reliability, cost-effectiveness and ease of use. If we are </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">27</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">unable to do so, we may not be able to generate product revenue from our sales efforts in Europe or other countries. Finally, if we are unable to establish and maintain adequate sales, marketing and distribution capabilities, independently or with others, our future revenue may be reduced and our business may be harmed.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Although many third-party payors have adopted some form of coverage policy on continuous glucose monitoring devices, our products do not always have some form of coverage, including simple broad-based contractual coverage, with third-party payors and we frequently experience administrative challenges in obtaining reimbursement for our customers. If we are unable to obtain adequately broad reimbursement at acceptable prices for our products or any future products from third-party payors, we will be unable to generate significant revenue. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As a medical device company, reimbursement from government and/or commercial third-party healthcare payors, including Medicare and Medicaid, is an important element of our success. In January 2017, the Centers for Medicare &amp; Medicaid Services, or CMS, established a classification of &#8220;Therapeutic Continuous Glucose Monitors&#8221; as durable medical equipment under Medicare Part B, subject to payment by Medicare under certain coverage conditions to be determined by CMS, by local Medicare Administrative Contractors or on a patient claim by claim basis. This is a decision we had pursued for many years and which was made possible by the FDA&#8217;s decision in December 2016 to approve a non-adjunctive indication, or use, for our G5 Mobile system. In March 2017, CMS Medicare Administrative Contractors issued interim instructions for individual claim adjudication providing instructions and billing codes for the reimbursement of individual claims for therapeutic CGM reimbursement that apply to our G6 and G5 Mobile systems, and in May 2017, CMS Medicare Administrative Contractors issued a revision to an existing joint Local Coverage Determination, which establishes the Medicare conditions of coverage for therapeutic CGM, including G5 Mobile and G6 systems. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Similarly, in September 2016, Germany&#8217;s Federal Joint Committee agreed to provide reimbursement for continuous glucose monitoring systems under certain conditions, which we believe are met by our G4 PLATINUM, G5 Mobile and G6 systems. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A number of regulatory and commercial hurdles remain relating to wide-scale sales where a government or commercial third-party payors provide reimbursement, including sales to Medicare beneficiaries. If we are unable to successfully address these hurdles, reimbursement of our products may be limited to a smaller subset of people with diabetes covered by Medicare or to those people with diabetes covered by other third-party payors that have adopted policies for CGM devices allowing for coverage of these devices if certain conditions are met. Adverse coverage or reimbursement decisions relating to our products by CMS, its Medicare Administrative Contractors, other state, federal or international payors, and/or third-party commercial payors could significantly reduce reimbursement, which could have an impact on the acceptance of, and demand for, our products and the prices that our customers are willing to pay for them.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, the seven largest private third-party payors, in terms of the number of covered lives, have issued coverage policies for the category of CGM devices. In addition, we have negotiated contracted rates with all seven of those third-party payors for the purchase of our G4 PLATINUM, G5 Mobile and G6 systems by their members. However, people with diabetes without insurance that covers our products will have to bear the financial cost of them. In the United States, people with diabetes using existing single-point finger stick devices are generally reimbursed all or part of the product cost by Medicare or other third-party payors. The commercial success of our products in both domestic and international markets will substantially depend on whether timely and comprehensive third-party reimbursement is widely available for individuals that use them. While many third-party payors have adopted some form of coverage policy on CGM devices, typically, though not exclusively, under durable medical equipment benefits, those coverage policies frequently are restrictive and require significant medical documentation and other requirements in order for policy holders to obtain reimbursement, and as a result, we have difficulty improving the efficiency of our customer service group. Moreover, it is not uncommon for governmental, including federal and/or state, agencies and their contractors to conduct periodic routine billing and compliance reviews that may entail extensive documentation requests, cooperation with which may require significant time and resources, and may result in identification of overpayment that may need to be refunded. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, Medicare, Medicaid, other governmental health programs, health maintenance organizations and other third-party payors are increasingly attempting to contain healthcare costs by limiting both coverage and the level of reimbursement of new and existing medical devices, and, as a result, they may be restrictive, or they may not cover or provide adequate payment for our products. Many of these programs impose documentation and other eligibility requirements that make it more difficult to obtain reimbursement. In order to obtain additional reimbursement arrangements, including under pharmacy benefits, we may have to agree to a net sales price lower than the net sales price we might charge in other sales channels. Our revenue may be limited by the continuing efforts of government and third-party payors to contain or reduce the costs of healthcare through various increasingly sophisticated means, such as leveraging increased competition, increasing eligibility requirements such as second opinions and other documentation, purchasing in a bundle, or redesigning benefits. We are unable to predict what effect the current or any future healthcare reform will have on our business, or the effect these matters will have on our customers. Our dependence on the commercial success of the G4 PLATINUM, G5 Mobile and G6 systems makes us particularly susceptible to any cost containment or reduction efforts. Accordingly, unless government and other third-party </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">28</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">payors provide adequate coverage and reimbursement for the G4 PLATINUM, G5 Mobile and G6 systems, people without coverage who have diabetes may not use our products. Furthermore, payors are increasingly basing reimbursement rates on factors such as the effectiveness of the product, clinical outcomes associated with the product, and any factors that negatively impact the effectiveness or clinical outcomes (or cause a perception of any such negative impact), such as the results of a clinical trial, a product defect, or a product recall, which could negatively impact the reimbursement rate.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Medicare does not cover any items or services that are not &#8220;reasonable and necessary.&#8221; In terms of CGM, Medicare covers the CGM system, which includes supplies necessary for the use of the device, under the Durable Medical Equipment (DME) benefit category. In order to be covered under this benefit, one component of the CGM system must meet the criteria for a durable medical device. To date, the receiver satisfied this criteria. To the extent that a receiver is not used by a Medicare beneficiary or CMS otherwise determines that the items and supplies ordered are not medically necessary, Medicare may not cover that CGM system or any associated supplies.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In some foreign markets, pricing and profitability of medical devices are subject to government control. In the United States, we expect that there will continue to be federal and state proposals for similar controls. Also, the trends toward managed healthcare in the United States and legislative efforts intended to reduce the cost of government insurance programs could significantly influence the purchase of healthcare services and products and may result in lower prices for our products or the exclusion of our products from reimbursement programs. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Our products may not continue to achieve market acceptance.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We expect that sales of our G4 PLATINUM system, G5 Mobile and G6 systems will account for substantially all of our product revenue for the foreseeable future. If and when we receive FDA or other regulators&#8217; approval for, and begin commercialization of, our next-generation CGM systems, we expect most patients will migrate onto those systems. Notwithstanding our prior experience in marketing and selling our products, we might be unable to successfully expand the commercialization of our existing products or begin commercialization of our next-generation CGM systems on a wide-scale for a number of reasons, including:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">with the relatively recent FDA authorizations to market our G6 system in the United States in March 2018 and the G6 Pro in the United States in October 2019, we have relatively limited experience selling our G6 and G6 Pro systems;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our G6 system prompts the user to replace the sensor no later than the tenth day, which might make it expensive for users;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">widespread market acceptance of our products by physicians and people with diabetes will largely depend on our ability to demonstrate their relative safety, effectiveness, reliability, cost-effectiveness and ease of use;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the limited size of our sales force;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">we may not have sufficient financial or other resources to adequately expand the commercialization efforts for our products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our FDA and other regulatory reviews and/or submissions may be delayed, or approved with limited product labeling;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">we may not be able to manufacture our products in commercial quantities commensurate with demand or at an acceptable cost;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">people with Type 2 diabetes do not generally receive broad reimbursement from third-party payors for their purchase of CGM products in the United States, since many payors require that a policy holder meet specific medical criteria to qualify for reimbursement, which may reduce widespread access to or use of our products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the uncertainties associated with establishing and qualifying new manufacturing facilities;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">people with diabetes may need to incur the costs of single-point finger stick devices, in addition to our systems;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the relative immaturity of the CGM market internationally, and limited international reimbursement of CGM systems by third-party payors and government healthcare providers outside the United States;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the introduction and market acceptance of competing products and technologies, which may have a lower cost or  price, allow for a convenience improvement and allow for improved accuracy and reliability;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our inability to obtain sufficient quantities of supplies at appropriate quality levels from our single- or sole-source and other key suppliers;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our inability to manufacture products that perform in accordance with expectations of consumers; and </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">rapid technological change may make our technology and our products obsolete.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition to the risks outlined above, the G6 has improved performance and is being adopted more quickly than anticipated. There is the risk that regulatory authorities will determine that the G4 PLATINUM or G5 Mobile systems are not as </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">29</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">effective as the G6 system and may change marketing approval, reimbursement or the extent of coverage for these products. Our G4 PLATINUM, G5 Mobile and G6 systems are more invasive than many other self-monitored glucose testing systems, including single-point finger stick devices, and people with diabetes may be unwilling to insert a sensor in their body, especially if their current diabetes management involves no more than two finger sticks per day. Moreover, people with diabetes may not perceive the benefits of CGM and may be unwilling to change their current treatment regimens. In addition, physicians tend to be slow to change their medical treatment practices because of perceived liability risks arising from the use of new products. Physicians may not recommend or prescribe our products unless and until (i)&#160;there is more long-term clinical evidence to convince them to alter their existing treatment methods, (ii)&#160;there are additional recommendations from prominent physicians that our products are effective in monitoring glucose levels, and (iii)&#160;reimbursement or insurance coverage is more widely available. We cannot predict when, if ever, healthcare professionals, including physicians, and people with diabetes may adopt more widespread use of CGM systems, including our systems. If our CGM systems do not achieve and maintain an adequate level of acceptance by people with diabetes, healthcare professionals, including physicians, and third party payors, our future revenue may be reduced and our business may be harmed.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We operate in a highly competitive market and face competition from large, well-established medical device manufacturers with significant resources, and, as a result, we may not be able to compete effectively. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The market for glucose monitoring devices is intensely competitive, subject to rapid change and significantly affected by new product introductions and other market activities of industry participants. In selling the G4 PLATINUM, G5 Mobile and G6 systems, we compete directly with the Diabetes Care division of Abbott Laboratories; Medtronic plc&#8217;s Diabetes Group; Roche Diabetes Care, a division of Roche Diagnostics; privately-held LifeScan, Inc.; and Ascensia Diabetes Care, each of which manufactures and markets products for the single-point finger stick device market. Collectively, these companies currently account for the majority of the worldwide sales of self-monitored glucose testing systems. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Several companies are developing and/or commercializing products for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin that compete directly with our products. In 2015, Abbott Diabetes Care, Inc. launched a consumer flash or intermittent scan glucose monitoring system, FreeStyle Libre outside the United States. </span><span style="font-family:inherit;font-size:10pt;">Abbott</span><span style="font-family:inherit;font-size:10pt;"> first received </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> approval for a professional-use version of this system in September 2016 for use in the United States for which readings are only made available to the patient through consultation with their healthcare provider. Abbott first received FDA approval for the consumer version of this system in September 2017 for use in the United States. Medtronic plc&#8217;s Diabetes Group markets and sells a standalone glucose monitoring product called Guardian Connect, which has launched both internationally and in the United States after receiving FDA approval in 2018. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Medtronic and other third parties have developed or are developing insulin pumps integrated with CGM systems that provide, among other things, the ability to suspend insulin administration while the user&#8217;s glucose levels are low and to automate basal and bolus insulin dosing. Medtronic launched its 670G insulin delivery system in 2017.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Some of the companies developing or marketing competing devices are publicly traded or divisions of publicly traded companies, and these companies may possess competitive advantages over us, including:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">greater name recognition;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">established relations with healthcare professionals, customers and third-party payors;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">established distribution networks;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">additional lines of products, and the ability to bundle products to offer higher discounts or incentives to gain a competitive advantage;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">greater experience in conducting research and development, manufacturing, clinical trials, obtaining regulatory approval for products and marketing approved products; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the ability to integrate multiple products to provide additional features beyond CGM systems; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">greater financial and human resources for product development, manufacturing, sales and marketing, and patent litigation.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As a result, we may not be able to compete effectively against these companies or their products, which may adversely impact our business. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additionally, some of our competitors are not subject to the Stark Law, since they do not bill Medicare directly for similar CGM systems and products. As noted above, the Stark Law is a strict liability statute and therefore, in order to ensure continued compliance, we must satisfy highly technical exceptions. These compliance efforts may limit our ability to engage in marketing practices commonly utilized by our competitors and as a result, our sales volumes may not keep pace. Conversely, if we do not strictly satisfy all criteria of an applicable Stark Law exception, we run the risk of incurring substantially financial penalties in the form of fines and potential False Claims Act damages as well as potential exclusion from participation in federal healthcare programs.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">30</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Technological breakthroughs by us or our competitors could materially impact sales of current or future generations of our products. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The glucose monitoring market is subject to rapid technological change and product innovation. Our products are based on our proprietary technology, but a number of companies and medical researchers are pursuing new technologies for the monitoring of glucose levels. </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> or other regulatory approval of a commercially viable continuous glucose monitor or sensor produced by one of our competitors could significantly reduce market acceptance of our systems. Several of our competitors are in various stages of developing continuous or flash or intermittent scan glucose monitors or sensors, including non-invasive and invasive devices, and the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> has approved a number of these competing products. In addition, certain development efforts throughout the diabetes industry, including that of the National Institutes of Health and other supporters of diabetes research are continually seeking ways to prevent, cure or improve treatment of diabetes. Therefore, our products may be rendered obsolete by technological breakthroughs in diabetes monitoring, treatment, prevention or cure. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, in the periods leading up to the launch of new or upgraded versions of our CGM systems, our customers&#8217; anticipation of the release of those products may cause them to cancel, change or delay current period purchases of our current products, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Quality problems could lead to recalls or safety alerts, reputational harm, and could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Quality is very important to us and our customers due to the serious and costly consequences of product failure, and our business exposes us to potential product liability risks that are inherent in the design, manufacture, and marketing of medical devices. Since the first commercial launch of our products in 2006, we have had periodic field failures related to our products and associated services, including reports of sensor errors, sensor failures, broken sensors, receiver malfunctions, audible alarms and alert failures, as well as server and transmitter failures. To comply with the FDA&#8217;s medical device reporting requirements, we have filed reports of applicable field failures. Although we believe we have taken and are taking appropriate action aimed at reducing and/or eliminating field failures, we anticipate that we will have other product failures in the future. Product or component failures, manufacturing nonconformances, design defects, off-label use, or inadequate disclosure of product-related risks or product-related information with respect to our products, if they were to occur, could result in an unsafe condition or injury to, or death of, a patient. These problems could lead to recall of, or issuance of a safety alert relating to, our products, and could result in product liability claims and lawsuits. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additionally, the production of our products must occur in a highly controlled and clean environment to minimize particles and other yield- and quality-limiting contaminants. Weaknesses in process control or minute impurities in materials may cause a substantial percentage of defective products. If we are not able to maintain stringent quality controls, or if contamination problems arise, our clinical development and commercialization efforts could be delayed, which would harm our business and our results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If we fail to meet any applicable product quality standards and our products are the subject of recalls or safety alerts, our reputation could be damaged, we could lose customers, our reputation could be harmed and our revenue and results of operations could decline. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We may never receive approval, marketing authorization or clearance from the U.S. </span><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">FDA</span><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"> and other governmental agencies to market additional CGM systems, expanded indications for use of current and future generation CGM systems, future software platforms, or any other products under development.</span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2018, via the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</span><span style="font-family:inherit;font-size:10pt;"> process, the FDA classified the G6 and substantially equivalent devices of this generic type (&#8220;integrated continuous glucose monitoring systems&#8221; or &#8220;iCGMs&#8221;) into Class II, meaning that going forward products of this generic type may utilize the 510(k) pathway.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Any subsequent modification of our G6 that could significantly affect its safety or effectiveness (for example, a significant change in design or manufacture), or that would constitute a major change in its intended use, will require us to obtain a new 510(k) clearance or could require a new </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</span><span style="font-family:inherit;font-size:10pt;"> submission or a PMA. The FDA requires each manufacturer to make this determination initially, but the FDA may review any such decision and may disagree with a manufacturer&#8217;s determination. If the FDA disagrees with a manufacturer&#8217;s determination, the FDA may require the manufacturer to cease marketing and/or recall the modified device until appropriate clearance or approval is obtained. Under these circumstances, the FDA may also subject a manufacturer to significant regulatory fines or other penalties.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:11pt;"><span style="font-family:inherit;font-size:10pt;">If future product candidates are not deemed by the FDA to meet the criteria for submission under the 510(k) pathway, or for down-classification under the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</span><span style="font-family:inherit;font-size:10pt;"> process or otherwise, we would need to pursue a </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;">. The </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> process requires us to prove the safety and effectiveness of our systems to the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">&#8217;s satisfaction. This process can be expensive, prolonged and uncertain, requires detailed and comprehensive scientific and human clinical data, and may never result in the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> granting a </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;">. In March 2018, our G6 system received </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</span><span style="font-family:inherit;font-size:10pt;"> classification from the FDA to be a Class II medical device. The </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</span><span style="font-family:inherit;font-size:10pt;"> classification under the generic name </span><span style="font-family:inherit;font-size:11pt;">&#8220;</span><span style="font-family:inherit;font-size:10pt;">integrated continuous glucose monitoring system,</span><span style="font-family:inherit;font-size:11pt;">&#8221;</span><span style="font-family:inherit;font-size:10pt;"> makes the G6 a predicate </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">31</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">device for future 510(k) submissions. Complying with this classification requires ongoing compliance with the general controls required by the federal Food Drug and Cosmetic Act and the special controls specified by the FDA&#8217;s G6 order. Any future system or expanded indications for use of current generation systems will require approval of the applicable regulatory authorities. In addition, we intend to seek either 510(k) clearances or </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> approvals for certain changes and modifications to our existing software platform, but cannot predict when, if ever, those changes and modifications will be approved.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> can refuse to grant a 510(k) clearance or a </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</span><span style="font-family:inherit;font-size:10pt;"> request for marketing authorization, or delay, limit or deny approval of a </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;"> application or supplement for many reasons, including: </span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the system may not be deemed by the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> to be substantially equivalent to appropriate predicate devices under the 510(k) pathway; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the system may not satisfy the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">&#8217;s safety or effectiveness requirements; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the data from pre-clinical studies and clinical trials may be insufficient to support approval, clearance and/or marketing authorization; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the manufacturing process or facilities used may not meet applicable requirements; and </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">changes in </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> approval policies or adoption of new regulations may require additional data. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Even if approved or cleared by the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> or foreign regulatory agencies, future generations of our CGM systems, expanded indications for use of current and future generation CGM systems, our software platforms or any other CGM system under development, may not be approved or cleared for the indications that are necessary or desirable for successful commercialization. We may not obtain the necessary regulatory approvals or clearances to market these CGM systems in the United States or outside of the United States. Any delay in, or failure to receive or maintain, approval or clearance for our products could prevent us from generating revenue from these products or achieving profitability. The uncertain timing of regulatory approvals for future generations of our products could subject our current inventory to excess or obsolescence charges, which could have an adverse effect on our business, financial condition and operating results.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">If we are unable to successfully complete the pre-clinical studies or clinical trials necessary to support additional </span><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">PMA</span><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">, de novo,&#160;or&#160;510(k) applications or supplements, we may be unable to commercialize our CGM systems under development, which could impair our business, financial condition and operating results.</span><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">To support current and any future additional </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;">, 510(k), </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo </span><span style="font-family:inherit;font-size:10pt;">applications or supplements, we together with our partners, must successfully complete pre-clinical studies, bench-testing, and in some cases clinical trials that will demonstrate that the product is safe and effective. Product development, including pre-clinical studies and clinical trials, is a long, expensive and uncertain process and is subject to delays and failure at any stage. Furthermore, the data obtained from the studies and trials may be inadequate to support approval of an application and the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> may request additional clinical data in support of those applications, which may result in significant additional clinical expenses and may delay product approvals. While we have in the past obtained, and may in the future obtain, an investigational device exemption, or IDE, prior to commencing clinical trials for our products, </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> approval of an </span><span style="font-family:inherit;font-size:10pt;">IDE</span><span style="font-family:inherit;font-size:10pt;"> application permitting us to conduct testing does not mean that the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> will consider the data gathered in the trial to be sufficient to support approval of a </span><span style="font-family:inherit;font-size:10pt;">PMA</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</span><span style="font-family:inherit;font-size:10pt;"> or 510(k) application or supplement, even if the trial&#8217;s intended safety and effectiveness endpoints are achieved. Additionally, since 2009, the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> has significantly increased the scrutiny applied to its oversight of companies subject to its regulations, including device marketing submissions, by hiring new investigators and increasing the frequency and scope of its inspections of manufacturing facilities. The ongoing oversight by the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">&#8217;s Center for Devices and Radiological Health could complicate the product approval process for certain of our and our partners&#8217; products, and we cannot predict the effect of such procedural changes and cannot ascertain if such changes will have a substantive impact on the approval of our products or our partners&#8217; products. If we fail to adequately respond to any&#160;changes&#160;to the 510(k) submission process and associated matters, our business may be adversely impacted. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unexpected changes to the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> or foreign regulatory approval processes could also delay or prevent the approval of our products submitted for review. For example, as part of the 21</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">st</sup></span><span style="font-family:inherit;font-size:10pt;"> Century Cures Act passed in 2016, Congress enacted several reforms that further affect medical device regulation both pre- and post-approval. In addition, the FDA is in the process of reviewing the 510(k) approval process and criteria and has announced initiatives to improve the current pre- and post-market regulatory processes and requirements associated with infusion pumps and other home use medical devices. As part of this effort, the FDA is reviewing the adverse event reporting and recall processes for insulin pumps. Any change in the laws or regulations that govern the clearance and approval processes relating to our current and future products could make it more difficult and costly to obtain clearance or approval for new products, or to produce, market and distribute existing products. The data contained in our submissions, including data drawn from our clinical trials, may not be sufficient to support approval of our products or additional or expanded indications. Medical device company stock prices have declined significantly in certain circumstances where companies have failed to meet expectations in regards to the timing of regulatory approval. If the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">&#8217;s response causes product approval delays, or is not favorable for any of our products, our stock price (and the market price of </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">32</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our convertible notes) could decline substantially. In November 2018, the FDA announced that it plans to make further changes aimed at modernizing the 510(k) clearance pathway, creating further uncertainty. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">The commencement or completion of any of our clinical trials may be delayed or halted, or be inadequate to support approval of FDA marketing applications</span><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;"> </span><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">or supplements, for numerous reasons, including, but not limited to, the following: </span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> or other regulatory authorities do not approve a clinical trial protocol or a clinical trial, or place a clinical trial on hold; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">patients do not enroll in clinical trials at the rate we expect; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">patients do not comply with trial protocols; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">patient follow-up does not occur at the rate we expect; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">patients experience adverse side effects; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">patients die during a clinical trial, even though their death may not be related to our products; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">institutional review boards and third-party clinical investigators may delay or reject our trial protocol; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">third-party clinical investigators decline to participate in a trial or do not perform a trial on our anticipated schedule or consistent with the investigator agreements, clinical trial protocol, good clinical practices or other </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> or institutional review board requirements; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DexCom or third-party organizations do not perform data collection, monitoring and/or analysis in a timely or accurate manner or consistent with the clinical trial protocol or investigational or statistical plans; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">third-party clinical investigators have significant financial interests related to DexCom or the study that the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> deems to make the study results unreliable, or DexCom or investigators fail to disclose such interests; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">regulatory inspections of our clinical trials or manufacturing facilities may, among other things, require us to undertake corrective action or suspend or terminate our clinical trials; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">changes in governmental regulations, policies or administrative actions applicable to our trial protocols; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the interim or final results of the clinical trial are inconclusive or unfavorable as to safety or efficacy; and </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> concludes that the results from our trial and/or trial design are inadequate to demonstrate safety and effectiveness of the product. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The results of pre-clinical studies do not necessarily predict future clinical trial results, and prior clinical trial results might not be repeated in subsequent clinical trials. Additionally, the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> may disagree with our interpretation of the data from our pre-clinical studies and clinical trials, or may find the clinical trial design, conduct or results inadequate to prove safety or effectiveness, and may require us to pursue additional pre-clinical studies or clinical trials, which could further delay the approval of our products. If we are unable to demonstrate the safety and effectiveness of our products in our clinical trials to the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">&#8217;s satisfaction, we will be unable to obtain regulatory approval to market our products in the United States. In addition, the data we collect from our current clinical trials, our pre-clinical studies and other clinical trials may not be sufficient to support </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> approval, even if our endpoints are met. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We may also conduct clinical studies to demonstrate the relative or comparative effectiveness of CGM systems for the treatment of diabetes. These types of studies, which often require substantial investment and effort, may not show adequate, or any, clinical benefit for the use of CGM systems.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We depend on clinical investigators and clinical sites to enroll patients in our clinical trials and other third parties to manage the trials and to perform related data collection and analysis, and, as a result, we may face costs and delays that are outside of our control.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We rely on clinical investigators and clinical sites to enroll patients in our clinical trials, and other third parties to manage the trial and to perform related data collection and analysis. However, we may not be able to control the amount and timing of resources that clinical sites may devote to our clinical trials. If these clinical investigators and clinical sites fail to enroll a sufficient number of patients in our clinical trials or fail to ensure compliance by patients with clinical protocols or fail to comply with regulatory requirements, we will be unable to complete these trials, which could prevent us from obtaining regulatory approvals for our products. Our agreements with clinical investigators and clinical sites for clinical testing place substantial responsibilities on these parties and, if these parties fail to perform as expected, our trials could be delayed or terminated. If these clinical investigators, clinical sites or other third parties do not carry out their contractual duties or obligations or fail to meet expected deadlines, or if the quality or accuracy of the clinical data they obtain is compromised due to their failure to adhere to our clinical protocols, regulatory requirements or for other reasons, our clinical trials may be extended, delayed or terminated, or the clinical data may be rejected by the FDA, and we may be unable to obtain regulatory approval for, or successfully commercialize, our products.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">33</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Potential long-term complications from our current or future products or other CGM systems under development may not be revealed by our clinical experience to date.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Based on our experience, complications from use of our products may include sensor errors, sensor failures, broken sensors, lodged sensors or skin irritation under the adhesive dressing of the sensor. Inflammation or redness, swelling, minor infection, and minor bleeding at the sensor insertion site are also possible risks with an individual&#8217;s use of our products. However, if unanticipated long-term side-effects result from the use of our products or other glucose monitoring systems we have under development, we could be subject to liability and the adoption of our systems may become more limited. With respect to our G4 PLATINUM and G5 Mobile systems, our clinical trials have been limited to seven days of continuous use, and with respect to our G6, our clinical trials have been limited to ten days of continuous use. It is possible that the results from our clinical studies and trials may not be indicative of the clinical results obtained when we examine the patients at later dates. We cannot assure you that repeated, long-term use would not result in unanticipated adverse effects, potentially even after the sensor is removed.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We enter into collaborations with third parties that may not result in the development of commercially viable products or the generation of significant future revenues.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the ordinary course of our business, we enter into collaborative arrangements to develop new products and to pursue new markets, such as our agreements with Eli Lilly, Insulet, Novo Nordisk and Tandem Diabetes, to integrate our CGM technology into their insulin delivery systems, and our amended agreement with Verily to develop one or more next-generation CGM products. Our Eli Lilly, Insulet, Novo Nordisk and Verily collaborations have not yet resulted in a commercial product. In December 2019, Tandem received FDA approval for its second sensor-augmented insulin delivery system, the t:slim X2&#8482; Insulin Pump with Control-IQ&#8482; technology, which integrates with our G6 system.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As a result of these development relationships, our operating results depend, to some extent, on the ability of our development partners to successfully commercialize their insulin delivery systems or monitoring products. Any factors that may limit our partners&#8217; ability to achieve widespread adoption of their systems, including competitive pressures, technological breakthroughs for the treatment or prevention of diabetes, adverse regulatory or legal actions relating to insulin pump products, or changes in reimbursement rates or policies of third-party payors relating to insulin pumps or similar products, could have an adverse impact on our operating results. For example, Animas announced in September 2017 that it has discontinued the manufacturing and sale of Animas&#174; Vibe&#174; and OneTouch Ping&#174; insulin pumps, then exited the insulin pump business. Animas selected Medtronic as its partner to facilitate a seamless transition for patients, caregivers and healthcare providers. Patients using an Animas insulin pump are offered the option to transfer to a Medtronic pump. As Animas Vibe is compatible with DexCom&#8217;s products, and Animas has served as a distributor for our products in certain geographies, the transition of Animas customers to Medtronic pumps, which are not integrated with our sensors, may adversely impact our revenues. As another example, UnitedHealthcare announced, effective July 1, 2016, that UnitedHealthcare Community Plan and Commercial members will no longer have an in-network choice among providers of insulin pumps, and designated Medtronic as its preferred, in-network provider. We do not have a relationship to integrate our CGM technology with Medtronic, which has developed an insulin pump augmented with its proprietary CGM system. The decision by UnitedHealthcare to establish Medtronic as its preferred provider of insulin pumps could result in a material reduction in the number of insulin pumps sold by other insulin pump manufacturers, including Tandem and Insulet. In addition, it is possible that other large third-party payors will establish preferred providers of insulin pumps, which may or may not include the pumps produced by our development partners.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Many of the companies that we collaborate with are also competitors or potential competitors who may decide to terminate our collaborative arrangement. In the event of such a termination, we may be required to devote additional resources to product development and commercialization, we may need to cancel some development programs and we may face increased competition. Additionally, collaborations may not result in the development of products that achieve commercial success and could be terminated prior to developing any products. Former collaborators may use the experience and insights they develop in the course of their collaborations with us to initiate or accelerate their development of products that compete with our products, which may create competitive disadvantages for us. Accordingly, we cannot provide assurance that any of our collaborations will result in the successful development of a commercially viable product or result in significant additional future revenues.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, our development timelines are highly dependent on our ability to achieve clinical endpoints and regulatory requirements and to overcome technology challenges, and may be delayed due to scheduling issues with patients and investigators, requests from institutional review boards, product performance and manufacturing supply constraints, among other factors. In addition, support of these clinical trials requires significant resources from employees involved in the production of our products, including research and development, manufacturing, quality assurance, and clinical and regulatory personnel. Even if our development and clinical trial efforts succeed, the FDA may not approve the combined products or may require additional product testing and clinical trials before approving the combined products, which would result in product </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">34</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">launch delays and additional expense. If approved by the FDA, the combined products may not be accepted in the marketplace by physicians and people with diabetes.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Our success will depend on our ability to attract and retain our personnel, while controlling labor costs.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We depend to a significant degree on our senior management, especially Kevin Sayer, our President and Chief Executive Officer. Our success will depend on our ability to retain our senior management and to attract and retain qualified personnel in the future, including sales persons, scientists, clinicians, engineers and other highly skilled personnel. Competition for senior management personnel, as well as sales persons, scientists, clinicians and engineers, is intense and we may not be able to retain our personnel. The loss of the services of members of our senior management, scientists, clinicians or engineers could prevent the implementation and completion of our objectives, including the commercialization of our current products and the development and introduction of additional products. The loss of a member of our senior management or our professional staff would require the remaining executive officers to divert immediate and substantial attention to seeking a replacement. Each of our officers may terminate their employment at any time without notice and without cause or good reason. Additionally, volatility or a lack of positive performance in our stock price may adversely affect our ability to retain key employees.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We expect to continue to expand our operations and grow our research and development, manufacturing, sales and marketing, product development and administrative operations. We expect this expansion to place a significant strain on our management and it will require hiring a significant number of qualified personnel. Accordingly, recruiting and retaining such personnel will be critical to our success. There is intense competition from other companies and research and academic institutions for qualified personnel in the areas of our activities. If we fail to identify, attract, retain and motivate these skilled personnel, we may be unable to continue our development and commercialization activities.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We may undertake a reorganization of our workforce, which may result in a temporary reduction in the number of employees in certain locations. We would undertake a reorganization to reduce operating expenses, though we cannot guarantee any specific amount of long-term cost savings. Further, the turnover in our employee base could result in operational and administrative inefficiencies, which could adversely impact the results of our operations, stock price and customer relationships, and could make recruiting for future management and other positions more difficult.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We may conduct additional financings to continue the commercialization of our G4 PLATINUM, G5 Mobile and G6 systems, or the development and commercialization of our future generation CGM and other systems.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our operations have consumed substantial amounts of cash since inception. We expect to continue to spend substantial amounts on commercialization of our products, including growth of our manufacturing capacity, and on research and development, including conducting clinical trials for our next-generation ambulatory CGM sensors and systems. Although we raised </span><span style="font-family:inherit;font-size:10pt;">$389.0 million</span><span style="font-family:inherit;font-size:10pt;"> in net proceeds through the private sale of our convertible notes in June 2017, $75.0 million of which was used to repay our credit facility, </span><span style="font-family:inherit;font-size:10pt;">$836.6 million</span><span style="font-family:inherit;font-size:10pt;"> in net proceeds through the private sale of our convertible notes in November 2018, </span><span style="font-family:inherit;font-size:10pt;">$100.0 million</span><span style="font-family:inherit;font-size:10pt;"> of which we used to purchase shares of our common stock, and now have </span><span style="font-family:inherit;font-size:10pt;">$195.6 million</span><span style="font-family:inherit;font-size:10pt;"> available to us under our credit facility (as reduced by our outstanding letters of credit), we could need funds to continue the commercialization of our current products and to develop and commercialize our next-generation sensors and systems or pursue other strategic initiatives. Additional financing may not be available on a timely basis on terms acceptable to us, or at all. Any additional financing may be dilutive to stockholders or may require us to grant a lender a security interest in our assets. The amount of funding we may need will depend on many factors, including:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the revenue generated by sales of our products and other future products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the costs, timing and risks of delay of additional regulatory approvals;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the expenses we incur in manufacturing, developing, selling and marketing our products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our ability to scale our manufacturing operations to meet demand for our current and any future products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the costs to produce our continuous glucose monitoring systems;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the rate of progress and cost of our clinical trials and other development activities; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the success of our research and development efforts;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the emergence of competing or complementary technologies;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the terms and timing of any collaborative, licensing and other arrangements that we may establish;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the cost of ongoing compliance with legal and regulatory requirements, and third-party payors&#8217; policies;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the cost of obtaining and maintaining regulatory or payor clearance or approval for our current or future products including those integrated with other companies&#8217; products; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the acquisition of business, products and technologies, although we currently have no commitments or agreements relating to any of these types of transactions. </span></div></td></tr></table><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">35</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If adequate funds are not available, we may not be able to commercialize our products at the rate we desire and/or we may have to delay the development or commercialization of our products or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize. We also may have to reduce sales, marketing, customer support or other resources devoted to our products. Any of these factors could harm our business and financial condition.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Uncollectible uninsured and patient due accounts could adversely affect our results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The primary collection risks for our accounts receivable relate to the uninsured patient accounts and patient accounts for which the primary insurance carrier has paid the amounts covered by the applicable agreement, but patient responsibility amounts (exclusions, deductibles and copayments) remain outstanding. In the event that we are unsuccessful in collecting payments owed by patients, and/or experience increases in the amount, or deterioration in the collectability, of uninsured and patient due accounts receivable, this could adversely affect our cash flows and results of operations. We may also be adversely affected by the growth in patient responsibility accounts as a result of increases in the adoption of plan structures, due to evolving health care policy and insurance landscapes that shift greater responsibility for care to individuals through greater exclusions and copayment and deductible amounts.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Environmental and social (E&amp;S) regulations, policies and provisions, as well as customer demand, may make our supply chain more complex and may adversely affect our relationships with customers.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There is an increasing focus on the governance of environmental and social risks. A number of our customers have adopted, or may adopt, procurement policies that include E&amp;S provisions that their suppliers must comply with, or they may seek to include such provisions in their terms and conditions. An increasing number of participants in the medical device industry are also joining voluntary E&amp;S initiatives, such as the Responsible Business Alliance. These E&amp;S provisions and initiatives are subject to change, can be unpredictable, and may be difficult and expensive for us to comply with, given the complexity of our supply chain and the outsourced manufacturing of certain components of our products. If we are unable to comply, or are unable to cause our suppliers to comply, with such policies or provisions, a customer may stop purchasing products from us, and may take legal action against us, which could harm our reputation, revenue and results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, as part of their E&amp;S programs, an increasing number of industry participants are seeking to source products that do not contain minerals sourced from areas where proceeds from the sale of such minerals are likely to be used to fund armed conflict, such as in the Democratic Republic of the Congo. This could adversely affect the sourcing, availability and pricing of minerals used in the manufacture of medical device, including our products. Since our supply chain is complex, we are not currently able to definitively ascertain the origins of all of the minerals and metals used in our products. As a result, we may face difficulties in satisfying these customers&#8217; demands, which may harm our sales and operating results.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Risks Related to Healthcare Industry Shifts and Changing Regulations</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Managed care trends and consolidation in the health care industry could have an adverse effect on our revenues and results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Private third-party payors and other managed care organizations,  such as pharmacy benefit managers, continue to take action to manage the utilization and control cost. Consolidation among managed care organizations has increased the negotiating power of managed care organizations and other private third-party payors. Private third-party payors, as well as governments, increasingly employ formularies to control costs by taking into account discounts in connection with decisions about formulary inclusion or favorable formulary placement. Failure to obtain or maintain timely adequate pricing or favorable formulary placement for our products, or failure to obtain such formulary placement at favorable pricing, could adversely impact revenue. Private third-party payors, including self-insured employers, often implement formularies with copayment tiers to encourage utilization of certain products and have also been raising co-payments required from beneficiaries, particularly for higher cost products. Private third-party payors also use additional measures such as value-based pricing/contracting to improve their cost containment efforts. Private third-party payors also are increasingly imposing utilization management tools, such as requiring prior authorization or requiring the patient to first fail on a lower cost product before permitting access to a higher cost product. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Many health care industry companies, including health care systems, distributors, manufacturers, providers, and insurers, are also consolidating or have formed strategic alliances. As the health care industry consolidates, competition to provide goods and services to industry participants may become more intense. This consolidation will continue to create larger enterprises with greater negotiating power, which they can try to use to negotiate price concessions or reductions for medical devices and components produced by us. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As the U.S. payor market consolidates further and we face greater pricing pressure from private third-party payors, who will continue to drive more of their patients to use lower cost alternatives, we may lose customers, our revenues may decrease and our business, financial condition, results of operations and cash flows may suffer.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">36</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Health care policy changes, including U.S. health care reform legislation, may have a material adverse effect on our business.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In response to perceived increases in health care costs in recent years, there have been and continue to be proposals by the federal government, state governments, regulators, and third-party payors to control these costs and, more generally, to reform the U.S. health care system. Certain of these proposals could limit the prices we are able to charge for our products or the amounts of reimbursement available for our products and could limit the acceptance and availability of our products. Further, while the United States has begun shifting to pay-for-performance rather than fee-for-service models and has been embracing many shared-risk arrangements, CMS and OIG specifically proposed to exclude medical device manufacturers from utilizing the new, more flexible Stark Law exceptions and Anti-Kickback Statute safe harbors under the Proposed Rules to Amend the Stark Law and Anti-Kickback Statute exceptions and safe harbors, part of the U.S. Department of Health and Human Services&#8217; Regulatory Sprint to Coordinated Care. This exclusion would not allow us to avail ourselves of the protections available under these exceptions and safe harbors, inviting greater scrutiny over our shared risk arrangements. The adoption of some or all of these proposals could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive healthcare legislation, signed into law in the United States in March 2010, titled the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act of 2010, collectively, the ACA, imposes certain stringent compliance, recordkeeping, and reporting requirements on companies in various sectors of the life sciences industry, with which we may need to comply, and enhanced penalties for non-compliance with the new and revised healthcare laws. However, there are many programs and requirements under the ACA for which the consequences are not fully understood, and it is unclear what the full impact will ultimately be from the ACA. Costs of compliance with this legislation, or any future amendments thereto, may have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The ACA also focuses on a number of Medicare provisions aimed at improving quality and decreasing costs. It is uncertain at this point what negative unintended consequences these provisions will have on patient access to new technologies. The Medicare provisions include value-based payment programs, increased funding of comparative effectiveness research, reduced hospital payments for avoidable readmissions and hospital acquired conditions, and pilot programs to evaluate alternative payment methodologies that promote care coordination, such as bundled physician and hospital payments.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We cannot predict whether the ACA will be repealed, replaced, or modified, or how such repeal, replacement or modification may be timed or structured. As a result, we cannot quantify or predict what the effect of such repeal, replacement, or modification might have on our business and results of operations. However, any changes that lower reimbursement for our products could materially and adversely affect our business, financial condition and results of operations. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There are pending federal Congressional proposals that would significantly expand government-provided health insurance coverage. Proposals range from establishing a single-payor, national health insurance system (e.g., Medicare for All Act of 2019 (H.R. 1384), to more limited buy-in options that would be available to individuals above a certain age (e.g., Medicare at 50 Act (S. 470). There is also legislation that would authorize states to permit individuals to &#8220;buy-in&#8221; to their state Medicaid program (e.g., State Public Option Act (S. 489, H.R. 1277)). If enacted, these proposals will likely have a significant impact on the healthcare industry. At this stage, we cannot predict how future legislation will affect our business. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other legal, regulatory and commercial policy influences are subjecting our industry to significant changes, and we cannot predict whether new regulations or policies will emerge from U.S. federal or state governments, foreign governments, or third-party payors. Government and commercial payors may, in the future, consider healthcare policies and proposals intended to curb rising healthcare costs, including those that could significantly affect reimbursement for healthcare products such as our systems. These policies have included, and may in the future include: basing reimbursement policies and rates on clinical outcomes, the comparative effectiveness, and costs, of different treatment technologies and modalities; imposing price controls and taxes on medical device providers; and other measures. Future significant changes in the healthcare systems in the United States or elsewhere could also have a negative impact on the demand for our current and future products. These include changes that may reduce reimbursement rates for our products and changes that may be proposed or implemented by the current or future laws or regulations.</span></div><div style="line-height:100%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Risks Related to Non-Compliance with Laws, Regulations and Contractual Requirements</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We conduct business in a heavily regulated industry and if we fail to comply with applicable laws and government regulations, we could become subject to penalties, excluded from participation in government programs, and/or be required to make significant changes to our operations. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The healthcare industry generally, and our business specifically, is subject to extensive foreign, federal, state and local laws and regulations, including those relating to: </span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">authorizations necessary for the investigation and commercial marketing of products;</span></div></td></tr></table><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">37</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the pricing of our products and services;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the distribution of our products and services;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">billing for products and services; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the obligation to report and return identified overpayments;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">financial relationships with physicians and other referral sources; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">inducements and courtesies given to physicians and other health care providers and patients; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">labeling products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the characteristics and quality of our products and services; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">confidentiality, maintenance and security issues associated with medical records and individually identifiable health and other personal information;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">medical device adverse event reporting; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">prohibitions on kickbacks, including the Anti-Kickback Statute and related laws and/or regulations;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">any scheme to defraud any healthcare benefit program;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">physician and other healthcare professional payment disclosure requirements;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">use and disclosure of personal health information;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">privacy of health information and personal information;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">data protection and data localization;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">mobile communications;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">patient access and non-discrimination;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">patient consent;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">false claims; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">professional licensure.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">These laws and regulations are extremely complex and, in many cases, still evolving. If our operations are found to violate any of the foreign, federal, state or local laws and regulations which govern our activities, we may be subject to litigation, government enforcement actions, and applicable penalties associated with the violation, potentially including civil and criminal penalties, damages, fines, exclusion from participation in certain payor programs or curtailment of our operations. Compliance obligations under these various laws are oftentimes detailed and onerous, further contributing to the risk that we could be found to be out of compliance with particular requirements. The risk of being found in violation of these laws and regulations is further increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, particularly with respect to new and emerging technologies and remote delivery of services, and their provisions are open to a variety of interpretations. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The FDA, CMS, OIG, Department of Justice, states&#8217; attorneys general and other governmental authorities actively enforce the laws and regulations discussed above. In the United States, medical device manufacturers have been the target of numerous government prosecutions and investigations alleging violations of law, including claims asserting impermissible off-label promotion of medical devices, payments intended to influence the referral of federal or state healthcare business, and submission of false claims for government reimbursement. While we make every effort to comply with applicable laws, we cannot rule out the possibility that the government or other third parties could interpret these laws differently and challenge our practices under one or more of these laws. This likelihood of allegations of non-compliance is increased by the fact that under certain federal and state laws applicable to our business, individuals, known as relators, may bring an action on behalf of the government alleging violations of such laws, and potentially be awarded a share of any damages or penalties ultimately awarded to the applicable government body.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Under the United States Federal Food, Drug, and Cosmetic Act, medical devices are classified into one of three classes &#8211; Class I, Class II or Class III &#8211; depending on the degree of risk associated with each medical device and the extent of control needed to ensure safety and effectiveness. Our G6 has been classified as a Class II device. Class II devices are subject to various general and special controls, including the Quality System Regulations and 510(k) pre-market notification requirements.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">From time to time, the FDA may disagree with the classification of a new Class II medical device and require the manufacturer of that device to apply for approval as a Class III medical device. In the event that the FDA determines that our Class II medical products should be classified as Class III medical devices, we could be precluded from marketing the devices for clinical use within the United States for months, years or longer, depending on the specific change in the classification. Reclassification of our Class II medical products as Class III medical devices could significantly increase our regulatory costs, including the timing and expense associated with required clinical trials and other costs.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">38</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Any action against us alleging a violation of these laws or regulations, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s time and attention from the operation of our business, and have a material effect on our business. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, the laws and regulations impacting or affecting our business may change significantly in the future. Any new laws or regulations may adversely affect our business. A review of our business by courts or regulatory authorities may result in a determination that could adversely affect our operations. Also, the regulatory environment applicable to our business may change in a way that restricts or adversely impacts our operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Our failure to comply with laws, regulations and contract requirements relating to reimbursement of health care goods and services may subject us to penalties and adversely impact our reputation, business, financial condition and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:11pt;"><span style="font-family:inherit;font-size:10pt;">Our products are purchased principally by individual patients, who may be eligible for insurance coverage of their devices from various third-party payors, such as governmental programs (</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">e.g.</span><span style="font-family:inherit;font-size:10pt;">, Medicare, Medicaid, TRICARE, other federal and state health benefit plans, and comparable non-U.S. programs), private insurance plans, and managed care plans. The ability of our customers to obtain appropriate reimbursement for products and services</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span><span style="font-family:inherit;font-size:10pt;">from third-party payors is critical because it affects which products customers purchase and the prices they are willing to pay. As a result, our products are subject to regulation regarding quality and cost by the U.S. Department for Health &amp; Human Services, including CMS, as well as comparable state and non-U.S. agencies responsible for reimbursement and regulation of health care goods and services. The principal U.S. federal laws that implicate reimbursement issues include those that prohibit (i) the filing of false or improper claims for federal payment, known as the federal civil False Claims Act, (ii) unlawful inducements for the referral of business reimbursable under federally-funded health care programs, known as the federal Anti-Kickback Statute, and (iii) health care service providers from seeking reimbursement for providing certain services to a patient who was referred by a physician who has certain types of direct or indirect financial relationships with the service provider, known as the federal Physician Self-Referral law, or commonly referred to as the </span><span style="font-family:inherit;font-size:11pt;">&#8220;</span><span style="font-family:inherit;font-size:10pt;">Stark Law.</span><span style="font-family:inherit;font-size:11pt;">&#8221;</span><span style="font-family:inherit;font-size:10pt;"> Many states have similar laws that apply to reimbursement by state Medicaid and other government-funded programs, as well as, in some cases, to all payors, including self-pay patients. In addition, the federal civil False Claims Act requires the reporting and returning of identified overpayments received from federal health care programs within 60 days of identification and quantification, and requires the exercise of reasonable diligence to investigate credible information regarding potential overpayments. Failure to timely refund known overpayments from federal healthcare programs, such as Medicare and Medicaid, would subject a company to civil False Claims Act liability. Insurance companies can also bring a private cause of action claiming treble damages against a manufacturer for causing a false claim to be filed under the federal Racketeer Influenced and Corrupt Organizations Act, or RICO. Additionally, as a manufacturer of U.S. FDA&#8209;approved devices reimbursable by federal healthcare programs, we are subject to the federal Physician Payments Sunshine Act, which requires us to annually report certain payments and other transfers of value we make to U.S.-licensed physicians or U.S. teaching hospitals. On October 25, 2018, President Trump signed into law the &#8220;Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act.&#8221; This law, in part (under a provision entitled &#8220;Fighting the Opioid Epidemic with Sunshine&#8221;), extends the reporting and transparency requirements for physicians in the Physician Payments Sunshine Act, to physician assistants, nurse practitioners, and other mid-level practitioners. Reporting requirements will go into effect in 2022 for payments and transfers of value made to these additional practitioner-types in 2021.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We may be subject to these and other laws regulating the provision of, and reimbursement for, health care goods and services, both in our capacity as a medical device manufacturer and/or as a supplier of covered items and services to federal health care program beneficiaries, with respect to which items and services we submit claims for reimbursement from such programs. The laws and regulations of health care goods and services that apply to us, including those described above, are subject to evolving interpretations and enforcement discretion. As part of our compliance program, we have reviewed our sales contracts, marketing materials, and billing practices (among others) to reduce the risk of non-compliance with these and other foreign, federal and state laws. If a governmental authority was to conclude that we are not in compliance with applicable laws and regulations, we and our officers, directors and employees could be subject to criminal and civil penalties, including, for example, exclusion from participation as a supplier of product to beneficiaries covered by federal healthcare programs, including but not limited to Medicare and Medicaid. Any failure to comply with laws, regulations or contractual requirements relating to reimbursement and health care goods and services could adversely affect our reputation, business, financial condition and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">With respect to the federal Anti-Kickback Statute, Congress and the OIG have established a large number of statutory exceptions and regulatory safe harbors. An arrangement that fits squarely into an exception or safe harbor is immune from prosecution under the Anti-Kickback Statute.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We train and educate employees and marketing representatives on the Anti-Kickback Statute and their obligations thereunder, and we endeavor to comply with the applicable safe harbors. However, some of our arrangements, like many other common and non-abusive arrangements, may implicate the Anti-Kickback Statute and are not covered by a safe harbor, but </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">39</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">nevertheless do not present a material risk to beneficiaries or federal healthcare programs and, as such, would not likely invite government scrutiny or prosecution or warrant the imposition of sanctions. However, we cannot offer assurance that arrangements that do not squarely meet an exception or safe harbor will not be found to violate the Anti-Kickback Statute. Allegations of violations of the Anti-Kickback Statute can also trigger liability under the federal Civil Monetary Penalty Law and federal civil False Claims Act,thereby increasing the penalty structure for these violations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our financial relationships with referring physicians and their immediate family members must comply with the Stark Law by meeting an applicable exception. We attempt to structure our relationships to meet an exception to the Stark Law, but the regulations implementing the exceptions are detailed and complex, and we cannot assure you that every relationship complies fully with the Stark Law. Unlike the Anti-Kickback Statute, failure to meet an exception under the Stark Law results in a violation of the Stark Law, even if such violation is technical in nature. Violations of the Stark Law create overpayment liability under the federal civil False Claims Act and can also trigger separate penalties under the Civil Monetary Penalties Law. Knowing violations of the Stark Law carry increased civil monetary penalties and would likely be classified as the knowing submission of a false claim or knowingly making a false statement to the government, triggering liability under the federal civil False Claims Act.  Certain Stark Law violations can also trigger exclusion from federal healthcare programs.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If we violate the Anti-Kickback Statute or Stark Law, or if we improperly bill for our services, or retain overpayments longer than 60 days after identification, or fail to act with reasonable diligence to investigate credible information regarding potential overpayments, we may be found to violate the federal civil False Claims Act, either under a suit brought by the government or by a private person under a&#160;</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">qui tam</span><span style="font-family:inherit;font-size:10pt;"> relator, or &#8220;whistleblower,&#8221; suit.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">If we or our suppliers or distributors fail to comply with ongoing regulatory requirements, or if we have unanticipated problems with our products, the products could be subject to restrictions or withdrawal from the market.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Any product for which we obtain marketing approval, clearance or authorization will be subject to continual review and periodic inspections by the FDA and other regulatory bodies, which may include inspection of our manufacturing processes, post-approval clinical data and promotional activities for such product. The FDA&#8217;s Medical Device Reporting, or MDR, regulations require that we report to the FDA any incident in which our product may have caused or contributed to a death or serious injury, or in which our product malfunctioned and, if the malfunction were to recur, it would likely cause or contribute to a death or serious injury.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If FDA determines that there is a reasonable probability that a device intended for human use would cause serious, adverse health consequences or death, the agency may issue a cease distribution and notification order and a mandatory recall order. We may also decide to recall a product voluntarily if we find a material deficiency, including unacceptable risks to health, manufacturing defects, design errors, component failures, labeling defects, or other issues. Recalls of our products could divert the attention of our management and have an adverse effect on our reputation, financial condition, and operating results.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We and our suppliers are also required to comply with the FDA&#8217;s Quality System Regulation, or QSR, and other regulations which cover the methods and documentation of the design, testing, production, control, selection and oversight of suppliers or contractors, quality assurance, labeling, packaging, storage, complaint handling, shipping and servicing of our products. The FDA enforces the QSR through unannounced inspections.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Compliance with ongoing regulatory requirements can be complex, expensive and time-consuming. Failure by us or one of our suppliers or distributors to comply with statutes and regulations administered by the FDA, competent authorities and other regulatory bodies, or failure to take adequate response to any observations, could result in, among other things, any of the following actions:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">warning letters or untitled letters that require corrective action; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">delays in approving, or refusal to approve, our CGM systems; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">fines and civil or criminal penalties; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">unanticipated expenditures; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">FDA refusal to issue certificates to foreign governments needed to export our products for sale in other countries;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">suspension or withdrawal of clearance or approval by the FDA or other regulatory bodies;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">product recall or seizure; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">administrative detention;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">interruption of production, partial suspension, or complete shutdown of production; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">interruption of the supply of components from our key component suppliers;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">operating restrictions; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">court consent decrees;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">FDA orders to repair, replace, or refund the cost of devices;</span></div></td></tr></table><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">40</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">injunctions; and </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">criminal prosecution. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The effect of these events can be difficult to quantify. If any of these actions were to occur, it would harm our reputation and cause our product sales and profitability to suffer. In addition, we believe events that could be classified as reportable events pursuant to MDR regulations are generally underreported by physicians and users, and any underlying problems could be of a larger magnitude than suggested by the number or types of MDRs filed by us. Furthermore, our key component suppliers may not currently be or may not continue to be in compliance with applicable regulatory requirements.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Even if regulatory approval or clearance of a product is granted, the approval or clearance may be subject to limitations on the indicated uses for which the product may be marketed or contain requirements for costly post-marketing testing or surveillance to monitor the safety or effectiveness of the product. Later discovery of previously unknown problems with our products, including software bugs, unanticipated adverse events or adverse events of unanticipated severity or frequency, manufacturing problems, or failure to comply with regulatory requirements such as the QSR, MDR reporting, or other post-market requirements may result in restrictions on such products or manufacturing processes, withdrawal of the products from the market, voluntary or mandatory recalls, fines, suspension of regulatory approvals, product seizures, injunctions, the imposition of civil or criminal penalties, or criminal prosecution. In addition, our distributors have rights to create marketing materials for their sales of our products, and may not adhere to contractual, legal or regulatory limitations that are imposed on their marketing efforts.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We may be liable for contamination or other harm caused by materials that we handle, and changes in environmental regulations could cause us to incur additional expense.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our research and development and clinical processes involve the handling of potentially harmful biological materials as well as hazardous materials. We are subject to international and domestic (including federal, state and local) laws, rules and regulations governing the use, handling, storage and disposal of hazardous and biological materials and we incur expenses relating to compliance with these laws and regulations. If violations of environmental, health and safety laws occur, we could be held liable for damages, penalties and costs of remedial actions. These expenses or this liability could have a significant negative impact on our financial condition. We may violate environmental, health and safety laws in the future as a result of human error, equipment failure or other causes. Environmental laws could become more stringent over time, imposing greater compliance costs and increasing risks and penalties associated with violations. We are subject to potentially conflicting and changing regulatory agendas of political, business and environmental groups. Changes to or restrictions on permitting requirements or processes, hazardous or biological material storage or handling might require an unplanned capital investment or relocation. Failure to comply with new or existing laws or regulations could harm our business, financial condition and results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We could become the subject of governmental investigations, claims and litigation.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Health care companies are subject to numerous investigations by various governmental agencies. Further, under the False Claims Act, private parties have the right to bring&#160;</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">qui tam</span><span style="font-family:inherit;font-size:10pt;">, or &#8220;whistleblower,&#8221; suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Depending upon whether the underlying conduct alleged in such inquiries or investigations could be considered systemic, the resolution could have a material, adverse effect on our financial position and results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Governmental agencies and their agents, such as CMS Medicare Administrative Contractors and other CMS contractors, as well as the OIG, state Medicaid programs, and other state and federal agencies may conduct audits of our operations, relating to covered items and services including those furnished to beneficiaries, health care providers and distributors. Commercial and government-funded managed care payors may conduct similar post-payment audits,. Depending on the nature of the conduct found in such audits and whether the underlying conduct could be considered systemic, the resolution of these audits could have a material adverse effect on our financial position and results of operations. We perform internal audits and monitoring to identify any potential issues.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">CMS contracts with Recovery Audit Contractors, or RACs, on a contingency fee basis to conduct post-payment reviews to detect and correct improper payments in the&#160;fee-for-service&#160;Medicare program. The ACA expanded the RAC program&#8217;s scope to include managed Medicare plans and Medicaid claims. RAC denials are appealable; however, there currently are significant delays in the assignment of new Medicare appeals to Administrative Law Judges, which negatively impacts our ability to appeal RAC payment denials. In addition, CMS employs various other program integrity contractors &#8211; including zone program integrity contractors, or ZPICs, Medicaid integrity contractors, or MICs, and unified program integrity contractors, or UPICs &#8211; to perform post-payment audits of claims and identify overpayments, and state Medicaid agencies and other contractors have increased their review and audit activities as well.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are not presently aware of any governmental investigations involving our executives or us. However, any future </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">41</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">investigations of our executives, our managers or us could result in significant liabilities or penalties to us, as well as adverse publicity. Should we be found out of compliance with any of these laws, regulations or programs, depending on the nature of the findings, our business, our financial position and our results of operations could be negatively impacted. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Risks Related to the Privacy and Security</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We are subject to complex and evolving U.S. and foreign laws and regulations regarding privacy, data protection, and other matters. Many of these laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, monetary penalties, increased cost of operations, or declines in user growth or engagement, or otherwise harm our business.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are subject to a number of foreign, federal and state laws and regulations protecting the use and confidentiality of certain patient health and personal information, including patient records, and restricting the use and disclosure of that protected information. These laws include foreign, federal and state medical privacy laws, breach notification laws and consumer protection laws.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, foreign data protection, privacy, and other laws and regulations can be more restrictive than those in the United States. For example, data localization laws in some countries generally mandate that certain types of data collected in a particular country be stored and/or processed within that country. We may be subject to inquiries, investigations and audits in Europe and around the world, particularly in the areas of consumer and data protection, which will arise in the ordinary course of business and may increase in frequency as we continue to grow and expand our operations. Legislators and regulators may make legal and regulatory changes, or interpret and apply existing laws, in ways that make our products less useful to our customers, require us to incur substantial costs, expose us to unanticipated civil or criminal liability, or cause us to change our business practices. These changes or increased costs could negatively impact our business and results of operations in material ways.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the ordinary course of our business, we collect and store sensitive data, such as our proprietary business information and that of our clients, contractors, vendors and others as well as personally identifiable information of our customers, vendors and others, which data may include full names, social security numbers, addresses, and birth dates, in our data centers and on our networks. Our employees, contractor and vendors may also have access to and may use personal health information in the ordinary course of our business. The secure processing, maintenance and transmission of this information is critical to our operations. Despite our security measures and business controls, our information technology and infrastructure may be vulnerable to attacks by hackers, breaches due to employee, contractor or vendor error, or malfeasance or other disruptions or subject to the inadvertent or intentional unauthorized release of information. Any such occurrence could compromise our networks and the information stored thereon could be accessed, publicly disclosed, lost or stolen. Any such access, disclosure or other loss of information could (i) result in legal claims or proceedings, and liability under laws that protect the privacy of personal information and regulatory penalties, (ii) disrupt our operations and the services we provide to our clients or (iii) damage our reputation, any of which could adversely affect our profitability, revenue and competitive position.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As we grow and expand our administrative, customer support or IT support services, we may also utilize the services of personnel and contractors located outside of the United States to perform certain functions. While we make every effort to review our applicable contracts and other payor requirements, a local, state, or federal government agency or one of our customers may find the use of offshore resources to be a violation of a legal or contractual requirement, which could result in termination of the contractual relationship, penalties, or changes in our business operations that could adversely affect our business, financial condition, and results of operations. Additionally, while we have implemented industry standard security measures for offshore access to protected health information and other personal information, unauthorized access or disclosure of such information by offshore personnel could (i) result in legal claims or proceedings, and liability under laws that protect the privacy of personal information and regulatory penalties, (ii) disrupt our operations and the services we provide to our clients, (iii) damage to our reputation or (iv) result in the termination of contractual relationships, penalties or the loss of coverage, any of which could adversely affect our profitability, revenue and competitive position.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Security breaches and other disruptions could compromise our information and expose us to liability, which would cause our business and reputation to suffer and could subject us to substantial liabilities.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Administrative Simplification Provisions of the Health Insurance Portability and Accountability Act of 1996, as amended, and implementing regulations, or HIPAA, extensively regulate the use and disclosure of individually identifiable health information, known as &#8220;protected health information,&#8221; and require covered entities, including health plans and most health care providers, to implement administrative, physical and technical safeguards to protect the security of such information. Certain provisions of the security and privacy regulations apply to business associates (entities that handle protected health information on behalf of covered entities), and business associates are subject to direct liability for violation of these provisions. In addition, a covered entity may be subject to penalties as a result of a business associate violating HIPAA, if the business associate is found to be an agent of the covered entity.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">42</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Covered entities must report breaches of unsecured protected health information to affected individuals without unreasonable delay and notification must also be made to the U.S. Department of Health &amp; Human Services, Office for Civil Rights, or OCR and, in certain situations involving large breaches, to the media. Various U.S. state laws and regulations may also require us to notify affected individuals and state agencies in the event of a data breach involving individually identifiable information.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Violations of the HIPAA privacy and security regulations may result in criminal and civil penalties. The OCR enforces the regulations and performs compliance audits. In addition to enforcement by OCR, state attorneys general are authorized to bring civil actions seeking either injunction or damages in response to violations that threaten the privacy of state residents. OCR may resolve HIPAA violations through informal means, such as allowing a covered entity to implement a corrective action plan, but OCR has the discretion to move directly to impose monetary penalties and is required to impose penalties for violations resulting from willful neglect. We follow and maintain a HIPAA compliance plan, which we believe complies with the HIPAA privacy and security regulations, but there can be no assurance that OCR or other regulators will agree. The HIPAA privacy regulations and security regulations have and will continue to impose significant costs on us in order to comply with these standards.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There are numerous other laws and legislative and regulatory initiatives at the federal and state levels addressing privacy and security concerns. We also remain subject to federal or state privacy-related laws that are more restrictive than the privacy regulations issued under HIPAA. These laws vary and could impose additional penalties. For example, the Federal Trade Commission uses its consumer protection authority to initiate enforcement actions in response to alleged privacy and data security violations. California recently enacted the California Consumer Privacy Act, or CCPA, which goes into effect January 1, 2020. The CCPA, among other things, creates new data privacy obligations for covered companies and provides new privacy rights to California residents, including the right to opt out of certain disclosures of their information. The CCPA also creates a private right of action with statutory damages for certain data breaches, thereby potentially increasing risks associated with a data breach. The California Attorney General clarifying regulations will not be finalized until 2020. It remains unclear what, if any, additional modifications will be made to this legislation or how it will be interpreted. Therefore the effects of the CCPA are significant and will likely require us to modify our data processing practices, and may cause us to incur substantial costs and expenses to comply.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are also subject to laws and regulations in foreign countries covering data privacy and other protection of health and employee information that may be more onerous than corresponding U.S. laws, including in particular the laws of Europe.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For instance, in the European Union, increasingly stringent data protection and privacy rules that have and will continue to have substantial impact on the use of patient data across the healthcare industry became effective in May 2018. The EU General Data Protection Regulation, or GDPR, applies across the European Union and includes, among other things, a requirement for prompt notice of data breaches to data subjects and supervisory authorities in certain circumstances and significant fines for non-compliance. The GDPR fine framework can be up to 20 million euros, or up to 4 % of the company&#8217;s total global turnover of the preceding fiscal year, whichever is higher. The GDPR also requires companies processing personal data of individuals residing in the European Union to comply with EU privacy and data protection rules, even if the company itself does not have a physical presence in the European Union. Noncompliance could result in the imposition of fines, penalties, or orders to stop noncompliant activities. Due to the strong consumer protection aspects of the GDPR, companies subject to its purview are allocating substantial legal costs to the development of necessary policies and procedures and overall compliance efforts. We expect continued costs associated with maintaining compliance with GDPR into the future, and these provisions as interpreted by EU agencies, could negatively impact our business, financial condition and results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Cybersecurity risks and cyber incidents could result in the compromise of confidential data or critical data systems and give rise to potential harm to customers, remediation and other expenses, expose us to liability under HIPAA, consumer protection laws, or other common law theories, subject us to litigation and federal and state governmental inquiries, damage our reputation, and otherwise be disruptive to our business and operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cyber incidents can result from deliberate attacks or unintentional events. We collect and store on our networks sensitive information, including intellectual property, proprietary business information and personally identifiable information of individuals, such as our customers and employees. The secure maintenance of this information and technology is critical to our business operations. We have implemented multiple layers of security measures to protect the confidentiality, integrity and availability of this data and the systems and devices that store and transmit such data. We utilize current security technologies, and our defenses are monitored and routinely tested internally and by external parties. Despite these efforts, threats from malicious persons and groups, new vulnerabilities and advanced new attacks against information systems create risk of cybersecurity incidents. These incidents can include, but are not limited to, gaining unauthorized access to digital systems for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational disruption. Because the techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently and may not immediately produce signs of intrusion, we may be unable to anticipate these incidents or techniques, timely discover them, or implement adequate preventative measures.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">43</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">These threats can come from a variety of sources, ranging in sophistication from an individual hacker to malfeasance by employees, consultants or other service providers to state-sponsored attacks. Cyber threats may be generic, or they may be custom-crafted against our information systems. Over the past several years, cyber-attacks have become more prevalent and much harder to detect and defend against. Our network and storage applications, as well as those of our contractors, may be vulnerable to cyber-attack, malicious intrusion, malfeasance, loss of data privacy or other significant disruption and may be subject to unauthorized access by hackers, employees, consultants or other service providers. In addition, hardware, software or applications we develop or procure from third parties may contain defects in design or manufacture or other problems that could unexpectedly compromise information security. Unauthorized parties may also attempt to gain access to our systems or facilities through fraud, trickery or other forms of deceiving our employees, contractors and temporary staff.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There can be no assurance that we will not be subject to cybersecurity incidents that bypass our security measures, impact the integrity, availability or privacy of personal health information or other data subject to privacy laws or disrupt our information systems, devices or business, including our ability to deliver services to our customers. As a result, cybersecurity, physical security and the continued development and enhancement of our controls, processes and practices designed to protect our enterprise, information systems and data from attack, damage or unauthorized access remain a priority for us. As cyber threats continue to evolve, we may be required to expend significant additional resources to continue to modify or enhance our protective measures or to investigate and remediate any cybersecurity vulnerabilities. The occurrence of any of these events could result in:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">harm to customers; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">business interruptions and delays; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the loss, misappropriation, corruption or unauthorized access of data; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">litigation, including potential class action litigation, and potential liability under privacy, security and consumer protection laws or other applicable laws; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">reputational damage; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">increase to insurance premiums; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">foreign, federal and state governmental inquiries, any of which could have a material, adverse effect on our financial position and results of operations and harm our business reputation.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Failure to protect our information technology infrastructure against cyber-based attacks, network security breaches, service interruptions, or data corruption could significantly disrupt our operations and adversely affect our business and operating results.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We rely on information technology and telephone networks and systems, including the Internet, to process and transmit sensitive electronic information and to manage or support a variety of business processes and activities, including sales, billing, customer service, procurement and supply chain, manufacturing, and distribution. We use enterprise information technology systems to record, process, and summarize financial information and results of operations for internal reporting purposes and to comply with regulatory financial reporting, legal, and tax requirements. Our information technology systems, some of which are managed by third-parties, may be susceptible to damage, disruptions or shutdowns due to computer viruses, ransomware or other malware, attacks by computer hackers, failures during the process of upgrading or replacing software, databases or components thereof, power outages, hardware failures, telecommunication failures, user errors or catastrophic events. Although we have developed systems and processes that are designed to protect customer information and prevent data loss and other security breaches, including systems and processes designed to reduce the impact of a security breach at a third-party vendor, such measures cannot provide absolute security. If our systems are breached or suffer severe damage, disruption or shutdown and we are unable to effectively resolve the issues in a timely manner, our business and operating results may significantly suffer and we may be subject to litigation, government enforcement actions and other actions for which we could face financial liability and other adverse consequences which may include:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">additional government oversight of our operations;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">loss of existing customers;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">difficulty in attracting new customers;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">problems in determining product cost estimates and establishing appropriate pricing;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">difficulty in preventing, detecting, and controlling fraud;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">disputes with customers, physicians, and other health care professionals; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">increases in operating expenses, incurrence of expenses, including remediation costs;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">loss of revenues (including through loss of coverage or reimbursement); </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">product development delays;</span></div></td></tr></table><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">44</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">disruption of key business operations; and </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">diversion of attention of management and key information technology resources.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Unauthorized third parties may seek to access our devices or other products and services, or related devices, products, and services, and modify or use them in a way inconsistent with our FDA clearances and approvals, which may create risks to users.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Medical devices are increasingly connected to the internet, hospital networks, and other medical devices to provide features that improve healthcare and increase the ability of healthcare providers to treat patients and patients to manage their conditions. These same features may also increase cybersecurity risks and the risks of unauthorized access and use by third parties. As such, unauthorized third parties may seek to access our devices or other products and services, or related devices, products, and services, and modify or use them in a way inconsistent with our FDA clearances and approvals, which may create risks to users and potential exposure to the company.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Risks Related to our International Operations</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Laws and regulations governing the export of our products could adversely impact our business.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The U.S. Department of the Treasury&#8217;s Office of Foreign Assets Control, and the Bureau of Industry and Security at the U.S. Department of Commerce, administer certain laws and regulations that restrict U.S. persons and, in some instances, non-U.S. persons, in conducting activities, and transacting business with or making investments in certain countries, governments, entities and individuals subject to U.S. economic sanctions. Due to our international operations, we are subject to such laws and regulations, which are complex, restrict our business dealings with certain countries and individuals, and are constantly changing. Further restrictions may be enacted, amended, enforced or interpreted in a manner that materially impacts our operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Violations of these regulations are punishable by civil penalties, including fines, denial of export privileges, injunctions, asset seizures, debarment from government contracts and revocations or restrictions of licenses, as well as criminal fines and imprisonment. We have established procedures designed to assist with our compliance with such laws and regulations. However, we have only limited experience dealing with these laws and regulations and we cannot guarantee that our procedures will effectively prevent us from violating these regulations in every transaction in which we may engage. Any such violation could adversely affect our reputation, business, financial condition and results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">The failure to comply with U.S. Foreign Corrupt Practices Act and similar worldwide anti-bribery laws in non-U.S. jurisdictions could materially adversely affect our business and result in civil and/or criminal sanctions.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The U.S. Foreign Corrupt Practices Act, the UK Bribery Act and similar worldwide anti-bribery laws in non-U.S. jurisdictions generally prohibit companies and their intermediaries from making improper payments to non-U.S. government officials and, in some instances, other persons for the purpose of obtaining or retaining business. Because of the predominance of government-sponsored healthcare systems around the world, most of our customer relationships outside of the United States are with governmental entities and are therefore potentially subject to such anti-bribery laws. Global enforcement of anti-corruption laws has increased substantially in recent years, with more frequent voluntary self-disclosures by companies, aggressive investigations and enforcement proceedings by U.S. and foreign governmental agencies, and assessment of significant fines and penalties against companies and individuals. Our international operations create the risk of unauthorized payments or offers of payments by one of our employees, consultants, sales agents, or distributors, because these parties are not always subject to our direct oversight and control. It is our policy to implement safeguards to educate our employees and agents on these legal requirements and discourage improper practices. However, our existing safeguards and any future improvements may prove to be less than effective, and our employees, consultants, sales agents, or distributors may engage in conduct for which we might be held responsible. In addition, the government agencies may seek to hold us liable for successor liability for anti-corruption law violations committed by any companies in which we invest or that we acquire. Any alleged or actual violations of these regulations may subject us to government scrutiny, severe criminal or civil sanctions and other liabilities, including exclusion from government contracting, and could disrupt our business, and result in a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Current uncertainty in global economic and political conditions makes it particularly difficult to predict product demand and other related matters and makes it more likely that our actual results could differ materially from expectations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our operations and performance depend on worldwide economic and political conditions. These conditions have been adversely impacted by continued global economic uncertainty, political instability and military hostilities in multiple geographies, concerns over the potential downgrade of U.S. sovereign debt and continued sovereign debt, monetary and financial uncertainties in Europe and other foreign countries. These include potential reductions in the overall stability and suitability of the Euro as a single currency, given the economic and political challenges facing individual Eurozone countries. </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">45</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">These conditions have made and may continue to make it difficult for our customers and potential customers to afford our products, and could cause our customers to stop using our products or to use them less frequently. If that were to occur, our revenue may decrease and our performance may be negatively impacted. In addition, the pressure on consumers to absorb more of their own health care costs has resulted in some cases in higher deductibles and limits on durable medical equipment, which may cause seasonality in purchasing patterns. Furthermore, during economic uncertainty, our customers have had job losses and may continue to have issues gaining timely access to sufficient health insurance or credit, which could result in their unwillingness to purchase products or impair their ability to make timely payments to us. We cannot predict the reoccurrence of any economic slowdown or the strength or sustainability of the economic recovery, worldwide, in the United States, or in our industry. These and other economic factors could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We are subject to a variety of risks due to our international operations that could adversely affect our business, our operations or profitability and operating results.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our operations in countries outside the United States, which accounted for approximately </span><span style="font-family:inherit;font-size:10pt;">21%</span><span style="font-family:inherit;font-size:10pt;"> of our revenues for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, are accompanied by certain financial and other risks. In addition to opening offices in </span><span style="font-family:inherit;font-size:10pt;">Austria, Canada, Germany, the Philippines, Switzerland and the United Kingdom</span><span style="font-family:inherit;font-size:10pt;">, in connection with distributor acquisitions and otherwise, we intend to continue to pursue growth opportunities in sales outside the United States, especially in Asia (including Japan and Korea) and Europe, and we may increase our use of administrative and support functions from locations outside the United States, which could expose us to greater risks associated with our sales and operations. As we pursue opportunities outside the United States, we may become more exposed to these risks and our ability to scale our operations effectively may be affected. Additionally, we may experience difficulties in scaling these functions from locations outside the United States and may not experience the expected cost efficiencies.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our profitability and international operations are, and will continue to be, subject to a number of risks and potential costs, including:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">local product preferences and product requirements;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">longer-term receivables than are typical in the United States; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">fluctuations in foreign currency exchange rates;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">less intellectual property protection in some countries outside the United States than exists in the United States;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">trade protection measures and import and export licensing requirements;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">workforce instability;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">fluctuations in trade policy and tariff regulations;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">political and economic instability; and </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the potential payment of U.S. income taxes on certain earnings of our subsidiaries outside the United States upon repatriation. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">While it is impossible for us to predict whether these and other proposals will be implemented, or how they will ultimately impact us, they may materially impact our results of operations if, for example, our profits earned abroad are subject to U.S. income tax, or we are otherwise disallowed deductions as a result of these profits.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As another example, changes in foreign currency exchange rates may reduce the reported value of our foreign currency denominated revenues, expenses, and cash flows. We cannot predict changes in currency exchange rates, the impact of exchange rate changes, nor the degree to which we will be able to manage the impact of currency exchange rate changes.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As a final example, on June 23, 2016, the United Kingdom, or U.K., held a referendum in which voters approved an exit from the European Union, commonly referred to as &#8220;Brexit.&#8221; As a result of the referendum, the U.K. government is negotiating the terms of the U.K.&#8217;s future relationship with the European Union. Although it is unknown what those terms will be, it is possible that there will be greater restrictions on imports and exports and on the movement of people between the U.K. and European Union countries, and increased regulatory complexities.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Failure to obtain any required regulatory authorization in foreign jurisdictions will prevent us from marketing our products abroad.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We conduct limited commercial and marketing efforts in </span><span style="font-family:inherit;font-size:10pt;">Africa, Asia, Australia, Canada, Europe, Latin America, the Middle East and New Zealand</span><span style="font-family:inherit;font-size:10pt;"> with respect to our CGM systems and may seek to market our products in other regions in the future. Outside the United States, we can market a product only if we receive a marketing authorization and, in some cases, pricing approval, from the appropriate regulatory authorities. The authorization and/or approval procedure varies among countries and can involve additional testing, and the time required to obtain any required authorization or approval may differ from that required to obtain FDA marketing authorization(s). The foreign regulatory authorization or approval process may </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">46</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">include all of the risks associated with obtaining FDA marketing authorization(s) in addition to other risks. We may not obtain foreign regulatory authorizations or approvals on a timely basis, if at all. Obtaining a marketing authorization from the FDA does not ensure authorization or approval by regulatory authorities in other countries, and authorization or approval by one foreign regulatory authority does not ensure authorization or approval by regulatory authorities in other foreign countries or by the FDA. In addition, in order to obtain the authorization to market our products in certain foreign jurisdictions, we may need to obtain a Certificate to Foreign Government from the FDA. The FDA may refuse to issue a Certificate to Foreign Government in certain instances, including without limitation, during the pendency of any outstanding warning letter. As a result, we may not be able to file for regulatory approvals or marketing authorizations and may not receive necessary approvals or authorizations to commercialize our products in any market outside the United States on a timely basis, or at all.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Risks Related to Intellectual Property Protection and Use</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We are subject to claims of infringement or misappropriation of the intellectual property rights of others, which could prohibit us from shipping affected products, require us to obtain licenses from third parties or to develop non-infringing alternatives, and subject us to substantial monetary damages and injunctive relief. We may also be subject to other claims or suits. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Third parties have asserted, and may assert, infringement or misappropriation claims against us with respect to our current or future products. We are aware of numerous patents issued to third parties that may relate to aspects of our business, including the design and manufacture of CGM sensors and membranes, as well as methods for continuous glucose monitoring. Whether a product infringes a patent involves complex legal and factual issues, the determination of which is often uncertain. Therefore, we cannot be certain that we have not infringed the intellectual property rights of such third parties or others. Our competitors may assert that our CGM systems or the methods we employ in the use of our systems are covered by U.S. or foreign patents held by them. We have in the past settled some such allegations and may need to do so again in the future. For example, in July 2014, we entered into a Settlement and License Agreement with Abbott to settle all pending patent infringement legal proceedings brought by Abbott against us which is set to expire on March 31, 2021. This risk is exacerbated by the fact that there are numerous issued patents and pending patent applications relating to self-monitored glucose testing systems in the medical technology field. Because patent applications may take years to issue, there may be applications now pending of which we are unaware that may later result in issued patents that our products infringe. There could also be existing patents of which we are unaware that one or more components of our system may inadvertently infringe. As the number of competitors in the market for CGM systems grows, the possibility of patent infringement by us or a patent infringement claim against us increases. If we are unable to successfully defend any such claims as they may arise or enter into or extend settlement and license agreements on acceptable terms or at all, our business operations may be harmed. We have been and continue to be involved in various patent infringement actions, including:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span>On March 28, 2016, AgaMatrix, Inc., or AgaMatrix, filed a patent infringement lawsuit against us in the U.S. District Court for the District of Oregon, asserting that certain of our products infringe three patents held by AgaMatrix. (After filing suit, AgaMatrix reorganized its business and the Court granted AgaMatrix&#8217;s motion to substitute the newly created entity WaveForm Technologies, Inc., as the plaintiff following AgaMatrix&#8217;s transfer of the three asserted patents to WaveForm.) DexCom filed petitions for </span><span style="font-style:italic;">inter partes</span><span> review with the Patent Trial and Appeal Board, or PTAB, of the U.S. Patent and Trademark Office, challenging each of the three asserted patents as being unpatentable in view of prior art. The PTAB issued a Final Written Decision for each of the first two patents on February 28, 2018, where the PTAB found the majority of asserted claims from the first patent unpatentable and the remaining claims under review not unpatentable. The PTAB found all claims under review from the second patent not unpatentable. On September 12, 2018, the PTAB found all of the asserted claims in the third patent unpatentable. In October 2018, we filed in the District Court a motion for summary judgment that all remaining asserted claims are invalid. The District Court granted that motion and, on August 23, 2019, entered judgment in our favor. On September 6, 2019, WaveForm appealed the judgment. The appeal is pending and no hearing date has been set.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have also filed several lawsuits against AgaMatrix. We filed a patent infringement lawsuit against AgaMatrix in the United States District Court for the Central District of California, or C.D. Cal., in which a Final Judgment of non-infringement was entered by the C.D. Cal judge on February 23, 2018 and affirmed on appeal by the Federal Circuit on March 7, 2019. AgaMatrix was awarded attorneys&#8217; fees for this lawsuit.</span><span style="font-family:inherit;font-size:10pt;"> As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we have accrued an immaterial amount for those fees. </span><span style="font-family:inherit;font-size:10pt;">The fee decision is currently on appeal to the Federal Circuit. On September 15, 2017, we filed a patent infringement lawsuit against AgaMatrix in the United States District Court for the District of Delaware, asserting certain single-point blood glucose monitoring products of AgaMatrix infringe two patents held by us. In addition, on September 18, 2017, we filed a Complaint against AgaMatrix in the International Trade Commission, referred to as the ITC, requesting that the ITC institute an investigation and issue an order excluding certain products of AgaMatrix from importation into or sale in the United States based on AgaMatrix&#8217;s infringement of the same two patents asserted in the Delaware litigation. The investigation was terminated by the ITC on April 4, 2019 with a finding of non-infringement. The decision is currently on appeal.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">47</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Neither&#160;the outcome of these lawsuits nor the amount and range of potential loss associated with the lawsuits can be assessed at this time. Other than the attorneys&#8217; fees described above, as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> we have accrued </span><span style="font-family:inherit;font-size:10pt;">no</span><span style="font-family:inherit;font-size:10pt;"> amounts for contingent losses associated with these suits. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Any infringement or misappropriation claim could cause us to incur significant costs, place significant strain on our financial resources, divert management&#8217;s attention from our business and harm our reputation. In addition, if the relevant patents are upheld as valid and enforceable and we are found to infringe such patents, we could be prohibited from selling any of our products that is found to infringe unless we could obtain licenses to use the technology covered by the patent or are able to design around the patent. We may be unable to obtain a license on terms acceptable to us, if at all, and we may not be able to redesign our products to avoid infringement. We may be unable to maintain or renew licenses on terms acceptable to us, if at all, and we may be prohibited from selling any of our products that required the technology covered by the relevant licensed patents. Even if we are able to redesign our products to avoid an infringement claim, we may not receive </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> approval for such changes in a timely manner or at all. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Any adverse determination in litigation or interference proceedings to which we are or may become a party relating to patents or other intellectual property rights could subject us to significant liabilities to third parties or require us to seek licenses from other third parties. If we are found to infringe third-party patents, a court could order us to pay damages to compensate the patent owner for the infringement, such as a reasonable royalty amount and/or profits lost by the patent owners, along with prejudgment and/or post-judgment interest. Furthermore, if we are found to willfully infringe third-party patents, we could, in addition to other penalties, be required to pay treble damages; and if the court finds the case to be exceptional, we may be required to pay attorneys&#8217; fees for the prevailing party. If we are found to infringe third-party copyrights or trademarks or misappropriate third-party trade secrets, based on the intellectual property at issue, a court could order us to pay statutory damages, actual damages, or profits, such as reasonably royalty, lost profits of the owners, unjust enrichment, disgorgement of profits, and/or a reasonable royalty, and the court could potentially award attorneys&#8217; fees or exemplary or enhanced damages. Although patent and intellectual property disputes in the medical device area have often been settled through licensing or similar arrangements, costs associated with such arrangements may be substantial and would likely include ongoing royalties. We may be unable to obtain necessary intellectual property licenses on satisfactory terms. If we do not obtain any such necessary licenses, we may not be able to redesign our products to avoid infringement and any redesign may not receive </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> approval or other requisite marketing authorization in a timely manner or at all. Adverse determinations in a judicial or administrative proceeding or failure to obtain necessary intellectual property licenses could prevent us from manufacturing and selling our products, which would have a significant adverse impact on our business. If litigation were to be initiated by intellectual property owners, there could significant legal fees and costs incurred in defending litigation (which may include filing administrative actions to attack the intellectual property) as well as a potential monetary settlement payment to the owners, even if the matter is resolved before going to trial. Moreover, the owners may take an overly aggressive approach and/or include multiple allegations in a single litigation. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, from time to time, we are subject to various claims and suits arising out of the ordinary course of business, including commercial or employment related matters. Although individually we do not expect these claims or suits to have a material adverse effect on DexCom, in the aggregate they may divert significant time and resources from our staff. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Our inability to adequately protect our intellectual property could allow our competitors and others to produce products based on our technology, which could substantially impair our ability to compete. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our success and our ability to compete depend, in part, upon our ability to maintain the proprietary nature of our technologies. We rely on a combination of patent, copyright and trademark law, and trade secrets and nondisclosure agreements to protect our intellectual property. However, such methods may not be adequate to protect us or permit us to gain or maintain a competitive advantage. Our patent applications may not issue as patents in a form that will be advantageous to us, or at all. Our issued patents, and those that may issue in the future, may be challenged, invalidated or circumvented, which could limit our ability to stop competitors from marketing related products. In addition, there are numerous recent changes to the patent laws and proposed changes to the rules of the U.S. Patent and Trademark Office, which may have a significant impact on our ability to protect our technology and enforce our intellectual property rights. For example, in September 2011, the United States enacted sweeping changes to its patent system under the Leahy-Smith America Invents Act, including changes that would transition the United States from a &#8220;first-to-invent&#8221; system to a &#8220;first-to-file&#8221; system and alter the processes for challenging issued patents. These changes could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">To protect our proprietary rights, we may in the future need to assert claims of infringement against third parties. The outcome of litigation to enforce our intellectual property rights in patents, copyrights, trade secrets or trademarks is highly unpredictable, could result in substantial costs and diversion of resources, and could have a material adverse effect on our business, financial condition and results of operations regardless of the final outcome of such litigation. In the event of an adverse judgment, a court could hold that some or all of our asserted intellectual property rights are not infringed, or are invalid or unenforceable, and could award attorney fees. </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">48</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Despite our efforts to safeguard our unpatented and unregistered intellectual property rights, we may not succeed in doing so or the steps taken by us in this regard may not be adequate to detect or deter misappropriation of our technology or to prevent an unauthorized third party from copying or otherwise obtaining and using our products, technology or other information that we regard as proprietary. In addition, third parties may be able to design around our patents. Furthermore, the laws of foreign countries may not protect our proprietary rights to the same extent as the laws of the United States.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Litigation Risks</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We face the risk of product liability claims and may be subject to damages, fines, penalties and injunctions, among other things.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our business exposes us to the risk of product liability claims that is inherent in the testing, manufacturing and marketing of medical devices, including those which may arise from the misuse (including system hacking or other unauthorized access by third parties to our systems) or malfunction of, or design flaws in, our products. This liability may vary based on the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> classification associated with our devices. Notably, the classification of our G6 system as a Class II medical device is likely to weaken our ability to rely on federal preemption of state law claims that assert liability against us for harms arising from use of the G6. We may be subject to product liability claims if our products cause, or merely appear to have caused, an injury. Claims may be made by customers, healthcare providers or others selling our products. The risk of product liability claims may increase now that our G5 Mobile system has obtained indications and approved labeling in the United States, in Canada, and in the countries utilizing the CE Mark that allow for our patients to make diabetes treatment decisions with our CGM system in conjunction with only two finger sticks required for calibration of the system and our G6 does not require confirmatory finger sticks when making treatment decisions or finger stick tests each day for calibration, although it does require finger stick tests when symptoms do not match readings and when readings are unavailable. The risk of claims may also increase if our products are subject to a product recall or seizure. An example of the difficulty of complying with the regulatory requirements associated with the manufacture of our products, we issued notifications to our customers regarding the audible alarms and alerts associated with our receivers.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Although we have insurance at levels that we believe is appropriate, this insurance is subject to deductibles and coverage limitations. Our current product liability insurance may not continue to be available to us on acceptable terms, if at all, and, if available, the coverage may not be adequate to protect us against any future product liability claims. Further, if additional products are approved for marketing, we may seek additional insurance coverage. If we are unable to obtain insurance at an acceptable cost or on acceptable terms with adequate coverage or otherwise protect against potential product liability claims, we will be exposed to significant liabilities, which may harm our business. A product liability claim, recall or other claim with respect to uninsured liabilities or for amounts in excess of insured liabilities could result in significant costs and significant harm to our business. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We may be subject to claims against us even if the apparent injury is due to the actions of others or misuse of the device or a partner device. Our customers, either on their own or following the advice of their physicians, may use our products in a manner not described in the products&#8217; labeling and that differs from the manner in which it was used in clinical studies and approved by the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">. For example, our current systems are designed to be used by an individual continuously for up to seven days for our G4 PLATINUM and G5 Mobile system and up to 10 days for our G6 system, but the individual might be able to circumvent the safeguards designed into the systems and use the products for longer than seven or 10 days. Off-label use of products by customers is common, and any such off-label use of our products could subject us to additional liability, or require design changes to limit this potential off-label use once discovered. The CE Mark and the HealthCanada and FDA approvals for our G5 Mobile system include indications that allow patients to make diabetes treatment decisions based on the information generated by such system, although both regulators still require finger stick calibrations two times per day. In addition, other regulatory agencies may in the future approve similar diabetes treatment indications. We expect that such diabetes treatment indications could expose us to additional liability. These liabilities could prevent or interfere with our product commercialization efforts. Defending a suit, regardless of merit, could be costly, could divert management attention and might result in adverse publicity, which could result in the withdrawal of, or inability to recruit, clinical trial volunteers or result in reduced acceptance of our products in the market.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We may be subject to fines, penalties and injunctions if we are determined to be promoting the use of our products for unapproved or improper off-label uses.</span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Although we believe our promotional materials and practices comply with FDCA and other applicable laws and regulations, as may be amended from time to time, if the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> or other regulatory body with competent jurisdiction over us, our activities or products takes the position that our marketing, promotional or other materials or activities constitute improper promotion or marketing of an unapproved or improper use, the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> or other regulatory body could request that we modify our materials or practices, or subject us to regulatory enforcement actions, including the issuance of a warning letter, injunction, seizure, civil fine and criminal penalties. It is also possible that other federal, state or foreign enforcement authorities might </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">49</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">take action if they consider promotional, marketing or other materials or activities to constitute improper promotion of an unapproved use, which could result in significant fines or penalties under other statutory authorities, such as laws prohibiting false claims for reimbursement. Recent court decisions have impacted the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">&#8217;s enforcement activity regarding off-label promotion in light of First Amendment considerations; however, there are still significant risks in this area in part due to the potential False Claims Act exposure.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Direct-to-consumer marketing and social media effort may expose us to additional regulatory scrutiny.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our efforts to promote our products via direct-to-consumer marketing and social media initiatives may subject us to additional scrutiny of our practices of effective communication of risk information, benefits or claims, under the oversight of the </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">, FTC, or both.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">In some instances in our advertising and promotion, we may make claims regarding our product as compared to competing products, which may subject us to heightened regulatory scrutiny, enforcement risk, and litigation risks.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> applies a heightened level of scrutiny to comparative claims when applying its statutory standards for advertising and promotion, including with regard to its requirement that promotional labeling be truthful and not misleading. There is potential for differing interpretations of whether certain communications are consistent with a product&#8217;s </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;">-required labeling, and </span><span style="font-family:inherit;font-size:10pt;">FDA</span><span style="font-family:inherit;font-size:10pt;"> will evaluate communications on a fact-specific basis.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, making comparative claims may draw concerns from our competitors.&#160; Where a company makes a claim in advertising or promotion that its product is superior to the product of a competitor (or that the competitor&#8217;s product is inferior), this creates a risk of a lawsuit by the competitor under federal and state false advertising or unfair and deceptive trade practices law, and possibly also state libel law.&#160; Such a suit may seek injunctive relief against further advertising, a court order directing corrective advertising, and compensatory and punitive damages where permitted by law.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.65625%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Risks Relating to Our Public Company Status, Tax Laws and Growth Through Acquisition</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We may face risks associated with acquisitions of companies, products and technologies and our business could be harmed if we are unable to address these risks.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If we are presented with appropriate opportunities, we could acquire or make other investments in complementary companies, products or technologies. We may not realize the anticipated benefit of our acquisitions, or the realization of the anticipated benefits may require greater expenditures than anticipated by us. We will likely face risks, uncertainties and disruptions associated with the integration process, including difficulties in the integration of the operations and services of any acquired company, integration of acquired technology with our products, diversion of our management&#8217;s attention from other business concerns, the potential loss of key employees or customers of the acquired businesses and impairment charges if future acquisitions are not as successful as we originally anticipate. If we fail to successfully integrate other companies, products or technologies that we acquire, our business could be harmed. Furthermore, we may have to incur debt or issue equity or equity-linked securities to pay for any future acquisitions or investments, the issuance of which could be dilutive to our existing stockholders. In addition, our operating results may suffer because of acquisition-related costs or amortization expenses or charges relating to acquired intangible assets. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Compliance with regulations relating to public company corporate governance matters and reporting is time consuming and expensive. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Many laws and regulations, notably those adopted in connection with the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, new SEC regulations and The Nasdaq Stock Market listing rules, impose obligations on public companies, such as ours, which have increased the scope, complexity and cost of corporate governance, reporting and disclosure practices. Compliance with these laws and regulations, including enhanced new disclosures, has required and will continue to require substantial management time and oversight and the incurrence of significant accounting and legal costs. The effects of new laws and regulations remain unclear and will likely require substantial management time and oversight and require us to incur significant additional accounting and legal costs. Additionally, changes to existing accounting rules or standards, such as the potential requirement that U.S. registrants prepare financial statements in accordance with International Financial Reporting Standards, may adversely impact our reported financial results and business, and may require us to incur greater accounting fees. </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">50</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">If we are unable to successfully maintain effective internal control over financial reporting, investors may lose confidence in our reported financial information and our stock price and our business may be adversely impacted.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As a public company, we are required to maintain internal control over financial reporting and our management is required to evaluate the effectiveness of our internal control over financial reporting as of the end of each fiscal year. If we are not successful in maintaining effective internal control over financial reporting, there could be inaccuracies or omissions in the consolidated financial information we are required to file with the SEC. Additionally, even if there are no inaccuracies or omissions, we will be required to publicly disclose the conclusion of our management that our internal control over financial reporting or disclosure controls and procedures are not effective. These events could cause investors to lose confidence in our reported financial information, adversely impact our stock price, result in increased costs to remediate any deficiencies, attract regulatory scrutiny or lawsuits that could be costly to resolve and distract management&#8217;s attention, limit our ability to access the capital markets or cause our stock to be delisted from The Nasdaq Stock Market or any other securities exchange on which it is then listed.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We could be subject to changes in our tax rates, new U.S. or international tax legislation or additional tax liabilities.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are subject to taxes in the United States and numerous foreign jurisdictions, where a number of our subsidiaries are organized. Due to economic and political conditions, tax rates in various jurisdictions may be subject to change. Our effective tax rates could be affected by numerous factors, including changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, and changes in tax laws or their interpretation, both in and outside the United States.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The U.S. government has recently enacted comprehensive tax legislation that includes significant changes to the taxation of business entities. These changes include, among others, (i) a permanent reduction to the corporate income tax rate, (ii) a partial limitation on the deductibility of business interest expense, (iii) a shift of the U.S. taxation of multinational corporations from a tax on worldwide income to a territorial system (along with certain rules designed to prevent erosion of the U.S. income tax base) and (iv) a one-time tax on accumulated offshore earnings held in cash and illiquid assets, with the latter taxed at a lower rate. The overall impact of this tax reform is uncertain, and our business and financial condition could be adversely affected.&#160;In addition, it is uncertain if and to what extent various states will conform to the newly enacted federal tax law.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our tax returns and other tax matters also are subject to examination by the U.S. Internal Revenue Service and other tax authorities and governmental bodies. We regularly assess the likelihood of an adverse outcome resulting from these examinations to determine the adequacy of our provision for taxes. We cannot guarantee the outcome of these examinations. If our effective tax rates were to increase, particularly in the United States, or if the ultimate determination of our taxes owed is for an amount in excess of amounts previously accrued, our financial condition, operating results and cash flows could be adversely affected.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Valuation of share-based payments, which we are required to perform for purposes of recording compensation expense under authoritative guidance for share-based payment, involves assumptions that are subject to change and difficult to predict. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We record compensation expense in the consolidated statement of operations for share-based payments, such as employee stock options, restricted stock units and employee stock purchase plan shares, using the fair value method. The requirements of the authoritative guidance for share-based payment have and will continue to have a material effect on our future financial results reported under U.S. generally accepted accounting principles, or GAAP, and make it difficult for us to accurately predict the impact on our future financial results. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For instance, estimating the fair value of share-based payments is highly dependent on assumptions regarding the future exercise behavior of our employees and changes in our stock price. If there are errors in our input assumptions for our valuations models, we may inaccurately calculate actual or estimated compensation expense for share-based payments. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The authoritative guidance for share-based payment could also adversely impact our ability to provide accurate guidance on our future financial results as assumptions that are used to estimate the fair value of share-based payments are based on estimates and judgments that may differ from period to period. We may also be unable to accurately predict the amount and timing of the recognition of tax benefits associated with share-based payments as they are highly dependent on the exercise behavior of our employees and the price of our stock relative to the exercise price of each outstanding stock option. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For those reasons, among others, the authoritative guidance for share-based payment may create variability and uncertainty in the share-based compensation expense we will record in future periods, which could adversely impact our stock price and increase our expected stock price volatility as compared to prior periods. </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">51</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Changes in financial accounting standards or practices or existing taxation rules or practices may cause adverse unexpected revenue and/or expense fluctuations and affect our reported results of operations. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A change in accounting standards or practices or a change in existing taxation rules or practices can have a significant effect on our reported results and may even affect our reporting of transactions completed before the change is effective. New accounting pronouncements and taxation rules and varying interpretations of accounting pronouncements and taxation practice have occurred and may occur in the future. The method in which we market and sell our products may have an impact on the manner in which we recognize revenue. In addition, changes to existing rules or the questioning of current practices may adversely affect our reported financial results or the way we conduct our business. Additionally, changes to existing accounting rules or standards, such as the potential requirement that U.S. registrants prepare financial statements in accordance with International Financial Reporting Standards, may adversely impact our reported financial results and business, and may further require us to incur greater accounting fees. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Risks Related to Our Common Stock</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Our stock price is highly volatile and investing in our stock involves a high degree of risk, which could result in substantial losses for investors. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Historically, the market price of our common stock, like the securities of many other medical products companies, fluctuates and could continue to be volatile in the future. From January&#160;1, </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> through </span><span style="font-family:inherit;font-size:10pt;">February&#160;7, 2020</span><span style="font-family:inherit;font-size:10pt;">, the closing price of our common stock on the Nasdaq Global Select Market was as high as </span><span style="font-family:inherit;font-size:10pt;">$243.70</span><span style="font-family:inherit;font-size:10pt;"> per share and as low as </span><span style="font-family:inherit;font-size:10pt;">$111.38</span><span style="font-family:inherit;font-size:10pt;"> per share. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The market price of our common stock is influenced by many factors that are beyond our control, including the following: </span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">securities analyst coverage or lack of coverage of our common stock or changes in their estimates of our financial performance; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">variations in quarterly operating results; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">future sales of our common stock by our stockholders; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">investor perception of us and our industry; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">announcements by us or our competitors of significant agreements, acquisitions, or capital commitments or product launches or discontinuations; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">changes in market valuation or earnings of our competitors; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">negative business or financial announcements regarding our partners; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">general economic conditions; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">regulatory actions; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">legislation and political conditions; and </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">terrorist acts. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Please also refer to the factors described elsewhere in this &#8220;Risk Factors&#8221; section. In addition, the stock market in general has experienced extreme price and volume fluctuations that have often been unrelated and disproportionate to the operating performance of companies in our industry. These broad market and industry factors may materially reduce the market price of our common stock, regardless of our operating performance.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Securities class action litigation has often been brought against public companies that experience periods of volatility in the market prices of their securities. Securities class action litigation could result in substantial costs and a diversion of our management&#8217;s attention and resources. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">If our financial performance fails to meet the expectations of investors and public market analysts, the market price of our common stock could decline. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our revenues and operating results may fluctuate significantly from quarter to quarter. We believe that period-to-period comparisons of our operating results may not be meaningful and should not be relied on as an indication of our future performance. If quarterly revenues or operating results fall below the expectations of investors or public market analysts, the trading price of our common stock could decline substantially. Factors that might cause quarterly fluctuations in our operating results include: </span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our inability to manufacture an adequate supply of product at appropriate quality levels and acceptable costs; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">possible delays in our research and development programs or in the completion of any clinical trials; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">a lack of acceptance of our products in the marketplace by physicians and people with diabetes; </span></div></td></tr></table><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">52</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the inability of customers to receive reimbursements from third-party payors; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">failures to comply with regulatory requirements, which could lead to withdrawal of products from the market; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our failure to continue the commercialization of any of our CGM systems; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">competition;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">inadequate financial and other resources; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">global and political economic conditions, political instability and military hostilities.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Failure to comply with covenants in our revolving credit agreement with JPMorgan Chase Bank and other syndicate lenders could result in our inability to borrow additional funds and adversely impact our business. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have entered into a revolving credit agreement and a pledge and security agreement with JPMorgan Chase Bank and four other lenders to fund our business operations. These agreements impose numerous financial and other restrictive covenants on our operations, including covenants relating to our general profitability and our liquidity. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we were in compliance with the covenants imposed by the loan and security agreement. If we violate these or any other covenants, any outstanding amounts under these agreements could become due and payable prior to their stated maturity dates, each lender could proceed against any collateral in our operating accounts and our ability to borrow funds in the future may be restricted or eliminated. These restrictions may also limit our ability to borrow additional funds and pursue other business opportunities or strategies that we would otherwise consider to be in our best interests. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Increasing our financial leverage could affect our operations and profitability</span><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In December 2018, we entered into a five-year </span><span style="font-family:inherit;font-size:10pt;">$200.0 million</span><span style="font-family:inherit;font-size:10pt;"> revolving credit agreement. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had </span><span style="font-family:inherit;font-size:10pt;">no</span><span style="font-family:inherit;font-size:10pt;"> outstanding borrowings, </span><span style="font-family:inherit;font-size:10pt;">$4.4 million</span><span style="font-family:inherit;font-size:10pt;"> in outstanding letters of credit, and a total available balance of </span><span style="font-family:inherit;font-size:10pt;">$195.6 million</span><span style="font-family:inherit;font-size:10pt;"> under our multi-currency revolving credit facility. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our leverage ratio may affect the availability to us of additional capital resources as well as our operations in several ways, including:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the terms on which credit may be available to us could be less attractive, both in the economic terms of the credit and the legal covenants;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the possible lack of availability of additional credit;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the potential for higher levels of interest expense to service or maintain our outstanding debt;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the possibility of additional borrowings in the future to repay our indebtedness when it comes due; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the possible diversion of capital resources from other uses.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">While we believe we will have the ability to service our debt and obtain additional resources in the future if and when needed, that will depend upon our results of operations and financial position at the time, the then-current state of the credit and financial markets, and other factors that may be beyond our control. Therefore, we cannot give assurances that sufficient credit will be available on terms that we consider attractive, or at all, if and when necessary or beneficial to us.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">The issuance of shares by us in the future or sales of shares by our stockholders may cause the market price of our common stock to drop significantly, even if our business is performing well. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">This issuance of shares by us in the future, including by conversion of our convertible notes in certain circumstances, the issuance of shares of our common stock to partners, including up to </span><span style="font-family:inherit;font-size:10pt;">2,025,036</span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock that we may issue to Verily and Onduo LLC pursuant to the Restated Collaboration Agreement, or sales of shares by our stockholders may cause the market price of our common stock to decline, perhaps significantly, even if our business is performing well. The market price of our common stock could also decline if there is a perception that sales of our shares are likely to occur in the future. This might also make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate. Also, we may issue securities in connection with future financings and acquisitions, and those shares could dilute the holdings of other stockholders.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We do not intend to pay dividends for the foreseeable future. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have never declared or paid cash dividends on our capital stock. We currently intend to retain any future earnings to finance the operation and expansion of our business, and we do not expect to declare or pay any dividends in the foreseeable future and the terms of our credit agreement restrict our ability to declare or pay dividends. As a result, stockholders (including holders of our convertible notes who receive shares of our common stock, if any, upon conversion of their notes) may only receive a return on their investment in our common stock if the market price of our common stock increases.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">53</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Anti-takeover effects of our charter documents and Delaware law could make a merger, tender offer or proxy contest difficult, thereby depressing the trading price of our common stock.</span><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, there are provisions in our certificate of incorporation and bylaws, as well as provisions in the Delaware General Corporation Law, that may discourage, delay or prevent a change of control that might otherwise be beneficial to stockholders. For example: </span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our Board of Directors may, without stockholder approval, issue shares of preferred stock with special voting or economic rights; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our stockholders do not have cumulative voting rights and, therefore, each of our directors can only be elected by holders of a majority of our outstanding common stock; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">a special meeting of stockholders may only be called by a majority of our Board of Directors, the Chairman of our Board of Directors, our Chief Executive Officer, our President or our Lead Independent Director; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our stockholders may not take action by written consent; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our Board of Directors is divided into three classes, only one of which is elected each year; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:64px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">we require advance notice for nominations for election to the Board of Directors or for proposing matters that can be acted upon by stockholders at stockholder meetings.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">Risks Related to Our Debt</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We have indebtedness in the form of convertible senior notes, which could adversely affect our financial health and our ability to respond to changes in our business. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2017, we completed an offering of </span><span style="font-family:inherit;font-size:10pt;">$400.0 million</span><span style="font-family:inherit;font-size:10pt;"> aggregate principal amount of </span><span style="font-family:inherit;font-size:10pt;">0.75%</span><span style="font-family:inherit;font-size:10pt;"> convertible senior notes due 2022, or 2022 Notes, which offering we refer to as the 2017 Notes Offering. In November 2018, we completed an offering of </span><span style="font-family:inherit;font-size:10pt;">$850.0 million</span><span style="font-family:inherit;font-size:10pt;"> aggregate principal amount of </span><span style="font-family:inherit;font-size:10pt;">0.75%</span><span style="font-family:inherit;font-size:10pt;"> convertible senior notes due 2023, or 2023 Notes, which offering we refer to as the 2018 Notes Offering. We refer to the 2017 Notes Offering and the 2018 Notes Offering together as the Notes Offerings, and we refer to the 2022 Notes and the 2023 Notes together as the Notes. As a result of the Notes Offerings, we incurred </span><span style="font-family:inherit;font-size:10pt;">$1.250 billion</span><span style="font-family:inherit;font-size:10pt;"> principal amount of indebtedness, the principal amount of which we may be required to pay at maturity. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Holders of the Notes will have the right to require us to repurchase their notes upon the occurrence of a fundamental change (as defined in the indenture for each of the 2022 Notes and the 2023 Notes) at a purchase price equal to </span><span style="font-family:inherit;font-size:10pt;">100%</span><span style="font-family:inherit;font-size:10pt;"> of the principal amount of the notes to be purchased, plus accrued and unpaid interest, if any. In addition, each indenture for the Notes provides that we are required to repay amounts due under each indenture in the event that there is an event of default for the Notes that results in the principal, premium, if any, and interest, if any, becoming due prior to maturity date for the Notes. There can be no assurance that we will be able to repay this indebtedness when due, or that we will be able to refinance this indebtedness on acceptable terms or at all. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As a result of our level of increased debt after the completion of the Notes Offerings: </span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:77px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:44px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our vulnerability to adverse general economic conditions and competitive pressures will be heightened;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:77px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:44px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">we will be required to dedicate a larger portion of our cash flow from operations to interest payments, limiting the availability of cash for other purposes;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:77px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:44px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our flexibility in planning for, or reacting to, changes in our business and industry may be more limited; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:77px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:44px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions, general corporate purposes or other purposes may be impaired.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We cannot be sure that our leverage resulting from the level of increased debt after the completion of the Notes Offerings will not materially and adversely affect our ability to finance our operations or capital needs or to engage in other business activities. In addition, we cannot be sure that additional financing will be available when required or, if available, will be on terms satisfactory to us. Further, even if we are able to obtain additional financing, we may be required to use such proceeds to repay a portion of our debt.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We may be unable to repurchase the Notes upon a fundamental change when required by the holders or repay prior to maturity any accelerated amounts due under the notes upon an event of default or redeem the Notes unless specified conditions are met under our credit facility, and our future debt may contain limitations on our ability to pay cash upon conversion, repurchase or repayment of the Notes.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Holders of the Notes will have the right to require us to repurchase their Notes upon the occurrence of a fundamental change at a purchase price equal to </span><span style="font-family:inherit;font-size:10pt;">100%</span><span style="font-family:inherit;font-size:10pt;"> of the principal amount of the Notes to be purchased, plus accrued and unpaid interest, if any, to, but not including, the fundamental change purchase date. In addition, each indenture for the Notes provides </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">54</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">that we are required to repay amounts due under each indenture in the event that there is an event of default for the Notes that results in the principal, premium, if any, and interest, if any, becoming due prior to maturity date for the Notes. In addition, upon conversion of the Notes, unless we elect to deliver solely shares of our common stock to settle such conversion (other than cash in lieu of any fractional share), we will be required to make cash payments in respect of the Notes being converted. However, we may not have enough available cash or be able to obtain financing at the time we are required to repurchase Notes surrendered upon a fundamental change or repay prior to maturity any accelerated amounts or pay cash for Notes being converted. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, our ability to purchase the Notes or repay prior to maturity any accelerated amounts under the Notes upon an event of default or pay cash upon conversions of the Notes may be limited by law, by regulatory authority or by agreements governing our indebtedness outstanding at the time, including our credit facility. Under our current credit facility we are only permitted to use cash to purchase the Notes or repay prior to maturity any accelerated amounts under the Notes if we meet certain conditions that are defined under the Credit Agreement. We may not meet these conditions in the future. Our failure to repurchase Notes at a time when the repurchase is required by the respective indenture (whether upon a fundamental change or otherwise under each indenture) or pay cash payable on future conversions of the Notes as required by the indenture would constitute a default under each indenture. A default under each indenture or the fundamental change itself could also lead to a default under agreements governing our existing or future indebtedness, including our credit facility. If the repayment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness, repurchase the Notes or make cash payments upon conversions thereof.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We may still incur substantially more debt or take other actions which would intensify the risks discussed above.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We may incur substantial additional debt in the future, subject to the restrictions contained in our debt instruments, some of which may be secured debt. We are not restricted under the terms of the indentures governing the Notes from incurring additional debt, securing existing or future debt, recapitalizing our debt, or taking a number of other actions that are not limited by the terms of the indenture governing the convertible senior notes that could have the effect of diminishing our ability to make payments on the Notes when due.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">The convertible note hedge and warrant transactions may affect the value of the 2023 Notes and our common stock.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In connection with the sale of the 2023 Notes, we entered into convertible note hedge, or the 2023 Note Hedge, transactions with certain financial institutions, or option counterparties. We also entered into warrant transactions with the option counterparties pursuant to which we sold warrants for the purchase of our common stock, or the 2023 Warrants. The 2023 Note Hedge transactions are expected generally to reduce the potential dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes. The 2023 Warrant transactions could separately have a dilutive effect to the extent that the market price per share of our common stock exceeds the exercise price of the 2023 Warrants, which is </span><span style="font-family:inherit;font-size:10pt;">$198.38</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The option counterparties and/or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our common stock and/or purchasing or selling our common stock in secondary market transactions prior to the maturity of 2023 Notes (and are likely to do so during any observation period related to a conversion of 2023 Notes, or following any repurchase of Notes by us on any fundamental change repurchase date (as defined in the indenture for the 2023 Notes) or otherwise). This activity could also cause or avoid an increase or a decrease in the market price of our common stock or the 2023 Notes, which could affect note holders&#8217; ability to convert the 2023 Notes and, to the extent the activity occurs during any observation period related to a conversion of the 2023 Notes, it could affect the amount and value of the consideration that note holders will receive upon conversion of the 2023 Notes.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The potential effect, if any, of these transactions and activities on the market price of our common stock or the 2023 Notes will depend in part on market conditions and cannot be ascertained at this time. Any of these activities could adversely affect the value of our common stock and the value of the 2023 Notes (and as a result, the value of the consideration, the amount of cash and/or the number of shares, if any, that note holders would receive upon the conversion of the 2023 Notes) and, under certain circumstances, the ability of the note holders to convert the 2023 Notes.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We do not make any representation or prediction as to the direction or magnitude of any potential effect that the transactions described above may have on the price of the 2023 Notes or our common stock. In addition, we do not make any representation that the option counterparties will engage in these transactions or that these transactions, once commenced, will not be discontinued without notice.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">We are subject to counterparty risk with respect to the 2023 Note Hedge transactions.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The option counterparties are financial institutions, and we will be subject to the risk that any or all of them may default under the 2023 Note Hedge transactions. Our exposure to the credit risk of the option counterparties will not be secured by any collateral. Recent global economic conditions have resulted in the actual or perceived failure or financial difficulties of many financial institutions. If an option counterparty becomes subject to insolvency proceedings, we will become an unsecured </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">55</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">creditor in those proceedings, with a claim equal to our exposure at that time under our transactions with that option counterparty. Our exposure will depend on many factors but, generally, an increase in our exposure will be correlated to an increase in the market price and in the volatility of our common stock. In addition, upon a default by an option counterparty, we may suffer adverse tax consequences and more dilution than we currently anticipate with respect to our common stock. We can provide no assurances as to the financial stability or viability of the option counterparties.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Servicing our debt requires a significant amount of cash, and we may not have sufficient cash flow from our business to pay our substantial debt.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our ability to make scheduled payments of the principal of, to pay interest on or to refinance our indebtedness, including the Notes, depends on our future financial condition and operating performance, which is subject to economic, financial, competitive and other factors beyond our control. Our business may not continue to generate cash flow from operations in the future sufficient to satisfy our obligations under the Notes, our existing indebtedness and any future indebtedness we may incur and to make necessary capital expenditures. We may not maintain a level of cash flows from operating activities sufficient to permit us to pay the principal, premium, if any, and interest on (as well as any cash due upon conversion of) our debt, including the Notes.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If we are unable to generate such cash flow, we may be required to adopt one or more alternatives, such as reducing or delaying investments or capital expenditures, selling assets, refinancing or obtaining additional equity capital on terms that may be onerous or highly dilutive. These alternative measures may not be successful and may not permit us to meet our scheduled debt servicing obligations. Further, we may need to refinance all or a portion of our debt on or before maturity, and our ability to refinance the Notes, existing indebtedness or future indebtedness will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these activities on commercially reasonable terms or at all, which could result in a default on the Notes or our current and future indebtedness.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Our credit facility imposes restrictions on us that may adversely affect our ability to operate our business.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our credit facility contains restrictive covenants relating to our capital raising activities and other financial and operational matters which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. In addition, our credit facility and the agreements governing the notes each contain cross-default provisions whereby a default under one agreement would likely result in cross defaults under agreements covering other borrowings. For example, the occurrence of a default with respect to any indebtedness or any failure to repay debt when due in an amount in excess of $25.0 million that causes such indebtedness to become due prior to its scheduled maturity date would cause a cross default under the indenture governing the Notes. In addition, the occurrence of a default with respect to any indebtedness or any failure to repay debt when due in an amount in excess of $15.0 million that causes such indebtedness to become due prior to its scheduled maturity date would cause a default under our credit facility. The occurrence of a default under any of these borrowing arrangements would permit the holders of the Notes or the lenders under our credit facility to declare all amounts outstanding under those borrowing arrangements to be immediately due and payable. If the Note holders or the trustee under the indenture governing the Notes or the lenders under our credit facility accelerate the repayment of borrowings, we cannot assure you that we will have sufficient assets to repay those borrowings.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Conversion of the Notes will, to the extent we deliver shares upon conversion of such Notes, dilute the ownership interest of existing stockholders, including holders who had previously converted their Notes, or may otherwise depress our stock price.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The conversion of some or all of the Notes will dilute the ownership interests of existing stockholders to the extent we deliver shares upon conversion of any of the Notes. Any sales in the public market of the common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, the existence of the Notes may encourage short selling by market participants because the conversion of the Notes could be used to satisfy short positions, or anticipated conversion of the Notes into shares of our common stock could depress our stock price.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">The conditional conversion feature of the Notes, if triggered, may adversely affect our financial condition and operating results.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the event the conditional conversion feature of the Notes is triggered, holders of the Notes will be entitled to convert the Notes at any time during specified periods at their option. If one or more holders elect to convert their Notes, unless we elect to satisfy our conversion obligation by delivering solely shares of our common stock (other than cash in lieu of any fractional share), we would be required to settle a portion or all of our conversion obligation through the payment of cash, which could adversely affect our liquidity. In addition, even if holders of the Notes do not elect to convert their Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">56</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">The accounting method for convertible debt securities that may be settled in cash, such as the Notes, may have a material effect on our reported financial results.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Under GAAP, an entity must separately account for the debt component and the embedded conversion option of convertible debt instruments that may be settled entirely or partially in cash upon conversion, such as the Notes, in a manner that reflects the issuer&#8217;s economic interest cost. The effect of the accounting treatment for such instruments is that the value of such embedded conversion option would be treated as original issue discount for purposes of accounting for the debt component of the Notes, and that original issue discount is amortized into interest expense over the term of the Notes using an effective yield method. As a result, we will be required to record a greater amount of non-cash interest expense because of the amortization of the original issue discount to the Notes&#8217; face amount over the term of the Notes and because of the amortization of the debt issuance costs. Accordingly, we will report greater interest expense and lower net income in our financial results because of the recognition of both the current period&#8217;s amortization of the debt discount and the Notes&#8217; coupon interest, which could adversely affect our reported or future financial results, the trading price of our common stock and the trading price of the Notes.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, if the conditional conversion feature of the Notes is triggered, even if holders do not elect to convert their Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">The fundamental change repurchase feature of the Notes may delay or prevent an otherwise beneficial attempt to take over DexCom.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The terms of the Notes require us to repurchase the Notes in the event of a fundamental change. A takeover of DexCom would trigger an option of the holders of the Notes to require us to repurchase the Notes. In addition, if a make-whole fundamental change occurs prior to the maturity date of the Notes, we will in some cases be required to increase the conversion rate for a holder that elects to convert its Notes in connection with such make-whole fundamental change. Furthermore, each indenture for the Notes prohibits us from engaging in certain mergers or acquisitions unless, among other things, the surviving entity assumes our obligations under the notes. These and other provisions of each indenture may have the effect of delaying or preventing a takeover of DexCom.</span></div><div><a id="s5148CF436CD954FEA9B04D4D60A8B424"></a></div><div style="line-height:120%;padding-bottom:8px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:84px;text-indent:-84px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 1B - UNRESOLVED STAFF COMMENTS</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">None.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">57</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><a id="s903B427E80075861AE918E170E37E4AF"></a></div><div style="line-height:120%;padding-bottom:8px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:84px;text-indent:-84px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 2 - PROPERTIES</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We lease real property to to support our business, including manufacturing, research and development, sales, marketing and administration. The following lists those properties that we believe are material to our business. We believe our facilities are suitable and adequate for our current and near-term needs, and that we will be able to locate additional facilities as needed.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.0234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:25%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:50%;"></td><td style="width:1%;"></td><td style="width:11%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Approximate</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Square Feet</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Purpose</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;Lease Expiration Dates</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:6px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">San Diego, CA</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">503,400</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:6px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Laboratory, Manufacturing, Research and Development, Warehouse, General and Administrative, Sales and Marketing</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;2026</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;(1)</sup></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Mesa, AZ</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">148,800</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:6px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">General and Administrative, Laboratory, Manufacturing, Warehouse</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;2028 </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span><span style="font-family:inherit;font-size:10pt;"> Excludes renewals that would be at our option to extend the term of a lease for approximately </span><span style="font-family:inherit;font-size:10pt;">351,400</span><span style="font-family:inherit;font-size:10pt;"> square feet of space expiring in </span><span style="font-family:inherit;font-size:10pt;color:#252525;">2023</span><span style="font-family:inherit;font-size:10pt;"> for two additional three to five-year terms.</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2) </sup></span><span style="font-family:inherit;font-size:10pt;color:#252525;">Excludes</span><span style="font-family:inherit;font-size:10pt;"> renewals that would be at our option to extend the term of this lease for four additional five-year terms.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We also lease various administrative and customer support real properties throughout the world including the U.S., Canada, Germany, the Philippines, Switzerland and the United Kingdom.</span></div><div><a id="sD537126CD9165A08A9C65F5A611C206F"></a></div><div style="line-height:120%;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:84px;text-indent:-84px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 3 - LEGAL PROCEEDINGS</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span>On March 28, 2016, AgaMatrix, Inc., or AgaMatrix, filed a patent infringement lawsuit against us in the U.S. District Court for the District of Oregon, asserting that certain of our products infringe three patents held by AgaMatrix. (After filing suit, AgaMatrix reorganized its business and the Court granted AgaMatrix&#8217;s motion to substitute the newly created entity WaveForm Technologies, Inc., as the plaintiff following AgaMatrix&#8217;s transfer of the three asserted patents to WaveForm.) DexCom filed petitions for </span><span style="font-style:italic;">inter partes</span><span> review with the Patent Trial and Appeal Board, or PTAB, of the U.S. Patent and Trademark Office, challenging each of the three asserted patents as being unpatentable in view of prior art. The PTAB issued a Final Written Decision for each of the first two patents on February 28, 2018, where the PTAB found the majority of asserted claims from the first patent unpatentable and the remaining claims under review not unpatentable. The PTAB found all claims under review from the second patent not unpatentable. On September 12, 2018, the PTAB found all of the asserted claims in the third patent unpatentable. In October 2018, we filed in the District Court a motion for summary judgment that all remaining asserted claims are invalid. The District Court granted that motion and, on August 23, 2019, entered judgment in our favor. On September 6, 2019, WaveForm appealed the judgment. The appeal is pending and no hearing date has been set.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have also filed several lawsuits against AgaMatrix. We filed a patent infringement lawsuit against AgaMatrix in the United States District Court for the Central District of California, or C.D. Cal., in which a Final Judgment of non-infringement was entered by the C.D. Cal judge on February 23, 2018 and affirmed on appeal by the Federal Circuit on March 7, 2019. AgaMatrix was awarded attorneys&#8217; fees for this lawsuit.</span><span style="font-family:inherit;font-size:10pt;"> As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we have accrued an immaterial amount for those fees. </span><span style="font-family:inherit;font-size:10pt;">The fee decision is currently on appeal to the Federal Circuit. On September 15, 2017, we filed a patent infringement lawsuit against AgaMatrix in the United States District Court for the District of Delaware, asserting certain single-point blood glucose monitoring products of AgaMatrix infringe two patents held by us. In addition, on September 18, 2017, we filed a Complaint against AgaMatrix in the International Trade Commission, referred to as the ITC, requesting that the ITC institute an investigation and issue an order excluding certain products of AgaMatrix from importation into or sale in the United States based on AgaMatrix&#8217;s infringement of the same two patents asserted in the Delaware litigation. The investigation was terminated by the ITC on April 4, 2019 with a finding of non-infringement. The decision is currently on appeal.</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Neither&#160;the outcome of these lawsuits nor the amount and range of potential loss associated with the lawsuits can be assessed at this time. Other than the attorneys&#8217; fees described above, as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> we have accrued </span><span style="font-family:inherit;font-size:10pt;">no</span><span style="font-family:inherit;font-size:10pt;"> amounts for contingent losses associated with these suits. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters. </span><span style="font-family:inherit;font-size:10pt;">We do not believe we are party to any currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition or results of operations.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">58</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><a id="sC64C48DCFD5D50B28B960A1753D33379"></a></div><div style="line-height:120%;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:90px;text-indent:-90px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 4 - MINE SAFETY DISCLOSURES</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:65px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Not applicable.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">59</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;font-size:14pt;"><span style="font-family:inherit;font-size:14pt;"><br/></span></div><div><a id="s254CB6BD8FAB5FA093A4B667A617C0FD"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">PART II</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><a id="sA8EC57ACEC355957A9CA1FE862822632"></a></div><div style="line-height:120%;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:18%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:90px;text-indent:-90px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 5 - MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Market Information for Common Stock</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DexCom&#8217;s common stock is traded on the Nasdaq Global Select Market under the symbol &#8220;DXCM.&#8221;</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Stockholders</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We had approximately </span><span style="font-family:inherit;font-size:10pt;">30</span><span style="font-family:inherit;font-size:10pt;"> stockholders of record as of </span><span style="font-family:inherit;font-size:10pt;">February&#160;7, 2020</span><span style="font-family:inherit;font-size:10pt;">. The number of beneficial owners of our common stock at that date was substantially greater than the number of record holders because a large portion of our common stock is held of record through brokerage firms in &#8220;street name.&#8221; </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Dividend Policy</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have never declared or paid any cash dividends on our capital stock. We currently intend to retain any future earnings to finance the operation and expansion of our business, and we do not expect to declare or pay any dividends in the foreseeable future.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Recent Sales of Unregistered Securities</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There were no unregistered sales of equity securities which have not been previously disclosed in a quarterly report on Form 10-Q or a current report on Form 8-K during the year ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Neither we nor any affiliated purchaser repurchased any of our equity securities in fiscal year&#160;2019.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Company Stock Price Performance</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The graph below compares the cumulative total stockholder return on our common stock with the cumulative total returns on the Nasdaq Composite Index and the Nasdaq Medical Equipment Index over the five-year period ending </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">. The graph assumes that $100 was invested in DexCom common stock and in each of the other indices on </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</span><span style="font-family:inherit;font-size:10pt;"> and that all dividends were reinvested. The comparisons in the graph below are based on historical data and are not intended to forecast the possible future performance of DexCom&#8217;s common stock.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The graph below and related information shall not be deemed &#8220;soliciting material&#8221; or be deemed to be &#8220;filed&#8221; with the SEC, nor shall such information be incorporated by reference into any future filing, except to the extent that we specifically incorporate it by reference into such filing.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">60</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-top:6px;text-align:center;text-indent:32px;"><img src="a2019chartitem5.jpg" alt="a2019chartitem5.jpg" style="height:521px;width:674px;"></img></div><div style="line-height:120%;padding-top:6px;text-align:center;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">* $100 invested on </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</span><span style="font-family:inherit;font-size:10pt;"> in stock or index, including reinvestment of any dividends.</span></div><div style="line-height:120%;padding-top:6px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25"></td></tr><tr><td style="width:22%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">December&#160;31, 2014</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">December&#160;31, 2015</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">December&#160;31, 2016</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">December&#160;31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">DexCom, Inc.</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">100.00</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">148.77</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">108.45</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">104.25</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">217.62</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">397.35</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">Nasdaq Composite</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">100.00</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">106.96</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">116.45</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">150.96</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">146.67</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">200.49</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">Nasdaq Medical Equipment</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">100.00</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">111.06</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">116.87</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">166.41</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">187.88</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8.5pt;"><span style="font-family:inherit;font-size:8.5pt;font-weight:bold;">227.84</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">61</span></div></div><hr style="page-break-after:always"></hr><div><a id="sDAEECAAB8B86591391F01122DB44A6A6"></a></div><div><br/></div><div style="line-height:120%;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:90px;text-indent:-90px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 6 - SELECTED FINANCIAL DATA</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">The consolidated statements of operations data for the years ended </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">December 31,</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">2019</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">2018</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">, and </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">2017</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> and the consolidated balance sheet data as of </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">December 31,</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">2019</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> and </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">2018</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> have been derived from our audited consolidated financial statements included elsewhere in this Annual Report. The statements of operations data for the years ended </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">December 31,</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">2016</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> and </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">2015</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> and the consolidated balance sheet data as of </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">December 31,</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">2017</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">2016</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> and </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">2015</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> have been derived from our audited consolidated financial statements not included in this Annual Report. The following selected financial data should be read in conjunction with our &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Part II, Item 7 and our consolidated financial statements and related notes in Part II, Item 8 of this Annual Report.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"></td></tr><tr><td style="width:50%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions, except per share data)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Consolidated Statements of Operations Data:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Product revenue</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,476.0</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,031.6</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">718.5</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">573.3</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">400.7</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Development grant and other revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.3</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total revenue</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,476.0</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,031.6</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">718.5</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">573.3</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">402.0</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">544.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">367.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">226.4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">194.9</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">123.6</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gross profit </span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">931.5</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">663.9</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">492.1</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">378.4</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">278.4</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating expenses:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Research and development</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">273.5</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">199.7</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">185.4</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">156.1</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">101.0</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Collaborative research and development fees</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">217.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">36.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Selling, general and administrative</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">515.7</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">432.8</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">349.2</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">286.2</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">198.0</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating expenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">789.2</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">850.2</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">534.6</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">442.3</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">335.5</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">142.3</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(186.3</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(42.5</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(63.9</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(57.1</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(60.3</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(22.7</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(12.8</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(0.7</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(0.4</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income (loss) from equity investments</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(4.2</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">80.1</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest and other income (expense), net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">26.4</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">6.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(0.3</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income (loss) before income taxes</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">104.2</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(126.5</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(48.6</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(64.9</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(57.5</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income tax expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">3.1</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.6</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.6</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.7</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.1</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">101.1</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(127.1</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(50.2</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(65.6</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(57.6</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic net income (loss) per share</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.11</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(1.44</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(0.58</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(0.78</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(0.72</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shares used to compute basic net income (loss) per share</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">91.1</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">88.2</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">86.3</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">83.6</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">79.8</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted net income (loss) per share</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.10</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(1.44</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(0.58</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(0.78</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(0.72</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shares used to compute diluted net income (loss) per share</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">92.3</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">88.2</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">86.3</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">83.6</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">79.8</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">As of December&#160;31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Consolidated Balance Sheet Data:</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash, cash equivalents, and short-term marketable securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,533.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,385.6</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">548.6</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">123.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">115.2</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Working capital</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,609.2</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,477.1</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">605.8</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">177.6</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">164.4</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2,395.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,916.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">904.1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">402.8</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">292.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term liabilities</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,152.2</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,030.3</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">345.8</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">16.6</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">3.9</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total stockholders&#8217; equity </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">882.6</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">663.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">419.4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">283.8</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">221.2</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:18px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">See Note&#160;2 to the consolidated financial statements in Part II, Item 8 of this Annual Report for a description of our </span><span style="font-family:inherit;font-size:10pt;">Restated Collaboration Agreement</span><span style="font-family:inherit;font-size:10pt;"> with Verily Life Sciences LLC and Verily Ireland Limited.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:18px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup>&#160;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">See Note&#160;1 to the consolidated financial statements in Part II, Item 8 of this Annual Report for a description of the method used to compute basic and diluted net loss per share attributable to common stockholders.</span></div></td></tr></table><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">62</span></div></div><hr style="page-break-after:always"></hr><div><a id="sC3A902C4DAC35550A0BE7005FFA5DC34"></a></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 7 - MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;font-weight:bold;">                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">This document, including the following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, contains forward-looking statements that are not purely historical regarding DexCom&#8217;s or its management&#8217;s intentions, beliefs, expectations and strategies for the future. These forward-looking statements fall within the meaning of the federal securities laws that relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221; or the negative of these terms or other comparable terminology. Forward-looking statements are made as of the date of this report, deal with future events, are subject to various risks and uncertainties, and actual results could differ materially from those anticipated in those forward looking statements. The risks and uncertainties that could cause actual results to differ materially are more fully described under &#8220;Risk Factors&#8221; and elsewhere in this report and in our other reports filed with the SEC. We assume no obligation to update any of the forward-looking statements after the date of this report or to conform these forward-looking statements to actual results. You should read the following discussion and analysis together with &#8220;Selected Financial Data&#8221; in Part II, Item 6 and our consolidated financial statements and related notes in Part II, Item 8 of this Annual Report. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">Overview</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for use by people with diabetes and by healthcare providers. We received approval from the Food and Drug Administration, or FDA, and commercialized our first product in 2006. We launched our latest generation system, the DexCom G6</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></span><span style="font-family:inherit;font-size:10pt;"> integrated Continuous Glucose Monitoring System, or G6, in 2018. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;DexCom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We sell our reusable transmitter and receiver, collectively referred to as &#8220;Reusable Hardware&#8221; and disposable sensors through a direct sales force in the United States, Canada and some countries in Europe, and through distribution arrangements in the </span><span style="font-family:inherit;font-size:10pt;">United States, and certain countries in Africa, Asia, Europe, Latin America, and the Middle East, as well as Australia, Canada, and New Zealand</span><span style="font-family:inherit;font-size:10pt;">. Most of our distributors stock our products and fulfill orders for our products from their inventory. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We plan to develop future generations of technologies that are focused on improved performance and convenience and that will enable intelligent insulin administration. We also are aggressively exploring how to extend our offerings to other opportunities, including for people with Type 2 diabetes that are non-insulin using, people with pre-diabetes, people who are obese, people who are pregnant, and people with diabetes in the hospital setting. We will continue to develop a networked platform with open architecture, connectivity and transmitters capable of communicating with other devices and software systems. We also intend to expand our efforts to accumulate CGM patient data and metrics and apply predictive modeling and machine learning to generate interactive CGM insights that can inform patient behavior.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For discussion related to the results of operations and changes in financial condition for&#160;fiscal 2018&#160;compared to&#160;fiscal 2017&#160;refer to Part II, Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in our&#160;fiscal 2018&#160;Form 10-K, which was filed with the United States Securities and Exchange Commission on February 21, 2019.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:21%;"></td><td style="width:19%;"></td><td style="width:19%;"></td><td style="width:19%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">Critical Accounting Policies and Estimates</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which we have prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements as well as the reported revenue and expenses during the reporting periods. On an ongoing basis, we evaluate our estimates and judgments. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">While our significant accounting policies are more fully described in Note 1 to the consolidated financial statements in Part II, Item 8 of this Annual Report, we believe that the following accounting policies and estimates are most critical to a full understanding and evaluation of our reported financial results. Members of our senior management have discussed the development and selection of these critical accounting policies and their disclosure in this Annual Report with the Audit Committee of our Board of Directors.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">63</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We generate our revenue from the sale of our Reusable Hardware and disposable sensors. Disposable sensors are sold separately. We also provide free-of-charge software and mobile applications for use with our Reusable Hardware and disposable sensors. In determining how revenue should be recognized, a five-step process is used, which requires judgment and estimates within the revenue recognition process. The primary judgments include identifying the performance obligations in the contract and determining whether the performance obligations are distinct. We exercise significant judgment when we determine the transaction price, including variable consideration adjustments. If the actual amounts of consideration that we receive differ from our estimates, we would adjust our estimates and that would affect reported revenue in the period that such variances become known. If any of these judgments were to change it could cause a material increase or decrease in the amount of revenue we report in a particular period.&#160;</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We generally recognize revenue when control is transferred to our customers in an amount that reflects the net consideration to which we expect to be entitled. </span><span style="font-family:inherit;font-size:10pt;">Transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix. </span><span style="font-family:inherit;font-size:10pt;">We recognize revenue only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. We estimate reductions for rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data. For more information, see </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">&#8220;Revenue Recognition&#8221;</span><span style="font-family:inherit;font-size:10pt;"> in Note 1 to the consolidated financial statements in Part II, Item 8 of this Annual Report.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Disaggregation of Revenue. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We disaggregate revenue by geographic region and by major sales channel. We have determined that disaggregating revenue into these categories achieves the ASC Topic 606 disclosure objectives of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Reconciliations of revenue disaggregated by geographic location and by major sales channel to total revenue are provided in Note 10 to the consolidated financial statements in Part II, Item 8 of this Annual Report.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Share-Based Compensation</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized straight-line over the requisite service period of the individual grants, which typically equals the vesting period. We value time-based Restricted Stock Units (&#8220;RSUs&#8221;) at the date of grant using the intrinsic value method. Certain RSUs granted to senior management vest based on the achievement of pre-established performance or market goals. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We estimate the fair value of performance-based RSUs at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We update our assessment of the probability that the specified performance criteria will be achieved each quarter and adjust our estimate of the fair value of the performance-based RSUs if necessary. The Monte Carlo methodology that we use to estimate the fair value of market-based RSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the market-based RSUs at the date of grant must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the performance of the specified market criteria. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If any of the assumptions used change significantly, share-based compensation expense may differ materially from what we have recorded in the current period.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value of Financial Instruments</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The authoritative guidance establishes a fair value hierarchy that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities. In general, the authoritative guidance requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset or liability&#8217;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the measurement of its fair value. The three levels of input defined by the authoritative guidance are as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level&#160;1&#8212;Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level&#160;2&#8212;Uses inputs other than quoted prices included in Level&#160;1 that are observable, either directly or indirectly, through correlation with market data. These include quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data for substantially the full term of the assets or liabilities.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">64</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level&#160;3&#8212;Uses unobservable inputs that are supported by little or no market activity and that are significant to the determination of fair value. Level 3 assets and liabilities include those whose fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques and significant judgment or estimation.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We estimate the fair value of most of our cash equivalents using Level 1 inputs. We estimate the fair value of our marketable equity securities using Level 1 inputs and we estimate the fair value of our marketable debt securities using Level 2 inputs. We carry our other financial instruments, such as cash, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, at cost, which approximates the related fair values due to the short-term maturities of these instruments. See Note 1 and Note 3 to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information about fair value measurements. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Accounts Receivable, Net and Related Valuation Accounts</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We maintain an allowance for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. We evaluate the collectability of our accounts receivable based on a combination of factors. We regularly analyze customer accounts, review the length of time receivables are outstanding, review historical loss rates and assess current economic trends that may impact the level of credit losses in the future. Our allowance for doubtful accounts has generally been adequate to cover our actual credit losses. However, since we cannot reliably predict future changes in the financial stability of our customers, we may need to increase our reserves if the financial conditions of our customers deteriorate. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Excess and Obsolete Inventory</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventory is valued at the lower of cost or net realizable value. We record adjustments to inventory for potentially excess, obsolete, or scrapped goods in order to state inventory at net realizable value. Factors influencing these adjustments include inventories on hand and on order compared to estimated future usage and sales for existing and new products, as well as judgments regarding quality control testing data and assumptions about the likelihood of scrap and obsolescence. Historically, our inventory reserves have been adequate to cover our actual losses. However, if actual product life cycles, product quality or market conditions differ from our assumptions, additional inventory adjustments that would increase cost of goods sold could be required. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We estimate our income taxes based on the various jurisdictions where we conduct business. Significant judgment is required in determining our worldwide income tax provision. The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations and the potential for future adjustment of our uncertain tax positions by the Internal Revenue Service or other taxing jurisdictions. While we believe we have appropriate support for the positions taken on our tax returns, we regularly assess the potential outcomes of examinations by tax authorities in determining the adequacy of our provision for income taxes. We continually assess the likelihood and amount of potential adjustments and adjust the income tax provision, income taxes payable, and deferred taxes in the period in which the facts that give rise to a revision become known. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We use the asset and liability approach to recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, and reliability of forecasting. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we have maintained a full valuation allowance on our deferred tax assets since inception based on our historical losses and the uncertainty of generating future taxable income to utilize our loss and credit carryforwards. A future release of our valuation allowance will result in a material tax benefit recognized in the quarter of the release. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We recognize and measure benefits for uncertain tax positions using a two-step approach. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that the tax position will be sustained upon audit, including resolution of any related appeals or litigation processes. For tax positions that are more likely than not of being sustained upon audit, the second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. Significant judgment is required to evaluate uncertain tax positions and is based upon a number of factors, including changes in facts or circumstances, changes in tax law, correspondence with tax authorities during the course of audits and effective settlement of audit issues. Changes in the recognition or measurement of uncertain tax positions could result in material increases or decreases in our income tax expense in the period in which we make the change, which could have a material impact on our effective tax rate and operating results.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">65</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Loss Contingencies</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are subject to certain legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. We review the status of each significant matter quarterly and assess our potential financial exposure. If the potential loss from a claim or legal proceeding is considered probable and the amount can be reasonably estimated, we record a liability and an expense for the estimated loss and disclose it in our consolidated financial statements if it is significant. If we determine that a loss is possible and the range of the loss can be reasonably determined, we do not record a liability or an expense but we disclose the range of the possible loss. Significant judgment is required in the determination of whether a potential loss is probable, reasonably possible, or remote as well as in the determination of whether a potential exposure is reasonably estimable. We base our judgments on the best information available at the time. As additional information becomes available, we reassess the potential liability related to our pending claims and litigation and may revise our estimates. Any revision of our estimates of potential liability could have a material impact on our financial position and operating results.</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">Results of Operations</span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Financial Overview</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><img src="a2019chartitem7.jpg" alt="a2019chartitem7.jpg" style="height:341px;width:682px;"></img><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26"></td></tr><tr><td style="width:31%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended December 31,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019 - 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 - 2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">$ Change</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">% Change</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">$ Change</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">% Change</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,476.0</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,031.6</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">718.5</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">444.4</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">43</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">313.1</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">44</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gross profit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">931.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">663.9</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">492.1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">267.6</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">40</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">171.8</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">35</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#e1ede6;">Operating income (loss)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">142.3</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(186.3</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(42.5</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">328.6</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(143.8</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income (loss)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">101.1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(127.1</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(50.2</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">228.2</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(76.9</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic net income (loss) per share</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.11</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(1.44</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(0.58</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.55</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(0.86</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted net income (loss) per share</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.10</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(1.44</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(0.58</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.54</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(0.86</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">* = Not Meaningful </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">66</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:21%;"></td><td style="width:19%;"></td><td style="width:19%;"></td><td style="width:19%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Revenue, Cost of Sales and Gross Profit</span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26"></td></tr><tr><td style="width:31%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended December 31,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019 - 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 - 2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">$ Change</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">% Change</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">$ Change</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">% Change</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,476.0</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,031.6</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">718.5</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">444.4</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">43</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">313.1</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">44</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of sales</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">544.5</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">367.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">226.4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">176.8</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">48</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">141.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">62</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gross profit</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">931.5</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">663.9</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">492.1</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">267.6</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">40</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">171.8</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">35</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gross profit as a percent of total revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">63</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">64</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">68</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We expect that revenues we generate from the sales of our products will fluctuate from quarter to quarter. We typically experience seasonality, with lower sales in the first quarter of each year compared to the immediately preceding fourth quarter. This seasonal sales pattern relates to U.S. annual insurance deductible resets and unfunded flexible spending accounts.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of sales includes direct labor and materials costs related to each product sold or produced, including assembly, test labor and scrap, as well as factory overhead supporting our manufacturing operations. Factory overhead includes facilities, material procurement and control, manufacturing engineering, quality assurance, supervision and management. These costs are primarily salary, fringe benefits, share-based compensation, facility expense, supplies and purchased services. All of our manufacturing costs are included in cost of sales. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Fiscal </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">2019</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Compared to Fiscal </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">2018</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total revenue </span><span style="font-family:inherit;font-size:10pt;">increased</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">$444.4 million</span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;">43%</span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months</span><span style="font-family:inherit;font-size:10pt;"> ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> compared to the </span><span style="font-family:inherit;font-size:10pt;">twelve months</span><span style="font-family:inherit;font-size:10pt;"> ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">. The </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> revenue increase was primarily driven by increased sales volume of our disposable sensors due to the continued growth of our worldwide customer base, partially offset by pricing pressure due to the evolution of our channel strategy and product mix. Disposable sensor and other revenue comprised approximately </span><span style="font-family:inherit;font-size:10pt;">78%</span><span style="font-family:inherit;font-size:10pt;"> of total revenue and Reusable Hardware revenue comprised approximately </span><span style="font-family:inherit;font-size:10pt;">22%</span><span style="font-family:inherit;font-size:10pt;"> of total revenue for the </span><span style="font-family:inherit;font-size:10pt;">twelve months</span><span style="font-family:inherit;font-size:10pt;"> ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">. Disposable sensor and other revenue comprised approximately </span><span style="font-family:inherit;font-size:10pt;">75%</span><span style="font-family:inherit;font-size:10pt;"> of total revenue and Reusable Hardware revenue comprised approximately </span><span style="font-family:inherit;font-size:10pt;">25%</span><span style="font-family:inherit;font-size:10pt;"> of total revenue for the </span><span style="font-family:inherit;font-size:10pt;">twelve months</span><span style="font-family:inherit;font-size:10pt;"> ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of sales </span><span style="font-family:inherit;font-size:10pt;">increased</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">$176.8 million</span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;">48%</span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months</span><span style="font-family:inherit;font-size:10pt;"> ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> compared to the </span><span style="font-family:inherit;font-size:10pt;">twelve months</span><span style="font-family:inherit;font-size:10pt;"> ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;"> primarily due to increased sales volume. The gross profit of </span><span style="font-family:inherit;font-size:10pt;">$931.5 million</span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;">63%</span><span style="font-family:inherit;font-size:10pt;"> of total revenue for the </span><span style="font-family:inherit;font-size:10pt;">twelve months</span><span style="font-family:inherit;font-size:10pt;"> ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">increased</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">$267.6 million</span><span style="font-family:inherit;font-size:10pt;"> compared to </span><span style="font-family:inherit;font-size:10pt;">$663.9 million</span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;">64%</span><span style="font-family:inherit;font-size:10pt;"> of total revenue for the same period in </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">. The </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> increase in gross profit dollars was primarily driven by increased revenues, partially offset by higher warranty, freight, and excess and obsolete inventory charges compared to </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">. The decrease in gross margin percentage is primarily a function of the evolution of our channel strategy and product mix as we launch new products and expand internationally. Our gross martin percentage for the </span><span style="font-family:inherit;font-size:10pt;">twelve months</span><span style="font-family:inherit;font-size:10pt;"> ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> was also impacted by investments to scale infrastructure as we drove significant production capacity expansion in 2019.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:21%;"></td><td style="width:19%;"></td><td style="width:19%;"></td><td style="width:19%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Operating Expenses</span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.61013645224172%;border-collapse:collapse;text-align:left;"><tr><td colspan="26"></td></tr><tr><td style="width:32%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended December 31,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019 - 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 - 2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">$ Change</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">% Change</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">$ Change</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">% Change</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Research and development</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">273.5</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">199.7</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">185.4</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">73.8</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">37</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">14.3</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">8</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">as a % of total revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">19</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">19</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">26</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Collaborative research and development fee</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">217.7</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times_New_Roman;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(217.7</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">217.7</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">as a % of total revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">21</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Selling, general and administrative</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">515.7</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">432.8</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">349.2</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">82.9</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">19</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">83.6</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">24</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">as a % of total revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">35</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">42</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">48</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating expenses</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">789.2</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">850.2</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">534.6</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(61.0</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(7</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">315.6</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">59</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">as a % of total revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">53</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">82</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">74</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:4px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">* = Not Meaningful </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our research and development expenses primarily consist of engineering and research expenses related to our continuous glucose monitoring technology, clinical trials, regulatory expenses, quality assurance programs, materials and products for clinical trials. Research and development expenses are primarily related to employee compensation, including salary, fringe </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">67</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">benefits, share-based compensation, and temporary employee expenses. We also incur significant expenses to operate our clinical trials including clinical site reimbursement, clinical trial product and associated travel expenses. Our research and development expenses also include fees for design services, contractors and development materials.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our selling, general and administrative expenses primarily consist of salary, fringe benefits and share-based compensation for our executive, financial, sales, marketing, information technology and administrative functions. Other significant expenses include commissions, marketing and advertising, IT software license costs, insurance, professional fees for our outside legal counsel and independent auditors, litigation expenses, patent application expenses and consulting expenses.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Fiscal </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">2019</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Compared to Fiscal </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">2018</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Research and Development Expense.</span><span style="font-family:inherit;font-size:10pt;"> Research and development expense </span><span style="font-family:inherit;font-size:10pt;">increased</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">$73.8 million</span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;">37%</span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months</span><span style="font-family:inherit;font-size:10pt;"> ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> compared to the same period of </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">. The increase was primarily due to </span><span style="font-family:inherit;font-size:10pt;">$39.7 million</span><span style="font-family:inherit;font-size:10pt;"> in additional salaries, bonus, and payroll-related costs, </span><span style="font-family:inherit;font-size:10pt;">$11.1 million</span><span style="font-family:inherit;font-size:10pt;"> in additional supplies costs, and </span><span style="font-family:inherit;font-size:10pt;">$7.3 million</span><span style="font-family:inherit;font-size:10pt;"> in additional facilities costs. We continue to believe that focused investments in research and development are critical to our future growth and competitive position in the marketplace, and to the development of new and updated products and services that are central to our core business strategy.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Collaborative Research and Development Fee.</span><span style="font-family:inherit;font-size:10pt;"> Collaborative research and development fee decreased </span><span style="font-family:inherit;font-size:10pt;">$217.7 million</span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months</span><span style="font-family:inherit;font-size:10pt;"> ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> compared to the same period of </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">. During </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, we recorded a one time </span><span style="font-family:inherit;font-size:10pt;">$217.7 million</span><span style="font-family:inherit;font-size:10pt;"> collaborative research and development charge related to our collaboration and license agreement with Verily.  See Note 2 to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information about this collaboration agreement.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Selling, General and Administrative Expense.</span><span style="font-family:inherit;font-size:10pt;"> Selling, general and administrative expense </span><span style="font-family:inherit;font-size:10pt;">increased</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">$82.9 million</span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;">19%</span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months</span><span style="font-family:inherit;font-size:10pt;"> ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> compared to the same period of </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">. The increase was primarily due to higher sales-related costs commensurate with revenue growth and the continued commercialization of our products in the United States and international markets. Significant elements of the increase in selling, general, and administrative expenses included </span><span style="font-family:inherit;font-size:10pt;">$20.5 million</span><span style="font-family:inherit;font-size:10pt;"> in additional third party service provider fees, </span><span style="font-family:inherit;font-size:10pt;">$13.1 million</span><span style="font-family:inherit;font-size:10pt;"> in additional salaries, bonus and payroll-related costs, </span><span style="font-family:inherit;font-size:10pt;">$11.0 million</span><span style="font-family:inherit;font-size:10pt;"> in additional consulting fees, </span><span style="font-family:inherit;font-size:10pt;">$9.3 million</span><span style="font-family:inherit;font-size:10pt;"> in additional marketing costs, </span><span style="font-family:inherit;font-size:10pt;">$8.6 million</span><span style="font-family:inherit;font-size:10pt;"> in additional depreciation, and </span><span style="font-family:inherit;font-size:10pt;">$7.5 million</span><span style="font-family:inherit;font-size:10pt;"> in restructuring charges. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:21%;"></td><td style="width:19%;"></td><td style="width:19%;"></td><td style="width:19%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Non-Operating Income and Expenses</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Interest Expense</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense increased </span><span style="font-family:inherit;font-size:10pt;">$37.6 million</span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;">$60.3 million</span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months</span><span style="font-family:inherit;font-size:10pt;"> ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> compared to </span><span style="font-family:inherit;font-size:10pt;">$22.7 million</span><span style="font-family:inherit;font-size:10pt;"> for the same period of </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">. The increase was primarily due to an additional interest expense for our 2023 Notes, which were issued in November 2018.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Income/Loss from Equity Investments</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss from equity investments of </span><span style="font-family:inherit;font-size:10pt;">$4.2 million</span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months</span><span style="font-family:inherit;font-size:10pt;"> ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and income from equity investments of </span><span style="font-family:inherit;font-size:10pt;">$80.1 million</span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;"> consist solely of realized and unrealized gains and losses on our equity investment in Tandem Diabetes Care, Inc. We sold all of our remaining equity investment in Tandem during the first quarter of 2019. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Interest and Other Income (Expense), Net</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> Interest income was </span><span style="font-family:inherit;font-size:10pt;">$28.4 million</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">$10.5 million</span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months</span><span style="font-family:inherit;font-size:10pt;"> ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">,  respectively, and is related to our marketable debt securities portfolio. The increase in interest income was primarily related to an increase in the average invested balances during </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> compared to </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other income (expense) for the twelve months ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> consists primarily of foreign currency transaction gains and losses due to the effects of foreign currency fluctuations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Income Tax Expense </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We recorded pre-tax income for the twelve months ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, and pre-tax loss for the twelve months ended December 31, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">. The income tax expense we recorded for </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> is primarily attributable to state and foreign income tax expense. The nominal income tax expense we recorded for </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> is primarily due to withholding and other income tax expenses in profitable jurisdictions. </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">68</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">Liquidity and Capital Resources</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Overview, Capital Resources, and Capital Requirements</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our principal sources of liquidity are our existing cash, cash equivalents and marketable securities, cash generated from operations, proceeds from our convertible notes issuances, and access to our revolving line of credit. Our primary uses of cash have been for research and development programs, selling and marketing activities, capital expenditures, acquisitions of businesses, and debt service costs.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We expect that cash provided by our operations may fluctuate in future periods as a result of a number of factors, including fluctuations in our operating results, working capital requirements and capital deployment decisions. We have historically invested our cash primarily in U.S. dollar-denominated, investment grade, highly liquid obligations of U.S. government-sponsored enterprises, commercial paper, corporate debt, and money market funds. Certain of these investments are subject to general credit, liquidity and other market risks. The general condition of the financial markets and the economy may increase those risks and may affect the value and liquidity of investments and restrict our ability to access the capital markets.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our future capital requirements will depend on many factors, including but not limited to:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the revenue generated by sales of our approved products and other future products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the expenses we incur in manufacturing, developing, selling and marketing our products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the quality levels of our products and services;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the third-party reimbursement of our products for our customers;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">our ability to efficiently scale our operations to meet demand for our current and any future products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the costs, timing and risks of delays of additional regulatory approvals;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the rate of progress and cost of our clinical trials and other development activities;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the success of our research and development efforts;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the emergence of competing or complementary technological developments;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the terms and timing of any collaborative, licensing and other arrangements that we may establish;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the acquisition of businesses, products and technologies and our ability to integrate and manage any acquired businesses, products and technologies; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the evolution of the international expansion of our business.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We expect that existing cash and cash flows from our future operations will generally be sufficient to fund our ongoing core business. As current borrowing sources become due, we may be required to access the capital markets for additional funding. As we assess inorganic growth strategies, we may need to supplement our internally generated cash flow with outside sources. In the event that we are required to access the debt market, we believe that we will be able to secure reasonable borrowing rates. As part of our liquidity strategy, we will continue to monitor our current level of earnings and cash flow generation as well as our ability to access the market in light of those earning levels. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> A substantial portion of our operations are located in the United States, and the majority of our sales since inception have been made in U.S. dollars. Accordingly, our assessment is that we have no material net exposure to foreign currency exchange rate fluctuations at this time. However, as our business in markets outside of the United States continues to increase, we will be exposed to foreign currency exchange risk related to our foreign operations. Fluctuations in the rate of exchange between the U.S. dollar and foreign currencies, primarily the British Pound, the Euro, and the Canadian Dollar, could adversely affect our financial results, including our revenues, revenue growth rates, gross margins, income and losses as well as assets and liabilities. We currently engage in limited hedging transactions to reduce foreign currency risks on certain intercompany balances. We will continue to monitor and manage our financial exposures due to exchange rate fluctuations as an integral part of our overall risk management program. Our cash, cash equivalents and short-term marketable securities totaled </span><span style="font-family:inherit;font-size:10pt;">$1,533.3 million</span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">. None of those funds were restricted and approximately </span><span style="font-family:inherit;font-size:10pt;">98%</span><span style="font-family:inherit;font-size:10pt;"> of those funds were located in the United States. We intend to reinvest a substantial portion of our foreign earnings in those businesses, and we currently do not anticipate that we will need funds generated by foreign operations to fund our domestic ones.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our cash, cash equivalents and short-term marketable securities as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">increased</span><span style="font-family:inherit;font-size:10pt;"> by </span><span style="font-family:inherit;font-size:10pt;">$147.7 million</span><span style="font-family:inherit;font-size:10pt;"> from </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;"> due to the factors described in &#8220;Cash Flows&#8221; below. We believe that our cash, cash equivalents, and marketable securities balances, projected cash contributions from our commercial operations, and our </span><span style="font-family:inherit;font-size:10pt;">$200.0 million</span><span style="font-family:inherit;font-size:10pt;"> revolving line of credit, of which </span><span style="font-family:inherit;font-size:10pt;">$195.6 million</span><span style="font-family:inherit;font-size:10pt;"> remains available, will be sufficient to meet our anticipated seasonal working capital </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">69</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">needs, capital expenditure requirements, contractual obligations, commitments, debt service requirements, and other liquidity requirements associated with our operations for at least the next 12 months. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Revolving Credit Agreement</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In December 2018, we entered into an amended and restated five-year </span><span style="font-family:inherit;font-size:10pt;">$200.0 million</span><span style="font-family:inherit;font-size:10pt;"> revolving Credit Agreement, including a sub-facility of up to </span><span style="font-family:inherit;font-size:10pt;">$10.0 million</span><span style="font-family:inherit;font-size:10pt;"> for letters of credit. Subject to customary conditions and the approval of any lender whose commitment would be increased, we have the option to increase the maximum principal amount available under the Credit Agreement by up to an additional $300.0 million, resulting in a maximum available principal amount of $500.0 million. However, at this time none of the lenders have committed to provide any such increase in their commitments. Revolving loans under the Credit Agreement will be available for general corporate purposes, including working capital and capital expenditures. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had no outstanding borrowings, </span><span style="font-family:inherit;font-size:10pt;">$4.4 million</span><span style="font-family:inherit;font-size:10pt;"> in outstanding letters of credit, and a total available balance of </span><span style="font-family:inherit;font-size:10pt;">$195.6 million</span><span style="font-family:inherit;font-size:10pt;"> under the Credit Agreement. We monitor counterparty risk associated with the institutional lenders that are providing the credit facility. We currently believe that the credit facility will be available to us should we choose to borrow under it. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Senior Convertible Notes</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following&#160;table summarizes our outstanding&#160;convertible note obligations:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:16%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:21%;"></td><td style="width:17%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Issuance Date</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Coupon</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Aggregate Principal </span><span style="font-family:inherit;font-size:10pt;font-weight:bold;font-style:italic;">(in millions)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Maturity Date</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Initial Conversion rate per share of common stock</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Conversion Price per Share of Common Stock</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">June 2017</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">400.0</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">May&#160;15, 2022</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.0918</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$99.09</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">November 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75%</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">850.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December&#160;1, 2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">6.0869</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$164.29</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,250.0</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We used a portion of the net proceeds from the offering of the Notes due 2022 (the 2022 Notes) to repay </span><span style="font-family:inherit;font-size:10pt;">$75.0</span><span style="font-family:inherit;font-size:10pt;"> million of borrowings under our existing credit facility in 2017. We used a portion of the net proceeds from the offering of the Notes due 2023 (the 2023 Notes) to repurchase 0.8 million shares of our common stock for $100.0 million in 2018. The remainder of the net proceeds from the Notes offerings are available for general corporate purposes and capital expenditures, including working capital needs. We may also use the net proceeds to expand our current business through in-licensing or acquisitions of, or investments in, other businesses, products or technologies; however, we do not have any significant commitments with respect to any such acquisitions or investments at this time. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">2023 Note Hedge</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions (the 2023 Note Hedge) with two of the initial purchasers of the 2023 Notes (the 2023 Counterparties) entitling us to purchase up to </span><span style="font-family:inherit;font-size:10pt;">5.2 million</span><span style="font-family:inherit;font-size:10pt;">&#160;shares of our common stock at an initial price of&#160;</span><span style="font-family:inherit;font-size:10pt;">$164.29</span><span style="font-family:inherit;font-size:10pt;">&#160;per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was&#160;</span><span style="font-family:inherit;font-size:10pt;">$218.9 million</span><span style="font-family:inherit;font-size:10pt;"> and it will expire on December 1, 2023. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge.&#160;The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">2023 Warrants</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In November 2018, we also sold warrants (the 2023 Warrants) to the 2023 Counterparties to acquire up to&#160;</span><span style="font-family:inherit;font-size:10pt;">5.2 million</span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock for cash proceeds of </span><span style="font-family:inherit;font-size:10pt;">$183.8 million</span><span style="font-family:inherit;font-size:10pt;">. The 2023 Warrants require net share settlement and a pro-rated number of warrants will expire on each of the 60 scheduled trading days starting on March 1, 2024. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">See Note 5 to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information about the terms of the Credit Agreement, 2022 Notes and the 2023 Notes, the 2023 Note Hedge, and the 2023 Warrants.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Cash Flows</span><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table sets forth a summary of our cash flows for the periods indicated. See the consolidated financial statements in Part II, Item 8 of this Annual Report for complete statements of cash flows for these periods.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">70</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.90643274853801%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td style="width:41%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019 - 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 - 2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash provided by operating activities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">314.5</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">123.2</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">92.0</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">191.3</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">31.2</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash used in investing activities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(1,015.2</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(139.8</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(144.4</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(875.4</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4.6</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash provided by financing activities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.7</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">710.4</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">399.1</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(699.7</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">311.3</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effect of exchange rates on cash, cash equivalents, and restricted cash</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(0.7</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.8</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.3</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(2.5</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increase (decrease) in cash, cash equivalents and restricted cash</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(690.7</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">695.6</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">347.0</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(1,386.3</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">348.6</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had </span><span style="font-family:inherit;font-size:10pt;">$1,533.3 million</span><span style="font-family:inherit;font-size:10pt;"> in cash, cash equivalents and short-term marketable securities, which is an </span><span style="font-family:inherit;font-size:10pt;">increase</span><span style="font-family:inherit;font-size:10pt;"> of </span><span style="font-family:inherit;font-size:10pt;">$147.7 million</span><span style="font-family:inherit;font-size:10pt;"> compared to </span><span style="font-family:inherit;font-size:10pt;">$1,385.6 million</span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">. The primary cash flows during the </span><span style="font-family:inherit;font-size:10pt;">twelve months</span><span style="font-family:inherit;font-size:10pt;"> ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and  </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> are described below.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Operating Cash Flows</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash </span><span style="font-family:inherit;font-size:10pt;">provided by</span><span style="font-family:inherit;font-size:10pt;"> operating activities during </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> was comprised of </span><span style="font-family:inherit;font-size:10pt;">net income</span><span style="font-family:inherit;font-size:10pt;"> of </span><span style="font-family:inherit;font-size:10pt;">$101.1 million</span><span style="font-family:inherit;font-size:10pt;">, net adjustments of </span><span style="font-family:inherit;font-size:10pt;">$207.3 million</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">$6.1 million</span><span style="font-family:inherit;font-size:10pt;"> of changes in working capital balances. Net adjustments were primarily related to share-based compensation, depreciation and amortization, non-cash interest expense for our senior convertible notes, and a loss on the sale of our remaining equity investment in Tandem Diabetes Care, Inc.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash </span><span style="font-family:inherit;font-size:10pt;">provided by</span><span style="font-family:inherit;font-size:10pt;"> operating activities during </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> was comprised of a </span><span style="font-family:inherit;font-size:10pt;">net loss</span><span style="font-family:inherit;font-size:10pt;"> of </span><span style="font-family:inherit;font-size:10pt;">$127.1 million</span><span style="font-family:inherit;font-size:10pt;">, offset by </span><span style="font-family:inherit;font-size:10pt;">$291.2 million</span><span style="font-family:inherit;font-size:10pt;"> of net adjustments and </span><span style="font-family:inherit;font-size:10pt;">$40.9 million</span><span style="font-family:inherit;font-size:10pt;"> of changes in working capital balances. Net adjustments were primarily related to share-based compensation, depreciation and amortization, and non-cash interest expense for our senior convertible notes, and realized and unrealized gains on our equity investment in Tandem Diabetes Care, Inc.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Investing Cash Flows</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash </span><span style="font-family:inherit;font-size:10pt;">used in</span><span style="font-family:inherit;font-size:10pt;"> investing activities during </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> was primarily comprised of </span><span style="font-family:inherit;font-size:10pt;">$835.2 million</span><span style="font-family:inherit;font-size:10pt;"> for net purchases of marketable securities and other equity investments and </span><span style="font-family:inherit;font-size:10pt;">$180.0 million</span><span style="font-family:inherit;font-size:10pt;"> for capital expenditures.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash </span><span style="font-family:inherit;font-size:10pt;">used in</span><span style="font-family:inherit;font-size:10pt;"> investing activities during </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> was primarily comprised of </span><span style="font-family:inherit;font-size:10pt;">$61.4 million</span><span style="font-family:inherit;font-size:10pt;"> for net purchases of marketable securities and other equity investments and </span><span style="font-family:inherit;font-size:10pt;">$67.1 million</span><span style="font-family:inherit;font-size:10pt;"> for capital expenditures.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Financing Cash Flows</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash provided by financing activities during </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> was primarily comprised of </span><span style="font-family:inherit;font-size:10pt;">$11.9 million</span><span style="font-family:inherit;font-size:10pt;"> in proceeds from the issuance of common stock under our employee stock plans.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash provided by financing activities during </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> was primarily comprised of </span><span style="font-family:inherit;font-size:10pt;">$836.6 million</span><span style="font-family:inherit;font-size:10pt;"> in net proceeds from the issuance of our 2023 Notes and </span><span style="font-family:inherit;font-size:10pt;">$183.8 million</span><span style="font-family:inherit;font-size:10pt;"> in proceeds from the sale of the 2023 Warrants, partially offset by </span><span style="font-family:inherit;font-size:10pt;">$218.9 million</span><span style="font-family:inherit;font-size:10pt;"> for the purchase of the 2023 Note Hedge and </span><span style="font-family:inherit;font-size:10pt;">$100.0 million</span><span style="font-family:inherit;font-size:10pt;"> to purchase shares of our common stock.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Contractual Obligations</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are party to various leasing arrangements, primarily for office, manufacturing and warehouse space that expire at various times through </span><span style="font-family:inherit;font-size:10pt;">March</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">2028</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes our outstanding contractual obligations as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and the effect those obligations are expected to have on our liquidity and cash flows in future periods:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"></td></tr><tr><td style="width:35%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</span><span style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Less</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">than</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">1&#160;Year</span><span style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">1-3</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Years</span><span style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">3-5</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Years</span><span style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">More</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">than</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">5&#160;Years</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior convertible notes </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,283.0</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">9.4</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">417.2</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">856.4</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Lease obligations </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">120.9</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">18.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">34.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">29.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">37.8</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1,403.9</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">28.1</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">451.9</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">886.1</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">37.8</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup>&#160;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We issued senior convertible notes in May and </span><span style="font-family:inherit;font-size:10pt;">June 2017</span><span style="font-family:inherit;font-size:10pt;"> that are due in </span><span style="font-family:inherit;font-size:10pt;">May 2022</span><span style="font-family:inherit;font-size:10pt;"> and we issued senior convertible notes in </span><span style="font-family:inherit;font-size:10pt;">November 2018</span><span style="font-family:inherit;font-size:10pt;"> that are due in </span><span style="font-family:inherit;font-size:10pt;">December 2023</span><span style="font-family:inherit;font-size:10pt;">. The obligations presented above include both principal and interest for these notes. Although these notes mature in </span><span style="font-family:inherit;font-size:10pt;">2022</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2023</span><span style="font-family:inherit;font-size:10pt;">, they may be converted into cash and shares of </span></div></td></tr></table><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">71</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-left:42px;padding-bottom:4px;text-align:left;"><span style="font-family:inherit;font-size:10pt;">our common stock prior to maturity if certain conditions are met. Any conversion prior to maturity can result in repayment of the principal amounts sooner than the scheduled repayment as indicated in the table. See Note 5 to the consolidated financial statements in Part II, Item 8 of this Annual Report for further discussion of the terms of our senior convertible notes. </span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></span><span style="font-family:inherit;font-size:10pt;"></span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Includes a finance lease obligation related to our Mesa, Arizona facility. See Note 6 to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are also party to various purchase arrangements related to components used in manufacturing and research and development activities. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had approximately </span><span style="font-family:inherit;font-size:10pt;">$165.8 million</span><span style="font-family:inherit;font-size:10pt;"> of open purchase orders and contractual obligations in the ordinary course of business, most of which are due within one year. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Off-Balance Sheet Arrangements</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we did not have any significant off-balance sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">Recent Accounting Guidance</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For a description of recently issued accounting guidance that is applicable to our financial statements, see Note 1 to the consolidated financial statements in Part II, Item 8 of this Annual Report. </span></div><div><a id="s7793CC0CECA051959268354C52BE01F6"></a></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:84px;text-indent:-84px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 7A - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Interest Rate Risk</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The primary objective of our investment activities is to preserve our capital for the purpose of funding operations while at the same time maximizing the income we receive from our investments without significantly increasing risk. To achieve these objectives, our investment policy allows us to maintain a portfolio of cash equivalents and short-term investments in a variety of securities, including money market funds, U.S. Treasury debt and corporate debt securities. Due to the short-term nature of our investments, we believe that we have no material exposure to interest rate risk.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Market Price Sensitive Instruments</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In order to reduce potential equity dilution, in connection with the issuance of the 2023 Notes we entered into the 2023 Hedge which entitles us to purchase shares of our common stock. Upon conversion of the 2023 Notes, the 2023 Hedge is expected to reduce the equity dilution if the daily volume-weighted average price per share of our common stock exceeds the strike price of the hedge. We also entered into warrant transactions with the counterparties of the 2023 Hedge entitling them to acquire shares of our common stock. The warrant transactions could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given quarterly or annual measurement period exceeds the strike price of the warrants. See Note 5 to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Foreign Currency Exchange Risk</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A substantial portion of our operations are located in the United States, and the majority of our sales since inception have been made in U.S. dollars. Accordingly, our assessment is that we have no material net exposure to foreign currency exchange rate fluctuations at this time. However, as our business in markets outside of the United States continues to increase, we will be exposed to foreign currency exchange risk related to our foreign operations. Fluctuations in the rate of exchange between the U.S. dollar and foreign currencies, primarily the British Pound, the Euro, and the Canadian Dollar, could adversely affect our financial results, including our revenues, revenue growth rates, gross margins, income and losses as well as assets and liabilities.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We translate the financial statements of our foreign subsidiaries with functional currencies other than the U.S. dollar into the U.S. dollar for consolidation using end-of-period exchange rates for assets and liabilities and average exchange rates during each reporting period for results of operations. We record net gains or losses resulting from the translation of foreign financial statements and the effect of exchange rate changes on intercompany receivables and payables of a long-term nature as a separate component of stockholders&#8217; equity. These adjustments will affect net income only upon sale or liquidation of the underlying investment in foreign subsidiaries.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We record exchange rate fluctuations resulting from the translation of the short-term intercompany balances between domestic entities and our foreign subsidiaries as foreign currency transaction gains or losses and include them in interest and other income (expense), net in our consolidated statement of operations. We occasionally enter into foreign currency forward </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">72</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">contracts for certain intercompany balances in order to partially offset the impact from fluctuation of the foreign currency rates. We entered into no foreign currency forward contracts during the year ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, a notional amount of </span><span style="font-family:inherit;font-size:10pt;">$8.0 million</span><span style="font-family:inherit;font-size:10pt;"> was outstanding to hedge currency risk relating to certain intercompany balances. The resulting impact from the hedging activity on our consolidated financial statements was not significant for the year ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">. The fair values of these derivatives are based on quoted market prices, which are Level 1 inputs, and the derivative instruments are recorded in other current assets or other current liabilities in our balance sheets consistent with the nature of the instrument at period end. Derivative gains and losses are included in </span><span style="font-family:inherit;font-size:10pt;">interest and other income, net</span><span style="font-family:inherit;font-size:10pt;"> in our consolidated statement of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Notional principal amounts provide one measure of the transaction volume outstanding as of period end, but they do not represent the amount of our exposure to market loss. Estimates of fair value are based on applicable and commonly used pricing models using prevailing financial market information. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments. We monitor and manage our financial exposures due to exchange rate fluctuations as an integral part of our overall risk management program, which recognizes the unpredictability of financial markets and seeks to reduce potentially adverse effects on our financial results.</span></div><div><a id="s2243A5FC435652FDB211483B996DF071"></a></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:84px;text-indent:-84px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 8 - CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The information required is set forth under &#8220;Report of Independent Registered Public Accounting Firm,&#8221; &#8220;Consolidated Balance Sheets,&#8221; &#8220;Consolidated Statements of Operations,&#8221; &#8220; </span><span style="font-family:inherit;font-size:10pt;">Consolidated Statements of Comprehensive Income (Loss)</span><span style="font-family:inherit;font-size:10pt;">,&#8221; &#8220;Consolidated Statements of Stockholders&#8217; Equity,&#8221; &#8220;Consolidated Statements of Cash Flows&#8221; and &#8220;Notes to Consolidated Financial Statements&#8221; on pages F-2 to F-39 of this Annual Report.</span></div><div><a id="s0420A6987E7C5A44BC135B263CFAFA0F"></a></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:84px;text-indent:-84px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 9 - CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Not applicable.</span></div><div><a id="s05B0AA515D805DE69D07EDB45A5709E2"></a></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:90px;text-indent:-90px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 9A - CONTROLS AND PROCEDURES</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Evaluation of Disclosure Controls and Procedures</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Regulations under the Securities Exchange Act of 1934 require public companies to maintain &#8220;disclosure controls and procedures,&#8221; which are defined to mean a company&#8217;s controls and other procedures that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and timely communicated to management, including our Chief Executive Officer and Chief Financial Officer, recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms. Our management, including our Chief Executive Officer and our Chief Financial Officer, conducted an evaluation as of the end of the period covered by this report of the effectiveness of our disclosure controls and procedures. Based on their evaluation as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of such date for this purpose. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Changes in Internal Control over Financial Reporting</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There were no changes in our internal control over financial reporting during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Management&#8217;s Report on Internal Control over Financial Reporting</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934. Our internal control over financial reporting is designed to provide reasonable assurance to our management and Board of Directors regarding the preparation and fair presentation of published financial statements.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our management, with the participation of the Chief Executive and Chief Financial Officers, assessed the effectiveness of our internal control over financial reporting as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">. In making this assessment, our management used the criteria set forth by the 2013 Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control&#8212;Integrated Framework. Based on this assessment, our management, with the participation of the Chief Executive and Chief Financial Officers, believes that, as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, our internal control over financial reporting is effective based on those criteria. The effectiveness of our internal control over financial reporting as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> has been audited by Ernst&#160;&amp; Young LLP an Independent Registered Public Accounting Firm, as stated in their report which is included herein.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">73</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The certifications of our Chief Executive Officer and Chief Financial Officer required under Section&#160;302 of the Sarbanes-Oxley Act have been filed as Exhibits 31.01 and 31.02 to this report.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Limitation on Effectiveness of Controls</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system are met. The design of any control system is based, in part, upon the benefits of the control system relative to its costs. Control systems can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. In addition, over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of these and other inherent limitations of control systems, we cannot guaranty that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">74</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:174%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Board of Directors and Stockholders of DexCom, Inc.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Opinion on Internal Control over Financial Reporting</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have audited DexCom, Inc.&#8217;s internal control over financial reporting as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework) (the COSO criteria). In our opinion, DexCom, Inc. (the Company) maintained, in all material respects, effective internal control over financial reporting as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, based on the COSO criteria. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of DexCom, Inc. as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, the related consolidated statements of operations, comprehensive income (loss), stockholders&#8217; equity and cash flows for each of the three years in the period ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, and the related notes and financial statement schedule listed in the Index at Item 15(a) and our report dated </span><span style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</span><span style="font-family:inherit;font-size:10pt;"> expressed an unqualified opinion thereon.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis for Opinion</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the consolidated financial statements.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">/s/ Ernst &amp; Young LLP</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">San Diego, California</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">75</span></div></div><hr style="page-break-after:always"></hr><div><a id="s5C4ADD9F0F5058379C3DC991B985B8B1"></a></div><div><br/></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:90px;text-indent:-90px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 9B - OTHER INFORMATION</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">None.</span></div><div><a id="s0709DC13F0985735B6AAA13BB547CACB"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">PART III</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><a id="s007EADF423D85A59A15561782B2B361B"></a></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:90px;text-indent:-90px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 10 - DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The information concerning our directors required by this Item is incorporated by reference to the section in our Proxy Statement entitled &#8220;Proposal No.&#160;1 &#8211; Election of Directors.&#8221;</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The information concerning our executive officers required by this Item is incorporated by reference to the section in our Proxy Statement entitled &#8220;Executive Officers.&#8221;</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The information concerning compliance with Section&#160;16(a) of the Securities Exchange Act of 1934 required by this Item is incorporated by reference to the section in our Proxy Statement entitled &#8220;Section 16(a) Beneficial Ownership Reporting Compliance.&#8221;</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have adopted a written code of ethics for financial employees that applies to our principal executive officer, principal financial officer, principal accounting officer, controller and other employees of the finance department designated by our Chief Financial Officer. This code of ethics, titled the &#8220;Code of Conduct and Ethics for Chief Executive Officer and Senior Finance Personnel,&#8221; is publicly available on our Internet website at https://dexcom.gcs-web.com/corporate-governance. The information contained on our Internet website is not incorporated by reference into this Annual Report on Form 10-K.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The information concerning the audit committee of the Board of Directors required by this Item is incorporated by reference to information set forth in the Proxy Statement.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The information concerning material changes to the procedures by which stockholders may recommend nominees to the Board of Directors required by this Item is incorporated by reference to information set forth in the Proxy Statement.</span></div><div><a id="sDE0C49E35FF658F1BA3FD25597E1D08C"></a></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:90px;text-indent:-90px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 11 - EXECUTIVE COMPENSATION</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The information required by this Item concerning executive compensation and our Compensation Committee is incorporated by reference to information set forth in the Proxy Statement under the heading &#8220;Executive Compensation.&#8221;</span></div><div><a id="sC0AA1D3BCDA35F3A839C41A2BEBE1A95"></a></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:90px;text-indent:-90px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 12 - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The information required by this Item is incorporated by reference to information set forth in the Proxy Statement under the headings &#8220;Principal Stockholders and Stock Ownership by Management&#8221; and &#8220;Equity Compensation Plan Information.&#8221;</span></div><div><a id="sB8B5251623995FB595E71F7D2D35E43C"></a></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:90px;text-indent:-90px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 13 - CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The information required by this Item with respect to director independence is incorporated by reference to information set forth in the Proxy Statement.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The information concerning certain relationships and related transactions required by the Item is incorporated by reference to the section in our Proxy Statement entitled &#8220;Certain Transactions.&#8221;</span></div><div><a id="sE12AB1B2DA55597E83FE9964C4A3E1A5"></a></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:90px;text-indent:-90px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 14 - PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The information concerning principal accountant fees and services required by this Item is incorporated by reference to the section in our Proxy Statement entitled &#8220;Ratification of Selection of Independent Registered Public Accounting Firm.&#8221;</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">76</span></div></div><hr style="page-break-after:always"></hr><div><a id="s8F84996AC6CD5334956B710D20FD3668"></a></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">PART IV</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><a id="s4D522FBEBB255F0A9D97052D6D9F5DEA"></a></div><div style="line-height:120%;text-align:left;text-indent:0px;-sec-extract:summary;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;padding-left:90px;text-indent:-90px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 15 - EXHIBITS, FINANCIAL STATEMENT SCHEDULES </span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><span style="font-family:inherit;font-size:10pt;">(a)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following documents are filed as part of this Annual Report:</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1. Financial Statements. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The consolidated financial statements listed in Part II, Item&#160;8 of this Annual Report. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2. Financial Statement Schedules. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the three fiscal years ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, Schedule II &#8211; Valuation and Qualifying Accounts.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial statement schedules not listed above have been omitted because information required to be set forth therein is not applicable, not required, or the information required by such schedules is shown in the consolidated financial statements or the notes thereto.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">3. Exhibits. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:36%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit</span></div><div style="font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit Description</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Incorporated by Reference</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Provided</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Herewith</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Form</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">File No.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Date of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">First Filing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit<br/>Number</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000104746905007840/a2154589zex-5_01.htm"><span style="font-family:inherit;font-size:10pt;">3.01</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000104746905007840/a2154589zex-5_01.htm"><span style="font-family:inherit;font-size:10pt;">Registrant&#8217;s Restated Certificate of Incorporation.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">S-1/A</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">333-122454</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 3,&#160;2005</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">3.03</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312517130445/d348320ddef14a.htm"><span style="font-family:inherit;font-size:10pt;">3.02</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312517130445/d348320ddef14a.htm"><span style="font-family:inherit;font-size:10pt;">Amendment No. 1 to Registrant&#8217;s Restated Certificate of Incorporation.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DEF 14 A</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">April 20, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Appendix B</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312514425218/d827921dex31.htm"><span style="font-family:inherit;font-size:10pt;">3.03</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312514425218/d827921dex31.htm"><span style="font-family:inherit;font-size:10pt;">Registrant&#8217;s Amended and Restated Bylaws.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">8-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">November 25, 2014</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">3.01</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000104746905007514/a2153933zex-4_01.htm"><span style="font-family:inherit;font-size:10pt;">4.01</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000104746905007514/a2153933zex-4_01.htm"><span style="font-family:inherit;font-size:10pt;">Form of Specimen Certificate for Registrant&#8217;s common stock.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">S-1/A</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">333-122454</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 24, 2005</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4.01</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312517168613/d397803dex41.htm"><span style="font-family:inherit;font-size:10pt;">4.02</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312517168613/d397803dex41.htm"><span style="font-family:inherit;font-size:10pt;">Indenture, dated as of May 12, 2017, between DexCom, Inc. and U.S. Bank National Association (including the form of 0.75% Convertible Senior Notes due 2022)</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">8-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">May 12, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4.1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312518340482/d667223dex41.htm"><span style="font-family:inherit;font-size:10pt;">4.03</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312518340482/d667223dex41.htm"><span style="font-family:inherit;font-size:10pt;">Indenture, dated as of November 30, 2019, between DexCom, Inc. and U.S. Bank National Association (including the form of 0.75% Convertible Senior Notes due 2023)</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">8-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 3, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4.1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit404.htm"><span style="font-family:inherit;font-size:10pt;">4.04</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit404.htm"><span style="font-family:inherit;font-size:10pt;">Description of Securities Registered Under Section 12 of the Exchange Act.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000104746905002052/a2150265zex-10_01.htm"><span style="font-family:inherit;font-size:10pt;">10.01</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000104746905002052/a2150265zex-10_01.htm"><span style="font-family:inherit;font-size:10pt;">Form of Indemnity Agreement between Registrant and each of its directors and executive officers.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">S-1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">333-122454</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February 1, 2005</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.01</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000110465906023702/a06-8554_1ex99d01.htm"><span style="font-family:inherit;font-size:10pt;">10.02</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000110465906023702/a06-8554_1ex99d01.htm"><span style="font-family:inherit;font-size:10pt;">Office Lease Agreement, dated March 31, 2006, between DexCom, Inc. and Kilroy Realty, L.P.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">8-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">April 7, 2006</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">99.01</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000110465906025014/a06-8874_1ex99d01.htm"><span style="font-family:inherit;font-size:10pt;">10.03</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000110465906025014/a06-8874_1ex99d01.htm"><span style="font-family:inherit;font-size:10pt;">Offer letter between DexCom, Inc. and Steven R. Pacelli dated April 10, 2006.*</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">8-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">April 13, 2006</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">99.01</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312509046182/dex1020.htm"><span style="font-family:inherit;font-size:10pt;">10.04</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312509046182/dex1020.htm"><span style="font-family:inherit;font-size:10pt;">Form of Amended and Restated Executive Change of Control &amp; Severance Agreement.*</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 5, 2009</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.20</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312509162218/dex1023.htm"><span style="font-family:inherit;font-size:10pt;">10.05</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312509162218/dex1023.htm"><span style="font-family:inherit;font-size:10pt;">Non-Exclusive Distribution Agreement, between RGH Enterprises, Inc. and DexCom, Inc., dated April 30, 2008.**</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">August 3, 2009</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.23</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312510051468/dex1025.htm"><span style="font-family:inherit;font-size:10pt;">10.06</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312510051468/dex1025.htm"><span style="font-family:inherit;font-size:10pt;">Amended and Restated Development, Manufacturing, Licensing and Supply Agreement, between DSM PTG, Inc. and DexCom, Inc., dated February&#160;19, 2010.**</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March&#160;9, 2010</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.25</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312510248085/dex1027.htm"><span style="font-family:inherit;font-size:10pt;">10.07</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312510248085/dex1027.htm"><span style="font-family:inherit;font-size:10pt;">First Amendment to Office Lease between DexCom, Inc. and Kilroy Realty, L.P., dated August 18, 2010.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">November&#160;4,&#160;2010</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.27</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">77</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:36%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td colspan="2" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit</span></div><div style="font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit Description</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Incorporated by Reference</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Provided</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Herewith</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Form</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">File No.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Date of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">First Filing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit<br/>Number</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312511179874/dex1026.htm"><span style="font-family:inherit;font-size:10pt;">10.08</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312511179874/dex1026.htm"><span style="font-family:inherit;font-size:10pt;">Amendment Number One to Non-Exclusive Distribution Agreement, between RGH Enterprises, Inc. and DexCom, Inc., dated March&#160;29, 2011.**</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-Q/A</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">July 1, 2011</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.26</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312511208448/dex1028.htm"><span style="font-family:inherit;font-size:10pt;">10.09</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312511208448/dex1028.htm"><span style="font-family:inherit;font-size:10pt;">Offer letter between DexCom, Inc. and Kevin Sayer dated May&#160;3, 2011.*</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">August&#160;3,&#160;2011</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.28</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355713000036/dxcm03312013ex1027.htm"><span style="font-family:inherit;font-size:10pt;">10.10</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355713000036/dxcm03312013ex1027.htm"><span style="font-family:inherit;font-size:10pt;">Amendment Number Two to Non-Exclusive Distribution Agreement between RGH Enterprises, Inc. and DexCom, Inc., dated March 28, 2013.**</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">May 1, 2013</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.27</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355714000028/dxcm12312013ex1028.htm"><span style="font-family:inherit;font-size:10pt;">10.11</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355714000028/dxcm12312013ex1028.htm"><span style="font-family:inherit;font-size:10pt;">Amendment Number Three to Non-Exclusive Distribution Agreement between RGH Enterprises, Inc. and DexCom, Inc., dated December 4, 2013.**</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February 20, 2014</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.28</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355714000028/dxcm12312013ex1029.htm"><span style="font-family:inherit;font-size:10pt;">10.12</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355714000028/dxcm12312013ex1029.htm"><span style="font-family:inherit;font-size:10pt;">Non-Exclusive Distribution Agreement between Dexcom, Inc. and Diabetes Specialty Center, LLC dated October 12, 2009, as amended on September 30, 2010, October 11, 2011, November 14, 2012 and November 1, 2013.**</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February 20, 2014</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.29</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355714000220/dxcm06302014ex1031.htm"><span style="font-family:inherit;font-size:10pt;">10.13</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355714000220/dxcm06302014ex1031.htm"><span style="font-family:inherit;font-size:10pt;">Settlement and License Agreement by and among Abbott Diabetes Care, Inc. and DexCom, Inc., dated July 2, 2014.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">August 6, 2014</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355714000220/dxcm06302014ex1032.htm"><span style="font-family:inherit;font-size:10pt;">10.14</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355714000220/dxcm06302014ex1032.htm"><span style="font-family:inherit;font-size:10pt;">Amendment No. 5 to Non-Exclusive Distribution Agreement between DexCom, Inc. and Diabetes Specialty Center, LLC, dated March 14, 2014.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">August 6, 2014</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.32</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355715000040/dxcm-12312014ex1033.htm"><span style="font-family:inherit;font-size:10pt;">10.15</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355715000040/dxcm-12312014ex1033.htm"><span style="font-family:inherit;font-size:10pt;">Second Amendment to Office Lease between DexCom, Inc. and Kilroy Realty, L.P., dated October 1, 2014.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February 25, 2015</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.32</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312515127507/d878103ddef14a.htm"><span style="font-family:inherit;font-size:10pt;">10.16</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312515127507/d878103ddef14a.htm"><span style="font-family:inherit;font-size:10pt;">2015 Employee Stock Purchase Plan</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DEF 14A</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">April 13, 2015</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Appendix A</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355715000171/exhibit102.htm"><span style="font-family:inherit;font-size:10pt;">10.17</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355715000171/exhibit102.htm"><span style="font-family:inherit;font-size:10pt;">Form of Subscription Agreement under 2015 Employee Stock Purchase Plan</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">8-K</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">June 2, 2015</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355716000511/dxcm03312016ex1036.htm"><span style="font-family:inherit;font-size:10pt;">10.18</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355716000511/dxcm03312016ex1036.htm"><span style="font-family:inherit;font-size:10pt;">Sublease between DexCom, Inc. and Entropic Communications, LLC dated February 1, 2016.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">April 27, 2016</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.36</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355716000511/dxcm03312016ex1037.htm"><span style="font-family:inherit;font-size:10pt;">10.19</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355716000511/dxcm03312016ex1037.htm"><span style="font-family:inherit;font-size:10pt;">Amended and Restated Non-Exclusive Distribution Agreement with Byram Healthcare dated February 1, 2016.**</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">April 27, 2016</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.37</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355716000624/dxcm063016exhibit1039.htm"><span style="font-family:inherit;font-size:10pt;">10.20</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355716000624/dxcm063016exhibit1039.htm"><span style="font-family:inherit;font-size:10pt;">Industrial Net Lease, Broadway dated April 28, 2016, by and between PRA/LB, L.L.C. and DexCom, Inc.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">August 2, 2016</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.39</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355716000624/dxcm063016ex1040.htm"><span style="font-family:inherit;font-size:10pt;">10.21</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355716000624/dxcm063016ex1040.htm"><span style="font-family:inherit;font-size:10pt;">Standard Form of Agreement dated May 2, 2016, by and between DexCom, Inc. and Skanska USA Building Inc.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">August 2, 2016</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.40</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355716000624/dxcm063016exhibit1041.htm"><span style="font-family:inherit;font-size:10pt;">10.22</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355716000624/dxcm063016exhibit1041.htm"><span style="font-family:inherit;font-size:10pt;">Amendment to Non-Exclusive Distribution Agreement dated April 30, 2016 by and between RGH Enterprises, Inc. d/b/a Cardinal Health at Home and DexCom, Inc. **</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">August 2, 2016</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.41</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355717000048/dxcm12312016ex1042.htm"><span style="font-family:inherit;font-size:10pt;">10.23</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355717000048/dxcm12312016ex1042.htm"><span style="font-family:inherit;font-size:10pt;">Amendment No. 1 to Collaboration and License Agreement dated October 25, 2016 by and between DexCom, Inc. and Verily Life Sciences LLC (formerly Google Life Sciences LLC).</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February 28, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.42</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312517195938/d361061dex102.htm"><span style="font-family:inherit;font-size:10pt;">10.24</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312517195938/d361061dex102.htm"><span style="font-family:inherit;font-size:10pt;">Severance and Change in Control Plan.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">8-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">June 6, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.20</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">78</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:36%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td colspan="2" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit</span></div><div style="font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit Description</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Incorporated by Reference</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Provided</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Herewith</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Form</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">File No.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Date of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">First Filing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit<br/>Number</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312517195938/d361061dex103.htm"><span style="font-family:inherit;font-size:10pt;">10.25</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000119312517195938/d361061dex103.htm"><span style="font-family:inherit;font-size:10pt;">Form of Participation Agreement to the Severance and Change in Control Plan.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">8-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">June 6, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.30</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355717000171/dxcm6302017exhibit1046.htm"><span style="font-family:inherit;font-size:10pt;">10.26</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355717000171/dxcm6302017exhibit1046.htm"><span style="font-family:inherit;font-size:10pt;">First Amendment to Credit Agreement dated June 17, 2016 by and among DexCom, Inc., the Lenders, and JPMorgan Chase Bank, as Administrative Agent.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">August 1, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.46</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355717000171/dxcm06302017ex1047.htm"><span style="font-family:inherit;font-size:10pt;">10.27</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355717000171/dxcm06302017ex1047.htm"><span style="font-family:inherit;font-size:10pt;">Standard Form of Agreement dated May 1, 2017, by and between DexCom, Inc. and Skanska USA Building Inc.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">August 1, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.47</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355717000168/dxcm080117ex101.htm"><span style="font-family:inherit;font-size:10pt;">10.28</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355717000168/dxcm080117ex101.htm"><span style="font-family:inherit;font-size:10pt;">Offer Letter for Quentin S. Blackford dated July 28, 2017. *</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">8-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">August 1, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.10</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355717000171/dxcm6302017exhibit1043.htm"><span style="font-family:inherit;font-size:10pt;">10.29</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355717000171/dxcm6302017exhibit1043.htm"><span style="font-family:inherit;font-size:10pt;">Form of Indemnity Agreement</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">August 1, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.43</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355718000018/dxcm12312017exhibit1051.htm"><span style="font-family:inherit;font-size:10pt;">10.30</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355718000018/dxcm12312017exhibit1051.htm"><span style="font-family:inherit;font-size:10pt;">Form of RSU Grant Agreement 2015 Plan Global Double Trigger</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February 27, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.51</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355718000018/dxcm12312017exhibit1052.htm"><span style="font-family:inherit;font-size:10pt;">10.31</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355718000018/dxcm12312017exhibit1052.htm"><span style="font-family:inherit;font-size:10pt;">Form of RSU Grant Agreement 2015 Plan Global General</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February 27, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.52</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355719000041/dxcm12312018exhibit1060.htm"><span style="font-family:inherit;font-size:10pt;">10.32</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355719000041/dxcm12312018exhibit1060.htm"><span style="font-family:inherit;font-size:10pt;">Amended and Restated Collaboration and License Agreement dated November 20, 2018 by and between DexCom, Inc., Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited.**</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February 21, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.60</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355719000041/dxcm12312018exhibit1061.htm"><span style="font-family:inherit;font-size:10pt;">10.33</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355719000041/dxcm12312018exhibit1061.htm"><span style="font-family:inherit;font-size:10pt;">Amended and Restated Credit Agreement dated December 19, 2018 by and among DexCom, Inc., Bank of America, Silicon Valley Bank and Union Bank, and JPMorgan Chase Bank, as Administrative Agent.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February 21, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.61</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355719000103/dxcm-2019xdef14a.htm#sc05aea42c3974fe2883a04a695d7a7ff"><span style="font-family:inherit;font-size:10pt;">10.34</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355719000103/dxcm-2019xdef14a.htm#sc05aea42c3974fe2883a04a695d7a7ff"><span style="font-family:inherit;font-size:10pt;">Amended and Restated 2015 Equity Incentive Plan</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">8-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">June 4, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.01</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355719000137/exhibit1002dexcomincexecut.htm"><span style="font-family:inherit;font-size:10pt;">10.35</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1093557/000109355719000137/exhibit1002dexcomincexecut.htm"><span style="font-family:inherit;font-size:10pt;">Executive Deferred Compensation Plan</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">8-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">June 4, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.02</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit1036.htm"><span style="font-family:inherit;font-size:10pt;">10.36</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit1036.htm"><span style="font-family:inherit;font-size:10pt;">Form of RSU Grant Agreement 2015 Plan (Board Members - Annual Grant)</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February 13, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.36</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit1037.htm"><span style="font-family:inherit;font-size:10pt;">10.37</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit1037.htm"><span style="font-family:inherit;font-size:10pt;">Form of RSU Grant Agreement 2015 Plan (Board Members - Incoming Grant)</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February 13, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.37</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit1038.htm"><span style="font-family:inherit;font-size:10pt;">10.38</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit1038.htm"><span style="font-family:inherit;font-size:10pt;">Distribution Services Agreement dated November 7, 2015 between DexCom, Inc. and AmerisourceBergen Drug Corporation.****</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February 13, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.38</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit1039.htm"><span style="font-family:inherit;font-size:10pt;">10.39</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit1039.htm"><span style="font-family:inherit;font-size:10pt;">Amendment to the Distribution Services Agreement between Dexcom Inc. and AmerisourceBergen Drug Corporation.****</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February 13, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.39</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit1040.htm"><span style="font-family:inherit;font-size:10pt;">10.40</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit1040.htm"><span style="font-family:inherit;font-size:10pt;">Third Amendment to Office Lease between DexCom, Inc. and John Hancock Life Insurance Company, dated January 9, 2019.****</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February 13, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.40</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit1041.htm"><span style="font-family:inherit;font-size:10pt;">10.41</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit1041.htm"><span style="font-family:inherit;font-size:10pt;">Fourth Amendment to Office Lease between DexCom, Inc. and Sequence Tech. Center CA LLC, dated September 9, 2019.****</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February 13, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.41</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit1042.htm"><span style="font-family:inherit;font-size:10pt;">10.42</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit1042.htm"><span style="font-family:inherit;font-size:10pt;">Fifth Amendment to Office Lease between DexCom, Inc. and Sequence Tech. Center CA LLC, dated October 21, 2019.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">000-51222</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February 13, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.42</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit2101.htm"><span style="font-family:inherit;font-size:10pt;">21.01</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit2101.htm"><span style="font-family:inherit;font-size:10pt;">List of Subsidiaries</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit2301.htm"><span style="font-family:inherit;font-size:10pt;">23.01</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit2301.htm"><span style="font-family:inherit;font-size:10pt;">Consent of Independent Registered Public Accounting Firm</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">24.01</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Power of Attorney (see signature page of this Form 10-K)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">79</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:36%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td colspan="2" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit</span></div><div style="font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit Description</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Incorporated by Reference</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Provided</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Herewith</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Form</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">File No.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Date of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">First Filing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit<br/>Number</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit3101.htm"><span style="font-family:inherit;font-size:10pt;">31.01</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit3101.htm"><span style="font-family:inherit;font-size:10pt;">Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a).</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit3102.htm"><span style="font-family:inherit;font-size:10pt;">31.02</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit3102.htm"><span style="font-family:inherit;font-size:10pt;">Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a).</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit3201.htm"><span style="font-family:inherit;font-size:10pt;">32.01</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit3201.htm"><span style="font-family:inherit;font-size:10pt;">Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).***</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit3202.htm"><span style="font-family:inherit;font-size:10pt;">32.02</span></a></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="dxcm12312019exhibit3202.htm"><span style="font-family:inherit;font-size:10pt;">Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).***</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">101.INS</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">101.SCH</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Schema Document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">101.CAL</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Calculation Linkbase Document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">101.DEF</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Definition Linkbase Document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">101.LAB</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Label Linkbase Document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">101.PRE</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Presentation Linkbase Document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">X</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Represents a management contract or compensatory plan.</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">**</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Confidential treatment has been requested for certain portions of this document pursuant to an application for confidential treatment sent to the Securities and Exchange Commission. Such portions are omitted from this filing and were filed separately with the Securities and Exchange Commission.</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">***</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">This certification is not deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent that DexCom specifically incorporates it by reference.</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">****</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Portions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K.</span></div></td></tr></table></div></div><div><a id="sE75A667AD6D15EF9A70E878B597AACD6"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #58a618;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">ITEM 16 - FORM 10-K SUMMARY</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:66px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">None</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">80</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><a id="s548FD3D53E6E587F9447FB90BBEF0F88"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</span></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="line-height:120%;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&#160;</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:41%;"></td><td style="width:3%;"></td><td style="width:6%;"></td><td style="width:3%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DEXCOM, INC.</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Registrant)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dated: February&#160;13, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">By:</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">/</span><span style="font-family:inherit;font-size:8pt;">S</span><span style="font-family:inherit;font-size:10pt;">/&#160;&#160;&#160;&#160;QUENTIN S. BLACKFORD</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Quentin S. Blackford,<br/>Chief Operating Officer and Chief Financial Officer                                                                                                                                                          (Principal Financial and Accounting Officer)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">POWER OF ATTORNEY</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Kevin Sayer and Quentin Blackford, jointly and severally, his attorneys-in-fact, each with the power of substitution, for him in any and all capacities, to sign any amendments to this Report on Form 10-K and to file same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitutes, may do or cause to be done by virtue hereof.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:42%;"></td><td style="width:3%;"></td><td style="width:33%;"></td><td style="width:4%;"></td><td style="width:18%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Signature</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Title</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Date</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">/S/&#160;&#160;&#160;&#160;KEVIN R. SAYER &#160;&#160;&#160;&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;&#160;</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Chairman of the Board of Directors, President and Chief&#160;Executive&#160;Officer (Principal Executive Officer)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Kevin R. Sayer</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">/S/&#160;&#160;&#160;&#160;QUENTIN S. BLACKFORD &#160;&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;&#160;</span></div></td><td rowspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Chief Operating Officer and Chief Financial Officer (Principal Financial and Accounting Officer)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quentin S. Blackford</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">/S/&#160;&#160;&#160;&#160;MARK FOLETTA&#160;&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;&#160;</span></div></td><td rowspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Lead Independent Director</span></div><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Mark Foletta</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">/S/&#160;&#160;&#160;&#160;STEVE ALTMAN &#160;&#160;&#160;&#160;&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;&#160;</span></div></td><td rowspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Director</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Steve Altman</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">/S/&#160;&#160;&#160;&#160;NICHOLAS AUGUSTINOS</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;&#160;</span></div></td><td rowspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Director</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nicholas Augustinos</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">/S/&#160;&#160;&#160;&#160;RICHARD COLLINS</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td rowspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Director</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Richard Collins</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">/S/&#160;&#160;&#160;&#160;BRIDGETTE HELLER</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td rowspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Director</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Bridgette Heller</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">/S/&#160;&#160;&#160;&#160;BARBARA KAHN &#160;&#160;&#160;&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td rowspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Director</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Barbara Kahn</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">/S/&#160;&#160;&#160;&#160;JAY SKYLER &#160;&#160;&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;&#160;</span></div></td><td rowspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Director</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Jay Skyler, M.D.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">/S/&#160;&#160;&#160;&#160;ERIC TOPOL &#160;&#160;&#160;&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;&#160;</span></div></td><td rowspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Director</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Eric Topol, M.D.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">81</span></div></div><hr style="page-break-after:always"></hr><div><a id="sEE048A8FD03C56309C828B14A300C70A"></a></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">DEXCOM,&#160;INC.</span></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:9pt;">&#160;</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:92%;"></td><td style="width:8%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Page</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Report of Independent Registered Public Accounting Firm</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-2</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Consolidated Balance Sheets</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-3</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Consolidated Statements of Operations</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-4</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Consolidated Statements of Comprehensive Income (Loss)</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-5</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Consolidated Statements of Stockholders&#8217; Equity </span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-6</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Consolidated Statements of Cash Flows</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-7</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;">Notes to Consolidated Financial Statements</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-9</span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-1</span></div></div><hr style="page-break-after:always"></hr><div><a id="s14C6A338F6165E5CA8DCB4745F6AFE9B"></a></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:174%;padding-bottom:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Board of Directors and Stockholders of DexCom, Inc.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Opinion on the Financial Statements</span></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have audited the accompanying consolidated balance sheets of DexCom, Inc. (the Company) as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, the related consolidated statements of operations, comprehensive income (loss), stockholders&#8217; equity and cash flows for each of the three years in the period ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, and the related notes and financial statement schedule listed in the Index at Item 15(a) (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, and the results of its operations and its cash flows for each of the three years in the period ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, in conformity with U.S. generally accepted accounting principles. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework) and our report dated </span><span style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</span><span style="font-family:inherit;font-size:10pt;"> expressed an unqualified opinion thereon.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis for Opinion</span></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Critical Audit Matter</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:18px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:83%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Estimation of transaction price and variable consideration for revenue recognition</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Description of the Matter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As discussed in Note 1 of the consolidated financial statements, the Company recognizes revenue from contracted insurance payors and distributors based on a transaction price which reflects the net consideration to which the Company expects to be entitled. The transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix. The Company estimates reductions for rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data. </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Auditing management&#8217;s determination of transaction price including variable consideration involved a high degree of subjectivity in evaluating management&#8217;s estimates. In determining transaction price, management develops estimates based on actual historical reimbursement experience by payor. In estimating variable consideration related to rebates, management applies contracted rates to estimates of products sold subject to rebate, known events or trends and channel inventory data.</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-2</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:18px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:83%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">How We Addressed the Matter in Our Audit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s processes to determine transaction price and variable consideration, including the underlying assumptions. </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our audit procedures also included, among others, evaluating the significant assumptions and the accuracy and completeness of the underlying data used in management&#8217;s calculations. For transaction price, this included testing management&#8217;s estimate of the claim denials and historical reimbursement experience through a combination of underlying data validation by inspection of source documents and independent recalculation of management&#8217;s analysis. For rebates, this included testing contractual rates, management&#8217;s estimates of products sold subject to rebate, and inventory held by distributors at the end of the period, through a combination of underlying data validation by inspection of source documents, agreement to underlying contracts, review for consistency against historical data, and trending of inventory held at distributors versus inventory sold into the channel. In addition, we inspected the results of the Company&#8217;s retrospective review analysis of rebates claimed, evaluated the estimates made based on historical experience and performed sensitivity analyses over the Company's significant assumptions.</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">/s/ Ernst &amp; Young LLP</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have served as the Company&#8217;s auditor since 2000</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">San Diego, California</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-3</span></div></div><hr style="page-break-after:always"></hr><div><a id="s883751504F425520A51A59863C0446B5"></a></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">DexCom, Inc.</span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">Consolidated Balance Sheets</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:71%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">(In millions&#8212;except par value data)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current assets:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e778-wk-Fact-C34A37AEC0925179A5FBD7370ABF40D4" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">446.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e797-wk-Fact-E529F8ACC9195FE8B669B378B77BC5C6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,137.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term marketable securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e812-wk-Fact-80E6274D31CA5E2BBF12320A118262A7" name="dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,087.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e831-wk-Fact-2D4754244E03538BA709DA0E74E53486" name="dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">248.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e851-wk-Fact-A66B1E2C7FDB54F7A77A83F184996920" name="us-gaap:AccountsReceivableNetCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">286.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e870-wk-Fact-4261B79509344401EAD21747E05FA096" name="us-gaap:AccountsReceivableNetCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">226.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventory</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e890-wk-Fact-5955DC66290A55438DBD16FF1CD033DF" name="us-gaap:InventoryNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">119.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e909-wk-Fact-75042F3537165827921BCEDFF6FB9129" name="us-gaap:InventoryNet" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">70.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prepaid and other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e929-wk-Fact-A63B0190E8DEDAE763C91747DFDC2B30" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e948-wk-Fact-FD1215ABFDF2506D912EE75C43B0135B" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e968-wk-Fact-37C298EBD784D228EE88EB34A81E2E5D" name="us-gaap:AssetsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,969.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e987-wk-Fact-8B7368907E33874A0478EB34A82AB829" name="us-gaap:AssetsCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,699.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property and equipment, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1007-wk-Fact-6E0096B0001E585FB1501D1E29BCFD4B" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">321.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1026-wk-Fact-4346F1EF4C125EFEA32FB8D88988ADF4" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">183.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease right-of-use assets </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1047-wk-Fact-7737A3146F355264A5C2CAF6FB9389D2" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">71.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1066-wk-Fact-63E97E70D3D0495440AAEB34A828A1AE" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1086-wk-Fact-9C55738824F05E488A199F7BA9E01DB6" name="us-gaap:Goodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1105-wk-Fact-C6CD020DFFF0531AB2821747E0625E63" name="us-gaap:Goodwill" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1125-wk-Fact-983EEEEC5B0252B95E2F1747E05996AC" name="us-gaap:OtherAssetsNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1144-wk-Fact-A66CAFEAE8E3FB58A3D91747E06A4C46" name="us-gaap:OtherAssetsNoncurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1169-wk-Fact-44611B698F9EA629B2FCEB34A82E5DBA" name="us-gaap:Assets" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,395.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1188-wk-Fact-EB9825F8E1C3C2E11A68EB34A824DEC1" name="us-gaap:Assets" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,916.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities and Stockholders&#8217; Equity</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts payable and accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1290-wk-Fact-D7C5F6E8423EF61C6BA41747E11B5939" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">256.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1309-wk-Fact-9B84C094B74D40D4FF8C1747E0185BAB" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">147.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued payroll and related expenses</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1324-wk-Fact-646AE25030BA1C2DDFB51747DFFA2E4E" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">88.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1343-wk-Fact-308A8A9CBCF75AD785EE7C8E8D5979C1" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">72.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease liabilities, current portion</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1363-wk-Fact-0372FC04FE7667FD19B61747DFBEB68B" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1382-wk-Fact-706DB3F3E7B4D0B9D1C7AB0466C9B9AB" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1402-wk-Fact-4993CE84A7175313ADB5DD09BFDDB69B" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1421-wk-Fact-8329E529F9095AB79A91E875342D55AE" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1441-wk-Fact-54FC9F78BF8C391E46A0EB34A8436D31" name="us-gaap:LiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">360.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1460-wk-Fact-2F8B34C067BBFD086D23EB34A8271596" name="us-gaap:LiabilitiesCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">222.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term senior convertible notes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1522-wk-Fact-ABCBA6589A4C5CDF91BC7F4BA960481B" name="us-gaap:ConvertibleLongTermNotesPayable" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,059.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1541-wk-Fact-1461EB17D9B653C4A7FC0FEF93AF8393" name="us-gaap:ConvertibleLongTermNotesPayable" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,010.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease liabilities, net of current portion</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1561-wk-Fact-B5DC66DA1FAA547BB8A5BB1A758CB367" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">72.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1580-wk-Fact-5DA1B31207ECCD75C573EB34A8248FC4" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other long-term liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1600-wk-Fact-48BC2EECC3D82B2A40941747E036D3DB" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">20.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1619-wk-Fact-25A91861877F5862CFD21747E066C461" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">20.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1639-wk-Fact-12EAC5258C69145D07ADEB34A7EE80DE" name="us-gaap:Liabilities" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,512.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1658-wk-Fact-2CE21C0E657C1C063E8AEB34A81E662A" name="us-gaap:Liabilities" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,252.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commitments and contingencies</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1678-wk-Fact-EDAD306B479A73BD9171EB34A8225FF6" name="us-gaap:CommitmentsAndContingencies" contextRef="FI2019Q4" unitRef="usd" xsi:nil="true" scale="6" format="ixt:nocontent"></ix:nonFraction></span><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1697-wk-Fact-A445EBF66103CC02A4D0EB34A81D1F68" name="us-gaap:CommitmentsAndContingencies" contextRef="FI2018Q4" unitRef="usd" xsi:nil="true" scale="6" format="ixt:nocontent"></ix:nonFraction></span><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at December 31, 2019 and December&#160;31, 2018, respectively</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1758-wk-Fact-39C46F85F00B5A6A94D48B850AD43C83" name="us-gaap:PreferredStockValueOutstanding" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1777-wk-Fact-89D90E0C76975AC388EDD25E61F627EC" name="us-gaap:PreferredStockValueOutstanding" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common stock, $0.001 par value, 200.0 million shares authorized; 92.4 million and 91.6 million shares issued and outstanding, respectively, at December 31, 2019; 91.1 million and 90.0 million shares issued and outstanding, respectively, at December&#160;31, 2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1797-wk-Fact-1CC933EEC58D51EFA76EE06A4D9E3B7F" name="us-gaap:CommonStockValueOutstanding" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1816-wk-Fact-49137616D6FD5049A395D5E2D5EA965A" name="us-gaap:CommonStockValueOutstanding" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additional paid-in capital</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1836-wk-Fact-61BB6B97BEBF5E0CAD55704A2CC06E6C" name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,675.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1855-wk-Fact-0C06FC2E00275E97A449FF52DE780B7E" name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,560.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive income</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1875-wk-Fact-C215D749E8305E5CBD962A4C32C28F7A" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1894-wk-Fact-50DA1214E38B94713FEC1747E120117E" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated deficit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37392035e1915-wk-Fact-B1A7FCDFFB10530DA1B92007FE568EE7" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">695.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37392035e1935-wk-Fact-C774713E89C15C1892C53E6C4706927C" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">798.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Treasury stock at cost; 0.8 million shares at December 31, 2019</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37392035e1956-wk-Fact-AB931CC8DBA94ABEAFBC1747DF9FBF29" name="us-gaap:TreasuryStockValue" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">100.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37392035e1976-wk-Fact-9150BAE1790C32262A251747DF6E2BE2" name="us-gaap:TreasuryStockValue" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">100.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total stockholders&#8217; equity</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e1997-wk-Fact-938ED76C40F35933492EEB34A827852E" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">882.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e2016-wk-Fact-B4189629853BAE21CFC2EB34A81BE193" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">663.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities and stockholders&#8217; equity</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e2041-wk-Fact-AC8D12DD5CA139CAAF6FEB34A82162B0" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,395.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37392035e2060-wk-Fact-D2CD57E1995B2B2CDF19EB34A825C8F5" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,916.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">See accompanying notes</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-4</span></div></div><hr style="page-break-after:always"></hr><div><a id="s29F26FFD242C53E78DF3232A662E4E77"></a></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">DexCom, Inc.</span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">Consolidated Statements of Operations</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:68%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">(In millions&#8212;except per share data)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e742-wk-Fact-64400440AC62A8CA769BEB34A85294A0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,476.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e761-wk-Fact-D38A90028A2F0CC3FFCBEB34A7EE80E4" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,031.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e780-wk-Fact-691FD3D368229313BD9DEB34A84333BF" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">718.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of sales</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e796-wk-Fact-387B1983D7E1F6BCFD17EB34A7EE0CCA" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">544.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e815-wk-Fact-5C3667A4FA5F2D4B00E6EB34A8524E4F" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">367.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e834-wk-Fact-E32294253FCC4A4D105BEB34A852786A" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">226.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gross profit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e855-wk-Fact-8DB96BBDC97D0DAEF83DEB34A852D9E4" name="us-gaap:GrossProfit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">931.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e874-wk-Fact-7E86407A8B21F3E6F5C2EB34A862F1B1" name="us-gaap:GrossProfit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">663.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e893-wk-Fact-398799229F9C1FEA872EEB34A86206C2" name="us-gaap:GrossProfit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">492.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating expenses</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Research and development</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e976-wk-Fact-043B955E88CC5C45A22AED1E034032E4" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">273.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e995-wk-Fact-1E82818A6BB95972B76218B310D384C8" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">199.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1014-wk-Fact-A2771BBC0BF8D45DA33AEB34A852652E" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">185.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Collaborative research and development fee</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1035-wk-Fact-8F38C7E9B476CC1FB72DEB34A843CDA4" name="dxcm:CollaborativeResearchAndDevelopmentFee" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1054-wk-Fact-097A730CC8CC2E9B00D5EB34A852474D" name="dxcm:CollaborativeResearchAndDevelopmentFee" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">217.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1073-wk-Fact-5EBD78D5B9B37C724DD6EB34A8528502" name="dxcm:CollaborativeResearchAndDevelopmentFee" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Selling, general and administrative</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1094-wk-Fact-FE95B6DA5CCDF3AEACD1174A947D4D49" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">515.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1113-wk-Fact-8A9D0CF374375757A6FF10A424689B36" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">432.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1132-wk-Fact-4E3E1E1D47D5568AED26EB34A7EE1CD4" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">349.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating expenses</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1153-wk-Fact-82686CDA9627213212CBEB34A862BFD8" name="us-gaap:OperatingExpenses" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">789.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1172-wk-Fact-DA2D84E245294CEA7F25EB34A7FEAF86" name="us-gaap:OperatingExpenses" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">850.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1191-wk-Fact-329746DB695B1382CA21EB34A852BDD4" name="us-gaap:OperatingExpenses" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">534.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating income (loss)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1212-wk-Fact-842AF12416274625ED01EB34A8525D65" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">142.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37397549e1231-wk-Fact-52351B6108238CE033D6EB34A843D2C2" name="us-gaap:OperatingIncomeLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">186.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37397549e1251-wk-Fact-15DE3B9C46E5A37FE4E6EB34A852CCDA" name="us-gaap:OperatingIncomeLoss" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">42.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37397549e1274-wk-Fact-6C77DDA5B8CC5B32B2ACAE2BE8A1D64C" name="us-gaap:InterestExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">60.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37397549e1294-wk-Fact-E01056B0436253EE97C1A4AA2DBE0697" name="us-gaap:InterestExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">22.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37397549e1314-wk-Fact-B6167333B48D8123BB4CEB34A8521F67" name="us-gaap:InterestExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income (loss) from equity investments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37397549e1336-wk-Fact-84D262FE1402AF794642174A943CE9B2" name="us-gaap:DebtAndEquitySecuritiesGainLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1356-wk-Fact-AE15260499DB5316983B3D2E988B107C" name="us-gaap:DebtAndEquitySecuritiesGainLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">80.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1375-wk-Fact-5ACB75D07BA38562950CEB34A85248FB" name="us-gaap:DebtAndEquitySecuritiesGainLoss" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest and other income, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1396-wk-Fact-C26E63723BD38DB86B31174A94284AF2" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">26.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1415-wk-Fact-CFDD276D9BDAE14F28DC174A9491525C" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1434-wk-Fact-95BD7C4B84B0C5DA35BEEB34A7EED50F" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income (loss) before income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1455-wk-Fact-E8BBA72F4C2508E82957EB34A862BD92" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">104.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37397549e1474-wk-Fact-D4B1AA5E529C3117B8EAEB34A7EE395C" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">126.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37397549e1494-wk-Fact-9727E2BA13DBEC12654AEB34A8625DC7" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">48.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income tax expense</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1516-wk-Fact-5382C869DEC35C369C5FBDE1CE4B43A0" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1535-wk-Fact-0D594FC0637D063FE795174A94692792" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1554-wk-Fact-DCF36026B268B00536B7EB34A8622EE0" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1580-wk-Fact-24A3E88E5EEE8AE1DA83EB34A7EE95FB" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">101.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37397549e1599-wk-Fact-0DCCCDB98C2E9FE76ED4EB34A84338F1" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">127.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37397549e1619-wk-Fact-73CC98F00980B0ADC146EB34A862BF96" name="us-gaap:NetIncomeLoss" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">50.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic net income (loss) per share</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1703-wk-Fact-DDC1D7D0280028A84DDCEB34A7EECF39" name="us-gaap:EarningsPerShareBasic" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.11</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37397549e1722-wk-Fact-8FDB206D5342C0E1905BEB34A852D12E" name="us-gaap:EarningsPerShareBasic" contextRef="FD2018Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">1.44</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37397549e1742-wk-Fact-3614467630BBCC97FCE7EB34A8525AE6" name="us-gaap:EarningsPerShareBasic" contextRef="FD2017Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.58</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shares used to compute basic net income (loss) per share</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1759-wk-Fact-AA0440B1DBA856CBABF41ADCFCF1B80E" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">91.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1778-wk-Fact-8A45C3A42C1C5A09984DC22E00A294B9" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">88.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1797-wk-Fact-2DB346FE864C954AF431B0DE8A1D0ABC" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2017Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">86.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted net income (loss) per share</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1823-wk-Fact-2431014538102260A524EB34A8433137" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37397549e1842-wk-Fact-14F3DC4B3584F251E8DDEB34A8627C5C" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2018Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">1.44</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37397549e1862-wk-Fact-9CA3C300FF5B6998565EEB34A8520B76" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2017Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.58</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shares used to compute diluted net income (loss) per share</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1879-wk-Fact-891794900913568DB10F3FCA89C0115D" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">92.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1898-wk-Fact-2C5F09467A8B6B26ED3E174A94500918" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">88.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37397549e1917-wk-Fact-42473C8A865D15F1338EEB34A8626C17" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2017Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">86.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">See accompanying notes</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-5</span></div></div><hr style="page-break-after:always"></hr><div><a id="s543F0049D16C59329FB2EB821741A406"></a></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">DexCom, Inc.</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#58a618;color:#ffffff;font-weight:bold;">Consolidated Statements of Comprehensive Income (Loss)</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:67%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">(In millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37390278e715-wk-Fact-24A3E88E5EEE8AE1DA83EB34A7EE95FB" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">101.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37390278e734-wk-Fact-0DCCCDB98C2E9FE76ED4EB34A84338F1" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">127.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37390278e755-wk-Fact-73CC98F00980B0ADC146EB34A862BF96" name="us-gaap:NetIncomeLoss" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">50.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss), net of income taxes:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency translation gain (loss)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37390278e843-wk-Fact-61C2680FBC305E5AB33B8949446A11E1" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37390278e862-wk-Fact-F78F8A3B6D045D199D5447B469F2658E" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37390278e881-wk-Fact-8FAF71CD19A588306581EB34A7EEEE92" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrealized gain (loss) on marketable debt securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37390278e908-wk-Fact-2787BCB24BD2500E896984423CD1E11C" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37390278e927-wk-Fact-5D56756C54CF5F93863DE0A16F822725" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37390278e946-wk-Fact-1A3E5000AF216309BFD5EB34A8432C6E" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total other comprehensive income (loss), net</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37390278e973-wk-Fact-942AEDA58D59FC8BE3C0EB34A7FE6EB0" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37390278e992-wk-Fact-6C13C21639AA9DC5BE3CEB34A822C077" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37390278e1011-wk-Fact-99737194025277B762D0EB34A8627959" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37390278e1043-wk-Fact-41B54CA05DC81E567FD9EB34A7EE6D6A" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">101.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37390278e1062-wk-Fact-47673D28DF14439D7DA4EB34A827DD68" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">123.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37390278e1083-wk-Fact-CA8C22660CF84FFC2D2EEB34A8200EDC" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">51.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">See accompanying notes</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-6</span></div></div><hr style="page-break-after:always"></hr><div><a id="sFBF85CE71F505027B31BFBD62AD60623"></a></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.85569985569985%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:16%;"></td><td style="width:14%;"></td><td style="width:14%;"></td><td style="width:14%;"></td><td style="width:42%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">DexCom, Inc.</span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">Consolidated Statements of Stockholders&#8217; Equity</span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.85569985569985%;border-collapse:collapse;text-align:left;"><tr><td colspan="28"></td></tr><tr><td style="width:35%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">(In millions)</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Common&#160;Stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Additional</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Paid-In</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Capital</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Comprehensive</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Income (Loss)</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Deficit</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Treasury Stock</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Stockholders&#8217;</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Equity</span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#e1ede6;font-weight:bold;">Balance at December 31, 2016</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e945-wk-Fact-8EC2E36FD024D7C213CFEB34A823EB30" name="us-gaap:SharesOutstanding" contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">84.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e964-wk-Fact-5EEC09CC9F7C99243A8CEB34A7FE00E2" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e983-wk-Fact-4D9C6B3B39B86D59C326EB34A843DEE0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">905.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e1003-wk-Fact-3D415D5087F029265D11EB34A843D503" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e1023-wk-Fact-A1F1121570086D41357FEB34A80F06C2" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">621.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e1044-wk-Fact-3189B290836DC9BE37EDEB34A843D049" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e1063-wk-Fact-46FFC2310EE78173D007EB34A7EE1854" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2016Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">283.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Issuance of common stock under equity incentive plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e1083-wk-Fact-61A801BF2A99ADF6C511EB34A843A711" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">2.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e1116-wk-Fact-4B7A1DCF6A4A3571D04AEB34A852EC60" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e1194-wk-Fact-EA8D076057644C8E2AA1EB34A7EE156F" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Issuance of common stock for Employee Stock Purchase Plan</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e1219-wk-Fact-DB2913CE5CCAEAED27D9EB34A7FEB4CE" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e1252-wk-Fact-FF8DAB1E5F4E64F564C9EB34A8624B24" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e1330-wk-Fact-4C3BB0BF391D9EC9F4D2EB34A7EE90C3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e1388-wk-Fact-363CF3AA70DE4222E262EB34A86248E1" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">106.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e1466-wk-Fact-7F81EDB02A32748EE4BDEB34A830BB75" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">106.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity component of convertible 2022 Note issuance, net of issuance costs</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e1524-wk-Fact-B6AA0BBC0BA48B8DD3D2EB34A852EF53" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">70.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e1602-wk-Fact-3ABBD4EDA0C57A23A0F5EB34A843CF21" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">70.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Adoption of ASU 2016-09</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e1660-wk-Fact-0C0F4A1895A26B19A160EB34A8520DCB" name="us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification" contextRef="FD2017Q4YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201609Member_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e1699-wk-Fact-A4FD814F4E066314B374EB34A8524671" name="us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification" contextRef="FD2017Q4YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201609Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#e1ede6;">Net loss</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e1836-wk-Fact-03927A746200B05EF52BEB34A81D8B37" name="us-gaap:NetIncomeLoss" contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">50.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e1876-wk-Fact-73CC98F00980B0ADC146EB34A862BF96" name="us-gaap:NetIncomeLoss" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">50.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e1955-wk-Fact-1E8FF205D09A26D108CEEB34A811874C" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e2014-wk-Fact-99737194025277B762D0EB34A8627959" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#e1ede6;font-weight:bold;">Balance at December 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2040-wk-Fact-0AF7DA579A5486709FA6EB34A852BA88" name="us-gaap:SharesOutstanding" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">87.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2054-wk-Fact-19EEF67A35993F4D5A46EB34A843FC63" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2073-wk-Fact-2593BEC33D846E286BBCEB34A8620433" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,093.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e2093-wk-Fact-A5400EBA0BAC0742C1FDEB34A862FC62" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">2.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e2113-wk-Fact-25DCBFFD1A260E375B57EB34A82FCCAF" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">671.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2133-wk-Fact-4AF62CE7D1899EFE1880EB34A7FE15B7" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2153-wk-Fact-C4B028A6BEB0632C0CB7EB34A843F328" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">419.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Issuance of common stock under equity incentive plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2179-wk-Fact-CC42E367E50BE3FDAC4EEB34A852D4E1" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2212-wk-Fact-75C0F293E08FEBD81556EB34A852836E" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2290-wk-Fact-D4D18986801FF76F287DEB34A86278B2" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Issuance of common stock for Employee Stock Purchase Plan</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2315-wk-Fact-25425463DED9DD628547EB34A80FBE2C" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2348-wk-Fact-B3D3B0EC95748DAD84EEEB34A827F7E9" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2426-wk-Fact-0B6CD2BC986B00624156EB34A8522C6C" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2484-wk-Fact-0FEEDFD6CC1141CCC2ABEB34A7FE8A12" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">101.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2562-wk-Fact-58D3EBE04DEFD31A59A6EB34A826DE77" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">101.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Issuance of common stock for collaborative research and development fee</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2587-wk-Fact-56DC37E0684396108230EB34A81162D6" name="us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2620-wk-Fact-5C07DB9370D0C923F04CEB34A862AB52" name="us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">217.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2698-wk-Fact-58CE720A841CA817A733EB34A7FE1C64" name="us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">217.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity component of convertible 2023 Note issuance, net of issuance costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2756-wk-Fact-734BA53C35C4BF7870C0EB34A862929B" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">171.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2834-wk-Fact-A0C5BCAA159D732A959FEB34A843C63D" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">171.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Sale of warrants</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2892-wk-Fact-1C09BDF21CAE7016A582EB34A8526DF5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">183.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e2970-wk-Fact-DB84D102DFD8E4791530EB34A824335F" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">183.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Convertible note hedge</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e3028-wk-Fact-0F64BCDC9CD67F14EE1BEB34A8521A1B" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">218.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e3107-wk-Fact-026FFC151BD57345F0F4EB34A852B813" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">218.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchases of treasury stock</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e3133-wk-Fact-4601204EE6AADD486656EB34A7EEB606" name="us-gaap:TreasuryStockSharesAcquired" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e3225-wk-Fact-870693956BCEEF5DA351EB34A7EEBFC5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">100.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e3246-wk-Fact-B4D08082E8C3B3B25F47EB34A7FE3518" name="us-gaap:TreasuryStockValueAcquiredCostMethod" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">100.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e3344-wk-Fact-B5630B9E3589C0D10A2CEB34A843FCA1" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">127.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e3384-wk-Fact-0DCCCDB98C2E9FE76ED4EB34A84338F1" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">127.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#e1ede6;">Other comprehensive income</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e3463-wk-Fact-6F5D7B6A8BE5168211DAEB34A862D211" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e3521-wk-Fact-6C13C21639AA9DC5BE3CEB34A822C077" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e3546-wk-Fact-27C5542A5C6A4CFA04B7EB34A8625F04" name="us-gaap:SharesOutstanding" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">90.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e3560-wk-Fact-67E5003D6013107EDDF9EB34A862C794" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e3579-wk-Fact-0A19C60EC44221E9D494EB34A843EB81" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,560.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e3599-wk-Fact-B91CFA2A42806CE550DEEB34A84328ED" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e3618-wk-Fact-6A84E85FD13F1F56E13AEB34A85297C6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">798.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e3638-wk-Fact-6F9F515769B82E908962EB34A833E4BF" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">100.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e3659-wk-Fact-B4189629853BAE21CFC2EB34A81BE193" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">663.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cumulative-effect adjustment from adoption of new lease accounting standard (Note 6)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e3757-wk-Fact-8109F621C2AB5338B7C8B9382E334719" name="us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification" contextRef="FD2019Q4YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e3796-wk-Fact-E80EF1BDAD6F3262B865EB34A862DF7C" name="us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification" contextRef="FD2019Q4YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Issuance of common stock under equity incentive plans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e3821-wk-Fact-05B5C023BA1555E594A030E0AEE92ACD" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e3854-wk-Fact-9EE13058BD8B547DBE735B1D9E2344BC" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e3932-wk-Fact-E33C8D112EAB778ADE3CEB34A7EEC570" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Issuance of common stock for Employee Stock Purchase Plan</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e3957-wk-Fact-086D6E33CC635483811CC82E1A2D7F97" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e3990-wk-Fact-A48EC733E0EB5E438C2F446C6A506ED4" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e4068-wk-Fact-3E82425C6C26D102D2B2EB34A843619F" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e4126-wk-Fact-B644C96442C25B3EB3F62483A971389D" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">102.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e4204-wk-Fact-99658C2653ED80F36C2CEB34A8526E65" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">102.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Realization of tax benefit related to 2023 Note Hedge</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e4262-wk-Fact-177996DFC89927FC95D8F38E5CD0A03E" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e4340-wk-Fact-9C339211A8B6B14182F3AB3544C8460C" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e4437-wk-Fact-DC508509AC3254139A6651DBA0F16911" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">101.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e4476-wk-Fact-24A3E88E5EEE8AE1DA83EB34A7EE95FB" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">101.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive income</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e4554-wk-Fact-9530A18315CF54ABBD28DE7D2192D779" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e4612-wk-Fact-942AEDA58D59FC8BE3C0EB34A7FE6EB0" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at December 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e4637-wk-Fact-0358F93AB688926C774CEB34A82AC32E" name="us-gaap:SharesOutstanding" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">91.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e4656-wk-Fact-B65591980B7F1B4C3C45EB34A8437737" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e4675-wk-Fact-FCFFF34F17FBC7C0CA6EEB34A852EFCF" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,675.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e4695-wk-Fact-C982CD81D04099E51074EB34A8431416" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e4714-wk-Fact-2334391E1F12B5622148EB34A8527597" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">695.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37402404e4735-wk-Fact-AE0C048BE034F65BADFCEB34A8433DB0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">100.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37402404e4755-wk-Fact-938ED76C40F35933492EEB34A827852E" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">882.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">See accompanying notes</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-7</span></div></div><hr style="page-break-after:always"></hr><div><a id="sAA1956FEE80752068206742247D1E118"></a></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:18%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">DexCom, Inc.</span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">Consolidated Statements of Cash Flows</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:68%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Operating activities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e804-wk-Fact-24A3E88E5EEE8AE1DA83EB34A7EE95FB" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">101.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e823-wk-Fact-0DCCCDB98C2E9FE76ED4EB34A84338F1" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">127.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e843-wk-Fact-73CC98F00980B0ADC146EB34A862BF96" name="us-gaap:NetIncomeLoss" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">50.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Adjustments to reconcile net income (loss) to cash provided by operating activities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e922-wk-Fact-BAF3D039662554AD9DDAD36E3D62AB2E" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">48.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e941-wk-Fact-40DE5200B9E750049E7F86493FD9D9CE" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">29.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e960-wk-Fact-C65113A8B8D88A84EE8EEB34A843A822" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e981-wk-Fact-CAAFDCAD6C495B359A27BBCE72C9083A" name="us-gaap:ShareBasedCompensation" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">102.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1000-wk-Fact-8503D7D80BFC59CEB66F1F73B6B038A4" name="us-gaap:ShareBasedCompensation" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">101.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1019-wk-Fact-8DAAE767FE0DC207367EEB34A8439A2C" name="us-gaap:ShareBasedCompensation" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">106.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-cash interest expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1040-wk-Fact-7515DFDC98F450AF931467F19D8E4827" name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">49.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1059-wk-Fact-28057FA0B3465BCD8ABB88FBFB1E8766" name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1078-wk-Fact-A63E9E880D15117A6E26EB34A8529792" name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-cash collaborative research and development fee through issuance of common stock</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1099-wk-Fact-4D81013D3931F4A17124EB34A7EEB1FD" name="dxcm:RDexpensethroughissuanceofcommonstock" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1118-wk-Fact-995313BF29226BEFE534EB34A8620DA3" name="dxcm:RDexpensethroughissuanceofcommonstock" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">217.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1137-wk-Fact-09705683290F48B46BEBEB34A862EFA6" name="dxcm:RDexpensethroughissuanceofcommonstock" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrealized gain on equity investment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1158-wk-Fact-5061BEB2CBA759039F0A866AB98616FB" name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e1177-wk-Fact-DA64AB868AF1509FBEF5656113EA912A" name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">36.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1197-wk-Fact-A8303D06397996C6F93EEB34A85205D4" name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Realized (gain) loss on equity investment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1218-wk-Fact-9F337F7FBCE6502983F71BD7E20ECFFF" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e1237-wk-Fact-14B1945BBDC65722923901C9406335CA" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">44.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1257-wk-Fact-20328F1E736421A8F892EB34A8432D2B" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other non-cash income and expenses</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1279-wk-Fact-6DFE3CA3A85A54A4967DCB3BE6D24440" name="us-gaap:OtherNoncashIncomeExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">2.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1298-wk-Fact-9AB1355BD6E55E9583F2D3F9D4EDF3AB" name="us-gaap:OtherNoncashIncomeExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1317-wk-Fact-B7B8C48DF7AD032CD851EB34A8523E8D" name="us-gaap:OtherNoncashIncomeExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">7.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Changes in operating assets and liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e1400-wk-Fact-89B2CF68A50052DFA5619E57D9F9EAA0" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">60.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e1420-wk-Fact-56B59099AF515CBF91ABFE5C5520C384" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">93.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e1440-wk-Fact-695D2F175EDE546860D7EB34A862DD7F" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">31.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventory</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e1462-wk-Fact-C53FC972C1CF586595595612DC17B1C6" name="us-gaap:IncreaseDecreaseInInventories" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">49.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e1482-wk-Fact-B73040042BAD5D229031BC2E7F1FD133" name="us-gaap:IncreaseDecreaseInInventories" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1502-wk-Fact-D9EFE3697A3F6617E595EB34A8436982" name="us-gaap:IncreaseDecreaseInInventories" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prepaid and other assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e1523-wk-Fact-90F3213B27F752888CA529FDFA22CB65" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e1543-wk-Fact-889A6256769855B1B532189B1E8BBFAA" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e1563-wk-Fact-5EFDDB10DCB7E3188321EB34A843548A" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease right-of-use assets and liabilities, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e1585-wk-Fact-FC4D4BE1110203EF16B4AB41E113C825" name="dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1605-wk-Fact-5499E4FA12F6C83EBE6CAB41E38397D9" name="dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1624-wk-Fact-802C5480FA8F353B4557AB41E5ED5F3E" name="dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts payable and accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1645-wk-Fact-58AD526DA508594FA715D2A5BD5AFEE5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">109.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1664-wk-Fact-6D94996F9494560E98B99C50880F0A36" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">56.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1683-wk-Fact-52DBDBCB0276031C0692EB34A852F037" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">21.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued payroll and related expenses</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1704-wk-Fact-62712C51FEAE5B5B8F79F82490B897D4" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1723-wk-Fact-075724A2A718549B85EF9E7A0EB7B38C" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">23.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1742-wk-Fact-3FFC113EF138169D1D18EB34A852AF23" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred revenue, deferred rent and other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e1763-wk-Fact-D5CD74E7F9FB5BE4802D039DB4E2B14D" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1783-wk-Fact-EDDD403F2D9E5FA58566DD5EFAEA61CF" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1802-wk-Fact-B483CEDBDA4CE0DA63E3EB34A862A9CF" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#e1ede6;">Net cash provided by operating activities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1823-wk-Fact-A0D7FDBB993215901290EB34A862BB19" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">314.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1842-wk-Fact-319F83059D381F009D8DEB34A843C464" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">123.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e1861-wk-Fact-97156E56333D22853F82EB34A85222D5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">92.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Investing activities</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchase of marketable securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e1945-wk-Fact-C208F49BDF565B0098AA9A82D789F2C7" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,030.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e1965-wk-Fact-B27C9292506F546EAAB474814A2EB0AC" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">452.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e1985-wk-Fact-A47D08AE4BEA1380097FEB34A7EECE8B" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">171.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Proceeds from sale and maturity of marketable securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2007-wk-Fact-0863F69E9BBD5D59B01C3CD49EBA982A" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,196.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2026-wk-Fact-037471B8D1EA5961A2D87F0C5611D2E9" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">392.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2045-wk-Fact-C67670F78C379AE9A2CAEB34A862B912" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">93.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchase of other equity investments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e2066-wk-Fact-CB30C2DAD3CA52EEB6FBBA8F0A31BDD2" name="us-gaap:PaymentsToAcquireOtherInvestments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e2086-wk-Fact-93FDD1FE670E5D3AA22276DA57F95294" name="us-gaap:PaymentsToAcquireOtherInvestments" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2106-wk-Fact-5D2B545F752BDA47585AEB34A843EBF8" name="us-gaap:PaymentsToAcquireOtherInvestments" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchase of property and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e2127-wk-Fact-59966C907F595036B9B4158AC7A24E66" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">180.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e2147-wk-Fact-0A719CE6830552C6B9AC80461EBE404B" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">67.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e2167-wk-Fact-C008B3400C96F8AFDF36EB34A8438770" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">66.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Acquisitions, net of cash acquired</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2189-wk-Fact-407BE9CAFB3C571686DF6B4F8982473F" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e2208-wk-Fact-EBA6B977F2B85CA89537EB34616D0A93" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2228-wk-Fact-92F6448B56B491EAECC1EB34A7FE7C93" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash used in investing activities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e2249-wk-Fact-75EDF7FD943AA2C6C42DEB34A843E174" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1,015.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e2269-wk-Fact-1AAFFDBCDF249B2B4906EB34A85296B8" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">139.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e2289-wk-Fact-337AA229276F9DB53F18EB34A843E51E" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">144.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Financing activities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net proceeds from issuance of common stock</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2373-wk-Fact-42E0919653D350A19E3D87F84CC42F9F" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2392-wk-Fact-5568C19CADEF5BA084DBF4DE32CB5032" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2411-wk-Fact-B33A76FBD17B850A7DB5EB34A862DF36" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchases of treasury stock</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2432-wk-Fact-AB6CFA0E5A6CAC680935EB34A8529E73" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e2451-wk-Fact-0A1A5E08EA37D383FEA70F2D0614B5E7" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">100.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2471-wk-Fact-4FF2871B410B58B41602EB34A852D623" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Proceeds from issuance of convertible debt, net of issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2492-wk-Fact-F0800166B17B29C82E8AEB34A852871C" name="us-gaap:ProceedsFromConvertibleDebt" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2511-wk-Fact-E0DDD794CEBBDD49776FEB34A7EEF823" name="us-gaap:ProceedsFromConvertibleDebt" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">836.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2530-wk-Fact-B37B5E1668D650CC6B54EB34A852B76E" name="us-gaap:ProceedsFromConvertibleDebt" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">389.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Proceeds from sale of warrants</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2551-wk-Fact-AAAA1B626146310ECA2AEB34A852A5D7" name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2570-wk-Fact-A64D3EEBE8FE6A84ECD4EB34A8625AB5" name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">183.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2589-wk-Fact-A22B2526D6A26D22A3BFEB34A7EE8634" name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Purchase of convertible note hedge</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2611-wk-Fact-411C6E4434136EEB34EAEB34A8436159" name="dxcm:PurchaseofConvertibleNoteHedge" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e2630-wk-Fact-9177148F6CA05F4CAB64EB34A85237D1" name="dxcm:PurchaseofConvertibleNoteHedge" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">218.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2650-wk-Fact-7BC65DDA8C5CACE1AC88EB34A843AB5C" name="dxcm:PurchaseofConvertibleNoteHedge" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Proceeds from short-term borrowings</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2671-wk-Fact-6BA6BF5399A8FB0F2E13EB34A843A9AC" name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2690-wk-Fact-EC06FF87AED0E1A83331EB34A7EEAB04" name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2709-wk-Fact-D3961398DFBC0BAC4448EB34A8523256" name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">75.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Repayment of short-term borrowings</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2730-wk-Fact-4944538D27363F7FE91EEB34A8526CA3" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2749-wk-Fact-958E146A4016772C73CEEB34A84308FA" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e2768-wk-Fact-C93E2DAF4E0B7CA41901EB34A84381EA" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">75.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other financing activities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e2790-wk-Fact-0B36BC45CBB74BA662760F2D061AF50D" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e2810-wk-Fact-E5EF5A331195071E35DC0F2D059DE6C5" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2830-wk-Fact-BACA44AB32CB8F3979480F2D05A3EB5C" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash provided by financing activities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2851-wk-Fact-AF729E4E4F73254274EAEB34A86214CD" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2870-wk-Fact-4763F0AAE2E7542FB444EB34A84338CA" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">710.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2889-wk-Fact-6F1F4CFB58DB7792BF34EB34A8437685" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">399.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e2910-wk-Fact-5BDA67E055625AB188EA062F45636A9A" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2930-wk-Fact-D53924BA606C57A88159F11F098CD3A6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2949-wk-Fact-7A6CEE736CC2C24D9CB2EB34A84371C8" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increase (decrease) in cash, cash equivalents and restricted cash</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37396062e2970-wk-Fact-4F135883E438644FC7D8EB34A843E827" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">690.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e2990-wk-Fact-B92660AD60812A466159EB34A843C12B" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">695.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3009-wk-Fact-135B3A534964A1866EA7EB34A8437797" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">347.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash, cash equivalents and restricted cash, beginning of period</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3030-wk-Fact-06F4FA507E245B65842774AC5E15BA64" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,137.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3049-wk-Fact-3766517489BEE0CF0D010F2D04D61D30" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">441.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3068-wk-Fact-47671CE5B0995FA0ACE0EB34A843804E" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2016Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">94.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash, cash equivalents and restricted cash, end of period</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3094-wk-Fact-F91CEBFB964BD19C2AEF0F2D05A8F644" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">446.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3113-wk-Fact-06F4FA507E245B65842774AC5E15BA64" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,137.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3132-wk-Fact-3766517489BEE0CF0D010F2D04D61D30" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">441.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Reconciliation of cash, cash equivalents and restricted cash, end of period:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3278-wk-Fact-C34A37AEC0925179A5FBD7370ABF40D4" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">446.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3297-wk-Fact-E529F8ACC9195FE8B669B378B77BC5C6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,137.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3316-wk-Fact-C85E2CD4EAD08F962F970F2D061F9A0B" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">441.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Restricted cash</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3332-wk-Fact-2A08BE9A0CFC51F19A754A9399400B32" name="us-gaap:RestrictedCash" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3351-wk-Fact-F8851C10E4C05C61937FBF36019984C2" name="us-gaap:RestrictedCash" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3370-wk-Fact-2347B2BAE5EC5D271A760F2D0624FA0E" name="us-gaap:RestrictedCash" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total cash, cash equivalents and restricted cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3396-wk-Fact-F91CEBFB964BD19C2AEF0F2D05A8F644" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">446.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3415-wk-Fact-06F4FA507E245B65842774AC5E15BA64" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,137.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3434-wk-Fact-3766517489BEE0CF0D010F2D04D61D30" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">441.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-8</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:68%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Supplemental disclosure of non-cash investing and financing transactions:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Acquisition of property and equipment included in accounts payable and accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3599-wk-Fact-D36BD2875D6C1FCCFEC5EB34A843EA37" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3618-wk-Fact-AD9812872873B2594D6EEB34A84346B7" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3637-wk-Fact-3E44AFD546B243F6A3B8EB34A8622A0E" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Supplemental cash flow information:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash paid during the year for interest</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3720-wk-Fact-978AA3D3CAB73DC59316EB34A85220A6" name="us-gaap:InterestPaidNet" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3739-wk-Fact-5B6AEBF2B0C81117770BEB34A85244C1" name="us-gaap:InterestPaidNet" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3758-wk-Fact-D3A6147C9DC849F8745AEB34A8521748" name="us-gaap:InterestPaidNet" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash paid during the year for income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3779-wk-Fact-8A8B6A67C9B1DD92ADF9EB34A852F9AA" name="us-gaap:IncomeTaxesPaid" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3798-wk-Fact-B8D640881C63BB9F03FCEB34A8527F33" name="us-gaap:IncomeTaxesPaid" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396062e3817-wk-Fact-12325BAFD4D9322B79C8EB34A852DE08" name="us-gaap:IncomeTaxesPaid" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;">See accompanying notes</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-9</span></div></div><hr style="page-break-after:always"></hr><div><a id="sEB3DDC400F8B54458940863B3CCC6F05"></a></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">DexCom, Inc.</span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Consolidated Financial Statements</span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">December&#160;31, 2019</span></div></td></tr></table></div></div><div><a id="s1A75EB66FF635FA2ABAEBE3DB7B9E6AA"></a></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-0-wk-Fact-C4B028C0439A7E7E3C8DEB34A7FEC201" continuedAt="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #ffffff;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">1. Organization and Significant Accounting Policies</span></div></td></tr></table></div></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:NatureOfOperations" id="TextSelection-F0F4221BDD2251EF0D75EB34A876CC44-0-wk-Fact-123751C6954074589295EB34A7EE9114" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Organization and Business</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DexCom, Inc. is a medical device company focused on the design, development and commercialization of CGM system(s) for use by people with diabetes and by healthcare providers. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;DexCom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ConsolidationPolicyTextBlock" id="TextSelection-2921A57E1E081FE3A712EB34A874AD41-0-wk-Fact-91A166347EF456E02980EB34A7EE5DF4" continuedAt="TextSelection-2921A57E1E081FE3A712EB34A874AD41-1" escape="true"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="TextSelection-844E2A18593237327906EB34A876935F-0-wk-Fact-023201F4A7EE3124D816EB34A7EE7991" continuedAt="TextSelection-844E2A18593237327906EB34A876935F-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:18%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Basis of Presentation and Principles of Consolidation</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric><ix:continuation id="TextSelection-2921A57E1E081FE3A712EB34A874AD41-1"><ix:continuation id="TextSelection-844E2A18593237327906EB34A876935F-1" continuedAt="TextSelection-844E2A18593237327906EB34A876935F-2"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div></ix:continuation><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><ix:continuation id="TextSelection-844E2A18593237327906EB34A876935F-2" continuedAt="TextSelection-844E2A18593237327906EB34A876935F-3"><span style="font-family:inherit;font-size:10pt;">The functional currencies of our international subsidiaries are generally the local currencies. We translate the financial statements of our foreign subsidiaries into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in </span><span style="font-family:inherit;font-size:10pt;">comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;"> and in </span><span style="font-family:inherit;font-size:10pt;">accumulated other comprehensive income</span><span style="font-family:inherit;font-size:10pt;"> in the equity section of our consolidated balance sheet. Gains and losses resulting from certain intercompany transactions as well as transactions with customers and vendors that are denominated in currencies other than the functional currency of each entity give rise to foreign exchange gains or losses that we record in </span><span style="font-family:inherit;font-size:10pt;">interest and other income, net</span></ix:continuation><span style="font-family:inherit;font-size:10pt;"><ix:continuation id="TextSelection-844E2A18593237327906EB34A876935F-3"> in our consolidated statements of operations</ix:continuation>.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:UseOfEstimates" id="TextSelection-F0D0FABD6BB02FCDCC2CEB34A873ED8C-0-wk-Fact-B5F82195FBB218732C7EEB34A7FEAB37" continuedAt="TextSelection-F0D0FABD6BB02FCDCC2CEB34A873ED8C-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Use of Estimates</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><ix:continuation id="TextSelection-F0D0FABD6BB02FCDCC2CEB34A873ED8C-1"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles, or GAAP, requires us to make certain estimates and assumptions that affect the amounts reported in our financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include pharmacy rebates, transaction price, net accounts receivable, excess or obsolete inventories and the valuation of inventory, and accruals for litigation contingencies. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div></ix:continuation><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="TextSelection-97C7D2BE51FBD67765AAEB34A87569F9-0-wk-Fact-70F268009BC25F168F18EB34A7EE6059" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Fair Value Measurements</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The authoritative guidance establishes a fair value hierarchy that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities. In general, the authoritative guidance requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset or liability&#8217;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the measurement of its fair value. The three levels of input defined by the authoritative guidance are as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level&#160;1&#8212;Unadjusted quoted prices that are available in active markets for identical assets or liabilities.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level&#160;2&#8212;Inputs other than quoted prices included in Level&#160;1 that are observable, either directly or indirectly, through correlation with market data. These include quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data for substantially the full term of the assets or liabilities.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level&#160;3&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the determination of fair value. Level 3 assets and liabilities include those whose fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques and significant judgment or estimation.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We carry our marketable securities at fair value. We carry our other financial instruments, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, at cost, which approximates the related fair values due to the short-term maturities of these instruments. For more information see Note 3, &#8220;Fair Value Measurements.&#8221;</span></div></ix:nonNumeric></ix:nonNumeric><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-10</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-1" continuedAt="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-2"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="TextSelection-E7F83F0D0215DAF22CD8EB34A8766A01-0-wk-Fact-8AB719CFC24DC21F03D2EB34A7EE720C" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Cash and Cash Equivalents</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We consider highly liquid investments with a maturity of </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37409491e912-wk-Fact-3D4F39339162BF648C09EB34A7FEEDE5" name="dxcm:MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" contextRef="FD2019Q4YTD" format="ixt-sec:durday">90</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;">&#160;days or less at the time of purchase to be cash equivalents.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:MarketableSecuritiesPolicy" id="TextSelection-85FDF9774A4693DADCFAEB34A874ACFE-0-wk-Fact-C6483AC34A3DE8C3533FEB34A81875BC" continuedAt="TextSelection-85FDF9774A4693DADCFAEB34A874ACFE-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Marketable Securities</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have classified our marketable securities with remaining maturity at purchase of more than three months and remaining maturities of one year or less as short-term marketable securities. We have also classified marketable securities with remaining maturities of greater than one year as short-term marketable securities based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We calculate realized gains or losses on our marketable securities using the specific identification method. We carry our marketable debt securities at fair value with unrealized gains and losses reported as a separate component of stockholders&#8217; equity in our consolidated balance sheets and included in </span><span style="font-family:inherit;font-size:10pt;">comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;">. Realized gains and losses on marketable debt securities are included in </span><span style="font-family:inherit;font-size:10pt;">interest and other income, net</span><span style="font-family:inherit;font-size:10pt;"> in our consolidated statements of operations. We carry our marketable equity securities at fair value with realized and unrealized gains and losses reported in income on equity investments in our consolidated statements of operations. </span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><ix:continuation id="TextSelection-85FDF9774A4693DADCFAEB34A874ACFE-1">We invest in various types of debt securities, including debt securities in government-sponsored entities, corporate debt securities, U.S. Treasury securities and commercial paper. We do not generally intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.</ix:continuation> See Note 3, &#8220;Fair Value Measurements&#8221; and Note 4, &#8220;Balance Sheet Details &#8211; </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Short-Term Marketable Securities</span><span style="font-family:inherit;font-size:10pt;">&#8221; for more information on our marketable debt securities and our marketable equity securities.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ReceivablesPolicyTextBlock" id="TextSelection-ED134050944CA31D2DF4EB34A8745CCF-0-wk-Fact-3E0EB9B4D00B9456A896EB34A817E636" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Accounts Receivable and Allowance for Doubtful Accounts</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable are generally recorded at the invoiced amount for Distributors and at net realizable value for Direct customers, which is determined using estimates of claim denials and historical reimbursement experience without regard to aging category. Accounts receivable are not interest bearing. We evaluate the creditworthiness of significant customers and generally do not require collateral from our customers. We maintain an allowance for doubtful accounts for potential credit losses. Uncollectable accounts are written off against the allowance after appropriate collection efforts have been exhausted and when it is deemed that a customer account is uncollectable.&#160;Generally, receivable balances greater than one year past due are deemed uncollectable.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ConcentrationRiskCreditRisk" id="TextSelection-3A887F02BC4C157C04D4EB34A874926F-0-wk-Fact-424D187CC548D761E2C6EB34A7EE51E2" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Significant Customers</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position. </span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="TextSelection-8C8F00185F9A5D202691B0CC574FF028-0-wk-Fact-1C91A8A04528A3ACB2C5B0D0C078A1E1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table sets forth the percentages of total revenue or gross accounts receivable for customers that represent 10% or more of the respective amounts for the periods shown:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:46%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Accounts Receivable</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">As of December 31, </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Distributor A</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e1379-wk-Fact-284A774335885DB6961FF9742F7B110A" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e1394-wk-Fact-1C9F1D2A913455DCA79103CD7D425429" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2018Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">15</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e1409-wk-Fact-185E3353C248AB6E5900EB34A8332B9B" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2017Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e1424-wk-Fact-E3E4AF3944B757DD8A2AAFD22A08BF18" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">21</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e1440-wk-Fact-FC76EE153B3A556BABBB5CA38CFF8484" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2018Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Distributor B</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e1456-wk-Fact-00B10A5990F35AA6B442260BBF11B47B" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerBMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span><ix:nonFraction id="d37409491e1471-wk-Fact-6BC6CD50869050FB9B917BE9E44C650C" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2018Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerBMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e1486-wk-Fact-59A626DEEB6DDB9CCD9DEB34A833D0E8" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2017Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerBMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">14</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e1516-wk-Fact-389FBD0809CF5CB1B3326EA833F28FBD" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2018Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerBMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">15</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Distributor C</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e1532-wk-Fact-32047E11E28453DF8DD75B5B2BEA56AB" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerCMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*     Less than 10%</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-11</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-2" continuedAt="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-3"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:InventoryPolicyTextBlock" id="TextSelection-7CE3ED3034F54F945C60EB34A875D91B-0-wk-Fact-76C8EE11086C6142476AEB34A7EE415E" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Inventory</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventory is valued at the lower of cost or net realizable value on a part-by-part basis that approximates first in, first out. We record adjustments to inventory for potentially excess, obsolete or scrapped goods in order to state inventory at net realizable value. Factors influencing these adjustments include inventories on hand and on order compared to estimated future usage and sales for existing and new products, as well as judgments regarding quality control testing data and assumptions about the likelihood of scrap and obsolescence. Once written down the adjustments are considered permanent and are not reversed until the related inventory is sold or disposed of.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our products require customized products and components that currently are available from a limited number of sources. We purchase certain components and materials from single sources due to quality considerations, costs or constraints resulting from regulatory requirements. </span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="TextSelection-5FDFDA70531988030B82EB34A8760301-0-wk-Fact-D419D7F100A4F061B16DEB34A7EE9403" continuedAt="TextSelection-5FDFDA70531988030B82EB34A8760301-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:18%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Property and Equipment</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property and equipment is stated at cost less accumulated depreciation. We calculate depreciation using the straight-line method over the estimated useful lives of the assets. Estimated useful lives are generally </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37409491e1730-wk-Fact-D8E92BDEC72693035D84EB34A7EE09AC" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="FD2019Q4YTD_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> for computer software and hardware, four to </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37409491e1734-wk-Fact-B8E936F7561AE673CDC4EB34A818B8E6" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember" format="ixt-sec:durwordsen">fifteen years</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> for machinery and equipment, and </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37409491e1738-wk-Fact-B06AB888FF841CDBF17DEB34A8168E2D" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="FD2019Q4YTD_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> for furniture and fixtures. Leasehold improvements are amortized over the shorter of the estimated useful lives of the assets or the remaining lease term. We include the amortization of assets that are recorded under finance leases in depreciation expense.</span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><ix:continuation id="TextSelection-5FDFDA70531988030B82EB34A8760301-1"><span style="font-family:inherit;font-size:10pt;">We review property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the recoverability of the asset by comparing the carrying amount to the future undiscounted cash flows that we expect the asset to generate. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.</span></ix:continuation><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="TextSelection-2BBF840D5321A745CCCAEB34A875913D-0-wk-Fact-F45A71E0240C1B317D9AEB34A817A92A" continuedAt="TextSelection-2BBF840D5321A745CCCAEB34A875913D-1" escape="true"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Goodwill</span></div></td></tr></table></div></ix:nonNumeric></div><ix:continuation id="TextSelection-2BBF840D5321A745CCCAEB34A875913D-1" continuedAt="TextSelection-2BBF840D5321A745CCCAEB34A875913D-2"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We record goodwill when the fair value of consideration transferred in a business combination exceeds the fair value of the identifiable assets acquired and liabilities assumed. Goodwill and other intangible assets that have indefinite useful lives are not amortized, but we test them annually for impairment in the fourth quarter of our fiscal year and whenever events or changes in circumstances indicate that it is more likely than not that the fair value is less than the carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate or operational performance of the business, and an adverse action or assessment by a regulator. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We perform our goodwill impairment analysis at the reporting unit level, which aligns with DexCom&#8217;s reporting structure and the availability of discrete financial information.&#160;We perform the first step of our annual impairment analysis by either comparing a reporting unit&#8217;s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit&#8217;s fair value from the last quantitative assessment to determine if there is potential impairment. We may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit&#8217;s estimated fair value was significantly in excess of the carrying value of its net assets and we do not believe there have been significant changes in the reporting unit&#8217;s operations that would significantly decrease its estimated fair value or significantly increase its net assets.&#160;If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections&#160;and/or use of a market approach by looking at market values of comparable companies. Key assumptions&#160;for these projections include revenue growth, future gross margin and operating margin growth, and weighted cost of capital and terminal growth rates. The revenue and margin growth are based on increased sales of new and existing products as we maintain investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements&#160;to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including the timing and probability of regulatory approvals for our products to be commercialized. We also consider DexCom&#8217;s market capitalization as a part of our analysis.</span></div></ix:continuation></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-12</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-3" continuedAt="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-4"><ix:continuation id="TextSelection-2BBF840D5321A745CCCAEB34A875913D-2"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If the estimated fair value of a reporting unit exceeds the carrying amount of the net assets assigned to that unit, goodwill is not impaired and no further analysis is required. If the carrying value of the net assets assigned to a reporting unit exceeds the estimated fair value of the unit, we perform the second step of the impairment test. In this step we allocate the fair value of the reporting unit calculated in step one to all of the assets and liabilities of that unit, as if we had just acquired the reporting unit in a business combination. The excess of the fair value of the reporting unit over the total amount allocated to the assets and liabilities represents the implied fair value of goodwill. If the carrying amount of a reporting unit&#8217;s goodwill exceeds its implied fair value, we would record an impairment loss equal to the difference. We recorded </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e1808-wk-Fact-EC75AE47FE5F6E66497DEB34A7EE842C" name="us-gaap:GoodwillAndIntangibleAssetImpairment" contextRef="FD2019Q4YTD" unitRef="usd" decimals="INF" scale="6" format="ixt-sec:numwordsen">no</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> goodwill impairment charges for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The change in goodwill for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> consisted of translation adjustments on our foreign currency denominated goodwill. The change in goodwill for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;"> consisted of goodwill we recorded for acquisitions that were not significant, individually or in the aggregate, and translation adjustments on our foreign currency denominated goodwill. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Intangible Assets and Other Long-Lived Assets</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We amortize intangible assets with a finite life, such as acquired technology, customer relationships, trade names and trademarks, on a straight-line basis over their estimated useful lives, which range from </span><span style="font-family:inherit;font-size:10pt;">two</span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;">five</span><span style="font-family:inherit;font-size:10pt;"> years. We review intangible assets that have finite lives and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference. </span></div></ix:continuation><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:IncomeTaxPolicyTextBlock" id="TextSelection-E18F9884862A2FE2CA2AEB34A8751251-0-wk-Fact-B9B0B7F10D6847C84582EB34A819E752" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Income Taxes</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We recognize deferred tax assets to the extent that we believe that these assets are more likely than not to be realized, which requires significant judgment. The realization of deferred tax assets is dependent, in part, upon future taxable income. In assessing whether our deferred tax assets will be realized, we consider all available evidence, both positive and negative. Such evidence includes historical earnings, future reversals of existing taxable temporary differences, estimates of future taxable income, and the feasibility of ongoing tax planning strategies. We have recorded a full valuation allowance on our net deferred tax asset balances for all periods presented because of the uncertainty related to utilization of our deferred tax assets.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We record uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than </span><span style="font-family:inherit;font-size:10pt;">50 percent</span><span style="font-family:inherit;font-size:10pt;"> likely to be realized upon ultimate settlement with the related tax authority.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We file federal and state income tax returns in the United States and income tax returns in various other foreign jurisdictions with varying statutes of limitations. Due to net operating losses incurred, our income tax returns from inception to date are subject to examination by taxing authorities. We recognize interest expense and penalties related to income tax matters, including unrecognized tax benefits, as a component of income tax expense. </span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:StandardProductWarrantyPolicy" id="TextSelection-3A84261AEB89B363FAC5EB34A87591E5-0-wk-Fact-EE13F6535E2D82B891BEEB34A7FEA207" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Warranty Accrual</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Estimated warranty costs associated with a product are recorded at the time revenue is recognized. We estimate future warranty costs by analyzing historical warranty experience for the timing and amount of returned product, and expectations for future warranty activity based on changes and improvements to the product or process that are in place or will be in place in the future. We evaluate these estimates on at least a quarterly basis to determine the continued appropriateness of our assumptions.</span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-13</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-4" continuedAt="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-5"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="TextSelection-2723E5D6DA42483CE7EBEB34A8739DFD-0-wk-Fact-C9C60EDEA714D81BFB19EB34A81601CE" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:18%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Loss Contingencies</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If the potential loss from a claim or legal proceeding is considered probable and the amount can be reasonably estimated, we record a liability and an expense for the estimated loss and disclose it in our financial statements if it is significant. If we determine that a loss is possible and the range of the loss can be reasonably determined, then we disclose the range of the possible loss. Significant judgment is required in the determination of whether a potential loss is probable, reasonably possible, or remote as well as in the determination of whether a potential exposure is reasonably estimable. </span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="TextSelection-CF16F474262D46D663BEEB34A8749C55-0-wk-Fact-2EF70892585789240AEBEB34A7EE3CFB" continuedAt="TextSelection-CF16F474262D46D663BEEB34A8749C55-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:16%;"></td><td style="width:14%;"></td><td style="width:14%;"></td><td style="width:14%;"></td><td style="width:14%;"></td><td style="width:14%;"></td><td style="width:14%;"></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Comprehensive Income (Loss)</span></div></td></tr></table></div></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><ix:continuation id="TextSelection-CF16F474262D46D663BEEB34A8749C55-1"><span style="font-family:inherit;font-size:10pt;">Comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;"> consists of two elements, </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">other comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;">. We report all components of </span><span style="font-family:inherit;font-size:10pt;">comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;">, including </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;">, in our financial statements in the period in which they are recognized. Total </span><span style="font-family:inherit;font-size:10pt;">comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;"> is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We report </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> and the components of </span><span style="font-family:inherit;font-size:10pt;">other comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;">, including foreign currency translation adjustments and unrealized gains and losses on marketable securities, net of their related tax effect to arrive at total </span><span style="font-family:inherit;font-size:10pt;">comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;">.</span></ix:continuation><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="TextSelection-6FB96A7E12DB170BCD9CEB34A8752EEC-0-wk-Fact-919AA32086A12DB06A8BEB34A8180328" continuedAt="TextSelection-6FB96A7E12DB170BCD9CEB34A8752EEC-1" escape="true"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:18%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Revenue Recognition</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></ix:nonNumeric></div><ix:continuation id="TextSelection-6FB96A7E12DB170BCD9CEB34A8752EEC-1" continuedAt="TextSelection-6FB96A7E12DB170BCD9CEB34A8752EEC-2"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We generate our revenue from the sale of our Reusable Hardware and disposable sensors, which we refer to in this section as &#8220;Components&#8221;. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We adopted ASC Topic 606 effective January 1, 2018 using the modified retrospective method. Our revenue recognition policies under ASC Topic 606 are explained below.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Policy elections and practical expedients taken</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We report revenue net of taxes collected from customers, which are subsequently remitted to governmental authorities;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We account for shipping and handling activities that are performed after a customer has obtained control of a good as fulfillment costs rather than as separate performance obligations;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We do not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If we expect, at contract inception, that the period between the transfer of control and corresponding payment from the customer will be one year or less, we do not adjust the amount of consideration for the effects of a significant financing component.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Contracts and performance obligations</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations. We also provide free-of-charge software, mobile applications and updates for our DexCom Share</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></span><span style="font-family:inherit;font-size:10pt;">remote monitoring system. The standalone selling prices of our free-of-charge software, mobile applications and updates are estimated based on an expected cost plus a margin approach.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Transaction price</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Transaction price for the Components reflects the net consideration to which we expect to be entitled. </span><span style="font-family:inherit;font-size:10pt;">Transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Variable consideration</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Rebates.</span><span style="font-family:inherit;font-size:10pt;"> We estimate reductions for rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Product Returns. </span><span style="font-family:inherit;font-size:10pt;">In accordance with the terms of their distribution agreements, most distributors do not have rights of return outside of our limited warranty. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. We generally provide a &#8220;</span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37409491e2286-wk-Fact-89E0E1345F585EBEB5C62B244646093F" name="dxcm:RevenueRecognitionSalesReturnsCoveragePeriod" contextRef="FD2019Q4YTD" format="ixt-sec:durday">30</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;">-day money back guarantee&#8221; program whereby first-time end-user customers may return Reusable Hardware. Product returns have historically been immaterial.</span></div></ix:continuation></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-14</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-5" continuedAt="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-6"><ix:continuation id="TextSelection-6FB96A7E12DB170BCD9CEB34A8752EEC-2"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue recognition</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The timing of revenue recognition is based on the satisfaction of performance obligations. Substantially all of the performance obligations associated with our Components are satisfied at a point in time, which typically occurs at shipment of our products. Terms of direct and distributor orders are generally</span><span style="font-family:inherit;font-size:10pt;color:#ee2724;"> </span><span style="font-family:inherit;font-size:10pt;">Freight on Board (FOB) shipping point for U.S. orders or Free Carrier (FCA) shipping point for international orders. For certain of our distributors, control transfers at delivery of the product to the customer. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In cases where our free-of-charge software, mobile applications and updates are deemed to be separate performance obligations, revenue is recognized over time on a ratable basis over the estimated life of the related hardware component. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our sales of Components include an assurance-type warranty.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Judgments and Estimates</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In determining how revenue should be recognized, a five-step process is used, which requires judgment and estimates that can have a significant impact on the amount and timing of revenue we report. These judgments and estimates include identifying performance obligations in the contract, determining whether the performance obligations are separate, allocating the transaction price to each separate performance obligation, determining the timing of revenue recognition for separate performance obligations and estimating the amount of variable consideration to include in the transaction price. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Contract balances</span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract balances represent amounts presented in the consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37409491e2320-wk-Fact-D624925B6F7FD0A1B036EB34A816B60D" name="dxcm:ContractPaymentTermsNumberofDays" contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember" format="ixt-sec:durday">30</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37409491e2324-wk-Fact-1F40DF33059AA8EA21F1EB34A81AEBE4" name="dxcm:ContractPaymentTermsNumberofDays" contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember" format="ixt-sec:durday">90</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> days. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> included unbilled accounts receivable of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37409491e2335-wk-Fact-D8A92F713B2C54BA930E1114159FAF79" name="us-gaap:UnbilledContractsReceivable" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.6</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">. Unbilled accounts receivable consists of revenue recognized for Components we have delivered but not yet invoiced to customers. We expect to invoice and collect all unbilled accounts receivable within twelve months. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation. <ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="TextSelection-FDDFDCF009565D06B9DFB0C51585DD56-0-wk-Fact-4ECE56E81788A2FAC92AB0C76B61F54A" continuedAt="TextSelection-FDDFDCF009565D06B9DFB0C51585DD56-1" escape="true">The table below shows revenue that we recognized as a result of changes in the contract liability balances in the periods shown.</ix:nonNumeric></span></div><ix:continuation id="TextSelection-FDDFDCF009565D06B9DFB0C51585DD56-1"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenue recognized in the period from:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts included in contract liabilities at the beginning of the period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e2496-wk-Fact-F70F760DF8EA594DAA2491498D86F987" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e2515-wk-Fact-69E01A5ACB925859814D12D5419EC9C9" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our performance obligations are generally satisfied within 12 months of the initial contract date. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, the deferred revenue balance related to performance obligations that will be satisfied after 12 months was </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37409491e2530-wk-Fact-9679AC80953F5A7DBFB9B0EF049FFA2D" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.1</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">. and is included in other long-term liabilities on our consolidated balance sheets. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">, we had </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e2538-wk-Fact-D30A7502FCE2DE5BDC40B0EF2039187F" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="FI2018Q4" unitRef="usd" decimals="INF" scale="6" format="ixt-sec:numwordsen">no</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> deferred revenue balance related to performance obligations that will be satisfied after 12 months.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred cost of sales</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred cost of sales are associated with sales for which revenue recognition criteria are not met but product has shipped and released from inventory. Deferred cost of sales are included in prepaid and other current assets in our consolidated balance sheets. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Incentive compensation costs</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37409491e2554-wk-Fact-45F813168E4F913D1FC7EB34A8185026" name="dxcm:AmortizationPeriodForIncentiveCompensationCosts" contextRef="FD2019Q4YTD" format="ixt-sec:durwordsen">one year</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> or less. We record these costs in selling, general and administrative expense in our consolidated statement of operations. </span></div></ix:continuation><ix:nonNumeric contextRef="FD2019Q4YTD" name="dxcm:ProductShipmentCostsPolicyTextBlock" id="TextSelection-FF5837F21C1024C77913B0BEC4AEF76F-0-wk-Fact-866F1A20CF718019EA45B0BF8AE6895F" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:18%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Product Shipment Costs</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We record the amounts we charge our customers for the shipping and handling of our products in revenue and we record the related costs as cost of sales in our statements of operations.</span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-15</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-6" continuedAt="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-7"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="TextSelection-B18B3D0BD1008F62FC99EB34A874582A-0-wk-Fact-5BB2EEAD21DD12F68A6AEB34A7EE38DE" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:18%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Research and Development</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We expense costs of research and development as we incur them. Our research and development expenses primarily consist of engineering and research expenses related to our continuous glucose monitoring technology, clinical trials, regulatory expenses, quality assurance programs, materials and products for clinical trials. Research and development expenses primarily consist of employee compensation, including salary, fringe benefits, share-based compensation, and temporary employee expenses. We also incur significant expenses to operate our clinical trials that include clinical site reimbursement, clinical trial product, and associated travel expenses. Our research and development expenses also include fees for design services, contractors, and development materials.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our CGM systems include certain software that we develop. We expense software development costs as we incur them until technological feasibility has been established, at which time we capitalize development costs until the product is available for general release to customers. To date, our software has been available for general release concurrent with the establishment of technological feasibility and, accordingly, we have not capitalized any development costs. </span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="TextSelection-DA4549FC193BFDEB2CB8EB34A8734A5A-0-wk-Fact-44F6B7A2E8C6B7F9AF6AEB34A81AE837" continuedAt="TextSelection-DA4549FC193BFDEB2CB8EB34A8734A5A-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Advertising Costs</span></div></td></tr></table></div></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><ix:continuation id="TextSelection-DA4549FC193BFDEB2CB8EB34A8734A5A-1">We expense advertising costs as we incur them to selling, general and administrative expenses.</ix:continuation> Advertising expense was </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37409491e2829-wk-Fact-DD9F4BA2719F641AAAD6EB34A7EE5285" name="us-gaap:AdvertisingExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">31.8</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37409491e2833-wk-Fact-67711199B0DD45CB1D3DEB34A7EE9FE8" name="us-gaap:AdvertisingExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.4</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37409491e2837-wk-Fact-A8F94257C4095FB4EA2EEB34A818BD6B" name="us-gaap:AdvertisingExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">21.9</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, respectively. </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:LesseeLeasesPolicyTextBlock" id="TextSelection-79500B22805B979BDD0BEB34A8746E6D-0-wk-Fact-B276F0E6BFC03D246245EB34A7EE9DFC" continuedAt="TextSelection-79500B22805B979BDD0BEB34A8746E6D-1" escape="true"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:18%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Leases</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></ix:nonNumeric></div><ix:continuation id="TextSelection-79500B22805B979BDD0BEB34A8746E6D-1"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We determine if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The interest rate used to determine the present value of the future lease payments is our incremental borrowing rate, because the interest rate implicit in most of our leases is not readily determinable. Our incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in similar economic environments. The operating lease right-of-use asset also includes any lease payments made and excludes lease incentives. We have lease agreements with lease and non-lease components, which are generally accounted for separately. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Variable lease payments that do not depend on a rate or index, payments associated with non-lease components, and costs related to leases with terms of less than 12 months are expensed as incurred.</span></div></ix:continuation><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="TextSelection-0628A6E4A510EC74D8D5EB34A8757502-0-wk-Fact-F4B9DC7612B9B199D2B6EB34A7EE296E" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:18%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Share-Based Compensation</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized straight-line over the requisite service period of the individual grants, which typically equals the vesting period. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We value time-based Restricted Stock Units (&#8220;RSUs&#8221;) at the date of grant using the intrinsic value method. Certain RSUs granted to senior management vest based on the achievement of pre-established performance or market goals.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We estimate the fair value of performance/market-based RSUs at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We update our assessment of the probability that the specified performance criteria will be achieved each quarter and adjust our estimate of the fair value of the performance-based RSUs if necessary. The Monte Carlo methodology that we use to estimate the fair value of market-based RSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the market-based RSUs at the date of grant must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the performance of the specified market criteria. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If any of the assumptions used change significantly, share-based compensation expense may differ materially from what we have recorded in the current period.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We account for forfeitures as they occur by reversing any share-based compensation expense related to awards that will not vest. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-16</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-7" continuedAt="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-8"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:EarningsPerSharePolicyTextBlock" id="TextSelection-A7F40B4E349C43AF9A80EB34A87425CC-0-wk-Fact-5B21521AC60AB73E3410EB34A7EE416E" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Net Income (Loss) Per Share</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> per share attributable to common stockholders is calculated by dividing the </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Potentially dilutive common shares consist of shares issuable from stock options, unvested RSUs, warrants and the 2022 and 2023 Senior Convertible Notes. Potentially dilutive common share equivalents shares from outstanding stock options, warrants and unvested RSUs are determined using the average share price for each period under the treasury stock method. Potentially dilutive shares issuable upon conversion of our 2022 and 2023 Senior Convertible Notes are determined using the if-converted method. </span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="TextSelection-1AE6FA94FA9380F1B5E8B0C3928421F0-0-wk-Fact-679C381E57B08DA9DD42B0C3F429BF4F" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table sets forth the computation of basic and diluted </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> per share for the periods shown.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:61%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3217-wk-Fact-24A3E88E5EEE8AE1DA83EB34A7EE95FB" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">101.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37409491e3236-wk-Fact-0DCCCDB98C2E9FE76ED4EB34A84338F1" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">127.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37409491e3257-wk-Fact-73CC98F00980B0ADC146EB34A862BF96" name="us-gaap:NetIncomeLoss" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">50.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income (loss) per common share</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3417-wk-Fact-DDC1D7D0280028A84DDCEB34A7EECF39" name="us-gaap:EarningsPerShareBasic" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.11</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37409491e3436-wk-Fact-8FDB206D5342C0E1905BEB34A852D12E" name="us-gaap:EarningsPerShareBasic" contextRef="FD2018Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">1.44</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37409491e3457-wk-Fact-3614467630BBCC97FCE7EB34A8525AE6" name="us-gaap:EarningsPerShareBasic" contextRef="FD2017Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.58</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3483-wk-Fact-2431014538102260A524EB34A8433137" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37409491e3502-wk-Fact-14F3DC4B3584F251E8DDEB34A8627C5C" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2018Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">1.44</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37409491e3523-wk-Fact-9CA3C300FF5B6998565EEB34A8520B76" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2017Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.58</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic weighted average shares outstanding</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3611-wk-Fact-AA0440B1DBA856CBABF41ADCFCF1B80E" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">91.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3630-wk-Fact-8A45C3A42C1C5A09984DC22E00A294B9" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">88.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3649-wk-Fact-2DB346FE864C954AF431B0DE8A1D0ABC" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2017Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">86.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dilutive potential common stock outstanding:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options and employee stock purchase plan</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3742-wk-Fact-8E673A6F0FB15846A1D330F05A58DB4D" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3761-wk-Fact-4C7DD23868F25A2AA991140215FFD92E" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3780-wk-Fact-0CEF3157FDF232BB3AA0B0DE8BBE359D" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Restricted stock units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3807-wk-Fact-8AFD717D9BC352A5907BE04DFAFEC4C9" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3826-wk-Fact-4CC42ABD4FF257A99559CB77CAD4A5B8" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3845-wk-Fact-5BA86F682B9525008F1EB0DE8DDA8025" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023 Warrants</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3871-wk-Fact-4E31D73F4F8BCA1A6A12B0E191FC1E8E" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3890-wk-Fact-E6D863524833D51373DEB0E1958F9A2D" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3909-wk-Fact-FE5DAD8ABF5398B0B189B0E198F6984F" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022 senior convertible notes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3935-wk-Fact-26F24A7786CA1AD0AE0DB0E19BC199E0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3954-wk-Fact-2BBF8051D05CA1D97F56B0E19EBC96C0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3973-wk-Fact-620CE7A4C5B4C09F535DB0E1A2B1C5B4" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023 senior convertible notes</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e3999-wk-Fact-7F1C26297A1FEB5208D9B0E1A52D6280" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4018-wk-Fact-0D1ED67B87929493AF3DB0E1A82CB8B7" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4037-wk-Fact-3633EA1495BEE4EC85FCB0E1AB5A7906" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted weighted average shares outstanding</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4063-wk-Fact-891794900913568DB10F3FCA89C0115D" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">92.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4082-wk-Fact-2C5F09467A8B6B26ED3E174A94500918" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">88.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4101-wk-Fact-42473C8A865D15F1338EEB34A8626C17" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2017Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">86.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In periods of net losses, we exclude potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="TextSelection-B8C92693A8212EAEF3CEEB34A8740A97-0-wk-Fact-2DFCADCF476D0E0504BFEB34A7EEBCF7" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outstanding anti-dilutive securities not included in the diluted </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> per share attributable to common stockholders calculations were as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:62%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options outstanding to purchase common stock</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4245-wk-Fact-F53D91D8B901D40ED459EB34A8249BC5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4259-wk-Fact-FAACBCCA7C5F1B0F616BEB34A8436087" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4273-wk-Fact-76FA15CA9104692AF7BCEB34A843C8AA" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unvested restricted stock units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4288-wk-Fact-2ECC2061E94022F28BCFEB34A862C095" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4302-wk-Fact-8FC1F604EFCC0C61AE72EB34A852312F" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">2.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4316-wk-Fact-91F87894A616C84654A0EB34A8332DE4" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">2.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023 Warrants</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4331-wk-Fact-E75DFE7C17620E3DDFEBEB34A825D062" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">5.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4345-wk-Fact-7E7C355D857616B8C053EB34A8434085" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">5.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4359-wk-Fact-8607F287E651A1F2D725EB34A825CC62" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior convertible notes due 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4374-wk-Fact-1384BA62AA66E0D56EBDEB34A81C39CD" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4388-wk-Fact-D06A7A99036EAF5F1C5DEB34A8435621" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4402-wk-Fact-861F13D0C2952A483D82EB34A81CDCAF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior convertible notes due 2023</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4417-wk-Fact-2BE1CF64831411AA210CEB34A82493A4" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">5.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4431-wk-Fact-FA86E824EC76321A7DBDEB34A8333EAC" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">5.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4445-wk-Fact-4BF496BB2D6CEC29C858EB34A833C389" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4460-wk-Fact-9C6D853DBF5EEFB2A306EB34A825420A" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">14.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4474-wk-Fact-BB337E5A76D9853C5979EB34A8622C63" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">17.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37409491e4488-wk-Fact-F2B4A256E91CB33DDF2AEB34A81BE2DD" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2017Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">7.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-17</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="TextSelection-2BFEE33513F1839FFA05EB34A87688C1-0-wk-Fact-319DD7476572278787E6EB34A7FE89D6" continuedAt="TextSelection-2BFEE33513F1839FFA05EB34A87688C1-1" escape="true"><ix:continuation id="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-8" continuedAt="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-9"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:18%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Recent Accounting Guidance</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted Accounting Pronouncements</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</span><span style="font-family:inherit;font-size:10pt;"> (ASU 2016-02), which requires a lessee to recognize most leases on the consolidated balance sheet as lease liabilities with corresponding right-of-use assets. </span><span style="font-family:inherit;font-size:10pt;color:#252525;">We adopted ASU&#160;2016-02 utilizing the modified retrospective transition method at the beginning of the first quarter of 2019. </span><span style="font-family:inherit;font-size:10pt;">See Note 6, &#8220;Leases and Other Commitments&#8221; for more information on the impact of our adoption of ASU 2016-02 and related disclosures.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">In August 2017, the FASB issued ASU No. 2017-12, </span><span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Derivatives and Hedging </span><span style="font-family:inherit;font-size:10pt;color:#252525;">(ASU 2017-12), which is intended to more closely align hedge accounting with companies&#8217; risk management strategies, simplify the application of hedge accounting, and increase transparency regarding the scope and results of hedging programs. The guidance in this update is applied using a cumulative-effect adjustment to retained earnings at the beginning of the fiscal year of adoption. ASU 2017-12 is effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Our adoption of ASU 2017-12 at the beginning of the first quarter of 2019 did not have a significant impact on our consolidated financial statements. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments - </span><span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Credit Losses: Measurement of Credit Losses on Financial Instruments</span><span style="font-family:inherit;font-size:10pt;color:#252525;">, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available-for-sale debt securities. This update is effective for annual periods beginning after December 15, 2019, and interim periods within those periods, and early adoption is permitted. </span><span style="font-family:inherit;font-size:10pt;">W</span><span style="font-family:inherit;font-size:10pt;color:#252525;">e expect to adopt the standard on its effective date in the first quarter of 2020. We believe the adoption will modify the way we analyze financial instruments, but currently do not expect the adoption to have a material financial impact on our consolidated financial statements. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">In January 2017, the FASB issued ASU No. 2017-04, </span><span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Intangibles &#8211; Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment </span><span style="font-family:inherit;font-size:10pt;color:#252525;">(ASU 2017-04). This new guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit&#8217;s carrying amount over its fair value. ASU 2017-04 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We do not expect the adoption to have a material financial impact on our consolidated financial statements. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-13,&#160;</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement: Disclosure Framework </span><span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">&#8211;</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Changes to the Disclosure Requirements for Fair Value Measurement </span><span style="font-family:inherit;font-size:10pt;">(ASU 2018-13), which&#160;adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance,&#160;entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public business entities will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. ASU 2018-13 is effective for public business entities for fiscal years beginning after December&#160;15, 2019, including interim periods within those fiscal years, and early adoption is permitted.&#160;</span><span style="font-family:inherit;font-size:10pt;color:#252525;">We do not expect the adoption to have a material financial impact on our consolidated financial statements. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">In August 2018, the FASB issued ASU No. 2018-15, </span><span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Intangibles - Goodwill and Other &#8211; Internal-Use Software: Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract</span><span style="font-family:inherit;font-size:10pt;color:#252525;"> (ASU 2018-15). This new guidance </span><span style="font-family:inherit;font-size:10pt;">requires a customer in a cloud computing arrangement to determine which implementation costs to capitalize as assets or expense as incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. </span><span style="font-family:inherit;font-size:10pt;color:#252525;">ASU 2018-15 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Application of this guidance can be applied either prospectively or retrospectively. We will adopt the new standard on January 1, 2020 on a prospective basis. We do not expect the adoption to have a material financial impact on our consolidated financial statements, however, the adoption of this standard will result in an increase in capitalized assets related to qualifying cloud computing arrangement implementation costs incurred after the adoption date.</span></div></ix:continuation></ix:nonNumeric><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-18</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-2BFEE33513F1839FFA05EB34A87688C1-1"><ix:continuation id="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-9"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In December 2019, the FASB issued&#160;ASU&#160;No. 2019-12, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Simplifying the Accounting for Income Taxes,</span><span style="font-family:inherit;font-size:10pt;"> which is intended to simplify various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years, and early adoption is permitted. </span><span style="font-family:inherit;font-size:10pt;color:#252525;">We are currently evaluating the impact that this guidance will have on our consolidated financial statements.</span></div></ix:continuation></ix:continuation><div><a id="s95D77ADDD6115C08911389E9C97C6DAA"></a></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="dxcm:DevelopmentAndOtherAgreementsTextBlock" id="TextSelection-CD490ADE909143F5D1D0EB34A876AEF0-0-wk-Fact-40B44FD7AA31D29F4749EB34A85299FD" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">2. Development and Other Agreements</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Collaboration with Verily Life Sciences</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On November 20, 2018, we entered into an Amended and Restated Collaboration and License Agreement with Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited (collectively, Verily), which we refer to as the Restated Collaboration Agreement. This replaced our original Collaboration and License Agreement with Verily dated August 10, 2015, as amended in October 2016, including the royalty obligations provisions under that original agreement. Pursuant to the Restated Collaboration Agreement, we and Verily have agreed to continue to jointly develop a certain next-generation CGM product, and potentially one or more additional CGM products, for which we will have exclusive commercialization rights. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The </span><span style="font-family:inherit;font-size:10pt;">Restated Collaboration Agreement</span><span style="font-family:inherit;font-size:10pt;"> also provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside of the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#8217;s other intellectual property rights to develop, manufacture and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities. The Restated Collaboration Agreement requires us to use commercially reasonable efforts to develop, launch and commercialize the CGM product(s) that are the subject of the collaboration according to certain timing and other objectives, and provides for one executive sponsor from each of DexCom and Verily to meet periodically and make decisions related to the collaboration (within a limited scope of authority) by consensus.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In consideration of Verily&#8217;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we have made upfront and incentive payments and we will make potential future milestone payments upon the achievement of certain goals. In the fourth quarter of 2018, we made an initial payment of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37396687e618-wk-Fact-29EFD642390838010598EB34A82D4387" name="dxcm:CollaborativeArrangementUpfrontFee" contextRef="I2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementInitialPaymentMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">250.0</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> through the issuance of </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396687e622-wk-Fact-6DE34CFAE0A5A31414D4EB34A814FB88" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="D2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementInitialPaymentMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">1,840,943</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock. We recorded a </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37396687e626-wk-Fact-63300AE0004A5D2BCE45EB34A8332011" name="dxcm:CollaborativeResearchAndDevelopmentFee" contextRef="FD2018Q4YTD_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementInitialPaymentMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">217.7</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> charge in our consolidated statement of operations during 2018 relating to the issuance of this common stock because this milestone payment did not meet the capitalization criteria. The amount of the charge was based on our closing stock price of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37396687e630-wk-Fact-D885B294EBA1982693C1EB34A81595CB" name="us-gaap:SharePrice" contextRef="I2018Q4December28_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementInitialPaymentMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember" unitRef="usdPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">118.28</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> per share on December 28, 2018, the date on which we obtained the necessary regulatory approvals and the transaction closed. During </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, we made an incentive payment of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37396687e639-wk-Fact-658B172608016C008C49CA4A35C49FAB" name="dxcm:CollaborativeResearchAndDevelopmentFee" contextRef="FD2019Q4YTD_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.2</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> due to the completion of certain development obligations and recorded as research and development in the consolidated statement of operations. Additional milestone payments of up to a total of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37396687e643-wk-Fact-884EB80CAEFB78804B40EB34A81359D6" name="dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments" contextRef="I2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">275.0</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> may become due and payable by us upon the achievement of future development, product regulatory approval and revenue milestones. These payments may be paid in cash or shares of our common stock, at our election. If we elect to make all </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37396687e647-wk-Fact-B0940043681F22EFC13FEB34A7FE147E" name="dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestones" contextRef="I2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">275.0</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> of these payments in shares, we will issue a total of </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37396687e651-wk-Fact-D2632106FAECEF19E965EB34A8172C4D" name="dxcm:PotentialFutureCommonStockIssuableSharesNewIssues" contextRef="FI2019Q4_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">2,025,036</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock, based on the volume weighted average trading price during the </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37396687e655-wk-Fact-FAF614BF2E8814CF52B1EB34A8438D22" name="dxcm:WeightedAverageSharePriceConsecutiveDaysEvaluated" contextRef="D2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember" format="ixt-sec:durday">15</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> consecutive days ending on the date of the Restated Collaboration Agreement. Alternatively, if we elect to make all </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37396687e659-wk-Fact-B0940043681F22EFC13FEB34A7FE147E" name="dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestones" contextRef="I2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">275.0</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> of these payments in cash, any such cash payment would be equal to the number of shares that would otherwise be issued for the given milestone payment multiplied by the value of our stock on the date the relevant milestone is achieved, adjusted for stock splits, dividends, and the like.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Restated Collaboration Agreement will continue until December 31, 2028, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party. Upon achievement of the first revenue milestone event and payment of the corresponding milestone fee by us, the term of the Restated Collaboration Agreement will be extended until December 31, 2033.</span></div></ix:nonNumeric><div><a id="s7DCEECDCBCB554C28DAC3CA3F63D88F7"></a></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="TextSelection-6C7F04AB78022E2C9D75EB34A876FAB1-0-wk-Fact-C307770E9BDF20827440EB34A83360AA" continuedAt="TextSelection-6C7F04AB78022E2C9D75EB34A876FAB1-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">3. Fair Value Measurements</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.</span></div></ix:nonNumeric><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-19</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-6C7F04AB78022E2C9D75EB34A876FAB1-1" continuedAt="TextSelection-6C7F04AB78022E2C9D75EB34A876FAB1-2"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement date, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values of our Level 2 marketable securities portfolio balance provided by our investment managers.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="TextSelection-09E894ED52AA6A8B8F54EB34A876C0EE-0-wk-Fact-4AB480C632FD335459BEEB34A833E1E8" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes financial assets that we measured at fair value on a recurring basis as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, classified in accordance with the fair value hierarchy:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:49%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements Using</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e786-wk-Fact-5DA7300368FD526DB305F46BFC68AEAC" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">110.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e805-wk-Fact-24DC71B9F33E5860909415F69536924B" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">144.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e824-wk-Fact-4471594EF2AF5D468C689ACEFF75F9D8" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e844-wk-Fact-DBD46E6F8BC3F0462BEBEB34A7FEB6BA" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">255.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. government agencies</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1023-wk-Fact-CCE5CDE30BE652BE8F17171F89ED71D9" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1042-wk-Fact-C699733AB23A561592353AB6F9D45FBA" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">676.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1061-wk-Fact-ABC8B8E4CD895B73ACE7B7613BCE650B" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1081-wk-Fact-8DEA67E07E0D1F5B9780EB34A7FE0800" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">676.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1101-wk-Fact-1DA53FFB66175095B84DB4FAEE367722" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1120-wk-Fact-716B2D0E44515A3684F033FBF4E85FA1" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">248.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1139-wk-Fact-08B1088FAD1155C490A5A1FD2C23DA47" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1159-wk-Fact-9E3246AEAE89AB269B47EB34A7FEDCEB" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">248.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1179-wk-Fact-07ADC57C6E7B53F5BF8E4FF2103B273D" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1198-wk-Fact-B20325E17EAA556E8226B630ADC6EF98" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">162.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1217-wk-Fact-D409A2F0E5535B1DAC40B9641A393111" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1237-wk-Fact-22D7F77DF4ED116010E0EB34A7FE3CB7" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">162.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1257-wk-Fact-9B4F33FC26115C438A46EB34A7FE1620" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1276-wk-Fact-69E0E58516B8BC402795EB34A7FE0CB9" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,087.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1295-wk-Fact-727F1E35E692A3BB0009EB34A7FEDBF6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1315-wk-Fact-51F5DEE4B0DD62E8AF91EB34A7FE41EB" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,087.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1419-wk-Fact-8C3FF9C67C9C69BD4ABED35C8BB1062B" name="us-gaap:OtherAssetsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1438-wk-Fact-2654D0B00E3506740479D35C8BF0D76E" name="us-gaap:OtherAssetsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1457-wk-Fact-0FEE44C29D527381E5D0D35C8BAD23A3" name="us-gaap:OtherAssetsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1477-wk-Fact-F8D585405301F68A4133D35C8C461AED" name="us-gaap:OtherAssetsFairValueDisclosure" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value on a recurring basis</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1585-wk-Fact-AC6D4ABCFCACC0FE35EEEB34A7FE0724" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">110.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1604-wk-Fact-5C61ACFEA9CFE97AD08FEB34A7FEB887" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,232.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1623-wk-Fact-BBCA5D3990CF0936B064EB34A7FE7E27" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1643-wk-Fact-DF5972FC0F1AE2F87B04EB34A7FE7CE8" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,342.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></span><span style="font-family:inherit;font-size:10pt;">Includes assets which are held pursuant to a deferred compensation plan for our executives, which consist mainly of mutual funds. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes financial assets that we measured at fair value on a recurring basis as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">, classified in accordance with the fair value hierarchy:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:49%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements Using</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1871-wk-Fact-B5CAB4A9AD2457B8A82FDE4162612D10" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">199.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1890-wk-Fact-826E650A12C151619B517B544FC33FDE" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">66.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1909-wk-Fact-58CDF9CBC6E0BBAB39FFEB34A7EE4FDE" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e1929-wk-Fact-8FF9E03FDF806C6E108FEB34A7EEFAB7" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">266.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity investment in Tandem Diabetes Care, Inc.</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2026-wk-Fact-F475380FEDBE5D0E9A50D7D58896F67E" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">38.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2045-wk-Fact-27DDC11D423E4A6764AAEB34A7EE83C0" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2064-wk-Fact-C8D8137D92D777344B2CEB34A82D86E0" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2084-wk-Fact-3FA63D201E0F211753C1B4BD74720685" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">38.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. government agencies</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2268-wk-Fact-391AA885ED49F4625E77EB34A82F93D8" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2287-wk-Fact-84A8FAF9EBF65D8287B7C29ED0AAD841" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">173.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2306-wk-Fact-C950A9E1C46B2AA4A1E6EB34A7EEE0ED" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2326-wk-Fact-54FB6FEEEC285B16FC0BEB34A82C8A26" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">173.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2346-wk-Fact-81F6B1515F99CE219457EB34A7EE7837" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2365-wk-Fact-754404DC33B1528C9E699D3977932DFE" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">36.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2384-wk-Fact-907B92EF614458CF4B4CEB34A7EEBFB0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2404-wk-Fact-E3C30EBA1EC77B8BC70DEB34A82D4A12" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">36.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2424-wk-Fact-DB436C171C93533ECCF2EB34A82B9903" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2443-wk-Fact-D8C9C4A0EAEA5B53882F591B47C2D3F6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2462-wk-Fact-CA2E5E89F5153D776DCEEB34A82E05CE" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2482-wk-Fact-CFEDE8F3A43E420B1CD6EB34A82C3CD6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2502-wk-Fact-679981B571E517CEB055EB34A82E5BD0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2521-wk-Fact-C5D37F3D8C08B1DE7F88EB34A7EE0FF3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">210.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2540-wk-Fact-726932A3351EC5C1209DEB34A82CBB31" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2560-wk-Fact-1773E0B34BE9A54263C4EB34A7EEB3BF" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">210.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value on a recurring basis</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2668-wk-Fact-C74BF7BB28AD353D0165EB34A82D68F0" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">237.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2687-wk-Fact-A449E7FDC34851F85C7BEB34A7EED5DE" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">277.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2706-wk-Fact-D1E60A2CE8CF28099041EB34A82CF9EC" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2726-wk-Fact-1170073264F54BEA9952EB34A7EEEDFA" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">514.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There were </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2739-wk-Fact-EB2D6B2F9943561ABD7FA3CB49960801" name="us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount" contextRef="FI2019Q4" unitRef="usd" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> transfers between Level 1 and Level 2 securities during the years ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">. There were </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2751-wk-Fact-1B79905AEA365A06AD4F93A23B0837D2" name="dxcm:FairValueAssetsLevel3TransfersAmount" contextRef="FI2019Q4" unitRef="usd" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> transfers into or out of Level 3 securities during the years ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">.</span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-20</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-6C7F04AB78022E2C9D75EB34A876FAB1-2" continuedAt="TextSelection-6C7F04AB78022E2C9D75EB34A876FAB1-3"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments are not significant and we include them in other assets in our consolidated balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are often privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant adverse effect on the fair values.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value of Senior Convertible Notes</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" id="TextSelection-CEC6548F9109D306DCEDB4B1AD70DCF6-0-wk-Fact-F2FC68CA13A5AEF4267DB4B251956422" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fair value, based on trading prices (Level 1), of our Senior Convertible Notes were as follows as of the dates indicated:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements Using Level 1</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2885-wk-Fact-9BF500809D2B5E359F5E59E6366745DE" name="us-gaap:ConvertibleDebtFairValueDisclosures" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">890.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2904-wk-Fact-E21904D554F15E79B4F34DA6F3B194A5" name="us-gaap:ConvertibleDebtFairValueDisclosures" contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">540.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2919-wk-Fact-42A4F7F889A35BF5BD7AD5A12E500849" name="us-gaap:ConvertibleDebtFairValueDisclosures" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,260.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2938-wk-Fact-53A780F2E6965FE28269B49BFF9134A2" name="us-gaap:ConvertibleDebtFairValueDisclosures" contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">859.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total fair value of outstanding senior convertible notes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2963-wk-Fact-A700319DB239E2457A14B4B4404DA039" name="us-gaap:ConvertibleDebtFairValueDisclosures" contextRef="FI2019Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,150.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e2982-wk-Fact-A0F5CED9BE9F7E9FDA4BB4B444A9E262" name="us-gaap:ConvertibleDebtFairValueDisclosures" contextRef="FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,399.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For more information on the carrying values of our 2022 Notes and 2023 Notes, see Note 5, &#8220;Debt.&#8221;</span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency and Derivative Financial Instruments</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">From time to time we engage in limited hedging transactions to reduce foreign currency risks. The fair values of these derivatives are based on quoted market prices, which are Level 1 inputs, and the derivative instruments are recorded in current assets or current liabilities in our balance sheets consistent with the nature of the instrument at period end. Derivative gains and losses are included in </span><span style="font-family:inherit;font-size:10pt;">interest and other income, net</span><span style="font-family:inherit;font-size:10pt;"> in our consolidated statement of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, a notional amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37405250e3009-wk-Fact-3B3EAD16B3C11AA65306AB54E66D8985" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.0</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> was outstanding to hedge currency risk relating to certain intercompany balances. The resulting impact from the hedging activity on our consolidated financial statements was not significant for the year ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">, a notional amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37405250e3024-wk-Fact-367D4465C4EF8BEDDEF3AB53A616B0AA" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2018Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">60.0</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> was outstanding to hedge currency risk relating to certain intercompany balances. Derivative instrument gains on forward exchange contracts were </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37405250e3028-wk-Fact-E36F06D57F11E5895A33AB53F00928D4" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> for the twelve months ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">. The fair value of the forward contract exchange derivative instrument liability was </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37405250e3036-wk-Fact-FF67A504BEC1323DC6E2AB54408FAD50" name="us-gaap:DerivativeInstrumentsAndHedgesLiabilities" contextRef="FI2018Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">. We entered into no foreign currency forward contracts during </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our foreign currency exposures vary but are primarily concentrated in the British Pound, the Euro, and the Canadian Dollar. We monitor the costs and the impact of foreign currency risks upon our financial results as part of our risk management program. We do not use derivative financial instruments for speculation or trading purposes or for activities other than risk management. We do not require and are not required to pledge collateral for these financial instruments and we do not carry any master netting arrangements to mitigate the credit risk. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</span></div></ix:continuation><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><ix:continuation id="TextSelection-6C7F04AB78022E2C9D75EB34A876FAB1-3" continuedAt="TextSelection-6C7F04AB78022E2C9D75EB34A876FAB1-4"><span style="font-family:inherit;font-size:10pt;">In accordance with authoritative guidance, we measure certain non-financial assets and liabilities at fair value on a non-recurring basis. These measurements are usually performed using the discounted cash flow method and Level 3 inputs. These include items such as non-financial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment. In general, non-financial assets, including goodwill, intangible assets, and property and equipment, are measured at fair value when there are indicators of impairment and are recorded at fair value only when any impairment is recognized. We recorded </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37405250e3058-wk-Fact-EC75AE47FE5F6E66497DEB34A7EE842C" name="us-gaap:GoodwillAndIntangibleAssetImpairment" contextRef="FD2019Q4YTD" unitRef="usd" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> significant impairment losses during the twelve months ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span></ix:continuation><span style="font-family:inherit;font-size:10pt;"><ix:continuation id="TextSelection-6C7F04AB78022E2C9D75EB34A876FAB1-4">.</ix:continuation> </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-21</span></div></div><hr style="page-break-after:always"></hr><div><a id="s96FE6B5723F856C3A43E8CA0A605A534"></a></div><div><br/></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="TextSelection-89907D14310DA68B2743EB34A876304B-0-wk-Fact-6A19B728C570FB7E8C97EB34A8333194" continuedAt="TextSelection-89907D14310DA68B2743EB34A876304B-1" escape="true"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">4. Balance Sheet Details</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Short-Term Marketable Securities</span></div></td></tr></table></div></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="TextSelection-7EA84118998B1C7C956AEB34A877205F-0-wk-Fact-D8996FDD712494F01DDBEB34A8330844" escape="true"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term marketable securities, consisting of equity securities and debt securities, were as follows as of the dates indicated:</span><span style="font-family:inherit;font-size:9pt;">&#160;&#160;</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:45%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gains</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Losses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Estimated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Market</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. government agencies</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e924-wk-Fact-97EAF2FFAC2C53818ED8D14DF1FC1C8D" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">675.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e943-wk-Fact-065C4F91BD485526BD3732F3D06B0676" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e962-wk-Fact-AB559856A74750EE8526CC24FAB09D5D" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e982-wk-Fact-8DEA67E07E0D1F5B9780EB34A7FE0800" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">676.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e997-wk-Fact-1EF822123514536DA6E56254E2FB5EC4" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">248.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1016-wk-Fact-370D0A9EF8A75A7A95E0A73F7758BB1B" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1035-wk-Fact-CCC39754F9DD5AB49733EB37916D25DA" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1055-wk-Fact-9E3246AEAE89AB269B47EB34A7FEDCEB" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">248.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate debt</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1075-wk-Fact-F83C3574CD4D5DFD8383331141CFD2AB" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">163.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1094-wk-Fact-916D191AD276598EA068D0047AF5857A" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37415254e1113-wk-Fact-3FB3153A2DCB5758A666873723149B39" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1134-wk-Fact-22D7F77DF4ED116010E0EB34A7FE3CB7" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">162.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1159-wk-Fact-B051291D6C07CABF6EBDEB34A7EE6458" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,086.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1178-wk-Fact-4649118511D7FE4606C8EB34A81415F2" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37415254e1197-wk-Fact-7E1FD7D190C712F5AB09EB34A8626A48" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1218-wk-Fact-51F5DEE4B0DD62E8AF91EB34A7FE41EB" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,087.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:45%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gains</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Losses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Estimated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Market</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity investment in Tandem Diabetes Care, Inc</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1446-wk-Fact-A83CD54985085C73B27EE2BE6D89515D" name="us-gaap:EquitySecuritiesFvNiCost" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1465-wk-Fact-AFEB585643F450B4B67504F2C034FC6E" name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">36.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1484-wk-Fact-DD94DBF71ADB5042BF99E6ADF420C91E" name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1504-wk-Fact-1013DA42D77D67A4B250EB34A7EE222E" name="us-gaap:EquitySecuritiesFvNi" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">38.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. government agencies</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1688-wk-Fact-902AF197DF0C5ADD85632E09BB648F31" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">173.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1707-wk-Fact-1958AA6D83D05BF6A613711EEBA850D8" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37415254e1726-wk-Fact-A48AF8241D2754C5B6627EF107297F70" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1747-wk-Fact-54FB6FEEEC285B16FC0BEB34A82C8A26" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">173.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1762-wk-Fact-5EBB83C5A7035691A191AAA093E4A3C8" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">36.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1781-wk-Fact-BF2EBC3ADA075996B7BA79DC8CD95FCA" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1800-wk-Fact-158595D3835556C3BC884F45153CE076" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1820-wk-Fact-E3C30EBA1EC77B8BC70DEB34A82D4A12" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">36.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1840-wk-Fact-2FF37B63B5105E3C84C5FAB4865B0380" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1859-wk-Fact-C859C75339EE55109F23E6E4D512D99D" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1878-wk-Fact-DD43319374A854509DCCEAC64CB0BD5C" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1898-wk-Fact-CFEDE8F3A43E420B1CD6EB34A82C3CD6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1923-wk-Fact-D9DFBB55DBA5125EE87FEB34A7FEFA93" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">210.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1942-wk-Fact-3CE3E61E7621F9182A12EB34A7FEBC39" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37415254e1961-wk-Fact-8DEDC756155D24D15F4AEB34A7EEE6CE" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e1982-wk-Fact-1773E0B34BE9A54263C4EB34A7EEB3BF" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">210.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total marketable securities </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e2084-wk-Fact-E6C7BF857726D0D16816EB34A7FE0501" name="dxcm:DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">212.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e2103-wk-Fact-081C2EF8C4AABD12C985EB34A7FECC4F" name="dxcm:DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">36.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37415254e2122-wk-Fact-0AE8F98BEF995B7B821BEB34A7FE0013" name="dxcm:DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e2143-wk-Fact-2D4754244E03538BA709DA0E74E53486" name="dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">248.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, all of our debt securities had contractual maturities of less than </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37415254e2169-wk-Fact-2B837C26F3D05A149EF35FDF8C871C24" name="us-gaap:DebtSecuritiesAvailableForSaleTerm" contextRef="FI2019Q4" format="ixt-sec:durwordsen">twelve months</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;">. Gross realized gains and losses on our debt securities for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> were not significant. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We periodically review our portfolio of debt securities to determine if any investment is other-than-temporarily impaired due to changes in credit risk or other potential valuation concerns. We believe that the investments we held at </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> were not other-than-temporarily impaired. Unrealized losses on available-for-sale debt securities at that date were not significant and were due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:GainLossOnInvestmentsTextBlock" id="TextSelection-9B3CA01AD5E705889057EB34A877DF2F-0-wk-Fact-B8C19AC03CEB17F347F3EB34A833210E" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table reconciles the net gain recognized on equity securities during the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> to the unrealized gain recognized during those periods on equity securities still held at the reporting dates.</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:59%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended&#160;<br/>&#160;December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net gains and losses recognized during the period on equity securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37415254e2376-wk-Fact-84D262FE1402AF794642174A943CE9B2" name="us-gaap:DebtAndEquitySecuritiesGainLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e2396-wk-Fact-AE15260499DB5316983B3D2E988B107C" name="us-gaap:DebtAndEquitySecuritiesGainLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">80.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e2415-wk-Fact-5ACB75D07BA38562950CEB34A85248FB" name="us-gaap:DebtAndEquitySecuritiesGainLoss" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Net gains and losses recognized during the period on equity securities sold during the period</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e2431-wk-Fact-7317DF40B1055C2985B9AF42FBB32864" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37415254e2450-wk-Fact-CBABBF72436A5EFCA4B4A55ABF8DF80B" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">44.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e2470-wk-Fact-4DBAFAE09463A93B8FE3EB34A833B596" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrealized gains recognized during the reporting period on equity securities still held at the reporting date</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e2496-wk-Fact-9563877633EC5AC3460BEB34A833277C" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e2515-wk-Fact-12AF46BD79BA2C8CB02CEB34A8337DF8" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">36.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e2534-wk-Fact-C720FCAA72413BFC9CDEEB34A833181F" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:nonNumeric><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-22</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-89907D14310DA68B2743EB34A876304B-1" continuedAt="TextSelection-89907D14310DA68B2743EB34A876304B-2"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:18px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Accounts Receivable</span></div></td></tr></table></div></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="TextSelection-9ED437146B53A35027D3EB34A877FBB3-0-wk-Fact-738508862D104AE4CB76EB34A8319911" escape="true"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e2702-wk-Fact-92F9D45FA8126E4AB9FAEB34A843F597" name="us-gaap:AccountsReceivableGross" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">292.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e2721-wk-Fact-4CFA2C7211A3D2FF0867EB34A843F29D" name="us-gaap:AccountsReceivableGross" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">233.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less allowance for doubtful accounts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37415254e2736-wk-Fact-563972F20C025B1C9B88EB34A84337F6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37415254e2756-wk-Fact-B371ADE755BE18E41D1FEB34A843171D" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total accounts receivable, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e2782-wk-Fact-ACC550047E2AB093E723EB34A843BD6A" name="us-gaap:AccountsReceivableNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">286.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e2801-wk-Fact-AA1FB6A31668BD190189EB34A8438BE9" name="us-gaap:AccountsReceivableNet" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">226.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Inventory</span><span style="font-family:inherit;font-size:9pt;color:#58a618;">&#160;</span></div></td></tr></table></div></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="TextSelection-33061DC45F50361860E5EB34A877D689-0-wk-Fact-39BCDD6F121EEE50F1C7EB34A83181A8" escape="true"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Raw materials</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e2975-wk-Fact-D51D9C7D6C8E55D98938E17204691247" name="us-gaap:InventoryRawMaterialsNetOfReserves" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">64.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e2994-wk-Fact-1C8CC575D4D952C598905C09996B653F" name="us-gaap:InventoryRawMaterialsNetOfReserves" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Work-in-process</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3009-wk-Fact-6A1C4C696C37571CB8B86B8A91693A3C" name="us-gaap:InventoryWorkInProcessNetOfReserves" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3028-wk-Fact-90383F6A3CF25E92815D8E3E4EEFBABD" name="us-gaap:InventoryWorkInProcessNetOfReserves" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished goods</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3048-wk-Fact-94F9BF530D635E7FB2C665C6B3DAD089" name="us-gaap:InventoryFinishedGoodsNetOfReserves" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">43.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3067-wk-Fact-18BD58B3EFAE5D4E8D7D1259B7D39368" name="us-gaap:InventoryFinishedGoodsNetOfReserves" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">28.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total inventory</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3092-wk-Fact-5955DC66290A55438DBD16FF1CD033DF" name="us-gaap:InventoryNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">119.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3111-wk-Fact-75042F3537165827921BCEDFF6FB9129" name="us-gaap:InventoryNet" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">70.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we recorded excess and obsolete inventory charges of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37415254e3137-wk-Fact-CA3800250A7356028AE04F2C9A0246CB" name="us-gaap:InventoryWriteDown" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_dxcm_ReceiverProductComponentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.1</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> in cost of sales as a result of our ongoing assessment of sales demand, inventory on hand for each product and the continuous improvement and innovation of our products. During the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">, we recorded excess and obsolete inventory charges of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37415254e3150-wk-Fact-06077AE6C16B5049AF84592C6A155BC3" name="us-gaap:InventoryWriteDown" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_dxcm_ReceiverProductComponentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.3</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> in cost of sales primarily as a result of the approval and launch of our G6 system and our ongoing assessment of sales demand and the continuous improvement and innovation of our products. </span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Property and Equipment</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="TextSelection-17FE84E3034212576C40EB34A8778BFC-0-wk-Fact-EFD32C798B81326DEC42EB34A8322B96" escape="true"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Building and land </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3311-wk-Fact-91A045A0F3E15A83B768EB498360253C" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3330-wk-Fact-9344FAD9E82A56E4A1C1CC83F0D4C9FF" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Furniture and fixtures</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3345-wk-Fact-6AA7F2DB8F4A5069A775C5102BCA3A7E" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3364-wk-Fact-D450D5B16BC158AFBFD3B3083C39E7A0" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Computer software and hardware</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3384-wk-Fact-9D53120B4D195BB1B95B991A7F102162" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">32.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3403-wk-Fact-A6F22820CAA85A36AB6D5C007543E784" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">29.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Machinery and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3423-wk-Fact-AD5623385A445453BA81B7EA2A3BAE39" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">130.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3442-wk-Fact-FF83706267065EBCB1DAD1F929EB1369" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">80.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leasehold improvements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3462-wk-Fact-E412D3784EA6535D8FD50E83474481D9" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">102.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3481-wk-Fact-E93C620AD8955E37AEBE1106EBDE464F" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">80.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Construction in progress </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3501-wk-Fact-3C6048345F545E0FA01B04B247F72F7F" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">132.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3520-wk-Fact-32DA109DF29653DB9511BD5B4A8C464E" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">57.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3540-wk-Fact-0C76B9D2536240BC2077EB34A7FE0031" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">426.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3559-wk-Fact-F802F0AFE3969BD28C1AEB34A843ADCC" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">262.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less accumulated depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37415254e3579-wk-Fact-E1C1531B09EA5AD88B5E92F0CA456864" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">105.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37415254e3599-wk-Fact-792F45518C5D5714917D8EAEBF878C9E" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">79.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total property and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3625-wk-Fact-6E0096B0001E585FB1501D1E29BCFD4B" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">321.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3644-wk-Fact-4346F1EF4C125EFEA32FB8D88988ADF4" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">183.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Building and Land. </span><span style="font-family:inherit;font-size:10pt;">Although we do not legally own these premises, under previous lease accounting standards we were deemed the owner of the construction project during the construction period of our manufacturing facility in Mesa, Arizona under a build-to-suit lease arrangement. As a result of our adoption of ASC 842, we de-recognized the estimated fair value of the building shell that was included in &#8220;building and land&#8221; in our consolidated balance sheets as of December 31, 2018 and the related lease liability and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019. The </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> balance in &#8220;building and land&#8221; represents our finance lease right-of-use assets as a result of our adoption of ASC 842. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Depreciation expense related to property and equipment for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37415254e3685-wk-Fact-B12293611B82CD563E63EB34A833451D" name="us-gaap:Depreciation" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">46.9</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37415254e3690-wk-Fact-F42A574AF2AD51A04345EB34A862A738" name="us-gaap:Depreciation" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">28.6</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37415254e3694-wk-Fact-9E188DF33757DD512291EB34A83132BA" name="us-gaap:Depreciation" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.1</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> Loss on disposal of property and equipment during the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> recorded in operating expenses was </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37415254e3717-wk-Fact-95BD94DE41A8C9BC4BF5EB34A83152D4" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">10.5</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37415254e3722-wk-Fact-9A7373AA7A6B868BA298EB34A8623D94" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">5.4</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37415254e3726-wk-Fact-7276A54ECC49A113EAA7B59CB51324D7" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">11.0</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-23</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-89907D14310DA68B2743EB34A876304B-2"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Accounts Payable and Accrued Liabilities</span><span style="font-family:inherit;font-size:9pt;color:#58a618;">&#160;</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="TextSelection-6B93F38367345C72B33EEB34A8773F3A-0-wk-Fact-F607D41E311D88E854D5EB34A8314EA0" escape="true"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts payable trade</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3917-wk-Fact-8EC3B14E9FAC5CCD914371E9FBC5FA91" name="us-gaap:AccountsPayableTradeCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">102.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3936-wk-Fact-92F563B1F87B5E9F823673AE025DD2AC" name="us-gaap:AccountsPayableTradeCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">75.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued tax, audit, and legal fees</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3951-wk-Fact-EC9927DAC2575446B7AD891A3326D061" name="dxcm:AccruedTaxAuditAndLegalFees" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3970-wk-Fact-6A360E879D5C57EE96DA9050F4D6EC6C" name="dxcm:AccruedTaxAuditAndLegalFees" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued rebates </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e3990-wk-Fact-64B59A9F98C351B8AAE0F89503A55E70" name="dxcm:PharmacyRebates" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">93.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4009-wk-Fact-30CCE2FC1FCE5B71ADA6811E814DE4E5" name="dxcm:PharmacyRebates" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">36.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued warranty</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4029-wk-Fact-BBC336A2E3D05068A1145E93F6256B18" name="us-gaap:StandardProductWarrantyAccrual" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4048-wk-Fact-C6E5D4F8BEA0510A99ED8A1A7184EA03" name="us-gaap:StandardProductWarrantyAccrual" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other accrued liabilities </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4068-wk-Fact-770C8ADF70855DBE92B5D9875069956E" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">39.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4087-wk-Fact-CAA6FCF35F075CF986C72E65F67BF99B" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total accounts payable and accrued liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4112-wk-Fact-D7C5F6E8423EF61C6BA41747E11B5939" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">256.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4131-wk-Fact-9B84C094B74D40D4FF8C1747E0185BAB" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">147.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Restructuring Plan.</span><span style="font-family:inherit;font-size:10pt;"> In February 2019, our Board of Directors approved a restructuring plan that resulted in the transition of certain of our operations to the Philippines. We incurred total pre-tax charges and costs of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37415254e4149-wk-Fact-A2E7DB4C8E8C547498A8759F81BFAF41" name="us-gaap:RestructuringCharges" contextRef="D2019Q4Feb01-Dec31" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.0</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">, primarily for employee severance benefits under both ongoing and one-time benefit arrangements. We incurred most of these costs in the first half of 2019 and the restructuring activities have been substantially completed as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Accrued Warranty</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Warranty costs are reflected in our statements of operations as cost of sales. <ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="TextSelection-B440B61B5282789C26F2EB34A87778BE-0-wk-Fact-42C60CFC736EB78B95FDEB34A82FFCDC" continuedAt="TextSelection-B440B61B5282789C26F2EB34A87778BE-1" escape="true">Reconciliations of our accrued warranty costs for the </ix:nonNumeric></span><ix:continuation id="TextSelection-B440B61B5282789C26F2EB34A87778BE-1" continuedAt="TextSelection-B440B61B5282789C26F2EB34A87778BE-2"><span style="font-family:inherit;font-size:10pt;">twelve</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></ix:continuation></div><ix:continuation id="TextSelection-B440B61B5282789C26F2EB34A87778BE-2"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended </span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4332-wk-Fact-C6E5D4F8BEA0510A99ED8A1A7184EA03" name="us-gaap:StandardProductWarrantyAccrual" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4351-wk-Fact-D51695776549D0787D59EB34A833B90D" name="us-gaap:StandardProductWarrantyAccrual" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges to costs and expenses</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4366-wk-Fact-B3986081666E7DEA102DEB34A833A372" name="dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">32.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4385-wk-Fact-DE6111891FE9078EA723EB34A8338D8B" name="dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Costs incurred</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37415254e4405-wk-Fact-94C3A0D69D09628CD5EFEB34A8336750" name="us-gaap:ProductWarrantyAccrualPayments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">32.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37415254e4425-wk-Fact-4949C75FF3DBA4B48A9FEB34A83333E5" name="us-gaap:ProductWarrantyAccrualPayments" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ending balance</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4451-wk-Fact-BBC336A2E3D05068A1145E93F6256B18" name="us-gaap:StandardProductWarrantyAccrual" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4470-wk-Fact-C6E5D4F8BEA0510A99ED8A1A7184EA03" name="us-gaap:StandardProductWarrantyAccrual" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Other Long-Term Liabilities</span></div></td></tr></table></div></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" id="TextSelection-DCA71D93ECD1C702689BEB34A877034A-0-wk-Fact-D7102A5A6505DF86B076EB34A8329C38" escape="true"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance lease obligations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4633-wk-Fact-15063033A80D527AAA3360F0EC083E14" name="dxcm:FinancingLeaseObligation" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4652-wk-Fact-681094F71A7D5ED2848648381D260269" name="dxcm:FinancingLeaseObligation" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred rent</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4686-wk-Fact-3BAC2E473BFF553BB11DB09C5163C369" name="us-gaap:DeferredRentCreditNoncurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4706-wk-Fact-FE5C8B566A2F530ABB40372B294901EF" name="us-gaap:OtherSundryLiabilitiesNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4725-wk-Fact-61969674E7E15C8F95FB3086DA4F7A99" name="us-gaap:OtherSundryLiabilitiesNoncurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total other liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4750-wk-Fact-48BC2EECC3D82B2A40941747E036D3DB" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">20.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415254e4769-wk-Fact-25A91861877F5862CFD21747E066C461" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">20.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our adoption of ASC 842 during the first quarter of 2019 affected the balances of finance lease liabilities and deferred rent. See Note 6, &#8220;Leases And Other Commitments&#8221; for more information on leases.</span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-24</span></div></div><hr style="page-break-after:always"></hr><div><a id="s72D39785BA275E558225E8D4A26AF500"></a></div><div><br/></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:DebtDisclosureTextBlock" id="TextSelection-A0B78AAE722F9714A85AEB34A877E8A5-0-wk-Fact-D2BC5664FE19135E7244EB34A83372A5" continuedAt="TextSelection-A0B78AAE722F9714A85AEB34A877E8A5-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.51219512195122%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">5. Debt</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:18%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Senior Convertible Notes</span></div></td></tr></table></div></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="TextSelection-84B9E1E746EE95DF0413EB34A878DE00-0-wk-Fact-4D288F34D19717AE9BD6EB34A8433AF2" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The carrying amounts of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2022:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Principal amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e763-wk-Fact-EC0AC27C96E55BE3BC10673FCBA667AB" name="us-gaap:DebtInstrumentFaceAmount" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">400.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e782-wk-Fact-5A5D03632C3A5B8CB8D424A5FBFEDEC9" name="us-gaap:DebtInstrumentFaceAmount" contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">400.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt discount</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37418911e797-wk-Fact-6A6B55A1DFBA570CA31812B1FE10DBC1" name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">37.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37418911e817-wk-Fact-BE5D52EC98AF567CBEDBD6F5D0DE073F" name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">51.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37418911e838-wk-Fact-2F9F6917E2C65FCF8C6E91388259FD9B" name="us-gaap:UnamortizedDebtIssuanceExpense" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37418911e858-wk-Fact-2A8680C181E15D0B92D92F1C9D15F851" name="us-gaap:UnamortizedDebtIssuanceExpense" contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net carrying amount of Senior Convertible Notes due 2022</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e879-wk-Fact-109F125CA0103E956A23EB34A84399FE" name="us-gaap:ConvertibleLongTermNotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">358.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e898-wk-Fact-720E54A67044D3061D06EB34A843B5C7" name="us-gaap:ConvertibleLongTermNotesPayable" contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">342.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2023:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Principal amount</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e1000-wk-Fact-F1B281C2C12E5551A37BD8B53D9F9320" name="us-gaap:DebtInstrumentFaceAmount" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">850.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e1019-wk-Fact-04709CB47B5D5BAA963CF39693E4EFB0" name="us-gaap:DebtInstrumentFaceAmount" contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">850.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt discount</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37418911e1039-wk-Fact-7E65E393AF9D5700BA2CFADEBAD51BCE" name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">140.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37418911e1059-wk-Fact-C4D75478C92D5D5AA9528D0E31180E01" name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">171.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37418911e1081-wk-Fact-02866FFB2C185202BC1686C8E9C45801" name="us-gaap:UnamortizedDebtIssuanceExpense" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37418911e1101-wk-Fact-9227BA3E663D51F2A46477C450F810F1" name="us-gaap:UnamortizedDebtIssuanceExpense" contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net carrying amount of Senior Convertible Notes due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e1122-wk-Fact-A9994552E844F4AC28DFEB34A7FEE70D" name="us-gaap:ConvertibleLongTermNotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">701.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e1141-wk-Fact-3729B8261ACE80427AB8EB34A852038C" name="us-gaap:ConvertibleLongTermNotesPayable" contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">667.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total net carrying amount of senior convertible notes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e1207-wk-Fact-FCFF1D978C43139D9D2FEB34A852D690" name="us-gaap:LongTermDebt" contextRef="FI2019Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,059.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e1226-wk-Fact-EAB878D185012531B888EB34A7FE14E6" name="us-gaap:LongTermDebt" contextRef="FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,010.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Carrying value of equity component of convertible senior notes, net of debt issuance costs</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e1328-wk-Fact-2ECC5C42FF970076F60ECA1B9647ABA7" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">70.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e1347-wk-Fact-DFDEBE515B2120F18F6DCA1B964BA1A1" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">70.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e1367-wk-Fact-A8BADCEB44945C6A7FCCCA1B96530F4B" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">171.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e1386-wk-Fact-54F09D29224CD3368C54CA1B965D7ED3" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">171.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Remaining&#160;amortization&#160;period&#160;of&#160;debt discount&#160;on&#160;the&#160;liability&#160;component</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37418911e1483-wk-Fact-AB1A5076EFE337850403CA1ED60B0B67" name="us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" format="ixt-sec:duryear">2.5</ix:nonNumeric> years</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37418911e1502-wk-Fact-EB296BB43747CF1A68FFCA1ED618C63A" name="us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" format="ixt-sec:duryear">3.5</ix:nonNumeric> years</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37418911e1523-wk-Fact-FF971EDD00A6CF10708ACA1ED612D6CB" name="us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" format="ixt-sec:duryear">4.0</ix:nonNumeric> years</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37418911e1542-wk-Fact-BBE698D4877E12BF7E62CA1ED6246568" name="us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" format="ixt-sec:duryear">5.0</ix:nonNumeric> years</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ConvertibleDebtTableTextBlock" id="TextSelection-19BC3B2F1317325D060BB5A6B29E7311-0-wk-Fact-A7B9E20A781B9A9090D9B5A7310F800F" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The amount by which the notes&#8217; if-converted value exceeds their principal amount is as of the dates indicated:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e1669-wk-Fact-2BBC776187565DC2AA9D2FEA99E0F505" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">486.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e1688-wk-Fact-81DF39BF014C5B9A9337AD85A495B806" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">125.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e1703-wk-Fact-9E88094DCB1157529EF0476C6DE954BB" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">372.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e1722-wk-Fact-D24D15A5823E5A3C96DA48A67FD0955D" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total by which the notes&#8217; if-converted value exceeds their principal amount</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e1747-wk-Fact-9FC918B483E0A36BF691CA1D5518AB88" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" contextRef="FD2019Q4YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">858.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e1766-wk-Fact-6ECC5F7847AD26CA2B29CA1D5CFB6355" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" contextRef="FD2018Q4YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">125.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:nonNumeric><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-25</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-A0B78AAE722F9714A85AEB34A877E8A5-1" continuedAt="TextSelection-A0B78AAE722F9714A85AEB34A877E8A5-2"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" id="TextSelection-135265C51118C7D6FAC2B5A818A4F597-0-wk-Fact-69F862594CDA615F50C2B5A8A788C43B" escape="true"><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;padding-left:0px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown. </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:59%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Interest expense recognized:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2022:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contractual coupon interest</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2062-wk-Fact-74AB2B953CD559BE83940F2A3886EB8C" name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2081-wk-Fact-CDD48AEA76865A89C82AEB34A83397D0" name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2100-wk-Fact-6A795CEB9184C83E2FB0EB34A7EE2631" name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accretion of debt discount </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2118-wk-Fact-68CE36619DB4583D8BDE7DD532D3C626" name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2137-wk-Fact-9707C5D30A1954525B24EB34A7FE541D" name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2156-wk-Fact-4E32A5F8A9AB36C180F2EB34A8334F1C" name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2177-wk-Fact-6180B976FDA55CF99517C3B0849EA8EC" name="us-gaap:AmortizationOfFinancingCosts" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2196-wk-Fact-B42BAF24395256116A31EB34A8433B1E" name="us-gaap:AmortizationOfFinancingCosts" contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2215-wk-Fact-F6EC54B05F86356F6F3CEB34A7FE5CF0" name="us-gaap:AmortizationOfFinancingCosts" contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense recognized on 2022 Notes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2236-wk-Fact-EFC96AA9C5CFD0A946E1EB34A7EED256" name="us-gaap:InterestExpenseDebt" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2255-wk-Fact-74C314B6120EFAC83E3FEB34A83349CC" name="us-gaap:InterestExpenseDebt" contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2274-wk-Fact-3B20342925C1C3FEF0C4EB34A8335FD3" name="us-gaap:InterestExpenseDebt" contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2023:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contractual coupon interest</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2419-wk-Fact-9D6A48C98CA2500D8624E5E6F68D75B3" name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2438-wk-Fact-5073A88F065E850BA9AFEB34A8334DDC" name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2457-wk-Fact-7B877C113CE690362EFFEB34A8332515" name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accretion of debt discount </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2481-wk-Fact-C46AECA75E5158A594389AD6FEC3AC16" name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">31.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2500-wk-Fact-3A99101B264059F25B8FEB34A833884D" name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2519-wk-Fact-C09D4CA60A7151887564EB34A833B07E" name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2540-wk-Fact-BECC146058C15B2E9A20437B5AA2C089" name="us-gaap:AmortizationOfFinancingCosts" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2559-wk-Fact-52E1C77F1513C24C48C2EB34A7FE3898" name="us-gaap:AmortizationOfFinancingCosts" contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2578-wk-Fact-B6752B997A666DC7BC11EB34A7EEB7A2" name="us-gaap:AmortizationOfFinancingCosts" contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense recognized on 2023 Notes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2599-wk-Fact-BB18C9BF3B78DE969B7CEB34A8336859" name="us-gaap:InterestExpenseDebt" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">40.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2618-wk-Fact-1EEC5A10F0650087CBEBEB34A833216F" name="us-gaap:InterestExpenseDebt" contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2637-wk-Fact-331BA2878FD38E193476EB34A83310F0" name="us-gaap:InterestExpenseDebt" contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total interest expense recognized on senior notes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2725-wk-Fact-8155F71833868ED126E6EB34A7EE1E5D" name="us-gaap:InterestExpenseDebt" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">58.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2744-wk-Fact-9105E680EFB9C318646EEB34A7EE85DA" name="us-gaap:InterestExpenseDebt" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">21.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2763-wk-Fact-09B4F6879A049AF99C60EB34A7FE99DA" name="us-gaap:InterestExpenseDebt" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Effective interest rates:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2903-wk-Fact-CF792559275159ABA94CFC4D4ED01556" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">5.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2923-wk-Fact-3C2C4BEB40245B89BFADFC34BBF7B6EC" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">5.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2943-wk-Fact-54325DDC79E3381B3AAFEB34A84392C1" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="FI2017Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">5.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2965-wk-Fact-8E3937E1F4F156F4BD4AA2F78A4F3C51" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">5.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e2985-wk-Fact-7D8FFE96B1451683B03BEB34A7EE24A0" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">5.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3005-wk-Fact-D3262541DE4AF086B9F7EB34A8334D28" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="FI2017Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member" unitRef="number" decimals="3" scale="-2" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)  </sup></span><span style="font-family:inherit;font-size:10pt;">The discount on the 2022 Notes is being amortized through May 15, 2022. Interest on the 2022 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.</span></div><div style="line-height:120%;padding-bottom:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)  </sup></span><span style="font-family:inherit;font-size:10pt;">The discount on the 2023 Notes is being amortized through December 1, 2023. Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year.</span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">0.75%</span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> Senior Convertible Notes due 2022 </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In </span><span style="font-family:inherit;font-size:10pt;">June 2017</span><span style="font-family:inherit;font-size:10pt;">, we completed an offering of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3041-wk-Fact-373CE5A9000251F7AD5DCDAC96EFCA3F" name="us-gaap:DebtInstrumentFaceAmount" contextRef="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">400.0</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> aggregate principal amount of unsecured senior convertible notes with a stated interest rate of </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3045-wk-Fact-268B3111605F53F0BD06C64005EB5C53" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">0.75</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> and a maturity date of </span><span style="font-family:inherit;font-size:10pt;">May&#160;15, 2022</span><span style="font-family:inherit;font-size:10pt;"> (the 2022 Notes). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and costs directly related to the offering, were approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3053-wk-Fact-8A16EB5F9CE658988840A0D26FE0A7A4" name="us-gaap:ProceedsFromConvertibleDebt" contextRef="D2017Q2June_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">389.0</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">. The initial conversion rate of the 2022 Notes is </span><span style="font-family:inherit;font-size:10pt;">10.0918</span><span style="font-family:inherit;font-size:10pt;"> shares per </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3062-wk-Fact-0B257C8F5CE05CB6BEF48F8DA0AD5F30" name="dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount" contextRef="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="INF" scale="0" format="ixt:numdotdecimal">1,000</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> principal amount of notes, which is equivalent to a conversion price of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3066-wk-Fact-3FF684AD7C3C50C2B1FA9C352032CD3D" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">99.09</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> per share, subject to adjustments. The 2022 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2022 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders&#8217; equity. As a result, we recognized </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3073-wk-Fact-5E44B0F183D955F1946EBFEDB72DB995" name="us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity" contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">72.6</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> in additional paid-in-capital during 2017.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">No principal payments are due on the 2022 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2022 Notes includes customary terms and covenants, including certain events of default after which the 2022 Notes may be due and payable immediately.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Conversion Rights at the Option of the Holders </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the event of a fundamental change (as defined in the indenture related to the 2022 Notes), holders of the 2022 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3086-wk-Fact-E5B3CF5C758153998B2343A3536D0B5F" name="dxcm:DebtInstrumentCovenantRepurchasePricePercentage" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> of the principal amount of the 2022 Notes, plus any accrued and unpaid interest. Holders of the 2022 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by DexCom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.</span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-26</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-A0B78AAE722F9714A85AEB34A877E8A5-2" continuedAt="TextSelection-A0B78AAE722F9714A85AEB34A877E8A5-3"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior to 5:00 p.m., New York City time, on the business day immediately preceding February&#160;15, 2022, holders of the 2022 Notes may convert all or a portion of their notes, in multiples of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3093-wk-Fact-0B257C8F5CE05CB6BEF48F8DA0AD5F30" name="dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount" contextRef="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="INF" scale="0" format="ixt:numdotdecimal">1,000</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> principal amount, only under the following circumstances:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">(1)</span></div></td><td style="vertical-align:top;padding-left:12px;"><div style="line-height:120%;text-align:left;font-size:10pt;text-indent:-12px;"><span style="font-family:inherit;font-size:10pt;">during any calendar quarter commencing after September&#160;30, 2017 (and only during such calendar quarter), if the last reported sale price of common stock for at least </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3104-wk-Fact-5DE999F651205A61A4DE6CE09AF56FE2" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="d" decimals="INF" scale="0" format="ixt:numdotdecimal">20</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> trading days (whether or not consecutive) during the period of </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3108-wk-Fact-6074CF2EEF2F5CA9950ED5DB0250A45F" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="d" decimals="INF" scale="0" format="ixt:numdotdecimal">30</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3112-wk-Fact-C16B5C52CE4F5CBCAE218ECFA689CF4E" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">130</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> of the applicable conversion price of the Notes on each such trading day;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">during the </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3123-wk-Fact-BB53762B5ECC59AC8B4D97E2CC09481E" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="d" decimals="INF" scale="0" format="ixt-sec:numwordsen">five</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> business day period after any </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3127-wk-Fact-6B531877C00656CB96B2A21E86F6111B" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="d" decimals="INF" scale="0" format="ixt-sec:numwordsen">five</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> consecutive trading day period in which the trading price per </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3131-wk-Fact-0B257C8F5CE05CB6BEF48F8DA0AD5F30" name="dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount" contextRef="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="INF" scale="0" format="ixt:numdotdecimal">1,000</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> principal amount of the Notes for each day of that </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3135-wk-Fact-6B531877C00656CB96B2A21E86F6111B" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="d" decimals="INF" scale="0" format="ixt-sec:numwordsen">five</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> day consecutive trading day period was less than </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3139-wk-Fact-9B1945FE21685CBC9AB4109104034AF5" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">98</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> of the product of the last reported sale price of common stock and the applicable conversion rate of the Notes on such trading day;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">if we call any or all of the Notes for redemption, at any time prior to the close on business on the scheduled trading day immediately preceding the redemption date; or</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">(4)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">upon the occurrence of specified corporate transactions.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;On or after </span><span style="font-family:inherit;font-size:10pt;">February&#160;15, 2022</span><span style="font-family:inherit;font-size:10pt;">, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2022 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Circumstance (1) listed above occurred during the quarters ended March 31, 2019, September 30, 2019 and December 31, 2019. As a result, the 2022 Notes became convertible at the option of the holders from April 1, 2019 through June 30, 2019, October 1, 2019 through December 31, 2019 and will remain convertible at the option of the holder from January 1, 2020 through March 31, 2020.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Holders of 2022 Notes with an insignificant principal amount exercised their option to convert their 2022 Notes during the second and fourth quarters of 2019 and we settled these conversions with shares of our common stock. We continue to classify the carrying value of the liability component of the 2022 Notes as long-term debt, and the equity component of the 2022 Notes as permanent equity in our consolidated balance sheets as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Conversion Rights at Our Option </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DexCom may not redeem the 2022 Notes prior to May 15, 2020. On or after May 15, 2020, DexCom may redeem for cash all or part of the 2022 Notes, at its option, if the last reported sale price of our common stock has been at least </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3182-wk-Fact-152B7B194793551A9616ED8AF0FEC4A4" name="dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">140</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> of the conversion price then in effect for at least </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3186-wk-Fact-5DE999F651205A61A4DE6CE09AF56FE2" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="d" decimals="INF" scale="0" format="ixt:numdotdecimal">20</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> trading days (whether or not consecutive) during any </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3190-wk-Fact-6074CF2EEF2F5CA9950ED5DB0250A45F" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="d" decimals="INF" scale="0" format="ixt:numdotdecimal">30</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> consecutive trading day period ending on, and including, the trading day immediately preceding the date on which DexCom provides notice of redemption. The redemption price will be equal to </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3194-wk-Fact-AE21501732115298A2F6105516285921" name="us-gaap:DebtInstrumentRedemptionPricePercentage" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> of the principal amount of the 2022 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="line-height:174%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">0.75% Senior Convertible Notes due 2023</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In </span><span style="font-family:inherit;font-size:10pt;">November 2018</span><span style="font-family:inherit;font-size:10pt;">, we completed an offering of&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3208-wk-Fact-D701A6342B3153C4B82407D378549D18" name="us-gaap:DebtInstrumentFaceAmount" contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">850.0</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">&#160;aggregate principal amount of unsecured senior convertible notes with a stated interest rate of&#160;</span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3212-wk-Fact-C40FB1D95FF25501A9893BA8984A7151" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">0.75</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;">&#160;and a maturity date of&#160;</span><span style="font-family:inherit;font-size:10pt;">December&#160;1, 2023</span><span style="font-family:inherit;font-size:10pt;">&#160;(the 2023 Notes). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and costs directly related to the offering, were approximately&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3220-wk-Fact-B9E0DC8732A653D6BE44155CF4E7A5CF" name="us-gaap:ProceedsFromConvertibleDebt" contextRef="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">836.6</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">. The initial conversion rate of the 2023 Notes is&#160;</span><span style="font-family:inherit;font-size:10pt;">6.0869</span><span style="font-family:inherit;font-size:10pt;">&#160;shares per&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3229-wk-Fact-AE1FE5E296C7581281B8E8BABE5AFAEF" name="dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount" contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="INF" scale="0" format="ixt:numdotdecimal">1,000</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> principal amount of notes, which is equivalent to a conversion price of approximately&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3233-wk-Fact-DFB62017AD0753E1BD441508B737340B" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">164.29</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;">&#160;per share, subject to adjustments. We entered into transactions for a convertible note hedge (the 2023 Note Hedge) and warrants (the 2023 Warrants) concurrently with the issuance of the 2023 Notes. The 2023 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2023 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders&#8217; equity. As a result, we recognized </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3240-wk-Fact-983D52C0DE805058BBE85F5AD93941A1" name="us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity" contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">174.4</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> in additional paid-in capital during 2018. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">No principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2023 Notes includes customary terms and covenants, including certain events of default after which the 2023 Notes may be due and payable immediately. </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-27</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-A0B78AAE722F9714A85AEB34A877E8A5-3" continuedAt="TextSelection-A0B78AAE722F9714A85AEB34A877E8A5-4"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Conversion Rights at the Option of the Holders </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Holders of the 2023 Notes have the right to require us to repurchase for cash all or a portion of their notes at </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3253-wk-Fact-73FFC9A551CF5DBBA20C0EA9B2B0FE10" name="dxcm:DebtInstrumentCovenantRepurchasePricePercentage" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the notes). We will also be required to increase the conversion rate for holders who convert their 2023 Notes in connection with certain fundamental changes occurring prior to the maturity date or following the delivery by DexCom of a notice of redemption.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Holders of the 2023 Notes may convert all or a portion of their notes at their option prior to 5:00 p.m., New York City time, on the business day immediately preceding September&#160;1, 2023, in multiples of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3261-wk-Fact-AE1FE5E296C7581281B8E8BABE5AFAEF" name="dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount" contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="INF" scale="0" format="ixt:numdotdecimal">1,000</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> principal amount, only under the following circumstances:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">during any calendar quarter commencing after March 31, 2019 (and only during such calendar quarter), if the last reported sale price of common stock for at least </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3272-wk-Fact-93A5A57473E65441B41D4399517E801D" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="d" decimals="INF" scale="0" format="ixt:numdotdecimal">20</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> trading days (whether or not consecutive) during the period of </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3276-wk-Fact-95FC3E5376425C0CA7BBAA378ED850F0" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="d" decimals="INF" scale="0" format="ixt:numdotdecimal">30</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3280-wk-Fact-43CDDBC383FC598EBE9D46EF0D9C8DC5" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">130</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> of the applicable conversion price of the 2023 Notes on each such trading day;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">during the </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3291-wk-Fact-47BE00B5BAB3523CB5625C5A77C7905E" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="d" decimals="INF" scale="0" format="ixt-sec:numwordsen">five</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> business day period after any </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3295-wk-Fact-55D14B9E9686515DA696E4066ED0C7B3" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="d" decimals="INF" scale="0" format="ixt-sec:numwordsen">five</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> consecutive trading day period in which the trading price per </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3299-wk-Fact-AE1FE5E296C7581281B8E8BABE5AFAEF" name="dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount" contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="INF" scale="0" format="ixt:numdotdecimal">1,000</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> principal amount of the 2023 Notes for each day of that </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3303-wk-Fact-55D14B9E9686515DA696E4066ED0C7B3" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="d" decimals="INF" scale="0" format="ixt-sec:numwordsen">five</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;">-day consecutive trading day period was less than </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3307-wk-Fact-A3F0CA7FD8145DB3B3D26DC498BFB7FD" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">98</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> of the product of the last reported sale price of common stock and the applicable conversion rate of the 2023 Notes on such trading day;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">if we call any or all of the 2023 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">(4)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">upon the occurrence of specified corporate transactions.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On or after </span><span style="font-family:inherit;font-size:10pt;">September&#160;1, 2023</span><span style="font-family:inherit;font-size:10pt;">, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2023 Notes may convert all or a portion of their notes regardless of the foregoing circumstances. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Circumstance (1) listed above occurred during the quarter ended December 31, 2019. As a result, the 2023 Notes are convertible at the option of the holders from January 1, 2020 and will remain convertible until March 31, 2020. We continue to classify the carrying value of the liability component of the 2023 Notes as long-term debt, and the equity component of the 2023 Notes as permanent equity in our consolidated balance sheets as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Conversion Rights at Our Option </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DexCom may not redeem the 2023 Notes prior to December 1, 2021. On or after December 1, 2021 and prior to September 1, 2023, DexCom may redeem for cash all or part of the 2023 Notes, at its option, if the last reported sale price of our common stock has been at least </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3346-wk-Fact-87FB52FEE91D51E2B7716F0D1B67BB58" name="dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">130</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> of the conversion price then in effect for at least </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3350-wk-Fact-93A5A57473E65441B41D4399517E801D" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="d" decimals="INF" scale="0" format="ixt:numdotdecimal">20</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> trading days (whether or not consecutive) during any </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3354-wk-Fact-95FC3E5376425C0CA7BBAA378ED850F0" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="d" decimals="INF" scale="0" format="ixt:numdotdecimal">30</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> consecutive trading day period ending on, and including, the trading day immediately preceding the date on which DexCom provides notice of redemption. The redemption price will be equal to </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3358-wk-Fact-57E4E01AAADC5CDCA4E64C2509823D0F" name="us-gaap:DebtInstrumentRedemptionPricePercentage" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> of the principal amount of the 2023 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">2023 Note Hedge</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions with two of the initial purchasers of the 2023 Notes (the 2023 Counterparties) entitling us to purchase up to&#160;</span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3368-wk-Fact-F35B68F9953E54D4B89C380A5CECF49F" name="dxcm:DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">5.2</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">&#160;shares of our common stock at an initial price of&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3372-wk-Fact-DFB62017AD0753E1BD441508B737340B" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">164.29</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;">&#160;per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3376-wk-Fact-EFFBE3DF86205D0994591714C94CAA32" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" contextRef="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">218.9</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> and we accounted for it as an equity instrument by recognizing </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3380-wk-Fact-EFFBE3DF86205D0994591714C94CAA32" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" contextRef="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">218.9</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> in&#160;additional paid-in capital&#160;during 2018. The 2023 Note Hedge will expire on </span><span style="font-family:inherit;font-size:10pt;">December&#160;1, 2023</span><span style="font-family:inherit;font-size:10pt;">. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge.&#160;The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge. An assumed exercise of the 2023 Note Hedge by us is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.</span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-28</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-A0B78AAE722F9714A85AEB34A877E8A5-4"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">2023 Warrants</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In November 2018, we also sold warrants to the 2023 Counterparties to acquire up to&#160;</span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3395-wk-Fact-1F641C533FC055CB95291771B6430C8E" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">5.2</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock. The 2023 Warrants require net share settlement and a pro rated number of warrants will expire on each of the </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3399-wk-Fact-81A14A69838C53AF8D359B192D274B4C" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="d" decimals="INF" scale="0" format="ixt:numdotdecimal">60</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> scheduled trading days starting on </span><span style="font-family:inherit;font-size:10pt;">March&#160;1, 2024</span><span style="font-family:inherit;font-size:10pt;">. We received&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3407-wk-Fact-52F54C5F18BD5C5882758606AFE627D3" name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">183.8</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">&#160;in cash proceeds from the sale of the 2023 Warrants, which we recorded in&#160;additional paid-in capital during 2018. The 2023 Warrants could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2023 Warrants. The strike price of the 2023 Warrants is initially </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3411-wk-Fact-323CA320E99E5E6698E21673435DD645" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">198.38</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> per share and is subject to certain adjustments under the terms of the warrant agreements. We use the treasury share method for assumed conversion of the 2023 Warrants when computing the weighted average common shares outstanding for diluted earnings per share.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:18%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Revolving Credit Agreement</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Terms of the Revolving Credit Agreement</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On December 19, 2018, we entered into an amended and restated revolving credit agreement (the Credit Agreement) which provides for available principal amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3459-wk-Fact-5E1CF49A3EAEBAD12E721C89DCD08E29" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="I2018Q4December19_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">200.0</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> which can be increased up to </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3463-wk-Fact-541E74093896554591848B518554901C" name="dxcm:LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" contextRef="I2018Q4December19_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">500.0</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> at our option subject to customary conditions and approval of our lenders. Borrowings under the Credit Agreement are available for general corporate purposes, including working capital and capital expenditures. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" id="TextSelection-22006D56DC45F12BC4F9CA0DCE6986FF-0-wk-Fact-3A3E05CCDE16E3275BC8CA0E6279CE47" escape="true"><span style="font-family:inherit;font-size:10pt;">Information related to availability and outstanding borrowings on our Credit Agreement is as follows: </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:86%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Available principal amount </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3537-wk-Fact-B3FE68D01254523F909C7B48BD69E37C" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="FI2019Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">200.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Letters of credit sub-facility</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3552-wk-Fact-EC01642A36295B9397C7A10A1CD62C72" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outstanding borrowings </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3572-wk-Fact-19B2F94E77727E30037DCA1221CECD6A" name="us-gaap:LineOfCredit" contextRef="FI2019Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outstanding letters of credit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3592-wk-Fact-3C3B9C2DCCD351FF810E1585D664AAED" name="us-gaap:LettersOfCreditOutstandingAmount" contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total available balance</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3612-wk-Fact-8123CF33D78F552FAB9D898BC27F9F9E" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">195.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></ix:nonNumeric><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup>&#160;</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revolving loans under the Credit Agreement bear interest at our choice of one of two base rates plus a range of applicable margin rates that are based on our leverage ratio. The first base rate is the highest of (a) the publicly announced JPMorgan Chase prime rate, (b) the federal funds rate, or (c) the overnight bank funding rate, and the applicable margin rate ranges from </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3629-wk-Fact-58038F72A0035D3EB14F8C5D45C52DCC" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="FI2018Q4_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">0.375</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3633-wk-Fact-049F9D5603495955BC838857EE1AF434" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="FI2018Q4_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">1.000</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;">. The second base rate is a LIBOR-based rate, and the applicable margin rate ranges from </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3637-wk-Fact-E7649191160F53E79E2B8F06235F50BB" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="D2018Q4December_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">1.375</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3641-wk-Fact-C1ECB4852A1A56A9B088AB48C3ACAB12" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="D2018Q4December_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">2.000</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;">. We will also pay a commitment fee of between </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3645-wk-Fact-C9DB2EB1BF3A5496B4395E2CFE7DE7E7" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" contextRef="D2018Q4December_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">0.2</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37418911e3650-wk-Fact-2C4392F151145405818F8E90078C47F4" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" contextRef="D2018Q4December_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">0.3</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;">, payable quarterly in arrears, on the average daily unused amount of the revolving facility based on our leverage ratio. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Credit Agreement will mature on the earlier to occur of (i) December 19, 2023 or (ii) 91 days prior to the maturity date of the 2022 Notes or (iii) 91 days prior to the maturity date of the 2023 Notes if both (a) the aggregate outstanding principal amount of the 2022 Notes or the 2023 Notes, as applicable, is greater than EBITDA for the period of four consecutive fiscal quarters ending prior to such date and (b) unrestricted domestic cash on hand is less than the aggregate outstanding principal amount of the 2022 Notes or the 2023 Notes, as applicable, plus </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37418911e3657-wk-Fact-26615DCAA0529CBB6B021BE7E98D1F65" name="dxcm:LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold" contextRef="FD2019Q4YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">100.0</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our obligations under the Credit Agreement are guaranteed by our existing and future wholly-owned domestic subsidiaries, and are secured by a first-priority security interest in substantially all of the assets of DexCom and the guarantors, including all or a portion of the equity interests of our domestic subsidiaries and first-tier foreign subsidiaries but excluding real property and intellectual property (which is subject to a negative pledge). The Credit Agreement contains covenants that limit certain indebtedness, liens, investments, transactions with affiliates, dividends and other restricted payments, subordinated indebtedness and amendments to subordinated indebtedness documents, and sale and leaseback transactions of DexCom or any of its domestic subsidiaries. The Credit Agreement also requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-29</span></div></div><hr style="page-break-after:always"></hr><div><a id="s75A0DAE405AB50A2BAFC755B3E79428E"></a></div><div><br/></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:LesseeFinanceLeasesTextBlock" id="TextSelection-EB4D6AA82D8D0FD7FCF5AB6380D57771-0-wk-Fact-6F33C7E6D296EB8CC123AB63D9FD234F" continuedAt="TextSelection-EB4D6AA82D8D0FD7FCF5AB6380D57771-1" escape="true"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:LesseeOperatingLeasesTextBlock" id="TextSelection-751364B3BD301C2F7DD7EB34A878319B-0-wk-Fact-85937774F9440D8523C2EB34A843C676" continuedAt="TextSelection-751364B3BD301C2F7DD7EB34A878319B-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:18%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">6. Leases And Other Commitments</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Leases</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We lease office, manufacturing and warehouse space facilities under various domestic and international operating leases that expire at various times through August 2026. Certain of our leases have renewal options which allow us to extend the lease term typically between </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37415613e621-wk-Fact-2D5B0C5F4F487493088ED48D77EA2118" name="us-gaap:LesseeOperatingLeaseRenewalTerm" contextRef="FI2019Q4_srt_RangeAxis_srt_MaximumMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> per option and some of our leases have multiple options to extend. We have </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e625-wk-Fact-4D9FE6A5D56071417EB8D361CD1E4AA9" name="dxcm:NumberofFinancingLeases" contextRef="FD2019Q4YTD_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member" unitRef="finance_lease" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> finance lease for our manufacturing facility in Mesa, Arizona under a lease that expires in </span><span style="font-family:inherit;font-size:10pt;">March 2028</span><span style="font-family:inherit;font-size:10pt;"> with options to renew this lease for </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e633-wk-Fact-6FA44FDBC41057F3AE3BABCF4A0A75DA" name="dxcm:LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms" contextRef="FD2019Q4YTD_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member" unitRef="renewal_term" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> additional </span><span style="font-family:inherit;font-size:10pt;">five</span><span style="font-family:inherit;font-size:10pt;">-year terms. Our facility leases generally provide for periodic rent increases and many contain escalation clauses. Certain leases also require us to pay taxes, insurance, and maintenance. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> The remaining lease terms of our leases range from less than </span><span style="font-family:inherit;font-size:10pt;">one year</span><span style="font-family:inherit;font-size:10pt;"> to approximately </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37415613e649-wk-Fact-E08695E2632B1ECBA8A8D48C23E6EE17" name="dxcm:LesseeOperatingLeaseRemainingLeaseTerm" contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember" format="ixt-sec:durwordsen">thirteen years</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;">; and represent the non-cancellable periods of the leases, including extension options that we determined are reasonably certain to be exercised. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">We adopted ASC 842 utilizing the modified retrospective transition method through a </span><span style="font-family:inherit;font-size:10pt;color:#252525;"><span>$<ix:nonFraction id="d37415613e656-wk-Fact-AFE2A4AD74985E3D8544B7642CEDF40C" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" contextRef="I2019Q1January1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">2.1</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;color:#252525;"> cumulative-effect adjustment to accumulated deficit at the beginning of the first quarter of 2019. We will continue to report financial information for fiscal years prior to 2019 under the previous lease accounting standards and as such prior comparative periods have not been recast. </span><span style="font-family:inherit;font-size:10pt;">We elected the package of practical expedients permitted under the transition guidance in the new standard, which allowed us to carry forward the historical classification of leases that were in place as of January 1, 2019. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Under the previous lease accounting standards we were deemed the owner of our Mesa, Arizona building during the construction period. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell and the related lease liability as of December 31, 2018 and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, as a result of our adoption of ASC 842 we recorded operating lease right-of-use assets of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37415613e668-wk-Fact-7E3ABC8C7E6759458495F85575592523" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="I2019Q1January1" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">26.7</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">, finance lease right-of-use assets of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37415613e672-wk-Fact-54903A63B8B05C5EB600E8476D20113E" name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="I2019Q1January1" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.3</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">, operating lease liabilities of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37415613e676-wk-Fact-04193007C52B5B24AF865074DA0E8ABF" name="us-gaap:OperatingLeaseLiability" contextRef="I2019Q1January1" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">40.4</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> and finance lease liabilities of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37415613e680-wk-Fact-27E36E89B5FE54B6A0C8E1BDA8E3C068" name="us-gaap:FinanceLeaseLiability" contextRef="I2019Q1January1" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.9</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> in our consolidated balance sheets at the beginning of the first quarter of 2019, with no material impact to our consolidated statement of operations. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease right-of-use assets and liabilities are presented separately in our consolidated balance sheets. Finance lease right-of-use assets are included in property and equipment and finance lease liabilities are included in accounts payable and accrued liabilities and in other long-term liabilities in our consolidated balance sheets.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="TextSelection-ED73E4EBE90DE73213E1D369951593A8-0-wk-Fact-C3B29077E68E132331E0D36A24DAA4E9" escape="true"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="TextSelection-7810342F9A1401F9D15BD36917914D16-0-wk-Fact-796B531A1708D3D0BD20D36989EEAD1B" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">As of </span><span style="font-family:inherit;font-size:10pt;color:#252525;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;color:#252525;">, the maturities of our operating and finance lease liabilities were as shown in the table below:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:76%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Finance Leases</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e766-wk-Fact-D1CBD600EAD25A1F811F83F9F8B674E4" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e785-wk-Fact-B506B6EC611559A09EB00DC716853A74" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e800-wk-Fact-44BA886224B75D8EB3C24A054625E5F4" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e819-wk-Fact-778FFD0FBA2D569BBFFDAD898415217C" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e839-wk-Fact-D0793AF57A2D55B4A5E661F3B58F1F45" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e858-wk-Fact-E7609422E3315B5C867D4C76FB917F2E" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e878-wk-Fact-3989434671AF5CCFA86926B60EF6605A" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e897-wk-Fact-910F7469426050A4AA200E951E38A975" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e917-wk-Fact-7190C391E0545D4D855EC81FA18ED8C8" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e936-wk-Fact-08D0D099DC6D5A28927BBD7D015930DB" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e956-wk-Fact-7ED43925C4415F50A5FD3577BB186AE4" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">23.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e975-wk-Fact-D486F5A7EAF6533D88CE2E6440C30CA4" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total future lease cost </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e997-wk-Fact-D9867D9FAC776AED6F27D36E2C389A94" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">100.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1016-wk-Fact-25F7C5BBBE1F4FBB2701D36E7C24730C" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">20.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Amount representing interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37415613e1036-wk-Fact-525D5E0195B75B2A9B4F090C474AF01A" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37415613e1056-wk-Fact-68FA736B0171527A8A332EA2EFF3CDE6" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Present value of future payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1077-wk-Fact-6382385673D6CF36C944D36E3E929B6C" name="dxcm:OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">85.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1096-wk-Fact-FA7112C29733E4C313F8D36E8AA7B838" name="dxcm:FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Short-term leases not recorded as a liability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1116-wk-Fact-91288A0DE3975019A5A20D70FD086E30" name="dxcm:LesseeOperatingLeasesShortTermLeasePaymentsDue" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1135-wk-Fact-BD1195672862550EA52D66C3290B4E62" name="dxcm:FinanceLeaseShortTermLeasesPaymentsDue" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revised present value of future lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1156-wk-Fact-01190B6667E34829682ED36E5507B0FF" name="us-gaap:OperatingLeaseLiability" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">86.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1175-wk-Fact-BDB784EF4E3E0319451FD36E9B016A1B" name="us-gaap:FinanceLeaseLiability" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Current portion</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37415613e1195-wk-Fact-0372FC04FE7667FD19B61747DFBEB68B" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37415613e1215-wk-Fact-48A39F24D8A45D338C94587F1934924E" name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term portion</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1241-wk-Fact-B5DC66DA1FAA547BB8A5BB1A758CB367" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">72.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1260-wk-Fact-DF79FE62C9BE08201DBCD36EAAE31D06" name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></span><span style="font-family:inherit;font-size:10pt;color:#252525;">Total future lease cost excludes </span><span style="font-family:inherit;font-size:10pt;color:#252525;"><span>$<ix:nonFraction id="d37415613e1271-wk-Fact-05B315D1F0BD45669354B5D1FB1ACDB1" name="dxcm:LesseeFutureLeaseCostLeaseNotyetCommenced" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.5</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;color:#252525;"> of legally binding minimum lease payments for leases signed but not yet </span><span style="font-family:inherit;font-size:10pt;">commenced</span><span style="font-family:inherit;font-size:10pt;color:#252525;">.</span></div></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-30</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-EB4D6AA82D8D0FD7FCF5AB6380D57771-1" continuedAt="TextSelection-0811AF40614B91BC2BDFAB6790CA64C6-0"><ix:continuation id="TextSelection-751364B3BD301C2F7DD7EB34A878319B-1" continuedAt="TextSelection-74C05BC85AA11F714D3CD371C8B7E256-0"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:LeaseCostTableTextBlock" id="TextSelection-AAC27830F1F57D38ADBDB5C58B744BD3-0-wk-Fact-2810E8F4902F01B05A59B5C5CB21BDB3" continuedAt="TextSelection-A04765CAC02B07006C50B5C65681F367-0" escape="true"><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of lease expense for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:89%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions) </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance lease cost:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1381-wk-Fact-6FFE0A070B0B5C0BA64354961469F2F8" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest on lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1396-wk-Fact-6153E5FCA8365B5A90AC72230D78E5BD" name="us-gaap:FinanceLeaseInterestExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1416-wk-Fact-1137E991345A54D5A047856F77CDE3CD" name="us-gaap:OperatingLeaseCost" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term lease cost </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1438-wk-Fact-A504E76BBAE25F49AD98AFF54305E6AD" name="us-gaap:ShortTermLeaseCost" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Variable lease cost </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1460-wk-Fact-F9233A6A31835AB5B43A499D7AA3CE4C" name="us-gaap:VariableLeaseCost" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1485-wk-Fact-83353F5DCCBEB263D5FBB5C49EA2E645" name="us-gaap:LeaseCost" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">21.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span><span style="font-family:inherit;font-size:10pt;color:#252525;"> </span><span style="font-family:inherit;font-size:10pt;">Short-term lease cost is primarily related to temporary office space associated with the transition of certain operations to the Philippines. </span></div><div style="line-height:120%;padding-top:4px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span><span style="font-family:inherit;font-size:10pt;color:#252525;"> </span><span style="font-family:inherit;font-size:10pt;">Variable lease costs are primarily related to common area maintenance charges and property taxes.</span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior to January 1, 2019, we recorded operating lease rent expense under ASC 840 on a straight-line basis over the non-cancellable lease term. Rent expense for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37415613e1521-wk-Fact-21620EB4E349FCB44086C9DCC2AACC32" name="us-gaap:LeaseAndRentalExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.5</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37415613e1525-wk-Fact-B4E4A24F4C05A8D473F1C9DCC14AA619" name="us-gaap:LeaseAndRentalExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.1</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><ix:continuation id="TextSelection-A04765CAC02B07006C50B5C65681F367-0"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.</span><span style="font-family:inherit;font-size:10pt;color:#252525;"> </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:88%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating cash flows from operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1622-wk-Fact-B99EABDDAB0A5CC1A7473CAADBE39B4F" name="us-gaap:OperatingLeasePayments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating cash flows from finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1642-wk-Fact-DA46DEEA2732539597C21079A5C9E21B" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financing cash flows from finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1662-wk-Fact-AE232EC0B9855277B46E3A78B3B060B1" name="us-gaap:FinanceLeasePrincipalPayments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Right-of-use assets obtained in exchange for lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1703-wk-Fact-B4AD167589CD56EC8F57FD629208F881" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">80.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1723-wk-Fact-E24EFC40C20258EDAF21EE913A179B7F" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average remaining lease term in years:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37415613e1759-wk-Fact-86611F4293BE5A669569C5C611662964" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="FI2019Q4" format="ixt-sec:duryear">6.2</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37415613e1780-wk-Fact-253219C788625B859F9526BF1AF69773" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" contextRef="FI2019Q4" format="ixt-sec:duryear">13.3</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average discount rate:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1821-wk-Fact-5792E30EAF6E51C6B44FC5E474342C1F" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="FI2019Q4" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">5.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37415613e1842-wk-Fact-F4445B1ABAFD5F8E83E4A50E5AEE02A8" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" contextRef="FI2019Q4" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">5.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of operating lease right-of-use asset included in cash flows from operating activities in the Consolidated Statements of Cash Flows was </span><span style="font-family:inherit;font-size:10pt;color:#252525;"><span>$<ix:nonFraction id="d37415613e1859-wk-Fact-E8391079BE6B5DD3AC0617249118990C" name="dxcm:LesseeOperatingLeasesLeaseCostAmortization" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.1</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div></ix:continuation></ix:continuation><div><a id="s4a72417dfdc445caa22636d109d61e51"></a></div><ix:continuation id="TextSelection-74C05BC85AA11F714D3CD371C8B7E256-0"><ix:continuation id="TextSelection-0811AF40614B91BC2BDFAB6790CA64C6-0"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Purchase Commitments</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are party to various purchase arrangements related to our manufacturing and research and development activities. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37409474e568-wk-Fact-EAC0738B2C9FD7A0A779EB34A83332CF" name="us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">165.8</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> of open purchase orders and contractual obligations in the ordinary course of business, most of which are due within </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37409474e572-wk-Fact-000AE188B2D759862A31EB34A7FE930D" name="dxcm:RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" contextRef="FD2019Q4YTD" format="ixt-sec:durwordsen">one year</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;">.</span></div></ix:continuation></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-31</span></div></div><hr style="page-break-after:always"></hr><div><a id="s44527FB6F17E5EFE9B3036CB63F6B593"></a></div><div><br/></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="TextSelection-262281F093802552ABF0EB34A8783C4B-0-wk-Fact-41D95BBCDBE3C9A00F31EB34A7FEDF94" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">7. Contingencies</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Litigation</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span>On March 28, 2016, AgaMatrix, Inc., or AgaMatrix, filed a patent infringement lawsuit against us in the U.S. District Court for the District of Oregon, asserting that certain of our products infringe three patents held by AgaMatrix. (After filing suit, AgaMatrix reorganized its business and the Court granted AgaMatrix&#8217;s motion to substitute the newly created entity WaveForm Technologies, Inc., as the plaintiff following AgaMatrix&#8217;s transfer of the three asserted patents to WaveForm.) DexCom filed petitions for </span><span style="font-style:italic;">inter partes</span><span> review with the Patent Trial and Appeal Board, or PTAB, of the U.S. Patent and Trademark Office, challenging each of the three asserted patents as being unpatentable in view of prior art. The PTAB issued a Final Written Decision for each of the first two patents on February 28, 2018, where the PTAB found the majority of asserted claims from the first patent unpatentable and the remaining claims under review not unpatentable. The PTAB found all claims under review from the second patent not unpatentable. On September 12, 2018, the PTAB found all of the asserted claims in the third patent unpatentable. In October 2018, we filed in the District Court a motion for summary judgment that all remaining asserted claims are invalid. The District Court granted that motion and, on August 23, 2019, entered judgment in our favor. On September 6, 2019, WaveForm appealed the judgment. The appeal is pending and no hearing date has been set.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have also filed several lawsuits against AgaMatrix. We filed a patent infringement lawsuit against AgaMatrix in the United States District Court for the Central District of California, or C.D. Cal., in which a Final Judgment of non-infringement was entered by the C.D. Cal judge on February 23, 2018 and affirmed on appeal by the Federal Circuit on March 7, 2019. AgaMatrix was awarded attorneys&#8217; fees for this lawsuit.</span><span style="font-family:inherit;font-size:10pt;"> As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we have accrued an immaterial amount for those fees. </span><span style="font-family:inherit;font-size:10pt;">The fee decision is currently on appeal to the Federal Circuit. On September 15, 2017, we filed a patent infringement lawsuit against AgaMatrix in the United States District Court for the District of Delaware, asserting certain single-point blood glucose monitoring products of AgaMatrix infringe two patents held by us. In addition, on September 18, 2017, we filed a Complaint against AgaMatrix in the International Trade Commission, referred to as the ITC, requesting that the ITC institute an investigation and issue an order excluding certain products of AgaMatrix from importation into or sale in the United States based on AgaMatrix&#8217;s infringement of the same two patents asserted in the Delaware litigation. The investigation was terminated by the ITC on April 4, 2019 with a finding of non-infringement. The decision is currently on appeal.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Neither&#160;the outcome of these lawsuits nor the amount and range of potential loss associated with the lawsuits can be assessed at this time. Other than the attorneys&#8217; fees described above, as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> we have accrued </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37414448e628-wk-Fact-47B130CFBC0321BAFC2EB06A7985A1EC" name="us-gaap:LitigationReserve" contextRef="FI2019Q4" unitRef="usd" decimals="INF" scale="6" format="ixt-sec:numwordsen">no</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> amounts for contingent losses associated with these suits.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters. </span><span style="font-family:inherit;font-size:10pt;">We do not expect that the resolution of these matters would, or will, have a material adverse effect or material impact on our financial position or results of operations.</span></div></ix:nonNumeric><div><a id="s540FB448558C5F5D87E0564939396349"></a></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:IncomeTaxDisclosureTextBlock" id="TextSelection-4907895FB7D4FFC36179EB34A8787544-0-wk-Fact-F10CE8521EE1DD9018D2EB34A8297CE6" continuedAt="TextSelection-4907895FB7D4FFC36179EB34A8787544-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">8. Income Taxes</span></div></td></tr></table></div></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="TextSelection-52FFA7061656CF61ABA1EB34A8782DB8-0-wk-Fact-2C119FEE62178ECAF00AEB34A7FE9E58" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income (loss) before income taxes subject to taxes in the following jurisdictions is as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:62%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e737-wk-Fact-248DF7C1BDDCD472ECEBEB34A810A3B1" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">119.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e756-wk-Fact-7EF334640DB694BF702FEB34A82670A2" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">28.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e776-wk-Fact-D860E1B974B34AE9C449EB34A7FE8459" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outside of the United States</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e792-wk-Fact-FD154313436347CB9B37EB34A7FE3625" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">14.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e812-wk-Fact-142F6CACDD275A17A158EB34A81C32F3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">98.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e832-wk-Fact-7CB9A7B1AC794488EA60EB34A7FE0D39" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">61.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e859-wk-Fact-13FDF4DE7E1C0C745710EB34A7FE0302" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">104.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e878-wk-Fact-E80D20BB487E0632B25EEB34A7EE6A42" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">126.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e898-wk-Fact-4EB598277566A39717FEEB34A8338E60" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">48.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:nonNumeric><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-32</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-4907895FB7D4FFC36179EB34A8787544-1" continuedAt="TextSelection-4907895FB7D4FFC36179EB34A8787544-2"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="TextSelection-3DDCB0F236DE73930173EB34A879CFB6-0-wk-Fact-3E305A7E63CC6C2A3645EB34A833083C" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Significant components of the provision for income taxes are as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:62%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Federal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1147-wk-Fact-47607B0A79B342C0A64CEB34A82F4E51" name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1166-wk-Fact-148D01E91C3FA175C69EEB34A7FE9722" name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1185-wk-Fact-4FA96EB9C1A35700DCF9EB34A7FEFCE1" name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">State</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1201-wk-Fact-66CDB8D4E0525C038A3BEB34A7FE1905" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1220-wk-Fact-F049C838F63B9F2A0B89EB34A7FE0490" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1239-wk-Fact-771D328AB93394423008EB34A7FE9972" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1260-wk-Fact-0ECF7B624355D53AC61FEB34A81195B0" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1279-wk-Fact-B1009629F70A6BB8EF33EB34A7FE41F6" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1298-wk-Fact-0BE5D1647C071B85ED71EB34A80E9129" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1319-wk-Fact-D20591E992159DC7972FEB34A7FE97C3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1338-wk-Fact-B71524CE2B9CF0E5B8BAEB34A7FEF613" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1357-wk-Fact-AD8C2DC3D6366DCF2265EB34A7FE5E13" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Federal</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1440-wk-Fact-3E255DFB68B8D2ED9EFFEB34A7FECAB2" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e1459-wk-Fact-66E321AA9FC314F9ACDFEB34A7FE1DCA" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1479-wk-Fact-45D23415F6769287C73FEB34A7FEE664" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">State</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1500-wk-Fact-98DEF4CA2839C695354FEB34A7FEFE86" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e1519-wk-Fact-1FB55DFDF6A8788EF9B3EB34A80E7AAC" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1539-wk-Fact-A2C1B2F5B744A4C5BA16EB34A7FEA24E" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1560-wk-Fact-04F064A76BB1DD26D5D7EB34A7FED444" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1579-wk-Fact-8934F1BA0A0CA7F010A1EB34A811CB29" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1598-wk-Fact-643F6E0E9A4483D88A4BEB34A7FE59DA" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total deferred income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1620-wk-Fact-BDC28B83799FF7637FF5EB34A80ECFEE" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e1639-wk-Fact-CAB6ABA37BBB9C8B1F05EB34A7FED423" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">2.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1659-wk-Fact-171439A46462979BE638EB34A8334A5E" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1685-wk-Fact-5382C869DEC35C369C5FBDE1CE4B43A0" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1704-wk-Fact-0D594FC0637D063FE795174A94692792" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1723-wk-Fact-DCF36026B268B00536B7EB34A8622EE0" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had federal, state and foreign tax net operating loss carryforwards of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37423883e1744-wk-Fact-7B052AB1B7FADC920795EB34A7FEFAAB" name="us-gaap:OperatingLossCarryforwards" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">438.8</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37423883e1748-wk-Fact-C5EC85A3E17C0CB26256EB34A81A45AB" name="us-gaap:OperatingLossCarryforwards" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">324.1</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37423883e1752-wk-Fact-6377128FE1BBF3B9C4D3EB34A82082F2" name="us-gaap:OperatingLossCarryforwards" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">124.1</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. The federal and state tax loss carryforwards will begin to expire in </span><span style="font-family:inherit;font-size:10pt;">2027</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2020</span><span style="font-family:inherit;font-size:10pt;">, respectively, unless previously utilized. The foreign net operating losses carry forward indefinitely. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we also had federal and state research and development tax credit carryforwards of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37423883e1772-wk-Fact-BAA466D8AB3DD64F40B0EB34A7FE683A" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.4</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37423883e1776-wk-Fact-D1393E67327408FE8FC7EB34A8237F27" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">52.7</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37423883e1780-wk-Fact-A25B83CDC2F94C7704B6EB34A7FEE4BA" name="dxcm:TaxCreditCarryforwardsResearchSubjecttoExpiration" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> of the federal research and development tax credit will begin to expire in </span><span style="font-family:inherit;font-size:10pt;">2020</span><span style="font-family:inherit;font-size:10pt;">, unless previously utilized. The state research and development tax credit will carryforward indefinitely until utilized.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Utilization of net operating losses and credit carryforwards is subject to an annual limitation due to ownership change limitations provided by Section&#160;382 and 383 of the Internal Revenue Code of 1986, as amended, and similar state provisions. An ownership change limitation occurred as a result of the stock offering completed in February 2009. The limitation will likely result in approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37423883e1791-wk-Fact-449E3FFF95E0F6F30A4FEB34A8214C21" name="dxcm:UnusedExpiredFederalIncomeTaxCredits" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.1</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> of U.S. income tax credits that will expire unused. The related deferred tax assets have been removed from the components of our deferred tax assets as summarized in the table below. We performed a Section 382 study on the remaining federal and state net operating losses and tax credit carryforwards and have determined that there is no annual limitation on them as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">. </span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="TextSelection-41FA9CC6D51E01BCD5C5EB34A878F6AD-0-wk-Fact-73C2AEADE6545433334CEB34A82D787B" continuedAt="TextSelection-41FA9CC6D51E01BCD5C5EB34A878F6AD-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Significant components of our deferred tax assets as of </span><span style="font-family:inherit;font-size:10pt;">December 31,</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> are shown below. A valuation allowance of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37423883e1815-wk-Fact-A79879BA313D7FFE5AB8EB34A7FE98F7" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">332.2</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> has been established as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> to offset the deferred tax assets, as realization of such assets is uncertain. We maintain a deferred tax liability related to indefinite-lived intangible assets that is not netted against the deferred tax assets. Reversal of the taxable temporary difference for these intangible assets cannot serve as a source of income for realization of the deferred tax assets because the deferred tax liability will not reverse until the intangible assets are sold or written down due to impairment.</span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-33</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-4907895FB7D4FFC36179EB34A8787544-2" continuedAt="TextSelection-4907895FB7D4FFC36179EB34A8787544-3"><ix:continuation id="TextSelection-41FA9CC6D51E01BCD5C5EB34A878F6AD-1"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Net operating loss carryforwards</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1980-wk-Fact-89FDA9917C6600A699CCB0496D882EBA" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">127.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e1999-wk-Fact-80A9375F0E499B2E0543B0496DA22B1C" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">162.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Capitalized research and development expenses</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2014-wk-Fact-715DF909E87697E7537CB049816B1693" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">57.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2033-wk-Fact-C293B896117C40EEA705B049816F9820" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">62.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Tax credits</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2053-wk-Fact-93D234F26651A86DC8CCB0499C19B8F6" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">78.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2072-wk-Fact-F1A5C23AD4C6ECD9E855B0499C2C824E" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">59.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2092-wk-Fact-4918EC27FDBC5BF3D17DB049ACA8D2AA" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2111-wk-Fact-1543075964BFE59C2CEEB049ACBB9046" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Fixed and intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2131-wk-Fact-310985A3B22E77EDA6E0B049BA3BB111" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2150-wk-Fact-81934F29F34BEB30B6CDB049BA3FE824" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Accrued liabilities and reserves</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2170-wk-Fact-254E7BE5C558D159407AB049C828AE86" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">62.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2189-wk-Fact-2F2D1427E28385415301B049C824CFBC" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">22.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Convertible Debt</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2209-wk-Fact-DED7E11B9B1092EE3F0FF393E9C757CB" name="dxcm:DeferredTaxAssetsConvertibleDebt" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2228-wk-Fact-2C8364C065B109D6F161F393EBF9A474" name="dxcm:DeferredTaxAssetsConvertibleDebt" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total gross deferred tax assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2248-wk-Fact-CF628FFBB067500893A2B049DC613B9F" name="us-gaap:DeferredTaxAssetsGross" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">351.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2267-wk-Fact-FDE162804C2D7F2DCB88B049DC762A6D" name="us-gaap:DeferredTaxAssetsGross" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">334.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: valuation allowance</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e2288-wk-Fact-A79879BA313D7FFE5AB8EB34A7FE98F7" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">332.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e2308-wk-Fact-398A27336299C3E64833B04A0F40C6E7" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">330.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net deferred tax assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2329-wk-Fact-A5E3F61632F9B2C8254DB04A302BDB11" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2348-wk-Fact-66DED172E80CD16E7FAAB04A303F25C0" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Fixed assets and acquired intangibles assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e2409-wk-Fact-56DA684D3B4A3383ED30B04A40C6257B" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e2429-wk-Fact-36AB94B3FCA9AB3741F1B04A40CA0495" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Convertible debt discount</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2450-wk-Fact-456E0A7186D7EE384B09B04A52F64D2A" name="dxcm:DeferredTaxLiabilitiesConvertibleDebtDiscount" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e2469-wk-Fact-1E9030FE8D1D2DC41AB3B04A530A5D7F" name="dxcm:DeferredTaxLiabilitiesConvertibleDebtDiscount" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total deferred tax liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e2490-wk-Fact-4B9BDBCF7F1127653606B04A64BD248C" name="us-gaap:DeferredTaxLiabilities" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e2510-wk-Fact-0034B3A01CDF5CCCA3F7B04A64D007F0" name="us-gaap:DeferredTaxLiabilities" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net deferred tax assets (liabilities)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e2536-wk-Fact-6EE2827AABEB7F262433B04A7319DDBF" name="dxcm:DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2556-wk-Fact-F28AC4EEEB888101E25EB04A731D8A6D" name="dxcm:DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, and reliability of forecasting. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we have maintained a full valuation allowance on our deferred tax assets since inception based on our historical losses and the uncertainty of generating future taxable income to utilize our loss and credit carryforwards. A future release of our valuation allowance will result in a material tax benefit recognized in the quarter of the release.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, deferred tax assets for which any subsequently recognized tax benefits will be credited to additional paid-in capital rather than to income tax benefit totaled </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37423883e2584-wk-Fact-2DD79E44D3E7C4EBA7D9EB34A8247FC4" name="dxcm:DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">55.7</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="TextSelection-69094E1B9A226E64E639EB34A879D032-0-wk-Fact-81C2FF7701A3277902B4EB34A81DE7A1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The reconciliation between our effective tax rate on income (loss) from continuing operations and the statutory rate is as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:62%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income taxes at statutory rates</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2755-wk-Fact-207A7365321ED16CBDE2B04B9CA74F38" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">21.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e2774-wk-Fact-27B86412824F0EC58322B04B9CA24A04" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">26.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e2794-wk-Fact-6096F4B721E892438E03B04B9CACE8A2" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">17.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">State income tax, net of federal benefit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e2811-wk-Fact-173B85CA7A6DEF7BC3B2B04BA72F6FD3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">2.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e2831-wk-Fact-8FBCF0FBA01A40893EDDB04BA72B5589" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">5.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e2851-wk-Fact-A878AE32B957477B8B5DB04BA7320553" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Permanent items</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2873-wk-Fact-1A819F5AB9291CF7AE8FB04C5381922A" name="dxcm:EffectiveIncomeTaxReconciliationPermanentItems" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2892-wk-Fact-B68A8457CFF806CCC7ACB04C537D679B" name="dxcm:EffectiveIncomeTaxReconciliationPermanentItems" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2911-wk-Fact-4B5EF3059E598EEF3D08B04C5379C2DB" name="dxcm:EffectiveIncomeTaxReconciliationPermanentItems" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Research and development credits</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e2932-wk-Fact-C8507796FD66CA66AC80B04C63AA1A7C" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e2952-wk-Fact-36A292408BA7A7C11E99B04C6396AE9C" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e2972-wk-Fact-A3514C44B06A975005F1B04C6388D842" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign rate differential</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e2994-wk-Fact-C0AFC912158FDEE5F938B04C834BD844" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3013-wk-Fact-9DD11D860D583BA0DE7EB04C8342CD40" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3032-wk-Fact-104DEC505424E248B519B04C8347164E" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock and officers compensation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e3053-wk-Fact-ED4D6DBD384B76967CB1B04C95550298" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">14.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e3073-wk-Fact-21BA3D45D02CFAD3D254B04C955135B2" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">5.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e3093-wk-Fact-E7CFD3981EAE8CC03367B04C95584FBD" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">10.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Rate change</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3115-wk-Fact-64C811981006BDF49105B04CA50D7DCD" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3134-wk-Fact-AB219E5A158D90998A1DB04CA51B5338" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e3153-wk-Fact-C1B9B073827749865274B04CA4F99899" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrecognized tax benefits</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3175-wk-Fact-1F81564B1CDE1A2DD66BB04CB3293FC5" name="dxcm:EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3194-wk-Fact-B1DC0BFFB9B30AECD8F4B04CB33DD7FE" name="dxcm:EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e3213-wk-Fact-43A8AE36695E5CB32C79B04CB3152205" name="dxcm:EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">15.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Impact of adoption of ASU 2016-16</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3235-wk-Fact-259049B321B60B8B5CB2B04CC34F273C" name="dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e3254-wk-Fact-045420041CF7EA42E04BB04CC347DBD5" name="dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">13.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3274-wk-Fact-DAAD236EC09E4A618CF3B04CC34C975F" name="dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Impact of Tax Cuts and Jobs Act of 2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3296-wk-Fact-ECFD8C9493431F9327D2B04CD754013D" name="dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e3315-wk-Fact-5929BF087978E964C3D0B04CD7500B61" name="dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3335-wk-Fact-95E43FC9976CDA4C653EB04CD74C9FF1" name="dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">105.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e3356-wk-Fact-36490673394858A548CBB04CE7D698C0" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3376-wk-Fact-C51BAC9B975E8979B9FAB04CE7B51A4B" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e3395-wk-Fact-547073F8FC372B64FBC2B04CE7C8DE01" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">2.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in valuation allowance</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3417-wk-Fact-46BDE8D9A53F71DE6D73B04CF804D5AF" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3436-wk-Fact-20DAE5DF22B87FD9D1D3B04CF80B6784" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">56.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e3455-wk-Fact-D7C466E490F5DA17B571B04CF80815A9" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">51.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income taxes at effective rates</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3482-wk-Fact-5382C869DEC35C369C5FBDE1CE4B43A0" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3501-wk-Fact-0D594FC0637D063FE795174A94692792" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3520-wk-Fact-DCF36026B268B00536B7EB34A8622EE0" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-34</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-4907895FB7D4FFC36179EB34A8787544-3" continuedAt="TextSelection-4907895FB7D4FFC36179EB34A8787544-4"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="TextSelection-0DF5601D336D1A33BF98EB34A879EF1F-0-wk-Fact-59C7E78559FBCC74AD73EB34A7FE5901" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the activity related to our gross unrecognized tax benefits:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:88%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at January&#160;1, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3591-wk-Fact-A2BC4107AA02159ED754EB34A816C839" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2016Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">39.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decreases related to prior year tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e3606-wk-Fact-7C62514F361077BE395BEB34A810123F" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increases related to current year tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3627-wk-Fact-F0066F1345FAA249BDAFEB34A811A43D" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decrease related to Tax Cuts and Jobs Act of 2017</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e3647-wk-Fact-2BEFC4309722BE1E8191EB34A8117864" name="dxcm:UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3668-wk-Fact-D31AEB213A6D0CD1C32BEB34A81339CD" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">22.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decreases related to prior year tax positions </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e3688-wk-Fact-06D8DC3585D8B544BA23EB34A810BE15" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increases related to current year tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3709-wk-Fact-5AF1606ABA3FF6F83DF0EB34A814A3A2" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3729-wk-Fact-27B8B3B6F9A9111AD171EB34A8149CEE" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decreases related to prior year tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37423883e3749-wk-Fact-CC72EA2176449C8895C2EB34A81B2345" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increases related to current year tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3770-wk-Fact-BE2AFCF560A1151A652AEB34A80FE4B5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3796-wk-Fact-BAB89C9FC14C5B3B46CEEB34A816297F" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">29.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due to the valuation allowance recorded against our deferred tax assets, </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37423883e3814-wk-Fact-EF432ACE9CC0253E3C61EB34A8332F98" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="INF" scale="6" format="ixt-sec:numwordsen">none</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> of the total unrecognized tax benefits as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> would reduce our annual effective tax rate if recognized. Interest and penalties are classified as a component of income tax expense and were not material for any period presented. Due to net operating losses incurred, tax years from 1999 and forward for federal and state purposes and from 2016 and forward for foreign jurisdictions remain open to examination by the major taxing jurisdictions to which we are subject. The IRS commenced an audit of our 2015 and 2016 federal income tax returns in February 2018. The audit closed in June 2019 with no significant changes to our unrecognized tax benefits. </span></div></ix:continuation><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><ix:continuation id="TextSelection-4907895FB7D4FFC36179EB34A8787544-4" continuedAt="TextSelection-4907895FB7D4FFC36179EB34A8787544-5"><span style="font-family:inherit;font-size:10pt;">We operate under a tax holiday in the Philippines, which is effective through December 31, 2023, and may be extended for another </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37423883e3828-wk-Fact-E3492262A6BC48CEACA30C0F510A8A69" name="dxcm:PossibleExtensionPeriodofTaxHoliday" contextRef="FD2019Q4YTD" format="ixt-sec:durwordsen">three years</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> if certain additional requirements are satisfied. The tax holiday is conditional upon remaining in good standing, committing no violation of PEZA Rules and Regulations, pertinent circulars and directives. The impact of this tax holiday decreased foreign taxes by </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37423883e3832-wk-Fact-ABAF6F845DA2D7CC08E20C101951E887" name="us-gaap:IncomeTaxHolidayAggregateDollarAmount" contextRef="FD2019Q4YTD_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction> million</span></span></ix:continuation><span style="font-family:inherit;font-size:10pt;"><ix:continuation id="TextSelection-4907895FB7D4FFC36179EB34A8787544-5"> in 2019.</ix:continuation> </span></div><div><a id="s5FB4ED629A685A87AEC98D7598E4E2E4"></a></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="TextSelection-47FF00A4BE190343F510EB34A8798E84-0-wk-Fact-51A9B6371E434975F49AEB34A82AC54E" continuedAt="TextSelection-47FF00A4BE190343F510EB34A8798E84-1" escape="true"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:18%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">9. Employee Benefit Plans and Stockholders&#8217; Equity</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">401(k) Plan </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have a defined contribution 401(k) retirement plan (the 401(k) Plan) covering substantially all employees in the United States that meet certain age requirements. Employees who participate in the 401(k) Plan may contribute up to </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e573-wk-Fact-5EC5C40A25DBF10C2E0EB038D0286970" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_A401kPlanMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> of their compensation each year, subject to Internal Revenue Service limitations and the terms and conditions of the plan. Under the terms of the 401(k) Plan, we may elect to match a discretionary percentage of contributions. In April 2018, we began matching </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e577-wk-Fact-A5BD1B79866E0A924F8CB0393E282A9B" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_A401kPlanMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">50</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> of contributions up to </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e581-wk-Fact-838A91B7A6288AEF9931B0395386D8BE" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_A401kPlanMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">4</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> of annual compensation. Total matching contributions were </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37425896e585-wk-Fact-01ADE38EEAB21B833AD1B038434A9165" name="us-gaap:DefinedContributionPlanCostRecognized" contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_A401kPlanMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.8</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37425896e589-wk-Fact-ADABFAAB1A722EA438D4B0386CB6F4F7" name="us-gaap:DefinedContributionPlanCostRecognized" contextRef="FD2018Q4YTD_us-gaap_PlanNameAxis_dxcm_A401kPlanMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.6</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Employee Stock Purchase Plan, or ESPP</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Under the 2015 Employee Stock Purchase Plan (the 2015 ESPP) eligible employees can purchase shares of our common stock at semi-annual intervals through periodic payroll deductions during defined Offering Periods. A total of up to </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e612-wk-Fact-45AED04D9A4E9632F4E7EB34A82604E8" name="dxcm:EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.5</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> shares may be issued under the 2015 ESPP and it expires upon the earliest to occur of (a) termination of the 2015 ESPP by our board of directors, (b) issuance of all of the shares of common stock reserved for issuance under the plan, or (c) May 28, 2025.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Payroll deductions may not exceed </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e619-wk-Fact-52A2877746EA071E2558EB34A82BBB5A" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" contextRef="FI2019Q4" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">10</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> of the participant&#8217;s cash compensation subject to certain limitations, and the purchase price will not be less than </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e623-wk-Fact-5CE8ADD4146143F5C1D8EB34A81E3CD1" name="dxcm:EmployeePurchasePriceFloorPercentage" contextRef="FD2019Q4YTD" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">85</ix:nonFraction>%</span></span><span style="font-family:inherit;font-size:10pt;"> of the lower of the fair market value of the common stock at either the beginning of the applicable Offering Period or the Purchase Date. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We issued </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e630-wk-Fact-AF8FF3E34A501230E5CEEB34A82BFA1F" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">150,408</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e634-wk-Fact-961A39551D2B6903FC93EB34A81FA130" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="FD2018Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">189,904</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e638-wk-Fact-DA0F0D6A8BA6836AE918EB34A82316A3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="FD2017Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">122,857</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> shares of common stock under the 2015 </span><span style="font-family:inherit;font-size:10pt;">ESPP</span><span style="font-family:inherit;font-size:10pt;"> during the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Equity Incentive Plans</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In May 2015, we adopted the </span><span style="font-family:inherit;font-size:10pt;">Amended and Restated 2015 Equity Incentive Plan (the 2015 Plan)</span><span style="font-family:inherit;font-size:10pt;">, which replaced our </span><span style="font-family:inherit;font-size:10pt;">2005 Equity Incentive Plan</span><span style="font-family:inherit;font-size:10pt;"> and provides for the grant of incentive and nonstatutory stock options, restricted stock, stock bonuses, stock appreciation rights, and restricted stock units to employees, directors or consultants of the Company. On May 30, 2019 our stockholders approved an increase to the maximum number of shares that may be issued under the </span><span style="font-family:inherit;font-size:10pt;">2015 Plan</span><span style="font-family:inherit;font-size:10pt;">. We are permitted to issue up to&#160;</span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e681-wk-Fact-09AE0A671B63BEA3024BEB34A82190CE" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="I2015Q2RSUsharesauthorized" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">9.8</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">&#160;shares under the </span><span style="font-family:inherit;font-size:10pt;">2015 Plan</span><span style="font-family:inherit;font-size:10pt;">. </span></div></ix:nonNumeric><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-35</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-47FF00A4BE190343F510EB34A8798E84-1" continuedAt="TextSelection-47FF00A4BE190343F510EB34A8798E84-2"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Treasury Stock</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Repurchased shares of our common stock are held as treasury shares until they are reissued or retired. When we reissue treasury stock, if the proceeds from the sale are more than the average price we paid to acquire the shares we record an increase in additional paid-in capital. Conversely, if the proceeds from the sale are less than the average price we paid to acquire the shares, we record a decrease in additional paid-in capital to the extent of increases previously recorded for similar transactions and a decrease in retained earnings for any remaining amount. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We issue new shares of common stock to satisfy option exercises and RSU vesting under our employee equity incentive plans. We have not yet determined the ultimate disposition of the </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e699-wk-Fact-FACDD6497EB1B013D269B036927DD4C3" name="us-gaap:TreasuryStockSharesAcquired" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> shares that we repurchased in 2018, and consequently we continue to hold them as treasury shares rather than retiring them. </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e703-wk-Fact-EB58685C53529C43005DB036C76520A5" name="us-gaap:TreasuryStockSharesAcquired" contextRef="FD2019Q4YTD" unitRef="shares" decimals="INF" scale="0" format="ixt-sec:numwordsen">No</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock were repurchased during </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Stock Options</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have not granted any stock options since 2010. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> we have </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e721-wk-Fact-B327273CA176C217F6ABEB34A82B99A0" name="dxcm:OptionsInMoneyNumber" contextRef="FD2019Q4YTD" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">28,385</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> options outstanding, all of which are in-the-money. The options have a weighted- average remaining contractual term of </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37425896e725-wk-Fact-8262E310A14B600DCCCD1BF88010D7AA" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member" format="ixt-sec:duryear">0.27</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> years, a weighted- average exercise price of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37425896e729-wk-Fact-F2CB27495A9BA3BFC611B0224AA0A202" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="FI2019Q4_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">10.11</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> per share, and an aggregate&#160;intrinsic value of </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37425896e733-wk-Fact-20EA6E56AF5007A1F4F7B0213B2B0D56" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="FI2019Q4_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.9</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">. The aggregate intrinsic value of options outstanding and exercisable is calculated as the difference between the exercise price of the underlying options and the </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37425896e738-wk-Fact-38658B29A4116696F1C7EB34A82D0A83" name="dxcm:InMoneyOptionsMaximumExercisePrice" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">218.74</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> per share market price of our common stock at </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="dxcm:ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock" id="TextSelection-9BD3FA0EE8ABFE4B141AEB34A879ECA8-0-wk-Fact-3208FAB92626E0D9A197EB34A81D4BDB" escape="true"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The total intrinsic value of stock options exercised as of the date of exercise was as follows:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:62%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intrinsic value of options exercised</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e945-wk-Fact-36196DEB50D6633F897FAFF359EABD46" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e964-wk-Fact-FA125FABE373BF5728DFAFF35A1DB2B9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e983-wk-Fact-FDF749842782EF21E0CFAFF35A045AE9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">21.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Restricted Stock Units (RSUs)</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU awards typically vest annually over </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;">four</span><span style="font-family:inherit;font-size:10pt;"> years and vesting is subject to continued services. <ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="TextSelection-123F24299A47DB3C1AC5EB34A87A4DDD-0-wk-Fact-BDAA686AA8A073013561EB34A828DC47" continuedAt="TextSelection-123F24299A47DB3C1AC5EB34A87A4DDD-1" escape="true">A summary of our RSU activity for the </ix:nonNumeric></span><ix:continuation id="TextSelection-123F24299A47DB3C1AC5EB34A87A4DDD-1" continuedAt="TextSelection-123F24299A47DB3C1AC5EB34A87A4DDD-2"><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> is as follows:</span></ix:continuation></div><ix:continuation id="TextSelection-123F24299A47DB3C1AC5EB34A87A4DDD-2"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:62%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions except weighted average grant date fair value)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted&#160;</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant&#160;Date</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair&#160;Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Intrinsic&#160;Value</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonvested at December 31, 2016</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1150-wk-Fact-2989D54369538F4F7CB3AFE654B1AAF7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2016Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">3.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1169-wk-Fact-A5CAE061FF9B7FAD8B0FAFE65845EF59" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2016Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">62.51</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1204-wk-Fact-AB4B04210CFAA5447E9EAFE65AE760DE" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1218-wk-Fact-2BFCEC91EB1F893729F3AFE65E21EA61" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">75.78</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37425896e1258-wk-Fact-61CD95205D6E920A4971AFE6606DBCD1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1273-wk-Fact-61E599F7B3F5D03268C6AFE66304A3BA" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">58.92</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37425896e1313-wk-Fact-440BB210F8BA5AFCDE79AFE6654EB7F1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1328-wk-Fact-DF8D81085310A352DEEAAFE667E7B116" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">67.97</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonvested at December 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1368-wk-Fact-FB81657A57B71D99BB50AFE3929E1E07" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">2.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1382-wk-Fact-B29FAF64843F0FC1EA9BAFE39486D572" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">70.68</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1406-wk-Fact-583AA432287A28D5D1C9AFE396798CCD" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">154.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1421-wk-Fact-5F6EE0CDAF973318E169AFE397C5886F" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1435-wk-Fact-5DD88508D88C63E40A74AFE399BA156B" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">66.07</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37425896e1475-wk-Fact-8443A7770428191345C2AFE39C55E754" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1490-wk-Fact-542D35F2CFBCA880012DAFE39E4E113E" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">68.44</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37425896e1530-wk-Fact-09B00032AF5A2B4EF202AFE3A0E3663E" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1545-wk-Fact-242F799AA579C05BC9B9AFE3A2D75647" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">68.56</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonvested at December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1585-wk-Fact-03F21B7766D96BDA0C1BAFE3A5776FB9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">2.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1599-wk-Fact-5B1AC85FFED66F75FED5AFE3A7662963" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">69.19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1618-wk-Fact-7FD4DA82BFE51CFC6143AFE3A959E456" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">319.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1638-wk-Fact-914359ABC42D94EFE35DAFE6CA03C25D" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1652-wk-Fact-E384FE21A79C5C02E517AFE6CC9ED176" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">144.37</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37425896e1693-wk-Fact-EF5AE6C2841BC0DB655BAFE6D05898CC" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1708-wk-Fact-3002C2BE54F6D69D719EAFE6D374E1F8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">69.45</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37425896e1748-wk-Fact-9879BE2F76FBB250725AAFE6D681169F" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1763-wk-Fact-AA1A73C08EE4DC596E70AFE6DA47C17A" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">83.45</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonvested at December 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1803-wk-Fact-9A26E2F4BC73A11C3EB6AFE6DE841DC6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1822-wk-Fact-187CE48D44AA13A5E448AFE6E1EC1693" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">96.63</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e1841-wk-Fact-BC657D178234EA37F3E2AFE6E50FAC68" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">392.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The total vest-date fair value of </span><span style="font-family:inherit;font-size:10pt;">RSUs</span><span style="font-family:inherit;font-size:10pt;"> vested was </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37425896e1862-wk-Fact-AB1D27AACB7F5F1B1830EB34A82AA032" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">207.2</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37425896e1866-wk-Fact-8EEB75C3C8E161E90966EB34A826FBE6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">120.9</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37425896e1870-wk-Fact-5DC838EE104079409B27EB34A82CEAF6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">144.5</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-36</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-47FF00A4BE190343F510EB34A8798E84-2" continuedAt="TextSelection-47FF00A4BE190343F510EB34A8798E84-3"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Common Stock Reserved for Future Issuance</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="dxcm:ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock" id="TextSelection-7E2D5ADF6E3A554786BDEB34A87905B4-0-wk-Fact-D15F2712839B2F4B6F62EB34A81D930F" escape="true"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shares of common stock reserved for future issuance were as follows as of the dated indicated:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:75%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options and awards under our plans:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options granted and outstanding</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2019-wk-Fact-197E462BC256D010B2EAAFE9F49B627B" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="FI2019Q4" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2033-wk-Fact-8BB1D5B8680EC54FE5A8AFE9F496A7B3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="FI2018Q4" unitRef="shares" decimals="1" scale="0" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unvested restricted stock units</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2048-wk-Fact-218A80B716EEF4609A02AFEA04B9E91A" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2019Q4" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2062-wk-Fact-815F9D07C6C5BF480B06AFEA04C6BB9F" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2018Q4" unitRef="shares" decimals="1" scale="0" format="ixt:numdotdecimal">2.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reserved for future grant</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2077-wk-Fact-E189AB783045FA60D59FAFEA12BAF662" name="dxcm:StockOptionsReservedForFutureGrant" contextRef="FI2019Q4" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">4.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2091-wk-Fact-D72DCECE867085C9087BAFEA12DE3DA9" name="dxcm:StockOptionsReservedForFutureGrant" contextRef="FI2018Q4" unitRef="shares" decimals="1" scale="0" format="ixt:numdotdecimal">3.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Employee Stock Purchase Plan</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2106-wk-Fact-5160637AFBCD98D267A0AFEA27A47CA5" name="dxcm:EmployeeStockPurchasePlanEsppSharesInEspp" contextRef="FI2019Q4" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2120-wk-Fact-47A96266CAFCD7EC335AAFEA27C44D76" name="dxcm:EmployeeStockPurchasePlanEsppSharesInEspp" contextRef="FI2018Q4" unitRef="shares" decimals="1" scale="0" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2135-wk-Fact-57D189EA2EB0F989638FAFEA39EB0099" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="FI2019Q4" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">7.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2149-wk-Fact-7F6FE4A12ECCCFBAB0B4AFEA39E71F32" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="FI2018Q4" unitRef="shares" decimals="1" scale="0" format="ixt:numdotdecimal">7.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Share-based Compensation</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="TextSelection-DDEC5BE132450A77D6EEEB34A879D68D-0-wk-Fact-743DCAD12EC3A6011374EB34A8230DCA" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes share-based compensation expense related to restricted stock units and employee stock purchases under the ESPP for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:59%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2346-wk-Fact-8AF920AFA15751A2A4E484827F3AFA16" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2365-wk-Fact-3E03D3B2542458E3AC3A61F3780C0E8B" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2384-wk-Fact-995F17D324DDB478B94DEB34A7FE9852" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2400-wk-Fact-32CAA734830E5DB193A726D5AAD0EF03" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">33.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2419-wk-Fact-9D44A94B59C857E2924118C568A72CD8" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">33.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2438-wk-Fact-46541E1D85B760448189EB34A7FE7A30" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">37.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Selling, general and administrative</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2459-wk-Fact-7B0D8A09FF785B91B3E19CED8C851F46" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_dxcm_SellingGeneralAndAdministrativeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">60.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2478-wk-Fact-007535EC3C4A588C84F66E0EF22965A4" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_dxcm_SellingGeneralAndAdministrativeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">59.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2497-wk-Fact-91C2E83A4CA93B549B8AEB34A80E6574" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_dxcm_SellingGeneralAndAdministrativeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">59.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total share-based compensation expense included in net loss</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2523-wk-Fact-E427ED85215AA224DF80CA56F0C97C52" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">102.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2542-wk-Fact-043FBC581574D1ED5455CA56F4356D16" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">101.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2561-wk-Fact-A2340A667760A58AD00DCA56F724D3B2" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">106.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="TextSelection-E46D2227CA197343E37DEB34A8798288-0-wk-Fact-7A47DEA6762E6EAF57CFEB34A81C38D3" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We estimate the fair value of ESPP purchase rights on the date of grant using the Black-Scholes option pricing model and the assumptions below for the specified reporting periods. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:62%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Risk free interest rate</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.72 - 2.55</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.55&#160;&#8211;&#160;2.25</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75&#160;&#8211;&#160;1.12</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividend yield</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2733-wk-Fact-A46B9D1F3DC51CCD2D97EB34A811D1B0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" unitRef="number" decimals="2" scale="-2" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2748-wk-Fact-E4C0B701CC0AF3E1E52BEB34A817288F" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="FD2018Q4QTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" unitRef="number" decimals="2" scale="-2" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37425896e2763-wk-Fact-BD3EB197660991E13585EB34A811C04C" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="FD2017Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" unitRef="number" decimals="2" scale="-2" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected volatility of DexCom common stock</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.40 - 0.51</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.50&#160;&#8211;&#160;0.67</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.33&#160;&#8211;&#160;0.56</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected life (in years)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37425896e2822-wk-Fact-3F9E646D68C636836335EB34A814EE1E" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" format="ixt-sec:duryear">1</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37425896e2836-wk-Fact-B27DBA6D4F64E0F00E75EB34A80E446A" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="FD2018Q4QTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" format="ixt-sec:duryear">1</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d37425896e2850-wk-Fact-32153104B55018405C6BEB34A8158C34" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="FD2017Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember" format="ixt-sec:duryear">1</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><ix:continuation id="TextSelection-47FF00A4BE190343F510EB34A8798E84-3" continuedAt="TextSelection-47FF00A4BE190343F510EB34A8798E84-4"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, unrecognized estimated compensation costs related to unvested restricted stock units and ESPP shares totaled </span><span style="font-family:inherit;font-size:10pt;"><span>$<ix:nonFraction id="d37425896e2865-wk-Fact-2A5270FAEF1D5C9E80AFCE9FF9956AC7" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">119.3</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> and are expected to be recognized through </span><span style="font-family:inherit;font-size:10pt;">2022</span></ix:continuation><span style="font-family:inherit;font-size:10pt;"><ix:continuation id="TextSelection-47FF00A4BE190343F510EB34A8798E84-4">.</ix:continuation> </span></div><div><a id="s925459F5250A5ECA836BF855863D92A0"></a></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:SegmentReportingDisclosureTextBlock" id="TextSelection-EDE4D99A6FD682620F32EB34A87A8DE5-0-wk-Fact-B98DB52E389D0DD725B1EB34A8209755" continuedAt="TextSelection-EDE4D99A6FD682620F32EB34A87A8DE5-1" escape="true"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:18%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:22%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">10. Business Segment and Geographic Information</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Reportable Segments</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">An operating segment is identified as a component of a business that has discrete financial information available and for which the chief operating decision maker must decide the level of resource allocation. In addition, the guidance for segment reporting indicates certain quantitative materiality thresholds. None of the components of our business meet the definition of an operating segment. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We currently consider our operations to be, and manage our business globally within, </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e573-wk-Fact-95CB2618983E036D9E04EB34A821842D" name="us-gaap:NumberOfReportableSegments" contextRef="FD2019Q4YTD" unitRef="segment" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction></span></span><span style="font-family:inherit;font-size:10pt;"> reportable segment, which is consistent with how our President and Chief Executive Officer, who is our chief operating decision maker, reviews our business, makes investment and resource allocation decisions, and assesses operating performance.</span></div></ix:nonNumeric><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-37</span></div></div><hr style="page-break-after:always"></hr><div><br/></div><ix:continuation id="TextSelection-EDE4D99A6FD682620F32EB34A87A8DE5-1"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Disaggregation of Revenue </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DexCom is domiciled in the United States. We sell our CGM systems through a direct sales force in the United States, Canada and some countries in Europe, and through distribution arrangements in the </span><span style="font-family:inherit;font-size:10pt;">United States, and certain countries in Africa, Asia, Europe, Latin America, and the Middle East, as well as Australia, Canada, and New Zealand</span><span style="font-family:inherit;font-size:10pt;">. We disaggregate our revenue from contracts by geography and by major sales channel as we believe they best depict how the nature, amount and timing of revenues and cash flows are affected by economic factors. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Revenues by geographic region</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, no individual country outside the United States generated revenue that represented more than 10% of our total revenue. <ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="TextSelection-6474802CD379ECB54E71EB34A87AF2AA-0-wk-Fact-CAF5133436D951E618E5EB34A820265A" continuedAt="TextSelection-6474802CD379ECB54E71EB34A87AF2AA-1" escape="true">The following table sets forth revenues by our two primary geographical markets, the United States and outside of the United States, based on the geographic location to which we deliver the product:</ix:nonNumeric></span></div><ix:continuation id="TextSelection-6474802CD379ECB54E71EB34A87AF2AA-1"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.0234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"></td></tr><tr><td style="width:41%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="20" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1082-wk-Fact-0529A0F449D25630B4FA8C2210724B24" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,161.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1096-wk-Fact-15A65B88B8D747AB268CEB34A8330684" name="dxcm:RevenuePercentage" contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">79</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1116-wk-Fact-847E2EDCF7FD57EE8135965599D81A45" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">818.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1131-wk-Fact-D3FFBF005BE968D5E9D9EB34A833F66E" name="dxcm:RevenuePercentage" contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">79</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1151-wk-Fact-F29000C17B9338CADCACEB34A8338734" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">596.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1165-wk-Fact-CC539047C07390B9A838EB34A83335D4" name="dxcm:RevenuePercentage" contextRef="FD2017Q4YTD_srt_StatementGeographicalAxis_country_US" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">83</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outside of the United States</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1181-wk-Fact-E6E649A906E95C96A9E863CA625D9876" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">314.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1200-wk-Fact-4794504DAFA11564DEAAEB34A833390A" name="dxcm:RevenuePercentage" contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">21</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1215-wk-Fact-117272D5CA54547FABC8D5FDCCCCFC74" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">213.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1235-wk-Fact-DDCAE03C4E45E3796062EB34A83348E7" name="dxcm:RevenuePercentage" contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">21</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1250-wk-Fact-A305D6DCE224D9C7C8C3EB34A8335913" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">122.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1269-wk-Fact-308A6FF6B2F45B378E8EEB34A8332E68" name="dxcm:RevenuePercentage" contextRef="FD2017Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1290-wk-Fact-64400440AC62A8CA769BEB34A85294A0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,476.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1304-wk-Fact-034D50E26A171F22FEC4EB34A8339404" name="dxcm:RevenuePercentage" contextRef="FD2019Q4YTD" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1324-wk-Fact-D38A90028A2F0CC3FFCBEB34A7EE80E4" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,031.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1339-wk-Fact-91B80C5916C3992B2C57EB34A8334718" name="dxcm:RevenuePercentage" contextRef="FD2018Q4YTD" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1359-wk-Fact-691FD3D368229313BD9DEB34A84333BF" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">718.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1373-wk-Fact-A1C63F52C715EC12449AEB34A83304B0" name="dxcm:RevenuePercentage" contextRef="FD2017Q4YTD" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The majority of our long-lived assets are located in the United States.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Revenues by customer sales channel</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="TextSelection-E63EF59377F57FDE659BEB34A87AF53A-0-wk-Fact-ECAE2BBCEE6FBB022C90EB34A8212BF6" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table sets forth revenues by major sales channel for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.0234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"></td></tr><tr><td style="width:41%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="20" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Distributor</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1882-wk-Fact-2199CDA4F3005E8D805A721BD5846F6C" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,011.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1896-wk-Fact-8759A6C3631F8EB9A307EB34A833A3F0" name="dxcm:RevenuePercentage" contextRef="FD2019Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">69</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1916-wk-Fact-320B097885D951D2B62CBA49A3FFBE73" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">652.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1931-wk-Fact-B8590379B3A0FBCC7BAEEB34A8430818" name="dxcm:RevenuePercentage" contextRef="FD2018Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">63</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1951-wk-Fact-32985E8D12DA82F2D183EB34A833B906" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">538.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1965-wk-Fact-9411A475BE792C6F4AD3EB34A8336733" name="dxcm:RevenuePercentage" contextRef="FD2017Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Direct</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e1981-wk-Fact-BCF1290C6FA253269B8623CCA1C1BCEA" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">464.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e2000-wk-Fact-4327ECE5E3B6890BAF2FEB34A8339051" name="dxcm:RevenuePercentage" contextRef="FD2019Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">31</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e2015-wk-Fact-F1BECDBC82475C83AC225878DCF864FD" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">378.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e2035-wk-Fact-94B0378D4CFD5F1CBB3BEB34A83356D8" name="dxcm:RevenuePercentage" contextRef="FD2018Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">37</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e2050-wk-Fact-7CF9EFB6CE56887818A7EB34A83360D8" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">180.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e2069-wk-Fact-0806E4AA1244C3E77280EB34A843792D" name="dxcm:RevenuePercentage" contextRef="FD2017Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">25</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e2090-wk-Fact-64400440AC62A8CA769BEB34A85294A0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,476.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e2104-wk-Fact-DE8825F124A33B1DEE1DEB34A833B2F5" name="dxcm:RevenuePercentage" contextRef="FD2019Q4YTD" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e2124-wk-Fact-D38A90028A2F0CC3FFCBEB34A7EE80E4" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,031.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e2139-wk-Fact-2D00262ECEA9DBFB6BEEEB34A833E60F" name="dxcm:RevenuePercentage" contextRef="FD2018Q4YTD" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e2159-wk-Fact-691FD3D368229313BD9DEB34A84333BF" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">718.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37426741e2173-wk-Fact-6A3E02FE759DF572D676EB34A8431CC6" name="dxcm:RevenuePercentage" contextRef="FD2017Q4YTD" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-38</span></div></div><hr style="page-break-after:always"></hr><div><a id="sDF517F1B0C0B586DADB10EA4933E36A3"></a></div><div><br/></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="TextSelection-26EDAAC837412722AE8FEB34A87AF34D-0-wk-Fact-1F02B5A3AF2642325175EB34A8275FC4" escape="true"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">11. Quarterly Financial Information (Unaudited)</span></div></td></tr></table></div></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" id="TextSelection-ADDBFA91D5E1310C51E7EB34A87A45C3-0-wk-Fact-1742CA2AE07F0492CD68EB34A826A29C" escape="true"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following is a summary of our quarterly results of operations for the years ended </span><span style="font-family:inherit;font-size:10pt;">December 31,</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"></td></tr><tr><td style="width:48%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">For the Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions except per share data)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Year ended December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e894-wk-Fact-C32A191D8E5691CB3A7CAF706098F79E" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">462.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e913-wk-Fact-F348F7E20F46E2AEBF08AF7060FB14FE" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">396.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e933-wk-Fact-F9454993FB4FDAA69CD3AF7060F007D9" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">336.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e952-wk-Fact-B704D960ECF351BC8A03AF70609F9471" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">280.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gross profit </span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e972-wk-Fact-5CEADA9A57C6DF3F91FDAF707BEBEF97" name="us-gaap:GrossProfit" contextRef="FD2019Q4QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">309.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e991-wk-Fact-9851C42F7E3C0F7E52C2AF707C724E9A" name="us-gaap:GrossProfit" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">246.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1010-wk-Fact-83758626A1FDC19008C7AF707BE7BA99" name="us-gaap:GrossProfit" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">206.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1030-wk-Fact-C5B5BBF8F9D75F182CABAF707BF2B63D" name="us-gaap:GrossProfit" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">168.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating expenses </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1055-wk-Fact-75D7CD8747C9656A427CAF708FAD37F2" name="us-gaap:OperatingExpenses" contextRef="FD2019Q4QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">207.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1074-wk-Fact-D0FAD13B0294221FD500AF708FA17A73" name="us-gaap:OperatingExpenses" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">190.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1093-wk-Fact-46F71BCD559E3AE7B1A0AF708FA68BD8" name="us-gaap:OperatingExpenses" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">207.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1113-wk-Fact-9C75CB75C7D40861BACFAF708FB996A4" name="us-gaap:OperatingExpenses" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">183.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1138-wk-Fact-CFBF2F29E076D53036DEAF70A5439989" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">92.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1157-wk-Fact-9848FC188CE3A436E4A7AF70A5A36B88" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">45.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37428561e1176-wk-Fact-70C94A9280690D6835B0AF70A5971FB7" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">10.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37428561e1197-wk-Fact-910F76DFCEF5A5C8872BAF70A53E0F6A" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">26.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic net income (loss) per share </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1230-wk-Fact-390852B2FC4C148EB388AF70BE1AF5C5" name="us-gaap:EarningsPerShareBasic" contextRef="FD2019Q4QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.01</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1249-wk-Fact-9F392EE649D7DCF640C2AF70BDC37647" name="us-gaap:EarningsPerShareBasic" contextRef="FD2019Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.50</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37428561e1269-wk-Fact-4E192321AABA61FC3B15AF70BDA911D7" name="us-gaap:EarningsPerShareBasic" contextRef="FD2019Q2QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37428561e1289-wk-Fact-FE3E7B9F718E640461CCAF70BDCA445B" name="us-gaap:EarningsPerShareBasic" contextRef="FD2019Q1QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.30</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted net income (loss) per share </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1317-wk-Fact-FC35D2700685C4E53212AF70D8E3BB62" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2019Q4QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.00</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1336-wk-Fact-1AE429202B1019C42837AF70D8FBFB0B" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2019Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.50</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37428561e1356-wk-Fact-F9228ADEDB60EC481F6EAF70D8E67D09" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2019Q2QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37428561e1376-wk-Fact-048623D6DED3B998F0FBAF70D8F020BA" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2019Q1QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.30</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Year ended December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1577-wk-Fact-5D8D1F61B24D3EAC7C19AF71122BFF6C" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">338.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1596-wk-Fact-CA5F790655241F2374B9AF7113999E36" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">266.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1616-wk-Fact-A9EBDF1028B7AE2945FEAF711519FDAA" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">242.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1635-wk-Fact-5389E2552BECA1014B3EAF7117D5E534" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">184.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gross profit </span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1655-wk-Fact-C2A4A6BFECD040CCE04CAF7119228ED6" name="us-gaap:GrossProfit" contextRef="FD2018Q4QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">222.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1674-wk-Fact-22BD2980D185A0E95256AF711AA0A700" name="us-gaap:GrossProfit" contextRef="FD2018Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">168.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1693-wk-Fact-88AA07EAF63F87FC1475AF711D0BFD3F" name="us-gaap:GrossProfit" contextRef="FD2018Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">153.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1713-wk-Fact-67F41AC134671AD14850AF711FA49367" name="us-gaap:GrossProfit" contextRef="FD2018Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">118.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating expenses </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1738-wk-Fact-929C2472CF1B52E00DD2AF71207CBDDF" name="us-gaap:OperatingExpenses" contextRef="FD2018Q4QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">387.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1757-wk-Fact-E1BDD579ED81DA050AD0AF7121EC30F1" name="us-gaap:OperatingExpenses" contextRef="FD2018Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">154.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1776-wk-Fact-877160596068C5C264CDAF7124358BB9" name="us-gaap:OperatingExpenses" contextRef="FD2018Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">158.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1796-wk-Fact-E47CE328603EBC0D1A08AF7126CF55BA" name="us-gaap:OperatingExpenses" contextRef="FD2018Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">149.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37428561e1821-wk-Fact-228E3322AE224496B4C2AF7127A5880D" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q4QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">179.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1841-wk-Fact-263112A10754A591127AAF71291C6FB9" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">46.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1860-wk-Fact-A8F184D9EB9EBFA93707AF712B8D2EB3" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37428561e1880-wk-Fact-0AFBF0B5C959F3FE0B79AF712E28C74B" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q1QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">24.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic net income (loss) per share </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37428561e1913-wk-Fact-9B631464B7D468676E5AAF712EF00240" name="us-gaap:EarningsPerShareBasic" contextRef="FD2018Q4QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">2.03</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1933-wk-Fact-CF2F667FC4076727F977AF71306F6899" name="us-gaap:EarningsPerShareBasic" contextRef="FD2018Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.53</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e1953-wk-Fact-0291485843EB190FDB1BAF71335EA507" name="us-gaap:EarningsPerShareBasic" contextRef="FD2018Q2QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.34</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37428561e1972-wk-Fact-1CF712C3F6D1FE9FBDA9AF7135529691" name="us-gaap:EarningsPerShareBasic" contextRef="FD2018Q1QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.28</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted net income (loss) per share </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37428561e2000-wk-Fact-C5B326FB3FC21467E989AF7136A2FCE5" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2018Q4QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">2.03</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e2020-wk-Fact-3810ADD528B8F23D85E1AF7139397B81" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2018Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.52</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37428561e2040-wk-Fact-3ABB046CA2AFF2A921D2AF713B2E0EB0" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2018Q2QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.34</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37428561e2059-wk-Fact-2BA838386739F883C665AF713C9B08E3" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2018Q1QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.28</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></span><span style="font-family:inherit;font-size:10pt;">Basic and diluted earnings per share are computed independently for each of the quarters presented. Therefore, the sum of quarterly basic and diluted per share information may not equal annual basic and diluted earnings per share.</span></div></ix:nonNumeric></ix:nonNumeric><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-39</span></div></div><hr style="page-break-after:always"></hr><div><a id="s7930978499EA5312B98C7AB71C77B78B"></a></div><div><br/></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="TextSelection-778A2E8DE7641F8A70B1EB34A87A2EF6-0-wk-Fact-BC7BC6ED0274612CAE6BEB34A7FEA3E4" escape="true"><div style="line-height:120%;padding-bottom:2px;padding-top:2px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">DexCom, Inc.</span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">SCHEDULE II</span><span style="font-family:inherit;font-size:10pt;color:#ffffff;">&#160;&#8211; </span><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">VALUATION AND QUALIFYING ACCOUNTS</span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">(In millions)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:9pt;">&#160;</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:88%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Allowance for doubtful accounts</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2016</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37429337e690-wk-Fact-C43F04A857B3CE8063CDEB34A821E4FD" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2016Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Provision for doubtful accounts</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37429337e705-wk-Fact-31E2C919F92B159B029CEB34A81200D6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Write-offs and adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37429337e725-wk-Fact-95C1290344FAA9991E9CEB34A843FB66" name="dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recoveries</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37429337e746-wk-Fact-C751DDF1754E1A00DE42EB34A8336F56" name="us-gaap:ValuationAllowancesAndReservesRecoveries" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37429337e771-wk-Fact-E93033BEAE2444EEF655EB34A833DA9B" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:88%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Allowance for doubtful accounts</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37429337e844-wk-Fact-E93033BEAE2444EEF655EB34A833DA9B" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Provision for doubtful accounts</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37429337e859-wk-Fact-826EE0F8FB0BD4F4BA10EB34A8335E46" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Write-offs and adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37429337e879-wk-Fact-005C8AE26AA9D145B580EB34A833AAE9" name="dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recoveries</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37429337e900-wk-Fact-D11AEC1D7BA6453B0A06EB34A84327B3" name="us-gaap:ValuationAllowancesAndReservesRecoveries" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37429337e925-wk-Fact-43C128D7D6BC16E4F687EB34A843042A" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:88%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Allowance for doubtful accounts</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37429337e998-wk-Fact-43C128D7D6BC16E4F687EB34A843042A" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Provision for doubtful accounts</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37429337e1013-wk-Fact-7DA406F60E64DB890548EB34A81CF224" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Write-offs and adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(<ix:nonFraction id="d37429337e1033-wk-Fact-6C71865AC4CA586AB116EB34A843F413" name="dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recoveries</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37429337e1054-wk-Fact-B4720B22CE982B1F9179EB34A8435047" name="us-gaap:ValuationAllowancesAndReservesRecoveries" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonFraction id="d37429337e1079-wk-Fact-567C4B0102E7D0C446EAEB34A8432D01" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">F-40</span></div></div>	</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.04
<SEQUENCE>2
<FILENAME>dxcm12312019exhibit404.htm
<DESCRIPTION>EXHIBIT 4.04
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s48CBE73DB43B8CDF7A2F1BA6A74E08A7"></a></div><div><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">EXHIBIT 4.04</font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">EXCHANGE ACT OF 1934</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">As of December 31, 2019, DexCom, Inc. (the &#8220;Company,&#8221; &#8220;we&#8221; or &#8220;our&#8221;) had one class of securities registered under Section 12 of the Securities Exchange Act of 1934: our common stock. </font></div><div style="line-height:120%;padding-top:24px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Description of Capital Stock</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following summary of the terms of our capital stock is based upon our restated certificate of incorporation, as amended, and our restated bylaws. The summary is not complete, and is qualified by reference to our restated certificate of incorporation, the certificate of amendment to the certificate of incorporation and our restated bylaws, which are filed as exhibits to this Annual Report on Form 10-K and are incorporated by reference herein. We encourage you to read our restated certificate of incorporation, the certificate of amendment to the certificate of incorporation, our restated bylaws and the applicable provisions of the Delaware General Corporation Law, or DGCL, for additional information.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">General </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">We have authorized capital stock consisting of 200,000,000 shares of common stock, $0.001 par value per share, and 5,000,000 shares of undesignated preferred stock, $0.001 par value per share. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Common Stock </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Dividend rights </font></div><div style="line-height:120%;padding-top:5px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Subject to preferences that may apply to any shares of preferred stock outstanding at the time, the holders of our common stock are entitled to receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends and then only at the times and in the amounts that our board of directors may determine. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Voting rights </font></div><div style="line-height:120%;padding-top:5px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">No preemptive or similar rights </font></div><div style="line-height:120%;padding-top:5px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Our common stock is not entitled to preemptive rights, and is not subject to conversion, redemption or sinking fund provisions. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Right to receive liquidation distributions </font></div><div style="line-height:120%;padding-top:5px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Upon our liquidation, dissolution or winding-up, the assets legally available for distribution to our stockholders would be distributable ratably among the holders of our common stock and any participating preferred stock outstanding at that time, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights of and the payment of liquidation preferences, if any, on any outstanding shares of preferred stock.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div><div style="line-height:100%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:5px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Preferred Stock </font></div><div style="line-height:120%;padding-top:5px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Our board of directors is authorized, subject to limitations prescribed by the DGCL, to issue from time to time up to 5,000,000 shares of preferred stock in one or more series, to establish from time to time the number of shares to be included in each series and to fix the designation, powers, preferences and rights of the shares of each series and any of their qualifications, limitations or restrictions, in each case without further vote or action by our stockholders. Our board of directors is also able to increase or decrease the number of shares of any series of preferred stock, but not below the number of shares of that series then outstanding, without any further vote or action by our stockholders. Our board of directors may be able to authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in control of our company and might adversely affect the market price of our common stock and the voting and other rights of the holders of our common stock. We have no current plan to issue any shares of preferred stock. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Anti-Takeover Provisions </font></div><div style="line-height:120%;padding-top:5px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The provisions of the DGCL, our restated certificate of incorporation, as amended, and our restated bylaws could have the effect of delaying, deferring or discouraging another person from acquiring control of our company. These provisions, which are summarized below, may have the effect of discouraging takeover bids. They are also designed, in part, to encourage persons seeking to acquire control of us to negotiate first with our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with an unfriendly or unsolicited acquirer outweigh the disadvantages of discouraging a proposal to acquire us because negotiation of these proposals could result in an improvement of their terms. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Delaware Law </font></div><div style="line-height:120%;padding-top:5px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">We are subject to the provisions of Section 203 of the DGCL regulating corporate takeovers. In general, DGCL Section 203 prohibits a publicly held Delaware corporation from engaging in a business combination with an interested stockholder for a period of three years following the date on which the person became an interested stockholder unless: </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, but not the outstanding voting stock owned by the interested stockholder, (i) shares owned by persons who are directors and also officers and (ii) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">at or subsequent to the date of the transaction, the business combination is approved by the board of directors of the corporation and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66.67% of the outstanding voting stock that is not owned by the interested stockholder. Generally, a business combination includes a merger, asset or stock sale, or other transaction or series of transactions together resulting in a financial benefit to the interested stockholder. An interested stockholder is a person who, together with affiliates and associates, owns or, within three years prior to the determination of interested stockholder status, did own 15% or more of a corporation&#8217;s outstanding voting stock. We expect the existence of this provision to have an anti-takeover effect with respect to transactions our board of directors does not approve in advance. We also anticipate that DGCL Section 203 may also discourage attempts that might result in a premium over the market price for the shares of common stock held by stockholders.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div><div style="line-height:100%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Restated Certificate of Incorporation and Restated Bylaws Provisions </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div><div style="line-height:100%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:5px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Our restated certificate of incorporation, as amended, and our restated bylaws include a number of provisions that could deter hostile takeovers or delay or prevent changes in control of our company, including the following: </font></div><div style="line-height:120%;padding-left:4px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:91.61793372319687%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:99%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:16px;text-align:justify;padding-left:48px;text-indent:-24px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Board of directors vacancies.</font><font style="font-family:inherit;font-size:11pt;">&#160;Our restated certificate of incorporation, as amended, and restated bylaws authorize only our board of directors to fill vacant directorships, including newly created seats. In addition, the number of directors constituting our board of directors is permitted to be set only by a resolution adopted by a majority vote of our entire board of directors. These provisions would prevent a stockholder from increasing the size of our board of directors and then gaining control of our board of directors by filling the resulting vacancies with its own nominees. This makes it more difficult to change the composition of our board of directors but promotes continuity of management. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;padding-left:48px;text-indent:-24px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Classified board.</font><font style="font-family:inherit;font-size:11pt;">&#160;Our restated certificate of incorporation, as amended, and restated bylaws provide that our board of directors will be classified into three classes of directors, each with staggered three-year terms. A third party may be discouraged from making a tender offer or otherwise attempting to obtain control of us as it is more difficult and time consuming for stockholders to replace a majority of the directors on a classified board of directors. </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;padding-left:48px;text-indent:-24px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Stockholder action; special meetings of stockholders.</font><font style="font-family:inherit;font-size:11pt;">&#160;Our restated certificate of incorporation, as amended, provides that our stockholders may not take action by written consent, but may only take action at annual or special meetings of our stockholders. As a result, a holder controlling a majority of our capital stock would not be able to amend our restated bylaws or remove directors without holding a meeting of our stockholders called in accordance with our restated bylaws. Further, our restated bylaws and restated certificate of incorporation, as amended, provide that special meetings of our stockholders may be called only by a majority of our board of directors, the chairman of our board of directors, our Chief Executive Officer, our President or our Lead Independent Director, thus prohibiting a stockholder from calling a special meeting. These provisions might delay the ability of our stockholders to force consideration of a proposal or for stockholders controlling a majority of our capital stock to take any action, including the removal of directors. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;padding-left:48px;text-indent:-24px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Advance notice requirements for stockholder proposals and director nominations.</font><font style="font-family:inherit;font-size:11pt;">&#160;Our restated bylaws provide advance notice procedures for stockholders seeking to bring business before our annual meeting of stockholders or to nominate candidates for election as directors at our annual meeting of stockholders. Our restated bylaws also specify certain requirements regarding the form and content of a stockholder&#8217;s notice. These provisions might preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our annual meeting of stockholders if the proper procedures are not followed. We expect that these provisions might also discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#8217;s own slate of directors or otherwise attempting to obtain control of our company. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;padding-left:48px;text-indent:-24px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">No cumulative voting.</font><font style="font-family:inherit;font-size:11pt;">&#160;The DGCL provides that stockholders are not entitled to the right to cumulate votes in the election of directors unless a corporation&#8217;s certificate of incorporation provides otherwise. Our restated certificate of incorporation, as amended, does not provide for cumulative voting. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;padding-left:48px;text-indent:-24px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Directors removed only for cause.</font><font style="font-family:inherit;font-size:11pt;">&#160;Our restated certificate of incorporation, as amended, provides that stockholders may remove directors only for cause and only by the affirmative vote of the holders of at least two-thirds of our outstanding common stock. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;padding-left:48px;text-indent:-24px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Issuance of undesignated preferred stock.</font><font style="font-family:inherit;font-size:11pt;">&#160;Our board of directors has the authority, without further action by the stockholders, to issue up to 5,000,000 shares of undesignated preferred stock with rights and preferences, including voting rights, designated from time to time by our board of directors. The existence of authorized but unissued shares of preferred stock would enable our board of directors to render more difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or other means. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Exchange Listing </font></div><div style="line-height:120%;padding-top:5px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Our common stock is listed on The Nasdaq Global Select Market under the symbol &#8220;DXCM.&#8221;</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div><div style="line-height:100%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.36
<SEQUENCE>3
<FILENAME>dxcm12312019exhibit1036.htm
<DESCRIPTION>EXHIBIT 10.36
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sab664fe8c80f4e4cae23bed17cb454b1"></a></div><div><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">EXHIBIT 10.36</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Form of RSU Grant Agreement &#8211; Board Members - Annual Grant </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">DEXCOM INC.</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">NOTICE OF RESTRICTED STOCK UNIT AWARD</font></div><div style="line-height:120%;padding-bottom:13px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">GRANT NUMBER:  </font><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:13px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Unless otherwise defined herein, the terms defined in the DexCom, Inc.</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:11pt;">(the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Company</font><font style="font-family:inherit;font-size:11pt;">&#8221;) 2015 Equity Incentive Plan (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Plan</font><font style="font-family:inherit;font-size:11pt;">&#8221;) shall have the same meanings in this Notice of Restricted Stock Unit Award (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Notice</font><font style="font-family:inherit;font-size:11pt;">&#8221;).  </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;padding-left:144px;text-indent:-96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Name:&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;padding-left:144px;text-indent:-96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Address:&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">You (&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Participant</font><font style="font-family:inherit;font-size:11pt;">&#8221;) have been granted an award of Restricted Stock Units (&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">RSUs</font><font style="font-family:inherit;font-size:11pt;">&#8221;) under the Plan subject to the terms and conditions of the Plan, this Notice and the attached Award Agreement (Restricted Stock Units) (hereinafter &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">RSU Agreement</font><font style="font-family:inherit;font-size:11pt;">&#8221;).</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;padding-left:258px;text-indent:-211px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Number of RSUs:</font><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;padding-left:258px;text-indent:-211px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Date of Grant:</font><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;padding-left:258px;text-indent:-211px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Vesting Commencement Date:&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:258px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:48px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Expiration Date:</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The date on which settlement of all RSUs granted hereunder occurs, with earlier expiration upon the Termination Date</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:48px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Vesting Schedule:</font><font style="font-family:inherit;font-size:11pt;">&#32;&#32;</font></div></td><td style="vertical-align:top;padding-left:210.66666666666666px;"><div style="line-height:120%;text-align:justify;font-size:11pt;text-indent:-210.66666666666666px;"><font style="font-family:inherit;font-size:11pt;">Subject to the limitations set forth in this Notice, the Plan and the RSU Agreement, the RSUs will vest in accordance with the following schedule:  </font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">in one annual installment (i.e., 100% of the RSUs subject to this Notice will vest upon the first anniversary of the Date of Grant).</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:48px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Corporate Transaction:</font></div></td><td style="vertical-align:top;padding-left:210.66666666666666px;"><div style="line-height:120%;text-align:justify;font-size:11pt;text-indent:-210.66666666666666px;"><font style="font-family:inherit;font-size:11pt;">If a Corporate Transaction occurs then the vesting and (if applicable) exercisability of the RSUs shall be accelerated in full and any reacquisition or repurchase rights held by the Company with respect to the shares of Common Stock subject to such acceleration shall lapse in full, as appropriate.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:13px;text-align:justify;padding-left:258px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Corporate Transaction</font><font style="font-family:inherit;font-size:11pt;">&#8221; means the occurrence of any of the following events: (i) any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the Company&#8217;s then-outstanding voting securities; provided, however, that for purposes of this subclause (i) the acquisition of additional securities by any one Person who is considered to own more than fifty percent (50%) of the total voting power of the securities of the Company will not be considered a Corporate Transaction; (ii) the consummation of the sale, transfer or disposition by the Company of all or substantially all of the Company&#8217;s assets; (iii) the consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) more than fifty percent (50%) of the total voting power </font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;padding-left:258px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation; (iv) any other transaction which qualifies as a &#8220;corporate transaction&#8221; under Section 424(a) of the Code wherein the stockholders of the Company give up all of their equity interest in the Company (except for the acquisition, sale or transfer of all or substantially all of the outstanding shares of the Company) or (v) a change in the effective control of the Company that occurs on the date that a majority of members of the Board is replaced during any twelve (12) month period by members of the Board whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election.  For purpose of this subclause (v), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Corporate Transaction.  For purposes of this definition, Persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. Notwithstanding the foregoing, to the extent that any amount constituting deferred compensation (as defined in Section 409A of the Code) would become payable under this Plan by reason of a Corporate Transaction, such amount shall become payable only if the event constituting a Corporate Transaction would also qualify as a change in ownership or effective control of the Company or a change in the ownership of a substantial portion of the assets of the Company, each as defined within the meaning of Code Section 409A, as it has been and may be amended from time to time, and any proposed or final Treasury Regulations and IRS guidance that has been promulgated or may be promulgated thereunder from time to time.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;padding-left:258px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Notwithstanding the foregoing, a Corporate Transaction shall not be deemed to result from any transaction precipitated by the Company&#8217;s insolvency, appointment of a conservator, or determination by a regulatory agency that the Company is insolvent, nor from any transaction the sole purpose of which is to change the state of the Company&#8217;s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#8217;s securities immediately before such transaction.</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">You understand that your relationship or service with the Company is for an unspecified duration, and that nothing in this Notice, the RSU Agreement or the Plan changes the at-will nature of that relationship.  You acknowledge that the vesting of the RSUs pursuant to this Notice is earned only by continuing service as an Employee, Director or Consultant of the Company.  You also understand that this Notice is subject to the terms and conditions of both the RSU Agreement and the Plan, both of which are incorporated herein by reference.  Participant has read both the RSU Agreement and the Plan.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:center;padding-left:90px;text-indent:-91px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.625%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:13%;"></td><td style="width:35%;"></td><td style="width:5%;"></td><td style="width:5%;"></td><td style="width:35%;"></td><td style="width:7%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:26px;text-align:left;padding-left:90px;text-indent:-91px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">PARTICIPANT</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:26px;text-align:left;padding-left:90px;text-indent:-91px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">DEXCOM, INC.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:left;padding-left:90px;text-indent:-91px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Signature: </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">_______________________________</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:left;padding-left:90px;text-indent:-91px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">_______________________________</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:left;padding-left:90px;text-indent:-91px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Print Name:</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">_______________________________</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:left;padding-left:90px;text-indent:-91px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Its:</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">_______________________________</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.37
<SEQUENCE>4
<FILENAME>dxcm12312019exhibit1037.htm
<DESCRIPTION>EXHIBIT 10.37
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s4c73f6a55a414192a4359b173ad4477d"></a></div><div><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">EXHIBIT 10.37</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Form of RSU Grant Agreement &#8211; Board Members &#8211; Incoming Grant</font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">DEXCOM, INC.</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">NOTICE OF RESTRICTED STOCK UNIT AWARD</font></div><div style="line-height:120%;padding-bottom:13px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">GRANT NUMBER:  </font><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Unless otherwise defined herein, the terms defined in the DexCom, Inc.</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:11pt;">(the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Company</font><font style="font-family:inherit;font-size:11pt;">&#8221;) 2015 Equity Incentive Plan (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Plan</font><font style="font-family:inherit;font-size:11pt;">&#8221;) shall have the same meanings in this Notice of Restricted Stock Unit Award (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Notice</font><font style="font-family:inherit;font-size:11pt;">&#8221;).  </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;padding-left:144px;text-indent:-96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Name:&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;padding-left:144px;text-indent:-96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Address:&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">You (&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Participant</font><font style="font-family:inherit;font-size:11pt;">&#8221;) have been granted an award of Restricted Stock Units (&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">RSUs</font><font style="font-family:inherit;font-size:11pt;">&#8221;) under the Plan subject to the terms and conditions of the Plan, this Notice and the attached Award Agreement (Restricted Stock Units) (hereinafter &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">RSU Agreement</font><font style="font-family:inherit;font-size:11pt;">&#8221;).</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;padding-left:258px;text-indent:-211px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Number of RSUs:</font><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;padding-left:258px;text-indent:-211px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Date of Grant:</font><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;padding-left:258px;text-indent:-211px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Vesting Commencement Date:&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:258px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:48px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Expiration Date:</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The date on which settlement of all RSUs granted hereunder occurs, with earlier expiration upon the Termination Date</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:48px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Vesting Schedule:</font><font style="font-family:inherit;font-size:11pt;">&#32;&#32;</font></div></td><td style="vertical-align:top;padding-left:210.66666666666666px;"><div style="line-height:120%;text-align:justify;font-size:11pt;text-indent:-210.66666666666666px;"><font style="font-family:inherit;font-size:11pt;">Subject to the limitations set forth in this Notice, the Plan and the RSU Agreement, the RSUs will vest in accordance with the following schedule:  </font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">in three annual installments (i.e., 33.3% of the RSUs subject to this Notice will vest upon the first anniversary of the Date of Grant; 33.3% of the RSUs subject to this Notice will vest upon the second anniversary of the Date of Grant; and 33.3% of the RSUs subject to this Notice will vest upon the third anniversary of the Date of Grant)</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:48px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Corporate Transaction:</font></div></td><td style="vertical-align:top;padding-left:210.66666666666666px;"><div style="line-height:120%;text-align:justify;font-size:11pt;text-indent:-210.66666666666666px;"><font style="font-family:inherit;font-size:11pt;">If a Corporate Transaction occurs then the vesting and (if applicable) exercisability of the RSUs shall be accelerated in full and any reacquisition or repurchase rights held by the Company with respect to the shares of Common Stock subject to such acceleration shall lapse in full, as appropriate.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:13px;text-align:justify;padding-left:258px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Corporate Transaction</font><font style="font-family:inherit;font-size:11pt;">&#8221; means the occurrence of any of the following events: (i) any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the Company&#8217;s then-outstanding voting securities; provided, however, that for purposes of this subclause (i) the acquisition of additional securities by any one Person who is considered to own more than fifty percent (50%) of the total voting power of the securities of the Company will not be considered a Corporate Transaction; (ii) the consummation of the sale, transfer or disposition by the Company of all or substantially all of the Company&#8217;s assets; (iii) the consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding </font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;padding-left:258px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">or by being converted into voting securities of the surviving entity or its parent) more than fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation; (iv) any other transaction which qualifies as a &#8220;corporate transaction&#8221; under Section 424(a) of the Code wherein the stockholders of the Company give up all of their equity interest in the Company (except for the acquisition, sale or transfer of all or substantially all of the outstanding shares of the Company) or (v) a change in the effective control of the Company that occurs on the date that a majority of members of the Board is replaced during any twelve (12) month period by members of the Board whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election.  For purpose of this subclause (v), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Corporate Transaction.  For purposes of this definition, Persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. Notwithstanding the foregoing, to the extent that any amount constituting deferred compensation (as defined in Section 409A of the Code) would become payable under this Plan by reason of a Corporate Transaction, such amount shall become payable only if the event constituting a Corporate Transaction would also qualify as a change in ownership or effective control of the Company or a change in the ownership of a substantial portion of the assets of the Company, each as defined within the meaning of Code Section 409A, as it has been and may be amended from time to time, and any proposed or final Treasury Regulations and IRS guidance that has been promulgated or may be promulgated thereunder from time to time.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;padding-left:258px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Notwithstanding the foregoing, a Corporate Transaction shall not be deemed to result from any transaction precipitated by the Company&#8217;s insolvency, appointment of a conservator, or determination by a regulatory agency that the Company is insolvent, nor from any transaction the sole purpose of which is to change the state of the Company&#8217;s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#8217;s securities immediately before such transaction.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;padding-left:258px;text-indent:-211px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">You understand that your relationship or service with the Company is for an unspecified duration, and that nothing in this Notice, the RSU Agreement or the Plan changes the at-will nature of that relationship.  You acknowledge that the vesting of the RSUs pursuant to this Notice is earned only by continuing service as an Employee, Director or Consultant of the Company.  You also understand that this Notice is subject to the terms and conditions of both the RSU Agreement and the Plan, both of which are incorporated herein by reference.  Participant has read both the RSU Agreement and the Plan.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:center;padding-left:90px;text-indent:-91px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.625%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:13%;"></td><td style="width:35%;"></td><td style="width:5%;"></td><td style="width:5%;"></td><td style="width:35%;"></td><td style="width:7%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:26px;text-align:left;padding-left:90px;text-indent:-91px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">PARTICIPANT</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:26px;text-align:left;padding-left:90px;text-indent:-91px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">DEXCOM, INC.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:left;padding-left:90px;text-indent:-91px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Signature: </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">_______________________________</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:left;padding-left:90px;text-indent:-91px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">_______________________________</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:left;padding-left:90px;text-indent:-91px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Print Name:</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">_______________________________</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:left;padding-left:90px;text-indent:-91px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Its:</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">_______________________________</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;text-align:left;padding-left:90px;text-indent:-91px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.38
<SEQUENCE>5
<FILENAME>dxcm12312019exhibit1038.htm
<DESCRIPTION>EXHIBIT 10.38
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s6388A460BE7477869DA0AC279D253D3B"></a></div><div><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">EXHIBIT 10.38</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">[***] =&#160;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Certain information has been excluded from this exhibit because it (i)&#160;is not material and (ii)&#160;would be competitively harmful if publicly disclosed.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">DISTRIBUTION SERVICES AGREEMENT</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Distribution Services Agreement (&#8220;Agreement&#8221;) is made as of the 7th day of November, 2015, by and between AmerisourceBergen Drug Corporation, with an address at 1300 Morris Drive, Chesterbrook, PA 19087-5594 and DEXCOM Inc. with an address of 6340 Sequence Drive San Diego, CA 92121, (&#8220;Supplier&#8221;).</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NOW, THEREFORE, for and in consideration of the mutual promises and obligations contained in this Agreement, the parties agree as follows;</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">APPOINTMENT OF SUPPLIER</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Engagement.</font><font style="font-family:inherit;font-size:12pt;">&#32;ABC and Supplier agree to a nonexclusive arrangement where Supplier agrees to sell consumer products (&#8220;Products&#8221;) to ABC on the terms and conditions set forth in this Agreement and any amendments or addendum thereto so that ABC may distribute the Product to customers. Supplier hereby appoints ABC (and all of its distribution centers) as an authorized distributor of record for all of its Products. Furthermore, Supplier will comply with all federal and state laws, requiring Supplier to publicly identify all of its authorized distributors.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Term</font><font style="font-family:inherit;font-size:12pt;">. This Agreement is effective as of the date set forth above (the &#8220;Effective Date&#8221;) and will continue in effect for two (2) years. Thereafter, this Agreement will automatically renew for subsequent terms of one (1) additional year, unless otherwise terminated by a party as allowed herein.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">c.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Breach</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">&#32;</font><font style="font-family:inherit;font-size:10.5pt;text-decoration:underline;">and</font><font style="font-family:inherit;font-size:10.5pt;text-decoration:underline;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Termination.</font><font style="font-family:inherit;font-size:12pt;">&#32;Either party may terminate this Agreement for cause, upon [***]  written notice of a material default to the other party of the reason for termination, and failure of that party to cure the default within the [***] period. Either party may terminate this Agreement with or without cause upon [***] prior written notice.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">PRICE AND PAYMENT</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Prices</font><font style="font-family:inherit;font-size:12pt;">. All prices and offers by Supplier will be available to ABC and all of its affiliates with similar classes of trade. The price for Products shall be [***].</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Terms of Payment</font><font style="font-family:inherit;font-size:12pt;">. Unless otherwise agreed, ABC will pay all Supplier invoices for undisputed orders in accordance with the due dates specified below; provided, however, that such payment terms are not less favorable to ABC than the payment terms offered to any other wholesale customer of Supplier and in no instances shall be less than: [***].</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Under no circumstances shall Supplier make additions to any invoice amounts due to Supplier, unless a written memorandum from ABC authorizing such additions has been issued by ABC to Supplier.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ABC reserves the right, among other remedies, to suspend further purchases of Product(s) upon Supplier&#8217;s continuing material non-compliance with this Agreement.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">c.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Debit Balance.</font><font style="font-family:inherit;font-size:12pt;">&#32;Supplier shall immediately remit any monies due to ABC in the event of an ABC accounts payable debit balance situation with Supplier that persists for more than [***]. </font></div></td></tr></table><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-left:96px;padding-bottom:16px;text-align:justify;"><font style="font-family:inherit;font-size:12pt;">Debit balance is defined as the sum of all transactions in ABC&#8217;s accounts payable system having due dates through, but not extending beyond, the then present date.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">d.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Electronic Payments</font><font style="font-family:inherit;font-size:12pt;">:  Supplier will receive payments for invoices by cheek. Without AmerisourceBergen&#8217;s prior written consent, the Supplier shall not have the right to debit any AmerisourceBergen account electronically. If AmerisourceBergen and Supplier elect electronic payments, the parties agree to participate in an Automated Clearing House (&#8220;ACH&#8221;) trade payments program within the operating guidelines of the National Automated Clearing House Association (&#8220;NACHA&#8221;).</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Supplier shall send any electronic payment made by AmerisourceBergen to a bank within the territorial jurisdiction of the United States and such payment shall not be subject to standing instructions to be transferred or forwarded to a foreign bank account or financial institution. In the event that Supplier elects, as part of a single payment transaction, to transfer or forward the entire amount of any electronic payment made by AmerisourceBergen to a bank account or financial institution located outside the territorial jurisdiction of the United States, Supplier will provide written notice to AmerisourceBergen.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:96px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">(i)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Remittance detail will accompany the actual funds transfer and be processed through the banking system in accordance with the provisions of NACHA&#8217;s ACH Rules, Corporate Trade Exchange Format (CTX).</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:96px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">(ii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In addition to Supplier&#8217;s standard non-ACH trade terms of [***], for ACH transactions, Supplier agrees to provide appropriate float to reflect the measured value of external and internal float days on all payment terms to AmerisourceBergen. The new base terms for payment via ACH will be current terms plus float days.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:96px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">(iii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Supplier will include the additional appropriate float days referenced in the immediately preceding paragraph on all Supplier invoicing sent to AmerisourceBergen via EDI or hard copy. AmerisourceBergen will not be responsible for late ACII payments arising from any change to the transmission of float days unless AmerisourceBergen is provided with a [***]  advance written notification of this change.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:96px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">(iv)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">AmerisourceBergen will exercise its best efforts to ensure that all ACH payments are made in accordance with the terms set forth in paragraph (ii) above.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:96px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">(v)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Standard trade discounts are considered earned under the following circumstances:</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:96px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#010000;">a.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The payment is generated properly and on time by AmerisourceBergen and good funds are available to Supplier on day [***] (plus float, if applicable) from the Supplier invoice date (&#8220;due date&#8221;). In the event that the due date is a Saturday, Sunday, or bank holiday, the due date will be the next business day.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:96px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#010000;">b.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The payment is generated properly and on time by AmerisourceBergen as evidenced by hard copy documentation, but availability to Supplier is delayed because of an infrequent system or procedural failure at AmerisourceBergen&#8217;s bank.</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:96px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#010000;">c.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The payment is generated properly and on time through AmerisourceBergen&#8217;s bank so that it would normally be available in accordance with the terms agreed to herein, but availability to Supplier is delayed through no fault of AmerisourceBergen&#8217;s bank.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">e.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Primary Distribution Services Fee</font><font style="font-family:inherit;font-size:12pt;">. Supplier shall pay a Primary Distribution Services Fee to ABC for primary distribution services, which consist of the [***] (collectively referred to as &#8220;Primary Distribution Services&#8221;). The amount of the Primary Distribution Services Fee is [***] Wholesale Acquisition Cost (&#8220;WAC&#8221;) and shall be invoiced monthly and payment shall be due within [***] of the date of the invoice. If the fees are not received within specified timeline, ABC reserves the right to deduct the amount due from payment to Supplier.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ABC OBLIGATIONS </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Stock Product</font><font style="font-family:inherit;font-size:12pt;">. ABC will make a good faith effort to maintain sufficient stock of Products to satisfactorily supply customer demand provided that such stock of products will not exceed [***] of inventory.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Legal Compliance</font><font style="font-family:inherit;font-size:12pt;">. ABC will comply with federal, state and local laws governing the purchase, storage, handling, sale, and distribution of Products.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">c.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Drop Shipments</font><font style="font-family:inherit;font-size:12pt;">. ABC will honor all invoices billed to ABC for drop shipments authorized by ABC, provided that the Product has been delivered and the invoice is not disputed by customer.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">d.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Storage Conditions</font><font style="font-family:inherit;font-size:12pt;">. ABC will use reasonable commercial efforts to maintain Products under proper conditions, both in storage and in transit to ABC customers.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">e.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Short Dated Product</font><font style="font-family:inherit;font-size:12pt;">. ABC will accept short dated Product (Product received with less than nine (9) months dating) in its sole discretion and on a case-by-case basis.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">f.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Inventory and Sales Reports</font><font style="font-family:inherit;font-size:12pt;">. ABC shall prepare and provide to Supplier, for the duration of this Agreement, Inventory Reports (&#8220;852&#8221;) and Sales Reports (&#8220;867&#8221;) as provided herein (together 852 and 867 are referred to as &#8220;Data&#8221;). All reports shall be transmitted in EDI format and shall be in the form, for the fee(s) and in accordance with other terms in this Agreement and Exhibits B and C. EDI 852 transmissions shall be sent weekly. They shall be provided by the end of the first business day following the end of the chosen reporting period. Records will only be created for those items which are actively stocked in an ABC division. This does not include any re-packaged inventory that may be purchased from American Health Packaging. ABC&#8217;s Puerto Rico Division activity Is typically included unless otherwise specified. EDI 867 transmissions shalt be sent weekly. They shall be provided by the end of the first business day following the end of the chosen reporting period. ABC may, solely due to contractual requirements, be required to block certain or all fields related to the data that discloses the identity of a particular shipping (DEA) location. ABC will not be required to share 867 data that allows the Supplier to determine the actual identity and physical address, including the full zip code, of the non-consumer end purchaser of the Product. Sales of any repackaged inventory that may be purchased from American Health Packaging will not be reported through this process.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">g.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Grant of Limited License to Use Data</font><font style="font-family:inherit;font-size:12pt;">. ABC hereby grants to Supplier a nonexclusive, assignable (in accordance with Section 12(b) of the Agreement) license to use the Data solely </font></div></td></tr></table><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-left:96px;padding-bottom:16px;text-align:justify;"><font style="font-family:inherit;font-size:12pt;">for Supplier&#8217;s Internal corporate purposes and in accordance with the confidentiality and other provisions of this Agreement. No Data may be sent to a third party unless Supplier receives prior written approval from ABC; provided, that, such Data may be provided to Supplier&#8217;s Affiliates and/or third parties that engaged by Supplier to perform internal business functions on Supplier&#8217;s behalf; provided, further, such Affiliates and/or third parties have agreed in writing to be bound by the provisions of this Agreement governing the use of, and restriction on, the Data.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">h.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">AmerisourceBergen Ownership of Data</font><font style="font-family:inherit;font-size:12pt;">. All Data provided by ABC to Supplier under this Agreement is confidential information (as discussed in Section 8) owned by ABC. ABC has granted a license to Supplier to use the Data internally and In accordance with this Agreement. Except for the license granted contained herein, this Agreement does not grant Supplier any title or right of ownership to the Data.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">i.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Limitations on Provision of Data</font><font style="font-family:inherit;font-size:12pt;">. Notwithstanding any other provision of this Agreement, to the extent that, and only the extent that, ABC is prohibited from providing certain Data to Supplier by any agreement between (i) ABC or any of its affiliates and (ii) a third party, including a customer, then ABC shall provide all other Data but shall have no obligation to provide the Data that is so restricted,; provided, however, ABC shall use commercially reasonable efforts to provide the Data in a manner or file type that would not be in violation of the aforementioned agreements.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">j.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">EDI Implementation</font><font style="font-family:inherit;font-size:12pt;">. Within [***] after the execution of this Agreement, the parties shall examine and test the capability of their respective EDI systems and implement a mutually agreeable system whereby transfers of information can be made effectively and on a consistent basis. In the event that critical internal support systems and electronic communication links, including EDI, are not available for [***], the parties will cooperate to promptly implement substitute procedures that may include excel files for 867 and 852 information. ABC reserves the right to change the frequency of 852 and 867 reports to monthly if sent in any format other than EDI. In the event that a disruption with the transmission occurs, ABC will have up to [***] following notification by Supplier to remedy the situation. ABC will exercise reasonable care to avoid material errors in gathering, processing and delivering data.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">k.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Products</font><font style="font-family:inherit;font-size:12pt;">. ABC acknowledges that each Product contain valuable trade secret information of Supplier. ABC shall not, and shall not permit or assist others to, reverse compile, reverse assemble or reverse engineer the Product or the software embedded therein. ABC shall not, and shall not permit or assist others to, remove or modify any copyright, patent or other proprietary labels or markings on the Product or the packaging provided by Supplier</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">SUPPLIER OBLIGATIONS</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Purchase Orders</font><font style="font-family:inherit;font-size:12pt;">. ABC shall submit purchase orders via EDI in the industry standard format. For the first [***]from the start of the contract, ABC shall submit purchase orders through email or via Fax. All purchase orders shall be subject to Supplier&#8217;s reasonable approval and acceptance. If ABC is requested to submit purchase orders other than via EDI in industry standard. Supplier agrees to accept purchase orders at the prices in effect on the day the order is transmitted. Supplier will notify ABC on the day the order is placed of any Product adjustments or purchase order delays. Purchase orders are valid for [***] and Product should not be shipped against a purchase order older than [***] without the ABC buyer&#8217;s written agreement.</font></div></td></tr></table><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">New Item Set-up</font><font style="font-family:inherit;font-size:12pt;">. Supplier will provide ABC with completed New Item Set-up Sheets for all new items proposed to ABC for stocking through the Link item set-up process, and promotional fact sheets for all promotions.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">c.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Minimum Order Amounts</font><font style="font-family:inherit;font-size:12pt;">. Supplier and ABC will set mutually agreeable minimum purchase order amounts, if applicable. The net amount of the original purchase order will determine if that minimum is met.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">d.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Delivery Times</font><font style="font-family:inherit;font-size:12pt;">. Supplier will make commercially reasonable efforts to ship all ABC orders completely and to deliver them within a mutual agreeable schedule not to exceed four (4) business days of order placement. A complete order is defined as all products not currently designated as backordered, unavailable, or discontinued at time of delivery. A notification of all Products falling into one of these designated status groups must be provided to ABC, in writing, within twenty-four (24) hours of order placement. This notification shall include the reason for the delay and the expected availability date.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">e.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Inbound Fill Rate</font><font style="font-family:inherit;font-size:12pt;">: Supplier agrees to maintain no less than a [***]raw fill rate measured monthly. The fill rate is defined as total quantity delivered within [***]of the -expected arrival date divided by the total quantity ordered. If ABC attempts to purchase more than [***] of its prior ninety (90) day average or [***] of a forecast submitted at least thirty (30) days in advance, the Product(s), to the extent in excess of [***] of the prior average or forecast, will not be included in the applicable month&#8217;s measurement. Products that are discontinued or unavailable will not be included after [***] upon written notification of such status.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">f.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Outbound Pill Rate</font><font style="font-family:inherit;font-size:12pt;">. Supplier agrees to support a raw outbound fill rate of [***]. This fill rate is measured monthly and is defined as customer lines filled divided by customer lines ordered. Supplier shall not be obligated to meet outbound fill rate incurred from errors caused due to storage and handling by ABC.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">g.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Shipping. Labels</font><font style="font-family:inherit;font-size:12pt;">. Supplier agrees to place a label on the package that states &#8220;REPACK&#8221; (this alerts the DCs that it contains multiple sku&#8217;s and ensure the packing slip lists the items enclosed and either placed in the outside plastic sleeve on the outside of the box or enclosed within.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">h.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Drip Ship Orders</font><font style="font-family:inherit;font-size:12pt;">. In the event ABC or Supplier elects to drop ship Product(s) to an ABC customer, all other provisions of the Agreement, including returns, remain in effect. To the extent that Supplier receives an order directly from one of ABC&#8217;s retail customers, Supplier must verify in advance that customer is in good standing with the servicing ABC division.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">i.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Invoicing</font><font style="font-family:inherit;font-size:12pt;">. The Supplier will not invoice orders until the Product has been shipped to ABC. Invoices and credit memos will be transmitted electronically in the industry standard format.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">j.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Shipment Champs, Title and. Risk of Loss</font><font style="font-family:inherit;font-size:12pt;">. All orders are to be shipped by Supplier to ABC [***]. Supplier shall pay for [***]. Supplier is responsible for [***]. Title to and risk of loss of products sold hereunder will pass to ABC upon [***].</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">k.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Short Dated Product</font><font style="font-family:inherit;font-size:12pt;">. Supplier agrees to ship Products with not less than [***] months shelf life remaining, unless Product is manufactured with a limited shelf life less than the above, in which case such Product will be shipped with ABC&#8217;s approval. At ABC&#8217;s discretion, short dated Product may be accepted on a case-by-case basis in individual purchase situations, and such shipment must be approved in writing by the ABC buyer.</font></div></td></tr></table><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">l.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Notice of Promotional Activities/Buy-in Opportunities</font><font style="font-family:inherit;font-size:12pt;">. Supplier agrees to provide ABC prior notice of marketing activities to ABC customers involving guaranteed sale provisions and/or other distribution and promotional activities.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">m.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Accounts Receivable Statement</font><font style="font-family:inherit;font-size:12pt;">. Supplier agrees to provide ABC with a monthly accounts receivable electronic statement for all open transactions when capable In the interim Supplier will supply ABC with an excel spreadsheet of accounts receivable open transactions.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">n.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Date of Price</font><font style="font-family:inherit;font-size:12pt;">. Supplier agrees to accept purchase orders at the prices in effect on the day of purchase. Supplier will notify ABC on the day the order is placed of any Product adjustments or other delays from held purchase order delays,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">o.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Price Changes</font><font style="font-family:inherit;font-size:12pt;">. Supplier agrees to electronically communicate all price changes to ABC no later than [***] prior to the effective date to: [***]. Supplier agrees to work with ABC to insure that adequate pre price increase inventory is available to ABC. In the event of a shortage, Supplier will back-order all inventory ordered on any dates prior to the effective date of the price increase. In some cases a mutually agreed to credit can be given in lieu of Product. If Supplier does not give notice in accordance with this section, Supplier agrees to compensate ABC for the dollar difference between the WAC in effect prior to the price change and the new WAC multiplied by the number of units sold between the effective date and the date and time ABC became aware of the price change and entered the pricing change into the system.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">p.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Price Protection</font><font style="font-family:inherit;font-size:12pt;">. Supplier agrees to provide price protection to ABC and to adjust on-hand and in-transit inventory in the event of a product price reduction.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">q.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Credits</font><font style="font-family:inherit;font-size:12pt;">. Supplier will pay ABC all compensation due (including without limitation, payments, credits, product allocations, and/or bill-back program amounts) within [***] of determination. Exceptions shall be resolved with ABC&#8217;s Accounts Payable Department. ABC reserves the right to make deductions. With respect to correspondence relating to invoices or claims due to shortages and/or damages (concealed or otherwise), returns, or pricing &#8212; Supplier will respond with POD or disposition by contacting the assigned Accounts Payable Vendor Services Representative via email at [***]. If Credits no longer hold value to ABC, Supplier will issue cash in lieu of credit.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">r.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Product Recall Reimbursement</font><font style="font-family:inherit;font-size:12pt;">. Supplier agrees to abide by all I-IDMA published guidelines for product recall reimbursement and will reimburse ABC in accordance with its standard rates. ABC will not be obligated to handle partial containers.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">s.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">JAW Compliance</font><font style="font-family:inherit;font-size:12pt;">. Supplier will comply with all applicable federal, state and local laws, and applicable government contracting requirements/regulations including but not limited to those laws, requirements and regulations governing the manufacture, purchase, handling, sale, marketing and distribution of Products purchased under this Agreement.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">t.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Supplier will work together with AmerisourceBergen to comply in all material respects with all applicable provisions of DSCSA, Title II of the Drug Quality and Security Act of 2013, as may be amended, with respect to the supply and distribution of the Products.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Supplier understands that all Products offered for sale to the United States Government under this Agreement must be compliant with the Trade Agreements Act (TAA) (19 U.S. C. 2501, et seq.). As such, Supplier certifies that all Products will be Country of Manufacture confirmed </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">pursuant to the TAA requirements. If Supplier is not the actual manufacturer of the Products supplied to ABC, Supplier certifies that it has supporting information on file from the manufacturer of the Product. If any information previously provided to ABC changes, Supplier shall provide thirty (30) days prior notice to ABC. Supplier understands that ABC is relying on Supplier&#8217;s certification to meet its contractual obligations to the government. If any information regarding Supplier&#8217;s compliance with the TAA that is provided by Supplier to ABC is inaccurate, Supplier shall be deemed to be in material breach of this Agreement.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Supplier agrees to comply with ABC&#8217;s Code of Ethics and Business Conduct Policy (&#8220;Code of Conduct&#8221;), including, but not limited to, those sections on Fraud &amp; Abuse Laws, Antitrust &amp; Competition Laws and Anti-Bribery/Anti-Corruption Laws, and specially the Anti-Bribery/Anti-Corruption Compliance Policy No. 6, The Code of Conduct can be found at Investor Relations tab, Corporate Governance, of www.amerisourcebergen.com. In the event Supplier violates ABC&#8217;s Code of Conduct, the Fraud &amp; Abuse Laws, Antitrust &amp; Competition Laws, or Anti-Bribery / Anti-Corruption Laws, Supplier shall be deemed to be in material breach of this Agreement.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">The parties agree that, as applicable, they will abide by the requirements of 41 CFR 60-1.4(a), 41 CFR 60-300.5(a) and 41 CFR 60-741.5(a) and that these laws are incorporated herein by reference. These regulations prohibit discrimination against qualified individuals based on their status as protected veterans or individuals with disabilities, and prohibit discrimination against all individuals based on their race, color, religion, sex, sexual orientation, gender identity, or national origin. These regulations require that covered prime contractors and subcontractors take affirmative action to employ and advance in employment individuals without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status or disability. The parties also agree that, as applicable, they will abide by the requirements of Executive Order 13496 (29 CFR Part 471, Appendix A to Subpart A), relating to the notice of employee rights under federal labor laws.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">u.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Supporting information / Records</font><font style="font-family:inherit;font-size:12pt;">. Each party shall provide any documentation, certification or instructions to the other party reasonably necessary for full compliance with federal, state and local laws with respect to the handling, storage, sale and distribution of the Products, including without limitation, any documentation, certification or instruction regarding the classification, handling and shipping of any hazardous materials and compliance with the TAA. Each party shall maintain federal, state and local registrations, licenses and permits necessary for the lawful handling or distribution of all Products and immediately notify the other party of any denial, revocation or suspension of any such registration or any changes in the Products subject to this Agreement. Supplier shall report any administrative, civil or criminal action currently pending or arising after the effective date of this Agreement by local, state or federal authorities against Supplier, its officers or employees, regarding alleged violations of the Controlled Substances Act of 1970, as amended, or other comparable legislation, and provide ABC with complete information concerning the disposition of such action. If Products include controlled substances, Supplier shall provide ABC with a copy of its DEA certificate.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">v.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Allocation</font><font style="font-family:inherit;font-size:12pt;">. Supplier agrees to work with ABC to ensure that any allocation program not related to Product availability does not cause an out-of-stock situation. If ABC validates to Supplier a potential out-of-stock condition, Supplier will use commercially reasonable efforts to adjust </font></div></td></tr></table><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-left:96px;padding-bottom:16px;text-align:justify;"><font style="font-family:inherit;font-size:12pt;">ABC&#8217;s allocation to meet demand. Supplier will use commercially reasonable efforts to provide ABC thirty (30) days (or such other period as is commercially feasible) advance notice of any changes in Supplier&#8217;s credit line and allocation processes.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">w.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">New Product Launches</font><font style="font-family:inherit;font-size:12pt;">. Recognizing the uncertainty associated with new Product launches, the parties agree as follows: Prior to the delivery of the initial stocking order, ABC and Supplier will jointly determine the amount of the initial stocking order that will be sold to ABC.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">x.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Chargebacks</font><font style="font-family:inherit;font-size:12pt;">. Supplier shall comply with ABC&#8217;s Contracts and Chargeback Administration policy in effect from time to time.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">RETURNS</font><font style="font-family:inherit;font-size:12pt;">&#32;</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In consideration of ABC agreeing not to return any Products (other than as expressly set forth or referenced in this Section 5), Supplier shall pay ABC a [***]. The returns allowance shall be invoiced monthly and payment shall be due within [***] of the date of the invoice, If the returns allowance is not received within specified timeline, ABC reserves the right to deduct the amount due from payments owing to Supplier. ABC shall be responsible for all third party returns that are initiated through, or by, or are within, or under, the control of, ABC (&#8220;ABC&#8217;s Third Party Returns&#8221;), excluding (1) returns made by a customer of ABC to whom Supplier has drop shipped the Product that is sought to be returned, and (2) returns initiated by the ultimate end user of a Product pursuant to a valid Product warranty claim; provided, that, with respect to third party product return claims (other than ABC&#8217;s Third Party Returns) that Supplier is responsible for resolving pursuant to the terms of this Agreement, the parties acknowledge and agree that: (A) Supplier shall be under no obligation to accept such returns, and (B) it shall be the sole decision of Supplier (in its sole and absolute discretion) as to whether, and in what manner, to accept any such returns.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Returns Allowance shall not cover: (i) products needing to be returned because of recalls (ii) return of damaged products pursuant to and in accordance with Section 6 hereof; and (iii) Products with regard to which ABC notifies Suppler within [***] of physical delivery of such Products to the destination specified by ABC that such Products were received in quantities less than shown on Supplier&#8217;s relevant shipping documents and ABC elects to return all Products received as opposed to having Supplier correct any shortfall (items (i) through (iii), are hereinafter referred to as &#8220;Permitted Returns&#8221;). With respect to Permitted Returns, the parties acknowledge and agree that; (A) Supplier shall be under no obligation to accept such returns, and (B) it shall be the sole decision of Supplier (in its sole and absolute discretion) as to whether, and in what manner, to accept any such returns. Supplier and ABC agree to review the Returns Allowance In [***] from effective date of this agreement, to the extent that, and only the extent that, the amount of Permitted Returns to Supplier and ABC&#8217;s Third Party Returns during that [***] exceed the Returns Allowance.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">6.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">DAMAGED PRODUCTS</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Should Products sold to ABC be received in obvious damaged condition, ABC will note on the delivery slip the apparent damage and shall be entitled to promptly return the damaged Product to the Supplier. Damage will be reported promptly to Supplier&#8217;s customer service department to determine the disposition instructions. ABC shall use commercially reasonable efforts to conduct a reasonable inspection of Products received by it pursuant to this Agreement to determine if there is any damage to such Products that was not apparent at the time of delivery. In the event of concealed damage that could not have been identified by ABC&#8217;s inspection and is not caused by ABC&#8217;s handling, storage or transportation of the applicable product, ABC shall report such concealed damage with [***] from </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">discovery. ABC shall hold such damaged Products for inspection by the insurer, the carrier, or Supplier&#8217;s designated representative for up to [***]. With respect to any Damaged Products that are not the result of ABC&#8217;s handling, storage or transportation of the Product, then ABC, shall be entitled to deduct any payments made for the applicable Damaged Product from amounts owing to Supplier and return the Product at the Supplier&#8217;s expense. Amounts deducted by, or credited back to, ABC for damaged products shall not be subject to the Primary Distribution Services Fee or the Return Allowance.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">7.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">SHIPMENT ERRORS</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In the event of an incomplete shipment, a shortage in shipment, the misdirection of any delivery, or any over shipment, the Supplier shall immediately contact the ABC purchasing department and shall comply with any reasonable directions provided by ABC. Supplier will be responsible for any related freight or accessorial charges caused by the error,</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">8.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">CONFIDENTIALITY</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In order to facilitate this Agreement, either party (&#8220;Disclosing Party&#8221;) may disclose to the other party (&#8220;Receiving Party&#8221;) certain confidential or proprietary information subject to this Agreement. All documents and other information provided to Receiving Party by Disclosing Party pursuant to this Agreement, including any information concerning prices, quantities purchased by any customer, data or other terms and conditions, shall be held by Receiving Party in strict confidence and not disclosed either directly or indirectly to any third party and shall only be used for purposes of Receiving Party fulfilling its obligations under this Agreement. Receiving Party acknowledges that money damages alone would not be a sufficient remedy for any violation by it of the terms of this Agreement addressing use or disclosure of other confidential information of Disclosing Party and that Disclosing Party will be entitled (in addition to any other remedies which may be available to it at law or in equity) to specific performance and injunctive relief as remedies for any such violation. Each party shall keep the terms and conditions of this Agreement and any amendments or addenda thereto confidential. The provisions of this Section shall survive termination,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The obligations imposed by this Section 8 shall not apply to information which (i) at the time of disclosure is in the public domain; (ii) after disclosure becomes a part of the public domain by publication or otherwise, through no fault of the Receiving Party; (iii) at the time of disclosure is already in the Receiving Party&#8217;s possession, except through prior disclosure by either party or an affiliate of either of them, and such possession can be properly documented by the Receiving Party in its written records, and was not made available to the Receiving Party by anyone owing an obligation of confidentiality to the Disclosing Party; or (iv) is rightfully made available to the Receiving Party from sources independent of the Disclosing Party.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">c.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">To the extent that Confidential Information of the Disclosing Party is legally required to be disclosed in the course of the litigation or other legal or administrative proceedings or otherwise as required by law, the Receiving Party shall, to the extent permitted, (1) give the other party prompt notice of the pending disclosure and shall cooperate in such other party&#8217;s attempts, at such other party&#8217;s sole expense, to seek an order maintaining the confidentiality of such information, (2) only disclose the minimum Confidential Information necessary with respect to the applicable litigation, legal administration proceeding or as required by applicable law.</font></div></td></tr></table><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">d.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The confidentiality provision of this Section 8 shall survive any termination or expiration of this Agreement.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">9.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">INSPECTION OF RECORDS</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Supplier and ABC agree to maintain complete and accurate records of all transactions related to the conduct of business under this Agreement. Both parties will permit reasonable audit and inspection of such records upon reasonable notice and during regular business hours for the limited purpose of resolving business disputes arising hereunder or in connection herewith or as necessary to respond to an audit or investigation by a government agency or other competent authority. If it is determined, based on any such inspection or audit, that either party has received excess credits, upon confirmation of such finding, such party shall immediately pay any excess amount to the other.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">10.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">RELATION OF PARTIES</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Except as otherwise specified, ABC is acting pursuant to this Agreement in the capacity of an independent contractor distributing the Products of Supplier as well as products of other manufacturers.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ABC shall have no authority to bind Supplier unless otherwise agreed to between Supplier and ABC.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">c.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Supplier shall not use ABC&#8217;s name, trademarks or commercial symbols without the prior written consent of ABC.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">d.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Nothing contained in this Agreement shall be interpreted or construed so as to characterize the relationship between the parties as a joint venture, partnership, agency or franchise for any purposes whatsoever.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">11.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">WARRANTY/INDEMNITY</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Continuing Guaranty</font><font style="font-family:inherit;font-size:12pt;">. As a condition precedent to ABC entering into this Agreement, Supplier shall execute the Continuing Guaranty and Indemnification Agreement set forth as Exhibit A.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Representations and Warranties</font><font style="font-family:inherit;font-size:12pt;">. Supplier represents and warrants to ABC that (I) [***].</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">12.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">INDEMNIFICATION</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In addition to any indemnities or remedies specifically set forth elsewhere in this Agreement, each party (the &#8220;Indemnifying Party&#8221;) shall indemnify, defend and hold harmless the other, its agents, servants, employees, officers, directors, attorneys, subsidiaries, affiliates, parent and assigns from and against ail third party claims (including, but not limited to, product liability claims and claims relating to &#8220;class of trade&#8221; pricing), losses, damages, liabilities and expenses, including without limitation reasonable legal fees and court costs (collectively, &#8220;Indemnifiable Losses&#8221;), arising out of (i) the material breach by the Indemnifying Party of any obligation contained herein, or (ii) the fraud, intentional misconduct, negligent acts or omissions or wrongdoing of any kind alleged or actual on the part of the Indemnifying Party.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In the event that any party to this Agreement shall incur any Indemnifiable Losses in respect of which indemnity may be sought by such party pursuant to this Section 11 or any other provision of this Agreement, the party Indemnified hereunder (the &#8220;Indemnified Party&#8221;) shall </font></div></td></tr></table><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-left:96px;padding-bottom:16px;text-align:justify;"><font style="font-family:inherit;font-size:12pt;">notify the Indemnifying Party promptly. Such notice shall in any event be given within a reasonable period of time of the filing or assertion or becoming aware of any claim against the Indemnified Party, stating the nature and basis of such claim; provided, however, that any delay or failure to notify the Indemnifying Party of any claim shall not relieve it from any liability except to the extent that the Indemnifying Party demonstrates that the defense of such action has been materially prejudiced by such delay or failure to notify. The Indemnifying Party shall, within a reasonable period of time of its receipt of notice of such claim or being made aware of such claim, notify the Indemnified Party of its intention to assume the defense of such claim. If the Indemnifying Party shall not assume the defense of any such claim or litigation resulting therefrom, the Indemnified Party may defend against any such claim or litigation in such manner as it may deem appropriate and the Indemnified Party may settle such claim or litigation on such terms as it may deem appropriate, and assert against the Indemnifying Party any rights or claims to which the Indemnified Party is entitled. Payment of Indemnifiable Losses shall be made within a reasonable time after a final determination of a claim. A. final determination of a disputed claim shall be (a) a judgment of any court determining the validity of disputed claim, if no appeal is pending from such judgment or if the time to appeal therefrom has elapsed, (b) an award of any arbitration determining the validity of such disputed claim, If there is not pending any motion to set aside such award or if the time within to move to set such award aside has elapsed, (c) a written  termination of the dispute with respect to such claim signed by all of the parties thereto or their attorneys, (d) a written acknowledgment of the Indemnifying Party that it no longer disputes the validity of such claim, or (e) such other evidence of final determination of a disputed claim as shall be acceptable to the parties.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">c.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The indemnification provisions of this Section 11 shall survive any termination or expiration of this Agreement.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">13.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">MISCELLANEOUS</font><font style="font-family:inherit;font-size:12pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Notice</font><font style="font-family:inherit;font-size:12pt;">. Any notice required or permitted hereunder shall be in writing and shall be deemed given upon delivery, when delivered personally or by overnight courier, fax or email with confirmation of receipt, or forty-eight (48) hours after being deposited in the United States Mail, postage prepaid, registered or certified, return receipt requested, addressed to the receiving party at its address indicated on page 1 of this Agreement or to such other address as such party shall have indicated by written notice. A copy of any notice provided to ABC must also be sent to ABC&#8217;s General Counsel at the ABC address listed on page 1.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Assignment</font><font style="font-family:inherit;font-size:12pt;">. This Agreement may not be assigned by either party without the prior written consent of the other party. Notwithstanding the foregoing, either party may assign its rights and obligations hereunder without the consent of the other party to a subsidiary or affiliate or to an entity which purchases all or substantially all of the party&#8217;s stock or assets or acquires control of the party, whether by merger, consolidation or any other means.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">c.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Governing Law/Interpretation</font><font style="font-family:inherit;font-size:12pt;">. The Agreement shall be governed by and construed in accordance with the internal laws of the State of Delaware. The parties have jointly negotiated this Agreement and, thus, neither this Agreement nor any provision will be interpreted for or against any party on the basis that it or its attorney drafted the Agreement or the provision at issue. Headings of the various Sections are not part of the context of this Agreement, and are only labels to assist in locating those Sections, and will be ignored in construing this </font></div></td></tr></table><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-left:96px;padding-bottom:16px;text-align:justify;"><font style="font-family:inherit;font-size:12pt;">Agreement. When this Agreement requires approval of one or more parties, such approval may not be unreasonably withheld or delayed. Words, regardless of the number and gender specifically used, will be construed to include any other number, singular or plural, and any gender, masculine, feminine, or neuter, as the context requires. &#8220;And&#8221; includes &#8220;or.&#8221; &#8220;Or&#8221; is disjunctive but not necessarily exclusive. &#8220;Including&#8221; means &#8220;including but not limited to.&#8221;</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">d.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Legal Compliance</font><font style="font-family:inherit;font-size:12pt;">. It is the Intent of the parties to this Agreement to comply now, and hereafter during the term of this Agreement, with all federal; state, professional and other laws, statutes, regulations, rules, policies and protocols applicable to the subject matter of the Agreement and the relationship of the patties, including, without limitation, any reporting obligations (such as Average Selling Price) under any state or federal law. In the event there is any change in law, regulation or interpretation thereof that has the effect of prohibiting any right or obligation of a party under this Agreement or materially affects such right or obligation, then such party may upon notice to the other party immediately terminate this Agreement in whole or in part.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">e.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Force Majeure</font><font style="font-family:inherit;font-size:12pt;">. Each party&#8217;s obligation under this Agreement will be excused to the extent any delay is caused by strikes or other labor disturbance, acts of God, war, terrorism, shortage of materials or transportation, or other conditions beyond the reasonable control of that party, but only during the duration of such condition and provided such party gives prompt written notice thereof to the other party.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">f.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Benefits</font><font style="font-family:inherit;font-size:12pt;">. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and permitted assigns.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">g.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Complete Agreement</font><font style="font-family:inherit;font-size:12pt;">. Except for any Continuing Guaranty and Indemnification Agreement, this Agreement, together with the Exhibits hereto, contains the entire agreement between the parties and supersedes any prior agreement or understanding concerning the subject matter herein between the parties, including any and all return policy terms and conditions that may be presented to ABC.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">h.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Modification</font><font style="font-family:inherit;font-size:12pt;">. This Agreement may be modified, or rights hereunder waived, only in a writing signed by both parties that expressly references this Agreement.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">i.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Publicity</font><font style="font-family:inherit;font-size:12pt;">. Neither party shall have the right to issue a press release, statement or publication regarding the terms and conditions of or the existence of this Agreement.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">j.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Most Favored Nations Clause</font><font style="font-family:inherit;font-size:12pt;">. Supplier agrees not to offer payment terms that are less favorable to ABC than the payment terms offered to any other wholesale customer of Supplier.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">k.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Survival</font><font style="font-family:inherit;font-size:12pt;">. The representations and warranties under this Agreement which, by their terms and conditions, show the parties intended them to survive the termination of this Agreement for any reason, including provisions governing confidentiality, indemnification and liability, shall survive the expiration or earlier termination of this Agreement.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">[Signature Page Follows]</font></div><div><br></div><div></div><hr style="page-break-after:always"><div><a name="s77AF78A762D5637B7E8FAC279D565107"></a></div><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">IN WITNESS WHEREOF, the parties have executed this Agreement by their duly authorized representatives.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:13%;"></td><td style="width:20%;"></td><td style="width:2%;"></td><td style="width:11%;"></td><td style="width:53%;"></td><td style="width:1%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">DEXCOM INC.&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">AMERISOURCEBERGEN DRUG CORPORATION</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">s/ Jess Roper</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;font-style:italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">s/ Timothy J. Baker&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Name:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Jess Roper&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Name:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Timothy J. Baker&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Title:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">CFO</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Title:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Vice President &#8211; Consumer Products&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Date:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">November 4, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Date:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">November 5, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div><a name="s8032769633A2EFC5AB9CAC279D77D3B2"></a></div><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">EXHIBIT A</font><font style="font-family:inherit;font-size:10.5pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">CONTINUING GUARANTY AND INDEMNIFICATION AGREEMENT</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The undersigned guarantees to AmerisourceBergen Corporation and each of Its subsidiary companies and their successors that (i) any food, drugs, devices, cosmetics, or other merchandise (&#8220;Products&#8221;) now or hereafter shipped or delivered by or on behalf of the undersigned and its affiliates (&#8220;Guarantors&#8221;) to or on the order of AmerisourceBergen Corporation or any of its subsidiaries will not be, at the time of such shipment or delivery, adulterated, misbranded, or otherwise prohibited under applicable federal, state and local laws, Including applicable provisions of the Federal Food, Drug and Cosmetic Act, 21 U.S.G. &#167;301 et seq. (&#8220;FDGA&#8221;), and Sections 351 and 361 of the Federal Public Health Service Act, 42 U.S.C. &#167;&#167; 262 and 264, and their implementing regulations (&#8220;Applicable Laws&#8221;), each as amended and in effect at the time of shipment or delivery of such Products; (ii) Products are not, at the time of such shipment or delivery, merchandise that may not otherwise be Introduced or delivered for introduction Into interstate commerce under Applicable Laws, including FDCA section 301 (21 U.S.C. &#167;33I); and (iii) Products are merchandise that may be legally transported or sold under the provisions of any other applicable federal, state or local law. Guarantors guarantee further that, in the case of food shipments, only those chemicals or sprays approved by federal, state or local authorities have been used, and any residue in excess of the amount allowed by any such authorities has been removed from Products.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Guarantors shall promptly defend, indemnify and hold AmerisourceBergen Corporation and each of its subsidiaries harmless against any and all claims, losses, damages, costs, liabilities and expenses, including attorneys&#8217; fees and expenses, arising as a result of (a) any actual or asserted violation of Applicable Laws or by virtue of which Products made, sold, supplied, or delivered by or on behalf of Guarantors may be alleged or determined to be adulterated, misbranded or otherwise not in full compliance with or in contravention of Applicable Laws, (b) the possession, distribution, sale and/or use of, or by reason of the seizure of, any Products of Guarantors, including any prosecution or action whatsoever by any governmental body or agency or by any private party, Including claims of bodily injury, death or property damage, (o) any actual or asserted claim that Guarantors&#8217; Products infringe any proprietary or intellectual property rights &#176;fury person, including infringement of any trademarks or service names, trade names, trade secrets, inventions, patents or violation of any copyright laws or any other applicable federal, state or local laws, and (d) any actual or asserted claim of negligence, willful misconduct or breach of contract except to the extent arising from the negligence, willful misconduct or breach of contract of AmerisourceBergen or its affiliates.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Guarantors shall maintain primary, noncontributory product liability insurance of not less than [***] per occurrence for claims relating to Products. This insurance must include AmerisourceBergen Corporation, its subsidiaries and their successors as additional insureds for claims arising out of Products. Guarantor shall provide for at least thirty days&#8217; advance written notice to AmerisourceBergen Corporation of cancellation or material reduction of the required insurance. If the required insurance is underwritten on a &#8220;claims made&#8221; basis, the insurance must include a provision for an extended reporting period (&#8220;ERP&#8221;) of not less than twenty-four months; Guarantors further agree to purchase the ERP If continuous claims made insurance, with a retroactive data not later than the date of this Agreement, is not continually maintained or is otherwise unavailable. This insurance shall be with an insurer and in a form acceptable to AmerisourceBergen Corporation, and any deductible or retained risk must be commercially and financially reasonable and acceptable to AmerlsoureeBergen Corporation. Guarantors warrant that they have sufficient assets to cover any self-insurance or retained risk. Upon request, Guarantors will promptly provide satisfactory evidence of the required insurance.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Provisions in this Continuing Guaranty and Indemnification Agreement are in addition to, and not in lieu of, any terms set forth in any purchase orders accepted by Guarantors or any separate agreement entered </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">into between AmerisourceBergen Corporation or any of its subsidiaries and Guarantors. If the language Agreement conflicts with the language in any other document, the language in this Agreement controls.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Dexcom, Inc.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">s/ Jess Roper&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;11-4-2015&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Guarantor&#8217;s Company Name&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Signature of Authorized Officer&#160;&#160;&#160;&#160;Date</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"></font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Jess Roper, CFO&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Print Name and Title</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">__________________________________________</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Address of Company</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">__________________________________________</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:240px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Phone</font></div><div><br></div><div></div><hr style="page-break-after:always"><div><a name="s48FBB607B78333B6D329AC279DA9873E"></a></div><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">EXHIBIT B</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">EDI852 PRODUCT ACTIVITY DATA</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">EDI 852 transmissions will be sent weekly, They are typically provided by the end of the first business day following the end of the chosen reporting period.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Table 1: EDI 852 Transmission Format</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:18%;"></td><td style="width:82%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Element</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Comments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reporting Date.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Division DUNS + 4</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ABC Corporate DUNS number plus four digit division identifier.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Division DEA Number</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ABC division registered DEA number.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">NDC or UPC</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contains the Item&#8217;s NDC or UPC Identifier. Typically, the NDC number Is sent If a Material has both. In the event that an NDC or UPC Is not available, Manufacturer Product Code or other Identifier will be sent.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ABC Item Number</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents ABC&#8217;s Internal SAP Material Number.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4P</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On Order Quantity&#8212;The amount of Inventory on-order with the manufacturer.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">QA</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On Hand Quantity&#8212;The saleable on-hand quantity at the time of the reporting snapshot.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">QS</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales Out Quantity&#8212; Represents the total invoice units for regular sales. It may also include Intercompany sales, or pm-book dock-to-dock sales If manufacturer does not separately receive one or more of those sales types. It does not Include drop-ship sales and Is not net of any customer returns. Credit/re-bill invoices are not Included,</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Omit Quantity&#8212; Filtered for customer order errors and corporately discontinued Items. Intercompany omits are always excluded,</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inbound Transfer Quantify&#8212; Represents Inbound stock transfer order quantity In the receiving division, Works in conjunction with QZ.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">QZ</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outbound Transfer Quantity&#8212; Represents the outbound stock transfer order quantity in shipping division, Works in conjunction with QI.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">QD</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forecaster/ Unit Demand&#8212; ABC&#8217;s 28-day unit forecast. A multiplying factor can be applied to represent data In a different time period upon request (i.e. 99 day forecast).</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">QR</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Saleable Quantity Received&#8212; Purchase order quantities received from the manufacturer and from stock transfer orders. Pre-book purchase order quantities are Included.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">QT</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory Adjustments (Positive)&#8212; Reports positive adjustments to saleable Inventory. Works In conjunction with QH.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">QH</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory Adjustments (Negative)&#8212; Reports negative adjustments to saleable inventory. Works In conjunction with QT.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">QU</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Saleable Customer Return Quantity&#8212; Inventory units returned by the customer which Is deemed saleable and returned to stock.</font></div></td></tr></table></div></div><div style="line-height:100%;padding-bottom:5px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Records will normally only be created for those Items which are actively stocked in an AmerisourceBergen division. This does not Include any re-packaged inventory that may be purchased from AHP. Puerto Rico Division activity </font><font style="font-family:inherit;font-size:3pt;font-weight:bold;">Is </font><font style="font-family:inherit;font-size:10pt;">typically Included unless otherwise specified.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the event that a disruption with the transmission occurs, AmerisourceBergen will have up to five (5) business days following notification by the supplier to remedy the situation. AmerisourceBergen will exercise reasonable care to avoid material errors In gathering, processing and delivering Data.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The parties will work together In good faith to establish EDI feeds. However, in the event that the supplier is unable to receive electronic EDI feeds, then a report in an alternate format will be provided.</font></div><div style="line-height:120%;padding-top:5px;text-align:justify;padding-left:9px;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div><a name="s559A8ECAC67BA43CC40EAC279DCA9680"></a></div><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">EXHIBIT C</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">EDI867 SALES REPORTING DATA</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">EDI 867 transmissions will be sent weekly. They are typically provided by the end of the first business day following the end of the chosen reporting period.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Table 2: EDI 867 Transmission Format</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:19%;"></td><td style="width:81%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Element</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Comments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date of Transmission</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date when EDI 867 transmission Is sent,</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date Range</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Time period of events Included in the current transmission.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Division DEA Number</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contains the DEA number assigned to the division.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Division HIM Number</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contains the IIIN number assigned to the division.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer Name and DEA Number</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents the customer&#8217;s name and the DEA number assigned to them,</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer Street Address</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents the street address for the customer.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer City, State, and P</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents the city, state, and ZIP of the customer&#8217;s location.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer HIN Number</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contains the HIN number assigned to that customer.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">NDC or UPC</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents the NDC or UPC number assigned to the product Involved In the transaction. In the event that an NDC or UPC Is not available, Manufacturer Product Code or other Identifier will be sent.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unit Cost</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents the wholesale acquisition cost for the product.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Invoice/Credit Number and Invoice/Credit Date</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents the Invoice/credit number and the time when the Invoice was issued.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">380</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unit Quantity Sold or Returned.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">782</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Extended Wholesale Cost&#8212; Based upon the quantity sold/returned multiplied by the wholesale acquisition cost of the product.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">SS</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Regular sales Quantity&#8212; Includes regular trade sales.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">BQ</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-took Dock-to-Dock Sales Quantity&#8212; Includes sales quantities reported from Invoices coded with pre-book special handling codes.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">RV</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer Quantity Retinal &#8211; Includes all quantity returned unless only saleable returns are specified.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AmerisourceBergen may, solely due to contractual requirements, be required to block all or certain fields related to the data that discloses the identity of a</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">particular shipping (DEA) location.  AmerisourceBergen will not be required to share 867 data that allows the Supplier to determine the actual identity and physical address, including the full zip code, of the non-consumer end purchaser of the product.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales of any re-packaged inventory that may be purchased from AHP will not be reported through this process.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the event that a disruption with the transmission occurs, AmerisourceBergen will have up to five (5) business days following notification by the supplier to remedy the situation.  AmerisourceBergen will exercise reasonable care to avoid material errors in gathering, processing and delivering Data.</font></div><div><br></div><div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.39
<SEQUENCE>6
<FILENAME>dxcm12312019exhibit1039.htm
<DESCRIPTION>EXHIBIT 10.39
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s178C484045F9653DD18DAC2B9698A4EC"></a></div><div><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">EXHIBIT 10.39</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">[***] =&#160;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Certain information has been excluded from this exhibit because it (i)&#160;is not material and (ii)&#160;would be competitively harmful if publicly disclosed.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">AMENDMENT TO THE <br>DISTRIBUTION SERVICES AGREEMENT <br>BETWEEN DEXCOM INC. <br>&amp; <br>AMERISOURCEBERGEN DRUG CORPORATION </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Amendment (the &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Amendment</font><font style="font-family:inherit;font-size:12pt;">&#8221;), effective as of the 1st day of November, 2018 (the &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Amendment Effective Date</font><font style="font-family:inherit;font-size:12pt;">&#8221;), is entered into by and between DEXCOM Inc. (&#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Supplier</font><font style="font-family:inherit;font-size:12pt;">&#8221;) and AmerisourceBergen Drug Corporation (&#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ABC</font><font style="font-family:inherit;font-size:12pt;">&#8221;), individually a &#8220;Party&#8221; and collectively the &#8220;Parties.&#8221; </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">WHEREAS</font><font style="font-family:inherit;font-size:12pt;">, the Parties have entered into a Distribution Services Agreement effective as of November 7, 2015 (as amended, the &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221;); and </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">WHEREAS</font><font style="font-family:inherit;font-size:12pt;">, the Parties now desire to amend the Agreement as set forth below. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">NOW, THEREFORE</font><font style="font-family:inherit;font-size:12pt;">, for and in consideration of the premises and the mutual covenants and agreements contained in the Agreement, and intending to be legally bound hereby, the Parties agree as follows: </font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;text-decoration:underline;">Definitions</font><font style="font-family:inherit;font-size:12pt;">.  Capitalized words used but not defined herein shall have the meanings ascribed thereto in the Agreement.  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;text-decoration:underline;">Amendments</font><font style="font-family:inherit;font-size:12pt;">. </font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#010000;">2.1</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The penultimate sentence of Section 2(f) of the Agreement shall be amended and restated in its entirety and shall read as follows: </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;The amount of the [***] is [***] basis points times the amount of ABC&#8217;s monthly gross purchases less damages at Wholesale Acquisition Cost (&#8220;WAC&#8221;) and shall be invoiced monthly and payment shall be due within [***] days of the date of the invoice.&#8221; </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.2</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The first sentence of Section 5 of the Agreement shall be amended and restated in its entirety and shall read as follows: </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;In consideration of ABC agreeing not to return any Products (other than as expressly set forth or referenced in this Section 5), Supplier shall pay ABC a &#8220;Returns Allowance&#8221; of [***] multiplied by the sum of (a) the amount of ABC&#8217;s monthly gross purchases less (b) Products that are: (i) returned (including Permitted Returns (as defined below)), (ii) drop shipped by Supplier to customers or third parties, (iii) third party product return claims other than ABC&#8217;s Third Party Returns, and (iv) damaged (as determined pursuant to Section 6 below), each at the applicable Wholesale Acquisition Costs.&#8221; </font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;text-decoration:underline;">Miscellaneous</font><font style="font-family:inherit;font-size:12pt;">.  Except as specifically amended herein, all other terms and conditions of the Agreement will remain in full force and effect.  This Amendment, together with the Agreement and any exhibits thereto, constitutes the entire agreement between the Parties with respect to the subject matter hereof and supersedes all other prior agreements and understandings, both written and oral, between the Parties with respect to the subject matter hereof.  In the event any provisions in this Amendment shall be inconsistent with the provisions of the Agreement, the provisions in this Amendment shall govern solely with respect to the subject matter herein.  This Amendment may be executed in any number of counterparts, each of which is deemed an original but all of which constitute the same instrument. </font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:justify;text-indent:624px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">[Signature Page Follows]</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:justify;text-indent:312px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><a name="s592A08D6540B44655294AC2B96B869C9"></a></div><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">IN WITNESS WHEROF</font><font style="font-family:inherit;font-size:12pt;">, the Parties have by their signatures of their duly authorized officers or representatives caused this Amendment to be executed and effective as of the Amendment Effective Date. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.22807017543859%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:11%;"></td><td style="width:53%;"></td><td style="width:2%;"></td><td style="width:13%;"></td><td style="width:20%;"></td><td style="width:1%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">AMERISOURCEBERGEN DRUG CORPORATION</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">DEXCOM INC.&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">s/ Doug Trueman&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">s/ Brice Bobzien</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;font-style:italic;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Name:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Doug Trueman&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Name:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Brice Bobzien</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;font-style:italic;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Title:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Vice President &#8211; Consumer Products&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Title:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">VP, Finance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Date:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">November 5, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Date:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">October 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:justify;text-indent:624px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.40
<SEQUENCE>7
<FILENAME>dxcm12312019exhibit1040.htm
<DESCRIPTION>EXHIBIT 10.40
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s3C587B29C55B56826E63DA1E636651E5"></a></div><div><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">EXHIBIT 10.40</font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">[***] =&#160;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Certain information has been excluded from this exhibit because it (i)&#160;is not material and (ii)&#160;would be competitively harmful if publicly disclosed.</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">THIRD AMENDMENT TO OFFICE LEASE</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This THIRD AMENDMENT TO OFFICE LEASE ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Third Amendment</font><font style="font-family:inherit;font-size:12pt;">") is made and entered into as of the 9</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">th</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;day of January, 2019, by and between JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.), a wholly owned subsidiary of Manulife Financial Corporation, a Michigan corporation ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Landlord</font><font style="font-family:inherit;font-size:12pt;">"), and DEXCOM, INC., a Delaware corporation ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Tenant</font><font style="font-family:inherit;font-size:12pt;">").</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:32px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">R E C I T A L S</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;">:</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">A.&#160;&#160;&#160;&#160;Landlord and Tenant entered into that certain Office Lease dated March&#160;31, 2006 (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Lease</font><font style="font-family:inherit;font-size:12pt;">"), as amended by (i)&#160;that certain First Amendment to Office Lease dated August&#160;18, 2010 ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">First Amendment</font><font style="font-family:inherit;font-size:12pt;">"), and (ii)&#160;that certain Second Amendment to Office Lease dated October&#160;1, 2014 ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Second Amendment</font><font style="font-family:inherit;font-size:12pt;">"), whereby Landlord leases to Tenant and Tenant leases from Landlord those certain premises (collectively, the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Premises</font><font style="font-family:inherit;font-size:12pt;">") located in the following buildings:  (i)&#160;that certain office building located at 6340 Sequence Drive, San Diego, California ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6340 Building</font><font style="font-family:inherit;font-size:12pt;">"), (ii)&#160;that certain office building located at 6310 Sequence Drive, San Diego, California ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6310 Building</font><font style="font-family:inherit;font-size:12pt;">") and (iii)&#160;that certain office building located at 6290 Sequence Drive, San Diego, California ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6290 Building</font><font style="font-family:inherit;font-size:12pt;">") (collectively, the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Buildings</font><font style="font-family:inherit;font-size:12pt;">"), which buildings are located in the Project (as defined in the Lease).  The Original Lease, as amended by the First Amendment and the Second Amendment, may be referred to herein as the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Lease</font><font style="font-family:inherit;font-size:12pt;">".</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">B.&#160;&#160;&#160;&#160;Tenant desires to perform sprinkler renovation work in the 6290 Building and Landlord has agreed to provide Tenant with an improvement allowance in connection with such work.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">C.&#160;&#160;&#160;&#160;In connection with the foregoing, Landlord and Tenant desire to amend the Lease as hereinafter provided.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:32px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">A G R E E M E N T</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;">:</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NOW, THEREFORE, in consideration of the foregoing recitals and the mutual covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:</font></div><div style="line-height:120%;padding-left:0px;padding-top:16px;text-align:justify;text-indent:48px;"><font style="padding-top:16px;text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">1.</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Capitalized Terms</font><font style="font-family:inherit;font-size:12pt;">.  All capitalized terms when used herein shall have the same meaning as is given such terms in the Lease unless expressly superseded by the terms of this Third Amendment.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Sprinkler Renovation</font><font style="font-family:inherit;font-size:12pt;">.  As soon as reasonably possible following the full execution and delivery of this Third Amendment by Landlord and Tenant, Tenant shall perform the sprinkler renovation work in the 6290 Building pursuant to the terms and conditions of the Tenant Work Letter attached hereto as </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Exhibit&#160;"A"</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Certified Access Specialist</font><font style="font-family:inherit;font-size:12pt;">.  For purposes of Section&#160;1938 of the California Civil Code, Landlord hereby discloses to Tenant, and Tenant hereby acknowledges, that neither the Premises nor the Building has undergone inspection by a Certified Access Specialist (CASp).  As required by Section 1938(e) of the California Civil Code, Landlord hereby states as follows:  "A Certified Access Specialist (CASp) can inspect the subject premises and determine whether the subject premises comply with all of the applicable construction-related accessibility standards under state law.  Although state law does not require a CASp </font></div><div><br></div><div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-8-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6340/6310/6290 SEQUENCE DRIVE</font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">[Expansion and Extension Amendment]</font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">[DexCom, Inc.]</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">inspection of the subject premises, the commercial property owner or lessor may not prohibit the lessee or tenant from obtaining a CASp inspection of the subject premises for the occupancy or potential occupancy of the lessee or tenant, if requested by the lessee or tenant.  The parties shall mutually agree on the arrangements for the time and manner of the CASp inspection, the payment of the fee for the CASp inspection, and the cost of making any repairs necessary to correct violations of construction-related accessibility standards within the premises."  In furtherance of the foregoing, Landlord and Tenant hereby agree as follows:  (i)&#160;any CASp inspection requested by Tenant shall be conducted, at Tenant's sole cost and expense, by a CASp designated by Landlord, subject to Landlord's reasonable rules and requirements; (ii)&#160;Tenant, at its sole cost and expense, shall be responsible for making any improvements or repairs within the Premises to correct violations of construction-related accessibility standards; and (iii) if anything done by or for Tenant in its use or occupancy of the Premises shall require any improvements or repairs to the Building or the Project (outside the Premises) to correct violations of construction-related accessibility standards, then Tenant shall reimburse Landlord upon demand, as Additional Rent, for the cost to Landlord of performing such improvements or repairs.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">No Further Modification</font><font style="font-family:inherit;font-size:12pt;">.  Except as set forth in this Third Amendment, all of the terms and provisions of the Lease shall remain unmodified and in full force and effect.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">IN WITNESS WHEREOF, this Third Amendment has been executed as of the day and year first above written.  </font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:91.22807017543859%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:51%;"></td><td style="width:49%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">"LANDLORD":</font></div><div style="padding-top:16px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.), <br>a wholly owned subsidiary of Manulife Financial Corporation,</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">a Michigan corporation</font></div><div style="padding-top:16px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">/s/ Ray Rothfelder</font></div><div style="padding-top:8px;padding-left:30px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Its: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Managing Director, Western U.S.</font></div><div style="padding-top:8px;padding-left:30px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">February 11, 2019</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:16px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">"TENANT":</font></div><div style="padding-top:16px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">DEXCOM, INC.,</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">a Delaware corporation</font></div><div style="padding-top:16px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">/s/ Quentin S. Blackford</font></div><div style="padding-top:8px;padding-left:33px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Its: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Chief Operating Officer and Chief Financial Officer</font></div><div style="padding-top:8px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">February 8, 2019</font></div><div style="padding-top:8px;padding-left:33px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div><a name="s3FADDA3987C237CDA1F8DA1E638CD78E"></a></div><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">EXHIBIT A</font></div><div style="line-height:240%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">TENANT WORK LETTER</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Tenant Work Letter ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Tenant Work Letter</font><font style="font-family:inherit;font-size:12pt;">") shall set forth the terms and conditions relating to the Sprinkler Renovation Work described below.</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">SECTION 1</font><font style="font-family:inherit;font-size:10pt;">&#32;<br> <br></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">GENERAL</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Except for the Improvement Allowance set forth below, Landlord shall not be obligated to make or pay for any alterations or improvements to the 6290 Building, the Building or the Project.</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">SECTION 2</font><font style="font-family:inherit;font-size:10pt;">&#32;<br> <br></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">IMPROVEMENT ALLOWANCE AND SPRINKLER RENOVATION WORK</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.1&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Improvement Allowance</font><font style="font-family:inherit;font-size:12pt;">.  Tenant shall be entitled to an improvement allowance (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Improvement Allowance</font><font style="font-family:inherit;font-size:12pt;">") in the amount of up to, but not exceeding, Two Million Three Hundred Eighty-Four Thousand Two Hundred Thirty-Two Dollars ($2,384,232.00), to help Tenant pay for the costs of the design, permitting and construction of the sprinkler renovation work in the 6290&#160;Building pursuant to the construction bids attached hereto as </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Schedule&#160;1</font><font style="font-family:inherit;font-size:12pt;">&#32;(collectively, the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Sprinkler Renovation Work</font><font style="font-family:inherit;font-size:12pt;">"); provided, however, that Landlord shall have no obligation to disburse all or any portion of the Improvement Allowance to Tenant unless Tenant makes a request for disbursement pursuant to the terms and conditions of Section&#160;2.2 below prior to June&#160;30, 2019.  In no event shall Landlord be obligated to make disbursements pursuant to this Tenant Work Letter in a total amount which exceeds the Improvement Allowance.  Tenant shall not be entitled to receive any cash payment or credit against Rent or otherwise for any unused portion of the Improvement Allowance which is not used to pay for the Improvement Allowance Items (as defined below).</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.2&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Disbursement of the Improvement Allowance</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.2.1&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Improvement Allowance Items</font><font style="font-family:inherit;font-size:12pt;">.  Except as otherwise set forth in this Tenant Work Letter, the Improvement Allowance shall be disbursed by Landlord only for the following items and costs (collectively, the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Improvement Allowance Items</font><font style="font-family:inherit;font-size:12pt;">"):</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.2.1.1&#160;&#160;&#160;&#160;Payment of (i)&#160;the fees of the Architect and the Engineers (as such terms are defined below), and (ii)&#160;the fees incurred by, and the cost of documents and materials supplied by, Landlord and Landlord's consultants in connection with the preparation and review of the Construction Drawings (as defined below);</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.2.1.2&#160;&#160;&#160;&#160;The payment of plan check, permit and license fees relating to construction of the Sprinkler Renovation Work;</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.2.1.3&#160;&#160;&#160;&#160;The cost of construction of the Sprinkler Renovation Work, including, without limitation, contractors' fees and general conditions, testing and inspection costs, costs of utilities, trash removal, parking and hoists, and the costs of after-hours freight elevator usage.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.2.1.4&#160;&#160;&#160;&#160;The cost of any changes to the Construction Drawings or Sprinkler Renovation Work required by applicable laws;</font></div><div><br></div><div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-8-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6340/6310/6290 SEQUENCE DRIVE</font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">[Expansion and Extension Amendment]</font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">[DexCom, Inc.]</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.2.1.5&#160;&#160;&#160;&#160;Sales and use taxes and Title 24 fees; and</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.2.1.6&#160;&#160;&#160;&#160;All other costs to be expended by Landlord in connection with the design, permitting and construction of the Sprinkler Renovation Work.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.2.2&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Disbursement of Improvement Allowance</font><font style="font-family:inherit;font-size:12pt;">.  Subject to Section&#160;2.1 above, during the construction of the Sprinkler Renovation Work, Landlord shall make monthly disbursements of the Improvement Allowance for Improvement Allowance Items for the benefit of Tenant and shall authorize the release of monies for the benefit of Tenant as follows:</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.2.2.1&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Monthly Disbursements</font><font style="font-family:inherit;font-size:12pt;">.  From time to time during the construction of the Sprinkler Renovation Work (but no more frequently than monthly), Tenant shall deliver to Landlord:  (i)&#160;a request for payment of the Contractor (as defined below), approved by Tenant, in a form to be provided by Landlord, showing the schedule, by trade, of percentage of completion of the Sprinkler Renovation Work, detailing the portion of the work completed and the portion not completed, and demonstrating that the relationship between the cost of the work completed and the cost of the work to be completed complies with the terms of the Construction Budget (as defined below); (ii)&#160;invoices from all of Tenant's Agents (as defined below), for labor rendered and materials delivered to the 6290 Building; (iii)&#160;executed mechanic's lien releases from all of Tenant's Agents which shall comply with the appropriate provisions, as reasonably determined by Landlord, of California Civil Code Section&#160;8138; and (iv)&#160;each of the general disbursement items referenced in Section&#160;2.2.2.2 below, and all other information reasonably requested by Landlord.  Tenant's request for payment shall be deemed Tenant's acceptance and approval of the work furnished and/or the materials supplied as set forth in Tenant's payment request.  Following Landlord's receipt of a completed disbursement request submission,, Landlord shall deliver a check to Tenant made jointly payable to the Contractor and Tenant in payment of the lesser of (A)&#160;the amounts so requested by Tenant, as set forth in this Section&#160;2.2.2.1, above, less a ten percent (10%) retention (the aggregate amount of such retentions to be known as the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Final Retention</font><font style="font-family:inherit;font-size:12pt;">") and (B)&#160;the balance of any remaining available portion of the Improvement Allowance (not including the Final Retention), provided that Landlord does not dispute any request for payment based on non-compliance of any work with the Approved Working Drawings (as defined below), or due to any substandard work, or for any other reason.  Landlord's payment of such amounts shall not be deemed Landlord's approval or acceptance of the work furnished or materials supplied as set forth in Tenant's payment request.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.2.2.2&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Final Retention</font><font style="font-family:inherit;font-size:12pt;">.  Subject to the provisions of this Tenant Work Letter, a check for the Final Retention payable jointly to Tenant and Contractor shall be delivered by Landlord to Tenant following the completion of construction of the Sprinkler Renovation Work, provided that (i)&#160;Landlord has determined that no substandard work exists which adversely affects the mechanical, electrical, plumbing, HVAC, life-safety or other systems of the Building, the curtain wall of the Building, or the structure or exterior appearance of the Building; and (ii)&#160;Tenant has delivered to Landlord:  (A)&#160;properly executed and final unconditional mechanics lien releases in compliance with applicable California law; (B)&#160;if applicable, a certificate of occupancy or permit cards signed off by the City of San Diego (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">City</font><font style="font-family:inherit;font-size:12pt;">") with respect to the 6290 Building; (C)&#160;as-built plans and City-permitted plans for the Sprinkler Renovation Work; (D)&#160;operation manuals and warranties for equipment included within the Sprinkler Renovation Work, if applicable; (E)&#160;copy of the contract with the Contractor; (F)&#160;copy of the Contractor's certificate of insurance, including Additional Insured endorsement naming Landlord (and any other party requested by Landlord) as additional insureds; and (G)&#160;the Contractor's schedule of values, showing total contract value.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.2.2.3&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Other Terms</font><font style="font-family:inherit;font-size:12pt;">.  Landlord shall only be obligated to make disbursements from the Improvement Allowance to the extent costs are incurred by Tenant for Improvement Allowance Items.</font></div><div><br></div><div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-8-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6340/6310/6290 SEQUENCE DRIVE</font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">[Expansion and Extension Amendment]</font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">[DexCom, Inc.]</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">SECTION 3</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;"><br>CONSTRUCTION DRAWINGS</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3.1&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Selection of Architect/Construction Drawings</font><font style="font-family:inherit;font-size:12pt;">.  Tenant shall retain the architect/space planner (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Architect</font><font style="font-family:inherit;font-size:12pt;">") and engineering consultants ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Engineers</font><font style="font-family:inherit;font-size:12pt;">") approved by Landlord, which approval shall not be unreasonably withheld, to prepare the Construction Drawings.  The plans and drawings to be prepared by Architect and the Engineers hereunder shall be known collectively as the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Construction Drawings</font><font style="font-family:inherit;font-size:12pt;">."  All Construction Drawings shall comply with the drawing format and specifications reasonably determined by Landlord, and shall be subject to Landlord's reasonable approval.  Tenant and Architect shall verify, in the field, the dimensions and conditions as shown on the relevant portions of the base building plans, and Tenant and Architect shall be solely responsible for the same, and Landlord shall have no responsibility in connection therewith.  Landlord's review of the Construction Drawings as set forth in this Section&#160;3, shall be for its sole purpose and shall not imply Landlord's review of the same, or obligate Landlord to review the same, for quality, design, code compliance or other like matters.  Accordingly, notwithstanding that any Construction Drawings are reviewed by Landlord or its space planner, architect, engineers and consultants, and notwithstanding any advice or assistance which may be rendered to Tenant by Landlord or Landlord's space planner, architect, engineers, and consultants, Landlord shall have no liability whatsoever in connection therewith and shall not be responsible for any omissions or errors contained in the Construction Drawings.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3.2&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Final Working Drawings</font><font style="font-family:inherit;font-size:12pt;">.  As soon as reasonably possible after the date hereof, Tenant shall cause the Architect and the Engineers to complete the architectural and engineering drawings for the Sprinkler Renovation Work, and cause the Architect to compile a fully coordinated set of architectural, structural, mechanical, electrical and plumbing working drawings in a form which is complete to obtain all applicable permits for the Sprinkler Renovation Work (collectively, the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Final Working Drawings</font><font style="font-family:inherit;font-size:12pt;">"), and shall submit the same to Landlord for Landlord's approval.  Tenant shall supply Landlord with four (4) copies signed by Tenant of such Final Working Drawings.  Landlord shall advise Tenant within five (5) business days after Landlord's receipt of the Final Working Drawings for the Sprinkler Renovation Work if the same is unsatisfactory or incomplete in any respect.  If Tenant is so advised, Tenant shall promptly (i)&#160;revise the Final Working Drawings in accordance with such review and any disapproval of Landlord in connection therewith, and (ii)&#160;deliver such revised Final Working Drawings to Landlord.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3.4&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Approved Working Drawings</font><font style="font-family:inherit;font-size:12pt;">.  The Final Working Drawings shall be approved by Landlord (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Approved Working Drawings</font><font style="font-family:inherit;font-size:12pt;">") prior to the commencement of the Sprinkler Renovation Work.  After approval by Landlord of the Final Working Drawings, Tenant shall promptly submit the same to the appropriate governmental authorities for all applicable building permits.  Tenant hereby agrees that neither Landlord nor Landlord's consultants shall be responsible for obtaining any building permit and that obtaining the same shall be Tenant's responsibility; provided, however, that Landlord shall cooperate with Tenant in executing permit applications and performing other ministerial acts reasonably necessary to enable Tenant to obtain any such permit.  No changes, modifications or alterations in the Approved Working Drawings may be made without the prior written consent of Landlord, which consent shall not be unreasonably withheld.</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">SECTION 4</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;"><br>CONSTRUCTION OF THE SPRINKLER RENOVATION WORK</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.1&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Tenant's Selection of Contractor and Tenant's Agents</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.1.1&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">The Contractor</font><font style="font-family:inherit;font-size:12pt;">.  Tenant shall select BNB Builders as the general contractor to construct the Sprinkler Renovation Work (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Contractor</font><font style="font-family:inherit;font-size:12pt;">").</font></div><div><br></div><div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-8-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6340/6310/6290 SEQUENCE DRIVE</font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">[Expansion and Extension Amendment]</font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">[DexCom, Inc.]</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.1.2&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Tenant's Agents</font><font style="font-family:inherit;font-size:12pt;">.  All subcontractors, laborers, materialmen, and suppliers used by Tenant (such subcontractors, laborers, materialmen, and suppliers, and the Contractor to be known collectively as "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Tenant's Agents</font><font style="font-family:inherit;font-size:12pt;">") must be approved in writing by Landlord, which approval shall not be unreasonably withheld or delayed.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.2&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Construction of Sprinkler Renovation Work by Tenant's Agents</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.2.1&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Construction Contract; Cost Budget</font><font style="font-family:inherit;font-size:12pt;">.  Prior to Tenant's execution of the construction contract and general conditions with Contractor (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Contract</font><font style="font-family:inherit;font-size:12pt;">"), Tenant shall submit the Contract to Landlord for its approval, which approval shall not be unreasonably withheld or delayed.  Prior to the commencement of the construction of the Sprinkler Renovation Work, Tenant shall provide Landlord with a written detailed cost breakdown (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Final Costs Statement</font><font style="font-family:inherit;font-size:12pt;">"), by trade, of the final costs to be incurred, or which have been incurred, as set forth more particularly in Section&#160;2.2.1.1 through 2.2.1.6 above, in connection with the design, permitting and construction of the Sprinkler Renovation Work to be performed by or at the direction of Tenant or the Contractor (which costs form a basis for the amount of the Contract, if any (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Final Costs</font><font style="font-family:inherit;font-size:12pt;">").</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.2.2&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Tenant's Agents</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.2.2.1&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Landlord's General Conditions for Tenant's Agents and Sprinkler Renovation Work</font><font style="font-family:inherit;font-size:12pt;">.  Tenant's and Tenant's Agents' construction of the Sprinkler Renovation Work shall comply with the following:  (i)&#160;the Sprinkler Renovation Work shall be constructed in strict accordance with the Approved Working Drawings; (ii)&#160;Tenant's Agents shall submit schedules of all work relating to the Sprinkler Renovation Work to Contractor and Contractor shall, within five (5) business days after Tenant's receipt thereof, inform Tenant's Agents of any changes which are necessary thereto, and Tenant's Agents shall adhere to such corrected schedule; and (iii)&#160;Tenant shall abide by all rules made by Landlord's Building contractor or Landlord's Building manager with respect to the use of freight, loading dock and service elevators, storage of materials, and any other matter in connection with this Tenant Work Letter, including, without limitation, the construction of the Sprinkler Renovation Work.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.2.2.2&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Indemnity</font><font style="font-family:inherit;font-size:12pt;">.  Tenant's indemnity of Landlord as set forth in the Lease shall also apply with respect to any and all costs, losses, damages, injuries and liabilities related in any way to any act or omission of Tenant or Tenant's Agents, or anyone directly or indirectly employed by any of them, or in connection with Tenant's non-payment of any amount arising out of the Sprinkler Renovation Work and/or Tenant's disapproval of all or any portion of any request for payment.  Such indemnity by Tenant, as set forth in the Lease, shall also apply with respect to any and all costs, losses, damages, injuries and liabilities related in any way to Landlord's performance of  any ministerial acts reasonably necessary (i)&#160;to permit Tenant to complete the Sprinkler Renovation Work, and (ii)&#160;to enable Tenant to obtain any building permit for the 6290 Building.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.2.2.3&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Insurance Requirements</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:192px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.2.2.3.1&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">General Coverages</font><font style="font-family:inherit;font-size:12pt;">.  All of Tenant's Agents shall carry worker's compensation insurance covering all of their respective employees, and shall also carry public liability insurance, including property damage, all with limits, in form and with companies as are required to be carried by Tenant as set forth in the Lease.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:192px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.2.2.3.2&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Special Coverages</font><font style="font-family:inherit;font-size:12pt;">.  Tenant shall carry "Builder's All Risk" insurance in an amount equal to the full replacement cost of the improvements being constructed by Tenant, and such other insurance as Landlord may reasonably require.  Such insurance shall be in amounts and shall include </font></div><div><br></div><div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-8-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6340/6310/6290 SEQUENCE DRIVE</font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">[Expansion and Extension Amendment]</font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">[DexCom, Inc.]</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">such extended coverage endorsements as may be reasonably required by Landlord, and in form and with companies as are required to be carried by Tenant as set forth in the Lease.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:192px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.2.2.3.3&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">General Terms</font><font style="font-family:inherit;font-size:12pt;">.  Certificates for all insurance carried pursuant to this Section&#160;4.2.2.4 shall be delivered to Landlord before the commencement of construction of the Sprinkler Renovation Work and before the Contractor's equipment is moved onto the site.  All such policies of insurance must contain a provision that the company writing said policy will give Landlord thirty (30) days prior written notice of any cancellation or lapse of the effective date or any reduction in the amounts of such insurance.  If the Sprinkler Renovation Work are damaged by any cause during the course of the construction thereof, Tenant shall immediately repair the same at Tenant's sole cost and expense.  All policies carried under this Section&#160;4.2.2.4 shall insure Landlord and Tenant, as their interests may appear, as well as Contractor and Tenant's Agents, and shall name as additional insureds Landlord's property manager, Landlord's asset manager, and all mortgagees and ground lessors of the Building and any other parties specified by Landlord.  All insurance, except Workers' Compensation, maintained by Tenant's Agents shall preclude subrogation claims by the insurer against anyone insured thereunder.  Such insurance shall provide that it is primary insurance as respects the owner and that any other insurance maintained by owner is excess and noncontributing with the insurance required hereunder.  The requirements for the foregoing insurance shall not derogate from the provisions for indemnification of Landlord by Tenant under Section&#160;4.2.2.3 of this Tenant Work Letter.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.2.3&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Governmental Compliance</font><font style="font-family:inherit;font-size:12pt;">.  The Sprinkler Renovation Work shall comply in all respects with the following:  (i)&#160;the Code and other state, federal, city or quasi-governmental laws, codes, ordinances and regulations, as each may apply according to the rulings of the controlling public official, agent or other person; (ii)&#160;applicable standards of the American Insurance Association (formerly, the National Board of Fire Underwriters) and the National Electrical Code; and (iii)&#160;building material manufacturer's specifications.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.2.4&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Inspection by Landlord</font><font style="font-family:inherit;font-size:12pt;">.  Landlord shall have the right to inspect the Sprinkler Renovation Work at all times, provided however, that Landlord's failure to inspect the Sprinkler Renovation Work shall in no event constitute a waiver of any of Landlord's rights hereunder nor shall Landlord's inspection of the Sprinkler Renovation Work constitute Landlord's approval of the same.  Should Landlord disapprove any portion of the Sprinkler Renovation Work, Landlord shall notify Tenant in writing of such disapproval and shall specify the items disapproved.  Any defects or deviations in, and/or disapproval by Landlord of, the Sprinkler Renovation Work shall be rectified by Tenant at no expense to Landlord, provided however, that if Landlord determines that a defect or deviation exists or disapproves of any matter in connection with any portion of the Sprinkler Renovation Work and such defect, deviation or matter might adversely affect the mechanical, electrical, plumbing, HVAC or life-safety systems of the Building, or the structure or exterior appearance of the Building, Landlord may, take such action as Landlord deems necessary, at Tenant's expense and without incurring any liability on Landlord's part, to correct any such defect, deviation and/or matter, including, without limitation, causing the cessation of performance of the construction of the Sprinkler Renovation Work until such time as the defect, deviation and/or matter is corrected to Landlord's satisfaction.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.2.5&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Meetings</font><font style="font-family:inherit;font-size:12pt;">.  Commencing upon the execution of the Third Amendment, Tenant shall hold weekly meetings at a reasonable time, with the Architect and the Contractor regarding the progress of the preparation of Construction Drawings and the construction of the Sprinkler Renovation Work, which meetings shall be held at a location designated by Landlord, and Landlord and/or its agents shall receive prior notice of, and shall have the right to attend, all such meetings, and, upon Landlord's request, certain of Tenant's Agents shall attend such meetings.  In addition, minutes shall be taken at all such meetings, a copy of which minutes shall be promptly delivered to Landlord.  One such meeting each month shall include the review of Contractor's current request for payment.</font></div><div><br></div><div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-8-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6340/6310/6290 SEQUENCE DRIVE</font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">[Expansion and Extension Amendment]</font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">[DexCom, Inc.]</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.3&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Notice of Completion; Copy of "As Built" Plans</font><font style="font-family:inherit;font-size:12pt;">.  Within ten (10) days after completion of construction of the Sprinkler Renovation Work, Tenant shall cause a Notice of Completion to be recorded in the office of the Recorder of the County in which the Building is located in accordance with Section&#160;3093 of the Civil Code of the State of California or any successor statute, and shall furnish a copy thereof to Landlord upon such recordation.  If Tenant fails to do so, Landlord may execute and file the same on behalf of Tenant as Tenant's agent for such purpose, at Tenant's sole cost and expense.  At the conclusion of construction, (i)&#160;Tenant shall cause the Architect and Contractor (A)&#160;to update the Approved Working Drawings as necessary to reflect all changes made to the Approved Working Drawings during the course of construction, (B)&#160;to certify to the best of their knowledge that the "record-set" of as-built drawings are true and correct, which certification shall survive the expiration or termination of the Lease, (C)&#160;to deliver to Landlord two (2) sets of sepias of such as-built drawings within ninety (90) days following issuance of a certificate of occupancy for the 6290 Building, and (D)&#160;to deliver to Landlord a computer disk containing the Approved Working Drawings in AutoCAD format, (ii)&#160;Tenant shall deliver to Landlord a copy of all warranties, guaranties, and operating manuals and information relating to the Sprinkler Renovation Work in the 6290 Building, and (iii)&#160;Tenant shall assign to Landlord all warranties and guaranties pertaining to the Sprinkler Renovation Work.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.4&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Coordination by Tenant's Agents with Landlord</font><font style="font-family:inherit;font-size:12pt;">.  Upon Tenant's delivery of the Contract to Landlord under Section&#160;4.2.1 of this Tenant Work Letter, Tenant shall furnish Landlord with a schedule setting forth the projected date of the completion of the Tenant Improvements and showing the critical time deadlines for each phase, item or trade relating to the construction of the Sprinkler Renovation Work.</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">SECTION 5</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;"><br>MISCELLANEOUS</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5.1&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Tenant's Representative</font><font style="font-family:inherit;font-size:12pt;">.  Tenant has designated Ian Fuller as its sole representative with respect to the matters set forth in this Tenant Work Letter, who shall have full authority and responsibility to act on behalf of the Tenant as required in this Tenant Work Letter.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5.2&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Landlord's Representative</font><font style="font-family:inherit;font-size:12pt;">.  Landlord has designated Holly Jump as its sole representative with respect to the matters set forth in this Tenant Work Letter, who, until further notice to Tenant, shall have full authority and responsibility to act on behalf of the Landlord as required in this Tenant Work Letter.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5.3&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Time of the Essence in This Tenant Work Letter</font><font style="font-family:inherit;font-size:12pt;">.  Unless otherwise indicated, all references herein to a "number of days" shall mean and refer to calendar days.  If any item requiring approval is timely disapproved by Landlord, the procedure for preparation of the document and approval thereof shall be repeated until the document is approved by Landlord.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5.4&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Tenant's Lease Default</font><font style="font-family:inherit;font-size:12pt;">.  Notwithstanding any provision to the contrary contained in the Lease, if an event of default by Tenant of this Tenant Work Letter or the Lease has occurred at any time on or before the completion of the Sprinkler Renovation Work, then (i)&#160;in addition to all other rights and remedies granted to Landlord pursuant to the Lease, at law and/or in equity, Landlord shall have the right to withhold payment of all or any portion of the Improvement Allowance and/or Landlord may cause Contractor to cease the construction of the Sprinkler Renovation Work, and (ii)&#160;all other obligations of Landlord under the terms of this Tenant Work Letter shall be forgiven until such time as such default is cured pursuant to the terms of the Lease.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-8-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">6340/6310/6290 SEQUENCE DRIVE</font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">[Expansion and Extension Amendment]</font></div><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">[DexCom, Inc.]</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sA5A8A184B3D44A6CCDBCDA1E63B14252"></a></div><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">SCHEDULE 1</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">CONSTRUCTION BID</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">[***]</font></div><div><br></div><div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.41
<SEQUENCE>8
<FILENAME>dxcm12312019exhibit1041.htm
<DESCRIPTION>EXHIBIT 10.41
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sAE87E37AF82BCC788666116ACF1E23B1"></a></div><div><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">EXHIBIT 10.41</font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">[***] =&#160;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Certain information has been excluded from this exhibit because it (i)&#160;is not material and (ii)&#160;would be competitively harmful if publicly disclosed.</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">FOURTH AMENDMENT TO OFFICE LEASE </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This FOURTH AMENDMENT TO OFFICE LEASE ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Fourth Amendment</font><font style="font-family:inherit;font-size:12pt;">") is made and entered into as of the 9th day of September, 2019 ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Effective Date</font><font style="font-family:inherit;font-size:12pt;">"), by and between SEQUENCE TECH. CENTER CA LLC, a Delaware limited liability company ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Landlord</font><font style="font-family:inherit;font-size:12pt;">"), and DEXCOM, INC., a Delaware corporation ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Tenant</font><font style="font-family:inherit;font-size:12pt;">").</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">R E C I T A L S</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;">:</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">A.&#160;&#160;&#160;&#160;Kilroy Realty, L.P., a Delaware limited partnership ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Original Landlord</font><font style="font-family:inherit;font-size:12pt;">") and Tenant entered into that certain Office Lease dated March&#160;31, 2006 (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Original</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Lease</font><font style="font-family:inherit;font-size:12pt;">"), as amended by (i)&#160;that certain First Amendment to Office Lease dated August&#160;18, 2010 by and between Original Landlord and Tenant ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">First Amendment</font><font style="font-family:inherit;font-size:12pt;">"), (ii)&#160;that certain Second Amendment to Office Lease dated October&#160;1, 2014 by and between Original Landlord and Tenant ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Second Amendment</font><font style="font-family:inherit;font-size:12pt;">"), and (iii)&#160;that certain Third Amendment to Office Lease dated February&#160;7, 2019 by and between John Hancock Life Insurance Company (U.S.A.), a wholly owned subsidiary of Manulife Financial Corporation, a Michigan corporation ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Second Landlord</font><font style="font-family:inherit;font-size:12pt;">") ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Third Amendment</font><font style="font-family:inherit;font-size:12pt;">"), whereby Landlord leases to Tenant and Tenant leases from Landlord those certain premises (collectively, the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Existing Premises</font><font style="font-family:inherit;font-size:12pt;">") located in the following buildings:  (i)&#160;that certain office building located at 6340 Sequence Drive, San Diego, California ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6340 Building</font><font style="font-family:inherit;font-size:12pt;">") containing approximately 66,400 rentable square feet, (ii)&#160;that certain office building located at 6310 Sequence Drive, San Diego, California ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6310 Building</font><font style="font-family:inherit;font-size:12pt;">") containing approximately 62,415 rentable square feet and (iii)&#160;that certain office building located at 6290 Sequence Drive, San Diego, California ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6290 Building</font><font style="font-family:inherit;font-size:12pt;">") containing approximately 90,000 rentable square feet (collectively, the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Buildings</font><font style="font-family:inherit;font-size:12pt;">"), which buildings are located in the Project (as defined in the Lease).  The Original Lease, as amended by the First Amendment, the Second Amendment and the Third Amendment, may be referred to herein as the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Lease</font><font style="font-family:inherit;font-size:12pt;">".  Landlord is the successor-in-interest in the Lease to second Landlord, successor-in-interest in the Lease to Original Landlord.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">B.&#160;&#160;&#160;&#160;Tenant desires to expand the Existing Premises to include a total of 132,600 rentable square feet of space ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6350 Expansion Premises</font><font style="font-family:inherit;font-size:12pt;">") comprising the entirety of that certain office building located at 6350 Sequence Drive, San Diego, California  (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6350 Building</font><font style="font-family:inherit;font-size:12pt;">"), and to make other modifications to the Lease.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">C.&#160;&#160;&#160;&#160;Landlord and Tenant acknowledge and agree that the 6350&#160;Building is, as of the date hereof, subject to a lease (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6350 Building Lease</font><font style="font-family:inherit;font-size:12pt;">") between Landlord and Entropic Communications, LLC, a Delaware limited liability company (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6350 Building Tenant</font><font style="font-family:inherit;font-size:12pt;">") and that certain sublease between the 6350 Building Tenant (as sublandlord) and Tenant (as subtenant) (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6350 Building Sublease</font><font style="font-family:inherit;font-size:12pt;">"), and that Tenant is currently in possession of the 6350 Expansion Premises pursuant to the 6350 Building Sublease.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">A G R E E M E N T</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;">:</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NOW, THEREFORE, in consideration of the foregoing recitals and the mutual covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:</font></div><div style="line-height:120%;padding-left:0px;padding-top:16px;text-align:justify;text-indent:48px;"><font style="padding-top:16px;text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">1.</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Capitalized Terms</font><font style="font-family:inherit;font-size:12pt;">.  All capitalized terms when used herein shall have the same meaning as is given such terms in the Lease unless expressly superseded by the terms of this Fourth Amendment.</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Expansion of Premises</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.1</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">6350 Expansion Premises</font><font style="font-family:inherit;font-size:12pt;">.  Effective as of the later of (i)&#160;the Effective Date or (ii)&#160;the date the Contingency (as defined in Section&#160;10 below) is satisfied (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Expansion Commencement Date</font><font style="font-family:inherit;font-size:12pt;">"), Tenant shall lease from Landlord and Landlord shall lease to Tenant the 6350 Expansion Premises.  Consequently, effective upon the Expansion Commencement Date, the Existing Premises shall be deemed expanded to include the 6350 Expansion Premises (the Existing Premises together with the 6350 Expansion Premises are sometimes collectively referred to herein as the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Premises</font><font style="font-family:inherit;font-size:12pt;">").  Landlord and Tenant hereby acknowledge that the Premises shall, effective as of the Expansion Commencement Date, contain a total of approximately 351,415 rentable square feet.  The actual Expansion Commencement Date shall be memorialized in a confirmation amendment to be prepared by Landlord, which agreement Tenant shall promptly execute.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.2</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">No-Remeasurement of 6350 Expansion Premises</font><font style="font-family:inherit;font-size:12pt;">.  For purposes of the Lease (as hereby amended), "rentable square feet" of the Premises shall be deemed as set forth in </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Recital A</font><font style="font-family:inherit;font-size:12pt;">&#32;and </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Recital B</font><font style="font-family:inherit;font-size:12pt;">&#32;of this Fourth Amendment, and therefore neither Landlord nor Tenant shall have the right to re-measure the Premises at any time.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Term</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3.1</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Extension of Existing Premises Lease Term</font><font style="font-family:inherit;font-size:12pt;">.  Landlord and Tenant acknowledge that Tenant's lease of the Existing Premises is scheduled to expire on February 28, 2022, pursuant to the terms of the Lease.  Notwithstanding anything to the contrary in the Lease, the term of Tenant's lease of the Existing Premises shall be extended to expire coterminously with the term of Tenant's lease of the 6350 Expansion Premises on the New Expiration Date, unless sooner terminated as provided in the Lease, as hereby amended.  The "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">New Expiration Date</font><font style="font-family:inherit;font-size:12pt;">" shall be December&#160;31, 2023.  The period commencing on the Expansion Commencement Date and terminating on the New Expiration Date shall be referred to herein as the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">New Expansion Term</font><font style="font-family:inherit;font-size:12pt;">."</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3.2</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Option Terms</font><font style="font-family:inherit;font-size:12pt;">.  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section&#160;3.4</font><font style="font-family:inherit;font-size:12pt;">&#32;of the Second Amendment is deemed modified to provide that Tenant's two (2)&#160;separate Option Terms to extend the Lease Term also apply to all of the 6350&#160;Building, all of the 6340&#160;Building, all of the 6310 Building and/or all of the 6290&#160;Building (but not for just a portion of any building).  Tenant may elect to extend the Lease Term for any or all of the 6350 Building, the 6340 Building, the 6310 Building or the 6290 Building, but in no event may Tenant exercise the second (2</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">nd</sup></font><font style="font-family:inherit;font-size:12pt;">) Option Term to extend for any such building for which the New Expansion Term was not extended for the first Option Term.  Notwithstanding anything above to the contrary, in the event Tenant elects to extend the Lease Term with respect to less than all of the Buildings leased by Tenant, then all Buildings for which Tenant exercised an Option Term to extend must be for Buildings which are contiguous.  For example, Tenant may not elect to exercise an Option Term to extend for all Buildings except the 6310&#160;Building.  </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3.3</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">No Termination Option</font><font style="font-family:inherit;font-size:12pt;">.  Effective as of the Effective Date, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section&#160;3.5</font><font style="font-family:inherit;font-size:12pt;">&#32;of the Second Amendment (Termination Option) is hereby deemed null and void and is of no further force or effect.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Base Rent</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.1</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Existing Premises Base Rent</font><font style="font-family:inherit;font-size:12pt;">.  Base Rent for the Existing Premises shall continue to be paid pursuant to the Base Rent Schedule set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section&#160;4.1</font><font style="font-family:inherit;font-size:12pt;">&#32;of the Second Amendment through February 28, 2022.  Commencing as of March&#160;1, 2022 and continuing through the New Expiration Date, Base Rent shall be payable for the Existing Premises as follows:</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:91.22807017543859%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:28%;"></td><td style="width:22%;"></td><td style="width:27%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:5px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Annualized</font><font style="font-family:inherit;font-size:10pt;">&#160;<br></font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Base Rent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Monthly Installment </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">of Base Rent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Approximate Monthly Rental Rate <br>per Rentable</font><font style="font-family:inherit;font-size:10pt;">&#160;<br></font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Square Foot</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:5px;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">03/01/22 &#8211; 02/28/23</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$5,908,005.00</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$492,333.75</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$2.25</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:5px;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">03/01/23 &#8211; 12/31/23</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$6,083,932.20</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$506,994.35</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$2.317</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.2</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">6350 Expansion Premises Base Rent</font><font style="font-family:inherit;font-size:12pt;">.  Commencing on the Expansion Commencement Date and continuing throughout the New Expansion Term, Tenant shall pay to Landlord monthly installments of Base Rent for the 6350 Expansion Premises as follows:</font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:91.22807017543859%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:28%;"></td><td style="width:22%;"></td><td style="width:27%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:5px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Annualized</font><font style="font-family:inherit;font-size:10pt;">&#160;<br></font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Base Rent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Monthly Installment </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">of Base Rent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Approximate Monthly Rental Rate <br>per Rentable</font><font style="font-family:inherit;font-size:10pt;">&#160;<br></font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Square Foot</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">*Effective Date &#8211; 01/31/20</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$3,286,689.48</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$273,890.79</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$2.07</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">02/01/20 &#8211; 01/31/21</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$3,401,723.61</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$283,476.97</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$2.14</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">02/01/21 &#8211; 01/31/22</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$3,520,783.94</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$293,398.66</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$2.21</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">02/01/22 &#8211; 02/28/22</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$3,421,080.00</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$285,090.00</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$2.15</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">03/01/22 &#8211; 02/28/23</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$3,580,200.00</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$298,350.00</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$2.25</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">03/01/23 &#8211; 12/31/23</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$3,686,810.40</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$307,234.20</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$2.317</font></div></td></tr><tr><td colspan="4" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;padding-left:46px;text-indent:-47px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">*   If the Expansion Commencement Date falls on a day of the month which is not the first day of such month, the Base Rent for such fractional month shall accrue on a daily basis and shall total an amount equal to the product of (i)&#160;a fraction, the numerator of which is the number of days in such fractional month and the denominator of which is the actual number of days occurring in such calendar month, and (ii)&#160;the then-applicable monthly installment of Base Rent.  Such fractional month shall be added to the first year of the New Expansion Term.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Direct Expenses</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5.1</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Tenant's Share</font><font style="font-family:inherit;font-size:12pt;">.  Tenant's Share with respect to the Existing Premises</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:12pt;">shall continue to be 100%.  Tenant's Share with respect to the 6350 Building shall, effective as of the Expansion Commencement Date, be 100%.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5.2</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">"Project" Definition</font><font style="font-family:inherit;font-size:12pt;">.  Landlord and Tenant hereby expressly acknowledge and agree that the definition of the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Project</font><font style="font-family:inherit;font-size:12pt;">" shall be revised to mean (i)&#160;the 6340 Building and its Common Areas, (ii)&#160;the land (which is improved with landscaping, parking facilities and other improvements) upon which the 6340 Building and its Common Areas are located, (iii)&#160;the 6310 Building and its Common Areas, (iv)&#160;the land (which is improved with landscaping, parking facilities and other improvements) upon which the 6310 Building and its Common Areas are located, (v)&#160;the 6290 Building and its Common Areas, (vi)&#160;the land (which is comprised with landscaping, parking facilities and other improvements) upon which the 6290 Building and its Common Areas are located, (vii)&#160;the 6350 Building and its Common Areas, and (viii)&#160;the land (which is improved with landscaping, parking facilities and other improvements) upon which the 6350&#160;Building and its Common Areas are located.  As the Project contains more than one (1)&#160;building, the </font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">parties acknowledge that the costs and expenses incurred in connection with the Project (i.e. the Direct Expenses) should be shared among the 6340 Building, the 6310 Building, the 6290 Building and the 6350&#160;Building.  Accordingly, as set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section&#160;4.2</font><font style="font-family:inherit;font-size:12pt;">&#32;of the Lease, Direct Expenses are determined annually for the Project as a whole, and a portion of the Direct Expenses, which portion shall be determined by Landlord on an equitable basis, shall be allocated to the 6340 Building, the 6310 Building, the 6290 Building or the 6350&#160;Building (as the case may be) and such portion shall be the Direct Expenses for purposes of the Lease (as amended).  Such portion of Direct Expenses allocated to the 6310 Building shall include all Direct Expenses attributable solely to the 6310 Building and an equitable portion of the Direct Expenses attributable to the Project as a whole.  Such portion of Direct Expenses allocated to the 6340 Building shall include all Direct Expenses attributable solely to the 6340 Building and an equitable portion of the Direct Expenses attributable to the Project as a whole.  Such portion of Direct Expenses allocated to the 6290 Building shall include all Direct Expenses attributable solely to the 6290 Building and an equitable portion of the Direct Expenses attributable to the Project as a whole.  Such portion of Direct Expenses allocated to the 6350 Building shall include all Direct Expenses attributable solely to the 6350 Building and an equitable portion of the Direct Expenses attributable to the Project as a whole.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">6.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Condition of 6350 Expansion Premises</font><font style="font-family:inherit;font-size:12pt;">.  Landlord shall not be obligated to provide or pay for any improvement work or services related to the improvement of the 6350 Expansion Premises, and Tenant shall accept the 6350 Expansion Premises in its presently existing, "as-is" condition.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Broker</font><font style="font-family:inherit;font-size:12pt;">.  Landlord and Tenant hereby warrant to each other that they have had no dealings with any real estate broker or agent in connection with the negotiation of this Fourth Amendment other than Cushman &amp; Wakefield of San Diego, Inc. (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Broker</font><font style="font-family:inherit;font-size:12pt;">"), and that they know of no other real estate broker or agent who is entitled to a commission in connection with this Fourth Amendment.  Each party agrees to indemnify and defend the other party against and hold the other party harmless from any and all claims, demands, losses, liabilities, lawsuits, judgments, and costs and expenses (including, without limitation, reasonable attorneys' fees) with respect to any leasing commission or equivalent compensation alleged to be owing on account of the indemnifying party's dealings with any real estate broker or agent, other than the Broker, occurring by, through, or under the indemnifying party.  The terms of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section&#160;7</font><font style="font-family:inherit;font-size:12pt;">&#32;shall survive the expiration or earlier termination of this Fourth Amendment.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">8.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Signage</font><font style="font-family:inherit;font-size:12pt;">.  Effective upon the Expansion Commencement Date, all signage rights and responsibilities set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article&#160;23</font><font style="font-family:inherit;font-size:12pt;">&#32;of the Original Lease in connection with the Existing Premises shall additionally apply with respect to the 6350 Expansion Premises.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">9.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Security Deposit/Letter of Credit</font><font style="font-family:inherit;font-size:12pt;">.  Landlord shall continue to hold the Security Deposit pursuant to the terms and conditions of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article&#160;21</font><font style="font-family:inherit;font-size:12pt;">&#32;of the Original Lease and the L-C in accordance with the terms and provisions of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article&#160;22</font><font style="font-family:inherit;font-size:12pt;">&#32;of the Original Lease throughout the New Expansion Term, as may be extended.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">10.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Contingency</font><font style="font-family:inherit;font-size:12pt;">. Landlord and Tenant acknowledge and agree that this Fourth Amendment is contingent upon the full execution and delivery of a lease termination agreement between Landlord and the 6350 Building Tenant pertaining to the 6350 Building Lease ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Lease Termination Agreement</font><font style="font-family:inherit;font-size:12pt;">"), which Lease Termination Agreement shall be on terms and conditions acceptable to Landlord in Landlord's sole discretion and which, upon execution, shall also serve to concurrently terminate the 6350 Building Sublease (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Contingency</font><font style="font-family:inherit;font-size:12pt;">").  Tenant, as the subtenant under the 6350 Building Sublease, hereby acknowledges and consents to the termination of the 6350 Building Lease and the concurrent termination of the 6350 Building Sublease, subject to this Fourth Amendment becoming effective on or before such termination of the 6350 </font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Building Lease and the 6350 Building Sublease, such that Tenant's current possession of the 6350 Expansion Premises in not interrupted.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">11.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Parking</font><font style="font-family:inherit;font-size:12pt;">.  Tenant shall be entitled to utilize, at no additional cost, the parking area serving the 6350&#160;Building as designated by Landlord.  Tenant's rights to utilize such parking shall be otherwise subject to all of the terms and conditions of the Lease.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">12.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Multiple Buildings</font><font style="font-family:inherit;font-size:12pt;">.  Landlord and Tenant acknowledge that it is Landlord's current intention to cause the ownership of all of the Buildings to be held by the same entity.  If, however, at any time during the New Expansion Term or any Option Term, Landlord determines to separate ownership of the Buildings or to separately finance the Buildings (where the lender requires separate documentation), Tenant agrees to promptly after request from Landlord, execute commercially reasonable documents in order to separate Tenant's lease of such building(s) of the Premises from the remaining building(s) of the Premises.  Any such documentation shall be on the exact same terms as specified in the Lease (as amended) but as applicable to the relevant portion of the Premises.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">13.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Certified Access Specialist Inspection</font><font style="font-family:inherit;font-size:12pt;">.  For purposes of Section 1938 of the California Civil Code, Landlord hereby discloses to Tenant, and Tenant hereby acknowledges, that the 6350 Expansion Premises have not undergone inspection by a Certified Access Specialist (CASp).  As required by Section 1938(e) of the California Civil Code, Landlord hereby states as follows:  "A Certified Access Specialist (CASp) can inspect the subject premises and determine whether the subject premises comply with all of the applicable construction-related accessibility standards under state law.  Although state law does not require a CASp inspection of the subject premises, the commercial property owner or lessor may not prohibit the lessee or tenant from obtaining a CASp inspection of the subject premises for the occupancy or potential occupancy of the lessee or tenant, if requested by the lessee or tenant.  The parties shall mutually agree on the arrangements for the time and manner of the CASp inspection, the payment of the fee for the CASp inspection, and the cost of making any repairs necessary to correct violations of construction-related accessibility standards within the premises."  In furtherance of the foregoing, Landlord and Tenant hereby agree that, in the event Tenant desires, in its sole discretion, to have the 6350 Expansion Premises undergo a CASp inspection, such, CASp inspection requested by Tenant shall be conducted, at Tenant's sole cost and expense, by a CASp designated by Tenant, and reasonably approved by Landlord, subject to Landlord's reasonable rules and requirements.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">14.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Perimeter Fencing</font><font style="font-family:inherit;font-size:12pt;">.  Subject to Landlord's prior approval of all plans and specifications, which approval shall not be unreasonably withheld or delayed, Landlord shall permit Tenant to install and maintain, at Tenant's sole cost and expense, perimeter fencing within the Project.  At Tenant's election, such fencing may be installed around the perimeter of the entire Project and/or around the perimeter of any of the Buildings and/or group of contiguous Buildings within the Project.  Landlord's approval of Tenant's proposed fencing may be conditioned upon Tenant complying with such reasonable requirements imposed by Landlord based upon the advice of Landlord's structural and mechanical engineers, so that the Project's systems and equipment are not adversely affected.  The installation of such fencing shall be done in compliance with Applicable Laws.  Any repairs and maintenance of such fencing shall be the sole responsibility of Tenant.  Unless Landlord otherwise notifies Tenant in writing that Landlord will not require Tenant to remove such fencing upon the expiration or earlier termination of the Lease, such fencing shall be removed by Tenant upon the expiration or earlier termination of the Lease, and Tenant shall repair damage resulting from such removal as necessary to restore the affected portions of the Project to substantially the same condition as existed prior to Tenant&#8217;s installation of the fencing. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">15.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Alterations</font><font style="font-family:inherit;font-size:12pt;">.&#160;&#160;&#160;&#160;</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">15.1</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">In the event Tenant, after the Effective Date of this Fourth Amendment, elects to construct Landlord approved Alterations and improvements in the Premises, Tenant shall have no obligation to remove the same, nor to restore the Premises to the condition that existed prior to such Alterations or improvements being made, unless Landlord provides written notice to Tenant at the time Landlord approves such proposed Alterations and improvements, with such written notice to Tenant specifying that Tenant shall be responsible for the removal of such proposed Alterations or improvements upon the expiration or earlier termination of the Lease.  </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">15.2</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Landlord and Tenant hereby knowledge and agree that Section 2.4 of Exhibit B to the Second Amendment, and the Schedule 2 referenced therein (collectively, the &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Prior Non-Confirming Improvements Provisions</font><font style="font-family:inherit;font-size:12pt;">&#8221;), are both hereby deleted.  In place of the Prior Non-Confirming Improvements Provisions, Landlord and Tenant hereby acknowledge and agree that, as to all Alterations and improvements existing in the Premises as of the Effective Date of this Fourth Amendment, Tenant shall have no obligation to remove any such Alterations or improvements, nor to restore the Premises to the condition that existed prior such Alterations or improvements being made, with the exception of those certain items identified on the </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Replacement Schedule 2</font><font style="font-family:inherit;font-size:12pt;">&#32;attached hereto (the &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Non-Conforming Improvements</font><font style="font-family:inherit;font-size:12pt;">&#8221;).  </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">15.3</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Additionally, as set forth on </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Replacement Schedule 2</font><font style="font-family:inherit;font-size:12pt;">, to Non-Conforming Improvements are divided into two (2) categories:  the &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Tier One Non-Conforming Improvements</font><font style="font-family:inherit;font-size:12pt;">&#8221;, and the &#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Tier Two Non-Conforming Improvements</font><font style="font-family:inherit;font-size:12pt;">&#8221;.  Landlord and Tenant hereby acknowledge and agree that, in the event Tenant exercises at least the first Option Term or otherwise enters into an amendment to the Lease to further extend the term of the Lease beyond the New Expiration Date for a period of thirty-six (36) months or longer, and such extension of the term of the Lease applies to at least fifty percent (50%) of the rentable square feet in the Buildings, then upon the expiration or earlier termination of the Lease, Tenant shall (a) no longer be obligated to remove any of the Tier Two Non-Conforming Improvements, and (b) only be obligated to remove the Tier One Non-Conforming Improvements, with such removal of the Tier One Non-Conforming Improvements to occur upon the expiration of the Lease as to any Building not leased by Tenant.  In contrast, if Tenant declines to exercise the first Option Term, and otherwise fails to enter into an amendment to extend the term of the Lease beyond the New Expiration Date for a period of thirty-six (36) months or longer (and for at least fifty percent (50%) of the rentable square feet in the Buildings), then Tenant shall remain obligated to remove the Tier One and Tier Two Non-Conforming Improvements upon the expiration or earlier termination of the Lease.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">16.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">California Energy Disclosures</font><font style="font-family:inherit;font-size:12pt;">.  Tenant acknowledges that Landlord has complied with Cal. Pub.  Res.  Code &#167;&#160;25402.10 and the disclosure regulations issued in connection therewith (e.g.,&#160;California Code of Regulations, Title&#160;20, Sections&#160;1680 &#8212; 1684) by, among other things, delivering to Tenant the Disclosure Summary Sheet, Statement of Energy Performance, Data Checklist and Facility Summary (as such terms are defined in California Code of Regulations, Title&#160;20, Section&#160;1681) for the 6350 Expansion Premises (collectively, the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Energy Information</font><font style="font-family:inherit;font-size:12pt;">") prior to the date hereof.  Tenant acknowledges and agrees that (i)&#160;Landlord makes no representation or warranty regarding the energy performance of the 6350 Expansion Premises or the accuracy or completeness of the Energy Information, (ii)&#160;the Energy Information is for the current occupancy and use of the 6350 Expansion Premises and that the energy performance of the 6350 Expansion Premises may vary, and (iii)&#160;Landlord shall have no liability for any errors or omissions in the Energy Information.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">17.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">No Further Modification</font><font style="font-family:inherit;font-size:12pt;">.  Except as set forth in this Fourth Amendment, all of the terms and provisions of the Lease shall apply with respect to the 6350 Expansion Premises and the Lease shall remain unmodified and in full force and effect.</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">[Signatures follow on next page]</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">IN WITNESS WHEREOF, this Fourth Amendment has been executed as of the day and year first above written.</font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:91.22807017543859%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">"LANDLORD":</font></div><div style="padding-top:16px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">SEQUENCE TECH. CENTER CA LLC,</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">a Delaware limited liability company</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">/s/ Ray Rothfelder</font></div><div style="text-align:justify;padding-left:22px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Its: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Managing Director, Western U.S.</font></div><div style="padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Dated: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">October 4, 2019</font></div><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">"TENANT":</font></div><div style="padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">DEXCOM, INC.,</font></div><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">a Delaware corporation</font></div><div style="padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">/s/ Jereme Sylvain</font></div><div style="text-align:justify;padding-left:22px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Its: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">VP, Finance</font></div><div style="padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">/s/ Brice Bobzien</font></div><div style="text-align:justify;padding-left:22px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Its: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">VP, Finance</font></div><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s8B3307FB644A57B692C1116ACF3D531C"></a></div><div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">EXHIBIT A</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">OUTLINE OF 6350 EXPANSION PREMISES</font></div><div style="line-height:120%;padding-top:16px;text-align:center;"><img src="sd8_image1a04.gif" alt="sd8_image1a04.gif" style="height:277px;width:756px;"></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">888452.03/SD</font></div><div style="font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">999903-14000/9-6-19/MLT/bp</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">EXHIBIT A</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-1-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s973AB54BC5C187F5E4C6116ACF708A40"></a></div><div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">REPLACEMENT SCHEDULE 2</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">NON-CONFORMING IMPROVEMENTS</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:55%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:11%;"></td><td style="width:11%;"></td><td style="width:11%;"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#92d050;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Non-Conforming Improvements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#92d050;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#92d050;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6290 Building</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#92d050;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6310 Building</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#92d050;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6340 Building</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#92d050;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6350 Building</font></div></td></tr><tr><td colspan="6" style="vertical-align:top;border-bottom:1px solid #00000a;background-color:#b6dde8;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Tier One Non-Conforming Improvements</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #00000a;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">[***]</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #00000a;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Not applicable</font></div><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Not applicable</font></div><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #00000a;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">[***]</font></div><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #00000a;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-top:1px solid #00000a;"><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">[***]</font></div><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Not applicable</font></div><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Not applicable</font></div><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Remove security systems including card access and cameras</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#f2f2f2;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td></tr><tr><td colspan="6" style="vertical-align:top;border-bottom:1px solid #00000a;background-color:#b6dde8;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Tier Two Non-Conforming Improvements</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Server/MDF/IDF and all associated equipment, including ladder racks, cabling and raised flooring.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Roof cable satellites</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Storage sheds, storage racks and storage shelves.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Not applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Not applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Not Applicable</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Generators not part of original building shell.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Not applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Parking lot signs, reserved spots etc.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Added trash compactors or bailers and associated equipment must be restored to original condition.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Not applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Not applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td><td style="vertical-align:top;border-bottom:1px solid #00000a;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #00000a;border-right:1px solid #00000a;border-top:1px solid #00000a;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Applicable</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">888452.03/SD</font></div><div style="font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">999903-14000/9-6-19/MLT/bp</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">REPLACEMENT SCHEDULE 2</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-2-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.42
<SEQUENCE>9
<FILENAME>dxcm12312019exhibit1042.htm
<DESCRIPTION>EXHIBIT 10.42
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s5DB34E8B65C9A17B7B0F1BA598BD0B74"></a></div><div><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">EXHIBIT 10.42</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">FIFTH AMENDMENT TO LEASE</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THIS FIFTH AMENDMENT TO LEASE ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Fifth Amendment"</font><font style="font-family:inherit;font-size:12pt;">) is made as of October&#160;21, 2019, by and between SEQUENCE TECH. CENTER CA LLC, a Delaware limited liability company ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Landlord</font><font style="font-family:inherit;font-size:12pt;">") and DEXCOM, INC., a Delaware corporation ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Tenant</font><font style="font-family:inherit;font-size:12pt;">").</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Recitals:</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">A.&#160;&#160;&#160;&#160;Kilroy Realty, L.P., a Delaware limited partnership ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Original Landlord</font><font style="font-family:inherit;font-size:12pt;">") and Tenant entered into that certain Office Lease dated March&#160;31, 2006 (the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Original</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Lease</font><font style="font-family:inherit;font-size:12pt;">"), as amended by (i)&#160;that certain First Amendment to Office Lease dated August&#160;18, 2010 by and between Original Landlord and Tenant ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">First Amendment</font><font style="font-family:inherit;font-size:12pt;">"), (ii)&#160;that certain Second Amendment to Office Lease dated October&#160;1, 2014 by and between Original Landlord and Tenant ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Second Amendment</font><font style="font-family:inherit;font-size:12pt;">"), (iii)&#160;that certain Third Amendment to Office Lease dated February&#160;7, 2019 by and between John Hancock Life Insurance Company (U.S.A.), a wholly owned subsidiary of Manulife Financial Corporation, a Michigan corporation ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Second Landlord</font><font style="font-family:inherit;font-size:12pt;">") ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Third Amendment</font><font style="font-family:inherit;font-size:12pt;">"), and (iv) that certain Fourth Amendment to Office Lease dated as of September 9, 2019 by and between Landlord and Tenant ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Fourth Amendment</font><font style="font-family:inherit;font-size:12pt;">"), whereby Landlord leases to Tenant and Tenant leases from Landlord those certain premises (collectively, the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Existing Premises</font><font style="font-family:inherit;font-size:12pt;">") located in the following buildings:  (i)&#160;that certain building located at 6340 Sequence Drive, San Diego, California ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6340 Building</font><font style="font-family:inherit;font-size:12pt;">") containing approximately 66,400 rentable square feet, (ii)&#160;that certain building located at 6310 Sequence Drive, San Diego, California ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6310 Building</font><font style="font-family:inherit;font-size:12pt;">") containing approximately 62,415 rentable square feet, (iii)&#160;that certain building located at 6290 Sequence Drive, San Diego, California ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6290 Building</font><font style="font-family:inherit;font-size:12pt;">") containing approximately 90,000 rentable square feet and (iv)&#160;that certain building located at 6350 Sequence Drive, San Diego, California ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6350 Building</font><font style="font-family:inherit;font-size:12pt;">") containing approximately 132,600 rentable square feet (collectively, the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Buildings</font><font style="font-family:inherit;font-size:12pt;">"), which buildings are located in the Project (as defined in the Lease).  The Original Lease, as amended by the First Amendment, the Second Amendment, the Third Amendment and the Fourth Amendment, may be referred to herein as the "</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Lease</font><font style="font-family:inherit;font-size:12pt;">".  Landlord is the successor-in-interest in the Lease to second Landlord, successor-in-interest in the Lease to Original Landlord.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">B.&#160;&#160;&#160;&#160;Landlord and Tenant desire to enter into this Fifth Amendment confirming the Expansion Commencement Date and other matters under the Lease. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NOW, THEREFORE, Landlord and Tenant agree as follows:</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.&#160;&#160;&#160;&#160;The actual Expansion Commencement Date is October 1, 2019.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.&#160;&#160;&#160;&#160;The New Expiration Date is December 31, 2023.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.2 of the Fifth Amendment is deleted in its entirety and the following is substituted therefor:</font></div></td></tr></table><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.46341463414635%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:29%;"></td><td style="width:20%;"></td><td style="width:25%;"></td><td style="width:24%;"></td><td style="width:2%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Annualized</font><font style="font-family:inherit;font-size:10pt;">&#160;<br></font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Base Rent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Monthly Installment </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">of Base Rent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Approximate Monthly Rental Rate <br>per Rentable</font><font style="font-family:inherit;font-size:10pt;">&#160;<br></font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Square Foot</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">*11/01/19 &#8211; 01/31/20</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$3,286,689.48</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$273,890.79</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$2.07</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">02/01/20 &#8211; 01/31/21</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$3,401,723.61</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$283,476.97</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$2.14</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">02/01/21 &#8211; 01/31/22</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$3,520,783.94</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$293,398.66</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$2.21</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">02/01/22 &#8211; 02/28/22</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$3,421,080.00</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$285,090.00</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$2.15</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">03/01/22 &#8211; 02/28/23</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$3,580,200.00</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$298,350.00</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$2.25</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">03/01/23 &#8211; 12/31/23</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$3,686,810.40</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$307,234.20</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$2.317</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">*Landlord and Tenant acknowledge and agree that the prior tenant of the Expansion Space referenced in the Fourth Amendment, Entropic Communications, LLC ("</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Entropic</font><font style="font-family:inherit;font-size:12pt;">") paid to Landlord the Base Rent for the month of October, 2019 and that Tenant has reimbursed Entropic for such payment.</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Capitalized terms not defined herein shall have the same meaning as set forth in the Lease.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Except as set forth in this Fifth Amendment, all of the terms and provisions of the Lease shall remain unmodified and in full force and effect.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">IN WITNESS WHEREOF, this Fifth Amendment has been executed as of the date last set forth below.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:91.31707317073172%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">"LANDLORD":</font></div><div style="padding-top:16px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">SEQUENCE TECH. CENTER CA LLC,</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">a Delaware limited liability company</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">/s/ Ray Rothfelder</font></div><div style="text-align:justify;padding-left:22px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Its: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Managing Director, Western U.S.</font></div><div style="padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Dated: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">October 29, 2019</font></div><div style="text-align:justify;padding-left:22px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">"TENANT":</font></div><div style="padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">DEXCOM, INC.,</font></div><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">a Delaware corporation</font></div><div style="padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">/s/ Brice Bobzien</font></div><div style="text-align:justify;padding-left:22px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Its: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">VP, Finance</font></div><div style="padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Dated: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">October 24, 2019</font></div><div style="padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">/s/ Jereme Sylvain</font></div><div style="text-align:justify;padding-left:22px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Its: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">VP, Finance</font></div><div style="padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Dated: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">October 24, 2019</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:19%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">890641.01/SD</font></div><div style="font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">287956-00155/10-21-19/MLT/pah</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.01
<SEQUENCE>10
<FILENAME>dxcm12312019exhibit2101.htm
<DESCRIPTION>EXHIBIT 21.01
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s9A23D08D197551AB8B1EB5BADE35430C"></a></div><div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:144%;padding-top:12px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 21.01</font></div><div style="line-height:144%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DEXCOM, INC.</font></div><div style="line-height:144%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:51%;"></td><td style="width:49%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:4px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">SUBSIDIARY</font></div><div style="padding-bottom:2px;padding-left:4px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">(Name under which subsidiary does business)</font></div></td><td style="vertical-align:bottom;padding-left:9px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:9px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">JURISDICTION&#160;OF INCORPORATION</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">SweetSpot Diabetes Care, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">TypeZero Technologies, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCapital, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Glucose Program, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nintamed Handels GmbH</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Austria</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom Canada, Co.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canada</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom (Canada) Inc. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canada</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom Deutschland GmbH</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Germany</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom Philippines, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Philippines</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom Asia Pacific Operations PTE Ltd.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Singapore</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom Kommanditbolag</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sweden</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom Suisse GmbH</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Switzerland</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom (UK) Ltd.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United Kingdom</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom (UK) Intermediate Holdings Ltd.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United Kingdom</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom Operating Ltd.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United Kingdom</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom International Ltd.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United Kingdom</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom (UK) Distribution Ltd.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United Kingdom</font></div></td></tr></table></div></div><div style="line-height:100%;padding-top:12px;text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;"><br></font></div><div style="line-height:144%;padding-top:12px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.01
<SEQUENCE>11
<FILENAME>dxcm12312019exhibit2301.htm
<DESCRIPTION>EXHIBIT 23.01
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s2CDE6DE620A65D79BE59D9791CBBFE04"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 23.01</font></div><div style="line-height:173%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:173%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="line-height:173%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We consent to the incorporation by reference in the following Registration Statements:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registration Statement (Form S-3 Nos. 333-206619, 333-211101 and 333-228495) of DexCom, Inc.,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registration Statement (Form S-8 No. 333-124059) pertaining to the 1999 Stock Option Plan, 2005 Equity Incentive Plan and the 2005 Employee Stock Purchase Plan of DexCom, Inc., </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registration Statement (Form S-8 Nos. 333-138174, 333-145159, 333-149734, 333-158993, 333-166552, 333-172604, 333-180421 and 333-188305) pertaining to the 2005 Equity Incentive Plan and the 2005 Employee Stock Purchase Plan of DexCom, Inc., </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registration Statement (Form S-8 Nos. 333-195660 and 333-202375) pertaining to the 2005 Equity Incentive Plan of DexCom, Inc.,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registration Statement (Form S-8 No. 333-204699) pertaining to the 2015 Equity Incentive Plan and the 2015 Employee Stock Purchase Plan of DexCom, Inc., and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registration Statement (Form S-8 Nos. 333-218562 and 333-234682) pertaining to the Amended and Restated 2015 Equity Incentive Plan of DexCom, Inc.;</font></div></td></tr></table><div style="line-height:173%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">of our reports dated </font><font style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</font><font style="font-family:inherit;font-size:10pt;">, with respect to the consolidated financial statements and schedule of DexCom, Inc., and the effectiveness of internal control over financial reporting of DexCom, Inc., included in this Annual Report (Form 10-K) of DexCom, Inc. for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:166%;padding-bottom:13px;text-align:left;padding-left:336px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Ernst &amp; Young LLP</font></div><div style="line-height:173%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:173%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">San Diego, California</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</font></div><div style="line-height:166%;padding-bottom:13px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.01
<SEQUENCE>12
<FILENAME>dxcm12312019exhibit3101.htm
<DESCRIPTION>EXHIBIT 31.01
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sA205A67A551B5BB5973DC54CCE43A45E"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 31.01</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I, Kevin R. Sayer, certify that:</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1. I have reviewed this </font><font style="font-family:inherit;font-size:10pt;">annual</font><font style="font-family:inherit;font-size:10pt;">&#32;report on Form </font><font style="font-family:inherit;font-size:10pt;">10-K</font><font style="font-family:inherit;font-size:10pt;">&#32;of DexCom, Inc.;</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including any consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">d) disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:47%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:48%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Kevin R. Sayer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Kevin R. Sayer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chairman of the Board of Directors, President and</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Executive Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Principal Executive Officer)</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.02
<SEQUENCE>13
<FILENAME>dxcm12312019exhibit3102.htm
<DESCRIPTION>EXHIBIT 31.02
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sF150AC10AFBC5C728F9A3601E367680B"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 31.02</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I, Quentin S. Blackford, certify that:</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1. I have reviewed this </font><font style="font-family:inherit;font-size:10pt;">annual</font><font style="font-family:inherit;font-size:10pt;">&#32;report on Form </font><font style="font-family:inherit;font-size:10pt;">10-K</font><font style="font-family:inherit;font-size:10pt;">&#32;of DexCom, Inc.;</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including any consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">d) disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:47%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:48%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Quentin S. Blackford</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quentin S. Blackford</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Operating Officer and Chief Financial Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Principal Financial and Accounting Officer)</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.01
<SEQUENCE>14
<FILENAME>dxcm12312019exhibit3201.htm
<DESCRIPTION>EXHIBIT 32.01
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s8B76E3F5EAA55FD88218C9D68B2491A9"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 32.01</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PURSUANT TO</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18 U.S.C SECTION 1350</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The undersigned, Kevin R. Sayer, President and Chief Executive Officer of DexCom, Inc. (the &#8220;Company&#8221;), pursuant to 18 U.S.C. &#167;1350, hereby certifies that:</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(i) the </font><font style="font-family:inherit;font-size:10pt;">annual</font><font style="font-family:inherit;font-size:10pt;">&#32;Report on Form </font><font style="font-family:inherit;font-size:10pt;">10-K</font><font style="font-family:inherit;font-size:10pt;">&#32;for the period ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;of the Company (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dated: </font><font style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:46.6796875%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Kevin R. Sayer</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Kevin R. Sayer</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chairman of the Board of Directors, President and</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Executive Officer</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Principal Executive Officer)</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.02
<SEQUENCE>15
<FILENAME>dxcm12312019exhibit3202.htm
<DESCRIPTION>EXHIBIT 32.02
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s8A3EB983705B50BB91A879031DD9F22F"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 32.02</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PURSUANT TO</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18 U.S.C. SECTION 1350</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The undersigned, Quentin S. Blackford, Chief Financial Officer of DexCom, Inc. (the &#8220;Company&#8221;), pursuant to 18 U.S.C. &#167;1350, hereby certifies:</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(i) the </font><font style="font-family:inherit;font-size:10pt;">annual</font><font style="font-family:inherit;font-size:10pt;">&#32;Report on Form </font><font style="font-family:inherit;font-size:10pt;">10-K</font><font style="font-family:inherit;font-size:10pt;">&#32;for the period ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;of the Company (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) and 15(d) of the Securities Exchange Act of 1934; and</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dated: </font><font style="font-family:inherit;font-size:10pt;">February&#160;13, 2020</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:46.6796875%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Quentin S. Blackford</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quentin S. Blackford</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Operating Officer and Chief Financial Officer</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Principal Financial and Accounting Officer)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>16
<FILENAME>dxcm-20191231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.dexcom.com/20191231" xmlns:dxcm="http://www.dexcom.com/20191231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20191231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20191231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20191231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20191231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="AntiDilutiveSecuritiesDetails" roleURI="http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails">
        <link:definition>2401407 - Disclosure - - Anti-Dilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetails">
        <link:definition>2104100 - Disclosure - Balance Sheet Details</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails">
        <link:definition>2404408 - Disclosure - Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsAccountsReceivableDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails">
        <link:definition>2404405 - Disclosure - Balance Sheet Details - Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsAccruedWarrantyDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails">
        <link:definition>2404409 - Disclosure - Balance Sheet Details - Accrued Warranty (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsInventoryDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails">
        <link:definition>2404406 - Disclosure - Balance Sheet Details - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsNarrativeDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails">
        <link:definition>2404403 - Disclosure - Balance Sheet Details - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails">
        <link:definition>2404404 - Disclosure - Balance Sheet Details - Net Gain (Loss) Recognized on Equity Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsOtherLiabilitiesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails">
        <link:definition>2404410 - Disclosure - Balance Sheet Details - Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsPropertyAndEquipmentDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails">
        <link:definition>2404407 - Disclosure - Balance Sheet Details - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails">
        <link:definition>2404402 - Disclosure - Balance Sheet Details - Short-term Marketable Securities, Available-for-Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsTables" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsTables">
        <link:definition>2304301 - Disclosure - Balance Sheet Details (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentAndGeographicInformation" roleURI="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformation">
        <link:definition>2110100 - Disclosure - Business Segment and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentAndGeographicInformationNarrativeDetails" roleURI="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationNarrativeDetails">
        <link:definition>2410402 - Disclosure - Business Segment and Geographic Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentAndGeographicInformationSummaryDetails" roleURI="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails">
        <link:definition>2410403 - Disclosure - Business Segment and Geographic Information - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentAndGeographicInformationTables" roleURI="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationTables">
        <link:definition>2310301 - Disclosure - Business Segment and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheets">
        <link:definition>1001000 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1001501 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfCashFlows" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows">
        <link:definition>1005000 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfCashFlowsCalc2" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlowsCalc2">
        <link:definition>1005000 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfComprehensiveIncomeLoss" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss">
        <link:definition>1003000 - Statement - Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfOperations" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfOperations">
        <link:definition>1002000 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfStockholdersEquity" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity">
        <link:definition>1004000 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.dexcom.com/role/Contingencies">
        <link:definition>2107100 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesNarrativeDetails" roleURI="http://www.dexcom.com/role/ContingenciesNarrativeDetails">
        <link:definition>2407401 - Disclosure - Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CoverPage" roleURI="http://www.dexcom.com/role/CoverPage">
        <link:definition>0001000 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails" roleURI="http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails">
        <link:definition>2405406 - Disclosure - Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails">
        <link:definition>2405404 - Disclosure - Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtConversionValueOfConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails">
        <link:definition>2405403 - Disclosure - Debt - Conversion Value of Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDebt" roleURI="http://www.dexcom.com/role/DebtDebt">
        <link:definition>2105100 - Disclosure - Debt Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://www.dexcom.com/role/DebtNarrativeDetails">
        <link:definition>2405405 - Disclosure - Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSeniorConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails">
        <link:definition>2405402 - Disclosure - Debt - Senior Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.dexcom.com/role/DebtTables">
        <link:definition>2305301 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DevelopmentAndOtherAgreements" roleURI="http://www.dexcom.com/role/DevelopmentAndOtherAgreements">
        <link:definition>2102100 - Disclosure - Development and Other Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DevelopmentAndOtherAgreementsNarrativeDetails" roleURI="http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails">
        <link:definition>2402401 - Disclosure - Development and Other Agreements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansAndStockholdersEquity" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquity">
        <link:definition>2109100 - Disclosure - Employee Benefit Plans and Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansAndStockholdersEquityIntrinsicValueOfOptionsExercisedAndFairValueOfOptionsVestedDetails" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityIntrinsicValueOfOptionsExercisedAndFairValueOfOptionsVestedDetails">
        <link:definition>2409403 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Intrinsic Value of Options Exercised and Fair Value of Options Vested (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails">
        <link:definition>2409402 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails">
        <link:definition>2409404 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Restricted Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails">
        <link:definition>2409406 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Share-based Compensation Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails">
        <link:definition>2409405 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Stock Options Reserved for Future Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansAndStockholdersEquityTables" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityTables">
        <link:definition>2309301 - Disclosure - Employee Benefit Plans and Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails">
        <link:definition>2409407 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Valuation Assumptions for Each Option Grant and Employee Stock Purchase Plan Purchase Rights (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.dexcom.com/role/FairValueMeasurements">
        <link:definition>2103100 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails" roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails">
        <link:definition>2403402 - Disclosure - Fair Value Measurements - Fair Value Hierarchy of Financial Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails">
        <link:definition>2403404 - Disclosure - Fair Value Measurements - Fair Value of Senior Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2403403 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.dexcom.com/role/FairValueMeasurementsTables">
        <link:definition>2303301 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.dexcom.com/role/IncomeTaxes">
        <link:definition>2108100 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsOfProvisionDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails">
        <link:definition>2408403 - Disclosure - Income Taxes - Components of Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails">
        <link:definition>2408405 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails">
        <link:definition>2408402 - Disclosure - Income Taxes - Jurisdictions, Net Income (Loss) Subject to Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2408404 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails">
        <link:definition>2408406 - Disclosure - Income Taxes - Reconciliation between Effective Tax Rate and Statutory Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.dexcom.com/role/IncomeTaxesTables">
        <link:definition>2308301 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUnrecognizedTaxBenefitsDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails">
        <link:definition>2408407 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAndOtherCommitments" roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitments">
        <link:definition>2106100 - Disclosure - Leases And Other Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAndOtherCommitmentsLeaseCostDetails" roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails">
        <link:definition>2406404 - Disclosure - Leases And Other Commitments - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails" roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails">
        <link:definition>2406403 - Disclosure - Leases And Other Commitments - Maturity of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetailsCalc2" roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetailsCalc2">
        <link:definition>2406403 - Disclosure - Leases And Other Commitments - Maturity of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAndOtherCommitmentsNarrativeDetails" roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails">
        <link:definition>2406402 - Disclosure - Leases And Other Commitments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAndOtherCommitmentsOtherInformationDetails" roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails">
        <link:definition>2406405 - Disclosure - Leases And Other Commitments - Other Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAndOtherCommitmentsTables" roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables">
        <link:definition>2306301 - Disclosure - Leases And Other Commitments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationAndSignificantAccountingPolicies" roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPolicies">
        <link:definition>2101100 - Disclosure - Organization and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails" roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails">
        <link:definition>2401406 - Disclosure - Organization and Significant Accounting Policies - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationAndSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2401403 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationAndSignificantAccountingPoliciesPolicies" roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies">
        <link:definition>2201201 - Disclosure - Organization and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationAndSignificantAccountingPoliciesRevenueRecognizedFromChangesInContractLiabilityBalancesDetails" roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenueRecognizedFromChangesInContractLiabilityBalancesDetails">
        <link:definition>2401405 - Disclosure - Organization and Significant Accounting Policies - Revenue Recognized from Changes in Contract Liability Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails" roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails">
        <link:definition>2401404 - Disclosure - Organization and Significant Accounting Policies - Revenues and Gross Accounts Receivable by Customer (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationAndSignificantAccountingPoliciesTables" roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesTables">
        <link:definition>2301302 - Disclosure - Organization and Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialInformationUnauditedQuarterlyFinancialInformationUnaudited" roleURI="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedQuarterlyFinancialInformationUnaudited">
        <link:definition>2111100 - Disclosure - Quarterly Financial Information (Unaudited) Quarterly Financial Information (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialInformationUnauditedSummaryDetails" roleURI="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedSummaryDetails">
        <link:definition>2411402 - Disclosure - Quarterly Financial Information (Unaudited) - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialInformationUnauditedTables" roleURI="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedTables">
        <link:definition>2311301 - Disclosure - Quarterly Financial Information (Unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIiValuationAndQualifyingAccounts" roleURI="http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccounts">
        <link:definition>2112100 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIiValuationAndQualifyingAccountsDetails" roleURI="http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccountsDetails">
        <link:definition>2412401 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="dxcm_A401kPlanMember" name="A401kPlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_AccruedTaxAuditAndLegalFees" name="AccruedTaxAuditAndLegalFees" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="dxcm_AgaMatrixMember" name="AgaMatrixMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_AmortizationPeriodForIncentiveCompensationCosts" name="AmortizationPeriodForIncentiveCompensationCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones" name="CollaborativeArrangementDevelopmentRegulatoryMilestones" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments" name="CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="dxcm_CollaborativeArrangementInitialPaymentMember" name="CollaborativeArrangementInitialPaymentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_CollaborativeArrangementMilestonePaymentsMember" name="CollaborativeArrangementMilestonePaymentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_CollaborativeArrangementUpfrontFee" name="CollaborativeArrangementUpfrontFee" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="dxcm_CollaborativeResearchAndDevelopmentFee" name="CollaborativeResearchAndDevelopmentFee" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="dxcm_ContractPaymentTermsNumberofDays" name="ContractPaymentTermsNumberofDays" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_ConvertibleNotesDue2022Member" name="ConvertibleNotesDue2022Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_ConvertibleNotesDue2023Member" name="ConvertibleNotesDue2023Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_CustomerAMember" name="CustomerAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_CustomerBMember" name="CustomerBMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_CustomerCMember" name="CustomerCMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_DebtInstrumentConversionTermAxis" name="DebtInstrumentConversionTermAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_DebtInstrumentConversionTermDomain" name="DebtInstrumentConversionTermDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_DebtInstrumentConversionTermOneMember" name="DebtInstrumentConversionTermOneMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_DebtInstrumentConversionTermTwoMember" name="DebtInstrumentConversionTermTwoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" name="DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant" />
  <xsd:element id="dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount" name="DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="dxcm_DebtInstrumentCovenantRepurchasePricePercentage" name="DebtInstrumentCovenantRepurchasePricePercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element id="dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" name="DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" name="DebtSecuritiesAvailableForSaleAndEquitySecurities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost" name="DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain" name="DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss" name="DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="dxcm_DeferredTaxAssetsConvertibleDebt" name="DeferredTaxAssetsConvertibleDebt" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet" name="DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital" name="DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount" name="DeferredTaxLiabilitiesConvertibleDebtDiscount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="dxcm_DevelopmentAgreementsLineItems" name="DevelopmentAgreementsLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_DevelopmentAgreementsTable" name="DevelopmentAgreementsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_DevelopmentAndOtherAgreementsTextBlock" name="DevelopmentAndOtherAgreementsTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" name="EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA" name="EffectiveIncomeTaxReconciliationImpactofTCJA" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="dxcm_EffectiveIncomeTaxReconciliationPermanentItems" name="EffectiveIncomeTaxReconciliationPermanentItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits" name="EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="dxcm_EmployeePurchasePriceFloorPercentage" name="EmployeePurchasePriceFloorPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_EmployeeStockPurchasePlan2015Member" name="EmployeeStockPurchasePlan2015Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" name="EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_EmployeeStockPurchasePlanEsppSharesInEspp" name="EmployeeStockPurchasePlanEsppSharesInEspp" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="dxcm_EmployeeStockPurchasePlanMember" name="EmployeeStockPurchasePlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_FairValueAssetsLevel3TransfersAmount" name="FairValueAssetsLevel3TransfersAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="dxcm_FinanceLeaseShortTermLeasesPaymentsDue" name="FinanceLeaseShortTermLeasesPaymentsDue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability" name="FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="dxcm_FinancialStatementDetailsLineItems" name="FinancialStatementDetailsLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_FinancialStatementDetailsTable" name="FinancialStatementDetailsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_FinancingLeaseObligation" name="FinancingLeaseObligation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="dxcm_InMoneyOptionsMaximumExercisePrice" name="InMoneyOptionsMaximumExercisePrice" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" name="IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member" name="LeasedBuildingsMesaArizonaExpiringMarch2028Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced" name="LesseeFutureLeaseCostLeaseNotyetCommenced" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms" name="LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_LesseeOperatingLeaseRemainingLeaseTerm" name="LesseeOperatingLeaseRemainingLeaseTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_LesseeOperatingLeasesLeaseCostAmortization" name="LesseeOperatingLeasesLeaseCostAmortization" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue" name="LesseeOperatingLeasesShortTermLeasePaymentsDue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" name="LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold" name="LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber" name="LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff" name="LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" name="MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_NameOfDefendantAxis" name="NameOfDefendantAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_NameOfDefendantDomain" name="NameOfDefendantDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_NameOfPlaintiffAxis" name="NameOfPlaintiffAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_NameOfPlaintiffDomain" name="NameOfPlaintiffDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_NumberofFinancingLeases" name="NumberofFinancingLeases" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability" name="OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="dxcm_OptionsInMoneyNumber" name="OptionsInMoneyNumber" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" name="OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" name="OrganizationAndSummaryOfSignificantAccountingPoliciesTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_PaymentsUnderCollaborationAgreementsAxis" name="PaymentsUnderCollaborationAgreementsAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_PaymentsUnderCollaborationAgreementsDomain" name="PaymentsUnderCollaborationAgreementsDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_PharmacyRebates" name="PharmacyRebates" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="dxcm_PossibleExtensionPeriodofTaxHoliday" name="PossibleExtensionPeriodofTaxHoliday" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" name="PotentialFutureCommonStockIssuableSharesNewIssues" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant" />
  <xsd:element id="dxcm_ProductShipmentCostsPolicyTextBlock" name="ProductShipmentCostsPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_PurchaseofConvertibleNoteHedge" name="PurchaseofConvertibleNoteHedge" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="dxcm_RDexpensethroughissuanceofcommonstock" name="RDexpensethroughissuanceofcommonstock" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_ReceiverProductComponentMember" name="ReceiverProductComponentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" name="RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_RevenuePercentage" name="RevenuePercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_RevenueRecognitionSalesReturnsCoveragePeriod" name="RevenueRecognitionSalesReturnsCoveragePeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" name="SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock" name="ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock" name="ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_SellingGeneralAndAdministrativeMember" name="SellingGeneralAndAdministrativeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses" name="StandardProductWarrantyAccrualChargesToCostsAndExpenses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="dxcm_StockOptionsReservedForFutureGrant" name="StockOptionsReservedForFutureGrant" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant" />
  <xsd:element id="dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration" name="TaxCreditCarryforwardsResearchSubjecttoExpiration" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017" name="UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="dxcm_UnusedExpiredFederalIncomeTaxCredits" name="UnusedExpiredFederalIncomeTaxCredits" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_VerilyLifeSciencesMember" name="VerilyLifeSciencesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="dxcm_WaveFormTechnologiesInc.Member" name="WaveFormTechnologiesInc.Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated" name="WeightedAverageSharePriceConsecutiveDaysEvaluated" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>17
<FILENAME>dxcm-20191231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails" xlink:href="dxcm-20191231.xsd#AntiDilutiveSecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsAccountsReceivableDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsAccruedWarrantyDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsInventoryDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsOtherLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsPropertyAndEquipmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsTables" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformation" xlink:href="dxcm-20191231.xsd#BusinessSegmentAndGeographicInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationNarrativeDetails" xlink:href="dxcm-20191231.xsd#BusinessSegmentAndGeographicInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails" xlink:href="dxcm-20191231.xsd#BusinessSegmentAndGeographicInformationSummaryDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationTables" xlink:href="dxcm-20191231.xsd#BusinessSegmentAndGeographicInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheets" xlink:href="dxcm-20191231.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="dxcm-20191231.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="dxcm-20191231.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlowsCalc2" xlink:href="dxcm-20191231.xsd#ConsolidatedStatementsOfCashFlowsCalc2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" xlink:href="dxcm-20191231.xsd#ConsolidatedStatementsOfComprehensiveIncomeLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfOperations" xlink:href="dxcm-20191231.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="dxcm-20191231.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/Contingencies" xlink:href="dxcm-20191231.xsd#Contingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ContingenciesNarrativeDetails" xlink:href="dxcm-20191231.xsd#ContingenciesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/CoverPage" xlink:href="dxcm-20191231.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails" xlink:href="dxcm-20191231.xsd#DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails" xlink:href="dxcm-20191231.xsd#DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails" xlink:href="dxcm-20191231.xsd#DebtConversionValueOfConvertibleNotesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtDebt" xlink:href="dxcm-20191231.xsd#DebtDebt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:href="dxcm-20191231.xsd#DebtNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:href="dxcm-20191231.xsd#DebtSeniorConvertibleNotesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtTables" xlink:href="dxcm-20191231.xsd#DebtTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentAndOtherAgreements" xlink:href="dxcm-20191231.xsd#DevelopmentAndOtherAgreements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails" xlink:href="dxcm-20191231.xsd#DevelopmentAndOtherAgreementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquity" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityIntrinsicValueOfOptionsExercisedAndFairValueOfOptionsVestedDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityIntrinsicValueOfOptionsExercisedAndFairValueOfOptionsVestedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityTables" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurements" xlink:href="dxcm-20191231.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails" xlink:href="dxcm-20191231.xsd#FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails" xlink:href="dxcm-20191231.xsd#FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="dxcm-20191231.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:href="dxcm-20191231.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxes" xlink:href="dxcm-20191231.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesComponentsOfProvisionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesTables" xlink:href="dxcm-20191231.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitments" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitmentsLeaseCostDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetailsCalc2" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetailsCalc2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitmentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitmentsOtherInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitmentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPolicies" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenueRecognizedFromChangesInContractLiabilityBalancesDetails" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesRevenueRecognizedFromChangesInContractLiabilityBalancesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesTables" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedQuarterlyFinancialInformationUnaudited" xlink:href="dxcm-20191231.xsd#QuarterlyFinancialInformationUnauditedQuarterlyFinancialInformationUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedSummaryDetails" xlink:href="dxcm-20191231.xsd#QuarterlyFinancialInformationUnauditedSummaryDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:href="dxcm-20191231.xsd#QuarterlyFinancialInformationUnauditedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:href="dxcm-20191231.xsd#ScheduleIiValuationAndQualifyingAccounts" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:href="dxcm-20191231.xsd#ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_c2676f97-95a2-35b7-c84b-243edbd84b35" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_51b23810-9c40-7332-bdd2-99200011c44c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_c2676f97-95a2-35b7-c84b-243edbd84b35" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_51b23810-9c40-7332-bdd2-99200011c44c" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_AccruedTaxAuditAndLegalFees" xlink:label="loc_dxcm_AccruedTaxAuditAndLegalFees_4075063b-ad91-d2a8-1d2d-c299a201cedb" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_c2676f97-95a2-35b7-c84b-243edbd84b35" xlink:to="loc_dxcm_AccruedTaxAuditAndLegalFees_4075063b-ad91-d2a8-1d2d-c299a201cedb" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PharmacyRebates" xlink:label="loc_dxcm_PharmacyRebates_34f2051f-03c1-69a5-3831-c299a24c2468" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_c2676f97-95a2-35b7-c84b-243edbd84b35" xlink:to="loc_dxcm_PharmacyRebates_34f2051f-03c1-69a5-3831-c299a24c2468" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_1c9b6e51-f411-9813-bc03-e23d18dfeaa0" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_c2676f97-95a2-35b7-c84b-243edbd84b35" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_1c9b6e51-f411-9813-bc03-e23d18dfeaa0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_fa7787c9-a33c-d084-bb97-5e2455f77a4c" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_c2676f97-95a2-35b7-c84b-243edbd84b35" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_fa7787c9-a33c-d084-bb97-5e2455f77a4c" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaap_AccountsReceivableNet_4b4af260-5798-ebce-50a5-f36925cb99d6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableGross" xlink:label="loc_us-gaap_AccountsReceivableGross_70dfe465-03b7-a758-1425-0f752ba90fc0" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNet_4b4af260-5798-ebce-50a5-f36925cb99d6" xlink:to="loc_us-gaap_AccountsReceivableGross_70dfe465-03b7-a758-1425-0f752ba90fc0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_5f747ae2-e4ca-f87d-a59b-5e6f1f3336a8" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNet_4b4af260-5798-ebce-50a5-f36925cb99d6" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_5f747ae2-e4ca-f87d-a59b-5e6f1f3336a8" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_cc720f44-4c90-5acc-2e7e-b88e80f2af28" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_a142eb63-af8d-4212-6321-d7c0ac27f958" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_cc720f44-4c90-5acc-2e7e-b88e80f2af28" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_a142eb63-af8d-4212-6321-d7c0ac27f958" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_f4920785-d6c0-a217-e01a-0e0ef529643a" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_cc720f44-4c90-5acc-2e7e-b88e80f2af28" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_f4920785-d6c0-a217-e01a-0e0ef529643a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2dee2782-8369-5635-44bf-51d0e8aa0f1e" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_cc720f44-4c90-5acc-2e7e-b88e80f2af28" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2dee2782-8369-5635-44bf-51d0e8aa0f1e" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_621f303c-751b-9349-bcf4-ad4fd6948d9c" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_fd7a3873-1d2e-18d2-27ba-de8bbf223d6c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_621f303c-751b-9349-bcf4-ad4fd6948d9c" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_fd7a3873-1d2e-18d2-27ba-de8bbf223d6c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_f5606eea-7366-96e6-b9b7-423a1b6aeda6" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_621f303c-751b-9349-bcf4-ad4fd6948d9c" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_f5606eea-7366-96e6-b9b7-423a1b6aeda6" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_8c850143-cd0c-0f85-9038-e19d8c4f7808" xlink:type="locator" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FinancingLeaseObligation" xlink:label="loc_dxcm_FinancingLeaseObligation_b39b7e37-db30-c737-2a08-c299a2178cc4" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_8c850143-cd0c-0f85-9038-e19d8c4f7808" xlink:to="loc_dxcm_FinancingLeaseObligation_b39b7e37-db30-c737-2a08-c299a2178cc4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent_5d3f3f8e-8f06-ee35-6076-a0312a3c4f12" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_8c850143-cd0c-0f85-9038-e19d8c4f7808" xlink:to="loc_us-gaap_DeferredRentCreditNoncurrent_5d3f3f8e-8f06-ee35-6076-a0312a3c4f12" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_dcfb6b3c-0e80-af2c-b605-283f04c941ca" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_8c850143-cd0c-0f85-9038-e19d8c4f7808" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_dcfb6b3c-0e80-af2c-b605-283f04c941ca" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4246ec24-1a4c-19dd-57c9-32d4a8e0cbaa" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_94cd7971-9d17-1c6e-6642-d4d38fb682b6" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_4246ec24-1a4c-19dd-57c9-32d4a8e0cbaa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_94cd7971-9d17-1c6e-6642-d4d38fb682b6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7b7a3a8d-eb3d-0c85-68cc-b3d4d184ff23" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_4246ec24-1a4c-19dd-57c9-32d4a8e0cbaa" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7b7a3a8d-eb3d-0c85-68cc-b3d4d184ff23" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_27940abc-0cb4-eab4-8ef0-df4a4c0bb415" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9fbaf9cb-468f-3b91-9cf2-18d26152173d" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_27940abc-0cb4-eab4-8ef0-df4a4c0bb415" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9fbaf9cb-468f-3b91-9cf2-18d26152173d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a23ab896-034e-8e96-1a84-63ffb40e496e" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_27940abc-0cb4-eab4-8ef0-df4a4c0bb415" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a23ab896-034e-8e96-1a84-63ffb40e496e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e562c48b-3e99-2c57-8e96-c3b81056b58c" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_27940abc-0cb4-eab4-8ef0-df4a4c0bb415" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e562c48b-3e99-2c57-8e96-c3b81056b58c" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_17ef3f41-42f7-52c0-cba1-93e7e0e1116a" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_0b3bd361-d592-2906-279e-2682647fdd27" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_17ef3f41-42f7-52c0-cba1-93e7e0e1116a" xlink:to="loc_us-gaap_AssetsCurrent_0b3bd361-d592-2906-279e-2682647fdd27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1de780cc-9607-daa3-0bed-03c88ae94769" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0b3bd361-d592-2906-279e-2682647fdd27" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1de780cc-9607-daa3-0bed-03c88ae94769" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_687cf6e5-2757-05e0-ae7f-c299a1de52b8" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0b3bd361-d592-2906-279e-2682647fdd27" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_687cf6e5-2757-05e0-ae7f-c299a1de52b8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_dd2cbe99-77d2-db20-3c91-750589881c79" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0b3bd361-d592-2906-279e-2682647fdd27" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_dd2cbe99-77d2-db20-3c91-750589881c79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_cc720f44-4c90-5acc-2e7e-b88e80f2af28" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0b3bd361-d592-2906-279e-2682647fdd27" xlink:to="loc_us-gaap_InventoryNet_cc720f44-4c90-5acc-2e7e-b88e80f2af28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5fd9c643-899e-95d7-aab9-c3a9d6240218" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0b3bd361-d592-2906-279e-2682647fdd27" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5fd9c643-899e-95d7-aab9-c3a9d6240218" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4246ec24-1a4c-19dd-57c9-32d4a8e0cbaa" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_17ef3f41-42f7-52c0-cba1-93e7e0e1116a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4246ec24-1a4c-19dd-57c9-32d4a8e0cbaa" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_37b440e2-656c-b624-0688-b7cf681bf981" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_17ef3f41-42f7-52c0-cba1-93e7e0e1116a" xlink:to="loc_us-gaap_Goodwill_37b440e2-656c-b624-0688-b7cf681bf981" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_bd8545de-cfc2-6f31-bff6-ed0d4012c357" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_17ef3f41-42f7-52c0-cba1-93e7e0e1116a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_bd8545de-cfc2-6f31-bff6-ed0d4012c357" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_dcf3df0d-2155-35f6-715d-83a9bc9cf3fb" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_17ef3f41-42f7-52c0-cba1-93e7e0e1116a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_dcf3df0d-2155-35f6-715d-83a9bc9cf3fb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d7f1ad03-6ed4-706a-15fc-eae794dee33a" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_44863786-cbc4-bac4-e070-0a1f19314584" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d7f1ad03-6ed4-706a-15fc-eae794dee33a" xlink:to="loc_us-gaap_Liabilities_44863786-cbc4-bac4-e070-0a1f19314584" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_30dca50d-a7bd-cff0-949a-3d7ae869c50d" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_44863786-cbc4-bac4-e070-0a1f19314584" xlink:to="loc_us-gaap_LiabilitiesCurrent_30dca50d-a7bd-cff0-949a-3d7ae869c50d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_c2676f97-95a2-35b7-c84b-243edbd84b35" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_30dca50d-a7bd-cff0-949a-3d7ae869c50d" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_c2676f97-95a2-35b7-c84b-243edbd84b35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a2b836a7-cc87-0e4f-38a0-c91a29535622" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_30dca50d-a7bd-cff0-949a-3d7ae869c50d" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a2b836a7-cc87-0e4f-38a0-c91a29535622" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_68a2ece1-b79e-558c-a305-f3ccae8c21c3" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_30dca50d-a7bd-cff0-949a-3d7ae869c50d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_68a2ece1-b79e-558c-a305-f3ccae8c21c3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b91d2f01-85c2-f9fb-3250-26a4b1b39c5e" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_30dca50d-a7bd-cff0-949a-3d7ae869c50d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b91d2f01-85c2-f9fb-3250-26a4b1b39c5e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_8c850143-cd0c-0f85-9038-e19d8c4f7808" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_44863786-cbc4-bac4-e070-0a1f19314584" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_8c850143-cd0c-0f85-9038-e19d8c4f7808" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_3fda818c-6b39-e088-a39a-b3bff4b8a17e" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_44863786-cbc4-bac4-e070-0a1f19314584" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_3fda818c-6b39-e088-a39a-b3bff4b8a17e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d18f979c-644d-9e92-9e89-21cfd1312948" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_44863786-cbc4-bac4-e070-0a1f19314584" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d18f979c-644d-9e92-9e89-21cfd1312948" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_4d934b0d-59bc-ae5c-ffb9-b6ced82ff9f8" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d7f1ad03-6ed4-706a-15fc-eae794dee33a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_4d934b0d-59bc-ae5c-ffb9-b6ced82ff9f8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2605fa18-bbd8-c7d7-35fc-aace43a8c019" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d7f1ad03-6ed4-706a-15fc-eae794dee33a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2605fa18-bbd8-c7d7-35fc-aace43a8c019" xlink:type="arc" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2605fa18-bbd8-c7d7-35fc-aace43a8c019" xlink:to="loc_us-gaap_CommitmentsAndContingencies_4d934b0d-59bc-ae5c-ffb9-b6ced82ff9f8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValueOutstanding" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_ab2495a9-4df2-c8a3-73df-db59edc6a026" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2605fa18-bbd8-c7d7-35fc-aace43a8c019" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_ab2495a9-4df2-c8a3-73df-db59edc6a026" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValueOutstanding" xlink:label="loc_us-gaap_CommonStockValueOutstanding_294c6946-9048-096a-8276-56aec7d04572" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2605fa18-bbd8-c7d7-35fc-aace43a8c019" xlink:to="loc_us-gaap_CommonStockValueOutstanding_294c6946-9048-096a-8276-56aec7d04572" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9a00ddef-ccc2-f99c-735a-66b1e1849bbf" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2605fa18-bbd8-c7d7-35fc-aace43a8c019" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9a00ddef-ccc2-f99c-735a-66b1e1849bbf" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_988c1346-b444-a867-fe80-f3aec1443d54" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2605fa18-bbd8-c7d7-35fc-aace43a8c019" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_988c1346-b444-a867-fe80-f3aec1443d54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_62305d8f-d807-0fe8-d0ab-f2c2b3d03011" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2605fa18-bbd8-c7d7-35fc-aace43a8c019" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_62305d8f-d807-0fe8-d0ab-f2c2b3d03011" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_e6069c8d-dfec-45ff-4b3f-643d125d5b29" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2605fa18-bbd8-c7d7-35fc-aace43a8c019" xlink:to="loc_us-gaap_TreasuryStockValue_e6069c8d-dfec-45ff-4b3f-643d125d5b29" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_21c019f0-62e8-3b20-07d1-495695054dce" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1de780cc-9607-daa3-0bed-03c88ae94769" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_21c019f0-62e8-3b20-07d1-495695054dce" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1de780cc-9607-daa3-0bed-03c88ae94769" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaap_RestrictedCash_d19dea7d-a17a-c30f-cafd-5849cd448318" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_21c019f0-62e8-3b20-07d1-495695054dce" xlink:to="loc_us-gaap_RestrictedCash_d19dea7d-a17a-c30f-cafd-5849cd448318" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_50231013-f048-89e7-0e20-ba139224c5f7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_50231013-f048-89e7-0e20-ba139224c5f7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_e170ce1e-c3a8-e8ee-88b0-37e8dd7b1d11" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_NetIncomeLoss_e170ce1e-c3a8-e8ee-88b0-37e8dd7b1d11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ebef248a-da21-637d-9d28-3d42ff90e8e2" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ebef248a-da21-637d-9d28-3d42ff90e8e2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_f0b9d825-b0b9-37fd-4d25-9294a8598890" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_ShareBasedCompensation_f0b9d825-b0b9-37fd-4d25-9294a8598890" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_a4567c23-eef7-473f-21b3-15ac8f57524e" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_a4567c23-eef7-473f-21b3-15ac8f57524e" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_RDexpensethroughissuanceofcommonstock" xlink:label="loc_dxcm_RDexpensethroughissuanceofcommonstock_295b14b0-338f-281b-1110-eb34bbcac8be" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_dxcm_RDexpensethroughissuanceofcommonstock_295b14b0-338f-281b-1110-eb34bbcac8be" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_25f3d0af-ced3-016f-c911-7e8b9a22875d" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_25f3d0af-ced3-016f-c911-7e8b9a22875d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_7e5523c1-5b1e-4805-6047-3ca7fde56d49" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_7e5523c1-5b1e-4805-6047-3ca7fde56d49" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_269710de-43ea-f1a2-1ab7-8a2fad8bcd72" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_269710de-43ea-f1a2-1ab7-8a2fad8bcd72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_09b7b41a-f5a1-c45e-d61b-846fff462802" xlink:type="locator" />
    <link:calculationArc order="9" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_09b7b41a-f5a1-c45e-d61b-846fff462802" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f2b34f8d-2445-12ee-2c68-fa0c5409d5e0" xlink:type="locator" />
    <link:calculationArc order="10" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f2b34f8d-2445-12ee-2c68-fa0c5409d5e0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_dfcbd6f7-83fa-00c2-bd9e-6c5c1de7d890" xlink:type="locator" />
    <link:calculationArc order="11" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_dfcbd6f7-83fa-00c2-bd9e-6c5c1de7d890" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7c1c3153-d95c-50b8-10ed-a75d1f3d7a68" xlink:type="locator" />
    <link:calculationArc order="12" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7c1c3153-d95c-50b8-10ed-a75d1f3d7a68" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_300c5b66-f508-fab7-3859-345853a2ad7c" xlink:type="locator" />
    <link:calculationArc order="13" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_300c5b66-f508-fab7-3859-345853a2ad7c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_965f24d9-d106-28bc-ea1f-fcc97d39cf0a" xlink:type="locator" />
    <link:calculationArc order="14" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_965f24d9-d106-28bc-ea1f-fcc97d39cf0a" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:label="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_30C2F627EA90F9904A63AB447404A794" xlink:type="locator" />
    <link:calculationArc order="15" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_30C2F627EA90F9904A63AB447404A794" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_50231013-f048-89e7-0e20-ba139224c5f7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_8b51ae5f-8f14-ae0e-00e7-8f4e716f2f96" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_8b51ae5f-8f14-ae0e-00e7-8f4e716f2f96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_83cf65a5-9616-b748-1d6c-92f0b7da6e69" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_83cf65a5-9616-b748-1d6c-92f0b7da6e69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_483713d8-e500-be9d-d173-6b5e26416fef" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_483713d8-e500-be9d-d173-6b5e26416fef" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0f8df60b-841f-6df5-83c3-e4049d366459" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0f8df60b-841f-6df5-83c3-e4049d366459" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6abb14d9-7978-302d-af6b-dbfc88f76bf2" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6abb14d9-7978-302d-af6b-dbfc88f76bf2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_50231013-f048-89e7-0e20-ba139224c5f7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_0f0975d6-8500-76a0-c74f-5d2f0ed8b620" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_0f0975d6-8500-76a0-c74f-5d2f0ed8b620" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3f804297-91a1-3939-541d-a39b6288c9f9" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3f804297-91a1-3939-541d-a39b6288c9f9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_0ccd9808-af25-d5c0-92fa-163b4b743159" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_0ccd9808-af25-d5c0-92fa-163b4b743159" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_05d828ea-8517-e6a0-8392-e3b4e2bbf225" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_05d828ea-8517-e6a0-8392-e3b4e2bbf225" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_513b446a-317d-9be1-1fc2-380a24dd13e0" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_513b446a-317d-9be1-1fc2-380a24dd13e0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_cb96fc07-e276-2c52-1042-f1ea0d192b51" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_cb96fc07-e276-2c52-1042-f1ea0d192b51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_3ddd0290-3d1a-2e62-5161-428d280d3fb6" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_3ddd0290-3d1a-2e62-5161-428d280d3fb6" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PurchaseofConvertibleNoteHedge" xlink:label="loc_dxcm_PurchaseofConvertibleNoteHedge_5c927790-6858-5875-c9f2-eb34bbb08f98" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_dxcm_PurchaseofConvertibleNoteHedge_5c927790-6858-5875-c9f2-eb34bbb08f98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6bd7c3da-2a5b-cbc6-d33a-bb097a23c2f6" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_50231013-f048-89e7-0e20-ba139224c5f7" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6bd7c3da-2a5b-cbc6-d33a-bb097a23c2f6" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlowsCalc2" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5c8b3520-1ca2-0a91-0912-70d62831826c" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_e170ce1e-c3a8-e8ee-88b0-37e8dd7b1d11" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5c8b3520-1ca2-0a91-0912-70d62831826c" xlink:to="loc_us-gaap_NetIncomeLoss_e170ce1e-c3a8-e8ee-88b0-37e8dd7b1d11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5e0cb0dc-b25c-aaae-62f8-cb90f31a16a1" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5c8b3520-1ca2-0a91-0912-70d62831826c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5e0cb0dc-b25c-aaae-62f8-cb90f31a16a1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_71d11517-34f8-505e-4c4b-e25ef3111aee" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5e0cb0dc-b25c-aaae-62f8-cb90f31a16a1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_71d11517-34f8-505e-4c4b-e25ef3111aee" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e88bd855-1cc4-7d92-7586-c29e344f0391" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5e0cb0dc-b25c-aaae-62f8-cb90f31a16a1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e88bd855-1cc4-7d92-7586-c29e344f0391" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_e170ce1e-c3a8-e8ee-88b0-37e8dd7b1d11" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_489b61b6-7c39-240c-7f68-1c1675bca3b7" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e170ce1e-c3a8-e8ee-88b0-37e8dd7b1d11" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_489b61b6-7c39-240c-7f68-1c1675bca3b7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_8db01d6d-ae17-523f-94b9-8ab4add4a22e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_489b61b6-7c39-240c-7f68-1c1675bca3b7" xlink:to="loc_us-gaap_OperatingIncomeLoss_8db01d6d-ae17-523f-94b9-8ab4add4a22e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_98c25af7-47ba-69a3-12c4-e52bd51b359e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8db01d6d-ae17-523f-94b9-8ab4add4a22e" xlink:to="loc_us-gaap_GrossProfit_98c25af7-47ba-69a3-12c4-e52bd51b359e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b88c060f-09b3-b6c0-4cdb-a77cb8e75ec8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_98c25af7-47ba-69a3-12c4-e52bd51b359e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b88c060f-09b3-b6c0-4cdb-a77cb8e75ec8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3549c1c0-2f2a-e44b-026b-b4042153e489" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_98c25af7-47ba-69a3-12c4-e52bd51b359e" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3549c1c0-2f2a-e44b-026b-b4042153e489" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_56807cce-1c23-b2ed-01fd-e029fa0d6e79" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8db01d6d-ae17-523f-94b9-8ab4add4a22e" xlink:to="loc_us-gaap_OperatingExpenses_56807cce-1c23-b2ed-01fd-e029fa0d6e79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ef2ac9e8-006f-b467-3389-9a8ceec4bee5" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_56807cce-1c23-b2ed-01fd-e029fa0d6e79" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ef2ac9e8-006f-b467-3389-9a8ceec4bee5" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeResearchAndDevelopmentFee" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee_dbec6c61-8e44-fded-61d3-eb34bc0c0964" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_56807cce-1c23-b2ed-01fd-e029fa0d6e79" xlink:to="loc_dxcm_CollaborativeResearchAndDevelopmentFee_dbec6c61-8e44-fded-61d3-eb34bc0c0964" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_89fcc343-1933-1e77-588e-68d1c2f1a04f" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_56807cce-1c23-b2ed-01fd-e029fa0d6e79" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_89fcc343-1933-1e77-588e-68d1c2f1a04f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_16e9f6a6-5524-a7b1-7e7c-73ee97610ec6" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_489b61b6-7c39-240c-7f68-1c1675bca3b7" xlink:to="loc_us-gaap_InterestExpense_16e9f6a6-5524-a7b1-7e7c-73ee97610ec6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_621f303c-751b-9349-bcf4-ad4fd6948d9c" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_489b61b6-7c39-240c-7f68-1c1675bca3b7" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_621f303c-751b-9349-bcf4-ad4fd6948d9c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7a3a9730-2927-590e-4e76-6aeb4157256e" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_489b61b6-7c39-240c-7f68-1c1675bca3b7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7a3a9730-2927-590e-4e76-6aeb4157256e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e170ce1e-c3a8-e8ee-88b0-37e8dd7b1d11" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/Contingencies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ContingenciesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/CoverPage" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtDebt" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_3fda818c-6b39-e088-a39a-b3bff4b8a17e" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_440d49bc-ab70-2673-3639-4fbbaa711932" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleLongTermNotesPayable_3fda818c-6b39-e088-a39a-b3bff4b8a17e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_440d49bc-ab70-2673-3639-4fbbaa711932" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_736d2dab-e6d0-241f-ea81-d597b26683aa" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleLongTermNotesPayable_3fda818c-6b39-e088-a39a-b3bff4b8a17e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_736d2dab-e6d0-241f-ea81-d597b26683aa" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_133a62ef-4f15-79a5-1ce7-91f3db28df83" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleLongTermNotesPayable_3fda818c-6b39-e088-a39a-b3bff4b8a17e" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_133a62ef-4f15-79a5-1ce7-91f3db28df83" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DevelopmentAndOtherAgreements" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityIntrinsicValueOfOptionsExercisedAndFairValueOfOptionsVestedDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c9d834bf-f438-2496-f972-a3b581d35a37" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_922768c9-f90f-e497-0ea9-311e9212e227" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c9d834bf-f438-2496-f972-a3b581d35a37" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_922768c9-f90f-e497-0ea9-311e9212e227" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6f518561-5077-12fb-3edf-9c0f0e148e91" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c9d834bf-f438-2496-f972-a3b581d35a37" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6f518561-5077-12fb-3edf-9c0f0e148e91" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_StockOptionsReservedForFutureGrant" xlink:label="loc_dxcm_StockOptionsReservedForFutureGrant_95501a9b-b130-bd87-cea2-eb34bbda5840" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c9d834bf-f438-2496-f972-a3b581d35a37" xlink:to="loc_dxcm_StockOptionsReservedForFutureGrant_95501a9b-b130-bd87-cea2-eb34bbda5840" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EmployeeStockPurchasePlanEsppSharesInEspp" xlink:label="loc_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_a9e4ff01-41a3-0565-367a-eb34bbea7113" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c9d834bf-f438-2496-f972-a3b581d35a37" xlink:to="loc_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_a9e4ff01-41a3-0565-367a-eb34bbea7113" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_a0a5801b-c8ce-1793-dd5f-edbcde4cc5a3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_1f69a228-18b0-c1db-9243-c9361fe5d18e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_a0a5801b-c8ce-1793-dd5f-edbcde4cc5a3" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_1f69a228-18b0-c1db-9243-c9361fe5d18e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e562c48b-3e99-2c57-8e96-c3b81056b58c" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_a0a5801b-c8ce-1793-dd5f-edbcde4cc5a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e562c48b-3e99-2c57-8e96-c3b81056b58c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_bf280f65-0fc4-55e7-c250-2c52c36331f3" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_a0a5801b-c8ce-1793-dd5f-edbcde4cc5a3" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_bf280f65-0fc4-55e7-c250-2c52c36331f3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_62d78024-4154-b2b0-919a-27b745106dda" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_a0a5801b-c8ce-1793-dd5f-edbcde4cc5a3" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_62d78024-4154-b2b0-919a-27b745106dda" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxes" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ad87dc87-7206-5d76-a1ae-6cecdf90521c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ad87dc87-7206-5d76-a1ae-6cecdf90521c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_1007d9fe-6d83-c6c6-eef9-c29803b14ec7" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ad87dc87-7206-5d76-a1ae-6cecdf90521c" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_1007d9fe-6d83-c6c6-eef9-c29803b14ec7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_7f37ab3b-992e-e1ba-f578-2c503524d7e4" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ad87dc87-7206-5d76-a1ae-6cecdf90521c" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_7f37ab3b-992e-e1ba-f578-2c503524d7e4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_dbb037c2-04c0-fa14-65e6-8ccd12d2a855" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ad87dc87-7206-5d76-a1ae-6cecdf90521c" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_dbb037c2-04c0-fa14-65e6-8ccd12d2a855" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3421bed6-296e-da4e-f0e9-a2a8fa1f6d19" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3421bed6-296e-da4e-f0e9-a2a8fa1f6d19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_db02e614-93e7-eddf-abe0-a58cca48e685" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3421bed6-296e-da4e-f0e9-a2a8fa1f6d19" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_db02e614-93e7-eddf-abe0-a58cca48e685" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_ca5c17e6-16a0-bee8-1413-d316d82a8942" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3421bed6-296e-da4e-f0e9-a2a8fa1f6d19" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_ca5c17e6-16a0-bee8-1413-d316d82a8942" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_8caef893-a841-2be2-863f-e20b53026f02" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3421bed6-296e-da4e-f0e9-a2a8fa1f6d19" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_8caef893-a841-2be2-863f-e20b53026f02" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet" xlink:label="loc_dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet_5ceffe6d-59a8-91a4-f30f-eb34bbae065f" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_0bdbea13-bfd8-228d-43ea-fae0c1330aaa" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet_5ceffe6d-59a8-91a4-f30f-eb34bbae065f" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_0bdbea13-bfd8-228d-43ea-fae0c1330aaa" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_e54f6543-25d5-ceb9-ff71-ca6ba1b37623" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_0bdbea13-bfd8-228d-43ea-fae0c1330aaa" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_e54f6543-25d5-ceb9-ff71-ca6ba1b37623" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_bc5d002e-802f-bf1e-7d7d-9f1d1a7551a7" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e54f6543-25d5-ceb9-ff71-ca6ba1b37623" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_bc5d002e-802f-bf1e-7d7d-9f1d1a7551a7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_1770a893-e2f5-e155-b9aa-1c85cb05acb7" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e54f6543-25d5-ceb9-ff71-ca6ba1b37623" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_1770a893-e2f5-e155-b9aa-1c85cb05acb7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_9fd2e560-0aac-aea4-6be8-8b4e4e77d184" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e54f6543-25d5-ceb9-ff71-ca6ba1b37623" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_9fd2e560-0aac-aea4-6be8-8b4e4e77d184" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_de5e795f-0165-d088-d22e-d01ff8d44317" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e54f6543-25d5-ceb9-ff71-ca6ba1b37623" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_de5e795f-0165-d088-d22e-d01ff8d44317" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_ac4e5578-f94c-fdad-c074-80060476cdef" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e54f6543-25d5-ceb9-ff71-ca6ba1b37623" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_ac4e5578-f94c-fdad-c074-80060476cdef" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_e1ccc1eb-ffbd-3ad3-bc7a-09819cccad11" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e54f6543-25d5-ceb9-ff71-ca6ba1b37623" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_e1ccc1eb-ffbd-3ad3-bc7a-09819cccad11" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DeferredTaxAssetsConvertibleDebt" xlink:label="loc_dxcm_DeferredTaxAssetsConvertibleDebt_CC7C42AC9C8267AA2F74F3956BC3E5E3" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e54f6543-25d5-ceb9-ff71-ca6ba1b37623" xlink:to="loc_dxcm_DeferredTaxAssetsConvertibleDebt_CC7C42AC9C8267AA2F74F3956BC3E5E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_55b78dfc-faa8-3c71-752a-e6857318d516" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_0bdbea13-bfd8-228d-43ea-fae0c1330aaa" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_55b78dfc-faa8-3c71-752a-e6857318d516" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_f31cb66e-0de8-54fb-4788-53b3cde0ec2f" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet_5ceffe6d-59a8-91a4-f30f-eb34bbae065f" xlink:to="loc_us-gaap_DeferredTaxLiabilities_f31cb66e-0de8-54fb-4788-53b3cde0ec2f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_5da8fd5a-89f1-3049-e781-200c2d180554" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_f31cb66e-0de8-54fb-4788-53b3cde0ec2f" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_5da8fd5a-89f1-3049-e781-200c2d180554" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount" xlink:label="loc_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_37c45a76-5c60-03a8-13df-eb34bb763f87" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_f31cb66e-0de8-54fb-4788-53b3cde0ec2f" xlink:to="loc_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_37c45a76-5c60-03a8-13df-eb34bb763f87" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d71649eb-5769-933d-7982-2a2ada9ea257" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_3ce82195-ed3e-f261-3529-b3a868ecf6c4" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d71649eb-5769-933d-7982-2a2ada9ea257" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_3ce82195-ed3e-f261-3529-b3a868ecf6c4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_89ebd542-78ee-71d0-be95-65de1bb3ef82" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d71649eb-5769-933d-7982-2a2ada9ea257" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_89ebd542-78ee-71d0-be95-65de1bb3ef82" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_7c7e16b8-0aa9-c1c4-f1b1-272374ca83dc" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_7c7e16b8-0aa9-c1c4-f1b1-272374ca83dc" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_f57a32ed-0dd0-7e89-043f-8fdc81833b87" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_f57a32ed-0dd0-7e89-043f-8fdc81833b87" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EffectiveIncomeTaxReconciliationPermanentItems" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_84b74c37-d280-7a12-e50a-eb34bbea50e1" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:to="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_84b74c37-d280-7a12-e50a-eb34bbea50e1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_3c49146a-876e-0398-a795-05386dec675e" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_3c49146a-876e-0398-a795-05386dec675e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_e124023a-4116-8f49-30c1-60c50fde5ff8" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_e124023a-4116-8f49-30c1-60c50fde5ff8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2998d3ea-3247-4459-9f66-28bd5dfb1499" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2998d3ea-3247-4459-9f66-28bd5dfb1499" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_05cc23a1-95bf-5dfd-ffdf-58b097230187" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_05cc23a1-95bf-5dfd-ffdf-58b097230187" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits_598a2f9e-fff2-8171-b922-eb34bc100a4c" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:to="loc_dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits_598a2f9e-fff2-8171-b922-eb34bc100a4c" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_acc1c55a-21ea-d375-b558-eb34bbda49f6" xlink:type="locator" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:to="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_acc1c55a-21ea-d375-b558-eb34bbda49f6" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_56020013-2ac4-2ae9-4c42-eb34bc3e2bfb" xlink:type="locator" />
    <link:calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:to="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_56020013-2ac4-2ae9-4c42-eb34bc3e2bfb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_49a08e86-47b2-01fa-94cc-0320e102ec63" xlink:type="locator" />
    <link:calculationArc order="11" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_49a08e86-47b2-01fa-94cc-0320e102ec63" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_a0223de0-196e-53c5-0690-f9f0d2ab9105" xlink:type="locator" />
    <link:calculationArc order="12" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_a0223de0-196e-53c5-0690-f9f0d2ab9105" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitments" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_ac3b1889-9651-365f-e4fc-e6474385db69" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e6bc46d1-fec7-6b3b-527e-4ad756896790" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ac3b1889-9651-365f-e4fc-e6474385db69" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e6bc46d1-fec7-6b3b-527e-4ad756896790" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_a4a8e3bb-2ee6-a2f3-d86b-f05bd98679a7" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ac3b1889-9651-365f-e4fc-e6474385db69" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_a4a8e3bb-2ee6-a2f3-d86b-f05bd98679a7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_88d5ba82-39dd-36ed-37fe-92977ff632df" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ac3b1889-9651-365f-e4fc-e6474385db69" xlink:to="loc_us-gaap_OperatingLeaseCost_88d5ba82-39dd-36ed-37fe-92977ff632df" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaap_ShortTermLeaseCost_4efa230c-b1e9-e41e-ae56-b6a8565f3216" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ac3b1889-9651-365f-e4fc-e6474385db69" xlink:to="loc_us-gaap_ShortTermLeaseCost_4efa230c-b1e9-e41e-ae56-b6a8565f3216" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost_3df88f41-850d-02ae-dd0b-ab0215935a95" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ac3b1889-9651-365f-e4fc-e6474385db69" xlink:to="loc_us-gaap_VariableLeaseCost_3df88f41-850d-02ae-dd0b-ab0215935a95" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_b983c2d8-8318-0a7e-1a5c-6ab2933f7be5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b91d2f01-85c2-f9fb-3250-26a4b1b39c5e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_b983c2d8-8318-0a7e-1a5c-6ab2933f7be5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b91d2f01-85c2-f9fb-3250-26a4b1b39c5e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d18f979c-644d-9e92-9e89-21cfd1312948" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_b983c2d8-8318-0a7e-1a5c-6ab2933f7be5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d18f979c-644d-9e92-9e89-21cfd1312948" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_66b601d4-fa3f-7d40-f560-84d87697ff03" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_c7d469db-1829-81a3-8e6c-82df6bd6f6bf" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_66b601d4-fa3f-7d40-f560-84d87697ff03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_c7d469db-1829-81a3-8e6c-82df6bd6f6bf" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_362d72d3-5e94-ebab-8f86-75d06c8c7ee4" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_66b601d4-fa3f-7d40-f560-84d87697ff03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_362d72d3-5e94-ebab-8f86-75d06c8c7ee4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1c2cd15f-6a97-015f-b126-1d0a0750698b" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5ad4ca01-bc52-b198-b1fd-3cded668d167" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1c2cd15f-6a97-015f-b126-1d0a0750698b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5ad4ca01-bc52-b198-b1fd-3cded668d167" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9b040bc1-f43c-735d-05f7-679f319d2bb6" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1c2cd15f-6a97-015f-b126-1d0a0750698b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9b040bc1-f43c-735d-05f7-679f319d2bb6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2f0ec234-4f20-7099-efb3-3c0ab4d024dd" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1c2cd15f-6a97-015f-b126-1d0a0750698b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2f0ec234-4f20-7099-efb3-3c0ab4d024dd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1ed751b1-5f94-4f6f-41e9-ef873c9f2bab" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1c2cd15f-6a97-015f-b126-1d0a0750698b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1ed751b1-5f94-4f6f-41e9-ef873c9f2bab" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8a8de21f-aadc-3af7-8c96-d54cf42b401b" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1c2cd15f-6a97-015f-b126-1d0a0750698b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8a8de21f-aadc-3af7-8c96-d54cf42b401b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b411eec9-2a0a-356b-e751-bd0680ab4d58" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1c2cd15f-6a97-015f-b126-1d0a0750698b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b411eec9-2a0a-356b-e751-bd0680ab4d58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_585156c8-71c1-ada7-fa32-ec99a518c7a0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_bd82ad03-73ff-ee64-92c5-487d7a5c93ed" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_585156c8-71c1-ada7-fa32-ec99a518c7a0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_bd82ad03-73ff-ee64-92c5-487d7a5c93ed" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_9048fd47-13cc-d6eb-d7dd-e8d53f87b993" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_585156c8-71c1-ada7-fa32-ec99a518c7a0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_9048fd47-13cc-d6eb-d7dd-e8d53f87b993" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c4c9d759-d9f6-eec5-3320-115ed3ebdd52" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_585156c8-71c1-ada7-fa32-ec99a518c7a0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c4c9d759-d9f6-eec5-3320-115ed3ebdd52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_48ac7df5-3392-98b1-a73f-b2f41673ff75" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_585156c8-71c1-ada7-fa32-ec99a518c7a0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_48ac7df5-3392-98b1-a73f-b2f41673ff75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_c21c69f2-c329-91b2-f24a-9debaed02565" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_585156c8-71c1-ada7-fa32-ec99a518c7a0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_c21c69f2-c329-91b2-f24a-9debaed02565" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_80ad803a-a5b3-2c23-a7a0-aed644e501db" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_585156c8-71c1-ada7-fa32-ec99a518c7a0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_80ad803a-a5b3-2c23-a7a0-aed644e501db" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetailsCalc2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_B83798EC661EF2A478741BEB0D3D36CE_b983c2d8-8318-0a7e-1a5c-6ab2933f7be5" xlink:type="locator" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability" xlink:label="loc_dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_B83798EC661EF2A478741BEB0D3D36CE_9ac1bc43-4a95-de39-0a56-c299a259de81" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_B83798EC661EF2A478741BEB0D3D36CE_b983c2d8-8318-0a7e-1a5c-6ab2933f7be5" xlink:to="loc_dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_B83798EC661EF2A478741BEB0D3D36CE_9ac1bc43-4a95-de39-0a56-c299a259de81" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue" xlink:label="loc_dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue_B83798EC661EF2A478741BEB0D3D36CE_63045c83-1a62-1d38-8c4c-c299a1ed4253" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_B83798EC661EF2A478741BEB0D3D36CE_b983c2d8-8318-0a7e-1a5c-6ab2933f7be5" xlink:to="loc_dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue_B83798EC661EF2A478741BEB0D3D36CE_63045c83-1a62-1d38-8c4c-c299a1ed4253" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_B83798EC661EF2A478741BEB0D3D36CE_66b601d4-fa3f-7d40-f560-84d87697ff03" xlink:type="locator" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability" xlink:label="loc_dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_B83798EC661EF2A478741BEB0D3D36CE_8f444738-1ece-126c-4b52-c299a26134b3" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_B83798EC661EF2A478741BEB0D3D36CE_66b601d4-fa3f-7d40-f560-84d87697ff03" xlink:to="loc_dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_B83798EC661EF2A478741BEB0D3D36CE_8f444738-1ece-126c-4b52-c299a26134b3" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FinanceLeaseShortTermLeasesPaymentsDue" xlink:label="loc_dxcm_FinanceLeaseShortTermLeasesPaymentsDue_B83798EC661EF2A478741BEB0D3D36CE_b30ea601-e121-f5f3-dacb-c299a21aa0fc" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_B83798EC661EF2A478741BEB0D3D36CE_66b601d4-fa3f-7d40-f560-84d87697ff03" xlink:to="loc_dxcm_FinanceLeaseShortTermLeasesPaymentsDue_B83798EC661EF2A478741BEB0D3D36CE_b30ea601-e121-f5f3-dacb-c299a21aa0fc" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_B83798EC661EF2A478741BEB0D3D36CE_1c2cd15f-6a97-015f-b126-1d0a0750698b" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_B83798EC661EF2A478741BEB0D3D36CE_07815ffa-512a-3133-dcbb-38e09d2626b9" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_B83798EC661EF2A478741BEB0D3D36CE_1c2cd15f-6a97-015f-b126-1d0a0750698b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_B83798EC661EF2A478741BEB0D3D36CE_07815ffa-512a-3133-dcbb-38e09d2626b9" xlink:type="arc" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_B83798EC661EF2A478741BEB0D3D36CE_1c2cd15f-6a97-015f-b126-1d0a0750698b" xlink:to="loc_dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_B83798EC661EF2A478741BEB0D3D36CE_9ac1bc43-4a95-de39-0a56-c299a259de81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_B83798EC661EF2A478741BEB0D3D36CE_585156c8-71c1-ada7-fa32-ec99a518c7a0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_B83798EC661EF2A478741BEB0D3D36CE_597d60ca-96f9-eb25-df87-2ed201ea93c3" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_B83798EC661EF2A478741BEB0D3D36CE_585156c8-71c1-ada7-fa32-ec99a518c7a0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_B83798EC661EF2A478741BEB0D3D36CE_597d60ca-96f9-eb25-df87-2ed201ea93c3" xlink:type="arc" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_B83798EC661EF2A478741BEB0D3D36CE_585156c8-71c1-ada7-fa32-ec99a518c7a0" xlink:to="loc_dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_B83798EC661EF2A478741BEB0D3D36CE_8f444738-1ece-126c-4b52-c299a26134b3" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenueRecognizedFromChangesInContractLiabilityBalancesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedQuarterlyFinancialInformationUnaudited" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedSummaryDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>18
<FILENAME>dxcm-20191231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails" xlink:href="dxcm-20191231.xsd#AntiDilutiveSecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsAccountsReceivableDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsAccruedWarrantyDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsInventoryDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsOtherLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsPropertyAndEquipmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsTables" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformation" xlink:href="dxcm-20191231.xsd#BusinessSegmentAndGeographicInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationNarrativeDetails" xlink:href="dxcm-20191231.xsd#BusinessSegmentAndGeographicInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails" xlink:href="dxcm-20191231.xsd#BusinessSegmentAndGeographicInformationSummaryDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationTables" xlink:href="dxcm-20191231.xsd#BusinessSegmentAndGeographicInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheets" xlink:href="dxcm-20191231.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="dxcm-20191231.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="dxcm-20191231.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" xlink:href="dxcm-20191231.xsd#ConsolidatedStatementsOfComprehensiveIncomeLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfOperations" xlink:href="dxcm-20191231.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="dxcm-20191231.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/Contingencies" xlink:href="dxcm-20191231.xsd#Contingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ContingenciesNarrativeDetails" xlink:href="dxcm-20191231.xsd#ContingenciesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/CoverPage" xlink:href="dxcm-20191231.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails" xlink:href="dxcm-20191231.xsd#DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails" xlink:href="dxcm-20191231.xsd#DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails" xlink:href="dxcm-20191231.xsd#DebtConversionValueOfConvertibleNotesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtDebt" xlink:href="dxcm-20191231.xsd#DebtDebt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:href="dxcm-20191231.xsd#DebtNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:href="dxcm-20191231.xsd#DebtSeniorConvertibleNotesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtTables" xlink:href="dxcm-20191231.xsd#DebtTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentAndOtherAgreements" xlink:href="dxcm-20191231.xsd#DevelopmentAndOtherAgreements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails" xlink:href="dxcm-20191231.xsd#DevelopmentAndOtherAgreementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquity" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityIntrinsicValueOfOptionsExercisedAndFairValueOfOptionsVestedDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityIntrinsicValueOfOptionsExercisedAndFairValueOfOptionsVestedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityTables" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurements" xlink:href="dxcm-20191231.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails" xlink:href="dxcm-20191231.xsd#FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails" xlink:href="dxcm-20191231.xsd#FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="dxcm-20191231.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:href="dxcm-20191231.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxes" xlink:href="dxcm-20191231.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesComponentsOfProvisionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesTables" xlink:href="dxcm-20191231.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitments" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitmentsLeaseCostDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitmentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitmentsOtherInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitmentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPolicies" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenueRecognizedFromChangesInContractLiabilityBalancesDetails" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesRevenueRecognizedFromChangesInContractLiabilityBalancesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesTables" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedQuarterlyFinancialInformationUnaudited" xlink:href="dxcm-20191231.xsd#QuarterlyFinancialInformationUnauditedQuarterlyFinancialInformationUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedSummaryDetails" xlink:href="dxcm-20191231.xsd#QuarterlyFinancialInformationUnauditedSummaryDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:href="dxcm-20191231.xsd#QuarterlyFinancialInformationUnauditedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:href="dxcm-20191231.xsd#ScheduleIiValuationAndQualifyingAccounts" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:href="dxcm-20191231.xsd#ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_B30818D9B4542ECFA629C9C2EF89E829" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_005B2164B99B8CF003BBC9C2EF86626F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_B30818D9B4542ECFA629C9C2EF89E829" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_005B2164B99B8CF003BBC9C2EF86626F" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_7D87AA772FE9A1D6A504C9C2EF862D58" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_005B2164B99B8CF003BBC9C2EF86626F" xlink:to="loc_us-gaap_DebtInstrumentAxis_7D87AA772FE9A1D6A504C9C2EF862D58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_55D26F726E4F4584FF08C9C2EF8783A9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7D87AA772FE9A1D6A504C9C2EF862D58" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_55D26F726E4F4584FF08C9C2EF8783A9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_55D26F726E4F4584FF08C9C2EF8783A9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7D87AA772FE9A1D6A504C9C2EF862D58" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_55D26F726E4F4584FF08C9C2EF8783A9" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2022Member" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_5A3AB53C2C25EE887C73C9C2EF87C9AB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55D26F726E4F4584FF08C9C2EF8783A9" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_5A3AB53C2C25EE887C73C9C2EF87C9AB" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2023Member" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_DC255A80A4B866A11499C9C2EF876F29" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55D26F726E4F4584FF08C9C2EF8783A9" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_DC255A80A4B866A11499C9C2EF876F29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7E622335A788F86B4234C9C2EF8768A8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_005B2164B99B8CF003BBC9C2EF86626F" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7E622335A788F86B4234C9C2EF8768A8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7E622335A788F86B4234C9C2EF8768A8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7E622335A788F86B4234C9C2EF8768A8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_08C91092FBBF31CA749CC9C2EF88D591" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB" xlink:to="loc_us-gaap_EmployeeStockOptionMember_08C91092FBBF31CA749CC9C2EF88D591" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5BB861A526D68DAB44E6C9C2EF8875F1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5BB861A526D68DAB44E6C9C2EF8875F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_2E5EA1C5A9FBAD754303C9C2EF88A1BC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB" xlink:to="loc_us-gaap_WarrantMember_2E5EA1C5A9FBAD754303C9C2EF88A1BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_8680D115E46763A6DAADC9C2EF89A3DC" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_8680D115E46763A6DAADC9C2EF89A3DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D23E621F7B95E382AFF0C9C2EF89E4F0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_B30818D9B4542ECFA629C9C2EF89E829" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D23E621F7B95E382AFF0C9C2EF89E4F0" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_CD6D7EFFAD97174592691BE3D1CB5B10" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_CD6D7EFFAD97174592691BE3D1CB5B10" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_639D8BCAB4A2FD51B7721BE3D1CB076D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_CD6D7EFFAD97174592691BE3D1CB5B10" xlink:to="loc_srt_ProductOrServiceAxis_639D8BCAB4A2FD51B7721BE3D1CB076D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_7612223BF21D57E575E51BE3D1CCA9CE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_639D8BCAB4A2FD51B7721BE3D1CB076D" xlink:to="loc_srt_ProductsAndServicesDomain_7612223BF21D57E575E51BE3D1CCA9CE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_7612223BF21D57E575E51BE3D1CCA9CE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_639D8BCAB4A2FD51B7721BE3D1CB076D" xlink:to="loc_srt_ProductsAndServicesDomain_7612223BF21D57E575E51BE3D1CCA9CE" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ReceiverProductComponentMember" xlink:label="loc_dxcm_ReceiverProductComponentMember_079E9A6CEDAD5CC10F291BE3D1CC0BD6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7612223BF21D57E575E51BE3D1CCA9CE" xlink:to="loc_dxcm_ReceiverProductComponentMember_079E9A6CEDAD5CC10F291BE3D1CC0BD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5EA4321873B2A1491D941BE3D1CCA422" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_CD6D7EFFAD97174592691BE3D1CB5B10" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5EA4321873B2A1491D941BE3D1CCA422" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_BFAA252C766F5DB3E0091BE3D1CDCB79_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5EA4321873B2A1491D941BE3D1CCA422" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_BFAA252C766F5DB3E0091BE3D1CDCB79_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_BFAA252C766F5DB3E0091BE3D1CDCB79" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5EA4321873B2A1491D941BE3D1CCA422" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_BFAA252C766F5DB3E0091BE3D1CDCB79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaap_ConstructionInProgressMember_7E805005EAF44C7245461BE3D1CDEEAA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_BFAA252C766F5DB3E0091BE3D1CDCB79" xlink:to="loc_us-gaap_ConstructionInProgressMember_7E805005EAF44C7245461BE3D1CDEEAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_09110C80EF23A5BAC2E01BE3D1CD4025" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_09110C80EF23A5BAC2E01BE3D1CD4025" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaap_InventoryWriteDown_2853544E4F0BD4EA24D41BE3D1CDFE6B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:to="loc_us-gaap_InventoryWriteDown_2853544E4F0BD4EA24D41BE3D1CDFE6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_0E2A23FDDC41F52A92061BE3D1CE701D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:to="loc_us-gaap_Depreciation_0E2A23FDDC41F52A92061BE3D1CE701D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0FB3BBB7973B7876CE011BE3D1CE28AE" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0FB3BBB7973B7876CE011BE3D1CE28AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_477946D853193AFDE40A1BE3D1CECC2C" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:to="loc_us-gaap_RestructuringCharges_477946D853193AFDE40A1BE3D1CECC2C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2A3DDFFC5272A4256851B570A89B3F5C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80F5D7739CB3750F8F23B570A898252B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2A3DDFFC5272A4256851B570A89B3F5C" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80F5D7739CB3750F8F23B570A898252B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ABD90C89902816E4DDEB570A89979B7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80F5D7739CB3750F8F23B570A898252B" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ABD90C89902816E4DDEB570A89979B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ABD90C89902816E4DDEB570A89979B7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ABD90C89902816E4DDEB570A89979B7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaap_BuildingMember_4FE7BCBBDA272B7F2EBBB570A89AB20F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18" xlink:to="loc_us-gaap_BuildingMember_4FE7BCBBDA272B7F2EBBB570A89AB20F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_14DEF0AA6076CCAD91FDB570A89AD267" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_14DEF0AA6076CCAD91FDB570A89AD267" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_0B4FDBA25C952AE716FAB570A89A2BFE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18" xlink:to="loc_us-gaap_ComputerEquipmentMember_0B4FDBA25C952AE716FAB570A89A2BFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaap_EquipmentMember_FE91F84F6EB01E687C98B570A89ABFC0" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18" xlink:to="loc_us-gaap_EquipmentMember_FE91F84F6EB01E687C98B570A89ABFC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_49683A91B6B8C0FD746BB570A89AF8AB" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_49683A91B6B8C0FD746BB570A89AF8AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaap_ConstructionInProgressMember_F09484251379FACD2FECB570A89B7083" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18" xlink:to="loc_us-gaap_ConstructionInProgressMember_F09484251379FACD2FECB570A89B7083" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_43320E2489793F76C88CB570A89B65C0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2A3DDFFC5272A4256851B570A89B3F5C" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_43320E2489793F76C88CB570A89B65C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_978B7458C547390AA804B570A89BF129" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2A3DDFFC5272A4256851B570A89B3F5C" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_978B7458C547390AA804B570A89BF129" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_EAB7314667573E869D48B570A89B5DFA" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2A3DDFFC5272A4256851B570A89B3F5C" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_EAB7314667573E869D48B570A89B5DFA" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails" xlink:type="extended">
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FinancialStatementDetailsLineItems" xlink:label="loc_dxcm_FinancialStatementDetailsLineItems_08C164A0CFD73D207504B570A8BD977F" xlink:type="locator" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FinancialStatementDetailsTable" xlink:label="loc_dxcm_FinancialStatementDetailsTable_9DBF1CDCD8342BAA967EB570A8BB2B58" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dxcm_FinancialStatementDetailsLineItems_08C164A0CFD73D207504B570A8BD977F" xlink:to="loc_dxcm_FinancialStatementDetailsTable_9DBF1CDCD8342BAA967EB570A8BB2B58" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_EA545335FAB409F5760CB570A8BC1275" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_FinancialStatementDetailsTable_9DBF1CDCD8342BAA967EB570A8BB2B58" xlink:to="loc_us-gaap_FinancialInstrumentAxis_EA545335FAB409F5760CB570A8BC1275" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_EA545335FAB409F5760CB570A8BC1275" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_EA545335FAB409F5760CB570A8BC1275" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_7C5012D11ACDEBD478DEB570A8BD5E60" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_7C5012D11ACDEBD478DEB570A8BD5E60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_C5328C3D3DC7BB2EA13EB570A8BDF012" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95" xlink:to="loc_us-gaap_CommercialPaperMember_C5328C3D3DC7BB2EA13EB570A8BDF012" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_6217DDE072E108F0369FB570A8BD0086" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_6217DDE072E108F0369FB570A8BD0086" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesGainLossAbstract" xlink:label="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_FinancialStatementDetailsLineItems_08C164A0CFD73D207504B570A8BD977F" xlink:to="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiCost" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_C632017D5B173F30A95AB570A8BE8792" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCost_C632017D5B173F30A95AB570A8BE8792" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_A196B24506B24A1B6E09B570A8BE3C99" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_A196B24506B24A1B6E09B570A8BE3C99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_87AF23B4C64EC6C98D3AB570A8BE7813" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_87AF23B4C64EC6C98D3AB570A8BE7813" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_70943FF07B54D96CA93BB570A8BE47A9" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_70943FF07B54D96CA93BB570A8BE47A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C24C728248B918CE0B21B570A8BF0656" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C24C728248B918CE0B21B570A8BF0656" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_C4951D1D35301A792AEBB570A8BF701A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_C4951D1D35301A792AEBB570A8BF701A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4D7C293616389F98F2C4B570A8BF1236" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4D7C293616389F98F2C4B570A8BF1236" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71088CD8A373991D0456B570A8BF95F0" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71088CD8A373991D0456B570A8BF95F0" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost_9AB57DDE39EFD5C0C3F9B570A8BFD27A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost_9AB57DDE39EFD5C0C3F9B570A8BFD27A" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain_E1F1A2FC254FBEA23C5FB570A8C02FB8" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain_E1F1A2FC254FBEA23C5FB570A8C02FB8" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss_17056E04469A85E5B90CB570A8C0FD3C" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss_17056E04469A85E5B90CB570A8C0FD3C" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_BCFDA11010A216900A54B570A8C062C0" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_BCFDA11010A216900A54B570A8C062C0" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationNarrativeDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_A1EB4F8C37EBCDB4EBBCAF6BBD1F6AD1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_D85E8FB9E30F975D2DA8AF6BBCE03E7E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_A1EB4F8C37EBCDB4EBBCAF6BBD1F6AD1" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_D85E8FB9E30F975D2DA8AF6BBCE03E7E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_6D1F7EBE104500D7F2CAAF6BBD1EF11E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_D85E8FB9E30F975D2DA8AF6BBCE03E7E" xlink:to="loc_srt_StatementGeographicalAxis_6D1F7EBE104500D7F2CAAF6BBD1EF11E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_3CF90B117D49FFBDC029AF6BBD1E21F4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_6D1F7EBE104500D7F2CAAF6BBD1EF11E" xlink:to="loc_srt_SegmentGeographicalDomain_3CF90B117D49FFBDC029AF6BBD1E21F4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_3CF90B117D49FFBDC029AF6BBD1E21F4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_6D1F7EBE104500D7F2CAAF6BBD1EF11E" xlink:to="loc_srt_SegmentGeographicalDomain_3CF90B117D49FFBDC029AF6BBD1E21F4" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_6458819F84A7B537E7A6AF6BBD1FC4D1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3CF90B117D49FFBDC029AF6BBD1E21F4" xlink:to="loc_country_US_6458819F84A7B537E7A6AF6BBD1FC4D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_BB0FBE89C88EE1114C8AAF6BBD1FB413" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3CF90B117D49FFBDC029AF6BBD1E21F4" xlink:to="loc_us-gaap_NonUsMember_BB0FBE89C88EE1114C8AAF6BBD1FB413" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ADA6DCB2052F4A2E3F93AF6BBD1DBBD2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_D85E8FB9E30F975D2DA8AF6BBCE03E7E" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ADA6DCB2052F4A2E3F93AF6BBD1DBBD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_5983E860EF8EC07DD35AAF6BBD1D48F3_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ADA6DCB2052F4A2E3F93AF6BBD1DBBD2" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_5983E860EF8EC07DD35AAF6BBD1D48F3_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_5983E860EF8EC07DD35AAF6BBD1D48F3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ADA6DCB2052F4A2E3F93AF6BBD1DBBD2" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_5983E860EF8EC07DD35AAF6BBD1D48F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_C9F490230DD730C49089AF6BBD1ED59A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_5983E860EF8EC07DD35AAF6BBD1D48F3" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_C9F490230DD730C49089AF6BBD1ED59A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_DFBCAEFFD29DC42E97C1AF6BBD1EA54D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_5983E860EF8EC07DD35AAF6BBD1D48F3" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_DFBCAEFFD29DC42E97C1AF6BBD1EA54D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_CDB47FED595D4405AD9FAF6BBD1FFFDF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_A1EB4F8C37EBCDB4EBBCAF6BBD1F6AD1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_CDB47FED595D4405AD9FAF6BBD1FFFDF" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_RevenuePercentage" xlink:label="loc_dxcm_RevenuePercentage_EE38F9287384D3CA0493AF6BBD2054C2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_A1EB4F8C37EBCDB4EBBCAF6BBD1F6AD1" xlink:to="loc_dxcm_RevenuePercentage_EE38F9287384D3CA0493AF6BBD2054C2" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsOfOperations" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_25B4D4DF679D69FDB8BD4027E6F9757D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_25B4D4DF679D69FDB8BD4027E6F9757D" xlink:to="loc_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6275C32C3A421CB786354027E6F5CD08" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6275C32C3A421CB786354027E6F5CD08" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_7B22C85A5F3CC81F3CAA4027E6F6C284_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6275C32C3A421CB786354027E6F5CD08" xlink:to="loc_us-gaap_EquityComponentDomain_7B22C85A5F3CC81F3CAA4027E6F6C284_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_7B22C85A5F3CC81F3CAA4027E6F6C284" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6275C32C3A421CB786354027E6F5CD08" xlink:to="loc_us-gaap_EquityComponentDomain_7B22C85A5F3CC81F3CAA4027E6F6C284" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_97408951439495686BD94027E6F654D4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7B22C85A5F3CC81F3CAA4027E6F6C284" xlink:to="loc_us-gaap_CommonStockMember_97408951439495686BD94027E6F654D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_A871A1C64A84B5DF437A4027E6F66F16" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7B22C85A5F3CC81F3CAA4027E6F6C284" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_A871A1C64A84B5DF437A4027E6F66F16" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_48A054AB5D5FCF031C8B4027E6F7670C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7B22C85A5F3CC81F3CAA4027E6F6C284" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_48A054AB5D5FCF031C8B4027E6F7670C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_3CFD45D2DD0904C383944027E6F72FAA" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7B22C85A5F3CC81F3CAA4027E6F6C284" xlink:to="loc_us-gaap_RetainedEarningsMember_3CFD45D2DD0904C383944027E6F72FAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_35B6A396CDCB7F8823924027E6F7AD9B" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7B22C85A5F3CC81F3CAA4027E6F6C284" xlink:to="loc_us-gaap_TreasuryStockMember_35B6A396CDCB7F8823924027E6F7AD9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_270DCAC96D2850E1B9264027E6F72878" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045" xlink:to="loc_us-gaap_DebtInstrumentAxis_270DCAC96D2850E1B9264027E6F72878" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9E5AF0328479CFF876BE4027E6F7E982_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_270DCAC96D2850E1B9264027E6F72878" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9E5AF0328479CFF876BE4027E6F7E982_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9E5AF0328479CFF876BE4027E6F7E982" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_270DCAC96D2850E1B9264027E6F72878" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9E5AF0328479CFF876BE4027E6F7E982" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2022Member" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_DC35EBAE66C30E457CDF4027E6F77228" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9E5AF0328479CFF876BE4027E6F7E982" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_DC35EBAE66C30E457CDF4027E6F77228" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2023Member" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_FD1D34ADE0FE380D39734027E6F8921E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9E5AF0328479CFF876BE4027E6F7E982" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_FD1D34ADE0FE380D39734027E6F8921E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_91C4085C161BEC3A76BE4027E6F8B752" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_91C4085C161BEC3A76BE4027E6F8B752" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_52A3A5AF269B774E4C3A4027E6F81365_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_91C4085C161BEC3A76BE4027E6F8B752" xlink:to="loc_us-gaap_TypeOfAdoptionMember_52A3A5AF269B774E4C3A4027E6F81365_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_52A3A5AF269B774E4C3A4027E6F81365" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_91C4085C161BEC3A76BE4027E6F8B752" xlink:to="loc_us-gaap_TypeOfAdoptionMember_52A3A5AF269B774E4C3A4027E6F81365" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201609Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201609Member_61CBD64614E303C330104027E6F8040E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_52A3A5AF269B774E4C3A4027E6F81365" xlink:to="loc_us-gaap_AccountingStandardsUpdate201609Member_61CBD64614E303C330104027E6F8040E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_96A4A0DA32226EC20E464027E6F9631E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_52A3A5AF269B774E4C3A4027E6F81365" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_96A4A0DA32226EC20E464027E6F9631E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_25B4D4DF679D69FDB8BD4027E6F9757D" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_1D7370063C2F24816D774027E6F997AD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_SharesOutstanding_1D7370063C2F24816D774027E6F997AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_BD2671A39C31AFFE48654027E6FA96D0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_BD2671A39C31AFFE48654027E6FA96D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_0B18B17513934FDFDB424027E6FAC6A7" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_0B18B17513934FDFDB424027E6FAC6A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_3296600714533B52DAF54027E6FA29A0" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_3296600714533B52DAF54027E6FA29A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6CBE9B22F3B1051CA5664027E6FA2096" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6CBE9B22F3B1051CA5664027E6FA2096" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_AC3E5207B8597C788B3F4027E6FAD576" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_AC3E5207B8597C788B3F4027E6FAD576" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9E9E5E94D7A47E944FD44027E6FAB72A" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9E9E5E94D7A47E944FD44027E6FAB72A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_9BBC6D81A8A46F092B914027E6FBB459" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_9BBC6D81A8A46F092B914027E6FBB459" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification" xlink:label="loc_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_0C2DDC0703E46C72AB3F4027E6FBDC53" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_0C2DDC0703E46C72AB3F4027E6FBDC53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_07BD85A469E9E349A5974027E6FB2EC9" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_07BD85A469E9E349A5974027E6FB2EC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_A5A90FFD2454B217ECF54027E6FBDA34" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_A5A90FFD2454B217ECF54027E6FBDA34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_8F9D8BA4C2C52BC205064027E6FBB83A" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_8F9D8BA4C2C52BC205064027E6FBB83A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_A8169FA8006D71A57FCB4027E6FCBED1" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_A8169FA8006D71A57FCB4027E6FCBED1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_433083D1CCE54B03D55F4027E6FCF7EF" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_433083D1CCE54B03D55F4027E6FCF7EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_363927C449E85DBAD77F4027E6FC2150" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_363927C449E85DBAD77F4027E6FC2150" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_D22ECF6FAE2FF8EFE5874027E6FC5548" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_NetIncomeLoss_D22ECF6FAE2FF8EFE5874027E6FC5548" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_48CF9200E172C7B2D23A4027E6FC394E" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_48CF9200E172C7B2D23A4027E6FC394E" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/Contingencies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_585F35AE0A1B98D1D740B03100D666F8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:to="loc_us-gaap_LossContingenciesTable_585F35AE0A1B98D1D740B03100D666F8" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_NameOfPlaintiffAxis" xlink:label="loc_dxcm_NameOfPlaintiffAxis_F238C8E5FDF4BCD492A2B03100D70EE4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_585F35AE0A1B98D1D740B03100D666F8" xlink:to="loc_dxcm_NameOfPlaintiffAxis_F238C8E5FDF4BCD492A2B03100D70EE4" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_NameOfPlaintiffDomain" xlink:label="loc_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dxcm_NameOfPlaintiffAxis_F238C8E5FDF4BCD492A2B03100D70EE4" xlink:to="loc_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E_default" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_NameOfPlaintiffDomain" xlink:label="loc_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dxcm_NameOfPlaintiffAxis_F238C8E5FDF4BCD492A2B03100D70EE4" xlink:to="loc_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_AgaMatrixMember" xlink:label="loc_dxcm_AgaMatrixMember_39B6CA486876913CE685B03100D7360F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E" xlink:to="loc_dxcm_AgaMatrixMember_39B6CA486876913CE685B03100D7360F" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_WaveFormTechnologiesInc.Member" xlink:label="loc_dxcm_WaveFormTechnologiesInc.Member_266DF00C0537C2F04E29B03100D8AA80" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E" xlink:to="loc_dxcm_WaveFormTechnologiesInc.Member_266DF00C0537C2F04E29B03100D8AA80" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_NameOfDefendantAxis" xlink:label="loc_dxcm_NameOfDefendantAxis_B612392BE3BF18347643B03100D6EF42" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_585F35AE0A1B98D1D740B03100D666F8" xlink:to="loc_dxcm_NameOfDefendantAxis_B612392BE3BF18347643B03100D6EF42" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_NameOfDefendantDomain" xlink:label="loc_dxcm_NameOfDefendantDomain_5638943F1D7B137EC49BB03100D735C4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dxcm_NameOfDefendantAxis_B612392BE3BF18347643B03100D6EF42" xlink:to="loc_dxcm_NameOfDefendantDomain_5638943F1D7B137EC49BB03100D735C4_default" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_NameOfDefendantDomain" xlink:label="loc_dxcm_NameOfDefendantDomain_5638943F1D7B137EC49BB03100D735C4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dxcm_NameOfDefendantAxis_B612392BE3BF18347643B03100D6EF42" xlink:to="loc_dxcm_NameOfDefendantDomain_5638943F1D7B137EC49BB03100D735C4" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_AgaMatrixMember" xlink:label="loc_dxcm_AgaMatrixMember_C21AE651D1D68C5DC6CBB03100D7A919" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_NameOfDefendantDomain_5638943F1D7B137EC49BB03100D735C4" xlink:to="loc_dxcm_AgaMatrixMember_C21AE651D1D68C5DC6CBB03100D7A919" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_020B09A424BC077AE3E1B03100D88A2B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_020B09A424BC077AE3E1B03100D88A2B" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber" xlink:label="loc_dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber_4BB33ECF0522C33AFCD1B07376463FE2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:to="loc_dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber_4BB33ECF0522C33AFCD1B07376463FE2" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff" xlink:label="loc_dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff_C2B227B4B4CAD64D237AB03100D84EC9" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:to="loc_dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff_C2B227B4B4CAD64D237AB03100D84EC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:label="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_E0D0B648D461890D81F9B03100D9A2B5" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:to="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_E0D0B648D461890D81F9B03100D9A2B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_1FF104E55986E5199F9EB03100D959BC" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:to="loc_us-gaap_LitigationReserve_1FF104E55986E5199F9EB03100D959BC" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/CoverPage" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_25F97EDE437404E4DF8ACA0FCB3EF040" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_25F97EDE437404E4DF8ACA0FCB3EF040" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5F2AAE999CE518815D5DCA0FCBBC7D81" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_25F97EDE437404E4DF8ACA0FCB3EF040" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5F2AAE999CE518815D5DCA0FCBBC7D81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4E8DA7DB15CAB8126CA4CA0FCBBEFAE0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5F2AAE999CE518815D5DCA0FCBBC7D81" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4E8DA7DB15CAB8126CA4CA0FCBBEFAE0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4E8DA7DB15CAB8126CA4CA0FCBBEFAE0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5F2AAE999CE518815D5DCA0FCBBC7D81" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4E8DA7DB15CAB8126CA4CA0FCBBEFAE0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_D7E1E8EEDA4C000B64E2CA0FCBF835E2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4E8DA7DB15CAB8126CA4CA0FCBBEFAE0" xlink:to="loc_us-gaap_LineOfCreditMember_D7E1E8EEDA4C000B64E2CA0FCBF835E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_F5DC2DF57EF79EB35C95CA0FCB46AB41" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_25F97EDE437404E4DF8ACA0FCB3EF040" xlink:to="loc_us-gaap_CreditFacilityAxis_F5DC2DF57EF79EB35C95CA0FCB46AB41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_D54C3538B21C29C6F1DECA0FCB46236E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_F5DC2DF57EF79EB35C95CA0FCB46AB41" xlink:to="loc_us-gaap_CreditFacilityDomain_D54C3538B21C29C6F1DECA0FCB46236E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_D54C3538B21C29C6F1DECA0FCB46236E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_F5DC2DF57EF79EB35C95CA0FCB46AB41" xlink:to="loc_us-gaap_CreditFacilityDomain_D54C3538B21C29C6F1DECA0FCB46236E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaap_LetterOfCreditMember_09C7264CDA641238012FCA0FCC17131E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_D54C3538B21C29C6F1DECA0FCB46236E" xlink:to="loc_us-gaap_LetterOfCreditMember_09C7264CDA641238012FCA0FCC17131E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_C765A822D5CC7EAC0D4FCA104F0606D1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_C765A822D5CC7EAC0D4FCA104F0606D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_CB1737CC352D442DCC20CA104EE84087" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE" xlink:to="loc_us-gaap_LineOfCredit_CB1737CC352D442DCC20CA104EE84087" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_759334C5E32CF2E8C59BCA12B5E902ED" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_759334C5E32CF2E8C59BCA12B5E902ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_099CADD79EEF7AC9865FCA104F1C6F52" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_099CADD79EEF7AC9865FCA104F1C6F52" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4A0151A7C18DEC8FDD08C9C4B94A5F01" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_58DBAB19B37E70E6F78AC9C4B949A692" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4A0151A7C18DEC8FDD08C9C4B94A5F01" xlink:to="loc_us-gaap_DebtInstrumentTable_58DBAB19B37E70E6F78AC9C4B949A692" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_E043385B74C36BA44866C9C4B9497FFE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_58DBAB19B37E70E6F78AC9C4B949A692" xlink:to="loc_us-gaap_DebtInstrumentAxis_E043385B74C36BA44866C9C4B9497FFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_D206B6EDC6CC69BCF703C9C4B94953DB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_E043385B74C36BA44866C9C4B9497FFE" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_D206B6EDC6CC69BCF703C9C4B94953DB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_D206B6EDC6CC69BCF703C9C4B94953DB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_E043385B74C36BA44866C9C4B9497FFE" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_D206B6EDC6CC69BCF703C9C4B94953DB" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2022Member" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_41FC0BFD3E6B01B78230C9C4B94ADAB1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D206B6EDC6CC69BCF703C9C4B94953DB" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_41FC0BFD3E6B01B78230C9C4B94ADAB1" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2023Member" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_5B36DD728DE9C151E3A3C9C4B94ABFB2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D206B6EDC6CC69BCF703C9C4B94953DB" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_5B36DD728DE9C151E3A3C9C4B94ABFB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_99C0DCA227AED8AEC9E7C9C4B94ACFC1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4A0151A7C18DEC8FDD08C9C4B94A5F01" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_99C0DCA227AED8AEC9E7C9C4B94ACFC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_A62EF4B4845C609CAA44C9C4B94B87CE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4A0151A7C18DEC8FDD08C9C4B94A5F01" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_A62EF4B4845C609CAA44C9C4B94B87CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_40A4979A772C35BE080DC9C4B94BF759" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4A0151A7C18DEC8FDD08C9C4B94A5F01" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_40A4979A772C35BE080DC9C4B94BF759" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt_8E017CB7C760638B5B0DC9C4B94B8EE3" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4A0151A7C18DEC8FDD08C9C4B94A5F01" xlink:to="loc_us-gaap_InterestExpenseDebt_8E017CB7C760638B5B0DC9C4B94B8EE3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2189208E55CE5C59E7C7C9C4B94BD86A" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4A0151A7C18DEC8FDD08C9C4B94A5F01" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2189208E55CE5C59E7C7C9C4B94BD86A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_30F3E32708FFFA8CC0F0CA18FCED7BFC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_049559033D40DAC972D9CA18FCE0422E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30F3E32708FFFA8CC0F0CA18FCED7BFC" xlink:to="loc_us-gaap_DebtInstrumentTable_049559033D40DAC972D9CA18FCE0422E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_75CAC48CE981911C910FCA18FCE1CEDD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_049559033D40DAC972D9CA18FCE0422E" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_75CAC48CE981911C910FCA18FCE1CEDD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_148274CCDC3C3F9A690FCA18FCE2458A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_75CAC48CE981911C910FCA18FCE1CEDD" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_148274CCDC3C3F9A690FCA18FCE2458A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_148274CCDC3C3F9A690FCA18FCE2458A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_75CAC48CE981911C910FCA18FCE1CEDD" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_148274CCDC3C3F9A690FCA18FCE2458A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_C1A9FADF17135CF81423CA18FD34F909" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_148274CCDC3C3F9A690FCA18FCE2458A" xlink:to="loc_us-gaap_SeniorNotesMember_C1A9FADF17135CF81423CA18FD34F909" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_5CC9AC9847555FD4478DCA18FCE26387" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_049559033D40DAC972D9CA18FCE0422E" xlink:to="loc_us-gaap_DebtInstrumentAxis_5CC9AC9847555FD4478DCA18FCE26387" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_804B8021885E38F3477ECA18FCE3CD0E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5CC9AC9847555FD4478DCA18FCE26387" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_804B8021885E38F3477ECA18FCE3CD0E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_804B8021885E38F3477ECA18FCE3CD0E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5CC9AC9847555FD4478DCA18FCE26387" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_804B8021885E38F3477ECA18FCE3CD0E" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2022Member" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_8E8D91B73A9B52E38A77CA18FD50FB6E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_804B8021885E38F3477ECA18FCE3CD0E" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_8E8D91B73A9B52E38A77CA18FD50FB6E" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2023Member" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_0E4DC1C67547AB426CD1CA18FD6E5DF4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_804B8021885E38F3477ECA18FCE3CD0E" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_0E4DC1C67547AB426CD1CA18FD6E5DF4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_BE4F32128F1FDFC79046CA18FD12EF2F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30F3E32708FFFA8CC0F0CA18FCED7BFC" xlink:to="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_BE4F32128F1FDFC79046CA18FD12EF2F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtDebt" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_8EE58DA0814DBBC24DBD1C846AB44178" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:to="loc_us-gaap_VariableRateAxis_8EE58DA0814DBBC24DBD1C846AB44178" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_CD5B14922052DC94B7421C846AB4CDBA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_8EE58DA0814DBBC24DBD1C846AB44178" xlink:to="loc_us-gaap_VariableRateDomain_CD5B14922052DC94B7421C846AB4CDBA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_CD5B14922052DC94B7421C846AB4CDBA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_8EE58DA0814DBBC24DBD1C846AB44178" xlink:to="loc_us-gaap_VariableRateDomain_CD5B14922052DC94B7421C846AB4CDBA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_80A7D399A020A3F0E0C01C846AB5683B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_CD5B14922052DC94B7421C846AB4CDBA" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_80A7D399A020A3F0E0C01C846AB5683B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_86D11126343B72120C6A1C846AB555D7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:to="loc_us-gaap_HedgingDesignationAxis_86D11126343B72120C6A1C846AB555D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_825E5603766E4DAF12851C846AB55A62_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_86D11126343B72120C6A1C846AB555D7" xlink:to="loc_us-gaap_HedgingDesignationDomain_825E5603766E4DAF12851C846AB55A62_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_825E5603766E4DAF12851C846AB55A62" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_86D11126343B72120C6A1C846AB555D7" xlink:to="loc_us-gaap_HedgingDesignationDomain_825E5603766E4DAF12851C846AB55A62" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_C9F22CB19038504CDE9A1C846AB69EB2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_825E5603766E4DAF12851C846AB55A62" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_C9F22CB19038504CDE9A1C846AB69EB2" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConversionTermAxis" xlink:label="loc_dxcm_DebtInstrumentConversionTermAxis_19C3F981D6052B8C2CE61C846AB6439A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:to="loc_dxcm_DebtInstrumentConversionTermAxis_19C3F981D6052B8C2CE61C846AB6439A" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConversionTermDomain" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis_19C3F981D6052B8C2CE61C846AB6439A" xlink:to="loc_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2_default" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConversionTermDomain" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis_19C3F981D6052B8C2CE61C846AB6439A" xlink:to="loc_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConversionTermOneMember" xlink:label="loc_dxcm_DebtInstrumentConversionTermOneMember_47490DCEAB519CAC081C1C846AB736F7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2" xlink:to="loc_dxcm_DebtInstrumentConversionTermOneMember_47490DCEAB519CAC081C1C846AB736F7" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConversionTermTwoMember" xlink:label="loc_dxcm_DebtInstrumentConversionTermTwoMember_52B863DD06BB510021261C846AB70C70" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2" xlink:to="loc_dxcm_DebtInstrumentConversionTermTwoMember_52B863DD06BB510021261C846AB70C70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_E1E72A7A8DFC5F9696421C846AB75FBF" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_E1E72A7A8DFC5F9696421C846AB75FBF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_39E778D0853A6845D8F41C846AB766F6_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_E1E72A7A8DFC5F9696421C846AB75FBF" xlink:to="loc_us-gaap_EquityComponentDomain_39E778D0853A6845D8F41C846AB766F6_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_39E778D0853A6845D8F41C846AB766F6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_E1E72A7A8DFC5F9696421C846AB75FBF" xlink:to="loc_us-gaap_EquityComponentDomain_39E778D0853A6845D8F41C846AB766F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_F1DA5CD67C1ACF4404561C846AB8A96F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_39E778D0853A6845D8F41C846AB766F6" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_F1DA5CD67C1ACF4404561C846AB8A96F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_325D748EDC60E51B963F1C846AB8A356" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_325D748EDC60E51B963F1C846AB8A356" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_72B41719839C4C4427B81C846AB94270_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_325D748EDC60E51B963F1C846AB8A356" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_72B41719839C4C4427B81C846AB94270_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_72B41719839C4C4427B81C846AB94270" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_325D748EDC60E51B963F1C846AB8A356" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_72B41719839C4C4427B81C846AB94270" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_9BE61590D7ED4576B9511C846AB9DDD6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_72B41719839C4C4427B81C846AB94270" xlink:to="loc_us-gaap_SeniorNotesMember_9BE61590D7ED4576B9511C846AB9DDD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_67EF8E589D0FEEADD85E1C846AB90B68" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_72B41719839C4C4427B81C846AB94270" xlink:to="loc_us-gaap_LineOfCreditMember_67EF8E589D0FEEADD85E1C846AB90B68" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_DBB763DEAE32719AE1E01C846AB94321" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:to="loc_us-gaap_DebtInstrumentAxis_DBB763DEAE32719AE1E01C846AB94321" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_CE9EBF274E61C43250DC1C846AB9DC4F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_DBB763DEAE32719AE1E01C846AB94321" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_CE9EBF274E61C43250DC1C846AB9DC4F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_CE9EBF274E61C43250DC1C846AB9DC4F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_DBB763DEAE32719AE1E01C846AB94321" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_CE9EBF274E61C43250DC1C846AB9DC4F" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2023Member" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_47D73FCE556C6050DBAA1C846ABA0488" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_CE9EBF274E61C43250DC1C846AB9DC4F" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_47D73FCE556C6050DBAA1C846ABA0488" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2022Member" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_D3BC324B1E4F353808591C846ABA58F9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_CE9EBF274E61C43250DC1C846AB9DC4F" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_D3BC324B1E4F353808591C846ABA58F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_149E737D604163D78CE31C846ABAF01E" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:to="loc_srt_RangeAxis_149E737D604163D78CE31C846ABAF01E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1D86964BFB4345646B771C846ABBB4BB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_149E737D604163D78CE31C846ABAF01E" xlink:to="loc_srt_RangeMember_1D86964BFB4345646B771C846ABBB4BB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1D86964BFB4345646B771C846ABBB4BB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_149E737D604163D78CE31C846ABAF01E" xlink:to="loc_srt_RangeMember_1D86964BFB4345646B771C846ABBB4BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_3D45F9E4E1E8CC1D3DB81C846ABB9FEB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1D86964BFB4345646B771C846ABBB4BB" xlink:to="loc_srt_MinimumMember_3D45F9E4E1E8CC1D3DB81C846ABB9FEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_F4D6E467D794DB1749111C846ABB1596" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1D86964BFB4345646B771C846ABBB4BB" xlink:to="loc_srt_MaximumMember_F4D6E467D794DB1749111C846ABB1596" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_622363E44E13899990581C846ABCBAE0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_622363E44E13899990581C846ABCBAE0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_22248925CE4A7BF67C761C846ABC535A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_22248925CE4A7BF67C761C846ABC535A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_A5DEC92C4DF65F0B23BD1C846ABCF87B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_A5DEC92C4DF65F0B23BD1C846ABCF87B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_4DDEF20BDDACF72614511C846ABC9C5E" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_4DDEF20BDDACF72614511C846ABC9C5E" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount" xlink:label="loc_dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount_9AED01AC933EAE464C031C846ABDAA8D" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount_9AED01AC933EAE464C031C846ABDAA8D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_39AABFF771DD5BD6362C1C846ABDACB1" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_39AABFF771DD5BD6362C1C846ABDACB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity" xlink:label="loc_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_55FA3CCA52322EFD959B1C846ABDB2F6" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_55FA3CCA52322EFD959B1C846ABDB2F6" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:label="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_89F8B844A826336B5E191C846ABD0CE5" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_89F8B844A826336B5E191C846ABD0CE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_3C6AF025884690A6B3C11C846AC1057D" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_3C6AF025884690A6B3C11C846AC1057D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6225B6F2C841FEC1DF4A1C846AC1D61E" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6225B6F2C841FEC1DF4A1C846AC1D61E" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:label="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_4CCEA09A678E2EF3F0E61C846AC2766B" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_4CCEA09A678E2EF3F0E61C846AC2766B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_5F88818FC02470C4B80A1C846AC29157" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_5F88818FC02470C4B80A1C846AC29157" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:label="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_3A68B2DBA17A28687D541C846AC2EB44" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_3A68B2DBA17A28687D541C846AC2EB44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_0C0CF4473609C6D3FBEE1C846AC2440B" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_0C0CF4473609C6D3FBEE1C846AC2440B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_86AB8F04F76047D604281C846AC2CADA" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_86AB8F04F76047D604281C846AC2CADA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_AC6F08D8A39E846D15CC1C846AC2EFAA" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_AC6F08D8A39E846D15CC1C846AC2EFAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7EA9285F61D71990C1801C846AC31164" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7EA9285F61D71990C1801C846AC31164" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_094F41CDC9291CDEA3E01C846AC391C1" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_094F41CDC9291CDEA3E01C846AC391C1" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:label="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_9F4C7FB2285F259892BC1C846AC38FE8" xlink:type="locator" />
    <link:definitionArc order="19" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_9F4C7FB2285F259892BC1C846AC38FE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_76EDE0665C8F4DC92E871C846AC385E5" xlink:type="locator" />
    <link:definitionArc order="20" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_76EDE0665C8F4DC92E871C846AC385E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_771894F7173F157E7C801C846AC4C793" xlink:type="locator" />
    <link:definitionArc order="21" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_771894F7173F157E7C801C846AC4C793" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold" xlink:label="loc_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_37EC05E720691C829D481C846AC4E0A6" xlink:type="locator" />
    <link:definitionArc order="22" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_37EC05E720691C829D481C846AC4E0A6" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_299219474231015CA15E1BE44A2C1B51" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_EAC18ADFC471BB81CD381BE44A2AC801" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299219474231015CA15E1BE44A2C1B51" xlink:to="loc_us-gaap_DebtInstrumentTable_EAC18ADFC471BB81CD381BE44A2AC801" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_785E022B0995D062B1AE1BE44A2A04CB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_EAC18ADFC471BB81CD381BE44A2AC801" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_785E022B0995D062B1AE1BE44A2A04CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_F5CDC584403135AF9CB61BE44A2B9AA0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_785E022B0995D062B1AE1BE44A2A04CB" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_F5CDC584403135AF9CB61BE44A2B9AA0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_F5CDC584403135AF9CB61BE44A2B9AA0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_785E022B0995D062B1AE1BE44A2A04CB" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_F5CDC584403135AF9CB61BE44A2B9AA0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_EC5AB864395697A1476D1BE44A2BBEE1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_F5CDC584403135AF9CB61BE44A2B9AA0" xlink:to="loc_us-gaap_SeniorNotesMember_EC5AB864395697A1476D1BE44A2BBEE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_DDE5C7DCF8F3B2A1072F1BE44A2BD5EA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_EAC18ADFC471BB81CD381BE44A2AC801" xlink:to="loc_us-gaap_DebtInstrumentAxis_DDE5C7DCF8F3B2A1072F1BE44A2BD5EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6D3021D1D52CA3DE6AA91BE44A2B74A5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_DDE5C7DCF8F3B2A1072F1BE44A2BD5EA" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6D3021D1D52CA3DE6AA91BE44A2B74A5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6D3021D1D52CA3DE6AA91BE44A2B74A5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_DDE5C7DCF8F3B2A1072F1BE44A2BD5EA" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6D3021D1D52CA3DE6AA91BE44A2B74A5" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2022Member" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_244A292332D8EBC8E1A11BE44A2CE3BF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6D3021D1D52CA3DE6AA91BE44A2B74A5" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_244A292332D8EBC8E1A11BE44A2CE3BF" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2023Member" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_DCD14CBF2EB1B340D7841BE44A2C2E37" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6D3021D1D52CA3DE6AA91BE44A2B74A5" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_DCD14CBF2EB1B340D7841BE44A2C2E37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299219474231015CA15E1BE44A2C1B51" xlink:to="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_07580C7439771E2019021BE44A2DD255" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_07580C7439771E2019021BE44A2DD255" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_EF1589EB6F419B4932581BE44A2D3B53" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_EF1589EB6F419B4932581BE44A2D3B53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_8C4359EE68F3233E7E841BE44A2DD053" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_8C4359EE68F3233E7E841BE44A2DD053" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_AA746C69B38DC2A3FBE91BE44A2D05DF" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_AA746C69B38DC2A3FBE91BE44A2D05DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3AD66EDB37AE2DADDBBC1BEAE8239E24" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299219474231015CA15E1BE44A2C1B51" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3AD66EDB37AE2DADDBBC1BEAE8239E24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_554F3704141B50A83E321BE44A2DE495" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299219474231015CA15E1BE44A2C1B51" xlink:to="loc_us-gaap_LongTermDebt_554F3704141B50A83E321BE44A2DE495" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_B620FF2FE5395DDBDB8C1BE44A2E42AF" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299219474231015CA15E1BE44A2C1B51" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_B620FF2FE5395DDBDB8C1BE44A2E42AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_3E76D34FBE0D172E2E6F1BE44A2ED490" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299219474231015CA15E1BE44A2C1B51" xlink:to="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_3E76D34FBE0D172E2E6F1BE44A2ED490" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DevelopmentAndOtherAgreements" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DevelopmentAgreementsLineItems" xlink:label="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:type="locator" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DevelopmentAgreementsTable" xlink:label="loc_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="loc_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_4E1CD75CA434773AC5A9360B0E5DC1B9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD" xlink:to="loc_us-gaap_TypeOfArrangementAxis_4E1CD75CA434773AC5A9360B0E5DC1B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6BF7ECAE09F85C67FA6C360B0E5E505E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_4E1CD75CA434773AC5A9360B0E5DC1B9" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6BF7ECAE09F85C67FA6C360B0E5E505E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6BF7ECAE09F85C67FA6C360B0E5E505E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_4E1CD75CA434773AC5A9360B0E5DC1B9" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6BF7ECAE09F85C67FA6C360B0E5E505E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CollaborativeArrangementMember" xlink:label="loc_us-gaap_CollaborativeArrangementMember_2D9CD5CBFE12F5980B70360B0E63E58F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6BF7ECAE09F85C67FA6C360B0E5E505E" xlink:to="loc_us-gaap_CollaborativeArrangementMember_2D9CD5CBFE12F5980B70360B0E63E58F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_D55E7B297A20B1D31F97360B0E6383F9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD" xlink:to="loc_srt_CounterpartyNameAxis_D55E7B297A20B1D31F97360B0E6383F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_A55EE51C2222A7425DAB360B0E64640A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_D55E7B297A20B1D31F97360B0E6383F9" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_A55EE51C2222A7425DAB360B0E64640A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_A55EE51C2222A7425DAB360B0E64640A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_D55E7B297A20B1D31F97360B0E6383F9" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_A55EE51C2222A7425DAB360B0E64640A" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_VerilyLifeSciencesMember" xlink:label="loc_dxcm_VerilyLifeSciencesMember_5F86425E568046E6D25E360B0E64E82A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_A55EE51C2222A7425DAB360B0E64640A" xlink:to="loc_dxcm_VerilyLifeSciencesMember_5F86425E568046E6D25E360B0E64E82A" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_6981A210A0F492F914DB360B0E6464FF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_6981A210A0F492F914DB360B0E6464FF" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_6981A210A0F492F914DB360B0E6464FF" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE_default" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_6981A210A0F492F914DB360B0E6464FF" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeArrangementInitialPaymentMember" xlink:label="loc_dxcm_CollaborativeArrangementInitialPaymentMember_6D808D45CC5A4CA7E19C360B0E65049D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE" xlink:to="loc_dxcm_CollaborativeArrangementInitialPaymentMember_6D808D45CC5A4CA7E19C360B0E65049D" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:label="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_0973B123033D8977D78E360B0E653D36" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE" xlink:to="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_0973B123033D8977D78E360B0E653D36" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeArrangementUpfrontFee" xlink:label="loc_dxcm_CollaborativeArrangementUpfrontFee_5834DAEEB81CDDA2DF64360B0E650A40" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="loc_dxcm_CollaborativeArrangementUpfrontFee_5834DAEEB81CDDA2DF64360B0E650A40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_FE9D5335AC9F47DA9AAE360B0E65B703" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_FE9D5335AC9F47DA9AAE360B0E65B703" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeResearchAndDevelopmentFee" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee_BA7EBA08872C1710968E360B0E663A09" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="loc_dxcm_CollaborativeResearchAndDevelopmentFee_BA7EBA08872C1710968E360B0E663A09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_BE5718F6E841B9262AE5360B0E66545A" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="loc_us-gaap_SharePrice_BE5718F6E841B9262AE5360B0E66545A" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments" xlink:label="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_28D5CC339740A50A781A360B0E665DA7" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_28D5CC339740A50A781A360B0E665DA7" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones" xlink:label="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_5385B3F35A92539A629E360B0E664954" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_5385B3F35A92539A629E360B0E664954" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:label="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_76721CA6B8EAA7C12B2E360B0E66F67F" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_76721CA6B8EAA7C12B2E360B0E66F67F" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated" xlink:label="loc_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_A49C797041CF6516C0A2360B0E67DA21" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="loc_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_A49C797041CF6516C0A2360B0E67DA21" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquity" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityIntrinsicValueOfOptionsExercisedAndFairValueOfOptionsVestedDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1CD9CC9E12952B735931BF6F0B080E3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1CD9CC9E12952B735931BF6F0B080E3" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_C34BE0459F65D937FBB31C0C5830D2D5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1CD9CC9E12952B735931BF6F0B080E3" xlink:to="loc_srt_RangeAxis_C34BE0459F65D937FBB31C0C5830D2D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_B55EE467C98F3537527F1C0C58318254_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_C34BE0459F65D937FBB31C0C5830D2D5" xlink:to="loc_srt_RangeMember_B55EE467C98F3537527F1C0C58318254_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_B55EE467C98F3537527F1C0C58318254" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_C34BE0459F65D937FBB31C0C5830D2D5" xlink:to="loc_srt_RangeMember_B55EE467C98F3537527F1C0C58318254" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_BB33D307F5386E7491191C0C5946BBF9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_B55EE467C98F3537527F1C0C58318254" xlink:to="loc_srt_MinimumMember_BB33D307F5386E7491191C0C5946BBF9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_75CD2E7EF9F79F358EE31C0C5C0EE3F6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_B55EE467C98F3537527F1C0C58318254" xlink:to="loc_srt_MaximumMember_75CD2E7EF9F79F358EE31C0C5C0EE3F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_520604E22EC8DFEF53CD1BF6F0DDCEED" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1CD9CC9E12952B735931BF6F0B080E3" xlink:to="loc_us-gaap_AwardTypeAxis_520604E22EC8DFEF53CD1BF6F0DDCEED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4481375EDF95116C65D11BF6F0DE76DD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_520604E22EC8DFEF53CD1BF6F0DDCEED" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4481375EDF95116C65D11BF6F0DE76DD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4481375EDF95116C65D11BF6F0DE76DD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_520604E22EC8DFEF53CD1BF6F0DDCEED" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4481375EDF95116C65D11BF6F0DE76DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_A8599E4749D00A359C9E1BEB0CE0F1E6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4481375EDF95116C65D11BF6F0DE76DD" xlink:to="loc_us-gaap_RestrictedStockMember_A8599E4749D00A359C9E1BEB0CE0F1E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_6C36070AEF9A8108E0441BF6F0F436B0" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1CD9CC9E12952B735931BF6F0B080E3" xlink:to="loc_us-gaap_PlanNameAxis_6C36070AEF9A8108E0441BF6F0F436B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_A0D33BC8E750ED64CA361BF89F51E030_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_6C36070AEF9A8108E0441BF6F0F436B0" xlink:to="loc_us-gaap_PlanNameDomain_A0D33BC8E750ED64CA361BF89F51E030_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_A0D33BC8E750ED64CA361BF89F51E030" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_6C36070AEF9A8108E0441BF6F0F436B0" xlink:to="loc_us-gaap_PlanNameDomain_A0D33BC8E750ED64CA361BF89F51E030" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_A401kPlanMember" xlink:label="loc_dxcm_A401kPlanMember_E7E048A9BE4B586E8DBC1BF86DCA35B8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_A0D33BC8E750ED64CA361BF89F51E030" xlink:to="loc_dxcm_A401kPlanMember_E7E048A9BE4B586E8DBC1BF86DCA35B8" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EmployeeStockPurchasePlan2015Member" xlink:label="loc_dxcm_EmployeeStockPurchasePlan2015Member_C1D03667F49283A4B6B11BF86DDC2602" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_A0D33BC8E750ED64CA361BF89F51E030" xlink:to="loc_dxcm_EmployeeStockPurchasePlan2015Member_C1D03667F49283A4B6B11BF86DDC2602" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_F82DD3F5D8E4A8D4F0431BEB0CE00DB4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_F82DD3F5D8E4A8D4F0431BEB0CE00DB4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_C7A69CD49E53E13018941BEB0CE00E78" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_C7A69CD49E53E13018941BEB0CE00E78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_69D25AB78201571E72941BEB0CE1FD40" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_69D25AB78201571E72941BEB0CE1FD40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_E11854326B6E98AE21A11BEB0CE12936" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_E11854326B6E98AE21A11BEB0CE12936" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" xlink:label="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_26E57CEA383206A6E9CD1BEB0CE14959" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_26E57CEA383206A6E9CD1BEB0CE14959" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_41890B1D03ECFAC578631BEB0CE1B4A8" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_41890B1D03ECFAC578631BEB0CE1B4A8" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EmployeePurchasePriceFloorPercentage" xlink:label="loc_dxcm_EmployeePurchasePriceFloorPercentage_09D7A4C2458B069146971BEB0CE16C3F" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_dxcm_EmployeePurchasePriceFloorPercentage_09D7A4C2458B069146971BEB0CE16C3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7EC721060A0365794D6A1BEB0CE17FF4" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7EC721060A0365794D6A1BEB0CE17FF4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3F779CEFAF34D67F994A1BEB0CE275F7" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3F779CEFAF34D67F994A1BEB0CE275F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_1593B4E84A6CB560AD461BEB0CE2BB7D" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_1593B4E84A6CB560AD461BEB0CE2BB7D" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_OptionsInMoneyNumber" xlink:label="loc_dxcm_OptionsInMoneyNumber_497AF7D68DB404B56B901BEB0CE24B05" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_dxcm_OptionsInMoneyNumber_497AF7D68DB404B56B901BEB0CE24B05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_67FD9A4B36B7FCDF7BF11BEB0CE25C6E" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_67FD9A4B36B7FCDF7BF11BEB0CE25C6E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_19B06510E7B3978D7BD71BEB0CE24B3F" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_19B06510E7B3978D7BD71BEB0CE24B3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_70ACD52AE0B3AF1EBD121BEB0CE2DF56" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_70ACD52AE0B3AF1EBD121BEB0CE2DF56" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_InMoneyOptionsMaximumExercisePrice" xlink:label="loc_dxcm_InMoneyOptionsMaximumExercisePrice_E543C81A60EB915A67B31BEB0CE31D5F" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_dxcm_InMoneyOptionsMaximumExercisePrice_E543C81A60EB915A67B31BEB0CE31D5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3BBD1B76677BD6361B891C0C56FAF839" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3BBD1B76677BD6361B891C0C56FAF839" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1BDA0FF6A6315D0F1F511BEB0CE37726" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1BDA0FF6A6315D0F1F511BEB0CE37726" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_B057C71CC130146ED0521BEB0CE3C67A" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_B057C71CC130146ED0521BEB0CE3C67A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5CBEC258C5DF65872AADC9C4B8A68B4A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8A024F1641F19DD7FEA4C9C4B8A5EBAC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5CBEC258C5DF65872AADC9C4B8A68B4A" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8A024F1641F19DD7FEA4C9C4B8A5EBAC" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_5C0C0B561A0900B8BF1FC9C4B8A5A126" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8A024F1641F19DD7FEA4C9C4B8A5EBAC" xlink:to="loc_us-gaap_AwardTypeAxis_5C0C0B561A0900B8BF1FC9C4B8A5A126" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F55C24251F9A72FFE9E2C9C4B8A69229_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5C0C0B561A0900B8BF1FC9C4B8A5A126" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F55C24251F9A72FFE9E2C9C4B8A69229_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F55C24251F9A72FFE9E2C9C4B8A69229" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5C0C0B561A0900B8BF1FC9C4B8A5A126" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F55C24251F9A72FFE9E2C9C4B8A69229" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_13B732DC150A1BAAA5DFC9C4B8A623BE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F55C24251F9A72FFE9E2C9C4B8A69229" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_13B732DC150A1BAAA5DFC9C4B8A623BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5CBEC258C5DF65872AADC9C4B8A68B4A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75BA8C4C8236C2A2D2DCC9C4B8A75BF1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75BA8C4C8236C2A2D2DCC9C4B8A75BF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1ADE0BCC747E079EF3ABC9C4B8A7309F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1ADE0BCC747E079EF3ABC9C4B8A7309F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0ED70B150F685E4F4C2AC9C4B8A8E87F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0ED70B150F685E4F4C2AC9C4B8A8E87F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_749F123157946CA30ABEC9C4B8A81BD8" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_749F123157946CA30ABEC9C4B8A81BD8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5CBEC258C5DF65872AADC9C4B8A68B4A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9F5F12D19CD4C10ACD7AC9C4B8A78CA2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9F5F12D19CD4C10ACD7AC9C4B8A78CA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7F0B2B4F3FBBC78129DAC9C4B8A747C6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7F0B2B4F3FBBC78129DAC9C4B8A747C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4FD38CAC8CE28B5DED4DC9C4B8A8B096" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4FD38CAC8CE28B5DED4DC9C4B8A8B096" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2E9041463BAC6C95B786C9C4B8A843BA" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2E9041463BAC6C95B786C9C4B8A843BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_B0BF3A67DDB70222A711C9C4B8A9DBDE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5CBEC258C5DF65872AADC9C4B8A68B4A" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_B0BF3A67DDB70222A711C9C4B8A9DBDE" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_63CE1C4A2BF887A2E93FC9C4B8B5218C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_657D13781837AAD1DBF1C9C4B8B40113" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_63CE1C4A2BF887A2E93FC9C4B8B5218C" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_657D13781837AAD1DBF1C9C4B8B40113" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_17708761665EBF49599DC9C4B8B42E45" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_657D13781837AAD1DBF1C9C4B8B40113" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_17708761665EBF49599DC9C4B8B42E45" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_E07455383545539E625CC9C4B8B52574_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_17708761665EBF49599DC9C4B8B42E45" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_E07455383545539E625CC9C4B8B52574_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_E07455383545539E625CC9C4B8B52574" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_17708761665EBF49599DC9C4B8B42E45" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_E07455383545539E625CC9C4B8B52574" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_D9FCE44634E5BD9134E1C9C4B8B553D5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_E07455383545539E625CC9C4B8B52574" xlink:to="loc_us-gaap_CostOfSalesMember_D9FCE44634E5BD9134E1C9C4B8B553D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_472B95F5720C552FD658C9C4B8B5120E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_E07455383545539E625CC9C4B8B52574" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_472B95F5720C552FD658C9C4B8B5120E" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_SellingGeneralAndAdministrativeMember" xlink:label="loc_dxcm_SellingGeneralAndAdministrativeMember_86C2CE019F0FF0EC2468C9C4B8B5CFEF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_E07455383545539E625CC9C4B8B52574" xlink:to="loc_dxcm_SellingGeneralAndAdministrativeMember_86C2CE019F0FF0EC2468C9C4B8B5CFEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5522FA9FD83E7F1D7985C9C4B8B604A4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_63CE1C4A2BF887A2E93FC9C4B8B5218C" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_5522FA9FD83E7F1D7985C9C4B8B604A4" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81A19860D6D0DDE97A6AC9C4B8AF3273" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3D4CB4548747EC2ADDBEC9C4B8AD534C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81A19860D6D0DDE97A6AC9C4B8AF3273" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3D4CB4548747EC2ADDBEC9C4B8AD534C" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_368CD606CB03881A0FAFC9C4B8AE186D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3D4CB4548747EC2ADDBEC9C4B8AD534C" xlink:to="loc_srt_RangeAxis_368CD606CB03881A0FAFC9C4B8AE186D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_05D6B82F8F09C551C4B2C9C4B8AE0E50_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_368CD606CB03881A0FAFC9C4B8AE186D" xlink:to="loc_srt_RangeMember_05D6B82F8F09C551C4B2C9C4B8AE0E50_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_05D6B82F8F09C551C4B2C9C4B8AE0E50" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_368CD606CB03881A0FAFC9C4B8AE186D" xlink:to="loc_srt_RangeMember_05D6B82F8F09C551C4B2C9C4B8AE0E50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_65DBA0EC3D40C67F531FC9C4B8AE1E79" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_05D6B82F8F09C551C4B2C9C4B8AE0E50" xlink:to="loc_srt_MinimumMember_65DBA0EC3D40C67F531FC9C4B8AE1E79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1BBFB4FCDA3F690442C1C9C4B8AE81A5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_05D6B82F8F09C551C4B2C9C4B8AE0E50" xlink:to="loc_srt_MaximumMember_1BBFB4FCDA3F690442C1C9C4B8AE81A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_3470260B98EDF57AD22EC9C4B8AF3F70" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3D4CB4548747EC2ADDBEC9C4B8AD534C" xlink:to="loc_us-gaap_PlanNameAxis_3470260B98EDF57AD22EC9C4B8AF3F70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_CD9710A5EA2860F0FB0AC9C4B8AFBB0B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_3470260B98EDF57AD22EC9C4B8AF3F70" xlink:to="loc_us-gaap_PlanNameDomain_CD9710A5EA2860F0FB0AC9C4B8AFBB0B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_CD9710A5EA2860F0FB0AC9C4B8AFBB0B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_3470260B98EDF57AD22EC9C4B8AF3F70" xlink:to="loc_us-gaap_PlanNameDomain_CD9710A5EA2860F0FB0AC9C4B8AFBB0B" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EmployeeStockPurchasePlanMember" xlink:label="loc_dxcm_EmployeeStockPurchasePlanMember_BB4DA387846D8135AD01C9C4B8AF23A9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_CD9710A5EA2860F0FB0AC9C4B8AFBB0B" xlink:to="loc_dxcm_EmployeeStockPurchasePlanMember_BB4DA387846D8135AD01C9C4B8AF23A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3FD20BD27BE310068BC1C9C4B8AF907E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81A19860D6D0DDE97A6AC9C4B8AF3273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3FD20BD27BE310068BC1C9C4B8AF907E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_86F3CC657A1036627935C9C4B8B04222" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81A19860D6D0DDE97A6AC9C4B8AF3273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_86F3CC657A1036627935C9C4B8B04222" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_E9238A35CC5848169985C9C4B8B0B0DF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81A19860D6D0DDE97A6AC9C4B8AF3273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_E9238A35CC5848169985C9C4B8B0B0DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7F7EB0A9FC7A5B48AF89C9C4B8B09AE8" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81A19860D6D0DDE97A6AC9C4B8AF3273" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7F7EB0A9FC7A5B48AF89C9C4B8B09AE8" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A989AC53867440205CBFD354A546BFB7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_75DABB7584E43F7B1F27D354A54352F5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A989AC53867440205CBFD354A546BFB7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_75DABB7584E43F7B1F27D354A54352F5" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3F04E82C39B1E35CFA9DD354A54307B4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_75DABB7584E43F7B1F27D354A54352F5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3F04E82C39B1E35CFA9DD354A54307B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7CEA0BC7B7382FF4AA47D354A5448A24_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3F04E82C39B1E35CFA9DD354A54307B4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7CEA0BC7B7382FF4AA47D354A5448A24_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7CEA0BC7B7382FF4AA47D354A5448A24" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3F04E82C39B1E35CFA9DD354A54307B4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7CEA0BC7B7382FF4AA47D354A5448A24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_5AD0662892BE5787B258D354A544AC28" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7CEA0BC7B7382FF4AA47D354A5448A24" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_5AD0662892BE5787B258D354A544AC28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_371CEDDB56A86210CCE6D354A544BCAD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7CEA0BC7B7382FF4AA47D354A5448A24" xlink:to="loc_us-gaap_CommercialPaperMember_371CEDDB56A86210CCE6D354A544BCAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_FA3D805FA8E602FA0CEBD354A545972E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7CEA0BC7B7382FF4AA47D354A5448A24" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_FA3D805FA8E602FA0CEBD354A545972E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B15CCD65B7047CEF4C5BD354A5457AE5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_75DABB7584E43F7B1F27D354A54352F5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B15CCD65B7047CEF4C5BD354A5457AE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B15CCD65B7047CEF4C5BD354A5457AE5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B15CCD65B7047CEF4C5BD354A5457AE5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3E17E306A77BD5C3C7D5D354A545884F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3E17E306A77BD5C3C7D5D354A545884F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0F3E0752C40836A2EDCDD354A5451582" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0F3E0752C40836A2EDCDD354A5451582" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_BE00A21654BF8250FC85D354A546EDF7" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_BE00A21654BF8250FC85D354A546EDF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_E639583AFD91B613C299D354A5460718" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A989AC53867440205CBFD354A546BFB7" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_E639583AFD91B613C299D354A5460718" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_E3B11CEF94119307B7CCD354A546ADE5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A989AC53867440205CBFD354A546BFB7" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_E3B11CEF94119307B7CCD354A546ADE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_B85DFD854EBA944287FFD354A5462B08" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A989AC53867440205CBFD354A546BFB7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_B85DFD854EBA944287FFD354A5462B08" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_2B148F4EE84A21554DEAD35C9099418B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A989AC53867440205CBFD354A546BFB7" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_2B148F4EE84A21554DEAD35C9099418B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_349F8A0C88879B1703C1D354A547CD66" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A989AC53867440205CBFD354A546BFB7" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_349F8A0C88879B1703C1D354A547CD66" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_E8A58E188CA6D71B869CB4B4207CF870" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7DCBED53C9F475BE2F66B4B42074025E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_E8A58E188CA6D71B869CB4B4207CF870" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7DCBED53C9F475BE2F66B4B42074025E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1EBC903FFA1EE9D352F2B4B420FA78C0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7DCBED53C9F475BE2F66B4B42074025E" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1EBC903FFA1EE9D352F2B4B420FA78C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_789A7CE764838AD2D1EEB4B420FC1163_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1EBC903FFA1EE9D352F2B4B420FA78C0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_789A7CE764838AD2D1EEB4B420FC1163_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_789A7CE764838AD2D1EEB4B420FC1163" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1EBC903FFA1EE9D352F2B4B420FA78C0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_789A7CE764838AD2D1EEB4B420FC1163" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_5A505A415F536D957099B4B4212F6745" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_789A7CE764838AD2D1EEB4B420FC1163" xlink:to="loc_us-gaap_SeniorNotesMember_5A505A415F536D957099B4B4212F6745" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_85C492C2A78A31619962B4B420C10F09" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7DCBED53C9F475BE2F66B4B42074025E" xlink:to="loc_us-gaap_DebtInstrumentAxis_85C492C2A78A31619962B4B420C10F09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_73A698CC66B303AE7510B4B420CBC503_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_85C492C2A78A31619962B4B420C10F09" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_73A698CC66B303AE7510B4B420CBC503_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_73A698CC66B303AE7510B4B420CBC503" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_85C492C2A78A31619962B4B420C10F09" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_73A698CC66B303AE7510B4B420CBC503" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2022Member" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_7E07318E899E733F3C8AB4B4214C9994" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_73A698CC66B303AE7510B4B420CBC503" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_7E07318E899E733F3C8AB4B4214C9994" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2023Member" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_860900A109693142D7CFB4B4215FE2D4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_73A698CC66B303AE7510B4B420CBC503" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_860900A109693142D7CFB4B4215FE2D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_6C0DA04E35687E006B2CB4B420A37A59" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_E8A58E188CA6D71B869CB4B4207CF870" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_6C0DA04E35687E006B2CB4B420A37A59" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_FB384A715A6EC403C2EFB4DBD5EF4F9F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_FB384A715A6EC403C2EFB4DBD5EF4F9F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ABAA715A65B9735DB37FB4DBD5F04F29_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_FB384A715A6EC403C2EFB4DBD5EF4F9F" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ABAA715A65B9735DB37FB4DBD5F04F29_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ABAA715A65B9735DB37FB4DBD5F04F29" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_FB384A715A6EC403C2EFB4DBD5EF4F9F" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ABAA715A65B9735DB37FB4DBD5F04F29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_8AADA925EC024D15375DB4DBD5F08C59" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ABAA715A65B9735DB37FB4DBD5F04F29" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_8AADA925EC024D15375DB4DBD5F08C59" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2B05C5D22F897D7B74A4B4DBD5F12059" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2B05C5D22F897D7B74A4B4DBD5F12059" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_208293FD9F9CC6BCD0EEB4DBD5F1628E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2B05C5D22F897D7B74A4B4DBD5F12059" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_208293FD9F9CC6BCD0EEB4DBD5F1628E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_208293FD9F9CC6BCD0EEB4DBD5F1628E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2B05C5D22F897D7B74A4B4DBD5F12059" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_208293FD9F9CC6BCD0EEB4DBD5F1628E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_D9BE5DC09227C3F315C3B4DBD5F229F6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_208293FD9F9CC6BCD0EEB4DBD5F1628E" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_D9BE5DC09227C3F315C3B4DBD5F229F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_75CFC219AB0773A9AC27B4DBD5F2AD8B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:to="loc_us-gaap_HedgingDesignationAxis_75CFC219AB0773A9AC27B4DBD5F2AD8B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_838153BE87C882B66195B4DBD5F37288_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_75CFC219AB0773A9AC27B4DBD5F2AD8B" xlink:to="loc_us-gaap_HedgingDesignationDomain_838153BE87C882B66195B4DBD5F37288_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_838153BE87C882B66195B4DBD5F37288" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_75CFC219AB0773A9AC27B4DBD5F2AD8B" xlink:to="loc_us-gaap_HedgingDesignationDomain_838153BE87C882B66195B4DBD5F37288" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_250A5ED8D1CA979A6777B4DBD5F36360" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_838153BE87C882B66195B4DBD5F37288" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_250A5ED8D1CA979A6777B4DBD5F36360" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_11BF5A32F38BACAEAF76B4DBD5F3A2B5" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_11BF5A32F38BACAEAF76B4DBD5F3A2B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_016BF54C3478F1958315B4DBD5F4B74E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_11BF5A32F38BACAEAF76B4DBD5F3A2B5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_016BF54C3478F1958315B4DBD5F4B74E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_016BF54C3478F1958315B4DBD5F4B74E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_11BF5A32F38BACAEAF76B4DBD5F3A2B5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_016BF54C3478F1958315B4DBD5F4B74E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_07F09065AE3DA6CD931CB4DBD5F4375A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_016BF54C3478F1958315B4DBD5F4B74E" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_07F09065AE3DA6CD931CB4DBD5F4375A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:label="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_B053B0281EC3999DFC41B4DBD5FA98B9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:to="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_B053B0281EC3999DFC41B4DBD5FA98B9" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FairValueAssetsLevel3TransfersAmount" xlink:label="loc_dxcm_FairValueAssetsLevel3TransfersAmount_620C63C0B484FEC62255B4DBD5FA595F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:to="loc_dxcm_FairValueAssetsLevel3TransfersAmount_620C63C0B484FEC62255B4DBD5FA595F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount" xlink:label="loc_us-gaap_DerivativeNotionalAmount_6BEF7075439523723CFEB4DBD5FB8924" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:to="loc_us-gaap_DerivativeNotionalAmount_6BEF7075439523723CFEB4DBD5FB8924" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_CF5C638F8E4B208B98C7B4DBD5FB5F4C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_CF5C638F8E4B208B98C7B4DBD5FB5F4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgesLiabilities" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgesLiabilities_C976C88CDF174D8936FAB4DBD5FB5E06" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgesLiabilities_C976C88CDF174D8936FAB4DBD5FB5E06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_7903C5773ADD021DAF3BB4DBD5FBE62E" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_7903C5773ADD021DAF3BB4DBD5FBE62E" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxes" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_0E9315C0558C4CDEBE7A206A61269E8A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_0E9315C0558C4CDEBE7A206A61269E8A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_50D0E93951598CE71D2D206A61269039" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_0E9315C0558C4CDEBE7A206A61269E8A" xlink:to="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_50D0E93951598CE71D2D206A61269039" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetDomain" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_FAAB3FEB9A04159349BB206A61265D2E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_50D0E93951598CE71D2D206A61269039" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_FAAB3FEB9A04159349BB206A61265D2E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetDomain" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_FAAB3FEB9A04159349BB206A61265D2E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_50D0E93951598CE71D2D206A61269039" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_FAAB3FEB9A04159349BB206A61265D2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5DFD06D4BF494F34F77C206A61270C00" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_FAAB3FEB9A04159349BB206A61265D2E" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5DFD06D4BF494F34F77C206A61270C00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_6137718D29A2AEEC8F29206A61270059" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_0E9315C0558C4CDEBE7A206A61269E8A" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_6137718D29A2AEEC8F29206A61270059" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_6137718D29A2AEEC8F29206A61270059" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_6137718D29A2AEEC8F29206A61270059" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_AB4BBE3A89F578C3896D206A61277FEF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_AB4BBE3A89F578C3896D206A61277FEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_E0D4188418A8990FA693206A61284C78" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_E0D4188418A8990FA693206A61284C78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_7BDE5CED5C40310825CB206A61285706" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8" xlink:to="loc_us-gaap_ForeignCountryMember_7BDE5CED5C40310825CB206A61285706" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_A24E10141E31AF8418FA206A61280F0C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_us-gaap_OperatingLossCarryforwards_A24E10141E31AF8418FA206A61280F0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8FC9A79CFFAA5F14BF54206A6129E245" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8FC9A79CFFAA5F14BF54206A6129E245" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration" xlink:label="loc_dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration_949B537C25C4D8A192E2206A6129E781" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration_949B537C25C4D8A192E2206A6129E781" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_UnusedExpiredFederalIncomeTaxCredits" xlink:label="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits_BB245A984F45AE86ECE4206A61290DB5" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits_BB245A984F45AE86ECE4206A61290DB5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_A8CD283F165E7BE045BA206A6129879F" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_A8CD283F165E7BE045BA206A6129879F" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital" xlink:label="loc_dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital_C0AD7320D6E891144872206A612900E4" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital_C0AD7320D6E891144872206A612900E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_44DD2844171426463BE7206A61297CE0" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_44DD2844171426463BE7206A61297CE0" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PossibleExtensionPeriodofTaxHoliday" xlink:label="loc_dxcm_PossibleExtensionPeriodofTaxHoliday_2F895CC69C78858F8706206A61296ADA" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_dxcm_PossibleExtensionPeriodofTaxHoliday_2F895CC69C78858F8706206A61296ADA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_1167A7E7AA3B88B03E192070EE694AA1" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_1167A7E7AA3B88B03E192070EE694AA1" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitments" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_343E9A3BC068E0788C083A2764DC3EE2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_343E9A3BC068E0788C083A2764DC3EE2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_E1D12C14F6A3ACC70BD63A2764DDC677_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_343E9A3BC068E0788C083A2764DC3EE2" xlink:to="loc_us-gaap_EquityComponentDomain_E1D12C14F6A3ACC70BD63A2764DDC677_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_E1D12C14F6A3ACC70BD63A2764DDC677" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_343E9A3BC068E0788C083A2764DC3EE2" xlink:to="loc_us-gaap_EquityComponentDomain_E1D12C14F6A3ACC70BD63A2764DDC677" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_DEE6EF3C15E3BEBEF0653A2764DDF936" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_E1D12C14F6A3ACC70BD63A2764DDC677" xlink:to="loc_us-gaap_RetainedEarningsMember_DEE6EF3C15E3BEBEF0653A2764DDF936" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_47330AC54A7524DFCE5C3A2764DD9246" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_47330AC54A7524DFCE5C3A2764DD9246" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_B987B2EF35BF89D0ECCF3A2764DD2714_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_47330AC54A7524DFCE5C3A2764DD9246" xlink:to="loc_us-gaap_TypeOfAdoptionMember_B987B2EF35BF89D0ECCF3A2764DD2714_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_B987B2EF35BF89D0ECCF3A2764DD2714" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_47330AC54A7524DFCE5C3A2764DD9246" xlink:to="loc_us-gaap_TypeOfAdoptionMember_B987B2EF35BF89D0ECCF3A2764DD2714" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_8AC4F3F195232E7483DA3A2764DECCC1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_B987B2EF35BF89D0ECCF3A2764DD2714" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_8AC4F3F195232E7483DA3A2764DECCC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_7A25662C5619A92BA1BF3A2764DE1585" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:to="loc_srt_RangeAxis_7A25662C5619A92BA1BF3A2764DE1585" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_BB8900FCF4D1604A5FE93A2764DED09A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7A25662C5619A92BA1BF3A2764DE1585" xlink:to="loc_srt_RangeMember_BB8900FCF4D1604A5FE93A2764DED09A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_BB8900FCF4D1604A5FE93A2764DED09A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7A25662C5619A92BA1BF3A2764DE1585" xlink:to="loc_srt_RangeMember_BB8900FCF4D1604A5FE93A2764DED09A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_12CFD2EC9E6A19523A243A2764DF311E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_BB8900FCF4D1604A5FE93A2764DED09A" xlink:to="loc_srt_MinimumMember_12CFD2EC9E6A19523A243A2764DF311E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_BBF067BC689A612156D63A2764DF4DD2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_BB8900FCF4D1604A5FE93A2764DED09A" xlink:to="loc_srt_MaximumMember_BBF067BC689A612156D63A2764DF4DD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_7140D3AE54EB34461D633A2764DF9106" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_7140D3AE54EB34461D633A2764DF9106" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_1D4D2DA5F2FF2341ECE53A2764DF2B80_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_7140D3AE54EB34461D633A2764DF9106" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_1D4D2DA5F2FF2341ECE53A2764DF2B80_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_1D4D2DA5F2FF2341ECE53A2764DF2B80" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_7140D3AE54EB34461D633A2764DF9106" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_1D4D2DA5F2FF2341ECE53A2764DF2B80" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member" xlink:label="loc_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member_EE14EF89862B4864C7673A2764E0C198" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_1D4D2DA5F2FF2341ECE53A2764DF2B80" xlink:to="loc_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member_EE14EF89862B4864C7673A2764E0C198" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_E1E29B38D3A9B16225683A2764E075D5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_E1E29B38D3A9B16225683A2764E075D5" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_NumberofFinancingLeases" xlink:label="loc_dxcm_NumberofFinancingLeases_AA685F70F10C8CB1310F3A2764E05412" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_dxcm_NumberofFinancingLeases_AA685F70F10C8CB1310F3A2764E05412" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms" xlink:label="loc_dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_C8AE1E37CBF65712095D3A2764E09D2E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_C8AE1E37CBF65712095D3A2764E09D2E" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="loc_dxcm_LesseeOperatingLeaseRemainingLeaseTerm_2C56B2F3D471F7D6D1FA3A2764E12B0B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_dxcm_LesseeOperatingLeaseRemainingLeaseTerm_2C56B2F3D471F7D6D1FA3A2764E12B0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_1A975ECCA241CFC58AA23A2764E1CF4D" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_1A975ECCA241CFC58AA23A2764E1CF4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_C62DB0DDC3F7C582214D3A2764E10687" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_C62DB0DDC3F7C582214D3A2764E10687" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_A12CB4515FEF257E47433A2764E181B4" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_A12CB4515FEF257E47433A2764E181B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_19781CF694EF7D260E483A2764E12BA4" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_us-gaap_OperatingLeaseLiability_19781CF694EF7D260E483A2764E12BA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_BB47EA3721F5FBFB0B903A2764E22FF5" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_us-gaap_FinanceLeaseLiability_BB47EA3721F5FBFB0B903A2764E22FF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_DA3E660FE29EA8B75C503A2764E2A7CC" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_us-gaap_LeaseAndRentalExpense_DA3E660FE29EA8B75C503A2764E2A7CC" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LesseeOperatingLeasesLeaseCostAmortization" xlink:label="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization_409A8543D7B5524486D23A2764E263F2" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization_409A8543D7B5524486D23A2764E263F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_A5564530E460436B94783A2764E28C99" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_A5564530E460436B94783A2764E28C99" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" xlink:label="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_C17F63E5A226E26C80293A2764E2FADA" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_C17F63E5A226E26C80293A2764E2FADA" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48E3FDF4C8D30298918AC9C2EFCAF1E9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48E3FDF4C8D30298918AC9C2EFCAF1E9" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_087DCDE0320B5F4FF628C9C2EFCA9DEF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48E3FDF4C8D30298918AC9C2EFCAF1E9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_087DCDE0320B5F4FF628C9C2EFCA9DEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24F4070BE4627E0322EEC9C2EFCA8103_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_087DCDE0320B5F4FF628C9C2EFCA9DEF" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24F4070BE4627E0322EEC9C2EFCA8103_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24F4070BE4627E0322EEC9C2EFCA8103" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_087DCDE0320B5F4FF628C9C2EFCA9DEF" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24F4070BE4627E0322EEC9C2EFCA8103" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8E9C756A99B0399FED08C9C2EFCA62D3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24F4070BE4627E0322EEC9C2EFCA8103" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8E9C756A99B0399FED08C9C2EFCA62D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_CB06A37873093A016992C9C2EFCB657C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24F4070BE4627E0322EEC9C2EFCA8103" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_CB06A37873093A016992C9C2EFCB657C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_4916DDDC139C4619583DC9C2EFCB0A93" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24F4070BE4627E0322EEC9C2EFCA8103" xlink:to="loc_us-gaap_WarrantMember_4916DDDC139C4619583DC9C2EFCB0A93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_EF684992A2974904568FC9C2EFCBDED9" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24F4070BE4627E0322EEC9C2EFCA8103" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_EF684992A2974904568FC9C2EFCBDED9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_5AB8B9E38F7D25707CB6C9C2EFCBA7FD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48E3FDF4C8D30298918AC9C2EFCAF1E9" xlink:to="loc_us-gaap_DebtInstrumentAxis_5AB8B9E38F7D25707CB6C9C2EFCBA7FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_B3FA376B09472C56BA73C9C2EFCB94D0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5AB8B9E38F7D25707CB6C9C2EFCBA7FD" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_B3FA376B09472C56BA73C9C2EFCB94D0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_B3FA376B09472C56BA73C9C2EFCB94D0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5AB8B9E38F7D25707CB6C9C2EFCBA7FD" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_B3FA376B09472C56BA73C9C2EFCB94D0" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2022Member" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_18337B8734A0BC6CF623C9C2EFCC06DF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_B3FA376B09472C56BA73C9C2EFCB94D0" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_18337B8734A0BC6CF623C9C2EFCC06DF" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2023Member" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_19EBEEECCE3B3F5F8650C9C2EFCC0ECD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_B3FA376B09472C56BA73C9C2EFCB94D0" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_19EBEEECCE3B3F5F8650C9C2EFCC0ECD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_9719AFC022DE60E4B8FDC9C2EFCCB183" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:to="loc_us-gaap_NetIncomeLoss_9719AFC022DE60E4B8FDC9C2EFCCB183" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_9BAB5FF66749B86AAA70C9C2EFCDC13D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:to="loc_us-gaap_EarningsPerShareBasic_9BAB5FF66749B86AAA70C9C2EFCDC13D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_DC69875AAF6F39539263C9C2EFCDBE3E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:to="loc_us-gaap_EarningsPerShareDiluted_DC69875AAF6F39539263C9C2EFCDBE3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8264DED3122F87397607C9C2EFCD46CA" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8264DED3122F87397607C9C2EFCD46CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DB7ACC95EA6A5121BE4FC9C2EFCD4C2E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DB7ACC95EA6A5121BE4FC9C2EFCD4C2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E8FBF90FA0B36E3C0908C9C2EFCDDB79" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E8FBF90FA0B36E3C0908C9C2EFCDDB79" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:type="locator" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_792AD7462B796829E33E210C27A7FF50" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442" xlink:to="loc_srt_RangeAxis_792AD7462B796829E33E210C27A7FF50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_2CBBFC96C74D76DFB310210C27A721B6_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_792AD7462B796829E33E210C27A7FF50" xlink:to="loc_srt_RangeMember_2CBBFC96C74D76DFB310210C27A721B6_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_2CBBFC96C74D76DFB310210C27A721B6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_792AD7462B796829E33E210C27A7FF50" xlink:to="loc_srt_RangeMember_2CBBFC96C74D76DFB310210C27A721B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_653B0520DAF8BD283C15210C27A8F96A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2CBBFC96C74D76DFB310210C27A721B6" xlink:to="loc_srt_MinimumMember_653B0520DAF8BD283C15210C27A8F96A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_AB7946D5063E66AEF2D8210C27A8A5B1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2CBBFC96C74D76DFB310210C27A721B6" xlink:to="loc_srt_MaximumMember_AB7946D5063E66AEF2D8210C27A8A5B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_D634576FD5FE38A72155210C27A8145A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_D634576FD5FE38A72155210C27A8145A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_EC349CD6158DC5626685210C27A873E4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_D634576FD5FE38A72155210C27A8145A" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_EC349CD6158DC5626685210C27A873E4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_EC349CD6158DC5626685210C27A873E4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_D634576FD5FE38A72155210C27A8145A" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_EC349CD6158DC5626685210C27A873E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_E7FD9F7E5930B68DB101210C27A8C66D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_EC349CD6158DC5626685210C27A873E4" xlink:to="loc_us-gaap_ComputerEquipmentMember_E7FD9F7E5930B68DB101210C27A8C66D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_A1031DD0D3762F71EB7B210C27A973B6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_EC349CD6158DC5626685210C27A873E4" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_A1031DD0D3762F71EB7B210C27A973B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_193E7ADB68138EA61B6C210C27A90466" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_EC349CD6158DC5626685210C27A873E4" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_193E7ADB68138EA61B6C210C27A90466" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" xlink:label="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_28EDAD9F801D44C3CC8C210C27A9F5EE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_28EDAD9F801D44C3CC8C210C27A9F5EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_C5F596FA31D4AA7F1397210C27AA8BC4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_C5F596FA31D4AA7F1397210C27AA8BC4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_868F5009C02AFD0DCADF210C27AA3D82" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_868F5009C02AFD0DCADF210C27AA3D82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9D19F6E446A6C4C5C575210C27AA6CA0" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9D19F6E446A6C4C5C575210C27AA6CA0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_BE1406EBE4BD44DC1645210C27AA7AE2" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_BE1406EBE4BD44DC1645210C27AA7AE2" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_RevenueRecognitionSalesReturnsCoveragePeriod" xlink:label="loc_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_DF71F8C5B4D17C35AAD1210C27AAA45C" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_DF71F8C5B4D17C35AAD1210C27AAA45C" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ContractPaymentTermsNumberofDays" xlink:label="loc_dxcm_ContractPaymentTermsNumberofDays_2CF5CF41656C2F57813B210C27AA0360" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_dxcm_ContractPaymentTermsNumberofDays_2CF5CF41656C2F57813B210C27AA0360" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnbilledContractsReceivable" xlink:label="loc_us-gaap_UnbilledContractsReceivable_FF67FF4B0FD246689C4A210C27AAD6BB" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_us-gaap_UnbilledContractsReceivable_FF67FF4B0FD246689C4A210C27AAD6BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_BA1790FF86E0FC9C8191210C27AAC639" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_BA1790FF86E0FC9C8191210C27AAC639" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_AmortizationPeriodForIncentiveCompensationCosts" xlink:label="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts_12E484D978A07C4F9FEB210C27ABCA04" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts_12E484D978A07C4F9FEB210C27ABCA04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaap_AdvertisingExpense_B2D38096741135326930210C27AB6BFB" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_us-gaap_AdvertisingExpense_B2D38096741135326930210C27AB6BFB" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenueRecognizedFromChangesInContractLiabilityBalancesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_24620DA3E2C9566CD3E2C9C2EB340E3B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_5AB5C445F1F657856C38C9C2EB302C01" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_24620DA3E2C9566CD3E2C9C2EB340E3B" xlink:to="loc_us-gaap_ConcentrationRiskTable_5AB5C445F1F657856C38C9C2EB302C01" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2B21FFB60973A0949618C9C2EB300C0F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_5AB5C445F1F657856C38C9C2EB302C01" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2B21FFB60973A0949618C9C2EB300C0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_C37A8953DB378A29516DC9C2EB318F30_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2B21FFB60973A0949618C9C2EB300C0F" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_C37A8953DB378A29516DC9C2EB318F30_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_C37A8953DB378A29516DC9C2EB318F30" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2B21FFB60973A0949618C9C2EB300C0F" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_C37A8953DB378A29516DC9C2EB318F30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_0FD8ACC431588936D886C9C2EB31E91C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_C37A8953DB378A29516DC9C2EB318F30" xlink:to="loc_us-gaap_SalesRevenueNetMember_0FD8ACC431588936D886C9C2EB31E91C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_9756397D2972FE3710C8C9C55B861118" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_C37A8953DB378A29516DC9C2EB318F30" xlink:to="loc_us-gaap_AccountsReceivableMember_9756397D2972FE3710C8C9C55B861118" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_43A9B44E8C160B0A9DE0C9C2EB314A03" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_5AB5C445F1F657856C38C9C2EB302C01" xlink:to="loc_srt_MajorCustomersAxis_43A9B44E8C160B0A9DE0C9C2EB314A03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_43A9B44E8C160B0A9DE0C9C2EB314A03" xlink:to="loc_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_43A9B44E8C160B0A9DE0C9C2EB314A03" xlink:to="loc_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CustomerAMember" xlink:label="loc_dxcm_CustomerAMember_5820A7163862FA736D5AC9C2EB32E12B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E" xlink:to="loc_dxcm_CustomerAMember_5820A7163862FA736D5AC9C2EB32E12B" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CustomerBMember" xlink:label="loc_dxcm_CustomerBMember_3D3A908A659BF3812A5CC9C2EB33A30D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E" xlink:to="loc_dxcm_CustomerBMember_3D3A908A659BF3812A5CC9C2EB33A30D" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CustomerCMember" xlink:label="loc_dxcm_CustomerCMember_DA9C8ACF6508BE42BB95C9C2EB33F43F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E" xlink:to="loc_dxcm_CustomerCMember_DA9C8ACF6508BE42BB95C9C2EB33F43F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_9B86475E1B6CAF78102AC9C2EB34D954" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_24620DA3E2C9566CD3E2C9C2EB340E3B" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_9B86475E1B6CAF78102AC9C2EB34D954" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedQuarterlyFinancialInformationUnaudited" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedSummaryDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>19
<FILENAME>dxcm-20191231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_E841F509A0142436B0D4C9C2EF85DE09_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_E841F509A0142436B0D4C9C2EF85DE09" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_E841F509A0142436B0D4C9C2EF85DE09" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_E841F509A0142436B0D4C9C2EF85DE09" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_E841F509A0142436B0D4C9C2EF85DE09" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_0EE1FF482383D0FFB9BAC9C2EF86F88A_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_0EE1FF482383D0FFB9BAC9C2EF86F88A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0EE1FF482383D0FFB9BAC9C2EF86F88A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0EE1FF482383D0FFB9BAC9C2EF86F88A" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_0EE1FF482383D0FFB9BAC9C2EF86F88A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_005B2164B99B8CF003BBC9C2EF86626F_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_005B2164B99B8CF003BBC9C2EF86626F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_005B2164B99B8CF003BBC9C2EF86626F_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_005B2164B99B8CF003BBC9C2EF86626F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_005B2164B99B8CF003BBC9C2EF86626F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_005B2164B99B8CF003BBC9C2EF86626F" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_005B2164B99B8CF003BBC9C2EF86626F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentAxis_7D87AA772FE9A1D6A504C9C2EF862D58_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_7D87AA772FE9A1D6A504C9C2EF862D58" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_7D87AA772FE9A1D6A504C9C2EF862D58_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_7D87AA772FE9A1D6A504C9C2EF862D58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_7D87AA772FE9A1D6A504C9C2EF862D58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis_7D87AA772FE9A1D6A504C9C2EF862D58" xlink:to="lab_us-gaap_DebtInstrumentAxis_7D87AA772FE9A1D6A504C9C2EF862D58" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_55D26F726E4F4584FF08C9C2EF8783A9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_55D26F726E4F4584FF08C9C2EF8783A9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_55D26F726E4F4584FF08C9C2EF8783A9_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_55D26F726E4F4584FF08C9C2EF8783A9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_55D26F726E4F4584FF08C9C2EF8783A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55D26F726E4F4584FF08C9C2EF8783A9" xlink:to="lab_us-gaap_DebtInstrumentNameDomain_55D26F726E4F4584FF08C9C2EF8783A9" xlink:type="arc" />
    <link:label id="lab_dxcm_ConvertibleNotesDue2022Member_5A3AB53C2C25EE887C73C9C2EF87C9AB_terseLabel_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2022Member_5A3AB53C2C25EE887C73C9C2EF87C9AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior convertible notes due 2022</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2022Member_5A3AB53C2C25EE887C73C9C2EF87C9AB_label_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2022Member_5A3AB53C2C25EE887C73C9C2EF87C9AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Notes Due 2022 [Member]</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2022Member_5A3AB53C2C25EE887C73C9C2EF87C9AB_documentation_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2022Member_5A3AB53C2C25EE887C73C9C2EF87C9AB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Notes Due 2022 [Member]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2022Member" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_5A3AB53C2C25EE887C73C9C2EF87C9AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ConvertibleNotesDue2022Member_5A3AB53C2C25EE887C73C9C2EF87C9AB" xlink:to="lab_dxcm_ConvertibleNotesDue2022Member_5A3AB53C2C25EE887C73C9C2EF87C9AB" xlink:type="arc" />
    <link:label id="lab_dxcm_ConvertibleNotesDue2023Member_DC255A80A4B866A11499C9C2EF876F29_terseLabel_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2023Member_DC255A80A4B866A11499C9C2EF876F29" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior convertible notes due 2023</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2023Member_DC255A80A4B866A11499C9C2EF876F29_label_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2023Member_DC255A80A4B866A11499C9C2EF876F29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Notes Due 2023 [Member]</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2023Member_DC255A80A4B866A11499C9C2EF876F29_documentation_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2023Member_DC255A80A4B866A11499C9C2EF876F29" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Notes Due 2023 [Member]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2023Member" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_DC255A80A4B866A11499C9C2EF876F29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ConvertibleNotesDue2023Member_DC255A80A4B866A11499C9C2EF876F29" xlink:to="lab_dxcm_ConvertibleNotesDue2023Member_DC255A80A4B866A11499C9C2EF876F29" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7E622335A788F86B4234C9C2EF8768A8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7E622335A788F86B4234C9C2EF8768A8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7E622335A788F86B4234C9C2EF8768A8_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7E622335A788F86B4234C9C2EF8768A8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7E622335A788F86B4234C9C2EF8768A8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7E622335A788F86B4234C9C2EF8768A8" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7E622335A788F86B4234C9C2EF8768A8" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_08C91092FBBF31CA749CC9C2EF88D591_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_08C91092FBBF31CA749CC9C2EF88D591" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Options outstanding to purchase common stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_08C91092FBBF31CA749CC9C2EF88D591_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_08C91092FBBF31CA749CC9C2EF88D591" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_08C91092FBBF31CA749CC9C2EF88D591" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember_08C91092FBBF31CA749CC9C2EF88D591" xlink:to="lab_us-gaap_EmployeeStockOptionMember_08C91092FBBF31CA749CC9C2EF88D591" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_5BB861A526D68DAB44E6C9C2EF8875F1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_5BB861A526D68DAB44E6C9C2EF8875F1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_5BB861A526D68DAB44E6C9C2EF8875F1_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_5BB861A526D68DAB44E6C9C2EF8875F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5BB861A526D68DAB44E6C9C2EF8875F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_5BB861A526D68DAB44E6C9C2EF8875F1" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember_5BB861A526D68DAB44E6C9C2EF8875F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_WarrantMember_2E5EA1C5A9FBAD754303C9C2EF88A1BC_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember_2E5EA1C5A9FBAD754303C9C2EF88A1BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023 Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_2E5EA1C5A9FBAD754303C9C2EF88A1BC_label_en-US" xlink:label="lab_us-gaap_WarrantMember_2E5EA1C5A9FBAD754303C9C2EF88A1BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_2E5EA1C5A9FBAD754303C9C2EF88A1BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember_2E5EA1C5A9FBAD754303C9C2EF88A1BC" xlink:to="lab_us-gaap_WarrantMember_2E5EA1C5A9FBAD754303C9C2EF88A1BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_8680D115E46763A6DAADC9C2EF89A3DC_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember_8680D115E46763A6DAADC9C2EF89A3DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_8680D115E46763A6DAADC9C2EF89A3DC_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember_8680D115E46763A6DAADC9C2EF89A3DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_8680D115E46763A6DAADC9C2EF89A3DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtSecuritiesMember_8680D115E46763A6DAADC9C2EF89A3DC" xlink:to="lab_us-gaap_ConvertibleDebtSecuritiesMember_8680D115E46763A6DAADC9C2EF89A3DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_B30818D9B4542ECFA629C9C2EF89E829_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_B30818D9B4542ECFA629C9C2EF89E829" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_B30818D9B4542ECFA629C9C2EF89E829_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_B30818D9B4542ECFA629C9C2EF89E829" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_B30818D9B4542ECFA629C9C2EF89E829" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_B30818D9B4542ECFA629C9C2EF89E829" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_B30818D9B4542ECFA629C9C2EF89E829" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D23E621F7B95E382AFF0C9C2EF89E4F0_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D23E621F7B95E382AFF0C9C2EF89E4F0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D23E621F7B95E382AFF0C9C2EF89E4F0_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D23E621F7B95E382AFF0C9C2EF89E4F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D23E621F7B95E382AFF0C9C2EF89E4F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D23E621F7B95E382AFF0C9C2EF89E4F0" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D23E621F7B95E382AFF0C9C2EF89E4F0" xlink:type="arc" />
    <link:label id="lab_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4_label_en-US" xlink:label="lab_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover page.</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="lab_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_8BA5643080C15F0BD11B4034D5C5355F_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_8BA5643080C15F0BD11B4034D5C5355F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_8BA5643080C15F0BD11B4034D5C5355F_label_en-US" xlink:label="lab_dei_AmendmentFlag_8BA5643080C15F0BD11B4034D5C5355F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_8BA5643080C15F0BD11B4034D5C5355F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_8BA5643080C15F0BD11B4034D5C5355F" xlink:to="lab_dei_AmendmentFlag_8BA5643080C15F0BD11B4034D5C5355F" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalYearFocus_28750BD4DD0869B61AA24034D5C51A63_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_28750BD4DD0869B61AA24034D5C51A63" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_28750BD4DD0869B61AA24034D5C51A63_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_28750BD4DD0869B61AA24034D5C51A63" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_28750BD4DD0869B61AA24034D5C51A63" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_28750BD4DD0869B61AA24034D5C51A63" xlink:to="lab_dei_DocumentFiscalYearFocus_28750BD4DD0869B61AA24034D5C51A63" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_79F5EA9BDD176EF3537D4034D5C54979_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_79F5EA9BDD176EF3537D4034D5C54979" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_79F5EA9BDD176EF3537D4034D5C54979_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_79F5EA9BDD176EF3537D4034D5C54979" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_79F5EA9BDD176EF3537D4034D5C54979" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_79F5EA9BDD176EF3537D4034D5C54979" xlink:to="lab_dei_DocumentFiscalPeriodFocus_79F5EA9BDD176EF3537D4034D5C54979" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_8423031EE2FD5DFE4B624034D5C5F997_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_8423031EE2FD5DFE4B624034D5C5F997" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_8423031EE2FD5DFE4B624034D5C5F997_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_8423031EE2FD5DFE4B624034D5C5F997" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_8423031EE2FD5DFE4B624034D5C5F997" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_8423031EE2FD5DFE4B624034D5C5F997" xlink:to="lab_dei_EntityCentralIndexKey_8423031EE2FD5DFE4B624034D5C5F997" xlink:type="arc" />
    <link:label id="lab_dei_CurrentFiscalYearEndDate_37416306FE8781D666FF4034D5C603D6_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_37416306FE8781D666FF4034D5C603D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_37416306FE8781D666FF4034D5C603D6_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_37416306FE8781D666FF4034D5C603D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_37416306FE8781D666FF4034D5C603D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_37416306FE8781D666FF4034D5C603D6" xlink:to="lab_dei_CurrentFiscalYearEndDate_37416306FE8781D666FF4034D5C603D6" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_F959EF9D4F8B484D5F404034D5C6F946_terseLabel_en-US" xlink:label="lab_dei_DocumentType_F959EF9D4F8B484D5F404034D5C6F946" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_F959EF9D4F8B484D5F404034D5C6F946_label_en-US" xlink:label="lab_dei_DocumentType_F959EF9D4F8B484D5F404034D5C6F946" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_F959EF9D4F8B484D5F404034D5C6F946" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_F959EF9D4F8B484D5F404034D5C6F946" xlink:to="lab_dei_DocumentType_F959EF9D4F8B484D5F404034D5C6F946" xlink:type="arc" />
    <link:label id="lab_dei_DocumentAnnualReport_0AADE6C0C8D61DDA558F4034D5C69039_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport_0AADE6C0C8D61DDA558F4034D5C69039" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_0AADE6C0C8D61DDA558F4034D5C69039_label_en-US" xlink:label="lab_dei_DocumentAnnualReport_0AADE6C0C8D61DDA558F4034D5C69039" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_0AADE6C0C8D61DDA558F4034D5C69039" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport_0AADE6C0C8D61DDA558F4034D5C69039" xlink:to="lab_dei_DocumentAnnualReport_0AADE6C0C8D61DDA558F4034D5C69039" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_55F5BD91FF3DE4CD9FAC4034D5C6ED7D_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_55F5BD91FF3DE4CD9FAC4034D5C6ED7D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_55F5BD91FF3DE4CD9FAC4034D5C6ED7D_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_55F5BD91FF3DE4CD9FAC4034D5C6ED7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_55F5BD91FF3DE4CD9FAC4034D5C6ED7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_55F5BD91FF3DE4CD9FAC4034D5C6ED7D" xlink:to="lab_dei_DocumentPeriodEndDate_55F5BD91FF3DE4CD9FAC4034D5C6ED7D" xlink:type="arc" />
    <link:label id="lab_dei_DocumentTransitionReport_08A4BBC118E63D7B64A54034D5C63B6D_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport_08A4BBC118E63D7B64A54034D5C63B6D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_08A4BBC118E63D7B64A54034D5C63B6D_label_en-US" xlink:label="lab_dei_DocumentTransitionReport_08A4BBC118E63D7B64A54034D5C63B6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_08A4BBC118E63D7B64A54034D5C63B6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport_08A4BBC118E63D7B64A54034D5C63B6D" xlink:to="lab_dei_DocumentTransitionReport_08A4BBC118E63D7B64A54034D5C63B6D" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_4B2E1B4E9FC5E05FDF784034D5C6250F_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber_4B2E1B4E9FC5E05FDF784034D5C6250F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_4B2E1B4E9FC5E05FDF784034D5C6250F_label_en-US" xlink:label="lab_dei_EntityFileNumber_4B2E1B4E9FC5E05FDF784034D5C6250F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_4B2E1B4E9FC5E05FDF784034D5C6250F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_4B2E1B4E9FC5E05FDF784034D5C6250F" xlink:to="lab_dei_EntityFileNumber_4B2E1B4E9FC5E05FDF784034D5C6250F" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_D23EE898B2865F8967874034D5C7BE2C_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_D23EE898B2865F8967874034D5C7BE2C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_D23EE898B2865F8967874034D5C7BE2C_label_en-US" xlink:label="lab_dei_EntityRegistrantName_D23EE898B2865F8967874034D5C7BE2C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_D23EE898B2865F8967874034D5C7BE2C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_D23EE898B2865F8967874034D5C7BE2C" xlink:to="lab_dei_EntityRegistrantName_D23EE898B2865F8967874034D5C7BE2C" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_B26BC152BAF1924115564034D5C7A80C_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_B26BC152BAF1924115564034D5C7A80C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_B26BC152BAF1924115564034D5C7A80C_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_B26BC152BAF1924115564034D5C7A80C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_B26BC152BAF1924115564034D5C7A80C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_B26BC152BAF1924115564034D5C7A80C" xlink:to="lab_dei_EntityIncorporationStateCountryCode_B26BC152BAF1924115564034D5C7A80C" xlink:type="arc" />
    <link:label id="lab_dei_EntityTaxIdentificationNumber_043F1B04790EC1EBE56D4034D5C756F2_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_043F1B04790EC1EBE56D4034D5C756F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_043F1B04790EC1EBE56D4034D5C756F2_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_043F1B04790EC1EBE56D4034D5C756F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_043F1B04790EC1EBE56D4034D5C756F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_043F1B04790EC1EBE56D4034D5C756F2" xlink:to="lab_dei_EntityTaxIdentificationNumber_043F1B04790EC1EBE56D4034D5C756F2" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_49F39C3A3CE3A13D2F744034D5C77BE8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_49F39C3A3CE3A13D2F744034D5C77BE8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_49F39C3A3CE3A13D2F744034D5C77BE8_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_49F39C3A3CE3A13D2F744034D5C77BE8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_49F39C3A3CE3A13D2F744034D5C77BE8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_49F39C3A3CE3A13D2F744034D5C77BE8" xlink:to="lab_dei_EntityAddressAddressLine1_49F39C3A3CE3A13D2F744034D5C77BE8" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_5D21D9E5601019EB5B6C4034D5C7187F_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_5D21D9E5601019EB5B6C4034D5C7187F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_5D21D9E5601019EB5B6C4034D5C7187F_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_5D21D9E5601019EB5B6C4034D5C7187F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_5D21D9E5601019EB5B6C4034D5C7187F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_5D21D9E5601019EB5B6C4034D5C7187F" xlink:to="lab_dei_EntityAddressCityOrTown_5D21D9E5601019EB5B6C4034D5C7187F" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressStateOrProvince_4936108792F6261F45864034D5C70E59_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_4936108792F6261F45864034D5C70E59" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4936108792F6261F45864034D5C70E59_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_4936108792F6261F45864034D5C70E59" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_4936108792F6261F45864034D5C70E59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_4936108792F6261F45864034D5C70E59" xlink:to="lab_dei_EntityAddressStateOrProvince_4936108792F6261F45864034D5C70E59" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_FBBB7639AC4AB4F155F74034D5C83C1E_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_FBBB7639AC4AB4F155F74034D5C83C1E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_FBBB7639AC4AB4F155F74034D5C83C1E_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_FBBB7639AC4AB4F155F74034D5C83C1E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_FBBB7639AC4AB4F155F74034D5C83C1E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_FBBB7639AC4AB4F155F74034D5C83C1E" xlink:to="lab_dei_EntityAddressPostalZipCode_FBBB7639AC4AB4F155F74034D5C83C1E" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_6D6353A149531140529E4034D5C8C22E_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode_6D6353A149531140529E4034D5C8C22E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_6D6353A149531140529E4034D5C8C22E_label_en-US" xlink:label="lab_dei_CityAreaCode_6D6353A149531140529E4034D5C8C22E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_6D6353A149531140529E4034D5C8C22E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_6D6353A149531140529E4034D5C8C22E" xlink:to="lab_dei_CityAreaCode_6D6353A149531140529E4034D5C8C22E" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_2E7A8DA712E824D9E4E94034D5C8D4D4_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber_2E7A8DA712E824D9E4E94034D5C8D4D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_2E7A8DA712E824D9E4E94034D5C8D4D4_label_en-US" xlink:label="lab_dei_LocalPhoneNumber_2E7A8DA712E824D9E4E94034D5C8D4D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_2E7A8DA712E824D9E4E94034D5C8D4D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_2E7A8DA712E824D9E4E94034D5C8D4D4" xlink:to="lab_dei_LocalPhoneNumber_2E7A8DA712E824D9E4E94034D5C8D4D4" xlink:type="arc" />
    <link:label id="lab_dei_Security12bTitle_3A93E591B67C16E9AB6B4034D5C80882_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle_3A93E591B67C16E9AB6B4034D5C80882" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_3A93E591B67C16E9AB6B4034D5C80882_label_en-US" xlink:label="lab_dei_Security12bTitle_3A93E591B67C16E9AB6B4034D5C80882" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_3A93E591B67C16E9AB6B4034D5C80882" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_3A93E591B67C16E9AB6B4034D5C80882" xlink:to="lab_dei_Security12bTitle_3A93E591B67C16E9AB6B4034D5C80882" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_20CBB9E8291762DEC0BC4034D5C8769A_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_20CBB9E8291762DEC0BC4034D5C8769A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_20CBB9E8291762DEC0BC4034D5C8769A_label_en-US" xlink:label="lab_dei_TradingSymbol_20CBB9E8291762DEC0BC4034D5C8769A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_20CBB9E8291762DEC0BC4034D5C8769A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_20CBB9E8291762DEC0BC4034D5C8769A" xlink:to="lab_dei_TradingSymbol_20CBB9E8291762DEC0BC4034D5C8769A" xlink:type="arc" />
    <link:label id="lab_dei_SecurityExchangeName_36F45FCA8D4432987E3B4034D5C8AB7D_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName_36F45FCA8D4432987E3B4034D5C8AB7D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_36F45FCA8D4432987E3B4034D5C8AB7D_label_en-US" xlink:label="lab_dei_SecurityExchangeName_36F45FCA8D4432987E3B4034D5C8AB7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_36F45FCA8D4432987E3B4034D5C8AB7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_36F45FCA8D4432987E3B4034D5C8AB7D" xlink:to="lab_dei_SecurityExchangeName_36F45FCA8D4432987E3B4034D5C8AB7D" xlink:type="arc" />
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_F691F81098511661C1E84034D5C9C72C_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_F691F81098511661C1E84034D5C9C72C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_F691F81098511661C1E84034D5C9C72C_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_F691F81098511661C1E84034D5C9C72C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_F691F81098511661C1E84034D5C9C72C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer_F691F81098511661C1E84034D5C9C72C" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer_F691F81098511661C1E84034D5C9C72C" xlink:type="arc" />
    <link:label id="lab_dei_EntityVoluntaryFilers_63CF6E7D0D09D152818D4034D5C9901A_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers_63CF6E7D0D09D152818D4034D5C9901A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_63CF6E7D0D09D152818D4034D5C9901A_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers_63CF6E7D0D09D152818D4034D5C9901A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_63CF6E7D0D09D152818D4034D5C9901A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers_63CF6E7D0D09D152818D4034D5C9901A" xlink:to="lab_dei_EntityVoluntaryFilers_63CF6E7D0D09D152818D4034D5C9901A" xlink:type="arc" />
    <link:label id="lab_dei_EntityCurrentReportingStatus_ADA8613D0821D5C01F634034D5C9F1D5_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_ADA8613D0821D5C01F634034D5C9F1D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_ADA8613D0821D5C01F634034D5C9F1D5_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_ADA8613D0821D5C01F634034D5C9F1D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_ADA8613D0821D5C01F634034D5C9F1D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_ADA8613D0821D5C01F634034D5C9F1D5" xlink:to="lab_dei_EntityCurrentReportingStatus_ADA8613D0821D5C01F634034D5C9F1D5" xlink:type="arc" />
    <link:label id="lab_dei_EntityInteractiveDataCurrent_C07127472D2406AE0A004034D5C9B491_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent_C07127472D2406AE0A004034D5C9B491" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_C07127472D2406AE0A004034D5C9B491_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent_C07127472D2406AE0A004034D5C9B491" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_C07127472D2406AE0A004034D5C9B491" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_C07127472D2406AE0A004034D5C9B491" xlink:to="lab_dei_EntityInteractiveDataCurrent_C07127472D2406AE0A004034D5C9B491" xlink:type="arc" />
    <link:label id="lab_dei_EntityFilerCategory_F07751743A7252B34E8B4034D5C93987_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory_F07751743A7252B34E8B4034D5C93987" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_F07751743A7252B34E8B4034D5C93987_label_en-US" xlink:label="lab_dei_EntityFilerCategory_F07751743A7252B34E8B4034D5C93987" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_F07751743A7252B34E8B4034D5C93987" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_F07751743A7252B34E8B4034D5C93987" xlink:to="lab_dei_EntityFilerCategory_F07751743A7252B34E8B4034D5C93987" xlink:type="arc" />
    <link:label id="lab_dei_EntitySmallBusiness_7577999975173A7DBB184034D5C9860B_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness_7577999975173A7DBB184034D5C9860B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_7577999975173A7DBB184034D5C9860B_label_en-US" xlink:label="lab_dei_EntitySmallBusiness_7577999975173A7DBB184034D5C9860B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_7577999975173A7DBB184034D5C9860B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness_7577999975173A7DBB184034D5C9860B" xlink:to="lab_dei_EntitySmallBusiness_7577999975173A7DBB184034D5C9860B" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_338FE32DB2CBE04E954C4034D5CA6B03_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_338FE32DB2CBE04E954C4034D5CA6B03" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_338FE32DB2CBE04E954C4034D5CA6B03_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_338FE32DB2CBE04E954C4034D5CA6B03" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_338FE32DB2CBE04E954C4034D5CA6B03" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_338FE32DB2CBE04E954C4034D5CA6B03" xlink:to="lab_dei_EntityEmergingGrowthCompany_338FE32DB2CBE04E954C4034D5CA6B03" xlink:type="arc" />
    <link:label id="lab_dei_EntityShellCompany_55CF3F9F974EC5ED921F4034D5CA7B3B_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany_55CF3F9F974EC5ED921F4034D5CA7B3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_55CF3F9F974EC5ED921F4034D5CA7B3B_label_en-US" xlink:label="lab_dei_EntityShellCompany_55CF3F9F974EC5ED921F4034D5CA7B3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_55CF3F9F974EC5ED921F4034D5CA7B3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany_55CF3F9F974EC5ED921F4034D5CA7B3B" xlink:to="lab_dei_EntityShellCompany_55CF3F9F974EC5ED921F4034D5CA7B3B" xlink:type="arc" />
    <link:label id="lab_dei_EntityPublicFloat_19AB5E63F7ED23C1A91A4034D5CA9509_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat_19AB5E63F7ED23C1A91A4034D5CA9509" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_19AB5E63F7ED23C1A91A4034D5CA9509_label_en-US" xlink:label="lab_dei_EntityPublicFloat_19AB5E63F7ED23C1A91A4034D5CA9509" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_19AB5E63F7ED23C1A91A4034D5CA9509" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat_19AB5E63F7ED23C1A91A4034D5CA9509" xlink:to="lab_dei_EntityPublicFloat_19AB5E63F7ED23C1A91A4034D5CA9509" xlink:type="arc" />
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_B88C20BC067E531CC2F34034D5CAB05F_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_B88C20BC067E531CC2F34034D5CAB05F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_B88C20BC067E531CC2F34034D5CAB05F_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_B88C20BC067E531CC2F34034D5CAB05F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_B88C20BC067E531CC2F34034D5CAB05F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_B88C20BC067E531CC2F34034D5CAB05F" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_B88C20BC067E531CC2F34034D5CAB05F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_3B03098A0A3ABD71299B1BEB0CEE459D_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_3B03098A0A3ABD71299B1BEB0CEE459D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3B03098A0A3ABD71299B1BEB0CEE459D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3B03098A0A3ABD71299B1BEB0CEE459D" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_3B03098A0A3ABD71299B1BEB0CEE459D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5B70EBF08D328DB842811BEB0CEEC9A5_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5B70EBF08D328DB842811BEB0CEEC9A5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5B70EBF08D328DB842811BEB0CEEC9A5_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5B70EBF08D328DB842811BEB0CEEC9A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5B70EBF08D328DB842811BEB0CEEC9A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5B70EBF08D328DB842811BEB0CEEC9A5" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5B70EBF08D328DB842811BEB0CEEC9A5" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_040C5F16DC4FCB4B42961BEB0CEFB8C1_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_040C5F16DC4FCB4B42961BEB0CEFB8C1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_040C5F16DC4FCB4B42961BEB0CEFB8C1_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_040C5F16DC4FCB4B42961BEB0CEFB8C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_040C5F16DC4FCB4B42961BEB0CEFB8C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_040C5F16DC4FCB4B42961BEB0CEFB8C1" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_040C5F16DC4FCB4B42961BEB0CEFB8C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_61E3E23C33C08F258B861BEB0CEFA73C_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_61E3E23C33C08F258B861BEB0CEFA73C" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decreases related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_61E3E23C33C08F258B861BEB0CEFA73C_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_61E3E23C33C08F258B861BEB0CEFA73C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_61E3E23C33C08F258B861BEB0CEFA73C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_61E3E23C33C08F258B861BEB0CEFA73C" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_61E3E23C33C08F258B861BEB0CEFA73C" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_739895D9B3FE43D1D4DF1BEB0CEFAEEE_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_739895D9B3FE43D1D4DF1BEB0CEFAEEE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increases related to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_739895D9B3FE43D1D4DF1BEB0CEFAEEE_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_739895D9B3FE43D1D4DF1BEB0CEFAEEE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_739895D9B3FE43D1D4DF1BEB0CEFAEEE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_739895D9B3FE43D1D4DF1BEB0CEFAEEE" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_739895D9B3FE43D1D4DF1BEB0CEFAEEE" xlink:type="arc" />
    <link:label id="lab_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017_0D444B638D9A8F47B6A41BEB0CEFA818_negatedTerseLabel_en-US" xlink:label="lab_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017_0D444B638D9A8F47B6A41BEB0CEFA818" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decrease related to Tax Cuts and Jobs Act of 2017</link:label>
    <link:label id="lab_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017_0D444B638D9A8F47B6A41BEB0CEFA818_label_en-US" xlink:label="lab_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017_0D444B638D9A8F47B6A41BEB0CEFA818" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Tax Cuts And Jobs Act Of 2017</link:label>
    <link:label id="lab_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017_0D444B638D9A8F47B6A41BEB0CEFA818_documentation_en-US" xlink:label="lab_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017_0D444B638D9A8F47B6A41BEB0CEFA818" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Tax Cuts And Jobs Act Of 2017</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017" xlink:label="loc_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017_0D444B638D9A8F47B6A41BEB0CEFA818" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017_0D444B638D9A8F47B6A41BEB0CEFA818" xlink:to="lab_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017_0D444B638D9A8F47B6A41BEB0CEFA818" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_110B4AC846A603FBC6411BEB0CF0F3E0_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_110B4AC846A603FBC6411BEB0CF0F3E0" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_110B4AC846A603FBC6411BEB0CF0F3E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_110B4AC846A603FBC6411BEB0CF0F3E0" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_110B4AC846A603FBC6411BEB0CF0F3E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeasesAbstract_C2FBA956DA45EB9FD927B5C447EC1771_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract_C2FBA956DA45EB9FD927B5C447EC1771" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_C2FBA956DA45EB9FD927B5C447EC1771" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract_C2FBA956DA45EB9FD927B5C447EC1771" xlink:to="lab_us-gaap_LeasesAbstract_C2FBA956DA45EB9FD927B5C447EC1771" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8FAE8649CA6482A3747DB5C447EFE9D4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8FAE8649CA6482A3747DB5C447EFE9D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8FAE8649CA6482A3747DB5C447EFE9D4_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8FAE8649CA6482A3747DB5C447EFE9D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8FAE8649CA6482A3747DB5C447EFE9D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8FAE8649CA6482A3747DB5C447EFE9D4" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8FAE8649CA6482A3747DB5C447EFE9D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_5B2604C78584CB40C80EB5C447F41630_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense_5B2604C78584CB40C80EB5C447F41630" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_5B2604C78584CB40C80EB5C447F41630_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense_5B2604C78584CB40C80EB5C447F41630" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_5B2604C78584CB40C80EB5C447F41630" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense_5B2604C78584CB40C80EB5C447F41630" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense_5B2604C78584CB40C80EB5C447F41630" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseCost_0BD45F85503FA0B51657B5C447F79E84_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost_0BD45F85503FA0B51657B5C447F79E84" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_0BD45F85503FA0B51657B5C447F79E84_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost_0BD45F85503FA0B51657B5C447F79E84" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_0BD45F85503FA0B51657B5C447F79E84" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost_0BD45F85503FA0B51657B5C447F79E84" xlink:to="lab_us-gaap_OperatingLeaseCost_0BD45F85503FA0B51657B5C447F79E84" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShortTermLeaseCost_1B63265868C69C1CE938B5C447FBC98A_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost_1B63265868C69C1CE938B5C447FBC98A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_1B63265868C69C1CE938B5C447FBC98A_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost_1B63265868C69C1CE938B5C447FBC98A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaap_ShortTermLeaseCost_1B63265868C69C1CE938B5C447FBC98A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost_1B63265868C69C1CE938B5C447FBC98A" xlink:to="lab_us-gaap_ShortTermLeaseCost_1B63265868C69C1CE938B5C447FBC98A" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableLeaseCost_EFF51D2CFFF020CFFCB6B5C447FE4050_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost_EFF51D2CFFF020CFFCB6B5C447FE4050" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_EFF51D2CFFF020CFFCB6B5C447FE4050_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost_EFF51D2CFFF020CFFCB6B5C447FE4050" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost_EFF51D2CFFF020CFFCB6B5C447FE4050" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost_EFF51D2CFFF020CFFCB6B5C447FE4050" xlink:to="lab_us-gaap_VariableLeaseCost_EFF51D2CFFF020CFFCB6B5C447FE4050" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseCost_F4F7279B9A730B183AEFB5C49E8841BF_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost_F4F7279B9A730B183AEFB5C49E8841BF" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_F4F7279B9A730B183AEFB5C49E8841BF_label_en-US" xlink:label="lab_us-gaap_LeaseCost_F4F7279B9A730B183AEFB5C49E8841BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_F4F7279B9A730B183AEFB5C49E8841BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost_F4F7279B9A730B183AEFB5C49E8841BF" xlink:to="lab_us-gaap_LeaseCost_F4F7279B9A730B183AEFB5C49E8841BF" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_59B4F365B83EDD51F5D6D354A4B4308E_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock_59B4F365B83EDD51F5D6D354A4B4308E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases And Other Commitments</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_59B4F365B83EDD51F5D6D354A4B4308E_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock_59B4F365B83EDD51F5D6D354A4B4308E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_59B4F365B83EDD51F5D6D354A4B4308E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock_59B4F365B83EDD51F5D6D354A4B4308E" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock_59B4F365B83EDD51F5D6D354A4B4308E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_DED5E8CAE1CC8DBEA2BCD354A4B4721C_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock_DED5E8CAE1CC8DBEA2BCD354A4B4721C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases And Other Commitments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_DED5E8CAE1CC8DBEA2BCD354A4B4721C_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock_DED5E8CAE1CC8DBEA2BCD354A4B4721C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_DED5E8CAE1CC8DBEA2BCD354A4B4721C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock_DED5E8CAE1CC8DBEA2BCD354A4B4721C" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock_DED5E8CAE1CC8DBEA2BCD354A4B4721C" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_EFD8F101D1611977230BD354A46311B5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_EFD8F101D1611977230BD354A46311B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_EFD8F101D1611977230BD354A46311B5_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_EFD8F101D1611977230BD354A46311B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_EFD8F101D1611977230BD354A46311B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_EFD8F101D1611977230BD354A46311B5" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_EFD8F101D1611977230BD354A46311B5" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_E11946B49421B07EEF2AD354A46F9013_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_E11946B49421B07EEF2AD354A46F9013" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_E11946B49421B07EEF2AD354A46F9013" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_E11946B49421B07EEF2AD354A46F9013" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_E11946B49421B07EEF2AD354A46F9013" xlink:type="arc" />
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_55F0EB9BD0FC706F1459D354A46F7FF5_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock_55F0EB9BD0FC706F1459D354A46F7FF5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_55F0EB9BD0FC706F1459D354A46F7FF5_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock_55F0EB9BD0FC706F1459D354A46F7FF5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_55F0EB9BD0FC706F1459D354A46F7FF5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock_55F0EB9BD0FC706F1459D354A46F7FF5" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock_55F0EB9BD0FC706F1459D354A46F7FF5" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_2195FAFC15E465ED42E3B4DBD5EF6AC8_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract_2195FAFC15E465ED42E3B4DBD5EF6AC8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2195FAFC15E465ED42E3B4DBD5EF6AC8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2195FAFC15E465ED42E3B4DBD5EF6AC8" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract_2195FAFC15E465ED42E3B4DBD5EF6AC8" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_FB384A715A6EC403C2EFB4DBD5EF4F9F_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_FB384A715A6EC403C2EFB4DBD5EF4F9F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_FB384A715A6EC403C2EFB4DBD5EF4F9F_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_FB384A715A6EC403C2EFB4DBD5EF4F9F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_FB384A715A6EC403C2EFB4DBD5EF4F9F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_FB384A715A6EC403C2EFB4DBD5EF4F9F" xlink:to="lab_us-gaap_IncomeStatementLocationAxis_FB384A715A6EC403C2EFB4DBD5EF4F9F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_ABAA715A65B9735DB37FB4DBD5F04F29_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_ABAA715A65B9735DB37FB4DBD5F04F29" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_ABAA715A65B9735DB37FB4DBD5F04F29_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_ABAA715A65B9735DB37FB4DBD5F04F29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ABAA715A65B9735DB37FB4DBD5F04F29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ABAA715A65B9735DB37FB4DBD5F04F29" xlink:to="lab_us-gaap_IncomeStatementLocationDomain_ABAA715A65B9735DB37FB4DBD5F04F29" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_8AADA925EC024D15375DB4DBD5F08C59_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_8AADA925EC024D15375DB4DBD5F08C59" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_8AADA925EC024D15375DB4DBD5F08C59_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_8AADA925EC024D15375DB4DBD5F08C59" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_8AADA925EC024D15375DB4DBD5F08C59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_8AADA925EC024D15375DB4DBD5F08C59" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_8AADA925EC024D15375DB4DBD5F08C59" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_2B05C5D22F897D7B74A4B4DBD5F12059_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_2B05C5D22F897D7B74A4B4DBD5F12059" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_2B05C5D22F897D7B74A4B4DBD5F12059_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_2B05C5D22F897D7B74A4B4DBD5F12059" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2B05C5D22F897D7B74A4B4DBD5F12059" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2B05C5D22F897D7B74A4B4DBD5F12059" xlink:to="lab_us-gaap_BalanceSheetLocationAxis_2B05C5D22F897D7B74A4B4DBD5F12059" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_208293FD9F9CC6BCD0EEB4DBD5F1628E_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_208293FD9F9CC6BCD0EEB4DBD5F1628E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_208293FD9F9CC6BCD0EEB4DBD5F1628E_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_208293FD9F9CC6BCD0EEB4DBD5F1628E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_208293FD9F9CC6BCD0EEB4DBD5F1628E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_208293FD9F9CC6BCD0EEB4DBD5F1628E" xlink:to="lab_us-gaap_BalanceSheetLocationDomain_208293FD9F9CC6BCD0EEB4DBD5F1628E" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_D9BE5DC09227C3F315C3B4DBD5F229F6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember_D9BE5DC09227C3F315C3B4DBD5F229F6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_D9BE5DC09227C3F315C3B4DBD5F229F6_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember_D9BE5DC09227C3F315C3B4DBD5F229F6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_D9BE5DC09227C3F315C3B4DBD5F229F6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember_D9BE5DC09227C3F315C3B4DBD5F229F6" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember_D9BE5DC09227C3F315C3B4DBD5F229F6" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationAxis_75CFC219AB0773A9AC27B4DBD5F2AD8B_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_75CFC219AB0773A9AC27B4DBD5F2AD8B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_75CFC219AB0773A9AC27B4DBD5F2AD8B_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_75CFC219AB0773A9AC27B4DBD5F2AD8B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_75CFC219AB0773A9AC27B4DBD5F2AD8B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis_75CFC219AB0773A9AC27B4DBD5F2AD8B" xlink:to="lab_us-gaap_HedgingDesignationAxis_75CFC219AB0773A9AC27B4DBD5F2AD8B" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationDomain_838153BE87C882B66195B4DBD5F37288_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_838153BE87C882B66195B4DBD5F37288" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_838153BE87C882B66195B4DBD5F37288_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_838153BE87C882B66195B4DBD5F37288" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_838153BE87C882B66195B4DBD5F37288" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain_838153BE87C882B66195B4DBD5F37288" xlink:to="lab_us-gaap_HedgingDesignationDomain_838153BE87C882B66195B4DBD5F37288" xlink:type="arc" />
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_250A5ED8D1CA979A6777B4DBD5F36360_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember_250A5ED8D1CA979A6777B4DBD5F36360" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_250A5ED8D1CA979A6777B4DBD5F36360_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember_250A5ED8D1CA979A6777B4DBD5F36360" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_250A5ED8D1CA979A6777B4DBD5F36360" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember_250A5ED8D1CA979A6777B4DBD5F36360" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember_250A5ED8D1CA979A6777B4DBD5F36360" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_11BF5A32F38BACAEAF76B4DBD5F3A2B5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_11BF5A32F38BACAEAF76B4DBD5F3A2B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_11BF5A32F38BACAEAF76B4DBD5F3A2B5_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_11BF5A32F38BACAEAF76B4DBD5F3A2B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_11BF5A32F38BACAEAF76B4DBD5F3A2B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_11BF5A32F38BACAEAF76B4DBD5F3A2B5" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis_11BF5A32F38BACAEAF76B4DBD5F3A2B5" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_016BF54C3478F1958315B4DBD5F4B74E_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_016BF54C3478F1958315B4DBD5F4B74E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_016BF54C3478F1958315B4DBD5F4B74E_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_016BF54C3478F1958315B4DBD5F4B74E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_016BF54C3478F1958315B4DBD5F4B74E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_016BF54C3478F1958315B4DBD5F4B74E" xlink:to="lab_us-gaap_DerivativeContractTypeDomain_016BF54C3478F1958315B4DBD5F4B74E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_07F09065AE3DA6CD931CB4DBD5F4375A_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember_07F09065AE3DA6CD931CB4DBD5F4375A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_07F09065AE3DA6CD931CB4DBD5F4375A_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember_07F09065AE3DA6CD931CB4DBD5F4375A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_07F09065AE3DA6CD931CB4DBD5F4375A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember_07F09065AE3DA6CD931CB4DBD5F4375A" xlink:to="lab_us-gaap_ForeignExchangeForwardMember_07F09065AE3DA6CD931CB4DBD5F4375A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_B053B0281EC3999DFC41B4DBD5FA98B9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_B053B0281EC3999DFC41B4DBD5FA98B9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transfers between Level 1 and Level 2 securities</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_B053B0281EC3999DFC41B4DBD5FA98B9_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_B053B0281EC3999DFC41B4DBD5FA98B9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets, Level 1 to Level 2 Transfers, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:label="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_B053B0281EC3999DFC41B4DBD5FA98B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_B053B0281EC3999DFC41B4DBD5FA98B9" xlink:to="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_B053B0281EC3999DFC41B4DBD5FA98B9" xlink:type="arc" />
    <link:label id="lab_dxcm_FairValueAssetsLevel3TransfersAmount_620C63C0B484FEC62255B4DBD5FA595F_terseLabel_en-US" xlink:label="lab_dxcm_FairValueAssetsLevel3TransfersAmount_620C63C0B484FEC62255B4DBD5FA595F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transfers in or out of Level 3 securities</link:label>
    <link:label id="lab_dxcm_FairValueAssetsLevel3TransfersAmount_620C63C0B484FEC62255B4DBD5FA595F_label_en-US" xlink:label="lab_dxcm_FairValueAssetsLevel3TransfersAmount_620C63C0B484FEC62255B4DBD5FA595F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets, Level 3 Transfers, Amount</link:label>
    <link:label id="lab_dxcm_FairValueAssetsLevel3TransfersAmount_620C63C0B484FEC62255B4DBD5FA595F_documentation_en-US" xlink:label="lab_dxcm_FairValueAssetsLevel3TransfersAmount_620C63C0B484FEC62255B4DBD5FA595F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value, Assets, Level 3 Transfers, Amount</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FairValueAssetsLevel3TransfersAmount" xlink:label="loc_dxcm_FairValueAssetsLevel3TransfersAmount_620C63C0B484FEC62255B4DBD5FA595F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FairValueAssetsLevel3TransfersAmount_620C63C0B484FEC62255B4DBD5FA595F" xlink:to="lab_dxcm_FairValueAssetsLevel3TransfersAmount_620C63C0B484FEC62255B4DBD5FA595F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_6BEF7075439523723CFEB4DBD5FB8924_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount_6BEF7075439523723CFEB4DBD5FB8924" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notional amount of outstanding hedge to currency risk</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_6BEF7075439523723CFEB4DBD5FB8924_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount_6BEF7075439523723CFEB4DBD5FB8924" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount" xlink:label="loc_us-gaap_DerivativeNotionalAmount_6BEF7075439523723CFEB4DBD5FB8924" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount_6BEF7075439523723CFEB4DBD5FB8924" xlink:to="lab_us-gaap_DerivativeNotionalAmount_6BEF7075439523723CFEB4DBD5FB8924" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_CF5C638F8E4B208B98C7B4DBD5FB5F4C_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_CF5C638F8E4B208B98C7B4DBD5FB5F4C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gains on forward exchange contract</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_CF5C638F8E4B208B98C7B4DBD5FB5F4C_label_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_CF5C638F8E4B208B98C7B4DBD5FB5F4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_CF5C638F8E4B208B98C7B4DBD5FB5F4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_CF5C638F8E4B208B98C7B4DBD5FB5F4C" xlink:to="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_CF5C638F8E4B208B98C7B4DBD5FB5F4C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgesLiabilities_C976C88CDF174D8936FAB4DBD5FB5E06_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgesLiabilities_C976C88CDF174D8936FAB4DBD5FB5E06" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recorded net exchange derivative instrument liability</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgesLiabilities_C976C88CDF174D8936FAB4DBD5FB5E06_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgesLiabilities_C976C88CDF174D8936FAB4DBD5FB5E06" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedges, Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgesLiabilities" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgesLiabilities_C976C88CDF174D8936FAB4DBD5FB5E06" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgesLiabilities_C976C88CDF174D8936FAB4DBD5FB5E06" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgesLiabilities_C976C88CDF174D8936FAB4DBD5FB5E06" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_7903C5773ADD021DAF3BB4DBD5FBE62E_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_7903C5773ADD021DAF3BB4DBD5FBE62E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and intangible asset impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_7903C5773ADD021DAF3BB4DBD5FBE62E_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_7903C5773ADD021DAF3BB4DBD5FBE62E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_7903C5773ADD021DAF3BB4DBD5FBE62E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_7903C5773ADD021DAF3BB4DBD5FBE62E" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_7903C5773ADD021DAF3BB4DBD5FBE62E" xlink:type="arc" />
    <link:label id="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_CFBC584B5328240087D6B58D6EC976DF_label_en-US" xlink:label="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_CFBC584B5328240087D6B58D6EC976DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_CFBC584B5328240087D6B58D6EC976DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_CFBC584B5328240087D6B58D6EC976DF" xlink:to="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_CFBC584B5328240087D6B58D6EC976DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_D718C07682994E3E137AB58EB21FC902_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_D718C07682994E3E137AB58EB21FC902" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net gain recognized on equity securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_D718C07682994E3E137AB58EB21FC902_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_D718C07682994E3E137AB58EB21FC902" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale, Gain (Loss) [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_D718C07682994E3E137AB58EB21FC902" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_D718C07682994E3E137AB58EB21FC902" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_D718C07682994E3E137AB58EB21FC902" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_606B3B02870674804D0FB58EB2217FD5_totalLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_606B3B02870674804D0FB58EB2217FD5" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net gains and losses recognized during the period on equity securities</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_606B3B02870674804D0FB58EB2217FD5_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_606B3B02870674804D0FB58EB2217FD5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt and Equity Securities, Gain (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_606B3B02870674804D0FB58EB2217FD5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_606B3B02870674804D0FB58EB2217FD5" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_606B3B02870674804D0FB58EB2217FD5" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_7B8470CFEC11E9E44051B58EB221122A_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_7B8470CFEC11E9E44051B58EB221122A" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: Net gains and losses recognized during the period on equity securities sold during the period</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_7B8470CFEC11E9E44051B58EB221122A_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_7B8470CFEC11E9E44051B58EB221122A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt and Equity Securities, Realized Gain (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_7B8470CFEC11E9E44051B58EB221122A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_7B8470CFEC11E9E44051B58EB221122A" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_7B8470CFEC11E9E44051B58EB221122A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_3199A64948C3D187012CB58EB2216417_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_3199A64948C3D187012CB58EB2216417" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gains recognized during the reporting period on equity securities still held at the reporting date</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_3199A64948C3D187012CB58EB2216417_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_3199A64948C3D187012CB58EB2216417" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt and Equity Securities, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_3199A64948C3D187012CB58EB2216417" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_3199A64948C3D187012CB58EB2216417" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_3199A64948C3D187012CB58EB2216417" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskTable_5AB5C445F1F657856C38C9C2EB302C01_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable_5AB5C445F1F657856C38C9C2EB302C01" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_5AB5C445F1F657856C38C9C2EB302C01_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable_5AB5C445F1F657856C38C9C2EB302C01" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_5AB5C445F1F657856C38C9C2EB302C01" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable_5AB5C445F1F657856C38C9C2EB302C01" xlink:to="lab_us-gaap_ConcentrationRiskTable_5AB5C445F1F657856C38C9C2EB302C01" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_2B21FFB60973A0949618C9C2EB300C0F_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_2B21FFB60973A0949618C9C2EB300C0F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_2B21FFB60973A0949618C9C2EB300C0F_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_2B21FFB60973A0949618C9C2EB300C0F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2B21FFB60973A0949618C9C2EB300C0F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2B21FFB60973A0949618C9C2EB300C0F" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_2B21FFB60973A0949618C9C2EB300C0F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_C37A8953DB378A29516DC9C2EB318F30_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain_C37A8953DB378A29516DC9C2EB318F30" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_C37A8953DB378A29516DC9C2EB318F30_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain_C37A8953DB378A29516DC9C2EB318F30" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_C37A8953DB378A29516DC9C2EB318F30" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_C37A8953DB378A29516DC9C2EB318F30" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain_C37A8953DB378A29516DC9C2EB318F30" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesRevenueNetMember_0FD8ACC431588936D886C9C2EB31E91C_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember_0FD8ACC431588936D886C9C2EB31E91C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_0FD8ACC431588936D886C9C2EB31E91C_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember_0FD8ACC431588936D886C9C2EB31E91C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_0FD8ACC431588936D886C9C2EB31E91C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember_0FD8ACC431588936D886C9C2EB31E91C" xlink:to="lab_us-gaap_SalesRevenueNetMember_0FD8ACC431588936D886C9C2EB31E91C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableMember_9756397D2972FE3710C8C9C55B861118_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember_9756397D2972FE3710C8C9C55B861118" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_9756397D2972FE3710C8C9C55B861118_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember_9756397D2972FE3710C8C9C55B861118" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_9756397D2972FE3710C8C9C55B861118" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember_9756397D2972FE3710C8C9C55B861118" xlink:to="lab_us-gaap_AccountsReceivableMember_9756397D2972FE3710C8C9C55B861118" xlink:type="arc" />
    <link:label id="lab_srt_MajorCustomersAxis_43A9B44E8C160B0A9DE0C9C2EB314A03_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis_43A9B44E8C160B0A9DE0C9C2EB314A03" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_43A9B44E8C160B0A9DE0C9C2EB314A03_label_en-US" xlink:label="lab_srt_MajorCustomersAxis_43A9B44E8C160B0A9DE0C9C2EB314A03" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_43A9B44E8C160B0A9DE0C9C2EB314A03" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis_43A9B44E8C160B0A9DE0C9C2EB314A03" xlink:to="lab_srt_MajorCustomersAxis_43A9B44E8C160B0A9DE0C9C2EB314A03" xlink:type="arc" />
    <link:label id="lab_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E" xlink:to="lab_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E" xlink:type="arc" />
    <link:label id="lab_dxcm_CustomerAMember_5820A7163862FA736D5AC9C2EB32E12B_terseLabel_en-US" xlink:label="lab_dxcm_CustomerAMember_5820A7163862FA736D5AC9C2EB32E12B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distributor A</link:label>
    <link:label id="lab_dxcm_CustomerAMember_5820A7163862FA736D5AC9C2EB32E12B_label_en-US" xlink:label="lab_dxcm_CustomerAMember_5820A7163862FA736D5AC9C2EB32E12B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer A [Member]</link:label>
    <link:label id="lab_dxcm_CustomerAMember_5820A7163862FA736D5AC9C2EB32E12B_documentation_en-US" xlink:label="lab_dxcm_CustomerAMember_5820A7163862FA736D5AC9C2EB32E12B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer A [Member]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CustomerAMember" xlink:label="loc_dxcm_CustomerAMember_5820A7163862FA736D5AC9C2EB32E12B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CustomerAMember_5820A7163862FA736D5AC9C2EB32E12B" xlink:to="lab_dxcm_CustomerAMember_5820A7163862FA736D5AC9C2EB32E12B" xlink:type="arc" />
    <link:label id="lab_dxcm_CustomerBMember_3D3A908A659BF3812A5CC9C2EB33A30D_terseLabel_en-US" xlink:label="lab_dxcm_CustomerBMember_3D3A908A659BF3812A5CC9C2EB33A30D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distributor B</link:label>
    <link:label id="lab_dxcm_CustomerBMember_3D3A908A659BF3812A5CC9C2EB33A30D_label_en-US" xlink:label="lab_dxcm_CustomerBMember_3D3A908A659BF3812A5CC9C2EB33A30D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer B [Member]</link:label>
    <link:label id="lab_dxcm_CustomerBMember_3D3A908A659BF3812A5CC9C2EB33A30D_documentation_en-US" xlink:label="lab_dxcm_CustomerBMember_3D3A908A659BF3812A5CC9C2EB33A30D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer B [Member]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CustomerBMember" xlink:label="loc_dxcm_CustomerBMember_3D3A908A659BF3812A5CC9C2EB33A30D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CustomerBMember_3D3A908A659BF3812A5CC9C2EB33A30D" xlink:to="lab_dxcm_CustomerBMember_3D3A908A659BF3812A5CC9C2EB33A30D" xlink:type="arc" />
    <link:label id="lab_dxcm_CustomerCMember_DA9C8ACF6508BE42BB95C9C2EB33F43F_terseLabel_en-US" xlink:label="lab_dxcm_CustomerCMember_DA9C8ACF6508BE42BB95C9C2EB33F43F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distributor C</link:label>
    <link:label id="lab_dxcm_CustomerCMember_DA9C8ACF6508BE42BB95C9C2EB33F43F_label_en-US" xlink:label="lab_dxcm_CustomerCMember_DA9C8ACF6508BE42BB95C9C2EB33F43F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer C [Member]</link:label>
    <link:label id="lab_dxcm_CustomerCMember_DA9C8ACF6508BE42BB95C9C2EB33F43F_documentation_en-US" xlink:label="lab_dxcm_CustomerCMember_DA9C8ACF6508BE42BB95C9C2EB33F43F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer C [Member]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CustomerCMember" xlink:label="loc_dxcm_CustomerCMember_DA9C8ACF6508BE42BB95C9C2EB33F43F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CustomerCMember_DA9C8ACF6508BE42BB95C9C2EB33F43F" xlink:to="lab_dxcm_CustomerCMember_DA9C8ACF6508BE42BB95C9C2EB33F43F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_24620DA3E2C9566CD3E2C9C2EB340E3B_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems_24620DA3E2C9566CD3E2C9C2EB340E3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_24620DA3E2C9566CD3E2C9C2EB340E3B_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems_24620DA3E2C9566CD3E2C9C2EB340E3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_24620DA3E2C9566CD3E2C9C2EB340E3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_24620DA3E2C9566CD3E2C9C2EB340E3B" xlink:to="lab_us-gaap_ConcentrationRiskLineItems_24620DA3E2C9566CD3E2C9C2EB340E3B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_9B86475E1B6CAF78102AC9C2EB34D954_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1_9B86475E1B6CAF78102AC9C2EB34D954" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration risk (as a percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_9B86475E1B6CAF78102AC9C2EB34D954_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1_9B86475E1B6CAF78102AC9C2EB34D954" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_9B86475E1B6CAF78102AC9C2EB34D954" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1_9B86475E1B6CAF78102AC9C2EB34D954" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1_9B86475E1B6CAF78102AC9C2EB34D954" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_343E9A3BC068E0788C083A2764DC3EE2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_343E9A3BC068E0788C083A2764DC3EE2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_343E9A3BC068E0788C083A2764DC3EE2_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_343E9A3BC068E0788C083A2764DC3EE2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_343E9A3BC068E0788C083A2764DC3EE2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_343E9A3BC068E0788C083A2764DC3EE2" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_343E9A3BC068E0788C083A2764DC3EE2" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityComponentDomain_E1D12C14F6A3ACC70BD63A2764DDC677_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_E1D12C14F6A3ACC70BD63A2764DDC677" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_E1D12C14F6A3ACC70BD63A2764DDC677_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_E1D12C14F6A3ACC70BD63A2764DDC677" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_E1D12C14F6A3ACC70BD63A2764DDC677" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain_E1D12C14F6A3ACC70BD63A2764DDC677" xlink:to="lab_us-gaap_EquityComponentDomain_E1D12C14F6A3ACC70BD63A2764DDC677" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsMember_DEE6EF3C15E3BEBEF0653A2764DDF936_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_DEE6EF3C15E3BEBEF0653A2764DDF936" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_DEE6EF3C15E3BEBEF0653A2764DDF936_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_DEE6EF3C15E3BEBEF0653A2764DDF936" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_DEE6EF3C15E3BEBEF0653A2764DDF936" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_DEE6EF3C15E3BEBEF0653A2764DDF936" xlink:to="lab_us-gaap_RetainedEarningsMember_DEE6EF3C15E3BEBEF0653A2764DDF936" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_47330AC54A7524DFCE5C3A2764DD9246_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_47330AC54A7524DFCE5C3A2764DD9246" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_47330AC54A7524DFCE5C3A2764DD9246_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_47330AC54A7524DFCE5C3A2764DD9246" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_47330AC54A7524DFCE5C3A2764DD9246" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_47330AC54A7524DFCE5C3A2764DD9246" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_47330AC54A7524DFCE5C3A2764DD9246" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_B987B2EF35BF89D0ECCF3A2764DD2714_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember_B987B2EF35BF89D0ECCF3A2764DD2714" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_B987B2EF35BF89D0ECCF3A2764DD2714_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember_B987B2EF35BF89D0ECCF3A2764DD2714" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_B987B2EF35BF89D0ECCF3A2764DD2714" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember_B987B2EF35BF89D0ECCF3A2764DD2714" xlink:to="lab_us-gaap_TypeOfAdoptionMember_B987B2EF35BF89D0ECCF3A2764DD2714" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_8AC4F3F195232E7483DA3A2764DECCC1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member_8AC4F3F195232E7483DA3A2764DECCC1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2016-02</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_8AC4F3F195232E7483DA3A2764DECCC1_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member_8AC4F3F195232E7483DA3A2764DECCC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_8AC4F3F195232E7483DA3A2764DECCC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member_8AC4F3F195232E7483DA3A2764DECCC1" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member_8AC4F3F195232E7483DA3A2764DECCC1" xlink:type="arc" />
    <link:label id="lab_srt_RangeAxis_7A25662C5619A92BA1BF3A2764DE1585_terseLabel_en-US" xlink:label="lab_srt_RangeAxis_7A25662C5619A92BA1BF3A2764DE1585" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_7A25662C5619A92BA1BF3A2764DE1585_label_en-US" xlink:label="lab_srt_RangeAxis_7A25662C5619A92BA1BF3A2764DE1585" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_7A25662C5619A92BA1BF3A2764DE1585" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_7A25662C5619A92BA1BF3A2764DE1585" xlink:to="lab_srt_RangeAxis_7A25662C5619A92BA1BF3A2764DE1585" xlink:type="arc" />
    <link:label id="lab_srt_RangeMember_BB8900FCF4D1604A5FE93A2764DED09A_terseLabel_en-US" xlink:label="lab_srt_RangeMember_BB8900FCF4D1604A5FE93A2764DED09A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_BB8900FCF4D1604A5FE93A2764DED09A_label_en-US" xlink:label="lab_srt_RangeMember_BB8900FCF4D1604A5FE93A2764DED09A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_BB8900FCF4D1604A5FE93A2764DED09A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember_BB8900FCF4D1604A5FE93A2764DED09A" xlink:to="lab_srt_RangeMember_BB8900FCF4D1604A5FE93A2764DED09A" xlink:type="arc" />
    <link:label id="lab_srt_MinimumMember_12CFD2EC9E6A19523A243A2764DF311E_terseLabel_en-US" xlink:label="lab_srt_MinimumMember_12CFD2EC9E6A19523A243A2764DF311E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_12CFD2EC9E6A19523A243A2764DF311E_label_en-US" xlink:label="lab_srt_MinimumMember_12CFD2EC9E6A19523A243A2764DF311E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_12CFD2EC9E6A19523A243A2764DF311E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_12CFD2EC9E6A19523A243A2764DF311E" xlink:to="lab_srt_MinimumMember_12CFD2EC9E6A19523A243A2764DF311E" xlink:type="arc" />
    <link:label id="lab_srt_MaximumMember_BBF067BC689A612156D63A2764DF4DD2_terseLabel_en-US" xlink:label="lab_srt_MaximumMember_BBF067BC689A612156D63A2764DF4DD2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_BBF067BC689A612156D63A2764DF4DD2_label_en-US" xlink:label="lab_srt_MaximumMember_BBF067BC689A612156D63A2764DF4DD2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_BBF067BC689A612156D63A2764DF4DD2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_BBF067BC689A612156D63A2764DF4DD2" xlink:to="lab_srt_MaximumMember_BBF067BC689A612156D63A2764DF4DD2" xlink:type="arc" />
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_7140D3AE54EB34461D633A2764DF9106_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_7140D3AE54EB34461D633A2764DF9106" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_7140D3AE54EB34461D633A2764DF9106_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_7140D3AE54EB34461D633A2764DF9106" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_7140D3AE54EB34461D633A2764DF9106" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_7140D3AE54EB34461D633A2764DF9106" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_7140D3AE54EB34461D633A2764DF9106" xlink:type="arc" />
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_1D4D2DA5F2FF2341ECE53A2764DF2B80_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_1D4D2DA5F2FF2341ECE53A2764DF2B80" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_1D4D2DA5F2FF2341ECE53A2764DF2B80_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_1D4D2DA5F2FF2341ECE53A2764DF2B80" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_1D4D2DA5F2FF2341ECE53A2764DF2B80" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_1D4D2DA5F2FF2341ECE53A2764DF2B80" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_1D4D2DA5F2FF2341ECE53A2764DF2B80" xlink:type="arc" />
    <link:label id="lab_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member_EE14EF89862B4864C7673A2764E0C198_terseLabel_en-US" xlink:label="lab_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member_EE14EF89862B4864C7673A2764E0C198" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leased Buildings - Mesa, Arizona Expiring March 2028</link:label>
    <link:label id="lab_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member_EE14EF89862B4864C7673A2764E0C198_label_en-US" xlink:label="lab_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member_EE14EF89862B4864C7673A2764E0C198" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leased Buildings - Mesa, Arizona Expiring March 2028 [Member]</link:label>
    <link:label id="lab_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member_EE14EF89862B4864C7673A2764E0C198_documentation_en-US" xlink:label="lab_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member_EE14EF89862B4864C7673A2764E0C198" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Leased Buildings - Mesa, Arizona Expiring March 2028 [Member]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member" xlink:label="loc_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member_EE14EF89862B4864C7673A2764E0C198" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member_EE14EF89862B4864C7673A2764E0C198" xlink:to="lab_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member_EE14EF89862B4864C7673A2764E0C198" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_E1E29B38D3A9B16225683A2764E075D5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_E1E29B38D3A9B16225683A2764E075D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_E1E29B38D3A9B16225683A2764E075D5_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_E1E29B38D3A9B16225683A2764E075D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_E1E29B38D3A9B16225683A2764E075D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_E1E29B38D3A9B16225683A2764E075D5" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_E1E29B38D3A9B16225683A2764E075D5" xlink:type="arc" />
    <link:label id="lab_dxcm_NumberofFinancingLeases_AA685F70F10C8CB1310F3A2764E05412_terseLabel_en-US" xlink:label="lab_dxcm_NumberofFinancingLeases_AA685F70F10C8CB1310F3A2764E05412" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of financing leases</link:label>
    <link:label id="lab_dxcm_NumberofFinancingLeases_AA685F70F10C8CB1310F3A2764E05412_label_en-US" xlink:label="lab_dxcm_NumberofFinancingLeases_AA685F70F10C8CB1310F3A2764E05412" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Financing Leases</link:label>
    <link:label id="lab_dxcm_NumberofFinancingLeases_AA685F70F10C8CB1310F3A2764E05412_documentation_en-US" xlink:label="lab_dxcm_NumberofFinancingLeases_AA685F70F10C8CB1310F3A2764E05412" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Financing Leases</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_NumberofFinancingLeases" xlink:label="loc_dxcm_NumberofFinancingLeases_AA685F70F10C8CB1310F3A2764E05412" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_NumberofFinancingLeases_AA685F70F10C8CB1310F3A2764E05412" xlink:to="lab_dxcm_NumberofFinancingLeases_AA685F70F10C8CB1310F3A2764E05412" xlink:type="arc" />
    <link:label id="lab_dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_C8AE1E37CBF65712095D3A2764E09D2E_terseLabel_en-US" xlink:label="lab_dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_C8AE1E37CBF65712095D3A2764E09D2E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of renewal terms</link:label>
    <link:label id="lab_dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_C8AE1E37CBF65712095D3A2764E09D2E_label_en-US" xlink:label="lab_dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_C8AE1E37CBF65712095D3A2764E09D2E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Leasing Arrangements, Operating Leases, Number Of Renewal Terms</link:label>
    <link:label id="lab_dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_C8AE1E37CBF65712095D3A2764E09D2E_documentation_en-US" xlink:label="lab_dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_C8AE1E37CBF65712095D3A2764E09D2E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Leasing Arrangements, Operating Leases, Number Of Renewal Terms</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms" xlink:label="loc_dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_C8AE1E37CBF65712095D3A2764E09D2E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_C8AE1E37CBF65712095D3A2764E09D2E" xlink:to="lab_dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_C8AE1E37CBF65712095D3A2764E09D2E" xlink:type="arc" />
    <link:label id="lab_dxcm_LesseeOperatingLeaseRemainingLeaseTerm_2C56B2F3D471F7D6D1FA3A2764E12B0B_terseLabel_en-US" xlink:label="lab_dxcm_LesseeOperatingLeaseRemainingLeaseTerm_2C56B2F3D471F7D6D1FA3A2764E12B0B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining lease terms</link:label>
    <link:label id="lab_dxcm_LesseeOperatingLeaseRemainingLeaseTerm_2C56B2F3D471F7D6D1FA3A2764E12B0B_label_en-US" xlink:label="lab_dxcm_LesseeOperatingLeaseRemainingLeaseTerm_2C56B2F3D471F7D6D1FA3A2764E12B0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:label id="lab_dxcm_LesseeOperatingLeaseRemainingLeaseTerm_2C56B2F3D471F7D6D1FA3A2764E12B0B_documentation_en-US" xlink:label="lab_dxcm_LesseeOperatingLeaseRemainingLeaseTerm_2C56B2F3D471F7D6D1FA3A2764E12B0B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="loc_dxcm_LesseeOperatingLeaseRemainingLeaseTerm_2C56B2F3D471F7D6D1FA3A2764E12B0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LesseeOperatingLeaseRemainingLeaseTerm_2C56B2F3D471F7D6D1FA3A2764E12B0B" xlink:to="lab_dxcm_LesseeOperatingLeaseRemainingLeaseTerm_2C56B2F3D471F7D6D1FA3A2764E12B0B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_1A975ECCA241CFC58AA23A2764E1CF4D_terseLabel_en-US" xlink:label="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_1A975ECCA241CFC58AA23A2764E1CF4D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative-effect adjustment</link:label>
    <link:label id="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_1A975ECCA241CFC58AA23A2764E1CF4D_label_en-US" xlink:label="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_1A975ECCA241CFC58AA23A2764E1CF4D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Effect of New Accounting Principle in Period of Adoption</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_1A975ECCA241CFC58AA23A2764E1CF4D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_1A975ECCA241CFC58AA23A2764E1CF4D" xlink:to="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_1A975ECCA241CFC58AA23A2764E1CF4D" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_C62DB0DDC3F7C582214D3A2764E10687_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_C62DB0DDC3F7C582214D3A2764E10687" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_C62DB0DDC3F7C582214D3A2764E10687_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_C62DB0DDC3F7C582214D3A2764E10687" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_C62DB0DDC3F7C582214D3A2764E10687" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_C62DB0DDC3F7C582214D3A2764E10687" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_C62DB0DDC3F7C582214D3A2764E10687" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_A12CB4515FEF257E47433A2764E181B4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset_A12CB4515FEF257E47433A2764E181B4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_A12CB4515FEF257E47433A2764E181B4_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset_A12CB4515FEF257E47433A2764E181B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_A12CB4515FEF257E47433A2764E181B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_A12CB4515FEF257E47433A2764E181B4" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset_A12CB4515FEF257E47433A2764E181B4" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiability_19781CF694EF7D260E483A2764E12BA4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_19781CF694EF7D260E483A2764E12BA4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_19781CF694EF7D260E483A2764E12BA4_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_19781CF694EF7D260E483A2764E12BA4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_19781CF694EF7D260E483A2764E12BA4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_19781CF694EF7D260E483A2764E12BA4" xlink:to="lab_us-gaap_OperatingLeaseLiability_19781CF694EF7D260E483A2764E12BA4" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiability_BB47EA3721F5FBFB0B903A2764E22FF5_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability_BB47EA3721F5FBFB0B903A2764E22FF5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_BB47EA3721F5FBFB0B903A2764E22FF5_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability_BB47EA3721F5FBFB0B903A2764E22FF5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_BB47EA3721F5FBFB0B903A2764E22FF5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability_BB47EA3721F5FBFB0B903A2764E22FF5" xlink:to="lab_us-gaap_FinanceLeaseLiability_BB47EA3721F5FBFB0B903A2764E22FF5" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_DA3E660FE29EA8B75C503A2764E2A7CC_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense_DA3E660FE29EA8B75C503A2764E2A7CC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rent expense</link:label>
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_DA3E660FE29EA8B75C503A2764E2A7CC_label_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense_DA3E660FE29EA8B75C503A2764E2A7CC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Rent Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_DA3E660FE29EA8B75C503A2764E2A7CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseAndRentalExpense_DA3E660FE29EA8B75C503A2764E2A7CC" xlink:to="lab_us-gaap_LeaseAndRentalExpense_DA3E660FE29EA8B75C503A2764E2A7CC" xlink:type="arc" />
    <link:label id="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization_409A8543D7B5524486D23A2764E263F2_terseLabel_en-US" xlink:label="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization_409A8543D7B5524486D23A2764E263F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of operating lease right-of-use asset</link:label>
    <link:label id="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization_409A8543D7B5524486D23A2764E263F2_label_en-US" xlink:label="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization_409A8543D7B5524486D23A2764E263F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases, Lease Cost, Amortization</link:label>
    <link:label id="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization_409A8543D7B5524486D23A2764E263F2_documentation_en-US" xlink:label="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization_409A8543D7B5524486D23A2764E263F2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases, Lease Cost, Amortization</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LesseeOperatingLeasesLeaseCostAmortization" xlink:label="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization_409A8543D7B5524486D23A2764E263F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization_409A8543D7B5524486D23A2764E263F2" xlink:to="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization_409A8543D7B5524486D23A2764E263F2" xlink:type="arc" />
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_A5564530E460436B94783A2764E28C99_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_A5564530E460436B94783A2764E28C99" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase obligations</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_A5564530E460436B94783A2764E28C99_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_A5564530E460436B94783A2764E28C99" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recorded Unconditional Purchase Obligation Due in Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_A5564530E460436B94783A2764E28C99" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_A5564530E460436B94783A2764E28C99" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_A5564530E460436B94783A2764E28C99" xlink:type="arc" />
    <link:label id="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_C17F63E5A226E26C80293A2764E2FADA_terseLabel_en-US" xlink:label="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_C17F63E5A226E26C80293A2764E2FADA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of purchase obligations</link:label>
    <link:label id="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_C17F63E5A226E26C80293A2764E2FADA_label_en-US" xlink:label="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_C17F63E5A226E26C80293A2764E2FADA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recorded Unconditional Purchase Obligation Due Within One Year Maximum Term</link:label>
    <link:label id="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_C17F63E5A226E26C80293A2764E2FADA_documentation_en-US" xlink:label="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_C17F63E5A226E26C80293A2764E2FADA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Recorded Unconditional Purchase Obligation Due Within One Year, Maximum Term</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" xlink:label="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_C17F63E5A226E26C80293A2764E2FADA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_C17F63E5A226E26C80293A2764E2FADA" xlink:to="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_C17F63E5A226E26C80293A2764E2FADA" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:to="lab_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7B792EFCF1B5AC2080C91CA2E7B087BF_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7B792EFCF1B5AC2080C91CA2E7B087BF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7B792EFCF1B5AC2080C91CA2E7B087BF_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7B792EFCF1B5AC2080C91CA2E7B087BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7B792EFCF1B5AC2080C91CA2E7B087BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7B792EFCF1B5AC2080C91CA2E7B087BF" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7B792EFCF1B5AC2080C91CA2E7B087BF" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_206FB1B48061FC9DDF401CA2E7B0DF74_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_206FB1B48061FC9DDF401CA2E7B0DF74" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_206FB1B48061FC9DDF401CA2E7B0DF74_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_206FB1B48061FC9DDF401CA2E7B0DF74" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_206FB1B48061FC9DDF401CA2E7B0DF74" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold_206FB1B48061FC9DDF401CA2E7B0DF74" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold_206FB1B48061FC9DDF401CA2E7B0DF74" xlink:type="arc" />
    <link:label id="lab_us-gaap_GrossProfit_04A425A1923528F08F7D1CA2E7B0DA6E_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit_04A425A1923528F08F7D1CA2E7B0DA6E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_04A425A1923528F08F7D1CA2E7B0DA6E_label_en-US" xlink:label="lab_us-gaap_GrossProfit_04A425A1923528F08F7D1CA2E7B0DA6E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_04A425A1923528F08F7D1CA2E7B0DA6E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit_04A425A1923528F08F7D1CA2E7B0DA6E" xlink:to="lab_us-gaap_GrossProfit_04A425A1923528F08F7D1CA2E7B0DA6E" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_B6620C6B6583C647ECAE1CA2E7B01BBA_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_B6620C6B6583C647ECAE1CA2E7B01BBA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_B6620C6B6583C647ECAE1CA2E7B01BBA_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_B6620C6B6583C647ECAE1CA2E7B01BBA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_B6620C6B6583C647ECAE1CA2E7B01BBA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_B6620C6B6583C647ECAE1CA2E7B01BBA" xlink:to="lab_us-gaap_OperatingExpensesAbstract_B6620C6B6583C647ECAE1CA2E7B01BBA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_343A33871EDF792CACB01CA2E7B14A52_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_343A33871EDF792CACB01CA2E7B14A52" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_343A33871EDF792CACB01CA2E7B14A52_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_343A33871EDF792CACB01CA2E7B14A52" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_343A33871EDF792CACB01CA2E7B14A52" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_343A33871EDF792CACB01CA2E7B14A52" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_343A33871EDF792CACB01CA2E7B14A52" xlink:type="arc" />
    <link:label id="lab_dxcm_CollaborativeResearchAndDevelopmentFee_694DEE523A4E1C50A9C01CA2E7B1E45A_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeResearchAndDevelopmentFee_694DEE523A4E1C50A9C01CA2E7B1E45A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative research and development fee</link:label>
    <link:label id="lab_dxcm_CollaborativeResearchAndDevelopmentFee_694DEE523A4E1C50A9C01CA2E7B1E45A_label_en-US" xlink:label="lab_dxcm_CollaborativeResearchAndDevelopmentFee_694DEE523A4E1C50A9C01CA2E7B1E45A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Research And Development Fee</link:label>
    <link:label id="lab_dxcm_CollaborativeResearchAndDevelopmentFee_694DEE523A4E1C50A9C01CA2E7B1E45A_documentation_en-US" xlink:label="lab_dxcm_CollaborativeResearchAndDevelopmentFee_694DEE523A4E1C50A9C01CA2E7B1E45A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Research and Development Fee</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeResearchAndDevelopmentFee" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee_694DEE523A4E1C50A9C01CA2E7B1E45A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeResearchAndDevelopmentFee_694DEE523A4E1C50A9C01CA2E7B1E45A" xlink:to="lab_dxcm_CollaborativeResearchAndDevelopmentFee_694DEE523A4E1C50A9C01CA2E7B1E45A" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_B6F8CABE8A22CDBA0BFC1CA2E7B13A2F_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_B6F8CABE8A22CDBA0BFC1CA2E7B13A2F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_B6F8CABE8A22CDBA0BFC1CA2E7B13A2F_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_B6F8CABE8A22CDBA0BFC1CA2E7B13A2F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_B6F8CABE8A22CDBA0BFC1CA2E7B13A2F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_B6F8CABE8A22CDBA0BFC1CA2E7B13A2F" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense_B6F8CABE8A22CDBA0BFC1CA2E7B13A2F" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpenses_AF61EA368946219C63511CA2E7B18F13_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses_AF61EA368946219C63511CA2E7B18F13" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_AF61EA368946219C63511CA2E7B18F13_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses_AF61EA368946219C63511CA2E7B18F13" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_AF61EA368946219C63511CA2E7B18F13" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_AF61EA368946219C63511CA2E7B18F13" xlink:to="lab_us-gaap_OperatingExpenses_AF61EA368946219C63511CA2E7B18F13" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_93E9D2CC429DF2D996C21CA2E7B2F309_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_93E9D2CC429DF2D996C21CA2E7B2F309" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_93E9D2CC429DF2D996C21CA2E7B2F309_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_93E9D2CC429DF2D996C21CA2E7B2F309" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_93E9D2CC429DF2D996C21CA2E7B2F309" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_93E9D2CC429DF2D996C21CA2E7B2F309" xlink:to="lab_us-gaap_OperatingIncomeLoss_93E9D2CC429DF2D996C21CA2E7B2F309" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpense_E9A690E605BE12B7E6641CA2E7B22401_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense_E9A690E605BE12B7E6641CA2E7B22401" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_E9A690E605BE12B7E6641CA2E7B22401_label_en-US" xlink:label="lab_us-gaap_InterestExpense_E9A690E605BE12B7E6641CA2E7B22401" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_E9A690E605BE12B7E6641CA2E7B22401" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense_E9A690E605BE12B7E6641CA2E7B22401" xlink:to="lab_us-gaap_InterestExpense_E9A690E605BE12B7E6641CA2E7B22401" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_7297FF46D6A7C33B872B1CA2E7B262B1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_7297FF46D6A7C33B872B1CA2E7B262B1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income (loss) from equity investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_7297FF46D6A7C33B872B1CA2E7B262B1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_7297FF46D6A7C33B872B1CA2E7B262B1" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_7297FF46D6A7C33B872B1CA2E7B262B1" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_B3210E8AEAFC3B9ABF6F1CA2E7B23F4E_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_B3210E8AEAFC3B9ABF6F1CA2E7B23F4E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest and other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_B3210E8AEAFC3B9ABF6F1CA2E7B23F4E_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_B3210E8AEAFC3B9ABF6F1CA2E7B23F4E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_B3210E8AEAFC3B9ABF6F1CA2E7B23F4E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_B3210E8AEAFC3B9ABF6F1CA2E7B23F4E" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense_B3210E8AEAFC3B9ABF6F1CA2E7B23F4E" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96133818E43A5011D8DD1CA2E7B2AA42_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96133818E43A5011D8DD1CA2E7B2AA42" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96133818E43A5011D8DD1CA2E7B2AA42_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96133818E43A5011D8DD1CA2E7B2AA42" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96133818E43A5011D8DD1CA2E7B2AA42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96133818E43A5011D8DD1CA2E7B2AA42" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96133818E43A5011D8DD1CA2E7B2AA42" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_494451429ECA59FB8E4A1CA2E7B2485A_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_494451429ECA59FB8E4A1CA2E7B2485A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_494451429ECA59FB8E4A1CA2E7B2485A_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_494451429ECA59FB8E4A1CA2E7B2485A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_494451429ECA59FB8E4A1CA2E7B2485A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_494451429ECA59FB8E4A1CA2E7B2485A" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_494451429ECA59FB8E4A1CA2E7B2485A" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_87DBBAB466E5F111BD641CA2E7B3AC98_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_87DBBAB466E5F111BD641CA2E7B3AC98" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_87DBBAB466E5F111BD641CA2E7B3AC98_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_87DBBAB466E5F111BD641CA2E7B3AC98" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_87DBBAB466E5F111BD641CA2E7B3AC98" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_87DBBAB466E5F111BD641CA2E7B3AC98" xlink:to="lab_us-gaap_NetIncomeLoss_87DBBAB466E5F111BD641CA2E7B3AC98" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasic_DAE39C6C9BA61AC8E7D81CA2E7B36611_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_DAE39C6C9BA61AC8E7D81CA2E7B36611" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic net income (loss) per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_DAE39C6C9BA61AC8E7D81CA2E7B36611_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_DAE39C6C9BA61AC8E7D81CA2E7B36611" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_DAE39C6C9BA61AC8E7D81CA2E7B36611" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_DAE39C6C9BA61AC8E7D81CA2E7B36611" xlink:to="lab_us-gaap_EarningsPerShareBasic_DAE39C6C9BA61AC8E7D81CA2E7B36611" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5A8BD981976EAC774FD41CA2E7B3220F_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5A8BD981976EAC774FD41CA2E7B3220F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares used to compute basic net income (loss) per share (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5A8BD981976EAC774FD41CA2E7B3220F_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5A8BD981976EAC774FD41CA2E7B3220F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5A8BD981976EAC774FD41CA2E7B3220F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5A8BD981976EAC774FD41CA2E7B3220F" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5A8BD981976EAC774FD41CA2E7B3220F" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_A3C78BD1263096CD65791CA2E7B3345E_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_A3C78BD1263096CD65791CA2E7B3345E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted net income (loss) per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_A3C78BD1263096CD65791CA2E7B3345E_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_A3C78BD1263096CD65791CA2E7B3345E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_A3C78BD1263096CD65791CA2E7B3345E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_A3C78BD1263096CD65791CA2E7B3345E" xlink:to="lab_us-gaap_EarningsPerShareDiluted_A3C78BD1263096CD65791CA2E7B3345E" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E2ECE21BF552EA63AA551CA2E7B32E35_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E2ECE21BF552EA63AA551CA2E7B32E35" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares used to compute diluted net income (loss) per share (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E2ECE21BF552EA63AA551CA2E7B32E35_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E2ECE21BF552EA63AA551CA2E7B32E35" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E2ECE21BF552EA63AA551CA2E7B32E35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E2ECE21BF552EA63AA551CA2E7B32E35" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E2ECE21BF552EA63AA551CA2E7B32E35" xlink:type="arc" />
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_4EC0D269D39D2C013A19B0D0C06A3E0F_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_4EC0D269D39D2C013A19B0D0C06A3E0F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedules of Percentage of Total Revenues and Accounts Receivable by Customer</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_4EC0D269D39D2C013A19B0D0C06A3E0F_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_4EC0D269D39D2C013A19B0D0C06A3E0F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_4EC0D269D39D2C013A19B0D0C06A3E0F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_4EC0D269D39D2C013A19B0D0C06A3E0F" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_4EC0D269D39D2C013A19B0D0C06A3E0F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_A18BF853E19CEE531ED9B0C76B53E940_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_A18BF853E19CEE531ED9B0C76B53E940" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Revenue Recognized as a Result of Changes in Contract Liability Balances</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_A18BF853E19CEE531ED9B0C76B53E940_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_A18BF853E19CEE531ED9B0C76B53E940" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset and Liability [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_A18BF853E19CEE531ED9B0C76B53E940" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_A18BF853E19CEE531ED9B0C76B53E940" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_A18BF853E19CEE531ED9B0C76B53E940" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3EE1FF2F103A614F42DFB0C3F4156B0F_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3EE1FF2F103A614F42DFB0C3F4156B0F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Basic and Diluted Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3EE1FF2F103A614F42DFB0C3F4156B0F_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3EE1FF2F103A614F42DFB0C3F4156B0F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3EE1FF2F103A614F42DFB0C3F4156B0F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3EE1FF2F103A614F42DFB0C3F4156B0F" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3EE1FF2F103A614F42DFB0C3F4156B0F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_5F2E294CC6A9F881F0C1B0B8FE623059_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_5F2E294CC6A9F881F0C1B0B8FE623059" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Outstanding Anti-Dilutive Securities Excluded in Diluted Net Income (Loss) per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_5F2E294CC6A9F881F0C1B0B8FE623059_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_5F2E294CC6A9F881F0C1B0B8FE623059" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_5F2E294CC6A9F881F0C1B0B8FE623059" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_5F2E294CC6A9F881F0C1B0B8FE623059" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_5F2E294CC6A9F881F0C1B0B8FE623059" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6B23324B23D79FF5CB46B031007C1A7F_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6B23324B23D79FF5CB46B031007C1A7F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6B23324B23D79FF5CB46B031007C1A7F_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6B23324B23D79FF5CB46B031007C1A7F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6B23324B23D79FF5CB46B031007C1A7F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6B23324B23D79FF5CB46B031007C1A7F" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6B23324B23D79FF5CB46B031007C1A7F" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_B205DD12316C4241DC46B031007CDDA3_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit_B205DD12316C4241DC46B031007CDDA3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_B205DD12316C4241DC46B031007CDDA3_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit_B205DD12316C4241DC46B031007CDDA3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_B205DD12316C4241DC46B031007CDDA3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit_B205DD12316C4241DC46B031007CDDA3" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit_B205DD12316C4241DC46B031007CDDA3" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_3BF6B1F9D8D6BBB17AF7B031007CF2A3_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_3BF6B1F9D8D6BBB17AF7B031007CF2A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_3BF6B1F9D8D6BBB17AF7B031007CF2A3_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_3BF6B1F9D8D6BBB17AF7B031007CF2A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_3BF6B1F9D8D6BBB17AF7B031007CF2A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_3BF6B1F9D8D6BBB17AF7B031007CF2A3" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_3BF6B1F9D8D6BBB17AF7B031007CF2A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_F8753F3D5DE3B58DA65CB03100826905_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit_F8753F3D5DE3B58DA65CB03100826905" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_F8753F3D5DE3B58DA65CB03100826905_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit_F8753F3D5DE3B58DA65CB03100826905" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_F8753F3D5DE3B58DA65CB03100826905" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit_F8753F3D5DE3B58DA65CB03100826905" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit_F8753F3D5DE3B58DA65CB03100826905" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_3939799E0DDF30C3F7A9B03100829D30_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_3939799E0DDF30C3F7A9B03100829D30" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current income taxes</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_3939799E0DDF30C3F7A9B03100829D30_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_3939799E0DDF30C3F7A9B03100829D30" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3939799E0DDF30C3F7A9B03100829D30" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3939799E0DDF30C3F7A9B03100829D30" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_3939799E0DDF30C3F7A9B03100829D30" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_11F5393ED54ACABD6208B031008251F7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_11F5393ED54ACABD6208B031008251F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_11F5393ED54ACABD6208B031008251F7_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_11F5393ED54ACABD6208B031008251F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_11F5393ED54ACABD6208B031008251F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_11F5393ED54ACABD6208B031008251F7" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_11F5393ED54ACABD6208B031008251F7" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7E92774E15034D9F2840B031008207C9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7E92774E15034D9F2840B031008207C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7E92774E15034D9F2840B031008207C9_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7E92774E15034D9F2840B031008207C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7E92774E15034D9F2840B031008207C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7E92774E15034D9F2840B031008207C9" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7E92774E15034D9F2840B031008207C9" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_BA6238AD725A9BE59248B03100831830_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_BA6238AD725A9BE59248B03100831830" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_BA6238AD725A9BE59248B03100831830_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_BA6238AD725A9BE59248B03100831830" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_BA6238AD725A9BE59248B03100831830" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_BA6238AD725A9BE59248B03100831830" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_BA6238AD725A9BE59248B03100831830" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_83E034FF3F7BDEE0D1E8B03100837C23_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_83E034FF3F7BDEE0D1E8B03100837C23" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_83E034FF3F7BDEE0D1E8B03100837C23_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_83E034FF3F7BDEE0D1E8B03100837C23" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_83E034FF3F7BDEE0D1E8B03100837C23" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_83E034FF3F7BDEE0D1E8B03100837C23" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_83E034FF3F7BDEE0D1E8B03100837C23" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_409402482993BF936E2EB03100832A22_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_409402482993BF936E2EB03100832A22" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_409402482993BF936E2EB03100832A22_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_409402482993BF936E2EB03100832A22" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_409402482993BF936E2EB03100832A22" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_409402482993BF936E2EB03100832A22" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_409402482993BF936E2EB03100832A22" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_AB664B755F3324F94B43B0310083992B_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_AB664B755F3324F94B43B0310083992B" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income taxes at effective rates</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_AB664B755F3324F94B43B0310083992B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_AB664B755F3324F94B43B0310083992B" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_AB664B755F3324F94B43B0310083992B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_095BF1854D9A3CA0D422F3900BB7FFAD_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_095BF1854D9A3CA0D422F3900BB7FFAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_095BF1854D9A3CA0D422F3900BB7FFAD_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_095BF1854D9A3CA0D422F3900BB7FFAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net, Classification [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_095BF1854D9A3CA0D422F3900BB7FFAD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_095BF1854D9A3CA0D422F3900BB7FFAD" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_095BF1854D9A3CA0D422F3900BB7FFAD" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4F8C8A06F1667DE0A83CF3900BB8599C_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4F8C8A06F1667DE0A83CF3900BB8599C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4F8C8A06F1667DE0A83CF3900BB8599C_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4F8C8A06F1667DE0A83CF3900BB8599C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4F8C8A06F1667DE0A83CF3900BB8599C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4F8C8A06F1667DE0A83CF3900BB8599C" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4F8C8A06F1667DE0A83CF3900BB8599C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_EF62FD27738C38C271CFF3900BB8D584_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_EF62FD27738C38C271CFF3900BB8D584" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized research and development expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_EF62FD27738C38C271CFF3900BB8D584_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_EF62FD27738C38C271CFF3900BB8D584" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_EF62FD27738C38C271CFF3900BB8D584" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_EF62FD27738C38C271CFF3900BB8D584" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_EF62FD27738C38C271CFF3900BB8D584" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_575975F3DEDF8311E733F3900BB8F14D_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_575975F3DEDF8311E733F3900BB8F14D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_575975F3DEDF8311E733F3900BB8F14D_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_575975F3DEDF8311E733F3900BB8F14D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_575975F3DEDF8311E733F3900BB8F14D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_575975F3DEDF8311E733F3900BB8F14D" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_575975F3DEDF8311E733F3900BB8F14D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4E6E65B1460525016543F3900BB8A763_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4E6E65B1460525016543F3900BB8A763" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4E6E65B1460525016543F3900BB8A763_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4E6E65B1460525016543F3900BB8A763" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4E6E65B1460525016543F3900BB8A763" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4E6E65B1460525016543F3900BB8A763" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4E6E65B1460525016543F3900BB8A763" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_B4E75E99123D45B7F79DF3900BB8C249_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_B4E75E99123D45B7F79DF3900BB8C249" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fixed and intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_B4E75E99123D45B7F79DF3900BB8C249_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_B4E75E99123D45B7F79DF3900BB8C249" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_B4E75E99123D45B7F79DF3900BB8C249" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_B4E75E99123D45B7F79DF3900BB8C249" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_B4E75E99123D45B7F79DF3900BB8C249" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_11C410861F3E643394A0F3900BB93C44_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_11C410861F3E643394A0F3900BB93C44" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities and reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_11C410861F3E643394A0F3900BB93C44_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_11C410861F3E643394A0F3900BB93C44" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_11C410861F3E643394A0F3900BB93C44" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_11C410861F3E643394A0F3900BB93C44" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_11C410861F3E643394A0F3900BB93C44" xlink:type="arc" />
    <link:label id="lab_dxcm_DeferredTaxAssetsConvertibleDebt_FE3A27E17B2758A84D31F395719DC830_terseLabel_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsConvertibleDebt_FE3A27E17B2758A84D31F395719DC830" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_dxcm_DeferredTaxAssetsConvertibleDebt_FE3A27E17B2758A84D31F395719DC830_label_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsConvertibleDebt_FE3A27E17B2758A84D31F395719DC830" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Convertible Debt</link:label>
    <link:label id="lab_dxcm_DeferredTaxAssetsConvertibleDebt_FE3A27E17B2758A84D31F395719DC830_documentation_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsConvertibleDebt_FE3A27E17B2758A84D31F395719DC830" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Convertible Debt</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DeferredTaxAssetsConvertibleDebt" xlink:label="loc_dxcm_DeferredTaxAssetsConvertibleDebt_FE3A27E17B2758A84D31F395719DC830" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DeferredTaxAssetsConvertibleDebt_FE3A27E17B2758A84D31F395719DC830" xlink:to="lab_dxcm_DeferredTaxAssetsConvertibleDebt_FE3A27E17B2758A84D31F395719DC830" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_4715570D6741575A520AF3900BB95CBC_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_4715570D6741575A520AF3900BB95CBC" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_4715570D6741575A520AF3900BB95CBC_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_4715570D6741575A520AF3900BB95CBC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_4715570D6741575A520AF3900BB95CBC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_4715570D6741575A520AF3900BB95CBC" xlink:to="lab_us-gaap_DeferredTaxAssetsGross_4715570D6741575A520AF3900BB95CBC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_C8E8CA3D249D1CC06D78F3900BB9DE2F_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_C8E8CA3D249D1CC06D78F3900BB9DE2F" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_C8E8CA3D249D1CC06D78F3900BB9DE2F_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_C8E8CA3D249D1CC06D78F3900BB9DE2F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_C8E8CA3D249D1CC06D78F3900BB9DE2F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_C8E8CA3D249D1CC06D78F3900BB9DE2F" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_C8E8CA3D249D1CC06D78F3900BB9DE2F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_4806F387968CAA3DD5C3F3900BB95477_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_4806F387968CAA3DD5C3F3900BB95477" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_4806F387968CAA3DD5C3F3900BB95477_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_4806F387968CAA3DD5C3F3900BB95477" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4806F387968CAA3DD5C3F3900BB95477" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4806F387968CAA3DD5C3F3900BB95477" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_4806F387968CAA3DD5C3F3900BB95477" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesClassificationAbstract_CC4C48B8237A6E408063F3900BB9FA24_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesClassificationAbstract_CC4C48B8237A6E408063F3900BB9FA24" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesClassificationAbstract_CC4C48B8237A6E408063F3900BB9FA24_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesClassificationAbstract_CC4C48B8237A6E408063F3900BB9FA24" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Net, Classification [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesClassificationAbstract" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesClassificationAbstract_CC4C48B8237A6E408063F3900BB9FA24" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesClassificationAbstract_CC4C48B8237A6E408063F3900BB9FA24" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesClassificationAbstract_CC4C48B8237A6E408063F3900BB9FA24" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_87B4FC4DFB4B543F37D0F3900BB90455_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_87B4FC4DFB4B543F37D0F3900BB90455" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Fixed assets and acquired intangibles assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_87B4FC4DFB4B543F37D0F3900BB90455_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_87B4FC4DFB4B543F37D0F3900BB90455" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_87B4FC4DFB4B543F37D0F3900BB90455" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_87B4FC4DFB4B543F37D0F3900BB90455" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_87B4FC4DFB4B543F37D0F3900BB90455" xlink:type="arc" />
    <link:label id="lab_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_74CB7C93B9F23BF5F496F3900BBAE304_negatedTerseLabel_en-US" xlink:label="lab_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_74CB7C93B9F23BF5F496F3900BBAE304" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Convertible debt discount</link:label>
    <link:label id="lab_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_74CB7C93B9F23BF5F496F3900BBAE304_label_en-US" xlink:label="lab_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_74CB7C93B9F23BF5F496F3900BBAE304" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Convertible Debt Discount</link:label>
    <link:label id="lab_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_74CB7C93B9F23BF5F496F3900BBAE304_documentation_en-US" xlink:label="lab_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_74CB7C93B9F23BF5F496F3900BBAE304" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Convertible Debt Discount</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount" xlink:label="loc_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_74CB7C93B9F23BF5F496F3900BBAE304" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_74CB7C93B9F23BF5F496F3900BBAE304" xlink:to="lab_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_74CB7C93B9F23BF5F496F3900BBAE304" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_887DC6B82A5C16734140F3900BBA1EAE_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities_887DC6B82A5C16734140F3900BBA1EAE" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_887DC6B82A5C16734140F3900BBA1EAE_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities_887DC6B82A5C16734140F3900BBA1EAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_887DC6B82A5C16734140F3900BBA1EAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities_887DC6B82A5C16734140F3900BBA1EAE" xlink:to="lab_us-gaap_DeferredTaxLiabilities_887DC6B82A5C16734140F3900BBA1EAE" xlink:type="arc" />
    <link:label id="lab_dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet_8AA4B0594F17458051F0F3900BBA900C_totalLabel_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet_8AA4B0594F17458051F0F3900BBA900C" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax assets (liabilities)</link:label>
    <link:label id="lab_dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet_8AA4B0594F17458051F0F3900BBA900C_label_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet_8AA4B0594F17458051F0F3900BBA900C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets (Liabilities), Less Valuation Allowance, Net</link:label>
    <link:label id="lab_dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet_8AA4B0594F17458051F0F3900BBA900C_documentation_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet_8AA4B0594F17458051F0F3900BBA900C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets (Liabilities), Less Valuation Allowance, Net</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet" xlink:label="loc_dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet_8AA4B0594F17458051F0F3900BBA900C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet_8AA4B0594F17458051F0F3900BBA900C" xlink:to="lab_dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet_8AA4B0594F17458051F0F3900BBA900C" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_1EBC903FFA1EE9D352F2B4B420FA78C0_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis_1EBC903FFA1EE9D352F2B4B420FA78C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_1EBC903FFA1EE9D352F2B4B420FA78C0_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis_1EBC903FFA1EE9D352F2B4B420FA78C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1EBC903FFA1EE9D352F2B4B420FA78C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1EBC903FFA1EE9D352F2B4B420FA78C0" xlink:to="lab_us-gaap_LongtermDebtTypeAxis_1EBC903FFA1EE9D352F2B4B420FA78C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_789A7CE764838AD2D1EEB4B420FC1163_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain_789A7CE764838AD2D1EEB4B420FC1163" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_789A7CE764838AD2D1EEB4B420FC1163_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain_789A7CE764838AD2D1EEB4B420FC1163" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_789A7CE764838AD2D1EEB4B420FC1163" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_789A7CE764838AD2D1EEB4B420FC1163" xlink:to="lab_us-gaap_LongtermDebtTypeDomain_789A7CE764838AD2D1EEB4B420FC1163" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeniorNotesMember_5A505A415F536D957099B4B4212F6745_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember_5A505A415F536D957099B4B4212F6745" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_5A505A415F536D957099B4B4212F6745_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember_5A505A415F536D957099B4B4212F6745" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_5A505A415F536D957099B4B4212F6745" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember_5A505A415F536D957099B4B4212F6745" xlink:to="lab_us-gaap_SeniorNotesMember_5A505A415F536D957099B4B4212F6745" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_6C0DA04E35687E006B2CB4B420A37A59_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures_6C0DA04E35687E006B2CB4B420A37A59" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total fair value of outstanding senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_6C0DA04E35687E006B2CB4B420A37A59_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures_6C0DA04E35687E006B2CB4B420A37A59" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_6C0DA04E35687E006B2CB4B420A37A59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures_6C0DA04E35687E006B2CB4B420A37A59" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures_6C0DA04E35687E006B2CB4B420A37A59" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_318C690B9B04DC0CB24FD354A424D249_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_318C690B9B04DC0CB24FD354A424D249" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_318C690B9B04DC0CB24FD354A424D249" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_318C690B9B04DC0CB24FD354A424D249" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_318C690B9B04DC0CB24FD354A424D249" xlink:type="arc" />
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_E939198C93E1CE2B031ED354A4244462_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_E939198C93E1CE2B031ED354A4244462" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Benefit Plans and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_E939198C93E1CE2B031ED354A4244462_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_E939198C93E1CE2B031ED354A4244462" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_E939198C93E1CE2B031ED354A4244462" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_E939198C93E1CE2B031ED354A4244462" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_E939198C93E1CE2B031ED354A4244462" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingAbstract_458D66C2F62A2755A1E1D354A3F006FA_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract_458D66C2F62A2755A1E1D354A3F006FA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_458D66C2F62A2755A1E1D354A3F006FA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract_458D66C2F62A2755A1E1D354A3F006FA" xlink:to="lab_us-gaap_SegmentReportingAbstract_458D66C2F62A2755A1E1D354A3F006FA" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_3467734AD683D6B95664D354A3F0BC3C_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_3467734AD683D6B95664D354A3F0BC3C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Segment and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_3467734AD683D6B95664D354A3F0BC3C_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_3467734AD683D6B95664D354A3F0BC3C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_3467734AD683D6B95664D354A3F0BC3C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock_3467734AD683D6B95664D354A3F0BC3C" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock_3467734AD683D6B95664D354A3F0BC3C" xlink:type="arc" />
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3049B6E61415B494D7FCAB669A63E2BC_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3049B6E61415B494D7FCAB669A63E2BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3049B6E61415B494D7FCAB669A63E2BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3049B6E61415B494D7FCAB669A63E2BC" xlink:to="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3049B6E61415B494D7FCAB669A63E2BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_1619DAA518563003DCEAAB669A638275_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_1619DAA518563003DCEAAB669A638275" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Quarterly Financial Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_1619DAA518563003DCEAAB669A638275_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_1619DAA518563003DCEAAB669A638275" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_1619DAA518563003DCEAAB669A638275" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_1619DAA518563003DCEAAB669A638275" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_1619DAA518563003DCEAAB669A638275" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_0E9315C0558C4CDEBE7A206A61269E8A_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable_0E9315C0558C4CDEBE7A206A61269E8A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_0E9315C0558C4CDEBE7A206A61269E8A_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable_0E9315C0558C4CDEBE7A206A61269E8A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_0E9315C0558C4CDEBE7A206A61269E8A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_0E9315C0558C4CDEBE7A206A61269E8A" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable_0E9315C0558C4CDEBE7A206A61269E8A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_50D0E93951598CE71D2D206A61269039_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_50D0E93951598CE71D2D206A61269039" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Allowance by Deferred Tax Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_50D0E93951598CE71D2D206A61269039_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_50D0E93951598CE71D2D206A61269039" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Allowance by Deferred Tax Asset [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_50D0E93951598CE71D2D206A61269039" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_50D0E93951598CE71D2D206A61269039" xlink:to="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_50D0E93951598CE71D2D206A61269039" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetDomain_FAAB3FEB9A04159349BB206A61265D2E_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetDomain_FAAB3FEB9A04159349BB206A61265D2E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetDomain_FAAB3FEB9A04159349BB206A61265D2E_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetDomain_FAAB3FEB9A04159349BB206A61265D2E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetDomain" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_FAAB3FEB9A04159349BB206A61265D2E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_FAAB3FEB9A04159349BB206A61265D2E" xlink:to="lab_us-gaap_DeferredTaxAssetDomain_FAAB3FEB9A04159349BB206A61265D2E" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_5DFD06D4BF494F34F77C206A61270C00_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_5DFD06D4BF494F34F77C206A61270C00" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_5DFD06D4BF494F34F77C206A61270C00_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_5DFD06D4BF494F34F77C206A61270C00" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5DFD06D4BF494F34F77C206A61270C00" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember_5DFD06D4BF494F34F77C206A61270C00" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember_5DFD06D4BF494F34F77C206A61270C00" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_6137718D29A2AEEC8F29206A61270059_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_6137718D29A2AEEC8F29206A61270059" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_6137718D29A2AEEC8F29206A61270059_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_6137718D29A2AEEC8F29206A61270059" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_6137718D29A2AEEC8F29206A61270059" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_6137718D29A2AEEC8F29206A61270059" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis_6137718D29A2AEEC8F29206A61270059" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_AB4BBE3A89F578C3896D206A61277FEF_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember_AB4BBE3A89F578C3896D206A61277FEF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_AB4BBE3A89F578C3896D206A61277FEF_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember_AB4BBE3A89F578C3896D206A61277FEF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_AB4BBE3A89F578C3896D206A61277FEF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember_AB4BBE3A89F578C3896D206A61277FEF" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember_AB4BBE3A89F578C3896D206A61277FEF" xlink:type="arc" />
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_E0D4188418A8990FA693206A61284C78_verboseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember_E0D4188418A8990FA693206A61284C78" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_E0D4188418A8990FA693206A61284C78_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember_E0D4188418A8990FA693206A61284C78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_E0D4188418A8990FA693206A61284C78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember_E0D4188418A8990FA693206A61284C78" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember_E0D4188418A8990FA693206A61284C78" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCountryMember_7BDE5CED5C40310825CB206A61285706_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember_7BDE5CED5C40310825CB206A61285706" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_7BDE5CED5C40310825CB206A61285706_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember_7BDE5CED5C40310825CB206A61285706" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_7BDE5CED5C40310825CB206A61285706" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember_7BDE5CED5C40310825CB206A61285706" xlink:to="lab_us-gaap_ForeignCountryMember_7BDE5CED5C40310825CB206A61285706" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_A24E10141E31AF8418FA206A61280F0C_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards_A24E10141E31AF8418FA206A61280F0C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_A24E10141E31AF8418FA206A61280F0C_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards_A24E10141E31AF8418FA206A61280F0C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_A24E10141E31AF8418FA206A61280F0C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards_A24E10141E31AF8418FA206A61280F0C" xlink:to="lab_us-gaap_OperatingLossCarryforwards_A24E10141E31AF8418FA206A61280F0C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8FC9A79CFFAA5F14BF54206A6129E245_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8FC9A79CFFAA5F14BF54206A6129E245" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8FC9A79CFFAA5F14BF54206A6129E245_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8FC9A79CFFAA5F14BF54206A6129E245" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8FC9A79CFFAA5F14BF54206A6129E245" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8FC9A79CFFAA5F14BF54206A6129E245" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8FC9A79CFFAA5F14BF54206A6129E245" xlink:type="arc" />
    <link:label id="lab_dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration_949B537C25C4D8A192E2206A6129E781_terseLabel_en-US" xlink:label="lab_dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration_949B537C25C4D8A192E2206A6129E781" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development tax credit carryforwards subject to expiration</link:label>
    <link:label id="lab_dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration_949B537C25C4D8A192E2206A6129E781_label_en-US" xlink:label="lab_dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration_949B537C25C4D8A192E2206A6129E781" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforwards, Research, Subject to Expiration</link:label>
    <link:label id="lab_dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration_949B537C25C4D8A192E2206A6129E781_documentation_en-US" xlink:label="lab_dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration_949B537C25C4D8A192E2206A6129E781" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research, Subject to Expiration</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration" xlink:label="loc_dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration_949B537C25C4D8A192E2206A6129E781" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration_949B537C25C4D8A192E2206A6129E781" xlink:to="lab_dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration_949B537C25C4D8A192E2206A6129E781" xlink:type="arc" />
    <link:label id="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits_BB245A984F45AE86ECE4206A61290DB5_terseLabel_en-US" xlink:label="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits_BB245A984F45AE86ECE4206A61290DB5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credit carryforwards subject to expiration</link:label>
    <link:label id="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits_BB245A984F45AE86ECE4206A61290DB5_label_en-US" xlink:label="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits_BB245A984F45AE86ECE4206A61290DB5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unused Expired Federal Income Tax Credits</link:label>
    <link:label id="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits_BB245A984F45AE86ECE4206A61290DB5_documentation_en-US" xlink:label="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits_BB245A984F45AE86ECE4206A61290DB5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Federal income tax credits likely to expire unused as a result of limitations</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_UnusedExpiredFederalIncomeTaxCredits" xlink:label="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits_BB245A984F45AE86ECE4206A61290DB5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits_BB245A984F45AE86ECE4206A61290DB5" xlink:to="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits_BB245A984F45AE86ECE4206A61290DB5" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_A8CD283F165E7BE045BA206A6129879F_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_A8CD283F165E7BE045BA206A6129879F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_A8CD283F165E7BE045BA206A6129879F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_A8CD283F165E7BE045BA206A6129879F" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_A8CD283F165E7BE045BA206A6129879F" xlink:type="arc" />
    <link:label id="lab_dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital_C0AD7320D6E891144872206A612900E4_terseLabel_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital_C0AD7320D6E891144872206A612900E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax benefits credited to additional paid-in capital</link:label>
    <link:label id="lab_dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital_C0AD7320D6E891144872206A612900E4_label_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital_C0AD7320D6E891144872206A612900E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Benefits Credited to Additional Paid In Capital</link:label>
    <link:label id="lab_dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital_C0AD7320D6E891144872206A612900E4_documentation_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital_C0AD7320D6E891144872206A612900E4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Benefits Credited to Additional Paid In Capital</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital" xlink:label="loc_dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital_C0AD7320D6E891144872206A612900E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital_C0AD7320D6E891144872206A612900E4" xlink:to="lab_dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital_C0AD7320D6E891144872206A612900E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_44DD2844171426463BE7206A61297CE0_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_44DD2844171426463BE7206A61297CE0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_44DD2844171426463BE7206A61297CE0_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_44DD2844171426463BE7206A61297CE0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_44DD2844171426463BE7206A61297CE0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_44DD2844171426463BE7206A61297CE0" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_44DD2844171426463BE7206A61297CE0" xlink:type="arc" />
    <link:label id="lab_dxcm_PossibleExtensionPeriodofTaxHoliday_2F895CC69C78858F8706206A61296ADA_terseLabel_en-US" xlink:label="lab_dxcm_PossibleExtensionPeriodofTaxHoliday_2F895CC69C78858F8706206A61296ADA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Possible extension period of tax holiday</link:label>
    <link:label id="lab_dxcm_PossibleExtensionPeriodofTaxHoliday_2F895CC69C78858F8706206A61296ADA_label_en-US" xlink:label="lab_dxcm_PossibleExtensionPeriodofTaxHoliday_2F895CC69C78858F8706206A61296ADA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Possible Extension Period of Tax Holiday</link:label>
    <link:label id="lab_dxcm_PossibleExtensionPeriodofTaxHoliday_2F895CC69C78858F8706206A61296ADA_documentation_en-US" xlink:label="lab_dxcm_PossibleExtensionPeriodofTaxHoliday_2F895CC69C78858F8706206A61296ADA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Possible Extension Period of Tax Holiday</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PossibleExtensionPeriodofTaxHoliday" xlink:label="loc_dxcm_PossibleExtensionPeriodofTaxHoliday_2F895CC69C78858F8706206A61296ADA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PossibleExtensionPeriodofTaxHoliday_2F895CC69C78858F8706206A61296ADA" xlink:to="lab_dxcm_PossibleExtensionPeriodofTaxHoliday_2F895CC69C78858F8706206A61296ADA" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount_1167A7E7AA3B88B03E192070EE694AA1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount_1167A7E7AA3B88B03E192070EE694AA1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease in foreign taxes from tax holiday</link:label>
    <link:label id="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount_1167A7E7AA3B88B03E192070EE694AA1_label_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount_1167A7E7AA3B88B03E192070EE694AA1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Holiday, Aggregate Dollar Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_1167A7E7AA3B88B03E192070EE694AA1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_1167A7E7AA3B88B03E192070EE694AA1" xlink:to="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount_1167A7E7AA3B88B03E192070EE694AA1" xlink:type="arc" />
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12E69AF93355B54F995D0E443E5F9C8C_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12E69AF93355B54F995D0E443E5F9C8C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12E69AF93355B54F995D0E443E5F9C8C_label_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12E69AF93355B54F995D0E443E5F9C8C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12E69AF93355B54F995D0E443E5F9C8C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12E69AF93355B54F995D0E443E5F9C8C" xlink:to="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12E69AF93355B54F995D0E443E5F9C8C" xlink:type="arc" />
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_BBC36EF50854D00BFCD50E443E5F683C_periodStartLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual_BBC36EF50854D00BFCD50E443E5F683C" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_BBC36EF50854D00BFCD50E443E5F683C_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual_BBC36EF50854D00BFCD50E443E5F683C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard Product Warranty Accrual</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_BBC36EF50854D00BFCD50E443E5F683C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual_BBC36EF50854D00BFCD50E443E5F683C" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual_BBC36EF50854D00BFCD50E443E5F683C" xlink:type="arc" />
    <link:label id="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_766CAC7B3FB65B2668440E443E60D54C_terseLabel_en-US" xlink:label="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_766CAC7B3FB65B2668440E443E60D54C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Charges to costs and expenses</link:label>
    <link:label id="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_766CAC7B3FB65B2668440E443E60D54C_label_en-US" xlink:label="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_766CAC7B3FB65B2668440E443E60D54C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard Product Warranty Accrual Charges To Costs And Expenses</link:label>
    <link:label id="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_766CAC7B3FB65B2668440E443E60D54C_documentation_en-US" xlink:label="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_766CAC7B3FB65B2668440E443E60D54C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Standard Product Warranty Accrual Charges To Costs And Expenses</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses" xlink:label="loc_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_766CAC7B3FB65B2668440E443E60D54C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_766CAC7B3FB65B2668440E443E60D54C" xlink:to="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_766CAC7B3FB65B2668440E443E60D54C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_239ED4A3A7F34F28D3090E443E60763E_negatedLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments_239ED4A3A7F34F28D3090E443E60763E" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Costs incurred</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_239ED4A3A7F34F28D3090E443E60763E_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments_239ED4A3A7F34F28D3090E443E60763E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_239ED4A3A7F34F28D3090E443E60763E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPayments_239ED4A3A7F34F28D3090E443E60763E" xlink:to="lab_us-gaap_ProductWarrantyAccrualPayments_239ED4A3A7F34F28D3090E443E60763E" xlink:type="arc" />
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_CBBE45A6A92AA4E361000E443E6090C2_periodEndLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual_CBBE45A6A92AA4E361000E443E6090C2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_CBBE45A6A92AA4E361000E443E6090C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual_CBBE45A6A92AA4E361000E443E6090C2" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual_CBBE45A6A92AA4E361000E443E6090C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_960AEDC96B9233607CDA1C846AB3CBA1_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract_960AEDC96B9233607CDA1C846AB3CBA1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_960AEDC96B9233607CDA1C846AB3CBA1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract_960AEDC96B9233607CDA1C846AB3CBA1" xlink:to="lab_us-gaap_DebtDisclosureAbstract_960AEDC96B9233607CDA1C846AB3CBA1" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:to="lab_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableRateAxis_8EE58DA0814DBBC24DBD1C846AB44178_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis_8EE58DA0814DBBC24DBD1C846AB44178" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_8EE58DA0814DBBC24DBD1C846AB44178_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis_8EE58DA0814DBBC24DBD1C846AB44178" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_8EE58DA0814DBBC24DBD1C846AB44178" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis_8EE58DA0814DBBC24DBD1C846AB44178" xlink:to="lab_us-gaap_VariableRateAxis_8EE58DA0814DBBC24DBD1C846AB44178" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableRateDomain_CD5B14922052DC94B7421C846AB4CDBA_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain_CD5B14922052DC94B7421C846AB4CDBA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_CD5B14922052DC94B7421C846AB4CDBA_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain_CD5B14922052DC94B7421C846AB4CDBA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_CD5B14922052DC94B7421C846AB4CDBA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain_CD5B14922052DC94B7421C846AB4CDBA" xlink:to="lab_us-gaap_VariableRateDomain_CD5B14922052DC94B7421C846AB4CDBA" xlink:type="arc" />
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_80A7D399A020A3F0E0C01C846AB5683B_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_80A7D399A020A3F0E0C01C846AB5683B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_80A7D399A020A3F0E0C01C846AB5683B_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_80A7D399A020A3F0E0C01C846AB5683B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_80A7D399A020A3F0E0C01C846AB5683B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_80A7D399A020A3F0E0C01C846AB5683B" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_80A7D399A020A3F0E0C01C846AB5683B" xlink:type="arc" />
    <link:label id="lab_dxcm_DebtInstrumentConversionTermAxis_19C3F981D6052B8C2CE61C846AB6439A_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermAxis_19C3F981D6052B8C2CE61C846AB6439A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term [Axis]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermAxis_19C3F981D6052B8C2CE61C846AB6439A_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermAxis_19C3F981D6052B8C2CE61C846AB6439A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term [Axis]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermAxis_19C3F981D6052B8C2CE61C846AB6439A_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermAxis_19C3F981D6052B8C2CE61C846AB6439A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term [Axis]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConversionTermAxis" xlink:label="loc_dxcm_DebtInstrumentConversionTermAxis_19C3F981D6052B8C2CE61C846AB6439A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis_19C3F981D6052B8C2CE61C846AB6439A" xlink:to="lab_dxcm_DebtInstrumentConversionTermAxis_19C3F981D6052B8C2CE61C846AB6439A" xlink:type="arc" />
    <link:label id="lab_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term [Domain]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term [Domain]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Debt Instrument Conversion Term [Axis]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConversionTermDomain" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2" xlink:to="lab_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2" xlink:type="arc" />
    <link:label id="lab_dxcm_DebtInstrumentConversionTermOneMember_47490DCEAB519CAC081C1C846AB736F7_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermOneMember_47490DCEAB519CAC081C1C846AB736F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term One</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermOneMember_47490DCEAB519CAC081C1C846AB736F7_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermOneMember_47490DCEAB519CAC081C1C846AB736F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term One [Member]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermOneMember_47490DCEAB519CAC081C1C846AB736F7_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermOneMember_47490DCEAB519CAC081C1C846AB736F7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term One [Member]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConversionTermOneMember" xlink:label="loc_dxcm_DebtInstrumentConversionTermOneMember_47490DCEAB519CAC081C1C846AB736F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermOneMember_47490DCEAB519CAC081C1C846AB736F7" xlink:to="lab_dxcm_DebtInstrumentConversionTermOneMember_47490DCEAB519CAC081C1C846AB736F7" xlink:type="arc" />
    <link:label id="lab_dxcm_DebtInstrumentConversionTermTwoMember_52B863DD06BB510021261C846AB70C70_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermTwoMember_52B863DD06BB510021261C846AB70C70" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term Two</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermTwoMember_52B863DD06BB510021261C846AB70C70_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermTwoMember_52B863DD06BB510021261C846AB70C70" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term Two [Member]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermTwoMember_52B863DD06BB510021261C846AB70C70_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermTwoMember_52B863DD06BB510021261C846AB70C70" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term Two [Member]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConversionTermTwoMember" xlink:label="loc_dxcm_DebtInstrumentConversionTermTwoMember_52B863DD06BB510021261C846AB70C70" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermTwoMember_52B863DD06BB510021261C846AB70C70" xlink:to="lab_dxcm_DebtInstrumentConversionTermTwoMember_52B863DD06BB510021261C846AB70C70" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditMember_67EF8E589D0FEEADD85E1C846AB90B68_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember_67EF8E589D0FEEADD85E1C846AB90B68" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_67EF8E589D0FEEADD85E1C846AB90B68_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember_67EF8E589D0FEEADD85E1C846AB90B68" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_67EF8E589D0FEEADD85E1C846AB90B68" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember_67EF8E589D0FEEADD85E1C846AB90B68" xlink:to="lab_us-gaap_LineOfCreditMember_67EF8E589D0FEEADD85E1C846AB90B68" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="lab_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_622363E44E13899990581C846ABCBAE0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount_622363E44E13899990581C846ABCBAE0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_622363E44E13899990581C846ABCBAE0_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount_622363E44E13899990581C846ABCBAE0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_622363E44E13899990581C846ABCBAE0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount_622363E44E13899990581C846ABCBAE0" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount_622363E44E13899990581C846ABCBAE0" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_22248925CE4A7BF67C761C846ABC535A_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_22248925CE4A7BF67C761C846ABC535A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate on convertible notes (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_22248925CE4A7BF67C761C846ABC535A_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_22248925CE4A7BF67C761C846ABC535A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_22248925CE4A7BF67C761C846ABC535A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_22248925CE4A7BF67C761C846ABC535A" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_22248925CE4A7BF67C761C846ABC535A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_A5DEC92C4DF65F0B23BD1C846ABCF87B_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt_A5DEC92C4DF65F0B23BD1C846ABCF87B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of convertible debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_A5DEC92C4DF65F0B23BD1C846ABCF87B_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt_A5DEC92C4DF65F0B23BD1C846ABCF87B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_A5DEC92C4DF65F0B23BD1C846ABCF87B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt_A5DEC92C4DF65F0B23BD1C846ABCF87B" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt_A5DEC92C4DF65F0B23BD1C846ABCF87B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_4DDEF20BDDACF72614511C846ABC9C5E_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_4DDEF20BDDACF72614511C846ABC9C5E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_4DDEF20BDDACF72614511C846ABC9C5E_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_4DDEF20BDDACF72614511C846ABC9C5E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_4DDEF20BDDACF72614511C846ABC9C5E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_4DDEF20BDDACF72614511C846ABC9C5E" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_4DDEF20BDDACF72614511C846ABC9C5E" xlink:type="arc" />
    <link:label id="lab_dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount_9AED01AC933EAE464C031C846ABDAA8D_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount_9AED01AC933EAE464C031C846ABDAA8D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion amount</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount_9AED01AC933EAE464C031C846ABDAA8D_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount_9AED01AC933EAE464C031C846ABDAA8D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Terms Of Conversion Feature, Conversion Amount</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount_9AED01AC933EAE464C031C846ABDAA8D_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount_9AED01AC933EAE464C031C846ABDAA8D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Terms Of Conversion Feature, Conversion Amount</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount" xlink:label="loc_dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount_9AED01AC933EAE464C031C846ABDAA8D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount_9AED01AC933EAE464C031C846ABDAA8D" xlink:to="lab_dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount_9AED01AC933EAE464C031C846ABDAA8D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_39AABFF771DD5BD6362C1C846ABDACB1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_39AABFF771DD5BD6362C1C846ABDACB1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion price of convertible notes (USD per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_39AABFF771DD5BD6362C1C846ABDACB1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_39AABFF771DD5BD6362C1C846ABDACB1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_39AABFF771DD5BD6362C1C846ABDACB1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_39AABFF771DD5BD6362C1C846ABDACB1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_39AABFF771DD5BD6362C1C846ABDACB1" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_55FA3CCA52322EFD959B1C846ABDB2F6_terseLabel_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_55FA3CCA52322EFD959B1C846ABDB2F6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recognized additional paid-in capital from cash conversion option</link:label>
    <link:label id="lab_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_55FA3CCA52322EFD959B1C846ABDB2F6_label_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_55FA3CCA52322EFD959B1C846ABDB2F6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity" xlink:label="loc_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_55FA3CCA52322EFD959B1C846ABDB2F6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_55FA3CCA52322EFD959B1C846ABDB2F6" xlink:to="lab_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_55FA3CCA52322EFD959B1C846ABDB2F6" xlink:type="arc" />
    <link:label id="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_89F8B844A826336B5E191C846ABD0CE5_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_89F8B844A826336B5E191C846ABD0CE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Holder's repurchase price percentage in event of fundamental change (as a percent)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_89F8B844A826336B5E191C846ABD0CE5_label_en-US" xlink:label="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_89F8B844A826336B5E191C846ABD0CE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant Repurchase Price, Percentage</link:label>
    <link:label id="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_89F8B844A826336B5E191C846ABD0CE5_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_89F8B844A826336B5E191C846ABD0CE5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant Repurchase Price, Percentage</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:label="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_89F8B844A826336B5E191C846ABD0CE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_89F8B844A826336B5E191C846ABD0CE5" xlink:to="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_89F8B844A826336B5E191C846ABD0CE5" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_3C6AF025884690A6B3C11C846AC1057D_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_3C6AF025884690A6B3C11C846AC1057D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_3C6AF025884690A6B3C11C846AC1057D_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_3C6AF025884690A6B3C11C846AC1057D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_3C6AF025884690A6B3C11C846AC1057D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_3C6AF025884690A6B3C11C846AC1057D" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_3C6AF025884690A6B3C11C846AC1057D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6225B6F2C841FEC1DF4A1C846AC1D61E_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6225B6F2C841FEC1DF4A1C846AC1D61E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proportion of applicable conversion price (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6225B6F2C841FEC1DF4A1C846AC1D61E_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6225B6F2C841FEC1DF4A1C846AC1D61E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6225B6F2C841FEC1DF4A1C846AC1D61E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6225B6F2C841FEC1DF4A1C846AC1D61E" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6225B6F2C841FEC1DF4A1C846AC1D61E" xlink:type="arc" />
    <link:label id="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_4CCEA09A678E2EF3F0E61C846AC2766B_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_4CCEA09A678E2EF3F0E61C846AC2766B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proportion of conversion price (as a percent)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_4CCEA09A678E2EF3F0E61C846AC2766B_label_en-US" xlink:label="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_4CCEA09A678E2EF3F0E61C846AC2766B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock</link:label>
    <link:label id="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_4CCEA09A678E2EF3F0E61C846AC2766B_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_4CCEA09A678E2EF3F0E61C846AC2766B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:label="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_4CCEA09A678E2EF3F0E61C846AC2766B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_4CCEA09A678E2EF3F0E61C846AC2766B" xlink:to="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_4CCEA09A678E2EF3F0E61C846AC2766B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_5F88818FC02470C4B80A1C846AC29157_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_5F88818FC02470C4B80A1C846AC29157" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redemption price (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_5F88818FC02470C4B80A1C846AC29157_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_5F88818FC02470C4B80A1C846AC29157" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_5F88818FC02470C4B80A1C846AC29157" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_5F88818FC02470C4B80A1C846AC29157" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_5F88818FC02470C4B80A1C846AC29157" xlink:type="arc" />
    <link:label id="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_3A68B2DBA17A28687D541C846AC2EB44_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_3A68B2DBA17A28687D541C846AC2EB44" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued upon conversion of senior notes (shares)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_3A68B2DBA17A28687D541C846AC2EB44_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_3A68B2DBA17A28687D541C846AC2EB44" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_3A68B2DBA17A28687D541C846AC2EB44_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_3A68B2DBA17A28687D541C846AC2EB44" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares1</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:label="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_3A68B2DBA17A28687D541C846AC2EB44" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_3A68B2DBA17A28687D541C846AC2EB44" xlink:to="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_3A68B2DBA17A28687D541C846AC2EB44" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_0C0CF4473609C6D3FBEE1C846AC2440B_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_0C0CF4473609C6D3FBEE1C846AC2440B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity component of convertible note issuance, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_0C0CF4473609C6D3FBEE1C846AC2440B_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_0C0CF4473609C6D3FBEE1C846AC2440B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_0C0CF4473609C6D3FBEE1C846AC2440B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_0C0CF4473609C6D3FBEE1C846AC2440B" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_0C0CF4473609C6D3FBEE1C846AC2440B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_86AB8F04F76047D604281C846AC2CADA_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_86AB8F04F76047D604281C846AC2CADA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock counterparties to acquire with warrants purchased (shares)</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_86AB8F04F76047D604281C846AC2CADA_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_86AB8F04F76047D604281C846AC2CADA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_86AB8F04F76047D604281C846AC2CADA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_86AB8F04F76047D604281C846AC2CADA" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_86AB8F04F76047D604281C846AC2CADA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_AC6F08D8A39E846D15CC1C846AC2EFAA_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants_AC6F08D8A39E846D15CC1C846AC2EFAA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_AC6F08D8A39E846D15CC1C846AC2EFAA_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants_AC6F08D8A39E846D15CC1C846AC2EFAA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Warrants</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_AC6F08D8A39E846D15CC1C846AC2EFAA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants_AC6F08D8A39E846D15CC1C846AC2EFAA" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants_AC6F08D8A39E846D15CC1C846AC2EFAA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7EA9285F61D71990C1801C846AC31164_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7EA9285F61D71990C1801C846AC31164" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price of warrants or rights (USD per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7EA9285F61D71990C1801C846AC31164_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7EA9285F61D71990C1801C846AC31164" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7EA9285F61D71990C1801C846AC31164" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7EA9285F61D71990C1801C846AC31164" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7EA9285F61D71990C1801C846AC31164" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_094F41CDC9291CDEA3E01C846AC391C1_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_094F41CDC9291CDEA3E01C846AC391C1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Maximum borrowing capacity of revolving credit agreement</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_094F41CDC9291CDEA3E01C846AC391C1_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_094F41CDC9291CDEA3E01C846AC391C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_094F41CDC9291CDEA3E01C846AC391C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_094F41CDC9291CDEA3E01C846AC391C1" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_094F41CDC9291CDEA3E01C846AC391C1" xlink:type="arc" />
    <link:label id="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_9F4C7FB2285F259892BC1C846AC38FE8_terseLabel_en-US" xlink:label="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_9F4C7FB2285F259892BC1C846AC38FE8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option to increase revolving line of credit</link:label>
    <link:label id="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_9F4C7FB2285F259892BC1C846AC38FE8_label_en-US" xlink:label="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_9F4C7FB2285F259892BC1C846AC38FE8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Option To Increase, Amount</link:label>
    <link:label id="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_9F4C7FB2285F259892BC1C846AC38FE8_documentation_en-US" xlink:label="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_9F4C7FB2285F259892BC1C846AC38FE8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity, Option to Increase, Amount</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:label="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_9F4C7FB2285F259892BC1C846AC38FE8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_9F4C7FB2285F259892BC1C846AC38FE8" xlink:to="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_9F4C7FB2285F259892BC1C846AC38FE8" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_76EDE0665C8F4DC92E871C846AC385E5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_76EDE0665C8F4DC92E871C846AC385E5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis spread on variable rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_76EDE0665C8F4DC92E871C846AC385E5_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_76EDE0665C8F4DC92E871C846AC385E5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_76EDE0665C8F4DC92E871C846AC385E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_76EDE0665C8F4DC92E871C846AC385E5" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_76EDE0665C8F4DC92E871C846AC385E5" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_771894F7173F157E7C801C846AC4C793_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_771894F7173F157E7C801C846AC4C793" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unused capacity fee (as a percent)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_771894F7173F157E7C801C846AC4C793_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_771894F7173F157E7C801C846AC4C793" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_771894F7173F157E7C801C846AC4C793" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_771894F7173F157E7C801C846AC4C793" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_771894F7173F157E7C801C846AC4C793" xlink:type="arc" />
    <link:label id="lab_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_37EC05E720691C829D481C846AC4E0A6_terseLabel_en-US" xlink:label="lab_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_37EC05E720691C829D481C846AC4E0A6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Value of unrestricted cash on hand threshold</link:label>
    <link:label id="lab_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_37EC05E720691C829D481C846AC4E0A6_label_en-US" xlink:label="lab_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_37EC05E720691C829D481C846AC4E0A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maturity, Conditional Restrictions, Value of Unrestricted Cash on Hand Threshold</link:label>
    <link:label id="lab_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_37EC05E720691C829D481C846AC4E0A6_documentation_en-US" xlink:label="lab_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_37EC05E720691C829D481C846AC4E0A6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maturity, Conditional Restrictions, Value of Unrestricted Cash on Hand Threshold</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold" xlink:label="loc_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_37EC05E720691C829D481C846AC4E0A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_37EC05E720691C829D481C846AC4E0A6" xlink:to="lab_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_37EC05E720691C829D481C846AC4E0A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48E3FDF4C8D30298918AC9C2EFCAF1E9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48E3FDF4C8D30298918AC9C2EFCAF1E9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48E3FDF4C8D30298918AC9C2EFCAF1E9_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48E3FDF4C8D30298918AC9C2EFCAF1E9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48E3FDF4C8D30298918AC9C2EFCAF1E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48E3FDF4C8D30298918AC9C2EFCAF1E9" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48E3FDF4C8D30298918AC9C2EFCAF1E9" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_8E9C756A99B0399FED08C9C2EFCA62D3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_8E9C756A99B0399FED08C9C2EFCA62D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options and employee stock purchase plan</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8E9C756A99B0399FED08C9C2EFCA62D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember_8E9C756A99B0399FED08C9C2EFCA62D3" xlink:to="lab_us-gaap_EmployeeStockOptionMember_8E9C756A99B0399FED08C9C2EFCA62D3" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_CB06A37873093A016992C9C2EFCB657C_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_CB06A37873093A016992C9C2EFCB657C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_CB06A37873093A016992C9C2EFCB657C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_CB06A37873093A016992C9C2EFCB657C" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember_CB06A37873093A016992C9C2EFCB657C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_9719AFC022DE60E4B8FDC9C2EFCCB183_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_9719AFC022DE60E4B8FDC9C2EFCCB183" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_9719AFC022DE60E4B8FDC9C2EFCCB183" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_9719AFC022DE60E4B8FDC9C2EFCCB183" xlink:to="lab_us-gaap_NetIncomeLoss_9719AFC022DE60E4B8FDC9C2EFCCB183" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8264DED3122F87397607C9C2EFCD46CA_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8264DED3122F87397607C9C2EFCD46CA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic weighted average shares outstanding (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8264DED3122F87397607C9C2EFCD46CA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8264DED3122F87397607C9C2EFCD46CA" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8264DED3122F87397607C9C2EFCD46CA" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DB7ACC95EA6A5121BE4FC9C2EFCD4C2E_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DB7ACC95EA6A5121BE4FC9C2EFCD4C2E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dilutive potential common stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DB7ACC95EA6A5121BE4FC9C2EFCD4C2E_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DB7ACC95EA6A5121BE4FC9C2EFCD4C2E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DB7ACC95EA6A5121BE4FC9C2EFCD4C2E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DB7ACC95EA6A5121BE4FC9C2EFCD4C2E" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DB7ACC95EA6A5121BE4FC9C2EFCD4C2E" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E8FBF90FA0B36E3C0908C9C2EFCDDB79_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E8FBF90FA0B36E3C0908C9C2EFCDDB79" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted weighted average shares outstanding (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E8FBF90FA0B36E3C0908C9C2EFCDDB79" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E8FBF90FA0B36E3C0908C9C2EFCDDB79" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E8FBF90FA0B36E3C0908C9C2EFCDDB79" xlink:type="arc" />
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_1095DC06E831C4C19AB1D354A3E2AA7B_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock_1095DC06E831C4C19AB1D354A3E2AA7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information (Unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_1095DC06E831C4C19AB1D354A3E2AA7B_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock_1095DC06E831C4C19AB1D354A3E2AA7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_1095DC06E831C4C19AB1D354A3E2AA7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock_1095DC06E831C4C19AB1D354A3E2AA7B" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock_1095DC06E831C4C19AB1D354A3E2AA7B" xlink:type="arc" />
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_CD6D7EFFAD97174592691BE3D1CB5B10_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable_CD6D7EFFAD97174592691BE3D1CB5B10" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_CD6D7EFFAD97174592691BE3D1CB5B10_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable_CD6D7EFFAD97174592691BE3D1CB5B10" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_CD6D7EFFAD97174592691BE3D1CB5B10" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_CD6D7EFFAD97174592691BE3D1CB5B10" xlink:to="lab_srt_ScheduleOfCondensedFinancialStatementsTable_CD6D7EFFAD97174592691BE3D1CB5B10" xlink:type="arc" />
    <link:label id="lab_srt_ProductOrServiceAxis_639D8BCAB4A2FD51B7721BE3D1CB076D_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis_639D8BCAB4A2FD51B7721BE3D1CB076D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_639D8BCAB4A2FD51B7721BE3D1CB076D_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis_639D8BCAB4A2FD51B7721BE3D1CB076D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_639D8BCAB4A2FD51B7721BE3D1CB076D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis_639D8BCAB4A2FD51B7721BE3D1CB076D" xlink:to="lab_srt_ProductOrServiceAxis_639D8BCAB4A2FD51B7721BE3D1CB076D" xlink:type="arc" />
    <link:label id="lab_srt_ProductsAndServicesDomain_7612223BF21D57E575E51BE3D1CCA9CE_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain_7612223BF21D57E575E51BE3D1CCA9CE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_7612223BF21D57E575E51BE3D1CCA9CE_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain_7612223BF21D57E575E51BE3D1CCA9CE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_7612223BF21D57E575E51BE3D1CCA9CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain_7612223BF21D57E575E51BE3D1CCA9CE" xlink:to="lab_srt_ProductsAndServicesDomain_7612223BF21D57E575E51BE3D1CCA9CE" xlink:type="arc" />
    <link:label id="lab_dxcm_ReceiverProductComponentMember_079E9A6CEDAD5CC10F291BE3D1CC0BD6_terseLabel_en-US" xlink:label="lab_dxcm_ReceiverProductComponentMember_079E9A6CEDAD5CC10F291BE3D1CC0BD6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receiver Product Component</link:label>
    <link:label id="lab_dxcm_ReceiverProductComponentMember_079E9A6CEDAD5CC10F291BE3D1CC0BD6_label_en-US" xlink:label="lab_dxcm_ReceiverProductComponentMember_079E9A6CEDAD5CC10F291BE3D1CC0BD6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receiver Product Component [Member]</link:label>
    <link:label id="lab_dxcm_ReceiverProductComponentMember_079E9A6CEDAD5CC10F291BE3D1CC0BD6_documentation_en-US" xlink:label="lab_dxcm_ReceiverProductComponentMember_079E9A6CEDAD5CC10F291BE3D1CC0BD6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Receiver Product Component [Member]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ReceiverProductComponentMember" xlink:label="loc_dxcm_ReceiverProductComponentMember_079E9A6CEDAD5CC10F291BE3D1CC0BD6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ReceiverProductComponentMember_079E9A6CEDAD5CC10F291BE3D1CC0BD6" xlink:to="lab_dxcm_ReceiverProductComponentMember_079E9A6CEDAD5CC10F291BE3D1CC0BD6" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5EA4321873B2A1491D941BE3D1CCA422_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5EA4321873B2A1491D941BE3D1CCA422" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5EA4321873B2A1491D941BE3D1CCA422_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5EA4321873B2A1491D941BE3D1CCA422" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5EA4321873B2A1491D941BE3D1CCA422" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5EA4321873B2A1491D941BE3D1CCA422" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5EA4321873B2A1491D941BE3D1CCA422" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_BFAA252C766F5DB3E0091BE3D1CDCB79_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_BFAA252C766F5DB3E0091BE3D1CDCB79" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_BFAA252C766F5DB3E0091BE3D1CDCB79_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_BFAA252C766F5DB3E0091BE3D1CDCB79" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_BFAA252C766F5DB3E0091BE3D1CDCB79" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_BFAA252C766F5DB3E0091BE3D1CDCB79" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_BFAA252C766F5DB3E0091BE3D1CDCB79" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConstructionInProgressMember_7E805005EAF44C7245461BE3D1CDEEAA_verboseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember_7E805005EAF44C7245461BE3D1CDEEAA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Construction in Progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_7E805005EAF44C7245461BE3D1CDEEAA_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember_7E805005EAF44C7245461BE3D1CDEEAA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaap_ConstructionInProgressMember_7E805005EAF44C7245461BE3D1CDEEAA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember_7E805005EAF44C7245461BE3D1CDEEAA" xlink:to="lab_us-gaap_ConstructionInProgressMember_7E805005EAF44C7245461BE3D1CDEEAA" xlink:type="arc" />
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07_label_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:to="lab_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm_09110C80EF23A5BAC2E01BE3D1CD4025_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm_09110C80EF23A5BAC2E01BE3D1CD4025" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum contractual maturities of debt securities held</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm_09110C80EF23A5BAC2E01BE3D1CD4025_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm_09110C80EF23A5BAC2E01BE3D1CD4025" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale, Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_09110C80EF23A5BAC2E01BE3D1CD4025" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_09110C80EF23A5BAC2E01BE3D1CD4025" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm_09110C80EF23A5BAC2E01BE3D1CD4025" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryWriteDown_2853544E4F0BD4EA24D41BE3D1CDFE6B_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown_2853544E4F0BD4EA24D41BE3D1CDFE6B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_2853544E4F0BD4EA24D41BE3D1CDFE6B_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown_2853544E4F0BD4EA24D41BE3D1CDFE6B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaap_InventoryWriteDown_2853544E4F0BD4EA24D41BE3D1CDFE6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown_2853544E4F0BD4EA24D41BE3D1CDFE6B" xlink:to="lab_us-gaap_InventoryWriteDown_2853544E4F0BD4EA24D41BE3D1CDFE6B" xlink:type="arc" />
    <link:label id="lab_us-gaap_Depreciation_0E2A23FDDC41F52A92061BE3D1CE701D_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation_0E2A23FDDC41F52A92061BE3D1CE701D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_0E2A23FDDC41F52A92061BE3D1CE701D_label_en-US" xlink:label="lab_us-gaap_Depreciation_0E2A23FDDC41F52A92061BE3D1CE701D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_0E2A23FDDC41F52A92061BE3D1CE701D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation_0E2A23FDDC41F52A92061BE3D1CE701D" xlink:to="lab_us-gaap_Depreciation_0E2A23FDDC41F52A92061BE3D1CE701D" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0FB3BBB7973B7876CE011BE3D1CE28AE_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0FB3BBB7973B7876CE011BE3D1CE28AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain (loss) on disposal of machinery and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0FB3BBB7973B7876CE011BE3D1CE28AE_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0FB3BBB7973B7876CE011BE3D1CE28AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0FB3BBB7973B7876CE011BE3D1CE28AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0FB3BBB7973B7876CE011BE3D1CE28AE" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0FB3BBB7973B7876CE011BE3D1CE28AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCharges_477946D853193AFDE40A1BE3D1CECC2C_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges_477946D853193AFDE40A1BE3D1CECC2C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring charges and costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_477946D853193AFDE40A1BE3D1CECC2C_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges_477946D853193AFDE40A1BE3D1CECC2C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_477946D853193AFDE40A1BE3D1CECC2C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges_477946D853193AFDE40A1BE3D1CECC2C" xlink:to="lab_us-gaap_RestructuringCharges_477946D853193AFDE40A1BE3D1CECC2C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_F5FC1952F1CDF42FCA94AFE0A5D2F06A_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_F5FC1952F1CDF42FCA94AFE0A5D2F06A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock options granted and outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_F5FC1952F1CDF42FCA94AFE0A5D2F06A_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_F5FC1952F1CDF42FCA94AFE0A5D2F06A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_F5FC1952F1CDF42FCA94AFE0A5D2F06A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_F5FC1952F1CDF42FCA94AFE0A5D2F06A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_F5FC1952F1CDF42FCA94AFE0A5D2F06A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_454E12F806B77FC6DF05AFE0A5D2BFB3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_454E12F806B77FC6DF05AFE0A5D2BFB3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested restricted stock units (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_454E12F806B77FC6DF05AFE0A5D2BFB3_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_454E12F806B77FC6DF05AFE0A5D2BFB3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_454E12F806B77FC6DF05AFE0A5D2BFB3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_454E12F806B77FC6DF05AFE0A5D2BFB3" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_454E12F806B77FC6DF05AFE0A5D2BFB3" xlink:type="arc" />
    <link:label id="lab_dxcm_StockOptionsReservedForFutureGrant_4D5FFEC652EAE8581381AFE0A5D3B6DC_terseLabel_en-US" xlink:label="lab_dxcm_StockOptionsReservedForFutureGrant_4D5FFEC652EAE8581381AFE0A5D3B6DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reserved for future grant (shares)</link:label>
    <link:label id="lab_dxcm_StockOptionsReservedForFutureGrant_4D5FFEC652EAE8581381AFE0A5D3B6DC_label_en-US" xlink:label="lab_dxcm_StockOptionsReservedForFutureGrant_4D5FFEC652EAE8581381AFE0A5D3B6DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Options Reserved For Future Grant</link:label>
    <link:label id="lab_dxcm_StockOptionsReservedForFutureGrant_4D5FFEC652EAE8581381AFE0A5D3B6DC_documentation_en-US" xlink:label="lab_dxcm_StockOptionsReservedForFutureGrant_4D5FFEC652EAE8581381AFE0A5D3B6DC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of stock options and awards reserved for future grant</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_StockOptionsReservedForFutureGrant" xlink:label="loc_dxcm_StockOptionsReservedForFutureGrant_4D5FFEC652EAE8581381AFE0A5D3B6DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_StockOptionsReservedForFutureGrant_4D5FFEC652EAE8581381AFE0A5D3B6DC" xlink:to="lab_dxcm_StockOptionsReservedForFutureGrant_4D5FFEC652EAE8581381AFE0A5D3B6DC" xlink:type="arc" />
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_0E501CB0F9839DC519B7AFE0A5D37034_terseLabel_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_0E501CB0F9839DC519B7AFE0A5D37034" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan (shares)</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_0E501CB0F9839DC519B7AFE0A5D37034_label_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_0E501CB0F9839DC519B7AFE0A5D37034" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan Espp Shares In Espp</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_0E501CB0F9839DC519B7AFE0A5D37034_documentation_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_0E501CB0F9839DC519B7AFE0A5D37034" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan ESPP Shares In ESPP</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EmployeeStockPurchasePlanEsppSharesInEspp" xlink:label="loc_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_0E501CB0F9839DC519B7AFE0A5D37034" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_0E501CB0F9839DC519B7AFE0A5D37034" xlink:to="lab_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_0E501CB0F9839DC519B7AFE0A5D37034" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_5A6C501F759AA6A93F37AFE0A5D38BCC_totalLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_5A6C501F759AA6A93F37AFE0A5D38BCC" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_5A6C501F759AA6A93F37AFE0A5D38BCC_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_5A6C501F759AA6A93F37AFE0A5D38BCC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_5A6C501F759AA6A93F37AFE0A5D38BCC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_5A6C501F759AA6A93F37AFE0A5D38BCC" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_5A6C501F759AA6A93F37AFE0A5D38BCC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_657D13781837AAD1DBF1C9C4B8B40113_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_657D13781837AAD1DBF1C9C4B8B40113" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_657D13781837AAD1DBF1C9C4B8B40113_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_657D13781837AAD1DBF1C9C4B8B40113" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_657D13781837AAD1DBF1C9C4B8B40113" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_657D13781837AAD1DBF1C9C4B8B40113" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_657D13781837AAD1DBF1C9C4B8B40113" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_17708761665EBF49599DC9C4B8B42E45_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_17708761665EBF49599DC9C4B8B42E45" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_17708761665EBF49599DC9C4B8B42E45" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_17708761665EBF49599DC9C4B8B42E45" xlink:to="lab_us-gaap_IncomeStatementLocationAxis_17708761665EBF49599DC9C4B8B42E45" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_E07455383545539E625CC9C4B8B52574_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_E07455383545539E625CC9C4B8B52574" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_E07455383545539E625CC9C4B8B52574" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_E07455383545539E625CC9C4B8B52574" xlink:to="lab_us-gaap_IncomeStatementLocationDomain_E07455383545539E625CC9C4B8B52574" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfSalesMember_D9FCE44634E5BD9134E1C9C4B8B553D5_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember_D9FCE44634E5BD9134E1C9C4B8B553D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_D9FCE44634E5BD9134E1C9C4B8B553D5_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember_D9FCE44634E5BD9134E1C9C4B8B553D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_D9FCE44634E5BD9134E1C9C4B8B553D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember_D9FCE44634E5BD9134E1C9C4B8B553D5" xlink:to="lab_us-gaap_CostOfSalesMember_D9FCE44634E5BD9134E1C9C4B8B553D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_472B95F5720C552FD658C9C4B8B5120E_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember_472B95F5720C552FD658C9C4B8B5120E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_472B95F5720C552FD658C9C4B8B5120E_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember_472B95F5720C552FD658C9C4B8B5120E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_472B95F5720C552FD658C9C4B8B5120E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember_472B95F5720C552FD658C9C4B8B5120E" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember_472B95F5720C552FD658C9C4B8B5120E" xlink:type="arc" />
    <link:label id="lab_dxcm_SellingGeneralAndAdministrativeMember_86C2CE019F0FF0EC2468C9C4B8B5CFEF_terseLabel_en-US" xlink:label="lab_dxcm_SellingGeneralAndAdministrativeMember_86C2CE019F0FF0EC2468C9C4B8B5CFEF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_dxcm_SellingGeneralAndAdministrativeMember_86C2CE019F0FF0EC2468C9C4B8B5CFEF_label_en-US" xlink:label="lab_dxcm_SellingGeneralAndAdministrativeMember_86C2CE019F0FF0EC2468C9C4B8B5CFEF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling General And Administrative [Member]</link:label>
    <link:label id="lab_dxcm_SellingGeneralAndAdministrativeMember_86C2CE019F0FF0EC2468C9C4B8B5CFEF_documentation_en-US" xlink:label="lab_dxcm_SellingGeneralAndAdministrativeMember_86C2CE019F0FF0EC2468C9C4B8B5CFEF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The allocation of expenses to selling, general and administrative</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_SellingGeneralAndAdministrativeMember" xlink:label="loc_dxcm_SellingGeneralAndAdministrativeMember_86C2CE019F0FF0EC2468C9C4B8B5CFEF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_SellingGeneralAndAdministrativeMember_86C2CE019F0FF0EC2468C9C4B8B5CFEF" xlink:to="lab_dxcm_SellingGeneralAndAdministrativeMember_86C2CE019F0FF0EC2468C9C4B8B5CFEF" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_63CE1C4A2BF887A2E93FC9C4B8B5218C_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_63CE1C4A2BF887A2E93FC9C4B8B5218C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_63CE1C4A2BF887A2E93FC9C4B8B5218C_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_63CE1C4A2BF887A2E93FC9C4B8B5218C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_63CE1C4A2BF887A2E93FC9C4B8B5218C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_63CE1C4A2BF887A2E93FC9C4B8B5218C" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_63CE1C4A2BF887A2E93FC9C4B8B5218C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_5522FA9FD83E7F1D7985C9C4B8B604A4_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_5522FA9FD83E7F1D7985C9C4B8B604A4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense included in operating expenses</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_5522FA9FD83E7F1D7985C9C4B8B604A4_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_5522FA9FD83E7F1D7985C9C4B8B604A4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5522FA9FD83E7F1D7985C9C4B8B604A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_5522FA9FD83E7F1D7985C9C4B8B604A4" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_5522FA9FD83E7F1D7985C9C4B8B604A4" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_353C8B4AC56726140FF4B031008D5330_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_353C8B4AC56726140FF4B031008D5330" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_353C8B4AC56726140FF4B031008D5330_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_353C8B4AC56726140FF4B031008D5330" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_353C8B4AC56726140FF4B031008D5330" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_353C8B4AC56726140FF4B031008D5330" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_353C8B4AC56726140FF4B031008D5330" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7AC757C6B3858A30DE4CB031008D33B4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7AC757C6B3858A30DE4CB031008D33B4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outside of the United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7AC757C6B3858A30DE4CB031008D33B4_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7AC757C6B3858A30DE4CB031008D33B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7AC757C6B3858A30DE4CB031008D33B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7AC757C6B3858A30DE4CB031008D33B4" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7AC757C6B3858A30DE4CB031008D33B4" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5D30E5C420A282EEF40BB031008D1120_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5D30E5C420A282EEF40BB031008D1120" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5D30E5C420A282EEF40BB031008D1120_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5D30E5C420A282EEF40BB031008D1120" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5D30E5C420A282EEF40BB031008D1120" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5D30E5C420A282EEF40BB031008D1120" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5D30E5C420A282EEF40BB031008D1120" xlink:type="arc" />
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3E3DD207FDF09AB97721AB02F8AB0880_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3E3DD207FDF09AB97721AB02F8AB0880" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization and Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3E3DD207FDF09AB97721AB02F8AB0880_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3E3DD207FDF09AB97721AB02F8AB0880" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3E3DD207FDF09AB97721AB02F8AB0880" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3E3DD207FDF09AB97721AB02F8AB0880" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3E3DD207FDF09AB97721AB02F8AB0880" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_094FC73E2967501E23F8B570A8CC2093_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_094FC73E2967501E23F8B570A8CC2093" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Short-term Marketable Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_094FC73E2967501E23F8B570A8CC2093_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_094FC73E2967501E23F8B570A8CC2093" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_094FC73E2967501E23F8B570A8CC2093" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_094FC73E2967501E23F8B570A8CC2093" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_094FC73E2967501E23F8B570A8CC2093" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_FD4095EEE1D6A7D5DE6CB570A8CC97CE_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock_FD4095EEE1D6A7D5DE6CB570A8CC97CE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Reconciliation of Net Gain (Loss) Recognized on Equity Securities</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_FD4095EEE1D6A7D5DE6CB570A8CC97CE_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock_FD4095EEE1D6A7D5DE6CB570A8CC97CE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Securities [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnInvestmentsTextBlock" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock_FD4095EEE1D6A7D5DE6CB570A8CC97CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestmentsTextBlock_FD4095EEE1D6A7D5DE6CB570A8CC97CE" xlink:to="lab_us-gaap_GainLossOnInvestmentsTextBlock_FD4095EEE1D6A7D5DE6CB570A8CC97CE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_613233148F3BDA2D3ACDB570A8CD19B0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_613233148F3BDA2D3ACDB570A8CD19B0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_613233148F3BDA2D3ACDB570A8CD19B0_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_613233148F3BDA2D3ACDB570A8CD19B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_613233148F3BDA2D3ACDB570A8CD19B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_613233148F3BDA2D3ACDB570A8CD19B0" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_613233148F3BDA2D3ACDB570A8CD19B0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_F427A700D43678498BEEB570A8CD8943_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_F427A700D43678498BEEB570A8CD8943" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_F427A700D43678498BEEB570A8CD8943_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_F427A700D43678498BEEB570A8CD8943" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_F427A700D43678498BEEB570A8CD8943" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_F427A700D43678498BEEB570A8CD8943" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_F427A700D43678498BEEB570A8CD8943" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_51428128216E23FFABB7B570A8CD30D5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_51428128216E23FFABB7B570A8CD30D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_51428128216E23FFABB7B570A8CD30D5_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_51428128216E23FFABB7B570A8CD30D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_51428128216E23FFABB7B570A8CD30D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_51428128216E23FFABB7B570A8CD30D5" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_51428128216E23FFABB7B570A8CD30D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_363A77057DABB2661CB1B570A8CD6328_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_363A77057DABB2661CB1B570A8CD6328" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_363A77057DABB2661CB1B570A8CD6328_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_363A77057DABB2661CB1B570A8CD6328" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_363A77057DABB2661CB1B570A8CD6328" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_363A77057DABB2661CB1B570A8CD6328" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_363A77057DABB2661CB1B570A8CD6328" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_E0B2AAE6FF643B82D266B570A8CD2017_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_E0B2AAE6FF643B82D266B570A8CD2017" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Warranty</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_E0B2AAE6FF643B82D266B570A8CD2017_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_E0B2AAE6FF643B82D266B570A8CD2017" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_E0B2AAE6FF643B82D266B570A8CD2017" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_E0B2AAE6FF643B82D266B570A8CD2017" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_E0B2AAE6FF643B82D266B570A8CD2017" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_247882BE2E4BA771AE9EB570A8CD21D2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_247882BE2E4BA771AE9EB570A8CD21D2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Long-Term Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_247882BE2E4BA771AE9EB570A8CD21D2_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_247882BE2E4BA771AE9EB570A8CD21D2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Other Assets and Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_247882BE2E4BA771AE9EB570A8CD21D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_247882BE2E4BA771AE9EB570A8CD21D2" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_247882BE2E4BA771AE9EB570A8CD21D2" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesTable_585F35AE0A1B98D1D740B03100D666F8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable_585F35AE0A1B98D1D740B03100D666F8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_585F35AE0A1B98D1D740B03100D666F8_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable_585F35AE0A1B98D1D740B03100D666F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_585F35AE0A1B98D1D740B03100D666F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable_585F35AE0A1B98D1D740B03100D666F8" xlink:to="lab_us-gaap_LossContingenciesTable_585F35AE0A1B98D1D740B03100D666F8" xlink:type="arc" />
    <link:label id="lab_dxcm_NameOfPlaintiffAxis_F238C8E5FDF4BCD492A2B03100D70EE4_terseLabel_en-US" xlink:label="lab_dxcm_NameOfPlaintiffAxis_F238C8E5FDF4BCD492A2B03100D70EE4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name Of Plaintiff [Axis]</link:label>
    <link:label id="lab_dxcm_NameOfPlaintiffAxis_F238C8E5FDF4BCD492A2B03100D70EE4_label_en-US" xlink:label="lab_dxcm_NameOfPlaintiffAxis_F238C8E5FDF4BCD492A2B03100D70EE4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Name Of Plaintiff [Axis]</link:label>
    <link:label id="lab_dxcm_NameOfPlaintiffAxis_F238C8E5FDF4BCD492A2B03100D70EE4_documentation_en-US" xlink:label="lab_dxcm_NameOfPlaintiffAxis_F238C8E5FDF4BCD492A2B03100D70EE4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Name Of Plaintiff [Axis]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_NameOfPlaintiffAxis" xlink:label="loc_dxcm_NameOfPlaintiffAxis_F238C8E5FDF4BCD492A2B03100D70EE4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_NameOfPlaintiffAxis_F238C8E5FDF4BCD492A2B03100D70EE4" xlink:to="lab_dxcm_NameOfPlaintiffAxis_F238C8E5FDF4BCD492A2B03100D70EE4" xlink:type="arc" />
    <link:label id="lab_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E_terseLabel_en-US" xlink:label="lab_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name Of Plaintiff [Domain]</link:label>
    <link:label id="lab_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E_label_en-US" xlink:label="lab_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Name Of Plaintiff [Domain]</link:label>
    <link:label id="lab_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E_documentation_en-US" xlink:label="lab_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Name Of Plaintiff [Axis]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_NameOfPlaintiffDomain" xlink:label="loc_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E" xlink:to="lab_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E" xlink:type="arc" />
    <link:label id="lab_dxcm_AgaMatrixMember_39B6CA486876913CE685B03100D7360F_terseLabel_en-US" xlink:label="lab_dxcm_AgaMatrixMember_39B6CA486876913CE685B03100D7360F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AgaMatrix</link:label>
    <link:label id="lab_dxcm_AgaMatrixMember_39B6CA486876913CE685B03100D7360F_label_en-US" xlink:label="lab_dxcm_AgaMatrixMember_39B6CA486876913CE685B03100D7360F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AgaMatrix [Member]</link:label>
    <link:label id="lab_dxcm_AgaMatrixMember_39B6CA486876913CE685B03100D7360F_documentation_en-US" xlink:label="lab_dxcm_AgaMatrixMember_39B6CA486876913CE685B03100D7360F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AgaMatrix [Member]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_AgaMatrixMember" xlink:label="loc_dxcm_AgaMatrixMember_39B6CA486876913CE685B03100D7360F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AgaMatrixMember_39B6CA486876913CE685B03100D7360F" xlink:to="lab_dxcm_AgaMatrixMember_39B6CA486876913CE685B03100D7360F" xlink:type="arc" />
    <link:label id="lab_dxcm_WaveFormTechnologiesInc.Member_266DF00C0537C2F04E29B03100D8AA80_terseLabel_en-US" xlink:label="lab_dxcm_WaveFormTechnologiesInc.Member_266DF00C0537C2F04E29B03100D8AA80" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">WaveForm Technologies, Inc.</link:label>
    <link:label id="lab_dxcm_WaveFormTechnologiesInc.Member_266DF00C0537C2F04E29B03100D8AA80_label_en-US" xlink:label="lab_dxcm_WaveFormTechnologiesInc.Member_266DF00C0537C2F04E29B03100D8AA80" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">WaveForm Technologies, Inc. [Member]</link:label>
    <link:label id="lab_dxcm_WaveFormTechnologiesInc.Member_266DF00C0537C2F04E29B03100D8AA80_documentation_en-US" xlink:label="lab_dxcm_WaveFormTechnologiesInc.Member_266DF00C0537C2F04E29B03100D8AA80" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">WaveForm Technologies, Inc. [Member]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_WaveFormTechnologiesInc.Member" xlink:label="loc_dxcm_WaveFormTechnologiesInc.Member_266DF00C0537C2F04E29B03100D8AA80" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_WaveFormTechnologiesInc.Member_266DF00C0537C2F04E29B03100D8AA80" xlink:to="lab_dxcm_WaveFormTechnologiesInc.Member_266DF00C0537C2F04E29B03100D8AA80" xlink:type="arc" />
    <link:label id="lab_dxcm_NameOfDefendantAxis_B612392BE3BF18347643B03100D6EF42_terseLabel_en-US" xlink:label="lab_dxcm_NameOfDefendantAxis_B612392BE3BF18347643B03100D6EF42" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name Of Defendant [Axis]</link:label>
    <link:label id="lab_dxcm_NameOfDefendantAxis_B612392BE3BF18347643B03100D6EF42_label_en-US" xlink:label="lab_dxcm_NameOfDefendantAxis_B612392BE3BF18347643B03100D6EF42" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Name Of Defendant [Axis]</link:label>
    <link:label id="lab_dxcm_NameOfDefendantAxis_B612392BE3BF18347643B03100D6EF42_documentation_en-US" xlink:label="lab_dxcm_NameOfDefendantAxis_B612392BE3BF18347643B03100D6EF42" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Name Of Defendant [Axis]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_NameOfDefendantAxis" xlink:label="loc_dxcm_NameOfDefendantAxis_B612392BE3BF18347643B03100D6EF42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_NameOfDefendantAxis_B612392BE3BF18347643B03100D6EF42" xlink:to="lab_dxcm_NameOfDefendantAxis_B612392BE3BF18347643B03100D6EF42" xlink:type="arc" />
    <link:label id="lab_dxcm_NameOfDefendantDomain_5638943F1D7B137EC49BB03100D735C4_terseLabel_en-US" xlink:label="lab_dxcm_NameOfDefendantDomain_5638943F1D7B137EC49BB03100D735C4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name Of Defendant [Domain]</link:label>
    <link:label id="lab_dxcm_NameOfDefendantDomain_5638943F1D7B137EC49BB03100D735C4_label_en-US" xlink:label="lab_dxcm_NameOfDefendantDomain_5638943F1D7B137EC49BB03100D735C4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Name Of Defendant [Domain]</link:label>
    <link:label id="lab_dxcm_NameOfDefendantDomain_5638943F1D7B137EC49BB03100D735C4_documentation_en-US" xlink:label="lab_dxcm_NameOfDefendantDomain_5638943F1D7B137EC49BB03100D735C4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Name Of Defendant [Axis]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_NameOfDefendantDomain" xlink:label="loc_dxcm_NameOfDefendantDomain_5638943F1D7B137EC49BB03100D735C4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_NameOfDefendantDomain_5638943F1D7B137EC49BB03100D735C4" xlink:to="lab_dxcm_NameOfDefendantDomain_5638943F1D7B137EC49BB03100D735C4" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:to="lab_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_020B09A424BC077AE3E1B03100D88A2B_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_020B09A424BC077AE3E1B03100D88A2B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of patents allegedly infringed upon by entity</link:label>
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_020B09A424BC077AE3E1B03100D88A2B_label_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_020B09A424BC077AE3E1B03100D88A2B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Patents Allegedly Infringed, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_020B09A424BC077AE3E1B03100D88A2B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_020B09A424BC077AE3E1B03100D88A2B" xlink:to="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_020B09A424BC077AE3E1B03100D88A2B" xlink:type="arc" />
    <link:label id="lab_dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber_4BB33ECF0522C33AFCD1B07376463FE2_terseLabel_en-US" xlink:label="lab_dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber_4BB33ECF0522C33AFCD1B07376463FE2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of patents allegedly infringed upon by entity that are not unpatentable</link:label>
    <link:label id="lab_dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber_4BB33ECF0522C33AFCD1B07376463FE2_label_en-US" xlink:label="lab_dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber_4BB33ECF0522C33AFCD1B07376463FE2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Patents Allegedly Infringed, Determined Patentable, Number</link:label>
    <link:label id="lab_dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber_4BB33ECF0522C33AFCD1B07376463FE2_documentation_en-US" xlink:label="lab_dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber_4BB33ECF0522C33AFCD1B07376463FE2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Patents Allegedly Infringed, Determined Patentable, Number</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber" xlink:label="loc_dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber_4BB33ECF0522C33AFCD1B07376463FE2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber_4BB33ECF0522C33AFCD1B07376463FE2" xlink:to="lab_dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber_4BB33ECF0522C33AFCD1B07376463FE2" xlink:type="arc" />
    <link:label id="lab_dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff_C2B227B4B4CAD64D237AB03100D84EC9_terseLabel_en-US" xlink:label="lab_dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff_C2B227B4B4CAD64D237AB03100D84EC9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of patent infringement claims transferred to new plaintiff</link:label>
    <link:label id="lab_dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff_C2B227B4B4CAD64D237AB03100D84EC9_label_en-US" xlink:label="lab_dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff_C2B227B4B4CAD64D237AB03100D84EC9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Patents Allegedly Infringed, Number Transferred To New Plaintiff</link:label>
    <link:label id="lab_dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff_C2B227B4B4CAD64D237AB03100D84EC9_documentation_en-US" xlink:label="lab_dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff_C2B227B4B4CAD64D237AB03100D84EC9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Patents Allegedly Infringed, Number Transferred To New Plaintiff</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff" xlink:label="loc_dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff_C2B227B4B4CAD64D237AB03100D84EC9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff_C2B227B4B4CAD64D237AB03100D84EC9" xlink:to="lab_dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff_C2B227B4B4CAD64D237AB03100D84EC9" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_E0D0B648D461890D81F9B03100D9A2B5_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_E0D0B648D461890D81F9B03100D9A2B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of patents allegedly infringed upon by counterparty</link:label>
    <link:label id="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_E0D0B648D461890D81F9B03100D9A2B5_label_en-US" xlink:label="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_E0D0B648D461890D81F9B03100D9A2B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain Contingency, Patents Allegedly Infringed upon, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:label="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_E0D0B648D461890D81F9B03100D9A2B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_E0D0B648D461890D81F9B03100D9A2B5" xlink:to="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_E0D0B648D461890D81F9B03100D9A2B5" xlink:type="arc" />
    <link:label id="lab_us-gaap_LitigationReserve_1FF104E55986E5199F9EB03100D959BC_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve_1FF104E55986E5199F9EB03100D959BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss contingency accrual</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_1FF104E55986E5199F9EB03100D959BC_label_en-US" xlink:label="lab_us-gaap_LitigationReserve_1FF104E55986E5199F9EB03100D959BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_1FF104E55986E5199F9EB03100D959BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve_1FF104E55986E5199F9EB03100D959BC" xlink:to="lab_us-gaap_LitigationReserve_1FF104E55986E5199F9EB03100D959BC" xlink:type="arc" />
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_DD880E0CB6F33ED630D9D354A3D7E8A1_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract_DD880E0CB6F33ED630D9D354A3D7E8A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_DD880E0CB6F33ED630D9D354A3D7E8A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_DD880E0CB6F33ED630D9D354A3D7E8A1" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract_DD880E0CB6F33ED630D9D354A3D7E8A1" xlink:type="arc" />
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_23F5BAC0C252F02BB46DD354A3D799A8_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_23F5BAC0C252F02BB46DD354A3D799A8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_23F5BAC0C252F02BB46DD354A3D799A8_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_23F5BAC0C252F02BB46DD354A3D799A8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_23F5BAC0C252F02BB46DD354A3D799A8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_23F5BAC0C252F02BB46DD354A3D799A8" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_23F5BAC0C252F02BB46DD354A3D799A8" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_9249AC76BBBDA554DDA60FB8CFEBEE34_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_9249AC76BBBDA554DDA60FB8CFEBEE34" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_9249AC76BBBDA554DDA60FB8CFEBEE34_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_9249AC76BBBDA554DDA60FB8CFEBEE34" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_9249AC76BBBDA554DDA60FB8CFEBEE34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock_9249AC76BBBDA554DDA60FB8CFEBEE34" xlink:to="lab_us-gaap_DebtDisclosureTextBlock_9249AC76BBBDA554DDA60FB8CFEBEE34" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_B1801F4FB2E06AB087ACD36A23E80B77_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_B1801F4FB2E06AB087ACD36A23E80B77" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Maturity of Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_B1801F4FB2E06AB087ACD36A23E80B77_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_B1801F4FB2E06AB087ACD36A23E80B77" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_B1801F4FB2E06AB087ACD36A23E80B77" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_B1801F4FB2E06AB087ACD36A23E80B77" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_B1801F4FB2E06AB087ACD36A23E80B77" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_0AE916B74B0DA86B8E14D36989C2674C_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_0AE916B74B0DA86B8E14D36989C2674C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Maturity of Finance Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_0AE916B74B0DA86B8E14D36989C2674C_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_0AE916B74B0DA86B8E14D36989C2674C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_0AE916B74B0DA86B8E14D36989C2674C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_0AE916B74B0DA86B8E14D36989C2674C" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_0AE916B74B0DA86B8E14D36989C2674C" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_E355F892C4491D86129AD354A4AF712A_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock_E355F892C4491D86129AD354A4AF712A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Lease Expense and Other Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_E355F892C4491D86129AD354A4AF712A_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock_E355F892C4491D86129AD354A4AF712A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_E355F892C4491D86129AD354A4AF712A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock_E355F892C4491D86129AD354A4AF712A" xlink:to="lab_us-gaap_LeaseCostTableTextBlock_E355F892C4491D86129AD354A4AF712A" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_19241D9903298A75227BB570A8A8CB0E_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract_19241D9903298A75227BB570A8A8CB0E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_19241D9903298A75227BB570A8A8CB0E_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract_19241D9903298A75227BB570A8A8CB0E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_19241D9903298A75227BB570A8A8CB0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_19241D9903298A75227BB570A8A8CB0E" xlink:to="lab_us-gaap_InventoryDisclosureAbstract_19241D9903298A75227BB570A8A8CB0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_A6DEDFA75BE3F74472B2B570A8A84F83_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves_A6DEDFA75BE3F74472B2B570A8A84F83" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_A6DEDFA75BE3F74472B2B570A8A84F83_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves_A6DEDFA75BE3F74472B2B570A8A84F83" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_A6DEDFA75BE3F74472B2B570A8A84F83" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves_A6DEDFA75BE3F74472B2B570A8A84F83" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves_A6DEDFA75BE3F74472B2B570A8A84F83" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_42011EE8B218D5E9A17AB570A8A81C67_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves_42011EE8B218D5E9A17AB570A8A81C67" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_42011EE8B218D5E9A17AB570A8A81C67_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves_42011EE8B218D5E9A17AB570A8A81C67" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_42011EE8B218D5E9A17AB570A8A81C67" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves_42011EE8B218D5E9A17AB570A8A81C67" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves_42011EE8B218D5E9A17AB570A8A81C67" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_9D14EACBAD8A8D57181AB570A8A8C2AE_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_9D14EACBAD8A8D57181AB570A8A8C2AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_9D14EACBAD8A8D57181AB570A8A8C2AE_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_9D14EACBAD8A8D57181AB570A8A8C2AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_9D14EACBAD8A8D57181AB570A8A8C2AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_9D14EACBAD8A8D57181AB570A8A8C2AE" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_9D14EACBAD8A8D57181AB570A8A8C2AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_A7C3419A7BD337E16945B570A8A8FCBE_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_A7C3419A7BD337E16945B570A8A8FCBE" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_A7C3419A7BD337E16945B570A8A8FCBE_label_en-US" xlink:label="lab_us-gaap_InventoryNet_A7C3419A7BD337E16945B570A8A8FCBE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_A7C3419A7BD337E16945B570A8A8FCBE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_A7C3419A7BD337E16945B570A8A8FCBE" xlink:to="lab_us-gaap_InventoryNet_A7C3419A7BD337E16945B570A8A8FCBE" xlink:type="arc" />
    <link:label id="lab_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock_BE21DEF91433C26E97A31BEB0CE8917F_terseLabel_en-US" xlink:label="lab_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock_BE21DEF91433C26E97A31BEB0CE8917F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Intrinsic Value of Options Exercised and Fair Value of Options Vested</link:label>
    <link:label id="lab_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock_BE21DEF91433C26E97A31BEB0CE8917F_label_en-US" xlink:label="lab_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock_BE21DEF91433C26E97A31BEB0CE8917F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Intrinsic Value Of Options Exercised Table [Table Text Block]</link:label>
    <link:label id="lab_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock_BE21DEF91433C26E97A31BEB0CE8917F_documentation_en-US" xlink:label="lab_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock_BE21DEF91433C26E97A31BEB0CE8917F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of intrinsic value of options exercised and fair value of options vested table.</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock" xlink:label="loc_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock_BE21DEF91433C26E97A31BEB0CE8917F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock_BE21DEF91433C26E97A31BEB0CE8917F" xlink:to="lab_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock_BE21DEF91433C26E97A31BEB0CE8917F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_0A0E11F0AEDF594A5A261BEB0CE98347_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_0A0E11F0AEDF594A5A261BEB0CE98347" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restricted Stock Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_0A0E11F0AEDF594A5A261BEB0CE98347_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_0A0E11F0AEDF594A5A261BEB0CE98347" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_0A0E11F0AEDF594A5A261BEB0CE98347" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_0A0E11F0AEDF594A5A261BEB0CE98347" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_0A0E11F0AEDF594A5A261BEB0CE98347" xlink:type="arc" />
    <link:label id="lab_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock_053C3B8DB5456C08DFA81BEB0CE9BCD2_terseLabel_en-US" xlink:label="lab_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock_053C3B8DB5456C08DFA81BEB0CE9BCD2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Options Reserved for Future Issuance</link:label>
    <link:label id="lab_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock_053C3B8DB5456C08DFA81BEB0CE9BCD2_label_en-US" xlink:label="lab_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock_053C3B8DB5456C08DFA81BEB0CE9BCD2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Shares Reserved For Future Issuance Table [Table Text Block]</link:label>
    <link:label id="lab_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock_053C3B8DB5456C08DFA81BEB0CE9BCD2_documentation_en-US" xlink:label="lab_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock_053C3B8DB5456C08DFA81BEB0CE9BCD2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Shares Reserved For Future Issuance [Table Text Block]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock" xlink:label="loc_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock_053C3B8DB5456C08DFA81BEB0CE9BCD2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock_053C3B8DB5456C08DFA81BEB0CE9BCD2" xlink:to="lab_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock_053C3B8DB5456C08DFA81BEB0CE9BCD2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_DEFBFC0DDE9F5D84C84C1BEB0CE90EED_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_DEFBFC0DDE9F5D84C84C1BEB0CE90EED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_DEFBFC0DDE9F5D84C84C1BEB0CE90EED_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_DEFBFC0DDE9F5D84C84C1BEB0CE90EED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_DEFBFC0DDE9F5D84C84C1BEB0CE90EED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_DEFBFC0DDE9F5D84C84C1BEB0CE90EED" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_DEFBFC0DDE9F5D84C84C1BEB0CE90EED" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_1E9AB07F89321115CB1E1BEB0CE90731_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_1E9AB07F89321115CB1E1BEB0CE90731" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Valuation Assumptions for Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_1E9AB07F89321115CB1E1BEB0CE90731_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_1E9AB07F89321115CB1E1BEB0CE90731" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_1E9AB07F89321115CB1E1BEB0CE90731" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_1E9AB07F89321115CB1E1BEB0CE90731" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_1E9AB07F89321115CB1E1BEB0CE90731" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_0E5B0C0C7ABBC9587C11AB511CE827A8_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_0E5B0C0C7ABBC9587C11AB511CE827A8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Details</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_0E5B0C0C7ABBC9587C11AB511CE827A8_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_0E5B0C0C7ABBC9587C11AB511CE827A8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_0E5B0C0C7ABBC9587C11AB511CE827A8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_0E5B0C0C7ABBC9587C11AB511CE827A8" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_0E5B0C0C7ABBC9587C11AB511CE827A8" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_BEF725650D3226407948AF6BBD26CB92_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_BEF725650D3226407948AF6BBD26CB92" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Revenue from External Customers by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_BEF725650D3226407948AF6BBD26CB92_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_BEF725650D3226407948AF6BBD26CB92" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_BEF725650D3226407948AF6BBD26CB92" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_BEF725650D3226407948AF6BBD26CB92" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_BEF725650D3226407948AF6BBD26CB92" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_058A75F6F9F90C4059AFAF6BBD260276_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_058A75F6F9F90C4059AFAF6BBD260276" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_058A75F6F9F90C4059AFAF6BBD260276_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_058A75F6F9F90C4059AFAF6BBD260276" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_058A75F6F9F90C4059AFAF6BBD260276" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_058A75F6F9F90C4059AFAF6BBD260276" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_058A75F6F9F90C4059AFAF6BBD260276" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_AC7F521D1771C179A2E3B570A88C849E_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent_AC7F521D1771C179A2E3B570A88C849E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable trade</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_AC7F521D1771C179A2E3B570A88C849E_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent_AC7F521D1771C179A2E3B570A88C849E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_AC7F521D1771C179A2E3B570A88C849E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent_AC7F521D1771C179A2E3B570A88C849E" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent_AC7F521D1771C179A2E3B570A88C849E" xlink:type="arc" />
    <link:label id="lab_dxcm_AccruedTaxAuditAndLegalFees_AE5E21241B703BF14100B570A88D6A01_terseLabel_en-US" xlink:label="lab_dxcm_AccruedTaxAuditAndLegalFees_AE5E21241B703BF14100B570A88D6A01" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued tax, audit, and legal fees</link:label>
    <link:label id="lab_dxcm_AccruedTaxAuditAndLegalFees_AE5E21241B703BF14100B570A88D6A01_label_en-US" xlink:label="lab_dxcm_AccruedTaxAuditAndLegalFees_AE5E21241B703BF14100B570A88D6A01" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Tax Audit And Legal Fees</link:label>
    <link:label id="lab_dxcm_AccruedTaxAuditAndLegalFees_AE5E21241B703BF14100B570A88D6A01_documentation_en-US" xlink:label="lab_dxcm_AccruedTaxAuditAndLegalFees_AE5E21241B703BF14100B570A88D6A01" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value as of the balance sheet date of accrued current tax, audit and legal fees.</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_AccruedTaxAuditAndLegalFees" xlink:label="loc_dxcm_AccruedTaxAuditAndLegalFees_AE5E21241B703BF14100B570A88D6A01" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AccruedTaxAuditAndLegalFees_AE5E21241B703BF14100B570A88D6A01" xlink:to="lab_dxcm_AccruedTaxAuditAndLegalFees_AE5E21241B703BF14100B570A88D6A01" xlink:type="arc" />
    <link:label id="lab_dxcm_PharmacyRebates_B9577C5CD41527CE992AB570A88D56A4_terseLabel_en-US" xlink:label="lab_dxcm_PharmacyRebates_B9577C5CD41527CE992AB570A88D56A4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued rebates</link:label>
    <link:label id="lab_dxcm_PharmacyRebates_B9577C5CD41527CE992AB570A88D56A4_label_en-US" xlink:label="lab_dxcm_PharmacyRebates_B9577C5CD41527CE992AB570A88D56A4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pharmacy Rebates</link:label>
    <link:label id="lab_dxcm_PharmacyRebates_B9577C5CD41527CE992AB570A88D56A4_documentation_en-US" xlink:label="lab_dxcm_PharmacyRebates_B9577C5CD41527CE992AB570A88D56A4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pharmacy Rebates</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PharmacyRebates" xlink:label="loc_dxcm_PharmacyRebates_B9577C5CD41527CE992AB570A88D56A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PharmacyRebates_B9577C5CD41527CE992AB570A88D56A4" xlink:to="lab_dxcm_PharmacyRebates_B9577C5CD41527CE992AB570A88D56A4" xlink:type="arc" />
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_0D115B7D7F54C21EE25DB570A88D1A59_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual_0D115B7D7F54C21EE25DB570A88D1A59" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued warranty</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_0D115B7D7F54C21EE25DB570A88D1A59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual_0D115B7D7F54C21EE25DB570A88D1A59" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual_0D115B7D7F54C21EE25DB570A88D1A59" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_9520C1870849E5EBDB14B570A88D552D_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_9520C1870849E5EBDB14B570A88D552D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_9520C1870849E5EBDB14B570A88D552D_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_9520C1870849E5EBDB14B570A88D552D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_9520C1870849E5EBDB14B570A88D552D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_9520C1870849E5EBDB14B570A88D552D" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent_9520C1870849E5EBDB14B570A88D552D" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_71FCC26D1FCE7A05B1F9B570A88DFE0B_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_71FCC26D1FCE7A05B1F9B570A88DFE0B" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_71FCC26D1FCE7A05B1F9B570A88DFE0B_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_71FCC26D1FCE7A05B1F9B570A88DFE0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_71FCC26D1FCE7A05B1F9B570A88DFE0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_71FCC26D1FCE7A05B1F9B570A88DFE0B" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_71FCC26D1FCE7A05B1F9B570A88DFE0B" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_10EC0705DF90178E12301BEB0F2ABAA4_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_10EC0705DF90178E12301BEB0F2ABAA4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_10EC0705DF90178E12301BEB0F2ABAA4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_10EC0705DF90178E12301BEB0F2ABAA4" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_10EC0705DF90178E12301BEB0F2ABAA4" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsAbstract_416C322B18A1AAAD31141BEB0F2B1639_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract_416C322B18A1AAAD31141BEB0F2B1639" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_416C322B18A1AAAD31141BEB0F2B1639_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract_416C322B18A1AAAD31141BEB0F2B1639" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_416C322B18A1AAAD31141BEB0F2B1639" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_416C322B18A1AAAD31141BEB0F2B1639" xlink:to="lab_us-gaap_AssetsAbstract_416C322B18A1AAAD31141BEB0F2B1639" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_D8DFEC2937C2971851231BEB0F2B54F0_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_D8DFEC2937C2971851231BEB0F2B54F0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_D8DFEC2937C2971851231BEB0F2B54F0_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_D8DFEC2937C2971851231BEB0F2B54F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_D8DFEC2937C2971851231BEB0F2B54F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_D8DFEC2937C2971851231BEB0F2B54F0" xlink:to="lab_us-gaap_AssetsCurrentAbstract_D8DFEC2937C2971851231BEB0F2B54F0" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_BBC473CD3C17048BBF451BEB0F2B859D_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_BBC473CD3C17048BBF451BEB0F2B859D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_BBC473CD3C17048BBF451BEB0F2B859D_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_BBC473CD3C17048BBF451BEB0F2B859D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_BBC473CD3C17048BBF451BEB0F2B859D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_BBC473CD3C17048BBF451BEB0F2B859D" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_BBC473CD3C17048BBF451BEB0F2B859D" xlink:type="arc" />
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_074650178696F67CC92E1BEB0F2C9814_terseLabel_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_074650178696F67CC92E1BEB0F2C9814" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term marketable securities</link:label>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_074650178696F67CC92E1BEB0F2C9814_label_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_074650178696F67CC92E1BEB0F2C9814" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities</link:label>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_074650178696F67CC92E1BEB0F2C9814_documentation_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_074650178696F67CC92E1BEB0F2C9814" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_074650178696F67CC92E1BEB0F2C9814" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_074650178696F67CC92E1BEB0F2C9814" xlink:to="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_074650178696F67CC92E1BEB0F2C9814" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_2F95E2FE02EB12BB04071BEB0F2C6A36_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_2F95E2FE02EB12BB04071BEB0F2C6A36" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_2F95E2FE02EB12BB04071BEB0F2C6A36_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_2F95E2FE02EB12BB04071BEB0F2C6A36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_2F95E2FE02EB12BB04071BEB0F2C6A36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_2F95E2FE02EB12BB04071BEB0F2C6A36" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent_2F95E2FE02EB12BB04071BEB0F2C6A36" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_6FA0B37BE164946288801BEB0F2C5CCD_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_6FA0B37BE164946288801BEB0F2C5CCD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_6FA0B37BE164946288801BEB0F2C5CCD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_6FA0B37BE164946288801BEB0F2C5CCD" xlink:to="lab_us-gaap_InventoryNet_6FA0B37BE164946288801BEB0F2C5CCD" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_FFABBAFF65BFB8B3C9741BEB0F315C88_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_FFABBAFF65BFB8B3C9741BEB0F315C88" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_FFABBAFF65BFB8B3C9741BEB0F315C88_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_FFABBAFF65BFB8B3C9741BEB0F315C88" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_FFABBAFF65BFB8B3C9741BEB0F315C88" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_FFABBAFF65BFB8B3C9741BEB0F315C88" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_FFABBAFF65BFB8B3C9741BEB0F315C88" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrent_8D186DE654A14F102E381BEB0F327AE3_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent_8D186DE654A14F102E381BEB0F327AE3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_8D186DE654A14F102E381BEB0F327AE3_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent_8D186DE654A14F102E381BEB0F327AE3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_8D186DE654A14F102E381BEB0F327AE3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_8D186DE654A14F102E381BEB0F327AE3" xlink:to="lab_us-gaap_AssetsCurrent_8D186DE654A14F102E381BEB0F327AE3" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_79408677CC11DA03C1F51BEB0F329036_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_79408677CC11DA03C1F51BEB0F329036" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_79408677CC11DA03C1F51BEB0F329036_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_79408677CC11DA03C1F51BEB0F329036" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_79408677CC11DA03C1F51BEB0F329036" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_79408677CC11DA03C1F51BEB0F329036" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_79408677CC11DA03C1F51BEB0F329036" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_ABE035D8860F311428151BEB0F32C8CB_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill_ABE035D8860F311428151BEB0F32C8CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_ABE035D8860F311428151BEB0F32C8CB_label_en-US" xlink:label="lab_us-gaap_Goodwill_ABE035D8860F311428151BEB0F32C8CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_ABE035D8860F311428151BEB0F32C8CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_ABE035D8860F311428151BEB0F32C8CB" xlink:to="lab_us-gaap_Goodwill_ABE035D8860F311428151BEB0F32C8CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_9D1A66F2AC761CCA02AA1BEB0F32AC1E_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_9D1A66F2AC761CCA02AA1BEB0F32AC1E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_9D1A66F2AC761CCA02AA1BEB0F32AC1E_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_9D1A66F2AC761CCA02AA1BEB0F32AC1E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9D1A66F2AC761CCA02AA1BEB0F32AC1E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_9D1A66F2AC761CCA02AA1BEB0F32AC1E" xlink:to="lab_us-gaap_OtherAssetsNoncurrent_9D1A66F2AC761CCA02AA1BEB0F32AC1E" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_A0D800DD615DCD97E88E1BEB0F32B74A_totalLabel_en-US" xlink:label="lab_us-gaap_Assets_A0D800DD615DCD97E88E1BEB0F32B74A" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_A0D800DD615DCD97E88E1BEB0F32B74A_label_en-US" xlink:label="lab_us-gaap_Assets_A0D800DD615DCD97E88E1BEB0F32B74A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_A0D800DD615DCD97E88E1BEB0F32B74A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_A0D800DD615DCD97E88E1BEB0F32B74A" xlink:to="lab_us-gaap_Assets_A0D800DD615DCD97E88E1BEB0F32B74A" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5496E47967BC0D6F07581BEB0F331C97_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5496E47967BC0D6F07581BEB0F331C97" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5496E47967BC0D6F07581BEB0F331C97_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5496E47967BC0D6F07581BEB0F331C97" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5496E47967BC0D6F07581BEB0F331C97" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5496E47967BC0D6F07581BEB0F331C97" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5496E47967BC0D6F07581BEB0F331C97" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_F56C992661FC86FC8FC31BEB0F33A0E1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_F56C992661FC86FC8FC31BEB0F33A0E1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_F56C992661FC86FC8FC31BEB0F33A0E1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_F56C992661FC86FC8FC31BEB0F33A0E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_F56C992661FC86FC8FC31BEB0F33A0E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_F56C992661FC86FC8FC31BEB0F33A0E1" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_F56C992661FC86FC8FC31BEB0F33A0E1" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_D0CA158C7D834E04B4D61BEB0F33D8F5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_D0CA158C7D834E04B4D61BEB0F33D8F5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_D0CA158C7D834E04B4D61BEB0F33D8F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_D0CA158C7D834E04B4D61BEB0F33D8F5" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_D0CA158C7D834E04B4D61BEB0F33D8F5" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_A164E04299A720648C7C1BEB0F33CF5C_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_A164E04299A720648C7C1BEB0F33CF5C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_A164E04299A720648C7C1BEB0F33CF5C_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_A164E04299A720648C7C1BEB0F33CF5C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_A164E04299A720648C7C1BEB0F33CF5C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_A164E04299A720648C7C1BEB0F33CF5C" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_A164E04299A720648C7C1BEB0F33CF5C" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_DEC0AEFE6A3FCFF65BCB1BEB0F337796_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_DEC0AEFE6A3FCFF65BCB1BEB0F337796" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_DEC0AEFE6A3FCFF65BCB1BEB0F337796_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_DEC0AEFE6A3FCFF65BCB1BEB0F337796" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_DEC0AEFE6A3FCFF65BCB1BEB0F337796" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_DEC0AEFE6A3FCFF65BCB1BEB0F337796" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent_DEC0AEFE6A3FCFF65BCB1BEB0F337796" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_C85360E6C9D3B232630C1BEB0F34A5BA_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent_C85360E6C9D3B232630C1BEB0F34A5BA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_C85360E6C9D3B232630C1BEB0F34A5BA_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent_C85360E6C9D3B232630C1BEB0F34A5BA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_C85360E6C9D3B232630C1BEB0F34A5BA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent_C85360E6C9D3B232630C1BEB0F34A5BA" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent_C85360E6C9D3B232630C1BEB0F34A5BA" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrent_6B9BAC9D769691841B771BEB0F340DDE_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_6B9BAC9D769691841B771BEB0F340DDE" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_6B9BAC9D769691841B771BEB0F340DDE_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_6B9BAC9D769691841B771BEB0F340DDE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_6B9BAC9D769691841B771BEB0F340DDE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_6B9BAC9D769691841B771BEB0F340DDE" xlink:to="lab_us-gaap_LiabilitiesCurrent_6B9BAC9D769691841B771BEB0F340DDE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_2CA803C64168695E24B41BEB0F3487BE_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable_2CA803C64168695E24B41BEB0F3487BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_2CA803C64168695E24B41BEB0F3487BE_label_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable_2CA803C64168695E24B41BEB0F3487BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Notes Payable, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_2CA803C64168695E24B41BEB0F3487BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleLongTermNotesPayable_2CA803C64168695E24B41BEB0F3487BE" xlink:to="lab_us-gaap_ConvertibleLongTermNotesPayable_2CA803C64168695E24B41BEB0F3487BE" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_7A0C1696B13EA91754F21BEB0F34F50F_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_7A0C1696B13EA91754F21BEB0F34F50F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_7A0C1696B13EA91754F21BEB0F34F50F_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_7A0C1696B13EA91754F21BEB0F34F50F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7A0C1696B13EA91754F21BEB0F34F50F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7A0C1696B13EA91754F21BEB0F34F50F" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_7A0C1696B13EA91754F21BEB0F34F50F" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_7148CBE7CFEF58DBAB701BEB0F3402A8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_7148CBE7CFEF58DBAB701BEB0F3402A8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_7148CBE7CFEF58DBAB701BEB0F3402A8_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_7148CBE7CFEF58DBAB701BEB0F3402A8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7148CBE7CFEF58DBAB701BEB0F3402A8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_7148CBE7CFEF58DBAB701BEB0F3402A8" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent_7148CBE7CFEF58DBAB701BEB0F3402A8" xlink:type="arc" />
    <link:label id="lab_us-gaap_Liabilities_45E96CA86F5E493725031BEB0F340C2B_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities_45E96CA86F5E493725031BEB0F340C2B" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_45E96CA86F5E493725031BEB0F340C2B_label_en-US" xlink:label="lab_us-gaap_Liabilities_45E96CA86F5E493725031BEB0F340C2B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_45E96CA86F5E493725031BEB0F340C2B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_45E96CA86F5E493725031BEB0F340C2B" xlink:to="lab_us-gaap_Liabilities_45E96CA86F5E493725031BEB0F340C2B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_954D8E47463A075E936D1BEB0F35B6AD_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies_954D8E47463A075E936D1BEB0F35B6AD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_954D8E47463A075E936D1BEB0F35B6AD_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies_954D8E47463A075E936D1BEB0F35B6AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_954D8E47463A075E936D1BEB0F35B6AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies_954D8E47463A075E936D1BEB0F35B6AD" xlink:to="lab_us-gaap_CommitmentsAndContingencies_954D8E47463A075E936D1BEB0F35B6AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_6A605B5BDB703041499C1BEB0F354D7B_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_6A605B5BDB703041499C1BEB0F354D7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_6A605B5BDB703041499C1BEB0F354D7B_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_6A605B5BDB703041499C1BEB0F354D7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_6A605B5BDB703041499C1BEB0F354D7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6A605B5BDB703041499C1BEB0F354D7B" xlink:to="lab_us-gaap_StockholdersEquityAbstract_6A605B5BDB703041499C1BEB0F354D7B" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockValueOutstanding_205E60EE7D76DBC4525E1BEB0F354137_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValueOutstanding_205E60EE7D76DBC4525E1BEB0F354137" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively</link:label>
    <link:label id="lab_us-gaap_PreferredStockValueOutstanding_205E60EE7D76DBC4525E1BEB0F354137_label_en-US" xlink:label="lab_us-gaap_PreferredStockValueOutstanding_205E60EE7D76DBC4525E1BEB0F354137" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValueOutstanding" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_205E60EE7D76DBC4525E1BEB0F354137" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValueOutstanding_205E60EE7D76DBC4525E1BEB0F354137" xlink:to="lab_us-gaap_PreferredStockValueOutstanding_205E60EE7D76DBC4525E1BEB0F354137" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_B39DE69500351B029CD41BEB0F35CDF7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding_B39DE69500351B029CD41BEB0F35CDF7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.001 par value, 200.0 million shares authorized; 92.4 million and 91.6 million shares issued and outstanding, respectively, at December 31, 2019; 91.1 million and 90.0 million shares issued and outstanding, respectively, at December 31, 2018</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_B39DE69500351B029CD41BEB0F35CDF7_label_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding_B39DE69500351B029CD41BEB0F35CDF7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValueOutstanding" xlink:label="loc_us-gaap_CommonStockValueOutstanding_B39DE69500351B029CD41BEB0F35CDF7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValueOutstanding_B39DE69500351B029CD41BEB0F35CDF7" xlink:to="lab_us-gaap_CommonStockValueOutstanding_B39DE69500351B029CD41BEB0F35CDF7" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_2D8BC6A7D40DBEA7AD131BEB0F354F6D_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock_2D8BC6A7D40DBEA7AD131BEB0F354F6D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_2D8BC6A7D40DBEA7AD131BEB0F354F6D_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock_2D8BC6A7D40DBEA7AD131BEB0F354F6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2D8BC6A7D40DBEA7AD131BEB0F354F6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2D8BC6A7D40DBEA7AD131BEB0F354F6D" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock_2D8BC6A7D40DBEA7AD131BEB0F354F6D" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_C166F5FFC9B7C05DEE251BEB0F36719F_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_C166F5FFC9B7C05DEE251BEB0F36719F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_C166F5FFC9B7C05DEE251BEB0F36719F_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_C166F5FFC9B7C05DEE251BEB0F36719F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_C166F5FFC9B7C05DEE251BEB0F36719F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_C166F5FFC9B7C05DEE251BEB0F36719F" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_C166F5FFC9B7C05DEE251BEB0F36719F" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_574B98345D231DF5563A1BEB0F3621B4_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_574B98345D231DF5563A1BEB0F3621B4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_574B98345D231DF5563A1BEB0F3621B4_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_574B98345D231DF5563A1BEB0F3621B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_574B98345D231DF5563A1BEB0F3621B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_574B98345D231DF5563A1BEB0F3621B4" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_574B98345D231DF5563A1BEB0F3621B4" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValue_25CAD8752A54C97F10301BEB0F3643BC_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_25CAD8752A54C97F10301BEB0F3643BC" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock at cost; 0.8 million shares at December 31, 2019</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_25CAD8752A54C97F10301BEB0F3643BC_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_25CAD8752A54C97F10301BEB0F3643BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_25CAD8752A54C97F10301BEB0F3643BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_25CAD8752A54C97F10301BEB0F3643BC" xlink:to="lab_us-gaap_TreasuryStockValue_25CAD8752A54C97F10301BEB0F3643BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_747DB6D6C5BD71E7E4CB1BEB0F36D072_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_747DB6D6C5BD71E7E4CB1BEB0F36D072" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_747DB6D6C5BD71E7E4CB1BEB0F36D072_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_747DB6D6C5BD71E7E4CB1BEB0F36D072" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_747DB6D6C5BD71E7E4CB1BEB0F36D072" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_747DB6D6C5BD71E7E4CB1BEB0F36D072" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_747DB6D6C5BD71E7E4CB1BEB0F36D072" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_8F036399BFE0FF1A3F2C1BEB0F363546_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_8F036399BFE0FF1A3F2C1BEB0F363546" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_8F036399BFE0FF1A3F2C1BEB0F363546_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_8F036399BFE0FF1A3F2C1BEB0F363546" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8F036399BFE0FF1A3F2C1BEB0F363546" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8F036399BFE0FF1A3F2C1BEB0F363546" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_8F036399BFE0FF1A3F2C1BEB0F363546" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Convertible Notes</link:label>
    <link:label id="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1_label_en-US" xlink:label="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1" xlink:to="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_EF1589EB6F419B4932581BE44A2D3B53_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount_EF1589EB6F419B4932581BE44A2D3B53" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unamortized debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_EF1589EB6F419B4932581BE44A2D3B53_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount_EF1589EB6F419B4932581BE44A2D3B53" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_EF1589EB6F419B4932581BE44A2D3B53" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount_EF1589EB6F419B4932581BE44A2D3B53" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount_EF1589EB6F419B4932581BE44A2D3B53" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_8C4359EE68F3233E7E841BE44A2DD053_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense_8C4359EE68F3233E7E841BE44A2DD053" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_8C4359EE68F3233E7E841BE44A2DD053_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense_8C4359EE68F3233E7E841BE44A2DD053" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_8C4359EE68F3233E7E841BE44A2DD053" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense_8C4359EE68F3233E7E841BE44A2DD053" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense_8C4359EE68F3233E7E841BE44A2DD053" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_AA746C69B38DC2A3FBE91BE44A2D05DF_totalLabel_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable_AA746C69B38DC2A3FBE91BE44A2D05DF" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net carrying amount of Senior Convertible Notes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_AA746C69B38DC2A3FBE91BE44A2D05DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleLongTermNotesPayable_AA746C69B38DC2A3FBE91BE44A2D05DF" xlink:to="lab_us-gaap_ConvertibleLongTermNotesPayable_AA746C69B38DC2A3FBE91BE44A2D05DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebt_554F3704141B50A83E321BE44A2DE495_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt_554F3704141B50A83E321BE44A2DE495" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total net carrying amount of senior convertible notes</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_554F3704141B50A83E321BE44A2DE495_label_en-US" xlink:label="lab_us-gaap_LongTermDebt_554F3704141B50A83E321BE44A2DE495" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_554F3704141B50A83E321BE44A2DE495" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt_554F3704141B50A83E321BE44A2DE495" xlink:to="lab_us-gaap_LongTermDebt_554F3704141B50A83E321BE44A2DE495" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_B620FF2FE5395DDBDB8C1BE44A2E42AF_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_B620FF2FE5395DDBDB8C1BE44A2E42AF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying value of equity component of convertible senior notes, net of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_B620FF2FE5395DDBDB8C1BE44A2E42AF_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_B620FF2FE5395DDBDB8C1BE44A2E42AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_B620FF2FE5395DDBDB8C1BE44A2E42AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_B620FF2FE5395DDBDB8C1BE44A2E42AF" xlink:to="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_B620FF2FE5395DDBDB8C1BE44A2E42AF" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_3E76D34FBE0D172E2E6F1BE44A2ED490_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_3E76D34FBE0D172E2E6F1BE44A2ED490" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining amortization period of debt discount on the liability component</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_3E76D34FBE0D172E2E6F1BE44A2ED490_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_3E76D34FBE0D172E2E6F1BE44A2ED490" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Remaining Discount Amortization Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_3E76D34FBE0D172E2E6F1BE44A2ED490" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_3E76D34FBE0D172E2E6F1BE44A2ED490" xlink:to="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_3E76D34FBE0D172E2E6F1BE44A2ED490" xlink:type="arc" />
    <link:label id="lab_us-gaap_PlanNameAxis_3470260B98EDF57AD22EC9C4B8AF3F70_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis_3470260B98EDF57AD22EC9C4B8AF3F70" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_3470260B98EDF57AD22EC9C4B8AF3F70_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis_3470260B98EDF57AD22EC9C4B8AF3F70" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_3470260B98EDF57AD22EC9C4B8AF3F70" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis_3470260B98EDF57AD22EC9C4B8AF3F70" xlink:to="lab_us-gaap_PlanNameAxis_3470260B98EDF57AD22EC9C4B8AF3F70" xlink:type="arc" />
    <link:label id="lab_us-gaap_PlanNameDomain_CD9710A5EA2860F0FB0AC9C4B8AFBB0B_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain_CD9710A5EA2860F0FB0AC9C4B8AFBB0B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_CD9710A5EA2860F0FB0AC9C4B8AFBB0B_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain_CD9710A5EA2860F0FB0AC9C4B8AFBB0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_CD9710A5EA2860F0FB0AC9C4B8AFBB0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain_CD9710A5EA2860F0FB0AC9C4B8AFBB0B" xlink:to="lab_us-gaap_PlanNameDomain_CD9710A5EA2860F0FB0AC9C4B8AFBB0B" xlink:type="arc" />
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanMember_BB4DA387846D8135AD01C9C4B8AF23A9_terseLabel_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanMember_BB4DA387846D8135AD01C9C4B8AF23A9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanMember_BB4DA387846D8135AD01C9C4B8AF23A9_label_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanMember_BB4DA387846D8135AD01C9C4B8AF23A9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanMember_BB4DA387846D8135AD01C9C4B8AF23A9_documentation_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanMember_BB4DA387846D8135AD01C9C4B8AF23A9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EmployeeStockPurchasePlanMember" xlink:label="loc_dxcm_EmployeeStockPurchasePlanMember_BB4DA387846D8135AD01C9C4B8AF23A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EmployeeStockPurchasePlanMember_BB4DA387846D8135AD01C9C4B8AF23A9" xlink:to="lab_dxcm_EmployeeStockPurchasePlanMember_BB4DA387846D8135AD01C9C4B8AF23A9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3FD20BD27BE310068BC1C9C4B8AF907E_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3FD20BD27BE310068BC1C9C4B8AF907E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3FD20BD27BE310068BC1C9C4B8AF907E_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3FD20BD27BE310068BC1C9C4B8AF907E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3FD20BD27BE310068BC1C9C4B8AF907E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3FD20BD27BE310068BC1C9C4B8AF907E" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3FD20BD27BE310068BC1C9C4B8AF907E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_86F3CC657A1036627935C9C4B8B04222_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_86F3CC657A1036627935C9C4B8B04222" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_86F3CC657A1036627935C9C4B8B04222_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_86F3CC657A1036627935C9C4B8B04222" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_86F3CC657A1036627935C9C4B8B04222" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_86F3CC657A1036627935C9C4B8B04222" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_86F3CC657A1036627935C9C4B8B04222" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_E9238A35CC5848169985C9C4B8B0B0DF_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_E9238A35CC5848169985C9C4B8B0B0DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility of the Company&#8217;s stock (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_E9238A35CC5848169985C9C4B8B0B0DF_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_E9238A35CC5848169985C9C4B8B0B0DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_E9238A35CC5848169985C9C4B8B0B0DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_E9238A35CC5848169985C9C4B8B0B0DF" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_E9238A35CC5848169985C9C4B8B0B0DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7F7EB0A9FC7A5B48AF89C9C4B8B09AE8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7F7EB0A9FC7A5B48AF89C9C4B8B09AE8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7F7EB0A9FC7A5B48AF89C9C4B8B09AE8_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7F7EB0A9FC7A5B48AF89C9C4B8B09AE8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7F7EB0A9FC7A5B48AF89C9C4B8B09AE8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7F7EB0A9FC7A5B48AF89C9C4B8B09AE8" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7F7EB0A9FC7A5B48AF89C9C4B8B09AE8" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_78A20AC7CEE207678E514027E6F5DBB5_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract_78A20AC7CEE207678E514027E6F5DBB5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_78A20AC7CEE207678E514027E6F5DBB5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_78A20AC7CEE207678E514027E6F5DBB5" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract_78A20AC7CEE207678E514027E6F5DBB5" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045_label_en-US" xlink:label="lab_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045" xlink:to="lab_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockMember_97408951439495686BD94027E6F654D4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember_97408951439495686BD94027E6F654D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_97408951439495686BD94027E6F654D4_label_en-US" xlink:label="lab_us-gaap_CommonStockMember_97408951439495686BD94027E6F654D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_97408951439495686BD94027E6F654D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_97408951439495686BD94027E6F654D4" xlink:to="lab_us-gaap_CommonStockMember_97408951439495686BD94027E6F654D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_48A054AB5D5FCF031C8B4027E6F7670C_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_48A054AB5D5FCF031C8B4027E6F7670C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_48A054AB5D5FCF031C8B4027E6F7670C_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_48A054AB5D5FCF031C8B4027E6F7670C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_48A054AB5D5FCF031C8B4027E6F7670C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_48A054AB5D5FCF031C8B4027E6F7670C" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_48A054AB5D5FCF031C8B4027E6F7670C" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsMember_3CFD45D2DD0904C383944027E6F72FAA_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_3CFD45D2DD0904C383944027E6F72FAA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_3CFD45D2DD0904C383944027E6F72FAA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_3CFD45D2DD0904C383944027E6F72FAA" xlink:to="lab_us-gaap_RetainedEarningsMember_3CFD45D2DD0904C383944027E6F72FAA" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockMember_35B6A396CDCB7F8823924027E6F7AD9B_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember_35B6A396CDCB7F8823924027E6F7AD9B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_35B6A396CDCB7F8823924027E6F7AD9B_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember_35B6A396CDCB7F8823924027E6F7AD9B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_35B6A396CDCB7F8823924027E6F7AD9B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember_35B6A396CDCB7F8823924027E6F7AD9B" xlink:to="lab_us-gaap_TreasuryStockMember_35B6A396CDCB7F8823924027E6F7AD9B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201609Member_61CBD64614E303C330104027E6F8040E_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201609Member_61CBD64614E303C330104027E6F8040E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2016-09</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201609Member_61CBD64614E303C330104027E6F8040E_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201609Member_61CBD64614E303C330104027E6F8040E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2016-09 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201609Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201609Member_61CBD64614E303C330104027E6F8040E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201609Member_61CBD64614E303C330104027E6F8040E" xlink:to="lab_us-gaap_AccountingStandardsUpdate201609Member_61CBD64614E303C330104027E6F8040E" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementLineItems_25B4D4DF679D69FDB8BD4027E6F9757D_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems_25B4D4DF679D69FDB8BD4027E6F9757D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_25B4D4DF679D69FDB8BD4027E6F9757D_label_en-US" xlink:label="lab_us-gaap_StatementLineItems_25B4D4DF679D69FDB8BD4027E6F9757D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_25B4D4DF679D69FDB8BD4027E6F9757D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_25B4D4DF679D69FDB8BD4027E6F9757D" xlink:to="lab_us-gaap_StatementLineItems_25B4D4DF679D69FDB8BD4027E6F9757D" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharesOutstanding_1D7370063C2F24816D774027E6F997AD_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding_1D7370063C2F24816D774027E6F997AD" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_1D7370063C2F24816D774027E6F997AD_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding_1D7370063C2F24816D774027E6F997AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_1D7370063C2F24816D774027E6F997AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_1D7370063C2F24816D774027E6F997AD" xlink:to="lab_us-gaap_SharesOutstanding_1D7370063C2F24816D774027E6F997AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_BD2671A39C31AFFE48654027E6FA96D0_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_BD2671A39C31AFFE48654027E6FA96D0" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_BD2671A39C31AFFE48654027E6FA96D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_BD2671A39C31AFFE48654027E6FA96D0" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_BD2671A39C31AFFE48654027E6FA96D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_0B18B17513934FDFDB424027E6FAC6A7_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_0B18B17513934FDFDB424027E6FAC6A7" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock under equity incentive plans (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_0B18B17513934FDFDB424027E6FAC6A7_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_0B18B17513934FDFDB424027E6FAC6A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Employee Benefit Plan</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_0B18B17513934FDFDB424027E6FAC6A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_0B18B17513934FDFDB424027E6FAC6A7" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_0B18B17513934FDFDB424027E6FAC6A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_3296600714533B52DAF54027E6FA29A0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_3296600714533B52DAF54027E6FA29A0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock under equity incentive plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_3296600714533B52DAF54027E6FA29A0_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_3296600714533B52DAF54027E6FA29A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Employee Benefit Plan</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_3296600714533B52DAF54027E6FA29A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_3296600714533B52DAF54027E6FA29A0" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_3296600714533B52DAF54027E6FA29A0" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6CBE9B22F3B1051CA5664027E6FA2096_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6CBE9B22F3B1051CA5664027E6FA2096" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock for Employee Stock Purchase Plan (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6CBE9B22F3B1051CA5664027E6FA2096_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6CBE9B22F3B1051CA5664027E6FA2096" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6CBE9B22F3B1051CA5664027E6FA2096" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6CBE9B22F3B1051CA5664027E6FA2096" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6CBE9B22F3B1051CA5664027E6FA2096" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_AC3E5207B8597C788B3F4027E6FAD576_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_AC3E5207B8597C788B3F4027E6FAD576" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock for Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_AC3E5207B8597C788B3F4027E6FAD576_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_AC3E5207B8597C788B3F4027E6FAD576" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_AC3E5207B8597C788B3F4027E6FAD576" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_AC3E5207B8597C788B3F4027E6FAD576" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_AC3E5207B8597C788B3F4027E6FAD576" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9E9E5E94D7A47E944FD44027E6FAB72A_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9E9E5E94D7A47E944FD44027E6FAB72A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9E9E5E94D7A47E944FD44027E6FAB72A_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9E9E5E94D7A47E944FD44027E6FAB72A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9E9E5E94D7A47E944FD44027E6FAB72A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9E9E5E94D7A47E944FD44027E6FAB72A" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9E9E5E94D7A47E944FD44027E6FAB72A" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_0C2DDC0703E46C72AB3F4027E6FBDC53_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_0C2DDC0703E46C72AB3F4027E6FBDC53" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative effect of adoption of new accounting pronouncement</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_0C2DDC0703E46C72AB3F4027E6FBDC53_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_0C2DDC0703E46C72AB3F4027E6FBDC53" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification" xlink:label="loc_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_0C2DDC0703E46C72AB3F4027E6FBDC53" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_0C2DDC0703E46C72AB3F4027E6FBDC53" xlink:to="lab_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_0C2DDC0703E46C72AB3F4027E6FBDC53" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_07BD85A469E9E349A5974027E6FB2EC9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_07BD85A469E9E349A5974027E6FB2EC9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock for collaborative research and development fee (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_07BD85A469E9E349A5974027E6FB2EC9_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_07BD85A469E9E349A5974027E6FB2EC9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Purchase of Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_07BD85A469E9E349A5974027E6FB2EC9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_07BD85A469E9E349A5974027E6FB2EC9" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_07BD85A469E9E349A5974027E6FB2EC9" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_A5A90FFD2454B217ECF54027E6FBDA34_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_A5A90FFD2454B217ECF54027E6FBDA34" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock for collaborative research and development fee</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_A5A90FFD2454B217ECF54027E6FBDA34_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_A5A90FFD2454B217ECF54027E6FBDA34" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Purchase of Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_A5A90FFD2454B217ECF54027E6FBDA34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_A5A90FFD2454B217ECF54027E6FBDA34" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_A5A90FFD2454B217ECF54027E6FBDA34" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_8F9D8BA4C2C52BC205064027E6FBB83A_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_8F9D8BA4C2C52BC205064027E6FBB83A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of warrants</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_8F9D8BA4C2C52BC205064027E6FBB83A_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_8F9D8BA4C2C52BC205064027E6FBB83A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_8F9D8BA4C2C52BC205064027E6FBB83A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_8F9D8BA4C2C52BC205064027E6FBB83A" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_8F9D8BA4C2C52BC205064027E6FBB83A" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_A8169FA8006D71A57FCB4027E6FCBED1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_A8169FA8006D71A57FCB4027E6FCBED1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_A8169FA8006D71A57FCB4027E6FCBED1_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_A8169FA8006D71A57FCB4027E6FCBED1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_A8169FA8006D71A57FCB4027E6FCBED1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired_A8169FA8006D71A57FCB4027E6FCBED1" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired_A8169FA8006D71A57FCB4027E6FCBED1" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_433083D1CCE54B03D55F4027E6FCF7EF_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_433083D1CCE54B03D55F4027E6FCF7EF" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_433083D1CCE54B03D55F4027E6FCF7EF_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_433083D1CCE54B03D55F4027E6FCF7EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_433083D1CCE54B03D55F4027E6FCF7EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_433083D1CCE54B03D55F4027E6FCF7EF" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_433083D1CCE54B03D55F4027E6FCF7EF" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_363927C449E85DBAD77F4027E6FC2150_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_363927C449E85DBAD77F4027E6FC2150" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Realization of tax benefit related to 2023 Note Hedge</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_363927C449E85DBAD77F4027E6FC2150_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_363927C449E85DBAD77F4027E6FC2150" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_363927C449E85DBAD77F4027E6FC2150" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_363927C449E85DBAD77F4027E6FC2150" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_363927C449E85DBAD77F4027E6FC2150" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_48CF9200E172C7B2D23A4027E6FC394E_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_48CF9200E172C7B2D23A4027E6FC394E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_48CF9200E172C7B2D23A4027E6FC394E_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_48CF9200E172C7B2D23A4027E6FC394E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_48CF9200E172C7B2D23A4027E6FC394E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_48CF9200E172C7B2D23A4027E6FC394E" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_48CF9200E172C7B2D23A4027E6FC394E" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharesOutstanding_9DA754289605700199B04027E6FC90C6_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding_9DA754289605700199B04027E6FC90C6" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_9DA754289605700199B04027E6FC90C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_9DA754289605700199B04027E6FC90C6" xlink:to="lab_us-gaap_SharesOutstanding_9DA754289605700199B04027E6FC90C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_914DA788ECA3F5D3A7CB4027E6FD5B25_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_914DA788ECA3F5D3A7CB4027E6FD5B25" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_914DA788ECA3F5D3A7CB4027E6FD5B25" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_914DA788ECA3F5D3A7CB4027E6FD5B25" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_914DA788ECA3F5D3A7CB4027E6FD5B25" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_278FFCC3FD315BC6E3CEAB02F93FBE51_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_278FFCC3FD315BC6E3CEAB02F93FBE51" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_278FFCC3FD315BC6E3CEAB02F93FBE51" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_278FFCC3FD315BC6E3CEAB02F93FBE51" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_278FFCC3FD315BC6E3CEAB02F93FBE51" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3CD671CD9FF2FE3E456AAB02F9409BE1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3CD671CD9FF2FE3E456AAB02F9409BE1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), net of income taxes:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3CD671CD9FF2FE3E456AAB02F9409BE1_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3CD671CD9FF2FE3E456AAB02F9409BE1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3CD671CD9FF2FE3E456AAB02F9409BE1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3CD671CD9FF2FE3E456AAB02F9409BE1" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3CD671CD9FF2FE3E456AAB02F9409BE1" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3600806B49276B8A5712AB02F9406CCB_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3600806B49276B8A5712AB02F9406CCB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation gain (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3600806B49276B8A5712AB02F9406CCB_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3600806B49276B8A5712AB02F9406CCB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3600806B49276B8A5712AB02F9406CCB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3600806B49276B8A5712AB02F9406CCB" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3600806B49276B8A5712AB02F9406CCB" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_6BEF936AEACF820E83FDAB02F9414D71_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_6BEF936AEACF820E83FDAB02F9414D71" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain (loss) on marketable debt securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_6BEF936AEACF820E83FDAB02F9414D71_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_6BEF936AEACF820E83FDAB02F9414D71" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_6BEF936AEACF820E83FDAB02F9414D71" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_6BEF936AEACF820E83FDAB02F9414D71" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_6BEF936AEACF820E83FDAB02F9414D71" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_AF9316F3B9E7C1C6F5EDAB02F940DFCF_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_AF9316F3B9E7C1C6F5EDAB02F940DFCF" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other comprehensive income (loss), net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_AF9316F3B9E7C1C6F5EDAB02F940DFCF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_AF9316F3B9E7C1C6F5EDAB02F940DFCF" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_AF9316F3B9E7C1C6F5EDAB02F940DFCF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_C18792C3586FB3C03D9AAB02F941A0E1_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_C18792C3586FB3C03D9AAB02F941A0E1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_C18792C3586FB3C03D9AAB02F941A0E1_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_C18792C3586FB3C03D9AAB02F941A0E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_C18792C3586FB3C03D9AAB02F941A0E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_C18792C3586FB3C03D9AAB02F941A0E1" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax_C18792C3586FB3C03D9AAB02F941A0E1" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_BE4F32128F1FDFC79046CA18FD12EF2F_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_BE4F32128F1FDFC79046CA18FD12EF2F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total by which the notes&#8217; if-converted value exceeds their principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_BE4F32128F1FDFC79046CA18FD12EF2F_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_BE4F32128F1FDFC79046CA18FD12EF2F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, If-converted Value in Excess of Principal</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_BE4F32128F1FDFC79046CA18FD12EF2F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_BE4F32128F1FDFC79046CA18FD12EF2F" xlink:to="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_BE4F32128F1FDFC79046CA18FD12EF2F" xlink:type="arc" />
    <link:label id="lab_dxcm_FinancialStatementDetailsTable_9DBF1CDCD8342BAA967EB570A8BB2B58_terseLabel_en-US" xlink:label="lab_dxcm_FinancialStatementDetailsTable_9DBF1CDCD8342BAA967EB570A8BB2B58" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Statement Details [Table]</link:label>
    <link:label id="lab_dxcm_FinancialStatementDetailsTable_9DBF1CDCD8342BAA967EB570A8BB2B58_label_en-US" xlink:label="lab_dxcm_FinancialStatementDetailsTable_9DBF1CDCD8342BAA967EB570A8BB2B58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Statement Details [Table]</link:label>
    <link:label id="lab_dxcm_FinancialStatementDetailsTable_9DBF1CDCD8342BAA967EB570A8BB2B58_documentation_en-US" xlink:label="lab_dxcm_FinancialStatementDetailsTable_9DBF1CDCD8342BAA967EB570A8BB2B58" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial Statement Details [Table]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FinancialStatementDetailsTable" xlink:label="loc_dxcm_FinancialStatementDetailsTable_9DBF1CDCD8342BAA967EB570A8BB2B58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FinancialStatementDetailsTable_9DBF1CDCD8342BAA967EB570A8BB2B58" xlink:to="lab_dxcm_FinancialStatementDetailsTable_9DBF1CDCD8342BAA967EB570A8BB2B58" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_EA545335FAB409F5760CB570A8BC1275_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis_EA545335FAB409F5760CB570A8BC1275" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_EA545335FAB409F5760CB570A8BC1275_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis_EA545335FAB409F5760CB570A8BC1275" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_EA545335FAB409F5760CB570A8BC1275" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis_EA545335FAB409F5760CB570A8BC1275" xlink:to="lab_us-gaap_FinancialInstrumentAxis_EA545335FAB409F5760CB570A8BC1275" xlink:type="arc" />
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95" xlink:type="arc" />
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_7C5012D11ACDEBD478DEB570A8BD5E60_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_7C5012D11ACDEBD478DEB570A8BD5E60" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. government agencies</link:label>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_7C5012D11ACDEBD478DEB570A8BD5E60_label_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_7C5012D11ACDEBD478DEB570A8BD5E60" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Government Corporations and Agencies Securities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_7C5012D11ACDEBD478DEB570A8BD5E60" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_7C5012D11ACDEBD478DEB570A8BD5E60" xlink:to="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_7C5012D11ACDEBD478DEB570A8BD5E60" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommercialPaperMember_C5328C3D3DC7BB2EA13EB570A8BDF012_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember_C5328C3D3DC7BB2EA13EB570A8BDF012" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_C5328C3D3DC7BB2EA13EB570A8BDF012_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember_C5328C3D3DC7BB2EA13EB570A8BDF012" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_C5328C3D3DC7BB2EA13EB570A8BDF012" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember_C5328C3D3DC7BB2EA13EB570A8BDF012" xlink:to="lab_us-gaap_CommercialPaperMember_C5328C3D3DC7BB2EA13EB570A8BDF012" xlink:type="arc" />
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_6217DDE072E108F0369FB570A8BD0086_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember_6217DDE072E108F0369FB570A8BD0086" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate debt</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_6217DDE072E108F0369FB570A8BD0086_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember_6217DDE072E108F0369FB570A8BD0086" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_6217DDE072E108F0369FB570A8BD0086" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember_6217DDE072E108F0369FB570A8BD0086" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember_6217DDE072E108F0369FB570A8BD0086" xlink:type="arc" />
    <link:label id="lab_dxcm_FinancialStatementDetailsLineItems_08C164A0CFD73D207504B570A8BD977F_terseLabel_en-US" xlink:label="lab_dxcm_FinancialStatementDetailsLineItems_08C164A0CFD73D207504B570A8BD977F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Statement Details [Line Items]</link:label>
    <link:label id="lab_dxcm_FinancialStatementDetailsLineItems_08C164A0CFD73D207504B570A8BD977F_label_en-US" xlink:label="lab_dxcm_FinancialStatementDetailsLineItems_08C164A0CFD73D207504B570A8BD977F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Statement Details [Line Items]</link:label>
    <link:label id="lab_dxcm_FinancialStatementDetailsLineItems_08C164A0CFD73D207504B570A8BD977F_documentation_en-US" xlink:label="lab_dxcm_FinancialStatementDetailsLineItems_08C164A0CFD73D207504B570A8BD977F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial Statement Details [Line Items]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FinancialStatementDetailsLineItems" xlink:label="loc_dxcm_FinancialStatementDetailsLineItems_08C164A0CFD73D207504B570A8BD977F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FinancialStatementDetailsLineItems_08C164A0CFD73D207504B570A8BD977F" xlink:to="lab_dxcm_FinancialStatementDetailsLineItems_08C164A0CFD73D207504B570A8BD977F" xlink:type="arc" />
    <link:label id="lab_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities, Gain (Loss) [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesGainLossAbstract" xlink:label="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:to="lab_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity investment in Tandem Diabetes Care, Inc</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss) [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCost_C632017D5B173F30A95AB570A8BE8792_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCost_C632017D5B173F30A95AB570A8BE8792" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCost_C632017D5B173F30A95AB570A8BE8792_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCost_C632017D5B173F30A95AB570A8BE8792" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiCost" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_C632017D5B173F30A95AB570A8BE8792" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiCost_C632017D5B173F30A95AB570A8BE8792" xlink:to="lab_us-gaap_EquitySecuritiesFvNiCost_C632017D5B173F30A95AB570A8BE8792" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain_A196B24506B24A1B6E09B570A8BE3C99_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain_A196B24506B24A1B6E09B570A8BE3C99" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain_A196B24506B24A1B6E09B570A8BE3C99_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain_A196B24506B24A1B6E09B570A8BE3C99" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_A196B24506B24A1B6E09B570A8BE3C99" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_A196B24506B24A1B6E09B570A8BE3C99" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain_A196B24506B24A1B6E09B570A8BE3C99" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_87AF23B4C64EC6C98D3AB570A8BE7813_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_87AF23B4C64EC6C98D3AB570A8BE7813" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_87AF23B4C64EC6C98D3AB570A8BE7813_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_87AF23B4C64EC6C98D3AB570A8BE7813" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_87AF23B4C64EC6C98D3AB570A8BE7813" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_87AF23B4C64EC6C98D3AB570A8BE7813" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_87AF23B4C64EC6C98D3AB570A8BE7813" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_70943FF07B54D96CA93BB570A8BE47A9_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi_70943FF07B54D96CA93BB570A8BE47A9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Market Value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_70943FF07B54D96CA93BB570A8BE47A9_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi_70943FF07B54D96CA93BB570A8BE47A9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_70943FF07B54D96CA93BB570A8BE47A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi_70943FF07B54D96CA93BB570A8BE47A9" xlink:to="lab_us-gaap_EquitySecuritiesFvNi_70943FF07B54D96CA93BB570A8BE47A9" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt securities, available for sale:</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C24C728248B918CE0B21B570A8BF0656_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C24C728248B918CE0B21B570A8BF0656" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C24C728248B918CE0B21B570A8BF0656_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C24C728248B918CE0B21B570A8BF0656" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C24C728248B918CE0B21B570A8BF0656" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C24C728248B918CE0B21B570A8BF0656" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C24C728248B918CE0B21B570A8BF0656" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_C4951D1D35301A792AEBB570A8BF701A_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_C4951D1D35301A792AEBB570A8BF701A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_C4951D1D35301A792AEBB570A8BF701A_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_C4951D1D35301A792AEBB570A8BF701A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_C4951D1D35301A792AEBB570A8BF701A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_C4951D1D35301A792AEBB570A8BF701A" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_C4951D1D35301A792AEBB570A8BF701A" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4D7C293616389F98F2C4B570A8BF1236_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4D7C293616389F98F2C4B570A8BF1236" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4D7C293616389F98F2C4B570A8BF1236_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4D7C293616389F98F2C4B570A8BF1236" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4D7C293616389F98F2C4B570A8BF1236" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4D7C293616389F98F2C4B570A8BF1236" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4D7C293616389F98F2C4B570A8BF1236" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71088CD8A373991D0456B570A8BF95F0_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71088CD8A373991D0456B570A8BF95F0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Estimated Market Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71088CD8A373991D0456B570A8BF95F0_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71088CD8A373991D0456B570A8BF95F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71088CD8A373991D0456B570A8BF95F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71088CD8A373991D0456B570A8BF95F0" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71088CD8A373991D0456B570A8BF95F0" xlink:type="arc" />
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost_9AB57DDE39EFD5C0C3F9B570A8BFD27A_terseLabel_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost_9AB57DDE39EFD5C0C3F9B570A8BFD27A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost_9AB57DDE39EFD5C0C3F9B570A8BFD27A_label_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost_9AB57DDE39EFD5C0C3F9B570A8BFD27A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities, Amortized Cost</link:label>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost_9AB57DDE39EFD5C0C3F9B570A8BFD27A_documentation_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost_9AB57DDE39EFD5C0C3F9B570A8BFD27A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities, Amortized Cost</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost_9AB57DDE39EFD5C0C3F9B570A8BFD27A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost_9AB57DDE39EFD5C0C3F9B570A8BFD27A" xlink:to="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost_9AB57DDE39EFD5C0C3F9B570A8BFD27A" xlink:type="arc" />
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain_E1F1A2FC254FBEA23C5FB570A8C02FB8_terseLabel_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain_E1F1A2FC254FBEA23C5FB570A8C02FB8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain_E1F1A2FC254FBEA23C5FB570A8C02FB8_label_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain_E1F1A2FC254FBEA23C5FB570A8C02FB8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities, Unrealized Gain</link:label>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain_E1F1A2FC254FBEA23C5FB570A8C02FB8_documentation_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain_E1F1A2FC254FBEA23C5FB570A8C02FB8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities, Unrealized Gain</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain_E1F1A2FC254FBEA23C5FB570A8C02FB8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain_E1F1A2FC254FBEA23C5FB570A8C02FB8" xlink:to="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain_E1F1A2FC254FBEA23C5FB570A8C02FB8" xlink:type="arc" />
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss_17056E04469A85E5B90CB570A8C0FD3C_negatedLabel_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss_17056E04469A85E5B90CB570A8C0FD3C" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss_17056E04469A85E5B90CB570A8C0FD3C_label_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss_17056E04469A85E5B90CB570A8C0FD3C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities, Unrealized Loss</link:label>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss_17056E04469A85E5B90CB570A8C0FD3C_documentation_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss_17056E04469A85E5B90CB570A8C0FD3C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities, Unrealized Loss</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss_17056E04469A85E5B90CB570A8C0FD3C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss_17056E04469A85E5B90CB570A8C0FD3C" xlink:to="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss_17056E04469A85E5B90CB570A8C0FD3C" xlink:type="arc" />
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_BCFDA11010A216900A54B570A8C062C0_verboseLabel_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_BCFDA11010A216900A54B570A8C062C0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Estimated Market Value</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_BCFDA11010A216900A54B570A8C062C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_BCFDA11010A216900A54B570A8C062C0" xlink:to="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_BCFDA11010A216900A54B570A8C062C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_16780DB5A0A2131869E635240207E384_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_16780DB5A0A2131869E635240207E384" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_16780DB5A0A2131869E635240207E384_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_16780DB5A0A2131869E635240207E384" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_16780DB5A0A2131869E635240207E384" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_16780DB5A0A2131869E635240207E384" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_16780DB5A0A2131869E635240207E384" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_A3B8D010A5F6EA5D676AB497AC41507C_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_A3B8D010A5F6EA5D676AB497AC41507C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value Hierarchy for Financial Assets</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_A3B8D010A5F6EA5D676AB497AC41507C_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_A3B8D010A5F6EA5D676AB497AC41507C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_A3B8D010A5F6EA5D676AB497AC41507C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_A3B8D010A5F6EA5D676AB497AC41507C" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_A3B8D010A5F6EA5D676AB497AC41507C" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_AECF6C73C69C3943F7CCB4B25189BCA0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_AECF6C73C69C3943F7CCB4B25189BCA0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value of Senior Convertible Notes</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_AECF6C73C69C3943F7CCB4B25189BCA0_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_AECF6C73C69C3943F7CCB4B25189BCA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_AECF6C73C69C3943F7CCB4B25189BCA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_AECF6C73C69C3943F7CCB4B25189BCA0" xlink:to="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_AECF6C73C69C3943F7CCB4B25189BCA0" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfReportableSegments_43564D284C510E2E41E8AB75C86D5115_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_43564D284C510E2E41E8AB75C86D5115" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_43564D284C510E2E41E8AB75C86D5115_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_43564D284C510E2E41E8AB75C86D5115" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_43564D284C510E2E41E8AB75C86D5115" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments_43564D284C510E2E41E8AB75C86D5115" xlink:to="lab_us-gaap_NumberOfReportableSegments_43564D284C510E2E41E8AB75C86D5115" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_25F97EDE437404E4DF8ACA0FCB3EF040_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable_25F97EDE437404E4DF8ACA0FCB3EF040" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_25F97EDE437404E4DF8ACA0FCB3EF040_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable_25F97EDE437404E4DF8ACA0FCB3EF040" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_25F97EDE437404E4DF8ACA0FCB3EF040" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_25F97EDE437404E4DF8ACA0FCB3EF040" xlink:to="lab_us-gaap_LineOfCreditFacilityTable_25F97EDE437404E4DF8ACA0FCB3EF040" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityAxis_F5DC2DF57EF79EB35C95CA0FCB46AB41_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_F5DC2DF57EF79EB35C95CA0FCB46AB41" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_F5DC2DF57EF79EB35C95CA0FCB46AB41_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_F5DC2DF57EF79EB35C95CA0FCB46AB41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_F5DC2DF57EF79EB35C95CA0FCB46AB41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis_F5DC2DF57EF79EB35C95CA0FCB46AB41" xlink:to="lab_us-gaap_CreditFacilityAxis_F5DC2DF57EF79EB35C95CA0FCB46AB41" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityDomain_D54C3538B21C29C6F1DECA0FCB46236E_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_D54C3538B21C29C6F1DECA0FCB46236E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_D54C3538B21C29C6F1DECA0FCB46236E_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_D54C3538B21C29C6F1DECA0FCB46236E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_D54C3538B21C29C6F1DECA0FCB46236E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain_D54C3538B21C29C6F1DECA0FCB46236E" xlink:to="lab_us-gaap_CreditFacilityDomain_D54C3538B21C29C6F1DECA0FCB46236E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LetterOfCreditMember_09C7264CDA641238012FCA0FCC17131E_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember_09C7264CDA641238012FCA0FCC17131E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_09C7264CDA641238012FCA0FCC17131E_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember_09C7264CDA641238012FCA0FCC17131E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaap_LetterOfCreditMember_09C7264CDA641238012FCA0FCC17131E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember_09C7264CDA641238012FCA0FCC17131E" xlink:to="lab_us-gaap_LetterOfCreditMember_09C7264CDA641238012FCA0FCC17131E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_C765A822D5CC7EAC0D4FCA104F0606D1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_C765A822D5CC7EAC0D4FCA104F0606D1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letters of credit sub-facility</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_C765A822D5CC7EAC0D4FCA104F0606D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_C765A822D5CC7EAC0D4FCA104F0606D1" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_C765A822D5CC7EAC0D4FCA104F0606D1" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCredit_CB1737CC352D442DCC20CA104EE84087_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit_CB1737CC352D442DCC20CA104EE84087" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding borrowings</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_CB1737CC352D442DCC20CA104EE84087_label_en-US" xlink:label="lab_us-gaap_LineOfCredit_CB1737CC352D442DCC20CA104EE84087" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_CB1737CC352D442DCC20CA104EE84087" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit_CB1737CC352D442DCC20CA104EE84087" xlink:to="lab_us-gaap_LineOfCredit_CB1737CC352D442DCC20CA104EE84087" xlink:type="arc" />
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_759334C5E32CF2E8C59BCA12B5E902ED_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount_759334C5E32CF2E8C59BCA12B5E902ED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding letters of credit</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_759334C5E32CF2E8C59BCA12B5E902ED_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount_759334C5E32CF2E8C59BCA12B5E902ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_759334C5E32CF2E8C59BCA12B5E902ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount_759334C5E32CF2E8C59BCA12B5E902ED" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount_759334C5E32CF2E8C59BCA12B5E902ED" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_099CADD79EEF7AC9865FCA104F1C6F52_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_099CADD79EEF7AC9865FCA104F1C6F52" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total available balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_099CADD79EEF7AC9865FCA104F1C6F52_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_099CADD79EEF7AC9865FCA104F1C6F52" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_099CADD79EEF7AC9865FCA104F1C6F52" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_099CADD79EEF7AC9865FCA104F1C6F52" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_099CADD79EEF7AC9865FCA104F1C6F52" xlink:type="arc" />
    <link:label id="lab_us-gaap_GrossProfit_2A417A7E96F7B82BEF84B0B8FC3124C0_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit_2A417A7E96F7B82BEF84B0B8FC3124C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_2A417A7E96F7B82BEF84B0B8FC3124C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit_2A417A7E96F7B82BEF84B0B8FC3124C0" xlink:to="lab_us-gaap_GrossProfit_2A417A7E96F7B82BEF84B0B8FC3124C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpenses_8BC0CCAE6F01F0646C6BB0B8FC314A35_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses_8BC0CCAE6F01F0646C6BB0B8FC314A35" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_8BC0CCAE6F01F0646C6BB0B8FC314A35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_8BC0CCAE6F01F0646C6BB0B8FC314A35" xlink:to="lab_us-gaap_OperatingExpenses_8BC0CCAE6F01F0646C6BB0B8FC314A35" xlink:type="arc" />
    <link:label id="lab_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD_terseLabel_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Development Agreements [Table]</link:label>
    <link:label id="lab_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD_label_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Development Agreements [Table]</link:label>
    <link:label id="lab_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD_documentation_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Development Agreements [Table]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DevelopmentAgreementsTable" xlink:label="loc_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD" xlink:to="lab_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_4E1CD75CA434773AC5A9360B0E5DC1B9_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis_4E1CD75CA434773AC5A9360B0E5DC1B9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_4E1CD75CA434773AC5A9360B0E5DC1B9_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis_4E1CD75CA434773AC5A9360B0E5DC1B9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_4E1CD75CA434773AC5A9360B0E5DC1B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis_4E1CD75CA434773AC5A9360B0E5DC1B9" xlink:to="lab_us-gaap_TypeOfArrangementAxis_4E1CD75CA434773AC5A9360B0E5DC1B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6BF7ECAE09F85C67FA6C360B0E5E505E_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6BF7ECAE09F85C67FA6C360B0E5E505E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6BF7ECAE09F85C67FA6C360B0E5E505E_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6BF7ECAE09F85C67FA6C360B0E5E505E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6BF7ECAE09F85C67FA6C360B0E5E505E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6BF7ECAE09F85C67FA6C360B0E5E505E" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6BF7ECAE09F85C67FA6C360B0E5E505E" xlink:type="arc" />
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_2D9CD5CBFE12F5980B70360B0E63E58F_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember_2D9CD5CBFE12F5980B70360B0E63E58F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_2D9CD5CBFE12F5980B70360B0E63E58F_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember_2D9CD5CBFE12F5980B70360B0E63E58F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CollaborativeArrangementMember" xlink:label="loc_us-gaap_CollaborativeArrangementMember_2D9CD5CBFE12F5980B70360B0E63E58F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember_2D9CD5CBFE12F5980B70360B0E63E58F" xlink:to="lab_us-gaap_CollaborativeArrangementMember_2D9CD5CBFE12F5980B70360B0E63E58F" xlink:type="arc" />
    <link:label id="lab_srt_CounterpartyNameAxis_D55E7B297A20B1D31F97360B0E6383F9_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis_D55E7B297A20B1D31F97360B0E6383F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_D55E7B297A20B1D31F97360B0E6383F9_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis_D55E7B297A20B1D31F97360B0E6383F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_D55E7B297A20B1D31F97360B0E6383F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis_D55E7B297A20B1D31F97360B0E6383F9" xlink:to="lab_srt_CounterpartyNameAxis_D55E7B297A20B1D31F97360B0E6383F9" xlink:type="arc" />
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_A55EE51C2222A7425DAB360B0E64640A_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain_A55EE51C2222A7425DAB360B0E64640A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_A55EE51C2222A7425DAB360B0E64640A_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain_A55EE51C2222A7425DAB360B0E64640A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_A55EE51C2222A7425DAB360B0E64640A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_A55EE51C2222A7425DAB360B0E64640A" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain_A55EE51C2222A7425DAB360B0E64640A" xlink:type="arc" />
    <link:label id="lab_dxcm_VerilyLifeSciencesMember_5F86425E568046E6D25E360B0E64E82A_terseLabel_en-US" xlink:label="lab_dxcm_VerilyLifeSciencesMember_5F86425E568046E6D25E360B0E64E82A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Verily Life Sciences</link:label>
    <link:label id="lab_dxcm_VerilyLifeSciencesMember_5F86425E568046E6D25E360B0E64E82A_label_en-US" xlink:label="lab_dxcm_VerilyLifeSciencesMember_5F86425E568046E6D25E360B0E64E82A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Verily Life Sciences [Member]</link:label>
    <link:label id="lab_dxcm_VerilyLifeSciencesMember_5F86425E568046E6D25E360B0E64E82A_documentation_en-US" xlink:label="lab_dxcm_VerilyLifeSciencesMember_5F86425E568046E6D25E360B0E64E82A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Verily Life Sciences  [Member]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_VerilyLifeSciencesMember" xlink:label="loc_dxcm_VerilyLifeSciencesMember_5F86425E568046E6D25E360B0E64E82A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_VerilyLifeSciencesMember_5F86425E568046E6D25E360B0E64E82A" xlink:to="lab_dxcm_VerilyLifeSciencesMember_5F86425E568046E6D25E360B0E64E82A" xlink:type="arc" />
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_6981A210A0F492F914DB360B0E6464FF_terseLabel_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_6981A210A0F492F914DB360B0E6464FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments Under Collaboration Agreements [Axis]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_6981A210A0F492F914DB360B0E6464FF_label_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_6981A210A0F492F914DB360B0E6464FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments Under Collaboration Agreements [Axis]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_6981A210A0F492F914DB360B0E6464FF_documentation_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_6981A210A0F492F914DB360B0E6464FF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments Under Collaboration Agreements [Axis]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_6981A210A0F492F914DB360B0E6464FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_6981A210A0F492F914DB360B0E6464FF" xlink:to="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_6981A210A0F492F914DB360B0E6464FF" xlink:type="arc" />
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE_terseLabel_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments Under Collaboration Agreements [Domain]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE_label_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments Under Collaboration Agreements [Domain]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE_documentation_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Payments Under Collaboration Agreements [Axis]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE" xlink:to="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE" xlink:type="arc" />
    <link:label id="lab_dxcm_CollaborativeArrangementInitialPaymentMember_6D808D45CC5A4CA7E19C360B0E65049D_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementInitialPaymentMember_6D808D45CC5A4CA7E19C360B0E65049D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Initial Payment</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementInitialPaymentMember_6D808D45CC5A4CA7E19C360B0E65049D_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementInitialPaymentMember_6D808D45CC5A4CA7E19C360B0E65049D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Initial Payment [Member]</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementInitialPaymentMember_6D808D45CC5A4CA7E19C360B0E65049D_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementInitialPaymentMember_6D808D45CC5A4CA7E19C360B0E65049D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Initial Payment [Member]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeArrangementInitialPaymentMember" xlink:label="loc_dxcm_CollaborativeArrangementInitialPaymentMember_6D808D45CC5A4CA7E19C360B0E65049D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementInitialPaymentMember_6D808D45CC5A4CA7E19C360B0E65049D" xlink:to="lab_dxcm_CollaborativeArrangementInitialPaymentMember_6D808D45CC5A4CA7E19C360B0E65049D" xlink:type="arc" />
    <link:label id="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_0973B123033D8977D78E360B0E653D36_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_0973B123033D8977D78E360B0E653D36" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Milestone Payments</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_0973B123033D8977D78E360B0E653D36_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_0973B123033D8977D78E360B0E653D36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Milestone Payments [Member]</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_0973B123033D8977D78E360B0E653D36_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_0973B123033D8977D78E360B0E653D36" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Milestone Payments [Member]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:label="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_0973B123033D8977D78E360B0E653D36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_0973B123033D8977D78E360B0E653D36" xlink:to="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_0973B123033D8977D78E360B0E653D36" xlink:type="arc" />
    <link:label id="lab_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE_terseLabel_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Development Agreements [Line Items]</link:label>
    <link:label id="lab_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE_label_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Development Agreements [Line Items]</link:label>
    <link:label id="lab_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE_documentation_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Development Agreements [Line Items]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DevelopmentAgreementsLineItems" xlink:label="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="lab_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:type="arc" />
    <link:label id="lab_dxcm_CollaborativeArrangementUpfrontFee_5834DAEEB81CDDA2DF64360B0E650A40_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementUpfrontFee_5834DAEEB81CDDA2DF64360B0E650A40" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial payment on collaborative agreement</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementUpfrontFee_5834DAEEB81CDDA2DF64360B0E650A40_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementUpfrontFee_5834DAEEB81CDDA2DF64360B0E650A40" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Upfront Fee</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementUpfrontFee_5834DAEEB81CDDA2DF64360B0E650A40_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementUpfrontFee_5834DAEEB81CDDA2DF64360B0E650A40" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Upfront Fee</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeArrangementUpfrontFee" xlink:label="loc_dxcm_CollaborativeArrangementUpfrontFee_5834DAEEB81CDDA2DF64360B0E650A40" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementUpfrontFee_5834DAEEB81CDDA2DF64360B0E650A40" xlink:to="lab_dxcm_CollaborativeArrangementUpfrontFee_5834DAEEB81CDDA2DF64360B0E650A40" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_FE9D5335AC9F47DA9AAE360B0E65B703_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_FE9D5335AC9F47DA9AAE360B0E65B703" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock in connection with acquisition, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_FE9D5335AC9F47DA9AAE360B0E65B703_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_FE9D5335AC9F47DA9AAE360B0E65B703" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_FE9D5335AC9F47DA9AAE360B0E65B703" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_FE9D5335AC9F47DA9AAE360B0E65B703" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_FE9D5335AC9F47DA9AAE360B0E65B703" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharePrice_BE5718F6E841B9262AE5360B0E66545A_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice_BE5718F6E841B9262AE5360B0E66545A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Closing stock price (USD per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_BE5718F6E841B9262AE5360B0E66545A_label_en-US" xlink:label="lab_us-gaap_SharePrice_BE5718F6E841B9262AE5360B0E66545A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_BE5718F6E841B9262AE5360B0E66545A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice_BE5718F6E841B9262AE5360B0E66545A" xlink:to="lab_us-gaap_SharePrice_BE5718F6E841B9262AE5360B0E66545A" xlink:type="arc" />
    <link:label id="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_28D5CC339740A50A781A360B0E665DA7_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_28D5CC339740A50A781A360B0E665DA7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional milestones and incentive payments</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_28D5CC339740A50A781A360B0E665DA7_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_28D5CC339740A50A781A360B0E665DA7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Development &amp; Regulatory Milestones, Total Regulatory and Incentive Payments</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_28D5CC339740A50A781A360B0E665DA7_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_28D5CC339740A50A781A360B0E665DA7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Development &amp; Regulatory Milestones, Total Regulatory and Incentive Payments</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments" xlink:label="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_28D5CC339740A50A781A360B0E665DA7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_28D5CC339740A50A781A360B0E665DA7" xlink:to="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_28D5CC339740A50A781A360B0E665DA7" xlink:type="arc" />
    <link:label id="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_5385B3F35A92539A629E360B0E664954_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_5385B3F35A92539A629E360B0E664954" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone payments due upon achievement of future development</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_5385B3F35A92539A629E360B0E664954_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_5385B3F35A92539A629E360B0E664954" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Development &amp; Regulatory Milestones</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_5385B3F35A92539A629E360B0E664954_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_5385B3F35A92539A629E360B0E664954" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Development &amp; Regulatory Milestones</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones" xlink:label="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_5385B3F35A92539A629E360B0E664954" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_5385B3F35A92539A629E360B0E664954" xlink:to="lab_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_5385B3F35A92539A629E360B0E664954" xlink:type="arc" />
    <link:label id="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_76721CA6B8EAA7C12B2E360B0E66F67F_terseLabel_en-US" xlink:label="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_76721CA6B8EAA7C12B2E360B0E66F67F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential future common stock issuable (shares)</link:label>
    <link:label id="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_76721CA6B8EAA7C12B2E360B0E66F67F_label_en-US" xlink:label="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_76721CA6B8EAA7C12B2E360B0E66F67F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential Future Common Stock Issuable, Shares, New Issues</link:label>
    <link:label id="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_76721CA6B8EAA7C12B2E360B0E66F67F_documentation_en-US" xlink:label="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_76721CA6B8EAA7C12B2E360B0E66F67F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Potential Future Common Stock Issuable, Shares, New Issues</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:label="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_76721CA6B8EAA7C12B2E360B0E66F67F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_76721CA6B8EAA7C12B2E360B0E66F67F" xlink:to="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_76721CA6B8EAA7C12B2E360B0E66F67F" xlink:type="arc" />
    <link:label id="lab_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_A49C797041CF6516C0A2360B0E67DA21_terseLabel_en-US" xlink:label="lab_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_A49C797041CF6516C0A2360B0E67DA21" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consecutive days used to calculate volume weighted average trading price</link:label>
    <link:label id="lab_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_A49C797041CF6516C0A2360B0E67DA21_label_en-US" xlink:label="lab_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_A49C797041CF6516C0A2360B0E67DA21" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Share Price, Consecutive Days Evaluated</link:label>
    <link:label id="lab_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_A49C797041CF6516C0A2360B0E67DA21_documentation_en-US" xlink:label="lab_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_A49C797041CF6516C0A2360B0E67DA21" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted Average Share Price, Consecutive Days Evaluated</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated" xlink:label="loc_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_A49C797041CF6516C0A2360B0E67DA21" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_A49C797041CF6516C0A2360B0E67DA21" xlink:to="lab_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_A49C797041CF6516C0A2360B0E67DA21" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableGross_56E852623C12D18117DCB570A8B15196_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross_56E852623C12D18117DCB570A8B15196" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGross_56E852623C12D18117DCB570A8B15196_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross_56E852623C12D18117DCB570A8B15196" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableGross" xlink:label="loc_us-gaap_AccountsReceivableGross_56E852623C12D18117DCB570A8B15196" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGross_56E852623C12D18117DCB570A8B15196" xlink:to="lab_us-gaap_AccountsReceivableGross_56E852623C12D18117DCB570A8B15196" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_DBA7018CEB2BEF8341D7B570A8B1B518_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_DBA7018CEB2BEF8341D7B570A8B1B518" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_DBA7018CEB2BEF8341D7B570A8B1B518_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_DBA7018CEB2BEF8341D7B570A8B1B518" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_DBA7018CEB2BEF8341D7B570A8B1B518" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_DBA7018CEB2BEF8341D7B570A8B1B518" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_DBA7018CEB2BEF8341D7B570A8B1B518" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableNet_C5612738884724C9E849B570A8B1A48A_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet_C5612738884724C9E849B570A8B1A48A" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNet_C5612738884724C9E849B570A8B1A48A_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet_C5612738884724C9E849B570A8B1A48A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaap_AccountsReceivableNet_C5612738884724C9E849B570A8B1A48A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet_C5612738884724C9E849B570A8B1A48A" xlink:to="lab_us-gaap_AccountsReceivableNet_C5612738884724C9E849B570A8B1A48A" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_F178183578C21F0C2DE6AF6BADCE93ED_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_F178183578C21F0C2DE6AF6BADCE93ED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_F178183578C21F0C2DE6AF6BADCE93ED_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_F178183578C21F0C2DE6AF6BADCE93ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_F178183578C21F0C2DE6AF6BADCE93ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_F178183578C21F0C2DE6AF6BADCE93ED" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_F178183578C21F0C2DE6AF6BADCE93ED" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_0FF52A50038F8BF4CF4CAF6BADD05202_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_0FF52A50038F8BF4CF4CAF6BADD05202" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_0FF52A50038F8BF4CF4CAF6BADD05202_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_0FF52A50038F8BF4CF4CAF6BADD05202" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_0FF52A50038F8BF4CF4CAF6BADD05202" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance_0FF52A50038F8BF4CF4CAF6BADD05202" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance_0FF52A50038F8BF4CF4CAF6BADD05202" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_1670BC7D8D52D1FABF5BAF6BADD1BED6_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_1670BC7D8D52D1FABF5BAF6BADD1BED6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_1670BC7D8D52D1FABF5BAF6BADD1BED6_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_1670BC7D8D52D1FABF5BAF6BADD1BED6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_1670BC7D8D52D1FABF5BAF6BADD1BED6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_1670BC7D8D52D1FABF5BAF6BADD1BED6" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_1670BC7D8D52D1FABF5BAF6BADD1BED6" xlink:type="arc" />
    <link:label id="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_B917192DCDCE510FCC2BAF6BADD24FB4_negatedTerseLabel_en-US" xlink:label="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_B917192DCDCE510FCC2BAF6BADD24FB4" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Write-offs and adjustments</link:label>
    <link:label id="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_B917192DCDCE510FCC2BAF6BADD24FB4_label_en-US" xlink:label="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_B917192DCDCE510FCC2BAF6BADD24FB4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction, Write-offs and Adjustments</link:label>
    <link:label id="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_B917192DCDCE510FCC2BAF6BADD24FB4_documentation_en-US" xlink:label="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_B917192DCDCE510FCC2BAF6BADD24FB4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total of the write-offs and adjustments in a given period to allowances and reserves for doubtful accounts</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" xlink:label="loc_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_B917192DCDCE510FCC2BAF6BADD24FB4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_B917192DCDCE510FCC2BAF6BADD24FB4" xlink:to="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_B917192DCDCE510FCC2BAF6BADD24FB4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_AD2E0FF724546B5ADB50AF6BADD3236C_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_AD2E0FF724546B5ADB50AF6BADD3236C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recoveries</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_AD2E0FF724546B5ADB50AF6BADD3236C_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_AD2E0FF724546B5ADB50AF6BADD3236C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_AD2E0FF724546B5ADB50AF6BADD3236C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_AD2E0FF724546B5ADB50AF6BADD3236C" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_AD2E0FF724546B5ADB50AF6BADD3236C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_C23A2C9FE58E4B60B573AF6BADD32659_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_C23A2C9FE58E4B60B573AF6BADD32659" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_C23A2C9FE58E4B60B573AF6BADD32659" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance_C23A2C9FE58E4B60B573AF6BADD32659" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance_C23A2C9FE58E4B60B573AF6BADD32659" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_0486156410F5A85A2DF1C9C4B978E9FC_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_0486156410F5A85A2DF1C9C4B978E9FC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_0486156410F5A85A2DF1C9C4B978E9FC_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_0486156410F5A85A2DF1C9C4B978E9FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_0486156410F5A85A2DF1C9C4B978E9FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_0486156410F5A85A2DF1C9C4B978E9FC" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_0486156410F5A85A2DF1C9C4B978E9FC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_C90D43EA91FE354FC1BDC9C4B979C4FD_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock_C90D43EA91FE354FC1BDC9C4B979C4FD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Converted Value of Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_C90D43EA91FE354FC1BDC9C4B979C4FD_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock_C90D43EA91FE354FC1BDC9C4B979C4FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock_C90D43EA91FE354FC1BDC9C4B979C4FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtTableTextBlock_C90D43EA91FE354FC1BDC9C4B979C4FD" xlink:to="lab_us-gaap_ConvertibleDebtTableTextBlock_C90D43EA91FE354FC1BDC9C4B979C4FD" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_AC89F2535A8FB7ED9C7CC9C4B979E881_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_AC89F2535A8FB7ED9C7CC9C4B979E881" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes</link:label>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_AC89F2535A8FB7ED9C7CC9C4B979E881_label_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_AC89F2535A8FB7ED9C7CC9C4B979E881" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income and Interest Expense Disclosure [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_AC89F2535A8FB7ED9C7CC9C4B979E881" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_AC89F2535A8FB7ED9C7CC9C4B979E881" xlink:to="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_AC89F2535A8FB7ED9C7CC9C4B979E881" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_9433E2D182973C3D46FFCA0E625EF792_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_9433E2D182973C3D46FFCA0E625EF792" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Availability and Outstanding Borrowings on Credit Agreement</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_9433E2D182973C3D46FFCA0E625EF792_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_9433E2D182973C3D46FFCA0E625EF792" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_9433E2D182973C3D46FFCA0E625EF792" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_9433E2D182973C3D46FFCA0E625EF792" xlink:to="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_9433E2D182973C3D46FFCA0E625EF792" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasePayments_9EA38CC494FC178A998CB5C7757026AB_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments_9EA38CC494FC178A998CB5C7757026AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_9EA38CC494FC178A998CB5C7757026AB_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments_9EA38CC494FC178A998CB5C7757026AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_9EA38CC494FC178A998CB5C7757026AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments_9EA38CC494FC178A998CB5C7757026AB" xlink:to="lab_us-gaap_OperatingLeasePayments_9EA38CC494FC178A998CB5C7757026AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_60A1301D71BEE4FAF338B5C775747E5F_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_60A1301D71BEE4FAF338B5C775747E5F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_60A1301D71BEE4FAF338B5C775747E5F_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_60A1301D71BEE4FAF338B5C775747E5F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_60A1301D71BEE4FAF338B5C775747E5F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_60A1301D71BEE4FAF338B5C775747E5F" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_60A1301D71BEE4FAF338B5C775747E5F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_C85178EBB47D2D70BD21B5C775789484_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments_C85178EBB47D2D70BD21B5C775789484" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_C85178EBB47D2D70BD21B5C775789484_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments_C85178EBB47D2D70BD21B5C775789484" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_C85178EBB47D2D70BD21B5C775789484" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments_C85178EBB47D2D70BD21B5C775789484" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments_C85178EBB47D2D70BD21B5C775789484" xlink:type="arc" />
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0A07AD7692F8E8F03A41B5C7757CEA2A_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0A07AD7692F8E8F03A41B5C7757CEA2A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets obtained in exchange for operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0A07AD7692F8E8F03A41B5C7757CEA2A_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0A07AD7692F8E8F03A41B5C7757CEA2A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0A07AD7692F8E8F03A41B5C7757CEA2A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0A07AD7692F8E8F03A41B5C7757CEA2A" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0A07AD7692F8E8F03A41B5C7757CEA2A" xlink:type="arc" />
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_43FFFF8357FBF65165D7B5C775803B6E_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_43FFFF8357FBF65165D7B5C775803B6E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets obtained in exchange for finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_43FFFF8357FBF65165D7B5C775803B6E_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_43FFFF8357FBF65165D7B5C775803B6E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_43FFFF8357FBF65165D7B5C775803B6E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_43FFFF8357FBF65165D7B5C775803B6E" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_43FFFF8357FBF65165D7B5C775803B6E" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_112E87CEE6A40D631B6BB5C775E4DEF3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_112E87CEE6A40D631B6BB5C775E4DEF3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining lease term of operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_112E87CEE6A40D631B6BB5C775E4DEF3_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_112E87CEE6A40D631B6BB5C775E4DEF3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_112E87CEE6A40D631B6BB5C775E4DEF3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_112E87CEE6A40D631B6BB5C775E4DEF3" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_112E87CEE6A40D631B6BB5C775E4DEF3" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_9E4BE316979D8623514FB5C777FD8085_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_9E4BE316979D8623514FB5C777FD8085" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining lease term of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_9E4BE316979D8623514FB5C777FD8085_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_9E4BE316979D8623514FB5C777FD8085" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_9E4BE316979D8623514FB5C777FD8085" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_9E4BE316979D8623514FB5C777FD8085" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_9E4BE316979D8623514FB5C777FD8085" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_8F6573856A39D62FCE4AB5C7780734CD_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_8F6573856A39D62FCE4AB5C7780734CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average discount rate of operating leases (as a percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_8F6573856A39D62FCE4AB5C7780734CD_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_8F6573856A39D62FCE4AB5C7780734CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_8F6573856A39D62FCE4AB5C7780734CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_8F6573856A39D62FCE4AB5C7780734CD" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_8F6573856A39D62FCE4AB5C7780734CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_E91A7C87436883BA770EB5C778103F30_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_E91A7C87436883BA770EB5C778103F30" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average discount rate of finance leases (as a percent)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_E91A7C87436883BA770EB5C778103F30_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_E91A7C87436883BA770EB5C778103F30" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_E91A7C87436883BA770EB5C778103F30" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_E91A7C87436883BA770EB5C778103F30" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_E91A7C87436883BA770EB5C778103F30" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_B15CCD65B7047CEF4C5BD354A5457AE5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_B15CCD65B7047CEF4C5BD354A5457AE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_B15CCD65B7047CEF4C5BD354A5457AE5_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_B15CCD65B7047CEF4C5BD354A5457AE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B15CCD65B7047CEF4C5BD354A5457AE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B15CCD65B7047CEF4C5BD354A5457AE5" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_B15CCD65B7047CEF4C5BD354A5457AE5" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_3E17E306A77BD5C3C7D5D354A545884F_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_3E17E306A77BD5C3C7D5D354A545884F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_3E17E306A77BD5C3C7D5D354A545884F_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_3E17E306A77BD5C3C7D5D354A545884F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3E17E306A77BD5C3C7D5D354A545884F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member_3E17E306A77BD5C3C7D5D354A545884F" xlink:to="lab_us-gaap_FairValueInputsLevel1Member_3E17E306A77BD5C3C7D5D354A545884F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_0F3E0752C40836A2EDCDD354A5451582_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_0F3E0752C40836A2EDCDD354A5451582" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_0F3E0752C40836A2EDCDD354A5451582_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_0F3E0752C40836A2EDCDD354A5451582" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0F3E0752C40836A2EDCDD354A5451582" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member_0F3E0752C40836A2EDCDD354A5451582" xlink:to="lab_us-gaap_FairValueInputsLevel2Member_0F3E0752C40836A2EDCDD354A5451582" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_BE00A21654BF8250FC85D354A546EDF7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_BE00A21654BF8250FC85D354A546EDF7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_BE00A21654BF8250FC85D354A546EDF7_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_BE00A21654BF8250FC85D354A546EDF7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_BE00A21654BF8250FC85D354A546EDF7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member_BE00A21654BF8250FC85D354A546EDF7" xlink:to="lab_us-gaap_FairValueInputsLevel3Member_BE00A21654BF8250FC85D354A546EDF7" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_E639583AFD91B613C299D354A5460718_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue_E639583AFD91B613C299D354A5460718" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_E639583AFD91B613C299D354A5460718_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue_E639583AFD91B613C299D354A5460718" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_E639583AFD91B613C299D354A5460718" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue_E639583AFD91B613C299D354A5460718" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue_E639583AFD91B613C299D354A5460718" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_E3B11CEF94119307B7CCD354A546ADE5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure_E3B11CEF94119307B7CCD354A546ADE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity investment in Tandem Diabetes Care, Inc.</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_E3B11CEF94119307B7CCD354A546ADE5_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure_E3B11CEF94119307B7CCD354A546ADE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_E3B11CEF94119307B7CCD354A546ADE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure_E3B11CEF94119307B7CCD354A546ADE5" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure_E3B11CEF94119307B7CCD354A546ADE5" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_B85DFD854EBA944287FFD354A5462B08_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_B85DFD854EBA944287FFD354A5462B08" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt securities, available for sale:</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_B85DFD854EBA944287FFD354A5462B08" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_B85DFD854EBA944287FFD354A5462B08" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_B85DFD854EBA944287FFD354A5462B08" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_2B148F4EE84A21554DEAD35C9099418B_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure_2B148F4EE84A21554DEAD35C9099418B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_2B148F4EE84A21554DEAD35C9099418B_label_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure_2B148F4EE84A21554DEAD35C9099418B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_2B148F4EE84A21554DEAD35C9099418B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsFairValueDisclosure_2B148F4EE84A21554DEAD35C9099418B" xlink:to="lab_us-gaap_OtherAssetsFairValueDisclosure_2B148F4EE84A21554DEAD35C9099418B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_349F8A0C88879B1703C1D354A547CD66_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure_349F8A0C88879B1703C1D354A547CD66" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_349F8A0C88879B1703C1D354A547CD66_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure_349F8A0C88879B1703C1D354A547CD66" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_349F8A0C88879B1703C1D354A547CD66" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_349F8A0C88879B1703C1D354A547CD66" xlink:to="lab_us-gaap_AssetsFairValueDisclosure_349F8A0C88879B1703C1D354A547CD66" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_339E8BE33A576725783FB031004CF890_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_339E8BE33A576725783FB031004CF890" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes at statutory rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_339E8BE33A576725783FB031004CF890_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_339E8BE33A576725783FB031004CF890" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_339E8BE33A576725783FB031004CF890" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_339E8BE33A576725783FB031004CF890" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_339E8BE33A576725783FB031004CF890" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_D0B7EBD5FA56AD1C36A1B031004DEA60_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_D0B7EBD5FA56AD1C36A1B031004DEA60" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State income tax, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_D0B7EBD5FA56AD1C36A1B031004DEA60_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_D0B7EBD5FA56AD1C36A1B031004DEA60" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_D0B7EBD5FA56AD1C36A1B031004DEA60" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_D0B7EBD5FA56AD1C36A1B031004DEA60" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_D0B7EBD5FA56AD1C36A1B031004DEA60" xlink:type="arc" />
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_31D58B56D288E4D721F4B031004DC213_terseLabel_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_31D58B56D288E4D721F4B031004DC213" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Permanent items</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_31D58B56D288E4D721F4B031004DC213_label_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_31D58B56D288E4D721F4B031004DC213" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Reconciliation, Permanent Items</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_31D58B56D288E4D721F4B031004DC213_documentation_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_31D58B56D288E4D721F4B031004DC213" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Reconciliation, Permanent Items</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EffectiveIncomeTaxReconciliationPermanentItems" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_31D58B56D288E4D721F4B031004DC213" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_31D58B56D288E4D721F4B031004DC213" xlink:to="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_31D58B56D288E4D721F4B031004DC213" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_918DBCDFEC06A20C83E0B031004D5185_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_918DBCDFEC06A20C83E0B031004D5185" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_918DBCDFEC06A20C83E0B031004D5185_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_918DBCDFEC06A20C83E0B031004D5185" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_918DBCDFEC06A20C83E0B031004D5185" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_918DBCDFEC06A20C83E0B031004D5185" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_918DBCDFEC06A20C83E0B031004D5185" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_4C9208333E6C77904A75B031004D4B4C_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_4C9208333E6C77904A75B031004D4B4C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign rate differential</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_4C9208333E6C77904A75B031004D4B4C_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_4C9208333E6C77904A75B031004D4B4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_4C9208333E6C77904A75B031004D4B4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_4C9208333E6C77904A75B031004D4B4C" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_4C9208333E6C77904A75B031004D4B4C" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9E2B97C41D9B81C82DA6B031004D307E_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9E2B97C41D9B81C82DA6B031004D307E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock and officers compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9E2B97C41D9B81C82DA6B031004D307E_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9E2B97C41D9B81C82DA6B031004D307E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9E2B97C41D9B81C82DA6B031004D307E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9E2B97C41D9B81C82DA6B031004D307E" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9E2B97C41D9B81C82DA6B031004D307E" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_F418E70E4E1D66FEC970B031004E963C_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_F418E70E4E1D66FEC970B031004E963C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rate change</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_F418E70E4E1D66FEC970B031004E963C_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_F418E70E4E1D66FEC970B031004E963C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_F418E70E4E1D66FEC970B031004E963C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_F418E70E4E1D66FEC970B031004E963C" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_F418E70E4E1D66FEC970B031004E963C" xlink:type="arc" />
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits_F35B4AFE81E397F1D58DB031004ECE8B_terseLabel_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits_F35B4AFE81E397F1D58DB031004ECE8B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits_F35B4AFE81E397F1D58DB031004ECE8B_label_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits_F35B4AFE81E397F1D58DB031004ECE8B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Reconciliation, Unrecognized tax benefits</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits_F35B4AFE81E397F1D58DB031004ECE8B_documentation_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits_F35B4AFE81E397F1D58DB031004ECE8B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Reconciliation, Unrecognized tax benefits</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits_F35B4AFE81E397F1D58DB031004ECE8B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits_F35B4AFE81E397F1D58DB031004ECE8B" xlink:to="lab_dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits_F35B4AFE81E397F1D58DB031004ECE8B" xlink:type="arc" />
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_38B448F8E622B3D93E81B031004EDB4F_terseLabel_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_38B448F8E622B3D93E81B031004EDB4F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of adoption of ASU 2016-16</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_38B448F8E622B3D93E81B031004EDB4F_label_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_38B448F8E622B3D93E81B031004EDB4F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Reconciliation, Impact of Adoption of ASU 2016-16</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_38B448F8E622B3D93E81B031004EDB4F_documentation_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_38B448F8E622B3D93E81B031004EDB4F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Reconciliation, Impact of Adoption of ASU 2016-16</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_38B448F8E622B3D93E81B031004EDB4F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_38B448F8E622B3D93E81B031004EDB4F" xlink:to="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_38B448F8E622B3D93E81B031004EDB4F" xlink:type="arc" />
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_A66223D7D852F6F377B0B031004EAA91_terseLabel_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_A66223D7D852F6F377B0B031004EAA91" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of Tax Cuts and Jobs Act of 2017</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_A66223D7D852F6F377B0B031004EAA91_label_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_A66223D7D852F6F377B0B031004EAA91" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Reconciliation, Impact of TCJA</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_A66223D7D852F6F377B0B031004EAA91_documentation_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_A66223D7D852F6F377B0B031004EAA91" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Reconciliation, Impact of TCJA</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_A66223D7D852F6F377B0B031004EAA91" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_A66223D7D852F6F377B0B031004EAA91" xlink:to="lab_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_A66223D7D852F6F377B0B031004EAA91" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_83B0094EB85A61720176B031004EAA02_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_83B0094EB85A61720176B031004EAA02" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_83B0094EB85A61720176B031004EAA02_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_83B0094EB85A61720176B031004EAA02" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_83B0094EB85A61720176B031004EAA02" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_83B0094EB85A61720176B031004EAA02" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_83B0094EB85A61720176B031004EAA02" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_BF2E61F6B40F6C7A0366B031004FA777_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_BF2E61F6B40F6C7A0366B031004FA777" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_BF2E61F6B40F6C7A0366B031004FA777_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_BF2E61F6B40F6C7A0366B031004FA777" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_BF2E61F6B40F6C7A0366B031004FA777" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_BF2E61F6B40F6C7A0366B031004FA777" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_BF2E61F6B40F6C7A0366B031004FA777" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_FD6A876E808B22937E6EAFE0A1A2CD12_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_FD6A876E808B22937E6EAFE0A1A2CD12" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_FD6A876E808B22937E6EAFE0A1A2CD12_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_FD6A876E808B22937E6EAFE0A1A2CD12" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_FD6A876E808B22937E6EAFE0A1A2CD12" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_FD6A876E808B22937E6EAFE0A1A2CD12" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_FD6A876E808B22937E6EAFE0A1A2CD12" xlink:type="arc" />
    <link:label id="lab_dxcm_DevelopmentAndOtherAgreementsTextBlock_25640EECE35C5854ED3BAB500B6CE778_terseLabel_en-US" xlink:label="lab_dxcm_DevelopmentAndOtherAgreementsTextBlock_25640EECE35C5854ED3BAB500B6CE778" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Development and Other Agreements</link:label>
    <link:label id="lab_dxcm_DevelopmentAndOtherAgreementsTextBlock_25640EECE35C5854ED3BAB500B6CE778_label_en-US" xlink:label="lab_dxcm_DevelopmentAndOtherAgreementsTextBlock_25640EECE35C5854ED3BAB500B6CE778" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Development And Other Agreements [Text Block]</link:label>
    <link:label id="lab_dxcm_DevelopmentAndOtherAgreementsTextBlock_25640EECE35C5854ED3BAB500B6CE778_documentation_en-US" xlink:label="lab_dxcm_DevelopmentAndOtherAgreementsTextBlock_25640EECE35C5854ED3BAB500B6CE778" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Development And Other Agreements [Text Block]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DevelopmentAndOtherAgreementsTextBlock" xlink:label="loc_dxcm_DevelopmentAndOtherAgreementsTextBlock_25640EECE35C5854ED3BAB500B6CE778" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DevelopmentAndOtherAgreementsTextBlock_25640EECE35C5854ED3BAB500B6CE778" xlink:to="lab_dxcm_DevelopmentAndOtherAgreementsTextBlock_25640EECE35C5854ED3BAB500B6CE778" xlink:type="arc" />
    <link:label id="lab_dxcm_FinancingLeaseObligation_29E7476629FD4930E9AAF38B00BCA4F7_terseLabel_en-US" xlink:label="lab_dxcm_FinancingLeaseObligation_29E7476629FD4930E9AAF38B00BCA4F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease obligations</link:label>
    <link:label id="lab_dxcm_FinancingLeaseObligation_29E7476629FD4930E9AAF38B00BCA4F7_label_en-US" xlink:label="lab_dxcm_FinancingLeaseObligation_29E7476629FD4930E9AAF38B00BCA4F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Lease Obligation</link:label>
    <link:label id="lab_dxcm_FinancingLeaseObligation_29E7476629FD4930E9AAF38B00BCA4F7_documentation_en-US" xlink:label="lab_dxcm_FinancingLeaseObligation_29E7476629FD4930E9AAF38B00BCA4F7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Lease Obligation</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FinancingLeaseObligation" xlink:label="loc_dxcm_FinancingLeaseObligation_29E7476629FD4930E9AAF38B00BCA4F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FinancingLeaseObligation_29E7476629FD4930E9AAF38B00BCA4F7" xlink:to="lab_dxcm_FinancingLeaseObligation_29E7476629FD4930E9AAF38B00BCA4F7" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredRentCreditNoncurrent_C1C7E42AFE9424402677F38B00BC379B_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRentCreditNoncurrent_C1C7E42AFE9424402677F38B00BC379B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred rent</link:label>
    <link:label id="lab_us-gaap_DeferredRentCreditNoncurrent_C1C7E42AFE9424402677F38B00BC379B_label_en-US" xlink:label="lab_us-gaap_DeferredRentCreditNoncurrent_C1C7E42AFE9424402677F38B00BC379B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Rent Credit, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent_C1C7E42AFE9424402677F38B00BC379B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRentCreditNoncurrent_C1C7E42AFE9424402677F38B00BC379B" xlink:to="lab_us-gaap_DeferredRentCreditNoncurrent_C1C7E42AFE9424402677F38B00BC379B" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_CC8D7406C9DD809B694AF38B00BC52A0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_CC8D7406C9DD809B694AF38B00BC52A0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_CC8D7406C9DD809B694AF38B00BC52A0_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_CC8D7406C9DD809B694AF38B00BC52A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Sundry Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_CC8D7406C9DD809B694AF38B00BC52A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_CC8D7406C9DD809B694AF38B00BC52A0" xlink:to="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_CC8D7406C9DD809B694AF38B00BC52A0" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_9596D6DCF20B27F1BE88F38B00BCE1A9_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_9596D6DCF20B27F1BE88F38B00BCE1A9" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_9596D6DCF20B27F1BE88F38B00BCE1A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_9596D6DCF20B27F1BE88F38B00BCE1A9" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent_9596D6DCF20B27F1BE88F38B00BCE1A9" xlink:type="arc" />
    <link:label id="lab_us-gaap_AwardTypeAxis_5C0C0B561A0900B8BF1FC9C4B8A5A126_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_5C0C0B561A0900B8BF1FC9C4B8A5A126" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_5C0C0B561A0900B8BF1FC9C4B8A5A126_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_5C0C0B561A0900B8BF1FC9C4B8A5A126" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_5C0C0B561A0900B8BF1FC9C4B8A5A126" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis_5C0C0B561A0900B8BF1FC9C4B8A5A126" xlink:to="lab_us-gaap_AwardTypeAxis_5C0C0B561A0900B8BF1FC9C4B8A5A126" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F55C24251F9A72FFE9E2C9C4B8A69229_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F55C24251F9A72FFE9E2C9C4B8A69229" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F55C24251F9A72FFE9E2C9C4B8A69229_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F55C24251F9A72FFE9E2C9C4B8A69229" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F55C24251F9A72FFE9E2C9C4B8A69229" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F55C24251F9A72FFE9E2C9C4B8A69229" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F55C24251F9A72FFE9E2C9C4B8A69229" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75BA8C4C8236C2A2D2DCC9C4B8A75BF1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75BA8C4C8236C2A2D2DCC9C4B8A75BF1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Nonvested at beginning of period (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75BA8C4C8236C2A2D2DCC9C4B8A75BF1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75BA8C4C8236C2A2D2DCC9C4B8A75BF1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75BA8C4C8236C2A2D2DCC9C4B8A75BF1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1ADE0BCC747E079EF3ABC9C4B8A7309F_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1ADE0BCC747E079EF3ABC9C4B8A7309F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1ADE0BCC747E079EF3ABC9C4B8A7309F_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1ADE0BCC747E079EF3ABC9C4B8A7309F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1ADE0BCC747E079EF3ABC9C4B8A7309F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1ADE0BCC747E079EF3ABC9C4B8A7309F" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1ADE0BCC747E079EF3ABC9C4B8A7309F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0ED70B150F685E4F4C2AC9C4B8A8E87F_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0ED70B150F685E4F4C2AC9C4B8A8E87F" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Vested (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0ED70B150F685E4F4C2AC9C4B8A8E87F_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0ED70B150F685E4F4C2AC9C4B8A8E87F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0ED70B150F685E4F4C2AC9C4B8A8E87F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0ED70B150F685E4F4C2AC9C4B8A8E87F" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0ED70B150F685E4F4C2AC9C4B8A8E87F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_749F123157946CA30ABEC9C4B8A81BD8_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_749F123157946CA30ABEC9C4B8A81BD8" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_749F123157946CA30ABEC9C4B8A81BD8_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_749F123157946CA30ABEC9C4B8A81BD8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_749F123157946CA30ABEC9C4B8A81BD8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_749F123157946CA30ABEC9C4B8A81BD8" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_749F123157946CA30ABEC9C4B8A81BD8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2C32A0B67F061EE431FCC9C4B8A822C0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2C32A0B67F061EE431FCC9C4B8A822C0" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Nonvested at end of period (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2C32A0B67F061EE431FCC9C4B8A822C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2C32A0B67F061EE431FCC9C4B8A822C0" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2C32A0B67F061EE431FCC9C4B8A822C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9F5F12D19CD4C10ACD7AC9C4B8A78CA2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9F5F12D19CD4C10ACD7AC9C4B8A78CA2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Nonvested at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9F5F12D19CD4C10ACD7AC9C4B8A78CA2_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9F5F12D19CD4C10ACD7AC9C4B8A78CA2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9F5F12D19CD4C10ACD7AC9C4B8A78CA2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9F5F12D19CD4C10ACD7AC9C4B8A78CA2" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9F5F12D19CD4C10ACD7AC9C4B8A78CA2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7F0B2B4F3FBBC78129DAC9C4B8A747C6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7F0B2B4F3FBBC78129DAC9C4B8A747C6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7F0B2B4F3FBBC78129DAC9C4B8A747C6_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7F0B2B4F3FBBC78129DAC9C4B8A747C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7F0B2B4F3FBBC78129DAC9C4B8A747C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7F0B2B4F3FBBC78129DAC9C4B8A747C6" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7F0B2B4F3FBBC78129DAC9C4B8A747C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4FD38CAC8CE28B5DED4DC9C4B8A8B096_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4FD38CAC8CE28B5DED4DC9C4B8A8B096" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4FD38CAC8CE28B5DED4DC9C4B8A8B096_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4FD38CAC8CE28B5DED4DC9C4B8A8B096" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4FD38CAC8CE28B5DED4DC9C4B8A8B096" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4FD38CAC8CE28B5DED4DC9C4B8A8B096" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4FD38CAC8CE28B5DED4DC9C4B8A8B096" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2E9041463BAC6C95B786C9C4B8A843BA_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2E9041463BAC6C95B786C9C4B8A843BA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2E9041463BAC6C95B786C9C4B8A843BA_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2E9041463BAC6C95B786C9C4B8A843BA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2E9041463BAC6C95B786C9C4B8A843BA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2E9041463BAC6C95B786C9C4B8A843BA" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2E9041463BAC6C95B786C9C4B8A843BA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A56A2971512BB003229BC9C4B8A887FF_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A56A2971512BB003229BC9C4B8A887FF" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Nonvested at end of period (USD per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A56A2971512BB003229BC9C4B8A887FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A56A2971512BB003229BC9C4B8A887FF" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A56A2971512BB003229BC9C4B8A887FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_B0BF3A67DDB70222A711C9C4B8A9DBDE_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_B0BF3A67DDB70222A711C9C4B8A9DBDE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_B0BF3A67DDB70222A711C9C4B8A9DBDE_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_B0BF3A67DDB70222A711C9C4B8A9DBDE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_B0BF3A67DDB70222A711C9C4B8A9DBDE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_B0BF3A67DDB70222A711C9C4B8A9DBDE" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_B0BF3A67DDB70222A711C9C4B8A9DBDE" xlink:type="arc" />
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442_terseLabel_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442_label_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442_documentation_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442" xlink:to="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComputerEquipmentMember_E7FD9F7E5930B68DB101210C27A8C66D_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember_E7FD9F7E5930B68DB101210C27A8C66D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer software and hardware</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_E7FD9F7E5930B68DB101210C27A8C66D_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember_E7FD9F7E5930B68DB101210C27A8C66D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_E7FD9F7E5930B68DB101210C27A8C66D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember_E7FD9F7E5930B68DB101210C27A8C66D" xlink:to="lab_us-gaap_ComputerEquipmentMember_E7FD9F7E5930B68DB101210C27A8C66D" xlink:type="arc" />
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_A1031DD0D3762F71EB7B210C27A973B6_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember_A1031DD0D3762F71EB7B210C27A973B6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Machinery and Equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_A1031DD0D3762F71EB7B210C27A973B6_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember_A1031DD0D3762F71EB7B210C27A973B6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_A1031DD0D3762F71EB7B210C27A973B6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember_A1031DD0D3762F71EB7B210C27A973B6" xlink:to="lab_us-gaap_MachineryAndEquipmentMember_A1031DD0D3762F71EB7B210C27A973B6" xlink:type="arc" />
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_193E7ADB68138EA61B6C210C27A90466_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember_193E7ADB68138EA61B6C210C27A90466" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_193E7ADB68138EA61B6C210C27A90466_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember_193E7ADB68138EA61B6C210C27A90466" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_193E7ADB68138EA61B6C210C27A90466" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember_193E7ADB68138EA61B6C210C27A90466" xlink:to="lab_us-gaap_FurnitureAndFixturesMember_193E7ADB68138EA61B6C210C27A90466" xlink:type="arc" />
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78_terseLabel_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78_label_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78_documentation_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:type="arc" />
    <link:label id="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_28EDAD9F801D44C3CC8C210C27A9F5EE_terseLabel_en-US" xlink:label="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_28EDAD9F801D44C3CC8C210C27A9F5EE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturity threshold of investments classified to cash equivalents</link:label>
    <link:label id="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_28EDAD9F801D44C3CC8C210C27A9F5EE_label_en-US" xlink:label="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_28EDAD9F801D44C3CC8C210C27A9F5EE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maturity Threshold Of Investments Classified To Cash Equivalents</link:label>
    <link:label id="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_28EDAD9F801D44C3CC8C210C27A9F5EE_documentation_en-US" xlink:label="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_28EDAD9F801D44C3CC8C210C27A9F5EE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maturity Threshold Of Investments Classified To Cash Equivalents</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" xlink:label="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_28EDAD9F801D44C3CC8C210C27A9F5EE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_28EDAD9F801D44C3CC8C210C27A9F5EE" xlink:to="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_28EDAD9F801D44C3CC8C210C27A9F5EE" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_C5F596FA31D4AA7F1397210C27AA8BC4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_C5F596FA31D4AA7F1397210C27AA8BC4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_C5F596FA31D4AA7F1397210C27AA8BC4_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_C5F596FA31D4AA7F1397210C27AA8BC4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_C5F596FA31D4AA7F1397210C27AA8BC4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_C5F596FA31D4AA7F1397210C27AA8BC4" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_C5F596FA31D4AA7F1397210C27AA8BC4" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9D19F6E446A6C4C5C575210C27AA6CA0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9D19F6E446A6C4C5C575210C27AA6CA0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Useful life of finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9D19F6E446A6C4C5C575210C27AA6CA0_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9D19F6E446A6C4C5C575210C27AA6CA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9D19F6E446A6C4C5C575210C27AA6CA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9D19F6E446A6C4C5C575210C27AA6CA0" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9D19F6E446A6C4C5C575210C27AA6CA0" xlink:type="arc" />
    <link:label id="lab_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_DF71F8C5B4D17C35AAD1210C27AAA45C_terseLabel_en-US" xlink:label="lab_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_DF71F8C5B4D17C35AAD1210C27AAA45C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales return period</link:label>
    <link:label id="lab_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_DF71F8C5B4D17C35AAD1210C27AAA45C_label_en-US" xlink:label="lab_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_DF71F8C5B4D17C35AAD1210C27AAA45C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Sales Returns, Coverage Period</link:label>
    <link:label id="lab_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_DF71F8C5B4D17C35AAD1210C27AAA45C_documentation_en-US" xlink:label="lab_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_DF71F8C5B4D17C35AAD1210C27AAA45C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Sales Returns, Coverage Period</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_RevenueRecognitionSalesReturnsCoveragePeriod" xlink:label="loc_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_DF71F8C5B4D17C35AAD1210C27AAA45C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_DF71F8C5B4D17C35AAD1210C27AAA45C" xlink:to="lab_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_DF71F8C5B4D17C35AAD1210C27AAA45C" xlink:type="arc" />
    <link:label id="lab_dxcm_ContractPaymentTermsNumberofDays_2CF5CF41656C2F57813B210C27AA0360_terseLabel_en-US" xlink:label="lab_dxcm_ContractPaymentTermsNumberofDays_2CF5CF41656C2F57813B210C27AA0360" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer contract payment terms</link:label>
    <link:label id="lab_dxcm_ContractPaymentTermsNumberofDays_2CF5CF41656C2F57813B210C27AA0360_label_en-US" xlink:label="lab_dxcm_ContractPaymentTermsNumberofDays_2CF5CF41656C2F57813B210C27AA0360" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract Payment Terms, Number of Days</link:label>
    <link:label id="lab_dxcm_ContractPaymentTermsNumberofDays_2CF5CF41656C2F57813B210C27AA0360_documentation_en-US" xlink:label="lab_dxcm_ContractPaymentTermsNumberofDays_2CF5CF41656C2F57813B210C27AA0360" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract Payment Terms, Number of Days</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ContractPaymentTermsNumberofDays" xlink:label="loc_dxcm_ContractPaymentTermsNumberofDays_2CF5CF41656C2F57813B210C27AA0360" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ContractPaymentTermsNumberofDays_2CF5CF41656C2F57813B210C27AA0360" xlink:to="lab_dxcm_ContractPaymentTermsNumberofDays_2CF5CF41656C2F57813B210C27AA0360" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_FF67FF4B0FD246689C4A210C27AAD6BB_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable_FF67FF4B0FD246689C4A210C27AAD6BB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unbilled accounts receivable</link:label>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_FF67FF4B0FD246689C4A210C27AAD6BB_label_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable_FF67FF4B0FD246689C4A210C27AAD6BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnbilledContractsReceivable" xlink:label="loc_us-gaap_UnbilledContractsReceivable_FF67FF4B0FD246689C4A210C27AAD6BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledContractsReceivable_FF67FF4B0FD246689C4A210C27AAD6BB" xlink:to="lab_us-gaap_UnbilledContractsReceivable_FF67FF4B0FD246689C4A210C27AAD6BB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_BA1790FF86E0FC9C8191210C27AAC639_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_BA1790FF86E0FC9C8191210C27AAC639" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue that will be satisfied after 12 months</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_BA1790FF86E0FC9C8191210C27AAC639_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_BA1790FF86E0FC9C8191210C27AAC639" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_BA1790FF86E0FC9C8191210C27AAC639" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_BA1790FF86E0FC9C8191210C27AAC639" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_BA1790FF86E0FC9C8191210C27AAC639" xlink:type="arc" />
    <link:label id="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts_12E484D978A07C4F9FEB210C27ABCA04_terseLabel_en-US" xlink:label="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts_12E484D978A07C4F9FEB210C27ABCA04" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization period for incentive compensation costs</link:label>
    <link:label id="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts_12E484D978A07C4F9FEB210C27ABCA04_label_en-US" xlink:label="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts_12E484D978A07C4F9FEB210C27ABCA04" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization Period For Incentive Compensation Costs</link:label>
    <link:label id="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts_12E484D978A07C4F9FEB210C27ABCA04_documentation_en-US" xlink:label="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts_12E484D978A07C4F9FEB210C27ABCA04" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amortization Period For Incentive Compensation Costs</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_AmortizationPeriodForIncentiveCompensationCosts" xlink:label="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts_12E484D978A07C4F9FEB210C27ABCA04" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts_12E484D978A07C4F9FEB210C27ABCA04" xlink:to="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts_12E484D978A07C4F9FEB210C27ABCA04" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdvertisingExpense_B2D38096741135326930210C27AB6BFB_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense_B2D38096741135326930210C27AB6BFB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_B2D38096741135326930210C27AB6BFB_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense_B2D38096741135326930210C27AB6BFB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaap_AdvertisingExpense_B2D38096741135326930210C27AB6BFB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense_B2D38096741135326930210C27AB6BFB" xlink:to="lab_us-gaap_AdvertisingExpense_B2D38096741135326930210C27AB6BFB" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_5A8E9B32969997BF46A61BEB0E9429BE_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_5A8E9B32969997BF46A61BEB0E9429BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_5A8E9B32969997BF46A61BEB0E9429BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5A8E9B32969997BF46A61BEB0E9429BE" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_5A8E9B32969997BF46A61BEB0E9429BE" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_656B4E5602E2D50171481BEB0E959271_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_656B4E5602E2D50171481BEB0E959271" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_656B4E5602E2D50171481BEB0E959271_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_656B4E5602E2D50171481BEB0E959271" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_656B4E5602E2D50171481BEB0E959271" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_656B4E5602E2D50171481BEB0E959271" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_656B4E5602E2D50171481BEB0E959271" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7FA35CFF68DD38C53EFE1BEB0E9AB07D_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7FA35CFF68DD38C53EFE1BEB0E9AB07D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net income (loss) to cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7FA35CFF68DD38C53EFE1BEB0E9AB07D_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7FA35CFF68DD38C53EFE1BEB0E9AB07D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7FA35CFF68DD38C53EFE1BEB0E9AB07D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7FA35CFF68DD38C53EFE1BEB0E9AB07D" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7FA35CFF68DD38C53EFE1BEB0E9AB07D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_9EAB597D7D20ED4710BC1BEB0E9ADBA0_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_9EAB597D7D20ED4710BC1BEB0E9ADBA0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_9EAB597D7D20ED4710BC1BEB0E9ADBA0_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_9EAB597D7D20ED4710BC1BEB0E9ADBA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9EAB597D7D20ED4710BC1BEB0E9ADBA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_9EAB597D7D20ED4710BC1BEB0E9ADBA0" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization_9EAB597D7D20ED4710BC1BEB0E9ADBA0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensation_FDC5B81F8E97EAABB8CA1BEB0E9CEF95_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_FDC5B81F8E97EAABB8CA1BEB0E9CEF95" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_FDC5B81F8E97EAABB8CA1BEB0E9CEF95_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_FDC5B81F8E97EAABB8CA1BEB0E9CEF95" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_FDC5B81F8E97EAABB8CA1BEB0E9CEF95" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_FDC5B81F8E97EAABB8CA1BEB0E9CEF95" xlink:to="lab_us-gaap_ShareBasedCompensation_FDC5B81F8E97EAABB8CA1BEB0E9CEF95" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_57D3803244910D874E111BEB0E9CD69C_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium_57D3803244910D874E111BEB0E9CD69C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_57D3803244910D874E111BEB0E9CD69C_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium_57D3803244910D874E111BEB0E9CD69C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_57D3803244910D874E111BEB0E9CD69C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium_57D3803244910D874E111BEB0E9CD69C" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium_57D3803244910D874E111BEB0E9CD69C" xlink:type="arc" />
    <link:label id="lab_dxcm_RDexpensethroughissuanceofcommonstock_BF3928AEF074C668D78F1BEB0E9C0CC0_terseLabel_en-US" xlink:label="lab_dxcm_RDexpensethroughissuanceofcommonstock_BF3928AEF074C668D78F1BEB0E9C0CC0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash collaborative research and development fee through issuance of common stock</link:label>
    <link:label id="lab_dxcm_RDexpensethroughissuanceofcommonstock_BF3928AEF074C668D78F1BEB0E9C0CC0_label_en-US" xlink:label="lab_dxcm_RDexpensethroughissuanceofcommonstock_BF3928AEF074C668D78F1BEB0E9C0CC0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">R&amp;D expense through issuance of common stock</link:label>
    <link:label id="lab_dxcm_RDexpensethroughissuanceofcommonstock_BF3928AEF074C668D78F1BEB0E9C0CC0_documentation_en-US" xlink:label="lab_dxcm_RDexpensethroughissuanceofcommonstock_BF3928AEF074C668D78F1BEB0E9C0CC0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-cash R&amp;D expense through issuance of common stock</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_RDexpensethroughissuanceofcommonstock" xlink:label="loc_dxcm_RDexpensethroughissuanceofcommonstock_BF3928AEF074C668D78F1BEB0E9C0CC0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RDexpensethroughissuanceofcommonstock_BF3928AEF074C668D78F1BEB0E9C0CC0" xlink:to="lab_dxcm_RDexpensethroughissuanceofcommonstock_BF3928AEF074C668D78F1BEB0E9C0CC0" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_6821F871758B2EB3296A1BEB0E9CABE7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments_6821F871758B2EB3296A1BEB0E9CABE7" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain on equity investment</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_6821F871758B2EB3296A1BEB0E9CABE7_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments_6821F871758B2EB3296A1BEB0E9CABE7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_6821F871758B2EB3296A1BEB0E9CABE7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments_6821F871758B2EB3296A1BEB0E9CABE7" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments_6821F871758B2EB3296A1BEB0E9CABE7" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_8FEF7A8594D0FBA697001BEB0E9DE77C_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_8FEF7A8594D0FBA697001BEB0E9DE77C" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Realized (gain) loss on equity investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_8FEF7A8594D0FBA697001BEB0E9DE77C_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_8FEF7A8594D0FBA697001BEB0E9DE77C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_8FEF7A8594D0FBA697001BEB0E9DE77C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_8FEF7A8594D0FBA697001BEB0E9DE77C" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_8FEF7A8594D0FBA697001BEB0E9DE77C" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_3BFBAD70CDFD172F28F41BEB0E9D4574_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense_3BFBAD70CDFD172F28F41BEB0E9D4574" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other non-cash income and expenses</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_3BFBAD70CDFD172F28F41BEB0E9D4574_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense_3BFBAD70CDFD172F28F41BEB0E9D4574" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_3BFBAD70CDFD172F28F41BEB0E9D4574" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense_3BFBAD70CDFD172F28F41BEB0E9D4574" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense_3BFBAD70CDFD172F28F41BEB0E9D4574" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_449571C065CA212B98B81BEB0E9D389E_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_449571C065CA212B98B81BEB0E9D389E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_449571C065CA212B98B81BEB0E9D389E_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_449571C065CA212B98B81BEB0E9D389E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_449571C065CA212B98B81BEB0E9D389E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_449571C065CA212B98B81BEB0E9D389E" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_449571C065CA212B98B81BEB0E9D389E" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_1F5EB2E2DB4930D5E9831BEB0E9D41CF_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_1F5EB2E2DB4930D5E9831BEB0E9D41CF" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_1F5EB2E2DB4930D5E9831BEB0E9D41CF_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_1F5EB2E2DB4930D5E9831BEB0E9D41CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1F5EB2E2DB4930D5E9831BEB0E9D41CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1F5EB2E2DB4930D5E9831BEB0E9D41CF" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_1F5EB2E2DB4930D5E9831BEB0E9D41CF" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_183BC861A95D64DD0D7B1BEB0E9D121B_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_183BC861A95D64DD0D7B1BEB0E9D121B" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_183BC861A95D64DD0D7B1BEB0E9D121B_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_183BC861A95D64DD0D7B1BEB0E9D121B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_183BC861A95D64DD0D7B1BEB0E9D121B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories_183BC861A95D64DD0D7B1BEB0E9D121B" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories_183BC861A95D64DD0D7B1BEB0E9D121B" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_449448BA9C2DF7861C891BEB0E9DD4B2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_449448BA9C2DF7861C891BEB0E9DD4B2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_449448BA9C2DF7861C891BEB0E9DD4B2_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_449448BA9C2DF7861C891BEB0E9DD4B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_449448BA9C2DF7861C891BEB0E9DD4B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_449448BA9C2DF7861C891BEB0E9DD4B2" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_449448BA9C2DF7861C891BEB0E9DD4B2" xlink:type="arc" />
    <link:label id="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_97984C4CFCB3F0B5C8DE1BEB0E9E65A0_negatedLabel_en-US" xlink:label="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_97984C4CFCB3F0B5C8DE1BEB0E9E65A0" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets and liabilities, net</link:label>
    <link:label id="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_97984C4CFCB3F0B5C8DE1BEB0E9E65A0_label_en-US" xlink:label="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_97984C4CFCB3F0B5C8DE1BEB0E9E65A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Assets and Liabilities, Net</link:label>
    <link:label id="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_97984C4CFCB3F0B5C8DE1BEB0E9E65A0_documentation_en-US" xlink:label="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_97984C4CFCB3F0B5C8DE1BEB0E9E65A0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Assets and Liabilities, Net</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:label="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_97984C4CFCB3F0B5C8DE1BEB0E9E65A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_97984C4CFCB3F0B5C8DE1BEB0E9E65A0" xlink:to="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_97984C4CFCB3F0B5C8DE1BEB0E9E65A0" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4B1B3A5B2C36F662409A1BEB0E9E80DF_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4B1B3A5B2C36F662409A1BEB0E9E80DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4B1B3A5B2C36F662409A1BEB0E9E80DF_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4B1B3A5B2C36F662409A1BEB0E9E80DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4B1B3A5B2C36F662409A1BEB0E9E80DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4B1B3A5B2C36F662409A1BEB0E9E80DF" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4B1B3A5B2C36F662409A1BEB0E9E80DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_F4BC0D1EFB6872DDF1DF1BEB0E9EE510_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_F4BC0D1EFB6872DDF1DF1BEB0E9EE510" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_F4BC0D1EFB6872DDF1DF1BEB0E9EE510_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_F4BC0D1EFB6872DDF1DF1BEB0E9EE510" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_F4BC0D1EFB6872DDF1DF1BEB0E9EE510" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_F4BC0D1EFB6872DDF1DF1BEB0E9EE510" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_F4BC0D1EFB6872DDF1DF1BEB0E9EE510" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability_3128F6253CEBAB86146E1BEB0E9EC6EC_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability_3128F6253CEBAB86146E1BEB0E9EC6EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue, deferred rent and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability_3128F6253CEBAB86146E1BEB0E9EC6EC_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability_3128F6253CEBAB86146E1BEB0E9EC6EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Deferred Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_3128F6253CEBAB86146E1BEB0E9EC6EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_3128F6253CEBAB86146E1BEB0E9EC6EC" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability_3128F6253CEBAB86146E1BEB0E9EC6EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_78AB7258C7B1FCE361A21BEB0E9EDB23_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_78AB7258C7B1FCE361A21BEB0E9EDB23" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_78AB7258C7B1FCE361A21BEB0E9EDB23_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_78AB7258C7B1FCE361A21BEB0E9EDB23" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78AB7258C7B1FCE361A21BEB0E9EDB23" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78AB7258C7B1FCE361A21BEB0E9EDB23" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_78AB7258C7B1FCE361A21BEB0E9EDB23" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_CBC9D0D123E5ECB8CA461BEB0E9E2CEB_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_CBC9D0D123E5ECB8CA461BEB0E9E2CEB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_CBC9D0D123E5ECB8CA461BEB0E9E2CEB_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_CBC9D0D123E5ECB8CA461BEB0E9E2CEB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_CBC9D0D123E5ECB8CA461BEB0E9E2CEB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_CBC9D0D123E5ECB8CA461BEB0E9E2CEB" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_CBC9D0D123E5ECB8CA461BEB0E9E2CEB" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_38E7CE86E116B780445F1BEB0E9F2B1E_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_38E7CE86E116B780445F1BEB0E9F2B1E" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_38E7CE86E116B780445F1BEB0E9F2B1E_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_38E7CE86E116B780445F1BEB0E9F2B1E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_38E7CE86E116B780445F1BEB0E9F2B1E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_38E7CE86E116B780445F1BEB0E9F2B1E" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_38E7CE86E116B780445F1BEB0E9F2B1E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_480EA09A5CC61B45C7A31BEB0E9F9287_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_480EA09A5CC61B45C7A31BEB0E9F9287" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale and maturity of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_480EA09A5CC61B45C7A31BEB0E9F9287_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_480EA09A5CC61B45C7A31BEB0E9F9287" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_480EA09A5CC61B45C7A31BEB0E9F9287" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_480EA09A5CC61B45C7A31BEB0E9F9287" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_480EA09A5CC61B45C7A31BEB0E9F9287" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_B72A51A1AEA9D79E5E131BEB0E9F68A9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments_B72A51A1AEA9D79E5E131BEB0E9F68A9" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of other equity investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_B72A51A1AEA9D79E5E131BEB0E9F68A9_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments_B72A51A1AEA9D79E5E131BEB0E9F68A9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_B72A51A1AEA9D79E5E131BEB0E9F68A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherInvestments_B72A51A1AEA9D79E5E131BEB0E9F68A9" xlink:to="lab_us-gaap_PaymentsToAcquireOtherInvestments_B72A51A1AEA9D79E5E131BEB0E9F68A9" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_97A74FDA51324AF46AC51BEB0E9F22AB_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_97A74FDA51324AF46AC51BEB0E9F22AB" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_97A74FDA51324AF46AC51BEB0E9F22AB_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_97A74FDA51324AF46AC51BEB0E9F22AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_97A74FDA51324AF46AC51BEB0E9F22AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_97A74FDA51324AF46AC51BEB0E9F22AB" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_97A74FDA51324AF46AC51BEB0E9F22AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D65992FC880870D6B4601BEB0E9F6ABE_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D65992FC880870D6B4601BEB0E9F6ABE" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D65992FC880870D6B4601BEB0E9F6ABE_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D65992FC880870D6B4601BEB0E9F6ABE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D65992FC880870D6B4601BEB0E9F6ABE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D65992FC880870D6B4601BEB0E9F6ABE" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D65992FC880870D6B4601BEB0E9F6ABE" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_F2667A0C7A3360FD68EC1BEB0EA0B938_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_F2667A0C7A3360FD68EC1BEB0EA0B938" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_F2667A0C7A3360FD68EC1BEB0EA0B938_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_F2667A0C7A3360FD68EC1BEB0EA0B938" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_F2667A0C7A3360FD68EC1BEB0EA0B938" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_F2667A0C7A3360FD68EC1BEB0EA0B938" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_F2667A0C7A3360FD68EC1BEB0EA0B938" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_5A4659E98751E710DCAC1BEB0EA0B6E3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_5A4659E98751E710DCAC1BEB0EA0B6E3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_5A4659E98751E710DCAC1BEB0EA0B6E3_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_5A4659E98751E710DCAC1BEB0EA0B6E3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5A4659E98751E710DCAC1BEB0EA0B6E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5A4659E98751E710DCAC1BEB0EA0B6E3" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_5A4659E98751E710DCAC1BEB0EA0B6E3" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_92DBE6EC446FFA85C5541BEB0EA01264_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_92DBE6EC446FFA85C5541BEB0EA01264" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_92DBE6EC446FFA85C5541BEB0EA01264_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_92DBE6EC446FFA85C5541BEB0EA01264" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_92DBE6EC446FFA85C5541BEB0EA01264" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_92DBE6EC446FFA85C5541BEB0EA01264" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_92DBE6EC446FFA85C5541BEB0EA01264" xlink:type="arc" />
    <link:label id="lab_dxcm_PurchaseofConvertibleNoteHedge_83F15716223DC72B54641BEB0EA11256_negatedTerseLabel_en-US" xlink:label="lab_dxcm_PurchaseofConvertibleNoteHedge_83F15716223DC72B54641BEB0EA11256" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of convertible note hedge</link:label>
    <link:label id="lab_dxcm_PurchaseofConvertibleNoteHedge_83F15716223DC72B54641BEB0EA11256_label_en-US" xlink:label="lab_dxcm_PurchaseofConvertibleNoteHedge_83F15716223DC72B54641BEB0EA11256" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of Convertible Note Hedge</link:label>
    <link:label id="lab_dxcm_PurchaseofConvertibleNoteHedge_83F15716223DC72B54641BEB0EA11256_documentation_en-US" xlink:label="lab_dxcm_PurchaseofConvertibleNoteHedge_83F15716223DC72B54641BEB0EA11256" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchase of Convertible Note Hedge</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PurchaseofConvertibleNoteHedge" xlink:label="loc_dxcm_PurchaseofConvertibleNoteHedge_83F15716223DC72B54641BEB0EA11256" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PurchaseofConvertibleNoteHedge_83F15716223DC72B54641BEB0EA11256" xlink:to="lab_dxcm_PurchaseofConvertibleNoteHedge_83F15716223DC72B54641BEB0EA11256" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_A21D05A572A6BCCA9E7B1BEB0EA1B861_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_A21D05A572A6BCCA9E7B1BEB0EA1B861" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_A21D05A572A6BCCA9E7B1BEB0EA1B861_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_A21D05A572A6BCCA9E7B1BEB0EA1B861" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_A21D05A572A6BCCA9E7B1BEB0EA1B861" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_A21D05A572A6BCCA9E7B1BEB0EA1B861" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_A21D05A572A6BCCA9E7B1BEB0EA1B861" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_8DA4F39481BC4E65CF3F1BEB0EA19FA9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_8DA4F39481BC4E65CF3F1BEB0EA19FA9" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayment of short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_8DA4F39481BC4E65CF3F1BEB0EA19FA9_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_8DA4F39481BC4E65CF3F1BEB0EA19FA9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-term Lines of Credit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_8DA4F39481BC4E65CF3F1BEB0EA19FA9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_8DA4F39481BC4E65CF3F1BEB0EA19FA9" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_8DA4F39481BC4E65CF3F1BEB0EA19FA9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A29F78BD74536C4533EE1BEB0EA1AB88_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A29F78BD74536C4533EE1BEB0EA1AB88" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financing activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A29F78BD74536C4533EE1BEB0EA1AB88_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A29F78BD74536C4533EE1BEB0EA1AB88" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A29F78BD74536C4533EE1BEB0EA1AB88" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A29F78BD74536C4533EE1BEB0EA1AB88" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A29F78BD74536C4533EE1BEB0EA1AB88" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_4FF6C5745BAAF62B102A1BEB0EA25015_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_4FF6C5745BAAF62B102A1BEB0EA25015" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_4FF6C5745BAAF62B102A1BEB0EA25015_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_4FF6C5745BAAF62B102A1BEB0EA25015" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4FF6C5745BAAF62B102A1BEB0EA25015" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4FF6C5745BAAF62B102A1BEB0EA25015" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_4FF6C5745BAAF62B102A1BEB0EA25015" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_88FA26DCE0D66E5F847C1BEB0EA228C7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_88FA26DCE0D66E5F847C1BEB0EA228C7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_88FA26DCE0D66E5F847C1BEB0EA228C7_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_88FA26DCE0D66E5F847C1BEB0EA228C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_88FA26DCE0D66E5F847C1BEB0EA228C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_88FA26DCE0D66E5F847C1BEB0EA228C7" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_88FA26DCE0D66E5F847C1BEB0EA228C7" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_C8C2F03753F85D0AB2941BEB0EA2E6C6_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_C8C2F03753F85D0AB2941BEB0EA2E6C6" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_C8C2F03753F85D0AB2941BEB0EA2E6C6_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_C8C2F03753F85D0AB2941BEB0EA2E6C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_C8C2F03753F85D0AB2941BEB0EA2E6C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_C8C2F03753F85D0AB2941BEB0EA2E6C6" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_C8C2F03753F85D0AB2941BEB0EA2E6C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_22548E4F179028E88EE71BEB0EA29C00_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_22548E4F179028E88EE71BEB0EA29C00" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_22548E4F179028E88EE71BEB0EA29C00_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_22548E4F179028E88EE71BEB0EA29C00" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_22548E4F179028E88EE71BEB0EA29C00" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_22548E4F179028E88EE71BEB0EA29C00" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_22548E4F179028E88EE71BEB0EA29C00" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_48946A44560955A008F31BEB0EA26CF4_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_48946A44560955A008F31BEB0EA26CF4" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_48946A44560955A008F31BEB0EA26CF4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_48946A44560955A008F31BEB0EA26CF4" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_48946A44560955A008F31BEB0EA26CF4" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_21ADD1202CD72F7BF5A31BEB0EA267A1_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_21ADD1202CD72F7BF5A31BEB0EA267A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of cash, cash equivalents and restricted cash, end of period:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_21ADD1202CD72F7BF5A31BEB0EA267A1_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_21ADD1202CD72F7BF5A31BEB0EA267A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_21ADD1202CD72F7BF5A31BEB0EA267A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_21ADD1202CD72F7BF5A31BEB0EA267A1" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_21ADD1202CD72F7BF5A31BEB0EA267A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3E6A0E3679503ACE3E4F1BEB0EA35569_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3E6A0E3679503ACE3E4F1BEB0EA35569" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3E6A0E3679503ACE3E4F1BEB0EA35569" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3E6A0E3679503ACE3E4F1BEB0EA35569" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3E6A0E3679503ACE3E4F1BEB0EA35569" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedCash_F6D5CEE11E601A7344B91BEB0EA3B82B_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash_F6D5CEE11E601A7344B91BEB0EA3B82B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_F6D5CEE11E601A7344B91BEB0EA3B82B_label_en-US" xlink:label="lab_us-gaap_RestrictedCash_F6D5CEE11E601A7344B91BEB0EA3B82B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaap_RestrictedCash_F6D5CEE11E601A7344B91BEB0EA3B82B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash_F6D5CEE11E601A7344B91BEB0EA3B82B" xlink:to="lab_us-gaap_RestrictedCash_F6D5CEE11E601A7344B91BEB0EA3B82B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_253830DC0581297076431BEB0EA372BC_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_253830DC0581297076431BEB0EA372BC" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_253830DC0581297076431BEB0EA372BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_253830DC0581297076431BEB0EA372BC" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_253830DC0581297076431BEB0EA372BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_12348D40AF0E275788F51BEB0EA35B1C_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_12348D40AF0E275788F51BEB0EA35B1C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing transactions:</link:label>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_12348D40AF0E275788F51BEB0EA35B1C_label_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_12348D40AF0E275788F51BEB0EA35B1C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_12348D40AF0E275788F51BEB0EA35B1C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_12348D40AF0E275788F51BEB0EA35B1C" xlink:to="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_12348D40AF0E275788F51BEB0EA35B1C" xlink:type="arc" />
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_20663C4C55C72BE6D9781BEB0EA9B2D6_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_20663C4C55C72BE6D9781BEB0EA9B2D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition of property and equipment included in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_20663C4C55C72BE6D9781BEB0EA9B2D6_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_20663C4C55C72BE6D9781BEB0EA9B2D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash or Part Noncash Acquisition, Fixed Assets Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_20663C4C55C72BE6D9781BEB0EA9B2D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_20663C4C55C72BE6D9781BEB0EA9B2D6" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_20663C4C55C72BE6D9781BEB0EA9B2D6" xlink:type="arc" />
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_4CCCC01D79896ACDC4761BEB0EA9B69C_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract_4CCCC01D79896ACDC4761BEB0EA9B69C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_4CCCC01D79896ACDC4761BEB0EA9B69C_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract_4CCCC01D79896ACDC4761BEB0EA9B69C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_4CCCC01D79896ACDC4761BEB0EA9B69C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4CCCC01D79896ACDC4761BEB0EA9B69C" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract_4CCCC01D79896ACDC4761BEB0EA9B69C" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestPaidNet_6C8D202BFCB49A428AD31BEB0EA92F24_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet_6C8D202BFCB49A428AD31BEB0EA92F24" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid during the year for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_6C8D202BFCB49A428AD31BEB0EA92F24_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet_6C8D202BFCB49A428AD31BEB0EA92F24" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_6C8D202BFCB49A428AD31BEB0EA92F24" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet_6C8D202BFCB49A428AD31BEB0EA92F24" xlink:to="lab_us-gaap_InterestPaidNet_6C8D202BFCB49A428AD31BEB0EA92F24" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxesPaid_0460ECAA9F038DFDCDC61BEB0EAA6D43_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid_0460ECAA9F038DFDCDC61BEB0EAA6D43" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid during the year for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_0460ECAA9F038DFDCDC61BEB0EAA6D43_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid_0460ECAA9F038DFDCDC61BEB0EAA6D43" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_0460ECAA9F038DFDCDC61BEB0EAA6D43" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid_0460ECAA9F038DFDCDC61BEB0EAA6D43" xlink:to="lab_us-gaap_IncomeTaxesPaid_0460ECAA9F038DFDCDC61BEB0EAA6D43" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_99C0DCA227AED8AEC9E7C9C4B94ACFC1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization_99C0DCA227AED8AEC9E7C9C4B94ACFC1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contractual coupon interest</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_99C0DCA227AED8AEC9E7C9C4B94ACFC1_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization_99C0DCA227AED8AEC9E7C9C4B94ACFC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_99C0DCA227AED8AEC9E7C9C4B94ACFC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization_99C0DCA227AED8AEC9E7C9C4B94ACFC1" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization_99C0DCA227AED8AEC9E7C9C4B94ACFC1" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_A62EF4B4845C609CAA44C9C4B94B87CE_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium_A62EF4B4845C609CAA44C9C4B94B87CE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accretion of debt discount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_A62EF4B4845C609CAA44C9C4B94B87CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium_A62EF4B4845C609CAA44C9C4B94B87CE" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium_A62EF4B4845C609CAA44C9C4B94B87CE" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_40A4979A772C35BE080DC9C4B94BF759_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts_40A4979A772C35BE080DC9C4B94BF759" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_40A4979A772C35BE080DC9C4B94BF759_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts_40A4979A772C35BE080DC9C4B94BF759" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_40A4979A772C35BE080DC9C4B94BF759" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts_40A4979A772C35BE080DC9C4B94BF759" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts_40A4979A772C35BE080DC9C4B94BF759" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpenseDebt_8E017CB7C760638B5B0DC9C4B94B8EE3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt_8E017CB7C760638B5B0DC9C4B94B8EE3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total interest expense recognized on senior notes</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_8E017CB7C760638B5B0DC9C4B94B8EE3_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt_8E017CB7C760638B5B0DC9C4B94B8EE3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt_8E017CB7C760638B5B0DC9C4B94B8EE3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt_8E017CB7C760638B5B0DC9C4B94B8EE3" xlink:to="lab_us-gaap_InterestExpenseDebt_8E017CB7C760638B5B0DC9C4B94B8EE3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2189208E55CE5C59E7C7C9C4B94BD86A_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2189208E55CE5C59E7C7C9C4B94BD86A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2189208E55CE5C59E7C7C9C4B94BD86A_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2189208E55CE5C59E7C7C9C4B94BD86A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2189208E55CE5C59E7C7C9C4B94BD86A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2189208E55CE5C59E7C7C9C4B94BD86A" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2189208E55CE5C59E7C7C9C4B94BD86A" xlink:type="arc" />
    <link:label id="lab_us-gaap_NatureOfOperations_64EC5E6A3C2404FC1F2735240266B1D8_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations_64EC5E6A3C2404FC1F2735240266B1D8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization and Business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_64EC5E6A3C2404FC1F2735240266B1D8_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations_64EC5E6A3C2404FC1F2735240266B1D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_64EC5E6A3C2404FC1F2735240266B1D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations_64EC5E6A3C2404FC1F2735240266B1D8" xlink:to="lab_us-gaap_NatureOfOperations_64EC5E6A3C2404FC1F2735240266B1D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_B9785EF65E688D0D85E6352402665429_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_B9785EF65E688D0D85E6352402665429" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_B9785EF65E688D0D85E6352402665429_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_B9785EF65E688D0D85E6352402665429" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_B9785EF65E688D0D85E6352402665429" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_B9785EF65E688D0D85E6352402665429" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_B9785EF65E688D0D85E6352402665429" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_9CF3433D3854F27EFE9635240266D858_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock_9CF3433D3854F27EFE9635240266D858" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_9CF3433D3854F27EFE9635240266D858_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock_9CF3433D3854F27EFE9635240266D858" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_9CF3433D3854F27EFE9635240266D858" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock_9CF3433D3854F27EFE9635240266D858" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock_9CF3433D3854F27EFE9635240266D858" xlink:type="arc" />
    <link:label id="lab_us-gaap_UseOfEstimates_ADBAC8BD38C0B2B81C8035240266FFCB_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates_ADBAC8BD38C0B2B81C8035240266FFCB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_ADBAC8BD38C0B2B81C8035240266FFCB_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates_ADBAC8BD38C0B2B81C8035240266FFCB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_ADBAC8BD38C0B2B81C8035240266FFCB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates_ADBAC8BD38C0B2B81C8035240266FFCB" xlink:to="lab_us-gaap_UseOfEstimates_ADBAC8BD38C0B2B81C8035240266FFCB" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_6DF5A8D8A2151B4B43F735240266DB15_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_6DF5A8D8A2151B4B43F735240266DB15" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_6DF5A8D8A2151B4B43F735240266DB15_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_6DF5A8D8A2151B4B43F735240266DB15" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_6DF5A8D8A2151B4B43F735240266DB15" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_6DF5A8D8A2151B4B43F735240266DB15" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_6DF5A8D8A2151B4B43F735240266DB15" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_C07DB6A4BFA760F3D60235240267A610_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_C07DB6A4BFA760F3D60235240267A610" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_C07DB6A4BFA760F3D60235240267A610_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_C07DB6A4BFA760F3D60235240267A610" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_C07DB6A4BFA760F3D60235240267A610" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_C07DB6A4BFA760F3D60235240267A610" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_C07DB6A4BFA760F3D60235240267A610" xlink:type="arc" />
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_21DDDC716C9ACF21ACDC352402679982_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy_21DDDC716C9ACF21ACDC352402679982" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_21DDDC716C9ACF21ACDC352402679982_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy_21DDDC716C9ACF21ACDC352402679982" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_21DDDC716C9ACF21ACDC352402679982" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy_21DDDC716C9ACF21ACDC352402679982" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy_21DDDC716C9ACF21ACDC352402679982" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_A4E4D9BA15B1D007A60B352402675C37_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock_A4E4D9BA15B1D007A60B352402675C37" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivables and Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_A4E4D9BA15B1D007A60B352402675C37_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock_A4E4D9BA15B1D007A60B352402675C37" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_A4E4D9BA15B1D007A60B352402675C37" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock_A4E4D9BA15B1D007A60B352402675C37" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock_A4E4D9BA15B1D007A60B352402675C37" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_6CB63DC8CBE9AFF5E1B2352402676123_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk_6CB63DC8CBE9AFF5E1B2352402676123" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration of Credit Risk and Significant Customers</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_6CB63DC8CBE9AFF5E1B2352402676123_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk_6CB63DC8CBE9AFF5E1B2352402676123" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_6CB63DC8CBE9AFF5E1B2352402676123" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk_6CB63DC8CBE9AFF5E1B2352402676123" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk_6CB63DC8CBE9AFF5E1B2352402676123" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_4792018E2B364731DAF83524026754FD_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock_4792018E2B364731DAF83524026754FD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_4792018E2B364731DAF83524026754FD_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock_4792018E2B364731DAF83524026754FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_4792018E2B364731DAF83524026754FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock_4792018E2B364731DAF83524026754FD" xlink:to="lab_us-gaap_InventoryPolicyTextBlock_4792018E2B364731DAF83524026754FD" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2FD59A73DDD32476440A352402679B6D_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2FD59A73DDD32476440A352402679B6D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2FD59A73DDD32476440A352402679B6D_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2FD59A73DDD32476440A352402679B6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2FD59A73DDD32476440A352402679B6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2FD59A73DDD32476440A352402679B6D" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2FD59A73DDD32476440A352402679B6D" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_3E533EEB78AC2D8A8FDC352402687E11_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_3E533EEB78AC2D8A8FDC352402687E11" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets and Other Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_3E533EEB78AC2D8A8FDC352402687E11_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_3E533EEB78AC2D8A8FDC352402687E11" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_3E533EEB78AC2D8A8FDC352402687E11" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_3E533EEB78AC2D8A8FDC352402687E11" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_3E533EEB78AC2D8A8FDC352402687E11" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_2895B63588F3DE3A40BE3524026880C5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock_2895B63588F3DE3A40BE3524026880C5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_2895B63588F3DE3A40BE3524026880C5_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock_2895B63588F3DE3A40BE3524026880C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_2895B63588F3DE3A40BE3524026880C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock_2895B63588F3DE3A40BE3524026880C5" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock_2895B63588F3DE3A40BE3524026880C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_8C40043D3B8FBF3E47BD35240268CE27_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy_8C40043D3B8FBF3E47BD35240268CE27" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warranty Accrual</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_8C40043D3B8FBF3E47BD35240268CE27_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy_8C40043D3B8FBF3E47BD35240268CE27" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_8C40043D3B8FBF3E47BD35240268CE27" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyPolicy_8C40043D3B8FBF3E47BD35240268CE27" xlink:to="lab_us-gaap_StandardProductWarrantyPolicy_8C40043D3B8FBF3E47BD35240268CE27" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_26552C4BA03C7E0583243524026974CE_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_26552C4BA03C7E0583243524026974CE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_26552C4BA03C7E0583243524026974CE_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_26552C4BA03C7E0583243524026974CE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_26552C4BA03C7E0583243524026974CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_26552C4BA03C7E0583243524026974CE" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_26552C4BA03C7E0583243524026974CE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_2F3265774B90594C1F9A3524026953AC_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_2F3265774B90594C1F9A3524026953AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_2F3265774B90594C1F9A3524026953AC_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_2F3265774B90594C1F9A3524026953AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_2F3265774B90594C1F9A3524026953AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_2F3265774B90594C1F9A3524026953AC" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_2F3265774B90594C1F9A3524026953AC" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7BEDE31FF5D483CAAEF7352402696612_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7BEDE31FF5D483CAAEF7352402696612" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7BEDE31FF5D483CAAEF7352402696612_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7BEDE31FF5D483CAAEF7352402696612" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7BEDE31FF5D483CAAEF7352402696612" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7BEDE31FF5D483CAAEF7352402696612" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7BEDE31FF5D483CAAEF7352402696612" xlink:type="arc" />
    <link:label id="lab_dxcm_ProductShipmentCostsPolicyTextBlock_3F21C4655F603624853C3541B43B8D38_terseLabel_en-US" xlink:label="lab_dxcm_ProductShipmentCostsPolicyTextBlock_3F21C4655F603624853C3541B43B8D38" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Shipment Costs</link:label>
    <link:label id="lab_dxcm_ProductShipmentCostsPolicyTextBlock_3F21C4655F603624853C3541B43B8D38_label_en-US" xlink:label="lab_dxcm_ProductShipmentCostsPolicyTextBlock_3F21C4655F603624853C3541B43B8D38" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Shipment Costs [Policy Text Block]</link:label>
    <link:label id="lab_dxcm_ProductShipmentCostsPolicyTextBlock_3F21C4655F603624853C3541B43B8D38_documentation_en-US" xlink:label="lab_dxcm_ProductShipmentCostsPolicyTextBlock_3F21C4655F603624853C3541B43B8D38" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Product Shipment Costs [Policy Text Block]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ProductShipmentCostsPolicyTextBlock" xlink:label="loc_dxcm_ProductShipmentCostsPolicyTextBlock_3F21C4655F603624853C3541B43B8D38" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ProductShipmentCostsPolicyTextBlock_3F21C4655F603624853C3541B43B8D38" xlink:to="lab_dxcm_ProductShipmentCostsPolicyTextBlock_3F21C4655F603624853C3541B43B8D38" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_676C11F43ED6EC2117BE3524026A7E2F_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_676C11F43ED6EC2117BE3524026A7E2F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_676C11F43ED6EC2117BE3524026A7E2F_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_676C11F43ED6EC2117BE3524026A7E2F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_676C11F43ED6EC2117BE3524026A7E2F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_676C11F43ED6EC2117BE3524026A7E2F" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_676C11F43ED6EC2117BE3524026A7E2F" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_DB10D73FDFCD647F4E6A3524026ADC5F_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock_DB10D73FDFCD647F4E6A3524026ADC5F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_DB10D73FDFCD647F4E6A3524026ADC5F_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock_DB10D73FDFCD647F4E6A3524026ADC5F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_DB10D73FDFCD647F4E6A3524026ADC5F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock_DB10D73FDFCD647F4E6A3524026ADC5F" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock_DB10D73FDFCD647F4E6A3524026ADC5F" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_774E5A590C18282348FA3524026ADD95_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock_774E5A590C18282348FA3524026ADD95" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_774E5A590C18282348FA3524026ADD95_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock_774E5A590C18282348FA3524026ADD95" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_774E5A590C18282348FA3524026ADD95" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock_774E5A590C18282348FA3524026ADD95" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock_774E5A590C18282348FA3524026ADD95" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ECBADF28E14AA58F98D93524026AD230_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ECBADF28E14AA58F98D93524026AD230" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ECBADF28E14AA58F98D93524026AD230_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ECBADF28E14AA58F98D93524026AD230" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ECBADF28E14AA58F98D93524026AD230" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ECBADF28E14AA58F98D93524026AD230" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ECBADF28E14AA58F98D93524026AD230" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_C054450FF8D8482B20583524026B2AF9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock_C054450FF8D8482B20583524026B2AF9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_C054450FF8D8482B20583524026B2AF9_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock_C054450FF8D8482B20583524026B2AF9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_C054450FF8D8482B20583524026B2AF9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock_C054450FF8D8482B20583524026B2AF9" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock_C054450FF8D8482B20583524026B2AF9" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_354FD2AC53A8F05A51AA3524026BAE0B_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_354FD2AC53A8F05A51AA3524026BAE0B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recent Accounting Guidance</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_354FD2AC53A8F05A51AA3524026BAE0B_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_354FD2AC53A8F05A51AA3524026BAE0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_354FD2AC53A8F05A51AA3524026BAE0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_354FD2AC53A8F05A51AA3524026BAE0B" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_354FD2AC53A8F05A51AA3524026BAE0B" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockMember_A8599E4749D00A359C9E1BEB0CE0F1E6_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember_A8599E4749D00A359C9E1BEB0CE0F1E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_A8599E4749D00A359C9E1BEB0CE0F1E6_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember_A8599E4749D00A359C9E1BEB0CE0F1E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_A8599E4749D00A359C9E1BEB0CE0F1E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember_A8599E4749D00A359C9E1BEB0CE0F1E6" xlink:to="lab_us-gaap_RestrictedStockMember_A8599E4749D00A359C9E1BEB0CE0F1E6" xlink:type="arc" />
    <link:label id="lab_dxcm_A401kPlanMember_E7E048A9BE4B586E8DBC1BF86DCA35B8_terseLabel_en-US" xlink:label="lab_dxcm_A401kPlanMember_E7E048A9BE4B586E8DBC1BF86DCA35B8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">401(k) Plan</link:label>
    <link:label id="lab_dxcm_A401kPlanMember_E7E048A9BE4B586E8DBC1BF86DCA35B8_label_en-US" xlink:label="lab_dxcm_A401kPlanMember_E7E048A9BE4B586E8DBC1BF86DCA35B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">401(k) Plan [Member]</link:label>
    <link:label id="lab_dxcm_A401kPlanMember_E7E048A9BE4B586E8DBC1BF86DCA35B8_documentation_en-US" xlink:label="lab_dxcm_A401kPlanMember_E7E048A9BE4B586E8DBC1BF86DCA35B8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">401(k) Plan [Member]</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_A401kPlanMember" xlink:label="loc_dxcm_A401kPlanMember_E7E048A9BE4B586E8DBC1BF86DCA35B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_A401kPlanMember_E7E048A9BE4B586E8DBC1BF86DCA35B8" xlink:to="lab_dxcm_A401kPlanMember_E7E048A9BE4B586E8DBC1BF86DCA35B8" xlink:type="arc" />
    <link:label id="lab_dxcm_EmployeeStockPurchasePlan2015Member_C1D03667F49283A4B6B11BF86DDC2602_terseLabel_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlan2015Member_C1D03667F49283A4B6B11BF86DDC2602" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan 2015</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlan2015Member_C1D03667F49283A4B6B11BF86DDC2602_label_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlan2015Member_C1D03667F49283A4B6B11BF86DDC2602" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan 2015 [Member]</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlan2015Member_C1D03667F49283A4B6B11BF86DDC2602_documentation_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlan2015Member_C1D03667F49283A4B6B11BF86DDC2602" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan 2015</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EmployeeStockPurchasePlan2015Member" xlink:label="loc_dxcm_EmployeeStockPurchasePlan2015Member_C1D03667F49283A4B6B11BF86DDC2602" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EmployeeStockPurchasePlan2015Member_C1D03667F49283A4B6B11BF86DDC2602" xlink:to="lab_dxcm_EmployeeStockPurchasePlan2015Member_C1D03667F49283A4B6B11BF86DDC2602" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_F82DD3F5D8E4A8D4F0431BEB0CE00DB4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_F82DD3F5D8E4A8D4F0431BEB0CE00DB4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum employee contribution (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_F82DD3F5D8E4A8D4F0431BEB0CE00DB4_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_F82DD3F5D8E4A8D4F0431BEB0CE00DB4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_F82DD3F5D8E4A8D4F0431BEB0CE00DB4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_F82DD3F5D8E4A8D4F0431BEB0CE00DB4" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_F82DD3F5D8E4A8D4F0431BEB0CE00DB4" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_C7A69CD49E53E13018941BEB0CE00E78_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_C7A69CD49E53E13018941BEB0CE00E78" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employer matching contribution (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_C7A69CD49E53E13018941BEB0CE00E78_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_C7A69CD49E53E13018941BEB0CE00E78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_C7A69CD49E53E13018941BEB0CE00E78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_C7A69CD49E53E13018941BEB0CE00E78" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_C7A69CD49E53E13018941BEB0CE00E78" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_69D25AB78201571E72941BEB0CE1FD40_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_69D25AB78201571E72941BEB0CE1FD40" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee contribution (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_69D25AB78201571E72941BEB0CE1FD40_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_69D25AB78201571E72941BEB0CE1FD40" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_69D25AB78201571E72941BEB0CE1FD40" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_69D25AB78201571E72941BEB0CE1FD40" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_69D25AB78201571E72941BEB0CE1FD40" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_E11854326B6E98AE21A11BEB0CE12936_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized_E11854326B6E98AE21A11BEB0CE12936" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total matching contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_E11854326B6E98AE21A11BEB0CE12936_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized_E11854326B6E98AE21A11BEB0CE12936" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_E11854326B6E98AE21A11BEB0CE12936" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized_E11854326B6E98AE21A11BEB0CE12936" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized_E11854326B6E98AE21A11BEB0CE12936" xlink:type="arc" />
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_26E57CEA383206A6E9CD1BEB0CE14959_terseLabel_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_26E57CEA383206A6E9CD1BEB0CE14959" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock authorized in ESPP (shares)</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_26E57CEA383206A6E9CD1BEB0CE14959_label_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_26E57CEA383206A6E9CD1BEB0CE14959" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan (ESPP), Number Of Shares Authorized</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_26E57CEA383206A6E9CD1BEB0CE14959_documentation_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_26E57CEA383206A6E9CD1BEB0CE14959" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan (ESPP), Number Of Shares Authorized</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" xlink:label="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_26E57CEA383206A6E9CD1BEB0CE14959" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_26E57CEA383206A6E9CD1BEB0CE14959" xlink:to="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_26E57CEA383206A6E9CD1BEB0CE14959" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_41890B1D03ECFAC578631BEB0CE1B4A8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_41890B1D03ECFAC578631BEB0CE1B4A8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum payroll deductions (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_41890B1D03ECFAC578631BEB0CE1B4A8_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_41890B1D03ECFAC578631BEB0CE1B4A8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_41890B1D03ECFAC578631BEB0CE1B4A8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_41890B1D03ECFAC578631BEB0CE1B4A8" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_41890B1D03ECFAC578631BEB0CE1B4A8" xlink:type="arc" />
    <link:label id="lab_dxcm_EmployeePurchasePriceFloorPercentage_09D7A4C2458B069146971BEB0CE16C3F_terseLabel_en-US" xlink:label="lab_dxcm_EmployeePurchasePriceFloorPercentage_09D7A4C2458B069146971BEB0CE16C3F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee purchase price floor (as a percent)</link:label>
    <link:label id="lab_dxcm_EmployeePurchasePriceFloorPercentage_09D7A4C2458B069146971BEB0CE16C3F_label_en-US" xlink:label="lab_dxcm_EmployeePurchasePriceFloorPercentage_09D7A4C2458B069146971BEB0CE16C3F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Purchase Price Floor Percentage</link:label>
    <link:label id="lab_dxcm_EmployeePurchasePriceFloorPercentage_09D7A4C2458B069146971BEB0CE16C3F_documentation_en-US" xlink:label="lab_dxcm_EmployeePurchasePriceFloorPercentage_09D7A4C2458B069146971BEB0CE16C3F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee purchase price floor, percentage</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EmployeePurchasePriceFloorPercentage" xlink:label="loc_dxcm_EmployeePurchasePriceFloorPercentage_09D7A4C2458B069146971BEB0CE16C3F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EmployeePurchasePriceFloorPercentage_09D7A4C2458B069146971BEB0CE16C3F" xlink:to="lab_dxcm_EmployeePurchasePriceFloorPercentage_09D7A4C2458B069146971BEB0CE16C3F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3F779CEFAF34D67F994A1BEB0CE275F7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3F779CEFAF34D67F994A1BEB0CE275F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock reserved for issuance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3F779CEFAF34D67F994A1BEB0CE275F7_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3F779CEFAF34D67F994A1BEB0CE275F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3F779CEFAF34D67F994A1BEB0CE275F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3F779CEFAF34D67F994A1BEB0CE275F7" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3F779CEFAF34D67F994A1BEB0CE275F7" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_1593B4E84A6CB560AD461BEB0CE2BB7D_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_1593B4E84A6CB560AD461BEB0CE2BB7D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_1593B4E84A6CB560AD461BEB0CE2BB7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired_1593B4E84A6CB560AD461BEB0CE2BB7D" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired_1593B4E84A6CB560AD461BEB0CE2BB7D" xlink:type="arc" />
    <link:label id="lab_dxcm_OptionsInMoneyNumber_497AF7D68DB404B56B901BEB0CE24B05_terseLabel_en-US" xlink:label="lab_dxcm_OptionsInMoneyNumber_497AF7D68DB404B56B901BEB0CE24B05" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options in-the-money</link:label>
    <link:label id="lab_dxcm_OptionsInMoneyNumber_497AF7D68DB404B56B901BEB0CE24B05_label_en-US" xlink:label="lab_dxcm_OptionsInMoneyNumber_497AF7D68DB404B56B901BEB0CE24B05" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Options In Money Number</link:label>
    <link:label id="lab_dxcm_OptionsInMoneyNumber_497AF7D68DB404B56B901BEB0CE24B05_documentation_en-US" xlink:label="lab_dxcm_OptionsInMoneyNumber_497AF7D68DB404B56B901BEB0CE24B05" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of options that were in-the-money at the balance sheet date</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_OptionsInMoneyNumber" xlink:label="loc_dxcm_OptionsInMoneyNumber_497AF7D68DB404B56B901BEB0CE24B05" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OptionsInMoneyNumber_497AF7D68DB404B56B901BEB0CE24B05" xlink:to="lab_dxcm_OptionsInMoneyNumber_497AF7D68DB404B56B901BEB0CE24B05" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_67FD9A4B36B7FCDF7BF11BEB0CE25C6E_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_67FD9A4B36B7FCDF7BF11BEB0CE25C6E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining contractual term of stock options</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_67FD9A4B36B7FCDF7BF11BEB0CE25C6E_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_67FD9A4B36B7FCDF7BF11BEB0CE25C6E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_67FD9A4B36B7FCDF7BF11BEB0CE25C6E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_67FD9A4B36B7FCDF7BF11BEB0CE25C6E" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_67FD9A4B36B7FCDF7BF11BEB0CE25C6E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_19B06510E7B3978D7BD71BEB0CE24B3F_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_19B06510E7B3978D7BD71BEB0CE24B3F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average exercise price of stock options (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_19B06510E7B3978D7BD71BEB0CE24B3F_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_19B06510E7B3978D7BD71BEB0CE24B3F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_19B06510E7B3978D7BD71BEB0CE24B3F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_19B06510E7B3978D7BD71BEB0CE24B3F" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_19B06510E7B3978D7BD71BEB0CE24B3F" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_70ACD52AE0B3AF1EBD121BEB0CE2DF56_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_70ACD52AE0B3AF1EBD121BEB0CE2DF56" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value of stock options</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_70ACD52AE0B3AF1EBD121BEB0CE2DF56_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_70ACD52AE0B3AF1EBD121BEB0CE2DF56" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_70ACD52AE0B3AF1EBD121BEB0CE2DF56" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_70ACD52AE0B3AF1EBD121BEB0CE2DF56" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_70ACD52AE0B3AF1EBD121BEB0CE2DF56" xlink:type="arc" />
    <link:label id="lab_dxcm_InMoneyOptionsMaximumExercisePrice_E543C81A60EB915A67B31BEB0CE31D5F_terseLabel_en-US" xlink:label="lab_dxcm_InMoneyOptionsMaximumExercisePrice_E543C81A60EB915A67B31BEB0CE31D5F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In-the-money options, maximum exercise price (USD per share)</link:label>
    <link:label id="lab_dxcm_InMoneyOptionsMaximumExercisePrice_E543C81A60EB915A67B31BEB0CE31D5F_label_en-US" xlink:label="lab_dxcm_InMoneyOptionsMaximumExercisePrice_E543C81A60EB915A67B31BEB0CE31D5F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Money Options Maximum Exercise Price</link:label>
    <link:label id="lab_dxcm_InMoneyOptionsMaximumExercisePrice_E543C81A60EB915A67B31BEB0CE31D5F_documentation_en-US" xlink:label="lab_dxcm_InMoneyOptionsMaximumExercisePrice_E543C81A60EB915A67B31BEB0CE31D5F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The maximum exercise price for options to be considered in-the-money</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_InMoneyOptionsMaximumExercisePrice" xlink:label="loc_dxcm_InMoneyOptionsMaximumExercisePrice_E543C81A60EB915A67B31BEB0CE31D5F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_InMoneyOptionsMaximumExercisePrice_E543C81A60EB915A67B31BEB0CE31D5F" xlink:to="lab_dxcm_InMoneyOptionsMaximumExercisePrice_E543C81A60EB915A67B31BEB0CE31D5F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3BBD1B76677BD6361B891C0C56FAF839_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3BBD1B76677BD6361B891C0C56FAF839" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3BBD1B76677BD6361B891C0C56FAF839_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3BBD1B76677BD6361B891C0C56FAF839" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3BBD1B76677BD6361B891C0C56FAF839" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3BBD1B76677BD6361B891C0C56FAF839" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3BBD1B76677BD6361B891C0C56FAF839" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1BDA0FF6A6315D0F1F511BEB0CE37726_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1BDA0FF6A6315D0F1F511BEB0CE37726" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of RSUs vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1BDA0FF6A6315D0F1F511BEB0CE37726_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1BDA0FF6A6315D0F1F511BEB0CE37726" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1BDA0FF6A6315D0F1F511BEB0CE37726" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1BDA0FF6A6315D0F1F511BEB0CE37726" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1BDA0FF6A6315D0F1F511BEB0CE37726" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_B057C71CC130146ED0521BEB0CE3C67A_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_B057C71CC130146ED0521BEB0CE3C67A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation costs related to unvested restricted stock units</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_B057C71CC130146ED0521BEB0CE3C67A_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_B057C71CC130146ED0521BEB0CE3C67A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_B057C71CC130146ED0521BEB0CE3C67A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_B057C71CC130146ED0521BEB0CE3C67A" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_B057C71CC130146ED0521BEB0CE3C67A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_49093E6B5C6355A4E16EB03100BFBF67_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_49093E6B5C6355A4E16EB03100BFBF67" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Income (Loss) before Income Taxes Subject to Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_49093E6B5C6355A4E16EB03100BFBF67_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_49093E6B5C6355A4E16EB03100BFBF67" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_49093E6B5C6355A4E16EB03100BFBF67" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_49093E6B5C6355A4E16EB03100BFBF67" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_49093E6B5C6355A4E16EB03100BFBF67" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_308ECEB9DEC0B38A085DB03100C00D65_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_308ECEB9DEC0B38A085DB03100C00D65" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_308ECEB9DEC0B38A085DB03100C00D65_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_308ECEB9DEC0B38A085DB03100C00D65" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_308ECEB9DEC0B38A085DB03100C00D65" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_308ECEB9DEC0B38A085DB03100C00D65" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_308ECEB9DEC0B38A085DB03100C00D65" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_62537C308711363C14F3B03100C0FC89_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_62537C308711363C14F3B03100C0FC89" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_62537C308711363C14F3B03100C0FC89_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_62537C308711363C14F3B03100C0FC89" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_62537C308711363C14F3B03100C0FC89" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_62537C308711363C14F3B03100C0FC89" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_62537C308711363C14F3B03100C0FC89" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_CC6897F03681FFE4F151B03100C071B2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_CC6897F03681FFE4F151B03100C071B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Reconciliation between Effective Tax Rate and Statutory Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_CC6897F03681FFE4F151B03100C071B2_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_CC6897F03681FFE4F151B03100C071B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_CC6897F03681FFE4F151B03100C071B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_CC6897F03681FFE4F151B03100C071B2" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_CC6897F03681FFE4F151B03100C071B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_1FBF38360BCE5F71F4A4B03100C00F14_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_1FBF38360BCE5F71F4A4B03100C00F14" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_1FBF38360BCE5F71F4A4B03100C00F14_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_1FBF38360BCE5F71F4A4B03100C00F14" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_1FBF38360BCE5F71F4A4B03100C00F14" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_1FBF38360BCE5F71F4A4B03100C00F14" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_1FBF38360BCE5F71F4A4B03100C00F14" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_EFD7C62A6C40AB756301B0CB6F066050_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_EFD7C62A6C40AB756301B0CB6F066050" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amounts included in contract liabilities at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_EFD7C62A6C40AB756301B0CB6F066050_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_EFD7C62A6C40AB756301B0CB6F066050" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_EFD7C62A6C40AB756301B0CB6F066050" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_EFD7C62A6C40AB756301B0CB6F066050" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_EFD7C62A6C40AB756301B0CB6F066050" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_71FA84573D13D84C2AA21BFE8BE7CD71_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_71FA84573D13D84C2AA21BFE8BE7CD71" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_71FA84573D13D84C2AA21BFE8BE7CD71_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_71FA84573D13D84C2AA21BFE8BE7CD71" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_71FA84573D13D84C2AA21BFE8BE7CD71" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_71FA84573D13D84C2AA21BFE8BE7CD71" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_71FA84573D13D84C2AA21BFE8BE7CD71" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_FC3BC1E278179EACECC01BEB0D452E84_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_FC3BC1E278179EACECC01BEB0D452E84" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_FC3BC1E278179EACECC01BEB0D452E84_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_FC3BC1E278179EACECC01BEB0D452E84" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_FC3BC1E278179EACECC01BEB0D452E84" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_FC3BC1E278179EACECC01BEB0D452E84" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_FC3BC1E278179EACECC01BEB0D452E84" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_63F3F66165F2E933C2261BEB0D4533A1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_63F3F66165F2E933C2261BEB0D4533A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_63F3F66165F2E933C2261BEB0D4533A1_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_63F3F66165F2E933C2261BEB0D4533A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_63F3F66165F2E933C2261BEB0D4533A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_63F3F66165F2E933C2261BEB0D4533A1" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_63F3F66165F2E933C2261BEB0D4533A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7B46F31697D71150F6781BEB0D459949_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7B46F31697D71150F6781BEB0D459949" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7B46F31697D71150F6781BEB0D459949_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7B46F31697D71150F6781BEB0D459949" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7B46F31697D71150F6781BEB0D459949" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7B46F31697D71150F6781BEB0D459949" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7B46F31697D71150F6781BEB0D459949" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9C821EC242CC4E5D2B551BEB0D46B27E_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9C821EC242CC4E5D2B551BEB0D46B27E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9C821EC242CC4E5D2B551BEB0D46B27E_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9C821EC242CC4E5D2B551BEB0D46B27E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9C821EC242CC4E5D2B551BEB0D46B27E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9C821EC242CC4E5D2B551BEB0D46B27E" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9C821EC242CC4E5D2B551BEB0D46B27E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_D47506ED10848A47E6251BEB0D461881_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_D47506ED10848A47E6251BEB0D461881" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_D47506ED10848A47E6251BEB0D461881_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_D47506ED10848A47E6251BEB0D461881" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_D47506ED10848A47E6251BEB0D461881" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_D47506ED10848A47E6251BEB0D461881" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_D47506ED10848A47E6251BEB0D461881" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_C841B0C668703DCEC8831BEB0D462B06_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_C841B0C668703DCEC8831BEB0D462B06" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total future lease cost</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_C841B0C668703DCEC8831BEB0D462B06_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_C841B0C668703DCEC8831BEB0D462B06" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_C841B0C668703DCEC8831BEB0D462B06" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_C841B0C668703DCEC8831BEB0D462B06" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_C841B0C668703DCEC8831BEB0D462B06" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D8D9F8BE4E72046887B51BEB0D464549_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D8D9F8BE4E72046887B51BEB0D464549" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: Amount representing interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D8D9F8BE4E72046887B51BEB0D464549_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D8D9F8BE4E72046887B51BEB0D464549" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D8D9F8BE4E72046887B51BEB0D464549" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D8D9F8BE4E72046887B51BEB0D464549" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D8D9F8BE4E72046887B51BEB0D464549" xlink:type="arc" />
    <link:label id="lab_dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_EEAF8EB7C90E5F32EEB61BEB0D464E26_terseLabel_en-US" xlink:label="lab_dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_EEAF8EB7C90E5F32EEB61BEB0D464E26" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Present value of future payments</link:label>
    <link:label id="lab_dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_EEAF8EB7C90E5F32EEB61BEB0D464E26_label_en-US" xlink:label="lab_dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_EEAF8EB7C90E5F32EEB61BEB0D464E26" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Less Payments Due On Short Term Leases Not Recorded As A Liability</link:label>
    <link:label id="lab_dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_EEAF8EB7C90E5F32EEB61BEB0D464E26_documentation_en-US" xlink:label="lab_dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_EEAF8EB7C90E5F32EEB61BEB0D464E26" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Less Payments Due On Short Term Leases Not Recorded As A Liability</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability" xlink:label="loc_dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_EEAF8EB7C90E5F32EEB61BEB0D464E26" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_EEAF8EB7C90E5F32EEB61BEB0D464E26" xlink:to="lab_dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_EEAF8EB7C90E5F32EEB61BEB0D464E26" xlink:type="arc" />
    <link:label id="lab_dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue_7444B862600E0DEFA9A61BEB0D46F41B_terseLabel_en-US" xlink:label="lab_dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue_7444B862600E0DEFA9A61BEB0D46F41B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: Short-term leases not recorded as a liability</link:label>
    <link:label id="lab_dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue_7444B862600E0DEFA9A61BEB0D46F41B_label_en-US" xlink:label="lab_dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue_7444B862600E0DEFA9A61BEB0D46F41B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases, Short Term Lease Payments Due</link:label>
    <link:label id="lab_dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue_7444B862600E0DEFA9A61BEB0D46F41B_documentation_en-US" xlink:label="lab_dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue_7444B862600E0DEFA9A61BEB0D46F41B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases, Short Term Lease Payments Due</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue" xlink:label="loc_dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue_7444B862600E0DEFA9A61BEB0D46F41B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue_7444B862600E0DEFA9A61BEB0D46F41B" xlink:to="lab_dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue_7444B862600E0DEFA9A61BEB0D46F41B" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiability_C19C68321D168FB538111BEB0D4729CE_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_C19C68321D168FB538111BEB0D4729CE" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Revised present value of future lease payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_C19C68321D168FB538111BEB0D4729CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_C19C68321D168FB538111BEB0D4729CE" xlink:to="lab_us-gaap_OperatingLeaseLiability_C19C68321D168FB538111BEB0D4729CE" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_26974B73B5787940A2591BEB0D4761B9_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_26974B73B5787940A2591BEB0D4761B9" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: Current portion</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_26974B73B5787940A2591BEB0D4761B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_26974B73B5787940A2591BEB0D4761B9" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent_26974B73B5787940A2591BEB0D4761B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_817270458B25354A847A1BEB0D47CB29_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_817270458B25354A847A1BEB0D47CB29" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-term portion</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_817270458B25354A847A1BEB0D47CB29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_817270458B25354A847A1BEB0D47CB29" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_817270458B25354A847A1BEB0D47CB29" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_880EF2FE920B6E2BA4291BFEA1A34C1D_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_880EF2FE920B6E2BA4291BFEA1A34C1D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_880EF2FE920B6E2BA4291BFEA1A34C1D_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_880EF2FE920B6E2BA4291BFEA1A34C1D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_880EF2FE920B6E2BA4291BFEA1A34C1D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_880EF2FE920B6E2BA4291BFEA1A34C1D" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_880EF2FE920B6E2BA4291BFEA1A34C1D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_FAC9477D5D22E42AFCAC1BEB0D47ADE9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_FAC9477D5D22E42AFCAC1BEB0D47ADE9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_FAC9477D5D22E42AFCAC1BEB0D47ADE9_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_FAC9477D5D22E42AFCAC1BEB0D47ADE9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_FAC9477D5D22E42AFCAC1BEB0D47ADE9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_FAC9477D5D22E42AFCAC1BEB0D47ADE9" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_FAC9477D5D22E42AFCAC1BEB0D47ADE9" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_FA657DE1C856B14DEF001BEB0D489140_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_FA657DE1C856B14DEF001BEB0D489140" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_FA657DE1C856B14DEF001BEB0D489140_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_FA657DE1C856B14DEF001BEB0D489140" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_FA657DE1C856B14DEF001BEB0D489140" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_FA657DE1C856B14DEF001BEB0D489140" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_FA657DE1C856B14DEF001BEB0D489140" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_B0FA038908314CFE74331BEB0D48BA9F_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_B0FA038908314CFE74331BEB0D48BA9F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_B0FA038908314CFE74331BEB0D48BA9F_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_B0FA038908314CFE74331BEB0D48BA9F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_B0FA038908314CFE74331BEB0D48BA9F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_B0FA038908314CFE74331BEB0D48BA9F" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_B0FA038908314CFE74331BEB0D48BA9F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_6400F9084D216AB464641BEB0D48EAAD_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_6400F9084D216AB464641BEB0D48EAAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_6400F9084D216AB464641BEB0D48EAAD_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_6400F9084D216AB464641BEB0D48EAAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_6400F9084D216AB464641BEB0D48EAAD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_6400F9084D216AB464641BEB0D48EAAD" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_6400F9084D216AB464641BEB0D48EAAD" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_FB8C3C80E44EAEA002431BEB0D48022D_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_FB8C3C80E44EAEA002431BEB0D48022D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_FB8C3C80E44EAEA002431BEB0D48022D_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_FB8C3C80E44EAEA002431BEB0D48022D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payments, Due after Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_FB8C3C80E44EAEA002431BEB0D48022D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_FB8C3C80E44EAEA002431BEB0D48022D" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_FB8C3C80E44EAEA002431BEB0D48022D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_E95EB7CA696E099420031BEB0D4869B2_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_E95EB7CA696E099420031BEB0D4869B2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total future lease cost</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_E95EB7CA696E099420031BEB0D4869B2_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_E95EB7CA696E099420031BEB0D4869B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_E95EB7CA696E099420031BEB0D4869B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_E95EB7CA696E099420031BEB0D4869B2" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_E95EB7CA696E099420031BEB0D4869B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2BCD8361708F025902F61BEB0D482A54_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2BCD8361708F025902F61BEB0D482A54" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: Amount representing interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2BCD8361708F025902F61BEB0D482A54_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2BCD8361708F025902F61BEB0D482A54" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2BCD8361708F025902F61BEB0D482A54" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2BCD8361708F025902F61BEB0D482A54" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2BCD8361708F025902F61BEB0D482A54" xlink:type="arc" />
    <link:label id="lab_dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_51AA0B8DE9E2F9DBFC6C1BEB0D49BACB_terseLabel_en-US" xlink:label="lab_dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_51AA0B8DE9E2F9DBFC6C1BEB0D49BACB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Present value of future payments</link:label>
    <link:label id="lab_dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_51AA0B8DE9E2F9DBFC6C1BEB0D49BACB_label_en-US" xlink:label="lab_dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_51AA0B8DE9E2F9DBFC6C1BEB0D49BACB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Leases, Liability, Less Payments Due On Short Term Leases Not Recorded As A Liability</link:label>
    <link:label id="lab_dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_51AA0B8DE9E2F9DBFC6C1BEB0D49BACB_documentation_en-US" xlink:label="lab_dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_51AA0B8DE9E2F9DBFC6C1BEB0D49BACB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Leases, Liability, Less Payments Due On Short Term Leases Not Recorded As A Liability</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability" xlink:label="loc_dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_51AA0B8DE9E2F9DBFC6C1BEB0D49BACB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_51AA0B8DE9E2F9DBFC6C1BEB0D49BACB" xlink:to="lab_dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_51AA0B8DE9E2F9DBFC6C1BEB0D49BACB" xlink:type="arc" />
    <link:label id="lab_dxcm_FinanceLeaseShortTermLeasesPaymentsDue_D79A15596B40F9FB26FD1BEB0D4924EB_terseLabel_en-US" xlink:label="lab_dxcm_FinanceLeaseShortTermLeasesPaymentsDue_D79A15596B40F9FB26FD1BEB0D4924EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: Short-term leases not recorded as a liability</link:label>
    <link:label id="lab_dxcm_FinanceLeaseShortTermLeasesPaymentsDue_D79A15596B40F9FB26FD1BEB0D4924EB_label_en-US" xlink:label="lab_dxcm_FinanceLeaseShortTermLeasesPaymentsDue_D79A15596B40F9FB26FD1BEB0D4924EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Short Term Leases, Payments Due</link:label>
    <link:label id="lab_dxcm_FinanceLeaseShortTermLeasesPaymentsDue_D79A15596B40F9FB26FD1BEB0D4924EB_documentation_en-US" xlink:label="lab_dxcm_FinanceLeaseShortTermLeasesPaymentsDue_D79A15596B40F9FB26FD1BEB0D4924EB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Lease, Short Term Leases, Payments Due</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FinanceLeaseShortTermLeasesPaymentsDue" xlink:label="loc_dxcm_FinanceLeaseShortTermLeasesPaymentsDue_D79A15596B40F9FB26FD1BEB0D4924EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FinanceLeaseShortTermLeasesPaymentsDue_D79A15596B40F9FB26FD1BEB0D4924EB" xlink:to="lab_dxcm_FinanceLeaseShortTermLeasesPaymentsDue_D79A15596B40F9FB26FD1BEB0D4924EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiability_71C742CF9B50D838346A1BEB0D495D89_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability_71C742CF9B50D838346A1BEB0D495D89" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Revised present value of future lease payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_71C742CF9B50D838346A1BEB0D495D89" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability_71C742CF9B50D838346A1BEB0D495D89" xlink:to="lab_us-gaap_FinanceLeaseLiability_71C742CF9B50D838346A1BEB0D495D89" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_6AEEF2C7C6FBF2E9ECDE1BEB0D49FADC_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent_6AEEF2C7C6FBF2E9ECDE1BEB0D49FADC" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: Current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_6AEEF2C7C6FBF2E9ECDE1BEB0D49FADC_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent_6AEEF2C7C6FBF2E9ECDE1BEB0D49FADC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_6AEEF2C7C6FBF2E9ECDE1BEB0D49FADC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent_6AEEF2C7C6FBF2E9ECDE1BEB0D49FADC" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent_6AEEF2C7C6FBF2E9ECDE1BEB0D49FADC" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_41D82150EB6ACFA7F57A1BEB0D49E651_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_41D82150EB6ACFA7F57A1BEB0D49E651" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_41D82150EB6ACFA7F57A1BEB0D49E651_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_41D82150EB6ACFA7F57A1BEB0D49E651" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_41D82150EB6ACFA7F57A1BEB0D49E651" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_41D82150EB6ACFA7F57A1BEB0D49E651" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_41D82150EB6ACFA7F57A1BEB0D49E651" xlink:type="arc" />
    <link:label id="lab_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced_50A8B2ADE044056FB9001BEB0D493482_terseLabel_en-US" xlink:label="lab_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced_50A8B2ADE044056FB9001BEB0D493482" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum lease payments for leases not yet commenced</link:label>
    <link:label id="lab_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced_50A8B2ADE044056FB9001BEB0D493482_label_en-US" xlink:label="lab_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced_50A8B2ADE044056FB9001BEB0D493482" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Future Lease Cost, Lease Not yet Commenced</link:label>
    <link:label id="lab_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced_50A8B2ADE044056FB9001BEB0D493482_documentation_en-US" xlink:label="lab_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced_50A8B2ADE044056FB9001BEB0D493482" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Future Lease Cost, Lease Not yet Commenced</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced" xlink:label="loc_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced_50A8B2ADE044056FB9001BEB0D493482" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced_50A8B2ADE044056FB9001BEB0D493482" xlink:to="lab_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced_50A8B2ADE044056FB9001BEB0D493482" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_4214F314196B0B17C609AB017E631E54_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare_4214F314196B0B17C609AB017E631E54" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_4214F314196B0B17C609AB017E631E54_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare_4214F314196B0B17C609AB017E631E54" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_4214F314196B0B17C609AB017E631E54" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare_4214F314196B0B17C609AB017E631E54" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare_4214F314196B0B17C609AB017E631E54" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_4EAD7B15998B166C252CAB017E63BB6B_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_4EAD7B15998B166C252CAB017E63BB6B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_4EAD7B15998B166C252CAB017E63BB6B_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_4EAD7B15998B166C252CAB017E63BB6B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_4EAD7B15998B166C252CAB017E63BB6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized_4EAD7B15998B166C252CAB017E63BB6B" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized_4EAD7B15998B166C252CAB017E63BB6B" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_0B2D3610A2724BEFB280AB017E6312C5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_0B2D3610A2724BEFB280AB017E6312C5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_0B2D3610A2724BEFB280AB017E6312C5_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_0B2D3610A2724BEFB280AB017E6312C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_0B2D3610A2724BEFB280AB017E6312C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued_0B2D3610A2724BEFB280AB017E6312C5" xlink:to="lab_us-gaap_PreferredStockSharesIssued_0B2D3610A2724BEFB280AB017E6312C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_9A65A025DEC783BC3401AB017E64444D_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding_9A65A025DEC783BC3401AB017E64444D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_9A65A025DEC783BC3401AB017E64444D_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding_9A65A025DEC783BC3401AB017E64444D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_9A65A025DEC783BC3401AB017E64444D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding_9A65A025DEC783BC3401AB017E64444D" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding_9A65A025DEC783BC3401AB017E64444D" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_B900779FF0D072C5CB50AB017E648B7F_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_B900779FF0D072C5CB50AB017E648B7F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_B900779FF0D072C5CB50AB017E648B7F_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_B900779FF0D072C5CB50AB017E648B7F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_B900779FF0D072C5CB50AB017E648B7F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare_B900779FF0D072C5CB50AB017E648B7F" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare_B900779FF0D072C5CB50AB017E648B7F" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_172B120A41FE50E6108AAB017E64C3EB_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_172B120A41FE50E6108AAB017E64C3EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_172B120A41FE50E6108AAB017E64C3EB_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_172B120A41FE50E6108AAB017E64C3EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_172B120A41FE50E6108AAB017E64C3EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_172B120A41FE50E6108AAB017E64C3EB" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_172B120A41FE50E6108AAB017E64C3EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_4619ACA6CAB5005DFE52AB017E663088_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_4619ACA6CAB5005DFE52AB017E663088" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_4619ACA6CAB5005DFE52AB017E663088_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_4619ACA6CAB5005DFE52AB017E663088" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_4619ACA6CAB5005DFE52AB017E663088" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_4619ACA6CAB5005DFE52AB017E663088" xlink:to="lab_us-gaap_CommonStockSharesIssued_4619ACA6CAB5005DFE52AB017E663088" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_EE77900260B8ACE6A52CAB017E66390F_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_EE77900260B8ACE6A52CAB017E66390F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_EE77900260B8ACE6A52CAB017E66390F_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_EE77900260B8ACE6A52CAB017E66390F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_EE77900260B8ACE6A52CAB017E66390F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_EE77900260B8ACE6A52CAB017E66390F" xlink:to="lab_us-gaap_CommonStockSharesOutstanding_EE77900260B8ACE6A52CAB017E66390F" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockShares_744E6329DC3B436963FFAB017E674FE2_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_744E6329DC3B436963FFAB017E674FE2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock at cost (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_744E6329DC3B436963FFAB017E674FE2_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_744E6329DC3B436963FFAB017E674FE2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_744E6329DC3B436963FFAB017E674FE2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares_744E6329DC3B436963FFAB017E674FE2" xlink:to="lab_us-gaap_TreasuryStockShares_744E6329DC3B436963FFAB017E674FE2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_D85E8FB9E30F975D2DA8AF6BBCE03E7E_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_D85E8FB9E30F975D2DA8AF6BBCE03E7E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_D85E8FB9E30F975D2DA8AF6BBCE03E7E_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_D85E8FB9E30F975D2DA8AF6BBCE03E7E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_D85E8FB9E30F975D2DA8AF6BBCE03E7E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_D85E8FB9E30F975D2DA8AF6BBCE03E7E" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_D85E8FB9E30F975D2DA8AF6BBCE03E7E" xlink:type="arc" />
    <link:label id="lab_srt_StatementGeographicalAxis_6D1F7EBE104500D7F2CAAF6BBD1EF11E_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis_6D1F7EBE104500D7F2CAAF6BBD1EF11E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_6D1F7EBE104500D7F2CAAF6BBD1EF11E_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis_6D1F7EBE104500D7F2CAAF6BBD1EF11E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_6D1F7EBE104500D7F2CAAF6BBD1EF11E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis_6D1F7EBE104500D7F2CAAF6BBD1EF11E" xlink:to="lab_srt_StatementGeographicalAxis_6D1F7EBE104500D7F2CAAF6BBD1EF11E" xlink:type="arc" />
    <link:label id="lab_srt_SegmentGeographicalDomain_3CF90B117D49FFBDC029AF6BBD1E21F4_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain_3CF90B117D49FFBDC029AF6BBD1E21F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_3CF90B117D49FFBDC029AF6BBD1E21F4_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain_3CF90B117D49FFBDC029AF6BBD1E21F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_3CF90B117D49FFBDC029AF6BBD1E21F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain_3CF90B117D49FFBDC029AF6BBD1E21F4" xlink:to="lab_srt_SegmentGeographicalDomain_3CF90B117D49FFBDC029AF6BBD1E21F4" xlink:type="arc" />
    <link:label id="lab_country_US_6458819F84A7B537E7A6AF6BBD1FC4D1_terseLabel_en-US" xlink:label="lab_country_US_6458819F84A7B537E7A6AF6BBD1FC4D1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_6458819F84A7B537E7A6AF6BBD1FC4D1_label_en-US" xlink:label="lab_country_US_6458819F84A7B537E7A6AF6BBD1FC4D1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_6458819F84A7B537E7A6AF6BBD1FC4D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US_6458819F84A7B537E7A6AF6BBD1FC4D1" xlink:to="lab_country_US_6458819F84A7B537E7A6AF6BBD1FC4D1" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonUsMember_BB0FBE89C88EE1114C8AAF6BBD1FB413_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember_BB0FBE89C88EE1114C8AAF6BBD1FB413" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outside of the United States</link:label>
    <link:label id="lab_us-gaap_NonUsMember_BB0FBE89C88EE1114C8AAF6BBD1FB413_label_en-US" xlink:label="lab_us-gaap_NonUsMember_BB0FBE89C88EE1114C8AAF6BBD1FB413" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_BB0FBE89C88EE1114C8AAF6BBD1FB413" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember_BB0FBE89C88EE1114C8AAF6BBD1FB413" xlink:to="lab_us-gaap_NonUsMember_BB0FBE89C88EE1114C8AAF6BBD1FB413" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_ADA6DCB2052F4A2E3F93AF6BBD1DBBD2_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis_ADA6DCB2052F4A2E3F93AF6BBD1DBBD2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_ADA6DCB2052F4A2E3F93AF6BBD1DBBD2_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis_ADA6DCB2052F4A2E3F93AF6BBD1DBBD2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ADA6DCB2052F4A2E3F93AF6BBD1DBBD2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ADA6DCB2052F4A2E3F93AF6BBD1DBBD2" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis_ADA6DCB2052F4A2E3F93AF6BBD1DBBD2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_5983E860EF8EC07DD35AAF6BBD1D48F3_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain_5983E860EF8EC07DD35AAF6BBD1D48F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_5983E860EF8EC07DD35AAF6BBD1D48F3_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain_5983E860EF8EC07DD35AAF6BBD1D48F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_5983E860EF8EC07DD35AAF6BBD1D48F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_5983E860EF8EC07DD35AAF6BBD1D48F3" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain_5983E860EF8EC07DD35AAF6BBD1D48F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_C9F490230DD730C49089AF6BBD1ED59A_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember_C9F490230DD730C49089AF6BBD1ED59A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distributor</link:label>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_C9F490230DD730C49089AF6BBD1ED59A_label_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember_C9F490230DD730C49089AF6BBD1ED59A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_C9F490230DD730C49089AF6BBD1ED59A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelThroughIntermediaryMember_C9F490230DD730C49089AF6BBD1ED59A" xlink:to="lab_us-gaap_SalesChannelThroughIntermediaryMember_C9F490230DD730C49089AF6BBD1ED59A" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_DFBCAEFFD29DC42E97C1AF6BBD1EA54D_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember_DFBCAEFFD29DC42E97C1AF6BBD1EA54D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Direct</link:label>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_DFBCAEFFD29DC42E97C1AF6BBD1EA54D_label_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember_DFBCAEFFD29DC42E97C1AF6BBD1EA54D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_DFBCAEFFD29DC42E97C1AF6BBD1EA54D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelDirectlyToConsumerMember_DFBCAEFFD29DC42E97C1AF6BBD1EA54D" xlink:to="lab_us-gaap_SalesChannelDirectlyToConsumerMember_DFBCAEFFD29DC42E97C1AF6BBD1EA54D" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_A1EB4F8C37EBCDB4EBBCAF6BBD1F6AD1_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems_A1EB4F8C37EBCDB4EBBCAF6BBD1F6AD1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_A1EB4F8C37EBCDB4EBBCAF6BBD1F6AD1_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems_A1EB4F8C37EBCDB4EBBCAF6BBD1F6AD1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_A1EB4F8C37EBCDB4EBBCAF6BBD1F6AD1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_A1EB4F8C37EBCDB4EBBCAF6BBD1F6AD1" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems_A1EB4F8C37EBCDB4EBBCAF6BBD1F6AD1" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_CDB47FED595D4405AD9FAF6BBD1FFFDF_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_CDB47FED595D4405AD9FAF6BBD1FFFDF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_CDB47FED595D4405AD9FAF6BBD1FFFDF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_CDB47FED595D4405AD9FAF6BBD1FFFDF" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_CDB47FED595D4405AD9FAF6BBD1FFFDF" xlink:type="arc" />
    <link:label id="lab_dxcm_RevenuePercentage_EE38F9287384D3CA0493AF6BBD2054C2_terseLabel_en-US" xlink:label="lab_dxcm_RevenuePercentage_EE38F9287384D3CA0493AF6BBD2054C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">% of Total</link:label>
    <link:label id="lab_dxcm_RevenuePercentage_EE38F9287384D3CA0493AF6BBD2054C2_label_en-US" xlink:label="lab_dxcm_RevenuePercentage_EE38F9287384D3CA0493AF6BBD2054C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Percentage</link:label>
    <link:label id="lab_dxcm_RevenuePercentage_EE38F9287384D3CA0493AF6BBD2054C2_documentation_en-US" xlink:label="lab_dxcm_RevenuePercentage_EE38F9287384D3CA0493AF6BBD2054C2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Percentage</link:label>
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_RevenuePercentage" xlink:label="loc_dxcm_RevenuePercentage_EE38F9287384D3CA0493AF6BBD2054C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RevenuePercentage_EE38F9287384D3CA0493AF6BBD2054C2" xlink:to="lab_dxcm_RevenuePercentage_EE38F9287384D3CA0493AF6BBD2054C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80F5D7739CB3750F8F23B570A898252B_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80F5D7739CB3750F8F23B570A898252B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80F5D7739CB3750F8F23B570A898252B_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80F5D7739CB3750F8F23B570A898252B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80F5D7739CB3750F8F23B570A898252B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80F5D7739CB3750F8F23B570A898252B" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80F5D7739CB3750F8F23B570A898252B" xlink:type="arc" />
    <link:label id="lab_us-gaap_BuildingMember_4FE7BCBBDA272B7F2EBBB570A89AB20F_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember_4FE7BCBBDA272B7F2EBBB570A89AB20F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Building and land</link:label>
    <link:label id="lab_us-gaap_BuildingMember_4FE7BCBBDA272B7F2EBBB570A89AB20F_label_en-US" xlink:label="lab_us-gaap_BuildingMember_4FE7BCBBDA272B7F2EBBB570A89AB20F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaap_BuildingMember_4FE7BCBBDA272B7F2EBBB570A89AB20F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember_4FE7BCBBDA272B7F2EBBB570A89AB20F" xlink:to="lab_us-gaap_BuildingMember_4FE7BCBBDA272B7F2EBBB570A89AB20F" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquipmentMember_FE91F84F6EB01E687C98B570A89ABFC0_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember_FE91F84F6EB01E687C98B570A89ABFC0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_FE91F84F6EB01E687C98B570A89ABFC0_label_en-US" xlink:label="lab_us-gaap_EquipmentMember_FE91F84F6EB01E687C98B570A89ABFC0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaap_EquipmentMember_FE91F84F6EB01E687C98B570A89ABFC0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember_FE91F84F6EB01E687C98B570A89ABFC0" xlink:to="lab_us-gaap_EquipmentMember_FE91F84F6EB01E687C98B570A89ABFC0" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_49683A91B6B8C0FD746BB570A89AF8AB_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember_49683A91B6B8C0FD746BB570A89AF8AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_49683A91B6B8C0FD746BB570A89AF8AB_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember_49683A91B6B8C0FD746BB570A89AF8AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_49683A91B6B8C0FD746BB570A89AF8AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember_49683A91B6B8C0FD746BB570A89AF8AB" xlink:to="lab_us-gaap_LeaseholdImprovementsMember_49683A91B6B8C0FD746BB570A89AF8AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConstructionInProgressMember_F09484251379FACD2FECB570A89B7083_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember_F09484251379FACD2FECB570A89B7083" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Construction in progress</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaap_ConstructionInProgressMember_F09484251379FACD2FECB570A89B7083" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember_F09484251379FACD2FECB570A89B7083" xlink:to="lab_us-gaap_ConstructionInProgressMember_F09484251379FACD2FECB570A89B7083" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_2A3DDFFC5272A4256851B570A89B3F5C_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems_2A3DDFFC5272A4256851B570A89B3F5C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_2A3DDFFC5272A4256851B570A89B3F5C_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems_2A3DDFFC5272A4256851B570A89B3F5C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2A3DDFFC5272A4256851B570A89B3F5C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2A3DDFFC5272A4256851B570A89B3F5C" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems_2A3DDFFC5272A4256851B570A89B3F5C" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_43320E2489793F76C88CB570A89B65C0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_43320E2489793F76C88CB570A89B65C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_43320E2489793F76C88CB570A89B65C0_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_43320E2489793F76C88CB570A89B65C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_43320E2489793F76C88CB570A89B65C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_43320E2489793F76C88CB570A89B65C0" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross_43320E2489793F76C88CB570A89B65C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_978B7458C547390AA804B570A89BF129_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_978B7458C547390AA804B570A89BF129" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_978B7458C547390AA804B570A89BF129_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_978B7458C547390AA804B570A89BF129" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_978B7458C547390AA804B570A89BF129" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_978B7458C547390AA804B570A89BF129" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_978B7458C547390AA804B570A89BF129" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_EAB7314667573E869D48B570A89B5DFA_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_EAB7314667573E869D48B570A89B5DFA" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total property and equipment, net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_EAB7314667573E869D48B570A89B5DFA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_EAB7314667573E869D48B570A89B5DFA" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_EAB7314667573E869D48B570A89B5DFA" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>20
<FILENAME>dxcm-20191231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails" xlink:href="dxcm-20191231.xsd#AntiDilutiveSecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsAccountsReceivableDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsAccruedWarrantyDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsInventoryDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsOtherLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsPropertyAndEquipmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsTables" xlink:href="dxcm-20191231.xsd#BalanceSheetDetailsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformation" xlink:href="dxcm-20191231.xsd#BusinessSegmentAndGeographicInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationNarrativeDetails" xlink:href="dxcm-20191231.xsd#BusinessSegmentAndGeographicInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails" xlink:href="dxcm-20191231.xsd#BusinessSegmentAndGeographicInformationSummaryDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationTables" xlink:href="dxcm-20191231.xsd#BusinessSegmentAndGeographicInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheets" xlink:href="dxcm-20191231.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="dxcm-20191231.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="dxcm-20191231.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" xlink:href="dxcm-20191231.xsd#ConsolidatedStatementsOfComprehensiveIncomeLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfOperations" xlink:href="dxcm-20191231.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="dxcm-20191231.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/Contingencies" xlink:href="dxcm-20191231.xsd#Contingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ContingenciesNarrativeDetails" xlink:href="dxcm-20191231.xsd#ContingenciesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/CoverPage" xlink:href="dxcm-20191231.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails" xlink:href="dxcm-20191231.xsd#DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails" xlink:href="dxcm-20191231.xsd#DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails" xlink:href="dxcm-20191231.xsd#DebtConversionValueOfConvertibleNotesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtDebt" xlink:href="dxcm-20191231.xsd#DebtDebt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:href="dxcm-20191231.xsd#DebtNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:href="dxcm-20191231.xsd#DebtSeniorConvertibleNotesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtTables" xlink:href="dxcm-20191231.xsd#DebtTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentAndOtherAgreements" xlink:href="dxcm-20191231.xsd#DevelopmentAndOtherAgreements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails" xlink:href="dxcm-20191231.xsd#DevelopmentAndOtherAgreementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquity" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityIntrinsicValueOfOptionsExercisedAndFairValueOfOptionsVestedDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityIntrinsicValueOfOptionsExercisedAndFairValueOfOptionsVestedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityTables" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails" xlink:href="dxcm-20191231.xsd#EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurements" xlink:href="dxcm-20191231.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails" xlink:href="dxcm-20191231.xsd#FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails" xlink:href="dxcm-20191231.xsd#FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="dxcm-20191231.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:href="dxcm-20191231.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxes" xlink:href="dxcm-20191231.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesComponentsOfProvisionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesTables" xlink:href="dxcm-20191231.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:href="dxcm-20191231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitments" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitmentsLeaseCostDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitmentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitmentsOtherInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables" xlink:href="dxcm-20191231.xsd#LeasesAndOtherCommitmentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPolicies" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenueRecognizedFromChangesInContractLiabilityBalancesDetails" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesRevenueRecognizedFromChangesInContractLiabilityBalancesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesTables" xlink:href="dxcm-20191231.xsd#OrganizationAndSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedQuarterlyFinancialInformationUnaudited" xlink:href="dxcm-20191231.xsd#QuarterlyFinancialInformationUnauditedQuarterlyFinancialInformationUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedSummaryDetails" xlink:href="dxcm-20191231.xsd#QuarterlyFinancialInformationUnauditedSummaryDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:href="dxcm-20191231.xsd#QuarterlyFinancialInformationUnauditedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:href="dxcm-20191231.xsd#ScheduleIiValuationAndQualifyingAccounts" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:href="dxcm-20191231.xsd#ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_E841F509A0142436B0D4C9C2EF85DE09" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0EE1FF482383D0FFB9BAC9C2EF86F88A" xlink:type="locator" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_E841F509A0142436B0D4C9C2EF85DE09" xlink:to="loc_us-gaap_AccountingPoliciesAbstract_0EE1FF482383D0FFB9BAC9C2EF86F88A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_005B2164B99B8CF003BBC9C2EF86626F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0EE1FF482383D0FFB9BAC9C2EF86F88A" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_005B2164B99B8CF003BBC9C2EF86626F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_7D87AA772FE9A1D6A504C9C2EF862D58" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_005B2164B99B8CF003BBC9C2EF86626F" xlink:to="loc_us-gaap_DebtInstrumentAxis_7D87AA772FE9A1D6A504C9C2EF862D58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_55D26F726E4F4584FF08C9C2EF8783A9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7D87AA772FE9A1D6A504C9C2EF862D58" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_55D26F726E4F4584FF08C9C2EF8783A9" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2022Member" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_5A3AB53C2C25EE887C73C9C2EF87C9AB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55D26F726E4F4584FF08C9C2EF8783A9" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_5A3AB53C2C25EE887C73C9C2EF87C9AB" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2023Member" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_DC255A80A4B866A11499C9C2EF876F29" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55D26F726E4F4584FF08C9C2EF8783A9" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_DC255A80A4B866A11499C9C2EF876F29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7E622335A788F86B4234C9C2EF8768A8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_005B2164B99B8CF003BBC9C2EF86626F" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7E622335A788F86B4234C9C2EF8768A8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7E622335A788F86B4234C9C2EF8768A8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_08C91092FBBF31CA749CC9C2EF88D591" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB" xlink:to="loc_us-gaap_EmployeeStockOptionMember_08C91092FBBF31CA749CC9C2EF88D591" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5BB861A526D68DAB44E6C9C2EF8875F1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5BB861A526D68DAB44E6C9C2EF8875F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_2E5EA1C5A9FBAD754303C9C2EF88A1BC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB" xlink:to="loc_us-gaap_WarrantMember_2E5EA1C5A9FBAD754303C9C2EF88A1BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_8680D115E46763A6DAADC9C2EF89A3DC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_EAA6B60F3B17FA1627D8C9C2EF88D5BB" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_8680D115E46763A6DAADC9C2EF89A3DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_B30818D9B4542ECFA629C9C2EF89E829" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_005B2164B99B8CF003BBC9C2EF86626F" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_B30818D9B4542ECFA629C9C2EF89E829" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D23E621F7B95E382AFF0C9C2EF89E4F0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_B30818D9B4542ECFA629C9C2EF89E829" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D23E621F7B95E382AFF0C9C2EF89E4F0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_F34AD7A0BEA45A2C1F7EAB511CE79572" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_0E5B0C0C7ABBC9587C11AB511CE827A8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_F34AD7A0BEA45A2C1F7EAB511CE79572" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_0E5B0C0C7ABBC9587C11AB511CE827A8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_AB72073C174026D048D3B570A88C11DD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_AC7F521D1771C179A2E3B570A88C849E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_AB72073C174026D048D3B570A88C11DD" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_AC7F521D1771C179A2E3B570A88C849E" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_AccruedTaxAuditAndLegalFees" xlink:label="loc_dxcm_AccruedTaxAuditAndLegalFees_AE5E21241B703BF14100B570A88D6A01" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_AB72073C174026D048D3B570A88C11DD" xlink:to="loc_dxcm_AccruedTaxAuditAndLegalFees_AE5E21241B703BF14100B570A88D6A01" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PharmacyRebates" xlink:label="loc_dxcm_PharmacyRebates_B9577C5CD41527CE992AB570A88D56A4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_AB72073C174026D048D3B570A88C11DD" xlink:to="loc_dxcm_PharmacyRebates_B9577C5CD41527CE992AB570A88D56A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_0D115B7D7F54C21EE25DB570A88D1A59" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_AB72073C174026D048D3B570A88C11DD" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_0D115B7D7F54C21EE25DB570A88D1A59" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_9520C1870849E5EBDB14B570A88D552D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_AB72073C174026D048D3B570A88C11DD" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_9520C1870849E5EBDB14B570A88D552D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_71FCC26D1FCE7A05B1F9B570A88DFE0B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_AB72073C174026D048D3B570A88C11DD" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_71FCC26D1FCE7A05B1F9B570A88DFE0B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_4880F9D40A988C3794D9B570A8B098BF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableGross" xlink:label="loc_us-gaap_AccountsReceivableGross_56E852623C12D18117DCB570A8B15196" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_4880F9D40A988C3794D9B570A8B098BF" xlink:to="loc_us-gaap_AccountsReceivableGross_56E852623C12D18117DCB570A8B15196" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_DBA7018CEB2BEF8341D7B570A8B1B518" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_4880F9D40A988C3794D9B570A8B098BF" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_DBA7018CEB2BEF8341D7B570A8B1B518" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaap_AccountsReceivableNet_C5612738884724C9E849B570A8B1A48A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_4880F9D40A988C3794D9B570A8B098BF" xlink:to="loc_us-gaap_AccountsReceivableNet_C5612738884724C9E849B570A8B1A48A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_65B5837B8E675AC859720E443E5F5AD0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12E69AF93355B54F995D0E443E5F9C8C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_65B5837B8E675AC859720E443E5F5AD0" xlink:to="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12E69AF93355B54F995D0E443E5F9C8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_BBC36EF50854D00BFCD50E443E5F683C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12E69AF93355B54F995D0E443E5F9C8C" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_BBC36EF50854D00BFCD50E443E5F683C" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses" xlink:label="loc_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_766CAC7B3FB65B2668440E443E60D54C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12E69AF93355B54F995D0E443E5F9C8C" xlink:to="loc_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_766CAC7B3FB65B2668440E443E60D54C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_239ED4A3A7F34F28D3090E443E60763E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12E69AF93355B54F995D0E443E5F9C8C" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_239ED4A3A7F34F28D3090E443E60763E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_CBBE45A6A92AA4E361000E443E6090C2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12E69AF93355B54F995D0E443E5F9C8C" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_CBBE45A6A92AA4E361000E443E6090C2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_3269E84DABFA826D2911B570A8A6DAC5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_19241D9903298A75227BB570A8A8CB0E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_3269E84DABFA826D2911B570A8A6DAC5" xlink:to="loc_us-gaap_InventoryDisclosureAbstract_19241D9903298A75227BB570A8A8CB0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_A6DEDFA75BE3F74472B2B570A8A84F83" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_19241D9903298A75227BB570A8A8CB0E" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_A6DEDFA75BE3F74472B2B570A8A84F83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_42011EE8B218D5E9A17AB570A8A81C67" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_19241D9903298A75227BB570A8A8CB0E" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_42011EE8B218D5E9A17AB570A8A81C67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_9D14EACBAD8A8D57181AB570A8A8C2AE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_19241D9903298A75227BB570A8A8CB0E" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_9D14EACBAD8A8D57181AB570A8A8C2AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_A7C3419A7BD337E16945B570A8A8FCBE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_19241D9903298A75227BB570A8A8CB0E" xlink:to="loc_us-gaap_InventoryNet_A7C3419A7BD337E16945B570A8A8FCBE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_1D648BF6B52848152ACD1BE3D1CBCC7A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_CD6D7EFFAD97174592691BE3D1CB5B10" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_1D648BF6B52848152ACD1BE3D1CBCC7A" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_CD6D7EFFAD97174592691BE3D1CB5B10" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_639D8BCAB4A2FD51B7721BE3D1CB076D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_CD6D7EFFAD97174592691BE3D1CB5B10" xlink:to="loc_srt_ProductOrServiceAxis_639D8BCAB4A2FD51B7721BE3D1CB076D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_7612223BF21D57E575E51BE3D1CCA9CE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_639D8BCAB4A2FD51B7721BE3D1CB076D" xlink:to="loc_srt_ProductsAndServicesDomain_7612223BF21D57E575E51BE3D1CCA9CE" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ReceiverProductComponentMember" xlink:label="loc_dxcm_ReceiverProductComponentMember_079E9A6CEDAD5CC10F291BE3D1CC0BD6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7612223BF21D57E575E51BE3D1CCA9CE" xlink:to="loc_dxcm_ReceiverProductComponentMember_079E9A6CEDAD5CC10F291BE3D1CC0BD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5EA4321873B2A1491D941BE3D1CCA422" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_CD6D7EFFAD97174592691BE3D1CB5B10" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5EA4321873B2A1491D941BE3D1CCA422" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_BFAA252C766F5DB3E0091BE3D1CDCB79" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5EA4321873B2A1491D941BE3D1CCA422" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_BFAA252C766F5DB3E0091BE3D1CDCB79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaap_ConstructionInProgressMember_7E805005EAF44C7245461BE3D1CDEEAA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_BFAA252C766F5DB3E0091BE3D1CDCB79" xlink:to="loc_us-gaap_ConstructionInProgressMember_7E805005EAF44C7245461BE3D1CDEEAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_CD6D7EFFAD97174592691BE3D1CB5B10" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_09110C80EF23A5BAC2E01BE3D1CD4025" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_09110C80EF23A5BAC2E01BE3D1CD4025" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaap_InventoryWriteDown_2853544E4F0BD4EA24D41BE3D1CDFE6B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:to="loc_us-gaap_InventoryWriteDown_2853544E4F0BD4EA24D41BE3D1CDFE6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_0E2A23FDDC41F52A92061BE3D1CE701D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:to="loc_us-gaap_Depreciation_0E2A23FDDC41F52A92061BE3D1CE701D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0FB3BBB7973B7876CE011BE3D1CE28AE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0FB3BBB7973B7876CE011BE3D1CE28AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_477946D853193AFDE40A1BE3D1CECC2C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_A944DE552B9E75C54AF91BE3D1CD9B07" xlink:to="loc_us-gaap_RestructuringCharges_477946D853193AFDE40A1BE3D1CECC2C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_CFBC584B5328240087D6B58D6EC976DF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_D718C07682994E3E137AB58EB21FC902" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_CFBC584B5328240087D6B58D6EC976DF" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_D718C07682994E3E137AB58EB21FC902" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_606B3B02870674804D0FB58EB2217FD5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_D718C07682994E3E137AB58EB21FC902" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_606B3B02870674804D0FB58EB2217FD5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_7B8470CFEC11E9E44051B58EB221122A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_D718C07682994E3E137AB58EB21FC902" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_7B8470CFEC11E9E44051B58EB221122A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_3199A64948C3D187012CB58EB2216417" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract_D718C07682994E3E137AB58EB21FC902" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_3199A64948C3D187012CB58EB2216417" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_397984C280487B24F735F38B00BB0A62" xlink:type="locator" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FinancingLeaseObligation" xlink:label="loc_dxcm_FinancingLeaseObligation_29E7476629FD4930E9AAF38B00BCA4F7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_397984C280487B24F735F38B00BB0A62" xlink:to="loc_dxcm_FinancingLeaseObligation_29E7476629FD4930E9AAF38B00BCA4F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent_C1C7E42AFE9424402677F38B00BC379B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_397984C280487B24F735F38B00BB0A62" xlink:to="loc_us-gaap_DeferredRentCreditNoncurrent_C1C7E42AFE9424402677F38B00BC379B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_CC8D7406C9DD809B694AF38B00BC52A0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_397984C280487B24F735F38B00BB0A62" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_CC8D7406C9DD809B694AF38B00BC52A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_9596D6DCF20B27F1BE88F38B00BCE1A9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_397984C280487B24F735F38B00BB0A62" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_9596D6DCF20B27F1BE88F38B00BCE1A9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_22C525321BDA394E73F9B570A8984911" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80F5D7739CB3750F8F23B570A898252B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_22C525321BDA394E73F9B570A8984911" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80F5D7739CB3750F8F23B570A898252B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ABD90C89902816E4DDEB570A89979B7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80F5D7739CB3750F8F23B570A898252B" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ABD90C89902816E4DDEB570A89979B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ABD90C89902816E4DDEB570A89979B7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaap_BuildingMember_4FE7BCBBDA272B7F2EBBB570A89AB20F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18" xlink:to="loc_us-gaap_BuildingMember_4FE7BCBBDA272B7F2EBBB570A89AB20F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_14DEF0AA6076CCAD91FDB570A89AD267" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_14DEF0AA6076CCAD91FDB570A89AD267" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_0B4FDBA25C952AE716FAB570A89A2BFE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18" xlink:to="loc_us-gaap_ComputerEquipmentMember_0B4FDBA25C952AE716FAB570A89A2BFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaap_EquipmentMember_FE91F84F6EB01E687C98B570A89ABFC0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18" xlink:to="loc_us-gaap_EquipmentMember_FE91F84F6EB01E687C98B570A89ABFC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_49683A91B6B8C0FD746BB570A89AF8AB" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_49683A91B6B8C0FD746BB570A89AF8AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaap_ConstructionInProgressMember_F09484251379FACD2FECB570A89B7083" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1B3648E5F020E1696681B570A8990B18" xlink:to="loc_us-gaap_ConstructionInProgressMember_F09484251379FACD2FECB570A89B7083" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2A3DDFFC5272A4256851B570A89B3F5C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80F5D7739CB3750F8F23B570A898252B" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2A3DDFFC5272A4256851B570A89B3F5C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_43320E2489793F76C88CB570A89B65C0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2A3DDFFC5272A4256851B570A89B3F5C" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_43320E2489793F76C88CB570A89B65C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_978B7458C547390AA804B570A89BF129" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2A3DDFFC5272A4256851B570A89B3F5C" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_978B7458C547390AA804B570A89BF129" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_EAB7314667573E869D48B570A89B5DFA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2A3DDFFC5272A4256851B570A89B3F5C" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_EAB7314667573E869D48B570A89B5DFA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_45AAA0E3FF1192DDA01AB570A8BB974D" xlink:type="locator" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FinancialStatementDetailsTable" xlink:label="loc_dxcm_FinancialStatementDetailsTable_9DBF1CDCD8342BAA967EB570A8BB2B58" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_45AAA0E3FF1192DDA01AB570A8BB974D" xlink:to="loc_dxcm_FinancialStatementDetailsTable_9DBF1CDCD8342BAA967EB570A8BB2B58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_EA545335FAB409F5760CB570A8BC1275" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_FinancialStatementDetailsTable_9DBF1CDCD8342BAA967EB570A8BB2B58" xlink:to="loc_us-gaap_FinancialInstrumentAxis_EA545335FAB409F5760CB570A8BC1275" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_EA545335FAB409F5760CB570A8BC1275" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_7C5012D11ACDEBD478DEB570A8BD5E60" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_7C5012D11ACDEBD478DEB570A8BD5E60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_C5328C3D3DC7BB2EA13EB570A8BDF012" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95" xlink:to="loc_us-gaap_CommercialPaperMember_C5328C3D3DC7BB2EA13EB570A8BDF012" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_6217DDE072E108F0369FB570A8BD0086" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6A3F4C608A5BD03CE644B570A8BDEC95" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_6217DDE072E108F0369FB570A8BD0086" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FinancialStatementDetailsLineItems" xlink:label="loc_dxcm_FinancialStatementDetailsLineItems_08C164A0CFD73D207504B570A8BD977F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_FinancialStatementDetailsTable_9DBF1CDCD8342BAA967EB570A8BB2B58" xlink:to="loc_dxcm_FinancialStatementDetailsLineItems_08C164A0CFD73D207504B570A8BD977F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesGainLossAbstract" xlink:label="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_FinancialStatementDetailsLineItems_08C164A0CFD73D207504B570A8BD977F" xlink:to="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiCost" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_C632017D5B173F30A95AB570A8BE8792" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCost_C632017D5B173F30A95AB570A8BE8792" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_A196B24506B24A1B6E09B570A8BE3C99" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_A196B24506B24A1B6E09B570A8BE3C99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_87AF23B4C64EC6C98D3AB570A8BE7813" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_87AF23B4C64EC6C98D3AB570A8BE7813" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_70943FF07B54D96CA93BB570A8BE47A9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract_25755767B63D71DBFF99B592E1B0BB0F" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_70943FF07B54D96CA93BB570A8BE47A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C24C728248B918CE0B21B570A8BF0656" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C24C728248B918CE0B21B570A8BF0656" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_C4951D1D35301A792AEBB570A8BF701A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_C4951D1D35301A792AEBB570A8BF701A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4D7C293616389F98F2C4B570A8BF1236" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4D7C293616389F98F2C4B570A8BF1236" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71088CD8A373991D0456B570A8BF95F0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_50C602B3DBBA7E1BBCA3B570A8BF2EC0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71088CD8A373991D0456B570A8BF95F0" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost_9AB57DDE39EFD5C0C3F9B570A8BFD27A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost_9AB57DDE39EFD5C0C3F9B570A8BFD27A" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain_E1F1A2FC254FBEA23C5FB570A8C02FB8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain_E1F1A2FC254FBEA23C5FB570A8C02FB8" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss_17056E04469A85E5B90CB570A8C0FD3C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss_17056E04469A85E5B90CB570A8C0FD3C" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_BCFDA11010A216900A54B570A8C062C0" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossAbstract_6B9B583B8D368A396DECB570A8BDAC4E" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_BCFDA11010A216900A54B570A8C062C0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_E1BAD0BB8E99D3F12B53B570A8CC96CE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_094FC73E2967501E23F8B570A8CC2093" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_E1BAD0BB8E99D3F12B53B570A8CC96CE" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_094FC73E2967501E23F8B570A8CC2093" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnInvestmentsTextBlock" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock_FD4095EEE1D6A7D5DE6CB570A8CC97CE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_E1BAD0BB8E99D3F12B53B570A8CC96CE" xlink:to="loc_us-gaap_GainLossOnInvestmentsTextBlock_FD4095EEE1D6A7D5DE6CB570A8CC97CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_613233148F3BDA2D3ACDB570A8CD19B0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_E1BAD0BB8E99D3F12B53B570A8CC96CE" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_613233148F3BDA2D3ACDB570A8CD19B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_F427A700D43678498BEEB570A8CD8943" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_E1BAD0BB8E99D3F12B53B570A8CC96CE" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_F427A700D43678498BEEB570A8CD8943" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_51428128216E23FFABB7B570A8CD30D5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_E1BAD0BB8E99D3F12B53B570A8CC96CE" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_51428128216E23FFABB7B570A8CD30D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_363A77057DABB2661CB1B570A8CD6328" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_E1BAD0BB8E99D3F12B53B570A8CC96CE" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_363A77057DABB2661CB1B570A8CD6328" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_E0B2AAE6FF643B82D266B570A8CD2017" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_E1BAD0BB8E99D3F12B53B570A8CC96CE" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_E0B2AAE6FF643B82D266B570A8CD2017" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_247882BE2E4BA771AE9EB570A8CD21D2" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_E1BAD0BB8E99D3F12B53B570A8CC96CE" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_247882BE2E4BA771AE9EB570A8CD21D2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_458D66C2F62A2755A1E1D354A3F006FA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_3467734AD683D6B95664D354A3F0BC3C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_458D66C2F62A2755A1E1D354A3F006FA" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_3467734AD683D6B95664D354A3F0BC3C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_20CCC937524C25B85B9AAB75C7DA9588" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_43564D284C510E2E41E8AB75C86D5115" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_20CCC937524C25B85B9AAB75C7DA9588" xlink:to="loc_us-gaap_NumberOfReportableSegments_43564D284C510E2E41E8AB75C86D5115" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_CAFF325DCB3FCB1EADCFAF6BBCE0FAAD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_D85E8FB9E30F975D2DA8AF6BBCE03E7E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_CAFF325DCB3FCB1EADCFAF6BBCE0FAAD" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_D85E8FB9E30F975D2DA8AF6BBCE03E7E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_6D1F7EBE104500D7F2CAAF6BBD1EF11E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_D85E8FB9E30F975D2DA8AF6BBCE03E7E" xlink:to="loc_srt_StatementGeographicalAxis_6D1F7EBE104500D7F2CAAF6BBD1EF11E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_3CF90B117D49FFBDC029AF6BBD1E21F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_6D1F7EBE104500D7F2CAAF6BBD1EF11E" xlink:to="loc_srt_SegmentGeographicalDomain_3CF90B117D49FFBDC029AF6BBD1E21F4" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_6458819F84A7B537E7A6AF6BBD1FC4D1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3CF90B117D49FFBDC029AF6BBD1E21F4" xlink:to="loc_country_US_6458819F84A7B537E7A6AF6BBD1FC4D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_BB0FBE89C88EE1114C8AAF6BBD1FB413" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3CF90B117D49FFBDC029AF6BBD1E21F4" xlink:to="loc_us-gaap_NonUsMember_BB0FBE89C88EE1114C8AAF6BBD1FB413" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ADA6DCB2052F4A2E3F93AF6BBD1DBBD2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_D85E8FB9E30F975D2DA8AF6BBCE03E7E" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ADA6DCB2052F4A2E3F93AF6BBD1DBBD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_5983E860EF8EC07DD35AAF6BBD1D48F3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ADA6DCB2052F4A2E3F93AF6BBD1DBBD2" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_5983E860EF8EC07DD35AAF6BBD1D48F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_C9F490230DD730C49089AF6BBD1ED59A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_5983E860EF8EC07DD35AAF6BBD1D48F3" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_C9F490230DD730C49089AF6BBD1ED59A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_DFBCAEFFD29DC42E97C1AF6BBD1EA54D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_5983E860EF8EC07DD35AAF6BBD1D48F3" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_DFBCAEFFD29DC42E97C1AF6BBD1EA54D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_A1EB4F8C37EBCDB4EBBCAF6BBD1F6AD1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_D85E8FB9E30F975D2DA8AF6BBCE03E7E" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_A1EB4F8C37EBCDB4EBBCAF6BBD1F6AD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_CDB47FED595D4405AD9FAF6BBD1FFFDF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_A1EB4F8C37EBCDB4EBBCAF6BBD1F6AD1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_CDB47FED595D4405AD9FAF6BBD1FFFDF" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_RevenuePercentage" xlink:label="loc_dxcm_RevenuePercentage_EE38F9287384D3CA0493AF6BBD2054C2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_A1EB4F8C37EBCDB4EBBCAF6BBD1F6AD1" xlink:to="loc_dxcm_RevenuePercentage_EE38F9287384D3CA0493AF6BBD2054C2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_C3032C980FC1B94B7CAFAF6BBD2578D8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_BEF725650D3226407948AF6BBD26CB92" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_C3032C980FC1B94B7CAFAF6BBD2578D8" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_BEF725650D3226407948AF6BBD26CB92" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_058A75F6F9F90C4059AFAF6BBD260276" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_C3032C980FC1B94B7CAFAF6BBD2578D8" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_058A75F6F9F90C4059AFAF6BBD260276" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_10EC0705DF90178E12301BEB0F2ABAA4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_416C322B18A1AAAD31141BEB0F2B1639" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_10EC0705DF90178E12301BEB0F2ABAA4" xlink:to="loc_us-gaap_AssetsAbstract_416C322B18A1AAAD31141BEB0F2B1639" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_D8DFEC2937C2971851231BEB0F2B54F0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_416C322B18A1AAAD31141BEB0F2B1639" xlink:to="loc_us-gaap_AssetsCurrentAbstract_D8DFEC2937C2971851231BEB0F2B54F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_BBC473CD3C17048BBF451BEB0F2B859D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_D8DFEC2937C2971851231BEB0F2B54F0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_BBC473CD3C17048BBF451BEB0F2B859D" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_074650178696F67CC92E1BEB0F2C9814" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_D8DFEC2937C2971851231BEB0F2B54F0" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_074650178696F67CC92E1BEB0F2C9814" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_2F95E2FE02EB12BB04071BEB0F2C6A36" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_D8DFEC2937C2971851231BEB0F2B54F0" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_2F95E2FE02EB12BB04071BEB0F2C6A36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_6FA0B37BE164946288801BEB0F2C5CCD" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_D8DFEC2937C2971851231BEB0F2B54F0" xlink:to="loc_us-gaap_InventoryNet_6FA0B37BE164946288801BEB0F2C5CCD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_FFABBAFF65BFB8B3C9741BEB0F315C88" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_D8DFEC2937C2971851231BEB0F2B54F0" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_FFABBAFF65BFB8B3C9741BEB0F315C88" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_8D186DE654A14F102E381BEB0F327AE3" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_D8DFEC2937C2971851231BEB0F2B54F0" xlink:to="loc_us-gaap_AssetsCurrent_8D186DE654A14F102E381BEB0F327AE3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_79408677CC11DA03C1F51BEB0F329036" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_416C322B18A1AAAD31141BEB0F2B1639" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_79408677CC11DA03C1F51BEB0F329036" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_5660F91C1C87AE67C6A61BEB0F323C5E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_416C322B18A1AAAD31141BEB0F2B1639" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_5660F91C1C87AE67C6A61BEB0F323C5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_ABE035D8860F311428151BEB0F32C8CB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_416C322B18A1AAAD31141BEB0F2B1639" xlink:to="loc_us-gaap_Goodwill_ABE035D8860F311428151BEB0F32C8CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9D1A66F2AC761CCA02AA1BEB0F32AC1E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_416C322B18A1AAAD31141BEB0F2B1639" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9D1A66F2AC761CCA02AA1BEB0F32AC1E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_A0D800DD615DCD97E88E1BEB0F32B74A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_416C322B18A1AAAD31141BEB0F2B1639" xlink:to="loc_us-gaap_Assets_A0D800DD615DCD97E88E1BEB0F32B74A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5496E47967BC0D6F07581BEB0F331C97" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_10EC0705DF90178E12301BEB0F2ABAA4" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5496E47967BC0D6F07581BEB0F331C97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_F56C992661FC86FC8FC31BEB0F33A0E1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5496E47967BC0D6F07581BEB0F331C97" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_F56C992661FC86FC8FC31BEB0F33A0E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_D0CA158C7D834E04B4D61BEB0F33D8F5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_F56C992661FC86FC8FC31BEB0F33A0E1" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_D0CA158C7D834E04B4D61BEB0F33D8F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_A164E04299A720648C7C1BEB0F33CF5C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_F56C992661FC86FC8FC31BEB0F33A0E1" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_A164E04299A720648C7C1BEB0F33CF5C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_DEC0AEFE6A3FCFF65BCB1BEB0F337796" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_F56C992661FC86FC8FC31BEB0F33A0E1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_DEC0AEFE6A3FCFF65BCB1BEB0F337796" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_C85360E6C9D3B232630C1BEB0F34A5BA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_F56C992661FC86FC8FC31BEB0F33A0E1" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_C85360E6C9D3B232630C1BEB0F34A5BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_6B9BAC9D769691841B771BEB0F340DDE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_F56C992661FC86FC8FC31BEB0F33A0E1" xlink:to="loc_us-gaap_LiabilitiesCurrent_6B9BAC9D769691841B771BEB0F340DDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_2CA803C64168695E24B41BEB0F3487BE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5496E47967BC0D6F07581BEB0F331C97" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_2CA803C64168695E24B41BEB0F3487BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7A0C1696B13EA91754F21BEB0F34F50F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5496E47967BC0D6F07581BEB0F331C97" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7A0C1696B13EA91754F21BEB0F34F50F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7148CBE7CFEF58DBAB701BEB0F3402A8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5496E47967BC0D6F07581BEB0F331C97" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7148CBE7CFEF58DBAB701BEB0F3402A8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_45E96CA86F5E493725031BEB0F340C2B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5496E47967BC0D6F07581BEB0F331C97" xlink:to="loc_us-gaap_Liabilities_45E96CA86F5E493725031BEB0F340C2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_954D8E47463A075E936D1BEB0F35B6AD" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5496E47967BC0D6F07581BEB0F331C97" xlink:to="loc_us-gaap_CommitmentsAndContingencies_954D8E47463A075E936D1BEB0F35B6AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_6A605B5BDB703041499C1BEB0F354D7B" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5496E47967BC0D6F07581BEB0F331C97" xlink:to="loc_us-gaap_StockholdersEquityAbstract_6A605B5BDB703041499C1BEB0F354D7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValueOutstanding" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_205E60EE7D76DBC4525E1BEB0F354137" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6A605B5BDB703041499C1BEB0F354D7B" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_205E60EE7D76DBC4525E1BEB0F354137" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValueOutstanding" xlink:label="loc_us-gaap_CommonStockValueOutstanding_B39DE69500351B029CD41BEB0F35CDF7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6A605B5BDB703041499C1BEB0F354D7B" xlink:to="loc_us-gaap_CommonStockValueOutstanding_B39DE69500351B029CD41BEB0F35CDF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2D8BC6A7D40DBEA7AD131BEB0F354F6D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6A605B5BDB703041499C1BEB0F354D7B" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2D8BC6A7D40DBEA7AD131BEB0F354F6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_C166F5FFC9B7C05DEE251BEB0F36719F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6A605B5BDB703041499C1BEB0F354D7B" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_C166F5FFC9B7C05DEE251BEB0F36719F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_574B98345D231DF5563A1BEB0F3621B4" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6A605B5BDB703041499C1BEB0F354D7B" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_574B98345D231DF5563A1BEB0F3621B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_25CAD8752A54C97F10301BEB0F3643BC" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6A605B5BDB703041499C1BEB0F354D7B" xlink:to="loc_us-gaap_TreasuryStockValue_25CAD8752A54C97F10301BEB0F3643BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_747DB6D6C5BD71E7E4CB1BEB0F36D072" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6A605B5BDB703041499C1BEB0F354D7B" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_747DB6D6C5BD71E7E4CB1BEB0F36D072" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8F036399BFE0FF1A3F2C1BEB0F363546" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5496E47967BC0D6F07581BEB0F331C97" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8F036399BFE0FF1A3F2C1BEB0F363546" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_A25B47681C89D6B290FFAB017E6355B2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_4214F314196B0B17C609AB017E631E54" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A25B47681C89D6B290FFAB017E6355B2" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_4214F314196B0B17C609AB017E631E54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_4EAD7B15998B166C252CAB017E63BB6B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A25B47681C89D6B290FFAB017E6355B2" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_4EAD7B15998B166C252CAB017E63BB6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_0B2D3610A2724BEFB280AB017E6312C5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A25B47681C89D6B290FFAB017E6355B2" xlink:to="loc_us-gaap_PreferredStockSharesIssued_0B2D3610A2724BEFB280AB017E6312C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_9A65A025DEC783BC3401AB017E64444D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A25B47681C89D6B290FFAB017E6355B2" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_9A65A025DEC783BC3401AB017E64444D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_B900779FF0D072C5CB50AB017E648B7F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A25B47681C89D6B290FFAB017E6355B2" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_B900779FF0D072C5CB50AB017E648B7F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_172B120A41FE50E6108AAB017E64C3EB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A25B47681C89D6B290FFAB017E6355B2" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_172B120A41FE50E6108AAB017E64C3EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_4619ACA6CAB5005DFE52AB017E663088" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A25B47681C89D6B290FFAB017E6355B2" xlink:to="loc_us-gaap_CommonStockSharesIssued_4619ACA6CAB5005DFE52AB017E663088" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_EE77900260B8ACE6A52CAB017E66390F" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A25B47681C89D6B290FFAB017E6355B2" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_EE77900260B8ACE6A52CAB017E66390F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_744E6329DC3B436963FFAB017E674FE2" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A25B47681C89D6B290FFAB017E6355B2" xlink:to="loc_us-gaap_TreasuryStockShares_744E6329DC3B436963FFAB017E674FE2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_5A8E9B32969997BF46A61BEB0E9429BE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_656B4E5602E2D50171481BEB0E959271" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5A8E9B32969997BF46A61BEB0E9429BE" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_656B4E5602E2D50171481BEB0E959271" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_BE65DCADB91BACDC1D161BEB0E9A7502" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_656B4E5602E2D50171481BEB0E959271" xlink:to="loc_us-gaap_NetIncomeLoss_BE65DCADB91BACDC1D161BEB0E9A7502" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7FA35CFF68DD38C53EFE1BEB0E9AB07D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_656B4E5602E2D50171481BEB0E959271" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7FA35CFF68DD38C53EFE1BEB0E9AB07D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9EAB597D7D20ED4710BC1BEB0E9ADBA0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7FA35CFF68DD38C53EFE1BEB0E9AB07D" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9EAB597D7D20ED4710BC1BEB0E9ADBA0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_FDC5B81F8E97EAABB8CA1BEB0E9CEF95" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7FA35CFF68DD38C53EFE1BEB0E9AB07D" xlink:to="loc_us-gaap_ShareBasedCompensation_FDC5B81F8E97EAABB8CA1BEB0E9CEF95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_57D3803244910D874E111BEB0E9CD69C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7FA35CFF68DD38C53EFE1BEB0E9AB07D" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_57D3803244910D874E111BEB0E9CD69C" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_RDexpensethroughissuanceofcommonstock" xlink:label="loc_dxcm_RDexpensethroughissuanceofcommonstock_BF3928AEF074C668D78F1BEB0E9C0CC0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7FA35CFF68DD38C53EFE1BEB0E9AB07D" xlink:to="loc_dxcm_RDexpensethroughissuanceofcommonstock_BF3928AEF074C668D78F1BEB0E9C0CC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_6821F871758B2EB3296A1BEB0E9CABE7" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7FA35CFF68DD38C53EFE1BEB0E9AB07D" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_6821F871758B2EB3296A1BEB0E9CABE7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_8FEF7A8594D0FBA697001BEB0E9DE77C" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7FA35CFF68DD38C53EFE1BEB0E9AB07D" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_8FEF7A8594D0FBA697001BEB0E9DE77C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_3BFBAD70CDFD172F28F41BEB0E9D4574" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7FA35CFF68DD38C53EFE1BEB0E9AB07D" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_3BFBAD70CDFD172F28F41BEB0E9D4574" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_449571C065CA212B98B81BEB0E9D389E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_656B4E5602E2D50171481BEB0E959271" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_449571C065CA212B98B81BEB0E9D389E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1F5EB2E2DB4930D5E9831BEB0E9D41CF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_449571C065CA212B98B81BEB0E9D389E" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1F5EB2E2DB4930D5E9831BEB0E9D41CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_183BC861A95D64DD0D7B1BEB0E9D121B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_449571C065CA212B98B81BEB0E9D389E" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_183BC861A95D64DD0D7B1BEB0E9D121B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_449448BA9C2DF7861C891BEB0E9DD4B2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_449571C065CA212B98B81BEB0E9D389E" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_449448BA9C2DF7861C891BEB0E9DD4B2" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:label="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_97984C4CFCB3F0B5C8DE1BEB0E9E65A0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_449571C065CA212B98B81BEB0E9D389E" xlink:to="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_97984C4CFCB3F0B5C8DE1BEB0E9E65A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4B1B3A5B2C36F662409A1BEB0E9E80DF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_449571C065CA212B98B81BEB0E9D389E" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4B1B3A5B2C36F662409A1BEB0E9E80DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_F4BC0D1EFB6872DDF1DF1BEB0E9EE510" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_449571C065CA212B98B81BEB0E9D389E" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_F4BC0D1EFB6872DDF1DF1BEB0E9EE510" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_3128F6253CEBAB86146E1BEB0E9EC6EC" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_449571C065CA212B98B81BEB0E9D389E" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_3128F6253CEBAB86146E1BEB0E9EC6EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78AB7258C7B1FCE361A21BEB0E9EDB23" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_449571C065CA212B98B81BEB0E9D389E" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78AB7258C7B1FCE361A21BEB0E9EDB23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_CBC9D0D123E5ECB8CA461BEB0E9E2CEB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5A8E9B32969997BF46A61BEB0E9429BE" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_CBC9D0D123E5ECB8CA461BEB0E9E2CEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_38E7CE86E116B780445F1BEB0E9F2B1E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_CBC9D0D123E5ECB8CA461BEB0E9E2CEB" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_38E7CE86E116B780445F1BEB0E9F2B1E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_480EA09A5CC61B45C7A31BEB0E9F9287" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_CBC9D0D123E5ECB8CA461BEB0E9E2CEB" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_480EA09A5CC61B45C7A31BEB0E9F9287" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_B72A51A1AEA9D79E5E131BEB0E9F68A9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_CBC9D0D123E5ECB8CA461BEB0E9E2CEB" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_B72A51A1AEA9D79E5E131BEB0E9F68A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_97A74FDA51324AF46AC51BEB0E9F22AB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_CBC9D0D123E5ECB8CA461BEB0E9E2CEB" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_97A74FDA51324AF46AC51BEB0E9F22AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D65992FC880870D6B4601BEB0E9F6ABE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_CBC9D0D123E5ECB8CA461BEB0E9E2CEB" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D65992FC880870D6B4601BEB0E9F6ABE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_F2667A0C7A3360FD68EC1BEB0EA0B938" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_CBC9D0D123E5ECB8CA461BEB0E9E2CEB" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_F2667A0C7A3360FD68EC1BEB0EA0B938" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5A8E9B32969997BF46A61BEB0E9429BE" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5A4659E98751E710DCAC1BEB0EA0B6E3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5A4659E98751E710DCAC1BEB0EA0B6E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_92DBE6EC446FFA85C5541BEB0EA01264" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_92DBE6EC446FFA85C5541BEB0EA01264" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_1CB3DFDFB0096A49E3F21BEB0EA04246" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_1CB3DFDFB0096A49E3F21BEB0EA04246" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_9E17D4098FD848AED0681BEB0EA100C8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_9E17D4098FD848AED0681BEB0EA100C8" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PurchaseofConvertibleNoteHedge" xlink:label="loc_dxcm_PurchaseofConvertibleNoteHedge_83F15716223DC72B54641BEB0EA11256" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957" xlink:to="loc_dxcm_PurchaseofConvertibleNoteHedge_83F15716223DC72B54641BEB0EA11256" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_A21D05A572A6BCCA9E7B1BEB0EA1B861" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_A21D05A572A6BCCA9E7B1BEB0EA1B861" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_8DA4F39481BC4E65CF3F1BEB0EA19FA9" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_8DA4F39481BC4E65CF3F1BEB0EA19FA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A29F78BD74536C4533EE1BEB0EA1AB88" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A29F78BD74536C4533EE1BEB0EA1AB88" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4FF6C5745BAAF62B102A1BEB0EA25015" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_A6F621FFF4D32F6498791BEB0EA03957" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4FF6C5745BAAF62B102A1BEB0EA25015" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_88FA26DCE0D66E5F847C1BEB0EA228C7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5A8E9B32969997BF46A61BEB0E9429BE" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_88FA26DCE0D66E5F847C1BEB0EA228C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_C8C2F03753F85D0AB2941BEB0EA2E6C6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5A8E9B32969997BF46A61BEB0E9429BE" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_C8C2F03753F85D0AB2941BEB0EA2E6C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_22548E4F179028E88EE71BEB0EA29C00" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5A8E9B32969997BF46A61BEB0E9429BE" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_22548E4F179028E88EE71BEB0EA29C00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_48946A44560955A008F31BEB0EA26CF4" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5A8E9B32969997BF46A61BEB0E9429BE" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_48946A44560955A008F31BEB0EA26CF4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_21ADD1202CD72F7BF5A31BEB0EA267A1" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5A8E9B32969997BF46A61BEB0E9429BE" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_21ADD1202CD72F7BF5A31BEB0EA267A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3E6A0E3679503ACE3E4F1BEB0EA35569" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_21ADD1202CD72F7BF5A31BEB0EA267A1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3E6A0E3679503ACE3E4F1BEB0EA35569" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaap_RestrictedCash_F6D5CEE11E601A7344B91BEB0EA3B82B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_21ADD1202CD72F7BF5A31BEB0EA267A1" xlink:to="loc_us-gaap_RestrictedCash_F6D5CEE11E601A7344B91BEB0EA3B82B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_253830DC0581297076431BEB0EA372BC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_21ADD1202CD72F7BF5A31BEB0EA267A1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_253830DC0581297076431BEB0EA372BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_12348D40AF0E275788F51BEB0EA35B1C" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5A8E9B32969997BF46A61BEB0E9429BE" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_12348D40AF0E275788F51BEB0EA35B1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_20663C4C55C72BE6D9781BEB0EA9B2D6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_12348D40AF0E275788F51BEB0EA35B1C" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_20663C4C55C72BE6D9781BEB0EA9B2D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_4CCCC01D79896ACDC4761BEB0EA9B69C" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5A8E9B32969997BF46A61BEB0E9429BE" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_4CCCC01D79896ACDC4761BEB0EA9B69C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_6C8D202BFCB49A428AD31BEB0EA92F24" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4CCCC01D79896ACDC4761BEB0EA9B69C" xlink:to="loc_us-gaap_InterestPaidNet_6C8D202BFCB49A428AD31BEB0EA92F24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_0460ECAA9F038DFDCDC61BEB0EAA6D43" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4CCCC01D79896ACDC4761BEB0EA9B69C" xlink:to="loc_us-gaap_IncomeTaxesPaid_0460ECAA9F038DFDCDC61BEB0EAA6D43" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_278FFCC3FD315BC6E3CEAB02F93FBE51" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_3B6BAE215361C6402B43AB02F93F0939" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_278FFCC3FD315BC6E3CEAB02F93FBE51" xlink:to="loc_us-gaap_NetIncomeLoss_3B6BAE215361C6402B43AB02F93F0939" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3CD671CD9FF2FE3E456AAB02F9409BE1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_278FFCC3FD315BC6E3CEAB02F93FBE51" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3CD671CD9FF2FE3E456AAB02F9409BE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3600806B49276B8A5712AB02F9406CCB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3CD671CD9FF2FE3E456AAB02F9409BE1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3600806B49276B8A5712AB02F9406CCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_6BEF936AEACF820E83FDAB02F9414D71" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3CD671CD9FF2FE3E456AAB02F9409BE1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_6BEF936AEACF820E83FDAB02F9414D71" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_AF9316F3B9E7C1C6F5EDAB02F940DFCF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3CD671CD9FF2FE3E456AAB02F9409BE1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_AF9316F3B9E7C1C6F5EDAB02F940DFCF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_C18792C3586FB3C03D9AAB02F941A0E1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_278FFCC3FD315BC6E3CEAB02F93FBE51" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_C18792C3586FB3C03D9AAB02F941A0E1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7B792EFCF1B5AC2080C91CA2E7B087BF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7B792EFCF1B5AC2080C91CA2E7B087BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_206FB1B48061FC9DDF401CA2E7B0DF74" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_206FB1B48061FC9DDF401CA2E7B0DF74" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_04A425A1923528F08F7D1CA2E7B0DA6E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:to="loc_us-gaap_GrossProfit_04A425A1923528F08F7D1CA2E7B0DA6E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_B6620C6B6583C647ECAE1CA2E7B01BBA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:to="loc_us-gaap_OperatingExpensesAbstract_B6620C6B6583C647ECAE1CA2E7B01BBA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_343A33871EDF792CACB01CA2E7B14A52" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_B6620C6B6583C647ECAE1CA2E7B01BBA" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_343A33871EDF792CACB01CA2E7B14A52" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeResearchAndDevelopmentFee" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee_694DEE523A4E1C50A9C01CA2E7B1E45A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_B6620C6B6583C647ECAE1CA2E7B01BBA" xlink:to="loc_dxcm_CollaborativeResearchAndDevelopmentFee_694DEE523A4E1C50A9C01CA2E7B1E45A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_B6F8CABE8A22CDBA0BFC1CA2E7B13A2F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_B6620C6B6583C647ECAE1CA2E7B01BBA" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_B6F8CABE8A22CDBA0BFC1CA2E7B13A2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_AF61EA368946219C63511CA2E7B18F13" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_B6620C6B6583C647ECAE1CA2E7B01BBA" xlink:to="loc_us-gaap_OperatingExpenses_AF61EA368946219C63511CA2E7B18F13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_93E9D2CC429DF2D996C21CA2E7B2F309" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:to="loc_us-gaap_OperatingIncomeLoss_93E9D2CC429DF2D996C21CA2E7B2F309" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_E9A690E605BE12B7E6641CA2E7B22401" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:to="loc_us-gaap_InterestExpense_E9A690E605BE12B7E6641CA2E7B22401" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_7297FF46D6A7C33B872B1CA2E7B262B1" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_7297FF46D6A7C33B872B1CA2E7B262B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_B3210E8AEAFC3B9ABF6F1CA2E7B23F4E" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_B3210E8AEAFC3B9ABF6F1CA2E7B23F4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96133818E43A5011D8DD1CA2E7B2AA42" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96133818E43A5011D8DD1CA2E7B2AA42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_494451429ECA59FB8E4A1CA2E7B2485A" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_494451429ECA59FB8E4A1CA2E7B2485A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_87DBBAB466E5F111BD641CA2E7B3AC98" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:to="loc_us-gaap_NetIncomeLoss_87DBBAB466E5F111BD641CA2E7B3AC98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_DAE39C6C9BA61AC8E7D81CA2E7B36611" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:to="loc_us-gaap_EarningsPerShareBasic_DAE39C6C9BA61AC8E7D81CA2E7B36611" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5A8BD981976EAC774FD41CA2E7B3220F" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5A8BD981976EAC774FD41CA2E7B3220F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_A3C78BD1263096CD65791CA2E7B3345E" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_A3C78BD1263096CD65791CA2E7B3345E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E2ECE21BF552EA63AA551CA2E7B32E35" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_89AD9B4E6E8513BA7B211CA2E7AF4DD3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E2ECE21BF552EA63AA551CA2E7B32E35" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_78A20AC7CEE207678E514027E6F5DBB5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_78A20AC7CEE207678E514027E6F5DBB5" xlink:to="loc_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6275C32C3A421CB786354027E6F5CD08" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6275C32C3A421CB786354027E6F5CD08" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_7B22C85A5F3CC81F3CAA4027E6F6C284" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6275C32C3A421CB786354027E6F5CD08" xlink:to="loc_us-gaap_EquityComponentDomain_7B22C85A5F3CC81F3CAA4027E6F6C284" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_97408951439495686BD94027E6F654D4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7B22C85A5F3CC81F3CAA4027E6F6C284" xlink:to="loc_us-gaap_CommonStockMember_97408951439495686BD94027E6F654D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_A871A1C64A84B5DF437A4027E6F66F16" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7B22C85A5F3CC81F3CAA4027E6F6C284" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_A871A1C64A84B5DF437A4027E6F66F16" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_48A054AB5D5FCF031C8B4027E6F7670C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7B22C85A5F3CC81F3CAA4027E6F6C284" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_48A054AB5D5FCF031C8B4027E6F7670C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_3CFD45D2DD0904C383944027E6F72FAA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7B22C85A5F3CC81F3CAA4027E6F6C284" xlink:to="loc_us-gaap_RetainedEarningsMember_3CFD45D2DD0904C383944027E6F72FAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_35B6A396CDCB7F8823924027E6F7AD9B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7B22C85A5F3CC81F3CAA4027E6F6C284" xlink:to="loc_us-gaap_TreasuryStockMember_35B6A396CDCB7F8823924027E6F7AD9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_270DCAC96D2850E1B9264027E6F72878" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045" xlink:to="loc_us-gaap_DebtInstrumentAxis_270DCAC96D2850E1B9264027E6F72878" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9E5AF0328479CFF876BE4027E6F7E982" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_270DCAC96D2850E1B9264027E6F72878" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9E5AF0328479CFF876BE4027E6F7E982" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2022Member" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_DC35EBAE66C30E457CDF4027E6F77228" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9E5AF0328479CFF876BE4027E6F7E982" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_DC35EBAE66C30E457CDF4027E6F77228" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2023Member" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_FD1D34ADE0FE380D39734027E6F8921E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9E5AF0328479CFF876BE4027E6F7E982" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_FD1D34ADE0FE380D39734027E6F8921E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_91C4085C161BEC3A76BE4027E6F8B752" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_91C4085C161BEC3A76BE4027E6F8B752" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_52A3A5AF269B774E4C3A4027E6F81365" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_91C4085C161BEC3A76BE4027E6F8B752" xlink:to="loc_us-gaap_TypeOfAdoptionMember_52A3A5AF269B774E4C3A4027E6F81365" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201609Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201609Member_61CBD64614E303C330104027E6F8040E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_52A3A5AF269B774E4C3A4027E6F81365" xlink:to="loc_us-gaap_AccountingStandardsUpdate201609Member_61CBD64614E303C330104027E6F8040E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_96A4A0DA32226EC20E464027E6F9631E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_52A3A5AF269B774E4C3A4027E6F81365" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_96A4A0DA32226EC20E464027E6F9631E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_25B4D4DF679D69FDB8BD4027E6F9757D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_787A1BCD91ED1711B9404027E6F51045" xlink:to="loc_us-gaap_StatementLineItems_25B4D4DF679D69FDB8BD4027E6F9757D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_25B4D4DF679D69FDB8BD4027E6F9757D" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_1D7370063C2F24816D774027E6F997AD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_SharesOutstanding_1D7370063C2F24816D774027E6F997AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_BD2671A39C31AFFE48654027E6FA96D0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_BD2671A39C31AFFE48654027E6FA96D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_0B18B17513934FDFDB424027E6FAC6A7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_0B18B17513934FDFDB424027E6FAC6A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_3296600714533B52DAF54027E6FA29A0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_3296600714533B52DAF54027E6FA29A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6CBE9B22F3B1051CA5664027E6FA2096" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6CBE9B22F3B1051CA5664027E6FA2096" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_AC3E5207B8597C788B3F4027E6FAD576" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_AC3E5207B8597C788B3F4027E6FAD576" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9E9E5E94D7A47E944FD44027E6FAB72A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9E9E5E94D7A47E944FD44027E6FAB72A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_9BBC6D81A8A46F092B914027E6FBB459" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_9BBC6D81A8A46F092B914027E6FBB459" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification" xlink:label="loc_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_0C2DDC0703E46C72AB3F4027E6FBDC53" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_0C2DDC0703E46C72AB3F4027E6FBDC53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_07BD85A469E9E349A5974027E6FB2EC9" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_07BD85A469E9E349A5974027E6FB2EC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_A5A90FFD2454B217ECF54027E6FBDA34" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_A5A90FFD2454B217ECF54027E6FBDA34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_8F9D8BA4C2C52BC205064027E6FBB83A" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_8F9D8BA4C2C52BC205064027E6FBB83A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_A8169FA8006D71A57FCB4027E6FCBED1" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_A8169FA8006D71A57FCB4027E6FCBED1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_433083D1CCE54B03D55F4027E6FCF7EF" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_433083D1CCE54B03D55F4027E6FCF7EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_363927C449E85DBAD77F4027E6FC2150" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_363927C449E85DBAD77F4027E6FC2150" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_D22ECF6FAE2FF8EFE5874027E6FC5548" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_NetIncomeLoss_D22ECF6FAE2FF8EFE5874027E6FC5548" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_48CF9200E172C7B2D23A4027E6FC394E" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_48CF9200E172C7B2D23A4027E6FC394E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_9DA754289605700199B04027E6FC90C6" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_SharesOutstanding_9DA754289605700199B04027E6FC90C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_914DA788ECA3F5D3A7CB4027E6FD5B25" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_C3BFD844A26D7401CC6E4027E6F9DCBA" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_914DA788ECA3F5D3A7CB4027E6FD5B25" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_E11946B49421B07EEF2AD354A46F9013" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_55F0EB9BD0FC706F1459D354A46F7FF5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_E11946B49421B07EEF2AD354A46F9013" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_55F0EB9BD0FC706F1459D354A46F7FF5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_51BEEAB37DD05D783210B03100D65168" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_585F35AE0A1B98D1D740B03100D666F8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_51BEEAB37DD05D783210B03100D65168" xlink:to="loc_us-gaap_LossContingenciesTable_585F35AE0A1B98D1D740B03100D666F8" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_NameOfPlaintiffAxis" xlink:label="loc_dxcm_NameOfPlaintiffAxis_F238C8E5FDF4BCD492A2B03100D70EE4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_585F35AE0A1B98D1D740B03100D666F8" xlink:to="loc_dxcm_NameOfPlaintiffAxis_F238C8E5FDF4BCD492A2B03100D70EE4" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_NameOfPlaintiffDomain" xlink:label="loc_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_NameOfPlaintiffAxis_F238C8E5FDF4BCD492A2B03100D70EE4" xlink:to="loc_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_AgaMatrixMember" xlink:label="loc_dxcm_AgaMatrixMember_C21AE651D1D68C5DC6CBB03100D7A919" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E" xlink:to="loc_dxcm_AgaMatrixMember_C21AE651D1D68C5DC6CBB03100D7A919" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_WaveFormTechnologiesInc.Member" xlink:label="loc_dxcm_WaveFormTechnologiesInc.Member_266DF00C0537C2F04E29B03100D8AA80" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_NameOfPlaintiffDomain_6E69FCAF5FC8CD731D4EB03100D7B94E" xlink:to="loc_dxcm_WaveFormTechnologiesInc.Member_266DF00C0537C2F04E29B03100D8AA80" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_NameOfDefendantAxis" xlink:label="loc_dxcm_NameOfDefendantAxis_B612392BE3BF18347643B03100D6EF42" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_585F35AE0A1B98D1D740B03100D666F8" xlink:to="loc_dxcm_NameOfDefendantAxis_B612392BE3BF18347643B03100D6EF42" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_NameOfDefendantDomain" xlink:label="loc_dxcm_NameOfDefendantDomain_5638943F1D7B137EC49BB03100D735C4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_NameOfDefendantAxis_B612392BE3BF18347643B03100D6EF42" xlink:to="loc_dxcm_NameOfDefendantDomain_5638943F1D7B137EC49BB03100D735C4" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_NameOfDefendantDomain_5638943F1D7B137EC49BB03100D735C4" xlink:to="loc_dxcm_AgaMatrixMember_C21AE651D1D68C5DC6CBB03100D7A919" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_585F35AE0A1B98D1D740B03100D666F8" xlink:to="loc_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_020B09A424BC077AE3E1B03100D88A2B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_020B09A424BC077AE3E1B03100D88A2B" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber" xlink:label="loc_dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber_4BB33ECF0522C33AFCD1B07376463FE2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:to="loc_dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber_4BB33ECF0522C33AFCD1B07376463FE2" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff" xlink:label="loc_dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff_C2B227B4B4CAD64D237AB03100D84EC9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:to="loc_dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff_C2B227B4B4CAD64D237AB03100D84EC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:label="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_E0D0B648D461890D81F9B03100D9A2B5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:to="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_E0D0B648D461890D81F9B03100D9A2B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_1FF104E55986E5199F9EB03100D959BC" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0EB859A8160C137389A5B03100D83A4E" xlink:to="loc_us-gaap_LitigationReserve_1FF104E55986E5199F9EB03100D959BC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_8BA5643080C15F0BD11B4034D5C5355F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_AmendmentFlag_8BA5643080C15F0BD11B4034D5C5355F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_28750BD4DD0869B61AA24034D5C51A63" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_DocumentFiscalYearFocus_28750BD4DD0869B61AA24034D5C51A63" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_79F5EA9BDD176EF3537D4034D5C54979" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_79F5EA9BDD176EF3537D4034D5C54979" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_8423031EE2FD5DFE4B624034D5C5F997" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityCentralIndexKey_8423031EE2FD5DFE4B624034D5C5F997" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_37416306FE8781D666FF4034D5C603D6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_CurrentFiscalYearEndDate_37416306FE8781D666FF4034D5C603D6" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_F959EF9D4F8B484D5F404034D5C6F946" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_DocumentType_F959EF9D4F8B484D5F404034D5C6F946" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_0AADE6C0C8D61DDA558F4034D5C69039" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_DocumentAnnualReport_0AADE6C0C8D61DDA558F4034D5C69039" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_55F5BD91FF3DE4CD9FAC4034D5C6ED7D" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_DocumentPeriodEndDate_55F5BD91FF3DE4CD9FAC4034D5C6ED7D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_08A4BBC118E63D7B64A54034D5C63B6D" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_DocumentTransitionReport_08A4BBC118E63D7B64A54034D5C63B6D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_4B2E1B4E9FC5E05FDF784034D5C6250F" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityFileNumber_4B2E1B4E9FC5E05FDF784034D5C6250F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_D23EE898B2865F8967874034D5C7BE2C" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityRegistrantName_D23EE898B2865F8967874034D5C7BE2C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_B26BC152BAF1924115564034D5C7A80C" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_B26BC152BAF1924115564034D5C7A80C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_043F1B04790EC1EBE56D4034D5C756F2" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityTaxIdentificationNumber_043F1B04790EC1EBE56D4034D5C756F2" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_49F39C3A3CE3A13D2F744034D5C77BE8" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityAddressAddressLine1_49F39C3A3CE3A13D2F744034D5C77BE8" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_5D21D9E5601019EB5B6C4034D5C7187F" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityAddressCityOrTown_5D21D9E5601019EB5B6C4034D5C7187F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_4936108792F6261F45864034D5C70E59" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityAddressStateOrProvince_4936108792F6261F45864034D5C70E59" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_FBBB7639AC4AB4F155F74034D5C83C1E" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityAddressPostalZipCode_FBBB7639AC4AB4F155F74034D5C83C1E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_6D6353A149531140529E4034D5C8C22E" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_CityAreaCode_6D6353A149531140529E4034D5C8C22E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_2E7A8DA712E824D9E4E94034D5C8D4D4" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_LocalPhoneNumber_2E7A8DA712E824D9E4E94034D5C8D4D4" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_3A93E591B67C16E9AB6B4034D5C80882" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_Security12bTitle_3A93E591B67C16E9AB6B4034D5C80882" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_20CBB9E8291762DEC0BC4034D5C8769A" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_TradingSymbol_20CBB9E8291762DEC0BC4034D5C8769A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_36F45FCA8D4432987E3B4034D5C8AB7D" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_SecurityExchangeName_36F45FCA8D4432987E3B4034D5C8AB7D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_F691F81098511661C1E84034D5C9C72C" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_F691F81098511661C1E84034D5C9C72C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_63CF6E7D0D09D152818D4034D5C9901A" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityVoluntaryFilers_63CF6E7D0D09D152818D4034D5C9901A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_ADA8613D0821D5C01F634034D5C9F1D5" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityCurrentReportingStatus_ADA8613D0821D5C01F634034D5C9F1D5" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_C07127472D2406AE0A004034D5C9B491" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityInteractiveDataCurrent_C07127472D2406AE0A004034D5C9B491" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_F07751743A7252B34E8B4034D5C93987" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityFilerCategory_F07751743A7252B34E8B4034D5C93987" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_7577999975173A7DBB184034D5C9860B" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntitySmallBusiness_7577999975173A7DBB184034D5C9860B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_338FE32DB2CBE04E954C4034D5CA6B03" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityEmergingGrowthCompany_338FE32DB2CBE04E954C4034D5CA6B03" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_55CF3F9F974EC5ED921F4034D5CA7B3B" xlink:type="locator" />
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityShellCompany_55CF3F9F974EC5ED921F4034D5CA7B3B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_19AB5E63F7ED23C1A91A4034D5CA9509" xlink:type="locator" />
    <link:presentationArc order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityPublicFloat_19AB5E63F7ED23C1A91A4034D5CA9509" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_B88C20BC067E531CC2F34034D5CAB05F" xlink:type="locator" />
    <link:presentationArc order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_62692D116E3370C947744034D5C4D2E4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_B88C20BC067E531CC2F34034D5CAB05F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_D1FDEACD1963FE75742DCA0FC5EC2F30" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_25F97EDE437404E4DF8ACA0FCB3EF040" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_D1FDEACD1963FE75742DCA0FC5EC2F30" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_25F97EDE437404E4DF8ACA0FCB3EF040" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5F2AAE999CE518815D5DCA0FCBBC7D81" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_25F97EDE437404E4DF8ACA0FCB3EF040" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5F2AAE999CE518815D5DCA0FCBBC7D81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4E8DA7DB15CAB8126CA4CA0FCBBEFAE0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5F2AAE999CE518815D5DCA0FCBBC7D81" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4E8DA7DB15CAB8126CA4CA0FCBBEFAE0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_D7E1E8EEDA4C000B64E2CA0FCBF835E2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4E8DA7DB15CAB8126CA4CA0FCBBEFAE0" xlink:to="loc_us-gaap_LineOfCreditMember_D7E1E8EEDA4C000B64E2CA0FCBF835E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_F5DC2DF57EF79EB35C95CA0FCB46AB41" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_25F97EDE437404E4DF8ACA0FCB3EF040" xlink:to="loc_us-gaap_CreditFacilityAxis_F5DC2DF57EF79EB35C95CA0FCB46AB41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_D54C3538B21C29C6F1DECA0FCB46236E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_F5DC2DF57EF79EB35C95CA0FCB46AB41" xlink:to="loc_us-gaap_CreditFacilityDomain_D54C3538B21C29C6F1DECA0FCB46236E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaap_LetterOfCreditMember_09C7264CDA641238012FCA0FCC17131E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_D54C3538B21C29C6F1DECA0FCB46236E" xlink:to="loc_us-gaap_LetterOfCreditMember_09C7264CDA641238012FCA0FCC17131E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_25F97EDE437404E4DF8ACA0FCB3EF040" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_C765A822D5CC7EAC0D4FCA104F0606D1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_C765A822D5CC7EAC0D4FCA104F0606D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_CB1737CC352D442DCC20CA104EE84087" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE" xlink:to="loc_us-gaap_LineOfCredit_CB1737CC352D442DCC20CA104EE84087" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_759334C5E32CF2E8C59BCA12B5E902ED" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_759334C5E32CF2E8C59BCA12B5E902ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_099CADD79EEF7AC9865FCA104F1C6F52" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_B20463A5EC2A65ACB3F5CA0FCB4733CE" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_099CADD79EEF7AC9865FCA104F1C6F52" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_999204635F93A7B98387C9C4B9497362" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_58DBAB19B37E70E6F78AC9C4B949A692" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_999204635F93A7B98387C9C4B9497362" xlink:to="loc_us-gaap_DebtInstrumentTable_58DBAB19B37E70E6F78AC9C4B949A692" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_E043385B74C36BA44866C9C4B9497FFE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_58DBAB19B37E70E6F78AC9C4B949A692" xlink:to="loc_us-gaap_DebtInstrumentAxis_E043385B74C36BA44866C9C4B9497FFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_D206B6EDC6CC69BCF703C9C4B94953DB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_E043385B74C36BA44866C9C4B9497FFE" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_D206B6EDC6CC69BCF703C9C4B94953DB" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2022Member" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_41FC0BFD3E6B01B78230C9C4B94ADAB1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D206B6EDC6CC69BCF703C9C4B94953DB" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_41FC0BFD3E6B01B78230C9C4B94ADAB1" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2023Member" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_5B36DD728DE9C151E3A3C9C4B94ABFB2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D206B6EDC6CC69BCF703C9C4B94953DB" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_5B36DD728DE9C151E3A3C9C4B94ABFB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4A0151A7C18DEC8FDD08C9C4B94A5F01" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_58DBAB19B37E70E6F78AC9C4B949A692" xlink:to="loc_us-gaap_DebtInstrumentLineItems_4A0151A7C18DEC8FDD08C9C4B94A5F01" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_99C0DCA227AED8AEC9E7C9C4B94ACFC1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4A0151A7C18DEC8FDD08C9C4B94A5F01" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_99C0DCA227AED8AEC9E7C9C4B94ACFC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_A62EF4B4845C609CAA44C9C4B94B87CE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4A0151A7C18DEC8FDD08C9C4B94A5F01" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_A62EF4B4845C609CAA44C9C4B94B87CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_40A4979A772C35BE080DC9C4B94BF759" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4A0151A7C18DEC8FDD08C9C4B94A5F01" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_40A4979A772C35BE080DC9C4B94BF759" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt_8E017CB7C760638B5B0DC9C4B94B8EE3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4A0151A7C18DEC8FDD08C9C4B94A5F01" xlink:to="loc_us-gaap_InterestExpenseDebt_8E017CB7C760638B5B0DC9C4B94B8EE3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2189208E55CE5C59E7C7C9C4B94BD86A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4A0151A7C18DEC8FDD08C9C4B94A5F01" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2189208E55CE5C59E7C7C9C4B94BD86A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ABDD97E5F23B0512CFF6CA18F6F504E6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_049559033D40DAC972D9CA18FCE0422E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ABDD97E5F23B0512CFF6CA18F6F504E6" xlink:to="loc_us-gaap_DebtInstrumentTable_049559033D40DAC972D9CA18FCE0422E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_75CAC48CE981911C910FCA18FCE1CEDD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_049559033D40DAC972D9CA18FCE0422E" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_75CAC48CE981911C910FCA18FCE1CEDD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_148274CCDC3C3F9A690FCA18FCE2458A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_75CAC48CE981911C910FCA18FCE1CEDD" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_148274CCDC3C3F9A690FCA18FCE2458A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_C1A9FADF17135CF81423CA18FD34F909" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_148274CCDC3C3F9A690FCA18FCE2458A" xlink:to="loc_us-gaap_SeniorNotesMember_C1A9FADF17135CF81423CA18FD34F909" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_5CC9AC9847555FD4478DCA18FCE26387" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_049559033D40DAC972D9CA18FCE0422E" xlink:to="loc_us-gaap_DebtInstrumentAxis_5CC9AC9847555FD4478DCA18FCE26387" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_804B8021885E38F3477ECA18FCE3CD0E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5CC9AC9847555FD4478DCA18FCE26387" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_804B8021885E38F3477ECA18FCE3CD0E" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2022Member" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_8E8D91B73A9B52E38A77CA18FD50FB6E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_804B8021885E38F3477ECA18FCE3CD0E" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_8E8D91B73A9B52E38A77CA18FD50FB6E" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2023Member" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_0E4DC1C67547AB426CD1CA18FD6E5DF4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_804B8021885E38F3477ECA18FCE3CD0E" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_0E4DC1C67547AB426CD1CA18FD6E5DF4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_30F3E32708FFFA8CC0F0CA18FCED7BFC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_049559033D40DAC972D9CA18FCE0422E" xlink:to="loc_us-gaap_DebtInstrumentLineItems_30F3E32708FFFA8CC0F0CA18FCED7BFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_BE4F32128F1FDFC79046CA18FD12EF2F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30F3E32708FFFA8CC0F0CA18FCED7BFC" xlink:to="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_BE4F32128F1FDFC79046CA18FD12EF2F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtDebt" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_20AA6B4E4A8C9CF11E150FB8CFEBD4D2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_9249AC76BBBDA554DDA60FB8CFEBEE34" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_20AA6B4E4A8C9CF11E150FB8CFEBD4D2" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_9249AC76BBBDA554DDA60FB8CFEBEE34" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_960AEDC96B9233607CDA1C846AB3CBA1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_960AEDC96B9233607CDA1C846AB3CBA1" xlink:to="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_8EE58DA0814DBBC24DBD1C846AB44178" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:to="loc_us-gaap_VariableRateAxis_8EE58DA0814DBBC24DBD1C846AB44178" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_CD5B14922052DC94B7421C846AB4CDBA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_8EE58DA0814DBBC24DBD1C846AB44178" xlink:to="loc_us-gaap_VariableRateDomain_CD5B14922052DC94B7421C846AB4CDBA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_80A7D399A020A3F0E0C01C846AB5683B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_CD5B14922052DC94B7421C846AB4CDBA" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_80A7D399A020A3F0E0C01C846AB5683B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_86D11126343B72120C6A1C846AB555D7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:to="loc_us-gaap_HedgingDesignationAxis_86D11126343B72120C6A1C846AB555D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_825E5603766E4DAF12851C846AB55A62" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_86D11126343B72120C6A1C846AB555D7" xlink:to="loc_us-gaap_HedgingDesignationDomain_825E5603766E4DAF12851C846AB55A62" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_C9F22CB19038504CDE9A1C846AB69EB2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_825E5603766E4DAF12851C846AB55A62" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_C9F22CB19038504CDE9A1C846AB69EB2" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConversionTermAxis" xlink:label="loc_dxcm_DebtInstrumentConversionTermAxis_19C3F981D6052B8C2CE61C846AB6439A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:to="loc_dxcm_DebtInstrumentConversionTermAxis_19C3F981D6052B8C2CE61C846AB6439A" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConversionTermDomain" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis_19C3F981D6052B8C2CE61C846AB6439A" xlink:to="loc_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConversionTermOneMember" xlink:label="loc_dxcm_DebtInstrumentConversionTermOneMember_47490DCEAB519CAC081C1C846AB736F7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2" xlink:to="loc_dxcm_DebtInstrumentConversionTermOneMember_47490DCEAB519CAC081C1C846AB736F7" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConversionTermTwoMember" xlink:label="loc_dxcm_DebtInstrumentConversionTermTwoMember_52B863DD06BB510021261C846AB70C70" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_787BA93C129C78F340A51C846AB6EBB2" xlink:to="loc_dxcm_DebtInstrumentConversionTermTwoMember_52B863DD06BB510021261C846AB70C70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_E1E72A7A8DFC5F9696421C846AB75FBF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_E1E72A7A8DFC5F9696421C846AB75FBF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_39E778D0853A6845D8F41C846AB766F6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_E1E72A7A8DFC5F9696421C846AB75FBF" xlink:to="loc_us-gaap_EquityComponentDomain_39E778D0853A6845D8F41C846AB766F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_F1DA5CD67C1ACF4404561C846AB8A96F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_39E778D0853A6845D8F41C846AB766F6" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_F1DA5CD67C1ACF4404561C846AB8A96F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_325D748EDC60E51B963F1C846AB8A356" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_325D748EDC60E51B963F1C846AB8A356" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_72B41719839C4C4427B81C846AB94270" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_325D748EDC60E51B963F1C846AB8A356" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_72B41719839C4C4427B81C846AB94270" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_9BE61590D7ED4576B9511C846AB9DDD6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_72B41719839C4C4427B81C846AB94270" xlink:to="loc_us-gaap_SeniorNotesMember_9BE61590D7ED4576B9511C846AB9DDD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_67EF8E589D0FEEADD85E1C846AB90B68" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_72B41719839C4C4427B81C846AB94270" xlink:to="loc_us-gaap_LineOfCreditMember_67EF8E589D0FEEADD85E1C846AB90B68" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_DBB763DEAE32719AE1E01C846AB94321" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:to="loc_us-gaap_DebtInstrumentAxis_DBB763DEAE32719AE1E01C846AB94321" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_CE9EBF274E61C43250DC1C846AB9DC4F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_DBB763DEAE32719AE1E01C846AB94321" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_CE9EBF274E61C43250DC1C846AB9DC4F" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2023Member" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_47D73FCE556C6050DBAA1C846ABA0488" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_CE9EBF274E61C43250DC1C846AB9DC4F" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_47D73FCE556C6050DBAA1C846ABA0488" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2022Member" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_D3BC324B1E4F353808591C846ABA58F9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_CE9EBF274E61C43250DC1C846AB9DC4F" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_D3BC324B1E4F353808591C846ABA58F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_149E737D604163D78CE31C846ABAF01E" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:to="loc_srt_RangeAxis_149E737D604163D78CE31C846ABAF01E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1D86964BFB4345646B771C846ABBB4BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_149E737D604163D78CE31C846ABAF01E" xlink:to="loc_srt_RangeMember_1D86964BFB4345646B771C846ABBB4BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_3D45F9E4E1E8CC1D3DB81C846ABB9FEB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1D86964BFB4345646B771C846ABBB4BB" xlink:to="loc_srt_MinimumMember_3D45F9E4E1E8CC1D3DB81C846ABB9FEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_F4D6E467D794DB1749111C846ABB1596" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1D86964BFB4345646B771C846ABBB4BB" xlink:to="loc_srt_MaximumMember_F4D6E467D794DB1749111C846ABB1596" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1F2B4E99DD4669AA01D71C846AB3F29A" xlink:to="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_622363E44E13899990581C846ABCBAE0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_622363E44E13899990581C846ABCBAE0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_22248925CE4A7BF67C761C846ABC535A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_22248925CE4A7BF67C761C846ABC535A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_A5DEC92C4DF65F0B23BD1C846ABCF87B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_A5DEC92C4DF65F0B23BD1C846ABCF87B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_4DDEF20BDDACF72614511C846ABC9C5E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_4DDEF20BDDACF72614511C846ABC9C5E" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount" xlink:label="loc_dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount_9AED01AC933EAE464C031C846ABDAA8D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount_9AED01AC933EAE464C031C846ABDAA8D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_39AABFF771DD5BD6362C1C846ABDACB1" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_39AABFF771DD5BD6362C1C846ABDACB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity" xlink:label="loc_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_55FA3CCA52322EFD959B1C846ABDB2F6" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity_55FA3CCA52322EFD959B1C846ABDB2F6" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:label="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_89F8B844A826336B5E191C846ABD0CE5" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_89F8B844A826336B5E191C846ABD0CE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_3C6AF025884690A6B3C11C846AC1057D" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_3C6AF025884690A6B3C11C846AC1057D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6225B6F2C841FEC1DF4A1C846AC1D61E" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6225B6F2C841FEC1DF4A1C846AC1D61E" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:label="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_4CCEA09A678E2EF3F0E61C846AC2766B" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_4CCEA09A678E2EF3F0E61C846AC2766B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_5F88818FC02470C4B80A1C846AC29157" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_5F88818FC02470C4B80A1C846AC29157" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:label="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_3A68B2DBA17A28687D541C846AC2EB44" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_3A68B2DBA17A28687D541C846AC2EB44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_0C0CF4473609C6D3FBEE1C846AC2440B" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_0C0CF4473609C6D3FBEE1C846AC2440B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_86AB8F04F76047D604281C846AC2CADA" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_86AB8F04F76047D604281C846AC2CADA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_AC6F08D8A39E846D15CC1C846AC2EFAA" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_AC6F08D8A39E846D15CC1C846AC2EFAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7EA9285F61D71990C1801C846AC31164" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7EA9285F61D71990C1801C846AC31164" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_094F41CDC9291CDEA3E01C846AC391C1" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_094F41CDC9291CDEA3E01C846AC391C1" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:label="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_9F4C7FB2285F259892BC1C846AC38FE8" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_9F4C7FB2285F259892BC1C846AC38FE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_76EDE0665C8F4DC92E871C846AC385E5" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_76EDE0665C8F4DC92E871C846AC385E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_771894F7173F157E7C801C846AC4C793" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_771894F7173F157E7C801C846AC4C793" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold" xlink:label="loc_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_37EC05E720691C829D481C846AC4E0A6" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6A2E67406D414C2D3F2C1C846ABB499C" xlink:to="loc_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold_37EC05E720691C829D481C846AC4E0A6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3CF4814F03516C702D951BE44A29F6BB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_EAC18ADFC471BB81CD381BE44A2AC801" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3CF4814F03516C702D951BE44A29F6BB" xlink:to="loc_us-gaap_DebtInstrumentTable_EAC18ADFC471BB81CD381BE44A2AC801" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_785E022B0995D062B1AE1BE44A2A04CB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_EAC18ADFC471BB81CD381BE44A2AC801" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_785E022B0995D062B1AE1BE44A2A04CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_F5CDC584403135AF9CB61BE44A2B9AA0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_785E022B0995D062B1AE1BE44A2A04CB" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_F5CDC584403135AF9CB61BE44A2B9AA0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_EC5AB864395697A1476D1BE44A2BBEE1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_F5CDC584403135AF9CB61BE44A2B9AA0" xlink:to="loc_us-gaap_SeniorNotesMember_EC5AB864395697A1476D1BE44A2BBEE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_DDE5C7DCF8F3B2A1072F1BE44A2BD5EA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_EAC18ADFC471BB81CD381BE44A2AC801" xlink:to="loc_us-gaap_DebtInstrumentAxis_DDE5C7DCF8F3B2A1072F1BE44A2BD5EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6D3021D1D52CA3DE6AA91BE44A2B74A5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_DDE5C7DCF8F3B2A1072F1BE44A2BD5EA" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6D3021D1D52CA3DE6AA91BE44A2B74A5" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2022Member" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_244A292332D8EBC8E1A11BE44A2CE3BF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6D3021D1D52CA3DE6AA91BE44A2B74A5" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_244A292332D8EBC8E1A11BE44A2CE3BF" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2023Member" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_DCD14CBF2EB1B340D7841BE44A2C2E37" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6D3021D1D52CA3DE6AA91BE44A2B74A5" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_DCD14CBF2EB1B340D7841BE44A2C2E37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_299219474231015CA15E1BE44A2C1B51" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_EAC18ADFC471BB81CD381BE44A2AC801" xlink:to="loc_us-gaap_DebtInstrumentLineItems_299219474231015CA15E1BE44A2C1B51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299219474231015CA15E1BE44A2C1B51" xlink:to="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_07580C7439771E2019021BE44A2DD255" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_07580C7439771E2019021BE44A2DD255" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_EF1589EB6F419B4932581BE44A2D3B53" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_EF1589EB6F419B4932581BE44A2D3B53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_8C4359EE68F3233E7E841BE44A2DD053" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_8C4359EE68F3233E7E841BE44A2DD053" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_AA746C69B38DC2A3FBE91BE44A2D05DF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_B2329C025F90C3FC4D6E1BE44A2C18E1" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_AA746C69B38DC2A3FBE91BE44A2D05DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3AD66EDB37AE2DADDBBC1BEAE8239E24" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299219474231015CA15E1BE44A2C1B51" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3AD66EDB37AE2DADDBBC1BEAE8239E24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_554F3704141B50A83E321BE44A2DE495" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299219474231015CA15E1BE44A2C1B51" xlink:to="loc_us-gaap_LongTermDebt_554F3704141B50A83E321BE44A2DE495" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_B620FF2FE5395DDBDB8C1BE44A2E42AF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299219474231015CA15E1BE44A2C1B51" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_B620FF2FE5395DDBDB8C1BE44A2E42AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_3E76D34FBE0D172E2E6F1BE44A2ED490" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299219474231015CA15E1BE44A2C1B51" xlink:to="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_3E76D34FBE0D172E2E6F1BE44A2ED490" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_77DA3CFB64289BF28A64C9C4B978CE0A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_0486156410F5A85A2DF1C9C4B978E9FC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_77DA3CFB64289BF28A64C9C4B978CE0A" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_0486156410F5A85A2DF1C9C4B978E9FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock_C90D43EA91FE354FC1BDC9C4B979C4FD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_77DA3CFB64289BF28A64C9C4B978CE0A" xlink:to="loc_us-gaap_ConvertibleDebtTableTextBlock_C90D43EA91FE354FC1BDC9C4B979C4FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_AC89F2535A8FB7ED9C7CC9C4B979E881" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_77DA3CFB64289BF28A64C9C4B978CE0A" xlink:to="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_AC89F2535A8FB7ED9C7CC9C4B979E881" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_9433E2D182973C3D46FFCA0E625EF792" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_77DA3CFB64289BF28A64C9C4B978CE0A" xlink:to="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_9433E2D182973C3D46FFCA0E625EF792" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DevelopmentAndOtherAgreements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7E7FEB5805C58BD6E8CCAB500B600BE2" xlink:type="locator" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DevelopmentAndOtherAgreementsTextBlock" xlink:label="loc_dxcm_DevelopmentAndOtherAgreementsTextBlock_95A428FC5BF4E951B4E6AB02F826D69A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7E7FEB5805C58BD6E8CCAB500B600BE2" xlink:to="loc_dxcm_DevelopmentAndOtherAgreementsTextBlock_95A428FC5BF4E951B4E6AB02F826D69A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_FC9186F6DFF0F919A9B3360B0E5A3028" xlink:type="locator" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DevelopmentAgreementsTable" xlink:label="loc_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_FC9186F6DFF0F919A9B3360B0E5A3028" xlink:to="loc_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_4E1CD75CA434773AC5A9360B0E5DC1B9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD" xlink:to="loc_us-gaap_TypeOfArrangementAxis_4E1CD75CA434773AC5A9360B0E5DC1B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6BF7ECAE09F85C67FA6C360B0E5E505E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_4E1CD75CA434773AC5A9360B0E5DC1B9" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6BF7ECAE09F85C67FA6C360B0E5E505E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CollaborativeArrangementMember" xlink:label="loc_us-gaap_CollaborativeArrangementMember_2D9CD5CBFE12F5980B70360B0E63E58F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6BF7ECAE09F85C67FA6C360B0E5E505E" xlink:to="loc_us-gaap_CollaborativeArrangementMember_2D9CD5CBFE12F5980B70360B0E63E58F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_D55E7B297A20B1D31F97360B0E6383F9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD" xlink:to="loc_srt_CounterpartyNameAxis_D55E7B297A20B1D31F97360B0E6383F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_A55EE51C2222A7425DAB360B0E64640A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_D55E7B297A20B1D31F97360B0E6383F9" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_A55EE51C2222A7425DAB360B0E64640A" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_VerilyLifeSciencesMember" xlink:label="loc_dxcm_VerilyLifeSciencesMember_5F86425E568046E6D25E360B0E64E82A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_A55EE51C2222A7425DAB360B0E64640A" xlink:to="loc_dxcm_VerilyLifeSciencesMember_5F86425E568046E6D25E360B0E64E82A" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_6981A210A0F492F914DB360B0E6464FF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_6981A210A0F492F914DB360B0E6464FF" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_6981A210A0F492F914DB360B0E6464FF" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeArrangementInitialPaymentMember" xlink:label="loc_dxcm_CollaborativeArrangementInitialPaymentMember_6D808D45CC5A4CA7E19C360B0E65049D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE" xlink:to="loc_dxcm_CollaborativeArrangementInitialPaymentMember_6D808D45CC5A4CA7E19C360B0E65049D" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:label="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_0973B123033D8977D78E360B0E653D36" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_A2E56C8015C56135E73E360B0E64ACBE" xlink:to="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_0973B123033D8977D78E360B0E653D36" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DevelopmentAgreementsLineItems" xlink:label="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsTable_0E078E2D1F2C2EFF0072360B0E5C58AD" xlink:to="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeArrangementUpfrontFee" xlink:label="loc_dxcm_CollaborativeArrangementUpfrontFee_5834DAEEB81CDDA2DF64360B0E650A40" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="loc_dxcm_CollaborativeArrangementUpfrontFee_5834DAEEB81CDDA2DF64360B0E650A40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_FE9D5335AC9F47DA9AAE360B0E65B703" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_FE9D5335AC9F47DA9AAE360B0E65B703" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeResearchAndDevelopmentFee" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee_BA7EBA08872C1710968E360B0E663A09" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="loc_dxcm_CollaborativeResearchAndDevelopmentFee_BA7EBA08872C1710968E360B0E663A09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_BE5718F6E841B9262AE5360B0E66545A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="loc_us-gaap_SharePrice_BE5718F6E841B9262AE5360B0E66545A" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments" xlink:label="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_28D5CC339740A50A781A360B0E665DA7" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments_28D5CC339740A50A781A360B0E665DA7" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones" xlink:label="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_5385B3F35A92539A629E360B0E664954" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="loc_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones_5385B3F35A92539A629E360B0E664954" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:label="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_76721CA6B8EAA7C12B2E360B0E66F67F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_76721CA6B8EAA7C12B2E360B0E66F67F" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated" xlink:label="loc_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_A49C797041CF6516C0A2360B0E67DA21" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_B9C13FD5F63FFB3F8185360B0E65A1CE" xlink:to="loc_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated_A49C797041CF6516C0A2360B0E67DA21" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_318C690B9B04DC0CB24FD354A424D249" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_E939198C93E1CE2B031ED354A4244462" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_318C690B9B04DC0CB24FD354A424D249" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_E939198C93E1CE2B031ED354A4244462" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityIntrinsicValueOfOptionsExercisedAndFairValueOfOptionsVestedDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2B059C6517C0846D303EAFE0A1A187DE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_FD6A876E808B22937E6EAFE0A1A2CD12" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2B059C6517C0846D303EAFE0A1A187DE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_FD6A876E808B22937E6EAFE0A1A2CD12" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A48472D234E081C1BF1A1BEB0CDEE5D3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1CD9CC9E12952B735931BF6F0B080E3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A48472D234E081C1BF1A1BEB0CDEE5D3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1CD9CC9E12952B735931BF6F0B080E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_C34BE0459F65D937FBB31C0C5830D2D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1CD9CC9E12952B735931BF6F0B080E3" xlink:to="loc_srt_RangeAxis_C34BE0459F65D937FBB31C0C5830D2D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_B55EE467C98F3537527F1C0C58318254" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_C34BE0459F65D937FBB31C0C5830D2D5" xlink:to="loc_srt_RangeMember_B55EE467C98F3537527F1C0C58318254" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_BB33D307F5386E7491191C0C5946BBF9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_B55EE467C98F3537527F1C0C58318254" xlink:to="loc_srt_MinimumMember_BB33D307F5386E7491191C0C5946BBF9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_75CD2E7EF9F79F358EE31C0C5C0EE3F6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_B55EE467C98F3537527F1C0C58318254" xlink:to="loc_srt_MaximumMember_75CD2E7EF9F79F358EE31C0C5C0EE3F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_520604E22EC8DFEF53CD1BF6F0DDCEED" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1CD9CC9E12952B735931BF6F0B080E3" xlink:to="loc_us-gaap_AwardTypeAxis_520604E22EC8DFEF53CD1BF6F0DDCEED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4481375EDF95116C65D11BF6F0DE76DD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_520604E22EC8DFEF53CD1BF6F0DDCEED" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4481375EDF95116C65D11BF6F0DE76DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_84C27A25AC30F30C4D9E1C0F3A19E8BC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4481375EDF95116C65D11BF6F0DE76DD" xlink:to="loc_us-gaap_RestrictedStockMember_84C27A25AC30F30C4D9E1C0F3A19E8BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_6C36070AEF9A8108E0441BF6F0F436B0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1CD9CC9E12952B735931BF6F0B080E3" xlink:to="loc_us-gaap_PlanNameAxis_6C36070AEF9A8108E0441BF6F0F436B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_A0D33BC8E750ED64CA361BF89F51E030" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_6C36070AEF9A8108E0441BF6F0F436B0" xlink:to="loc_us-gaap_PlanNameDomain_A0D33BC8E750ED64CA361BF89F51E030" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_A401kPlanMember" xlink:label="loc_dxcm_A401kPlanMember_E7E048A9BE4B586E8DBC1BF86DCA35B8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_A0D33BC8E750ED64CA361BF89F51E030" xlink:to="loc_dxcm_A401kPlanMember_E7E048A9BE4B586E8DBC1BF86DCA35B8" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EmployeeStockPurchasePlan2015Member" xlink:label="loc_dxcm_EmployeeStockPurchasePlan2015Member_C1D03667F49283A4B6B11BF86DDC2602" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_A0D33BC8E750ED64CA361BF89F51E030" xlink:to="loc_dxcm_EmployeeStockPurchasePlan2015Member_C1D03667F49283A4B6B11BF86DDC2602" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1CD9CC9E12952B735931BF6F0B080E3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_F82DD3F5D8E4A8D4F0431BEB0CE00DB4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_F82DD3F5D8E4A8D4F0431BEB0CE00DB4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_C7A69CD49E53E13018941BEB0CE00E78" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_C7A69CD49E53E13018941BEB0CE00E78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_69D25AB78201571E72941BEB0CE1FD40" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_69D25AB78201571E72941BEB0CE1FD40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_E11854326B6E98AE21A11BEB0CE12936" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_E11854326B6E98AE21A11BEB0CE12936" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" xlink:label="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_26E57CEA383206A6E9CD1BEB0CE14959" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_26E57CEA383206A6E9CD1BEB0CE14959" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_41890B1D03ECFAC578631BEB0CE1B4A8" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_41890B1D03ECFAC578631BEB0CE1B4A8" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EmployeePurchasePriceFloorPercentage" xlink:label="loc_dxcm_EmployeePurchasePriceFloorPercentage_09D7A4C2458B069146971BEB0CE16C3F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_dxcm_EmployeePurchasePriceFloorPercentage_09D7A4C2458B069146971BEB0CE16C3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7EC721060A0365794D6A1BEB0CE17FF4" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7EC721060A0365794D6A1BEB0CE17FF4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3F779CEFAF34D67F994A1BEB0CE275F7" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3F779CEFAF34D67F994A1BEB0CE275F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_1593B4E84A6CB560AD461BEB0CE2BB7D" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_1593B4E84A6CB560AD461BEB0CE2BB7D" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_OptionsInMoneyNumber" xlink:label="loc_dxcm_OptionsInMoneyNumber_497AF7D68DB404B56B901BEB0CE24B05" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_dxcm_OptionsInMoneyNumber_497AF7D68DB404B56B901BEB0CE24B05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_67FD9A4B36B7FCDF7BF11BEB0CE25C6E" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_67FD9A4B36B7FCDF7BF11BEB0CE25C6E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_19B06510E7B3978D7BD71BEB0CE24B3F" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_19B06510E7B3978D7BD71BEB0CE24B3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_70ACD52AE0B3AF1EBD121BEB0CE2DF56" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_70ACD52AE0B3AF1EBD121BEB0CE2DF56" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_InMoneyOptionsMaximumExercisePrice" xlink:label="loc_dxcm_InMoneyOptionsMaximumExercisePrice_E543C81A60EB915A67B31BEB0CE31D5F" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_dxcm_InMoneyOptionsMaximumExercisePrice_E543C81A60EB915A67B31BEB0CE31D5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3BBD1B76677BD6361B891C0C56FAF839" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3BBD1B76677BD6361B891C0C56FAF839" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1BDA0FF6A6315D0F1F511BEB0CE37726" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1BDA0FF6A6315D0F1F511BEB0CE37726" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_B057C71CC130146ED0521BEB0CE3C67A" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BFADD539FF24D09FCFEC1BF6F100CE39" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_B057C71CC130146ED0521BEB0CE3C67A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_215FA75C5E629A2C7F94C9C4B8A5BD0F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8A024F1641F19DD7FEA4C9C4B8A5EBAC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_215FA75C5E629A2C7F94C9C4B8A5BD0F" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8A024F1641F19DD7FEA4C9C4B8A5EBAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_5C0C0B561A0900B8BF1FC9C4B8A5A126" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8A024F1641F19DD7FEA4C9C4B8A5EBAC" xlink:to="loc_us-gaap_AwardTypeAxis_5C0C0B561A0900B8BF1FC9C4B8A5A126" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F55C24251F9A72FFE9E2C9C4B8A69229" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5C0C0B561A0900B8BF1FC9C4B8A5A126" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F55C24251F9A72FFE9E2C9C4B8A69229" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_13B732DC150A1BAAA5DFC9C4B8A623BE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F55C24251F9A72FFE9E2C9C4B8A69229" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_13B732DC150A1BAAA5DFC9C4B8A623BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5CBEC258C5DF65872AADC9C4B8A68B4A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8A024F1641F19DD7FEA4C9C4B8A5EBAC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5CBEC258C5DF65872AADC9C4B8A68B4A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5CBEC258C5DF65872AADC9C4B8A68B4A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75BA8C4C8236C2A2D2DCC9C4B8A75BF1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75BA8C4C8236C2A2D2DCC9C4B8A75BF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1ADE0BCC747E079EF3ABC9C4B8A7309F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1ADE0BCC747E079EF3ABC9C4B8A7309F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0ED70B150F685E4F4C2AC9C4B8A8E87F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0ED70B150F685E4F4C2AC9C4B8A8E87F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_749F123157946CA30ABEC9C4B8A81BD8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_749F123157946CA30ABEC9C4B8A81BD8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2C32A0B67F061EE431FCC9C4B8A822C0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9971343890C72E49A9A6C9C4B8A6594E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2C32A0B67F061EE431FCC9C4B8A822C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5CBEC258C5DF65872AADC9C4B8A68B4A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9F5F12D19CD4C10ACD7AC9C4B8A78CA2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9F5F12D19CD4C10ACD7AC9C4B8A78CA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7F0B2B4F3FBBC78129DAC9C4B8A747C6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7F0B2B4F3FBBC78129DAC9C4B8A747C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4FD38CAC8CE28B5DED4DC9C4B8A8B096" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4FD38CAC8CE28B5DED4DC9C4B8A8B096" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2E9041463BAC6C95B786C9C4B8A843BA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2E9041463BAC6C95B786C9C4B8A843BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A56A2971512BB003229BC9C4B8A887FF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_DBA95495B90A198CC068CA589536D360" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A56A2971512BB003229BC9C4B8A887FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_B0BF3A67DDB70222A711C9C4B8A9DBDE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5CBEC258C5DF65872AADC9C4B8A68B4A" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_B0BF3A67DDB70222A711C9C4B8A9DBDE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_54D5019DC29B9111A102C9C4B8B455E7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_657D13781837AAD1DBF1C9C4B8B40113" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_54D5019DC29B9111A102C9C4B8B455E7" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_657D13781837AAD1DBF1C9C4B8B40113" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_17708761665EBF49599DC9C4B8B42E45" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_657D13781837AAD1DBF1C9C4B8B40113" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_17708761665EBF49599DC9C4B8B42E45" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_E07455383545539E625CC9C4B8B52574" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_17708761665EBF49599DC9C4B8B42E45" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_E07455383545539E625CC9C4B8B52574" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_D9FCE44634E5BD9134E1C9C4B8B553D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_E07455383545539E625CC9C4B8B52574" xlink:to="loc_us-gaap_CostOfSalesMember_D9FCE44634E5BD9134E1C9C4B8B553D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_472B95F5720C552FD658C9C4B8B5120E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_E07455383545539E625CC9C4B8B52574" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_472B95F5720C552FD658C9C4B8B5120E" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_SellingGeneralAndAdministrativeMember" xlink:label="loc_dxcm_SellingGeneralAndAdministrativeMember_86C2CE019F0FF0EC2468C9C4B8B5CFEF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_E07455383545539E625CC9C4B8B52574" xlink:to="loc_dxcm_SellingGeneralAndAdministrativeMember_86C2CE019F0FF0EC2468C9C4B8B5CFEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_63CE1C4A2BF887A2E93FC9C4B8B5218C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_657D13781837AAD1DBF1C9C4B8B40113" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_63CE1C4A2BF887A2E93FC9C4B8B5218C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5522FA9FD83E7F1D7985C9C4B8B604A4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_63CE1C4A2BF887A2E93FC9C4B8B5218C" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_5522FA9FD83E7F1D7985C9C4B8B604A4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_64A48F39543A7669A289AFE0A5D07120" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_F5FC1952F1CDF42FCA94AFE0A5D2F06A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_64A48F39543A7669A289AFE0A5D07120" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_F5FC1952F1CDF42FCA94AFE0A5D2F06A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_454E12F806B77FC6DF05AFE0A5D2BFB3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_64A48F39543A7669A289AFE0A5D07120" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_454E12F806B77FC6DF05AFE0A5D2BFB3" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_StockOptionsReservedForFutureGrant" xlink:label="loc_dxcm_StockOptionsReservedForFutureGrant_4D5FFEC652EAE8581381AFE0A5D3B6DC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_64A48F39543A7669A289AFE0A5D07120" xlink:to="loc_dxcm_StockOptionsReservedForFutureGrant_4D5FFEC652EAE8581381AFE0A5D3B6DC" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EmployeeStockPurchasePlanEsppSharesInEspp" xlink:label="loc_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_0E501CB0F9839DC519B7AFE0A5D37034" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_64A48F39543A7669A289AFE0A5D07120" xlink:to="loc_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp_0E501CB0F9839DC519B7AFE0A5D37034" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_5A6C501F759AA6A93F37AFE0A5D38BCC" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_64A48F39543A7669A289AFE0A5D07120" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_5A6C501F759AA6A93F37AFE0A5D38BCC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_88BD9AE5AEC4E6F8C0331BEB0CE841E1" xlink:type="locator" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock" xlink:label="loc_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock_BE21DEF91433C26E97A31BEB0CE8917F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_88BD9AE5AEC4E6F8C0331BEB0CE841E1" xlink:to="loc_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock_BE21DEF91433C26E97A31BEB0CE8917F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_0A0E11F0AEDF594A5A261BEB0CE98347" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_88BD9AE5AEC4E6F8C0331BEB0CE841E1" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_0A0E11F0AEDF594A5A261BEB0CE98347" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock" xlink:label="loc_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock_053C3B8DB5456C08DFA81BEB0CE9BCD2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_88BD9AE5AEC4E6F8C0331BEB0CE841E1" xlink:to="loc_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock_053C3B8DB5456C08DFA81BEB0CE9BCD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_DEFBFC0DDE9F5D84C84C1BEB0CE90EED" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_88BD9AE5AEC4E6F8C0331BEB0CE841E1" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_DEFBFC0DDE9F5D84C84C1BEB0CE90EED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_1E9AB07F89321115CB1E1BEB0CE90731" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_88BD9AE5AEC4E6F8C0331BEB0CE841E1" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_1E9AB07F89321115CB1E1BEB0CE90731" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3709BB411757F1888CDCC9C4B8AD72BE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3D4CB4548747EC2ADDBEC9C4B8AD534C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3709BB411757F1888CDCC9C4B8AD72BE" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3D4CB4548747EC2ADDBEC9C4B8AD534C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_368CD606CB03881A0FAFC9C4B8AE186D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3D4CB4548747EC2ADDBEC9C4B8AD534C" xlink:to="loc_srt_RangeAxis_368CD606CB03881A0FAFC9C4B8AE186D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_05D6B82F8F09C551C4B2C9C4B8AE0E50" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_368CD606CB03881A0FAFC9C4B8AE186D" xlink:to="loc_srt_RangeMember_05D6B82F8F09C551C4B2C9C4B8AE0E50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_65DBA0EC3D40C67F531FC9C4B8AE1E79" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_05D6B82F8F09C551C4B2C9C4B8AE0E50" xlink:to="loc_srt_MinimumMember_65DBA0EC3D40C67F531FC9C4B8AE1E79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1BBFB4FCDA3F690442C1C9C4B8AE81A5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_05D6B82F8F09C551C4B2C9C4B8AE0E50" xlink:to="loc_srt_MaximumMember_1BBFB4FCDA3F690442C1C9C4B8AE81A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_3470260B98EDF57AD22EC9C4B8AF3F70" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3D4CB4548747EC2ADDBEC9C4B8AD534C" xlink:to="loc_us-gaap_PlanNameAxis_3470260B98EDF57AD22EC9C4B8AF3F70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_CD9710A5EA2860F0FB0AC9C4B8AFBB0B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3470260B98EDF57AD22EC9C4B8AF3F70" xlink:to="loc_us-gaap_PlanNameDomain_CD9710A5EA2860F0FB0AC9C4B8AFBB0B" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EmployeeStockPurchasePlanMember" xlink:label="loc_dxcm_EmployeeStockPurchasePlanMember_BB4DA387846D8135AD01C9C4B8AF23A9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_CD9710A5EA2860F0FB0AC9C4B8AFBB0B" xlink:to="loc_dxcm_EmployeeStockPurchasePlanMember_BB4DA387846D8135AD01C9C4B8AF23A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81A19860D6D0DDE97A6AC9C4B8AF3273" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3D4CB4548747EC2ADDBEC9C4B8AD534C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81A19860D6D0DDE97A6AC9C4B8AF3273" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3FD20BD27BE310068BC1C9C4B8AF907E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81A19860D6D0DDE97A6AC9C4B8AF3273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3FD20BD27BE310068BC1C9C4B8AF907E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_86F3CC657A1036627935C9C4B8B04222" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81A19860D6D0DDE97A6AC9C4B8AF3273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_86F3CC657A1036627935C9C4B8B04222" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_E9238A35CC5848169985C9C4B8B0B0DF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81A19860D6D0DDE97A6AC9C4B8AF3273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_E9238A35CC5848169985C9C4B8B0B0DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7F7EB0A9FC7A5B48AF89C9C4B8B09AE8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81A19860D6D0DDE97A6AC9C4B8AF3273" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7F7EB0A9FC7A5B48AF89C9C4B8B09AE8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_F0AEB82A08EB33F92A96352402060509" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_16780DB5A0A2131869E635240207E384" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_F0AEB82A08EB33F92A96352402060509" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_16780DB5A0A2131869E635240207E384" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_277094DC9F7CEE327FE8D354A5431F54" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_75DABB7584E43F7B1F27D354A54352F5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_277094DC9F7CEE327FE8D354A5431F54" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_75DABB7584E43F7B1F27D354A54352F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3F04E82C39B1E35CFA9DD354A54307B4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_75DABB7584E43F7B1F27D354A54352F5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3F04E82C39B1E35CFA9DD354A54307B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7CEA0BC7B7382FF4AA47D354A5448A24" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3F04E82C39B1E35CFA9DD354A54307B4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7CEA0BC7B7382FF4AA47D354A5448A24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_5AD0662892BE5787B258D354A544AC28" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7CEA0BC7B7382FF4AA47D354A5448A24" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_5AD0662892BE5787B258D354A544AC28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_371CEDDB56A86210CCE6D354A544BCAD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7CEA0BC7B7382FF4AA47D354A5448A24" xlink:to="loc_us-gaap_CommercialPaperMember_371CEDDB56A86210CCE6D354A544BCAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_FA3D805FA8E602FA0CEBD354A545972E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7CEA0BC7B7382FF4AA47D354A5448A24" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_FA3D805FA8E602FA0CEBD354A545972E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B15CCD65B7047CEF4C5BD354A5457AE5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_75DABB7584E43F7B1F27D354A54352F5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B15CCD65B7047CEF4C5BD354A5457AE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B15CCD65B7047CEF4C5BD354A5457AE5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3E17E306A77BD5C3C7D5D354A545884F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3E17E306A77BD5C3C7D5D354A545884F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0F3E0752C40836A2EDCDD354A5451582" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0F3E0752C40836A2EDCDD354A5451582" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_BE00A21654BF8250FC85D354A546EDF7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_305B15B31AC41346F659D354A545BC81" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_BE00A21654BF8250FC85D354A546EDF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A989AC53867440205CBFD354A546BFB7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_75DABB7584E43F7B1F27D354A54352F5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A989AC53867440205CBFD354A546BFB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_E639583AFD91B613C299D354A5460718" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A989AC53867440205CBFD354A546BFB7" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_E639583AFD91B613C299D354A5460718" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_E3B11CEF94119307B7CCD354A546ADE5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A989AC53867440205CBFD354A546BFB7" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_E3B11CEF94119307B7CCD354A546ADE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_B85DFD854EBA944287FFD354A5462B08" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A989AC53867440205CBFD354A546BFB7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_B85DFD854EBA944287FFD354A5462B08" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_2B148F4EE84A21554DEAD35C9099418B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A989AC53867440205CBFD354A546BFB7" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_2B148F4EE84A21554DEAD35C9099418B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_349F8A0C88879B1703C1D354A547CD66" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A989AC53867440205CBFD354A546BFB7" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_349F8A0C88879B1703C1D354A547CD66" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_C373718D9C0A3DBC4D6AB4B41CDF1060" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7DCBED53C9F475BE2F66B4B42074025E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_C373718D9C0A3DBC4D6AB4B41CDF1060" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7DCBED53C9F475BE2F66B4B42074025E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1EBC903FFA1EE9D352F2B4B420FA78C0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7DCBED53C9F475BE2F66B4B42074025E" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1EBC903FFA1EE9D352F2B4B420FA78C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_789A7CE764838AD2D1EEB4B420FC1163" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1EBC903FFA1EE9D352F2B4B420FA78C0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_789A7CE764838AD2D1EEB4B420FC1163" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_5A505A415F536D957099B4B4212F6745" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_789A7CE764838AD2D1EEB4B420FC1163" xlink:to="loc_us-gaap_SeniorNotesMember_5A505A415F536D957099B4B4212F6745" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_85C492C2A78A31619962B4B420C10F09" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7DCBED53C9F475BE2F66B4B42074025E" xlink:to="loc_us-gaap_DebtInstrumentAxis_85C492C2A78A31619962B4B420C10F09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_73A698CC66B303AE7510B4B420CBC503" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_85C492C2A78A31619962B4B420C10F09" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_73A698CC66B303AE7510B4B420CBC503" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2022Member" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_7E07318E899E733F3C8AB4B4214C9994" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_73A698CC66B303AE7510B4B420CBC503" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_7E07318E899E733F3C8AB4B4214C9994" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2023Member" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_860900A109693142D7CFB4B4215FE2D4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_73A698CC66B303AE7510B4B420CBC503" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_860900A109693142D7CFB4B4215FE2D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_E8A58E188CA6D71B869CB4B4207CF870" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7DCBED53C9F475BE2F66B4B42074025E" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_E8A58E188CA6D71B869CB4B4207CF870" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_6C0DA04E35687E006B2CB4B420A37A59" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_E8A58E188CA6D71B869CB4B4207CF870" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_6C0DA04E35687E006B2CB4B420A37A59" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2195FAFC15E465ED42E3B4DBD5EF6AC8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2195FAFC15E465ED42E3B4DBD5EF6AC8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_FB384A715A6EC403C2EFB4DBD5EF4F9F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_FB384A715A6EC403C2EFB4DBD5EF4F9F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ABAA715A65B9735DB37FB4DBD5F04F29" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_FB384A715A6EC403C2EFB4DBD5EF4F9F" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ABAA715A65B9735DB37FB4DBD5F04F29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_8AADA925EC024D15375DB4DBD5F08C59" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ABAA715A65B9735DB37FB4DBD5F04F29" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_8AADA925EC024D15375DB4DBD5F08C59" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2B05C5D22F897D7B74A4B4DBD5F12059" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2B05C5D22F897D7B74A4B4DBD5F12059" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_208293FD9F9CC6BCD0EEB4DBD5F1628E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2B05C5D22F897D7B74A4B4DBD5F12059" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_208293FD9F9CC6BCD0EEB4DBD5F1628E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_D9BE5DC09227C3F315C3B4DBD5F229F6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_208293FD9F9CC6BCD0EEB4DBD5F1628E" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_D9BE5DC09227C3F315C3B4DBD5F229F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_75CFC219AB0773A9AC27B4DBD5F2AD8B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:to="loc_us-gaap_HedgingDesignationAxis_75CFC219AB0773A9AC27B4DBD5F2AD8B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_838153BE87C882B66195B4DBD5F37288" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_75CFC219AB0773A9AC27B4DBD5F2AD8B" xlink:to="loc_us-gaap_HedgingDesignationDomain_838153BE87C882B66195B4DBD5F37288" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_250A5ED8D1CA979A6777B4DBD5F36360" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_838153BE87C882B66195B4DBD5F37288" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_250A5ED8D1CA979A6777B4DBD5F36360" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_11BF5A32F38BACAEAF76B4DBD5F3A2B5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_11BF5A32F38BACAEAF76B4DBD5F3A2B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_016BF54C3478F1958315B4DBD5F4B74E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_11BF5A32F38BACAEAF76B4DBD5F3A2B5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_016BF54C3478F1958315B4DBD5F4B74E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_07F09065AE3DA6CD931CB4DBD5F4375A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_016BF54C3478F1958315B4DBD5F4B74E" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_07F09065AE3DA6CD931CB4DBD5F4375A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C85D5C2D2B8B9419414FB4DBD5EF4AA9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:label="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_B053B0281EC3999DFC41B4DBD5FA98B9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:to="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_B053B0281EC3999DFC41B4DBD5FA98B9" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FairValueAssetsLevel3TransfersAmount" xlink:label="loc_dxcm_FairValueAssetsLevel3TransfersAmount_620C63C0B484FEC62255B4DBD5FA595F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:to="loc_dxcm_FairValueAssetsLevel3TransfersAmount_620C63C0B484FEC62255B4DBD5FA595F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount" xlink:label="loc_us-gaap_DerivativeNotionalAmount_6BEF7075439523723CFEB4DBD5FB8924" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:to="loc_us-gaap_DerivativeNotionalAmount_6BEF7075439523723CFEB4DBD5FB8924" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_CF5C638F8E4B208B98C7B4DBD5FB5F4C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_CF5C638F8E4B208B98C7B4DBD5FB5F4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgesLiabilities" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgesLiabilities_C976C88CDF174D8936FAB4DBD5FB5E06" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgesLiabilities_C976C88CDF174D8936FAB4DBD5FB5E06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_7903C5773ADD021DAF3BB4DBD5FBE62E" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C5C5A3E38ABF73C17941B4DBD5FAA2D0" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_7903C5773ADD021DAF3BB4DBD5FBE62E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_946A2E7F749F6679DFE9B497AC41C5A9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_A3B8D010A5F6EA5D676AB497AC41507C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_946A2E7F749F6679DFE9B497AC41C5A9" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_A3B8D010A5F6EA5D676AB497AC41507C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_AECF6C73C69C3943F7CCB4B25189BCA0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_946A2E7F749F6679DFE9B497AC41C5A9" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_AECF6C73C69C3943F7CCB4B25189BCA0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_579DC585ECFFB6915C32D354A4625A7C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_EFD8F101D1611977230BD354A46311B5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_579DC585ECFFB6915C32D354A4625A7C" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_EFD8F101D1611977230BD354A46311B5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_B5F5C012F731242F2CF1B031007C4697" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6B23324B23D79FF5CB46B031007C1A7F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_B5F5C012F731242F2CF1B031007C4697" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6B23324B23D79FF5CB46B031007C1A7F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_B205DD12316C4241DC46B031007CDDA3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6B23324B23D79FF5CB46B031007C1A7F" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_B205DD12316C4241DC46B031007CDDA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_3BF6B1F9D8D6BBB17AF7B031007CF2A3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6B23324B23D79FF5CB46B031007C1A7F" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_3BF6B1F9D8D6BBB17AF7B031007CF2A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_F8753F3D5DE3B58DA65CB03100826905" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6B23324B23D79FF5CB46B031007C1A7F" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_F8753F3D5DE3B58DA65CB03100826905" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3939799E0DDF30C3F7A9B03100829D30" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6B23324B23D79FF5CB46B031007C1A7F" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3939799E0DDF30C3F7A9B03100829D30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_11F5393ED54ACABD6208B031008251F7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_B5F5C012F731242F2CF1B031007C4697" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_11F5393ED54ACABD6208B031008251F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7E92774E15034D9F2840B031008207C9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_11F5393ED54ACABD6208B031008251F7" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7E92774E15034D9F2840B031008207C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_BA6238AD725A9BE59248B03100831830" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_11F5393ED54ACABD6208B031008251F7" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_BA6238AD725A9BE59248B03100831830" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_83E034FF3F7BDEE0D1E8B03100837C23" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_11F5393ED54ACABD6208B031008251F7" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_83E034FF3F7BDEE0D1E8B03100837C23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_409402482993BF936E2EB03100832A22" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_11F5393ED54ACABD6208B031008251F7" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_409402482993BF936E2EB03100832A22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_AB664B755F3324F94B43B0310083992B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_B5F5C012F731242F2CF1B031007C4697" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_AB664B755F3324F94B43B0310083992B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_98B1449013C1CFD59E51F3900BB7010A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_095BF1854D9A3CA0D422F3900BB7FFAD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_98B1449013C1CFD59E51F3900BB7010A" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_095BF1854D9A3CA0D422F3900BB7FFAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4F8C8A06F1667DE0A83CF3900BB8599C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_095BF1854D9A3CA0D422F3900BB7FFAD" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4F8C8A06F1667DE0A83CF3900BB8599C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_EF62FD27738C38C271CFF3900BB8D584" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_095BF1854D9A3CA0D422F3900BB7FFAD" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_EF62FD27738C38C271CFF3900BB8D584" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_575975F3DEDF8311E733F3900BB8F14D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_095BF1854D9A3CA0D422F3900BB7FFAD" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_575975F3DEDF8311E733F3900BB8F14D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4E6E65B1460525016543F3900BB8A763" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_095BF1854D9A3CA0D422F3900BB7FFAD" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4E6E65B1460525016543F3900BB8A763" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_B4E75E99123D45B7F79DF3900BB8C249" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_095BF1854D9A3CA0D422F3900BB7FFAD" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_B4E75E99123D45B7F79DF3900BB8C249" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_11C410861F3E643394A0F3900BB93C44" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_095BF1854D9A3CA0D422F3900BB7FFAD" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_11C410861F3E643394A0F3900BB93C44" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DeferredTaxAssetsConvertibleDebt" xlink:label="loc_dxcm_DeferredTaxAssetsConvertibleDebt_FE3A27E17B2758A84D31F395719DC830" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract_095BF1854D9A3CA0D422F3900BB7FFAD" xlink:to="loc_dxcm_DeferredTaxAssetsConvertibleDebt_FE3A27E17B2758A84D31F395719DC830" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_4715570D6741575A520AF3900BB95CBC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_98B1449013C1CFD59E51F3900BB7010A" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_4715570D6741575A520AF3900BB95CBC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_C8E8CA3D249D1CC06D78F3900BB9DE2F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_98B1449013C1CFD59E51F3900BB7010A" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_C8E8CA3D249D1CC06D78F3900BB9DE2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4806F387968CAA3DD5C3F3900BB95477" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_98B1449013C1CFD59E51F3900BB7010A" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4806F387968CAA3DD5C3F3900BB95477" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesClassificationAbstract" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesClassificationAbstract_CC4C48B8237A6E408063F3900BB9FA24" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_98B1449013C1CFD59E51F3900BB7010A" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesClassificationAbstract_CC4C48B8237A6E408063F3900BB9FA24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_87B4FC4DFB4B543F37D0F3900BB90455" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesClassificationAbstract_CC4C48B8237A6E408063F3900BB9FA24" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_87B4FC4DFB4B543F37D0F3900BB90455" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount" xlink:label="loc_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_74CB7C93B9F23BF5F496F3900BBAE304" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesClassificationAbstract_CC4C48B8237A6E408063F3900BB9FA24" xlink:to="loc_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount_74CB7C93B9F23BF5F496F3900BBAE304" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_887DC6B82A5C16734140F3900BBA1EAE" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_98B1449013C1CFD59E51F3900BB7010A" xlink:to="loc_us-gaap_DeferredTaxLiabilities_887DC6B82A5C16734140F3900BBA1EAE" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet" xlink:label="loc_dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet_8AA4B0594F17458051F0F3900BBA900C" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_98B1449013C1CFD59E51F3900BB7010A" xlink:to="loc_dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet_8AA4B0594F17458051F0F3900BBA900C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_75159B01FC0339096E1AB031008C86B8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_353C8B4AC56726140FF4B031008D5330" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_75159B01FC0339096E1AB031008C86B8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_353C8B4AC56726140FF4B031008D5330" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7AC757C6B3858A30DE4CB031008D33B4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_75159B01FC0339096E1AB031008C86B8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7AC757C6B3858A30DE4CB031008D33B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5D30E5C420A282EEF40BB031008D1120" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_75159B01FC0339096E1AB031008C86B8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5D30E5C420A282EEF40BB031008D1120" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_35B27833DC15C1724176206A61264707" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_0E9315C0558C4CDEBE7A206A61269E8A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_35B27833DC15C1724176206A61264707" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_0E9315C0558C4CDEBE7A206A61269E8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_50D0E93951598CE71D2D206A61269039" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_0E9315C0558C4CDEBE7A206A61269E8A" xlink:to="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_50D0E93951598CE71D2D206A61269039" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetDomain" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_FAAB3FEB9A04159349BB206A61265D2E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_50D0E93951598CE71D2D206A61269039" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_FAAB3FEB9A04159349BB206A61265D2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5DFD06D4BF494F34F77C206A61270C00" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_FAAB3FEB9A04159349BB206A61265D2E" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5DFD06D4BF494F34F77C206A61270C00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_6137718D29A2AEEC8F29206A61270059" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_0E9315C0558C4CDEBE7A206A61269E8A" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_6137718D29A2AEEC8F29206A61270059" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_6137718D29A2AEEC8F29206A61270059" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_AB4BBE3A89F578C3896D206A61277FEF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_AB4BBE3A89F578C3896D206A61277FEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_E0D4188418A8990FA693206A61284C78" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_E0D4188418A8990FA693206A61284C78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_7BDE5CED5C40310825CB206A61285706" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_A4D0E27EC384E64BFD6E206A612718D8" xlink:to="loc_us-gaap_ForeignCountryMember_7BDE5CED5C40310825CB206A61285706" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_0E9315C0558C4CDEBE7A206A61269E8A" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_A24E10141E31AF8418FA206A61280F0C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_us-gaap_OperatingLossCarryforwards_A24E10141E31AF8418FA206A61280F0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8FC9A79CFFAA5F14BF54206A6129E245" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8FC9A79CFFAA5F14BF54206A6129E245" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration" xlink:label="loc_dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration_949B537C25C4D8A192E2206A6129E781" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration_949B537C25C4D8A192E2206A6129E781" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_UnusedExpiredFederalIncomeTaxCredits" xlink:label="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits_BB245A984F45AE86ECE4206A61290DB5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits_BB245A984F45AE86ECE4206A61290DB5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_A8CD283F165E7BE045BA206A6129879F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_A8CD283F165E7BE045BA206A6129879F" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital" xlink:label="loc_dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital_C0AD7320D6E891144872206A612900E4" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital_C0AD7320D6E891144872206A612900E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_44DD2844171426463BE7206A61297CE0" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_44DD2844171426463BE7206A61297CE0" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_PossibleExtensionPeriodofTaxHoliday" xlink:label="loc_dxcm_PossibleExtensionPeriodofTaxHoliday_2F895CC69C78858F8706206A61296ADA" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_dxcm_PossibleExtensionPeriodofTaxHoliday_2F895CC69C78858F8706206A61296ADA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_1167A7E7AA3B88B03E192070EE694AA1" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_FD63CE79473BDE79C9DF206A6128E872" xlink:to="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_1167A7E7AA3B88B03E192070EE694AA1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_48FA12AB2313C1B46937B031004CBB4F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:type="locator" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_48FA12AB2313C1B46937B031004CBB4F" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_339E8BE33A576725783FB031004CF890" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_339E8BE33A576725783FB031004CF890" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_D0B7EBD5FA56AD1C36A1B031004DEA60" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_D0B7EBD5FA56AD1C36A1B031004DEA60" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EffectiveIncomeTaxReconciliationPermanentItems" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_31D58B56D288E4D721F4B031004DC213" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:to="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_31D58B56D288E4D721F4B031004DC213" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_918DBCDFEC06A20C83E0B031004D5185" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_918DBCDFEC06A20C83E0B031004D5185" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_4C9208333E6C77904A75B031004D4B4C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_4C9208333E6C77904A75B031004D4B4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9E2B97C41D9B81C82DA6B031004D307E" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9E2B97C41D9B81C82DA6B031004D307E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_F418E70E4E1D66FEC970B031004E963C" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_F418E70E4E1D66FEC970B031004E963C" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits_F35B4AFE81E397F1D58DB031004ECE8B" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:to="loc_dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits_F35B4AFE81E397F1D58DB031004ECE8B" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_38B448F8E622B3D93E81B031004EDB4F" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:to="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616_38B448F8E622B3D93E81B031004EDB4F" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_A66223D7D852F6F377B0B031004EAA91" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:to="loc_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA_A66223D7D852F6F377B0B031004EAA91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_83B0094EB85A61720176B031004EAA02" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_83B0094EB85A61720176B031004EAA02" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_BF2E61F6B40F6C7A0366B031004FA777" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_BF2E61F6B40F6C7A0366B031004FA777" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_AE75FD583AF84119DFF7B031004F8BEC" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_3D60F2DB89D8092101E0B031004CA4A7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_AE75FD583AF84119DFF7B031004F8BEC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_FD9C31D3F1E2B0A29854B03100BFA7BB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_49093E6B5C6355A4E16EB03100BFBF67" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_FD9C31D3F1E2B0A29854B03100BFA7BB" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_49093E6B5C6355A4E16EB03100BFBF67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_308ECEB9DEC0B38A085DB03100C00D65" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_FD9C31D3F1E2B0A29854B03100BFA7BB" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_308ECEB9DEC0B38A085DB03100C00D65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_62537C308711363C14F3B03100C0FC89" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_FD9C31D3F1E2B0A29854B03100BFA7BB" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_62537C308711363C14F3B03100C0FC89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_CC6897F03681FFE4F151B03100C071B2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_FD9C31D3F1E2B0A29854B03100BFA7BB" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_CC6897F03681FFE4F151B03100C071B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_1FBF38360BCE5F71F4A4B03100C00F14" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_FD9C31D3F1E2B0A29854B03100BFA7BB" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_1FBF38360BCE5F71F4A4B03100C00F14" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3B03098A0A3ABD71299B1BEB0CEE459D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5B70EBF08D328DB842811BEB0CEEC9A5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3B03098A0A3ABD71299B1BEB0CEE459D" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5B70EBF08D328DB842811BEB0CEEC9A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_040C5F16DC4FCB4B42961BEB0CEFB8C1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5B70EBF08D328DB842811BEB0CEEC9A5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_040C5F16DC4FCB4B42961BEB0CEFB8C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_61E3E23C33C08F258B861BEB0CEFA73C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5B70EBF08D328DB842811BEB0CEEC9A5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_61E3E23C33C08F258B861BEB0CEFA73C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_739895D9B3FE43D1D4DF1BEB0CEFAEEE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5B70EBF08D328DB842811BEB0CEEC9A5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_739895D9B3FE43D1D4DF1BEB0CEFAEEE" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017" xlink:label="loc_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017_0D444B638D9A8F47B6A41BEB0CEFA818" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5B70EBF08D328DB842811BEB0CEEC9A5" xlink:to="loc_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017_0D444B638D9A8F47B6A41BEB0CEFA818" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_110B4AC846A603FBC6411BEB0CF0F3E0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5B70EBF08D328DB842811BEB0CEEC9A5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_110B4AC846A603FBC6411BEB0CF0F3E0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitments" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_B911C26D07D83F580189D354A4B38276" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_59B4F365B83EDD51F5D6D354A4B4308E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_B911C26D07D83F580189D354A4B38276" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_59B4F365B83EDD51F5D6D354A4B4308E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_DED5E8CAE1CC8DBEA2BCD354A4B4721C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_B911C26D07D83F580189D354A4B38276" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_DED5E8CAE1CC8DBEA2BCD354A4B4721C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_C2FBA956DA45EB9FD927B5C447EC1771" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8FAE8649CA6482A3747DB5C447EFE9D4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C2FBA956DA45EB9FD927B5C447EC1771" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8FAE8649CA6482A3747DB5C447EFE9D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_5B2604C78584CB40C80EB5C447F41630" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C2FBA956DA45EB9FD927B5C447EC1771" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_5B2604C78584CB40C80EB5C447F41630" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_0BD45F85503FA0B51657B5C447F79E84" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C2FBA956DA45EB9FD927B5C447EC1771" xlink:to="loc_us-gaap_OperatingLeaseCost_0BD45F85503FA0B51657B5C447F79E84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaap_ShortTermLeaseCost_1B63265868C69C1CE938B5C447FBC98A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C2FBA956DA45EB9FD927B5C447EC1771" xlink:to="loc_us-gaap_ShortTermLeaseCost_1B63265868C69C1CE938B5C447FBC98A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost_EFF51D2CFFF020CFFCB6B5C447FE4050" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C2FBA956DA45EB9FD927B5C447EC1771" xlink:to="loc_us-gaap_VariableLeaseCost_EFF51D2CFFF020CFFCB6B5C447FE4050" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_F4F7279B9A730B183AEFB5C49E8841BF" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C2FBA956DA45EB9FD927B5C447EC1771" xlink:to="loc_us-gaap_LeaseCost_F4F7279B9A730B183AEFB5C49E8841BF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_E7CFA5BD15BE9C3E691C1BEB0D449160" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_E7CFA5BD15BE9C3E691C1BEB0D449160" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_71FA84573D13D84C2AA21BFE8BE7CD71" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_71FA84573D13D84C2AA21BFE8BE7CD71" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_FC3BC1E278179EACECC01BEB0D452E84" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_FC3BC1E278179EACECC01BEB0D452E84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_63F3F66165F2E933C2261BEB0D4533A1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_63F3F66165F2E933C2261BEB0D4533A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7B46F31697D71150F6781BEB0D459949" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7B46F31697D71150F6781BEB0D459949" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9C821EC242CC4E5D2B551BEB0D46B27E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9C821EC242CC4E5D2B551BEB0D46B27E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_D47506ED10848A47E6251BEB0D461881" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_D47506ED10848A47E6251BEB0D461881" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_C841B0C668703DCEC8831BEB0D462B06" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_C841B0C668703DCEC8831BEB0D462B06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D8D9F8BE4E72046887B51BEB0D464549" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_D8D9F8BE4E72046887B51BEB0D464549" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability" xlink:label="loc_dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_EEAF8EB7C90E5F32EEB61BEB0D464E26" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:to="loc_dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_EEAF8EB7C90E5F32EEB61BEB0D464E26" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue" xlink:label="loc_dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue_7444B862600E0DEFA9A61BEB0D46F41B" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:to="loc_dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue_7444B862600E0DEFA9A61BEB0D46F41B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_C19C68321D168FB538111BEB0D4729CE" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:to="loc_us-gaap_OperatingLeaseLiability_C19C68321D168FB538111BEB0D4729CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_26974B73B5787940A2591BEB0D4761B9" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_26974B73B5787940A2591BEB0D4761B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_817270458B25354A847A1BEB0D47CB29" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_EB7012C03D1090B87A801BEB0D447367" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_817270458B25354A847A1BEB0D47CB29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_E7CFA5BD15BE9C3E691C1BEB0D449160" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_880EF2FE920B6E2BA4291BFEA1A34C1D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_880EF2FE920B6E2BA4291BFEA1A34C1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_FAC9477D5D22E42AFCAC1BEB0D47ADE9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_FAC9477D5D22E42AFCAC1BEB0D47ADE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_FA657DE1C856B14DEF001BEB0D489140" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_FA657DE1C856B14DEF001BEB0D489140" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_B0FA038908314CFE74331BEB0D48BA9F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_B0FA038908314CFE74331BEB0D48BA9F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_6400F9084D216AB464641BEB0D48EAAD" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_6400F9084D216AB464641BEB0D48EAAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_FB8C3C80E44EAEA002431BEB0D48022D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_FB8C3C80E44EAEA002431BEB0D48022D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_E95EB7CA696E099420031BEB0D4869B2" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_E95EB7CA696E099420031BEB0D4869B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2BCD8361708F025902F61BEB0D482A54" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2BCD8361708F025902F61BEB0D482A54" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability" xlink:label="loc_dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_51AA0B8DE9E2F9DBFC6C1BEB0D49BACB" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:to="loc_dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability_51AA0B8DE9E2F9DBFC6C1BEB0D49BACB" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_FinanceLeaseShortTermLeasesPaymentsDue" xlink:label="loc_dxcm_FinanceLeaseShortTermLeasesPaymentsDue_D79A15596B40F9FB26FD1BEB0D4924EB" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:to="loc_dxcm_FinanceLeaseShortTermLeasesPaymentsDue_D79A15596B40F9FB26FD1BEB0D4924EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_71C742CF9B50D838346A1BEB0D495D89" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:to="loc_us-gaap_FinanceLeaseLiability_71C742CF9B50D838346A1BEB0D495D89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_6AEEF2C7C6FBF2E9ECDE1BEB0D49FADC" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_6AEEF2C7C6FBF2E9ECDE1BEB0D49FADC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_41D82150EB6ACFA7F57A1BEB0D49E651" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_AB2563F4D961F97830E71BEB0D47D533" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_41D82150EB6ACFA7F57A1BEB0D49E651" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced" xlink:label="loc_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced_50A8B2ADE044056FB9001BEB0D493482" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_E7CFA5BD15BE9C3E691C1BEB0D449160" xlink:to="loc_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced_50A8B2ADE044056FB9001BEB0D493482" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_B7BF6F9720C7540D59A63A2764DC5005" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_B7BF6F9720C7540D59A63A2764DC5005" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_343E9A3BC068E0788C083A2764DC3EE2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_343E9A3BC068E0788C083A2764DC3EE2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_E1D12C14F6A3ACC70BD63A2764DDC677" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_343E9A3BC068E0788C083A2764DC3EE2" xlink:to="loc_us-gaap_EquityComponentDomain_E1D12C14F6A3ACC70BD63A2764DDC677" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_DEE6EF3C15E3BEBEF0653A2764DDF936" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_E1D12C14F6A3ACC70BD63A2764DDC677" xlink:to="loc_us-gaap_RetainedEarningsMember_DEE6EF3C15E3BEBEF0653A2764DDF936" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_47330AC54A7524DFCE5C3A2764DD9246" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_47330AC54A7524DFCE5C3A2764DD9246" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_B987B2EF35BF89D0ECCF3A2764DD2714" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_47330AC54A7524DFCE5C3A2764DD9246" xlink:to="loc_us-gaap_TypeOfAdoptionMember_B987B2EF35BF89D0ECCF3A2764DD2714" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_8AC4F3F195232E7483DA3A2764DECCC1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_B987B2EF35BF89D0ECCF3A2764DD2714" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_8AC4F3F195232E7483DA3A2764DECCC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_7A25662C5619A92BA1BF3A2764DE1585" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:to="loc_srt_RangeAxis_7A25662C5619A92BA1BF3A2764DE1585" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_BB8900FCF4D1604A5FE93A2764DED09A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7A25662C5619A92BA1BF3A2764DE1585" xlink:to="loc_srt_RangeMember_BB8900FCF4D1604A5FE93A2764DED09A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_12CFD2EC9E6A19523A243A2764DF311E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_BB8900FCF4D1604A5FE93A2764DED09A" xlink:to="loc_srt_MinimumMember_12CFD2EC9E6A19523A243A2764DF311E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_BBF067BC689A612156D63A2764DF4DD2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_BB8900FCF4D1604A5FE93A2764DED09A" xlink:to="loc_srt_MaximumMember_BBF067BC689A612156D63A2764DF4DD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_7140D3AE54EB34461D633A2764DF9106" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_7140D3AE54EB34461D633A2764DF9106" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_1D4D2DA5F2FF2341ECE53A2764DF2B80" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_7140D3AE54EB34461D633A2764DF9106" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_1D4D2DA5F2FF2341ECE53A2764DF2B80" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member" xlink:label="loc_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member_EE14EF89862B4864C7673A2764E0C198" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_1D4D2DA5F2FF2341ECE53A2764DF2B80" xlink:to="loc_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member_EE14EF89862B4864C7673A2764E0C198" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_ED913A660860298100D03A2764DC8F49" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_E1E29B38D3A9B16225683A2764E075D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_E1E29B38D3A9B16225683A2764E075D5" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_NumberofFinancingLeases" xlink:label="loc_dxcm_NumberofFinancingLeases_AA685F70F10C8CB1310F3A2764E05412" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_dxcm_NumberofFinancingLeases_AA685F70F10C8CB1310F3A2764E05412" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms" xlink:label="loc_dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_C8AE1E37CBF65712095D3A2764E09D2E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_C8AE1E37CBF65712095D3A2764E09D2E" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="loc_dxcm_LesseeOperatingLeaseRemainingLeaseTerm_2C56B2F3D471F7D6D1FA3A2764E12B0B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_dxcm_LesseeOperatingLeaseRemainingLeaseTerm_2C56B2F3D471F7D6D1FA3A2764E12B0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_1A975ECCA241CFC58AA23A2764E1CF4D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_1A975ECCA241CFC58AA23A2764E1CF4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_C62DB0DDC3F7C582214D3A2764E10687" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_C62DB0DDC3F7C582214D3A2764E10687" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_A12CB4515FEF257E47433A2764E181B4" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_A12CB4515FEF257E47433A2764E181B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_19781CF694EF7D260E483A2764E12BA4" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_us-gaap_OperatingLeaseLiability_19781CF694EF7D260E483A2764E12BA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_BB47EA3721F5FBFB0B903A2764E22FF5" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_us-gaap_FinanceLeaseLiability_BB47EA3721F5FBFB0B903A2764E22FF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_DA3E660FE29EA8B75C503A2764E2A7CC" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_us-gaap_LeaseAndRentalExpense_DA3E660FE29EA8B75C503A2764E2A7CC" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_LesseeOperatingLeasesLeaseCostAmortization" xlink:label="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization_409A8543D7B5524486D23A2764E263F2" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization_409A8543D7B5524486D23A2764E263F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_A5564530E460436B94783A2764E28C99" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_A5564530E460436B94783A2764E28C99" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" xlink:label="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_C17F63E5A226E26C80293A2764E2FADA" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_1244E81AD29EFC6574833A2764E0E62D" xlink:to="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_C17F63E5A226E26C80293A2764E2FADA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_AC73F527E3C6DA82DAA1B5C7756BDD2C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_9EA38CC494FC178A998CB5C7757026AB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_AC73F527E3C6DA82DAA1B5C7756BDD2C" xlink:to="loc_us-gaap_OperatingLeasePayments_9EA38CC494FC178A998CB5C7757026AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_60A1301D71BEE4FAF338B5C775747E5F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_AC73F527E3C6DA82DAA1B5C7756BDD2C" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_60A1301D71BEE4FAF338B5C775747E5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_C85178EBB47D2D70BD21B5C775789484" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_AC73F527E3C6DA82DAA1B5C7756BDD2C" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_C85178EBB47D2D70BD21B5C775789484" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0A07AD7692F8E8F03A41B5C7757CEA2A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_AC73F527E3C6DA82DAA1B5C7756BDD2C" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0A07AD7692F8E8F03A41B5C7757CEA2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_43FFFF8357FBF65165D7B5C775803B6E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_AC73F527E3C6DA82DAA1B5C7756BDD2C" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_43FFFF8357FBF65165D7B5C775803B6E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_112E87CEE6A40D631B6BB5C775E4DEF3" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_AC73F527E3C6DA82DAA1B5C7756BDD2C" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_112E87CEE6A40D631B6BB5C775E4DEF3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_9E4BE316979D8623514FB5C777FD8085" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_AC73F527E3C6DA82DAA1B5C7756BDD2C" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_9E4BE316979D8623514FB5C777FD8085" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_8F6573856A39D62FCE4AB5C7780734CD" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_AC73F527E3C6DA82DAA1B5C7756BDD2C" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_8F6573856A39D62FCE4AB5C7780734CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_E91A7C87436883BA770EB5C778103F30" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_AC73F527E3C6DA82DAA1B5C7756BDD2C" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_E91A7C87436883BA770EB5C778103F30" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_6202104C2024C604340ED354A4AFFE96" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_B1801F4FB2E06AB087ACD36A23E80B77" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6202104C2024C604340ED354A4AFFE96" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_B1801F4FB2E06AB087ACD36A23E80B77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_0AE916B74B0DA86B8E14D36989C2674C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6202104C2024C604340ED354A4AFFE96" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_0AE916B74B0DA86B8E14D36989C2674C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_E355F892C4491D86129AD354A4AF712A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6202104C2024C604340ED354A4AFFE96" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_E355F892C4491D86129AD354A4AF712A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3B97BFFFFB2D8A606005AB02F8ABF5F1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3E3DD207FDF09AB97721AB02F8AB0880" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3B97BFFFFB2D8A606005AB02F8ABF5F1" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3E3DD207FDF09AB97721AB02F8AB0880" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_213224E8F78D6E4AA6FEC9C2EFC85436" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48E3FDF4C8D30298918AC9C2EFCAF1E9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_213224E8F78D6E4AA6FEC9C2EFC85436" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48E3FDF4C8D30298918AC9C2EFCAF1E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_087DCDE0320B5F4FF628C9C2EFCA9DEF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48E3FDF4C8D30298918AC9C2EFCAF1E9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_087DCDE0320B5F4FF628C9C2EFCA9DEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24F4070BE4627E0322EEC9C2EFCA8103" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_087DCDE0320B5F4FF628C9C2EFCA9DEF" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24F4070BE4627E0322EEC9C2EFCA8103" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8E9C756A99B0399FED08C9C2EFCA62D3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24F4070BE4627E0322EEC9C2EFCA8103" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8E9C756A99B0399FED08C9C2EFCA62D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_CB06A37873093A016992C9C2EFCB657C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24F4070BE4627E0322EEC9C2EFCA8103" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_CB06A37873093A016992C9C2EFCB657C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_4916DDDC139C4619583DC9C2EFCB0A93" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24F4070BE4627E0322EEC9C2EFCA8103" xlink:to="loc_us-gaap_WarrantMember_4916DDDC139C4619583DC9C2EFCB0A93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_EF684992A2974904568FC9C2EFCBDED9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24F4070BE4627E0322EEC9C2EFCA8103" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_EF684992A2974904568FC9C2EFCBDED9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_5AB8B9E38F7D25707CB6C9C2EFCBA7FD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48E3FDF4C8D30298918AC9C2EFCAF1E9" xlink:to="loc_us-gaap_DebtInstrumentAxis_5AB8B9E38F7D25707CB6C9C2EFCBA7FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_B3FA376B09472C56BA73C9C2EFCB94D0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5AB8B9E38F7D25707CB6C9C2EFCBA7FD" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_B3FA376B09472C56BA73C9C2EFCB94D0" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2022Member" xlink:label="loc_dxcm_ConvertibleNotesDue2022Member_18337B8734A0BC6CF623C9C2EFCC06DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_B3FA376B09472C56BA73C9C2EFCB94D0" xlink:to="loc_dxcm_ConvertibleNotesDue2022Member_18337B8734A0BC6CF623C9C2EFCC06DF" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ConvertibleNotesDue2023Member" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_19EBEEECCE3B3F5F8650C9C2EFCC0ECD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_B3FA376B09472C56BA73C9C2EFCB94D0" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_19EBEEECCE3B3F5F8650C9C2EFCC0ECD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48E3FDF4C8D30298918AC9C2EFCAF1E9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_9719AFC022DE60E4B8FDC9C2EFCCB183" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:to="loc_us-gaap_NetIncomeLoss_9719AFC022DE60E4B8FDC9C2EFCCB183" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_9BAB5FF66749B86AAA70C9C2EFCDC13D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:to="loc_us-gaap_EarningsPerShareBasic_9BAB5FF66749B86AAA70C9C2EFCDC13D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_DC69875AAF6F39539263C9C2EFCDBE3E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:to="loc_us-gaap_EarningsPerShareDiluted_DC69875AAF6F39539263C9C2EFCDBE3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8264DED3122F87397607C9C2EFCD46CA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8264DED3122F87397607C9C2EFCD46CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DB7ACC95EA6A5121BE4FC9C2EFCD4C2E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DB7ACC95EA6A5121BE4FC9C2EFCD4C2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E8FBF90FA0B36E3C0908C9C2EFCDDB79" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7312EB1688EEFFB09F7BC9C2EFCC2A7B" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E8FBF90FA0B36E3C0908C9C2EFCDDB79" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1CE59FAC63EFB85BD10F210C27A7CB7B" xlink:type="locator" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1CE59FAC63EFB85BD10F210C27A7CB7B" xlink:to="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_792AD7462B796829E33E210C27A7FF50" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442" xlink:to="loc_srt_RangeAxis_792AD7462B796829E33E210C27A7FF50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_2CBBFC96C74D76DFB310210C27A721B6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_792AD7462B796829E33E210C27A7FF50" xlink:to="loc_srt_RangeMember_2CBBFC96C74D76DFB310210C27A721B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_653B0520DAF8BD283C15210C27A8F96A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2CBBFC96C74D76DFB310210C27A721B6" xlink:to="loc_srt_MinimumMember_653B0520DAF8BD283C15210C27A8F96A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_AB7946D5063E66AEF2D8210C27A8A5B1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2CBBFC96C74D76DFB310210C27A721B6" xlink:to="loc_srt_MaximumMember_AB7946D5063E66AEF2D8210C27A8A5B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_D634576FD5FE38A72155210C27A8145A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_D634576FD5FE38A72155210C27A8145A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_EC349CD6158DC5626685210C27A873E4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_D634576FD5FE38A72155210C27A8145A" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_EC349CD6158DC5626685210C27A873E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_E7FD9F7E5930B68DB101210C27A8C66D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_EC349CD6158DC5626685210C27A873E4" xlink:to="loc_us-gaap_ComputerEquipmentMember_E7FD9F7E5930B68DB101210C27A8C66D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_A1031DD0D3762F71EB7B210C27A973B6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_EC349CD6158DC5626685210C27A873E4" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_A1031DD0D3762F71EB7B210C27A973B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_193E7ADB68138EA61B6C210C27A90466" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_EC349CD6158DC5626685210C27A873E4" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_193E7ADB68138EA61B6C210C27A90466" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_349E6D33C8DCBB9D74D6210C27A71442" xlink:to="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" xlink:label="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_28EDAD9F801D44C3CC8C210C27A9F5EE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_28EDAD9F801D44C3CC8C210C27A9F5EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_C5F596FA31D4AA7F1397210C27AA8BC4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_C5F596FA31D4AA7F1397210C27AA8BC4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_868F5009C02AFD0DCADF210C27AA3D82" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_868F5009C02AFD0DCADF210C27AA3D82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9D19F6E446A6C4C5C575210C27AA6CA0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9D19F6E446A6C4C5C575210C27AA6CA0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_BE1406EBE4BD44DC1645210C27AA7AE2" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_BE1406EBE4BD44DC1645210C27AA7AE2" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_RevenueRecognitionSalesReturnsCoveragePeriod" xlink:label="loc_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_DF71F8C5B4D17C35AAD1210C27AAA45C" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod_DF71F8C5B4D17C35AAD1210C27AAA45C" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ContractPaymentTermsNumberofDays" xlink:label="loc_dxcm_ContractPaymentTermsNumberofDays_2CF5CF41656C2F57813B210C27AA0360" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_dxcm_ContractPaymentTermsNumberofDays_2CF5CF41656C2F57813B210C27AA0360" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnbilledContractsReceivable" xlink:label="loc_us-gaap_UnbilledContractsReceivable_FF67FF4B0FD246689C4A210C27AAD6BB" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_us-gaap_UnbilledContractsReceivable_FF67FF4B0FD246689C4A210C27AAD6BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_BA1790FF86E0FC9C8191210C27AAC639" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_BA1790FF86E0FC9C8191210C27AAC639" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_AmortizationPeriodForIncentiveCompensationCosts" xlink:label="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts_12E484D978A07C4F9FEB210C27ABCA04" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts_12E484D978A07C4F9FEB210C27ABCA04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaap_AdvertisingExpense_B2D38096741135326930210C27AB6BFB" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_38AC4B3E1C3DB2C58966210C27A99A78" xlink:to="loc_us-gaap_AdvertisingExpense_B2D38096741135326930210C27AB6BFB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_64EC5E6A3C2404FC1F2735240266B1D8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_NatureOfOperations_64EC5E6A3C2404FC1F2735240266B1D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_B9785EF65E688D0D85E6352402665429" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_B9785EF65E688D0D85E6352402665429" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_9CF3433D3854F27EFE9635240266D858" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_9CF3433D3854F27EFE9635240266D858" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_ADBAC8BD38C0B2B81C8035240266FFCB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_UseOfEstimates_ADBAC8BD38C0B2B81C8035240266FFCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_6DF5A8D8A2151B4B43F735240266DB15" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_6DF5A8D8A2151B4B43F735240266DB15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_C07DB6A4BFA760F3D60235240267A610" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_C07DB6A4BFA760F3D60235240267A610" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_21DDDC716C9ACF21ACDC352402679982" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_21DDDC716C9ACF21ACDC352402679982" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_A4E4D9BA15B1D007A60B352402675C37" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_A4E4D9BA15B1D007A60B352402675C37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_6CB63DC8CBE9AFF5E1B2352402676123" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_6CB63DC8CBE9AFF5E1B2352402676123" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_4792018E2B364731DAF83524026754FD" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_4792018E2B364731DAF83524026754FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2FD59A73DDD32476440A352402679B6D" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2FD59A73DDD32476440A352402679B6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_3E533EEB78AC2D8A8FDC352402687E11" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_3E533EEB78AC2D8A8FDC352402687E11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_2895B63588F3DE3A40BE3524026880C5" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_2895B63588F3DE3A40BE3524026880C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_8C40043D3B8FBF3E47BD35240268CE27" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_StandardProductWarrantyPolicy_8C40043D3B8FBF3E47BD35240268CE27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_26552C4BA03C7E0583243524026974CE" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_26552C4BA03C7E0583243524026974CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_2F3265774B90594C1F9A3524026953AC" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_2F3265774B90594C1F9A3524026953AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7BEDE31FF5D483CAAEF7352402696612" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7BEDE31FF5D483CAAEF7352402696612" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_ProductShipmentCostsPolicyTextBlock" xlink:label="loc_dxcm_ProductShipmentCostsPolicyTextBlock_3F21C4655F603624853C3541B43B8D38" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_dxcm_ProductShipmentCostsPolicyTextBlock_3F21C4655F603624853C3541B43B8D38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_676C11F43ED6EC2117BE3524026A7E2F" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_676C11F43ED6EC2117BE3524026A7E2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_DB10D73FDFCD647F4E6A3524026ADC5F" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_DB10D73FDFCD647F4E6A3524026ADC5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_774E5A590C18282348FA3524026ADD95" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_774E5A590C18282348FA3524026ADD95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ECBADF28E14AA58F98D93524026AD230" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ECBADF28E14AA58F98D93524026AD230" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_C054450FF8D8482B20583524026B2AF9" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_C054450FF8D8482B20583524026B2AF9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_354FD2AC53A8F05A51AA3524026BAE0B" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_545F8A81B490C6E8F53E352402658103" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_354FD2AC53A8F05A51AA3524026BAE0B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenueRecognizedFromChangesInContractLiabilityBalancesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9346CD5C96C38454FEA2B0CB6E9CAEC8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_EFD7C62A6C40AB756301B0CB6F066050" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9346CD5C96C38454FEA2B0CB6E9CAEC8" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_EFD7C62A6C40AB756301B0CB6F066050" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_DC66F6605C94DFCCF16AC9C2EB2FDE42" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_5AB5C445F1F657856C38C9C2EB302C01" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_DC66F6605C94DFCCF16AC9C2EB2FDE42" xlink:to="loc_us-gaap_ConcentrationRiskTable_5AB5C445F1F657856C38C9C2EB302C01" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2B21FFB60973A0949618C9C2EB300C0F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_5AB5C445F1F657856C38C9C2EB302C01" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2B21FFB60973A0949618C9C2EB300C0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_C37A8953DB378A29516DC9C2EB318F30" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2B21FFB60973A0949618C9C2EB300C0F" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_C37A8953DB378A29516DC9C2EB318F30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_0FD8ACC431588936D886C9C2EB31E91C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_C37A8953DB378A29516DC9C2EB318F30" xlink:to="loc_us-gaap_SalesRevenueNetMember_0FD8ACC431588936D886C9C2EB31E91C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_9756397D2972FE3710C8C9C55B861118" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_C37A8953DB378A29516DC9C2EB318F30" xlink:to="loc_us-gaap_AccountsReceivableMember_9756397D2972FE3710C8C9C55B861118" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_43A9B44E8C160B0A9DE0C9C2EB314A03" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_5AB5C445F1F657856C38C9C2EB302C01" xlink:to="loc_srt_MajorCustomersAxis_43A9B44E8C160B0A9DE0C9C2EB314A03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_43A9B44E8C160B0A9DE0C9C2EB314A03" xlink:to="loc_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CustomerAMember" xlink:label="loc_dxcm_CustomerAMember_5820A7163862FA736D5AC9C2EB32E12B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E" xlink:to="loc_dxcm_CustomerAMember_5820A7163862FA736D5AC9C2EB32E12B" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CustomerBMember" xlink:label="loc_dxcm_CustomerBMember_3D3A908A659BF3812A5CC9C2EB33A30D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E" xlink:to="loc_dxcm_CustomerBMember_3D3A908A659BF3812A5CC9C2EB33A30D" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_CustomerCMember" xlink:label="loc_dxcm_CustomerCMember_DA9C8ACF6508BE42BB95C9C2EB33F43F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1EF1486A720CF186F3DEC9C2EB310A2E" xlink:to="loc_dxcm_CustomerCMember_DA9C8ACF6508BE42BB95C9C2EB33F43F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_24620DA3E2C9566CD3E2C9C2EB340E3B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_5AB5C445F1F657856C38C9C2EB302C01" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_24620DA3E2C9566CD3E2C9C2EB340E3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_9B86475E1B6CAF78102AC9C2EB34D954" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_24620DA3E2C9566CD3E2C9C2EB340E3B" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_9B86475E1B6CAF78102AC9C2EB34D954" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6BA529672CACD59D133DB0B8FE624CE5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_4EC0D269D39D2C013A19B0D0C06A3E0F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6BA529672CACD59D133DB0B8FE624CE5" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_4EC0D269D39D2C013A19B0D0C06A3E0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_A18BF853E19CEE531ED9B0C76B53E940" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6BA529672CACD59D133DB0B8FE624CE5" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_A18BF853E19CEE531ED9B0C76B53E940" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3EE1FF2F103A614F42DFB0C3F4156B0F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6BA529672CACD59D133DB0B8FE624CE5" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3EE1FF2F103A614F42DFB0C3F4156B0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_5F2E294CC6A9F881F0C1B0B8FE623059" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6BA529672CACD59D133DB0B8FE624CE5" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_5F2E294CC6A9F881F0C1B0B8FE623059" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedQuarterlyFinancialInformationUnaudited" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_C89CCC5D948D586986A4D354A3E2D360" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_1095DC06E831C4C19AB1D354A3E2AA7B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_C89CCC5D948D586986A4D354A3E2D360" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_1095DC06E831C4C19AB1D354A3E2AA7B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedSummaryDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_B4ADB998D7B27A7479D1B0B8FC306461" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_70AD6AF47A646BCFE130B0B8FC30DCD3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_B4ADB998D7B27A7479D1B0B8FC306461" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_70AD6AF47A646BCFE130B0B8FC30DCD3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_2A417A7E96F7B82BEF84B0B8FC3124C0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_B4ADB998D7B27A7479D1B0B8FC306461" xlink:to="loc_us-gaap_GrossProfit_2A417A7E96F7B82BEF84B0B8FC3124C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_8BC0CCAE6F01F0646C6BB0B8FC314A35" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_B4ADB998D7B27A7479D1B0B8FC306461" xlink:to="loc_us-gaap_OperatingExpenses_8BC0CCAE6F01F0646C6BB0B8FC314A35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_72E953575476EB380187B0B8FC311314" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_B4ADB998D7B27A7479D1B0B8FC306461" xlink:to="loc_us-gaap_NetIncomeLoss_72E953575476EB380187B0B8FC311314" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_AEB3C9F65D9E45D2B41EB0B8FC313F71" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_B4ADB998D7B27A7479D1B0B8FC306461" xlink:to="loc_us-gaap_EarningsPerShareBasic_AEB3C9F65D9E45D2B41EB0B8FC313F71" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_ED173E37D6CFDED0A2FDB0B8FC31B43E" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_B4ADB998D7B27A7479D1B0B8FC306461" xlink:to="loc_us-gaap_EarningsPerShareDiluted_ED173E37D6CFDED0A2FDB0B8FC31B43E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3049B6E61415B494D7FCAB669A63E2BC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_1619DAA518563003DCEAAB669A638275" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3049B6E61415B494D7FCAB669A63E2BC" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_1619DAA518563003DCEAAB669A638275" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_DD880E0CB6F33ED630D9D354A3D7E8A1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_23F5BAC0C252F02BB46DD354A3D799A8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_DD880E0CB6F33ED630D9D354A3D7E8A1" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_23F5BAC0C252F02BB46DD354A3D799A8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_6ECCB3DCA9BFFA38104CAF6BADCC6597" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_F178183578C21F0C2DE6AF6BADCE93ED" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_6ECCB3DCA9BFFA38104CAF6BADCC6597" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_F178183578C21F0C2DE6AF6BADCE93ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_0FF52A50038F8BF4CF4CAF6BADD05202" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_F178183578C21F0C2DE6AF6BADCE93ED" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_0FF52A50038F8BF4CF4CAF6BADD05202" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_1670BC7D8D52D1FABF5BAF6BADD1BED6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_F178183578C21F0C2DE6AF6BADCE93ED" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_1670BC7D8D52D1FABF5BAF6BADD1BED6" xlink:type="arc" />
    <link:loc xlink:href="dxcm-20191231.xsd#dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" xlink:label="loc_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_B917192DCDCE510FCC2BAF6BADD24FB4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_F178183578C21F0C2DE6AF6BADCE93ED" xlink:to="loc_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_B917192DCDCE510FCC2BAF6BADD24FB4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_AD2E0FF724546B5ADB50AF6BADD3236C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_F178183578C21F0C2DE6AF6BADCE93ED" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_AD2E0FF724546B5ADB50AF6BADD3236C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_C23A2C9FE58E4B60B573AF6BADD32659" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_F178183578C21F0C2DE6AF6BADCE93ED" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_C23A2C9FE58E4B60B573AF6BADD32659" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>a2019chartitem5.jpg
<TEXT>
begin 644 a2019chartitem5.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" () J(# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[:&[M+Y_"/PO\(^'_BQH=M DR:]/^SIJNF?;;?\ X29[F@#]DOA-_P %B/\
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M[/?>.]$\0Z#XGLK.VM-8L["V /V>L_\ @K)HL_[-'_!/GXP:A\*]%T+XL?\
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M9Z';Z+X:TCQ>WC'2=4F@+6_C'Q/XRLDT[QMXCN]#L_#L4B1S?LM_P7B>./\
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M#<'AC2-8^%VCKKC:-XST;P[!=2K="+5?!GC?1%FTLR6VH6$/A#4MYF\1Q-,
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M6-AJ#Q-=V=GJLFCZ3)J5M;S1P7TFEZ:]U'*UC:F+3HH **** "BBB@ HHHH
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MG?T=#:00I&%."%.-I]"%Z'VIWM_]?\__ *] '\JW_!17]@7]HW7?B-_P1O\
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MSSTZX)&"0#@X[X(.#S@@]Z;N7U)&,Y^8K@=RW*\>YXH _G;_ ."CG[)NB?\
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M/)Y(ZLP' .!R0.@.!CI3@0>AYP"0<@@'IE3R,X[@=Z /X<_VQ?V(/VR?"_\
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MNZMH\%MX@LS:V$T<6L6FFP>(]$DN].TN_N/#^KZ5<ZAI.EWLTUC!]*C Z ]
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M([W4+[XEZ9XJ\S4KJT^+^N75[+-J=UXD\'_ [2O&GBG6-8UF[GN]=^('P?\
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M;Z/<:!+X?U[29[K6[XZ+J$,NCS176FP75\KZ6?TM_P""'?[*OQR_8B_X)M?
M;]DS]HKPOI/A_P")7P;D^)MCJMSX:\9Z3XU\*:[9^,_BWX]^(&EWNB:CIHM;
MF)(=*\56=IJ-IJ>F64T&IQW0M7O+8I<D _-[X0?M/?$+_@J)_P %N_VTOV3/
M&7CKQYX._8K_ ."=W@J?PO:?!?X<^.O%GPT_X7G\;=0\0Z1X.USQC\9_$?@3
M5/#OBOQ9X3\-ZF/&-OX<^'X\0VGA)7T?PEK.H:;J%[-K2WNB/VG_ (N?\$^?
M^"^GP9_X)V:5XY\=_$3]CG]N[]GP_$3X=^ ?B7XT\2?$74?V=/C)X;L_BK%=
MQ?#CQEXSU3Q!XZM/AEXJD^$I75O NKZ[J^BZ'?>,7U'PC#HEEH2:7>?3T/\
MP3M^,?['W_!5?XT?\%(_V5/#FA_%_P"&'[8GPZM/!W[4O[.UWXNTOP#\0/#_
M ,1-$N="U+0OC%\&M=\4+;> _$\.KW'ALVWBWP-XS\2>"YK34/%'B+Q!H_B+
M4DNK31-,9X1_X)Q?&+]H7_@JA=?\%5_VI]*T7X;3?!/X&7GP%_8P_9]\/>+K
M#QIXN\,QZCIGC6V\1?%[XN>+]*ME\#:=XROIOB)XWM/"_A#P7?\ BK3-'M=8
MTC5M3\6R:KX>@AN0#\8_V6?^"C/PZ^(NH_%W]A[_ (*4?'#]J'_@GU_P6 N/
MB9\2])T[]H#Q'\5/B7X'^$OB?6M>^)&N:O\ "+P[\/K>/6Y/A#X-^$-OX9NM
M%^'VF>"M>\$VG@;QGX5M8?&7@WQSJ'C[Q3!K=E]N?\%$/'/Q)T+_ (.(O^"1
MGP7\._%KXR>&?@]\=/ 'Q4UGXO\ PG\+_&+XG^&OAK\0=5\#Z/\ %34O#=YX
MG\$:%XKT[PYJ<UA>:/I?GF73435;?3;*SU>*\M(%MQZ?^U]^P#^U/_P48_8'
M\&_LE_MF_LE? /Q!^UY:>#/ _AG3_P!MG1?BCX=UOP#\+/$%A-H7_"1_%;0[
MB\T30/V@1XDN]*BU>[\0?"#0_"MW\/O&OBAKG1+OQU9^&+^U\1:=I?M.?\$[
M_P!JOQ1_P5R_X)8_M7_#;P-9>,_V?_V#?A#J7PM\>>)O$_Q3\):3\2/&LVO>
M&/&GA Z]HWAJ^,AU&;3;77-*UO5IM6U;2+C6+Q]4L[."$P6][>@'Q3_P<G^"
M/B?^PY_P3[U?]HWX,_M2?M:^'/CU\4_V\;>\U3Q[H?[4W[0&AV7AWX>_%*+X
MS>*['X1>"? ^F_$2U\">$O '@_2])\)Z%H^EZ-X:MIB^A2:B]UYVI72-^O7[
M0O[+=O\  S]C_P#;E^-?PY^,W[1NGVNO?\$_?&^K:;X3US]I+X_>,D^'_P 6
M_A9\,_B7XX\/_%[X7^(_&7Q)U_Q-\/\ Q5J$VM6=KXB'AK6;"QU9_"OAF[FL
M_/M;MKSR/_@XJ_8)_::_X*1_L2>"?V:/V8/"?AC6/&=G\?O GQ3UC6?&WCO1
M?!'AG3/#_A'PE\1-&NK07%W%J&IW^L7FH>*=,%K;6VEK9BU6\N9]1BEMXK2Z
M_2#]IWP-\6/BI_P3\^.?PC\(?#OS?B_\5?V7OB1\(=%\$ZKXQ\+Z;8Z9XP\<
M_"W6_ MDVM>,5N;O1(]"L-4U&.ZO=4TZ+4KLZ:IFMM(FNRU@@!_,Q_P1Z\1_
M#O\ X* ?L)_LV? S6_VN/VN6_P""B?COX#?M#_'[Q;\9]%_:X_:U@\2^!H?A
M%^TY!X$^'VH^,=,OOB&_PU\3:)X@3Q3X1\,ZGX0M]'U!-8\&Z=JXO([+5'BU
M$_V9ZMIMIJ^EWFE7Z2366HQ/:7217-W:2/;W3B.18[JRGMKN!MCD)-;SPS1D
M!HW5@#7\TG_!/?\ 9Z_X*1?L#_\ !/'X$_LX:-^Q#\,_B%^U/^SQX%^/?@3X
M<_%/6/VJOA[IOPEM4^./Q2U/XC7%_J2P>&[SQX?#UE=)X-O?$7A&PT:)_$.I
M>#XH+?6]/%W;ZKI_](&F1>(M!\$Z5#JKW/C/Q1I'A[2HM2FM3IFGW?B77-/T
MZUCO[F$W<NEZ3:3:MJ$,]PHEELK* W&W,,2A5 /Y&O\ @@[XO^)7[0O["/\
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MWM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6;I6LZ1KMF-1T35-.
MUC3VN+ZT%]I=]:ZA9F[TN^N=+U.U%U9RS0&XT[4[*\TZ^A$ADM+^TN;.X6.X
MMY8T^>/VMOCAIGP&^#>I^))_&'A'P/XC\5:WX>^&?P_\0^.-:T/0?#>F>//'
M^I)H6AZUJEYXCN;/2)=.\'V\NI>/=8L;BYC:]T+PGJMM 'FDC1OYS?\ @VL_
M:6U?P'XV_;P_X)+_ !2^+6D_&'QM^R%\=/B!\4?@I\3K#Q'I'B6W^+GP$^+/
MC.XUS6?%FFZCH.IZOIEQGQOXCT[XB:TJ7]Q<6%_\;6T>Z*7.CW4<0!_33X(_
M:'^ 7Q,\9^)/AS\.?C?\(?'WQ"\&0W-QXP\!^"_B5X+\4>-/"<%G?6^EWDOB
M;PKHFMWVOZ EIJ=W:Z;=-JVGV:VVH7$%G,4N9HXF9=_M%_L_Z?>^/M-OOCA\
M([+4?A1;0WOQ2L+KXC>$+>]^&EE<1O+;WOQ!M9=82?P797$$4MQ;W?B6/3+:
M>VBEN8I7MXWD7^4W_@JW^P;^T#X$_:(^.'_!:;_@G#]IL/VS/V2?CK9V_P 8
MOACI=K>W>E_M(_L[Z+^SK\!K[Q)I-_X:T^6)?$&MZ%HNH:U;>(_#]G'!JWCO
MP5<W%WI-T/B)X,\'/J/V_P#LS?MN_ W_ (*/_L1_\%&OVOO@IIT.DV_Q&_93
M70OB7X8O+?=XB\#_ !.\)?LQ_$FT\5?#KQ1J,EE9_P#"1OX8:^MFT/7HHGTW
M7O"VJZ-J]FEJ-0FT^T /VN\!?M?_ +)WQ4UFP\._"_\ :=_9Y^)'B#59WMM,
MT+P#\:_AGXPUG4+A$:1X+'2_#WBC4;Z\F2-'D:*U@FD5$9B@"DCZ&EFB@BDF
MFECAAB1Y99976..*.-2\DDCN55$C169V8A452S$ $U_!)^PQ\#?AA\8?^#03
MXQ:MXY\.Z'<>(OA'X:_; ^.?PR\8-IUA!XK\"_%#X0>/M?\ ''@OQ+X0\3)'
M#K7AW6CJ.B1:'/?:/?VEY>Z)JNHZ+*\UE?36LG]*G_!##X\_%7]LC_@D)^R3
M\5?V@]1US7?B)XS^&_C/P/XL\5:O<$:]XSL? ?C[QQ\*M)\97^H>9+=7>M^)
M/#/AG3M1U76KHB\U76WOM8F!EO"S@'V6G_!0K]@:06K1_MO_ +(+K?,Z6;)^
MTM\%F%T\<GE.ML5\;$7#)+^[98?,*R?(P#<5U[?MD_LB+X%D^*)_:G_9R_X5
MG%XDO/!LOQ%_X7?\,O\ A XO%^GQ64]]X4E\8_\ "3_\(Y%XELX-2T^>YT&7
M4DU6&&]M)9+14N(F?^63_@L_\)_AQ\'O^"JO_!LG\)_AKX+\-^#_ (>^!_C]
MJ_@WPQX6T31M-L-*TOPYX<^(W[,.FZ1IL-K;6L4)AM+6WC"[D):4R3MF:61V
M^N?^#FGX/?#?X6_\$5OV]=8\ ^$]&\+W7Q9^,?[.GQ2\=Q:/I]C866M_$"?X
MM_ CP+?>+);*TMH+9-:U3PYX,\/6NKZ@J&ZU*:Q-W=RRW-Q.\@!^^7B7]K+]
MEKP7X1\,?$#QC^TC\!O"7@+QLB2>#/''B?XO?#[P_P"#O%T<D,EQ%)X7\4:O
MXAL]"\0)-;12W,+:3?W:S6T<ES$7@1I!%XS_ &N?V5/AQ#X:N/B)^TO\ ? %
MOXTLCJ7@ZX\;_&+X>>$8/%FFAXD;4/#$WB'Q%IT?B"Q5IX UUI#7D"_:+?+C
MSX=_\3?_  <$_$KXC^)_^" W[#'A/Q-^S'\0OAEX4T3QA^QDVB?$3Q)XR^ N
MN^%M7;3OV9_'NEZ=;Z-H'@/XG^*?&FFG6]+N;F_T_P#M+PKI4-II\4]MJCZ=
M=S06,OW)_P ''4\UA\9O^#?;4;'P[)XIU'3_ -O?P#-I_AVTDT&TO]<FBUW]
MGRYB\/Z??^)KS3= T^76+FWM[.*;6M3TS0XIV@GU:]M;.![B$ _J3^&7[3_[
M-7QJ\1:EX0^#?[0WP-^+7BO1M(_X2#5_#/PS^+7@#QYXATO03=VUA_;>HZ+X
M5\0:KJ=CI'VZ\L[+^TKJUBLOM=W;6WG^=/$C:?Q4_:$^ GP,_L;_ (79\;?A
M'\'_ /A(II;?P^?BE\2?!GP]77;B$9G@T9_%VM:.FJ3P@AIH;%IY8E96D158
M$_(W[&.FP?';5IOVP?BO^S['\ _VE/#7B/\ :E_9F'AW4;3P6WCG0O@[I/QX
ML8-#\)>,_$_@Q;[2?&,.H1_";PC\0]"N]'\0Z]X;L6\3ZI<>&M5U33]7EU*\
MXC_@K/\ L4?"#_@H1\%_A%^RE\:[6[3PI\3OC=J-G8>)='$2^)? ?BS2_P!G
M/]H;6_"7CCPU+.#"=3\-^(M,TS4)M-N@VF^(=,AOO#NKQR:9JERH /T/\=_%
MKX6?"ZVT.]^)GQ)\!_#RS\3:O9^'_#=UXW\7:!X5MO$.OZC)%#IV@Z'/KFH6
M,6KZWJ,LT46GZ1I[W&H7TDBI:6TS'%=AJFL:3H>E7^NZUJFG:1HFE6-SJ>J:
MQJE[;:?I6FZ;9PO<W>H7^H7<L-I9V5K;QO/<W=S-%!!"CRRR(BLP_B^_X)Y?
MMB?&_P" /Q2\'_\ !"?_ (*8QIJG[1W[.O[1O[-'B#]C?XQ:M9WNK:!^T'\"
M?"GQ3T/5?"PT;7=0AE,VJ^#?"^DSZS\//$%Y(FH3^%]%UOP#KQTOQ[\-+N'7
MOV)_X+IW]Q\8OV//BS^Q#X'^.7P^^"OQ/^/?P+^*/BY-5\:^._!/@Q]=\*?#
M6STV^L?AE8S^,-?T-$?XZ_$&Z\,?"V_U&!YDT[P5=_$'4'5GL$C< _<@D 9/
M^?PZY]NN>*\&T']J?]F?Q1XJN_ OAO\ :"^"FN^,['5GT&Z\*Z1\4?!&H>((
M]<BU&/1Y]'72K77);R?5;769H-&N]/MHIKRSUB:+2[J&&_D6W/X\_P#!)/\
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M<Q0'2K2)X[E+B-62=9'ZVP_:X_94U7X>:O\ %S2_VF/V?]3^%'A_79O"^O\
MQ/T[XR_#F^^'>A>);>*SGG\/:UXVM?$DWAG2=;BAU'3I)-*U#5+:^1=0L"T
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M6;Q/'KUG\0M0A\=>'WDU/5-)\31Z98:GI6BVKZ+)X6\&ZI'#>WV@Q-+^T5%
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M;V^UHB>WDM]+TJ"V_82B@#\$-$_X(;Z?XM_9-_9M_8-_:<_:D\6?&?\ 8_\
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M)^W?^T5^W)^RC\<].^&6H?M@Z7X5C_:4^#WQ,^$8^+?@/Q/XM\(/<?V/\0?
M6K:+\1_A7XO\!^(2+W5I]4TN\U;Q5X8U34/$&M7DNEPF32XM)_6P(@.0J@GD
MD* 2?7(&:=0!\(_&W]BAOBS^QY^T1^ROIWQ2O?#^L_M0^%_BCH/Q7^,&M^$K
M7Q;K5[?_ !CT6YT#QIKVD>%(-?\ "^B:;/9Z++::%X+TL7LND^&-#T?1;&6W
MUF:REO+OXBO?^",]]>_\$>XO^"0DG[3)7P&FA67A!OC0OP6M!XT?PCI_QB@^
M,=M8#PO_ ,+._P"$<36/[5@30I=:^TM#)HF9/[)35R=1K]RZ* /GG]E/X'ZI
M^S7^S3\#_P!G?4/&EM\0%^!WPF\ ?"'2/&47A;_A#Y]>T+X=>$=(\'Z)J>K:
M#'XA\1VMOK%U8:1#<:JVGZC%83WDDKV=G90E85^4?B__ ,$W?#_[4'[*_P"T
M]^R5^U1X_M/B5\/?VCOBAXC^),>H>#/A_;_#?7OA])JWCG2?'^B:?HUQ=>*_
M'$6IW_A'6=$L(])\33)IVI7MD;N#5X+K[2[5^FE% 'X[_MU?\$G4_;'^.'_!
M/OXM^'OCC8? S0_^"=7Q+T[XG_"+X=:#\&M.\5Z+KNIZ7K/PPU*RT'Q'?77C
M_P .-9>%;*P^%NDZ#I^E^'=.TVXM-.O[Z3[=+<Q6$EKD_M8?\$IO'O[1_P#P
M4&_9;_X*'^&OVI-*^%OQ(_9*\%ZSX0^'/@J;]G^U^('@_5?^$KA\96GBS4?%
MLU_\7?#6L7[:G8^-M2LM/M=+N=(_L:.UL+F"YGOUN+J?]GJ* /S5M?V-OVG=
M9U#X^:[\2/VS-)\4ZG\3?@)K/P'^%'AWPU^S=I'@7X7? >U\72WMSXZ\>:7X
M&C^+/B/4?'WC?Q3=+X<FEN_%/C"#3K*/PMI]C%8R:?=:A;3^X?%W]COX;_M-
M?LA:U^Q_^U'::1\6?!7C#X;Z?X \:ZCIWA]?")OKO2;"UM](\;>%],GU3Q0W
M@[Q9H.JV&G^*?#5_:ZKJ+:!XCL;:[LY&MXA:M]=44 ?,'A;]G6\\"_L>>#OV
M4?"OCH>;X(_9Y\,?L_Z5\1/$7A>/5I[FQ\-?#BR^&\?BK4O"NFZYX?M9M2N[
M"S_M233;;6;.P34)/*5S9KY3?*W_  22_P"":R_\$JOV8I_V6]'^-%Q\;/"$
M/Q!\5_$#0_$&L?#VT\">(=.N?&$6C#5-)O%TSQ?XDTW4[&*ZTAKNRG%M8WD3
M7LT$TEQ##;A/U(HH _.C_@J7^P(__!3+]D3QI^R#?_%N3X-^$_B'K?@K5?%7
MBK3_  ';^._$#VW@7Q?HOC;2;#1;6_\ %?AC3M,:YUK0K)=1O;E=3D>Q$MM;
M0VSRM..O\(_LJ_%7P?X:_8F\*6'QT\,3:7^R+I6FZ1K0G^"[^?\ &&UTCX)Z
M[\$+![J5?BCGX?SQZ+KT_B"9]"_M>.;Q%!;J8DT+SM(F^Z** /A[]H;]@;X)
M?M#_ +2/[(_[6FNV T#X\_L>^.M9\1^ _'>DV%H^I:_X,\4^%/$WACQ1\+/%
M3RM&VH>$KZ;Q&/$^C.SO?>%_%&GF_P!&>*TUWQ/8ZS\1:[_P2-^(\?\ P5"\
M=?\ !4CX>_M::1X.^*'C;X1V7P/?X>:Q^SE9>-/!6F^ K/0O#.C$Q7L_QET'
M6;KQ)++X6L=3&KRM%8I<RSVK:--IS&U;]OJ* /S>_8__ .";/PV_8RG_ &BO
MB9X'\9>(?B/^U;^U?XMO/'OQW_:=^,NEZ/X@\4>,O$TUQ?7>F:9;^#_!J^!/
M#'A;X<>%;K5=1/ACX>^$SHUG9V\MM;7^JZF-/T][7XJ_8*_X(]?M(?\ !./]
MGCQU^SE^SK^WQX6D\/>,_B9XK^+UKXO^(?[&7AOQ;XT\'^//&7AOP]X9U35?
M#4D/QYT?PPT5O;>&K*\TZTU[PSK44%Y<7L4_VO2YUTV/]]J* /SWT+]C?XM:
M/:_L>>$[_P#:;E\8?#+]FG2],U'XF>%O&?PGL=8\0?M/_%C3-"DMK3XL?$?Q
MG%X[LVT34M)\:WNI?%;P_P"&M%\/W6@V/Q%FTW7M4&MR>&_#8TGY2\0?\$>+
MC2_^"K9_X*I? ;]I*?X#^,/$OA31?!/QE^#6@?""RUSP-\=?#]O:0:=XE?XC
MZG+\1='O)]=\1V6F>&;B+6=(TK3CI&O^#O#/B;[)J6LP:K<:O^VM% "#( !.
M3Z],^_''Y<>U+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%<[XL\6^&/ OA[4_%GC+7M*\,^&]&A2?4];UN^@T_3K..:XAM
M+<2W-RZ1^;=7EQ;65G;H6N+V]N;:RM(IKJXAADYKP/\ %WX9_$?P=-X^\%^-
M=!UKPC:1S2:IK"W?V!-!:VTVUUJ[MO$UIJB6-_X7U"RT>^LM5U#3?$-IIE_8
M:?>6MY>6T-O/%*X!Z/17S7X__;"_9B^%_P ,OAO\9?'7QO\ A]X?^%_Q@_X1
MQOA9XWN-;6ZT'X@0^+=#/B7PU<^$KK38;YM<L]:T +J^GWMC%+:3V$UO<"<)
M<V_F^FZA\7OA?I/CC2_AKJ?CWPI8>/M9AM)],\)7>M64&NW2ZC%J-QI<:V$D
MJRQW6KVVC:Y<Z-8S^5>ZS;:#KUQI=O>0:)JDEH >CT4=>E% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJZ/[*U+_ *&/4?\ P"T/_P"5=;M% &%_96I?]#'J/_@%H?\ \JZ#I6I $_\
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M4O\ H8]1_P# +0__ )5T?V5J7_0QZC_X!:'_ /*NMVB@#"_LK4O^ACU'_P
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MT/\ ^5=;M% &%_96I?\ 0QZC_P" 6A__ "KH_LK4O^ACU'_P"T/_ .5=;M%
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M\:?]A?2O_48T2NKKE-!_Y#GC3_L+Z5_ZC&B4 =71110 4444 %%%% !1110
M4444 <CK?_(Q^#O^OS6__3#=5UU<CK?_ ",?@[_K\UO_ -,-U774 %%%% !1
M110 4444 %%%% !7*^.?^1.\3?\ 8%U#_P!)WKJJY7QS_P B=XF_[ NH?^D[
MT =51110 4444 %%%% !1110 4444 %<OX0_Y!5U_P!C)XP_]2O6JZBN7\(?
M\@JZ_P"QD\8?^I7K5 '44444 %%%% !1110 4444 %%%!(')_P _XD]AU)H
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M^";7_ID^.U?N'0!@?8O$'_0<MO\ P2Q__+&C[%X@_P"@Y;?^"6/_ .6-;]%
M&!]B\0?]!RV_\$L?_P L:0V?B#!_XGEMT/\ S!8__EC704C=#]#_ "H \_\
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MC6_10!@?8O$'_0<MO_!+'_\ +&C[%X@_Z#EM_P""6/\ ^6-;]% &!]B\0?\
M0<MO_!+'_P#+&C[%X@_Z#EM_X)8__EC6_10!@?8O$'_0<MO_  2Q_P#RQH^Q
M>(/^@Y;?^"6/_P"6-;]% &!]B\0?]!RV_P#!+'_\L:/L7B#_ *#EM_X)8_\
MY8UOT4 >;ZQ::X/$'A(/K-NSF[UCRV&C1@(1HET7+#^T#OW)E<97!(/. #U/
MV+Q!_P!!RV_\$L?_ ,L:H:W_ ,C'X._Z_-;_ /3#=5UU &!]B\0?]!RV_P#!
M+'_\L:/L7B#_ *#EM_X)8_\ Y8UOT4 8'V+Q!_T'+;_P2Q__ "QH^Q>(/^@Y
M;?\ @EC_ /EC6_10!@?8O$'_ $'+;_P2Q_\ RQH^Q>(/^@Y;?^"6/_Y8UOT4
M 8'V+Q!_T'+;_P $L?\ \L:/L7B#_H.6W_@EC_\ EC6_10!@?8O$'_0<MO\
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MO$'_ $'+;_P2Q_\ RQK?HH P/L7B#_H.6W_@EC_^6-'V+Q!_T'+;_P $L?\
M\L:WZ* ,#[%X@_Z#EM_X)8__ )8T?8O$'_0<MO\ P2Q__+&M^B@# ^Q>(/\
MH.6W_@EC_P#EC7Q%_P %%?'7Q ^%W[(/Q:\2>%_%T>DZW=6GA_PS;:A:06^D
M:K:VOBOQ-I.@:O)HMXVHM.NKC1K[4?LAL(Y-0@'FWMJ(WM3<0?3/QW^.WP[_
M &<_AOK?Q/\ B9JQTW0-($<%O:6JPW&M:_JUT66PT#P]ITLT!U+6+]E=H;=9
M$BM[:&ZU"^FMM.L[NYA_*+X7_ WXM?\ !1_QMHW[1'[5=O?^$?V=-*NI[WX,
M? &UN[ZR3Q#I4CHUIXB\03P/:7,FGZG  M[KTD=MK/BR)3;:&NA>#6MWU?\
M)_$KB.O6PN,\/>%Z=;,>-N*<GQV&PU+"8AX6GPWEN-I5,#4XHSO'QA5>68'!
M2J2EA%&G/&YCC*<<)@*4IN=:A\MQ'F,YTJV099&IB,ZS/"5J=.-&HZ4<NP]:
M,J,LRQN(49?5J-%R;I)1=;$5HJE0BY-SA_-PJ#>H"*")0XVC:RRA]PD5U(D6
M<2?.)U<3B7$HD$@#U_9-^P+XL^)OQ&_9#^"7BWQMXAFNM>OO#5Y9OJ&JZ:MW
MJ6K:7HNOZOHF@:Q?7CWL,M[<ZGH6G:?=2WTL8EOF<WDC2/.TTOSTG_!)']D
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M$W_8%U#_ -)WKJJY7QS_ ,B=XF_[ NH?^D[T =51110 4444 %%%% !1110
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MI*K5EC,RQLUB,SS"JE[7%XEQ2TZ4L-0C^ZPF&A:G0HQC&*<G.<N07_D>I/\
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M+<O$S^2850"8']WMGB?_ )ZZ%_WYU+_Y)K\6_P!E#_E.A_P5I_[-B_X)M?\
MID^.U?N'0!@;/$__ #UT+_OSJ7_R31L\3_\ /70O^_.I?_)-;]% &!L\3_\
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M70O^_.I?_)-&SQ/_ ,]="_[\ZE_\DUOT4 8&SQ/_ ,]="_[\ZE_\DT;/$_\
MSUT+_OSJ7_R36_10!@;/$_\ SUT+_OSJ7_R31L\3_P#/70O^_.I?_)-;]% &
M!L\3_P#/70O^_.I?_)-<SXS7Q$/"?B/SI-$,7]CW_F!(M1#E?L[YV$W!&[^[
MN!7.-P(S7HM<KXY_Y$[Q-_V!=0_])WH M[/$_P#SUT+_ +\ZE_\ )-&SQ/\
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M_P C'X._Z_-;_P#3#=5UU<CK?_(Q^#O^OS6__3#=5UU !1110 4444 %%%%
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MB*]O]<G^)=M^UGX4_9>UK1+SPU>:9)X>T*R@\4_!;XY:;\0TN)]:U?61'?\
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M=Z-XO^(>N:7\3]:A\0:C=ZE%XD^)-IXL\0I)*L7]J&V@MH(>JUC]G;X,:_\
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MT4 8']IZO_T+L_\ X,],_P#C]']IZO\ ]"[/_P"#/3/_ (_6_10!@?VGJ_\
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M?VGJ_P#T+L__ (,],_\ C];]% &!_:>K_P#0NS_^#/3/_C]']IZO_P!"[/\
M^#/3/_C];]% &!_:>K_]"[/_ .#/3/\ X_1_:>K_ /0NS_\ @STS_P"/UOT4
M 8']IZO_ -"[/_X,],_^/T?VGJ__ $+L_P#X,],_^/UOT4 8']IZO_T+L_\
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M2JXEN\*V,C3I*,H49M] -3U<#'_".S_^#/2^?4G]_P!2>3[TO]IZO_T+L_\
MX,],_P#C];]%?M9]F8']IZO_ -"[/_X,],_^/T?VGJ__ $+L_P#X,],_^/UO
MT4 8']IZO_T+L_\ X,],_P#C]']IZO\ ]"[/_P"#/3/_ (_6_10!@?VGJ_\
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M_P 7_A=\++1KWXA^/O"?@Z(1B5(]>UNQL;RX1C@?9-->5M2O&)!PEI:3.<'
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MX:Z)\2/C)KFXI;6G@GPC>PVL[@/_ ,O&M"SU$QEPJ^9;:+=<,756"FN(U_\
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M !^SI^P+_P ).]M_PB_P1_L\:'%<!?\ A-K/_C].I2Q,^W_A+M^?("@MMQD
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MA#69HO"?AF,:)KD@3P_HZATM+4HX&GVXWH3?J2C=5)525()4$X'1?VY-_P!
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M)5?1JY30?^0YXT_["^E?^HQHE %O^W)O^@#KW_@):?\ RPH_MR;_ * .O?\
M@):?_+"N@HH Y_\ MR;_ * .O?\ @):?_+"C^W)O^@#KW_@):?\ RPKH** .
M?_MR;_H Z]_X"6G_ ,L*/[<F_P"@#KW_ ("6G_RPKH** .?_ +<F_P"@#KW_
M ("6G_RPH_MR;_H Z]_X"6G_ ,L*Z"B@#G_[<F_Z .O?^ EI_P#+"C^W)O\
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M>$] TZ,S7^N^)[_0?#VC640!)>ZU76-:LK"$8!(#W 9L':IP:_GD_P""O/\
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MJ2%_Q$7AO!V63>$7 &&46VJF;U>+>(J_DV\QXE6$D^Z>"Y';X+:+\S#\*O\
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MNM&U0W6KW?F_BS]B+X:^+OB'XI\5WFM^)K7P=\0_C!\&_P!H/XD_"JU.D_\
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MAB-DU,LGA_1T8IH>MR)N73[<';)'IS1NN1PZ,R,.58J03T?_  D&G?W-5_\
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MM_9>C^$-.(_XE_AB2:*+43^JB(D:+'&JHB*%1% 5550 JJH "JH "J  H
M  KXW_5_BSQ*E&MQK3K\)\%2:G0X$P>+7]M9[2NG!\:9K@YJ.&PE2*YI<.93
M6<9>T]GF>/KRI.@>/]0S7B-J><QJ95DS=X9'1J_[9CH:.+SC%496ITFM7EV%
MG9\W+B:\W'D/-?A)\'OAS\#?!.E?#[X8>%]/\+>&=)C&RULT,EW?WC(JW&K:
MUJ4Y>_UK6;TJ'O=5U*>XO+A@%,BQ)'%'Z9117Z]@\'A,OPN'P.!PU#!X+"4:
M>'PN$PM*G0P^'H4HJ%.C0HTHQITJ5.*480A%1BDDDD?6TJ-*A2IT*%.G1HTH
M1ITJ5*$:=.G"*M&$(12C&,4DE&*22T2"BBBNDT"BBB@ KE_"'_(*NO\ L9/&
M'_J5ZU745R_A#_D%77_8R>,/_4KUJ@#J**** "BBB@ HHHH **** "BBB@#D
M%_Y'J3_L5(?_ $]SUU]<@O\ R/4G_8J0_P#I[GKKZ "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ^;_ -K3XQ^,/@%\!O&7Q8\$^!=7^(.J>%+S
MP?)JFD:%X=U[QEJ6B>#=5\;>'=$\?_$*+P1X3SXN\=V_PL\#ZEXA^)%_X&\(
MC_A*?%]AX6N= \/E=3OK=E^8=9_:V^(^C_\ !.WXB_M@>"/%?P$^.=[X<^%,
MGQ5^&?C/PK/K=O\ #3XC^&](\+>'M3UA];M/#^O>(;K1/$%OKT?C3PW>:=HN
MO7%E!J6E6$MU'HDDVIZ+I7WSX_T/Q=X@\/&R\#^,T\">(X=4T74+37+CP_;>
M*=/EMM/U2UNM3T75M#GO](EN]*U_3([O2+V33M9T;6+%+L:AI.J6>H6L$E?
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M(7A3QMXMN8?B#/J>N7/ANTCFN)K/3=%'A)+6>XE$\+21S:D@DV>2CQJ6D/\
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MPG_\%%?V&OB[^R?\.?AGXK^*/[0WA;XN+XO\9:CX<MO#_A[PGJ7ARWT.]M-
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M_P"[\38;).+\):Z?*YXW 8+.&K*S_P"%E3DMYWU/I?[!S/#_ /(NXHS:DO\
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M4 %%%% !1110 4444 %%%% '(ZW_ ,C'X._Z_-;_ /3#=5UU<CK?_(Q^#O\
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M@VPO;DV5G>^*_$6C>'+2ZO!$\YM;:YUJ]L8)[D01R3&"*1Y1$CR;-BLPZL#
MQ]2<<9).2<9.,DDXS69JFB:-KD4<&LZ3INK0PR>=%%J=A::A%%*4,9DCCO(9
MD20HS(750VTE<[200#^7/1/^"D'[$7[(?_!:;_@I3XW_ &@OVA_!G@CPE\4_
MV=_V!-$^'_B*PLO%?C_1?$^J^"/#_P 7YO%EC8ZK\,O#GC/3X;K0H]?T4WT%
M_<V<W_$RMS DX6X,'Z _\1"W_!'7_H]?PA_X;;X[_P#SJ:_8W3-&TG18&MM'
MTW3]*MW<R/!IMC:6,+2$8+M%:PPQLY  +%2V !G%:.#ZG]/\* /QA_XB%O\
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M48/J?T_PH _&'_B(6_X(Z_\ 1Z_A#_PVWQW_ /G4T?\ $0M_P1U_Z/7\(?\
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MPVYX)V'P[%;>3_PKKX[_ &G<-6FE\[R?^%3Y%OSY0F)VF;,8R0<=)_Q$+?\
M!'7_ */7\(?^&V^._P#\ZFOO:'X9>-D_;2U'XPMIT0^'UQ^S#HWPVBUC^T[$
MW+>,+3XOZ]XKN--.D";^T5@30+VVN1J)MQ9.[M:+*9T:,?5&#ZG]/\* /QA_
MXB%O^".O_1Z_A#_PVWQW_P#G4T?\1"W_  1U_P"CU_"'_AMOCO\ _.IK]GL'
MU/Z?X48/J?T_PH _&'_B(6_X(Z_]'K^$/_#;?'?_ .=31_Q$*_\ !';_ */7
M\(?^&V^._P#\ZFOV>P?4_I_A1@^I_3_"@#B_AM\1?!GQ>^'O@;XJ_#K7(?$W
M@#XD^$?#WCKP3XBM[:_LK?7?"GBO2K76_#^KPV>JVEAJ=K%J.EWMK=QV^H6-
MG>PK*([JU@F5XE[6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHKY67XW>-5_;-N_V>)='\+-X$?]F:W^-&FZU$^L#Q@?%4'Q7E\!
M:EH]ZLDHT)?#\FF36%YI\EO"=2&H_;!>2+:I;B4 ^J:*^!O WQL_:8\+_M)^
M,?A?\?=,^"6J?"P? '7OC[I_C?X2V/C[2-3^#Q\/>.['PS#\-?BA_P )?K.O
M:=X[G\::#=Z_XB\$?$/PW;> !?S?"_XAZ?J'P[L+:+1[^7C/BA^TG^T'\*_B
M)^QE8ZIXC_9ALM!_:,^(OA'X>^(_A3\0=1UWP)\9=3N/&&C>)?%.OZA\+O%E
M]XOMO!ESK/PLTNUTVW3X;WO@OQ#K?Q2.G:E:Z/XFT#Q)JFBZ/( ?I917RYH?
MQI\9WO[8?Q#_ &?=0TKPNG@CP[^SG\)?C)X=UJS.L'Q7-K_C;XE?%OP)XBTC
M6UGG.BG1K.#P!H][HDNG0)?/-?ZHFH/Y<-D'\U^(W[2?Q'\&Z/\ L^>*]$TS
MP?JWA_XY_M>>%OA \>M6^M6EWIOP?\9W'C'2?#OB3P[)I]TL5]XFU(^&-*\4
M02ZRJZ6-'\0S6_V=[BSM!, ?=M%?$'[2G[4?BOX2_$S]F+P!X#\-:%X@MOBM
M^TC\//A#\5=;UT:OY/A'PWX\\"?%+Q3I\/A4:;)!;ZAX[N;KP'97L]KJ-PVG
M^'O"-RVKZK:S7.O>%X+W[=1BR(QQED5CCID@$XZ\4 .HHHH **** "BOFK]J
M3XN^,O@KX*^'_BOP9IWA?5)=>_:,_9E^%/B2U\4'6%2+P=\;?CMX#^$/B34=
M!.CRPD^*-&LO&O\ :^AIJ;G1Y;FQ,6H))&ZHWE'[5_Q8_:N^#FL>"/&_PJ\/
M_!3QE\+7^)WP3^'7B/X7Z_;>-A\:OB)'\4_B9H'@3Q%J_P ./&&G^(=-\$^#
MK_P!I7B)_%UOH'B3P=XTM_%VF^%_$1U3Q!X!TY4U:U /NRBOC/X[_%SXI>'?
M!_QW\7_#OQ[\#OAAH?P?M]+M[[X@?'GPYXM\4_#_ $.?1?#%[XR\>ZQK&D^!
M_%_@G7M4LXK37?!?AVU@MO$NE_V3?6OB2]VZ[?06V@3^<W7[6WQ0'[,W[#OQ
MQ@\-_"9M?_:/\?\ [(GA?XG:1H?C.\\?^"M#TS]H:XT32O%-Q\*O'7AB2+3?
M& T+5-;BG\*>(+QGT+6=(A>[E2:62!9 #]$J*\6\0>-/%4OB_P 5:!X3.AA/
M!_PHO/$E\^M1W4ME-XU\37%X/ =A=RZ=(+^#3+&S\*>([_Q%;V:-J$MGK&AR
MVSQ,$%Q\?>*?VN?C-_PP!^S[^TOX5^']]=_$OXV?"OX)>-_%-UX!^#'CS]HO
MPG\'5^(7P[T_Q_XT\::C\&O!GCOP+\6OB%X%\-?Z7X?L-&\&>([CQS)>:SH6
MH_V;JUO8ZM:R 'Z545Y)\!?&P^)7P5^%7Q"7X@>!OBJGC?P!X6\5Q?$CX9Z'
MJ/AGX?>-X=?TBUU2'Q-X-\/:OXF\9:MHGAS5X;E+K2M+U3Q3KNI6-LZ6]_J5
MQ=QS$>MT %%%% !115/4?M_V"]&EFT74C:7 T]K]9VL1?&%Q:&\6V9+AK47'
MEFY$#I,8=XB82;30!<HKX-^%WQB_:7_:#_8N_9Y^-?PVF^ GP[^*_P 6/A/X
M'^(_C34_B)H?C[QC\*_"$^N>$8M;UBRT3PMH7C#P/XKUVRDUB:.RL+K5O'F@
M?V-HB7>M:BVJWEM#H]YI_ O]H#XQ_&CX)_LR>+=8\ Z!\-OBW\7/ASJ_Q'\;
M^#+O4-0UCPMH^GZ#X?>SBN=(UF2SL]>3POXP\9^(/ 6J>';R_P!&3Q)%X(UF
MY6^TJ+7[:XA@ /M^BOSR_9>_:5^+OQ9\-_M=Z5XH\5_LR?$/QG^SM\4_$GPV
M\,^-_@AJ7B&S\%ZW?6'PJ\)>-_[-^(WPXU+QCX^\:_#CQ%X3\5^(-1\):Y8R
M>+]3/BS1])MO&GAR+3;36(=/M_4?A1\=_&7Q1_9G_9)^*$NGZ%H_Q%_:2\#?
M ;Q7J.EZ5'=7GAS0[CQUX$TGXH?$=-*CU.Y_M"33-$\*VGBN#0I=0GEN/M0T
M;[<TTTKI* ?7E%?"$O[8T?PVTO\ X*$^.OCO;Z'HGPS_ &)O&?F1:IX,MM7U
M#7M:^&R?LS?"3X]2OJ.FZG=B/4/'LNI>/]6\-:9I>AO:Z;JCV^@V]OMO;RZ9
M?2_V9/CZWQLL/%=EXFU+PIH?Q9\&OX9E^)/P0TJ#7H?%/P3;QKI$GB?PIH/B
M^\\2P:7?^*9M2T*7;:>.M%\.Z3X%\3W^CZZO@Z74;/2[NX4 ^I**** "BBB@
M HH^E?(/PY^-WQ2\>?%/]L[X8P:!X"%]\!O%WP^\/_"FX-[XBL+;7[?Q_P#
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MLU6[NM$U&Y;]#]>\5ZJGQ$\!>"M%-HHU&V\5^*O%DLZ"9X?"OA^VM]#LK6W
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M^'X-'BM/AQXD_98/Q*\3V-VSSP^-M=T+XDW/QU\+6VD^(_%6C75QH&G:C<>
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MNDV'AOP_<:2W@_1O&GA&XM8[WPSX<%G;3V'BFV71]6U&YU>"UNT5K"X]UHH
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M_!7[)WB;XBC6? #Z-I_C3XH?!SP+\7/AWXHL=!@\2S^)-3\&:PGC[1_"^LW
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MZ[KWB'X<_8K\^$))K;Q,M_XHU_\ X2'Q& ]UX@@U PW<2?9;%[4 U=-_;T\
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MX]3\<I#! OC+58TU3Q,-5U!1<@ _)CQS_P %$?VI_!_@_P"*'C"/0O@)J">
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MP?I>GRVMAX6U>9[K0K>P; $/C[]BO]G;Q;X"N?!^A_!WX/\ A/4=.;XLZOX
MU^'X8^'[Q/A[XV^-%KJ:^/\ QCH>F61T1TN_%>IZF^M^+K"TU/3;;Q9J%O;3
MZN\EQ;6ES; 'Q-^VY^T#\2]>_P""<O[/?Q;LM0F^&NC_ !^^(/\ P3]TW]I'
MQKX-UW4O#TGPG_9^_:%^+7P>T[]H/7M"\4"XBU;PQI=IX/\ %NJ^%+OQJ+^R
MU+P3X9U[4/&2:OIEYH:ZG;?0?[3EO\!OV'_A!\0OVQ_"?P>\/V'BG]G[X+>.
M;+2=-\(6_P#PAVF7WA36]1\''4H?%]IH-LEI<^%M%U70O#&O:_XOU#2=6U?P
M9X;TW7M2TZY2&^U2UU+Z>^$WP:T[P#^S[\//@#XNN-(^)&C>#OA)X5^$6O7&
MK>&;2WT7QQHOAWP=8>"KU]7\(ZA>^(;!+'Q'I=BW]JZ%=7NK6+)>7-D\ES:M
MM.MX5^"'PC\%>&-4\%>&OAYX5TWPAK6F7FA:GX9&E07F@WGAZ_MGLKKPW+I6
MH_;++_A&I;&1[$^'$A30ELF-FFG);?NJ /SO^(7[9'[1WPP^-^N? 6_T;X.^
M)]0TGXO?L):?:_$>WT7QMHVC:M\+OVR_&/QF^&VL:2WA&+Q5J\NE_$WX9^+/
M@WJ&O65T?%NH^'?$G@?Q-X:-[IVD:P;J\DYCX5?MP_M*^(O&OPH\->+M-^"5
MYI_B_P#::_;M_9'\0W?A_P *>/M"NF\7?LGZ3\;?$/@_XLZ0-0\?>(8=/\/^
M,-/^$*:3XG^%]RNJZAI=]K,VKZ1\2KF"P71Y/T2L/V7?V=M-T'0?#%G\%OAL
MF@^%_%/ASQOX=TR3PII=Q;Z+XP\&QI!X-\2Z;]I@FEM=:\'6T-O9^$=0BE$_
MA>QM;2RT%M/M+2WABK-^R]\"=/%MJ/A7X1?"WP[XIT3Q3XY^(GA'Q%%X'TMK
MCPS\4/B+IVH:?XR^(MC]B;3;V+Q5XMBU/4(_&&MV.HZ?K7BBTU#5+75-4D74
M[QY #\C=+_X*F_M!^$OAE^S%\4?BMX.^".IZ#^UU^QM\%OC[X5F\&V?C_P .
M:?\  _XC_$7XU?LE? [7+3XHZGK7B/Q,OB3X017W[6NA>.=/\3Z=!X-UK1M/
M^'OBWPQJ":N=2T_Q5IWT7XL_;._:4\&ZU^T5\/W^&-OX[U/]F_XR_#;0?%OQ
M-^%OPV\1>-&F^"OQ.^!$_P 5;#QSIGP 3XBZ;XU\;>,O /B]-/\ "/Q.^'_P
MV\:^)?%+> ]7T[XG^#/#NHWEY)X.TSZ2_9=_88^#G[.O[-7@3]G;5?"?P]^)
M</A_X(^#/@1X[\3ZK\.=(L8/BQX0\&^'H?#J0>+/"^IWWBJQ&F:]$EUJVN>%
MDU"Z\-SZ[K&MZC#8QOJ4PKV6[_9I^ M_X8TSP=>_"GP9=>']&UV;Q/IEG/I*
M236OB2YT*;PK=^(%U)G.K/K5YX5N)_"][JDU_)?7GAJ63P_<SRZ.WV*@#\L?
MC7^V!\86\+?'GQ7\%M<^ FE:[;_ W_@EE\2/!?QV\*?#K7O$A\>>%_VJ_CIX
M\\#>)K*Z_MSQ)HEYJ_@^'2]*U75/A#)+<P7_ (<L/'&N37=O<Z])]I@^D?A'
M^U?^T-\7?C>-"\,?#OX>:A\%/ O[0/QB_9K^-OBG4/$V@>&/%'A_Q3\*O#FL
M_8?%7A3P\_Q#\0>*+C4?%OC'2].O+;X5>(/!EE<)\(_&OA[XCZ3\0-8@T[R?
M%'UYK/[,G[/'B*#QI;:Y\$OA=JEO\1O!GAGX=>.H+SP1H$L/BOP'X):63P5X
M/UN+[$([[PYX-FGN;GPCI$B_8O#%W=75WH<-A<W,\LEK1?V<?@%X<^*VH_'3
MP_\ !GX9:)\9-8\/V'A?5_B?I7@K0+#QUJN@Z790:7IVG:EXEM;&+5+Z*RTF
MTL]&MY;JXEN8]&LK/2%G_LVTM[6, ]I'(%%%% !1110 4444 (<X..3@X^O:
MOSW^+/B/_@HI9_$;Q9;?"+P!\(M5^&\.HPKX2U'Q!>Z=%K-UIQTZQ::2_CF\
M9Z=*LRZBU]&H>QMSY*1'800[?H317QW&G"-7C'+\+E]+BWC#@^6&QL<8\?P9
MFF$RK,,2HT:U'ZGBJ^,RW,Z=3!R=95I4HT:<W7HT9^T48.$OIN%N)*?#.-Q&
M,J<.<-<2JOA9858/BC 8G,,'0;K4:WUFA2PV-P,X8J*HNE&I*I.*I5:L7!N2
ME'\LO^$M_P""K?\ T3'X%?\ @QTG_P">#7Y>?M.?M,_M%>,OB'H>@_$_4?"^
MA>*_@=XKN+K3K7X>[5TS2_&EI/I\\E_-?0ZOK-OJ6JZ/-8Q6"/'<F'3Y!J=B
M8_-EO W]1LB>8C(69-RLNY#M==P(W(V#M9<[E;'RL >U?!]W_P $VOV4K^ZN
MKZ^\'>)KR]O;FXO+R[N?B+XVFN+J[NYGN+JYGF?5B\L]Q<2R3S2.2TDLCNQ)
M8U_)/C?]&_Q9XFX?P.1>'7BYQIFM+%XR-;B*EXC<<36 >'P%7"8K+*>!PN0\
M(1K5L0LPHPQDZ^(Q5*&&E@J'LZ-:=5U,/_17A9XW>'F1YQB\VXS\.N&,NJX;
M#>RR6IP3PI!XQ5<73K8;'SQ6(SCB5TZ5'ZG.6&C1HT*DJ\<55YZM*%'DK_,7
MPM^/_P#P4B^,O@O3?'OPZ\%_ G7O#&IS7UK;WCS6.GW4=WIEW+8WUI?Z==^/
M8;NPNX9XBS07$,;M#)!<QJUO<0N_H?\ PEG_  5;[_##X%?^#'2?_G@U]Q_!
M/X ?#?\ 9]T;6?#_ ,,K#5])T;7-4CUF]T[4?$>M:_;)J:6D=C)>6::Q=W7V
M*6YM8;:*[%L46Y^RVS2JSPJU>U5^F<*>!O&4^',G?&?C7XPT.*5@J4<]I\/\
M<9=B,E>80M"M5RVICN#:&,CA:_(J].CB(2JX=5?J\ZV(=+V]7X?B#Q8X9AG6
M9+ACPM\-:W#_ -:G+*9YSPIC*&:K!SY9TJ>.A@^)JN%>)HINC4J4)*G6=-5H
MTJ"G["'F'P9N_BG??#3PO=?&O3-#T?XGRPZB?%6F^&Y(I=%MIUUC4$TX6,D%
M_J<3+)HRZ=--LOKC%Q),"48&-/BS]M7X$^._B-\4_@E\2/V??$EE\/OVHOA!
MX3^,'C3X3>)M4FOK?P)X[ETV;X96NJ_ WX]66F(]QXB^"'Q3TC5-3\.:VZ6]
MWKWPY\17GA[XL>!53Q;X-L;34OTBKD-2\ >"M8\7^'?'^J>%]$U#QKX2L-7T
MKPQXINK"&;7-!TW7_LW]N6&DZBZFXLK/6396)U2W@9(K]K&Q:Z64V=L8OZ,R
MO O+,LR[+98W'9E++\#A,#+,<TK0Q&98]X3#T\.\;F%>E2H4Z^.Q3INOBZU.
MA1A4Q%2I.%*G&2A'\2Q^+6/Q^-QT<+A,#'&8O$XI8' 4YT<#@UB*TZRPN"HU
M*E:I2PF'4_98:E.M5G3HPA"52;3D_P DOA%^UCIWC;2O%/Q*^#?A/PG\)_C+
M\9OVIO#_ ,"_B[\,?B3X:U76_C/X&^,'@#]FC_A)/B7\)H/ _A:?0;?XF?$_
MP)=^%X-7ENKCQKX5^%UU\'+_ %CX^V?CJ^\+#2XO$?1_#']OOXQ^-_!O[#WQ
M*\8>!-"^&_P__:@^%W[,>N:YXZL_!_B;XE_#K3OB_P#&WQA!X:UWX1:WX@\.
M>,;/Q1\%WUX:CX7TSX ?$'QKX-\4_#KX@^.O%D7@?Q#XFT+6+/24\1_I-XS^
M!_P=^(CV,OCGX7^ _%<^F>.M"^)^GW.N>%M'O[NT^(GAK1D\-Z%XW@NYK4W*
M>*=-\,QKX7M];\TWX\+E_#<DSZ'))8-RWAW]EG]G+PC<^#[GPK\$OAGX;;P!
M8:7I?@V'0O".DZ39>'=-T'7=;\4>';#3-/L8(-/AL_#/B;Q+K_B+PQ;FU>/P
MUKNL:AJ^A+I^H7,EP>\Y#\9+_P#:V\2?$CQ7^R/^WF-1^!/AW0O$W[#_ /P4
M8^)OPTTSQG<>)_#>F?#^WTW6?V;/^$7\(_&7X@Z5+XGU.^MK:ZLM-LOBE;^&
M_ MIX@\*>/[?4/"OAS1-;N6A ^I_AU^W?\6/%7Q$C_9_UO0_#.@?$KQ#^V7\
M1OV9_"?CS5_!>MZ+HL?A3P#^QOX'_:[N?$FO_#<^/M7N[7XA:CIGBZX\*:-X
M)'CZW\^QTB_\:ZM!I5QI&L^"X/M2Y_8L_9%O;CQ7=7O[,_P,O)_&Z_$5?%;7
M7PP\(7"ZVOQ?M+:R^+"7D4NE/#L^)L-G _Q 2".%?&%VKW^OB_OIIKF2S/\
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MQT?[(_[,*:!XY\+-\ _A-<>'OB9X>MO"?Q!TB^\#Z#J-CXR\,65U=7UEX?\
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5** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>a2019chartitem7.jpg
<TEXT>
begin 644 a2019chartitem7.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %5 JH# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHR.>>G7V^M% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %-;A6Q_=/\C3J:_W&_P!UOY&@#^;?X>?M(?'K4/\ @IE_P5Y^&E_\
M8OB+=?#[X1_%?]C_ $GX7^#)_%.H2^&_ .F^+OV4M&\5^*;+PGI4CM;:+;>(
M?$EQ+K>KP68CCO=39KV53.SNWV8OQ>^)_P#T4+Q:?KK5Q_/O^9K\O?AU+L_X
M*U?\%NATS\9_V'C[X'[&7A[/0_3L>37W0EQ[^Y_IT_J/6@QDWS/7M^2_R1[
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M?BS2QXH\'?L9>(OB _QDTOX4ZMHNM^(;/PC\2R)-:T+PYX_^(FD+I,H2WO\
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M_@)?_P#R)0!T%%<__P )1HO_ #]M_P" E_\ _(E'_"4:+_S]M_X"7_\ \B4
M=!17/_\ "4:+_P _;?\ @)?_ /R)1_PE&B_\_;?^ E__ /(E '045S__  E&
MB_\ /VW_ ("7_P#\B5N0RI/%'-$=T<L:21MAEW(ZAE.UPK+D$'#*K#H0#D4
M24444 %%%% !1110 4444 %%%% !7SCXX^.NJ>!/VC_@;\%]4\&PMX,^./A;
MXL+H?Q'C\0/]JLOBI\.-.T#Q?I_PZG\*'1A&]MXH^'"_$/Q9:^(U\0F2WG\
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M^S^,-)\/_MN4_= $L&6/&5=AR%YY4@GD<$\_G4N!Z#IC\/3Z4U_N-_NM_(T
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MWKPC4Q->KB)Q@L%@)*$9UISDHIRE+E3LI2E*UY-OJ4NW'_+1N?\ :;K^8/\
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M/^>C_P#?;9 _//Z&N72X]^.G^>H_E5E+CWX_3 _,?J* _K^ON.H2\D_YZ/\
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MT&,_B?R_)'B?[3<OF>!]%&?^9JMV_P#*3J@_KZG\*^'*^T_VCY"_@O1\@_\
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M]?3G^AZ_6LKQ GB.ZTJ1/"&O6/AKQ'#>:1>Z;J^IZ/-K^FQG3M8T_4+RSO\
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M_P#RQ(Q]*G7]MWX']?M/C,_]RC,>/;.H\Y]C^?%?"KQD\*G_ ,W!X3Z?\SO
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MK?\ ?)Z_@"/S [5929L=&Q_NG^6",_E0'S;U6W3:_P#P>MKKN=(EQ[_7_/\
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M)^!+7PK<:?' FEZ7;1>#?#(OM!LM*U=M'LWU%DH ^D*\=USXX^"_#OQP\ _
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MM<_'+3XKN".XA/A+QBWERH'3>ME:;6VMQE2>#U!/%?*%?5W[&#[?CGIYZ?\
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MXKG\CU^M4DN/?]>WX8/Y@U92X]_?_./ZCVH#7?3IKWO;M?S6[U2+JZ)X?_Z
MVF>G_'I%^/\ "#_/BOH'1HXXM)TR.%%BBCL+1(XT 5(XU@C"(JC "JH   X
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MGJ? /[3G@SXN67C?QVOAJWT7Q-\0_CC\>_V1-7_96\:Z;KL4/CKX+V/PPO\
MP'%\9M,U#0Y;&34M/^&'AKPIX=^)_P 1/$_B+1M1B\(^*])^)FN^#?&\"^(=
M4T*S\0?J[+<0//.\"&.W>XG:WC;AH[=I7:%&R3RD11#DYRISS7$6EKIEI<R7
MEII^GVMY-:V]E-=V]G:P7<MC:+$MK8R74427$EC:B" 6]FTK6L)@A:.)6BC9
M==+D=B.PZ\_T/\Z ;O;RT_K^NYT2R^C>_/\ C^O!J=9F'^?_ -1_4U@)<>_^
M??\ 'U!JREQ[_P#Z_?K^H% C=2X]_;KS_0_SJTEQ[_Y]_P ?4&L!9U/7Z9__
M %9'\JF64=F_/IQ[]!^8H Z)+CW_ ,^_X>H%64N/?V]O?U'\JYM9B/?OZ_\
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M[\GKTUV>]K'2I<>_Z\X_0_H?6K*7'O[G^G3^H]:YE+CIS_GOZC^565N/?_\
M5^/'Y'I]*!I[==4O2W)^%_Q.F2X]_P##/X9'Y@=JLI<>_P#GN>X_E7-+<>__
M .O\>?R/7ZU92X]_\]SV/\Z 3[V6S_\ 2+?(Z5;CW_\ U?CQ^1Z?2K2W'O\
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M,DT+3DT'3=+\50WGAJ[GDU_0/$ZZ)90ZO<1V5KJ>I:3;7$U[T"Z[8CK.V/\
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ML@[-CZ]/ZBIEF(]Q[<\?C_0BL!;CW]O\]#_.K*7'O^O./T/Z'UH WEN/?_\
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M8ETCPG':WVKX5^)?[1FB_'']FGP/XT;XGZ'\8/BC\>OVTO"_QH\/ZE'=ZO\
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M5];]O]-MOZV'TQ@U92UD_P"@OK>?^OVV_K8=>O2LU+CW^O\ G_$=ZLI<>_\
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M_P##5WX^31KS2VTZU^(&MPIX&\.Z_KNN^&O!NC:]=POXDU^TGN]%LM2_R_\
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M$@=_;)]"?UJTEQ[_ /ZO?I^H- 7LMUTV_P"W>O?OOJMNJOK92 9_MK7\@?\
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M?-M%%%?Y-G\P!1110 5B>(/^0=_V\P?RDK;K$\0?\@[_ +>8/Y25_7/T"?\
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M HHHH **** "FO\ <;_=;^1IU-?[C?[K?R- '\+OQS_Y3!?\%A?^RJ?L=_\
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M,.D?^ET%?HO7_)E_I#?_ "?GP"_[-)G'_K8XX_ZOO]'M_P"3$^/G_9VLG_\
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M?O\ TEV\(_\ BNGX<_\ S]:_J&HH_P"("^"?_1IO#S_Q$,B\O^H'R_JRL?\
M$:?%W_HYG'73_FJ,YZ6_ZC/[J_$_EY_X<3_M^?\ 277PC^/_  3I^')_][K6
M7_PX/_;MSG_A[AX1R223_P .Z?AMDY.3S_PO&OZFJ*^LX6X!X(X(>.?!W"7#
MO"[S-899B\ARC Y5]>6#]O\ 5/K?U*A1]O\ 5OK6)]A[7F]E]8K<G+[25_F.
M(^-.+N,%@UQ5Q-GO$:R_ZQ]1_MK-,9F7U/ZTJ"Q/U;ZW6J^Q^L?5</[;V?+[
M3V-+FOR1M_+./^""7[=XZ?\ !7'PA_XKH^&W]/CD ?RIX_X(*_MXCI_P5Q\'
M_P#BN?X:_P#S\J_J5HKZX^7Y5V7W'\M@_P""#'[>8Z?\%<O!_P#XKF^&G_S\
M:R-9_P"#?O\ ;AUY+>/4O^"MOA25+5Y'A$7_  3N^'-N5:555RQC^.)+ A%
M!X')ZFOZJJ*\_-,JRS/,!B,JSG+\'FF6XM4UBL!C\/2Q>#Q$:-:GB*2K8>O"
M=*HJ=>E2K04XOEJ4X3C:48M88G"87&T*F%Q>'HXG#55%5:%>G"K2J*$XU(J=
M.:<9*,X1FKIVE%/=(_DV_P"(=;]LO_I+/X:_\5\?#W_Y^-'_ !#K?ME_])9_
M#7_BOCX>_P#S\:_K)HKXO_B$?A=_T;S@S_Q',I_^9/ZN_*WC_P"J?#'_ $3^
M3_\ ANPO_P J/Y-O^(=;]LO_ *2S^&O_ !7Q\/?_ )^-'_$.M^V7_P!)9_#7
M_BOCX>__ #\:_K)HH_XA'X7?]&\X,_\ $<RG_P"9/ZN_*Q_JGPQ_T3^3_P#A
MNPO_ ,J/Y-O^(=;]LO\ Z2S^&O\ Q7Q\/?\ Y^-5[K_@W,_;$O8O)N?^"LOA
MQH]ZR;5_X)]> $)9<@?,GQS1L?,<@,,]\BOZT:*]OAS@?@W@_/<JXGX5X6R#
MAWB/(\92S#)L\R7*<#EN:Y7CZ#YJ.,P&/PE"CB<)B:4O>IUJ%2%2#=XR6EN3
M'<"\%YG@\1E^8\*</X[ XNE*ABL'B\IP.(PV)HSTG2KT*M&5.K3DM)0G%Q:T
M:9_(]_Q#;_M:_P#26#P]_P"( >!O_G\4?\0V_P"UK_TE@\/?^( >!O\ Y_%?
MUPT5_0'_ !';QH_Z.KX@]/\ FK<\Z6_ZC?[J_$^+_P")?O S_HT'AK_XA?#W
M_P [_P"KORM_%;\9O^"#?[6WPDU/X(Z</^"G_AW7O^%P_&_PS\'6E/["?@C3
M3X?C\0^%?'/B5O$"QCXT7PU-[4^#5LTTQGLDF&H-.U[%]E6.?W!?^#;C]K5E
M!_X>P>'N0#Q^P!X'QR,]_CN#^8!]A7]5WC#X=^#/'USX,O/%VAPZU<_#[QGI
MWQ"\'2S7-];G1/&.DZ9K6C:=K<*V5U;+<S6VF>(M9M5MKY;JQ=;YWEM7EC@D
MB[,   #@   >PZ4?\1V\:-/^-J^(.FW_ !EN>=+?]1OE^8?\2_>!G_1H/#;_
M ,0OA[_YW]?\S^1__B&W_:U_Z2P>'O\ Q #P-_\ /XK4T7_@W0_;%\/ZG:ZO
MI7_!67PW#?V;2-;RR?\ !/KP%.B&6"6W<F*7X[LC9BFD R/E8AUPR@C^LVBO
M+SSQ:\4.)<ES?AOB'Q"XRSOA_B#*\?DF>9+FO$6:X_*\WR?-<)4P&9Y7F6!Q
M.*J8;&8#,,%6K83&83$4ZE#$8>M5HU82ISE%^IDG@SX2<-9UE'$?#WAGP)DF
M?Y!F> SK(\YRKA7),!F>49OE6*HX[+<SR['8;!4\3@\?@,;AZ.*PF*P]2G6P
M^(I4ZU*<)PC)?R\_\.*/V_/^DNWA'_Q73\.?_GZT?\.*/V_?^DNWA'_Q73\.
M?_GZU_4-17\Q?\0%\$_^C3^'G_B(9%Y?]0/E_5E;^F?^(T^+O_1S..?_ !*,
MY\O^HSR1_+S_ ,.*/V_?^DNWA'_Q73\.?_GZT?\ #BC]OW_I+MX1_P#%=/PY
M_P#GZU_4-11_Q 7P3_Z--X>?^(AD7E_U ^7]65C_ (C3XN_]',XZZ?\ -49S
MTM_U&?W5^)_+S_PXH_;]_P"DNWA'_P 5T_#G_P"?K3D_X(5_M_1O'(G_  5V
M\(;XI(Y4+?\ !.?X;NH>)UD0E6^.A5@&495@5894@@D5_4)15T_ GP6HU(5:
M7A3X?4ZE*<:E.I#A+(XSA.#C*$XR6"3C*,HIIIIII-6LK14\9O%JK3G2J>)7
M'$Z=2$J=2$^)\XE&<)1491E%XMJ4915I)IIIM-69_-)_PY:_X*-=?^'OG@7G
M.?\ C6M\*^_/_1<.GMTIP_X(N_\ !1L?\Y?/ GX_\$U?A7_\_"OZ6:*_5]]S
M\S48I625EHM$?S4C_@C!_P %'1T_X*^^!/\ Q6I\*O\ Y^%.'_!&/_@H^.G_
M  5^\"?^*U/A3_\ /PK^E2B@.6/9?<?RX>-O^"#G[>OQ!;36\3?\%<O!]V=)
M6[2R^R_\$YOAGI_EK>M;M<>8+;XX#SMQMH=I?[FUMOWS7"_\0ZW[9?\ TEG\
M-?\ BOCX>_\ S\:_K)HKXS-?#G@'/,PQ&:YSP;PSFN9XMTWBL?F&29=B\9B'
M1HT\/2]MB*^'G5J>SH4:5&'/-\E*G"$;1C%+R,5P]D.-KU,5C,GRW%8FKR^T
MKU\%AZM6IR0C3ASU)TW*7+"$81NW:,4EHD?R;?\ $.M^V7_TEG\-?^*^/A[_
M //QH_XAUOVR_P#I+/X:_P#%?'P]_P#GXU_6317G?\0C\+O^C><&?^(YE/\
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M)?O S_HT'AM_XA?#WE_U+_+\7Y6_E2_XAM_VM?\ I+!X>_\ $ / W_S^*/\
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MX0_;L_Z2W>#_ /Q71\-?_GXU_4Q11_Q+[X%_]&>\-/\ Q"N'?_G?_5WY6/\
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M"/A;\&6N_AKX-81);6HDL?$7B+3_ (A?$O2Y3&=]C\0X60^68P/K:@ HHHH
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M?/LW_-C/S^7'NY^;8F<[5PX*!G QG&>O) QDYZG& 2>3@9)P*0,"<8;J1RK
M?*<'DC&#V.<,.1D5X9XB_: \)^'_ (JZU\%8M!\<Z]\1-*^"&L?'JST70O#3
M3VWB3PKHWB5?"4VB>&];U&^TS1+_ ,:7&NS6-K!X>GO[(1Q:GIMY?7]E9WD<
M] 'NM%06\YG@@F:">W::**4P7"!9X3+&LABF$;RQK+$28Y0LKHLBLJNPPS39
M&<<_D<<>^,?K0 M%%% !1110 4444 %%%% !1110 4444 %%%% ",JNK(ZAE
M8%65@&5E88*L#D$$$@@@@@X-($1<E4522Q)4!22Y!<DC!RQ +'JQ )SBG44
M-"*"Q"@%^6(X9B %!9AR2%  ).0  . *0QH4,912A7:4*@H5QC;M(V[<<;<8
M]N:?10 Q8XT)9(T4MG)554G<[2-D@ G<[NYSU=F8\L218XU)9416.<E54$[G
M:1LD $[G=G/J[,QY))?10 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?DS^T+\$/
M&7Q=_P""COPTDB_X7?X'^&&H_P#!/K]JCX,>*_C'\,-%M;&UT?Q/\3?C5^S3
MK^C^#$\=ZWX6\36?AO7/$'@[P5XUU+3==T:TMM3T.YT2-K;7]'UF?2HKSR/P
MY\ ?%_P\_:D\%_ >QT;]J[X8_ [X!>(/V;[_ /8RU3X&^']%UKX)VW[.OPG^
M#W@CP7XG^"WQ,^*>JKK^O>'+=_$GASXB:?\ %'P)XXG@U?XH>$O$G@G6OAYJ
M.L>,8(I_"?[@X&=V!D# .!D ]1GKCVHVJ3N*@L.AP,\9QSUXR?S/K0!^#/PJ
M^$_Q>\,_ []B+7XO!O[3]O\ %*3]NK2KOXW2^)-7^,FK>,5^#WAGQS^TI8Z)
M>_%"WU_Q1J0N_AMI_A+QCX0>S75UO[*>PNO#ES<VUUJ/AZSET7S.\^'G_!1F
M_P#@WX9UWX7:7\5?#7[<?A/X0?MT>%_VEM0UW6=5T;X;_&/QO>^$O&$'P U3
MX?\ B'Q',OPWU^^U?XG_ /"O_%'[.FO: QB^#W@*37?"/C1_"VGIKWA:]_HQ
MVJ  %4 '(&!@').0,<'))R.<DTN!Z#G.>!SGK^??U[T ?EE^Q-X:L[?]IC]I
M+XA^#_@O\?OA3\-/B=^SK^QQ_8!^./AKQMX=U&?QEX,UC]IZU\=^&YK/Q[K.
MJZU;>+_#L/B;PG<>,R@&FZ[J>LGQ79:KXC?6KO7K_P !^#'AOQ?X _:)_;T\
M<^)/#/[;VAGQQ^WSH7Q4^$_@_P"'?@'Q5!\,OC!X0TK]G3]E?X?0:IJM[)X5
MGT*ST#7?&_@/Q=X<\1:CXD\5^&8%T/P]#K%S%;Z*EO>ZC^Y851T4#@#@ <#H
M..P[4GEH3DHA.<YVC.?7.,Y]Z /PC_X0']H[3/B??>./ OAS]H.V^(R?\%$_
MVMK3P3K?C:X^+6J_#VP^"/C_ /9 ^)UAX O/$NDWVM:AX=/[.MS^TM%\*]2L
M+9],EL="U;3K+5="T[2--TZ>2V^>K'X<_&SQ+\/OB7XQTSX"_MA^#_C5XB_X
M(T_&+X3^/M4UZS^(5CXXO_VU;#6]%NCI'A_Q=I_B:-M;^)'B;QW=:AK>B?$;
MX<72^$/&>B65AJECXJ_X1W0K"VTS^F':O]U>N[H/O'JW3K[]:-B<C8N",$;1
MR#U!XZ<#CI0!^#_Q#\$_&[4/B1\;/B!8>$?VIYM2T3XM_P#!*GQ?\)Y=-/Q?
MCTFVM="\5>#=)_:@G\)>&+;6HM"&CP_"V;Q7I'QIT%](32]:LY]5@O=*U77K
MHS7"_"CQ?XR\0_MG^';?QEKG[6S>%O!O[5_[5M[HWQ9M_A=\23\ _C+X3^(D
MMYH/P;^#_B#Q_P"#_%^H_#=?!7P5UZ.70_ ^KZI9ZE87^I>$O#MKJ.G^$/$G
MB?QY9Q_N^40@@HI!VY^4<[?NGIU7 VGMCC%>)>"?V:O@%\-O&VO_ !&\ _"'
MP!X.\:>)[O4-0UO7?#GARPTFXO-2UBYN;W6]56"TCCL;35=>O;V]O=?U.PM+
M6_UR]O+R[U:XO+BZGDD /;@00".A (SG..V<\_GSZTM%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (2!U('U.*3>
MG]Y?^^A_C7Y'_P#!63]H;XS?L_>$/@OJ7P=\=ZAX&O?$OB[Q7IVNSZ?IV@:@
MVHV5AX=M+RS@E77=(U:.)8+J1YE:W2&1F;;([( H_$S_ (>3?MO?]' >(_\
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M.X^(/AR;PCX&UC1_"?B;2?A-XLO](\7^&8_&&C:%J-WX0\/>-9/#VI^+M)W
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MWA+3O$.DWOB31[![M]/2^U+1+>[DU*SLFU".6P^US6R6ZW\4MB\BW<;PCM*
M"BBO@S_@I5\6?B'\$OV1?'_Q$^%OB:Z\(>--(UKP#;:;KMG::7?7%K!J_C;1
M-+U&-+;6+'4K!Q=6%U/;.9;21D60M$T<@5U^CX0X:QO&?%7#G"675L+AL?Q-
MG>5Y#@L1C9588.CBLVQM' T*N*G0HXBM'#PJUX2JRI4*U14U)PI3DE%_.<8<
M38+@OA3B3B_,J.*Q.7\,9'FF?8[#X&-*>,K83*<'6QV(I86%>MAZ$L14I491
MHQJUZ--U'%3JPC>2^\LCU'YBER#T.:_B=_X>?_MX?]'$>(O_  E_AU_\QM?O
MY_P2+_:#^,?[1/P<^*'B7XS^.+_QUK>A?%%=!TF_O]/T+3I++23X/\/:D;..
M+0=*TFW>,WMY<S[YH99MTI7S=@55_HKQ7^B)Q_X0\&8WC?B#B'@[,,LP.*P&
M$JX;)L7G=7'3J9CBJ>$HRIPQV18##N$*E12J.6(C)03Y8SDDG_-OA'],7P\\
M9.-<'P-P[P_QEE^:8W!X_&T\3G.#R2C@(4LNPSQ-:-2>"SW'XA3G&+C34</)
M.37-*,;R/UFHHHK^4C^M0HKY-UC]I:]UW]H/Q;^S1\&/"6E>.?'GPN\ >"OB
M+\9-?\2>*Y?"?@CX:Z;\3M0\16GPR\,W5UI?A[Q;X@U_Q[XWLO!?B_Q!;:!I
MNB0:?X>\+:3:Z[XFUS3V\1^%-,UWL-+_ &@?#7ASP_I<_P"T+?\ @3]G?QGJ
MFK>,[&S\'^-OBIX-D36=*\*>+U\,VGBGPKK-Y/X??Q#X=\06FI>%-:M9AH^G
MZCI"^+M&T7Q#IVF:X[6; 'T%17GMC\6_A;J?B3Q!X.T[XC>!KWQ9X4T_4-6\
M3>&K7Q7H4VNZ!I>DW<=AJNHZOI27YO=/L-*OIH;+5+RYACM],O9HK2_DMKF6
M.)N:D_:-_9_BT%_%,OQN^$\/AF/5KK0I_$$WQ!\*0Z-:ZU8Z;9:S>Z3>:C+J
MJ6EEJ%GH^I:;JUW:7<L,UKIFHZ??W"1VE]:33 'L]%?(7[7?[3VM_LR:9\#;
MO0?AQI_Q)O\ XW_M&_"C]G+3[+4/'4O@.UT'6_BWJ-]INB^);[4(O!GC62\T
M;2Y]/F?6+2UTY=1%N\<EA'=R!X1RGP-_;^^!_P 4/#?Q(O?B%X@\+_ /Q7\(
M/CK\8_V=_'WACXF?$+P5I]H?'_P1ET&X\77O@KQ+/J>FV7C7PBWAWQ=X1\20
MZS:66GW^DVGB"#2?%VB>&_$=CJ.D6P!]T45YQ_PN'X4'Q'KOA ?$KP'_ ,)5
MX8TG4M?\1^'#XNT!=;T'0]&DMX]:UC6-,;4!>:?I>B->6?\ ;5]<PQV^D?;;
M+^TI+4WEJ)OA_P#9^_X*!Z-\?FTKXF:7>_ 'PY^S/XB\%_$SQEHGC36_C[IZ
M_%^./X4ZKJ.G^,+36/A';^&I=-L],T#0+;1/B'XF\2IX\>'PSX:\8:)I^J:0
MEZJW^H 'Z3T5YS\)/BW\./CM\-_!WQ<^$GB_1?'7P[\?:#IOB3PKXGT"\BO=
M/U/2M4M(;RV?=$S/:W<<4Z1WVG7:PZAIMVLMCJ%M;7D$T$?HU !1110 4F1Z
MC\Q7DOQ\\0ZSX2^"'Q>\4>';^32]?\._#7QMK>BZE%';S2V&JZ9X>O[RPO(X
MKJ&XMI'MKF*.54N()H690)(G0E3_ #:C]O7]KP@'_A=FN<@?\P#P3_\ ,Q7\
MV^.'TGN"? ;-\DR?BK)>*<TQ&>Y=7S+"U<@PV4UZ%*C0Q/U6<*[S#.,MJ1JN
M2<HJG3J0<;7FI>Z?MWA7X$<4^+>79IF>09ID& H93C:6!Q$,XKYC1JU*M6@L
M1&=%8++<=!TU!\K<YPDI;1:U/ZI,@]"#^-+7Y"?\$V/VBOC3\:_&GQ1TSXI>
M/=0\7V&@^%_#5]I%M>:;H%BME=WVLZE;74Z/H^D:=+(TT$,4;+/)*BA 456)
M)_7NOTOPH\3,E\7N",KX\X?P6:9?E>:ULPH4,+G%+"4<?"678ZO@*SJT\%C,
M=AU&=7#SG2Y,3-NFXN:A*\5\/XA<"YIX;\58_A+.,5@,9C\OI8*K5Q&65,14
MP<XX[!T,;35.>*PV$K-PIXB,:BE0BE-247.*4F445\N?%K]I.+P7\:?A5^S9
MX#\+KX^^.'Q8\)?$+XE66B7>N+X:\+>"/A-\+[SPGH?B_P")7CWQ!#IFOZG9
M:0GB[Q_X'\&>&]&T3P]K&N^*?$OB$16T%AH>B>)=?T;]'/B3ZCHKP'1OC+J?
MAO2?&^J_M$Z'X/\ @5IWA?QG#X:\/^)-3^)>DZMX/\?:+/X2T7Q%%XLT36-3
MTKPG>:4@U&Z\2Z!=>&]<TNWUJQF\'ZIJSFXT2XL]0D[>]^,/PGTVZ\'V.H_$
MSP#87?Q!@TFY\"07GB_P_;OXR@UZ:WM]!E\+^9J"C7H]=N+JV@T1]+-TNL33
MQ1::;IVVT >CT5Y!\%/CY\'/VC/!TWQ ^"/Q%\+?$OP?;^(O$WA2?7O"FK6N
MJ64.O>$=>U'PYK=A,UO([P/%J.F7$EJTZ1KJ&FR66KV/GZ9J%E=3^6?&?]M7
M]GOX-_ KXX?'NZ^)'@KQ?X9^ W@_5/%'C#3?"?C/PMJ.J&\M]*O]2T#PQ'MU
M0V]IKOC*:P;3_"\5\\,6JW#F2S:YA@F90#ZRHKX<\?\ [7MS\#/V:OB!^TA\
M;-*^%]EX-\+>-O"^C>&?&'@+XMIXB^%WB+P#\0?&G@/P1X/^*WBGQWJ7A33(
MOASX.T;5_',DWQ1U&ZL/$^G^"/#?A/Q!XPM]2US27M;=/6?#7QSGTW0_%'B/
MXXV7@'X3^%M)U'PU!X3^(</Q3TCQ#\./B5HOB7PIINO6GB#PIX@U+2O"EU#'
M_:4^J:&FDZAIYOKN32FU73I;_2+ZRNG /HJBOF!?VD;*Z_:/\!?!C2=,\/:Q
MX$\?_LR^//VC=&^+>E^-+:_L+BQ\%^/OA7X133;72[72Y=)O- UC2/BA8>)K
M#QE;>+)K66"REMETS[-)'J4GH-S^T#\"K+PW?^,;WXR?"^R\)Z5KE[X9U3Q+
M=^//"]KH6F>(=-L8]4U'1=1U2?4X[.PU/3])ECU>^LKR:">ST>1-6N4BTUTN
MV /7J*B@G@NH8KFVFBN+>XBCF@G@D2:&:&5%DBFBEC+))%+&RR1R(S(Z,K*2
MI!,M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'XG_P#!:'P-XV\;>"/@
M-;^"_!OBWQA/8>-O&4]_#X4\,ZYXDFL8)O"]G%#/>Q:)87TEI#-*K112W"QQ
MR2 QHS,"!^ '_"@_CK_T1/XP_P#AK?'O_P SU?W7$ ]<_@2/Y$4FT>K?]]O_
M /%5_,GB1]&K+?$7B_,N+<1Q5CLKJYC3P-.6"H990Q-.E]1P&%P$7&M4Q5*4
MG4CAE4:<%RRERJZ5S\VXA\.<-Q!FV)S6IFE?#3Q,:"=&&&A4C'V&'I4$U.56
M+?,J:D_=5F[:VN_@+_@F'X>\0>%OV,/A=HGB?0M:\-ZU::E\0VNM'\0Z3J&A
MZK;+<_$/Q+<V[7&FZI;6E[ MQ;RQ7$#2P()H)(YHRT;HQ^_Z ,#'/XDD_F<F
MBOW[A?(X<,\-Y#P[3Q$L73R+)\LRB&*G35*>(AEN"H8.->=.,IQIRJJBJDH*
M4E%R<5)I7?W>68*.6Y=@,NA4=6.!P>&P<:LHJ,JD<-1A14W%-J+DH<SBFTF[
M)L*^+/B=\&/BAXH_;B_98^/6A:?X3E^&7P:^#'[4?PZ\92ZCXHOK'Q;/K/QY
MUG]G[5?#UWX>\.P^&+_3]2TS1$^"FI0:_)?^(]'N=WB'2Y-,MKX6E^@^TZ*]
MT[C\3IO^">'QN\1^ ?"/P;\3ZSX!G7X)_&O]N/XL> /CO=ZSJ.H>,/B3H7[6
MOP[_ &K?"'A_P?XXT"/PS;W_ (?U#2[S]IFPF^+.H6VNZSI/BU_A)X:US1+:
M6^\0IIO@C"\1?L6_M>^+)_A"E]X*_9\TJQ^'^E?\$R?$-Q+H/Q&UG1M>U'Q1
M^QO\>-.\>?$OPMX]\06GPEEU'XHZ;!X>&HZG\"+_ %"72O"WA/5=8\4P7'@K
M3O$.L-XJNOW.HH ^.OV6?@]\2/@\O[3D_C2Q\,M-\4?VI/BW\:O!%OX?\27>
MJ^?X3\:6_A<:'::_->^'=%71?$'FZ!<)J5C:IK>GV:W%N\&KW_[Y8_SC_9 _
MX)Q?M"_LBS_!+XP>"X/A&OQETSQ1\?/ O[4'@=_'?B:\\ ?&3X!_%W]H#XE?
M'+P'XL\%^*;GP%]O\%_'GX-ZEXQT6V#IX4T[PS\2_#\GC/P+XSU6X@LOA=XN
M\&_O#10!^/\ ^S)_P3ZU;P]_PE_@3]I[X5_";XC:9H_@'X]_ [0?CS'\7OBU
MXT\;_&/X(_M ^*4U;Q/H'B'X3^+-+M/"?P;U#Q)H&G>'5^,%EX8\2>*]"\9>
M/-!MO$7ANVT33WMX--U/&/['?[3D_P"S'\ ]#E\6^ _BS^T'\!_BUX*\:^*D
MU[Q[\2_A9X;_ &@_ ?PT\(>._@WX?\.:O\4?!=E>^._A[X\O_AOXDTKXI)XB
MM-)U[PY9_M"6-\]YI,_@O6+N:'];** /PP\<?\$X?B'=^#_C?X4^%WP;_9Z^
M&^B?%'_@GS\4?V;O#?A*S^(OB?6=*\+?%SXM_&GXE?&#7&U3Q%K_ ,,]2\0:
MUX-36_B/=>(-=\8%!JFN^+SK6H:?X"T>WO+ 0>H?$#]CG]H?Q+\;?B#XLT71
MOA*/"/C_ /;C_8E_;-?5-:\>:W#K>EV7P-^%_P &_A3\2_A^^C67PZOH[KQ+
M9V_PA?Q'X1\4+JXTKQ%;^(+30[ZV\-RV%Q?U^O\ 10!^5G[#_P"QG\0/@1XU
MM[WXQ^!/AAXC\3?"+1/BG\/?AG^TUI?Q>^+/C+XA_$OX<?$_Q]IOC*:'5OA5
MXNTRT\)_!?5]6MO#GA&\^+5AX9\2>+-!\8?$'P];^(/#=OHVEO!;V/ZIT44
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
%BB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>dexcomgreenstandalone.jpg
<TEXT>
begin 644 dexcomgreenstandalone.jpg
M_]C_X0KZ17AI9@  34T *@    @ # $   ,    ! W\   $!  ,    ! (4
M  $"  ,    $    G@$&  ,    !  4   $2  ,    !  $   $5  ,    !
M  0   $:  4    !    I@$;  4    !    K@$H  ,    !  (   $Q  (
M   D    M@$R  (    4    VH=I  0    !    \    2@ "  (  @ "  6
MXV   "<0 !;C8   )Q!!9&]B92!0:&]T;W-H;W @0T,@,C Q.2 H36%C:6YT
M;W-H*0 R,#$Y.C T.C$P(#$P.C(P.C4V      20   '    !# R,C&@ 0 #
M     0 !  "@ @ $     0   W^@ P $     0   (4         !@$#  ,
M   !  8   $:  4    !   !=@$;  4    !   !?@$H  ,    !  (   (!
M  0    !   !A@("  0    !   );         !(     0   $@    !_]C_
M[0 ,061O8F5?0TT  ?_N  Y!9&]B90!D@     '_VP"$  P(" @)" P)"0P1
M"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,# P,# P1
M# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( !@ H ,!(@ "$0$#
M$0'_W0 $  K_Q $_   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $%
M 0$! 0$!          $  @,$!08'" D*"Q   00! P($ @4'!@@% PPS 0 "
M$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S-1:B
MLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U5F9V
MAI:FML;6YO8W1U=G=X>7I[?'U^?W$0 " @$"! 0#! 4&!P<&!34!  (1 R$Q
M$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"
MTD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&
MUN;V)S='5V=WAY>GM\?_V@ , P$  A$#$0 _ +V#CG+S:,4V%GK.V[QK&CG<
M?V5H]5Z1G=$%>11EV.J>[87L+JW-<=6[FM<YCV.VJIT3_EG"_P"-_P"^O74_
M6S;^Q+9YWU;?CZC%GX\<98IR_2C='R#0QP$L4Y?I1NCY!;ZM=9MZC195DP<G
M'C<X  /:Z=EFT?1?[7-L5'ZT=>R*+S@8CS3L:'9%K?I>[5M3#^9[/>]ZJ_4V
M?VG?''H:_'>W;_WY9_U@UZQG;Y^F)^'IU_\ ?4^66?W>)O4GAOP72RS^[Q-Z
MD\-^#K8_U9ZED8K<JSJ%M>38T/:PN>8D;FMLM]3?N_?V_0_X1/\ 5?KF79E#
MI^8]UHL:XTO>9>US?<^M[_\ "-V[O<Y&?7]<LIGI3CXK"(WUF#'];]8V_P!A
M&Z+]5V]/O9EWW>K?6#L8P;6-W L=]+<^SVN_D)T82XX''&40/G,].+Z+HP(G
M XXRB!\YE^E]'-^LM74\#,^T495[<7(,LBQ^VNSDU;=VW8^/4K_ZY4MO'^L6
M#9TH]0M=L-8#;JAJX6_Z)C?SO4_P7\A7.HG!&#=^T-OV3;^EW\1VB/=OW?S>
MS])ZG\W[UYU9Z/JN]+?Z<^S?M]39VW1^C]7:AED<,R8FQ,?*?T2K)(X9DQ-B
M?Z)_1+L])/5NL=3<YV3?70'^KDAEKPQH)W,QJ]KA]/Z'_%?I%T'UAZN[IF(W
MT0#DWDMJ#M0 !-EKA^=L_P"K1>A'IIZ;7^S?YD3NW?3W_P"$]?\ X;_6O]%Z
M:POKIN^V8D_1]-^WX[F;O^^)Q!QX#(2XI2KU?WNR3>/"9"7%*5>K^]V:_3,#
MJW7#9?;G6,J8[:7ESC+XW%M=-;ZJV-:URU\#H76,++8YO4W/Q1!>Q[7.W:ZU
M[+7V-K_XVMZ)]4=O[&;'/JV;OCN/_?5M)V'#$QC,V9'U7Q278L43&,S?$?5?
M%)Q/K)UNSIU;,?%(&5>"=Y$AC!IOVGZ3W._FUC].Z-U;J^.<RS.?6UQ(J+W/
M>7;3M<Z&V5MJ9O4?K;N_;/NX]"O;\-UO_?ET?U<C]AX<?Z/7XR=W_23 /=SR
MC(GAB-(W2P#W<THROAB-(W3S6'UKJ71LY^/FV.OIJ?LOK>XO('^FHL?^D^A^
MDV?GU_N6+L,NC[7C/J9:^DO'MNJ=M<.X<URXGZS1^V\OPBN?^VV+LNE;OV7A
M[OI>A5/QV-1Y<GBR8R;C$FK_ ,5=@)XLF,FXQ)J_\5XC#R^K#(.+C95C;<E_
MHN+GDM+B=GJ;K/4=7]'^<9^E5WK/2,WIE%64_/MO?98*W'<]I!+7/W-?ZKW?
MX-4NG?\ +>/_ .&O^_N71_7/_DVC_P ,-_ZBY0PB#BG(V3'Y==F&$0<4Y&R8
M_+KLYG2L3K'6ZG>IU"VK&H_1_2)<YT!^UVQU>_VN_G+GV*B<G/Z3U&RNK)>X
MXUD$%SMCP(=#ZG.<WWL=_8_,6]]2_P"@Y/\ Q_\ Z+J7/]:_Y8S?^-_[ZQ*8
MK%"8)XR?FM4Q6*$P3Q$[V__0O8.0<3-HRO3-GH.W;.)T<WZ4']Y:/4^J]1ZX
M*Z*,.QM+';MC ZPN?]%I?9L96QK=R\+269#CX)5?MWZZIS8<?!*K]N_75/TE
M]6^C6=-QWV9$?:<B"]HU#&MG95N_.=[G.L6;]:>AY-N2<_%K-S+6AM];!+P6
MC8VQK/I/:YGL=L7S^DK,_:]@;\/Z/[W$V9^U[ WX?T?WN)]_Q/K;D8]%>-D8
M;[+ZVAD@EI=&@+JG,WM>M?H_4NI9QL.7@G$J&M=CC$_R/2L:RW_KNS8OFE)'
M%[UQX[X?\#_G?I*Q>]8X[X?\#_G?I/O'UCNZEU#/./5C7NQL=VRIHK?M?9]!
MUQ=MV?2/IUO_ '/TG^$6YC_5S!KZ4>GVMWNLAUUP^EZL?SM9_-]/_!?R/[:^
M:TDW'P>YD]SYOZVW!_51#@]S)[GS?UMN'P?<NF_M/HO5#NHN?4'>ED^G6]S'
MLGVWLVM=]#=ZK/Y'Z)=%]8ND/ZGB--$?::"75!V@<"(LJG\W?_U;%\UI(8N'
MVI\5^U>E_P#<HQ</M3XK]N]+_8^Z=,ZIU#H/J49.(\TO=NVO!86O^BYS+=KZ
M[&NV_O+7P/K!U/.RV-KZ:X8KM'6EQ&W7^<]2QE=3_;_@J_>OG1)#%[OIX>+V
M[T^3B_YR,7N^FN+V[T^3B?H[ZS=$MZ@RO)Q0'9-(+2PD#>PZ[0YWMWL=_-K'
MZ=U[/Z/C_8K\1S@TDU"S=4YNX[G-]U;_ %&[W+PE)'+?NGVK]RO55</_ #DY
M/YT^U?N5ZJKA_P"<^Y8G2.I=:SGY&76ZFFU^^^US2R6\>ECM?[W>QOI;_P Q
M=N &@ " -  OE9)2<MPU*KX[]?%NOY;AJ57QWZ^+=]MZ?B9C>LX[W8]S6#*D
MN-3PT#>[W;BW;M70?6^JZWIU+:JWVN&0TEM;2\QLMUVL#E\Y)*+'P^SDW8L=
M>SDWW?HOZGTW5860+:WU$W2!8US"1LKU&\-6#UC$S'=7S',Q[GM=;+7-J>01
MM;]%S6[5XDDADX?8Q[U:LG#[&/>K?__9_^T2M%!H;W1O<VAO<" S+C  .$))
M300$       1' (   (  !P"!0 %4')I;G0 .$))300E       0UPI0%;\,
M*P7ZOCQ>"-2! 3A"24T$.@     !#0   !     !       +<')I;G1/=71P
M=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L
M<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4
M    %0!# &$ ;@!O &X ( !- %@ -  Y #  ( !S &4 <@!I &4 <P @ #,
M      ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4
M= !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL
M=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !
M   2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB
M<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP
M     $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN
M=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P    !29" @
M9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@(&1O=6)
M;^            !"<F1456YT1B-2;'0               !";&0@56YT1B-2
M;'0               !2<VQT56YT1B-0>&Q 8L            IV96-T;W)$
M871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15
M;G1&(U)L=                %1O<"!5;G1&(U)L=                %-C
M;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L
M  YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<
M        #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO
M;F<      #A"24T#[0      $ "6     0 ! )8    !  $X0DE-!"8
M  X             /X   #A"24T$#0      !    !XX0DE-!!D       0
M   >.$))30/S       )           ! #A"24TG$       "@ !
M  $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8
M      $ ,@    $ 6@    8       $ -0    $ +0    8       $X0DE-
M _@      '   /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M     /____________________________\#Z   .$))300(       0
M 0   D    )      #A"24T$'@      !      X0DE-!!H      U$    &
M              "%   #?P    X 9 !E '@ 8P!O &T +0!N &\ +0!M &$
M<@!K     0                         !              -_    A0
M                   !                         !     !
M;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4
M;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG    A0
M  !29VAT;&]N9P   W\    &<VQI8V5S5FQ,<P    %/8FIC     0
M!7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M        !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE
M<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
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M='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M   ,     C_P        .$))3004       $     3A"24T$#      )B
M  $   "@    &    >   "T    );  8  '_V/_M  Q!9&]B95]#30 !_^X
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M &\ = !O ', : !O '     7 $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@
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M     $E%0R!S4D="               !  #VU@ !     -,M2% @(
M                                                        $6-P
M<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P    %&)K<'0   ($
M%')865H   (8    %&=865H   (L    %&)865H   )     %&1M;F0   )4
M    <&1M9&0   +$    B'9U960   -,    AG9I97<   /4    )&QU;6D
M  /X    %&UE87,   0,    )'1E8V@   0P    #')44D,   0\   (#&=4
M4D,   0\   (#&)44D,   0\   (#'1E>'0     0V]P>7)I9VAT("AC*2 Q
M.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C         !)S4D="
M($E%0S8Q.38V+3(N,0              $G-21T(@245#-C$Y-C8M,BXQ
M
M  !865H@        \U$  0    $6S%A96B                      6%E:
M(        &^B   X]0   Y!865H@        8ID  +>%   8VEA96B
M   DH   #X0  +;/9&5S8P         6245#(&AT=' Z+R]W=W<N:65C+F-H
M               6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                             &1E<V,
M+DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'
M0@              +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R
M('-P86-E("T@<U)'0@                            !D97-C
M "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M               L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%
M0S8Q.38V+3(N,0                                  =FEE=P
M$Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(       3 E6 %    !7
M'^=M96%S          $                        "CP    )S:6<@
M $-25"!C=7)V        !      %  H #P 4 !D '@ C "@ +0 R #< .P!
M $4 2@!/ %0 60!> &, : !M '( =P!\ ($ A@"+ )  E0": )\ I "I *X
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M_P"OOW[XW;_HZ7'_ #E?_H+KW[]WS_H\W?\ SFD_Z"Z[/9/8OT_O]O47Y/\
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M[T\^SZA'?01$C\$*&GV:P_V9Q\JYZ3__  Y=\VN/^,T_[;KCJ7_[ _Z>TO\
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M1?!H]JM;>RB(P:>+(/\ ;. G_5+CGH.>G_YFWR>ZRR\T^Y=S1=M8"MJGJ*[
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ME8YJYX9 &C^RII/HZGWC?[^\T"*VV_E*UE_5D(FGI_ I(B0_Z9@SD'(T(>#
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MD+: ?+6%KT".8/;WFWEF)KG=-J;Z('^UC(D0?-BI)0?-U7/18N+_ .W/^O\
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MZ"W77TY/'U_XW_L../>^O==WY_WUOZ_XV(/OW7NO?U_WG_B+CWK_  =>Z?\
M%;4W1G8FEPFV\]F(4_7-BL-D,A$MV9?5)1T\JCUJ1]?J"/K?VK@L;VZ!:VLY
M9%'FJLW^ 'I;;;;N5VNNUL)I4]41F'[0#Y]1LKM_/8-TBS>$R^'=[:(\KC*S
M'NUQJ&E*N&)FNO(X_P ?=)[6ZM6"W5N\;>C*5/\ ,#JES97MGI%W:2Q$\-:,
MO_'@.FG\_7Z_G\C\V'^%O;'27KP_W@_[#Z?[;^GO77NO7_X@_3_>/]?W[KW7
M7]1_O9_XCZ>_=>ZL ^#OS>W)\8MTT^VMS5-=F^E-PY!!N'!,TU3-M6IJ9%23
M=FV(?48JFG_564B#17PBUO,(G65/;7W(O.3+Y+.\=I.796_43),1/^BQCR(X
MNHPX'\0!$J>V_N/=<GWB6-\[2<N2OWKDF(G_ $2,?S=!\8X#52NTQ@\WB=S8
M;%;AP.1I,O@\YCJ/+8C*8^=:BAR.,R%/'545=1U$9TRT]33S*ZL/J#[S8MKB
MWO+>"[M95DMI4#*RFH96%58'S!!J/MZS-@N(;J&&YMI5>WD4,K*:AE85!!X$
M$&H/3M[?Z>Z][]U[KWOW7NO>_=>Z;LKBL9G<9D,+FL?293$96DJ<=E,7D::&
MKH,C05D+P55)64LZ205-+4PRE71E(8$@^VIX8;F&6VN8ED@D4JRL 592*%6!
MP01@@X(Z:FABGBE@GC5X'4JRL*A@<$$&H((XCK5]_F&_#F/XV;ZI=X[(IYCU
M%V%D*TX6G.J7^YVXAY*VKVA).;L^.:EU3XQY"96IXI(F+M3M++A;[K^WPY.W
M--PVU3^X+MCH''P9/B,1/FM,QDY*AE))0LV'/NMR"O*6XQ[EMJ?[HKISI'^^
MI,L8O]*15HZYH&!KI!-<GY_V!_J+?3Z?T]Q)U$?7B?\ 7'-C_O?^MS[]U[KO
M_>/]]_A_A[UU[KPO_P C_P!?WOKW77'^%^?KQ_C_ +#Z^_=>^WITPV#S.X\G
M1X3;V'RF=S.0E\%!B,+CZK*9.MF(+""DQ]#%4555*0/THI-N;>WK>WN+N:.V
MM('EN'-%5%+,3Z!0"3^0/3]M:W-[.EM9VSRW#8"(I9CYX502?R'1V]D_RV/E
M]O:D@KQUDFTZ&I5#%+O;<&%V_5*'TW,^$>KJ-Q49C5KL):.-N" "1;W(^V^S
M_/VXQI*-F\"(\#,Z1G/JE3(/S0>?4C[=[/\ />XHLC;4MO&>!FD53^:@LX^=
M5'V=+W+?RG_EMCJ-ZFCQ_7V>G4^G'XG>L4-9+9&/H?.8_#8\7*Z?5.O+#\7L
M:3^QO/<,9>.&UE<?A68 G["ZHO[6]/M!G-['<[Q1ET^CE8?A64@G_>T5?VL/
M\/1 M];"WGUEN?);,W_MK+;3W1B'1*_"YBF-+51+* \%1";F&KHJJ,AX9X6>
M":,AD9E(/N+=SVO<=FO9MNW6S>"]C/<CBA^1'D01D,"01D&F>HNW3:MRV6\F
MV[=;-X+Q.*L,YX$'@RGR()!\B1TD?\/KS_L?K_7Z<'V@Z+^O?U_'^M_R(_U]
M^Z]UUQ>__$_B_!^OT]^Z]UWQ;\?\1_OC?WZO7NO?\C/_ !'^]>_=>Z6FQ^N-
M_P#9N83 =>;-W+O7,65WQ^V<-7Y>>GA?5:>K^SAE2CI1H8F68I&MN38'V8;;
MM.Z;S/\ 2[3MTUS<?PQHSD?,T!H/F:#C4]&>U[-NN]3_ $NT[?-<3^8C4M2O
MFQ HHQQ:@Z.YMK^5M\P,_!%4UVT-L;269 ZQ[FWK@S.$90R^6FV]-N"6!V6W
MH<*ZGAPI!M)-E[)\_P!TJM)M\,%17]29*_LC,A'V&A' @=2-9^RW/=TBO-:V
M]O7RDE6O[(_$I]A/VTZQ[S_E>_+G:&*J<K3;3V]O**D@>IJ*39NYZ3(9411A
MV<4V,RL6&K<E4!4XAI4GF>X"(S&WNNX>RW/EA \Z6$5PJBI$,@9J?)6T,Q^2
M@DXH#UK</9?GFQ@>>.U@N-(J5BDJWY*X34?DM2?($]5]U='5X^KJ:"OI9Z&N
MH:B>DK:*L@DIJNCJZ65H:FEJ::98Y:>HIY4*.C*'1@00""/<5.DD+O%*C+*I
M((((((-""#D$&H((QU%4D4D,DD4T;),C$,K @J0:$$'((/$<0>/4;_>OKP/Q
M_K_3B_X]UZIU[^G^V_VWT^GT^GO77NO?0?X?G\WN/J?I^?>^O="%UMOW(=>Y
MC/9*@EE6+</7W9.P<E3J[>.KQV_=C9[:KPSJK#R)3U64BJ5!X6:!&_'LUVC=
M)=IN+F:)L2VEQ P]5GA>+/J 6##YJ#Y='&R[I)M-Q=RQL0DUG<0,/430O& ?
MD&96^U0>O__2$OC_ %A?_$\WY]\S<=<V.O?T'/\ Q7ZC\_X^_=>Z];@_GBW^
M\?\ &_?NO==7'^M?_BGX/'OW7NKM/Y+W&[N^OZ?W<V)_3_G9[D_I_7WD=]W?
M_<_FC_FC#_QZ3K(S[OG^Y?-/_-.#_#+U?U[RDZR;Z][]U[J-54M-7TM115E/
M!5TE7!-2U=)5PQU%+4TU1&T5135-/*&BG@GA<JZ,"K*;$$>Z.B2(\<B!HV!!
M! ((.""#Q!\Q^1ZJRK(K(Z@H10@Y!!X@CS!ZUXOYC'P*QG5,%5WITOB31=?S
MU:KOK9E$CO2[*K*ZH2*FSN"0%FI]K9"LG$4M+PF.G=!#_D[B.FQ.]V_:^'8@
M_,W+EOIVDM^M$.$)8T#IZ1,30KPC8C3V&B8L^['ME!L\<G,O+T&G;J_K0J,1
M$G$B#RC)-&480D:0$-$IW_WWYO<_7Z7M[@'J .N[?[ZY^OOW7NO'ZC\ <_[Q
M_K>]=>Z];_?#CZ_FW-C[WU[JW_\ E._)2?9O8=7\?MRY!AM3L:6IRFSA.RB+
M%;^I*0//1K(Y40T^Z,30E--_56TT"HNJ9R9\]C.;WV[=Y.5;R7_$+NK15X).
M!4@>@D04_P!.J@"K'J?/8_FYK+<Y.5;R4_1W1+PU_#,!5E^0D5?LUJ !5SUL
M7>\MNLJ^O>_=>Z][]U[KWOW7N@"^37>&+^._2V]>T,@*>>MQ%#]GMC%U#D#-
M;MREZ3;^-*HXE:F:N835.CU)1PS.!Z/87YRYE@Y2Y=W+>Y0#+&M(U/XY6Q&O
MV5[FID(&/ET&N;N8H.5>7]QWJ8 M$E$4_CD;"+ZT+$:O103P'6G3N/<6;W?G
M\UNG<N2JLQN'<64KLSFLI6R>6JR&3R-1)5U=7/(?K)+/*20.!] + #WS]N[N
MXOKJXO;R9I+J5R[LW%F8U8G[3GK >]O+K<;NYOKV8R7<SEG8G)9C4G^?#RX#
M'3)_7@_TM^/R/Q?@W]I^DO7?^/\ K?4_ZX_WH^_=>ZZ_WPOQQ]/I;CW[KW5Z
MO\M;X*X++83$?(SN/"09E,B[U75^S,O2I4XT4<+F*/>^<Q]4C)72U,\;'%P2
MKX4A45=G+T[19+^SWME;3V]OS=S#;"0/FVA<56@-/&=3\1)!\,$4I^IW%D*Y
M+^T/MM;/;6_-F_VXD=^ZWB854+Y3.I&2>,8(H%H^25TWL^\F^LD.O>_=>Z][
M]U[JN3^89\1=O=\=79[?^W<134O<'7^%J\SB<G2PB.MW5@L3 U9D]I9-HEOD
M'DHHG;&LX9X:L+&K)'-+>(_=CD*UYGV6YW6S@ W^UC+JP%#*B@EHFI\6*F.N
M0V 0K-U%?NER+:\T;+<[A:P ;]:QEHV'&15RT3>M1717X7I0@,U=6T_C^O\
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MJ=+)18O&TD;SU$I!T1H; MI!-=DV;<>8=SM-HVN R7LS4 X >99CY*HJ6/D
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M2*$,#0@@\""""#P/'J+]?]['''XY]M_X>F^NOZ?7\?T_'^O?WOKW7?\ OO\
M??3WKKW5Y7\IOY2U"5M3\8]ZY-Y:6ICK\YU-4U<S,U+40+-D-R;,B+:K4]3
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M $5A3_2*:_$137<_/^/^\\_UM^/>)GV=8G]>_P 3_CS8#W[KW7C_ *]A^?\
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MF5N7^3[F&"33?7S> E#D*P)E;[ @*U&0SJ>HP]VN9#R]RA=K!)IOKP^!'3B
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MMMMVWVS2WLS!41>))_D !4DD@**DD $A;MVW7F[7UMMNW6[2WTS:44<2?\
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M_??X6_K[]U[KKZ_C_;_['WKKW7N/I_O%O]C_ *UP?>^O=;J7Q_\ ^9#])_\
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MVQL:R1BI,!/F/6(G@>*<#BAZJH_WUK?C_'CZV]PAU"'7C]/ZCZ&Q_H;WYO\
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M9B2;W)//OF^2222<_P ^N=#,78LS$L<DG)/S/K7S_;UPM_QHG^O'OW6NN_\
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MO _\E7ES_GGD_P"/CJFD?X?7^MK'\@'GWCWUCWUW?_ 6_K_O9_VWOW7NNO\
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M+F><6W+?,-R2:1V-PV./;$YQPSC'S\^M+7_8_P!?Z?U^H^OY]\[.N>O71O\
MTM_K?['\W%A[WU[KWX _I;_>!_7FUO?NO=>_XKP?^*\CW[[.M]'(^%GRHHOB
M9O\ W1O6NV75[WCW%L^3:R8ZDS<6!>D:3-8K+?>/4S8O*K,H7&>/QZ%-WOJX
ML9 ]NN=X^1=UO=REVXW*RVYBTAPE*NCUKI:OPTI3SX]2#[=\[0\C[E?WT^WM
M<+-!X8"L%([@U22I]*4ZLAJOYTN(2*]'\=\E/-<?MU/9]+2Q:3^H^:+8=:]Q
M_3QF_P#7W+S_ 'B8 *Q\IN6^=R /VB ]2U+]X.T"'PN5Y&?T:<*/VB)O\'0?
MYW^<[ORH$G]VNCMHX@L3XOX[N[,[B\:V4 2?88K:WE.N_*Z."!;BY*[K[PVY
MOJ^BY:@C]-<KR?\ '5CK_+HKN/O!7[ _2\M1(?+7,S_MI''_ *OV]%EW_P#S
M0_EOOF.:DQVZMN]=T-0ACFI]@[:I:2=HVY_9R^XY]RYRBE!M^Y3U4+\?4 D$
M&[K[T\^;FK)%?16D9&1!& ?R:0R./M5@>@=N?O1SSN"E(+N"T0\?!C )'^FD
M,C#[5*GY]$2W/N[=6]LQ4[@WEN7/[LSM8;U.9W'E\AF\I/;Z"6NR,U34.J#]
M(U6 X 'N,;V_O=RG>ZW"\EGN6XO([.Q^UF))ZC6]W&_W.X:ZW&]EGN6XM(S.
MW[6)QZ#@/+I/?3C_ 'WU_P /Z#_#VEQTBZ\/]CQ_K?ZU_P#8^_=>Z]?C\'_8
MV_/]?I[]U[IQQ.'RV?R5%AL#B\CF\SDITI,;B<30U62R=?52?YNGHJ"CCGJJ
MJH?3Z41"QMQ[=MX)[J:.VM8'DN'-%5%+,Q] H!)/R Z?M[:XNYH[>T@>6X<T
M5$4LQ/H% ))^P=6V_&?^5!V#O>2@W1\@:NJZUVF2DZ;-QTM+4;^S,7H=$KI/
M\JQNTJ:=7]1D^YK@5*-30DB03MR=[&[KN31WW-4AL['CX2T,[CY\5B!^>I^(
M**37J=>3_9#<K\Q7G-4AM;/CX*D&9ODQRL8/^V?R*H<];#."PF-VU@\-MS"T
MPH\-@,5CL)B:-6=EI,9BJ.&@H*9'<L[+!2P(H)))M];^\L+6VAL[:WM+>/3;
MQ1JBCC15 "C\@*=92P0Q6T$-M NF&-0JCT"B@'Y  =.WM_I[KWOW7NO>_=>Z
M][]U[KWOW7NHE;14>3HZO&Y*DIJ_'5]-44-?05U/%5T5=15<3P55)5TLZ20U
M%-40R,DD;JR.A((()'NDD<4T4D,T:O$ZE65@"""*$$'!!%001G@>J.B2H\4J
M!HF!!!%00<$$'B#YCA3K7 ^>G\O/*=.568[=Z9QU3E>I)YC69W;-.*BLRW7,
ME0SM/+$NF66OV5');1.6:>A#A)P8E^X;$/W0]J)N7GN=_P"7H2^PDU>,5+6]
M>)_I0^C5JG!J@:CB?[F^U4VQM<;_ ,O0E]E)U21"I:"O$KYF']I2N>T%A4X#
M_OO][_UO<&=07U[\?X_X_P"O]/>NO=>_UQ_O/X_/T_I[]U[KW^\G\_[?_BOO
M?7NE1LK9>ZNQ=TX796R<'7[BW1N&MCH,3B,=$9*FIJ)";NY8K%3TT$=Y)II6
M2&")&=V5%)"S;MNOMVO;?;MNMFFO96"HBY)/^  <2QH%%2Q !/2_;=MOMWOK
M?;MMM6FO96HJKZGS)X #BQ-  "20!UL_?"+X,;7^,6 I]T;IAQFYNZ\S2_[E
MMPB):FCVC33PLDVW-I33Q"6*/QRLE76J$EK22OI@ 3WFC[;^V=GR9:K>WJI-
MS'(O<]*K$",QQ$\.-&?!?(PM!UF3[=>W%CR;:+=782;F&1>^2E1&#_H<514+
M_$V"YXT6BBP?W*O4G]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW18/FEE&PWQ1[_J
MU>9&FZQW-BKP:=97.TAPCHP9E'AD3(E9.;B,M8$\$%^XDYM^1N:7!.;*1<?T
MQH_9W9^700Y^E\#DKFEQ7-C*N/Z2%?V9S_+K3P_QL.?\/\/\3[P!ZP'Z[^G^
M^'X_WCWKKW7OZ_@6/_(_Q[]U[KW^M]/Z?D?CWOKW5C'\JZFAG^7^U))4U24>
MT=\U-.P9U,4S8*:E,E@5#C[>I=;-<<WM< ^Y;]D45^?K)B,K!,1]N@C_  $C
M\_V2[[)(K<\P%AE;:8C[: ?X"?\ 53K:5]YK]9E=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UHV;DR1S6XL]F/)Y3E<UE<EY
M?'XC)]_73U.OQV7QES+?386^EN/?-6[F-Q=W-P37Q)&;T^)B?RZYQ[A.+J_O
M;H-423.U:4KJ8GAY<>'3+^?P/Z?UX_V'T'M/TDZ]S_KC_D7^WM[UU[KW]?\
M>1]?]C_L1[WU[H<OC!1QUWR4^/M'+ M5!4=V]515%.4\B2TQWS@ON5E0 ZHO
MM@VN_ 2_XO[$O)B"7G#E2-EU*=RMJCY>,E?RIQZ$O)D?B<W\K)HU [C;5''
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M_K>]];Z__]<2[_[S_@?]A[YF]<V.O?X?G_'G_8\F_/OW6^O'\?T_H/\ ;_\
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MO_.)R@IOCCL3%K)(DV3[FPL[(JWCEH\=LS?)G61K@#35U5.RCZG3_@?<$_>
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ML^Z.>O>_=>Z][]U[K7G_ )S/_,U>G!?_ )I]F+#D?\Q'-_3WBC]X7_DM\O\
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MWE_:G4O[(] /S'1Y/<E=2)U[W[KW7O?NO=:<7R^V&W6WR=[NVG]M]G34^_\
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MY1Y=W'7J=[5 QX]Z#PY/^-JW70+D_<QO/*VP[D&J\MLFH\>]1I?]CJP_P]&
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MD^>A?TT_FK,/DU>K1?<T]3%U[W[KW7O?NO=>]^Z]T!/RC_[)E^17_B">W/\
MWW^X/89YU_Y4WFW_ *5EU_U8DZ#7.?\ RI_-?_2MNO\ JP_6F/QQ_7ZBQ^H)
M_P!@#[YY\.N?O7?TXL?\".?^-_CW[KW77X%N/];_ !_'!^GOW7NO<_3\?[XC
MW[KW6T#_ "GO^R2:#_Q(.]?^MN/'O-#V,_Y42+_GKF_PKUF=[*?\J':?\]$W
M_'^K+?<Q=2SU[W[KW7O?NO=5<?S=O^R5\3_XES:7_N@WA_O?N%/?K_E2;?\
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MF0O<2NSLQXLS$LQ/S))/Y]8#75S/>7-Q>7+EKB61G=CYLQ)8_F23TV'\&_\
MQO\ VW]?;/3'7K?7^O\ 3C_8G^O/OW7NNO\ &_\ K6%_\/?NO=#;\<NG<EWU
MW5L#JW')*(=QYN'^.U<-[XO;&.#9'<N2,H#)%)38:EF\.JPDJ"D?ZG (CY2Y
M?FYHYBVK9(@=,T@UD?AB7ND;TP@-*\6HO$CH2\H<OR\S\Q[7LT:GPY)*R$?A
MB7ND-1P.D$"OXB!Q/6YICL?0XC'T.*QE-#18W&4=+CL?1TZZ*>CHJ*!*:EI8
M$%PD-/!$J*/P%'OH7##%!%%!$@6)%"J!P"@4 'R  IUG]'&D,<<42A8U4  <
M  * #[!U-]N=.=>]^Z]U[W[KW6O%_.&ZEEPG9NP>Y*"E"XW?.WFVIG9HDX7<
MVTY&FHJBKD/'ERFWLA%%"!_9QK?['$_W_P!A:VWK:^88D_0N8O"<C_?D602?
M5HV 'RC/6+/OWL;0;IM7,$:?I3Q^$Y_IQDLI/S9&('RCSU3>/]Z_XK_Q4>\?
M>L?NO?7_ !Y_/^/_ !H^_=>Z]_O8OP/Z7N+?U]^Z]TN>LM]Y+K#L78W8N'&O
M([)W5@MSTT)9D2K.&R$%=)0S$<_;UT,30R#\QN1]#[,MFW.;9MVVW=[<5FMI
MTD K2NA@VDT\FII/R)'1ILFZ2[)O&V;M /U+:=)*>H5@2OV,*J?D>MTW9N[L
M%O\ VGMO>NV*Q,CMW=>%QV?Q%8A3]['Y.ECJJ?R*K/XYU233(E[I(K*>01[Z
M*;??6VZ6%IN-G*'M)XU=#ZJP!%?F.!'D:@]="+&]MMQL[2_LY ]K-&KJP\U8
M C^1X>1Z4_M9TKZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[ILR^7Q>W\5D<[FZ^EQ6'Q%%59/*Y*NF2GHL?044#SU=94SRE8
MX8*>"-G9CP #[9GN(;2WFNKF58[>-2S,QHJJHJ23Y #)].FIIH;>*6XGD"0H
MI9F)H  *DDG@ ,D]:HGSC^769^479,RXNHJZ+J;9U7646PL$YD@%>-;05&[\
MO3$V;+YI%'B5Q_DE*5B4!S.TN#?N3S[<<Z[PW@.R[%;L1 G"OD97'\;^0/P+
M11DL3A-[E<]S\Y;L8[9V78K=B(4X:SP,K#^)AA:_"F  2]206_'XYX_WWX]Q
MO_AZC;KW^^_VU_\ 7^OOWV=>Z]S_ +[C\_3_ &WOV.O=&0^+/QLW9\G^TL=L
M/ &;&X2E$>4WMNLT[34FV-MQSK'/4E25CJ<M7.?#0TQ93/.;G3$DLB"_DGD^
M_P"=-[AVNU)2V'=-+2HCC\SY58_"B^;<:*&*C#DGD^]YSWJ/;;>J6B@--+2H
MC2O["[<$7S-3P#'K;BZUZWV?U)LC;W7VP\/!A-L;:H8J''T<5FE<B[5-=75!
M"O6Y/(5#--4SO>2:9V9N3[SPV?:-OV';K7:=K@$5E"M% \_5F/XF8Y9CDDU/
M6<VU;58;)MUKM>VVXBLH5"JH_F2>)9CEF.6)).3TN_9GT8]5W_/GX78WY*[+
MDW?M"DIJ/N?9N/E; U040#>.(IS+/-LW*2EE3S2.S/C:A[^"I)C)6&>1EB;W
M2]NX><-N:_V^,+S%;IV'AXJBI\)CZ\3&3\+&F Q(BWW,]OH.<-N-Y9HJ\P6Z
MGPVX>(HR8G^WBA_"W]%FZU;*ZAK<975F-R-+4T.0QU544%?0UD,E/5T5;23-
M3U5)54\RK+!4TT\;(Z. RL+&UC[PIDCDAD>&:-EE5B&4BA!!H00<@@X(XCK"
MZ6*6"66":,K,C%65A0JP-""#D$$$$'@>HG/]1_7_ &'/^OQQ[ITWUV?\?I_O
MN>>+#W[KW7O]]?\ V_\ A[UU[K8P_EF_-)^S\%2]!=GY7R]A[6QW^_'SU?4?
MY3O7:V.BM_":R24WJMS;;IHQZ[F2MH1Y&!E@GEERW]F_<4[S;Q\K;U<5W:!/
MT78YFB4?"3YR1@<>+ID]R,S9:>T'N"=\M%Y:WB:N[P)^D[',T8\B3QDC'$\7
M6C&I#DV^^Y\ZG/KWOW7NO>_=>Z][]U[JDG^<)T<^2V_L7Y 82C+S;:==A;W>
M&(,R83)U,E;M/)S,J#Q4V/S4]322,[-JDR-.H  )..'O]RTTUKMG-5O'5H3X
M$U!^!CJB8_)7+*:\3(H%*9QY]^>7#/9;;S/;Q]\!\&:@_P!#<UC8GT5R5\\R
M+PSU0/?_ &Q-_IQ]+_G_  ]XN=8O=>-A^;$\G\\ ?UM?\>_=;Z]_2WT_ _KQ
M>_T]^ZUUW_Q7_6_!']??NO=;)W\JCY%4'8/4!Z4SN04;WZF688F"=T6;+[ K
M:MY,;54P]+3-MRLJFH9U /A@-*2Q,AMF!['\VP[KL']7+F7_ '96/P \7@)[
M2/7PV.@^B^'7CC+WV6YKCW?E\<OW$O\ NRL!0 \6A).@CA\%=!] $))U=6O^
MYRZFKKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HEOS
MYZ)E[Z^-^[\'B:-JW=^S]&_MEPQ*7J:G,;>IZO[W%4Z+9I9\U@*JKI8D)TM4
MR1$\J#[CKW2Y9;FGE"^MH(M5_;GQX0.):,&JBG$NA=0.&HJ?+  ]R^6CS/RE
MN%I!'JOX1XT(\R\8-5'S="R#YL#Y=:DI!5C<$$<$6-[C\'_$'W@E_AZP7((-
M#QZZ_/\ L>>/]:PY_P!?W[KW79_WW_$?7W[KW7$6/T_V/_%/Z#Z^_=>ZOI_E
M!_(&@DQ.Z?CEGJQ8<G35=7OGK]9Y(T%=05*0Q[LP=,7D1FJ<?/%'7Q0HKN\<
MU4YLL)]Y/>P?-430WW*-U+28,9H*_B4T$J#YJ0) !4D-(>"]9.>Q'-,;VMYR
MG<R 3HQFAKYJW]HH^:MWTXD,QX*>KQ?>2G61?7O?NO=>]^Z]U[W[KW6KC_,[
M[\H>Y?D"^V-N5JUVT>GZ*IV?15,$HFI*_=%15)4[RR-(RG3XDK((,>6%U?\
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MZ?F__&A^#]/?NO=7:?R7O^/N[Z_\-S8O_NSW)_O/O(W[N_\ N?S1_P T8?\
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M4@<?&+8>395"T>4[;R%#,07$BQUF%V-Y8VOHT-'7Y!0.;TT6KBH0XR>^//3
MCDS:YZ8#73 \?-(?\#R>O8M?B'6-_O;SP4 Y.VR:C$!KEE/D<K#CUP[CTT#(
M+#JBD?\ %/\ ??C^OO&CK&CKO_??XWM?_>O>NO=>_P!?_B?]\?>^O=/NV-M9
MS>>XL'M/;&-J<SN+<F5H<+A,52+JJ:_)Y*HCIJ2FC#%45GED U,55!ZF(4$A
M396=UN%W;6%E TEW,X1%'%F8T _,GSQZD=*K*RN=RO+6PLH3)=S.$11Q+,:
M?+[3@#)P*];=7Q(^,^WOB_U1C-ET7VU?NW)_;YC?^Y8(RK9W<;P@2Q4\DBK,
M,+A4D--1(VG]H-(566:6^>?(?)MIR5L4.WQ:6OI*//(/QR4X#ST(.U!C U$:
MF;K.WDCE&TY.V.#;8:-=M1II*?')3/\ M5^%!Z9XD]&F]C;H8=>]^Z]U[W[K
MW5%O\T_X>HT57\GNNL6J2(:>#MW"T,0"RHVBEH=_00H% E5O'394+?4&BJ2M
MQ52G&?WM]OUTOSIM$.<"Z11^2S@?L62G]%R/[1CCC[T\A"1).<=JA_46@ND
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MGKWJMYK:?:N4"^IP5:Y(*T'GX2FC5(_&P4K^$$T84:$W)9N2Q-R?J2?J3?\
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M_P /?NO=>_J/]<_\3[]U[KU[#_6_XBW_ !'OW7NMH#^4]_V23C__ !(.]/\
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M1_Q(_'^V]^Z]U[_??3^O_&_?NO=7/?R_?Y>63W3DL#WAWS@)*+9M']OE]D;
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MWU]@'H =>O\ CZ<V_K?_ (US[]U[KH?3_7^G^/\ 3C^@]ZZ]U[Z?[#_7^O\
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M]_QJ_P#R+_'WX=>Z]_O7^Q/_ "/WKK?7N/R>?]M^>./\#[WUKKK_ 'PYX_'
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M24WGLG:G8FVLIL_>^ QFYMM9J#[;)X;+P"JHJF/4LBG2=+Q3P2('BEC*RPN
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M]V<]_#?[S?WW\7\,M1?QG^&?WF_R#^)_8W_3^]]KY[<:O8Y]O?\ 6E_K$O\
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M_P"Q.7_?QO\ V+/^']>/?O\ P'[_ )?/^SKK7_@/_P#R\?\ 9YU[_L3E8_\
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MNO>_=>Z#OM[^YO\ HG[0_P!(OW7^C[_1WO3^_?V7WGW?]S?[MY/^\_VG\/\
M\N^Y_@GGT>#][5;1ZK>RG?\ ]W_N+>OWMJ_=7TDWC4K7PO#;Q*:>ZNC52F?3
M-.BO?/W?^Y-X_>U?W5]++XU-5?"\-O$II[JZ*TTY],]43?\ 8G'_ +^+^/\
MG[/]?\/\?>,O_@/W_+W_ -G76-__ (#_ /\ +Q_V>=>_[$Y?C_2+_L/]+'OW
M_@/W_+Y_V==;_P# ?_\ EX_[/.O?]B<OS_I&_/U_TL_['_8?\1[]_P" _?\
M+Y_V==:_\!__ .7C_L\Z[/\ PSE?_FHU['Z?Z6/\/Z^_?^ _?\O?_9UUO_F
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M;Z?]_9]^_P# ?O\ E[_[.NM_\P _Y>/^SSKK_L3C_P!_&^O_ ']FW^/^PO\
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BR_[^-^/^?LV_V%_?O_ ?O^7O_LYZU_X#_P#\O'_9YU__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>sd8_image1a04.gif
<DESCRIPTION>SD LEASE
<TEXT>
begin 644 sd8_image1a04.gif
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M&C;F01&ZF =EAK&;#DT4N.9%)!K^QS'$I71#Q"(:\8@46L,=1+&,>MBB'MM
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M<%F#D=EXD01!*S7%=.P#80 3&)_1=$@YBLIXBK#V!XAP!YZ !2@P!&. !$A
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MJ2)  CAP!9>:GL2J?4)7D9=5)TCS!CT!/O@9@EKPGYI18N5ZM#AVC QF6=&
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ML0E;8 4 UL1F,;TV)HEK=IN^$6O^&\)]&(N%9H@BKF*U74$A/P6-X@(26_*
M",NCF*)5A] %>* -=N #*F ")C "G/S)G^P!/C %J' *FE *Q1 )5H>IZ=<(
MH9F!"N07 O-!&2&;^@HKUR8=6D 49Q0)=9*]=_,^E8(IEJM;^)L 09L%#Q "
M/LNR1;"_3AL #) !!4 "!V"T</  +&!$3X ")<P 2Z !+KR^ J "'TRS^+L!
M'@S"$BS.X]S.-[S.ZTRSN $$ S#.,DO/,JS#N5'#+:L!-YS.B] !"U %+U
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M-_1G4-M)"T+)\L D=<HHYZC@/*;)C[B<@8CGX"(M/.8.:/;37E)9U.QZLYS
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MIK\/IS>"IZN:'*A@))Q"&M" #*B<$P2!"T#!("#"'0 "((2!)S3!$/3 *-;
M"D !% \9$YD+AL8-3X&!1^H[GA',&H4'OX@)&%!346#[>C!&77C3&NB)C\\T
M@F]E9U6]$R,M "-MTE)U57_]F!-MEN:H-E^L& _0:=N%NKO^Y!FASH3V3.>L
MF /1 A=@'(.@"%2%1N^ZZ)FKQ/O.;?^&!-AS/6Q\O;JT(A=W1F!M@BUR@7CT
M#X,UK&!<B=A'+OC*"ZSNPA<@@0QT< T@ 16<P@AW S,P S"<_NG_>>Y>"EFI
M1/[=A83YX\MN A9LP9#ECH"N"^%'<,$:,A91%>Y5?&0Z_E/@"-.']4-C?<:C
M2V8U_[O61";\P1RX@B=XPBED@RU,00U P1H@@O>WNA:L@ P$ 1(@ 0Z@  TT
M 1J0@H?+26\TO_.;BXW]P1C< 1"OZ71 -Q_]F5$3'G?,"4#0BH:-8#1BQ,ZQ
M&B.*E:E(?PA&E$B0V*Z!Q"*]^6/^*%)'CQ]!AA0YDF1)DR=1IE2YDJ7).YL0
M$A-X#MLY45Q,G3-U!N; <]$LGMOUY\Q$B=&0)C6XZTPD5JPBK=F%S:+1@C)%
M&?JSD6-+KU_!HNP:2:LA4\0&6E5+<-=/8G?>T-JU20M:M-@$IK5:<=?=:+1,
M&5JCD:,APV-#;E6\&+'8PQTW119ERI1 OMC2#'$AP\4*&DH"X>O6;6UIHP8/
MICZHUW3KUM%8<:3%ZAQ-U[=QY]9ME)8[=TBQO:6RY@[7QV&1DS7L,?(FLI$D
MFWHJM^]JX&JCF5IC*IJH.Y'N[A9O^F_6/\4CB4J^7B4C]^\9=2SN_8P77E2H
M?&ES94K^DBN>7'EE#EK0> 4***S@SXDFO/#DCCL\(46KCN"#CZ3#M#KOCC76
MB*0M;("S3;?:RMODP[50JRF[K9[:Y \/@Q-HH:?.(X:\M%B!B[T=>>S1QY8,
M>;"K#3>1RR^#@-ID#5IHN<.0O#Z4*[OMI@*Q(AO7RFJ3AEY$4JW:9-JDK,9^
M+#.YY9SCR)2J=(OFMTB^8V43,$01B**#R%N-JJS(-',EK9P4Q<4SD"!AFSQL
MR6.((*Y(Q%&1%,-P.9*B8\5(M)12JK9--PU.-=50W.0E;-S9I3<1QTM5U=QV
M<<<4JL"@X@WU_*SUHPQ?K!-3FM#ZR3M#=A'E#U'L6M78B(S^3$HFJ)3+<%);
M6:K0O8X O2,=1+18X0="4-GFBA6<".050+P ) QP!G%BB!YZ4&(+=\"8%4Y#
MF%TO2+-$66.++>Y@9:F^!D**%E]\@863-+XHXPU.0@D%EEZJJ<:77EB[C9A-
ML'@C,B;_(&X34]YX@Q73 "8&*B&A35GEE:D];*L'[Z %.V)$.4.N','[-#56
MMHCIHBJQ$S:2V<"P$SND3 YR(Y:9OM"PK3C:I,[=[#KC23&W$,^@FC!RLNF4
MCM.JB15D""((SI (A)!'OQ[II;R\1,K4J4IU\BR*^CI6[[U/P^8,+,8HCI:F
MVNY1*Q,#!BZMH?Y@DI4S1@8Q&E3^+;Y*Y_".Y<M45M2#&KJ'T"M<VOB@$Q,0
M,JP@@Q12!,$##R=D<&*03^9@8PY2$DF"W2!ZJ&$(*]XHS,GO:@T2YN/OX*+Q
MB&]Y6)V(H8_^FS;S9F4KJ?]X@RJ0#<'<*J1W"2STPLDO7Z7"_A"3"YG5<N<<
M6M(G%J[(C=IEH;Y(/-&JOER4CI8W3/$" 8#@%\[H  3\(#EL9,$!',B#8?@P
M@0UXHA$O8$ 5.@*$ BPA)'Q8008,(( =P$$! 3"A"1E@ P$(H2-1.( 0@+#"
M2"A" PP80@E/&  ;*F""D8@A#&78$1+F4(<8[ @-(Q 'CT0P BID804O2 0#
M[" +" C^P1!SR( $1N0OYWC#'1ABB"VP+S>KD0F<BM.G\CUM:9&!@@QJ4 /.
MK" (B7@%V\P''4N%!WRU 5&._H"E+YWC('3B7&685)W5^+$@J+D<GOAV&YKL
M8@M8(-P;UK"T/(;E/)%84^(*\IOSU&D39Q#%4NQ"1MQ@"2.&():5*A;)HYA,
M4)MT&AO_  A/L($-GO"E)U[QBOV$X0I0H$(8#G$(3(Q"$WIHQ"(.H8A%_-(3
MB7"/'.2@1AYEDBQO.$.';'0EN1'#?2,B)"VP1 M#C*%GQ !9))92FI]8[SLN
MTN9(HF#%/$3! 2'@@P4D( 4^8" !2W A#"(QT! H @,2J,+^0!=@Q([\TZ&1
MR((%("!16V9P@QVY:$%[)":N= Q8L6RD.XBQ/L!\$3N[X + ME8:BQ#C#UQX
MRDY>)3FEW.4G#O'<1@NW)58"S#2F&$-EE+0%DUJL0QJ;T-<X@0E,:$(36VG$
M51>QB&=2<Q \0<57\Z %+%2R"W.($"?FD$Q;E84L4)N:6A"R"ZV,;*D4B88A
MH'"&:*PA,EY!TV3\ETBB@FD7BC1C:C)55Z&XPTZ1 !Q0O1(I7)[E<FFAQ1AI
M(2R(Z.TGI')(G#+[(HL@R8^"-%:(_"@W.;&U?*+HW!K 8 4H*"$)2:B!"DR0
MVQ&80 4NN$(]@,N+*>2@!";8K0_^X@"*1.A!JE+E1"(  8BL0DM2&#(%4:RV
MBWD04BE<S-L@:;+3C,#SNA[Z36*3$AQAU5.3*R&" P(PP#B\@(@!V( B;%#"
M!*0@#Y%XP@1,F  6@N0)'3BA!'S00@ '0 (<7$1^ U !'GKBOP%(P =>&(DH
M++C!-+Q@)$@X03YTP  ZY."( \S?CP!A "<<( 8]C,$(]E"*"%2P"1OLM(<
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M5\V7>JMWM$IUB+T+_0NKG)!2)@""6*0_;\!P67/''<([9]Q%,_6#!HT5**A
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MI1+>9_+=L4XRCTO=2":F.,U#Y!/E)$K9Q/QP(X.PXK.?1+E'3(HD><ZAIL/
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M#8: 06LP#\Y2;G*U-)^89Z+R)-9!3))TBC$R9N+F+_0Q.\:15.=A*%S@.$H
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MX O->0O5H [K<#K'!I0O(F*,LD[1UR2!I$2 LQK> 7-2(A.T\);D,9W?<1>
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M".G "Z\0#O5P.MLD,ZEB'2-2(\3!?X_DE]\!%(]D6\Y"(03K'=J@#?5 #_G
M#_D #_"0#_F01*E1#_60#T&C$FEE(9IU-^SC+,-")$FX4OZ(.82W"6N@!#,@
MB2]Z [&R$2+ %4?P TJP!N[0BLNEHSRS<Y2!(KUR%IO"+"WY-;\$1M&P!:)S
M'-1A" >[JG43,K&T'QC3C_#*MV41-,SU!IL0%+'U!_B42F<EJCZ!/"'$G*_J
MG+':"[.:",Z@",O0!U(0 R>@N2>P!$SPJZ, "G2 N2<0 \A*"+:P"(>P"'K
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M-/1PLZ]@!62P#/! #99:#;= JXG0";=PGT>Q#.F0#MGX@)ZP!5B@"(L0#N#
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M%%V6@F2!!YXPG710!U5@!W70",,@F+_P"WT0"MY !WGP!8%@"AD>!FA0"*&
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MF8(\; 0(!M@!((AP !@H @,,6$(4'"  (0#AG)%0A :<J4UN>A,&<%!  H3
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M?T=N5"P'4ON7.3 GX$+N_E@$/4!$@EA$A-)D$V:&T?P+-?:B"#<*&P9C4+3
M$S6E9<X "EY5%%+Q"'ZS": 7>YB4DR)ONRPKN$PKD&PF#S.M*JHM&W\$.03F
M);ND<@R5UZ3N>HU" "D#0(^)M6#+AK*N'WTL4FOCN[#51"(8 -W#GL:/APB'
M1TPH[A2*0GYX@16UMDYD'%LD/'I7O\!%9#M4+V38\7+EIPK^J*!&%#ID\E#&
MT'YK2XJCLEGZ%6+$*QY!,+XN2,YR,('@F*X:M:R$RVOX8@WV]4^@4J$:+FS6
MASON5248H_5V@0MN4D,\E.= 9?0Z"2$8XE7,>#@L2 C= 4I]UBN$,4,_,H$
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M'ZLLSW(_1_7BB9B.)XF66/44O'$<YW&UV8(!)W X3DC.+)Z$LFQ0EI%<N\N
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M25\U)/#>6%2OH&^ T(.=4*@><JB**\$V*RXVM%@W2E(0WO?>P<>]!T&0F^I
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M6^_K;@J*E<6B@;@LK+2"ZZQSW-G52>J&]<U+OJZ-7/+)&ZF\\K088:00/=S
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M&GN<S:+^ZN(5H"RGA;2:QT=8X;Z_ )&;W8R$$!N!.4;H@1&IJ,\I E&"#&3
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M-N< M2%2$A6J+%HAI3MS+JLM*DC/:@U@0%=[E+XD3[/$$*1 A!:T, A>!")
M*TBN%MA@"F7P@A1A^(&#'G3='?GQ\-1+4J":A(E$K.$+?V4(LI,]G.J B!9;
MTT)*Y!D)2"]YOIS^N_.1A%_]@CN2Q, =;KCBZ+3N GZZ*GJOK&(NW+3%M9M4
MS]S^%&/[YBC22]X%& QQKS5@ 50*6<DE+010IELH#7<#T!2^4&N#L&64HW6V
M4AUDL0L1%&!B%Q+A9@C/8SDWTEU- E<[P78I(1UT-G>VLGWG4!MGH5G3<R,4
M<DG/-Q2;$%%I(69J@PU[)"OR)!#^EE$3!Y8KE28*81-)K&59U,&!]Y$F3/(W
MQ^(338((G\!WGG *GD &GG 'RS4';' *]? *R^4*Q; (:8 )I6 AC; (70@(
MR^4)B2 ?A5 (Q=0:M_<4T\8(Y\(%;P!FZA -P0 -W_ -Q  -WJ!LP7<0X $3
M9[ %M6$ERN<E-Y$9F!<444!&6*,U5S0S#+!"BY!P(35#$>=210 4,<-16)-2
MH 4$ V U2+-"/_%OSA$H+2$I9O(JQ)!DM+ 2?V FJ45+MU)MZ&$(8-!+Y/81
MB>,=#W-^;))^]548L#6#<T$+8% 8;*,%D/=:7&$C3@$WB: :FJ )3M$(U6B-
MAC '<S#^")[ ":+P!X% "+9@"Z^P"(V (Z;P"9U1C:DB4(*T?J<C&YBV"8QE
M9J)@!5L0#7=P:>^!AL[X$S=X@6\6BXJS%@<Q6>/Q(3RX?.[ "FEA"OO"(T#X
M'";8C\KQ=G.VB]/S$CAA.INDC.!V#O>A'*3C%1MH5JQ3>W_$9NP!98MP('.P
M7(* !W' !$C@ S?9 TBP3=PP"H.@!G-P"(?0!8T AF$H']5HB)J!3_BW:7]@
MD(23%@A5'@6A*[BA+UX!:I%P&P_T)3'!(TYV%(O0 0NPB9'P05=EE@?  EO%
M$T"P #_P $I5<Y;8$Q\DES5W592HB$GT APE11L0<B2FEUG^0S4+@$4B%0F8
MV%&)*3,T$XHCME(T9$-X<'!.$P(FQ):1L%6#J35 D5]Z 173IH-SE(H%Y3TM
M82:[P 4SZ'TT01"&0&:L,&[=H8MF,1FM0RPFN"0]PBF4-A=8T9";< 9<\)%C
MIQ V AL9(C6<P)RK$176V(6&T B90 I)& ACL O:4 =34)-#X)U3=@7-Y E=
M< CA5(B"@8,S(1>TX!14H8PD8050XC9\X8]KQW8WZ&:M,AFQI8OKUH >N"7$
M,'0[HIM  65<\P>;PGY?8HL3]%F<9!V%)RQOL ERX4 F21?W(ILWF))<MI)L
MU@A!:2V_0),YH (C, (FH*(K:@+^.2 %S90(.%(,C< 3JX%U2!E.SGB#ZH(<
M 19)DL* ,H(6TE%INQ )\X=F.\*'7 D37-$623E5%W"84F5P)1=&5\5S O !
M!U!%<!"7/Q&)2.,"6I.9*50$*V>6(1:81U2F!5 $&D"6D>!B7NIR9JE&,M8
M(> 3&\83)Y5O<*HT)05#-Q1P:QFG*D67/O&9[2&:D@8BQ$!F<,$2J;F:L'48
M:;$V^ 07SC:#&'EFN F6!0H?O%F0LC5VGV$IL+D&Q=F T6 GSNAG'.,)J$ (
MRU4[C<"/A*"KA( *?3 %/I "*J "*^H!*:H".< $O\ -:6">[6@(Z3E'C6$Y
MNV$5:N'^#IIU$C:B=FWB)%+AC&UF*7 1K@;IGZI3KA]Q#@F#J9%0>=DFJ@-T
MH!:2@9%FI$[Y/8;@H[MD%3BB'BVA&ZP:>912$"HA5]WU,7< E,Z0#;^: B:
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M5;ON82YCX!*5!K @P1LK."=KL!Z^9BGP VY=Z:2A:A0F9I;\UF$)D*@U!P.
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M)>]3)8/E%<FA@KQ1*XZV%J:@!:)0&SKA%416%H2#'E6"&0'='&]!P.<:$EC
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M%Q 329M@BV\^T51!26^7.75=[^V2YZJS9/">@&#P!AX(Z,3@W3$M-;S:N)Z
M"(@ G=[>"'>@!XR@!U?@!#APOBQ:S1=+!=' ;>RAQ7$'ZFN3$Z7^4 -!I%B)
M'*!Y>_D73-W*$OG%U=C1ZJ*Z%[O+Y"*AX5[!6>/!20.Q1YC#7^Q)H;6!R6-.
MU0KI28J#4+P(\AJ#H$3O";S@"6"0![S "VW@!$A0 S4@ W?^7P,ZR0F]D IN
M\ 8A.I1?N%R'3H9FN#'/>FE^=L=J1F26D>^1<2L^ B7NA]$)^2'JT2= ./&T
M'8%<L^X?X169@\?O!NS8^QV? 3%R81G$2!9H9IJY$3]YOF@$S#IG[UM+0<HF
M6&"L@K9FXQ5W\@9_'GP*P<6><>6:,:LC7_+068[#4 B-8+^EP MI$.D[G>/"
M6@,^X 1A1:!L0ACX":14;18)R+S[61E_#BL03B=:<.1-PA-V'E QC8)XL1.!
M%M Z*MQ;1UB5Q+P/8XS[ Q#8! XD6-"@P5U_UAS$1NN/(5.T1#VD=8[816+1
M-&IDV-%C1UJ&1/XA^=!0))0I5:[^9-G2Y<N7AMZL.7-FS9N','7NY-FS)Y@M
M9T2=FT>,%K&/#*-A<T?KSAU3NR*!814MXSELNS)BB[;+E*$[?S;Y)%O6[%FT
M:=6Z/&GHS]-(N\YA/6BU:S0PFVBQ^C/&(E)BNSCN&A-UZ\=S2]UMXK*+5L@_
M<G=A0]IQETBW)46:+=F9Y,FUH5EB)CTR$BND77<)5AKICREL=[88TIK48&!1
M."/=$>56]&^>GGC5(L4&"Q4H4)I0T7+GTR=$;,( ?[E)5,2,&Z-9G,<5&ZN\
M'9L2.T=KDY:WH*FO9]_>?<K,I[=37LJU-C%188FQ.A,IXT7; CPGMT@8LF@-
M,&C!QI3^.][89""Z-*HL0 H+LLJ\/]X(2[WWU,JLLPY#5&D++=9@99ZF4*L0
MPM6(^4HL5GACA36N#MO/-0Y%U'%''N&+Q"VXY*++(+L$RVNOOOZB3+"E"#.L
MOHZPJB_&35B!3#+*/+IPD[>>RK&GTDCKT:<//?OCM-16H_$V!V=\(Z_#*G1,
ME#7ND(G+,\=,:Q-2/!ED$$](^<031/P<9(XY!D'D$U)$K)(6K;2+9IZCYG+H
MC0EOJY2_+4S2\U-0J;N.EOKN<F=!5BR2*1+SUC!%0BA7K&LW43JRBL&X0CK#
M2BBMFDQ68&]TZ\M06=IDK)&>NJ-8X,X 8XU-FEQSQ<!6R^_^#XD,T6LI6+'!
MRJL?F15W7)[:ZC*NN93*R$B]^/(+P, &*RQ2Q+:Z]8V(W,(R4X:$S8E</4]2
M4;5I"=H%C(A86:,P?@.\B,&3Q-H,8)TRX1(--NY )))![LC$DT@0$7ED$46)
MM%2KW#$JL4CPC?6@P,X;H\$\*;9Y7%&.PJA)8DY]+!I:WGA#%%; VN74EX$U
MF"0%#>QN5598F2B2J+@-3.D*?=W+%%'&NOE'#?,$:XTUOC[KS3.B%6A("KM*
M[#%3WIK13@4U4M*=Q%C9A%BS^];1W"#3K6M=O-I-$EXFLYHW3H94EI RA*\\
M9[*&";+**%:X]MJL8SOW_&O/0T?^:6 UDQ9HERT>$V6,7<E3.B3K#)':;V.C
MSMR43UP32Z7,E@U1E*TBO&B[R5C1T**/JAU#E#.H&(-VZ!V-2J!X$\M.(ZGJ
MC#JL:)#&^J 8(U.7O'-,F6D3%\FN*!HK3_T^P*7F KJWIS[#C*3H\U^)2]>@
ML$K%%0'-*$BYS!UF!)9:X>TB].)*MD!CG;&\I6;ZHR!9(D:3/Y"'<9;+SFK&
M\ >IB64REXL??DQ$'X\(!FGS8(46CD*+2*S!*FP;'$9LN(O.P2=,I;'.=:P4
MJ19)2&] 4E81)[B_T'7.%$MD8A.=R$3;13%JOZK+M\CCCFC0J5:&>!:O9.4,
M&R@@  G^2 $J3/&$"01  ""(@VONL(8L/& #)$%C  *P@"*$R0@6L&,"5!"'
MSU%,$1JPHQW7* 661.$ 0D@)LDZR"5/,R%;=(P983#&Y*"$%:<08PQ;>4$%0
MAL8ZJ#D'WK)$G_*XXPR&V,\;#-$5\IGN(QSA"D?.L8;7L*)?K,&<*$:WB:>@
M+V_OLPTLK48+4^SM?O8+9?2Z!A8N4(%ZLK05Y293GC^<X1R;P(DN3Q68PW0E
MF1(DS6>:><Z8N$5#:MO@0.RBF@^&<!,C')ZW3*C+=AIL/N2A!1>B D,9NDY+
M-B3H8[:V1%$D5*$+]>%C&%C/;TDMB9TCFA1M9U",.E1-&RW^V$ (:D-J[G,[
MDZ,5,>[ A3?,B)H,X<,#+H *C.Q"!P58PBX4,8&7^A((!C# '.'P !:0A @&
M*$)G7I" )8AD$1U80!4,4<=#1D(1+S!  "K@@ W 00$; !D0!,!(J() "G!H
MP%7'* 1#,.()?%QC'-2:QJBF9) 1:"-*AKH#LE;   4@P2(Q< $\&$(1?\U#
M6.T ,[Q!K&>Z-) F:]3)3Z)3LCR!)*F\5:-IEH<8G_3*'1X$H,3(2E(;V:SL
M&'L;)@DF,9NHTT6R&1GD$7.6092041+Z(\U,MF\)38\23#$/JXCV<:>*Q!;P
MTR!T64]2@6&%[CJ#&=WJ%DA_R)G^KV3Y3@^"<"+SK%'P[HG"CEPE*UR!UF-B
M.,-9?G1GM>5H>UMT/0A!2$K5RJA!M:)>_-:S+J/=2 !':J^X&<)D;^#"'5:S
MTH,HT@,.&&,1TB&0+(A1 E6(AC,ZP &M<E61C(S$3UE FJE6=8TYP,,?7M!4
ME "A $7 *1XB$86M9KBK7SUQ%5)<@!HHX )Y8(17A3!4&#!"R"9N*B,BH>(B
MR%4#=$T)'R80 :T"]L6+5.0.3$Q3'31U+BI>PFU49LE2GM8@R-LD9,D2!02$
M( ]1<$ (XGB!.!#A #"(A),YC)+!3I@/&$!QDRTPX4ADP0(0L+'9N(P202.5
M/1$YV>/^:CDYD40D/Z; 8D<IM#.!(/.3R!S?@2GS%7RY*$.&:)ILM<3?"R7S
M0WR+[K@V0P4L]%=6D-+.9:C;M4B8K):H1J8O,S.Q5J,3+)X=H:<'ASW":%>$
MW2TAG?"Y4KLUI&=NB<AY!6JK_ J.M/F]7G^U4\M=HUK<XZ9FM=K;;4FI2WY+
M(08WK6.*,32'@1129!$R0M80/'@@7E7! XJPBPR_8L-1\W!+E/J"KVJ  85&
MB8SK/(&L;G7&0E XPSN\U3_T^*L^%C(C#E%Q([-DKG6MLQP=ON&E+H ':5Z$
MPOWP$2RV+%I8K-S:'&L5,_=DL$QFR2)L,&= ')7!9%SS(E'^@F86J*2E$EC"
M2MX<ARQ,@ )Q0/@.]AR B'/UR%]]>M2GKH&V[G0'BWA! 8001PA,0>%+4$0'
M%)V20Z-DJ0L'.PSXH 2(HWD'4OUKUZ5.<I7H[*,"B1]A3&:*W; "'P+$FE%4
M^YT,S;-6!YF+8QHHR5T@"'TX%+"I$2.EY6:K?MH*-L5\TS)10$%MLMIF1?:C
MH'-L8?.^-$5JTNU.KR@3V*4/I4QX@PW@'N6Z'4RV/.GI76>#5]W?V<4\N)DS
M:].02-F.4&WS:WUNHYO<R\6O:/$[?&\-QA"N6B(8FI.=%17C!1+P@S-T@%0T
MPV 9P\  !7YQN0S7PAD8F/!@F[K^T)T2JTV @T&K@CB2 "G@ Z:J K%30*P;
M+ 98 C3BN@= 0 5<@!_ .(T3 B<C-#:[@ -,P 54,IXC @>8NI,SNI8*  CP
M@VCX*0JP@[9KJH(X!WZ@!9N@!2RJB$QBBL?R))]PL@1@I#@* :7# $)3B4&"
M ",PN@X#JI9X A3@HP@DI$)2(Q60N(?+NHFSPD)*N(6[."Z$NP&X0JP#F1MK
M.I1HA*-:@HK;PI2K@K(K B\TI#M3"299((P@O-/! M2@GUW@!\8#%HOXF<32
M$).9O+:QEC.Q$M8:&*.@-<_SB"O*HC=R)=XC%V8R!"Q('>G#&@)Q#+"@A>X8
M*,?0')3^* W-V"%6;$57=,6O@<6RR(ECP2T[J1(:B1>EB)^E6 /9D0@PX KK
M\0ZD^*2,L"R&<(S40 U:6!ZO4 C@HJ5)G,9+RSZ0NASU<B\UX;9)L8A2.@_4
MV(0S>)[M$#-LY$9J-(CZ,J@G8B*'^Y&1,!-Y] RAJ1^3(+TRB83-J8Z&.@K1
MTA#8LQ3+L)K ^ ,L^"!/&8DO62HIFZL1/+(5^RL7FZN"F[([G,,F@SB,E"N)
M?+$8TT*$$X*-Q+,WS+"?XKD72[.7B+N2 ZPW=#*N6KHT"[H52XF<F*[:BY*N
MP 9\F(VCB"%64"![ 99&<X==X +T8:T H@5\6(QE,2\!$[[^;TM'"\D.VU*(
M3!R7SWB(.\ "++@DSTL($-J%_(@$]]G%<S0*A,*U5W3%>7Q+N&2U4"F3YT*+
M^VD0:,$.;K&+70P_;/!%*Q&%8-R.X&(W;#!&H"FWVF ?JRBOYM(F^*)*R829
M[X.24IJ'[A"W\5&OD;(+8HB$,;@(<23'4WFO^I"?[YM,PD,U;02XK7J%VTFH
M?5P)5NP2>UQ%9M*)BOJADPF@KY@G**FY6@(GK'@#*L@+9/$2?70)$U0C-GHQ
MN!(KJ0JC,4J!/(B$.CHKEGB"#B@D"?"!HTNC &"Z2/ Y,:H B:NC!/@ HXL"
M\62Z00I#&5/ JHK .NO.ZKQ.,OS^0A"PL?BT,9@$F:%JP?"T(Z:+QS/Q1P-Y
MI[39A:+!EF\JE6#I-E,X@VI[@Q4ABHNPB):)A&@X":())]7T*-6RB++,2F8Q
M":ZT BM8/5/;KJAQ#60DDJDDO, XJ*Z9S7)I2QZ5RV)I1;LTDQD9'M*Z+E[\
MRU\43&$LS"Q!S!DEDOMHFH>(B$T @WB1QA&=S/QZK__8/K0<+:]PT'?C$GQA
M+3 8 ]H0",PTI1L=4L[,TGZIS 5R#(.RJ*A)IHGR&E5DIAYB*#\5/'2CEJ&A
M%[[<1>(\AS^@ BXXD[&@F5J,GG=$IR[1%I4ZM6@8BWP9&L)$"JP0SH'*CN:*
M"P:Y ];^TXI3&556\:5<>](1E35?05%F62;CM()7\KREF)K' (N:&ZV/XJC'
ML%-@M9T\'59B!9UAM4N1&"7+XJ])\DO !,8E38TF]8_$3*'_J(C%H"X7V8*(
M*%0XE<S\,B4;78UU?(P[& -T3==TK0EV95=?I!_K0(E Q <<RA!GT8*P655>
M2DW5%+?KV[:-PB\Z7<<[Y1K9W!ME51- )2CM8-@501VY("TJJ@O"JPWS\<JR
MF0@-\5%8#96]\9*<3(JNV!5(41][VHYO4IHKG;0L\D71ZJY3G(C'X)*9XTP$
M"\NOJ)]4[%@1\0U#2!LKF(V)?1^5:2ZZV855(B"Y*(H-8E;^R]D^J-6(<D6F
M=M0<8ITHLP!2F;@)B+"2VWDB55TF_$G%,J&H'\JG6;(;I,B/>5*8R:N/8VP(
ML0BN4^-#KA +H_C9RJ@63*.,J(&4^\*>OJV\P(V?3Q39RR%79.H=H9F)A6$=
MLJG'#9F8L8"DJK62<FW-F(FD_3 %?I@'?&@(2'D,=X"BBU*8FJB3/.&NM9F+
M=)$UVW!=&H)==\(^8ZO=FZ515(M,D>57RIP+4'65_R"H8K*:,<""LM$=Z.)9
MT_L,7%RIK6 %*V"AN/%04[,]KFB9G_P]_\)&<OTD*T&\TT@,5,M2M72C#6'>
M#@&+,W$E*M@"4<C=MMD/L-"+\8O^7XUP!RR27ZK4W-T5V&"M6@'&TXEZIH?(
M&>VKM872422*I+/E7PO)7Z2($?\PG@*AI;@UJ5?RU([0D,RI4M8H);P!/<70
M7VV;CQI1W()E2[J$RY)XHYL(BW_IH4C2*(4MV*B@TQ4>UA9>Q3#)M8GHFOP8
M@]M!D.1]#1D&41_Z#P?E&I2 X<:5W)P@&N';K_(-MYCB4LO\UJSQW:IT'8R@
MD_R2%879 BZ@FC<B/?75Q(>H++1=S5UXHZZ@",^K#&[17JEX#5G94J$!GI P
M(%H2'@A6FM326#M98_=@7Y0  RC8@J,)2Z:(AKCQK&8T(*:0$BZFS#?-FM;L
M9&V<VE_^_=N1JJ:!+5@:OBA((5+#%2Y*^HYE::4+AEN@H0P[H=L5H8BH(3\<
MO@Z%TKT7;A P.%.;N FA.9:$JF%/W@L[O2_'^-J(V!I<^Y$B>HK&)1NR85=T
ME6$S(17^XC:MH"=#F)<*/6-O$0SFVILW& ,NV +(U8UW ^7,\:4,H0E<:F,J
M-M77I:\$OKU,#B OYJ!2 1=6ZKX,Y0\M (,S&19$'I=#9C3TVT4E!1YHF40[
MSMXW@!37@ U.UF*-X(?<X W'H)5*I1Y+FT;6^)^].:*%%HT/N0-8>P,4EBTA
MR8K\N(-VHYL:\=9^]E=MY,:HW;XM#2>4S0KWNIXYW<9K=%K^8-D(E7'E"OXD
M<*,/!=%@6ZX0DNA65](0?3QFWO0*S W<)6GF>#89L;;:'LZF8$YKM0[F=@;9
MORU<AT(_2PFBM3G+K-E=M\G>PM ;H'BER9G*N=!?F*5:.A%F5X*DK@[EL486
MDF@0+AB#.EG5=2EJV[W=?L:V39X^[V"?T1GCAT6*3?!*-(ZLE0X5.T%@"56*
MD, 4O8$*BN;#:,#CC%[*5-:OYG,'.EF#PSMM -)%U8S$RB!+WRGMWX@89X$"
M?"GII5:NR\"4<V@94JL-5N7B<8L2V75=RJC,GT[+&]*DQ"C1+SWJGC%AW.5N
M#K;BIJ9@6([J#*[E\SX(D5 0?"#^H$_CY<U1")H81[6VYLC5$-Y8J"7ZVW*]
M6>RK71LR\&I!\.P;Y($8(4MD'^9!4\&0#"X='H;M+\&94V66YYFHB8VMK-0*
MY;6433<BFYD!44DJI<.];'?ZYQ8GWP71#\^6$W/>A"VP@C-65>+^E-,FE=>U
M%5^*D7,8&@65K8J.[8O.XZ^HB,FI%+L.D*K(&]?0"V72BP1G<8& QWA4SATG
M$TS@A#*P BS A%[H!5^H!C1/\S27%95YO =UT+?XK:98<2RO<SL7#U-*7(X*
M9%N29*^!H&U)E^$I"K!(E?<NB$H:&KTY2-W8ZAJN;?6Z<TGGH$@67\0;3>OM
MGE:]B+W^\+6WJ$=S&ITHPJAH[IT&"1MM0>;A];9 ]1;RMM$) 5A_=?'5-,K2
MA>JA_1X2\HKQ0]>-U2&X['*6KA(;N2_\RB;!, 6JF$;R#2Y6(&*G>"6<V);5
MW&.)1;P[D(@, 2&\ :#+_N!A^Q=A[XD_P 0]N (K" 582(1>\ 8U?W>E(2%)
M]JS,.8GFLP@&GW1]'U&^5645'T['6(VO(!O9H0P!&^6&Y5"H"*V'?2/#N.C+
MJJ%(WW=)OPI)IE0N@6S@$<8LK=' %G2Q3EU0CS0GLIW+LJT21U=<RK5(DHO5
MC"GY"FR5(=+616I:,F^TE>!ZC=]#MPUPPAZ]B:$M.%/57<[^MQSWM7!CN#7V
MCZK>5KH#;O&\9I]@:(]OL'"EU.IY@@ G>V(MB)"(!D$?.T=I"<HU!D;ZE5@=
M',<$3("%:BCS=U=ST5(@%8IMD XPGE1NBM_[;U7EUNU4O7F3+3A("=+!TG46
M5B$*Y?*6NF';F*:0 7D-9#IC75K3ZL-YK>=[:H1QSCN\,4!HU,#2R;SNK>_5
M7,=N<9()+O#*,9CVJ""*IN15HV#L-QK'M*%A!SX1%,GG3-'SZ]M%XJ*N>2,F
M>9<0,;V#,]B"H<?$HT=[M$AE[COV;+]4+CB14Y*MJ?\.:/^* H&A:1_I+FZT
MO3B)2.H-X<]W4_.5#T86Y]>)-]#^ BT8!%C A%M0AVHX\[A'<UGI#OT*C$W+
M'H!@-2]:-&P&#R),J' APX8.'T*,*'$BQ8H&Y[D[1XQ5I#MGQJRY\\?0)E.T
MB$4C1FR7J3]CSAC:A2VERH+G;KIC55#4'4/1YEDD]N=,25%@3!6<25#EKETJ
MGT(E9G$JU:I6;Z:,1FN3(5&[:&GALNDI0:L5EZYL2HM64ZC1-FT29=)I4J4$
M[Z:E94K4IDB&WH !<R;DGTB13#UM^I461\.&'D,>_*:P*%9L%:.T>8YF5)0,
M4YYSM^:-3&+NS"+$&Y557%:L1/U]^6<V;=J&;^/.K7LW[]Z^?P,/+GQXP;O&
M.S]]<^?^ZZ8MIF>B/KAY*3968RSO,K2&WSQBD=:LB23SG,&[$-%F+A[IC7AB
MF_YLVI64<_2(-5.^-G0G4E^_D(<#&*"  _)&4D=O&,+*'UALD<8?F(12C83>
M>".AA1=:-)!GFTFUR1WQT3)970ZA559])Z(XE8D'T30B-C=ADUYY*Z:D5U]K
MG*$<27)9QI@HD?SQQD<('D:+9EBU]>)-YQBIE7[$D%?1.0H:HM>',C5DG)8G
M;IGBC%JBAQR88QIGD%,S_>65*0QN4I!G7BYDGD$P*B2G72UJ2=:7YI%7(RM[
M>2C2;)"1%)<IV$'%&*#^_7$'>#V9-!^8"?&)#2UCD';:=&/^JJB::GKQY9=A
M+QG2J$B&W :9;02RVJJKPJ&:FURIY8D2,2<1(PJ"N\#VAE1T1O<K3;3 9]EW
M_/"##S8_\L>*?.7I>=9&<)G4DB@G$?35F7 F1-=,&S&;ZG^ODEMN@+7=X2@7
M6+P!(2R]7!AOO"<*]88H&WU((E--:<:MO_]^NR]FG3F%TCGS(.R.5KJ>\=$9
M^[&RD2D3BU)QQ4*N42R4&5E4%D'?/2OE+G^L08M<50)L4%KW%<?98FLI%K/,
M,]/<5,?("2PS2DZ%1K(I+ 6V"38*[Z)15':FG'2=R"D&JGY"C@&7Q15/?&B/
M'#D:V!I=78TKRRFQ5))I"D>,<XK^8"MJRB9O4(%%3R.9!)>Y<]/]:D^.%?9S
ME@9K%<TNDQVJG2G0H<AA>I&,<5)+R2++SSFFO+$U+:%A@YE%K!R\BZ,_<W58
MR"O^ZRV,*P&)*EQ]Q5JWZG6;>@<86IQ1<2CO^B*O[=6<>([F9Y@RCU%>=S:I
MDDH3;U9:'H<I\U8D.[P?7S_/IQ<87("1<23.;LPQV"%3A#S(+D:DT7>NZ<I*
MTBN&AO!&EAGLCL)KP1^__//37S_P1V?)Z9(%!>G:&UMPX0_.8DQZPE2\ ^Y)
M3$IR!\+4XIH_[:54Z1I)97;AFF@P$!N0XP),(E&9]N%C'ASYF;9B9#8NC6DC
M0NJ)HW3^%"NIR65U,IRA82;SF$%=JR'\HAROWE"2O_RA:$8[D3LL:)K'K6$,
M/\'&)AK7. WJQW.)D8J4LA(-R-WA-5*+6'G.!SJ#L 9UA*(A&5NEG2UH80V6
M,<3L;E$["MT.0_79#$\B<:N>0&E)>KP33;:%P#_:YUGN\]MKQ#6;='G064TI
M)&U.E<B).:L@[L '/J*TE,50L7LM^YY%R&.*-?Q,%&,8' *3LJ1OK05[.%OE
M*FM6,*;5K(#'D4\T_+<<5@QI$T9ZD<+0!RQ IHQ,=4$+OU1#%K_9"$A!RM@F
MKE:UO?CE#I'#T1D$.*)5HJA+*J/%8^ 2I-8):B2I*R,Y757^&,>0A(L,.1.,
M6M),GOP!>B8\D;->Y)V0_,Q]IG BLD+HG<C]@18O2DG';!*CEF21-:A"#/&.
MXQ:6:&<P=RLG18&SB3.$93\DV44O>O%&.,910BA2"2O^<A*0I"NE*1V)Y\H$
MS)>2:"O2% DZ^<,CU_BE4<HY)Z(DQ:(^MD5&5?'>&K@WD9NP8@WQ$0471)&T
ME3#F3Z'*S>GD5JZJ8C6K6MWJ5M=BF(QMY"4[':.AL <^F +LE":T4Y06Z+XB
M"C(C*R$I5TXE-ZD="GY-:8D+#8%-%!I3)<NZG@4K<SIQC;.BBAU.2?8B%RPU
MA#Q/T8]7/Z25B)VU*B?A5:-T28O^2 ATG_QLW#Q&%A*OO"AF0F7(*ME#D(O&
M9'A\S"R*W%<Y4P#I#9-9;#EK\QC^>"B)F(K/%P](Q<_&<V@$.1@_BVB(EXP%
M*VFA"]+0FC_.U.0@_!I>C; U$ZSIEJ8E<>:/&H4C4/:4EUX\ZTGF<0Y=1<(=
M]FOEK5PRCTV )SY!-4]@!6O"KT#PAJ;2+9$,Q9;J(H1.+FN+B<C#EOLH29AZ
MG#!VW?*9/'ZV)\ZZCH.Q=:L_O4=(TSM5K"QF-=? S%MNE:M0^W2<86'&1*XL
MH(4!6>&G@!$V7!@#9<X10KTH$K^CF8PN,^FWF T3NVMYT[<R>^.G4*QB5N4$
M)Q)AY3_^Z&$0@[!R(@I1B"QK69R$4E5M:)-8WNI&@A,TW5\7XAILX(,8'_F9
M?LSGCEO]RB)"M&"3:)$3(?G5':) 8Y5$.UID#00V><OD3VF[2@6Y%AMI*ABG
M ,;?Y>T6S63<;<4Z<@8.AN1Z.],),/$1C8Z %L[\I"0^^%G:OTQ&%$E&,%JO
MF-Y?SFF/'^[(&L PA@]M]C6' I2:[6J2-[79TFACC)$BR<V'-6E,KF0+-\>0
MDU(AY5;EU>V0P[O2RPCUP67!B5UR?1HRS75#;\6(]H!*W;(\,][]T8U<XCTQ
MR":$&":1*9%9\0;,D>=@K0XJR^*W7_=)MI"E4HXCJ75,O*#^&-P$03B+_ NM
MZ>Y726TM)<Z^\A-\,) 8:^#"H13-G](U\S(@]O7#/'<P!3/%PR]3\=(ZOI@'
M3BP4F-CYSJF<B$'H=A!Z*$0BJ,Q599:9I9HN4*F4+K83+H1?N0+V>U*M$9YM
M7"*VVA8W_7*O:(@B1W\SQ*$.W=R2SF8L_0);0UC)68B98J&1-*[!' R;,R^=
M;JB3)C7#4]8#P]0]^6HUJUOM1%8C;!XAE.]LY&/;[%I7(<?,-49B9#(@]43-
MZ03RLW)%,@2AJC+BAE'+_.NRM:PWP9*52BWEPDJDE[E0=]#"Y3/VP ?"3)M^
M2S>8D).:G-'L-7Q!W6S>,(;C'[_^80WS-DOA\LJC"9-,%KS] SW4%1Y!"1L/
M0]73>J+\[S>,"P 4C LCQ^FY+(;!28FY5.'2='#ZD&IY'=BX;6O,[=K8;*<Q
MF4Q&]H;+)Q+YC(9XS47$@=C"V5!)/-@.(=Q<79C9J(9BW,(MT (LU$(H8& &
MZER59=E.)=T'FEG>,9UAR,6#0=W2+$]\M$1+E5O6V0?@58[UL860#<Y;[ <M
MF%US>=Z'1 JTX%N^K=)-[,[UX%8Z18-:!=,U?46XB*#JZ =X6,^U% RS_80+
M$L^NN,/A]1.[S</A=2&R/,Y( -RM&%7D55QAH0YX)&!E0-!EF$R0W%#D0 S-
M40JM+9C^0"5AF$ 5B)D7Z(W98US&S#R8*21.4^S'++4%Z1W9@:E$V@R?5:E*
MPZ@AB?TA9#03=E :+R%,X860XE'2X7$BJ^5@#H9B*5)2XAE>*MX$XK';6Q$>
M1AA.<:P$B.44NDR03<U=:/@24E&,W C8;P&75X .KAW0D^V+3I364/R!=UP)
MV#P'N#B&N)"@2;1?3NF6!QT*P3G97Z%'4U2(A?A"1_4"+&B@!L(>",9>$_*&
M@=G*"2K$+L@@3Y#=N]'6>9Q)+3W&M7P6>(@"PJR%<NS"*'XB=[@'0%V++/X@
M0JS2<B&,*52/7N3->+@@K5W%Q27%5O@'WJDC< !C3C4,3=W^E+,<S&E 7BE%
MPU%D(<AE8;(,A(<@2,1,$K*XC^+QPRZ<@7C4B!\U6CW&R5"YC"EL@:\Q4S;Z
M%(S\B$=0CP\9B25EQDR\$O@0$\%U1GW48R.JC9J5E7PH8@HEQLSH&QA<8C6I
MWT5.TT=,3U *BDU9C70PT"8.Y"C"93_%)4N^U5S:Y5V.EN$YD5N^92>^I4 ^
MSJD<H49TVE^< 1@ $,/AXLYDUY)HRK=8QL3H!TM9#3T6H]EL1M'<%TR@1*F8
M3UOAG^4%8F&1#(_]EN@U!6QXA&Q<RVI=G)ATHS=2"$A)B/NH0S7X BU<((38
MV\2\!PAN)%65H&<DFU+,B8+< 6+^&-^]! Q//@1H,,E0^,3?1$WFU*!N!21>
MGL-.%1E%DLB<'!20Z%+<L<<1O4B,:$N26!I+= 0E!F<M*MW)]83[&1\7:$'S
MS1^C<5S=U1*08 -+RB4K2).]A :Q9%&K?6&KR=D84$_#,.CXY4C>6 ;UW1Y4
M.N=,Z(5?K($6;,&OM91[W)2X/8SY70]'@(%3[=Y**$TWP@]4-,TNZ8_?K,T8
M; $6%.*;A,9;<8@#(1P2OE5&M!75/-?_90<76 &#5%,SR<<FXF63WJ5?FETE
M,9!>]A.5DE;B82E-.NF6'EJ68JD>36GC-,$'0 $^S, 0<$&4\ -LG$,_G0:B
MK05W_('^%N@6%U !%%B!@%+++DR27"B>=T1"C!S&K3!*2K'''B&$]NRA*2A8
MB;"5X> ,!MU+Y*C)':"H3BZ$VS%&7SC*34*2";J'\FT-8H3&A.G1PQV$.*IJ
M1\41-+"?E-4;7ZB9\4D49>S%H/QAFE4BH:"C;Z5.8_5454;87&E$D-S+)H!!
M$*7(V"B( (4(: VF%6%;DU:2@ (.+1649B"3HV .+L6.+CY9RB0&7]G0>[X?
MKOY6J9S!%@1E//&(N*'5N:T?1QA"FPYD%UX42 C-G8G"'XC"2H;0*1X4U:B<
M:]@;5_GB@*DA@3&L2*P4-C;)HO+%!#5?Q>S2\J3:E=2$Q0'^#"LID%,JE#21
M77[BQ8))I>YAES+QW4?\&AM>B^(Q4)1ZHBAR*2J:XE]B!%^>8H[.[%\FRRF"
M8N(YJ4K^Z$S>[,V2XM%2Z2>: A0< 0K\P!T@ 0T,P1#0 "W<P S<P \< 14<
M@>[\'\AU(9R)[3E$ I.PCX+T&MF-AG9<8ZX@ABSYS2.*D7ADXI*D&\:E&*49
M8V.^AD@<BE^83XLX1"OI#%T](9'E%?Q T_LETK,@JEVLJJK&T3?,2%Y06U0Y
M5JQB'HY@"L7^QQC=!E> X*YV) R5H,05%T(<&)C,QK680D\(E!5215+P"C9R
M!6JYF$'T:Q,YZ;6-A)+>S(9$";'^P 1Y_(4N/1]4B"MQQMV@F&O2I8N0< $'
MQ9./P SDT:[2*,PQZ<4;1 /A(1H_<),TP8>'C,'9-DY,DF^'3L: A=.X'$9O
M+N[>OLS\[$4D$9)JKA3TIEA30L=F()0HG$/NLAX  \Q^F1+:-*ZIA!X,D@BZ
M?87:6"/##4JCS,41?J'CQ"3-<J&65BF7<FDI-@[-!FV/?@G\&&S5]$:]V5N/
MS \M34K1_BC21BDG)AX66&T36($('$$+K, /W( ,_, ,8 $4"#$-S  MG&D3
M),$-*'$D#($2-($26 &RW&12* L_O(BR+,@6R$?FA1.Z_M9X7<;4'-8EPJNI
MVH7''F'^Y2C']8@"*#E4X>(,HMY%J5H>!9=*Z$6<HDB9&%F-N!7$Y(ICY6Z<
M0V'<$CJ65C%*Z^ J<(E1KJYCU?SQ\VF3Y%$7AB85:+6$LB[KG>6NR0#;8!JG
MI93*""^+^0J-M$S>0*W-O]52NK"/I.@GG*Q,MIA<] Z8;AWFJ%+;GVCCZA8/
M(;'%0!%#4QW,%R;H6R@'YEAI3(*=5S 0T3C%SA+27C#L-@?&2XQ&Q4Z-Q; %
M3XR!8!1+?^FMYL;(&W.$T"B('9'D.J=,1BR,8?Y:\![;>0K/>7Z+\AQE$HD?
MA_Y:,V$0P"[>DOCLXFFI2B9,6_9L"2=,:(CPSLZ$0U.<GQC^[/ 9@H,&1O4"
MT& 0AEI27_RL4E11*/VJC4JIE/$A7TN7<V# -$QWVS9?(HH5##;,@RDH 13X
MF!+, ! K@1 K0=;^P HHP2Z(0-6N  JL@%&+@!)L@=5B 0G<P K< !100=7^
MP"Y@!!?\  G,@ S<P!VLHL]J"-;0*!9@@41UQ4F\2&Z\'QL^V+#J'T%L03R9
M*)^JAATS#;@MT%S-QTI@D%;PVJ-4C<4<EF%45<48,JO>CN7&2:1RS 3+#6)C
MU9J9CEP@[%;M&[@]W#YG:E-.G0"55')FYH5*Q"[@@^8$5*CJ39_PYU^([19:
M:0[>&6YMSLN1X?:V'17Y6WA8D%+^+AE-B.NV^ UN-0JZKLH,E;&L)G?/I<$7
M?$$:8 (L[%P&TH)'X8X90L0<]V.R9.<6@G _&42R?-(?Y*$P18>;2(50@(%X
M[,7D  451>7]QC#TE<6T_ 444@VB)(94?1!Z9@8T8E10;E]<J#8GPF5ML]J/
M\F7.CG<G>N)<VM^'1= R'69 JS6'4H\WBQ,V]HC<HO9$>&R)UUAHPY("$W-7
MQDPL0\U9CA(R8<,/_,!*0('3<L$=/"T*D  4H,"-;RT4?,!_8H,2H( (R( (
M( $!(_$1F (^?$ 3S  *W, 1B$+ 2G0)L^(6*JH6:(%@[,?/Y)%^1TZ2,I1T
M,49!!%#^,WG(\I:XN$)07^C4O[GA5;H.F LO7/W*9A!0Y/)15.C0S4$07_2W
MN$%0;U*H:R1D5<B'$151Y/BF!TDDBM "/I2*+K'"B696=\!&!X?I70(%2R"(
MF#-9[?+*%OG;&,B:@!?W?!161KY?1\H0F7UX)'#"('S!& P")V "E6$@+&1W
M[52#-W W1 3F&_1.7H8BHBF>@*),L:O(/+W%UO *X+9,C)D;D*+G_0[ZZ=P<
MO)Y;3:2/8,%(V$S3?"H23NLLE[:EE=ILTIIP)2'310U@\XD*Q!9,5FY()G.&
M=WK)0@H3P$??P+M49'_LLJ&8I/E$]5Z*4G$031'F&1"#(:S^M2DD 1(,01,T
M01%G+1CX&!+, !400Q(8]0S\0,7(I-@&+(-+>$.?XOO\B"$$QI5<G 61;F%4
M%<7#!T\4528>1'%:6EZ@74J1!#7B'.FV4*J1I/YZS&N.&S'^U+XPKDV_2<#'
MTHDX!5W<DR[]B"YE!<?4AU1(Z$7AX4+P^?6D9(+6]BAB1&[Y*Y:,N'0$S$%=
M^L0F"%,$4U,RL*PVG:S/NNG(.8Y(=[OT>B) ".5."(5 >^%."7;Z#2I>:33?
M@:KS]N+OS5W(U$8$B7@@G"(O4C@_HF+/Q<;*R)+0'#)EZ#+M%*DML^*!<.&-
M-RFVHBGV+"=JCP6IC8> M"-YD%[^J5;-PP_,I04_;\^D!TRI<XN)*[_;U<RL
M$?/QXT\;KTQWZ,[!Z!O/X-:U\)H6V*@'19'!]D6_*LL\4($05WDD6,$-)$$(
M<8<GQGX)&^W:CY9[P>. KE0S#?@$1T)@.(OUQ:94 @0Q@0*Q%31X$&%"A0L-
MGG/X\%PT8KM8B8IDZ,^?.W\BB3+%"B0K6J8BO3ESYLXF5L2P17,Y<"+,73,)
M+G1Y$^= EP4=ML3Y$V@TAD,9SA0:;=.:.Q0C16*%[=Q,J$2I'HR&T=3(/X:$
MVG1I\2D^?F/GS1M[%FU:M,1,_7GS9Q.MFE6MQBRX2]2=,\3<&3ICB-8N6G0)
M*PPJ4+#^J4T8MQIJ^AAR9,F3*3<UY'C319-<U&#2,P@3K6K5>L$:?1IU8=6K
MJ\XC%NF/*(D:#9G:Y7(7-K-G\?4V]2822];#B5,])_#F\359%6\R)91E1%JB
M#*T9P^7-)E$> Q,3>J[@2YKNR+L#'TUP1%:1](X9 \8V-G=B\<V;S]N\0W=E
MQ:KUSV^>_O[KK;ZRL)G(%$/>&&,+++@X8XW8=CDG0'=NFH@66D0::";!,H0)
M1(A$#$\\FE["4$/ABJ,*1)B@$K&GH$YLT3L9,PQLEQJ'DHC&:" ZB,)H1'&'
M&/!H(5*4VZ8BAA]\:($N&GR$,D445EP: XHMUM!""R[ P";^. M9XH^L_0CL
MK:PT Q1PP-[(B@B;_FC!Z(TZ#5$I1UK&V.1 DYK23J0<9VQQQ:IXK/'"K+XS
MKR5WL,'+D#O>N...CTRY]*/ _AACC;><"\Q'_7YD"+F=# +*H(DZ7!515 LM
MR#OP?JN4EJVL]$FBKE[=90RGUC/$NZ$$LDU!4W;[#UFTW*&%O3MJRTTU53NL
MD1A1.!4J+T.@?94A5ULB9CJ-MHHDL\K,/5<R!<'H\B]68 GE%E]N"2647M2)
MIQI?].V%7WZY_9>H7=XJ<E/G;D,OJ34V(<8L? IJ4I0( 9ZXL.-TQ,>=,\8P
MA)6VE(HTJPY-12@G5ET\,-PSN,#^PI DSR$P(OKLHQ"M^O1S,]ED'=V%)(VL
ML,+!,=XBMU7O2@W*PPQ-UDE&&5O4E6+B:!QVDZJMKEK!.K6N<XVNO?YZZ[ Q
MJS)'H@Z=^FCT:$'30A\EXN=;[]PQI<A06=F$GV@&BP:DW'+,S9U=_IB2EDWN
ML':+E;$ XX^/ &<S9_SN\Z\^^FP6,B,L;#.%BS%R0T\QMR!$.^J$'B+Q0L$$
MI1!M8E@QA,$MSHCKQAM#BJ33.R()>>2$<$24Q!YMFAKJ%7V<9Y<[QA#E'$/
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MC[I(>ZZ#R?RJ2OKN(P]J)4[H4?(BO>C1>;B@R49OTEY// U!+/:#-?F!5]Z
M86X1%#5/4N2S&3U-M11B/IRM#Z?#2C!+]V:'03IG)GT$"I! *_&&'[I0"5I
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MDS(_L<?.T(ZVM.TGF$F>X6 *>4.9GJ13"=_-9U0-]W)X=I>3*(:J;LMCD]>
MMM&\DW^4GMQ)+"DEA.(E&I$8@Q:T(!93;-K3;?KT+=$23&P(2 M8L"%(4!.4
MJ&Z+)+EY-=OBS6W(7% Z>?V-0%C25Y)@>,<2.@DV\$&,F!SLS.0JBF%GU1/O
M81FQ^$#/L41A68%3#WQ<X:A,*A5R);%B(H-=SOGZ<L=I@Y%-N0VE4\RG*Y@H
MD3K>AAZ3B#LE2RV[+#(AEP '++/^GX_.7K!M;*.Z' V8=V5S;.4*Z\IRM0=I
M<JF?HFFYSQE:$_'NS7"/.A]YQ%5LA @XKBL-U5+$L8?RK$WMD^)*A#)?A43G
MH@@Q'(KT9T*N&_WRF,]\1P16(VMC.\[;1O06]?[V_QR>1IO*949D(YMU;XG8
M9<JOJD"L\$SQ*]R \LU=#*,O@:#G#9L 4%K^'6.T"$IDRQ7U&-[0&WS0D$1I
M3>"G:,,XS;S)7D-;&3>73M>9Q7M=\IE'(S/H2><6%.12J=)&4[.+82*6@\62
M26J8E5SJK84KALEQ-4GBJ_<XBG^-8A#<Y5::%QA%0CH=IDPMA"_[XC-;)WJU
M(7T7LB?^="0GXK%U)38D$842Y;$_DJ0VQD$]D046I:1=+;(ZQ00F02(:#'4B
MX 13QG,[%99%;8(QX[42I.$3*+$0B*$O%I-A.O(@AG &%"123Q%:)E@O%X)L
MI#82J 4T!1B%4AAMG/=@[O1YVI9N$8:!A[=4YV1?YF,UI&9U72@K1+)N!](X
MI ,1HD(B*+(:!A% $\)"1S0DX3(@YL,_Q/ YRV(=G:8HPB1FH\-17<8_(=*&
M]<4:C>$D2V)#MY$;]O44-E$Y^R,4/C,_%?$0=E(>?'% PS-I?:,9?3$1T#$6
MW/-RU:,6UW-MY\ \(=,]-J=<7T:"3F&(;%@22@)K%$$+YL'^4"PS2Q"(>7F"
M8RXX$NW#$HQG20B21;XB*B-"$S73- )F'QB6-,\A:G>@*_)4'#"&6':"(?LQ
M,14B;FHT4V_D6G\R2S"%2KKT4&ZS=4F#3HD3-#]A9(:'([;G<4/F*,^S;#4$
MB0."'N]T( ^385HXA0B9D#U5A=1QA0D!>@?9;5N'B^VA&(8 !G($._X#1Z'5
M@S6A5#G2>B83%. F.9'&-KDA>2<R8L3F#HJ#552$)S4X:=ID.>"23\4TB\/2
M,!715;BA$E=3>45Q(6DR*M*'+FD$(&4B"F\@1[V1'QZ&:9RU$47A*G352/UH
M>4H2*,BD%C2V"__V?LU"3,5D",+^1EIA&3HXUQ7%47( 5&=*TE_O(A)[XQ!.
MT1('II#MD2*(<Q"-A#+9.'+X)VN=$77!&!L)J"]H@W:+E%195"-?TY1FL8=9
MX2;\I$BWA 5<T&7] 42SPH=_L3E#0A* D4WUI2L>(1N:TS,) F$*Q"]K $FL
MQ5)[$FQ;8"QV-1^UTU8?(9HS\B!VHC&LT#!"LP9R1$%?@0U <0=@628R66[J
MH9?2.9WTPY">]Y!96''6I'>XN(,\X2(7IC5<L'S\<V/FTYEF*)*10)(!9WR7
M(EL\8CR"$90MDD"C.2<Y,1\HX1-J VN')YJFL 98@ 5CL DC1W\%*6.Q>$P+
M@P5; #_^R5%,.PA I$)  92:GU&#.[$%3Z&$GJ1O!LH1;<(/-&83^0:62W87
M:+.5[P$N>&,0Q" R?YAEX>&)3Y$VU8**H8-9*&)C):4IMR) /'$PKZ)A!Z53
M>B4CI&-7-=JC+=B#/5B?6ODW$X9'."1YI"2?$N$@Z79JBX,-.).'7H>*,?85
M+OD'*,,266E4,VA%=Y*2)%(3LY5H&L9'2?I/*>$H*O(@V&<YR%AG;P<9>@54
MF;8GF 9U=@48K# 0DD2=COJH6_1MJ95!RR9!D-0;[5%0@#,AA:F=Y32#? 0<
MF,9-;PB'?BD>,7$BKX,;&_)*[")+_K$ZQ'!M<_.F*4$BKW/^/J^F5Y.CI%%2
M=4#F.G25-L:E.6GY/5TS'F]8(L"8'QUC$B8I=>=R3O/2&AUV-:\$K;B!IJ\$
M%%%5=3X54H^5-B+U!@!"3)\CEE>1@LSG0@!RK&8G?@;3,G@B41VQ=9Z$:7="
M0GUU@'FT4_>#4P33*#QAB^B4+V<34O4:8)D!-';JC'%*=5LWFBPI,,H:'2M3
M1VSE0</B0=?Q+GKR.O5YBUO'I<0V.QL)GAUC4ZK$5 )[/ZB1JX7W$,@6E.QA
M>I>4ETQR@<\1$QRHAZGY$?_S49!:M$;[-B66-+3PG2'A2?F"&/MRLHZICS,#
M4=R29-<'E$)!B7A9)VV5-N\2*H?^@R$^6!(24:^R2JMP(VEI83-/VA(Q-&Y<
MDH&QY39*^ARERAI$X3"9TQT;E!W<6$K2(7@415>0TV=2]C;Q4C >$GE#(V<?
M\36,P5%K,$[]4DY/J!+R%1^<J)/JBB@F,WF5.TB?FRC-0HR1,HHU<J]99"J&
MH"8"(E\ 8X<ZZT5(TR9X8SE2"1+ 48A4]YYPMW+X@6.I:AJ@:A_^@T5"-Q#G
M&:/&-7S(U6*$@DPXR!*"X5T3B2=9DQ)1*H>KQ[#?.SF+%$)-.9"D$A+7,B!G
M,[O9M#JRQ6?EU!P_\6C8!Z.W85?6TG:'>;3\V[_I9D9>(Q!CM'!NR'9]R9)2
M2R&#04#^.;*X.#/ 9(&M$K5JSF0R8$ 3*)*P;H6V9:*VF^2E V8?GC@3-'$0
M*?<Y96(X6Y(U,!AQ(D:P@<<7[?)5G49PTMM8V*IU6/J#<L,NB[1LADJX[6-"
M%'BQ%.1MW#(1S>HHP^,U-%%<[O>YQ22YB-%\I6L=7*%+/8J>%L*ZM=4>*I%!
M]?NLUAAA]B)J7?9ZS[$&8$"$99>"'F>V'B<]M-1-E#* ?>0@,^59#J2?X'@&
M8,"DG7&L#T-F61$> 6H%%PPL7_=JRI$2&$AW)V+"4T5O7.>I'H$;*6D*Y-D_
M.300_)$3_#!O?*86\P$GLA:7%'%^Q% >#8$AV<(E%&$G@?7^<_U[R[A,IT;:
M+8^;C7"2$ _I.C(+M3'Y-/.1B^;FOAPU/"CE)RDWQQ*!PHMS$ZRP!6=3BLG1
M+;':P9CZP8"S'-\E&M[W1@\Y>S[AM>6&2G629PDT<I/4.B3T!N3R;_#Z$76Q
M*Q8U$K!L0OL+&:WW.686'28D'JJE/:V\!I$ K?%)D9LA7L366YL9"7O86*\[
M'+A$?VA!/2-'RR;87_ZDHX!+G*?!;D[1G*-H?6[$E*\;F7\04N?\P8X37E'A
M&:6T6L1UQJ[S(8XL,%\R?=3'./*&77+ZTZ474=& D<C87Y8%O3)J'78"%'(D
M>(Y3M2BYCA1!)[NG$BMS$.B#NQS^P2.G%QL'N"88@C(2TS&FHD3&"R4&%:@-
MK8&Q(1 'LA3,XQ]LTFCZZ@ZG,8"YW-?]FR2<$B5Z<C+H44):LS4N<ABQN05E
M RZ'-G'AUAXE$A)#$U0,L6$,O7I% 3"T 'SCL2%T8A0E<1,0JBWLJ%-#J9)Q
M."K?EKSI!E&$8U]7\SSHVHU9IA-8MR4"HQ#[(DY$<;R0D5#$MFPNU1 T,1[;
MY$9MHTIL.CIQ5CX]<2<E$B*\O0LC^#UDZBZ[T%P9Y!7&]'(8/1^+VA(S010K
M2J4L+'DTL1+Q0Q_-*"9(MSYMN*P9-5HQK(04U\^KQU*A@F.3TC]29;6P!U*Q
M@7U#1ZS^ZVIS'W1VQ)VF_/R>?>0C2*>T/YDB^Z*,;HU&@L&EIID:[Z8XI2.L
MAAB1"!8-.!-\(L5N]TLP*C' Y?(8?AWC,JY"$+L:JN*"Y3E?! NE<#C=DM.2
M%N$93)F-J)%!1:1%3/8T2]L0C70'#R;:5D<=768QW;5@A*,8(S(I+C@NRVT;
M<R([.)1,K5H[Z.H=?V@<L.2!7G.7V2IE7P[C8#0E!3,NW+&H9E&%U><<]381
M9#&D\V5!^K*'AL%:D75_MG1<Q\2/J6$*5C$1X,U6(^,.&9RJU22*%FC>YC$N
MO74&.Y2XF[&"/3+?*5*>^74RHSI.7CJ5D9$01,=7;YB./IW^QXMS1#@AN?Q!
M+M(+5B^&KC]AG*3Q//(=<0H78%@E>:@23ESG62>M1^.&6BRE'S8KJ]R[(E$%
MK>.AWUQ4<O"S4;_&>1"U&$]1)P-SS#->[KG<3"%,4S]6.- A'<+:$%L#S,!L
MG*-F8S!U)ZZ<$*[<*Z?M'*^QBZ36Y$\>*E%^#E.N+7/:;4A25**2$D^[VH8G
MM?'AR+%!V)%DVZ(SB\A$Z<L16()7C01(I5T($M#1&ZR3+VGX&)ZN1S[R)DYK
MB;A;8 &8GR&D.I2%<R+(%B/*#YH+?;2 Q<)"+1RK=B3:$DQ)1(9EUV=;BD.Q
M,,Q74ITE;O:B'P3!&B_!@W$8B@?^56 TLR3IK!CV!?-U.RM)@TDSM35 \13S
M7*;&.BB3A*98H 7:L]'SELI4TO#HM!HM(QE\K$I%T3XHPQ@1T:<DI*M.>.38
MWD6ZX@Z;(!;AX=DAO,H$J]L^9NZ6_]=OCE25L8Y:HQ@J,T<C6SB)#7U(B#(H
MOA+R!8H9WA[__O9,OB$#WTST8? ]@?#2^D75QS;L:$4LU8*PI9O9/%T(4X.D
M$V=GH$$C QZ@0\N0$J'O#&^Z1SH^];]+N7%G(R"N1.7K=*^<<2<M>#9FQ"FX
M.UAJXC5OP J5I:-WL?Q> 5"OTQNQ*#I,34Q:D>]_X"4_=3!_42R]Q'MG4TX
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MEADG0-ZM] [ZVP9*:"X^>JPI)(M< A'D'%MH<8X!+;9;N>A1&HTFAA1T!EH
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:4[Y8(90&V:T@U*N9%X=;W%F#7^ZC-P(" #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>singledaydataa05.jpg
<TEXT>
begin 644 singledaydataa05.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 9      !_^$ 2D5X:68
M $U- "H    (  ,!&@ %     0   #(!&P %     0   #H!*  #     0 "
M         &     !    8     $  /_M#\!0:&]T;W-H;W @,RXP #A"24T#
M[0      $ !@     0 ! &     !  $X0DE-! T       0    >.$))3009
M       $    'CA"24T#\P      "0           0 X0DE-! H       $
M #A"24TG$       "@ !          (X0DE- _4      $@ +V9F  $ ;&9F
M  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8       $
M-0    $ +0    8       $X0DE- _@      '   /__________________
M__________\#Z     #_____________________________ ^@     ____
M_________________________P/H     /__________________________
M__\#Z   .$))300(       0     0   D    )      #A"24T$'@
M!      X0DE-!!H      &T    &              &+   "<@    8 9P T
M #8 ;P Q #,    !                          $              G(
M  &+                                             #A"24T$$0
M     0$ .$))3004       $     CA"24T$#      -(P    $   !P
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M1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_V@ , P$
M A$#$0 _ /2\M_4FV5C#JJLK)'JFU[F$"1]#8RS=[-R'57<]I=Z3'2]^KKG@
M_2=_P94\SJ+,2VJMU%]QM( =36; V3MFS9]!J6/DL97M++"0Y_%;R/IN_DI*
M6]&__05_]O/_ /227H7_ .@K_P"WG_\ I)..IXI$M;>0>",>XC[Q4E^TL?\
M<O\ _8>__P!(I*6]"_\ T%?_ &\__P!)*EU/J6+TK[.<]M=0R[ACU.]5Y&]P
M<YOJ?HOT=7M]]WT*UH,SZ+ 2QMI@P?T5@(/FU[&N6+?7C]7ZYF5Y;++<#$P_
ML9I#'C=9F#ULW?L;ZFYN)7A-K]_Z/UK4E)>C]>JZQ98W%Q2UC1ZE%MCRUMU)
M?90,BC:Q[MGJT6^RUM5FSTK?YNYBTO1O_P!!7_V\_P#])+.ZKTVK)IJLZ8VS
M#ZC@UEO3GM;;52WZ#FXV152&UV85GHUU65O9^BJ_FMBN=,ZU1U'!JRV56L+Y
M;97Z;R66,<:LB@N#=K_0O993O9^C]GL24E]&_P#T%?\ V\__ -))>A?_ *"O
M_MY__I)1MSW!Y# X-:&[AZ+WN&[U#O=6TL?Z?Z+]SZ:A^TCM#FN<YIF",:Z#
M W:>Y)27T+_]!7_V\_\ ]))>A?\ Z"O_ +>?_P"DE!^;<QS6D.=+BPEM#S!&
M_P!S@+-^S]']/;_HT2J_(NI-M;P !(%E-E9XW?1L>U_=)2WHW_Z"O_MY_P#Z
M23EEX+2:F-&YLN;8XD>X?F^DU3;F,+037:"0#_-O_P#(IGY+'@-#+ 2YNIK>
M!](=RU)3_]#T#!Z@QF1G4Y>2V:\DMJ-A:P!A92]M-?T=WI.N;N_XQ7\72J/Y
M3_\ JW*EAT8V5DYQOJKN-.3L87,:2T>G1=&XM_TCO45O&KK=5):"=S]8'[[D
ME.::[BQKJQ[Q6T .OMJU K;L=57]#BW_ #*OW[$:JFE[G.R :G;=C',O>XD$
M@R=K:]K_ -&SW_SBTO39^Z/N2]-G[H^Y)3FUU]09;=9AVLMI+V@49 <)#:ZZ
MYJRV39[G-_2/NIRUG]!ZS@U49&5G6C%=U#+ML#[2WT9:[[#737EL)H>[9B,;
M^D>RY_\ HEL]2R*\# R,T5>J['K=8RMH&Y[FC]'4S^78_P!C%6Z-T3$P>DXN
M+;CU&ZNEC;W%H)=9 ]=SG'=NWV[DE-\Y6-QZS)_K#^]<F,KJ=?7K^D]/>[ Q
M<S*-U-]K0]KYJW]2JZ>[]-34YV[]I4^K5Z?VS[5Z_P#.>DNH_9W3_P#N+3_V
MVW_R*H]5Z6\-Q\OI.-C_ &W#M]1E;XJ98Q['XUU5EU==CV-V7>M]#^=IJ24E
M;T;&J8:Z?:QY%ECM[Q8^P%Q]:^]CO4N=K_A/W%,X&]YFQY(#06B^T   ;=&V
M?R?I?GK"JROK1F8]_5L?'KQVXS@QO1[J077>B!]N]/+#FV5V77^O1A/]+TOU
M>BVRK].]#Z;T3$^L5N5]8/7S<-F;:6TUT6OQI9C[<.B]];=EK;=M62SW_P""
MR?\ 2>G8DIZ$=/\ :T.>7E@@/-E@=PYNKV.9[MKT]6 ^HN>UY>]S7,WV/>_1
MQW[?<[\U91?USH;"<UC.K],IDNRVZ9S*N=^1CM9Z&;Z#?;99COIOMK_2_9[+
MOYS)JZEAY&;;]9[+/3IPL\8=C'N<T4X+JW8K3D8IV>E]HS[_ +;9ZU7J55^E
MZOI_9[$E/;MAK0V9@ 3\%&TC8-?SF_\ 5-3BND@$-:0>" %&RNL-!#6@[FZP
M/WFI*?_1]&LZ/CO<YS;;J=]OKO%+S6'.T^GZ6S>WV_G+('6L=V6_$IZC6;MU
MKVTMMK+MC;+&N=_8A=!E-RW,;]D>RMX>"\V-+P6?GM]KZ]K_ -URR3]6>D9;
M;;+L'$L-UUEMA?3)<\N=[WG=[GZ)*8#*RW %M[W!VH+2T@@\%I:U(Y>4&[G9
M#FM&FYQ:T2>/<YH:AN^I.%L953E9>-0QP(QZLFX5!@^GC,J=:[TJ+/\ @W>I
M5_VG]%./J7T]]OJ9UC^J #;37U!QO94#]/TJR6-WV?Z6WU+?W$E./E]1RNOW
M#IV'>ZWI +79_4:W-<TN9LRJ\#&(V_I'_H_7R-MGI_S*UB[*)G[9D_Y[/_2*
MMX7U9PL!UYQFM8W(>'NK]^QI V[:*VV-;4S_ %_<5G]EL\&?^"?^EDE./==G
M5-#F79=\D@M8^O<!!=/OK:UWN]GTD'[;U(@$-ZA&XM/OI!@!QWANWW-W-]/^
MVM[]EL\&?^"?^EDCTML<,_\ !/\ TLDIQJ,C-N:YS[LW'VF VU]<G3Z3=E;_
M &IL.[-MP\>ZS-R"^VFM[R','N<UKG:>C^\5H^C1N<TU6>T?2%5KFF1_@W-L
M]W*'1BT8U+,8TWO&,QE7J>D_W;!LWMV6^[^;_P &DI!NRO\ N9D_Y[/_ $DA
M>@=EM?KW-9?N]8--;=Y<-CW6;:?<]S?SUK5]/8]U@AGZ-^T?SG[K7?Z7^4I_
MLMG@S_P3_P!+)*>8HZCU#HE1P\AN;D8-+@W&SZ6UVQ60QM./=BT 9%;Z7_J[
M?3Q_3L_G$?"^LN9DYN/CNPNH,%UM89ZK&M!KW>^^W<&MIKK9M?Z?J>L_U/3]
M/>NA'2V@R-@/_7/_ $LE^SQ66O\ ;[7L.F_]X?O6N:DI_]+U#)N?12;*ZG7N
M!:/39&XASFL<[WEK?8UWJ(=+[:V;32\^Y^LLXW.(/T_SE90L?&IQ:A32"U@+
MG027:O<ZU_N>7.^F])2WKV?Z"SF.6?YW\XD+[#/Z"S0QRS_._G%*FFNEKFUB
M YSGG6?<\E[^?Y3DJJ:ZB\L!'J.+WR2?<8'YQ.WZ*2F/KV'=^KV>T@:EFN@.
MYOZ3S2]>S6*+#'&K-?A^D3U8]5+[7L!#KW^I9+B9<&MJ]H<3L]E;/H),QJ:[
M[<AC2+;PT6.DD'9(9[2=C?I?FI*6-]DD"BPP)!ED'GV_SB1NL)+?0LXF99&O
M;^<5;(J;BY1SJ,2S(ON&RTUOU#6C<V*[7LI]WIL8@OR+!E59@Z9DNL=6]CG!
MU>Y@#M&.J]?TG>KZ>[V.24R=AML)99CN=Z@+GNF!((T]N1[7>[\U$HQWT6;Z
MZK Y[8<7.+P #,19DN;_ )JGCM;E7#+MQK<>ZKV,%KAJ(/NV4VV5._G'?31;
M</'MR:<I[2;L?=Z3@YP W#:_<QK@Q_\ UQ)3"EUU9<74O)M>7&-@ T#?]*[]
MQ$-]@C]!89,:%FG/N/Z3R39&%C9-E-MS2Y^.[?40YP@R#PQS=WT/STV5@XV6
MZIU[2XT/%M<.<V'M,M=["W=_5<DID;[!_@+#) T+._YW\XF?98X;?1>/<W4E
MG$M,Z/2RL/'RV,9>TN:QP>T D>X C\V/WDLO"Q\VH59#2YC7!X <6^YOT?=6
M6N24_P#_T_551JLPFM(M#=X>^9;)^F[O"^8TDE/T^;NGQPS_ #/_ #%4B;_3
M>!D8AL(]A^RO: Z6^Y_ZQ9N;LW^S_P $7S:DDI^DC9DZ$/PYD;OT-D1^=M]W
MTE%S\O< VS#V]R:+))GR?]':OF]))3](MLRBUPL?A@P-A;39S.N_<[Z.Q'Q+
M:PQWVTT.?N]IIK<T;8'TO4W^Y?,Z22GZ?];IW@S_ #/_ #%96*WJU6,!D96'
M?DA]I)-#FM+'&<5GLV[/39[7^U__ %S_  GSJDDI^D0_*VUES\,.G]*T4V$1
M+?YMVX>[^<5NFW#%3!=Z9MVCU"QA#2Z/?L#@7;=R^8TDE/T_ZW3O!G^9_P"8
MIG6X3MHK#=Y>S;#8_.;Y+YA224__V0 X0DE-!"$      %4    ! 0    \
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M P,# P,# P,#_\  $0@!BP)R P$1  (1 0,1 ?_$ !\   $#!0$! 0
M       ! @@#! <)"@8%"__$ (40   $!0("! 4(#@\.#PX#"0$" P0 $04&
M!R$(,1)!41,)89$B%!AQ@3(5%A=7EZ&QT4)2DB,S4U34U=98P>'2)#0E-94F
M5I8W&3D*\+)#<Y.4539&)V=W*&GQ8G*"HF-$A+1%I4>G.$FSTV1TI&5UA;5F
M=H:V2(/$Q5G"\J/#IL9X*?_$ !0! 0                    #_Q  4$0$
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MN[\$^J /?/[Q_P" #;_\9EW?@G 'OG]X_P# !M_^,R[OP3@#WS^\?^ #;_\
M&9=WX)P![Y_>/_ !M_\ C,N[\$X ]\_O'_@ V_\ QF7=^"< >^?WC_P ;?\
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MGRANG.8X"(Y0:+:CP4&U*%Y8".H'D0H3XR ("9A2($$!*0Y1#I(60#Z@AI*
MN.<L@^IJ#I.8DF(^$?# 4A7),0[)28"/SHA_H0%4#E$ 'LCZ@ ^P@%Y@^Q'^
MD" .<OV(_P!) '.'V(_TD <Y?L1_I( YR_8C_P!3@#F#[$?Z0( YP^Q'^D#Y
ML <Q>'9'_J>D <Q?L1_I @#G#[$?Z0/FP!S%^Q'Z_8! ',7[$?Z0( YR_8C_
M $D <P?8C_2! '.7[$?Z2 .<OV(_TD <X?8C_2!\V .<OV(_TD <P?8C_2!
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M/2(PU\+6-OW8V_\ ?B /2)PS\+.-NK^W&W_OQ 'I%X5X#EO'$]= O"@<=0D
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M\P@'^AQM5#CM\P[IQ'WO[9#_ /3](!0V=[5I2]'[#NG^#ZV/D_I>, ST-=K
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MCNF Q[L)H]*HF#_:JD4]G3:=3,A9'94]BR;I-FK)HC=%132;MD$BE311(0H
M!2@!0 )0$WI!U>#UNJ __]/OX@$D SF :Z#IQ#J& HG:MC@(';HF 1F/,F49
MCV8I3&8:CV8\OJ:0%/S!ER@3S1OR@0J8%[(D@3*,RD ):% >B :G3:>D*HIL
MFQ!6*!%1*BF7M" !B@4\B^44 ,(2'K@'G;H$2/RHIEY4S<LB%"4BC*6FDH"%
M6V 1-EG=.0PS)[Y301((S+,UKT0!&0Z3& FZ0A$PY2%*0O44  /$$ O*7J#Q
M! + )(.H/$$ <H=0>((!8 @" (!)!U!X@@%@$D'4'B@#E#J#Q! $@Z@\00!(
M.H/$$ <I>H/$$ L 0! )(.H/% + $!8K',"JH 8P ",P #"  (2UD' =8"Q<
M',5,%BJ2[!'M3E,L*93IR 55!&8 84Y<>B _-'[Z+<8&Y+?UEFI-%CU.A8^.
M&*[<32$RY)41TND]73F)BAVSY=3G$) 84@GP@)(]S]WLU=V85-[A3))[FO;#
MMZW#1AH*"%5%^?%[IS4"-5W%N4QV95!-J^=.CJNBE( %.6?$(#;-_*(MY%E/
M-MV.L/XGRJB>[;GR-0ZY>%-MBO+EJ[>U&ML51Z#>X63%9,B;==^NU#E,7V0!
MI, @-"7<Z89P[N)WL6+8.8Z+<]QHG,G==']IW0E9+56@">HJHW2R<I*.ZJU<
M*2YA((%#B><!N$_E%FQ1&F&M;=UCRB4.B4BB4IG:=^4U@DE3'(G=50_M35C-
M6!$47*B#D3%55, CR@68\(#8=_)R=Q6;\V[7KZH66#/*A;>+KDM^T,8W8_2,
M16L4T:54'-5IQG*AA4<>TJ3-H3F$?)[3PP'1L 3 !,4H&$ F :@ ].L@G +(
M.H/$$ L 0"2#J#Q! '*7J#Q! + $ 0"2#J#Q! '*'4'B" 6 20=0>* .4.H/
M$$ <H=0>((!8!)!U!XH!8 @" 20=0>* .4O4'B" .4.H/$$ <I?H0\00!RAU
M!X@@#E#J#Q! + )(.H/$$ 2#J#Q! + )RAQD$_4" )!U!X@@%@$D'4'B" 6
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M-[(! TM0Y##S%"?1Q" N X!Z@0"P! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $!;N_T,O_2S?*@(=;'/WFZC_C)R3_\ 5=3@
M)E2'_82]> __U>_B ( @" ("FM]:5_I9_P"=& @]M=$??8W4C,9ADIKK/72U
MZ)*4!.6 ( @" ( @" ( @" ( @" ( @" ( @" ( @" L'9"F*L)B@(@F(%$0
MF(3(/#I@.6O^4;;R[>L[ +':[:5PM#7_ )#K+%S>]+IZI5:C2;"9M7KCE>$3
M,)6:E0J"!# (2.8A0GP@,5_R9VW,IMK'RI7*[;(-<35-R5&R+@4IK4SE6KE4
M0&K-:34>3SMXD0$B]J10>4H%"7" FQWUG=:7AODM:U\E8@<)#ES%K2NLZ92'
MB38A+LH5:5I*RE-,LJ4O(5%5JH9(#&D F&4!&KN?.Z%N/&EAY03WMX;L:L.[
MHK-(<6?:US4^CW0[8%I;1\=\[.Z[)PHV,N#E'R!. B)"SX! =.-KV?;ME6W2
M+:M:B4Z@6[26J5.I5&IC-)DQ8L$9=DT1:I%(5)(L@\F7'PP'HZVV2>4EV@J3
MM6[I!1%5/E QC%5*9)9,"B S(J01 0Z0XP'YS?>G[+,W;*]UEV9"Q]2KCM['
M.2:[7;GQ_>-BDK+#VL<5%P@6I6V]7I?U=DW24=J<B9>4GEB)0U@-95KU?+>#
M+SL7-:C6[J,Z)<R-Q42J54*Q3#W(E2'""]0:^<K"BJXYIC(YAF;FGTP'Z/?=
MZ=XU@O>UCEB[LNZF3?)%)MQK4K\L%PHH6OT%8#E:F63!8)NV2ZI1'G)S&"<Q
M@-FI'!1*7FD!N4.8 $3!.7 #<OE0%5-4JH")>@9#ZL!4@" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" MW?Z&7_I9OE0$.]CO[
MSS_J]\O)?K_LKJ7RH"9D@ZO!ZW5 ?__6[^( @" (!O.6<IZ]6L U7ZRI_2S_
M ,Z,!"+:\ >^WNG"02]\IG,)::VO1./JP$X8 @" ( @" ( @" ( @" ( @"
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MH,Y]I@O$!I#R\@6+;YC!T:\K 0F$H"\1VA;65R$40P3B4X*% X%]PEN#(#
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M&G,45;>(40GU:0%,>\DV^$$2"PRT)BCRC_>>R";4-!\HM#Y3>J&D O\ "0X
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M*J7G"93"<O, )  Z3*,!]A/GDAVDNT% O:"0Q3%$13 3R,0A ,43<! "@/5
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MIKDKILQ=,U4E6CE/F37!4KHABD"0*D5 3$/S@$^8!'FG 7;EZ\3$O8I(JAQ
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M3=YOS[Y&\'^(-H%)KF%-L[1[V%W92?*/Z0\N.E.%!27:O*LY.D4Q3(S%-HT
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MP*%)Y 'Y@U -)P'T8 @*:WUI7^EG_G1@(2;7?WV-T'^,UMX_<O1)CZHP$WX
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M7+S^U:)4[UN2ZF%K42S&-9>NE6=EU>HLWQTTW"KHSXQFK RBCAO)- 5 *(C
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M;BA,4G9E,.(:P8P$X\H&'67-K 63G>#8CP9NL*[B7.H" +XAJZ@!()!R@<#
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M]T=T?B85_P#KC&OWP@#W1W1^)?7_ .N,:_?" N N&YA* ^A=7^C_ '3C2?\
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MP3(0AJG3Z89NT5YI<QC@0!$PP&2_X9/O71 #?P<[@9A.9*7>W(.DYE 74^6
M/X9'O7O_ -G*[X_V+O;A_74 !WR/>O?_ +.9UX/TLO7[J&< ?PR/>O?_ +.9
MUX?TLO7[J@*A>^6[V)/V'=T/"B/T-,O4)^K^>M8!H]\OWL(G!0W=V.1.4I@
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MXAM9OSP -TV3ZTQ"KZP#1W%YH_%<OP/_ )ILG[\0#_2+S1I_DLWY^ZBR?OO
M1]W/;W\MX*PCD3+3W;M==$0M"W'-337K]?M%Q2@J1BG29%J#5G60J96 K ',
M9$P"(:A :9N[9[]+<3NJS:]PM?>"*%=%2J5$KM6HBV,W2](>,7#90BR(5=*O
MU-W3#L2L!.4B@^R4$IIB,!T$);D,PLVR)5]K]^D O9)J+J7C9BR1! @ DB $
M=H%*HH$I@ \8"\-N.S(:1B;7\@&*L/U$&]W60J!CD^N$$Q7!^S'K 1$0& ?Z
M1N93"!PVM7\4 F!B#=5DS 0X@/Z;%F(#X @'#N2S&!BD]%6_9G"8#[K+(Z>$
MOTYG .](W,<Q_P E:_\ CK^RZROOU (&XO-.G^2Q?@!U>ZFRA'P3'VWU& /2
M+S5^*S?G[J+)^^T >D7FG\5J_/W463U?^EPZ8 ](O-/XK-^?NILG[[0"^D;F
M3IVK7]/K"[K+ )^I[<A+6 ^#6=V&1K::NJE=&W6Z[=IC04R*/ZE?./63414D
M(%*H[K9"BH$]=8#Q%)W]FK <]-Q<1^W65.U;@VRSB\SHRZ9Q3,42FN*0' P:
MA*4X#)*&Y3+SA%!RUVQ7^[07 ?-S$O&Q%6[M( \I5!RV<G*/*&LP,,^L8"Z#
M<7FB02VLW[*6D[JLHPREI,PU4!$0ZQXP"^D7FG\5J_/7NBR>OP5?J@#TB\TR
MTVM7Y/\ ^*+)U_Y7T@%](O-'XK-^?NHLG[[0%4-Q.:Q !]%&_ATX^ZNR==./
MZKP%(=Q>:0'_ *K-^<1F4;HLG3P3"K]$ >D9FCIVLWYT?W463Z__ !O 50W$
MYK$ EM1OX9AQ]U=D@ Z!K^J\!1](O-/XK%^!X/=39(B'7_QM 'I%YI_%9OS]
MU-D??6 LG^X',2[-5 VU[(1#';JF%8+ILD#%'64A&L3"0\(#YO=_/JA4L!-'
MSREN*([=7SD!5W2GJI'2Z*I[HJ)E"JN$C'2%5,P\IA*(E$0&0B$!.N0=7@];
MJ@/_T.Y?(V.6F0*)5:%5'U29(*K'>,WM(J2[.J,Z@"BAV#JGJ-S)FIRK)0Q1
M Q!FL(>5Q& UL#M.W4/;OJ-)>=X9?R^.40%FZM%K9&-&EW-4JD!$&].4NP]%
M=/5DSHE!,552%> &HK";RH#(^3N[)VMYM=VY6,GXX-?5P4)@2@LZ]5KIN<7@
M,E2@NJ_5%-_YL\?+2'M%0"1S"(],!DB[=A^VJZR8AJ55QXLHK@QG2:9BHB54
MJ[<MG)41HBRIP4ZG@N).9%!N4HG]D>4Q'6 ^HILEV\U7)".4*GC:CN+L&KT>
MYW#]9:H$(]NZA-!9TNYWM* _FKJL,D3F*FL<!.4IA"<!,5!%!L5=(A.44FPC
M-),4R<PEF<Y"?.<PZR@(>[6@ V3MSX#Y10R<UY0'67[%:-XAZX"<'(4>)2^(
M/F0!REX<I9>H$ <I?H2]? ( Y2_0E\00"\H=0>((!.4OT)?$$ Z4M T" 3E#
MJ#Q! + $ 0! )(.H/$$ <I>H/$$ 2#J#Q! + ()2B,Q*41#I$ $?' '*7Z$O
MB" .4O4'B" 3D+]"7Q!\R PKN!O5ICC#.4;[>F!!I:5A75<!SJ$( &-3:8NZ
M*C,0&9%12&8=(0'Y^W=$9'N^I=XV=Y2K*"_+;SW4KHM7(I:E235.F-K+NZLE
MKM>>J.UDE46+UH^IS>0B("9(QPX",!^@UB?%^/\ %UK>YBP;1MJU:$5T=RG2
M:#3FE.8@L<0$53-FZ1$^V-()C*8R@,J V;RU;HAIP[(GB]C (+1J(S%L@(AT
MBDG^9@%\U;2EYN@ 3 9 DF 3#@.A>(0""U:C,1;H")AF812(,QG/7R==0@'>
M;-_M='3A]23T_P!C )YLV^UT/ZDG^9@%\V;_ &!'^I$_,P">;-N'FZ$OZ4G^
M9@%\V;_8$?ZD3\S 'FS?[ C_ %(GYF /-F_VNC_4D_S, GFK:<_-T)]?9)S_
M )V XD/Y0M8-&Q?OGVM9;IE+8TT+G?4QS5WS-HDQ3=O[3N6C.UW#U9(I077:
MTYR,C&F( (P'9'CJ[K<O6R[1NFAU)K4:97J*P79/6:S=RT,"S1)44BN&XF!-
M0W-J R&?& R@4A0*4 *4) '0 ] =,M>$!26%,B9CG*4I2CJ(@' -.J ^89[3
MTPFHHDD60F$3F2 H\!^N*\H$"7AT@*Z:[-8I#HE342,/*FLD=)5,Q^H3%.(&
ME/PP%45FX)F!,Q#'+H(  3 0F A+26L!40437(,@+,-!&0<>GY,!<@4L@F4O
M1T! <^?\HLRZ..-BE7MUHX30J&3[GHML)H$-R+J,4E7*KT  /*,D<"A,.$!Q
M!;7=TV:=G=_-<I85KB%$J(]M0ZDJ_IB#YA<+(A6CL](<E7(HR*@;LP >Q JV
MFHS@)Q;V.^)W5[O*G:3*A737\86M1J)2$:C9UJ/1IC>J7BV1*9]5EG+,$7;J
MG+ K-)$PF[.12\0@/BXC[Y_O!\*V;4\=4C+0UJE^;KLF:EXV^SJ]R454X=F+
MFG5M9N"YS-Y>2FJ)A"6NL!)C:G_*#-Z.*[_H),Y7XCEK%2]60/<S&MT&EMKA
M2IAP*W<+6_4&30CA<$#S'LA,)0$(#K,VZ][?L:W)W;0K2L;,%-;7C66Z"B-N
M7&SJE'?&=K))G3IK<ST?,E79#'Y#2T$P#* VF)K,W !V79F/*9@ 0-(1X@(A
MH,AZ0@+X.S  "10T#3EZO6@'\I.(%+]*'S( Y2_0E\00!RE^A+X@@/)5>HH-
MB/#& $2L4A>><)J%*F5N2?;'<"<0(!2:\9P'YYG?-=Y1E+=+N)O?#ME7+4J7
MA+&=P/+2I5OT)T1H>YZNR<)M*K4*R]8E(NX5\_1$K-.9@Y- Z8""N2MD^]7
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MFBH!"%( (F('* !(I22 H>  " A-M=_?4W3^#)C.0=7[%:-J'5. G! $ 0!
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M$0Z8#[\ 0%-;ZTK_ $L_\Z,!"/:_/WVMU!0X#DIGX=?<O1-8"<$ 0! $ 0!
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M4!**9BZ'3D.@]4!>0! $ 0! $ 0! $!;N_T,O_2S?*@(=;'/WFZC_C)R5_\
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M( "<^J 6;KZ%/QP!-U]"GXX FZ^A3\< 3=_0I^. 404-+F[(1+KK(9#PT]>
MMQ(\$PB"A.(RU#A/AQ@+=S3C.A(<3D[0@@/-Q$HAP&>NNHP'C;DM-*Z*;6:"
M]6$[2KTAW2W2J8=F9$CI$4%>Q'H.=,9&'I" XA]YO=<[A<*Y6ND]A6)<&0L<
MURLU*KVK<%M,C586_GCU9TXIKIDR*)DUFYEA3UUF6 EGW5/=EYC6S7;6>,TV
M?4[*MBPWAZC1*'<+0S6L7.Z5;&(F?VL4$I&"+%:7E\O,:4Q&<!V")"J9!$"<
MA!!).91$3"4>4/)$9S&77TP&,<AXQM3)]KUNR[^HU,N*T[B1.WK5MU=,BK%X
MW,8!$>0X&((FY 'A.80'&YWXW=#65B*WF^Y+:[:E*M2Q;8I2C7*UM-'1A:H+
M+.4$Z/5:4T 2E()B** N8H#T0$ZOY,KB4+9VTY/RRG=*U6)D>^6E/):Y33]R
MQZ(@N59VL03B4%'J3HHRY0F4H=4!T^MGY%"<G:IG4E]3[+V(%^= P![$0#B
MP%^"Y0 .80G+77IZ>CK@%[<G\P_E0"=N3P>/\J 7MR?S#^5X8!.W)X ]?\J
M7MR?S#^5 )VY.L/'^5 6+MS^=W4QE(@R#JT^; 1(V.B X4?CUY&R-X9SN^J0
M$S(#_];KZWUMRK89KU<+8CG(U/LNX*+>5S6*R0\]=7/0[9K8O'[5NW4(J4X
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M]5V@V7KH8IJ1632#JYAJH\P  <>F JAWKG?-R"6S^P0TZ:76P'UP"XR@ R\
M0#OX5WOG/Q0+"_6RN?A+T! *'>M]\T/':%86O_FZNA+K_NFX3& 3^%=[YS\4
M&P?ULKOX2P%N/>O]\],?\D.QN(Z>UU:^0'MP(_)& /X5[OGOQ0[#]>FUS\BX
MR_*" 3^%<[YR<QVA6%^MM<\>ER], G\*]WSOXH5B]?ZFUKY$ZN:?C& N0[UO
MOFY!_D?V#P#7VKKFH_NC#7U@@+93O5^^:,<"FVAV*( (&Y0IM:D!@Z0_3@=?
M' 4#]ZCWR1P,DKLXQ^IS&YO*I%7'RIB/-+VU$)Z\8"DCWI??(>67T/;# #"'
M,4*76P#R!Y@#R;C+H4VO ("^#O6^^;+PV@V$$M _2VN!IT3 +EU&4 @]ZQWS
M@EY?0YL<Q=?^+ZY(9C.8?IP;B/A& U>=X]OX[R_,EIT&P,X6 KANSJ\E4&%0
MI5FTVIC3[Q:J 54S.IH*GJZ7(@H 2,<H  A. Q#L"[V+)FQ?".5<,VG0Z(LO
M=[A6OTBYJJH_=/J%72-CL9(4XPE;]LF(<PB!"^46<@@)X=U1WK?>'Y*S/7K#
MK=V4O+UOO*-4*JL^R R\V:6PH1T+E)4*I3@2=+"Y.N9,B:IQ\@H%Z(#H<;[L
M-X:X^3;V& #AVB@W" &#H, >>   (= =$!7]*W>&&GN9PL,M)]M<&O1/]&^O
M 'I7;P_VL87ZOK]P:=/V]PU@%]*[>'.7N8PM_5[AE_P[PP!Z5V\/]K&%NC^C
MW#T_[^Z @$]*_>'^UC"_]7N'K_\ 'NN /2NWA_M9PMU?7[@_(>\("T=[J]XB
MK=P!;9PX'DB B5O=0]'T7G_E>KTP$D>[CKU7JVVR@O;A"G!6JG>60'#]"E"J
M*!'*ES5!5;E*L)C]F10X@4!$1E*<!L%]<?D>/AQ@/__7[W7-!ISHZQG#4JW;
MBKVH'$!*<JH'!0IBCH8ARJ& 0&8" C >;9XRL1A4QK+&V**RJAERNCNV=.9-
M7)W*>I5SKH-TUA5*8)SG 5*[CJRKE>-GMP6I0ZVX:&*9!:JLFK]1L<O+R&0%
MTBL*)B"0)"60A(("YJ-AVA6&+>D5:VZ34Z.R!$65,?L6KRG-5$!*9%1LU<)G
M1241$H"4P  E'A 6?O:6.-82N)>U*(YKJ)TU4:LM362E12433%%(Y'8H=N!T
M4C"4HSF4- @/4>U3,A5![$YP6*0AT^<1 2$"1""$_8D#0 #J@-'RI2AN"W.\
MI>6>3Z>D(:_6@M"C22GTE"7" ].9,@B/D](ZC.7$9_)& 3L49^P*/'HGZXB$
M G8I?8RCPZ)<0$1ZM(!102E,"%Z.CQB.D G8H\>0LM-)=?0 S\$ =BD&G9DZ
MM/!IU]< [L$)>P+K+@'6/$ F(ZP"=@EP!,HCQZ/%U0"=BE(?J9-!]?0!]: 7
ML4I?6RAZP:R !Z>$  @ETI%U&02X!IX( [%+7ZD7^:<^L E* .Q2Z4RA+ID'
M1T2X# '8I#.21.KK]</ $ =BC,?J9!Z- F&H#J 3Z](!>Q1^@)KPTD'Y7" 3
M\[!H((AUAV<Q >D!'E@/F.ZBQIK%W5'E08TYI3Q,J_?+]BDS;M2B(B)SN!!(
MJA20&D#O7]^>0L--L,TC;QD^FL'5QJ5VL5FM4 *35G"[!@LT19TQ9)<KE!DF
M[[8TS@ <TIP'/QBK&.=]ZN9G;>WAK%\9#N);VWN&YJLZ5?BW9-GR*ZKQZ^,8
M4F[-L903%2 2IRT ):0'<KBFRAL"P[,M%VA25JQ;5IT6WZL]I+!HP\\?4VG-
MF;]<JK9),YTG+E$QM1&<X#(9$4DC"*:8)#J(@ C.8^&?& JRF.H:CUS\<_"(
MP"<I>DH:B/0,^OIE,( Y"Z3 )S$)>/7AQ 8!>C2?3+4= #UY# )RA/@ Z^L$
M]?5]> 40#H"?1T]72'JC +/JZ!Z-1 -/#(9R\,!3,4ZFA$I>$"RF(!QZ., U
M!-4AA[1/F"8AY03TG 7*RJ>DB@40Z@X:='1IZD P%DI!Y/4(S&?4,YCIK /[
M5(.@)>KZO#UX"D($G, "0],M!#0>@8"GVY F'(F,M->TZ--)#* J@,]?4\D!
M$ "8:2F,^, O.C*0D+IQTGKI/HG,8!W:I::!U\?!PX:<( YT-?(+P#Q3]3K@
M&!QT 9>IT= 2#H"  * A*6H>'0?!X)P <WU%PF01*H*2!Q$II&YNWD!N(#/E
MT]2 T0T$%EN^RO!)50ZA?>O-S 8>(ITHHE$9"'L1"<!O>33+V#8HEX%5*(:\
M"3 H3X^2$ %X!*7   9=0?)X0"ZRU 1X2 .O767@" :)2](>O+B'#I'C .ET
M%&6NO7PGKXH Y0GT> 9^IPU$>$ WE#@(%ETCI*?AX?D0!REUD4!XA*0AJ$O5
MZX!>4)<-.H->CH#U>, !()=$^G4./AXB 0#13*(S NL]1$?RN(C  % 3 80\
MH D CQ"75K. =H$I:".LPET@$^/A" .4HZ\H3Z0_)T#PP (%/H0)" 2T&6H#
M(?)ZI0%JYH5&K"1T*U2Z;4P124+R5%DW>%716"2B @X24DF<HR&7& T";S^Y
M5]\&]JADS;C7;>MI"X%S.G]A51%XA16M27,*JYJ6]36)V:RZQC"*8 !2SD&@
M0$1NZ,R/;.W/<IEK%N2:FPMI_66*]CBB]7,5FO>=O7*#4R2#E0>=<5"&,)2&
M$0Y#0'5P0>=5<HJ$462* E!.0,U$0T3.B0OD%$Q)"$H!X)%$ 'LT0$0 9:3
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MT"$ HR"8!X.@9C,.L>$X T#P>#I#HT$=!G* .D0$1F' 0UT_(&4 @ (=7R.
M!X!#@/R8!0\F8AH.FNA9CT@,NH1@%$QM3"(B.H3]276'7 (N102\P&-V8F*H
M<DQY15('DGY>'.7K@..CO5,0.=L^\!7)5HMQ;T'(3EEDZA'<(]HU3NL3IMZR
MQ$)<@$,Z;@H8-)B><!DG#W?;[C;7N.AERC1K+O2Q$Q39.Z)3*$A0JT#!L!43
M*4^OLDB$4=)I$_H@&UXP&Y?'_>U[+KXM[V[JF1EL;.?.B$"UKQ8."UEI,-3#
M4F3&H,'[8!G(5#DY@U$ G* G7C7,N.<RVZWNO%UXT>\K=%82>V]&<)+M.T 9
MBDJF(@OVI1T$I@*0!T )0'T39&Q\M4*XQ2NZ@+/J 4#U2G^WU,0>4P32,96J
M(F6 $6H"(RD " :0&DC=#WO-X8GW,+8MPS;&/,B6)0VE+I];J;Y:L/EGES.4
MA>.!IM3HU819E8)(F!,0D(<P:ZP$7[X[PW<]>=<=UVF7T]L]B"I%*;0* W9I
MTIJ 3'LC.!**YB%]B)C"8QI3$1& V.=W_O5RAFRYJYCC*+VBU1S3J 6X*/7&
MQ$V-3 R9R).F;\2<I'I1),P'-H6<X!FYSO@<!8%NM:Q+6I;[,U>I]25:W$M:
M52;T^B6V1,#)N*8-0=(N?;.HE6*('"8E*<! (#9CW*&_O$6YK%MP8RM9"XJ+
M?&/:I6JW6[9JJ2 I-:1<M<,NT>L7J*:8U8I#O (J<_L33Y=(#?=/_3E^L3X#
M]/\ ZGP0'__1[^( @" ( @/C5@XE;F AEP-/G 4!* D @S.*BJGDIIR#74(#
M1H"AG>==S#QJL54KC)34/.6YD7")3(VI1B\O,F(D,J4"R&7& ]<JNW8MW%1=
MJ%20IR85%RJY[=)'VO:]J=Y]2%0I#F(0FL@XA 0'P]WF.U[+^3@Q%1;K>L;H
M/6W])I!JVP09T>J/&!UD%TT*F0I7#GME4A%(AC" S" GNVF))&5.?F#F,8XZ
MD,(3$!Z0$.$!=E#H T]) ;4>:6D^(#S"$ 2$>B0B$^GY4A_F& /"$^,I"(3Z
M>D>F< : /$?D:SGH,^'KP""/AD&D@XREP$!U@%'37Q=?@\(RD ZP!PX3"8\>
MG7IGT@,IP!J(CZDQGT" <>'1X( EKX.G40$>/&?7 $AX\92XS$9^MT@/R(!"
M"*@B4.("(3#IEUAQ@*O9$#B>73H:7#B :S@,!7]N<P1BJ\*78>0<I6;:]V5L
MH.J;1:J^%%Z#7M"MP,X(*A4P*N)P$O-+48#%^[S=AA_ V*+T>U"_K>:W=4[$
MK3FRJ8WJ9%JA45'[ R=+J"39%0Q3HOO.@ HCQ+((#F [N3:K9^\+.]3'(]Z-
M&Q[>>J7S6;/.Q<)/;RI17#A:HF9O$U2]BF#IRB18-0.)]8#9G='<;4VH9JJ=
MP4_)B-$Q54:^K5&=K-*47VTIS=(Z:XTUL[$_.0H(""<^)I:P&_6U+/96-:]!
MLZBB+:D6M26%#I23D 5<*LZ8U29-U1.'UM15% HCX1@/OA/3F"1PES<>@  1
M'H&4X EPD CX.(<-)\=8!1F,NKIX]?">H"(0":RGUAKQ\?$!U" 40GJ(:R#4
M/D3#P\(!=>(CT^J =/2, DM>(>N$I"/@G*<H ZM9^ )]<IS$>@8 *8P (%$0
M#30.$P ./C@/CUUK4*C2*DA3W!&3]RP<-4GYFQ7J+,YR&*FJ9!4!+SE PZP$
M*,-;1;AQ-B#+6+V.3E')\HU^[[I9UMI146%4MFI7*S336<-2IC)9$KD- GK*
M CU1.[.JE'8W\U>Y=/5'N0<.TW%-:J1+6;$.FW957VU6J:Y3/P,=RH5;RC:#
M,PP%YNUP/E=+%^V3%6/_ #2N5?%SM-@_NX;83JS5"GT"EMV5#7=M*8])5F?G
MC3F(J9)0IC  @(P'FL5;,\CWDPQ/DJNC:F(L@XAK%ZV73D[8LM)];5]8UK+Q
MBY\X5M>O>=-V;US5J@Z4*L<#*#(1$1, C 2TQQM >XZW%7CGRG7T TV\;*M6
MT;@M12W6+-1T]H#I14JE-.W B2#=8H@,B%  */5 ?#SCLN)F/<#:&;*S=;(:
M9:MDW'8KZPAH31ZT6MNZVRK)\1V\5 W,Y,=43)FE-(X (2E 8DI?=Z7U;M@V
M[BMAN/N)#'%JWU[JJ#;]8H[!V+6@KF>(N[3<.E.91TS BQ>R 1D$@&4 MD=W
M4^M6W\.4)+*RBK+#^1\BY H9"VRT[=PK?(BDLT?* 'U4C4$![.>FDP@, Y5V
M?Y>QNAB+&^/*BRN)O;KS,=R5>[[JL=S4Z,BM>[FD"%J/U+?%&JLRODW"HD*J
MH9$\IB6 S/C/9U?E<>XAS6NO:V)LB4"V:G85W6>ULUC6;9N.UVE6'S!2E6X_
M3.UHKI5J7F*MR]H FF(SF,!M>I+8&%,:TXH22IZ)&R28)$1(0$R 0>1$@%(D
M \OL0D < @+@0D$NL0 1'JZ.J 0_LB?^*!_PD8#1#;@?_P#;2\./[V"OR*2'
M" WPI?66W^I6^6, R8 !0E+AQ ):@&LX!9:SXCU#KZW7I/PP!K.7DZAIII+P
M2@ 0'U>CKXS&6OJ! '1+7CR^I\O36 0>,AEI(/!*0^OQ& !U\.OJ:<=/7 8
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M5CTVV:ZJVIS"GB8>9NFL=J10TM!/K ;ZI&^@-]8E]<'V7T'#V7^F@/_2[^(
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MKHZ)^I* 3K$)]?5I+4==8!. < T'@.@RE/IZ.J 74/#T3D(AU#. )=$@];B
M3"?A& 3CJ !(1X2&7'2?1. )C/JTG(?!KKPF(R]6 4>'JR#HD$@&0:\0\, L
M^("89&  $ T W*,@ 0Z90#!(42D3$ $A 'E+I(H"//(!#74XS]> !*43&4D'
M.<ADSFD S(8I2F*80X@)2!/U("L!23*IVDC%,!RF 2@8IP$P@,^,P$YO' 4P
M$2@0I!$ 2EV<AD!.43"7EE*0 *@^#6 84A2@4I2Z$$PD )B!3"7D$0F.DR
M3ZH!03($@Y>"9D@EI-,3=H9/3B45!$9=<  4  H<@<I.80Y@Y@+S^SE,/GNF
M 3L#CSFF("KR@?HY@(!@3#C\Z!Q]88"H G#DF89I'44*("/LU2 10TQ'4YRZ
M:P# (4)>3+EF!==2@(:AT" 2\, X/) 9: /2 SEZOC@$TD&O@D'$?6F/'UH
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MJ@%\X((#QUGUZ=/4$ G;D\/3\GCQG )VY/#USET_DP"]N00Z0\&LAU];K@'
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M(=KV,YC^R"O?U5+Y'YW@$':UC50! EPW  @'0LD'_P"5@#T4\>_MDK_@_/3
M-/4%B(P"FVKV"CVBH7!73$(G, ,LB)0D'&96TI^I <SUK8YH9/Y0->MF#45
MI3;%I!\Y*H@*ZO;4QB8I"%/) RLC:SU$>B Z82[5,?/2IK'N"Y$%"E#E3%Q3
M""',74) S,!=1X:R& 7T3K #3W1W)IT^<TV6FGVC 'HNXZ+Y(U^OC+3V:8B,
MM.)6LA'3H@$]%S'']GJ]U>S3^5YM ,':KCT=0N&OR'4/JJ6D]0_W)U0#_12Q
M_P#MCN'H^>;Z?^1S@**6U:PE5O-R7'7C@,YAVR','@!5),!(.G#2 NAVF6,
M\OM]7]!EJX9&X=8F()A'PCK 'HEV%TUZX_#)RP^1]1& K>B;C^7ZN7'ZOG3'
MH#_Q> 9Z)%B#PKUR_P!79?\ >(!_HFX_#C7+CTZW3#[G@&^B18G'V]N27]/9
M?]X@#T2\?=-;N.?2/G3'4>G_ '/ .]$W'_#V[N/^NF/W/ 'HFX__ +-W%_73
M'[G@%]$W'_\ 9NX_ZZ8_<\!:CM)L68C[H+D )Z?GECP\'U'PP%P&TW'X  #7
M+CT"6KICK+2?Z'\$ OHFX_\ [-W%_73'[G@%]$^P/[.W'_7;'[G@$]$W'_\
M9NXNO]%,?N> /1.Q_P#V;N+^NF/W/ 'HFX__ +-W%_73'[G@%]$ZP/[.7)X
M\Z8\/!^=X"T=[3\?((.7 5VXC"1JJ/9"Y8F 3  R-($.(2@/)[ V+.BX!2IR
M"BJJ;:_;_;I*'EVA4R7344P 1*$@$P%\J6@P$[)>KU<1_FG ?__5[^(! _)'
MY8P%D<QR(+&.;EF8>44A\J7A'KE :IM[^.E\JY$PCA*BVNJWH^2;Z0N_*UX,
M:8D50;4LQJ%07ISQZ5&:KFHHD323!01YA+*4!H5R7M6S@I?.:\',K0O=_=5Z
M=XG;&5;?KI6*WM=4<;K.QK2-PH5,A1*F%+9M1\KFD E*'@@.M:_[*NJ[,?#;
MEMW?4K)K946H)W)1V[9PX,":90/V17_.1-,XZR 9 &D!K2P!@3-=8R-N"2IV
MY2_J.I3,C-VM0<-J;:Y_;!5.TZ*F*ZR1J88)J"$Y3'U8"6!-L^X4@:;M<AA,
M=?TEM0!GP&<J6$ _T:MQ$I>EQD271^DUJZ=&GZ60#@VV;B@_^[C(GKT6U/O7
M 'HV;BOQN,B?K+:GWK@*/HW;@^ [M\D](B 42U0"?2.E+#I@#T;L_2Y!W:Y'
M$!+R" T6U1 2CJ)1 :7(0$8!Y=MVX(-2[M<BAS!Q]I;3F(#T#^EG5 4_1JW
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M?(E*14.4.68#H$@+P#H#PP%U(.H/$$ 2#J#Q! $@Z@\00!(.H/$$ 2#J#Q!
M$@Z@\00!RAU!X@@#E+U!X@@"0=0>(( Y2]0>(( D'4'B" )!U!X@@#E+]"7Q
M! $@Z@\00!(.H/$$ <I>H/$$ 2#J#Q! 6KM,GFR_D%U3-T! 0^V.3]YFH!,9
M!DK)0 $Q$)!==2&4AX  C 3)GX1]A/\ +X\8#__7[^( @" (!G9DE+E"0#,
M'60]80#5P R*H"$P%,\P_P!:,!![:Z(AEO=, #( R2TD'0'[%:+P@)S0! $
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M> \#5/%%B91;/Q85.]\MW5>>1KE5:B"=,4K]Q),Z:U3*X*0AG:=/IC-) QS
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MN4P](@%KT:0<>B G! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M[?\ C?H/_P!'4/C ; I2.G+Z$!#KX /#PB,!=P! $ 0! $ 0! $ 0! $ 0!
M$ 0! 6[O]#+_ -+-\J AWL=_>:J(?.ADG)0 &LI>ZRIC+QC 3)F/^PGZ\!__
MT>_B ( @" ("FM]:5_I9_P"=& A'M>_?:W3 ' N2V9@#H 1M>B3'P3@)P0!
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M>BR#UH";Y> >H''U(!8 @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @&F&11'P0&O[<GD*U["S7MIN>[KD8VU0F]=R&T7JM84\V
M9>=O+)JQ6C>9B'*C)9J)0,/T<^F RN;=KMO5+,^:<=<@@454S5MH8.8 ETG*
M \LN,@@*A=V&USD3+[\&.Y)<HD#VW9R*)>;E$OU6?D\PRZIZ0 3=3M63F)<Q
MXY#F,)S -<:"'.*8I":1E!D(IF$/4@'H[M-K[;G*AF/'R15# )P)66H%,(%
M@&$.V !D4)<("W6W7[7P#]^JP2B)#DD6M-/8*#S')]=#0PS@*'I5[6Q,53WZ
M+ D4J9!G66<I) <$RR[34"]H;QC  [J=K)A-_?FL&1RE*(>W+/EY"^Q)(%9
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M!4)(\Y?*]6 ]TR>@Y;)."+%5373(LF< )(2*% Y9?5!U$#0%YVP_1E_V'YN
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MY>QZ@@,G-<"866(;L\7V0)@&0F-:U%,2>OL !(1Y=(#Z1<!X/*  KB['Y]
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MERZ<$M:ZJC:-54.F#<4ZM2C$(N5$O:CSHE.IY0],H#*153 4O,H432#F$ (
M",M1#R^D8"W>. [!4.D4%-)EEH Z@':ATA 1$V0<Q<)N# 4#@?(^1S&.DH',
M ^ZZJ 832F$^N F;(/D2]: __]3OX@" (#Y542%5@^ #&$3(J$(3B7F .4!
M.N Y0,X]V5N!N+)>XS&=+M1U4[2W%[H<;YGI612/&I*)0[64KOMU>J%:*NF9
M\SJU%45,W;&1&9BB66@0'2%=V*Z5?6/_ '%5&I7!2VBM.I[=2JT"LNZ)5&R#
M1NFDU4;+I&!5,ZZ9 %3K$8" V(.[Z:M+SS2>OWEF>CTZI7@T6HSRG9)JS,U5
M8FMJD-2NEE4S\RYTU""',.L!(DFP:S"^4.4LYE+Q*3WU;C,!2FX!,%I#(.F
MH*;"K$YE"#D[-QR\HB(FRC<@B<1F/9&FL("6>D!\>W^[DQ=04784F_<P4E)\
M]<U-R@PR/<#=-5Z^647<N%@35)VBZRJ@B<PZB(C >B+L)L@  H92SB   2Y<
MI7&4 #HE]7E( @*)MA%G  F]]+.!A%)8HICE.Y.4X#, "7; / 8",^V?N_6-
M'M&XVEY7-F>W*I[Y63U&I6F0[B9MEK?J^0*R^MVJI&2J!.9X]IATSJJ"$S"8
M1Z8"3I=A5D\H2RIG'@$A#*5R2'0)"$W C+3I$8"W<;!+ 63 !RIG/F(8/^=.
MY) 8HGY936$ Y1./C@/@6IW<>*;.HR=&MF^\PT.G)+.%$&5,R77VC5,[IX9\
MY.1%-0" HN\4%4X@&IS"(ZP'J"[";(*4"^^EG(.4)!_?2N/271+MX#S5U;"+
M07M^X2M,A9MJ+X:15!8M39/N%=%\N>E.VJ;)VFHMR'0<*"!3 .@A 84VK=WX
MPIF";!IEYW3F6U[D8TIZ1[1*?DNX:8R9**5=0R29445B@F95'7ATP$D1V%V.
M(S)E/.7(.I/[ZER&'EGI,PK"(Z=(\8#X]6[OK&M5ISJE5'(>:J@S?(+-72#K
M)]Q*(JMUP$%45$S+&*=-0LY@.@A .HO=X8TH%(IU#H^0\T4VE4MJDU8,&>3;
MA1:-$$4BI)I((D5*1-,B90*  &@! ?5#839!0 H92SB!0TD&4KC#271]7& Q
M-FW8';E0Q#DNG6S?^;JY<CNS+BI]%I9LEUUXA4'[BFN_-FKI%5Z4JB+E4QDA
M 0U+,("XQ-L MU#'%A#<%^YLHU<1L^W6M8H[;)5R(-V%52I#5-\@B@G4^R2*
M@Y*8H 70 "0:0&40V%63( ]]3.0Z2G[Z-R:C(-=7 \?# ?!N/NZL7730JI;-
M?OW-5>H]=1.V?TY_D^X%6;EL8O9KMUT553)JHJ%T,40$!@/JM=@6/VR"+9MD
M?-C9-LBFW(5/*5Q@)2)$!,A1$%@ 0  @+D-A-DAY(Y3SEII^^G<<]/"*P=$!
M'+='L&8O,*7O2+,NS-%VW+4:4#"G4E?(MR5!HLF=Q-PHN@K40*9?D<CRZ?.0
M&=Z3L*LXS% %LE9O;*$13(*(90N0DA*F4!*8H.! G*(2D$X#ZP;"K)D$\I9R
M =!$ RG<DN'"?;SE >4N/NY,.731U*!<]]Y>K5+\_:OBM:ED:X'29WC=<'*'
M;)J*&*;L7'E$$9\IH#U8;";(   ,HYP( 2 I"92N,"E )2*7ZMH4.'J0%,=@
MUBCJ.3\X"/3/*5R?]^@(L[I^[U;U+']!1L*ZLQW=6&V0;/=/*:]R+6GR)**W
MKS8[UV1)=Z >=,TU%!3,$N68P$EF.PFPC%3,7)&<FI>4AB)CE"Y"*)C(! IB
M@N8I3%G(0 1" ^J.PNR1_P"=/.6O3[Z5QS\(_7N,!Y6Z.[>Q)<Y:06XKXR_6
MBT:J(5FD*5+)->=*M*JU$PMW2/:*F[)5OSB!3!(P ,!]UML#L,DRER7G-/60
MD3RO<P$((![$H J/DAT>" O/0)LD.&4\Y@ < '*5R#X)"/;ST@(S9_[O)G5*
M[A/W,W+F"X6C7*E%>W6XJ&0KC=#2J-3J?65?;5B<]0#L'*:[I, .  (&*$!)
M5/8+8A"%*GD_.1" 4.4OOI7& @ !H _5S:@'A& J!L*LD/\ G2SE+J]]*Y!^
M6O >4J_=MXCK;RC/JO>N7:@]HC\S^D.7F2*^NM37ADU$3NF2BAQ,W7,BJ8HF
M+(9&& ]*;8#80FF.4,Y3"?\ SI7)IT?9^J ME]@MCD3()<GYS 1.(&_OIW+,
M0$1D _51G 1;R]L!,.:-O[RV:[F:MVO1Z]5QO.O.<AW"JM1DG#,WFB[!0S\#
M)\QQ #B !K 2C:;![**8QCY/SD',F!Q*&4KD(',8)SY>V,!=1X3& NPV"6"$
MA5RAG,2B'SV4[E'09R_HVD!Y>J=V]AZK5VB7#4+SR]4:M1"O3TJI.LD7 L]I
MQG*947)F:YE!40[9(@%/RRY@" ]2TV$V(5(W+DG.9 -KRAE:Y  9]0=K( E
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M2$>80'376 KBB<1F C(1 0T&6LQZ^$ >:&&4U3!*<@ 1D'-Q -?# ,!H<H2
MYY!H'&4@\, _S0_V8T_5& M')V+0@G>/&C1(3%FX<+(I"90@Z )UC  <H^&
MII*MG!4E&KHCA(W,1(R)D3(+@$@'D60Y@YR!X=!@+X$#!*1C" :!S")Y@ :3
M'YX1ZX!@M!,83"(S&0CIU#I+U.B J>:''45C3'CJ/S8"B9N=*8J+&!,-3'$P
M^2'S8"@56GJJ&32=("LD4!-(S=10I ,!@$R>IDPYR@/,(<8!$'C-T=9)H^3=
MJ-Q*50C<[904Q4GR]H")Q-RAX0" O/-E!&8J& 1X\O"?3(. ! 'F.O-V@\W7
MJ(_+@$!H8!T.;C*83GZL [L@3 PJJ@ )ASF&8>Q_TVLP (#YPU!BJ"P(O6Y@
M;J FOR*-S\AU2E4[%20B*$D9&F,NN 5H^ISTHF8U-L\1 XAVC=T@Y*)PF D%
M9$Y^40$)2G ?3!N40":I@Z9 <1 -.N>H0%$68B/LA&0B)=!&0]8>M 5P(L 2
MYSZ>KX/!X(!INT*$Q4+V9?*,=40D AX1T"4X#YZ;QHJ8Q$GB)C$.9LH0#IK<
MAQ 7(@IR&FF<Y F0!UE -0=HO%%DFE0(N5NHD13LUDS';K%**RC9WR&$Q#*(
M*%$ -T!X8#Z8(%,4H"N8P2"0B:>DM!G. 8#90N@*' "S LNH>/C@'%15*$@,
M(!*6@#\GK@&#R%$Q5E"\R8"<QN<$B  B$@/,9#XX"V!9@LF"X.&H(E/R<R"R
M2I#*$$WDF4"90$#&$)#T\8!Z:[9US*(.4A3*!D3D(=(TE1F!1YTS&$@@(0%0
MC51,  #G 9:ZB81'IF/2/A@'^;J>2(*'F " "/0!N( (ATS@%\T/]F-\GYL!
M;G 6W,H=<"(R$# ($,<!#3F444&12Z>* M%']-%(%E'[)-J:?9+=NT427.7Z
MX)53FY 42,64@'2 KHJINTDC-79%FXD&1B]DJ10B<B_4ED3"0#!X("X*W,8I
M1*=20E 2@,YR$ $)CTC(8 \T-*0F'KX?)G*< _L%?LAY!PT'UO4@+)=XT9$.
MJ]J2#%$A@[<SA=!%),X>P(99<Q2D$X!.73 4SOZ>"2;KVT9),U ^HJ Y:F35
M.)1F"*QS F(C/HZX"X2 JA2F1=%4YBE-(3E&0"$PX>2,!=I-@Y1 R@F*8=2@
M:91'6<YS#C '8&+.4M1^AZ"R NO2,H!QDB$#F.<0X:",@GT\!@/DK/6C*9WS
MEJW2,()G,JH#<@*'^M "K@Z9%#'++R0$8"BY>4=N1N=:IL6P+J@#8QG;9N95
M3B)4NT/RN3"8/8A. ^GYN)D>9%P9093GS!TAT<LRA /!LK()G/.0"/'090!Y
M@$^8#B SG/6?CG -[ 9";MSA*>G,,M-/4XP'SG51IS/L3/:FV;D%0J)4W#IL
MBF=0X\.V6,0RIO\ 2@(P%96HL"<I%'K5(HE!3M!7(F4Q3GY6ZA5C"4IC'4&0
M%GK ?7F?Z,WZ'G];#V?T?^J_TL!__];OX@" ( @" C9NXORX<6[;,UY#M1F1
M_=%HXZNRN6^S.F9=%S5V-*=.&"9D"^4H;MB%D'7 <V'=S[BLODS[L=9.;JN&
MZB[CL*WA<&7?;%==\2H5].Z7LZ^)5#&*U78 GV0&$ D0)0'6-2.8Y%C@<3%,
M<PD&7* @)A$HB7YV8='1 ?;#0 #P0"P! 8(RU0W=U69<5OA7*C:K2I,ZDQ=5
MFF'(UJ3=JHH=5P9LL(@5@*C<!#MYSEK :B^[2Q9<N-,_[IGM"O>ZJCMXN&L6
MPTQE1;^N1Q6:Y4*E;QW 7Q=%(\Z764+;:E<<"W R4B."@0P:2@-\Z0B9),3!
MRB)"B(#T")0TUF,!4@" 0Q2FT,$PZA@(;[R=QEL[:\3.KVN6L-K?)4JY3K9I
M%7>ING#6GOZFJ9LU=O6R!3',U1<#-3HY " UE=R?G@V5*EO+&NY/7R/5BY]5
M?TRKN'+UP@>W5VHL6)J<1T("S:'J F$B4@Y4#%" W^$$1(01$!$2E$1+[$1D
M$Q#P# .@" ^:/EJD 0Y0$7$Y (<W*(@7Y'" T]=[3N7RA@'$%B6]B1<:3>>;
MLI6UBAA<@', T)I=+L[1TZ:F*  +V2?DJCJAS::P'I.[ SU;&7[-R-932W:O
M;U]X$O\ JN+\GO*S7'5:<5NZZ.NZ0=UTKI8QBN/;5PS44  ER%/ ;<BS$ $0
MY1D$PXR&7">G" 6 ( @-$W?)9"R=8"VW"KXL>(774B7U7 JV C.5V3C,% ;T
MA5:H=@X;&3,4*$ =H!)S$VNL!FSN;LDM<J;/F5UDN>NUQPYR+?1*G2KA,JH^
MLI[Y\@G[CDG"PF54:T$I.0HB,Q[01Z8#;.W 2I%*(SY0Y9\="A(./J0%: ("
MP?H]NS<MQ.)>=NJ7M)R$AS>Q&<].7H@.7V[<U9CPQN&[U%6WKNN.[#8RP%:-
M?LBEU:H.'PT*L7 I4VS]6G) (%12:I?50*4)@! ZH#Z_=QYER0UWM8-L0M<K
M=Q6OF38?1,HWVF_?.'3?W=MZY4CJ7$V!4YBLW;X!!N<?GR"4/G8#IY*("4HA
MJ E 0'P"$ L 0'D[A3[1!ZB)CE2<MC(*K-U.S<-S*!(BA33T$L](#G_V1J7+
MD;)O>4V+=63KP]IJ)FME0*35G=;?BXI=OA;)EZJS858YP"D<J/,!1*  $!F3
MNS,=7%CC)FY9>@WQ=M=P16;EIK7#5!O2KK5NM*>U!>SN^XZ:M45E7*E!J-25
M(U1,40+VJ:BA=!@-XB90[,DRE 1(7F )B #()R$=93@*D 0'C[M1\[H=08=L
MY;^<-GJ9UV1S)O$!,W4%-9JL&B:I#2$!Z!@.;#9-N[<X1Q-O<OC*F1'[X66[
MBM8^M&XKX>/ZDE24BM.Q;J.'*H**&3IW*)N0  A1#32 S#W(^?'F7[@WMDN'
M*+O)%:;[B7[RF5-PZ<@B6SW=#02I!Z.@K]3(B9ZBL4 D$D>S@.AL@!RE'DY1
M$H3*(!Y.G#UH!\ 0&$LOM3O+'O9 E2>TIP6C5A1JZIJXMWR9TJ>)TSI. U2,
MFIJ'A@.9JG[K<XX_[L[':]J7+7:ID_,FYFXL0LK_ *T^5?OZ0FI?E<1.JLY,
M814<*4ZG@BDN,NQ$T@@-MO=K9VM?*]B7W:+*AUZ@7;AV_P!YCG(KBNU=Q6U:
M_<+)N5T>XTJRN(J*#45^8QDM"D T@" VQ)S%,@FXB0L^C603T]6 ? $!"/O!
MW=68[1\YUBA5^M6U5:'8-=JU-J=">'8OR.V+-=5,H+D\LH"H0.F Y[LG97SA
M1MF'=NW?9]QN+VN>XJ%7JK=6&*G4'A*UFMMR/G%4?JOT5"K&<TQ(N@B,YEG
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M*6E0W[B]KZN"\@:4M-=-PBSHC6L/#H4\RZZ1#J 4H!S@$!L%2^MIZ'#R"Z'
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MZB+LW-\7G5KYO6MU*HB]JMQ715E5SNZJX.8@"8RPKF H#H4HR@)7E"10#4)
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M_5V]08MZ=SBT3HYJRJ<M.05.H8QB)Z )M9P$Y%%%"F3*!C%\@LPF Z\H=(
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M='!;=A=(X]1NQ&]Z*@]O!^_K% O=K6E[@2K])JQR@=JJL^<',9,H2*)A"8A
M2,P!M?QQMSI=RTVP:2[36O6Z'-W795:F^&HU:N7"Z+R+/7BY@+VAQ('* CKR
M@$!*<HS !ERS !D/1IP]: 6 (##6;L16QG.P+@QE>:U9+:]SL%J?7FM$JKNC
M/7U/7*9-5J%39_5DDU"&$# '1 1$;=W1@FF6[AZW:4C>+%/ A:K[U-7/==0J
M%7M"F5MH>GU&D(OE@%6I-W"9C& IP^I"80@)';==N>/-LE@*X]Q92!H]$<5B
ML7.^\X<&<OZO<M?>^>5JNU)4X?5'3LQ2] 2* 0$D2RY2RX2"71I+33H@%@"
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M[^( @" ( @&"0@C,2@(\P'G_ *8. ^M  )D ) 4  >;@'T8\Q_IAU@'P! $
M0#1*4W$)R@$%-,>)"C*7$ 'APXSU" >&F@< @" (!) /$. S#U>OU8 $I1G,
M UE/0-9:A/KD, WLR:^2&HS'U=1G\F <4H% "E"0!P" 6 ( EP'JX0#0(4!$
M>4)B,Q'P_P PP"=F03"82EYA"4Y:R#@$ X     T  D'J! + $ 0%+L4IB/9
MDF(" C+40$9C/K&< \2E$ *( (!*0#KPX>K *        &@  2  Z@ .$ L
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M<YYP&[RF&$RA?(%(#(IG[(1F)!%,#<HCTB41EZT!]R ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" __2[^( @" ( @" ( @" ( @" (
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M@;@(#R&$N@AT0#/3EQF']R^5-)_\W%=X!_KN(P!Z<^+>FV<K /2 8WK^@]/
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MJ5*B+'J5/<TMPUJU*632<-5T'0B)#D,J "'7 9MYE.LGUCFXA]<Z_P#4>'A
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M01Z?G"]?A" OBMFPE*/8):@ ^P+U>I 45T$"E 013#7H(7\J<!;<K7I12$>
MZ%]0>CJ" 9V*/$$DY#P\@O@\?& =RM0E-!+3CY).KU.N 4&S0=>5/60^Q#Q<
M. 3@+5\[8TQN=5RJU;)(E%4QW!T2ARC+^B*\A"!(- & ^-2+MHE;YDZ8^ISE
M5'59(CEBNJ"7-[,"H*&,.D!ZQ !,D4YRHR,:91*0L^SUY9R"4^6 0S9N)A^H
MI#,3#/LR]?3 )YLWT^H)=>I"_,XP%$2M &78):"(2Y"3T]: 233[ E]*3YD
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M*U041N=NVIHM^T.E1SG RQA^M\L!]3^$)VL><T1JCE!@]5N:PJQDZD S:N'
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MI%,YR@5;S=P<D^HT!&M/NQ-@A"$(7:9BXI2E*4H#;R B     "(JST (!_\
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MB6*(JB05)W/1A W9SY)AYQ+R9_)@'!F?$@ 8H9$LB1A 32N>C:B70/\ =/0
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MV,3'^+5]D/PO3XAQ_P!-^3 )^QB8?Q:G'_"]/B/#P_DP%7]C&G\6U_TO=71
M4?V,<_\ V:G#_"]S_P"A ;&=J?F?O9(^9>\5V'MI5N7WA/;WW%S[=/FG[H/T
6P]L9_HCFTYI2@)/?U/ZW_-_^' ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6998254496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Senior Convertible Notes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Net carrying amount of Senior Convertible Notes</a></td>
<td class="nump">$ 1,059,700,000<span></span>
</td>
<td class="nump">$ 1,010,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total net carrying amount of senior convertible notes</a></td>
<td class="nump">1,059,700,000<span></span>
</td>
<td class="nump">1,010,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior convertible notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">400,000,000.0<span></span>
</td>
<td class="nump">400,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt discount</a></td>
<td class="num">(37,200,000)<span></span>
</td>
<td class="num">(51,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance costs</a></td>
<td class="num">(4,600,000)<span></span>
</td>
<td class="num">(6,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Net carrying amount of Senior Convertible Notes</a></td>
<td class="nump">358,200,000<span></span>
</td>
<td class="nump">342,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Carrying value of equity component of convertible senior notes, net of debt issuance costs</a></td>
<td class="nump">$ 70,600,000<span></span>
</td>
<td class="nump">$ 70,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1', window );">Remaining amortization period of debt discount on the liability component</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior convertible notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 850,000,000.0<span></span>
</td>
<td class="nump">$ 850,000,000.0<span></span>
</td>
<td class="nump">$ 850,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt discount</a></td>
<td class="num">(140,000,000.0)<span></span>
</td>
<td class="num">(171,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance costs</a></td>
<td class="num">(8,500,000)<span></span>
</td>
<td class="num">(10,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Net carrying amount of Senior Convertible Notes</a></td>
<td class="nump">701,500,000<span></span>
</td>
<td class="nump">667,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Carrying value of equity component of convertible senior notes, net of debt issuance costs</a></td>
<td class="nump">$ 171,600,000<span></span>
</td>
<td class="nump">$ 171,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1', window );">Remaining amortization period of debt discount on the liability component</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period for discount on the liability component of convertible debt which may be settled in cash upon conversion, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6813081440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTerm', window );">Maximum contractual maturities of debt securities held</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46.9<span></span>
</td>
<td class="nump">$ 28.6<span></span>
</td>
<td class="nump">$ 16.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain (loss) on disposal of machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.5)<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
<td class="num">$ (11.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges and costs</a></td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dxcm_ReceiverProductComponentMember', window );">Receiver Product Component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.1<span></span>
</td>
<td class="nump">$ 7.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dxcm_ReceiverProductComponentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dxcm_ReceiverProductComponentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6995499088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Property and Equipment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">$ 426.3<span></span>
</td>
<td class="nump">$ 262.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(105.0)<span></span>
</td>
<td class="num">(79.8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">321.3<span></span>
</td>
<td class="nump">183.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building and land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">15.5<span></span>
</td>
<td class="nump">6.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">12.8<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer software and hardware</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">32.7<span></span>
</td>
<td class="nump">29.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">130.2<span></span>
</td>
<td class="nump">80.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">102.5<span></span>
</td>
<td class="nump">80.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">$ 132.6<span></span>
</td>
<td class="nump">$ 57.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6993411824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity - Stock Options Reserved for Future Issuance (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options granted and outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock units (shares)</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_StockOptionsReservedForFutureGrant', window );">Reserved for future grant (shares)</a></td>
<td class="nump">4,900,000<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp', window );">Employee Stock Purchase Plan (shares)</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (shares)</a></td>
<td class="nump">7,600,000<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EmployeeStockPurchasePlanEsppSharesInEspp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan ESPP Shares In ESPP</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EmployeeStockPurchasePlanEsppSharesInEspp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StockOptionsReservedForFutureGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock options and awards reserved for future grant</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StockOptionsReservedForFutureGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6817022112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at beginning of period</a></td>
<td class="nump">$ 25.9<span></span>
</td>
<td class="nump">$ 22.8<span></span>
</td>
<td class="nump">$ 39.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decreases related to prior year tax positions</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(14.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases related to current year tax positions</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017', window );">Decrease related to Tax Cuts and Jobs Act of 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at end of period</a></td>
<td class="nump">$ 29.5<span></span>
</td>
<td class="nump">$ 25.9<span></span>
</td>
<td class="nump">$ 22.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Decrease Resulting from Tax Cuts And Jobs Act Of 2017</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=SL37586934-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6984606752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases And Other Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Operating Lease Liabilities</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">As of </span><span style="font-family:inherit;font-size:10pt;color:#252525;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;color:#252525;">, the maturities of our operating and finance lease liabilities were as shown in the table below:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:76%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Finance Leases</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total future lease cost </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Amount representing interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Present value of future payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>85.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Short-term leases not recorded as a liability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revised present value of future lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Current portion</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term portion</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></span><span style="font-family:inherit;font-size:10pt;color:#252525;">Total future lease cost excludes </span><span style="font-family:inherit;font-size:10pt;color:#252525;"><span>$5.5 million</span></span><span style="font-family:inherit;font-size:10pt;color:#252525;"> of legally binding minimum lease payments for leases signed but not yet </span><span style="font-family:inherit;font-size:10pt;">commenced</span><span style="font-family:inherit;font-size:10pt;color:#252525;">.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Finance Lease Liabilities</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">As of </span><span style="font-family:inherit;font-size:10pt;color:#252525;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;color:#252525;">, the maturities of our operating and finance lease liabilities were as shown in the table below:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:76%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Finance Leases</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total future lease cost </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Amount representing interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Present value of future payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>85.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Short-term leases not recorded as a liability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revised present value of future lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Current portion</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term portion</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></span><span style="font-family:inherit;font-size:10pt;color:#252525;">Total future lease cost excludes </span><span style="font-family:inherit;font-size:10pt;color:#252525;"><span>$5.5 million</span></span><span style="font-family:inherit;font-size:10pt;color:#252525;"> of legally binding minimum lease payments for leases signed but not yet </span><span style="font-family:inherit;font-size:10pt;">commenced</span><span style="font-family:inherit;font-size:10pt;color:#252525;">.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Components of Lease Expense and Other Information</a></td>
<td class="text"><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of lease expense for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:89%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions) </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance lease cost:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest on lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term lease cost </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Variable lease cost </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span><span style="font-family:inherit;font-size:10pt;color:#252525;"> </span><span style="font-family:inherit;font-size:10pt;">Short-term lease cost is primarily related to temporary office space associated with the transition of certain operations to the Philippines. </span></div><div style="line-height:120%;padding-top:4px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span><span style="font-family:inherit;font-size:10pt;color:#252525;"> </span><span style="font-family:inherit;font-size:10pt;">Variable lease costs are primarily related to common area maintenance charges and property taxes.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.</span><span style="font-family:inherit;font-size:10pt;color:#252525;"> </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating cash flows from operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating cash flows from finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financing cash flows from finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Right-of-use assets obtained in exchange for lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>80.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average remaining lease term in years:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average discount rate:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6829224928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedules of Percentage of Total Revenues and Accounts Receivable by Customer</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table sets forth the percentages of total revenue or gross accounts receivable for customers that represent 10% or more of the respective amounts for the periods shown:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:46%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Accounts Receivable</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">As of December 31, </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Distributor A</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Distributor B</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Distributor C</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*     Less than 10%</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Revenue Recognized as a Result of Changes in Contract Liability Balances</a></td>
<td class="text">The table below shows revenue that we recognized as a result of changes in the contract liability balances in the periods shown.<div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenue recognized in the period from:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts included in contract liabilities at the beginning of the period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Net Income (Loss) Per Share</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table sets forth the computation of basic and diluted </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> per share for the periods shown.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:61%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>101.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(127.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(50.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income (loss) per common share</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.11</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.44</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.58</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.10</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.44</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.58</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic weighted average shares outstanding</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>88.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dilutive potential common stock outstanding:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options and employee stock purchase plan</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Restricted stock units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023 Warrants</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022 senior convertible notes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023 senior convertible notes</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted weighted average shares outstanding</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>88.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Outstanding Anti-Dilutive Securities Excluded in Diluted Net Income (Loss) per Share</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outstanding anti-dilutive securities not included in the diluted </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> per share attributable to common stockholders calculations were as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:62%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options outstanding to purchase common stock</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unvested restricted stock units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023 Warrants</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior convertible notes due 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior convertible notes due 2023</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contract balances and changes in contract balances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6984325232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Information (Unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Schedule of Quarterly Financial Information</a></td>
<td class="text"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following is a summary of our quarterly results of operations for the years ended </span><span style="font-family:inherit;font-size:10pt;">December 31,</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">For the Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions except per share data)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Year ended December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>462.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>396.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>336.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>280.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gross profit </span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>309.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>246.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>206.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>168.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating expenses </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>207.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>190.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>207.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>183.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(26.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic net income (loss) per share </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.01</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.50</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.12</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.30</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted net income (loss) per share </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.00</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.50</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.12</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.30</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Year ended December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>338.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>266.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>242.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>184.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gross profit </span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>222.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>168.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>153.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>118.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating expenses </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>387.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>154.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>158.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>149.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(179.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(24.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic net income (loss) per share </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.03</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.53</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.34</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.28</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted net income (loss) per share </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.03</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.52</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.34</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.28</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></span><span style="font-family:inherit;font-size:10pt;">Basic and diluted earnings per share are computed independently for each of the quarters presented. Therefore, the sum of quarterly basic and diluted per share information may not equal annual basic and diluted earnings per share.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118952077&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6821968720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segment and Geographic Information</a></td>
<td class="text"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">10. Business Segment and Geographic Information</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Reportable Segments</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">An operating segment is identified as a component of a business that has discrete financial information available and for which the chief operating decision maker must decide the level of resource allocation. In addition, the guidance for segment reporting indicates certain quantitative materiality thresholds. None of the components of our business meet the definition of an operating segment. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We currently consider our operations to be, and manage our business globally within, </span><span style="font-family:inherit;font-size:10pt;"><span>one</span></span><span style="font-family:inherit;font-size:10pt;"> reportable segment, which is consistent with how our President and Chief Executive Officer, who is our chief operating decision maker, reviews our business, makes investment and resource allocation decisions, and assesses operating performance.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Disaggregation of Revenue </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DexCom is domiciled in the United States. We sell our CGM systems through a direct sales force in the United States, Canada and some countries in Europe, and through distribution arrangements in the </span><span style="font-family:inherit;font-size:10pt;">United States, and certain countries in Africa, Asia, Europe, Latin America, and the Middle East, as well as Australia, Canada, and New Zealand</span><span style="font-family:inherit;font-size:10pt;">. We disaggregate our revenue from contracts by geography and by major sales channel as we believe they best depict how the nature, amount and timing of revenues and cash flows are affected by economic factors. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Revenues by geographic region</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, no individual country outside the United States generated revenue that represented more than 10% of our total revenue. The following table sets forth revenues by our two primary geographical markets, the United States and outside of the United States, based on the geographic location to which we deliver the product:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.0234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="20" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,161.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>818.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>596.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>83</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outside of the United States</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>314.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>213.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,476.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,031.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>718.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The majority of our long-lived assets are located in the United States.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Revenues by customer sales channel</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table sets forth revenues by major sales channel for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.0234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="20" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Distributor</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,011.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>69</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>652.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>63</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>538.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Direct</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>464.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>378.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>37</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>180.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,476.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,031.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>718.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6821958464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases And Other Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases And Other Commitments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">6. Leases And Other Commitments</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Leases</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We lease office, manufacturing and warehouse space facilities under various domestic and international operating leases that expire at various times through August 2026. Certain of our leases have renewal options which allow us to extend the lease term typically between </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>five years</span></span><span style="font-family:inherit;font-size:10pt;"> per option and some of our leases have multiple options to extend. We have </span><span style="font-family:inherit;font-size:10pt;"><span>one</span></span><span style="font-family:inherit;font-size:10pt;"> finance lease for our manufacturing facility in Mesa, Arizona under a lease that expires in </span><span style="font-family:inherit;font-size:10pt;">March 2028</span><span style="font-family:inherit;font-size:10pt;"> with options to renew this lease for </span><span style="font-family:inherit;font-size:10pt;"><span>four</span></span><span style="font-family:inherit;font-size:10pt;"> additional </span><span style="font-family:inherit;font-size:10pt;">five</span><span style="font-family:inherit;font-size:10pt;">-year terms. Our facility leases generally provide for periodic rent increases and many contain escalation clauses. Certain leases also require us to pay taxes, insurance, and maintenance. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> The remaining lease terms of our leases range from less than </span><span style="font-family:inherit;font-size:10pt;">one year</span><span style="font-family:inherit;font-size:10pt;"> to approximately </span><span style="font-family:inherit;font-size:10pt;"><span>thirteen years</span></span><span style="font-family:inherit;font-size:10pt;">; and represent the non-cancellable periods of the leases, including extension options that we determined are reasonably certain to be exercised. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">We adopted ASC 842 utilizing the modified retrospective transition method through a </span><span style="font-family:inherit;font-size:10pt;color:#252525;"><span>$2.1 million</span></span><span style="font-family:inherit;font-size:10pt;color:#252525;"> cumulative-effect adjustment to accumulated deficit at the beginning of the first quarter of 2019. We will continue to report financial information for fiscal years prior to 2019 under the previous lease accounting standards and as such prior comparative periods have not been recast. </span><span style="font-family:inherit;font-size:10pt;">We elected the package of practical expedients permitted under the transition guidance in the new standard, which allowed us to carry forward the historical classification of leases that were in place as of January 1, 2019. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Under the previous lease accounting standards we were deemed the owner of our Mesa, Arizona building during the construction period. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell and the related lease liability as of December 31, 2018 and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, as a result of our adoption of ASC 842 we recorded operating lease right-of-use assets of </span><span style="font-family:inherit;font-size:10pt;"><span>$26.7 million</span></span><span style="font-family:inherit;font-size:10pt;">, finance lease right-of-use assets of </span><span style="font-family:inherit;font-size:10pt;"><span>$15.3 million</span></span><span style="font-family:inherit;font-size:10pt;">, operating lease liabilities of </span><span style="font-family:inherit;font-size:10pt;"><span>$40.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> and finance lease liabilities of </span><span style="font-family:inherit;font-size:10pt;"><span>$15.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> in our consolidated balance sheets at the beginning of the first quarter of 2019, with no material impact to our consolidated statement of operations. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease right-of-use assets and liabilities are presented separately in our consolidated balance sheets. Finance lease right-of-use assets are included in property and equipment and finance lease liabilities are included in accounts payable and accrued liabilities and in other long-term liabilities in our consolidated balance sheets.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">As of </span><span style="font-family:inherit;font-size:10pt;color:#252525;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;color:#252525;">, the maturities of our operating and finance lease liabilities were as shown in the table below:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:76%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Finance Leases</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total future lease cost </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Amount representing interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Present value of future payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>85.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Short-term leases not recorded as a liability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revised present value of future lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Current portion</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term portion</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></span><span style="font-family:inherit;font-size:10pt;color:#252525;">Total future lease cost excludes </span><span style="font-family:inherit;font-size:10pt;color:#252525;"><span>$5.5 million</span></span><span style="font-family:inherit;font-size:10pt;color:#252525;"> of legally binding minimum lease payments for leases signed but not yet </span><span style="font-family:inherit;font-size:10pt;">commenced</span><span style="font-family:inherit;font-size:10pt;color:#252525;">.</span></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of lease expense for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:89%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions) </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance lease cost:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest on lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term lease cost </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Variable lease cost </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span><span style="font-family:inherit;font-size:10pt;color:#252525;"> </span><span style="font-family:inherit;font-size:10pt;">Short-term lease cost is primarily related to temporary office space associated with the transition of certain operations to the Philippines. </span></div><div style="line-height:120%;padding-top:4px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span><span style="font-family:inherit;font-size:10pt;color:#252525;"> </span><span style="font-family:inherit;font-size:10pt;">Variable lease costs are primarily related to common area maintenance charges and property taxes.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior to January 1, 2019, we recorded operating lease rent expense under ASC 840 on a straight-line basis over the non-cancellable lease term. Rent expense for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$12.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$11.1 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.</span><span style="font-family:inherit;font-size:10pt;color:#252525;"> </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating cash flows from operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating cash flows from finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financing cash flows from finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Right-of-use assets obtained in exchange for lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>80.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average remaining lease term in years:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average discount rate:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of operating lease right-of-use asset included in cash flows from operating activities in the Consolidated Statements of Cash Flows was </span><span style="font-family:inherit;font-size:10pt;color:#252525;"><span>$9.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Purchase Commitments</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are party to various purchase arrangements related to our manufacturing and research and development activities. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$165.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> of open purchase orders and contractual obligations in the ordinary course of business, most of which are due within </span><span style="font-family:inherit;font-size:10pt;"><span>one year</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases And Other Commitments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">6. Leases And Other Commitments</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Leases</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We lease office, manufacturing and warehouse space facilities under various domestic and international operating leases that expire at various times through August 2026. Certain of our leases have renewal options which allow us to extend the lease term typically between </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>five years</span></span><span style="font-family:inherit;font-size:10pt;"> per option and some of our leases have multiple options to extend. We have </span><span style="font-family:inherit;font-size:10pt;"><span>one</span></span><span style="font-family:inherit;font-size:10pt;"> finance lease for our manufacturing facility in Mesa, Arizona under a lease that expires in </span><span style="font-family:inherit;font-size:10pt;">March 2028</span><span style="font-family:inherit;font-size:10pt;"> with options to renew this lease for </span><span style="font-family:inherit;font-size:10pt;"><span>four</span></span><span style="font-family:inherit;font-size:10pt;"> additional </span><span style="font-family:inherit;font-size:10pt;">five</span><span style="font-family:inherit;font-size:10pt;">-year terms. Our facility leases generally provide for periodic rent increases and many contain escalation clauses. Certain leases also require us to pay taxes, insurance, and maintenance. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> The remaining lease terms of our leases range from less than </span><span style="font-family:inherit;font-size:10pt;">one year</span><span style="font-family:inherit;font-size:10pt;"> to approximately </span><span style="font-family:inherit;font-size:10pt;"><span>thirteen years</span></span><span style="font-family:inherit;font-size:10pt;">; and represent the non-cancellable periods of the leases, including extension options that we determined are reasonably certain to be exercised. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">We adopted ASC 842 utilizing the modified retrospective transition method through a </span><span style="font-family:inherit;font-size:10pt;color:#252525;"><span>$2.1 million</span></span><span style="font-family:inherit;font-size:10pt;color:#252525;"> cumulative-effect adjustment to accumulated deficit at the beginning of the first quarter of 2019. We will continue to report financial information for fiscal years prior to 2019 under the previous lease accounting standards and as such prior comparative periods have not been recast. </span><span style="font-family:inherit;font-size:10pt;">We elected the package of practical expedients permitted under the transition guidance in the new standard, which allowed us to carry forward the historical classification of leases that were in place as of January 1, 2019. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Under the previous lease accounting standards we were deemed the owner of our Mesa, Arizona building during the construction period. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell and the related lease liability as of December 31, 2018 and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition, as a result of our adoption of ASC 842 we recorded operating lease right-of-use assets of </span><span style="font-family:inherit;font-size:10pt;"><span>$26.7 million</span></span><span style="font-family:inherit;font-size:10pt;">, finance lease right-of-use assets of </span><span style="font-family:inherit;font-size:10pt;"><span>$15.3 million</span></span><span style="font-family:inherit;font-size:10pt;">, operating lease liabilities of </span><span style="font-family:inherit;font-size:10pt;"><span>$40.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> and finance lease liabilities of </span><span style="font-family:inherit;font-size:10pt;"><span>$15.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> in our consolidated balance sheets at the beginning of the first quarter of 2019, with no material impact to our consolidated statement of operations. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease right-of-use assets and liabilities are presented separately in our consolidated balance sheets. Finance lease right-of-use assets are included in property and equipment and finance lease liabilities are included in accounts payable and accrued liabilities and in other long-term liabilities in our consolidated balance sheets.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">As of </span><span style="font-family:inherit;font-size:10pt;color:#252525;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;color:#252525;">, the maturities of our operating and finance lease liabilities were as shown in the table below:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:76%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Finance Leases</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total future lease cost </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Amount representing interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Present value of future payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>85.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Short-term leases not recorded as a liability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revised present value of future lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Current portion</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term portion</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></span><span style="font-family:inherit;font-size:10pt;color:#252525;">Total future lease cost excludes </span><span style="font-family:inherit;font-size:10pt;color:#252525;"><span>$5.5 million</span></span><span style="font-family:inherit;font-size:10pt;color:#252525;"> of legally binding minimum lease payments for leases signed but not yet </span><span style="font-family:inherit;font-size:10pt;">commenced</span><span style="font-family:inherit;font-size:10pt;color:#252525;">.</span></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of lease expense for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:89%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions) </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance lease cost:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest on lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term lease cost </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Variable lease cost </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span><span style="font-family:inherit;font-size:10pt;color:#252525;"> </span><span style="font-family:inherit;font-size:10pt;">Short-term lease cost is primarily related to temporary office space associated with the transition of certain operations to the Philippines. </span></div><div style="line-height:120%;padding-top:4px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span><span style="font-family:inherit;font-size:10pt;color:#252525;"> </span><span style="font-family:inherit;font-size:10pt;">Variable lease costs are primarily related to common area maintenance charges and property taxes.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior to January 1, 2019, we recorded operating lease rent expense under ASC 840 on a straight-line basis over the non-cancellable lease term. Rent expense for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$12.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$11.1 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.</span><span style="font-family:inherit;font-size:10pt;color:#252525;"> </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating cash flows from operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating cash flows from finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financing cash flows from finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Right-of-use assets obtained in exchange for lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>80.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average remaining lease term in years:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average discount rate:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of operating lease right-of-use asset included in cash flows from operating activities in the Consolidated Statements of Cash Flows was </span><span style="font-family:inherit;font-size:10pt;color:#252525;"><span>$9.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Purchase Commitments</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are party to various purchase arrangements related to our manufacturing and research and development activities. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$165.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> of open purchase orders and contractual obligations in the ordinary course of business, most of which are due within </span><span style="font-family:inherit;font-size:10pt;"><span>one year</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6821926592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Significant Accounting Policies</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #ffffff;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">1. Organization and Significant Accounting Policies</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Organization and Business</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DexCom, Inc. is a medical device company focused on the design, development and commercialization of CGM system(s) for use by people with diabetes and by healthcare providers. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;DexCom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Basis of Presentation and Principles of Consolidation</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The functional currencies of our international subsidiaries are generally the local currencies. We translate the financial statements of our foreign subsidiaries into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in </span><span style="font-family:inherit;font-size:10pt;">comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;"> and in </span><span style="font-family:inherit;font-size:10pt;">accumulated other comprehensive income</span><span style="font-family:inherit;font-size:10pt;"> in the equity section of our consolidated balance sheet. Gains and losses resulting from certain intercompany transactions as well as transactions with customers and vendors that are denominated in currencies other than the functional currency of each entity give rise to foreign exchange gains or losses that we record in </span><span style="font-family:inherit;font-size:10pt;">interest and other income, net</span><span style="font-family:inherit;font-size:10pt;"> in our consolidated statements of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Use of Estimates</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles, or GAAP, requires us to make certain estimates and assumptions that affect the amounts reported in our financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include pharmacy rebates, transaction price, net accounts receivable, excess or obsolete inventories and the valuation of inventory, and accruals for litigation contingencies. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Fair Value Measurements</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The authoritative guidance establishes a fair value hierarchy that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities. In general, the authoritative guidance requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset or liability&#8217;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the measurement of its fair value. The three levels of input defined by the authoritative guidance are as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level&#160;1&#8212;Unadjusted quoted prices that are available in active markets for identical assets or liabilities.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level&#160;2&#8212;Inputs other than quoted prices included in Level&#160;1 that are observable, either directly or indirectly, through correlation with market data. These include quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data for substantially the full term of the assets or liabilities.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level&#160;3&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the determination of fair value. Level 3 assets and liabilities include those whose fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques and significant judgment or estimation.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We carry our marketable securities at fair value. We carry our other financial instruments, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, at cost, which approximates the related fair values due to the short-term maturities of these instruments. For more information see Note 3, &#8220;Fair Value Measurements.&#8221;</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Cash and Cash Equivalents</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We consider highly liquid investments with a maturity of </span><span style="font-family:inherit;font-size:10pt;"><span>90</span></span><span style="font-family:inherit;font-size:10pt;">&#160;days or less at the time of purchase to be cash equivalents.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Marketable Securities</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have classified our marketable securities with remaining maturity at purchase of more than three months and remaining maturities of one year or less as short-term marketable securities. We have also classified marketable securities with remaining maturities of greater than one year as short-term marketable securities based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We calculate realized gains or losses on our marketable securities using the specific identification method. We carry our marketable debt securities at fair value with unrealized gains and losses reported as a separate component of stockholders&#8217; equity in our consolidated balance sheets and included in </span><span style="font-family:inherit;font-size:10pt;">comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;">. Realized gains and losses on marketable debt securities are included in </span><span style="font-family:inherit;font-size:10pt;">interest and other income, net</span><span style="font-family:inherit;font-size:10pt;"> in our consolidated statements of operations. We carry our marketable equity securities at fair value with realized and unrealized gains and losses reported in income on equity investments in our consolidated statements of operations. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We invest in various types of debt securities, including debt securities in government-sponsored entities, corporate debt securities, U.S. Treasury securities and commercial paper. We do not generally intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity. See Note 3, &#8220;Fair Value Measurements&#8221; and Note 4, &#8220;Balance Sheet Details &#8211; </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Short-Term Marketable Securities</span><span style="font-family:inherit;font-size:10pt;">&#8221; for more information on our marketable debt securities and our marketable equity securities.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Accounts Receivable and Allowance for Doubtful Accounts</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable are generally recorded at the invoiced amount for Distributors and at net realizable value for Direct customers, which is determined using estimates of claim denials and historical reimbursement experience without regard to aging category. Accounts receivable are not interest bearing. We evaluate the creditworthiness of significant customers and generally do not require collateral from our customers. We maintain an allowance for doubtful accounts for potential credit losses. Uncollectable accounts are written off against the allowance after appropriate collection efforts have been exhausted and when it is deemed that a customer account is uncollectable.&#160;Generally, receivable balances greater than one year past due are deemed uncollectable.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Significant Customers</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table sets forth the percentages of total revenue or gross accounts receivable for customers that represent 10% or more of the respective amounts for the periods shown:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:46%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Accounts Receivable</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">As of December 31, </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Distributor A</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Distributor B</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Distributor C</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">*     Less than 10%</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Inventory</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventory is valued at the lower of cost or net realizable value on a part-by-part basis that approximates first in, first out. We record adjustments to inventory for potentially excess, obsolete or scrapped goods in order to state inventory at net realizable value. Factors influencing these adjustments include inventories on hand and on order compared to estimated future usage and sales for existing and new products, as well as judgments regarding quality control testing data and assumptions about the likelihood of scrap and obsolescence. Once written down the adjustments are considered permanent and are not reversed until the related inventory is sold or disposed of.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our products require customized products and components that currently are available from a limited number of sources. We purchase certain components and materials from single sources due to quality considerations, costs or constraints resulting from regulatory requirements. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Property and Equipment</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property and equipment is stated at cost less accumulated depreciation. We calculate depreciation using the straight-line method over the estimated useful lives of the assets. Estimated useful lives are generally </span><span style="font-family:inherit;font-size:10pt;"><span>three years</span></span><span style="font-family:inherit;font-size:10pt;"> for computer software and hardware, four to </span><span style="font-family:inherit;font-size:10pt;"><span>fifteen years</span></span><span style="font-family:inherit;font-size:10pt;"> for machinery and equipment, and </span><span style="font-family:inherit;font-size:10pt;"><span>five years</span></span><span style="font-family:inherit;font-size:10pt;"> for furniture and fixtures. Leasehold improvements are amortized over the shorter of the estimated useful lives of the assets or the remaining lease term. We include the amortization of assets that are recorded under finance leases in depreciation expense.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We review property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the recoverability of the asset by comparing the carrying amount to the future undiscounted cash flows that we expect the asset to generate. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Goodwill</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We record goodwill when the fair value of consideration transferred in a business combination exceeds the fair value of the identifiable assets acquired and liabilities assumed. Goodwill and other intangible assets that have indefinite useful lives are not amortized, but we test them annually for impairment in the fourth quarter of our fiscal year and whenever events or changes in circumstances indicate that it is more likely than not that the fair value is less than the carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate or operational performance of the business, and an adverse action or assessment by a regulator. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We perform our goodwill impairment analysis at the reporting unit level, which aligns with DexCom&#8217;s reporting structure and the availability of discrete financial information.&#160;We perform the first step of our annual impairment analysis by either comparing a reporting unit&#8217;s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit&#8217;s fair value from the last quantitative assessment to determine if there is potential impairment. We may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit&#8217;s estimated fair value was significantly in excess of the carrying value of its net assets and we do not believe there have been significant changes in the reporting unit&#8217;s operations that would significantly decrease its estimated fair value or significantly increase its net assets.&#160;If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections&#160;and/or use of a market approach by looking at market values of comparable companies. Key assumptions&#160;for these projections include revenue growth, future gross margin and operating margin growth, and weighted cost of capital and terminal growth rates. The revenue and margin growth are based on increased sales of new and existing products as we maintain investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements&#160;to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including the timing and probability of regulatory approvals for our products to be commercialized. We also consider DexCom&#8217;s market capitalization as a part of our analysis.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If the estimated fair value of a reporting unit exceeds the carrying amount of the net assets assigned to that unit, goodwill is not impaired and no further analysis is required. If the carrying value of the net assets assigned to a reporting unit exceeds the estimated fair value of the unit, we perform the second step of the impairment test. In this step we allocate the fair value of the reporting unit calculated in step one to all of the assets and liabilities of that unit, as if we had just acquired the reporting unit in a business combination. The excess of the fair value of the reporting unit over the total amount allocated to the assets and liabilities represents the implied fair value of goodwill. If the carrying amount of a reporting unit&#8217;s goodwill exceeds its implied fair value, we would record an impairment loss equal to the difference. We recorded </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> goodwill impairment charges for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The change in goodwill for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> consisted of translation adjustments on our foreign currency denominated goodwill. The change in goodwill for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;"> consisted of goodwill we recorded for acquisitions that were not significant, individually or in the aggregate, and translation adjustments on our foreign currency denominated goodwill. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Intangible Assets and Other Long-Lived Assets</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We amortize intangible assets with a finite life, such as acquired technology, customer relationships, trade names and trademarks, on a straight-line basis over their estimated useful lives, which range from </span><span style="font-family:inherit;font-size:10pt;">two</span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;">five</span><span style="font-family:inherit;font-size:10pt;"> years. We review intangible assets that have finite lives and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Income Taxes</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We recognize deferred tax assets to the extent that we believe that these assets are more likely than not to be realized, which requires significant judgment. The realization of deferred tax assets is dependent, in part, upon future taxable income. In assessing whether our deferred tax assets will be realized, we consider all available evidence, both positive and negative. Such evidence includes historical earnings, future reversals of existing taxable temporary differences, estimates of future taxable income, and the feasibility of ongoing tax planning strategies. We have recorded a full valuation allowance on our net deferred tax asset balances for all periods presented because of the uncertainty related to utilization of our deferred tax assets.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We record uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than </span><span style="font-family:inherit;font-size:10pt;">50 percent</span><span style="font-family:inherit;font-size:10pt;"> likely to be realized upon ultimate settlement with the related tax authority.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We file federal and state income tax returns in the United States and income tax returns in various other foreign jurisdictions with varying statutes of limitations. Due to net operating losses incurred, our income tax returns from inception to date are subject to examination by taxing authorities. We recognize interest expense and penalties related to income tax matters, including unrecognized tax benefits, as a component of income tax expense. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Warranty Accrual</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Estimated warranty costs associated with a product are recorded at the time revenue is recognized. We estimate future warranty costs by analyzing historical warranty experience for the timing and amount of returned product, and expectations for future warranty activity based on changes and improvements to the product or process that are in place or will be in place in the future. We evaluate these estimates on at least a quarterly basis to determine the continued appropriateness of our assumptions.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Loss Contingencies</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If the potential loss from a claim or legal proceeding is considered probable and the amount can be reasonably estimated, we record a liability and an expense for the estimated loss and disclose it in our financial statements if it is significant. If we determine that a loss is possible and the range of the loss can be reasonably determined, then we disclose the range of the possible loss. Significant judgment is required in the determination of whether a potential loss is probable, reasonably possible, or remote as well as in the determination of whether a potential exposure is reasonably estimable. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:16%;"/><td style="width:14%;"/><td style="width:14%;"/><td style="width:14%;"/><td style="width:14%;"/><td style="width:14%;"/><td style="width:14%;"/></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Comprehensive Income (Loss)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;"> consists of two elements, </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">other comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;">. We report all components of </span><span style="font-family:inherit;font-size:10pt;">comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;">, including </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;">, in our financial statements in the period in which they are recognized. Total </span><span style="font-family:inherit;font-size:10pt;">comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;"> is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We report </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> and the components of </span><span style="font-family:inherit;font-size:10pt;">other comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;">, including foreign currency translation adjustments and unrealized gains and losses on marketable securities, net of their related tax effect to arrive at total </span><span style="font-family:inherit;font-size:10pt;">comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;">.</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Revenue Recognition</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We generate our revenue from the sale of our Reusable Hardware and disposable sensors, which we refer to in this section as &#8220;Components&#8221;. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We adopted ASC Topic 606 effective January 1, 2018 using the modified retrospective method. Our revenue recognition policies under ASC Topic 606 are explained below.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Policy elections and practical expedients taken</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We report revenue net of taxes collected from customers, which are subsequently remitted to governmental authorities;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We account for shipping and handling activities that are performed after a customer has obtained control of a good as fulfillment costs rather than as separate performance obligations;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We do not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If we expect, at contract inception, that the period between the transfer of control and corresponding payment from the customer will be one year or less, we do not adjust the amount of consideration for the effects of a significant financing component.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Contracts and performance obligations</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations. We also provide free-of-charge software, mobile applications and updates for our DexCom Share</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></span><span style="font-family:inherit;font-size:10pt;">remote monitoring system. The standalone selling prices of our free-of-charge software, mobile applications and updates are estimated based on an expected cost plus a margin approach.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Transaction price</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Transaction price for the Components reflects the net consideration to which we expect to be entitled. </span><span style="font-family:inherit;font-size:10pt;">Transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Variable consideration</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Rebates.</span><span style="font-family:inherit;font-size:10pt;"> We estimate reductions for rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Product Returns. </span><span style="font-family:inherit;font-size:10pt;">In accordance with the terms of their distribution agreements, most distributors do not have rights of return outside of our limited warranty. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. We generally provide a &#8220;</span><span style="font-family:inherit;font-size:10pt;"><span>30</span></span><span style="font-family:inherit;font-size:10pt;">-day money back guarantee&#8221; program whereby first-time end-user customers may return Reusable Hardware. Product returns have historically been immaterial.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue recognition</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The timing of revenue recognition is based on the satisfaction of performance obligations. Substantially all of the performance obligations associated with our Components are satisfied at a point in time, which typically occurs at shipment of our products. Terms of direct and distributor orders are generally</span><span style="font-family:inherit;font-size:10pt;color:#ee2724;"> </span><span style="font-family:inherit;font-size:10pt;">Freight on Board (FOB) shipping point for U.S. orders or Free Carrier (FCA) shipping point for international orders. For certain of our distributors, control transfers at delivery of the product to the customer. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In cases where our free-of-charge software, mobile applications and updates are deemed to be separate performance obligations, revenue is recognized over time on a ratable basis over the estimated life of the related hardware component. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our sales of Components include an assurance-type warranty.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Judgments and Estimates</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In determining how revenue should be recognized, a five-step process is used, which requires judgment and estimates that can have a significant impact on the amount and timing of revenue we report. These judgments and estimates include identifying performance obligations in the contract, determining whether the performance obligations are separate, allocating the transaction price to each separate performance obligation, determining the timing of revenue recognition for separate performance obligations and estimating the amount of variable consideration to include in the transaction price. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Contract balances</span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract balances represent amounts presented in the consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from </span><span style="font-family:inherit;font-size:10pt;"><span>30</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>90</span></span><span style="font-family:inherit;font-size:10pt;"> days. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> included unbilled accounts receivable of </span><span style="font-family:inherit;font-size:10pt;"><span>$3.6 million</span></span><span style="font-family:inherit;font-size:10pt;">. Unbilled accounts receivable consists of revenue recognized for Components we have delivered but not yet invoiced to customers. We expect to invoice and collect all unbilled accounts receivable within twelve months. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation. The table below shows revenue that we recognized as a result of changes in the contract liability balances in the periods shown.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenue recognized in the period from:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts included in contract liabilities at the beginning of the period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our performance obligations are generally satisfied within 12 months of the initial contract date. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, the deferred revenue balance related to performance obligations that will be satisfied after 12 months was </span><span style="font-family:inherit;font-size:10pt;"><span>$2.1 million</span></span><span style="font-family:inherit;font-size:10pt;">. and is included in other long-term liabilities on our consolidated balance sheets. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">, we had </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> deferred revenue balance related to performance obligations that will be satisfied after 12 months.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred cost of sales</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred cost of sales are associated with sales for which revenue recognition criteria are not met but product has shipped and released from inventory. Deferred cost of sales are included in prepaid and other current assets in our consolidated balance sheets. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Incentive compensation costs</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been </span><span style="font-family:inherit;font-size:10pt;"><span>one year</span></span><span style="font-family:inherit;font-size:10pt;"> or less. We record these costs in selling, general and administrative expense in our consolidated statement of operations. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Product Shipment Costs</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We record the amounts we charge our customers for the shipping and handling of our products in revenue and we record the related costs as cost of sales in our statements of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Research and Development</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We expense costs of research and development as we incur them. Our research and development expenses primarily consist of engineering and research expenses related to our continuous glucose monitoring technology, clinical trials, regulatory expenses, quality assurance programs, materials and products for clinical trials. Research and development expenses primarily consist of employee compensation, including salary, fringe benefits, share-based compensation, and temporary employee expenses. We also incur significant expenses to operate our clinical trials that include clinical site reimbursement, clinical trial product, and associated travel expenses. Our research and development expenses also include fees for design services, contractors, and development materials.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our CGM systems include certain software that we develop. We expense software development costs as we incur them until technological feasibility has been established, at which time we capitalize development costs until the product is available for general release to customers. To date, our software has been available for general release concurrent with the establishment of technological feasibility and, accordingly, we have not capitalized any development costs. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Advertising Costs</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We expense advertising costs as we incur them to selling, general and administrative expenses. Advertising expense was </span><span style="font-family:inherit;font-size:10pt;"><span>$31.8 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$25.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$21.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, respectively. </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Leases</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We determine if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The interest rate used to determine the present value of the future lease payments is our incremental borrowing rate, because the interest rate implicit in most of our leases is not readily determinable. Our incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in similar economic environments. The operating lease right-of-use asset also includes any lease payments made and excludes lease incentives. We have lease agreements with lease and non-lease components, which are generally accounted for separately. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Variable lease payments that do not depend on a rate or index, payments associated with non-lease components, and costs related to leases with terms of less than 12 months are expensed as incurred.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Share-Based Compensation</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized straight-line over the requisite service period of the individual grants, which typically equals the vesting period. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We value time-based Restricted Stock Units (&#8220;RSUs&#8221;) at the date of grant using the intrinsic value method. Certain RSUs granted to senior management vest based on the achievement of pre-established performance or market goals.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We estimate the fair value of performance/market-based RSUs at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We update our assessment of the probability that the specified performance criteria will be achieved each quarter and adjust our estimate of the fair value of the performance-based RSUs if necessary. The Monte Carlo methodology that we use to estimate the fair value of market-based RSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the market-based RSUs at the date of grant must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the performance of the specified market criteria. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If any of the assumptions used change significantly, share-based compensation expense may differ materially from what we have recorded in the current period.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We account for forfeitures as they occur by reversing any share-based compensation expense related to awards that will not vest. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Net Income (Loss) Per Share</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> per share attributable to common stockholders is calculated by dividing the </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Potentially dilutive common shares consist of shares issuable from stock options, unvested RSUs, warrants and the 2022 and 2023 Senior Convertible Notes. Potentially dilutive common share equivalents shares from outstanding stock options, warrants and unvested RSUs are determined using the average share price for each period under the treasury stock method. Potentially dilutive shares issuable upon conversion of our 2022 and 2023 Senior Convertible Notes are determined using the if-converted method. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table sets forth the computation of basic and diluted </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> per share for the periods shown.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:61%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>101.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(127.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(50.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income (loss) per common share</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.11</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.44</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.58</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.10</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.44</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.58</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic weighted average shares outstanding</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>88.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dilutive potential common stock outstanding:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options and employee stock purchase plan</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Restricted stock units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023 Warrants</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022 senior convertible notes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023 senior convertible notes</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted weighted average shares outstanding</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>88.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In periods of net losses, we exclude potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outstanding anti-dilutive securities not included in the diluted </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> per share attributable to common stockholders calculations were as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:62%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options outstanding to purchase common stock</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unvested restricted stock units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023 Warrants</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior convertible notes due 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior convertible notes due 2023</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Recent Accounting Guidance</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted Accounting Pronouncements</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</span><span style="font-family:inherit;font-size:10pt;"> (ASU 2016-02), which requires a lessee to recognize most leases on the consolidated balance sheet as lease liabilities with corresponding right-of-use assets. </span><span style="font-family:inherit;font-size:10pt;color:#252525;">We adopted ASU&#160;2016-02 utilizing the modified retrospective transition method at the beginning of the first quarter of 2019. </span><span style="font-family:inherit;font-size:10pt;">See Note 6, &#8220;Leases and Other Commitments&#8221; for more information on the impact of our adoption of ASU 2016-02 and related disclosures.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">In August 2017, the FASB issued ASU No. 2017-12, </span><span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Derivatives and Hedging </span><span style="font-family:inherit;font-size:10pt;color:#252525;">(ASU 2017-12), which is intended to more closely align hedge accounting with companies&#8217; risk management strategies, simplify the application of hedge accounting, and increase transparency regarding the scope and results of hedging programs. The guidance in this update is applied using a cumulative-effect adjustment to retained earnings at the beginning of the fiscal year of adoption. ASU 2017-12 is effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Our adoption of ASU 2017-12 at the beginning of the first quarter of 2019 did not have a significant impact on our consolidated financial statements. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments - </span><span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Credit Losses: Measurement of Credit Losses on Financial Instruments</span><span style="font-family:inherit;font-size:10pt;color:#252525;">, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available-for-sale debt securities. This update is effective for annual periods beginning after December 15, 2019, and interim periods within those periods, and early adoption is permitted. </span><span style="font-family:inherit;font-size:10pt;">W</span><span style="font-family:inherit;font-size:10pt;color:#252525;">e expect to adopt the standard on its effective date in the first quarter of 2020. We believe the adoption will modify the way we analyze financial instruments, but currently do not expect the adoption to have a material financial impact on our consolidated financial statements. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">In January 2017, the FASB issued ASU No. 2017-04, </span><span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Intangibles &#8211; Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment </span><span style="font-family:inherit;font-size:10pt;color:#252525;">(ASU 2017-04). This new guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit&#8217;s carrying amount over its fair value. ASU 2017-04 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We do not expect the adoption to have a material financial impact on our consolidated financial statements. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-13,&#160;</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement: Disclosure Framework </span><span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">&#8211;</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Changes to the Disclosure Requirements for Fair Value Measurement </span><span style="font-family:inherit;font-size:10pt;">(ASU 2018-13), which&#160;adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance,&#160;entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public business entities will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. ASU 2018-13 is effective for public business entities for fiscal years beginning after December&#160;15, 2019, including interim periods within those fiscal years, and early adoption is permitted.&#160;</span><span style="font-family:inherit;font-size:10pt;color:#252525;">We do not expect the adoption to have a material financial impact on our consolidated financial statements. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">In August 2018, the FASB issued ASU No. 2018-15, </span><span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Intangibles - Goodwill and Other &#8211; Internal-Use Software: Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract</span><span style="font-family:inherit;font-size:10pt;color:#252525;"> (ASU 2018-15). This new guidance </span><span style="font-family:inherit;font-size:10pt;">requires a customer in a cloud computing arrangement to determine which implementation costs to capitalize as assets or expense as incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. </span><span style="font-family:inherit;font-size:10pt;color:#252525;">ASU 2018-15 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Application of this guidance can be applied either prospectively or retrospectively. We will adopt the new standard on January 1, 2020 on a prospective basis. We do not expect the adoption to have a material financial impact on our consolidated financial statements, however, the adoption of this standard will result in an increase in capitalized assets related to qualifying cloud computing arrangement implementation costs incurred after the adoption date.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In December 2019, the FASB issued&#160;ASU&#160;No. 2019-12, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Simplifying the Accounting for Income Taxes,</span><span style="font-family:inherit;font-size:10pt;"> which is intended to simplify various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years, and early adoption is permitted. </span><span style="font-family:inherit;font-size:10pt;color:#252525;">We are currently evaluating the impact that this guidance will have on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6822027872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value of Senior Convertible Notes (Details) - Senior Notes - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Total fair value of outstanding senior convertible notes</a></td>
<td class="nump">$ 2,150.8<span></span>
</td>
<td class="nump">$ 1,399.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior convertible notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Total fair value of outstanding senior convertible notes</a></td>
<td class="nump">890.8<span></span>
</td>
<td class="nump">540.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior convertible notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Total fair value of outstanding senior convertible notes</a></td>
<td class="nump">$ 1,260.0<span></span>
</td>
<td class="nump">$ 859.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6832105392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 1,476.0<span></span>
</td>
<td class="nump">$ 1,031.6<span></span>
</td>
<td class="nump">$ 718.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">544.5<span></span>
</td>
<td class="nump">367.7<span></span>
</td>
<td class="nump">226.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">931.5<span></span>
</td>
<td class="nump">663.9<span></span>
</td>
<td class="nump">492.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">273.5<span></span>
</td>
<td class="nump">199.7<span></span>
</td>
<td class="nump">185.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_CollaborativeResearchAndDevelopmentFee', window );">Collaborative research and development fee</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">217.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">515.7<span></span>
</td>
<td class="nump">432.8<span></span>
</td>
<td class="nump">349.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">789.2<span></span>
</td>
<td class="nump">850.2<span></span>
</td>
<td class="nump">534.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">142.3<span></span>
</td>
<td class="num">(186.3)<span></span>
</td>
<td class="num">(42.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(60.3)<span></span>
</td>
<td class="num">(22.7)<span></span>
</td>
<td class="num">(12.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesGainLoss', window );">Income (loss) from equity investments</a></td>
<td class="num">(4.2)<span></span>
</td>
<td class="nump">80.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Interest and other income, net</a></td>
<td class="nump">26.4<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">6.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">104.2<span></span>
</td>
<td class="num">(126.5)<span></span>
</td>
<td class="num">(48.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 101.1<span></span>
</td>
<td class="num">$ (127.1)<span></span>
</td>
<td class="num">$ (50.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per share (USD per share)</a></td>
<td class="nump">$ 1.11<span></span>
</td>
<td class="num">$ (1.44)<span></span>
</td>
<td class="num">$ (0.58)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used to compute basic net income (loss) per share (shares)</a></td>
<td class="nump">91.1<span></span>
</td>
<td class="nump">88.2<span></span>
</td>
<td class="nump">86.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per share (USD per share)</a></td>
<td class="nump">$ 1.10<span></span>
</td>
<td class="num">$ (1.44)<span></span>
</td>
<td class="num">$ (0.58)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute diluted net income (loss) per share (shares)</a></td>
<td class="nump">92.3<span></span>
</td>
<td class="nump">88.2<span></span>
</td>
<td class="nump">86.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CollaborativeResearchAndDevelopmentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Research and Development Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CollaborativeResearchAndDevelopmentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6998643488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents', window );">Maturity threshold of investments classified to cash equivalents</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and intangible asset impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod', window );">Sales return period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled accounts receivable</a></td>
<td class="nump">$ 3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue that will be satisfied after 12 months</a></td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_AmortizationPeriodForIncentiveCompensationCosts', window );">Amortization period for incentive compensation costs</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">$ 31,800,000<span></span>
</td>
<td class="nump">$ 25,400,000<span></span>
</td>
<td class="nump">$ 21,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer software and hardware</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of finite-lived intangible assets</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_ContractPaymentTermsNumberofDays', window );">Customer contract payment terms</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Machinery and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of finite-lived intangible assets</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_ContractPaymentTermsNumberofDays', window );">Customer contract payment terms</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Machinery and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AmortizationPeriodForIncentiveCompensationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization Period For Incentive Compensation Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AmortizationPeriodForIncentiveCompensationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ContractPaymentTermsNumberofDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract Payment Terms, Number of Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ContractPaymentTermsNumberofDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maturity Threshold Of Investments Classified To Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Organization And Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_RevenueRecognitionSalesReturnsCoveragePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue Recognition, Sales Returns, Coverage Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_RevenueRecognitionSalesReturnsCoveragePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118261985&amp;loc=d3e55302-109406<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6829162800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>- Anti-Dilutive Securities (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (shares)</a></td>
<td class="nump">14.6<span></span>
</td>
<td class="nump">17.2<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options outstanding to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Unvested restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (shares)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">2023 Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (shares)</a></td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member', window );">Senior convertible notes due 2022 | Senior convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (shares)</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior convertible notes due 2023 | Senior convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (shares)</a></td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6972569088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases And Other Commitments - Lease Cost (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">$ 1.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">12.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">3.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 21.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837504224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2018 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>d</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 19, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible debt, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 836,600,000<span></span>
</td>
<td class="nump">$ 389,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible note issuance, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(218,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from sale of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">183,800,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior convertible notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible note issuance, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member', window );">Senior convertible notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible note issuance, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior convertible notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 850,000,000.0<span></span>
</td>
<td class="nump">$ 850,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000.0<span></span>
</td>
<td class="nump">850,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible debt, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 836,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0060869<span></span>
</td>
<td class="nump">0.0100918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount', window );">Conversion amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible notes (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 164.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentCovenantRepurchasePricePercentage', window );">Holder's repurchase price percentage in event of fundamental change (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock', window );">Proportion of conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Stock counterparties to acquire with warrants purchased (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from sale of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants or rights (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 198.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior convertible notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 400,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000.0<span></span>
</td>
<td class="nump">$ 400,000,000.0<span></span>
</td>
<td class="nump">$ 400,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible debt, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 389,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount', window );">Conversion amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible notes (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentCovenantRepurchasePricePercentage', window );">Holder's repurchase price percentage in event of fundamental change (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock', window );">Proportion of conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity of revolving credit agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount', window );">Option to increase revolving line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold', window );">Value of unrestricted cash on hand threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity fee (as a percent)</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity fee (as a percent)</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible note issuance, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (218,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital | Senior convertible notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible note issuance, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital | Senior convertible notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible note issuance, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital | Senior Notes | Senior convertible notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity', window );">Recognized additional paid-in capital from cash conversion option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 174,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital | Senior Notes | Senior convertible notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity', window );">Recognized additional paid-in capital from cash conversion option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 72,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember', window );">Debt Instrument Conversion Term One | Senior Notes | Senior convertible notes due 2023 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember', window );">Debt Instrument Conversion Term One | Senior Notes | Senior convertible notes due 2023 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember', window );">Debt Instrument Conversion Term One | Senior Notes | Senior convertible notes due 2022 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember', window );">Debt Instrument Conversion Term One | Senior Notes | Senior convertible notes due 2022 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember', window );">Debt Instrument Conversion Term Two | Senior Notes | Senior convertible notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember', window );">Debt Instrument Conversion Term Two | Senior Notes | Senior convertible notes due 2023 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember', window );">Debt Instrument Conversion Term Two | Senior Notes | Senior convertible notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember', window );">Debt Instrument Conversion Term Two | Senior Notes | Senior convertible notes due 2022 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Senior Notes | Senior convertible notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares', window );">Stock issued upon conversion of senior notes (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible note issuance, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 218,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) | Line of Credit | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="nump">1.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) | Line of Credit | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Terms Of Conversion Feature, Conversion Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentCovenantRepurchasePricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Repurchase Price, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentCovenantRepurchasePricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Maximum Borrowing Capacity, Option to Increase, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Maturity, Conditional Restrictions, Value of Unrestricted Cash on Hand Threshold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=51819886&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the liability for the conversion option reclassified to stockholders' equity when the embedded option no longer required separation from the host instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35708913&amp;loc=d3e50896-113970<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6659460256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Provision (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income taxes</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income taxes</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes at effective rates</a></td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6988299472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Information (Unaudited) - Summary (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 462.8<span></span>
</td>
<td class="nump">$ 396.3<span></span>
</td>
<td class="nump">$ 336.4<span></span>
</td>
<td class="nump">$ 280.5<span></span>
</td>
<td class="nump">$ 338.0<span></span>
</td>
<td class="nump">$ 266.7<span></span>
</td>
<td class="nump">$ 242.5<span></span>
</td>
<td class="nump">$ 184.4<span></span>
</td>
<td class="nump">$ 1,476.0<span></span>
</td>
<td class="nump">$ 1,031.6<span></span>
</td>
<td class="nump">$ 718.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">309.3<span></span>
</td>
<td class="nump">246.9<span></span>
</td>
<td class="nump">206.5<span></span>
</td>
<td class="nump">168.8<span></span>
</td>
<td class="nump">222.8<span></span>
</td>
<td class="nump">168.6<span></span>
</td>
<td class="nump">153.6<span></span>
</td>
<td class="nump">118.9<span></span>
</td>
<td class="nump">931.5<span></span>
</td>
<td class="nump">663.9<span></span>
</td>
<td class="nump">492.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">207.8<span></span>
</td>
<td class="nump">190.9<span></span>
</td>
<td class="nump">207.3<span></span>
</td>
<td class="nump">183.2<span></span>
</td>
<td class="nump">387.4<span></span>
</td>
<td class="nump">154.7<span></span>
</td>
<td class="nump">158.5<span></span>
</td>
<td class="nump">149.6<span></span>
</td>
<td class="nump">789.2<span></span>
</td>
<td class="nump">850.2<span></span>
</td>
<td class="nump">534.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 92.7<span></span>
</td>
<td class="nump">$ 45.8<span></span>
</td>
<td class="num">$ (10.5)<span></span>
</td>
<td class="num">$ (26.9)<span></span>
</td>
<td class="num">$ (179.7)<span></span>
</td>
<td class="nump">$ 46.6<span></span>
</td>
<td class="nump">$ 30.2<span></span>
</td>
<td class="num">$ (24.2)<span></span>
</td>
<td class="nump">$ 101.1<span></span>
</td>
<td class="num">$ (127.1)<span></span>
</td>
<td class="num">$ (50.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per share (USD per share)</a></td>
<td class="nump">$ 1.01<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.30)<span></span>
</td>
<td class="num">$ (2.03)<span></span>
</td>
<td class="nump">$ 0.53<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="nump">$ 1.11<span></span>
</td>
<td class="num">$ (1.44)<span></span>
</td>
<td class="num">$ (0.58)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per share (USD per share)</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.30)<span></span>
</td>
<td class="num">$ (2.03)<span></span>
</td>
<td class="nump">$ 0.52<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="nump">$ 1.10<span></span>
</td>
<td class="num">$ (1.44)<span></span>
</td>
<td class="num">$ (0.58)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6978226448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Employee Benefit Plans and Stockholders' Equity</a></td>
<td class="text"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">9. Employee Benefit Plans and Stockholders&#8217; Equity</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">401(k) Plan </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have a defined contribution 401(k) retirement plan (the 401(k) Plan) covering substantially all employees in the United States that meet certain age requirements. Employees who participate in the 401(k) Plan may contribute up to </span><span style="font-family:inherit;font-size:10pt;"><span>75%</span></span><span style="font-family:inherit;font-size:10pt;"> of their compensation each year, subject to Internal Revenue Service limitations and the terms and conditions of the plan. Under the terms of the 401(k) Plan, we may elect to match a discretionary percentage of contributions. In April 2018, we began matching </span><span style="font-family:inherit;font-size:10pt;"><span>50%</span></span><span style="font-family:inherit;font-size:10pt;"> of contributions up to </span><span style="font-family:inherit;font-size:10pt;"><span>4%</span></span><span style="font-family:inherit;font-size:10pt;"> of annual compensation. Total matching contributions were </span><span style="font-family:inherit;font-size:10pt;"><span>$4.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$2.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Employee Stock Purchase Plan, or ESPP</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Under the 2015 Employee Stock Purchase Plan (the 2015 ESPP) eligible employees can purchase shares of our common stock at semi-annual intervals through periodic payroll deductions during defined Offering Periods. A total of up to </span><span style="font-family:inherit;font-size:10pt;"><span>1.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares may be issued under the 2015 ESPP and it expires upon the earliest to occur of (a) termination of the 2015 ESPP by our board of directors, (b) issuance of all of the shares of common stock reserved for issuance under the plan, or (c) May 28, 2025.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Payroll deductions may not exceed </span><span style="font-family:inherit;font-size:10pt;"><span>10%</span></span><span style="font-family:inherit;font-size:10pt;"> of the participant&#8217;s cash compensation subject to certain limitations, and the purchase price will not be less than </span><span style="font-family:inherit;font-size:10pt;"><span>85%</span></span><span style="font-family:inherit;font-size:10pt;"> of the lower of the fair market value of the common stock at either the beginning of the applicable Offering Period or the Purchase Date. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We issued </span><span style="font-family:inherit;font-size:10pt;"><span>150,408</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>189,904</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>122,857</span></span><span style="font-family:inherit;font-size:10pt;"> shares of common stock under the 2015 </span><span style="font-family:inherit;font-size:10pt;">ESPP</span><span style="font-family:inherit;font-size:10pt;"> during the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Equity Incentive Plans</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In May 2015, we adopted the </span><span style="font-family:inherit;font-size:10pt;">Amended and Restated 2015 Equity Incentive Plan (the 2015 Plan)</span><span style="font-family:inherit;font-size:10pt;">, which replaced our </span><span style="font-family:inherit;font-size:10pt;">2005 Equity Incentive Plan</span><span style="font-family:inherit;font-size:10pt;"> and provides for the grant of incentive and nonstatutory stock options, restricted stock, stock bonuses, stock appreciation rights, and restricted stock units to employees, directors or consultants of the Company. On May 30, 2019 our stockholders approved an increase to the maximum number of shares that may be issued under the </span><span style="font-family:inherit;font-size:10pt;">2015 Plan</span><span style="font-family:inherit;font-size:10pt;">. We are permitted to issue up to&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>9.8 million</span></span><span style="font-family:inherit;font-size:10pt;">&#160;shares under the </span><span style="font-family:inherit;font-size:10pt;">2015 Plan</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Treasury Stock</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Repurchased shares of our common stock are held as treasury shares until they are reissued or retired. When we reissue treasury stock, if the proceeds from the sale are more than the average price we paid to acquire the shares we record an increase in additional paid-in capital. Conversely, if the proceeds from the sale are less than the average price we paid to acquire the shares, we record a decrease in additional paid-in capital to the extent of increases previously recorded for similar transactions and a decrease in retained earnings for any remaining amount. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We issue new shares of common stock to satisfy option exercises and RSU vesting under our employee equity incentive plans. We have not yet determined the ultimate disposition of the </span><span style="font-family:inherit;font-size:10pt;"><span>0.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares that we repurchased in 2018, and consequently we continue to hold them as treasury shares rather than retiring them. </span><span style="font-family:inherit;font-size:10pt;"><span>No</span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock were repurchased during </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Stock Options</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have not granted any stock options since 2010. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> we have </span><span style="font-family:inherit;font-size:10pt;"><span>28,385</span></span><span style="font-family:inherit;font-size:10pt;"> options outstanding, all of which are in-the-money. The options have a weighted- average remaining contractual term of </span><span style="font-family:inherit;font-size:10pt;"><span>0.27</span></span><span style="font-family:inherit;font-size:10pt;"> years, a weighted- average exercise price of </span><span style="font-family:inherit;font-size:10pt;"><span>$10.11</span></span><span style="font-family:inherit;font-size:10pt;"> per share, and an aggregate&#160;intrinsic value of </span><span style="font-family:inherit;font-size:10pt;"><span>$5.9 million</span></span><span style="font-family:inherit;font-size:10pt;">. The aggregate intrinsic value of options outstanding and exercisable is calculated as the difference between the exercise price of the underlying options and the </span><span style="font-family:inherit;font-size:10pt;"><span>$218.74</span></span><span style="font-family:inherit;font-size:10pt;"> per share market price of our common stock at </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The total intrinsic value of stock options exercised as of the date of exercise was as follows:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intrinsic value of options exercised</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Restricted Stock Units (RSUs)</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU awards typically vest annually over </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;">four</span><span style="font-family:inherit;font-size:10pt;"> years and vesting is subject to continued services. A summary of our RSU activity for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> is as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:62%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions except weighted average grant date fair value)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted&#160;</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant&#160;Date</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair&#160;Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Intrinsic&#160;Value</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonvested at December 31, 2016</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>62.51</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.78</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>58.92</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>67.97</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonvested at December 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>70.68</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>154.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>66.07</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68.44</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68.56</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonvested at December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>69.19</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>319.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>144.37</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>69.45</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>83.45</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonvested at December 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>96.63</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>392.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The total vest-date fair value of </span><span style="font-family:inherit;font-size:10pt;">RSUs</span><span style="font-family:inherit;font-size:10pt;"> vested was </span><span style="font-family:inherit;font-size:10pt;"><span>$207.2 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$120.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$144.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Common Stock Reserved for Future Issuance</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shares of common stock reserved for future issuance were as follows as of the dated indicated:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:75%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options and awards under our plans:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options granted and outstanding</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unvested restricted stock units</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reserved for future grant</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Employee Stock Purchase Plan</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Share-based Compensation</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes share-based compensation expense related to restricted stock units and employee stock purchases under the ESPP for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>37.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Selling, general and administrative</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>59.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>59.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total share-based compensation expense included in net loss</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>101.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>106.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We estimate the fair value of ESPP purchase rights on the date of grant using the Black-Scholes option pricing model and the assumptions below for the specified reporting periods. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:62%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Risk free interest rate</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.72 - 2.55</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.55&#160;&#8211;&#160;2.25</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75&#160;&#8211;&#160;1.12</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividend yield</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected volatility of DexCom common stock</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.40 - 0.51</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.50&#160;&#8211;&#160;0.67</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.33&#160;&#8211;&#160;0.56</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected life (in years)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, unrecognized estimated compensation costs related to unvested restricted stock units and ESPP shares totaled </span><span style="font-family:inherit;font-size:10pt;"><span>$119.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> and are expected to be recognized through </span><span style="font-family:inherit;font-size:10pt;">2022</span>.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI http://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6821902848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.51219512195122%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">5. Debt</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Senior Convertible Notes</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The carrying amounts of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2022:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Principal amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>400.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>400.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt discount</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(37.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(51.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net carrying amount of Senior Convertible Notes due 2022</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>358.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>342.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2023:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Principal amount</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>850.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>850.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt discount</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(140.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(171.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net carrying amount of Senior Convertible Notes due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>701.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>667.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total net carrying amount of senior convertible notes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,059.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,010.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Carrying value of equity component of convertible senior notes, net of debt issuance costs</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>70.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>70.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>171.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>171.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Remaining&#160;amortization&#160;period&#160;of&#160;debt discount&#160;on&#160;the&#160;liability&#160;component</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.5 years</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.5 years</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.0 years</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.0 years</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The amount by which the notes&#8217; if-converted value exceeds their principal amount is as of the dates indicated:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>486.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>125.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>372.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total by which the notes&#8217; if-converted value exceeds their principal amount</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>858.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>125.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;padding-left:0px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown. </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Interest expense recognized:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2022:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contractual coupon interest</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accretion of debt discount </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense recognized on 2022 Notes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2023:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contractual coupon interest</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accretion of debt discount </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense recognized on 2023 Notes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>40.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total interest expense recognized on senior notes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>58.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Effective interest rates:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)  </sup></span><span style="font-family:inherit;font-size:10pt;">The discount on the 2022 Notes is being amortized through May 15, 2022. Interest on the 2022 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.</span></div><div style="line-height:120%;padding-bottom:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)  </sup></span><span style="font-family:inherit;font-size:10pt;">The discount on the 2023 Notes is being amortized through December 1, 2023. Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">0.75%</span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> Senior Convertible Notes due 2022 </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In </span><span style="font-family:inherit;font-size:10pt;">June 2017</span><span style="font-family:inherit;font-size:10pt;">, we completed an offering of </span><span style="font-family:inherit;font-size:10pt;"><span>$400.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> aggregate principal amount of unsecured senior convertible notes with a stated interest rate of </span><span style="font-family:inherit;font-size:10pt;"><span>0.75%</span></span><span style="font-family:inherit;font-size:10pt;"> and a maturity date of </span><span style="font-family:inherit;font-size:10pt;">May&#160;15, 2022</span><span style="font-family:inherit;font-size:10pt;"> (the 2022 Notes). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and costs directly related to the offering, were approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$389.0 million</span></span><span style="font-family:inherit;font-size:10pt;">. The initial conversion rate of the 2022 Notes is </span><span style="font-family:inherit;font-size:10pt;">10.0918</span><span style="font-family:inherit;font-size:10pt;"> shares per </span><span style="font-family:inherit;font-size:10pt;"><span>$1,000</span></span><span style="font-family:inherit;font-size:10pt;"> principal amount of notes, which is equivalent to a conversion price of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$99.09</span></span><span style="font-family:inherit;font-size:10pt;"> per share, subject to adjustments. The 2022 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2022 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders&#8217; equity. As a result, we recognized </span><span style="font-family:inherit;font-size:10pt;"><span>$72.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> in additional paid-in-capital during 2017.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">No principal payments are due on the 2022 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2022 Notes includes customary terms and covenants, including certain events of default after which the 2022 Notes may be due and payable immediately.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Conversion Rights at the Option of the Holders </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the event of a fundamental change (as defined in the indenture related to the 2022 Notes), holders of the 2022 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to </span><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span><span style="font-family:inherit;font-size:10pt;"> of the principal amount of the 2022 Notes, plus any accrued and unpaid interest. Holders of the 2022 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by DexCom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior to 5:00 p.m., New York City time, on the business day immediately preceding February&#160;15, 2022, holders of the 2022 Notes may convert all or a portion of their notes, in multiples of </span><span style="font-family:inherit;font-size:10pt;"><span>$1,000</span></span><span style="font-family:inherit;font-size:10pt;"> principal amount, only under the following circumstances:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">(1)</span></div></td><td style="vertical-align:top;padding-left:12px;"><div style="line-height:120%;text-align:left;font-size:10pt;text-indent:-12px;"><span style="font-family:inherit;font-size:10pt;">during any calendar quarter commencing after September&#160;30, 2017 (and only during such calendar quarter), if the last reported sale price of common stock for at least </span><span style="font-family:inherit;font-size:10pt;"><span>20</span></span><span style="font-family:inherit;font-size:10pt;"> trading days (whether or not consecutive) during the period of </span><span style="font-family:inherit;font-size:10pt;"><span>30</span></span><span style="font-family:inherit;font-size:10pt;"> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to </span><span style="font-family:inherit;font-size:10pt;"><span>130%</span></span><span style="font-family:inherit;font-size:10pt;"> of the applicable conversion price of the Notes on each such trading day;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">during the </span><span style="font-family:inherit;font-size:10pt;"><span>five</span></span><span style="font-family:inherit;font-size:10pt;"> business day period after any </span><span style="font-family:inherit;font-size:10pt;"><span>five</span></span><span style="font-family:inherit;font-size:10pt;"> consecutive trading day period in which the trading price per </span><span style="font-family:inherit;font-size:10pt;"><span>$1,000</span></span><span style="font-family:inherit;font-size:10pt;"> principal amount of the Notes for each day of that </span><span style="font-family:inherit;font-size:10pt;"><span>five</span></span><span style="font-family:inherit;font-size:10pt;"> day consecutive trading day period was less than </span><span style="font-family:inherit;font-size:10pt;"><span>98%</span></span><span style="font-family:inherit;font-size:10pt;"> of the product of the last reported sale price of common stock and the applicable conversion rate of the Notes on such trading day;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">if we call any or all of the Notes for redemption, at any time prior to the close on business on the scheduled trading day immediately preceding the redemption date; or</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">(4)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">upon the occurrence of specified corporate transactions.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;On or after </span><span style="font-family:inherit;font-size:10pt;">February&#160;15, 2022</span><span style="font-family:inherit;font-size:10pt;">, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2022 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Circumstance (1) listed above occurred during the quarters ended March 31, 2019, September 30, 2019 and December 31, 2019. As a result, the 2022 Notes became convertible at the option of the holders from April 1, 2019 through June 30, 2019, October 1, 2019 through December 31, 2019 and will remain convertible at the option of the holder from January 1, 2020 through March 31, 2020.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Holders of 2022 Notes with an insignificant principal amount exercised their option to convert their 2022 Notes during the second and fourth quarters of 2019 and we settled these conversions with shares of our common stock. We continue to classify the carrying value of the liability component of the 2022 Notes as long-term debt, and the equity component of the 2022 Notes as permanent equity in our consolidated balance sheets as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Conversion Rights at Our Option </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DexCom may not redeem the 2022 Notes prior to May 15, 2020. On or after May 15, 2020, DexCom may redeem for cash all or part of the 2022 Notes, at its option, if the last reported sale price of our common stock has been at least </span><span style="font-family:inherit;font-size:10pt;"><span>140%</span></span><span style="font-family:inherit;font-size:10pt;"> of the conversion price then in effect for at least </span><span style="font-family:inherit;font-size:10pt;"><span>20</span></span><span style="font-family:inherit;font-size:10pt;"> trading days (whether or not consecutive) during any </span><span style="font-family:inherit;font-size:10pt;"><span>30</span></span><span style="font-family:inherit;font-size:10pt;"> consecutive trading day period ending on, and including, the trading day immediately preceding the date on which DexCom provides notice of redemption. The redemption price will be equal to </span><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span><span style="font-family:inherit;font-size:10pt;"> of the principal amount of the 2022 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="line-height:174%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">0.75% Senior Convertible Notes due 2023</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In </span><span style="font-family:inherit;font-size:10pt;">November 2018</span><span style="font-family:inherit;font-size:10pt;">, we completed an offering of&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>$850.0 million</span></span><span style="font-family:inherit;font-size:10pt;">&#160;aggregate principal amount of unsecured senior convertible notes with a stated interest rate of&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>0.75%</span></span><span style="font-family:inherit;font-size:10pt;">&#160;and a maturity date of&#160;</span><span style="font-family:inherit;font-size:10pt;">December&#160;1, 2023</span><span style="font-family:inherit;font-size:10pt;">&#160;(the 2023 Notes). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and costs directly related to the offering, were approximately&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>$836.6 million</span></span><span style="font-family:inherit;font-size:10pt;">. The initial conversion rate of the 2023 Notes is&#160;</span><span style="font-family:inherit;font-size:10pt;">6.0869</span><span style="font-family:inherit;font-size:10pt;">&#160;shares per&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>$1,000</span></span><span style="font-family:inherit;font-size:10pt;"> principal amount of notes, which is equivalent to a conversion price of approximately&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>$164.29</span></span><span style="font-family:inherit;font-size:10pt;">&#160;per share, subject to adjustments. We entered into transactions for a convertible note hedge (the 2023 Note Hedge) and warrants (the 2023 Warrants) concurrently with the issuance of the 2023 Notes. The 2023 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2023 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders&#8217; equity. As a result, we recognized </span><span style="font-family:inherit;font-size:10pt;"><span>$174.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> in additional paid-in capital during 2018. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">No principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2023 Notes includes customary terms and covenants, including certain events of default after which the 2023 Notes may be due and payable immediately. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Conversion Rights at the Option of the Holders </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Holders of the 2023 Notes have the right to require us to repurchase for cash all or a portion of their notes at </span><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span><span style="font-family:inherit;font-size:10pt;"> of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the notes). We will also be required to increase the conversion rate for holders who convert their 2023 Notes in connection with certain fundamental changes occurring prior to the maturity date or following the delivery by DexCom of a notice of redemption.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Holders of the 2023 Notes may convert all or a portion of their notes at their option prior to 5:00 p.m., New York City time, on the business day immediately preceding September&#160;1, 2023, in multiples of </span><span style="font-family:inherit;font-size:10pt;"><span>$1,000</span></span><span style="font-family:inherit;font-size:10pt;"> principal amount, only under the following circumstances:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">during any calendar quarter commencing after March 31, 2019 (and only during such calendar quarter), if the last reported sale price of common stock for at least </span><span style="font-family:inherit;font-size:10pt;"><span>20</span></span><span style="font-family:inherit;font-size:10pt;"> trading days (whether or not consecutive) during the period of </span><span style="font-family:inherit;font-size:10pt;"><span>30</span></span><span style="font-family:inherit;font-size:10pt;"> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to </span><span style="font-family:inherit;font-size:10pt;"><span>130%</span></span><span style="font-family:inherit;font-size:10pt;"> of the applicable conversion price of the 2023 Notes on each such trading day;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">during the </span><span style="font-family:inherit;font-size:10pt;"><span>five</span></span><span style="font-family:inherit;font-size:10pt;"> business day period after any </span><span style="font-family:inherit;font-size:10pt;"><span>five</span></span><span style="font-family:inherit;font-size:10pt;"> consecutive trading day period in which the trading price per </span><span style="font-family:inherit;font-size:10pt;"><span>$1,000</span></span><span style="font-family:inherit;font-size:10pt;"> principal amount of the 2023 Notes for each day of that </span><span style="font-family:inherit;font-size:10pt;"><span>five</span></span><span style="font-family:inherit;font-size:10pt;">-day consecutive trading day period was less than </span><span style="font-family:inherit;font-size:10pt;"><span>98%</span></span><span style="font-family:inherit;font-size:10pt;"> of the product of the last reported sale price of common stock and the applicable conversion rate of the 2023 Notes on such trading day;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">if we call any or all of the 2023 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">(4)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">upon the occurrence of specified corporate transactions.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On or after </span><span style="font-family:inherit;font-size:10pt;">September&#160;1, 2023</span><span style="font-family:inherit;font-size:10pt;">, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2023 Notes may convert all or a portion of their notes regardless of the foregoing circumstances. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Circumstance (1) listed above occurred during the quarter ended December 31, 2019. As a result, the 2023 Notes are convertible at the option of the holders from January 1, 2020 and will remain convertible until March 31, 2020. We continue to classify the carrying value of the liability component of the 2023 Notes as long-term debt, and the equity component of the 2023 Notes as permanent equity in our consolidated balance sheets as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Conversion Rights at Our Option </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DexCom may not redeem the 2023 Notes prior to December 1, 2021. On or after December 1, 2021 and prior to September 1, 2023, DexCom may redeem for cash all or part of the 2023 Notes, at its option, if the last reported sale price of our common stock has been at least </span><span style="font-family:inherit;font-size:10pt;"><span>130%</span></span><span style="font-family:inherit;font-size:10pt;"> of the conversion price then in effect for at least </span><span style="font-family:inherit;font-size:10pt;"><span>20</span></span><span style="font-family:inherit;font-size:10pt;"> trading days (whether or not consecutive) during any </span><span style="font-family:inherit;font-size:10pt;"><span>30</span></span><span style="font-family:inherit;font-size:10pt;"> consecutive trading day period ending on, and including, the trading day immediately preceding the date on which DexCom provides notice of redemption. The redemption price will be equal to </span><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span><span style="font-family:inherit;font-size:10pt;"> of the principal amount of the 2023 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">2023 Note Hedge</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions with two of the initial purchasers of the 2023 Notes (the 2023 Counterparties) entitling us to purchase up to&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>5.2 million</span></span><span style="font-family:inherit;font-size:10pt;">&#160;shares of our common stock at an initial price of&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>$164.29</span></span><span style="font-family:inherit;font-size:10pt;">&#160;per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>$218.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> and we accounted for it as an equity instrument by recognizing </span><span style="font-family:inherit;font-size:10pt;"><span>$218.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> in&#160;additional paid-in capital&#160;during 2018. The 2023 Note Hedge will expire on </span><span style="font-family:inherit;font-size:10pt;">December&#160;1, 2023</span><span style="font-family:inherit;font-size:10pt;">. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge.&#160;The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge. An assumed exercise of the 2023 Note Hedge by us is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">2023 Warrants</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In November 2018, we also sold warrants to the 2023 Counterparties to acquire up to&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>5.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock. The 2023 Warrants require net share settlement and a pro rated number of warrants will expire on each of the </span><span style="font-family:inherit;font-size:10pt;"><span>60</span></span><span style="font-family:inherit;font-size:10pt;"> scheduled trading days starting on </span><span style="font-family:inherit;font-size:10pt;">March&#160;1, 2024</span><span style="font-family:inherit;font-size:10pt;">. We received&#160;</span><span style="font-family:inherit;font-size:10pt;"><span>$183.8 million</span></span><span style="font-family:inherit;font-size:10pt;">&#160;in cash proceeds from the sale of the 2023 Warrants, which we recorded in&#160;additional paid-in capital during 2018. The 2023 Warrants could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2023 Warrants. The strike price of the 2023 Warrants is initially </span><span style="font-family:inherit;font-size:10pt;"><span>$198.38</span></span><span style="font-family:inherit;font-size:10pt;"> per share and is subject to certain adjustments under the terms of the warrant agreements. We use the treasury share method for assumed conversion of the 2023 Warrants when computing the weighted average common shares outstanding for diluted earnings per share.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Revolving Credit Agreement</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Terms of the Revolving Credit Agreement</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On December 19, 2018, we entered into an amended and restated revolving credit agreement (the Credit Agreement) which provides for available principal amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$200.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> which can be increased up to </span><span style="font-family:inherit;font-size:10pt;"><span>$500.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> at our option subject to customary conditions and approval of our lenders. Borrowings under the Credit Agreement are available for general corporate purposes, including working capital and capital expenditures. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Information related to availability and outstanding borrowings on our Credit Agreement is as follows: </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:86%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Available principal amount </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>200.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Letters of credit sub-facility</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outstanding borrowings </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outstanding letters of credit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total available balance</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup>&#160;</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revolving loans under the Credit Agreement bear interest at our choice of one of two base rates plus a range of applicable margin rates that are based on our leverage ratio. The first base rate is the highest of (a) the publicly announced JPMorgan Chase prime rate, (b) the federal funds rate, or (c) the overnight bank funding rate, and the applicable margin rate ranges from </span><span style="font-family:inherit;font-size:10pt;"><span>0.375%</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>1.000%</span></span><span style="font-family:inherit;font-size:10pt;">. The second base rate is a LIBOR-based rate, and the applicable margin rate ranges from </span><span style="font-family:inherit;font-size:10pt;"><span>1.375%</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>2.000%</span></span><span style="font-family:inherit;font-size:10pt;">. We will also pay a commitment fee of between </span><span style="font-family:inherit;font-size:10pt;"><span>0.2%</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>0.3%</span></span><span style="font-family:inherit;font-size:10pt;">, payable quarterly in arrears, on the average daily unused amount of the revolving facility based on our leverage ratio. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Credit Agreement will mature on the earlier to occur of (i) December 19, 2023 or (ii) 91 days prior to the maturity date of the 2022 Notes or (iii) 91 days prior to the maturity date of the 2023 Notes if both (a) the aggregate outstanding principal amount of the 2022 Notes or the 2023 Notes, as applicable, is greater than EBITDA for the period of four consecutive fiscal quarters ending prior to such date and (b) unrestricted domestic cash on hand is less than the aggregate outstanding principal amount of the 2022 Notes or the 2023 Notes, as applicable, plus </span><span style="font-family:inherit;font-size:10pt;"><span>$100.0 million</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our obligations under the Credit Agreement are guaranteed by our existing and future wholly-owned domestic subsidiaries, and are secured by a first-priority security interest in substantially all of the assets of DexCom and the guarantors, including all or a portion of the equity interests of our domestic subsidiaries and first-tier foreign subsidiaries but excluding real property and intellectual property (which is subject to a negative pledge). The Credit Agreement contains covenants that limit certain indebtedness, liens, investments, transactions with affiliates, dividends and other restricted payments, subordinated indebtedness and amendments to subordinated indebtedness documents, and sale and leaseback transactions of DexCom or any of its domestic subsidiaries. The Credit Agreement also requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6998048176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 101.1<span></span>
</td>
<td class="num">$ (127.1)<span></span>
</td>
<td class="num">$ (50.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation gain (loss)</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on marketable debt securities</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">$ 101.9<span></span>
</td>
<td class="num">$ (123.0)<span></span>
</td>
<td class="num">$ (51.8)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e557-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6832078256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Revenues and Gross Accounts Receivable by Customer (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue | Distributor A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue | Distributor B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue | Distributor C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Gross Accounts Receivable | Distributor A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Gross Accounts Receivable | Distributor B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13537-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=dxcm_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=dxcm_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=dxcm_CustomerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=dxcm_CustomerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=dxcm_CustomerCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=dxcm_CustomerCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6829300448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Development and Other Agreements - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 20, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 28, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DevelopmentAgreementsLineItems', window );"><strong>Development Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_CollaborativeResearchAndDevelopmentFee', window );">Collaborative research and development fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 217.7<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement | Verily Life Sciences | Collaborative Arrangement, Initial Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DevelopmentAgreementsLineItems', window );"><strong>Development Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_CollaborativeArrangementUpfrontFee', window );">Initial payment on collaborative agreement</a></td>
<td class="nump">$ 250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with acquisition, shares</a></td>
<td class="nump">1,840,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_CollaborativeResearchAndDevelopmentFee', window );">Collaborative research and development fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 217.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing stock price (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118.28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement | Verily Life Sciences | Collaborative Arrangement, Milestone Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DevelopmentAgreementsLineItems', window );"><strong>Development Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_CollaborativeResearchAndDevelopmentFee', window );">Collaborative research and development fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments', window );">Additional milestones and incentive payments</a></td>
<td class="nump">$ 275.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones', window );">Milestone payments due upon achievement of future development</a></td>
<td class="nump">$ 275.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues', window );">Potential future common stock issuable (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,025,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated', window );">Consecutive days used to calculate volume weighted average trading price</a></td>
<td class="text">15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Development &amp; Regulatory Milestones</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Development &amp; Regulatory Milestones, Total Regulatory and Incentive Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CollaborativeArrangementUpfrontFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Upfront Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CollaborativeArrangementUpfrontFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CollaborativeResearchAndDevelopmentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Research and Development Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CollaborativeResearchAndDevelopmentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DevelopmentAgreementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Development Agreements [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DevelopmentAgreementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential Future Common Stock Issuable, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PotentialFutureCommonStockIssuableSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Share Price, Consecutive Days Evaluated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=dxcm_VerilyLifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=dxcm_VerilyLifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementInitialPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementInitialPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6831935344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Feb. 07, 2020</div></th>
<th class="th"><div>Jun. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover page.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001093557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-51222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DEXCOM, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0857544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6340 Sequence Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">200-0200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 Par Value Per Share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DXCM<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,556.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,594,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 20-F, 40-F<br> -Number 240<br> -Section 15<br> -Subsection d-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6991959264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Development and Other Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DevelopmentAndOtherAgreementsTextBlock', window );">Development and Other Agreements</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">2. Development and Other Agreements</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Collaboration with Verily Life Sciences</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On November 20, 2018, we entered into an Amended and Restated Collaboration and License Agreement with Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited (collectively, Verily), which we refer to as the Restated Collaboration Agreement. This replaced our original Collaboration and License Agreement with Verily dated August 10, 2015, as amended in October 2016, including the royalty obligations provisions under that original agreement. Pursuant to the Restated Collaboration Agreement, we and Verily have agreed to continue to jointly develop a certain next-generation CGM product, and potentially one or more additional CGM products, for which we will have exclusive commercialization rights. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The </span><span style="font-family:inherit;font-size:10pt;">Restated Collaboration Agreement</span><span style="font-family:inherit;font-size:10pt;"> also provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside of the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#8217;s other intellectual property rights to develop, manufacture and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities. The Restated Collaboration Agreement requires us to use commercially reasonable efforts to develop, launch and commercialize the CGM product(s) that are the subject of the collaboration according to certain timing and other objectives, and provides for one executive sponsor from each of DexCom and Verily to meet periodically and make decisions related to the collaboration (within a limited scope of authority) by consensus.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In consideration of Verily&#8217;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we have made upfront and incentive payments and we will make potential future milestone payments upon the achievement of certain goals. In the fourth quarter of 2018, we made an initial payment of </span><span style="font-family:inherit;font-size:10pt;"><span>$250.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> through the issuance of </span><span style="font-family:inherit;font-size:10pt;"><span>1,840,943</span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock. We recorded a </span><span style="font-family:inherit;font-size:10pt;"><span>$217.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> charge in our consolidated statement of operations during 2018 relating to the issuance of this common stock because this milestone payment did not meet the capitalization criteria. The amount of the charge was based on our closing stock price of </span><span style="font-family:inherit;font-size:10pt;"><span>$118.28</span></span><span style="font-family:inherit;font-size:10pt;"> per share on December 28, 2018, the date on which we obtained the necessary regulatory approvals and the transaction closed. During </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, we made an incentive payment of </span><span style="font-family:inherit;font-size:10pt;"><span>$3.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> due to the completion of certain development obligations and recorded as research and development in the consolidated statement of operations. Additional milestone payments of up to a total of </span><span style="font-family:inherit;font-size:10pt;"><span>$275.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> may become due and payable by us upon the achievement of future development, product regulatory approval and revenue milestones. These payments may be paid in cash or shares of our common stock, at our election. If we elect to make all </span><span style="font-family:inherit;font-size:10pt;"><span>$275.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> of these payments in shares, we will issue a total of </span><span style="font-family:inherit;font-size:10pt;"><span>2,025,036</span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock, based on the volume weighted average trading price during the </span><span style="font-family:inherit;font-size:10pt;"><span>15</span></span><span style="font-family:inherit;font-size:10pt;"> consecutive days ending on the date of the Restated Collaboration Agreement. Alternatively, if we elect to make all </span><span style="font-family:inherit;font-size:10pt;"><span>$275.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> of these payments in cash, any such cash payment would be equal to the number of shares that would otherwise be issued for the given milestone payment multiplied by the value of our stock on the date the relevant milestone is achieved, adjusted for stock splits, dividends, and the like.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Restated Collaboration Agreement will continue until December 31, 2028, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party. Upon achievement of the first revenue milestone event and payment of the corresponding milestone fee by us, the term of the Restated Collaboration Agreement will be extended until December 31, 2033.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DevelopmentAndOtherAgreementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Development And Other Agreements [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DevelopmentAndOtherAgreementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6834691504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details - Short-term Marketable Securities, Available-for-Sale (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract', window );"><strong>Equity investment in Tandem Diabetes Care, Inc</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCost', window );">Amortized Cost</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain', window );">Gross Unrealized Gains</a></td>
<td class="nump">36.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss', window );">Gross Unrealized Losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Estimated Market Value</a></td>
<td class="nump">38.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">210.7<span></span>
</td>
<td class="nump">$ 1,086.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">210.6<span></span>
</td>
<td class="nump">1,087.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">212.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain', window );">Gross Unrealized Gains</a></td>
<td class="nump">36.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities', window );">Estimated Market Value</a></td>
<td class="nump">248.6<span></span>
</td>
<td class="nump">1,087.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">173.2<span></span>
</td>
<td class="nump">675.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">173.1<span></span>
</td>
<td class="nump">676.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">36.2<span></span>
</td>
<td class="nump">248.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">36.2<span></span>
</td>
<td class="nump">248.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt securities, available for sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">163.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 162.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale And Equity Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale And Equity Securities, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale And Equity Securities, Unrealized Gain</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale And Equity Securities, Unrealized Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26610-111562<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116654751&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116654751&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6986565968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Jurisdictions, Net Income (Loss) Subject to Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="nump">$ 119.1<span></span>
</td>
<td class="num">$ (28.3)<span></span>
</td>
<td class="nump">$ 12.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Outside of the United States</a></td>
<td class="num">(14.9)<span></span>
</td>
<td class="num">(98.2)<span></span>
</td>
<td class="num">(61.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Total</a></td>
<td class="nump">$ 104.2<span></span>
</td>
<td class="num">$ (126.5)<span></span>
</td>
<td class="num">$ (48.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6988367840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases And Other Commitments - Maturity of Lease Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2020</a></td>
<td class="nump">$ 17.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2021</a></td>
<td class="nump">17.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2022</a></td>
<td class="nump">14.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2023</a></td>
<td class="nump">14.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2024</a></td>
<td class="nump">12.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">23.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future lease cost</a></td>
<td class="nump">100.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Amount representing interest</a></td>
<td class="num">(14.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability', window );">Present value of future payments</a></td>
<td class="nump">85.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue', window );">Less: Short-term leases not recorded as a liability</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Revised present value of future lease payments</a></td>
<td class="nump">86.0<span></span>
</td>
<td class="nump">$ 40.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: Current portion</a></td>
<td class="num">(13.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion</a></td>
<td class="nump">72.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2020</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2021</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2022</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2023</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2024</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">13.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total future lease cost</a></td>
<td class="nump">20.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: Amount representing interest</a></td>
<td class="num">(5.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability', window );">Present value of future payments</a></td>
<td class="nump">15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_FinanceLeaseShortTermLeasesPaymentsDue', window );">Less: Short-term leases not recorded as a liability</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Revised present value of future lease payments</a></td>
<td class="nump">15.0<span></span>
</td>
<td class="nump">$ 15.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Less: Current portion</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term portion</a></td>
<td class="nump">14.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced', window );">Minimum lease payments for leases not yet commenced</a></td>
<td class="nump">$ 5.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_FinanceLeaseShortTermLeasesPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Short Term Leases, Payments Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_FinanceLeaseShortTermLeasesPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Leases, Liability, Less Payments Due On Short Term Leases Not Recorded As A Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Future Lease Cost, Lease Not yet Commenced</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Leases, Short Term Lease Payments Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Liability, Less Payments Due On Short Term Leases Not Recorded As A Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due after fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due in next fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fourth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due in third fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due in second fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6995498560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Accretion of debt discount</a></td>
<td class="nump">$ 49.6<span></span>
</td>
<td class="nump">$ 17.9<span></span>
</td>
<td class="nump">$ 9.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest expense recognized on senior notes</a></td>
<td class="nump">58.8<span></span>
</td>
<td class="nump">21.3<span></span>
</td>
<td class="nump">11.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member', window );">Senior convertible notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual coupon interest</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Accretion of debt discount</a></td>
<td class="nump">13.9<span></span>
</td>
<td class="nump">13.4<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest expense recognized on senior notes</a></td>
<td class="nump">$ 18.6<span></span>
</td>
<td class="nump">$ 18.0<span></span>
</td>
<td class="nump">$ 11.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as a percent)</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior convertible notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual coupon interest</a></td>
<td class="nump">$ 6.3<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Accretion of debt discount</a></td>
<td class="nump">31.9<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest expense recognized on senior notes</a></td>
<td class="nump">$ 40.2<span></span>
</td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as a percent)</a></td>
<td class="nump">5.60%<span></span>
</td>
<td class="nump">5.60%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6663614832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="nump">$ 11.4<span></span>
</td>
<td class="nump">$ 12.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Provision for doubtful accounts</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">5.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments', window );">Write-offs and adjustments</a></td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(8.3)<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesRecoveries', window );">Recoveries</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="nump">$ 5.8<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="nump">$ 11.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the write-offs and adjustments in a given period to allowances and reserves for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from recovery of amount previously written off or reestablishment of reserve previously utilized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6995062272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details - Net Gain (Loss) Recognized on Equity Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract', window );"><strong>Net gain recognized on equity securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesGainLoss', window );">Net gains and losses recognized during the period on equity securities</a></td>
<td class="num">$ (4.2)<span></span>
</td>
<td class="nump">$ 80.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss', window );">Less: Net gains and losses recognized during the period on equity securities sold during the period</a></td>
<td class="nump">4.2<span></span>
</td>
<td class="num">(44.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss', window );">Unrealized gains recognized during the reporting period on equity securities still held at the reporting date</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 36.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6734958720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable trade</a></td>
<td class="nump">$ 102.3<span></span>
</td>
<td class="nump">$ 75.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_AccruedTaxAuditAndLegalFees', window );">Accrued tax, audit, and legal fees</a></td>
<td class="nump">14.0<span></span>
</td>
<td class="nump">11.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_PharmacyRebates', window );">Accrued rebates</a></td>
<td class="nump">93.3<span></span>
</td>
<td class="nump">36.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Accrued warranty</a></td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
<td class="nump">$ 8.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">39.4<span></span>
</td>
<td class="nump">17.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Total accounts payable and accrued liabilities</a></td>
<td class="nump">$ 256.4<span></span>
</td>
<td class="nump">$ 147.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AccruedTaxAuditAndLegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of accrued current tax, audit and legal fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AccruedTaxAuditAndLegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PharmacyRebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pharmacy Rebates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PharmacyRebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6822067728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Conversion Value of Convertible Notes (Details) - Senior Notes - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Total by which the notes&#8217; if-converted value exceeds their principal amount</a></td>
<td class="nump">$ 858.6<span></span>
</td>
<td class="nump">$ 125.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior convertible notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Total by which the notes&#8217; if-converted value exceeds their principal amount</a></td>
<td class="nump">486.2<span></span>
</td>
<td class="nump">125.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior convertible notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Total by which the notes&#8217; if-converted value exceeds their principal amount</a></td>
<td class="nump">$ 372.4<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6988668192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity - Restricted Stock Units Activity (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (shares)</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (shares)</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Unvested restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (shares)</a></td>
<td class="nump">2,700,000<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares)</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (shares)</a></td>
<td class="num">(1,400,000)<span></span>
</td>
<td class="num">(1,400,000)<span></span>
</td>
<td class="num">(1,900,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares)</a></td>
<td class="num">(200,000)<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="num">(400,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (shares)</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (USD per share)</a></td>
<td class="nump">$ 69.19<span></span>
</td>
<td class="nump">$ 70.68<span></span>
</td>
<td class="nump">$ 62.51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share)</a></td>
<td class="nump">144.37<span></span>
</td>
<td class="nump">66.07<span></span>
</td>
<td class="nump">75.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (USD per share)</a></td>
<td class="nump">69.45<span></span>
</td>
<td class="nump">68.44<span></span>
</td>
<td class="nump">58.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share)</a></td>
<td class="nump">83.45<span></span>
</td>
<td class="nump">68.56<span></span>
</td>
<td class="nump">67.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (USD per share)</a></td>
<td class="nump">$ 96.63<span></span>
</td>
<td class="nump">$ 69.19<span></span>
</td>
<td class="nump">$ 70.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Aggregate Intrinsic Value</a></td>
<td class="nump">$ 392.0<span></span>
</td>
<td class="nump">$ 319.0<span></span>
</td>
<td class="nump">$ 154.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6988388096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation between Effective Tax Rate and Statutory Rate (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Amount [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income taxes at statutory rates</a></td>
<td class="nump">$ 21.9<span></span>
</td>
<td class="num">$ (26.6)<span></span>
</td>
<td class="num">$ (17.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income tax, net of federal benefit</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(5.5)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_EffectiveIncomeTaxReconciliationPermanentItems', window );">Permanent items</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development credits</a></td>
<td class="num">(10.8)<span></span>
</td>
<td class="num">(11.7)<span></span>
</td>
<td class="num">(13.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock and officers compensation</a></td>
<td class="num">(14.7)<span></span>
</td>
<td class="num">(5.1)<span></span>
</td>
<td class="num">(10.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Rate change</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(15.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616', window );">Impact of adoption of ASU 2016-16</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(13.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA', window );">Impact of Tax Cuts and Jobs Act of 2017</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">105.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">56.9<span></span>
</td>
<td class="num">(51.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes at effective rates</a></td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Impact of Adoption of ASU 2016-16</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Impact of TCJA</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EffectiveIncomeTaxReconciliationPermanentItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Permanent Items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EffectiveIncomeTaxReconciliationPermanentItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Unrecognized tax benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e32059-109318<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6978226448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Revenue from External Customers by Geographic Areas</a></td>
<td class="text">The following table sets forth revenues by our two primary geographical markets, the United States and outside of the United States, based on the geographic location to which we deliver the product:<div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.0234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="20" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,161.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>818.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>596.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>83</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outside of the United States</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>314.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>213.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,476.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,031.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>718.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table sets forth revenues by major sales channel for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.0234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="20" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">%<br/>of&#160;Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Distributor</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,011.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>69</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>652.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>63</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>538.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Direct</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>464.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>378.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>37</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>180.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,476.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,031.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>718.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>dxcm-12312019x10kasof1_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2017-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:dxcm="http://www.dexcom.com/20191231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2019-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  xmlns:utreg="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dxcm-20191231.xsd" xlink:type="simple"/>
    <context id="FD2019Q4YTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="I2020Q1Feb07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2020-02-07</instant>
        </period>
    </context>
    <context id="I2019Q2Jun28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2019-06-28</instant>
        </period>
    </context>
    <context id="FI2018Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FI2016Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FI2017Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201609Member_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201609Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201609Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201609Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerBMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerBMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerCMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerBMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerBMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="D2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementInitialPaymentMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-20</startDate>
            <endDate>2018-11-20</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="D2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-20</startDate>
            <endDate>2018-11-20</endDate>
        </period>
    </context>
    <context id="I2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-20</instant>
        </period>
    </context>
    <context id="I2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementInitialPaymentMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-20</instant>
        </period>
    </context>
    <context id="FI2019Q4_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementInitialPaymentMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="I2018Q4December28_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementInitialPaymentMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-28</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ProductOrServiceAxis_dxcm_ReceiverProductComponentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dxcm:ReceiverProductComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="D2019Q4Feb01-Dec31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ProductOrServiceAxis_dxcm_ReceiverProductComponentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dxcm:ReceiverProductComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="D2018Q4December_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="D2018Q4December_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2018Q4_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="D2018Q4December_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="I2018Q4December19_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-19</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="D2018Q4December_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="D2017Q2June_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-06-01</startDate>
            <endDate>2017-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="D2017Q2June_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-06-01</startDate>
            <endDate>2017-06-30</endDate>
        </period>
    </context>
    <context id="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="I2019Q1January1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">dxcm:LeasedBuildingsMesaArizonaExpiringMarch2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_srt_RangeAxis_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="I2019Q1January1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">dxcm:LeasedBuildingsMesaArizonaExpiringMarch2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_RangeAxis_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="D2016Q1March28_dxcm_NameOfPlaintiffAxis_dxcm_WaveFormTechnologiesInc.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dxcm:NameOfPlaintiffAxis">dxcm:WaveFormTechnologiesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-28</startDate>
            <endDate>2016-03-28</endDate>
        </period>
    </context>
    <context id="D2016Q1March28_dxcm_NameOfPlaintiffAxis_dxcm_AgaMatrixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dxcm:NameOfPlaintiffAxis">dxcm:AgaMatrixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-28</startDate>
            <endDate>2016-03-28</endDate>
        </period>
    </context>
    <context id="D2018Q1Feb28_dxcm_NameOfPlaintiffAxis_dxcm_WaveFormTechnologiesInc.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dxcm:NameOfPlaintiffAxis">dxcm:WaveFormTechnologiesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-28</startDate>
            <endDate>2018-02-28</endDate>
        </period>
    </context>
    <context id="D2017Q3Sep15_dxcm_NameOfDefendantAxis_dxcm_AgaMatrixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dxcm:NameOfDefendantAxis">dxcm:AgaMatrixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-15</startDate>
            <endDate>2017-09-15</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4QTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_dxcm_SellingGeneralAndAdministrativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_dxcm_SellingGeneralAndAdministrativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_dxcm_SellingGeneralAndAdministrativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_PlanNameAxis_dxcm_A401kPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A401kPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_A401kPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A401kPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="I2015Q2RSUsharesauthorized">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2015-05-28</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2016Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2018Q3QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FD2018Q2QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q2QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q1QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2018Q1QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="d">
        <measure>utreg:D</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="patent">
        <measure>dxcm:number_patents</measure>
    </unit>
    <unit id="segment">
        <measure>dxcm:segment</measure>
    </unit>
    <unit id="renewal_term">
        <measure>dxcm:renewal_term</measure>
    </unit>
    <unit id="finance_lease">
        <measure>dxcm:finance_lease</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="FD2019Q4YTD"
      id="Fact-9E0865A17F60D9469B55EB34A8521ECF-wk-Fact-9E0865A17F60D9469B55EB34A8521ECF">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="FD2019Q4YTD"
      id="Fact-9897DACFA071E366EB970F96EB4A29BD-wk-Fact-9897DACFA071E366EB970F96EB4A29BD">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="FD2019Q4YTD"
      id="Fact-CE1B7A46FE4F8E515F55EB34A8521452-wk-Fact-CE1B7A46FE4F8E515F55EB34A8521452">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="FD2019Q4YTD"
      id="Fact-A45B79DFD9105FC799D074E310CBAACF-wk-Fact-A45B79DFD9105FC799D074E310CBAACF">2019</dei:DocumentFiscalYearFocus>
    <dei:EntityCentralIndexKey
      contextRef="FD2019Q4YTD"
      id="Fact-BF17FEEF0D4A073C171FEB34A8529A46-wk-Fact-BF17FEEF0D4A073C171FEB34A8529A46">0001093557</dei:EntityCentralIndexKey>
    <dxcm:FairValueAssetsLevel3TransfersAmount
      contextRef="FI2018Q4"
      decimals="INF"
      id="Fact-F2C3900BC4B45D4164E7B4C32C2338C5-wk-Fact-F2C3900BC4B45D4164E7B4C32C2338C5"
      unitRef="usd">0</dxcm:FairValueAssetsLevel3TransfersAmount>
    <dxcm:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember"
      id="Fact-FEA71BEB20744EFED6EE3A3280004FD3-wk-Fact-FEA71BEB20744EFED6EE3A3280004FD3">P1Y</dxcm:LesseeOperatingLeaseRemainingLeaseTerm>
    <dxcm:LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber
      contextRef="D2018Q1Feb28_dxcm_NameOfPlaintiffAxis_dxcm_WaveFormTechnologiesInc.Member"
      decimals="INF"
      id="Fact-FD148B65EF8B43F23A0AB073765ADB59-wk-Fact-FD148B65EF8B43F23A0AB073765ADB59"
      unitRef="patent">2</dxcm:LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber>
    <dxcm:LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff
      contextRef="D2016Q1March28_dxcm_NameOfPlaintiffAxis_dxcm_WaveFormTechnologiesInc.Member"
      decimals="INF"
      id="Fact-05932699E4B6A39079EAB06CCCAD9434-wk-Fact-05932699E4B6A39079EAB06CCCAD9434"
      unitRef="patent">3</dxcm:LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="FI2018Q4"
      decimals="INF"
      id="Fact-9ADA991B01095821A1F9014EFC4E1E46-wk-Fact-9ADA991B01095821A1F9014EFC4E1E46"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-8A33731F91A4554FAC0E41DA9604E4B1-wk-Fact-8A33731F91A4554FAC0E41DA9604E4B1"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="FI2018Q4"
      decimals="INF"
      id="Fact-65E3C1D4884E58508A2D8F0F4F156181-wk-Fact-65E3C1D4884E58508A2D8F0F4F156181"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-98F41E524955570E8814040C80BD1644-wk-Fact-98F41E524955570E8814040C80BD1644"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2018Q4"
      decimals="-5"
      id="Fact-A7809165C55F5A73BCACB2B951DA64CA-wk-Fact-A7809165C55F5A73BCACB2B951DA64CA"
      unitRef="shares">91100000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2019Q4"
      decimals="-5"
      id="Fact-AF24C46C9B9C516DA07C028C1D1652E0-wk-Fact-AF24C46C9B9C516DA07C028C1D1652E0"
      unitRef="shares">92400000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="FI2018Q4"
      decimals="-5"
      id="Fact-DC0A363621EE5E75BC5ED5D907F13739-wk-Fact-DC0A363621EE5E75BC5ED5D907F13739"
      unitRef="shares">90000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="FI2019Q4"
      decimals="-5"
      id="Fact-38AED5E818BC5247AAD229AC617ABC1F-wk-Fact-38AED5E818BC5247AAD229AC617ABC1F"
      unitRef="shares">91600000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="D2017Q2June_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="7"
      id="Fact-98939C21F7C37AAB4AE1EB34A832758B-wk-Fact-98939C21F7C37AAB4AE1EB34A832758B"
      unitRef="number">0.0100918</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="7"
      id="Fact-7FFEB2573C2E1ED2562CEB34A83211C5-wk-Fact-7FFEB2573C2E1ED2562CEB34A83211C5"
      unitRef="number">0.0060869</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="Fact-747F77BDEE4C5AD898091BEB40211FAD-wk-Fact-747F77BDEE4C5AD898091BEB40211FAD"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount
      contextRef="FI2018Q4"
      decimals="INF"
      id="Fact-04DA6FCDA578F03514B8B4C2D92D1A14-wk-Fact-04DA6FCDA578F03514B8B4C2D92D1A14"
      unitRef="usd">0</us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember"
      id="Fact-EAC7044633B7864A4F5BC9CD307E0004-wk-Fact-EAC7044633B7864A4F5BC9CD307E0004">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember"
      id="Fact-117BA70552F5E25DBC2CC9CCC81C472C-wk-Fact-117BA70552F5E25DBC2CC9CCC81C472C">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber
      contextRef="D2017Q3Sep15_dxcm_NameOfDefendantAxis_dxcm_AgaMatrixMember"
      decimals="INF"
      id="Fact-6E34E4A5BC18DC5B7F00B06E67E51677-wk-Fact-6E34E4A5BC18DC5B7F00B06E67E51677"
      unitRef="patent">2</us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="FD2017Q4YTD"
      decimals="INF"
      id="Fact-2A212D98ED7CED625772C9CDCCB55642-wk-Fact-2A212D98ED7CED625772C9CDCCB55642"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="FD2018Q4YTD"
      decimals="INF"
      id="Fact-FE789D10CDBCCECD05CDC9CDC08AE362-wk-Fact-FE789D10CDBCCECD05CDC9CDC08AE362"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="FI2019Q4_srt_RangeAxis_srt_MinimumMember"
      id="Fact-AD2C6A38A7598D502B0F3A31B5D1F516-wk-Fact-AD2C6A38A7598D502B0F3A31B5D1F516">P3Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="FI2019Q4_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member"
      id="Fact-39ADA2190258692E6C703A3164415D86-wk-Fact-39ADA2190258692E6C703A3164415D86">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LossContingencyPatentsAllegedlyInfringedNumber
      contextRef="D2016Q1March28_dxcm_NameOfPlaintiffAxis_dxcm_AgaMatrixMember"
      decimals="INF"
      id="Fact-54302A1A6E3EA980F599B06BBBC20376-wk-Fact-54302A1A6E3EA980F599B06BBBC20376"
      unitRef="patent">3</us-gaap:LossContingencyPatentsAllegedlyInfringedNumber>
    <us-gaap:LossContingencyPatentsAllegedlyInfringedNumber
      contextRef="D2016Q1March28_dxcm_NameOfPlaintiffAxis_dxcm_WaveFormTechnologiesInc.Member"
      decimals="INF"
      id="Fact-566CB59FD371CE9B83CDB06D118B5B7B-wk-Fact-566CB59FD371CE9B83CDB06D118B5B7B"
      unitRef="patent">3</us-gaap:LossContingencyPatentsAllegedlyInfringedNumber>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="FI2018Q4"
      decimals="INF"
      id="Fact-848804054CEA571AA991638CE176DB8E-wk-Fact-848804054CEA571AA991638CE176DB8E"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-5FA5621C72D35E0CAB8DD0627B9F5C65-wk-Fact-5FA5621C72D35E0CAB8DD0627B9F5C65"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="FI2018Q4"
      decimals="INF"
      id="Fact-D38D3D1F4C2A5A10A2FDB08598EB115A-wk-Fact-D38D3D1F4C2A5A10A2FDB08598EB115A"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-75DF8DBA38A75373A7743729EDA463F6-wk-Fact-75DF8DBA38A75373A7743729EDA463F6"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="FI2018Q4"
      decimals="INF"
      id="Fact-AC7A9090EA011005B626EB34A814E7A7-wk-Fact-AC7A9090EA011005B626EB34A814E7A7"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-8D3FF2E61E5A90393B0AEB34A8161A08-wk-Fact-8D3FF2E61E5A90393B0AEB34A8161A08"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="FI2018Q4"
      decimals="INF"
      id="Fact-E7E877AC818C920B89BFEB34A817A5A9-wk-Fact-E7E877AC818C920B89BFEB34A817A5A9"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-E61FB2ECC913F2990B65EB34A8150081-wk-Fact-E61FB2ECC913F2990B65EB34A8150081"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember"
      id="Fact-406AE4B3D55448FDC5D6C9C8A99CFFD4-wk-Fact-406AE4B3D55448FDC5D6C9C8A99CFFD4">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      id="Fact-3042733F2ACD97849D62AFEDE4510189-wk-Fact-3042733F2ACD97849D62AFEDE4510189">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      id="Fact-490442D4F8688A00EABCAFEDB917B39B-wk-Fact-490442D4F8688A00EABCAFEDB917B39B">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="FD2017Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      decimals="4"
      id="Fact-D36A2B56FA0DB61D63CFEB34A8156A97-wk-Fact-D36A2B56FA0DB61D63CFEB34A8156A97"
      unitRef="number">0.0056</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="FD2017Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      decimals="4"
      id="Fact-2D333815BA26F3EFC73AEB34A81AF927-wk-Fact-2D333815BA26F3EFC73AEB34A81AF927"
      unitRef="number">0.0033</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="FD2018Q4QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      decimals="4"
      id="Fact-20ECAE3947010606AA8EEB34A81AF9AE-wk-Fact-20ECAE3947010606AA8EEB34A81AF9AE"
      unitRef="number">0.0067</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="FD2018Q4QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      decimals="4"
      id="Fact-F33F452D4F2C51088AEBEB34A81B1659-wk-Fact-F33F452D4F2C51088AEBEB34A81B1659"
      unitRef="number">0.0050</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      decimals="4"
      id="Fact-0F91CAA4CF9ECEE17E59EB34A81BEB95-wk-Fact-0F91CAA4CF9ECEE17E59EB34A81BEB95"
      unitRef="number">0.0051</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      decimals="4"
      id="Fact-8A2679F60796A80445ECEB34A81B3C40-wk-Fact-8A2679F60796A80445ECEB34A81B3C40"
      unitRef="number">0.0040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="FD2017Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      decimals="4"
      id="Fact-E9D9E04F471E9FB0DFEAEB34A8177E4B-wk-Fact-E9D9E04F471E9FB0DFEAEB34A8177E4B"
      unitRef="number">0.0112</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="FD2017Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      decimals="4"
      id="Fact-FE943925A56C5DCBBFE3EB34A815A976-wk-Fact-FE943925A56C5DCBBFE3EB34A815A976"
      unitRef="number">0.0075</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="FD2018Q4QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      decimals="4"
      id="Fact-016B1FE28B89EAA453BDEB34A819D2C8-wk-Fact-016B1FE28B89EAA453BDEB34A819D2C8"
      unitRef="number">0.0225</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="FD2018Q4QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      decimals="4"
      id="Fact-B7C2D9EBA585FEECB753EB34A81A8C65-wk-Fact-B7C2D9EBA585FEECB753EB34A81A8C65"
      unitRef="number">0.0155</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      decimals="4"
      id="Fact-FC932E3E280565379B4FEB34A8168780-wk-Fact-FC932E3E280565379B4FEB34A8168780"
      unitRef="number">0.0255</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      decimals="4"
      id="Fact-1E8D553C6BA0B7863D86EB34A8194E2C-wk-Fact-1E8D553C6BA0B7863D86EB34A8194E2C"
      unitRef="number">0.0172</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:TreasuryStockShares
      contextRef="FI2019Q4"
      decimals="-5"
      id="Fact-A955A08A8500E80053D8EB34A81369C1-wk-Fact-A955A08A8500E80053D8EB34A81369C1"
      unitRef="shares">800000</us-gaap:TreasuryStockShares>
    <dei:DocumentType
      contextRef="FD2019Q4YTD"
      id="d37371145e547-wk-Fact-A3C625C60B5AF96539080F84D0092DAE">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="FD2019Q4YTD"
      id="d37371145e565-wk-Fact-9C5876AA87E5E198801D403877EE29C5">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="FD2019Q4YTD"
      id="d37371145e577-wk-Fact-6B5B7E13FAA89D2862B70F856964B175">2019-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="FD2019Q4YTD"
      id="d37371145e596-wk-Fact-C10DABFE8D9E21D5C1C840389878D00A">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="FD2019Q4YTD"
      id="d37371145e609-wk-Fact-6DF098CDD9EA27E637880F860F852A46">000-51222</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="FD2019Q4YTD"
      id="d37371145e618-wk-Fact-E9B49DB4893B1BFF377A0F958206A159">DEXCOM, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="FD2019Q4YTD"
      id="d37371145e641-wk-Fact-DA692B418DE3AC2242960F86DCD5B791">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="FD2019Q4YTD"
      id="d37371145e651-wk-Fact-F4450ACAC902E462CC8D0F8700DCBC44">33-0857544</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="FD2019Q4YTD"
      id="d37371145e670-wk-Fact-CAB9573ECBC86EC1A55A678175C7F4DA">6340 Sequence Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="FD2019Q4YTD"
      id="d37371145e675-wk-Fact-0A64F544F649CC0490DC6781B317C448">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="FD2019Q4YTD"
      id="d37371145e680-wk-Fact-050AD23E14DA27BD9B6F6781D6E1D6BB">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="FD2019Q4YTD"
      id="d37371145e685-wk-Fact-4C86B40AD99EA73969D16781FB05D3C5">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="FD2019Q4YTD"
      id="d37371145e698-wk-Fact-ABC7C113656C9FB6BE2D1C110D6EB76E">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="FD2019Q4YTD"
      id="d37371145e703-wk-Fact-A90DAB94CD2B06B493401C11363DDA8D">200-0200</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="FD2019Q4YTD"
      id="d37371145e742-wk-Fact-1511A9E342CE4C375CCD0F88D998E31C">Common Stock, $0.001 Par Value Per Share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="FD2019Q4YTD"
      id="d37371145e747-wk-Fact-B05E29F818D7CA7DEA0A0F88F7638E5C">DXCM</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="FD2019Q4YTD"
      id="d37371145e752-wk-Fact-0EF06584DC36B43A133C0F89148D35D2">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="FD2019Q4YTD"
      id="d37371145e778-wk-Fact-52F4F26C3DB3F4C890860F8F3CF46F6D">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="FD2019Q4YTD"
      id="d37371145e798-wk-Fact-A7E6ED9D4A106CC14D5A0F8F7422346C">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="FD2019Q4YTD"
      id="d37371145e807-wk-Fact-E44870D6E22F329A1B850F8FB6655421">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="FD2019Q4YTD"
      id="d37371145e820-wk-Fact-6CD28FA106906CF265320F8FF2C2E296">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="FD2019Q4YTD"
      id="d37371145e834-wk-Fact-C5F5768ED8E112F28A5A0F901DCB8F77">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="FD2019Q4YTD"
      id="d37371145e851-wk-Fact-C363B45E268E96B47DBB0F9054FC5CD2">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="FD2019Q4YTD"
      id="d37371145e861-wk-Fact-0F94A2D94BE02808BBDA0F907FCE31E2">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="FD2019Q4YTD"
      id="d37371145e874-wk-Fact-EB5940767E979D7407DF0F8EE29F2863">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="I2019Q2Jun28"
      decimals="-5"
      id="d37371145e888-wk-Fact-F01D275506541F7A15A2EB34A852A5CC"
      unitRef="usd">13556600000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="I2020Q1Feb07"
      decimals="INF"
      id="d37371145e940-wk-Fact-5E8A04668C055F94BEB1A1ED583A9691"
      unitRef="shares">91594142</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e778-wk-Fact-C34A37AEC0925179A5FBD7370ABF40D4"
      unitRef="usd">446200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e797-wk-Fact-E529F8ACC9195FE8B669B378B77BC5C6"
      unitRef="usd">1137000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e812-wk-Fact-80E6274D31CA5E2BBF12320A118262A7"
      unitRef="usd">1087100000</dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities>
    <dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e831-wk-Fact-2D4754244E03538BA709DA0E74E53486"
      unitRef="usd">248600000</dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e851-wk-Fact-A66B1E2C7FDB54F7A77A83F184996920"
      unitRef="usd">286300000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e870-wk-Fact-4261B79509344401EAD21747E05FA096"
      unitRef="usd">226700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e890-wk-Fact-5955DC66290A55438DBD16FF1CD033DF"
      unitRef="usd">119800000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e909-wk-Fact-75042F3537165827921BCEDFF6FB9129"
      unitRef="usd">70700000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e929-wk-Fact-A63B0190E8DEDAE763C91747DFDC2B30"
      unitRef="usd">30000000.0</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e948-wk-Fact-FD1215ABFDF2506D912EE75C43B0135B"
      unitRef="usd">16500000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e968-wk-Fact-37C298EBD784D228EE88EB34A81E2E5D"
      unitRef="usd">1969400000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e987-wk-Fact-8B7368907E33874A0478EB34A82AB829"
      unitRef="usd">1699500000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1007-wk-Fact-6E0096B0001E585FB1501D1E29BCFD4B"
      unitRef="usd">321300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1026-wk-Fact-4346F1EF4C125EFEA32FB8D88988ADF4"
      unitRef="usd">183100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1047-wk-Fact-7737A3146F355264A5C2CAF6FB9389D2"
      unitRef="usd">71500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1066-wk-Fact-63E97E70D3D0495440AAEB34A828A1AE"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1086-wk-Fact-9C55738824F05E488A199F7BA9E01DB6"
      unitRef="usd">18600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1105-wk-Fact-C6CD020DFFF0531AB2821747E0625E63"
      unitRef="usd">18700000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1125-wk-Fact-983EEEEC5B0252B95E2F1747E05996AC"
      unitRef="usd">14200000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1144-wk-Fact-A66CAFEAE8E3FB58A3D91747E06A4C46"
      unitRef="usd">14700000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1169-wk-Fact-44611B698F9EA629B2FCEB34A82E5DBA"
      unitRef="usd">2395000000.0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1188-wk-Fact-EB9825F8E1C3C2E11A68EB34A824DEC1"
      unitRef="usd">1916000000.0</us-gaap:Assets>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1290-wk-Fact-D7C5F6E8423EF61C6BA41747E11B5939"
      unitRef="usd">256400000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1309-wk-Fact-9B84C094B74D40D4FF8C1747E0185BAB"
      unitRef="usd">147100000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1324-wk-Fact-646AE25030BA1C2DDFB51747DFFA2E4E"
      unitRef="usd">88500000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1343-wk-Fact-308A8A9CBCF75AD785EE7C8E8D5979C1"
      unitRef="usd">72400000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1363-wk-Fact-0372FC04FE7667FD19B61747DFBEB68B"
      unitRef="usd">13600000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1382-wk-Fact-706DB3F3E7B4D0B9D1C7AB0466C9B9AB"
      unitRef="usd">0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1402-wk-Fact-4993CE84A7175313ADB5DD09BFDDB69B"
      unitRef="usd">1700000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1421-wk-Fact-8329E529F9095AB79A91E875342D55AE"
      unitRef="usd">2900000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1441-wk-Fact-54FC9F78BF8C391E46A0EB34A8436D31"
      unitRef="usd">360200000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1460-wk-Fact-2F8B34C067BBFD086D23EB34A8271596"
      unitRef="usd">222400000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1522-wk-Fact-ABCBA6589A4C5CDF91BC7F4BA960481B"
      unitRef="usd">1059700000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1541-wk-Fact-1461EB17D9B653C4A7FC0FEF93AF8393"
      unitRef="usd">1010300000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1561-wk-Fact-B5DC66DA1FAA547BB8A5BB1A758CB367"
      unitRef="usd">72400000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1580-wk-Fact-5DA1B31207ECCD75C573EB34A8248FC4"
      unitRef="usd">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1600-wk-Fact-48BC2EECC3D82B2A40941747E036D3DB"
      unitRef="usd">20100000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1619-wk-Fact-25A91861877F5862CFD21747E066C461"
      unitRef="usd">20000000.0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1639-wk-Fact-12EAC5258C69145D07ADEB34A7EE80DE"
      unitRef="usd">1512400000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1658-wk-Fact-2CE21C0E657C1C063E8AEB34A81E662A"
      unitRef="usd">1252700000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="FI2019Q4"
      id="d37392035e1678-wk-Fact-EDAD306B479A73BD9171EB34A8225FF6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="FI2018Q4"
      id="d37392035e1697-wk-Fact-A445EBF66103CC02A4D0EB34A81D1F68"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValueOutstanding
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1758-wk-Fact-39C46F85F00B5A6A94D48B850AD43C83"
      unitRef="usd">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:PreferredStockValueOutstanding
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1777-wk-Fact-89D90E0C76975AC388EDD25E61F627EC"
      unitRef="usd">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1797-wk-Fact-1CC933EEC58D51EFA76EE06A4D9E3B7F"
      unitRef="usd">100000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1816-wk-Fact-49137616D6FD5049A395D5E2D5EA965A"
      unitRef="usd">100000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1836-wk-Fact-61BB6B97BEBF5E0CAD55704A2CC06E6C"
      unitRef="usd">1675900000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1855-wk-Fact-0C06FC2E00275E97A449FF52DE780B7E"
      unitRef="usd">1560600000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1875-wk-Fact-C215D749E8305E5CBD962A4C32C28F7A"
      unitRef="usd">2300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1894-wk-Fact-50DA1214E38B94713FEC1747E120117E"
      unitRef="usd">1500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1915-wk-Fact-B1A7FCDFFB10530DA1B92007FE568EE7"
      unitRef="usd">-695700000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1935-wk-Fact-C774713E89C15C1892C53E6C4706927C"
      unitRef="usd">-798900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockValue
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1956-wk-Fact-AB931CC8DBA94ABEAFBC1747DF9FBF29"
      unitRef="usd">100000000.0</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e1976-wk-Fact-9150BAE1790C32262A251747DF6E2BE2"
      unitRef="usd">100000000.0</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e1997-wk-Fact-938ED76C40F35933492EEB34A827852E"
      unitRef="usd">882600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e2016-wk-Fact-B4189629853BAE21CFC2EB34A81BE193"
      unitRef="usd">663300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37392035e2041-wk-Fact-AC8D12DD5CA139CAAF6FEB34A82162B0"
      unitRef="usd">2395000000.0</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37392035e2060-wk-Fact-D2CD57E1995B2B2CDF19EB34A825C8F5"
      unitRef="usd">1916000000.0</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37397549e742-wk-Fact-64400440AC62A8CA769BEB34A85294A0"
      unitRef="usd">1476000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37397549e761-wk-Fact-D38A90028A2F0CC3FFCBEB34A7EE80E4"
      unitRef="usd">1031600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37397549e780-wk-Fact-691FD3D368229313BD9DEB34A84333BF"
      unitRef="usd">718500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37397549e796-wk-Fact-387B1983D7E1F6BCFD17EB34A7EE0CCA"
      unitRef="usd">544500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37397549e815-wk-Fact-5C3667A4FA5F2D4B00E6EB34A8524E4F"
      unitRef="usd">367700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37397549e834-wk-Fact-E32294253FCC4A4D105BEB34A852786A"
      unitRef="usd">226400000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37397549e855-wk-Fact-8DB96BBDC97D0DAEF83DEB34A852D9E4"
      unitRef="usd">931500000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37397549e874-wk-Fact-7E86407A8B21F3E6F5C2EB34A862F1B1"
      unitRef="usd">663900000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37397549e893-wk-Fact-398799229F9C1FEA872EEB34A86206C2"
      unitRef="usd">492100000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37397549e976-wk-Fact-043B955E88CC5C45A22AED1E034032E4"
      unitRef="usd">273500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37397549e995-wk-Fact-1E82818A6BB95972B76218B310D384C8"
      unitRef="usd">199700000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37397549e1014-wk-Fact-A2771BBC0BF8D45DA33AEB34A852652E"
      unitRef="usd">185400000</us-gaap:ResearchAndDevelopmentExpense>
    <dxcm:CollaborativeResearchAndDevelopmentFee
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37397549e1035-wk-Fact-8F38C7E9B476CC1FB72DEB34A843CDA4"
      unitRef="usd">0</dxcm:CollaborativeResearchAndDevelopmentFee>
    <dxcm:CollaborativeResearchAndDevelopmentFee
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37397549e1054-wk-Fact-097A730CC8CC2E9B00D5EB34A852474D"
      unitRef="usd">217700000</dxcm:CollaborativeResearchAndDevelopmentFee>
    <dxcm:CollaborativeResearchAndDevelopmentFee
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37397549e1073-wk-Fact-5EBD78D5B9B37C724DD6EB34A8528502"
      unitRef="usd">0</dxcm:CollaborativeResearchAndDevelopmentFee>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37397549e1094-wk-Fact-FE95B6DA5CCDF3AEACD1174A947D4D49"
      unitRef="usd">515700000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37397549e1113-wk-Fact-8A9D0CF374375757A6FF10A424689B36"
      unitRef="usd">432800000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37397549e1132-wk-Fact-4E3E1E1D47D5568AED26EB34A7EE1CD4"
      unitRef="usd">349200000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37397549e1153-wk-Fact-82686CDA9627213212CBEB34A862BFD8"
      unitRef="usd">789200000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37397549e1172-wk-Fact-DA2D84E245294CEA7F25EB34A7FEAF86"
      unitRef="usd">850200000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37397549e1191-wk-Fact-329746DB695B1382CA21EB34A852BDD4"
      unitRef="usd">534600000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37397549e1212-wk-Fact-842AF12416274625ED01EB34A8525D65"
      unitRef="usd">142300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37397549e1231-wk-Fact-52351B6108238CE033D6EB34A843D2C2"
      unitRef="usd">-186300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37397549e1251-wk-Fact-15DE3B9C46E5A37FE4E6EB34A852CCDA"
      unitRef="usd">-42500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37397549e1274-wk-Fact-6C77DDA5B8CC5B32B2ACAE2BE8A1D64C"
      unitRef="usd">60300000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37397549e1294-wk-Fact-E01056B0436253EE97C1A4AA2DBE0697"
      unitRef="usd">22700000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37397549e1314-wk-Fact-B6167333B48D8123BB4CEB34A8521F67"
      unitRef="usd">12800000</us-gaap:InterestExpense>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37397549e1336-wk-Fact-84D262FE1402AF794642174A943CE9B2"
      unitRef="usd">-4200000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37397549e1356-wk-Fact-AE15260499DB5316983B3D2E988B107C"
      unitRef="usd">80100000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37397549e1375-wk-Fact-5ACB75D07BA38562950CEB34A85248FB"
      unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37397549e1396-wk-Fact-C26E63723BD38DB86B31174A94284AF2"
      unitRef="usd">26400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37397549e1415-wk-Fact-CFDD276D9BDAE14F28DC174A9491525C"
      unitRef="usd">2400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37397549e1434-wk-Fact-95BD7C4B84B0C5DA35BEEB34A7EED50F"
      unitRef="usd">6700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37397549e1455-wk-Fact-E8BBA72F4C2508E82957EB34A862BD92"
      unitRef="usd">104200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37397549e1474-wk-Fact-D4B1AA5E529C3117B8EAEB34A7EE395C"
      unitRef="usd">-126500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37397549e1494-wk-Fact-9727E2BA13DBEC12654AEB34A8625DC7"
      unitRef="usd">-48600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37397549e1516-wk-Fact-5382C869DEC35C369C5FBDE1CE4B43A0"
      unitRef="usd">3100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37397549e1535-wk-Fact-0D594FC0637D063FE795174A94692792"
      unitRef="usd">600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37397549e1554-wk-Fact-DCF36026B268B00536B7EB34A8622EE0"
      unitRef="usd">1600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37397549e1580-wk-Fact-24A3E88E5EEE8AE1DA83EB34A7EE95FB"
      unitRef="usd">101100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37397549e1599-wk-Fact-0DCCCDB98C2E9FE76ED4EB34A84338F1"
      unitRef="usd">-127100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37397549e1619-wk-Fact-73CC98F00980B0ADC146EB34A862BF96"
      unitRef="usd">-50200000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d37397549e1703-wk-Fact-DDC1D7D0280028A84DDCEB34A7EECF39"
      unitRef="usdPerShare">1.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2018Q4YTD"
      decimals="2"
      id="d37397549e1722-wk-Fact-8FDB206D5342C0E1905BEB34A852D12E"
      unitRef="usdPerShare">-1.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2017Q4YTD"
      decimals="2"
      id="d37397549e1742-wk-Fact-3614467630BBCC97FCE7EB34A8525AE6"
      unitRef="usdPerShare">-0.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37397549e1759-wk-Fact-AA0440B1DBA856CBABF41ADCFCF1B80E"
      unitRef="shares">91100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37397549e1778-wk-Fact-8A45C3A42C1C5A09984DC22E00A294B9"
      unitRef="shares">88200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37397549e1797-wk-Fact-2DB346FE864C954AF431B0DE8A1D0ABC"
      unitRef="shares">86300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d37397549e1823-wk-Fact-2431014538102260A524EB34A8433137"
      unitRef="usdPerShare">1.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2018Q4YTD"
      decimals="2"
      id="d37397549e1842-wk-Fact-14F3DC4B3584F251E8DDEB34A8627C5C"
      unitRef="usdPerShare">-1.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2017Q4YTD"
      decimals="2"
      id="d37397549e1862-wk-Fact-9CA3C300FF5B6998565EEB34A8520B76"
      unitRef="usdPerShare">-0.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37397549e1879-wk-Fact-891794900913568DB10F3FCA89C0115D"
      unitRef="shares">92300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37397549e1898-wk-Fact-2C5F09467A8B6B26ED3E174A94500918"
      unitRef="shares">88200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37397549e1917-wk-Fact-42473C8A865D15F1338EEB34A8626C17"
      unitRef="shares">86300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37390278e715-wk-Fact-24A3E88E5EEE8AE1DA83EB34A7EE95FB"
      unitRef="usd">101100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37390278e734-wk-Fact-0DCCCDB98C2E9FE76ED4EB34A84338F1"
      unitRef="usd">-127100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37390278e755-wk-Fact-73CC98F00980B0ADC146EB34A862BF96"
      unitRef="usd">-50200000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37390278e843-wk-Fact-61C2680FBC305E5AB33B8949446A11E1"
      unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37390278e862-wk-Fact-F78F8A3B6D045D199D5447B469F2658E"
      unitRef="usd">4000000.0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37390278e881-wk-Fact-8FAF71CD19A588306581EB34A7EEEE92"
      unitRef="usd">-1400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37390278e908-wk-Fact-2787BCB24BD2500E896984423CD1E11C"
      unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37390278e927-wk-Fact-5D56756C54CF5F93863DE0A16F822725"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37390278e946-wk-Fact-1A3E5000AF216309BFD5EB34A8432C6E"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37390278e973-wk-Fact-942AEDA58D59FC8BE3C0EB34A7FE6EB0"
      unitRef="usd">800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37390278e992-wk-Fact-6C13C21639AA9DC5BE3CEB34A822C077"
      unitRef="usd">4100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37390278e1011-wk-Fact-99737194025277B762D0EB34A8627959"
      unitRef="usd">-1600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37390278e1043-wk-Fact-41B54CA05DC81E567FD9EB34A7EE6D6A"
      unitRef="usd">101900000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37390278e1062-wk-Fact-47673D28DF14439D7DA4EB34A827DD68"
      unitRef="usd">-123000000.0</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37390278e1083-wk-Fact-CA8C22660CF84FFC2D2EEB34A8200EDC"
      unitRef="usd">-51800000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d37402404e945-wk-Fact-8EC2E36FD024D7C213CFEB34A823EB30"
      unitRef="shares">84600000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d37402404e964-wk-Fact-5EEC09CC9F7C99243A8CEB34A7FE00E2"
      unitRef="usd">100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e983-wk-Fact-4D9C6B3B39B86D59C326EB34A843DEE0"
      unitRef="usd">905700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d37402404e1003-wk-Fact-3D415D5087F029265D11EB34A843D503"
      unitRef="usd">-1000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d37402404e1023-wk-Fact-A1F1121570086D41357FEB34A80F06C2"
      unitRef="usd">-621000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d37402404e1044-wk-Fact-3189B290836DC9BE37EDEB34A843D049"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2016Q4"
      decimals="-5"
      id="d37402404e1063-wk-Fact-46FFC2310EE78173D007EB34A7EE1854"
      unitRef="usd">283800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan
      contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d37402404e1083-wk-Fact-61A801BF2A99ADF6C511EB34A843A711"
      unitRef="shares">2300000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e1116-wk-Fact-4B7A1DCF6A4A3571D04AEB34A852EC60"
      unitRef="usd">2700000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37402404e1194-wk-Fact-EA8D076057644C8E2AA1EB34A7EE156F"
      unitRef="usd">2700000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d37402404e1219-wk-Fact-DB2913CE5CCAEAED27D9EB34A7FEB4CE"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e1252-wk-Fact-FF8DAB1E5F4E64F564C9EB34A8624B24"
      unitRef="usd">7400000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37402404e1330-wk-Fact-4C3BB0BF391D9EC9F4D2EB34A7EE90C3"
      unitRef="usd">7400000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e1388-wk-Fact-363CF3AA70DE4222E262EB34A86248E1"
      unitRef="usd">106700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37402404e1466-wk-Fact-7F81EDB02A32748EE4BDEB34A830BB75"
      unitRef="usd">106700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e1524-wk-Fact-B6AA0BBC0BA48B8DD3D2EB34A852EF53"
      unitRef="usd">70600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37402404e1602-wk-Fact-3ABBD4EDA0C57A23A0F5EB34A843CF21"
      unitRef="usd">70600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
      contextRef="FD2017Q4YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201609Member_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e1660-wk-Fact-0C0F4A1895A26B19A160EB34A8520DCB"
      unitRef="usd">600000</us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification>
    <us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
      contextRef="FD2017Q4YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201609Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d37402404e1699-wk-Fact-A4FD814F4E066314B374EB34A8524671"
      unitRef="usd">-600000</us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification>
    <us-gaap:NetIncomeLoss
      contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d37402404e1836-wk-Fact-03927A746200B05EF52BEB34A81D8B37"
      unitRef="usd">-50200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37402404e1876-wk-Fact-73CC98F00980B0ADC146EB34A862BF96"
      unitRef="usd">-50200000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d37402404e1955-wk-Fact-1E8FF205D09A26D108CEEB34A811874C"
      unitRef="usd">-1600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37402404e2014-wk-Fact-99737194025277B762D0EB34A8627959"
      unitRef="usd">-1600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d37402404e2040-wk-Fact-0AF7DA579A5486709FA6EB34A852BA88"
      unitRef="shares">87000000.0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d37402404e2054-wk-Fact-19EEF67A35993F4D5A46EB34A843FC63"
      unitRef="usd">100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e2073-wk-Fact-2593BEC33D846E286BBCEB34A8620433"
      unitRef="usd">1093700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d37402404e2093-wk-Fact-A5400EBA0BAC0742C1FDEB34A862FC62"
      unitRef="usd">-2600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d37402404e2113-wk-Fact-25DCBFFD1A260E375B57EB34A82FCCAF"
      unitRef="usd">-671800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d37402404e2133-wk-Fact-4AF62CE7D1899EFE1880EB34A7FE15B7"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2017Q4"
      decimals="-5"
      id="d37402404e2153-wk-Fact-C4B028A6BEB0632C0CB7EB34A843F328"
      unitRef="usd">419400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d37402404e2179-wk-Fact-CC42E367E50BE3FDAC4EEB34A852D4E1"
      unitRef="shares">1800000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e2212-wk-Fact-75C0F293E08FEBD81556EB34A852836E"
      unitRef="usd">1900000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37402404e2290-wk-Fact-D4D18986801FF76F287DEB34A86278B2"
      unitRef="usd">1900000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d37402404e2315-wk-Fact-25425463DED9DD628547EB34A80FBE2C"
      unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e2348-wk-Fact-B3D3B0EC95748DAD84EEEB34A827F7E9"
      unitRef="usd">8900000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37402404e2426-wk-Fact-0B6CD2BC986B00624156EB34A8522C6C"
      unitRef="usd">8900000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e2484-wk-Fact-0FEEDFD6CC1141CCC2ABEB34A7FE8A12"
      unitRef="usd">101900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37402404e2562-wk-Fact-58D3EBE04DEFD31A59A6EB34A826DE77"
      unitRef="usd">101900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d37402404e2587-wk-Fact-56DC37E0684396108230EB34A81162D6"
      unitRef="shares">1800000</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e2620-wk-Fact-5C07DB9370D0C923F04CEB34A862AB52"
      unitRef="usd">217700000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37402404e2698-wk-Fact-58CE720A841CA817A733EB34A7FE1C64"
      unitRef="usd">217700000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e2756-wk-Fact-734BA53C35C4BF7870C0EB34A862929B"
      unitRef="usd">171600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37402404e2834-wk-Fact-A0C5BCAA159D732A959FEB34A843C63D"
      unitRef="usd">171600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e2892-wk-Fact-1C09BDF21CAE7016A582EB34A8526DF5"
      unitRef="usd">183800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37402404e2970-wk-Fact-DB84D102DFD8E4791530EB34A824335F"
      unitRef="usd">183800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e3028-wk-Fact-0F64BCDC9CD67F14EE1BEB34A8521A1B"
      unitRef="usd">-218900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37402404e3107-wk-Fact-026FFC151BD57345F0F4EB34A852B813"
      unitRef="usd">-218900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d37402404e3133-wk-Fact-4601204EE6AADD486656EB34A7EEB606"
      unitRef="shares">800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d37402404e3225-wk-Fact-870693956BCEEF5DA351EB34A7EEBFC5"
      unitRef="usd">100000000.0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37402404e3246-wk-Fact-B4D08082E8C3B3B25F47EB34A7FE3518"
      unitRef="usd">100000000.0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d37402404e3344-wk-Fact-B5630B9E3589C0D10A2CEB34A843FCA1"
      unitRef="usd">-127100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37402404e3384-wk-Fact-0DCCCDB98C2E9FE76ED4EB34A84338F1"
      unitRef="usd">-127100000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d37402404e3463-wk-Fact-6F5D7B6A8BE5168211DAEB34A862D211"
      unitRef="usd">4100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37402404e3521-wk-Fact-6C13C21639AA9DC5BE3CEB34A822C077"
      unitRef="usd">4100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d37402404e3546-wk-Fact-27C5542A5C6A4CFA04B7EB34A8625F04"
      unitRef="shares">90000000.0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d37402404e3560-wk-Fact-67E5003D6013107EDDF9EB34A862C794"
      unitRef="usd">100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e3579-wk-Fact-0A19C60EC44221E9D494EB34A843EB81"
      unitRef="usd">1560600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d37402404e3599-wk-Fact-B91CFA2A42806CE550DEEB34A84328ED"
      unitRef="usd">1500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d37402404e3618-wk-Fact-6A84E85FD13F1F56E13AEB34A85297C6"
      unitRef="usd">-798900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d37402404e3638-wk-Fact-6F9F515769B82E908962EB34A833E4BF"
      unitRef="usd">-100000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37402404e3659-wk-Fact-B4189629853BAE21CFC2EB34A81BE193"
      unitRef="usd">663300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
      contextRef="FD2019Q4YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d37402404e3757-wk-Fact-8109F621C2AB5338B7C8B9382E334719"
      unitRef="usd">2100000</us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification>
    <us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
      contextRef="FD2019Q4YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="-5"
      id="d37402404e3796-wk-Fact-E80EF1BDAD6F3262B865EB34A862DF7C"
      unitRef="usd">2100000</us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d37402404e3821-wk-Fact-05B5C023BA1555E594A030E0AEE92ACD"
      unitRef="shares">1400000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e3854-wk-Fact-9EE13058BD8B547DBE735B1D9E2344BC"
      unitRef="usd">300000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37402404e3932-wk-Fact-E33C8D112EAB778ADE3CEB34A7EEC570"
      unitRef="usd">300000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d37402404e3957-wk-Fact-086D6E33CC635483811CC82E1A2D7F97"
      unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e3990-wk-Fact-A48EC733E0EB5E438C2F446C6A506ED4"
      unitRef="usd">11600000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37402404e4068-wk-Fact-3E82425C6C26D102D2B2EB34A843619F"
      unitRef="usd">11600000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e4126-wk-Fact-B644C96442C25B3EB3F62483A971389D"
      unitRef="usd">102700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37402404e4204-wk-Fact-99658C2653ED80F36C2CEB34A8526E65"
      unitRef="usd">102700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e4262-wk-Fact-177996DFC89927FC95D8F38E5CD0A03E"
      unitRef="usd">700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37402404e4340-wk-Fact-9C339211A8B6B14182F3AB3544C8460C"
      unitRef="usd">700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d37402404e4437-wk-Fact-DC508509AC3254139A6651DBA0F16911"
      unitRef="usd">101100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37402404e4476-wk-Fact-24A3E88E5EEE8AE1DA83EB34A7EE95FB"
      unitRef="usd">101100000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d37402404e4554-wk-Fact-9530A18315CF54ABBD28DE7D2192D779"
      unitRef="usd">800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37402404e4612-wk-Fact-942AEDA58D59FC8BE3C0EB34A7FE6EB0"
      unitRef="usd">800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d37402404e4637-wk-Fact-0358F93AB688926C774CEB34A82AC32E"
      unitRef="shares">91600000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d37402404e4656-wk-Fact-B65591980B7F1B4C3C45EB34A8437737"
      unitRef="usd">100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37402404e4675-wk-Fact-FCFFF34F17FBC7C0CA6EEB34A852EFCF"
      unitRef="usd">1675900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d37402404e4695-wk-Fact-C982CD81D04099E51074EB34A8431416"
      unitRef="usd">2300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d37402404e4714-wk-Fact-2334391E1F12B5622148EB34A8527597"
      unitRef="usd">-695700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d37402404e4735-wk-Fact-AE0C048BE034F65BADFCEB34A8433DB0"
      unitRef="usd">-100000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37402404e4755-wk-Fact-938ED76C40F35933492EEB34A827852E"
      unitRef="usd">882600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e804-wk-Fact-24A3E88E5EEE8AE1DA83EB34A7EE95FB"
      unitRef="usd">101100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e823-wk-Fact-0DCCCDB98C2E9FE76ED4EB34A84338F1"
      unitRef="usd">-127100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e843-wk-Fact-73CC98F00980B0ADC146EB34A862BF96"
      unitRef="usd">-50200000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e922-wk-Fact-BAF3D039662554AD9DDAD36E3D62AB2E"
      unitRef="usd">48700000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e941-wk-Fact-40DE5200B9E750049E7F86493FD9D9CE"
      unitRef="usd">29100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e960-wk-Fact-C65113A8B8D88A84EE8EEB34A843A822"
      unitRef="usd">16100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e981-wk-Fact-CAAFDCAD6C495B359A27BBCE72C9083A"
      unitRef="usd">102700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e1000-wk-Fact-8503D7D80BFC59CEB66F1F73B6B038A4"
      unitRef="usd">101900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e1019-wk-Fact-8DAAE767FE0DC207367EEB34A8439A2C"
      unitRef="usd">106200000</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e1040-wk-Fact-7515DFDC98F450AF931467F19D8E4827"
      unitRef="usd">49600000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e1059-wk-Fact-28057FA0B3465BCD8ABB88FBFB1E8766"
      unitRef="usd">17900000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e1078-wk-Fact-A63E9E880D15117A6E26EB34A8529792"
      unitRef="usd">9400000</us-gaap:AmortizationOfDebtDiscountPremium>
    <dxcm:RDexpensethroughissuanceofcommonstock
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e1099-wk-Fact-4D81013D3931F4A17124EB34A7EEB1FD"
      unitRef="usd">0</dxcm:RDexpensethroughissuanceofcommonstock>
    <dxcm:RDexpensethroughissuanceofcommonstock
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e1118-wk-Fact-995313BF29226BEFE534EB34A8620DA3"
      unitRef="usd">217700000</dxcm:RDexpensethroughissuanceofcommonstock>
    <dxcm:RDexpensethroughissuanceofcommonstock
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e1137-wk-Fact-09705683290F48B46BEBEB34A862EFA6"
      unitRef="usd">0</dxcm:RDexpensethroughissuanceofcommonstock>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e1158-wk-Fact-5061BEB2CBA759039F0A866AB98616FB"
      unitRef="usd">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e1177-wk-Fact-DA64AB868AF1509FBEF5656113EA912A"
      unitRef="usd">36000000.0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e1197-wk-Fact-A8303D06397996C6F93EEB34A85205D4"
      unitRef="usd">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e1218-wk-Fact-9F337F7FBCE6502983F71BD7E20ECFFF"
      unitRef="usd">-4200000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e1237-wk-Fact-14B1945BBDC65722923901C9406335CA"
      unitRef="usd">44100000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e1257-wk-Fact-20328F1E736421A8F892EB34A8432D2B"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e1279-wk-Fact-6DFE3CA3A85A54A4967DCB3BE6D24440"
      unitRef="usd">-2100000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e1298-wk-Fact-9AB1355BD6E55E9583F2D3F9D4EDF3AB"
      unitRef="usd">-4700000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e1317-wk-Fact-B7B8C48DF7AD032CD851EB34A8523E8D"
      unitRef="usd">-7900000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e1400-wk-Fact-89B2CF68A50052DFA5619E57D9F9EAA0"
      unitRef="usd">60000000.0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e1420-wk-Fact-56B59099AF515CBF91ABFE5C5520C384"
      unitRef="usd">93200000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e1440-wk-Fact-695D2F175EDE546860D7EB34A862DD7F"
      unitRef="usd">31800000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e1462-wk-Fact-C53FC972C1CF586595595612DC17B1C6"
      unitRef="usd">49100000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e1482-wk-Fact-B73040042BAD5D229031BC2E7F1FD133"
      unitRef="usd">25500000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e1502-wk-Fact-D9EFE3697A3F6617E595EB34A8436982"
      unitRef="usd">-400000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e1523-wk-Fact-90F3213B27F752888CA529FDFA22CB65"
      unitRef="usd">7200000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e1543-wk-Fact-889A6256769855B1B532189B1E8BBFAA"
      unitRef="usd">3000000.0</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e1563-wk-Fact-5EFDDB10DCB7E3188321EB34A843548A"
      unitRef="usd">6700000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e1585-wk-Fact-FC4D4BE1110203EF16B4AB41E113C825"
      unitRef="usd">2400000</dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet>
    <dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e1605-wk-Fact-5499E4FA12F6C83EBE6CAB41E38397D9"
      unitRef="usd">0</dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet>
    <dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e1624-wk-Fact-802C5480FA8F353B4557AB41E5ED5F3E"
      unitRef="usd">0</dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e1645-wk-Fact-58AD526DA508594FA715D2A5BD5AFEE5"
      unitRef="usd">109000000.0</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e1664-wk-Fact-6D94996F9494560E98B99C50880F0A36"
      unitRef="usd">56200000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e1683-wk-Fact-52DBDBCB0276031C0692EB34A852F037"
      unitRef="usd">21100000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e1704-wk-Fact-62712C51FEAE5B5B8F79F82490B897D4"
      unitRef="usd">16000000.0</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e1723-wk-Fact-075724A2A718549B85EF9E7A0EB7B38C"
      unitRef="usd">23800000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e1742-wk-Fact-3FFC113EF138169D1D18EB34A852AF23"
      unitRef="usd">14800000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e1763-wk-Fact-D5CD74E7F9FB5BE4802D039DB4E2B14D"
      unitRef="usd">-200000</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e1783-wk-Fact-EDDD403F2D9E5FA58566DD5EFAEA61CF"
      unitRef="usd">800000</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e1802-wk-Fact-B483CEDBDA4CE0DA63E3EB34A862A9CF"
      unitRef="usd">4800000</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e1823-wk-Fact-A0D7FDBB993215901290EB34A862BB19"
      unitRef="usd">314500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e1842-wk-Fact-319F83059D381F009D8DEB34A843C464"
      unitRef="usd">123200000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e1861-wk-Fact-97156E56333D22853F82EB34A85222D5"
      unitRef="usd">92000000.0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e1945-wk-Fact-C208F49BDF565B0098AA9A82D789F2C7"
      unitRef="usd">2030400000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e1965-wk-Fact-B27C9292506F546EAAB474814A2EB0AC"
      unitRef="usd">452500000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e1985-wk-Fact-A47D08AE4BEA1380097FEB34A7EECE8B"
      unitRef="usd">171800000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e2007-wk-Fact-0863F69E9BBD5D59B01C3CD49EBA982A"
      unitRef="usd">1196400000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e2026-wk-Fact-037471B8D1EA5961A2D87F0C5611D2E9"
      unitRef="usd">392100000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e2045-wk-Fact-C67670F78C379AE9A2CAEB34A862B912"
      unitRef="usd">93400000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e2066-wk-Fact-CB30C2DAD3CA52EEB6FBBA8F0A31BDD2"
      unitRef="usd">1200000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e2086-wk-Fact-93FDD1FE670E5D3AA22276DA57F95294"
      unitRef="usd">1000000.0</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e2106-wk-Fact-5D2B545F752BDA47585AEB34A843EBF8"
      unitRef="usd">0</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e2127-wk-Fact-59966C907F595036B9B4158AC7A24E66"
      unitRef="usd">180000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e2147-wk-Fact-0A719CE6830552C6B9AC80461EBE404B"
      unitRef="usd">67100000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e2167-wk-Fact-C008B3400C96F8AFDF36EB34A8438770"
      unitRef="usd">66000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e2189-wk-Fact-407BE9CAFB3C571686DF6B4F8982473F"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e2208-wk-Fact-EBA6B977F2B85CA89537EB34616D0A93"
      unitRef="usd">11300000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e2228-wk-Fact-92F6448B56B491EAECC1EB34A7FE7C93"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e2249-wk-Fact-75EDF7FD943AA2C6C42DEB34A843E174"
      unitRef="usd">-1015200000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e2269-wk-Fact-1AAFFDBCDF249B2B4906EB34A85296B8"
      unitRef="usd">-139800000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e2289-wk-Fact-337AA229276F9DB53F18EB34A843E51E"
      unitRef="usd">-144400000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e2373-wk-Fact-42E0919653D350A19E3D87F84CC42F9F"
      unitRef="usd">11900000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e2392-wk-Fact-5568C19CADEF5BA084DBF4DE32CB5032"
      unitRef="usd">10800000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e2411-wk-Fact-B33A76FBD17B850A7DB5EB34A862DF36"
      unitRef="usd">10100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e2432-wk-Fact-AB6CFA0E5A6CAC680935EB34A8529E73"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e2451-wk-Fact-0A1A5E08EA37D383FEA70F2D0614B5E7"
      unitRef="usd">100000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e2471-wk-Fact-4FF2871B410B58B41602EB34A852D623"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e2492-wk-Fact-F0800166B17B29C82E8AEB34A852871C"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e2511-wk-Fact-E0DDD794CEBBDD49776FEB34A7EEF823"
      unitRef="usd">836600000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e2530-wk-Fact-B37B5E1668D650CC6B54EB34A852B76E"
      unitRef="usd">389000000.0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e2551-wk-Fact-AAAA1B626146310ECA2AEB34A852A5D7"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e2570-wk-Fact-A64D3EEBE8FE6A84ECD4EB34A8625AB5"
      unitRef="usd">183800000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e2589-wk-Fact-A22B2526D6A26D22A3BFEB34A7EE8634"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <dxcm:PurchaseofConvertibleNoteHedge
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e2611-wk-Fact-411C6E4434136EEB34EAEB34A8436159"
      unitRef="usd">0</dxcm:PurchaseofConvertibleNoteHedge>
    <dxcm:PurchaseofConvertibleNoteHedge
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e2630-wk-Fact-9177148F6CA05F4CAB64EB34A85237D1"
      unitRef="usd">218900000</dxcm:PurchaseofConvertibleNoteHedge>
    <dxcm:PurchaseofConvertibleNoteHedge
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e2650-wk-Fact-7BC65DDA8C5CACE1AC88EB34A843AB5C"
      unitRef="usd">0</dxcm:PurchaseofConvertibleNoteHedge>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e2671-wk-Fact-6BA6BF5399A8FB0F2E13EB34A843A9AC"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e2690-wk-Fact-EC06FF87AED0E1A83331EB34A7EEAB04"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e2709-wk-Fact-D3961398DFBC0BAC4448EB34A8523256"
      unitRef="usd">75000000.0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e2730-wk-Fact-4944538D27363F7FE91EEB34A8526CA3"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e2749-wk-Fact-958E146A4016772C73CEEB34A84308FA"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e2768-wk-Fact-C93E2DAF4E0B7CA41901EB34A84381EA"
      unitRef="usd">75000000.0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e2790-wk-Fact-0B36BC45CBB74BA662760F2D061AF50D"
      unitRef="usd">-1200000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e2810-wk-Fact-E5EF5A331195071E35DC0F2D059DE6C5"
      unitRef="usd">-1900000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e2830-wk-Fact-BACA44AB32CB8F3979480F2D05A3EB5C"
      unitRef="usd">0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e2851-wk-Fact-AF729E4E4F73254274EAEB34A86214CD"
      unitRef="usd">10700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e2870-wk-Fact-4763F0AAE2E7542FB444EB34A84338CA"
      unitRef="usd">710400000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e2889-wk-Fact-6F1F4CFB58DB7792BF34EB34A8437685"
      unitRef="usd">399100000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e2910-wk-Fact-5BDA67E055625AB188EA062F45636A9A"
      unitRef="usd">-700000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e2930-wk-Fact-D53924BA606C57A88159F11F098CD3A6"
      unitRef="usd">1800000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e2949-wk-Fact-7A6CEE736CC2C24D9CB2EB34A84371C8"
      unitRef="usd">300000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e2970-wk-Fact-4F135883E438644FC7D8EB34A843E827"
      unitRef="usd">-690700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e2990-wk-Fact-B92660AD60812A466159EB34A843C12B"
      unitRef="usd">695600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e3009-wk-Fact-135B3A534964A1866EA7EB34A8437797"
      unitRef="usd">347000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37396062e3030-wk-Fact-06F4FA507E245B65842774AC5E15BA64"
      unitRef="usd">1137100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2017Q4"
      decimals="-5"
      id="d37396062e3049-wk-Fact-3766517489BEE0CF0D010F2D04D61D30"
      unitRef="usd">441500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2016Q4"
      decimals="-5"
      id="d37396062e3068-wk-Fact-47671CE5B0995FA0ACE0EB34A843804E"
      unitRef="usd">94500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37396062e3094-wk-Fact-F91CEBFB964BD19C2AEF0F2D05A8F644"
      unitRef="usd">446400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37396062e3113-wk-Fact-06F4FA507E245B65842774AC5E15BA64"
      unitRef="usd">1137100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2017Q4"
      decimals="-5"
      id="d37396062e3132-wk-Fact-3766517489BEE0CF0D010F2D04D61D30"
      unitRef="usd">441500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37396062e3278-wk-Fact-C34A37AEC0925179A5FBD7370ABF40D4"
      unitRef="usd">446200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37396062e3297-wk-Fact-E529F8ACC9195FE8B669B378B77BC5C6"
      unitRef="usd">1137000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2017Q4"
      decimals="-5"
      id="d37396062e3316-wk-Fact-C85E2CD4EAD08F962F970F2D061F9A0B"
      unitRef="usd">441500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37396062e3332-wk-Fact-2A08BE9A0CFC51F19A754A9399400B32"
      unitRef="usd">200000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37396062e3351-wk-Fact-F8851C10E4C05C61937FBF36019984C2"
      unitRef="usd">100000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="FI2017Q4"
      decimals="-5"
      id="d37396062e3370-wk-Fact-2347B2BAE5EC5D271A760F2D0624FA0E"
      unitRef="usd">0</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37396062e3396-wk-Fact-F91CEBFB964BD19C2AEF0F2D05A8F644"
      unitRef="usd">446400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37396062e3415-wk-Fact-06F4FA507E245B65842774AC5E15BA64"
      unitRef="usd">1137100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2017Q4"
      decimals="-5"
      id="d37396062e3434-wk-Fact-3766517489BEE0CF0D010F2D04D61D30"
      unitRef="usd">441500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e3599-wk-Fact-D36BD2875D6C1FCCFEC5EB34A843EA37"
      unitRef="usd">14200000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e3618-wk-Fact-AD9812872873B2594D6EEB34A84346B7"
      unitRef="usd">10800000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e3637-wk-Fact-3E44AFD546B243F6A3B8EB34A8622A0E"
      unitRef="usd">6300000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:InterestPaidNet
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e3720-wk-Fact-978AA3D3CAB73DC59316EB34A85220A6"
      unitRef="usd">10400000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e3739-wk-Fact-5B6AEBF2B0C81117770BEB34A85244C1"
      unitRef="usd">3600000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e3758-wk-Fact-D3A6147C9DC849F8745AEB34A8521748"
      unitRef="usd">2400000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37396062e3779-wk-Fact-8A8B6A67C9B1DD92ADF9EB34A852F9AA"
      unitRef="usd">4800000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37396062e3798-wk-Fact-B8D640881C63BB9F03FCEB34A8527F33"
      unitRef="usd">2300000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37396062e3817-wk-Fact-12325BAFD4D9322B79C8EB34A852DE08"
      unitRef="usd">1400000</us-gaap:IncomeTaxesPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-4CBF0F3C1C1260DB16FDEB34A875E6E8-0-wk-Fact-C4B028C0439A7E7E3C8DEB34A7FEC201">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #ffffff;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;"&gt;1. Organization and Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Organization and Business&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;DexCom, Inc. is a medical device company focused on the design, development and commercialization of CGM system(s) for use by people with diabetes and by healthcare providers. Unless the context requires otherwise, the terms &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; the &#x201c;company,&#x201d; or &#x201c;DexCom&#x201d; refer to DexCom, Inc. and its subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The functional currencies of our international subsidiaries are generally the local currencies. We translate the financial statements of our foreign subsidiaries into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;comprehensive income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;accumulated other comprehensive income&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; in the equity section of our consolidated balance sheet. Gains and losses resulting from certain intercompany transactions as well as transactions with customers and vendors that are denominated in currencies other than the functional currency of each entity give rise to foreign exchange gains or losses that we record in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;interest and other income, net&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles, or GAAP, requires us to make certain estimates and assumptions that affect the amounts reported in our financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include pharmacy rebates, transaction price, net accounts receivable, excess or obsolete inventories and the valuation of inventory, and accruals for litigation contingencies. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The authoritative guidance establishes a fair value hierarchy that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities. In general, the authoritative guidance requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset or liability&#x2019;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the measurement of its fair value. The three levels of input defined by the authoritative guidance are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Level&#160;1&#x2014;Unadjusted quoted prices that are available in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Level&#160;2&#x2014;Inputs other than quoted prices included in Level&#160;1 that are observable, either directly or indirectly, through correlation with market data. These include quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Level&#160;3&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the determination of fair value. Level 3 assets and liabilities include those whose fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques and significant judgment or estimation.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We carry our marketable securities at fair value. We carry our other financial instruments, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, at cost, which approximates the related fair values due to the short-term maturities of these instruments. For more information see Note 3, &#x201c;Fair Value Measurements.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We consider highly liquid investments with a maturity of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;90&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;days or less at the time of purchase to be cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We have classified our marketable securities with remaining maturity at purchase of more than three months and remaining maturities of one year or less as short-term marketable securities. We have also classified marketable securities with remaining maturities of greater than one year as short-term marketable securities based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We calculate realized gains or losses on our marketable securities using the specific identification method. We carry our marketable debt securities at fair value with unrealized gains and losses reported as a separate component of stockholders&#x2019; equity in our consolidated balance sheets and included in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;comprehensive income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. Realized gains and losses on marketable debt securities are included in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;interest and other income, net&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; in our consolidated statements of operations. We carry our marketable equity securities at fair value with realized and unrealized gains and losses reported in income on equity investments in our consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We invest in various types of debt securities, including debt securities in government-sponsored entities, corporate debt securities, U.S. Treasury securities and commercial paper. We do not generally intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity. See Note 3, &#x201c;Fair Value Measurements&#x201d; and Note 4, &#x201c;Balance Sheet Details &#x2013; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Short-Term Marketable Securities&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#x201d; for more information on our marketable debt securities and our marketable equity securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accounts receivable are generally recorded at the invoiced amount for Distributors and at net realizable value for Direct customers, which is determined using estimates of claim denials and historical reimbursement experience without regard to aging category. Accounts receivable are not interest bearing. We evaluate the creditworthiness of significant customers and generally do not require collateral from our customers. We maintain an allowance for doubtful accounts for potential credit losses. Uncollectable accounts are written off against the allowance after appropriate collection efforts have been exhausted and when it is deemed that a customer account is uncollectable.&#160;Generally, receivable balances greater than one year past due are deemed uncollectable.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Concentration of Credit Risk and Significant Customers&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table sets forth the percentages of total revenue or gross accounts receivable for customers that represent 10% or more of the respective amounts for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="15"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gross Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;As of December 31, &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Distributor A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Distributor B&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Distributor C&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;*     Less than 10%&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Inventory is valued at the lower of cost or net realizable value on a part-by-part basis that approximates first in, first out. We record adjustments to inventory for potentially excess, obsolete or scrapped goods in order to state inventory at net realizable value. Factors influencing these adjustments include inventories on hand and on order compared to estimated future usage and sales for existing and new products, as well as judgments regarding quality control testing data and assumptions about the likelihood of scrap and obsolescence. Once written down the adjustments are considered permanent and are not reversed until the related inventory is sold or disposed of.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Our products require customized products and components that currently are available from a limited number of sources. We purchase certain components and materials from single sources due to quality considerations, costs or constraints resulting from regulatory requirements. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Property and equipment is stated at cost less accumulated depreciation. We calculate depreciation using the straight-line method over the estimated useful lives of the assets. Estimated useful lives are generally &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;three years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; for computer software and hardware, four to &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;fifteen years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; for machinery and equipment, and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; for furniture and fixtures. Leasehold improvements are amortized over the shorter of the estimated useful lives of the assets or the remaining lease term. We include the amortization of assets that are recorded under finance leases in depreciation expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We review property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the recoverability of the asset by comparing the carrying amount to the future undiscounted cash flows that we expect the asset to generate. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We record goodwill when the fair value of consideration transferred in a business combination exceeds the fair value of the identifiable assets acquired and liabilities assumed. Goodwill and other intangible assets that have indefinite useful lives are not amortized, but we test them annually for impairment in the fourth quarter of our fiscal year and whenever events or changes in circumstances indicate that it is more likely than not that the fair value is less than the carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate or operational performance of the business, and an adverse action or assessment by a regulator. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We perform our goodwill impairment analysis at the reporting unit level, which aligns with DexCom&#x2019;s reporting structure and the availability of discrete financial information.&#160;We perform the first step of our annual impairment analysis by either comparing a reporting unit&#x2019;s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit&#x2019;s fair value from the last quantitative assessment to determine if there is potential impairment. We may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit&#x2019;s estimated fair value was significantly in excess of the carrying value of its net assets and we do not believe there have been significant changes in the reporting unit&#x2019;s operations that would significantly decrease its estimated fair value or significantly increase its net assets.&#160;If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections&#160;and/or use of a market approach by looking at market values of comparable companies. Key assumptions&#160;for these projections include revenue growth, future gross margin and operating margin growth, and weighted cost of capital and terminal growth rates. The revenue and margin growth are based on increased sales of new and existing products as we maintain investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements&#160;to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including the timing and probability of regulatory approvals for our products to be commercialized. We also consider DexCom&#x2019;s market capitalization as a part of our analysis.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;If the estimated fair value of a reporting unit exceeds the carrying amount of the net assets assigned to that unit, goodwill is not impaired and no further analysis is required. If the carrying value of the net assets assigned to a reporting unit exceeds the estimated fair value of the unit, we perform the second step of the impairment test. In this step we allocate the fair value of the reporting unit calculated in step one to all of the assets and liabilities of that unit, as if we had just acquired the reporting unit in a business combination. The excess of the fair value of the reporting unit over the total amount allocated to the assets and liabilities represents the implied fair value of goodwill. If the carrying amount of a reporting unit&#x2019;s goodwill exceeds its implied fair value, we would record an impairment loss equal to the difference. We recorded &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; goodwill impairment charges for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; or &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The change in goodwill for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; consisted of translation adjustments on our foreign currency denominated goodwill. The change in goodwill for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; consisted of goodwill we recorded for acquisitions that were not significant, individually or in the aggregate, and translation adjustments on our foreign currency denominated goodwill. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Intangible Assets and Other Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We amortize intangible assets with a finite life, such as acquired technology, customer relationships, trade names and trademarks, on a straight-line basis over their estimated useful lives, which range from &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;two&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; to &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;five&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; years. We review intangible assets that have finite lives and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We recognize deferred tax assets to the extent that we believe that these assets are more likely than not to be realized, which requires significant judgment. The realization of deferred tax assets is dependent, in part, upon future taxable income. In assessing whether our deferred tax assets will be realized, we consider all available evidence, both positive and negative. Such evidence includes historical earnings, future reversals of existing taxable temporary differences, estimates of future taxable income, and the feasibility of ongoing tax planning strategies. We have recorded a full valuation allowance on our net deferred tax asset balances for all periods presented because of the uncertainty related to utilization of our deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We record uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;50 percent&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; likely to be realized upon ultimate settlement with the related tax authority.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We file federal and state income tax returns in the United States and income tax returns in various other foreign jurisdictions with varying statutes of limitations. Due to net operating losses incurred, our income tax returns from inception to date are subject to examination by taxing authorities. We recognize interest expense and penalties related to income tax matters, including unrecognized tax benefits, as a component of income tax expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Warranty Accrual&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Estimated warranty costs associated with a product are recorded at the time revenue is recognized. We estimate future warranty costs by analyzing historical warranty experience for the timing and amount of returned product, and expectations for future warranty activity based on changes and improvements to the product or process that are in place or will be in place in the future. We evaluate these estimates on at least a quarterly basis to determine the continued appropriateness of our assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Loss Contingencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;If the potential loss from a claim or legal proceeding is considered probable and the amount can be reasonably estimated, we record a liability and an expense for the estimated loss and disclose it in our financial statements if it is significant. If we determine that a loss is possible and the range of the loss can be reasonably determined, then we disclose the range of the possible loss. Significant judgment is required in the determination of whether a potential loss is probable, reasonably possible, or remote as well as in the determination of whether a potential exposure is reasonably estimable. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.8046875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Comprehensive income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; consists of two elements, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;net income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;other comprehensive income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. We report all components of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;comprehensive income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, including &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;net income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, in our financial statements in the period in which they are recognized. Total &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;comprehensive income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We report &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;net income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and the components of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;other comprehensive income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, including foreign currency translation adjustments and unrealized gains and losses on marketable securities, net of their related tax effect to arrive at total &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;comprehensive income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;.&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We generate our revenue from the sale of our Reusable Hardware and disposable sensors, which we refer to in this section as &#x201c;Components&#x201d;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We adopted ASC Topic 606 effective January 1, 2018 using the modified retrospective method. Our revenue recognition policies under ASC Topic 606 are explained below.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Policy elections and practical expedients taken&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#x2022;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We report revenue net of taxes collected from customers, which are subsequently remitted to governmental authorities;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#x2022;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We account for shipping and handling activities that are performed after a customer has obtained control of a good as fulfillment costs rather than as separate performance obligations;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#x2022;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We do not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer; and&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#x2022;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;If we expect, at contract inception, that the period between the transfer of control and corresponding payment from the customer will be one year or less, we do not adjust the amount of consideration for the effects of a significant financing component.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Contracts and performance obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations. We also provide free-of-charge software, mobile applications and updates for our DexCom Share&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;&#xae; &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;remote monitoring system. The standalone selling prices of our free-of-charge software, mobile applications and updates are estimated based on an expected cost plus a margin approach.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Transaction price&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Transaction price for the Components reflects the net consideration to which we expect to be entitled. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Variable consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Rebates.&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; We estimate reductions for rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Product Returns. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In accordance with the terms of their distribution agreements, most distributors do not have rights of return outside of our limited warranty. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. We generally provide a &#x201c;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;-day money back guarantee&#x201d; program whereby first-time end-user customers may return Reusable Hardware. Product returns have historically been immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The timing of revenue recognition is based on the satisfaction of performance obligations. Substantially all of the performance obligations associated with our Components are satisfied at a point in time, which typically occurs at shipment of our products. Terms of direct and distributor orders are generally&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ee2724;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Freight on Board (FOB) shipping point for U.S. orders or Free Carrier (FCA) shipping point for international orders. For certain of our distributors, control transfers at delivery of the product to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In cases where our free-of-charge software, mobile applications and updates are deemed to be separate performance obligations, revenue is recognized over time on a ratable basis over the estimated life of the related hardware component. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Our sales of Components include an assurance-type warranty.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Judgments and Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In determining how revenue should be recognized, a five-step process is used, which requires judgment and estimates that can have a significant impact on the amount and timing of revenue we report. These judgments and estimates include identifying performance obligations in the contract, determining whether the performance obligations are separate, allocating the transaction price to each separate performance obligation, determining the timing of revenue recognition for separate performance obligations and estimating the amount of variable consideration to include in the transaction price. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Contract balances&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Contract balances represent amounts presented in the consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; to &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;90&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; days. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accounts receivable as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; included unbilled accounts receivable of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$3.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. Unbilled accounts receivable consists of revenue recognized for Components we have delivered but not yet invoiced to customers. We expect to invoice and collect all unbilled accounts receivable within twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation. The table below shows revenue that we recognized as a result of changes in the contract liability balances in the periods shown.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Revenue recognized in the period from:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Amounts included in contract liabilities at the beginning of the period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Our performance obligations are generally satisfied within 12 months of the initial contract date. As of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, the deferred revenue balance related to performance obligations that will be satisfied after 12 months was &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$2.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. and is included in other long-term liabilities on our consolidated balance sheets. As of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, we had &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; deferred revenue balance related to performance obligations that will be satisfied after 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Deferred cost of sales&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Deferred cost of sales are associated with sales for which revenue recognition criteria are not met but product has shipped and released from inventory. Deferred cost of sales are included in prepaid and other current assets in our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Incentive compensation costs&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; or less. We record these costs in selling, general and administrative expense in our consolidated statement of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Product Shipment Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We record the amounts we charge our customers for the shipping and handling of our products in revenue and we record the related costs as cost of sales in our statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We expense costs of research and development as we incur them. Our research and development expenses primarily consist of engineering and research expenses related to our continuous glucose monitoring technology, clinical trials, regulatory expenses, quality assurance programs, materials and products for clinical trials. Research and development expenses primarily consist of employee compensation, including salary, fringe benefits, share-based compensation, and temporary employee expenses. We also incur significant expenses to operate our clinical trials that include clinical site reimbursement, clinical trial product, and associated travel expenses. Our research and development expenses also include fees for design services, contractors, and development materials.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Our CGM systems include certain software that we develop. We expense software development costs as we incur them until technological feasibility has been established, at which time we capitalize development costs until the product is available for general release to customers. To date, our software has been available for general release concurrent with the establishment of technological feasibility and, accordingly, we have not capitalized any development costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We expense advertising costs as we incur them to selling, general and administrative expenses. Advertising expense was &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$31.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$25.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$21.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, respectively. &lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We determine if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The interest rate used to determine the present value of the future lease payments is our incremental borrowing rate, because the interest rate implicit in most of our leases is not readily determinable. Our incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in similar economic environments. The operating lease right-of-use asset also includes any lease payments made and excludes lease incentives. We have lease agreements with lease and non-lease components, which are generally accounted for separately. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Variable lease payments that do not depend on a rate or index, payments associated with non-lease components, and costs related to leases with terms of less than 12 months are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Share-based compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized straight-line over the requisite service period of the individual grants, which typically equals the vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We value time-based Restricted Stock Units (&#x201c;RSUs&#x201d;) at the date of grant using the intrinsic value method. Certain RSUs granted to senior management vest based on the achievement of pre-established performance or market goals.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We estimate the fair value of performance/market-based RSUs at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We update our assessment of the probability that the specified performance criteria will be achieved each quarter and adjust our estimate of the fair value of the performance-based RSUs if necessary. The Monte Carlo methodology that we use to estimate the fair value of market-based RSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the market-based RSUs at the date of grant must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the performance of the specified market criteria. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;If any of the assumptions used change significantly, share-based compensation expense may differ materially from what we have recorded in the current period.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We account for forfeitures as they occur by reversing any share-based compensation expense related to awards that will not vest. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Net Income (Loss) Per Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Basic &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;net income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; per share attributable to common stockholders is calculated by dividing the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;net income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;net income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Potentially dilutive common shares consist of shares issuable from stock options, unvested RSUs, warrants and the 2022 and 2023 Senior Convertible Notes. Potentially dilutive common share equivalents shares from outstanding stock options, warrants and unvested RSUs are determined using the average share price for each period under the treasury stock method. Potentially dilutive shares issuable upon conversion of our 2022 and 2023 Senior Convertible Notes are determined using the if-converted method. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table sets forth the computation of basic and diluted &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;net income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; per share for the periods shown.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Net income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;101.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(127.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(50.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Net income (loss) per common share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(1.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(1.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;91.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;88.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;86.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Dilutive potential common stock outstanding:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Stock options and employee stock purchase plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Restricted stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2023 Warrants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2022 senior convertible notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2023 senior convertible notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Diluted weighted average shares outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;92.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;88.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;86.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In periods of net losses, we exclude potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Outstanding anti-dilutive securities not included in the diluted &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;net income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; per share attributable to common stockholders calculations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Options outstanding to purchase common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Unvested restricted stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2023 Warrants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Senior convertible notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Senior convertible notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;7.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Recent Accounting Guidance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases (Topic 842)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; (ASU 2016-02), which requires a lessee to recognize most leases on the consolidated balance sheet as lease liabilities with corresponding right-of-use assets. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;We adopted ASU&#160;2016-02 utilizing the modified retrospective transition method at the beginning of the first quarter of 2019. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;See Note 6, &#x201c;Leases and Other Commitments&#x201d; for more information on the impact of our adoption of ASU 2016-02 and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;In August 2017, the FASB issued ASU No. 2017-12, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;"&gt;Derivatives and Hedging &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;(ASU 2017-12), which is intended to more closely align hedge accounting with companies&#x2019; risk management strategies, simplify the application of hedge accounting, and increase transparency regarding the scope and results of hedging programs. The guidance in this update is applied using a cumulative-effect adjustment to retained earnings at the beginning of the fiscal year of adoption. ASU 2017-12 is effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Our adoption of ASU 2017-12 at the beginning of the first quarter of 2019 did not have a significant impact on our consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;In June 2016, the FASB issued ASU 2016-13, Financial Instruments - &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;"&gt;Credit Losses: Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available-for-sale debt securities. This update is effective for annual periods beginning after December 15, 2019, and interim periods within those periods, and early adoption is permitted. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;W&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;e expect to adopt the standard on its effective date in the first quarter of 2020. We believe the adoption will modify the way we analyze financial instruments, but currently do not expect the adoption to have a material financial impact on our consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;In January 2017, the FASB issued ASU No. 2017-04, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;"&gt;Intangibles &#x2013; Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;(ASU 2017-04). This new guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit&#x2019;s carrying amount over its fair value. ASU 2017-04 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We do not expect the adoption to have a material financial impact on our consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In August 2018, the FASB issued ASU No. 2018-13,&#160;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Fair Value Measurement: Disclosure Framework &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;"&gt;&#x2013;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt; Changes to the Disclosure Requirements for Fair Value Measurement &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;(ASU 2018-13), which&#160;adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance,&#160;entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public business entities will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. ASU 2018-13 is effective for public business entities for fiscal years beginning after December&#160;15, 2019, including interim periods within those fiscal years, and early adoption is permitted.&#160;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;We do not expect the adoption to have a material financial impact on our consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;In August 2018, the FASB issued ASU No. 2018-15, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;"&gt;Intangibles - Goodwill and Other &#x2013; Internal-Use Software: Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt; (ASU 2018-15). This new guidance &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;requires a customer in a cloud computing arrangement to determine which implementation costs to capitalize as assets or expense as incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;ASU 2018-15 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Application of this guidance can be applied either prospectively or retrospectively. We will adopt the new standard on January 1, 2020 on a prospective basis. We do not expect the adoption to have a material financial impact on our consolidated financial statements, however, the adoption of this standard will result in an increase in capitalized assets related to qualifying cloud computing arrangement implementation costs incurred after the adoption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In December 2019, the FASB issued&#160;ASU&#160;No. 2019-12, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Simplifying the Accounting for Income Taxes,&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; which is intended to simplify various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years, and early adoption is permitted. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;We are currently evaluating the impact that this guidance will have on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NatureOfOperations
      contextRef="FD2019Q4YTD"
      id="TextSelection-F0F4221BDD2251EF0D75EB34A876CC44-0-wk-Fact-123751C6954074589295EB34A7EE9114">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Organization and Business&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;DexCom, Inc. is a medical device company focused on the design, development and commercialization of CGM system(s) for use by people with diabetes and by healthcare providers. Unless the context requires otherwise, the terms &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; the &#x201c;company,&#x201d; or &#x201c;DexCom&#x201d; refer to DexCom, Inc. and its subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-2921A57E1E081FE3A712EB34A874AD41-0-wk-Fact-91A166347EF456E02980EB34A7EE5DF4">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The functional currencies of our international subsidiaries are generally the local currencies. We translate the financial statements of our foreign subsidiaries into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;comprehensive income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;accumulated other comprehensive income&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; in the equity section of our consolidated balance sheet. Gains and losses resulting from certain intercompany transactions as well as transactions with customers and vendors that are denominated in currencies other than the functional currency of each entity give rise to foreign exchange gains or losses that we record in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;interest and other income, net&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-844E2A18593237327906EB34A876935F-0-wk-Fact-023201F4A7EE3124D816EB34A7EE7991">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The functional currencies of our international subsidiaries are generally the local currencies. We translate the financial statements of our foreign subsidiaries into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;comprehensive income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;accumulated other comprehensive income&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; in the equity section of our consolidated balance sheet. Gains and losses resulting from certain intercompany transactions as well as transactions with customers and vendors that are denominated in currencies other than the functional currency of each entity give rise to foreign exchange gains or losses that we record in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;interest and other income, net&lt;/span&gt; in our consolidated statements of operations</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="FD2019Q4YTD"
      id="TextSelection-F0D0FABD6BB02FCDCC2CEB34A873ED8C-0-wk-Fact-B5F82195FBB218732C7EEB34A7FEAB37">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles, or GAAP, requires us to make certain estimates and assumptions that affect the amounts reported in our financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include pharmacy rebates, transaction price, net accounts receivable, excess or obsolete inventories and the valuation of inventory, and accruals for litigation contingencies. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-97C7D2BE51FBD67765AAEB34A87569F9-0-wk-Fact-70F268009BC25F168F18EB34A7EE6059">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The authoritative guidance establishes a fair value hierarchy that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities. In general, the authoritative guidance requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset or liability&#x2019;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the measurement of its fair value. The three levels of input defined by the authoritative guidance are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Level&#160;1&#x2014;Unadjusted quoted prices that are available in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Level&#160;2&#x2014;Inputs other than quoted prices included in Level&#160;1 that are observable, either directly or indirectly, through correlation with market data. These include quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Level&#160;3&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the determination of fair value. Level 3 assets and liabilities include those whose fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques and significant judgment or estimation.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We carry our marketable securities at fair value. We carry our other financial instruments, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, at cost, which approximates the related fair values due to the short-term maturities of these instruments. For more information see Note 3, &#x201c;Fair Value Measurements.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-E7F83F0D0215DAF22CD8EB34A8766A01-0-wk-Fact-8AB719CFC24DC21F03D2EB34A7EE720C">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We consider highly liquid investments with a maturity of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;90&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;days or less at the time of purchase to be cash equivalents.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <dxcm:MaturityThresholdOfInvestmentsClassifiedToCashEquivalents
      contextRef="FD2019Q4YTD"
      id="d37409491e912-wk-Fact-3D4F39339162BF648C09EB34A7FEEDE5">P90D</dxcm:MaturityThresholdOfInvestmentsClassifiedToCashEquivalents>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="FD2019Q4YTD"
      id="TextSelection-85FDF9774A4693DADCFAEB34A874ACFE-0-wk-Fact-C6483AC34A3DE8C3533FEB34A81875BC">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We have classified our marketable securities with remaining maturity at purchase of more than three months and remaining maturities of one year or less as short-term marketable securities. We have also classified marketable securities with remaining maturities of greater than one year as short-term marketable securities based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We calculate realized gains or losses on our marketable securities using the specific identification method. We carry our marketable debt securities at fair value with unrealized gains and losses reported as a separate component of stockholders&#x2019; equity in our consolidated balance sheets and included in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;comprehensive income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. Realized gains and losses on marketable debt securities are included in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;interest and other income, net&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; in our consolidated statements of operations. We carry our marketable equity securities at fair value with realized and unrealized gains and losses reported in income on equity investments in our consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;We invest in various types of debt securities, including debt securities in government-sponsored entities, corporate debt securities, U.S. Treasury securities and commercial paper. We do not generally intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-ED134050944CA31D2DF4EB34A8745CCF-0-wk-Fact-3E0EB9B4D00B9456A896EB34A817E636">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accounts receivable are generally recorded at the invoiced amount for Distributors and at net realizable value for Direct customers, which is determined using estimates of claim denials and historical reimbursement experience without regard to aging category. Accounts receivable are not interest bearing. We evaluate the creditworthiness of significant customers and generally do not require collateral from our customers. We maintain an allowance for doubtful accounts for potential credit losses. Uncollectable accounts are written off against the allowance after appropriate collection efforts have been exhausted and when it is deemed that a customer account is uncollectable.&#160;Generally, receivable balances greater than one year past due are deemed uncollectable.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="FD2019Q4YTD"
      id="TextSelection-3A887F02BC4C157C04D4EB34A874926F-0-wk-Fact-424D187CC548D761E2C6EB34A7EE51E2">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Concentration of Credit Risk and Significant Customers&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position. &lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-8C8F00185F9A5D202691B0CC574FF028-0-wk-Fact-1C91A8A04528A3ACB2C5B0D0C078A1E1">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table sets forth the percentages of total revenue or gross accounts receivable for customers that represent 10% or more of the respective amounts for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="15"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gross Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;As of December 31, &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Distributor A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Distributor B&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Distributor C&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;*     Less than 10%&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember"
      decimals="2"
      id="d37409491e1379-wk-Fact-284A774335885DB6961FF9742F7B110A"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2018Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember"
      decimals="2"
      id="d37409491e1394-wk-Fact-1C9F1D2A913455DCA79103CD7D425429"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2017Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember"
      decimals="2"
      id="d37409491e1409-wk-Fact-185E3353C248AB6E5900EB34A8332B9B"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember"
      decimals="2"
      id="d37409491e1424-wk-Fact-E3E4AF3944B757DD8A2AAFD22A08BF18"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2018Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember"
      decimals="2"
      id="d37409491e1440-wk-Fact-FC76EE153B3A556BABBB5CA38CFF8484"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerBMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember"
      decimals="2"
      id="d37409491e1456-wk-Fact-00B10A5990F35AA6B442260BBF11B47B"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2018Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerBMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember"
      decimals="2"
      id="d37409491e1471-wk-Fact-6BC6CD50869050FB9B917BE9E44C650C"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2017Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerBMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember"
      decimals="2"
      id="d37409491e1486-wk-Fact-59A626DEEB6DDB9CCD9DEB34A833D0E8"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2018Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerBMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember"
      decimals="2"
      id="d37409491e1516-wk-Fact-389FBD0809CF5CB1B3326EA833F28FBD"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerCMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember"
      decimals="2"
      id="d37409491e1532-wk-Fact-32047E11E28453DF8DD75B5B2BEA56AB"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-7CE3ED3034F54F945C60EB34A875D91B-0-wk-Fact-76C8EE11086C6142476AEB34A7EE415E">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Inventory is valued at the lower of cost or net realizable value on a part-by-part basis that approximates first in, first out. We record adjustments to inventory for potentially excess, obsolete or scrapped goods in order to state inventory at net realizable value. Factors influencing these adjustments include inventories on hand and on order compared to estimated future usage and sales for existing and new products, as well as judgments regarding quality control testing data and assumptions about the likelihood of scrap and obsolescence. Once written down the adjustments are considered permanent and are not reversed until the related inventory is sold or disposed of.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Our products require customized products and components that currently are available from a limited number of sources. We purchase certain components and materials from single sources due to quality considerations, costs or constraints resulting from regulatory requirements. &lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-5FDFDA70531988030B82EB34A8760301-0-wk-Fact-D419D7F100A4F061B16DEB34A7EE9403">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Property and equipment is stated at cost less accumulated depreciation. We calculate depreciation using the straight-line method over the estimated useful lives of the assets. Estimated useful lives are generally &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;three years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; for computer software and hardware, four to &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;fifteen years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; for machinery and equipment, and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; for furniture and fixtures. Leasehold improvements are amortized over the shorter of the estimated useful lives of the assets or the remaining lease term. We include the amortization of assets that are recorded under finance leases in depreciation expense.&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We review property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the recoverability of the asset by comparing the carrying amount to the future undiscounted cash flows that we expect the asset to generate. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.&lt;/span&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="FD2019Q4YTD_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember"
      id="d37409491e1730-wk-Fact-D8E92BDEC72693035D84EB34A7EE09AC">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember"
      id="d37409491e1734-wk-Fact-B8E936F7561AE673CDC4EB34A818B8E6">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="FD2019Q4YTD_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember"
      id="d37409491e1738-wk-Fact-B06AB888FF841CDBF17DEB34A8168E2D">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-2BBF840D5321A745CCCAEB34A875913D-0-wk-Fact-F45A71E0240C1B317D9AEB34A817A92A">&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We record goodwill when the fair value of consideration transferred in a business combination exceeds the fair value of the identifiable assets acquired and liabilities assumed. Goodwill and other intangible assets that have indefinite useful lives are not amortized, but we test them annually for impairment in the fourth quarter of our fiscal year and whenever events or changes in circumstances indicate that it is more likely than not that the fair value is less than the carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate or operational performance of the business, and an adverse action or assessment by a regulator. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We perform our goodwill impairment analysis at the reporting unit level, which aligns with DexCom&#x2019;s reporting structure and the availability of discrete financial information.&#160;We perform the first step of our annual impairment analysis by either comparing a reporting unit&#x2019;s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit&#x2019;s fair value from the last quantitative assessment to determine if there is potential impairment. We may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit&#x2019;s estimated fair value was significantly in excess of the carrying value of its net assets and we do not believe there have been significant changes in the reporting unit&#x2019;s operations that would significantly decrease its estimated fair value or significantly increase its net assets.&#160;If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections&#160;and/or use of a market approach by looking at market values of comparable companies. Key assumptions&#160;for these projections include revenue growth, future gross margin and operating margin growth, and weighted cost of capital and terminal growth rates. The revenue and margin growth are based on increased sales of new and existing products as we maintain investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements&#160;to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including the timing and probability of regulatory approvals for our products to be commercialized. We also consider DexCom&#x2019;s market capitalization as a part of our analysis.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;If the estimated fair value of a reporting unit exceeds the carrying amount of the net assets assigned to that unit, goodwill is not impaired and no further analysis is required. If the carrying value of the net assets assigned to a reporting unit exceeds the estimated fair value of the unit, we perform the second step of the impairment test. In this step we allocate the fair value of the reporting unit calculated in step one to all of the assets and liabilities of that unit, as if we had just acquired the reporting unit in a business combination. The excess of the fair value of the reporting unit over the total amount allocated to the assets and liabilities represents the implied fair value of goodwill. If the carrying amount of a reporting unit&#x2019;s goodwill exceeds its implied fair value, we would record an impairment loss equal to the difference. We recorded &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; goodwill impairment charges for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; or &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The change in goodwill for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; consisted of translation adjustments on our foreign currency denominated goodwill. The change in goodwill for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; consisted of goodwill we recorded for acquisitions that were not significant, individually or in the aggregate, and translation adjustments on our foreign currency denominated goodwill. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Intangible Assets and Other Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We amortize intangible assets with a finite life, such as acquired technology, customer relationships, trade names and trademarks, on a straight-line basis over their estimated useful lives, which range from &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;two&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; to &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;five&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; years. We review intangible assets that have finite lives and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference. &lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="FD2019Q4YTD"
      decimals="INF"
      id="d37409491e1808-wk-Fact-EC75AE47FE5F6E66497DEB34A7EE842C"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-E18F9884862A2FE2CA2AEB34A8751251-0-wk-Fact-B9B0B7F10D6847C84582EB34A819E752">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We recognize deferred tax assets to the extent that we believe that these assets are more likely than not to be realized, which requires significant judgment. The realization of deferred tax assets is dependent, in part, upon future taxable income. In assessing whether our deferred tax assets will be realized, we consider all available evidence, both positive and negative. Such evidence includes historical earnings, future reversals of existing taxable temporary differences, estimates of future taxable income, and the feasibility of ongoing tax planning strategies. We have recorded a full valuation allowance on our net deferred tax asset balances for all periods presented because of the uncertainty related to utilization of our deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We record uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;50 percent&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; likely to be realized upon ultimate settlement with the related tax authority.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We file federal and state income tax returns in the United States and income tax returns in various other foreign jurisdictions with varying statutes of limitations. Due to net operating losses incurred, our income tax returns from inception to date are subject to examination by taxing authorities. We recognize interest expense and penalties related to income tax matters, including unrecognized tax benefits, as a component of income tax expense. &lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:StandardProductWarrantyPolicy
      contextRef="FD2019Q4YTD"
      id="TextSelection-3A84261AEB89B363FAC5EB34A87591E5-0-wk-Fact-EE13F6535E2D82B891BEEB34A7FEA207">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Warranty Accrual&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Estimated warranty costs associated with a product are recorded at the time revenue is recognized. We estimate future warranty costs by analyzing historical warranty experience for the timing and amount of returned product, and expectations for future warranty activity based on changes and improvements to the product or process that are in place or will be in place in the future. We evaluate these estimates on at least a quarterly basis to determine the continued appropriateness of our assumptions.&lt;/span&gt;&lt;/div&gt;</us-gaap:StandardProductWarrantyPolicy>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-2723E5D6DA42483CE7EBEB34A8739DFD-0-wk-Fact-C9C60EDEA714D81BFB19EB34A81601CE">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Loss Contingencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;If the potential loss from a claim or legal proceeding is considered probable and the amount can be reasonably estimated, we record a liability and an expense for the estimated loss and disclose it in our financial statements if it is significant. If we determine that a loss is possible and the range of the loss can be reasonably determined, then we disclose the range of the possible loss. Significant judgment is required in the determination of whether a potential loss is probable, reasonably possible, or remote as well as in the determination of whether a potential exposure is reasonably estimable. &lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-CF16F474262D46D663BEEB34A8749C55-0-wk-Fact-2EF70892585789240AEBEB34A7EE3CFB">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.8046875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Comprehensive income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; consists of two elements, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;net income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;other comprehensive income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. We report all components of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;comprehensive income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, including &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;net income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, in our financial statements in the period in which they are recognized. Total &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;comprehensive income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We report &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;net income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and the components of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;other comprehensive income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, including foreign currency translation adjustments and unrealized gains and losses on marketable securities, net of their related tax effect to arrive at total &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;comprehensive income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;.&lt;/span&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-6FB96A7E12DB170BCD9CEB34A8752EEC-0-wk-Fact-919AA32086A12DB06A8BEB34A8180328">&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We generate our revenue from the sale of our Reusable Hardware and disposable sensors, which we refer to in this section as &#x201c;Components&#x201d;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We adopted ASC Topic 606 effective January 1, 2018 using the modified retrospective method. Our revenue recognition policies under ASC Topic 606 are explained below.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Policy elections and practical expedients taken&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#x2022;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We report revenue net of taxes collected from customers, which are subsequently remitted to governmental authorities;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#x2022;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We account for shipping and handling activities that are performed after a customer has obtained control of a good as fulfillment costs rather than as separate performance obligations;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#x2022;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We do not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer; and&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#x2022;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;If we expect, at contract inception, that the period between the transfer of control and corresponding payment from the customer will be one year or less, we do not adjust the amount of consideration for the effects of a significant financing component.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Contracts and performance obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations. We also provide free-of-charge software, mobile applications and updates for our DexCom Share&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;&#xae; &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;remote monitoring system. The standalone selling prices of our free-of-charge software, mobile applications and updates are estimated based on an expected cost plus a margin approach.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Transaction price&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Transaction price for the Components reflects the net consideration to which we expect to be entitled. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Variable consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Rebates.&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; We estimate reductions for rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Product Returns. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In accordance with the terms of their distribution agreements, most distributors do not have rights of return outside of our limited warranty. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. We generally provide a &#x201c;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;-day money back guarantee&#x201d; program whereby first-time end-user customers may return Reusable Hardware. Product returns have historically been immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The timing of revenue recognition is based on the satisfaction of performance obligations. Substantially all of the performance obligations associated with our Components are satisfied at a point in time, which typically occurs at shipment of our products. Terms of direct and distributor orders are generally&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ee2724;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Freight on Board (FOB) shipping point for U.S. orders or Free Carrier (FCA) shipping point for international orders. For certain of our distributors, control transfers at delivery of the product to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In cases where our free-of-charge software, mobile applications and updates are deemed to be separate performance obligations, revenue is recognized over time on a ratable basis over the estimated life of the related hardware component. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Our sales of Components include an assurance-type warranty.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Judgments and Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In determining how revenue should be recognized, a five-step process is used, which requires judgment and estimates that can have a significant impact on the amount and timing of revenue we report. These judgments and estimates include identifying performance obligations in the contract, determining whether the performance obligations are separate, allocating the transaction price to each separate performance obligation, determining the timing of revenue recognition for separate performance obligations and estimating the amount of variable consideration to include in the transaction price. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Contract balances&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Contract balances represent amounts presented in the consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; to &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;90&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; days. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accounts receivable as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; included unbilled accounts receivable of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$3.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. Unbilled accounts receivable consists of revenue recognized for Components we have delivered but not yet invoiced to customers. We expect to invoice and collect all unbilled accounts receivable within twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation. The table below shows revenue that we recognized as a result of changes in the contract liability balances in the periods shown.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Revenue recognized in the period from:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Amounts included in contract liabilities at the beginning of the period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Our performance obligations are generally satisfied within 12 months of the initial contract date. As of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, the deferred revenue balance related to performance obligations that will be satisfied after 12 months was &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$2.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. and is included in other long-term liabilities on our consolidated balance sheets. As of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, we had &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; deferred revenue balance related to performance obligations that will be satisfied after 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Deferred cost of sales&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Deferred cost of sales are associated with sales for which revenue recognition criteria are not met but product has shipped and released from inventory. Deferred cost of sales are included in prepaid and other current assets in our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Incentive compensation costs&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; or less. We record these costs in selling, general and administrative expense in our consolidated statement of operations. &lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <dxcm:RevenueRecognitionSalesReturnsCoveragePeriod
      contextRef="FD2019Q4YTD"
      id="d37409491e2286-wk-Fact-89E0E1345F585EBEB5C62B244646093F">P30D</dxcm:RevenueRecognitionSalesReturnsCoveragePeriod>
    <dxcm:ContractPaymentTermsNumberofDays
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember"
      id="d37409491e2320-wk-Fact-D624925B6F7FD0A1B036EB34A816B60D">P30D</dxcm:ContractPaymentTermsNumberofDays>
    <dxcm:ContractPaymentTermsNumberofDays
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember"
      id="d37409491e2324-wk-Fact-1F40DF33059AA8EA21F1EB34A81AEBE4">P90D</dxcm:ContractPaymentTermsNumberofDays>
    <us-gaap:UnbilledContractsReceivable
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37409491e2335-wk-Fact-D8A92F713B2C54BA930E1114159FAF79"
      unitRef="usd">3600000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-FDDFDCF009565D06B9DFB0C51585DD56-0-wk-Fact-4ECE56E81788A2FAC92AB0C76B61F54A">The table below shows revenue that we recognized as a result of changes in the contract liability balances in the periods shown.&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Revenue recognized in the period from:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Amounts included in contract liabilities at the beginning of the period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37409491e2496-wk-Fact-F70F760DF8EA594DAA2491498D86F987"
      unitRef="usd">2600000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37409491e2515-wk-Fact-69E01A5ACB925859814D12D5419EC9C9"
      unitRef="usd">1900000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37409491e2530-wk-Fact-9679AC80953F5A7DBFB9B0EF049FFA2D"
      unitRef="usd">2100000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="FI2018Q4"
      decimals="INF"
      id="d37409491e2538-wk-Fact-D30A7502FCE2DE5BDC40B0EF2039187F"
      unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <dxcm:AmortizationPeriodForIncentiveCompensationCosts
      contextRef="FD2019Q4YTD"
      id="d37409491e2554-wk-Fact-45F813168E4F913D1FC7EB34A8185026">P1Y</dxcm:AmortizationPeriodForIncentiveCompensationCosts>
    <dxcm:ProductShipmentCostsPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-FF5837F21C1024C77913B0BEC4AEF76F-0-wk-Fact-866F1A20CF718019EA45B0BF8AE6895F">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Product Shipment Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We record the amounts we charge our customers for the shipping and handling of our products in revenue and we record the related costs as cost of sales in our statements of operations.&lt;/span&gt;&lt;/div&gt;</dxcm:ProductShipmentCostsPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="FD2019Q4YTD"
      id="TextSelection-B18B3D0BD1008F62FC99EB34A874582A-0-wk-Fact-5BB2EEAD21DD12F68A6AEB34A7EE38DE">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We expense costs of research and development as we incur them. Our research and development expenses primarily consist of engineering and research expenses related to our continuous glucose monitoring technology, clinical trials, regulatory expenses, quality assurance programs, materials and products for clinical trials. Research and development expenses primarily consist of employee compensation, including salary, fringe benefits, share-based compensation, and temporary employee expenses. We also incur significant expenses to operate our clinical trials that include clinical site reimbursement, clinical trial product, and associated travel expenses. Our research and development expenses also include fees for design services, contractors, and development materials.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Our CGM systems include certain software that we develop. We expense software development costs as we incur them until technological feasibility has been established, at which time we capitalize development costs until the product is available for general release to customers. To date, our software has been available for general release concurrent with the establishment of technological feasibility and, accordingly, we have not capitalized any development costs. &lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-DA4549FC193BFDEB2CB8EB34A8734A5A-0-wk-Fact-44F6B7A2E8C6B7F9AF6AEB34A81AE837">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;We expense advertising costs as we incur them to selling, general and administrative expenses.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37409491e2829-wk-Fact-DD9F4BA2719F641AAAD6EB34A7EE5285"
      unitRef="usd">31800000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37409491e2833-wk-Fact-67711199B0DD45CB1D3DEB34A7EE9FE8"
      unitRef="usd">25400000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37409491e2837-wk-Fact-A8F94257C4095FB4EA2EEB34A818BD6B"
      unitRef="usd">21900000</us-gaap:AdvertisingExpense>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-79500B22805B979BDD0BEB34A8746E6D-0-wk-Fact-B276F0E6BFC03D246245EB34A7EE9DFC">&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We determine if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The interest rate used to determine the present value of the future lease payments is our incremental borrowing rate, because the interest rate implicit in most of our leases is not readily determinable. Our incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in similar economic environments. The operating lease right-of-use asset also includes any lease payments made and excludes lease incentives. We have lease agreements with lease and non-lease components, which are generally accounted for separately. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Variable lease payments that do not depend on a rate or index, payments associated with non-lease components, and costs related to leases with terms of less than 12 months are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="FD2019Q4YTD"
      id="TextSelection-0628A6E4A510EC74D8D5EB34A8757502-0-wk-Fact-F4B9DC7612B9B199D2B6EB34A7EE296E">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Share-based compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized straight-line over the requisite service period of the individual grants, which typically equals the vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We value time-based Restricted Stock Units (&#x201c;RSUs&#x201d;) at the date of grant using the intrinsic value method. Certain RSUs granted to senior management vest based on the achievement of pre-established performance or market goals.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We estimate the fair value of performance/market-based RSUs at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We update our assessment of the probability that the specified performance criteria will be achieved each quarter and adjust our estimate of the fair value of the performance-based RSUs if necessary. The Monte Carlo methodology that we use to estimate the fair value of market-based RSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the market-based RSUs at the date of grant must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the performance of the specified market criteria. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;If any of the assumptions used change significantly, share-based compensation expense may differ materially from what we have recorded in the current period.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We account for forfeitures as they occur by reversing any share-based compensation expense related to awards that will not vest. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-A7F40B4E349C43AF9A80EB34A87425CC-0-wk-Fact-5B21521AC60AB73E3410EB34A7EE416E">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Net Income (Loss) Per Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Basic &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;net income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; per share attributable to common stockholders is calculated by dividing the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;net income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;net income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Potentially dilutive common shares consist of shares issuable from stock options, unvested RSUs, warrants and the 2022 and 2023 Senior Convertible Notes. Potentially dilutive common share equivalents shares from outstanding stock options, warrants and unvested RSUs are determined using the average share price for each period under the treasury stock method. Potentially dilutive shares issuable upon conversion of our 2022 and 2023 Senior Convertible Notes are determined using the if-converted method. &lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-1AE6FA94FA9380F1B5E8B0C3928421F0-0-wk-Fact-679C381E57B08DA9DD42B0C3F429BF4F">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table sets forth the computation of basic and diluted &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;net income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; per share for the periods shown.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Net income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;101.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(127.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(50.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Net income (loss) per common share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(1.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(1.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;91.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;88.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;86.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Dilutive potential common stock outstanding:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Stock options and employee stock purchase plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Restricted stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2023 Warrants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2022 senior convertible notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2023 senior convertible notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Diluted weighted average shares outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;92.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;88.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;86.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37409491e3217-wk-Fact-24A3E88E5EEE8AE1DA83EB34A7EE95FB"
      unitRef="usd">101100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37409491e3236-wk-Fact-0DCCCDB98C2E9FE76ED4EB34A84338F1"
      unitRef="usd">-127100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37409491e3257-wk-Fact-73CC98F00980B0ADC146EB34A862BF96"
      unitRef="usd">-50200000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d37409491e3417-wk-Fact-DDC1D7D0280028A84DDCEB34A7EECF39"
      unitRef="usdPerShare">1.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2018Q4YTD"
      decimals="2"
      id="d37409491e3436-wk-Fact-8FDB206D5342C0E1905BEB34A852D12E"
      unitRef="usdPerShare">-1.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2017Q4YTD"
      decimals="2"
      id="d37409491e3457-wk-Fact-3614467630BBCC97FCE7EB34A8525AE6"
      unitRef="usdPerShare">-0.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d37409491e3483-wk-Fact-2431014538102260A524EB34A8433137"
      unitRef="usdPerShare">1.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2018Q4YTD"
      decimals="2"
      id="d37409491e3502-wk-Fact-14F3DC4B3584F251E8DDEB34A8627C5C"
      unitRef="usdPerShare">-1.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2017Q4YTD"
      decimals="2"
      id="d37409491e3523-wk-Fact-9CA3C300FF5B6998565EEB34A8520B76"
      unitRef="usdPerShare">-0.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37409491e3611-wk-Fact-AA0440B1DBA856CBABF41ADCFCF1B80E"
      unitRef="shares">91100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37409491e3630-wk-Fact-8A45C3A42C1C5A09984DC22E00A294B9"
      unitRef="shares">88200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37409491e3649-wk-Fact-2DB346FE864C954AF431B0DE8A1D0ABC"
      unitRef="shares">86300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-5"
      id="d37409491e3742-wk-Fact-8E673A6F0FB15846A1D330F05A58DB4D"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-5"
      id="d37409491e3761-wk-Fact-4C7DD23868F25A2AA991140215FFD92E"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-5"
      id="d37409491e3780-wk-Fact-0CEF3157FDF232BB3AA0B0DE8BBE359D"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37409491e3807-wk-Fact-8AFD717D9BC352A5907BE04DFAFEC4C9"
      unitRef="shares">1200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37409491e3826-wk-Fact-4CC42ABD4FF257A99559CB77CAD4A5B8"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37409491e3845-wk-Fact-5BA86F682B9525008F1EB0DE8DDA8025"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember"
      decimals="-5"
      id="d37409491e3871-wk-Fact-4E31D73F4F8BCA1A6A12B0E191FC1E8E"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember"
      decimals="-5"
      id="d37409491e3890-wk-Fact-E6D863524833D51373DEB0E1958F9A2D"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember"
      decimals="-5"
      id="d37409491e3909-wk-Fact-FE5DAD8ABF5398B0B189B0E198F6984F"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37409491e3935-wk-Fact-26F24A7786CA1AD0AE0DB0E19BC199E0"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37409491e3954-wk-Fact-2BBF8051D05CA1D97F56B0E19EBC96C0"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37409491e3973-wk-Fact-620CE7A4C5B4C09F535DB0E1A2B1C5B4"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37409491e3999-wk-Fact-7F1C26297A1FEB5208D9B0E1A52D6280"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37409491e4018-wk-Fact-0D1ED67B87929493AF3DB0E1A82CB8B7"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37409491e4037-wk-Fact-3633EA1495BEE4EC85FCB0E1AB5A7906"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37409491e4063-wk-Fact-891794900913568DB10F3FCA89C0115D"
      unitRef="shares">92300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37409491e4082-wk-Fact-2C5F09467A8B6B26ED3E174A94500918"
      unitRef="shares">88200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37409491e4101-wk-Fact-42473C8A865D15F1338EEB34A8626C17"
      unitRef="shares">86300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-B8C92693A8212EAEF3CEEB34A8740A97-0-wk-Fact-2DFCADCF476D0E0504BFEB34A7EEBCF7">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Outstanding anti-dilutive securities not included in the diluted &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;net income (loss)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; per share attributable to common stockholders calculations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Options outstanding to purchase common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Unvested restricted stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2023 Warrants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Senior convertible notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Senior convertible notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;7.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-5"
      id="d37409491e4245-wk-Fact-F53D91D8B901D40ED459EB34A8249BC5"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-5"
      id="d37409491e4259-wk-Fact-FAACBCCA7C5F1B0F616BEB34A8436087"
      unitRef="shares">100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-5"
      id="d37409491e4273-wk-Fact-76FA15CA9104692AF7BCEB34A843C8AA"
      unitRef="shares">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37409491e4288-wk-Fact-2ECC2061E94022F28BCFEB34A862C095"
      unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37409491e4302-wk-Fact-8FC1F604EFCC0C61AE72EB34A852312F"
      unitRef="shares">2700000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37409491e4316-wk-Fact-91F87894A616C84654A0EB34A8332DE4"
      unitRef="shares">2700000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember"
      decimals="-5"
      id="d37409491e4331-wk-Fact-E75DFE7C17620E3DDFEBEB34A825D062"
      unitRef="shares">5200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember"
      decimals="-5"
      id="d37409491e4345-wk-Fact-7E7C355D857616B8C053EB34A8434085"
      unitRef="shares">5200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember"
      decimals="-5"
      id="d37409491e4359-wk-Fact-8607F287E651A1F2D725EB34A825CC62"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37409491e4374-wk-Fact-1384BA62AA66E0D56EBDEB34A81C39CD"
      unitRef="shares">4000000.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37409491e4388-wk-Fact-D06A7A99036EAF5F1C5DEB34A8435621"
      unitRef="shares">4000000.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37409491e4402-wk-Fact-861F13D0C2952A483D82EB34A81CDCAF"
      unitRef="shares">4000000.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37409491e4417-wk-Fact-2BE1CF64831411AA210CEB34A82493A4"
      unitRef="shares">5200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37409491e4431-wk-Fact-FA86E824EC76321A7DBDEB34A8333EAC"
      unitRef="shares">5200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertibleDebtSecuritiesMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37409491e4445-wk-Fact-4BF496BB2D6CEC29C858EB34A833C389"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37409491e4460-wk-Fact-9C6D853DBF5EEFB2A306EB34A825420A"
      unitRef="shares">14600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37409491e4474-wk-Fact-BB337E5A76D9853C5979EB34A8622C63"
      unitRef="shares">17200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37409491e4488-wk-Fact-F2B4A256E91CB33DDF2AEB34A81BE2DD"
      unitRef="shares">7100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-2BFEE33513F1839FFA05EB34A87688C1-0-wk-Fact-319DD7476572278787E6EB34A7FE89D6">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Recent Accounting Guidance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases (Topic 842)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; (ASU 2016-02), which requires a lessee to recognize most leases on the consolidated balance sheet as lease liabilities with corresponding right-of-use assets. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;We adopted ASU&#160;2016-02 utilizing the modified retrospective transition method at the beginning of the first quarter of 2019. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;See Note 6, &#x201c;Leases and Other Commitments&#x201d; for more information on the impact of our adoption of ASU 2016-02 and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;In August 2017, the FASB issued ASU No. 2017-12, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;"&gt;Derivatives and Hedging &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;(ASU 2017-12), which is intended to more closely align hedge accounting with companies&#x2019; risk management strategies, simplify the application of hedge accounting, and increase transparency regarding the scope and results of hedging programs. The guidance in this update is applied using a cumulative-effect adjustment to retained earnings at the beginning of the fiscal year of adoption. ASU 2017-12 is effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Our adoption of ASU 2017-12 at the beginning of the first quarter of 2019 did not have a significant impact on our consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;In June 2016, the FASB issued ASU 2016-13, Financial Instruments - &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;"&gt;Credit Losses: Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available-for-sale debt securities. This update is effective for annual periods beginning after December 15, 2019, and interim periods within those periods, and early adoption is permitted. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;W&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;e expect to adopt the standard on its effective date in the first quarter of 2020. We believe the adoption will modify the way we analyze financial instruments, but currently do not expect the adoption to have a material financial impact on our consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;In January 2017, the FASB issued ASU No. 2017-04, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;"&gt;Intangibles &#x2013; Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;(ASU 2017-04). This new guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit&#x2019;s carrying amount over its fair value. ASU 2017-04 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We do not expect the adoption to have a material financial impact on our consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In August 2018, the FASB issued ASU No. 2018-13,&#160;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Fair Value Measurement: Disclosure Framework &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;"&gt;&#x2013;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt; Changes to the Disclosure Requirements for Fair Value Measurement &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;(ASU 2018-13), which&#160;adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance,&#160;entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public business entities will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. ASU 2018-13 is effective for public business entities for fiscal years beginning after December&#160;15, 2019, including interim periods within those fiscal years, and early adoption is permitted.&#160;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;We do not expect the adoption to have a material financial impact on our consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;In August 2018, the FASB issued ASU No. 2018-15, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;"&gt;Intangibles - Goodwill and Other &#x2013; Internal-Use Software: Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt; (ASU 2018-15). This new guidance &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;requires a customer in a cloud computing arrangement to determine which implementation costs to capitalize as assets or expense as incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;ASU 2018-15 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Application of this guidance can be applied either prospectively or retrospectively. We will adopt the new standard on January 1, 2020 on a prospective basis. We do not expect the adoption to have a material financial impact on our consolidated financial statements, however, the adoption of this standard will result in an increase in capitalized assets related to qualifying cloud computing arrangement implementation costs incurred after the adoption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In December 2019, the FASB issued&#160;ASU&#160;No. 2019-12, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Simplifying the Accounting for Income Taxes,&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; which is intended to simplify various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years, and early adoption is permitted. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;We are currently evaluating the impact that this guidance will have on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <dxcm:DevelopmentAndOtherAgreementsTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-CD490ADE909143F5D1D0EB34A876AEF0-0-wk-Fact-40B44FD7AA31D29F4749EB34A85299FD">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;"&gt;2. Development and Other Agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Collaboration with Verily Life Sciences&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;On November 20, 2018, we entered into an Amended and Restated Collaboration and License Agreement with Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited (collectively, Verily), which we refer to as the Restated Collaboration Agreement. This replaced our original Collaboration and License Agreement with Verily dated August 10, 2015, as amended in October 2016, including the royalty obligations provisions under that original agreement. Pursuant to the Restated Collaboration Agreement, we and Verily have agreed to continue to jointly develop a certain next-generation CGM product, and potentially one or more additional CGM products, for which we will have exclusive commercialization rights. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Restated Collaboration Agreement&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; also provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside of the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#x2019;s other intellectual property rights to develop, manufacture and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities. The Restated Collaboration Agreement requires us to use commercially reasonable efforts to develop, launch and commercialize the CGM product(s) that are the subject of the collaboration according to certain timing and other objectives, and provides for one executive sponsor from each of DexCom and Verily to meet periodically and make decisions related to the collaboration (within a limited scope of authority) by consensus.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In consideration of Verily&#x2019;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we have made upfront and incentive payments and we will make potential future milestone payments upon the achievement of certain goals. In the fourth quarter of 2018, we made an initial payment of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$250.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; through the issuance of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,840,943&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; shares of our common stock. We recorded a &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$217.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; charge in our consolidated statement of operations during 2018 relating to the issuance of this common stock because this milestone payment did not meet the capitalization criteria. The amount of the charge was based on our closing stock price of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$118.28&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; per share on December 28, 2018, the date on which we obtained the necessary regulatory approvals and the transaction closed. During &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, we made an incentive payment of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$3.2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; due to the completion of certain development obligations and recorded as research and development in the consolidated statement of operations. Additional milestone payments of up to a total of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$275.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; may become due and payable by us upon the achievement of future development, product regulatory approval and revenue milestones. These payments may be paid in cash or shares of our common stock, at our election. If we elect to make all &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$275.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of these payments in shares, we will issue a total of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2,025,036&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; shares of our common stock, based on the volume weighted average trading price during the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; consecutive days ending on the date of the Restated Collaboration Agreement. Alternatively, if we elect to make all &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$275.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of these payments in cash, any such cash payment would be equal to the number of shares that would otherwise be issued for the given milestone payment multiplied by the value of our stock on the date the relevant milestone is achieved, adjusted for stock splits, dividends, and the like.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The Restated Collaboration Agreement will continue until December 31, 2028, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party. Upon achievement of the first revenue milestone event and payment of the corresponding milestone fee by us, the term of the Restated Collaboration Agreement will be extended until December 31, 2033.&lt;/span&gt;&lt;/div&gt;</dxcm:DevelopmentAndOtherAgreementsTextBlock>
    <dxcm:CollaborativeArrangementUpfrontFee
      contextRef="I2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementInitialPaymentMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember"
      decimals="-5"
      id="d37396687e618-wk-Fact-29EFD642390838010598EB34A82D4387"
      unitRef="usd">250000000.0</dxcm:CollaborativeArrangementUpfrontFee>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="D2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementInitialPaymentMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember"
      decimals="INF"
      id="d37396687e622-wk-Fact-6DE34CFAE0A5A31414D4EB34A814FB88"
      unitRef="shares">1840943</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <dxcm:CollaborativeResearchAndDevelopmentFee
      contextRef="FD2018Q4YTD_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementInitialPaymentMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember"
      decimals="-5"
      id="d37396687e626-wk-Fact-63300AE0004A5D2BCE45EB34A8332011"
      unitRef="usd">217700000</dxcm:CollaborativeResearchAndDevelopmentFee>
    <us-gaap:SharePrice
      contextRef="I2018Q4December28_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementInitialPaymentMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember"
      decimals="INF"
      id="d37396687e630-wk-Fact-D885B294EBA1982693C1EB34A81595CB"
      unitRef="usdPerShare">118.28</us-gaap:SharePrice>
    <dxcm:CollaborativeResearchAndDevelopmentFee
      contextRef="FD2019Q4YTD_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember"
      decimals="-5"
      id="d37396687e639-wk-Fact-658B172608016C008C49CA4A35C49FAB"
      unitRef="usd">3200000</dxcm:CollaborativeResearchAndDevelopmentFee>
    <dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments
      contextRef="I2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember"
      decimals="-5"
      id="d37396687e643-wk-Fact-884EB80CAEFB78804B40EB34A81359D6"
      unitRef="usd">275000000.0</dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments>
    <dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestones
      contextRef="I2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember"
      decimals="-5"
      id="d37396687e647-wk-Fact-B0940043681F22EFC13FEB34A7FE147E"
      unitRef="usd">275000000.0</dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestones>
    <dxcm:PotentialFutureCommonStockIssuableSharesNewIssues
      contextRef="FI2019Q4_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember"
      decimals="INF"
      id="d37396687e651-wk-Fact-D2632106FAECEF19E965EB34A8172C4D"
      unitRef="shares">2025036</dxcm:PotentialFutureCommonStockIssuableSharesNewIssues>
    <dxcm:WeightedAverageSharePriceConsecutiveDaysEvaluated
      contextRef="D2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember"
      id="d37396687e655-wk-Fact-FAF614BF2E8814CF52B1EB34A8438D22">P15D</dxcm:WeightedAverageSharePriceConsecutiveDaysEvaluated>
    <dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestones
      contextRef="I2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementMilestonePaymentsMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember"
      decimals="-5"
      id="d37396687e659-wk-Fact-B0940043681F22EFC13FEB34A7FE147E"
      unitRef="usd">275000000.0</dxcm:CollaborativeArrangementDevelopmentRegulatoryMilestones>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-6C7F04AB78022E2C9D75EB34A876FAB1-0-wk-Fact-C307770E9BDF20827440EB34A83360AA">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;"&gt;3. Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement date, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values of our Level 2 marketable securities portfolio balance provided by our investment managers.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:49%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Level&#160;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;110.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;144.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;255.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:21px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:21px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:21px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:21px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:21px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:21px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:21px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:21px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Debt securities, available for sale:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;U.S. government agencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;676.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;676.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Commercial paper&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;248.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;248.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Corporate debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;162.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;162.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total debt securities, available for sale&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,087.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,087.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Other assets &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;110.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,232.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,342.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;padding-left:42px;text-indent:-12px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1) &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Includes assets which are held pursuant to a deferred compensation plan for our executives, which consist mainly of mutual funds. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:49%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Level&#160;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;199.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;66.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;266.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Equity investment in Tandem Diabetes Care, Inc.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;38.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;38.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Debt securities, available for sale:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;U.S. government agencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;173.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;173.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Commercial paper&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;36.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;36.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Corporate debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total debt securities, available for sale&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;210.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;210.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;237.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;277.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;514.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;There were &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; transfers between Level 1 and Level 2 securities during the years ended &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. There were &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; transfers into or out of Level 3 securities during the years ended &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments are not significant and we include them in other assets in our consolidated balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are often privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant adverse effect on the fair values.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Fair Value of Senior Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The fair value, based on trading prices (Level 1), of our Senior Convertible Notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fair Value Measurements Using Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75% Senior Convertible Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;890.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;540.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75% Senior Convertible Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,260.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;859.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total fair value of outstanding senior convertible notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2,150.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,399.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;For more information on the carrying values of our 2022 Notes and 2023 Notes, see Note 5, &#x201c;Debt.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Foreign Currency and Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;From time to time we engage in limited hedging transactions to reduce foreign currency risks. The fair values of these derivatives are based on quoted market prices, which are Level 1 inputs, and the derivative instruments are recorded in current assets or current liabilities in our balance sheets consistent with the nature of the instrument at period end. Derivative gains and losses are included in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;interest and other income, net&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; in our consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; As of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, a notional amount of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$8.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; was outstanding to hedge currency risk relating to certain intercompany balances. The resulting impact from the hedging activity on our consolidated financial statements was not significant for the year ended &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, a notional amount of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$60.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; was outstanding to hedge currency risk relating to certain intercompany balances. Derivative instrument gains on forward exchange contracts were &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$0.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; for the twelve months ended &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. The fair value of the forward contract exchange derivative instrument liability was &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$0.2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. We entered into no foreign currency forward contracts during &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Our foreign currency exposures vary but are primarily concentrated in the British Pound, the Euro, and the Canadian Dollar. We monitor the costs and the impact of foreign currency risks upon our financial results as part of our risk management program. We do not use derivative financial instruments for speculation or trading purposes or for activities other than risk management. We do not require and are not required to pledge collateral for these financial instruments and we do not carry any master netting arrangements to mitigate the credit risk. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In accordance with authoritative guidance, we measure certain non-financial assets and liabilities at fair value on a non-recurring basis. These measurements are usually performed using the discounted cash flow method and Level 3 inputs. These include items such as non-financial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment. In general, non-financial assets, including goodwill, intangible assets, and property and equipment, are measured at fair value when there are indicators of impairment and are recorded at fair value only when any impairment is recognized. We recorded &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; significant impairment losses during the twelve months ended &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;.</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-09E894ED52AA6A8B8F54EB34A876C0EE-0-wk-Fact-4AB480C632FD335459BEEB34A833E1E8">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:49%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Level&#160;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;110.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;144.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;255.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:21px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:21px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:21px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:21px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:21px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:21px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:21px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:21px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Debt securities, available for sale:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;U.S. government agencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;676.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;676.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Commercial paper&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;248.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;248.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Corporate debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;162.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;162.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total debt securities, available for sale&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,087.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,087.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Other assets &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;110.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,232.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,342.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;padding-left:42px;text-indent:-12px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1) &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Includes assets which are held pursuant to a deferred compensation plan for our executives, which consist mainly of mutual funds. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:49%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Level&#160;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;199.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;66.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;266.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Equity investment in Tandem Diabetes Care, Inc.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;38.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;38.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Debt securities, available for sale:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;U.S. government agencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;173.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;173.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Commercial paper&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;36.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;36.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Corporate debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total debt securities, available for sale&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;210.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;210.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;237.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;277.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;514.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member"
      decimals="-5"
      id="d37405250e786-wk-Fact-5DA7300368FD526DB305F46BFC68AEAC"
      unitRef="usd">110100000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member"
      decimals="-5"
      id="d37405250e805-wk-Fact-24DC71B9F33E5860909415F69536924B"
      unitRef="usd">144900000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member"
      decimals="-5"
      id="d37405250e824-wk-Fact-4471594EF2AF5D468C689ACEFF75F9D8"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37405250e844-wk-Fact-DBD46E6F8BC3F0462BEBEB34A7FEB6BA"
      unitRef="usd">255000000.0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-5"
      id="d37405250e1023-wk-Fact-CCE5CDE30BE652BE8F17171F89ED71D9"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-5"
      id="d37405250e1042-wk-Fact-C699733AB23A561592353AB6F9D45FBA"
      unitRef="usd">676000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-5"
      id="d37405250e1061-wk-Fact-ABC8B8E4CD895B73ACE7B7613BCE650B"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-5"
      id="d37405250e1081-wk-Fact-8DEA67E07E0D1F5B9780EB34A7FE0800"
      unitRef="usd">676000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="-5"
      id="d37405250e1101-wk-Fact-1DA53FFB66175095B84DB4FAEE367722"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="-5"
      id="d37405250e1120-wk-Fact-716B2D0E44515A3684F033FBF4E85FA1"
      unitRef="usd">248200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="-5"
      id="d37405250e1139-wk-Fact-08B1088FAD1155C490A5A1FD2C23DA47"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="-5"
      id="d37405250e1159-wk-Fact-9E3246AEAE89AB269B47EB34A7FEDCEB"
      unitRef="usd">248200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember"
      decimals="-5"
      id="d37405250e1179-wk-Fact-07ADC57C6E7B53F5BF8E4FF2103B273D"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember"
      decimals="-5"
      id="d37405250e1198-wk-Fact-B20325E17EAA556E8226B630ADC6EF98"
      unitRef="usd">162900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember"
      decimals="-5"
      id="d37405250e1217-wk-Fact-D409A2F0E5535B1DAC40B9641A393111"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember"
      decimals="-5"
      id="d37405250e1237-wk-Fact-22D7F77DF4ED116010E0EB34A7FE3CB7"
      unitRef="usd">162900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member"
      decimals="-5"
      id="d37405250e1257-wk-Fact-9B4F33FC26115C438A46EB34A7FE1620"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member"
      decimals="-5"
      id="d37405250e1276-wk-Fact-69E0E58516B8BC402795EB34A7FE0CB9"
      unitRef="usd">1087100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member"
      decimals="-5"
      id="d37405250e1295-wk-Fact-727F1E35E692A3BB0009EB34A7FEDBF6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37405250e1315-wk-Fact-51F5DEE4B0DD62E8AF91EB34A7FE41EB"
      unitRef="usd">1087100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member"
      decimals="-5"
      id="d37405250e1419-wk-Fact-8C3FF9C67C9C69BD4ABED35C8BB1062B"
      unitRef="usd">700000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member"
      decimals="-5"
      id="d37405250e1438-wk-Fact-2654D0B00E3506740479D35C8BF0D76E"
      unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member"
      decimals="-5"
      id="d37405250e1457-wk-Fact-0FEE44C29D527381E5D0D35C8BAD23A3"
      unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37405250e1477-wk-Fact-F8D585405301F68A4133D35C8C461AED"
      unitRef="usd">700000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member"
      decimals="-5"
      id="d37405250e1585-wk-Fact-AC6D4ABCFCACC0FE35EEEB34A7FE0724"
      unitRef="usd">110800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member"
      decimals="-5"
      id="d37405250e1604-wk-Fact-5C61ACFEA9CFE97AD08FEB34A7FEB887"
      unitRef="usd">1232000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member"
      decimals="-5"
      id="d37405250e1623-wk-Fact-BBCA5D3990CF0936B064EB34A7FE7E27"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37405250e1643-wk-Fact-DF5972FC0F1AE2F87B04EB34A7FE7CE8"
      unitRef="usd">1342800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member"
      decimals="-5"
      id="d37405250e1871-wk-Fact-B5CAB4A9AD2457B8A82FDE4162612D10"
      unitRef="usd">199300000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member"
      decimals="-5"
      id="d37405250e1890-wk-Fact-826E650A12C151619B517B544FC33FDE"
      unitRef="usd">66700000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member"
      decimals="-5"
      id="d37405250e1909-wk-Fact-58CDF9CBC6E0BBAB39FFEB34A7EE4FDE"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37405250e1929-wk-Fact-8FF9E03FDF806C6E108FEB34A7EEFAB7"
      unitRef="usd">266000000.0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member"
      decimals="-5"
      id="d37405250e2026-wk-Fact-F475380FEDBE5D0E9A50D7D58896F67E"
      unitRef="usd">38000000.0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member"
      decimals="-5"
      id="d37405250e2045-wk-Fact-27DDC11D423E4A6764AAEB34A7EE83C0"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member"
      decimals="-5"
      id="d37405250e2064-wk-Fact-C8D8137D92D777344B2CEB34A82D86E0"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37405250e2084-wk-Fact-3FA63D201E0F211753C1B4BD74720685"
      unitRef="usd">38000000.0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-5"
      id="d37405250e2268-wk-Fact-391AA885ED49F4625E77EB34A82F93D8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-5"
      id="d37405250e2287-wk-Fact-84A8FAF9EBF65D8287B7C29ED0AAD841"
      unitRef="usd">173100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-5"
      id="d37405250e2306-wk-Fact-C950A9E1C46B2AA4A1E6EB34A7EEE0ED"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-5"
      id="d37405250e2326-wk-Fact-54FB6FEEEC285B16FC0BEB34A82C8A26"
      unitRef="usd">173100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="-5"
      id="d37405250e2346-wk-Fact-81F6B1515F99CE219457EB34A7EE7837"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="-5"
      id="d37405250e2365-wk-Fact-754404DC33B1528C9E699D3977932DFE"
      unitRef="usd">36200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="-5"
      id="d37405250e2384-wk-Fact-907B92EF614458CF4B4CEB34A7EEBFB0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="-5"
      id="d37405250e2404-wk-Fact-E3C30EBA1EC77B8BC70DEB34A82D4A12"
      unitRef="usd">36200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember"
      decimals="-5"
      id="d37405250e2424-wk-Fact-DB436C171C93533ECCF2EB34A82B9903"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember"
      decimals="-5"
      id="d37405250e2443-wk-Fact-D8C9C4A0EAEA5B53882F591B47C2D3F6"
      unitRef="usd">1300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember"
      decimals="-5"
      id="d37405250e2462-wk-Fact-CA2E5E89F5153D776DCEEB34A82E05CE"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember"
      decimals="-5"
      id="d37405250e2482-wk-Fact-CFEDE8F3A43E420B1CD6EB34A82C3CD6"
      unitRef="usd">1300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member"
      decimals="-5"
      id="d37405250e2502-wk-Fact-679981B571E517CEB055EB34A82E5BD0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member"
      decimals="-5"
      id="d37405250e2521-wk-Fact-C5D37F3D8C08B1DE7F88EB34A7EE0FF3"
      unitRef="usd">210600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member"
      decimals="-5"
      id="d37405250e2540-wk-Fact-726932A3351EC5C1209DEB34A82CBB31"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37405250e2560-wk-Fact-1773E0B34BE9A54263C4EB34A7EEB3BF"
      unitRef="usd">210600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member"
      decimals="-5"
      id="d37405250e2668-wk-Fact-C74BF7BB28AD353D0165EB34A82D68F0"
      unitRef="usd">237300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member"
      decimals="-5"
      id="d37405250e2687-wk-Fact-A449E7FDC34851F85C7BEB34A7EED5DE"
      unitRef="usd">277300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member"
      decimals="-5"
      id="d37405250e2706-wk-Fact-D1E60A2CE8CF28099041EB34A82CF9EC"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37405250e2726-wk-Fact-1170073264F54BEA9952EB34A7EEEDFA"
      unitRef="usd">514600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount
      contextRef="FI2019Q4"
      decimals="INF"
      id="d37405250e2739-wk-Fact-EB2D6B2F9943561ABD7FA3CB49960801"
      unitRef="usd">0</us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount>
    <dxcm:FairValueAssetsLevel3TransfersAmount
      contextRef="FI2019Q4"
      decimals="INF"
      id="d37405250e2751-wk-Fact-1B79905AEA365A06AD4F93A23B0837D2"
      unitRef="usd">0</dxcm:FairValueAssetsLevel3TransfersAmount>
    <us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-CEC6548F9109D306DCEDB4B1AD70DCF6-0-wk-Fact-F2FC68CA13A5AEF4267DB4B251956422">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The fair value, based on trading prices (Level 1), of our Senior Convertible Notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fair Value Measurements Using Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75% Senior Convertible Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;890.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;540.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75% Senior Convertible Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,260.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;859.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total fair value of outstanding senior convertible notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2,150.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,399.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;For more information on the carrying values of our 2022 Notes and 2023 Notes, see Note 5, &#x201c;Debt.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37405250e2885-wk-Fact-9BF500809D2B5E359F5E59E6366745DE"
      unitRef="usd">890800000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37405250e2904-wk-Fact-E21904D554F15E79B4F34DA6F3B194A5"
      unitRef="usd">540200000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37405250e2919-wk-Fact-42A4F7F889A35BF5BD7AD5A12E500849"
      unitRef="usd">1260000000.0</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37405250e2938-wk-Fact-53A780F2E6965FE28269B49BFF9134A2"
      unitRef="usd">859600000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="FI2019Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37405250e2963-wk-Fact-A700319DB239E2457A14B4B4404DA039"
      unitRef="usd">2150800000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37405250e2982-wk-Fact-A0F5CED9BE9F7E9FDA4BB4B444A9E262"
      unitRef="usd">1399800000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-5"
      id="d37405250e3009-wk-Fact-3B3EAD16B3C11AA65306AB54E66D8985"
      unitRef="usd">8000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2018Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-5"
      id="d37405250e3024-wk-Fact-367D4465C4EF8BEDDEF3AB53A616B0AA"
      unitRef="usd">60000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember"
      decimals="-5"
      id="d37405250e3028-wk-Fact-E36F06D57F11E5895A33AB53F00928D4"
      unitRef="usd">400000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:DerivativeInstrumentsAndHedgesLiabilities
      contextRef="FI2018Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-5"
      id="d37405250e3036-wk-Fact-FF67A504BEC1323DC6E2AB54408FAD50"
      unitRef="usd">200000</us-gaap:DerivativeInstrumentsAndHedgesLiabilities>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="FD2019Q4YTD"
      decimals="INF"
      id="d37405250e3058-wk-Fact-EC75AE47FE5F6E66497DEB34A7EE842C"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-89907D14310DA68B2743EB34A876304B-0-wk-Fact-6A19B728C570FB7E8C97EB34A8333194">&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;"&gt;4. Balance Sheet Details&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Short-Term Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Short-term marketable securities, consisting of equity securities and debt securities, were as follows as of the dates indicated:&lt;/span&gt;&lt;span style="font-family:inherit;font-size:9pt;"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.89888776541962%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Estimated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Market&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-top:6px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Debt securities, available for sale:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;U.S. government agencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;675.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;676.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Commercial paper&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;248.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;248.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Corporate debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;163.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;162.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total debt securities, available for sale&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,086.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,087.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Estimated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Market&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Equity investment in Tandem Diabetes Care, Inc&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;36.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;38.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Debt securities, available for sale:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;U.S. government agencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;173.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;173.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Commercial paper&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;36.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;36.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Corporate debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total debt securities, available for sale&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;210.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;210.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total marketable securities &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;212.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;36.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;248.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, all of our debt securities had contractual maturities of less than &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;twelve months&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. Gross realized gains and losses on our debt securities for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; were not significant. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We periodically review our portfolio of debt securities to determine if any investment is other-than-temporarily impaired due to changes in credit risk or other potential valuation concerns. We believe that the investments we held at &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; were not other-than-temporarily impaired. Unrealized losses on available-for-sale debt securities at that date were not significant and were due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table reconciles the net gain recognized on equity securities during the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; to the unrealized gain recognized during those periods on equity securities still held at the reporting dates.&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.89888776541962%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:59%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&#160;&lt;br/&gt;&#160;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Net gains and losses recognized during the period on equity securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;80.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less: Net gains and losses recognized during the period on equity securities sold during the period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(44.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Unrealized gains recognized during the reporting period on equity securities still held at the reporting date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;36.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-top:18px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;292.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;233.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less allowance for doubtful accounts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(5.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(7.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total accounts receivable, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;286.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;226.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-top:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Inventory&lt;/span&gt;&lt;span style="font-family:inherit;font-size:9pt;color:#58a618;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Raw materials&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;64.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;30.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Work-in-process&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;11.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;11.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Finished goods&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;43.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;28.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total inventory&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;119.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;70.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;During the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, we recorded excess and obsolete inventory charges of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$14.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; in cost of sales as a result of our ongoing assessment of sales demand, inventory on hand for each product and the continuous improvement and innovation of our products. During the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, we recorded excess and obsolete inventory charges of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$7.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; in cost of sales primarily as a result of the approval and launch of our G6 system and our ongoing assessment of sales demand and the continuous improvement and innovation of our products. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Building and land &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;12.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;9.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Computer software and hardware&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;32.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;29.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Machinery and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;130.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;80.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;102.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;80.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Construction in progress &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;132.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;57.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;426.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;262.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(105.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(79.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;321.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;183.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Building and Land. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Although we do not legally own these premises, under previous lease accounting standards we were deemed the owner of the construction project during the construction period of our manufacturing facility in Mesa, Arizona under a build-to-suit lease arrangement. As a result of our adoption of ASC 842, we de-recognized the estimated fair value of the building shell that was included in &#x201c;building and land&#x201d; in our consolidated balance sheets as of December 31, 2018 and the related lease liability and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019. The &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; balance in &#x201c;building and land&#x201d; represents our finance lease right-of-use assets as a result of our adoption of ASC 842. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Depreciation expense related to property and equipment for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; was &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$46.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$28.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$16.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; Loss on disposal of property and equipment during the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; recorded in operating expenses was &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$10.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$5.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$11.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-top:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;span style="font-family:inherit;font-size:9pt;color:#58a618;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;padding-left:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accounts payable trade&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;102.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;75.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accrued tax, audit, and legal fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;11.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accrued rebates &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;93.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;36.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accrued warranty&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;7.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;6.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Other accrued liabilities &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;39.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total accounts payable and accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;256.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;147.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Restructuring Plan.&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; In February 2019, our Board of Directors approved a restructuring plan that resulted in the transition of certain of our operations to the Philippines. We incurred total pre-tax charges and costs of approximately &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$8.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, primarily for employee severance benefits under both ongoing and one-time benefit arrangements. We incurred most of these costs in the first half of 2019 and the restructuring activities have been substantially completed as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Accrued Warranty&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Warranty costs are reflected in our statements of operations as cost of sales. Reconciliations of our accrued warranty costs for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Beginning balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;6.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;8.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Charges to costs and expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;32.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Costs incurred&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(32.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(19.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;7.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;6.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-top:16px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Other Long-Term Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Finance lease obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;7.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Deferred rent&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;9.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;20.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;20.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:36px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Our adoption of ASC 842 during the first quarter of 2019 affected the balances of finance lease liabilities and deferred rent. See Note 6, &#x201c;Leases And Other Commitments&#x201d; for more information on leases.&lt;/span&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-7EA84118998B1C7C956AEB34A877205F-0-wk-Fact-D8996FDD712494F01DDBEB34A8330844">&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Short-term marketable securities, consisting of equity securities and debt securities, were as follows as of the dates indicated:&lt;/span&gt;&lt;span style="font-family:inherit;font-size:9pt;"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.89888776541962%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Estimated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Market&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-top:6px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Debt securities, available for sale:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;U.S. government agencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;675.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;676.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Commercial paper&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;248.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;248.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Corporate debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;163.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;162.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total debt securities, available for sale&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,086.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,087.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Estimated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Market&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Equity investment in Tandem Diabetes Care, Inc&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;36.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;38.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Debt securities, available for sale:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;U.S. government agencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;173.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;173.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Commercial paper&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;36.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;36.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Corporate debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total debt securities, available for sale&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;210.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;210.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total marketable securities &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;212.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;36.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;248.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-5"
      id="d37415254e924-wk-Fact-97EAF2FFAC2C53818ED8D14DF1FC1C8D"
      unitRef="usd">675600000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-5"
      id="d37415254e943-wk-Fact-065C4F91BD485526BD3732F3D06B0676"
      unitRef="usd">400000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-5"
      id="d37415254e962-wk-Fact-AB559856A74750EE8526CC24FAB09D5D"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-5"
      id="d37415254e982-wk-Fact-8DEA67E07E0D1F5B9780EB34A7FE0800"
      unitRef="usd">676000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="-5"
      id="d37415254e997-wk-Fact-1EF822123514536DA6E56254E2FB5EC4"
      unitRef="usd">248100000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="-5"
      id="d37415254e1016-wk-Fact-370D0A9EF8A75A7A95E0A73F7758BB1B"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="-5"
      id="d37415254e1035-wk-Fact-CCC39754F9DD5AB49733EB37916D25DA"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="-5"
      id="d37415254e1055-wk-Fact-9E3246AEAE89AB269B47EB34A7FEDCEB"
      unitRef="usd">248200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember"
      decimals="-5"
      id="d37415254e1075-wk-Fact-F83C3574CD4D5DFD8383331141CFD2AB"
      unitRef="usd">163000000.0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember"
      decimals="-5"
      id="d37415254e1094-wk-Fact-916D191AD276598EA068D0047AF5857A"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember"
      decimals="-5"
      id="d37415254e1113-wk-Fact-3FB3153A2DCB5758A666873723149B39"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember"
      decimals="-5"
      id="d37415254e1134-wk-Fact-22D7F77DF4ED116010E0EB34A7FE3CB7"
      unitRef="usd">162900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e1159-wk-Fact-B051291D6C07CABF6EBDEB34A7EE6458"
      unitRef="usd">1086700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e1178-wk-Fact-4649118511D7FE4606C8EB34A81415F2"
      unitRef="usd">500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e1197-wk-Fact-7E1FD7D190C712F5AB09EB34A8626A48"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e1218-wk-Fact-51F5DEE4B0DD62E8AF91EB34A7FE41EB"
      unitRef="usd">1087100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNiCost
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e1446-wk-Fact-A83CD54985085C73B27EE2BE6D89515D"
      unitRef="usd">2000000.0</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37415254e1465-wk-Fact-AFEB585643F450B4B67504F2C034FC6E"
      unitRef="usd">36000000.0</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37415254e1484-wk-Fact-DD94DBF71ADB5042BF99E6ADF420C91E"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e1504-wk-Fact-1013DA42D77D67A4B250EB34A7EE222E"
      unitRef="usd">38000000.0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-5"
      id="d37415254e1688-wk-Fact-902AF197DF0C5ADD85632E09BB648F31"
      unitRef="usd">173200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-5"
      id="d37415254e1707-wk-Fact-1958AA6D83D05BF6A613711EEBA850D8"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-5"
      id="d37415254e1726-wk-Fact-A48AF8241D2754C5B6627EF107297F70"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-5"
      id="d37415254e1747-wk-Fact-54FB6FEEEC285B16FC0BEB34A82C8A26"
      unitRef="usd">173100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="-5"
      id="d37415254e1762-wk-Fact-5EBB83C5A7035691A191AAA093E4A3C8"
      unitRef="usd">36200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="-5"
      id="d37415254e1781-wk-Fact-BF2EBC3ADA075996B7BA79DC8CD95FCA"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="-5"
      id="d37415254e1800-wk-Fact-158595D3835556C3BC884F45153CE076"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CommercialPaperMember"
      decimals="-5"
      id="d37415254e1820-wk-Fact-E3C30EBA1EC77B8BC70DEB34A82D4A12"
      unitRef="usd">36200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember"
      decimals="-5"
      id="d37415254e1840-wk-Fact-2FF37B63B5105E3C84C5FAB4865B0380"
      unitRef="usd">1300000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember"
      decimals="-5"
      id="d37415254e1859-wk-Fact-C859C75339EE55109F23E6E4D512D99D"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember"
      decimals="-5"
      id="d37415254e1878-wk-Fact-DD43319374A854509DCCEAC64CB0BD5C"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_CorporateDebtSecuritiesMember"
      decimals="-5"
      id="d37415254e1898-wk-Fact-CFEDE8F3A43E420B1CD6EB34A82C3CD6"
      unitRef="usd">1300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e1923-wk-Fact-D9DFBB55DBA5125EE87FEB34A7FEFA93"
      unitRef="usd">210700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e1942-wk-Fact-3CE3E61E7621F9182A12EB34A7FEBC39"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e1961-wk-Fact-8DEDC756155D24D15F4AEB34A7EEE6CE"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e1982-wk-Fact-1773E0B34BE9A54263C4EB34A7EEB3BF"
      unitRef="usd">210600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <dxcm:DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e2084-wk-Fact-E6C7BF857726D0D16816EB34A7FE0501"
      unitRef="usd">212700000</dxcm:DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost>
    <dxcm:DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37415254e2103-wk-Fact-081C2EF8C4AABD12C985EB34A7FECC4F"
      unitRef="usd">36000000.0</dxcm:DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain>
    <dxcm:DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37415254e2122-wk-Fact-0AE8F98BEF995B7B821BEB34A7FE0013"
      unitRef="usd">100000</dxcm:DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss>
    <dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e2143-wk-Fact-2D4754244E03538BA709DA0E74E53486"
      unitRef="usd">248600000</dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleTerm
      contextRef="FI2019Q4"
      id="d37415254e2169-wk-Fact-2B837C26F3D05A149EF35FDF8C871C24">P12M</us-gaap:DebtSecuritiesAvailableForSaleTerm>
    <us-gaap:GainLossOnInvestmentsTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-9B3CA01AD5E705889057EB34A877DF2F-0-wk-Fact-B8C19AC03CEB17F347F3EB34A833210E">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table reconciles the net gain recognized on equity securities during the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; to the unrealized gain recognized during those periods on equity securities still held at the reporting dates.&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.89888776541962%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:59%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&#160;&lt;br/&gt;&#160;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Net gains and losses recognized during the period on equity securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;80.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less: Net gains and losses recognized during the period on equity securities sold during the period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(44.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Unrealized gains recognized during the reporting period on equity securities still held at the reporting date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;36.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:GainLossOnInvestmentsTextBlock>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415254e2376-wk-Fact-84D262FE1402AF794642174A943CE9B2"
      unitRef="usd">-4200000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37415254e2396-wk-Fact-AE15260499DB5316983B3D2E988B107C"
      unitRef="usd">80100000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37415254e2415-wk-Fact-5ACB75D07BA38562950CEB34A85248FB"
      unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415254e2431-wk-Fact-7317DF40B1055C2985B9AF42FBB32864"
      unitRef="usd">-4200000</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37415254e2450-wk-Fact-CBABBF72436A5EFCA4B4A55ABF8DF80B"
      unitRef="usd">44100000</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37415254e2470-wk-Fact-4DBAFAE09463A93B8FE3EB34A833B596"
      unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415254e2496-wk-Fact-9563877633EC5AC3460BEB34A833277C"
      unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37415254e2515-wk-Fact-12AF46BD79BA2C8CB02CEB34A8337DF8"
      unitRef="usd">36000000.0</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37415254e2534-wk-Fact-C720FCAA72413BFC9CDEEB34A833181F"
      unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-9ED437146B53A35027D3EB34A877FBB3-0-wk-Fact-738508862D104AE4CB76EB34A8319911">&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;292.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;233.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less allowance for doubtful accounts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(5.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(7.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total accounts receivable, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;286.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;226.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGross
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e2702-wk-Fact-92F9D45FA8126E4AB9FAEB34A843F597"
      unitRef="usd">292100000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e2721-wk-Fact-4CFA2C7211A3D2FF0867EB34A843F29D"
      unitRef="usd">233900000</us-gaap:AccountsReceivableGross>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e2736-wk-Fact-563972F20C025B1C9B88EB34A84337F6"
      unitRef="usd">5800000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e2756-wk-Fact-B371ADE755BE18E41D1FEB34A843171D"
      unitRef="usd">7200000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e2782-wk-Fact-ACC550047E2AB093E723EB34A843BD6A"
      unitRef="usd">286300000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e2801-wk-Fact-AA1FB6A31668BD190189EB34A8438BE9"
      unitRef="usd">226700000</us-gaap:AccountsReceivableNet>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-33061DC45F50361860E5EB34A877D689-0-wk-Fact-39BCDD6F121EEE50F1C7EB34A83181A8">&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Raw materials&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;64.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;30.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Work-in-process&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;11.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;11.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Finished goods&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;43.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;28.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total inventory&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;119.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;70.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e2975-wk-Fact-D51D9C7D6C8E55D98938E17204691247"
      unitRef="usd">64900000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e2994-wk-Fact-1C8CC575D4D952C598905C09996B653F"
      unitRef="usd">30800000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e3009-wk-Fact-6A1C4C696C37571CB8B86B8A91693A3C"
      unitRef="usd">11100000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e3028-wk-Fact-90383F6A3CF25E92815D8E3E4EEFBABD"
      unitRef="usd">11200000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e3048-wk-Fact-94F9BF530D635E7FB2C665C6B3DAD089"
      unitRef="usd">43800000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e3067-wk-Fact-18BD58B3EFAE5D4E8D7D1259B7D39368"
      unitRef="usd">28700000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e3092-wk-Fact-5955DC66290A55438DBD16FF1CD033DF"
      unitRef="usd">119800000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e3111-wk-Fact-75042F3537165827921BCEDFF6FB9129"
      unitRef="usd">70700000</us-gaap:InventoryNet>
    <us-gaap:InventoryWriteDown
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_dxcm_ReceiverProductComponentMember"
      decimals="-5"
      id="d37415254e3137-wk-Fact-CA3800250A7356028AE04F2C9A0246CB"
      unitRef="usd">14100000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_dxcm_ReceiverProductComponentMember"
      decimals="-5"
      id="d37415254e3150-wk-Fact-06077AE6C16B5049AF84592C6A155BC3"
      unitRef="usd">7300000</us-gaap:InventoryWriteDown>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-17FE84E3034212576C40EB34A8778BFC-0-wk-Fact-EFD32C798B81326DEC42EB34A8322B96">&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Building and land &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;12.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;9.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Computer software and hardware&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;32.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;29.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Machinery and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;130.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;80.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;102.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;80.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Construction in progress &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;132.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;57.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;426.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;262.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(105.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(79.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;321.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;183.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="-5"
      id="d37415254e3311-wk-Fact-91A045A0F3E15A83B768EB498360253C"
      unitRef="usd">15500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="-5"
      id="d37415254e3330-wk-Fact-9344FAD9E82A56E4A1C1CC83F0D4C9FF"
      unitRef="usd">6000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember"
      decimals="-5"
      id="d37415254e3345-wk-Fact-6AA7F2DB8F4A5069A775C5102BCA3A7E"
      unitRef="usd">12800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember"
      decimals="-5"
      id="d37415254e3364-wk-Fact-D450D5B16BC158AFBFD3B3083C39E7A0"
      unitRef="usd">9000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember"
      decimals="-5"
      id="d37415254e3384-wk-Fact-9D53120B4D195BB1B95B991A7F102162"
      unitRef="usd">32700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember"
      decimals="-5"
      id="d37415254e3403-wk-Fact-A6F22820CAA85A36AB6D5C007543E784"
      unitRef="usd">29200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember"
      decimals="-5"
      id="d37415254e3423-wk-Fact-AD5623385A445453BA81B7EA2A3BAE39"
      unitRef="usd">130200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember"
      decimals="-5"
      id="d37415254e3442-wk-Fact-FF83706267065EBCB1DAD1F929EB1369"
      unitRef="usd">80700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember"
      decimals="-5"
      id="d37415254e3462-wk-Fact-E412D3784EA6535D8FD50E83474481D9"
      unitRef="usd">102500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember"
      decimals="-5"
      id="d37415254e3481-wk-Fact-E93C620AD8955E37AEBE1106EBDE464F"
      unitRef="usd">80700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"
      decimals="-5"
      id="d37415254e3501-wk-Fact-3C6048345F545E0FA01B04B247F72F7F"
      unitRef="usd">132600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"
      decimals="-5"
      id="d37415254e3520-wk-Fact-32DA109DF29653DB9511BD5B4A8C464E"
      unitRef="usd">57300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e3540-wk-Fact-0C76B9D2536240BC2077EB34A7FE0031"
      unitRef="usd">426300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e3559-wk-Fact-F802F0AFE3969BD28C1AEB34A843ADCC"
      unitRef="usd">262900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e3579-wk-Fact-E1C1531B09EA5AD88B5E92F0CA456864"
      unitRef="usd">105000000.0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e3599-wk-Fact-792F45518C5D5714917D8EAEBF878C9E"
      unitRef="usd">79800000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e3625-wk-Fact-6E0096B0001E585FB1501D1E29BCFD4B"
      unitRef="usd">321300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e3644-wk-Fact-4346F1EF4C125EFEA32FB8D88988ADF4"
      unitRef="usd">183100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415254e3685-wk-Fact-B12293611B82CD563E63EB34A833451D"
      unitRef="usd">46900000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37415254e3690-wk-Fact-F42A574AF2AD51A04345EB34A862A738"
      unitRef="usd">28600000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37415254e3694-wk-Fact-9E188DF33757DD512291EB34A83132BA"
      unitRef="usd">16100000</us-gaap:Depreciation>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415254e3717-wk-Fact-95BD94DE41A8C9BC4BF5EB34A83152D4"
      unitRef="usd">-10500000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37415254e3722-wk-Fact-9A7373AA7A6B868BA298EB34A8623D94"
      unitRef="usd">-5400000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37415254e3726-wk-Fact-7276A54ECC49A113EAA7B59CB51324D7"
      unitRef="usd">-11000000.0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-6B93F38367345C72B33EEB34A8773F3A-0-wk-Fact-F607D41E311D88E854D5EB34A8314EA0">&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;padding-left:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accounts payable trade&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;102.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;75.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accrued tax, audit, and legal fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;11.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accrued rebates &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;93.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;36.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accrued warranty&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;7.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;6.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Other accrued liabilities &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;39.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total accounts payable and accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;256.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;147.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e3917-wk-Fact-8EC3B14E9FAC5CCD914371E9FBC5FA91"
      unitRef="usd">102300000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e3936-wk-Fact-92F563B1F87B5E9F823673AE025DD2AC"
      unitRef="usd">75500000</us-gaap:AccountsPayableTradeCurrent>
    <dxcm:AccruedTaxAuditAndLegalFees
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e3951-wk-Fact-EC9927DAC2575446B7AD891A3326D061"
      unitRef="usd">14000000.0</dxcm:AccruedTaxAuditAndLegalFees>
    <dxcm:AccruedTaxAuditAndLegalFees
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e3970-wk-Fact-6A360E879D5C57EE96DA9050F4D6EC6C"
      unitRef="usd">11700000</dxcm:AccruedTaxAuditAndLegalFees>
    <dxcm:PharmacyRebates
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e3990-wk-Fact-64B59A9F98C351B8AAE0F89503A55E70"
      unitRef="usd">93300000</dxcm:PharmacyRebates>
    <dxcm:PharmacyRebates
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e4009-wk-Fact-30CCE2FC1FCE5B71ADA6811E814DE4E5"
      unitRef="usd">36100000</dxcm:PharmacyRebates>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e4029-wk-Fact-BBC336A2E3D05068A1145E93F6256B18"
      unitRef="usd">7400000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e4048-wk-Fact-C6E5D4F8BEA0510A99ED8A1A7184EA03"
      unitRef="usd">6800000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e4068-wk-Fact-770C8ADF70855DBE92B5D9875069956E"
      unitRef="usd">39400000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e4087-wk-Fact-CAA6FCF35F075CF986C72E65F67BF99B"
      unitRef="usd">17000000.0</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e4112-wk-Fact-D7C5F6E8423EF61C6BA41747E11B5939"
      unitRef="usd">256400000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e4131-wk-Fact-9B84C094B74D40D4FF8C1747E0185BAB"
      unitRef="usd">147100000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:RestructuringCharges
      contextRef="D2019Q4Feb01-Dec31"
      decimals="-5"
      id="d37415254e4149-wk-Fact-A2E7DB4C8E8C547498A8759F81BFAF41"
      unitRef="usd">8000000.0</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-B440B61B5282789C26F2EB34A87778BE-0-wk-Fact-42C60CFC736EB78B95FDEB34A82FFCDC">Reconciliations of our accrued warranty costs for the &lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; were as follows:&lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Beginning balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;6.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;8.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Charges to costs and expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;32.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Costs incurred&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(32.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(19.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;7.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;6.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e4332-wk-Fact-C6E5D4F8BEA0510A99ED8A1A7184EA03"
      unitRef="usd">6800000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="FI2017Q4"
      decimals="-5"
      id="d37415254e4351-wk-Fact-D51695776549D0787D59EB34A833B90D"
      unitRef="usd">8800000</us-gaap:StandardProductWarrantyAccrual>
    <dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415254e4366-wk-Fact-B3986081666E7DEA102DEB34A833A372"
      unitRef="usd">32700000</dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses>
    <dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37415254e4385-wk-Fact-DE6111891FE9078EA723EB34A8338D8B"
      unitRef="usd">17400000</dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415254e4405-wk-Fact-94C3A0D69D09628CD5EFEB34A8336750"
      unitRef="usd">32100000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37415254e4425-wk-Fact-4949C75FF3DBA4B48A9FEB34A83333E5"
      unitRef="usd">19400000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e4451-wk-Fact-BBC336A2E3D05068A1145E93F6256B18"
      unitRef="usd">7400000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e4470-wk-Fact-C6E5D4F8BEA0510A99ED8A1A7184EA03"
      unitRef="usd">6800000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-DCA71D93ECD1C702689BEB34A877034A-0-wk-Fact-D7102A5A6505DF86B076EB34A8329C38">&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Finance lease obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;7.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Deferred rent&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;9.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;20.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;20.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock>
    <dxcm:FinancingLeaseObligation
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e4633-wk-Fact-15063033A80D527AAA3360F0EC083E14"
      unitRef="usd">14400000</dxcm:FinancingLeaseObligation>
    <dxcm:FinancingLeaseObligation
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e4652-wk-Fact-681094F71A7D5ED2848648381D260269"
      unitRef="usd">7300000</dxcm:FinancingLeaseObligation>
    <us-gaap:DeferredRentCreditNoncurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e4686-wk-Fact-3BAC2E473BFF553BB11DB09C5163C369"
      unitRef="usd">9400000</us-gaap:DeferredRentCreditNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e4706-wk-Fact-FE5C8B566A2F530ABB40372B294901EF"
      unitRef="usd">5700000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e4725-wk-Fact-61969674E7E15C8F95FB3086DA4F7A99"
      unitRef="usd">3300000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415254e4750-wk-Fact-48BC2EECC3D82B2A40941747E036D3DB"
      unitRef="usd">20100000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37415254e4769-wk-Fact-25A91861877F5862CFD21747E066C461"
      unitRef="usd">20000000.0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-A0B78AAE722F9714A85AEB34A877E8A5-0-wk-Fact-D2BC5664FE19135E7244EB34A83372A5">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.51219512195122%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;"&gt;5. Debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90243902439025%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Senior Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The carrying amounts of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(Dollars in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75% Senior Convertible Notes due 2022:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Principal amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;400.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;400.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Unamortized debt discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(37.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(51.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(4.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(6.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Net carrying amount of Senior Convertible Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;358.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;342.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75% Senior Convertible Notes due 2023:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Principal amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;850.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;850.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Unamortized debt discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(140.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(171.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(8.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(10.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Net carrying amount of Senior Convertible Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;701.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;667.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total net carrying amount of senior convertible notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,059.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,010.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Carrying value of equity component of convertible senior notes, net of debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Senior Convertible Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;70.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;70.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;171.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;171.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Remaining&#160;amortization&#160;period&#160;of&#160;debt discount&#160;on&#160;the&#160;liability&#160;component&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Senior Convertible Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.5 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.5 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.0 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.0 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The amount by which the notes&#x2019; if-converted value exceeds their principal amount is as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Senior Convertible Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;486.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;125.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;372.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total by which the notes&#x2019; if-converted value exceeds their principal amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;858.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;125.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;padding-left:0px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown. &lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:59%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(Dollars in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Interest expense recognized:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75% Senior Convertible Notes due 2022:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Contractual coupon interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accretion of debt discount &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;13.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;13.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;8.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Interest expense recognized on 2022 Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;18.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;18.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;11.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75% Senior Convertible Notes due 2023:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Contractual coupon interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;6.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accretion of debt discount &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;31.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Interest expense recognized on 2023 Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;40.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total interest expense recognized on senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;58.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;21.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;11.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Effective interest rates:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75% Senior Convertible Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75% Senior Convertible Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)  &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The discount on the 2022 Notes is being amortized through May 15, 2022. Interest on the 2022 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(2)  &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The discount on the 2023 Notes is being amortized through December 1, 2023. Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;0.75%&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt; Senior Convertible Notes due 2022 &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;June 2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, we completed an offering of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$400.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; aggregate principal amount of unsecured senior convertible notes with a stated interest rate of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.75%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and a maturity date of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;May&#160;15, 2022&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; (the 2022 Notes). The net proceeds from the offering, after deducting initial purchasers&#x2019; discounts and costs directly related to the offering, were approximately &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$389.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. The initial conversion rate of the 2022 Notes is &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;10.0918&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; shares per &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$1,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; principal amount of notes, which is equivalent to a conversion price of approximately &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$99.09&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; per share, subject to adjustments. The 2022 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2022 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders&#x2019; equity. As a result, we recognized &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$72.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; in additional paid-in-capital during 2017.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;No principal payments are due on the 2022 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2022 Notes includes customary terms and covenants, including certain events of default after which the 2022 Notes may be due and payable immediately.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Conversion Rights at the Option of the Holders &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In the event of a fundamental change (as defined in the indenture related to the 2022 Notes), holders of the 2022 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of the principal amount of the 2022 Notes, plus any accrued and unpaid interest. Holders of the 2022 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by DexCom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Prior to 5:00 p.m., New York City time, on the business day immediately preceding February&#160;15, 2022, holders of the 2022 Notes may convert all or a portion of their notes, in multiples of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$1,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; principal amount, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:12px;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;text-indent:-12px;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;during any calendar quarter commencing after September&#160;30, 2017 (and only during such calendar quarter), if the last reported sale price of common stock for at least &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; trading days (whether or not consecutive) during the period of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;130%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of the applicable conversion price of the Notes on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;during the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;five&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; business day period after any &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;five&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; consecutive trading day period in which the trading price per &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$1,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; principal amount of the Notes for each day of that &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;five&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; day consecutive trading day period was less than &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;98%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of the product of the last reported sale price of common stock and the applicable conversion rate of the Notes on such trading day;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;if we call any or all of the Notes for redemption, at any time prior to the close on business on the scheduled trading day immediately preceding the redemption date; or&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;upon the occurrence of specified corporate transactions.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;On or after &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;February&#160;15, 2022&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2022 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Circumstance (1) listed above occurred during the quarters ended March 31, 2019, September 30, 2019 and December 31, 2019. As a result, the 2022 Notes became convertible at the option of the holders from April 1, 2019 through June 30, 2019, October 1, 2019 through December 31, 2019 and will remain convertible at the option of the holder from January 1, 2020 through March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Holders of 2022 Notes with an insignificant principal amount exercised their option to convert their 2022 Notes during the second and fourth quarters of 2019 and we settled these conversions with shares of our common stock. We continue to classify the carrying value of the liability component of the 2022 Notes as long-term debt, and the equity component of the 2022 Notes as permanent equity in our consolidated balance sheets as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Conversion Rights at Our Option &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;DexCom may not redeem the 2022 Notes prior to May 15, 2020. On or after May 15, 2020, DexCom may redeem for cash all or part of the 2022 Notes, at its option, if the last reported sale price of our common stock has been at least &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;140%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of the conversion price then in effect for at least &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; trading days (whether or not consecutive) during any &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; consecutive trading day period ending on, and including, the trading day immediately preceding the date on which DexCom provides notice of redemption. The redemption price will be equal to &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of the principal amount of the 2022 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:174%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;0.75% Senior Convertible Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;November 2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, we completed an offering of&#160;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$850.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;aggregate principal amount of unsecured senior convertible notes with a stated interest rate of&#160;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.75%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;and a maturity date of&#160;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;1, 2023&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;(the 2023 Notes). The net proceeds from the offering, after deducting initial purchasers&#x2019; discounts and costs directly related to the offering, were approximately&#160;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$836.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. The initial conversion rate of the 2023 Notes is&#160;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;6.0869&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;shares per&#160;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$1,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; principal amount of notes, which is equivalent to a conversion price of approximately&#160;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$164.29&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;per share, subject to adjustments. We entered into transactions for a convertible note hedge (the 2023 Note Hedge) and warrants (the 2023 Warrants) concurrently with the issuance of the 2023 Notes. The 2023 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2023 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders&#x2019; equity. As a result, we recognized &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$174.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; in additional paid-in capital during 2018. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;No principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2023 Notes includes customary terms and covenants, including certain events of default after which the 2023 Notes may be due and payable immediately. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Conversion Rights at the Option of the Holders &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Holders of the 2023 Notes have the right to require us to repurchase for cash all or a portion of their notes at &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the notes). We will also be required to increase the conversion rate for holders who convert their 2023 Notes in connection with certain fundamental changes occurring prior to the maturity date or following the delivery by DexCom of a notice of redemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Holders of the 2023 Notes may convert all or a portion of their notes at their option prior to 5:00 p.m., New York City time, on the business day immediately preceding September&#160;1, 2023, in multiples of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$1,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; principal amount, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;during any calendar quarter commencing after March 31, 2019 (and only during such calendar quarter), if the last reported sale price of common stock for at least &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; trading days (whether or not consecutive) during the period of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;130%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of the applicable conversion price of the 2023 Notes on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;during the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;five&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; business day period after any &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;five&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; consecutive trading day period in which the trading price per &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$1,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; principal amount of the 2023 Notes for each day of that &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;five&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;-day consecutive trading day period was less than &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;98%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of the product of the last reported sale price of common stock and the applicable conversion rate of the 2023 Notes on such trading day;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;if we call any or all of the 2023 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;upon the occurrence of specified corporate transactions.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;On or after &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;September&#160;1, 2023&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2023 Notes may convert all or a portion of their notes regardless of the foregoing circumstances. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Circumstance (1) listed above occurred during the quarter ended December 31, 2019. As a result, the 2023 Notes are convertible at the option of the holders from January 1, 2020 and will remain convertible until March 31, 2020. We continue to classify the carrying value of the liability component of the 2023 Notes as long-term debt, and the equity component of the 2023 Notes as permanent equity in our consolidated balance sheets as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Conversion Rights at Our Option &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;DexCom may not redeem the 2023 Notes prior to December 1, 2021. On or after December 1, 2021 and prior to September 1, 2023, DexCom may redeem for cash all or part of the 2023 Notes, at its option, if the last reported sale price of our common stock has been at least &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;130%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of the conversion price then in effect for at least &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; trading days (whether or not consecutive) during any &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; consecutive trading day period ending on, and including, the trading day immediately preceding the date on which DexCom provides notice of redemption. The redemption price will be equal to &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of the principal amount of the 2023 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;2023 Note Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions with two of the initial purchasers of the 2023 Notes (the 2023 Counterparties) entitling us to purchase up to&#160;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;shares of our common stock at an initial price of&#160;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$164.29&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was&#160;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$218.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and we accounted for it as an equity instrument by recognizing &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$218.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; in&#160;additional paid-in capital&#160;during 2018. The 2023 Note Hedge will expire on &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;1, 2023&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge.&#160;The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge. An assumed exercise of the 2023 Note Hedge by us is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;2023 Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In November 2018, we also sold warrants to the 2023 Counterparties to acquire up to&#160;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; shares of our common stock. The 2023 Warrants require net share settlement and a pro rated number of warrants will expire on each of the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;60&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; scheduled trading days starting on &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;March&#160;1, 2024&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. We received&#160;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$183.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;in cash proceeds from the sale of the 2023 Warrants, which we recorded in&#160;additional paid-in capital during 2018. The 2023 Warrants could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2023 Warrants. The strike price of the 2023 Warrants is initially &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$198.38&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; per share and is subject to certain adjustments under the terms of the warrant agreements. We use the treasury share method for assumed conversion of the 2023 Warrants when computing the weighted average common shares outstanding for diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90243902439025%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Revolving Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Terms of the Revolving Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;On December 19, 2018, we entered into an amended and restated revolving credit agreement (the Credit Agreement) which provides for available principal amount of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$200.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; which can be increased up to &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$500.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; at our option subject to customary conditions and approval of our lenders. Borrowings under the Credit Agreement are available for general corporate purposes, including working capital and capital expenditures. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Information related to availability and outstanding borrowings on our Credit Agreement is as follows: &lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:86%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Available principal amount &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;200.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Letters of credit sub-facility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Outstanding borrowings &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Outstanding letters of credit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total available balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;195.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt; &lt;/sup&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Revolving loans under the Credit Agreement bear interest at our choice of one of two base rates plus a range of applicable margin rates that are based on our leverage ratio. The first base rate is the highest of (a) the publicly announced JPMorgan Chase prime rate, (b) the federal funds rate, or (c) the overnight bank funding rate, and the applicable margin rate ranges from &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.375%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; to &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.000%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. The second base rate is a LIBOR-based rate, and the applicable margin rate ranges from &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.375%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; to &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.000%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. We will also pay a commitment fee of between &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.2%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.3%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, payable quarterly in arrears, on the average daily unused amount of the revolving facility based on our leverage ratio. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The Credit Agreement will mature on the earlier to occur of (i) December 19, 2023 or (ii) 91 days prior to the maturity date of the 2022 Notes or (iii) 91 days prior to the maturity date of the 2023 Notes if both (a) the aggregate outstanding principal amount of the 2022 Notes or the 2023 Notes, as applicable, is greater than EBITDA for the period of four consecutive fiscal quarters ending prior to such date and (b) unrestricted domestic cash on hand is less than the aggregate outstanding principal amount of the 2022 Notes or the 2023 Notes, as applicable, plus &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$100.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Our obligations under the Credit Agreement are guaranteed by our existing and future wholly-owned domestic subsidiaries, and are secured by a first-priority security interest in substantially all of the assets of DexCom and the guarantors, including all or a portion of the equity interests of our domestic subsidiaries and first-tier foreign subsidiaries but excluding real property and intellectual property (which is subject to a negative pledge). The Credit Agreement contains covenants that limit certain indebtedness, liens, investments, transactions with affiliates, dividends and other restricted payments, subordinated indebtedness and amendments to subordinated indebtedness documents, and sale and leaseback transactions of DexCom or any of its domestic subsidiaries. The Credit Agreement also requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-84B9E1E746EE95DF0413EB34A878DE00-0-wk-Fact-4D288F34D19717AE9BD6EB34A8433AF2">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The carrying amounts of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(Dollars in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75% Senior Convertible Notes due 2022:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Principal amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;400.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;400.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Unamortized debt discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(37.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(51.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(4.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(6.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Net carrying amount of Senior Convertible Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;358.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;342.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75% Senior Convertible Notes due 2023:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Principal amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;850.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;850.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Unamortized debt discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(140.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(171.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(8.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(10.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Net carrying amount of Senior Convertible Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;701.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;667.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total net carrying amount of senior convertible notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,059.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,010.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Carrying value of equity component of convertible senior notes, net of debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Senior Convertible Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;70.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;70.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;171.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;171.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Remaining&#160;amortization&#160;period&#160;of&#160;debt discount&#160;on&#160;the&#160;liability&#160;component&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Senior Convertible Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.5 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.5 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.0 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.0 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e763-wk-Fact-EC0AC27C96E55BE3BC10673FCBA667AB"
      unitRef="usd">400000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e782-wk-Fact-5A5D03632C3A5B8CB8D424A5FBFEDEC9"
      unitRef="usd">400000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e797-wk-Fact-6A6B55A1DFBA570CA31812B1FE10DBC1"
      unitRef="usd">37200000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e817-wk-Fact-BE5D52EC98AF567CBEDBD6F5D0DE073F"
      unitRef="usd">51100000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e838-wk-Fact-2F9F6917E2C65FCF8C6E91388259FD9B"
      unitRef="usd">4600000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e858-wk-Fact-2A8680C181E15D0B92D92F1C9D15F851"
      unitRef="usd">6300000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e879-wk-Fact-109F125CA0103E956A23EB34A84399FE"
      unitRef="usd">358200000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e898-wk-Fact-720E54A67044D3061D06EB34A843B5C7"
      unitRef="usd">342600000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e1000-wk-Fact-F1B281C2C12E5551A37BD8B53D9F9320"
      unitRef="usd">850000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e1019-wk-Fact-04709CB47B5D5BAA963CF39693E4EFB0"
      unitRef="usd">850000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1039-wk-Fact-7E65E393AF9D5700BA2CFADEBAD51BCE"
      unitRef="usd">140000000.0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1059-wk-Fact-C4D75478C92D5D5AA9528D0E31180E01"
      unitRef="usd">171800000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1081-wk-Fact-02866FFB2C185202BC1686C8E9C45801"
      unitRef="usd">8500000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1101-wk-Fact-9227BA3E663D51F2A46477C450F810F1"
      unitRef="usd">10500000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1122-wk-Fact-A9994552E844F4AC28DFEB34A7FEE70D"
      unitRef="usd">701500000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1141-wk-Fact-3729B8261ACE80427AB8EB34A852038C"
      unitRef="usd">667700000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:LongTermDebt
      contextRef="FI2019Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1207-wk-Fact-FCFF1D978C43139D9D2FEB34A852D690"
      unitRef="usd">1059700000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1226-wk-Fact-EAB878D185012531B888EB34A7FE14E6"
      unitRef="usd">1010300000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1328-wk-Fact-2ECC5C42FF970076F60ECA1B9647ABA7"
      unitRef="usd">70600000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1347-wk-Fact-DFDEBE515B2120F18F6DCA1B964BA1A1"
      unitRef="usd">70600000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1367-wk-Fact-A8BADCEB44945C6A7FCCCA1B96530F4B"
      unitRef="usd">171600000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1386-wk-Fact-54F09D29224CD3368C54CA1B965D7ED3"
      unitRef="usd">171600000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      id="d37418911e1483-wk-Fact-AB1A5076EFE337850403CA1ED60B0B67">P2Y6M</us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1>
    <us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
      contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      id="d37418911e1502-wk-Fact-EB296BB43747CF1A68FFCA1ED618C63A">P3Y6M</us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1>
    <us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      id="d37418911e1523-wk-Fact-FF971EDD00A6CF10708ACA1ED612D6CB">P4Y</us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1>
    <us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
      contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      id="d37418911e1542-wk-Fact-BBE698D4877E12BF7E62CA1ED6246568">P5Y</us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1>
    <us-gaap:ConvertibleDebtTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-19BC3B2F1317325D060BB5A6B29E7311-0-wk-Fact-A7B9E20A781B9A9090D9B5A7310F800F">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The amount by which the notes&#x2019; if-converted value exceeds their principal amount is as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Senior Convertible Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;486.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;125.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;372.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total by which the notes&#x2019; if-converted value exceeds their principal amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;858.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;125.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1669-wk-Fact-2BBC776187565DC2AA9D2FEA99E0F505"
      unitRef="usd">486200000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
      contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1688-wk-Fact-81DF39BF014C5B9A9337AD85A495B806"
      unitRef="usd">125400000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1703-wk-Fact-9E88094DCB1157529EF0476C6DE954BB"
      unitRef="usd">372400000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
      contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1722-wk-Fact-D24D15A5823E5A3C96DA48A67FD0955D"
      unitRef="usd">0</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
      contextRef="FD2019Q4YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1747-wk-Fact-9FC918B483E0A36BF691CA1D5518AB88"
      unitRef="usd">858600000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
      contextRef="FD2018Q4YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e1766-wk-Fact-6ECC5F7847AD26CA2B29CA1D5CFB6355"
      unitRef="usd">125400000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-135265C51118C7D6FAC2B5A818A4F597-0-wk-Fact-69F862594CDA615F50C2B5A8A788C43B">&lt;div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;padding-left:0px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown. &lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:59%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(Dollars in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Interest expense recognized:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75% Senior Convertible Notes due 2022:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Contractual coupon interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accretion of debt discount &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;13.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;13.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;8.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Interest expense recognized on 2022 Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;18.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;18.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;11.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75% Senior Convertible Notes due 2023:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Contractual coupon interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;6.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Accretion of debt discount &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;31.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Interest expense recognized on 2023 Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;40.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total interest expense recognized on senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;58.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;21.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;11.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Effective interest rates:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75% Senior Convertible Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75% Senior Convertible Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)  &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The discount on the 2022 Notes is being amortized through May 15, 2022. Interest on the 2022 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(2)  &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The discount on the 2023 Notes is being amortized through December 1, 2023. Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year.&lt;/span&gt;&lt;/div&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37418911e2062-wk-Fact-74AB2B953CD559BE83940F2A3886EB8C"
      unitRef="usd">3000000.0</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37418911e2081-wk-Fact-CDD48AEA76865A89C82AEB34A83397D0"
      unitRef="usd">3000000.0</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37418911e2100-wk-Fact-6A795CEB9184C83E2FB0EB34A7EE2631"
      unitRef="usd">1900000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37418911e2118-wk-Fact-68CE36619DB4583D8BDE7DD532D3C626"
      unitRef="usd">13900000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37418911e2137-wk-Fact-9707C5D30A1954525B24EB34A7FE541D"
      unitRef="usd">13400000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37418911e2156-wk-Fact-4E32A5F8A9AB36C180F2EB34A8334F1C"
      unitRef="usd">8200000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37418911e2177-wk-Fact-6180B976FDA55CF99517C3B0849EA8EC"
      unitRef="usd">1700000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37418911e2196-wk-Fact-B42BAF24395256116A31EB34A8433B1E"
      unitRef="usd">1600000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37418911e2215-wk-Fact-F6EC54B05F86356F6F3CEB34A7FE5CF0"
      unitRef="usd">1000000.0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:InterestExpenseDebt
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37418911e2236-wk-Fact-EFC96AA9C5CFD0A946E1EB34A7EED256"
      unitRef="usd">18600000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37418911e2255-wk-Fact-74C314B6120EFAC83E3FEB34A83349CC"
      unitRef="usd">18000000.0</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="-5"
      id="d37418911e2274-wk-Fact-3B20342925C1C3FEF0C4EB34A8335FD3"
      unitRef="usd">11100000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37418911e2419-wk-Fact-9D6A48C98CA2500D8624E5E6F68D75B3"
      unitRef="usd">6300000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37418911e2438-wk-Fact-5073A88F065E850BA9AFEB34A8334DDC"
      unitRef="usd">500000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37418911e2457-wk-Fact-7B877C113CE690362EFFEB34A8332515"
      unitRef="usd">0</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37418911e2481-wk-Fact-C46AECA75E5158A594389AD6FEC3AC16"
      unitRef="usd">31900000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37418911e2500-wk-Fact-3A99101B264059F25B8FEB34A833884D"
      unitRef="usd">2600000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37418911e2519-wk-Fact-C09D4CA60A7151887564EB34A833B07E"
      unitRef="usd">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37418911e2540-wk-Fact-BECC146058C15B2E9A20437B5AA2C089"
      unitRef="usd">2000000.0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37418911e2559-wk-Fact-52E1C77F1513C24C48C2EB34A7FE3898"
      unitRef="usd">200000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37418911e2578-wk-Fact-B6752B997A666DC7BC11EB34A7EEB7A2"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:InterestExpenseDebt
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37418911e2599-wk-Fact-BB18C9BF3B78DE969B7CEB34A8336859"
      unitRef="usd">40200000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37418911e2618-wk-Fact-1EEC5A10F0650087CBEBEB34A833216F"
      unitRef="usd">3300000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="-5"
      id="d37418911e2637-wk-Fact-331BA2878FD38E193476EB34A83310F0"
      unitRef="usd">0</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37418911e2725-wk-Fact-8155F71833868ED126E6EB34A7EE1E5D"
      unitRef="usd">58800000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37418911e2744-wk-Fact-9105E680EFB9C318646EEB34A7EE85DA"
      unitRef="usd">21300000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37418911e2763-wk-Fact-09B4F6879A049AF99C60EB34A7FE99DA"
      unitRef="usd">11100000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="3"
      id="d37418911e2903-wk-Fact-CF792559275159ABA94CFC4D4ED01556"
      unitRef="number">0.051</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="3"
      id="d37418911e2923-wk-Fact-3C2C4BEB40245B89BFADFC34BBF7B6EC"
      unitRef="number">0.051</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="FI2017Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member"
      decimals="3"
      id="d37418911e2943-wk-Fact-54325DDC79E3381B3AAFEB34A84392C1"
      unitRef="number">0.051</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="3"
      id="d37418911e2965-wk-Fact-8E3937E1F4F156F4BD4AA2F78A4F3C51"
      unitRef="number">0.056</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="3"
      id="d37418911e2985-wk-Fact-7D8FFE96B1451683B03BEB34A7EE24A0"
      unitRef="number">0.056</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="FI2017Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member"
      decimals="3"
      id="d37418911e3005-wk-Fact-D3262541DE4AF086B9F7EB34A8334D28"
      unitRef="number">0</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3041-wk-Fact-373CE5A9000251F7AD5DCDAC96EFCA3F"
      unitRef="usd">400000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3045-wk-Fact-268B3111605F53F0BD06C64005EB5C53"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="D2017Q2June_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e3053-wk-Fact-8A16EB5F9CE658988840A0D26FE0A7A4"
      unitRef="usd">389000000.0</us-gaap:ProceedsFromConvertibleDebt>
    <dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount
      contextRef="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3062-wk-Fact-0B257C8F5CE05CB6BEF48F8DA0AD5F30"
      unitRef="usd">1000</dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="2"
      id="d37418911e3066-wk-Fact-3FF684AD7C3C50C2B1FA9C352032CD3D"
      unitRef="usdPerShare">99.09</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
      contextRef="FD2017Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37418911e3073-wk-Fact-5E44B0F183D955F1946EBFEDB72DB995"
      unitRef="usd">72600000</us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity>
    <dxcm:DebtInstrumentCovenantRepurchasePricePercentage
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3086-wk-Fact-E5B3CF5C758153998B2343A3536D0B5F"
      unitRef="number">1</dxcm:DebtInstrumentCovenantRepurchasePricePercentage>
    <dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount
      contextRef="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3093-wk-Fact-0B257C8F5CE05CB6BEF48F8DA0AD5F30"
      unitRef="usd">1000</dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3104-wk-Fact-5DE999F651205A61A4DE6CE09AF56FE2"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3108-wk-Fact-6074CF2EEF2F5CA9950ED5DB0250A45F"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3112-wk-Fact-C16B5C52CE4F5CBCAE218ECFA689CF4E"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3123-wk-Fact-BB53762B5ECC59AC8B4D97E2CC09481E"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3127-wk-Fact-6B531877C00656CB96B2A21E86F6111B"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount
      contextRef="FI2017Q2_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3131-wk-Fact-0B257C8F5CE05CB6BEF48F8DA0AD5F30"
      unitRef="usd">1000</dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3135-wk-Fact-6B531877C00656CB96B2A21E86F6111B"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="2"
      id="d37418911e3139-wk-Fact-9B1945FE21685CBC9AB4109104034AF5"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3182-wk-Fact-152B7B194793551A9616ED8AF0FEC4A4"
      unitRef="number">1.40</dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3186-wk-Fact-5DE999F651205A61A4DE6CE09AF56FE2"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3190-wk-Fact-6074CF2EEF2F5CA9950ED5DB0250A45F"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2022Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3194-wk-Fact-AE21501732115298A2F6105516285921"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3208-wk-Fact-D701A6342B3153C4B82407D378549D18"
      unitRef="usd">850000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3212-wk-Fact-C40FB1D95FF25501A9893BA8984A7151"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e3220-wk-Fact-B9E0DC8732A653D6BE44155CF4E7A5CF"
      unitRef="usd">836600000</us-gaap:ProceedsFromConvertibleDebt>
    <dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount
      contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3229-wk-Fact-AE1FE5E296C7581281B8E8BABE5AFAEF"
      unitRef="usd">1000</dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="2"
      id="d37418911e3233-wk-Fact-DFB62017AD0753E1BD441508B737340B"
      unitRef="usdPerShare">164.29</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
      contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d37418911e3240-wk-Fact-983D52C0DE805058BBE85F5AD93941A1"
      unitRef="usd">174400000</us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity>
    <dxcm:DebtInstrumentCovenantRepurchasePricePercentage
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3253-wk-Fact-73FFC9A551CF5DBBA20C0EA9B2B0FE10"
      unitRef="number">1</dxcm:DebtInstrumentCovenantRepurchasePricePercentage>
    <dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount
      contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3261-wk-Fact-AE1FE5E296C7581281B8E8BABE5AFAEF"
      unitRef="usd">1000</dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3272-wk-Fact-93A5A57473E65441B41D4399517E801D"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3276-wk-Fact-95FC3E5376425C0CA7BBAA378ED850F0"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3280-wk-Fact-43CDDBC383FC598EBE9D46EF0D9C8DC5"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3291-wk-Fact-47BE00B5BAB3523CB5625C5A77C7905E"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3295-wk-Fact-55D14B9E9686515DA696E4066ED0C7B3"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount
      contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3299-wk-Fact-AE1FE5E296C7581281B8E8BABE5AFAEF"
      unitRef="usd">1000</dxcm:DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3303-wk-Fact-55D14B9E9686515DA696E4066ED0C7B3"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermTwoMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3307-wk-Fact-A3F0CA7FD8145DB3B3D26DC498BFB7FD"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3346-wk-Fact-87FB52FEE91D51E2B7716F0D1B67BB58"
      unitRef="number">1.30</dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3350-wk-Fact-93A5A57473E65441B41D4399517E801D"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="FD2019Q4YTD_dxcm_DebtInstrumentConversionTermAxis_dxcm_DebtInstrumentConversionTermOneMember_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3354-wk-Fact-95FC3E5376425C0CA7BBAA378ED850F0"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3358-wk-Fact-57E4E01AAADC5CDCA4E64C2509823D0F"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <dxcm:DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares
      contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3368-wk-Fact-F35B68F9953E54D4B89C380A5CECF49F"
      unitRef="shares">5200000</dxcm:DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="2"
      id="d37418911e3372-wk-Fact-DFB62017AD0753E1BD441508B737340B"
      unitRef="usdPerShare">164.29</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e3376-wk-Fact-EFFBE3DF86205D0994591714C94CAA32"
      unitRef="usd">218900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e3380-wk-Fact-EFFBE3DF86205D0994591714C94CAA32"
      unitRef="usd">218900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e3395-wk-Fact-1F641C533FC055CB95291771B6430C8E"
      unitRef="shares">5200000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="INF"
      id="d37418911e3399-wk-Fact-81A14A69838C53AF8D359B192D274B4C"
      unitRef="d">60</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="-5"
      id="d37418911e3407-wk-Fact-52F54C5F18BD5C5882758606AFE627D3"
      unitRef="usd">183800000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="I2018Q4November30_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember"
      decimals="2"
      id="d37418911e3411-wk-Fact-323CA320E99E5E6698E21673435DD645"
      unitRef="usdPerShare">198.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="I2018Q4December19_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember"
      decimals="INF"
      id="d37418911e3459-wk-Fact-5E1CF49A3EAEBAD12E721C89DCD08E29"
      unitRef="usd">200000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <dxcm:LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount
      contextRef="I2018Q4December19_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember"
      decimals="INF"
      id="d37418911e3463-wk-Fact-541E74093896554591848B518554901C"
      unitRef="usd">500000000.0</dxcm:LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-22006D56DC45F12BC4F9CA0DCE6986FF-0-wk-Fact-3A3E05CCDE16E3275BC8CA0E6279CE47">&lt;span style="font-family:inherit;font-size:10pt;"&gt;Information related to availability and outstanding borrowings on our Credit Agreement is as follows: &lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:86%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Available principal amount &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;200.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Letters of credit sub-facility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Outstanding borrowings &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Outstanding letters of credit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total available balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;195.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="FI2019Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember"
      decimals="-5"
      id="d37418911e3537-wk-Fact-B3FE68D01254523F909C7B48BD69E37C"
      unitRef="usd">200000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember"
      decimals="-5"
      id="d37418911e3552-wk-Fact-EC01642A36295B9397C7A10A1CD62C72"
      unitRef="usd">10000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="FI2019Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember"
      decimals="-5"
      id="d37418911e3572-wk-Fact-19B2F94E77727E30037DCA1221CECD6A"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember"
      decimals="-5"
      id="d37418911e3592-wk-Fact-3C3B9C2DCCD351FF810E1585D664AAED"
      unitRef="usd">4400000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37418911e3612-wk-Fact-8123CF33D78F552FAB9D898BC27F9F9E"
      unitRef="usd">195600000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="FI2018Q4_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember"
      decimals="INF"
      id="d37418911e3629-wk-Fact-58038F72A0035D3EB14F8C5D45C52DCC"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="FI2018Q4_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember"
      decimals="INF"
      id="d37418911e3633-wk-Fact-049F9D5603495955BC838857EE1AF434"
      unitRef="number">0.01000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="D2018Q4December_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember"
      decimals="INF"
      id="d37418911e3637-wk-Fact-E7649191160F53E79E2B8F06235F50BB"
      unitRef="number">0.01375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="D2018Q4December_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember"
      decimals="INF"
      id="d37418911e3641-wk-Fact-C1ECB4852A1A56A9B088AB48C3ACAB12"
      unitRef="number">0.02000</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="D2018Q4December_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember"
      decimals="INF"
      id="d37418911e3645-wk-Fact-C9DB2EB1BF3A5496B4395E2CFE7DE7E7"
      unitRef="number">0.002</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="D2018Q4December_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember"
      decimals="INF"
      id="d37418911e3650-wk-Fact-2C4392F151145405818F8E90078C47F4"
      unitRef="number">0.003</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <dxcm:LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold
      contextRef="FD2019Q4YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember"
      decimals="-5"
      id="d37418911e3657-wk-Fact-26615DCAA0529CBB6B021BE7E98D1F65"
      unitRef="usd">100000000.0</dxcm:LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-EB4D6AA82D8D0FD7FCF5AB6380D57771-0-wk-Fact-6F33C7E6D296EB8CC123AB63D9FD234F">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;"&gt;6. Leases And Other Commitments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We lease office, manufacturing and warehouse space facilities under various domestic and international operating leases that expire at various times through August 2026. Certain of our leases have renewal options which allow us to extend the lease term typically between &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;three&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; per option and some of our leases have multiple options to extend. We have &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;one&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; finance lease for our manufacturing facility in Mesa, Arizona under a lease that expires in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;March 2028&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; with options to renew this lease for &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;four&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; additional &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;five&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;-year terms. Our facility leases generally provide for periodic rent increases and many contain escalation clauses. Certain leases also require us to pay taxes, insurance, and maintenance. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; The remaining lease terms of our leases range from less than &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;one year&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; to approximately &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;thirteen years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;; and represent the non-cancellable periods of the leases, including extension options that we determined are reasonably certain to be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;We adopted ASC 842 utilizing the modified retrospective transition method through a &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;span&gt;$2.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt; cumulative-effect adjustment to accumulated deficit at the beginning of the first quarter of 2019. We will continue to report financial information for fiscal years prior to 2019 under the previous lease accounting standards and as such prior comparative periods have not been recast. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We elected the package of practical expedients permitted under the transition guidance in the new standard, which allowed us to carry forward the historical classification of leases that were in place as of January 1, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Under the previous lease accounting standards we were deemed the owner of our Mesa, Arizona building during the construction period. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell and the related lease liability as of December 31, 2018 and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In addition, as a result of our adoption of ASC 842 we recorded operating lease right-of-use assets of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$26.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, finance lease right-of-use assets of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$15.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, operating lease liabilities of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$40.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and finance lease liabilities of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$15.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; in our consolidated balance sheets at the beginning of the first quarter of 2019, with no material impact to our consolidated statement of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating lease right-of-use assets and liabilities are presented separately in our consolidated balance sheets. Finance lease right-of-use assets are included in property and equipment and finance lease liabilities are included in accounts payable and accrued liabilities and in other long-term liabilities in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;As of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;, the maturities of our operating and finance lease liabilities were as shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:76%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;12.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;23.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;13.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total future lease cost &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;20.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less: Amount representing interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(14.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(5.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Present value of future payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;85.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less: Short-term leases not recorded as a liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Revised present value of future lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;86.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less: Current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(13.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Long-term portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;72.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1) &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;Total future lease cost excludes &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;span&gt;$5.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt; of legally binding minimum lease payments for leases signed but not yet &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;commenced&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The components of lease expense for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; were as follows:&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:89%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Finance lease cost:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;12.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Short-term lease cost &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Variable lease cost &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;21.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Short-term lease cost is primarily related to temporary office space associated with the transition of certain operations to the Philippines. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:4px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Variable lease costs are primarily related to common area maintenance charges and property taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Prior to January 1, 2019, we recorded operating lease rent expense under ASC 840 on a straight-line basis over the non-cancellable lease term. Rent expense for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; was &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$12.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$11.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt; &lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:88%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(Dollars in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Right-of-use assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;80.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Weighted average remaining lease term in years:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;6.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;13.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Amortization of operating lease right-of-use asset included in cash flows from operating activities in the Consolidated Statements of Cash Flows was &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;span&gt;$9.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Purchase Commitments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We are party to various purchase arrangements related to our manufacturing and research and development activities. As of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, we had approximately &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$165.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of open purchase orders and contractual obligations in the ordinary course of business, most of which are due within &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-751364B3BD301C2F7DD7EB34A878319B-0-wk-Fact-85937774F9440D8523C2EB34A843C676">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;"&gt;6. Leases And Other Commitments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We lease office, manufacturing and warehouse space facilities under various domestic and international operating leases that expire at various times through August 2026. Certain of our leases have renewal options which allow us to extend the lease term typically between &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;three&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; per option and some of our leases have multiple options to extend. We have &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;one&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; finance lease for our manufacturing facility in Mesa, Arizona under a lease that expires in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;March 2028&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; with options to renew this lease for &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;four&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; additional &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;five&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;-year terms. Our facility leases generally provide for periodic rent increases and many contain escalation clauses. Certain leases also require us to pay taxes, insurance, and maintenance. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; The remaining lease terms of our leases range from less than &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;one year&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; to approximately &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;thirteen years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;; and represent the non-cancellable periods of the leases, including extension options that we determined are reasonably certain to be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;We adopted ASC 842 utilizing the modified retrospective transition method through a &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;span&gt;$2.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt; cumulative-effect adjustment to accumulated deficit at the beginning of the first quarter of 2019. We will continue to report financial information for fiscal years prior to 2019 under the previous lease accounting standards and as such prior comparative periods have not been recast. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We elected the package of practical expedients permitted under the transition guidance in the new standard, which allowed us to carry forward the historical classification of leases that were in place as of January 1, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Under the previous lease accounting standards we were deemed the owner of our Mesa, Arizona building during the construction period. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell and the related lease liability as of December 31, 2018 and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In addition, as a result of our adoption of ASC 842 we recorded operating lease right-of-use assets of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$26.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, finance lease right-of-use assets of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$15.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, operating lease liabilities of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$40.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and finance lease liabilities of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$15.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; in our consolidated balance sheets at the beginning of the first quarter of 2019, with no material impact to our consolidated statement of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating lease right-of-use assets and liabilities are presented separately in our consolidated balance sheets. Finance lease right-of-use assets are included in property and equipment and finance lease liabilities are included in accounts payable and accrued liabilities and in other long-term liabilities in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;As of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;, the maturities of our operating and finance lease liabilities were as shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:76%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;12.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;23.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;13.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total future lease cost &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;20.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less: Amount representing interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(14.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(5.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Present value of future payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;85.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less: Short-term leases not recorded as a liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Revised present value of future lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;86.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less: Current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(13.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Long-term portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;72.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1) &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;Total future lease cost excludes &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;span&gt;$5.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt; of legally binding minimum lease payments for leases signed but not yet &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;commenced&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The components of lease expense for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; were as follows:&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:89%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Finance lease cost:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;12.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Short-term lease cost &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Variable lease cost &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;21.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Short-term lease cost is primarily related to temporary office space associated with the transition of certain operations to the Philippines. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:4px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Variable lease costs are primarily related to common area maintenance charges and property taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Prior to January 1, 2019, we recorded operating lease rent expense under ASC 840 on a straight-line basis over the non-cancellable lease term. Rent expense for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; was &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$12.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$11.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt; &lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:88%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(Dollars in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Right-of-use assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;80.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Weighted average remaining lease term in years:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;6.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;13.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Amortization of operating lease right-of-use asset included in cash flows from operating activities in the Consolidated Statements of Cash Flows was &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;span&gt;$9.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Purchase Commitments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We are party to various purchase arrangements related to our manufacturing and research and development activities. As of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, we had approximately &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$165.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of open purchase orders and contractual obligations in the ordinary course of business, most of which are due within &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="FI2019Q4_srt_RangeAxis_srt_MaximumMember"
      id="d37415613e621-wk-Fact-2D5B0C5F4F487493088ED48D77EA2118">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <dxcm:NumberofFinancingLeases
      contextRef="FD2019Q4YTD_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member"
      decimals="INF"
      id="d37415613e625-wk-Fact-4D9FE6A5D56071417EB8D361CD1E4AA9"
      unitRef="finance_lease">1</dxcm:NumberofFinancingLeases>
    <dxcm:LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms
      contextRef="FD2019Q4YTD_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member"
      decimals="INF"
      id="d37415613e633-wk-Fact-6FA44FDBC41057F3AE3BABCF4A0A75DA"
      unitRef="renewal_term">4</dxcm:LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms>
    <dxcm:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember"
      id="d37415613e649-wk-Fact-E08695E2632B1ECBA8A8D48C23E6EE17">P13Y</dxcm:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="I2019Q1January1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d37415613e656-wk-Fact-AFE2A4AD74985E3D8544B7642CEDF40C"
      unitRef="usd">-2100000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="I2019Q1January1"
      decimals="-5"
      id="d37415613e668-wk-Fact-7E3ABC8C7E6759458495F85575592523"
      unitRef="usd">26700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="I2019Q1January1"
      decimals="-5"
      id="d37415613e672-wk-Fact-54903A63B8B05C5EB600E8476D20113E"
      unitRef="usd">15300000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="I2019Q1January1"
      decimals="-5"
      id="d37415613e676-wk-Fact-04193007C52B5B24AF865074DA0E8ABF"
      unitRef="usd">40400000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="I2019Q1January1"
      decimals="-5"
      id="d37415613e680-wk-Fact-27E36E89B5FE54B6A0C8E1BDA8E3C068"
      unitRef="usd">15900000</us-gaap:FinanceLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-ED73E4EBE90DE73213E1D369951593A8-0-wk-Fact-C3B29077E68E132331E0D36A24DAA4E9">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;As of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;, the maturities of our operating and finance lease liabilities were as shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:76%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;12.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;23.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;13.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total future lease cost &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;20.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less: Amount representing interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(14.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(5.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Present value of future payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;85.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less: Short-term leases not recorded as a liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Revised present value of future lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;86.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less: Current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(13.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Long-term portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;72.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1) &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;Total future lease cost excludes &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;span&gt;$5.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt; of legally binding minimum lease payments for leases signed but not yet &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;commenced&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-7810342F9A1401F9D15BD36917914D16-0-wk-Fact-796B531A1708D3D0BD20D36989EEAD1B">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;As of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;, the maturities of our operating and finance lease liabilities were as shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:76%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;12.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;23.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;13.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total future lease cost &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;20.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less: Amount representing interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(14.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(5.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Present value of future payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;85.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less: Short-term leases not recorded as a liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Revised present value of future lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;86.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Less: Current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(13.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Long-term portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;72.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1) &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;Total future lease cost excludes &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;span&gt;$5.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt; of legally binding minimum lease payments for leases signed but not yet &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;commenced&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e766-wk-Fact-D1CBD600EAD25A1F811F83F9F8B674E4"
      unitRef="usd">17400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e785-wk-Fact-B506B6EC611559A09EB00DC716853A74"
      unitRef="usd">1300000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e800-wk-Fact-44BA886224B75D8EB3C24A054625E5F4"
      unitRef="usd">17400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e819-wk-Fact-778FFD0FBA2D569BBFFDAD898415217C"
      unitRef="usd">1300000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e839-wk-Fact-D0793AF57A2D55B4A5E661F3B58F1F45"
      unitRef="usd">14600000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e858-wk-Fact-E7609422E3315B5C867D4C76FB917F2E"
      unitRef="usd">1400000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e878-wk-Fact-3989434671AF5CCFA86926B60EF6605A"
      unitRef="usd">14300000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e897-wk-Fact-910F7469426050A4AA200E951E38A975"
      unitRef="usd">1400000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e917-wk-Fact-7190C391E0545D4D855EC81FA18ED8C8"
      unitRef="usd">12500000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e936-wk-Fact-08D0D099DC6D5A28927BBD7D015930DB"
      unitRef="usd">1500000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e956-wk-Fact-7ED43925C4415F50A5FD3577BB186AE4"
      unitRef="usd">23900000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e975-wk-Fact-D486F5A7EAF6533D88CE2E6440C30CA4"
      unitRef="usd">13900000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e997-wk-Fact-D9867D9FAC776AED6F27D36E2C389A94"
      unitRef="usd">100100000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e1016-wk-Fact-25F7C5BBBE1F4FBB2701D36E7C24730C"
      unitRef="usd">20800000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e1036-wk-Fact-525D5E0195B75B2A9B4F090C474AF01A"
      unitRef="usd">14300000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e1056-wk-Fact-68FA736B0171527A8A332EA2EFF3CDE6"
      unitRef="usd">5800000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <dxcm:OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e1077-wk-Fact-6382385673D6CF36C944D36E3E929B6C"
      unitRef="usd">85800000</dxcm:OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability>
    <dxcm:FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e1096-wk-Fact-FA7112C29733E4C313F8D36E8AA7B838"
      unitRef="usd">15000000.0</dxcm:FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability>
    <dxcm:LesseeOperatingLeasesShortTermLeasePaymentsDue
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e1116-wk-Fact-91288A0DE3975019A5A20D70FD086E30"
      unitRef="usd">200000</dxcm:LesseeOperatingLeasesShortTermLeasePaymentsDue>
    <dxcm:FinanceLeaseShortTermLeasesPaymentsDue
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e1135-wk-Fact-BD1195672862550EA52D66C3290B4E62"
      unitRef="usd">0</dxcm:FinanceLeaseShortTermLeasesPaymentsDue>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e1156-wk-Fact-01190B6667E34829682ED36E5507B0FF"
      unitRef="usd">86000000.0</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e1175-wk-Fact-BDB784EF4E3E0319451FD36E9B016A1B"
      unitRef="usd">15000000.0</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e1195-wk-Fact-0372FC04FE7667FD19B61747DFBEB68B"
      unitRef="usd">13600000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e1215-wk-Fact-48A39F24D8A45D338C94587F1934924E"
      unitRef="usd">600000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e1241-wk-Fact-B5DC66DA1FAA547BB8A5BB1A758CB367"
      unitRef="usd">72400000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37415613e1260-wk-Fact-DF79FE62C9BE08201DBCD36EAAE31D06"
      unitRef="usd">14400000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <dxcm:LesseeFutureLeaseCostLeaseNotyetCommenced
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415613e1271-wk-Fact-05B315D1F0BD45669354B5D1FB1ACDB1"
      unitRef="usd">5500000</dxcm:LesseeFutureLeaseCostLeaseNotyetCommenced>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-AAC27830F1F57D38ADBDB5C58B744BD3-0-wk-Fact-2810E8F4902F01B05A59B5C5CB21BDB3">&lt;div style="line-height:120%;padding-top:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The components of lease expense for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; were as follows:&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:89%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Finance lease cost:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;12.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Short-term lease cost &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Variable lease cost &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;21.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Short-term lease cost is primarily related to temporary office space associated with the transition of certain operations to the Philippines. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:4px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Variable lease costs are primarily related to common area maintenance charges and property taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#252525;"&gt; &lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:88%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(Dollars in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Right-of-use assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;80.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;15.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Weighted average remaining lease term in years:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;6.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;13.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415613e1381-wk-Fact-6FFE0A070B0B5C0BA64354961469F2F8"
      unitRef="usd">1100000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415613e1396-wk-Fact-6153E5FCA8365B5A90AC72230D78E5BD"
      unitRef="usd">800000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:OperatingLeaseCost
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415613e1416-wk-Fact-1137E991345A54D5A047856F77CDE3CD"
      unitRef="usd">12200000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415613e1438-wk-Fact-A504E76BBAE25F49AD98AFF54305E6AD"
      unitRef="usd">3500000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415613e1460-wk-Fact-F9233A6A31835AB5B43A499D7AA3CE4C"
      unitRef="usd">3900000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415613e1485-wk-Fact-83353F5DCCBEB263D5FBB5C49EA2E645"
      unitRef="usd">21500000</us-gaap:LeaseCost>
    <us-gaap:LeaseAndRentalExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37415613e1521-wk-Fact-21620EB4E349FCB44086C9DCC2AACC32"
      unitRef="usd">12500000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37415613e1525-wk-Fact-B4E4A24F4C05A8D473F1C9DCC14AA619"
      unitRef="usd">11100000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:OperatingLeasePayments
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415613e1622-wk-Fact-B99EABDDAB0A5CC1A7473CAADBE39B4F"
      unitRef="usd">14300000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415613e1642-wk-Fact-DA46DEEA2732539597C21079A5C9E21B"
      unitRef="usd">800000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415613e1662-wk-Fact-AE232EC0B9855277B46E3A78B3B060B1"
      unitRef="usd">500000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415613e1703-wk-Fact-B4AD167589CD56EC8F57FD629208F881"
      unitRef="usd">80600000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415613e1723-wk-Fact-E24EFC40C20258EDAF21EE913A179B7F"
      unitRef="usd">15500000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="FI2019Q4"
      id="d37415613e1759-wk-Fact-86611F4293BE5A669569C5C611662964">P6Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="FI2019Q4"
      id="d37415613e1780-wk-Fact-253219C788625B859F9526BF1AF69773">P13Y3M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="FI2019Q4"
      decimals="3"
      id="d37415613e1821-wk-Fact-5792E30EAF6E51C6B44FC5E474342C1F"
      unitRef="number">0.050</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="FI2019Q4"
      decimals="3"
      id="d37415613e1842-wk-Fact-F4445B1ABAFD5F8E83E4A50E5AEE02A8"
      unitRef="number">0.050</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <dxcm:LesseeOperatingLeasesLeaseCostAmortization
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37415613e1859-wk-Fact-E8391079BE6B5DD3AC0617249118990C"
      unitRef="usd">9100000</dxcm:LesseeOperatingLeasesLeaseCostAmortization>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37409474e568-wk-Fact-EAC0738B2C9FD7A0A779EB34A83332CF"
      unitRef="usd">165800000</us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear>
    <dxcm:RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm
      contextRef="FD2019Q4YTD"
      id="d37409474e572-wk-Fact-000AE188B2D759862A31EB34A7FE930D">P1Y</dxcm:RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm>
    <us-gaap:LegalMattersAndContingenciesTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-262281F093802552ABF0EB34A8783C4B-0-wk-Fact-41D95BBCDBE3C9A00F31EB34A7FEDF94">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;"&gt;7. Contingencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span&gt;On March 28, 2016, AgaMatrix, Inc., or AgaMatrix, filed a patent infringement lawsuit against us in the U.S. District Court for the District of Oregon, asserting that certain of our products infringe three patents held by AgaMatrix. (After filing suit, AgaMatrix reorganized its business and the Court granted AgaMatrix&#x2019;s motion to substitute the newly created entity WaveForm Technologies, Inc., as the plaintiff following AgaMatrix&#x2019;s transfer of the three asserted patents to WaveForm.) DexCom filed petitions for &lt;/span&gt;&lt;span style="font-style:italic;"&gt;inter partes&lt;/span&gt;&lt;span&gt; review with the Patent Trial and Appeal Board, or PTAB, of the U.S. Patent and Trademark Office, challenging each of the three asserted patents as being unpatentable in view of prior art. The PTAB issued a Final Written Decision for each of the first two patents on February 28, 2018, where the PTAB found the majority of asserted claims from the first patent unpatentable and the remaining claims under review not unpatentable. The PTAB found all claims under review from the second patent not unpatentable. On September 12, 2018, the PTAB found all of the asserted claims in the third patent unpatentable. In October 2018, we filed in the District Court a motion for summary judgment that all remaining asserted claims are invalid. The District Court granted that motion and, on August 23, 2019, entered judgment in our favor. On September 6, 2019, WaveForm appealed the judgment. The appeal is pending and no hearing date has been set.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We have also filed several lawsuits against AgaMatrix. We filed a patent infringement lawsuit against AgaMatrix in the United States District Court for the Central District of California, or C.D. Cal., in which a Final Judgment of non-infringement was entered by the C.D. Cal judge on February 23, 2018 and affirmed on appeal by the Federal Circuit on March 7, 2019. AgaMatrix was awarded attorneys&#x2019; fees for this lawsuit.&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; As of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, we have accrued an immaterial amount for those fees. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The fee decision is currently on appeal to the Federal Circuit. On September 15, 2017, we filed a patent infringement lawsuit against AgaMatrix in the United States District Court for the District of Delaware, asserting certain single-point blood glucose monitoring products of AgaMatrix infringe two patents held by us. In addition, on September 18, 2017, we filed a Complaint against AgaMatrix in the International Trade Commission, referred to as the ITC, requesting that the ITC institute an investigation and issue an order excluding certain products of AgaMatrix from importation into or sale in the United States based on AgaMatrix&#x2019;s infringement of the same two patents asserted in the Delaware litigation. The investigation was terminated by the ITC on April 4, 2019 with a finding of non-infringement. The decision is currently on appeal.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:29px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Neither&#160;the outcome of these lawsuits nor the amount and range of potential loss associated with the lawsuits can be assessed at this time. Other than the attorneys&#x2019; fees described above, as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; we have accrued &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; amounts for contingent losses associated with these suits.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We do not expect that the resolution of these matters would, or will, have a material adverse effect or material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <us-gaap:LitigationReserve
      contextRef="FI2019Q4"
      decimals="INF"
      id="d37414448e628-wk-Fact-47B130CFBC0321BAFC2EB06A7985A1EC"
      unitRef="usd">0</us-gaap:LitigationReserve>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-4907895FB7D4FFC36179EB34A8787544-0-wk-Fact-F10CE8521EE1DD9018D2EB34A8297CE6">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;"&gt;8. Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Income (loss) before income taxes subject to taxes in the following jurisdictions is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;119.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(28.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;12.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Outside of the United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(14.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(98.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(61.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;104.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(126.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(48.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Significant components of the provision for income taxes are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Current:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Federal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;State&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Foreign&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total current income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Deferred:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Federal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;State&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Foreign&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;At &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, we had federal, state and foreign tax net operating loss carryforwards of approximately &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$438.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$324.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$124.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, respectively. The federal and state tax loss carryforwards will begin to expire in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2027&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, respectively, unless previously utilized. The foreign net operating losses carry forward indefinitely. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;At &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, we also had federal and state research and development tax credit carryforwards of approximately &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$54.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$52.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, respectively. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$0.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of the federal research and development tax credit will begin to expire in &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, unless previously utilized. The state research and development tax credit will carryforward indefinitely until utilized.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Utilization of net operating losses and credit carryforwards is subject to an annual limitation due to ownership change limitations provided by Section&#160;382 and 383 of the Internal Revenue Code of 1986, as amended, and similar state provisions. An ownership change limitation occurred as a result of the stock offering completed in February 2009. The limitation will likely result in approximately &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$2.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of U.S. income tax credits that will expire unused. The related deferred tax assets have been removed from the components of our deferred tax assets as summarized in the table below. We performed a Section 382 study on the remaining federal and state net operating losses and tax credit carryforwards and have determined that there is no annual limitation on them as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Significant components of our deferred tax assets as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December 31,&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; are shown below. A valuation allowance of approximately &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$332.2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; has been established as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; to offset the deferred tax assets, as realization of such assets is uncertain. We maintain a deferred tax liability related to indefinite-lived intangible assets that is not netted against the deferred tax assets. Reversal of the taxable temporary difference for these intangible assets cannot serve as a source of income for realization of the deferred tax assets because the deferred tax liability will not reverse until the intangible assets are sold or written down due to impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Deferred tax assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Net operating loss carryforwards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;127.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;162.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Capitalized research and development expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;57.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;62.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Tax credits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;78.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;59.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;10.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;12.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Fixed and intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;16.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Accrued liabilities and reserves&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;62.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;22.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Convertible Debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total gross deferred tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;351.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;334.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: valuation allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(332.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(330.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net deferred tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;19.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Fixed assets and acquired intangibles assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(19.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(3.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Convertible debt discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total deferred tax liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(19.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(3.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Net deferred tax assets (liabilities)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, and reliability of forecasting. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. As of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, we have maintained a full valuation allowance on our deferred tax assets since inception based on our historical losses and the uncertainty of generating future taxable income to utilize our loss and credit carryforwards. A future release of our valuation allowance will result in a material tax benefit recognized in the quarter of the release.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, deferred tax assets for which any subsequently recognized tax benefits will be credited to additional paid-in capital rather than to income tax benefit totaled &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$55.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The reconciliation between our effective tax rate on income (loss) from continuing operations and the statutory rate is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Income taxes at statutory rates&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;21.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(26.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(17.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;State income tax, net of federal benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(2.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(5.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Permanent items&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Research and development credits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(10.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(11.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(13.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Foreign rate differential&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Stock and officers compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(14.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(5.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(10.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Rate change&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Unrecognized tax benefits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(15.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Impact of adoption of ASU 2016-16&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(13.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Impact of Tax Cuts and Jobs Act of 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;105.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;56.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(51.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Income taxes at effective rates&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:36px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes the activity related to our gross unrecognized tax benefits:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:88%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Balance at January&#160;1, 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;39.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Decreases related to prior year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(14.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Decrease related to Tax Cuts and Jobs Act of 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(5.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;22.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Decreases related to prior year tax positions &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;25.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Decreases related to prior year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;29.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Due to the valuation allowance recorded against our deferred tax assets, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;none&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of the total unrecognized tax benefits as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; would reduce our annual effective tax rate if recognized. Interest and penalties are classified as a component of income tax expense and were not material for any period presented. Due to net operating losses incurred, tax years from 1999 and forward for federal and state purposes and from 2016 and forward for foreign jurisdictions remain open to examination by the major taxing jurisdictions to which we are subject. The IRS commenced an audit of our 2015 and 2016 federal income tax returns in February 2018. The audit closed in June 2019 with no significant changes to our unrecognized tax benefits. &lt;/span&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We operate under a tax holiday in the Philippines, which is effective through December 31, 2023, and may be extended for another &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;three years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; if certain additional requirements are satisfied. The tax holiday is conditional upon remaining in good standing, committing no violation of PEZA Rules and Regulations, pertinent circulars and directives. The impact of this tax holiday decreased foreign taxes by &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$0.2 million&lt;/span&gt;&lt;/span&gt; in 2019.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-52FFA7061656CF61ABA1EB34A8782DB8-0-wk-Fact-2C119FEE62178ECAF00AEB34A7FE9E58">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Income (loss) before income taxes subject to taxes in the following jurisdictions is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;119.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(28.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;12.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Outside of the United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(14.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(98.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(61.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;104.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(126.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(48.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e737-wk-Fact-248DF7C1BDDCD472ECEBEB34A810A3B1"
      unitRef="usd">119100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e756-wk-Fact-7EF334640DB694BF702FEB34A82670A2"
      unitRef="usd">-28300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e776-wk-Fact-D860E1B974B34AE9C449EB34A7FE8459"
      unitRef="usd">12400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e792-wk-Fact-FD154313436347CB9B37EB34A7FE3625"
      unitRef="usd">-14900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e812-wk-Fact-142F6CACDD275A17A158EB34A81C32F3"
      unitRef="usd">-98200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e832-wk-Fact-7CB9A7B1AC794488EA60EB34A7FE0D39"
      unitRef="usd">-61000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e859-wk-Fact-13FDF4DE7E1C0C745710EB34A7FE0302"
      unitRef="usd">104200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e878-wk-Fact-E80D20BB487E0632B25EEB34A7EE6A42"
      unitRef="usd">-126500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e898-wk-Fact-4EB598277566A39717FEEB34A8338E60"
      unitRef="usd">-48600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-3DDCB0F236DE73930173EB34A879CFB6-0-wk-Fact-3E305A7E63CC6C2A3645EB34A833083C">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Significant components of the provision for income taxes are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Current:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Federal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;State&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Foreign&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total current income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Deferred:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Federal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;State&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Foreign&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e1147-wk-Fact-47607B0A79B342C0A64CEB34A82F4E51"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e1166-wk-Fact-148D01E91C3FA175C69EEB34A7FE9722"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e1185-wk-Fact-4FA96EB9C1A35700DCF9EB34A7FEFCE1"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e1201-wk-Fact-66CDB8D4E0525C038A3BEB34A7FE1905"
      unitRef="usd">1000000.0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e1220-wk-Fact-F049C838F63B9F2A0B89EB34A7FE0490"
      unitRef="usd">2700000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e1239-wk-Fact-771D328AB93394423008EB34A7FE9972"
      unitRef="usd">100000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e1260-wk-Fact-0ECF7B624355D53AC61FEB34A81195B0"
      unitRef="usd">1900000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e1279-wk-Fact-B1009629F70A6BB8EF33EB34A7FE41F6"
      unitRef="usd">100000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e1298-wk-Fact-0BE5D1647C071B85ED71EB34A80E9129"
      unitRef="usd">1500000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e1319-wk-Fact-D20591E992159DC7972FEB34A7FE97C3"
      unitRef="usd">2900000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e1338-wk-Fact-B71524CE2B9CF0E5B8BAEB34A7FEF613"
      unitRef="usd">2800000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e1357-wk-Fact-AD8C2DC3D6366DCF2265EB34A7FE5E13"
      unitRef="usd">1600000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e1440-wk-Fact-3E255DFB68B8D2ED9EFFEB34A7FECAB2"
      unitRef="usd">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e1459-wk-Fact-66E321AA9FC314F9ACDFEB34A7FE1DCA"
      unitRef="usd">-1700000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e1479-wk-Fact-45D23415F6769287C73FEB34A7FEE664"
      unitRef="usd">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e1500-wk-Fact-98DEF4CA2839C695354FEB34A7FEFE86"
      unitRef="usd">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e1519-wk-Fact-1FB55DFDF6A8788EF9B3EB34A80E7AAC"
      unitRef="usd">-500000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e1539-wk-Fact-A2C1B2F5B744A4C5BA16EB34A7FEA24E"
      unitRef="usd">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e1560-wk-Fact-04F064A76BB1DD26D5D7EB34A7FED444"
      unitRef="usd">200000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e1579-wk-Fact-8934F1BA0A0CA7F010A1EB34A811CB29"
      unitRef="usd">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e1598-wk-Fact-643F6E0E9A4483D88A4BEB34A7FE59DA"
      unitRef="usd">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e1620-wk-Fact-BDC28B83799FF7637FF5EB34A80ECFEE"
      unitRef="usd">200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e1639-wk-Fact-CAB6ABA37BBB9C8B1F05EB34A7FED423"
      unitRef="usd">-2200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e1659-wk-Fact-171439A46462979BE638EB34A8334A5E"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e1685-wk-Fact-5382C869DEC35C369C5FBDE1CE4B43A0"
      unitRef="usd">3100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e1704-wk-Fact-0D594FC0637D063FE795174A94692792"
      unitRef="usd">600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e1723-wk-Fact-DCF36026B268B00536B7EB34A8622EE0"
      unitRef="usd">1600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OperatingLossCarryforwards
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember"
      decimals="-5"
      id="d37423883e1744-wk-Fact-7B052AB1B7FADC920795EB34A7FEFAAB"
      unitRef="usd">438800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-5"
      id="d37423883e1748-wk-Fact-C5EC85A3E17C0CB26256EB34A81A45AB"
      unitRef="usd">324100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember"
      decimals="-5"
      id="d37423883e1752-wk-Fact-6377128FE1BBF3B9C4D3EB34A82082F2"
      unitRef="usd">124100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember"
      decimals="-5"
      id="d37423883e1772-wk-Fact-BAA466D8AB3DD64F40B0EB34A7FE683A"
      unitRef="usd">54400000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-5"
      id="d37423883e1776-wk-Fact-D1393E67327408FE8FC7EB34A8237F27"
      unitRef="usd">52700000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <dxcm:TaxCreditCarryforwardsResearchSubjecttoExpiration
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember"
      decimals="-5"
      id="d37423883e1780-wk-Fact-A25B83CDC2F94C7704B6EB34A7FEE4BA"
      unitRef="usd">100000</dxcm:TaxCreditCarryforwardsResearchSubjecttoExpiration>
    <dxcm:UnusedExpiredFederalIncomeTaxCredits
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e1791-wk-Fact-449E3FFF95E0F6F30A4FEB34A8214C21"
      unitRef="usd">2100000</dxcm:UnusedExpiredFederalIncomeTaxCredits>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-41FA9CC6D51E01BCD5C5EB34A878F6AD-0-wk-Fact-73C2AEADE6545433334CEB34A82D787B">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Significant components of our deferred tax assets as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December 31,&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; are shown below. A valuation allowance of approximately &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$332.2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; has been established as of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; to offset the deferred tax assets, as realization of such assets is uncertain. We maintain a deferred tax liability related to indefinite-lived intangible assets that is not netted against the deferred tax assets. Reversal of the taxable temporary difference for these intangible assets cannot serve as a source of income for realization of the deferred tax assets because the deferred tax liability will not reverse until the intangible assets are sold or written down due to impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Deferred tax assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Net operating loss carryforwards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;127.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;162.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Capitalized research and development expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;57.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;62.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Tax credits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;78.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;59.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;10.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;12.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Fixed and intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;14.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;16.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Accrued liabilities and reserves&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;62.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;22.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Convertible Debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total gross deferred tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;351.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;334.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: valuation allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(332.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(330.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net deferred tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;19.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Fixed assets and acquired intangibles assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(19.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(3.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;Convertible debt discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total deferred tax liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(19.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(3.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Net deferred tax assets (liabilities)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37423883e1815-wk-Fact-A79879BA313D7FFE5AB8EB34A7FE98F7"
      unitRef="usd">332200000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37423883e1980-wk-Fact-89FDA9917C6600A699CCB0496D882EBA"
      unitRef="usd">127400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37423883e1999-wk-Fact-80A9375F0E499B2E0543B0496DA22B1C"
      unitRef="usd">162000000.0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37423883e2014-wk-Fact-715DF909E87697E7537CB049816B1693"
      unitRef="usd">57100000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37423883e2033-wk-Fact-C293B896117C40EEA705B049816F9820"
      unitRef="usd">62100000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37423883e2053-wk-Fact-93D234F26651A86DC8CCB0499C19B8F6"
      unitRef="usd">78600000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37423883e2072-wk-Fact-F1A5C23AD4C6ECD9E855B0499C2C824E"
      unitRef="usd">59000000.0</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37423883e2092-wk-Fact-4918EC27FDBC5BF3D17DB049ACA8D2AA"
      unitRef="usd">10900000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37423883e2111-wk-Fact-1543075964BFE59C2CEEB049ACBB9046"
      unitRef="usd">12500000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37423883e2131-wk-Fact-310985A3B22E77EDA6E0B049BA3BB111"
      unitRef="usd">14000000.0</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37423883e2150-wk-Fact-81934F29F34BEB30B6CDB049BA3FE824"
      unitRef="usd">16000000.0</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37423883e2170-wk-Fact-254E7BE5C558D159407AB049C828AE86"
      unitRef="usd">62000000.0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37423883e2189-wk-Fact-2F2D1427E28385415301B049C824CFBC"
      unitRef="usd">22500000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <dxcm:DeferredTaxAssetsConvertibleDebt
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37423883e2209-wk-Fact-DED7E11B9B1092EE3F0FF393E9C757CB"
      unitRef="usd">1700000</dxcm:DeferredTaxAssetsConvertibleDebt>
    <dxcm:DeferredTaxAssetsConvertibleDebt
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37423883e2228-wk-Fact-2C8364C065B109D6F161F393EBF9A474"
      unitRef="usd">0</dxcm:DeferredTaxAssetsConvertibleDebt>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37423883e2248-wk-Fact-CF628FFBB067500893A2B049DC613B9F"
      unitRef="usd">351700000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37423883e2267-wk-Fact-FDE162804C2D7F2DCB88B049DC762A6D"
      unitRef="usd">334100000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37423883e2288-wk-Fact-A79879BA313D7FFE5AB8EB34A7FE98F7"
      unitRef="usd">332200000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37423883e2308-wk-Fact-398A27336299C3E64833B04A0F40C6E7"
      unitRef="usd">330100000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37423883e2329-wk-Fact-A5E3F61632F9B2C8254DB04A302BDB11"
      unitRef="usd">19500000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37423883e2348-wk-Fact-66DED172E80CD16E7FAAB04A303F25C0"
      unitRef="usd">4000000.0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37423883e2409-wk-Fact-56DA684D3B4A3383ED30B04A40C6257B"
      unitRef="usd">19600000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37423883e2429-wk-Fact-36AB94B3FCA9AB3741F1B04A40CA0495"
      unitRef="usd">3800000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <dxcm:DeferredTaxLiabilitiesConvertibleDebtDiscount
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37423883e2450-wk-Fact-456E0A7186D7EE384B09B04A52F64D2A"
      unitRef="usd">0</dxcm:DeferredTaxLiabilitiesConvertibleDebtDiscount>
    <dxcm:DeferredTaxLiabilitiesConvertibleDebtDiscount
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37423883e2469-wk-Fact-1E9030FE8D1D2DC41AB3B04A530A5D7F"
      unitRef="usd">100000</dxcm:DeferredTaxLiabilitiesConvertibleDebtDiscount>
    <us-gaap:DeferredTaxLiabilities
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37423883e2490-wk-Fact-4B9BDBCF7F1127653606B04A64BD248C"
      unitRef="usd">19600000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37423883e2510-wk-Fact-0034B3A01CDF5CCCA3F7B04A64D007F0"
      unitRef="usd">3900000</us-gaap:DeferredTaxLiabilities>
    <dxcm:DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37423883e2536-wk-Fact-6EE2827AABEB7F262433B04A7319DDBF"
      unitRef="usd">-100000</dxcm:DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet>
    <dxcm:DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37423883e2556-wk-Fact-F28AC4EEEB888101E25EB04A731D8A6D"
      unitRef="usd">100000</dxcm:DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet>
    <dxcm:DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e2584-wk-Fact-2DD79E44D3E7C4EBA7D9EB34A8247FC4"
      unitRef="usd">55700000</dxcm:DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-69094E1B9A226E64E639EB34A879D032-0-wk-Fact-81C2FF7701A3277902B4EB34A81DE7A1">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The reconciliation between our effective tax rate on income (loss) from continuing operations and the statutory rate is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Income taxes at statutory rates&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;21.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(26.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(17.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;State income tax, net of federal benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(2.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(5.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Permanent items&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Research and development credits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(10.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(11.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(13.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Foreign rate differential&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Stock and officers compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(14.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(5.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(10.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Rate change&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Unrecognized tax benefits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(15.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Impact of adoption of ASU 2016-16&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(13.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Impact of Tax Cuts and Jobs Act of 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;105.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;56.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(51.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Income taxes at effective rates&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e2755-wk-Fact-207A7365321ED16CBDE2B04B9CA74F38"
      unitRef="usd">21900000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e2774-wk-Fact-27B86412824F0EC58322B04B9CA24A04"
      unitRef="usd">-26600000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e2794-wk-Fact-6096F4B721E892438E03B04B9CACE8A2"
      unitRef="usd">-17000000.0</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e2811-wk-Fact-173B85CA7A6DEF7BC3B2B04BA72F6FD3"
      unitRef="usd">-2300000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e2831-wk-Fact-8FBCF0FBA01A40893EDDB04BA72B5589"
      unitRef="usd">-5500000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e2851-wk-Fact-A878AE32B957477B8B5DB04BA7320553"
      unitRef="usd">-700000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <dxcm:EffectiveIncomeTaxReconciliationPermanentItems
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e2873-wk-Fact-1A819F5AB9291CF7AE8FB04C5381922A"
      unitRef="usd">1000000.0</dxcm:EffectiveIncomeTaxReconciliationPermanentItems>
    <dxcm:EffectiveIncomeTaxReconciliationPermanentItems
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e2892-wk-Fact-B68A8457CFF806CCC7ACB04C537D679B"
      unitRef="usd">1300000</dxcm:EffectiveIncomeTaxReconciliationPermanentItems>
    <dxcm:EffectiveIncomeTaxReconciliationPermanentItems
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e2911-wk-Fact-4B5EF3059E598EEF3D08B04C5379C2DB"
      unitRef="usd">700000</dxcm:EffectiveIncomeTaxReconciliationPermanentItems>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e2932-wk-Fact-C8507796FD66CA66AC80B04C63AA1A7C"
      unitRef="usd">10800000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e2952-wk-Fact-36A292408BA7A7C11E99B04C6396AE9C"
      unitRef="usd">11700000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e2972-wk-Fact-A3514C44B06A975005F1B04C6388D842"
      unitRef="usd">13300000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e2994-wk-Fact-C0AFC912158FDEE5F938B04C834BD844"
      unitRef="usd">5600000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e3013-wk-Fact-9DD11D860D583BA0DE7EB04C8342CD40"
      unitRef="usd">3700000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e3032-wk-Fact-104DEC505424E248B519B04C8347164E"
      unitRef="usd">5400000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e3053-wk-Fact-ED4D6DBD384B76967CB1B04C95550298"
      unitRef="usd">-14700000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e3073-wk-Fact-21BA3D45D02CFAD3D254B04C955135B2"
      unitRef="usd">-5100000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e3093-wk-Fact-E7CFD3981EAE8CC03367B04C95584FBD"
      unitRef="usd">-10400000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e3115-wk-Fact-64C811981006BDF49105B04CA50D7DCD"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e3134-wk-Fact-AB219E5A158D90998A1DB04CA51B5338"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e3153-wk-Fact-C1B9B073827749865274B04CA4F99899"
      unitRef="usd">-100000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <dxcm:EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e3175-wk-Fact-1F81564B1CDE1A2DD66BB04CB3293FC5"
      unitRef="usd">0</dxcm:EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits>
    <dxcm:EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e3194-wk-Fact-B1DC0BFFB9B30AECD8F4B04CB33DD7FE"
      unitRef="usd">0</dxcm:EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits>
    <dxcm:EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e3213-wk-Fact-43A8AE36695E5CB32C79B04CB3152205"
      unitRef="usd">-15400000</dxcm:EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits>
    <dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e3235-wk-Fact-259049B321B60B8B5CB2B04CC34F273C"
      unitRef="usd">0</dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616>
    <dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e3254-wk-Fact-045420041CF7EA42E04BB04CC347DBD5"
      unitRef="usd">-13300000</dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616>
    <dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e3274-wk-Fact-DAAD236EC09E4A618CF3B04CC34C975F"
      unitRef="usd">0</dxcm:EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616>
    <dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e3296-wk-Fact-ECFD8C9493431F9327D2B04CD754013D"
      unitRef="usd">0</dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA>
    <dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e3315-wk-Fact-5929BF087978E964C3D0B04CD7500B61"
      unitRef="usd">-400000</dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA>
    <dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e3335-wk-Fact-95E43FC9976CDA4C653EB04CD74C9FF1"
      unitRef="usd">105700000</dxcm:EffectiveIncomeTaxReconciliationImpactofTCJA>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e3356-wk-Fact-36490673394858A548CBB04CE7D698C0"
      unitRef="usd">-1000000.0</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e3376-wk-Fact-C51BAC9B975E8979B9FAB04CE7B51A4B"
      unitRef="usd">1300000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e3395-wk-Fact-547073F8FC372B64FBC2B04CE7C8DE01"
      unitRef="usd">-2200000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e3417-wk-Fact-46BDE8D9A53F71DE6D73B04CF804D5AF"
      unitRef="usd">3400000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e3436-wk-Fact-20DAE5DF22B87FD9D1D3B04CF80B6784"
      unitRef="usd">56900000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e3455-wk-Fact-D7C466E490F5DA17B571B04CF80815A9"
      unitRef="usd">-51100000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e3482-wk-Fact-5382C869DEC35C369C5FBDE1CE4B43A0"
      unitRef="usd">3100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e3501-wk-Fact-0D594FC0637D063FE795174A94692792"
      unitRef="usd">600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e3520-wk-Fact-DCF36026B268B00536B7EB34A8622EE0"
      unitRef="usd">1600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-0DF5601D336D1A33BF98EB34A879EF1F-0-wk-Fact-59C7E78559FBCC74AD73EB34A7FE5901">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:36px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes the activity related to our gross unrecognized tax benefits:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:88%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Balance at January&#160;1, 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;39.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Decreases related to prior year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(14.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Decrease related to Tax Cuts and Jobs Act of 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(5.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;22.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Decreases related to prior year tax positions &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;25.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Decreases related to prior year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;29.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2016Q4"
      decimals="-5"
      id="d37423883e3591-wk-Fact-A2BC4107AA02159ED754EB34A816C839"
      unitRef="usd">39800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e3606-wk-Fact-7C62514F361077BE395BEB34A810123F"
      unitRef="usd">14900000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e3627-wk-Fact-F0066F1345FAA249BDAFEB34A811A43D"
      unitRef="usd">3300000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <dxcm:UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37423883e3647-wk-Fact-2BEFC4309722BE1E8191EB34A8117864"
      unitRef="usd">5400000</dxcm:UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2017Q4"
      decimals="-5"
      id="d37423883e3668-wk-Fact-D31AEB213A6D0CD1C32BEB34A81339CD"
      unitRef="usd">22800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e3688-wk-Fact-06D8DC3585D8B544BA23EB34A810BE15"
      unitRef="usd">300000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37423883e3709-wk-Fact-5AF1606ABA3FF6F83DF0EB34A814A3A2"
      unitRef="usd">3400000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37423883e3729-wk-Fact-27B8B3B6F9A9111AD171EB34A8149CEE"
      unitRef="usd">25900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e3749-wk-Fact-CC72EA2176449C8895C2EB34A81B2345"
      unitRef="usd">900000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37423883e3770-wk-Fact-BE2AFCF560A1151A652AEB34A80FE4B5"
      unitRef="usd">4500000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37423883e3796-wk-Fact-BAB89C9FC14C5B3B46CEEB34A816297F"
      unitRef="usd">29500000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
      contextRef="FD2019Q4YTD"
      decimals="INF"
      id="d37423883e3814-wk-Fact-EF432ACE9CC0253E3C61EB34A8332F98"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense>
    <dxcm:PossibleExtensionPeriodofTaxHoliday
      contextRef="FD2019Q4YTD"
      id="d37423883e3828-wk-Fact-E3492262A6BC48CEACA30C0F510A8A69">P3Y</dxcm:PossibleExtensionPeriodofTaxHoliday>
    <us-gaap:IncomeTaxHolidayAggregateDollarAmount
      contextRef="FD2019Q4YTD_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember"
      decimals="-5"
      id="d37423883e3832-wk-Fact-ABAF6F845DA2D7CC08E20C101951E887"
      unitRef="usd">200000</us-gaap:IncomeTaxHolidayAggregateDollarAmount>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-47FF00A4BE190343F510EB34A8798E84-0-wk-Fact-51A9B6371E434975F49AEB34A82AC54E">&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;"&gt;9. Employee Benefit Plans and Stockholders&#x2019; Equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;401(k) Plan &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We have a defined contribution 401(k) retirement plan (the 401(k) Plan) covering substantially all employees in the United States that meet certain age requirements. Employees who participate in the 401(k) Plan may contribute up to &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;75%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of their compensation each year, subject to Internal Revenue Service limitations and the terms and conditions of the plan. Under the terms of the 401(k) Plan, we may elect to match a discretionary percentage of contributions. In April 2018, we began matching &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;50%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of contributions up to &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of annual compensation. Total matching contributions were &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$4.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$2.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Employee Stock Purchase Plan, or ESPP&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Under the 2015 Employee Stock Purchase Plan (the 2015 ESPP) eligible employees can purchase shares of our common stock at semi-annual intervals through periodic payroll deductions during defined Offering Periods. A total of up to &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; shares may be issued under the 2015 ESPP and it expires upon the earliest to occur of (a) termination of the 2015 ESPP by our board of directors, (b) issuance of all of the shares of common stock reserved for issuance under the plan, or (c) May 28, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Payroll deductions may not exceed &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;10%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of the participant&#x2019;s cash compensation subject to certain limitations, and the purchase price will not be less than &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;85%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; of the lower of the fair market value of the common stock at either the beginning of the applicable Offering Period or the Purchase Date. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We issued &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;150,408&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;189,904&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;122,857&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; shares of common stock under the 2015 &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;ESPP&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; during the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Equity Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;In May 2015, we adopted the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Amended and Restated 2015 Equity Incentive Plan (the 2015 Plan)&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, which replaced our &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2005 Equity Incentive Plan&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and provides for the grant of incentive and nonstatutory stock options, restricted stock, stock bonuses, stock appreciation rights, and restricted stock units to employees, directors or consultants of the Company. On May 30, 2019 our stockholders approved an increase to the maximum number of shares that may be issued under the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2015 Plan&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. We are permitted to issue up to&#160;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;9.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;shares under the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2015 Plan&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Repurchased shares of our common stock are held as treasury shares until they are reissued or retired. When we reissue treasury stock, if the proceeds from the sale are more than the average price we paid to acquire the shares we record an increase in additional paid-in capital. Conversely, if the proceeds from the sale are less than the average price we paid to acquire the shares, we record a decrease in additional paid-in capital to the extent of increases previously recorded for similar transactions and a decrease in retained earnings for any remaining amount. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We issue new shares of common stock to satisfy option exercises and RSU vesting under our employee equity incentive plans. We have not yet determined the ultimate disposition of the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; shares that we repurchased in 2018, and consequently we continue to hold them as treasury shares rather than retiring them. &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;No&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; shares of our common stock were repurchased during &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We have not granted any stock options since 2010. As of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; we have &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;28,385&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; options outstanding, all of which are in-the-money. The options have a weighted- average remaining contractual term of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.27&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; years, a weighted- average exercise price of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$10.11&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; per share, and an aggregate&#160;intrinsic value of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$5.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. The aggregate intrinsic value of options outstanding and exercisable is calculated as the difference between the exercise price of the underlying options and the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$218.74&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; per share market price of our common stock at &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The total intrinsic value of stock options exercised as of the date of exercise was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Intrinsic value of options exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;7.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;30.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;21.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Restricted Stock Units (RSUs)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;RSU awards typically vest annually over &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;three&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; or &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;four&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; years and vesting is subject to continued services. A summary of our RSU activity for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions except weighted average grant date fair value)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Weighted&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Grant&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fair&#160;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Intrinsic&#160;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Nonvested at December 31, 2016&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;62.51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;75.78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;58.92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;67.97&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Nonvested at December 31, 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;70.68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;154.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;66.07&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;68.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;68.56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Nonvested at December 31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;69.19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;319.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;144.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;69.45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;83.45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Nonvested at December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;96.63&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;392.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The total vest-date fair value of &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;RSUs&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; vested was &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$207.2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$120.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$144.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Common Stock Reserved for Future Issuance&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Shares of common stock reserved for future issuance were as follows as of the dated indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Stock options and awards under our plans:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Stock options granted and outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Unvested restricted stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Reserved for future grant&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;7.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;7.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Share-based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes share-based compensation expense related to restricted stock units and employee stock purchases under the ESPP for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:59%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;9.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;9.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;9.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;33.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;33.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;37.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Selling, general and administrative&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;60.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;59.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;59.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total share-based compensation expense included in net loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;102.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;101.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;106.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We estimate the fair value of ESPP purchase rights on the date of grant using the Black-Scholes option pricing model and the assumptions below for the specified reporting periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Risk free interest rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;1.72 - 2.55&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;1.55&#160;&#x2013;&#160;2.25&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75&#160;&#x2013;&#160;1.12&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Expected volatility of DexCom common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.40 - 0.51&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.50&#160;&#x2013;&#160;0.67&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.33&#160;&#x2013;&#160;0.56&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Expected life (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;At &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, unrecognized estimated compensation costs related to unvested restricted stock units and ESPP shares totaled &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;$119.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and are expected to be recognized through &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/span&gt;.</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_A401kPlanMember"
      decimals="INF"
      id="d37425896e573-wk-Fact-5EC5C40A25DBF10C2E0EB038D0286970"
      unitRef="number">0.75</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_A401kPlanMember"
      decimals="INF"
      id="d37425896e577-wk-Fact-A5BD1B79866E0A924F8CB0393E282A9B"
      unitRef="number">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_A401kPlanMember"
      decimals="INF"
      id="d37425896e581-wk-Fact-838A91B7A6288AEF9931B0395386D8BE"
      unitRef="number">0.04</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_A401kPlanMember"
      decimals="-5"
      id="d37425896e585-wk-Fact-01ADE38EEAB21B833AD1B038434A9165"
      unitRef="usd">4800000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="FD2018Q4YTD_us-gaap_PlanNameAxis_dxcm_A401kPlanMember"
      decimals="-5"
      id="d37425896e589-wk-Fact-ADABFAAB1A722EA438D4B0386CB6F4F7"
      unitRef="usd">2600000</us-gaap:DefinedContributionPlanCostRecognized>
    <dxcm:EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37425896e612-wk-Fact-45AED04D9A4E9632F4E7EB34A82604E8"
      unitRef="shares">1500000</dxcm:EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="FI2019Q4"
      decimals="INF"
      id="d37425896e619-wk-Fact-52A2877746EA071E2558EB34A82BBB5A"
      unitRef="number">0.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <dxcm:EmployeePurchasePriceFloorPercentage
      contextRef="FD2019Q4YTD"
      decimals="INF"
      id="d37425896e623-wk-Fact-5CE8ADD4146143F5C1D8EB34A81E3CD1"
      unitRef="number">0.85</dxcm:EmployeePurchasePriceFloorPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member"
      decimals="INF"
      id="d37425896e630-wk-Fact-AF8FF3E34A501230E5CEEB34A82BFA1F"
      unitRef="shares">150408</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="FD2018Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member"
      decimals="INF"
      id="d37425896e634-wk-Fact-961A39551D2B6903FC93EB34A81FA130"
      unitRef="shares">189904</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="FD2017Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member"
      decimals="INF"
      id="d37425896e638-wk-Fact-DA0F0D6A8BA6836AE918EB34A82316A3"
      unitRef="shares">122857</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="I2015Q2RSUsharesauthorized"
      decimals="-5"
      id="d37425896e681-wk-Fact-09AE0A671B63BEA3024BEB34A82190CE"
      unitRef="shares">9800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37425896e699-wk-Fact-FACDD6497EB1B013D269B036927DD4C3"
      unitRef="shares">800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="FD2019Q4YTD"
      decimals="INF"
      id="d37425896e703-wk-Fact-EB58685C53529C43005DB036C76520A5"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <dxcm:OptionsInMoneyNumber
      contextRef="FD2019Q4YTD"
      decimals="INF"
      id="d37425896e721-wk-Fact-B327273CA176C217F6ABEB34A82B99A0"
      unitRef="shares">28385</dxcm:OptionsInMoneyNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member"
      id="d37425896e725-wk-Fact-8262E310A14B600DCCCD1BF88010D7AA">P0Y3M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="FI2019Q4_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member"
      decimals="2"
      id="d37425896e729-wk-Fact-F2CB27495A9BA3BFC611B0224AA0A202"
      unitRef="usdPerShare">10.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="FI2019Q4_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlan2015Member"
      decimals="-5"
      id="d37425896e733-wk-Fact-20EA6E56AF5007A1F4F7B0213B2B0D56"
      unitRef="usd">5900000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <dxcm:InMoneyOptionsMaximumExercisePrice
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d37425896e738-wk-Fact-38658B29A4116696F1C7EB34A82D0A83"
      unitRef="usdPerShare">218.74</dxcm:InMoneyOptionsMaximumExercisePrice>
    <dxcm:ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-9BD3FA0EE8ABFE4B141AEB34A879ECA8-0-wk-Fact-3208FAB92626E0D9A197EB34A81D4BDB">&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The total intrinsic value of stock options exercised as of the date of exercise was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Intrinsic value of options exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;7.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;30.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;21.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</dxcm:ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37425896e945-wk-Fact-36196DEB50D6633F897FAFF359EABD46"
      unitRef="usd">7400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37425896e964-wk-Fact-FA125FABE373BF5728DFAFF35A1DB2B9"
      unitRef="usd">30000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37425896e983-wk-Fact-FDF749842782EF21E0CFAFF35A045AE9"
      unitRef="usd">21600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-123F24299A47DB3C1AC5EB34A87A4DDD-0-wk-Fact-BDAA686AA8A073013561EB34A828DC47">A summary of our RSU activity for the &lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; is as follows:&lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions except weighted average grant date fair value)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Weighted&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Grant&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fair&#160;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Intrinsic&#160;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Nonvested at December 31, 2016&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;62.51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;75.78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;58.92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;67.97&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Nonvested at December 31, 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;70.68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;154.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;66.07&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;68.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;68.56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Nonvested at December 31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;69.19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;319.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;144.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;69.45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;83.45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Nonvested at December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;96.63&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;392.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2016Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37425896e1150-wk-Fact-2989D54369538F4F7CB3AFE654B1AAF7"
      unitRef="shares">3700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2016Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d37425896e1169-wk-Fact-A5CAE061FF9B7FAD8B0FAFE65845EF59"
      unitRef="usdPerShare">62.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37425896e1204-wk-Fact-AB4B04210CFAA5447E9EAFE65AE760DE"
      unitRef="shares">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d37425896e1218-wk-Fact-2BFCEC91EB1F893729F3AFE65E21EA61"
      unitRef="usdPerShare">75.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37425896e1258-wk-Fact-61CD95205D6E920A4971AFE6606DBCD1"
      unitRef="shares">1900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d37425896e1273-wk-Fact-61E599F7B3F5D03268C6AFE66304A3BA"
      unitRef="usdPerShare">58.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37425896e1313-wk-Fact-440BB210F8BA5AFCDE79AFE6654EB7F1"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d37425896e1328-wk-Fact-DF8D81085310A352DEEAAFE667E7B116"
      unitRef="usdPerShare">67.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37425896e1368-wk-Fact-FB81657A57B71D99BB50AFE3929E1E07"
      unitRef="shares">2700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d37425896e1382-wk-Fact-B29FAF64843F0FC1EA9BAFE39486D572"
      unitRef="usdPerShare">70.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
      contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37425896e1406-wk-Fact-583AA432287A28D5D1C9AFE396798CCD"
      unitRef="usd">154500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37425896e1421-wk-Fact-5F6EE0CDAF973318E169AFE397C5886F"
      unitRef="shares">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d37425896e1435-wk-Fact-5DD88508D88C63E40A74AFE399BA156B"
      unitRef="usdPerShare">66.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37425896e1475-wk-Fact-8443A7770428191345C2AFE39C55E754"
      unitRef="shares">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d37425896e1490-wk-Fact-542D35F2CFBCA880012DAFE39E4E113E"
      unitRef="usdPerShare">68.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37425896e1530-wk-Fact-09B00032AF5A2B4EF202AFE3A0E3663E"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d37425896e1545-wk-Fact-242F799AA579C05BC9B9AFE3A2D75647"
      unitRef="usdPerShare">68.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37425896e1585-wk-Fact-03F21B7766D96BDA0C1BAFE3A5776FB9"
      unitRef="shares">2700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d37425896e1599-wk-Fact-5B1AC85FFED66F75FED5AFE3A7662963"
      unitRef="usdPerShare">69.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
      contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37425896e1618-wk-Fact-7FD4DA82BFE51CFC6143AFE3A959E456"
      unitRef="usd">319000000.0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37425896e1638-wk-Fact-914359ABC42D94EFE35DAFE6CA03C25D"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d37425896e1652-wk-Fact-E384FE21A79C5C02E517AFE6CC9ED176"
      unitRef="usdPerShare">144.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37425896e1693-wk-Fact-EF5AE6C2841BC0DB655BAFE6D05898CC"
      unitRef="shares">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d37425896e1708-wk-Fact-3002C2BE54F6D69D719EAFE6D374E1F8"
      unitRef="usdPerShare">69.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37425896e1748-wk-Fact-9879BE2F76FBB250725AAFE6D681169F"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d37425896e1763-wk-Fact-AA1A73C08EE4DC596E70AFE6DA47C17A"
      unitRef="usdPerShare">83.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37425896e1803-wk-Fact-9A26E2F4BC73A11C3EB6AFE6DE841DC6"
      unitRef="shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d37425896e1822-wk-Fact-187CE48D44AA13A5E448AFE6E1EC1693"
      unitRef="usdPerShare">96.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="d37425896e1841-wk-Fact-BC657D178234EA37F3E2AFE6E50FAC68"
      unitRef="usd">392000000.0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      decimals="-5"
      id="d37425896e1862-wk-Fact-AB1D27AACB7F5F1B1830EB34A82AA032"
      unitRef="usd">207200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      decimals="-5"
      id="d37425896e1866-wk-Fact-8EEB75C3C8E161E90966EB34A826FBE6"
      unitRef="usd">120900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      decimals="-5"
      id="d37425896e1870-wk-Fact-5DC838EE104079409B27EB34A82CEAF6"
      unitRef="usd">144500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <dxcm:ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-7E2D5ADF6E3A554786BDEB34A87905B4-0-wk-Fact-D15F2712839B2F4B6F62EB34A81D930F">&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Shares of common stock reserved for future issuance were as follows as of the dated indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Stock options and awards under our plans:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Stock options granted and outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Unvested restricted stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Reserved for future grant&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;4.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;7.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;7.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</dxcm:ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37425896e2019-wk-Fact-197E462BC256D010B2EAAFE9F49B627B"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="FI2018Q4"
      decimals="1"
      id="d37425896e2033-wk-Fact-8BB1D5B8680EC54FE5A8AFE9F496A7B3"
      unitRef="shares">0.1</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37425896e2048-wk-Fact-218A80B716EEF4609A02AFEA04B9E91A"
      unitRef="shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2018Q4"
      decimals="1"
      id="d37425896e2062-wk-Fact-815F9D07C6C5BF480B06AFEA04C6BB9F"
      unitRef="shares">2.7</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <dxcm:StockOptionsReservedForFutureGrant
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37425896e2077-wk-Fact-E189AB783045FA60D59FAFEA12BAF662"
      unitRef="shares">4900000</dxcm:StockOptionsReservedForFutureGrant>
    <dxcm:StockOptionsReservedForFutureGrant
      contextRef="FI2018Q4"
      decimals="1"
      id="d37425896e2091-wk-Fact-D72DCECE867085C9087BAFEA12DE3DA9"
      unitRef="shares">3.2</dxcm:StockOptionsReservedForFutureGrant>
    <dxcm:EmployeeStockPurchasePlanEsppSharesInEspp
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37425896e2106-wk-Fact-5160637AFBCD98D267A0AFEA27A47CA5"
      unitRef="shares">900000</dxcm:EmployeeStockPurchasePlanEsppSharesInEspp>
    <dxcm:EmployeeStockPurchasePlanEsppSharesInEspp
      contextRef="FI2018Q4"
      decimals="1"
      id="d37425896e2120-wk-Fact-47A96266CAFCD7EC335AAFEA27C44D76"
      unitRef="shares">1.1</dxcm:EmployeeStockPurchasePlanEsppSharesInEspp>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37425896e2135-wk-Fact-57D189EA2EB0F989638FAFEA39EB0099"
      unitRef="shares">7600000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="FI2018Q4"
      decimals="1"
      id="d37425896e2149-wk-Fact-7F6FE4A12ECCCFBAB0B4AFEA39E71F32"
      unitRef="shares">7.1</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-DDEC5BE132450A77D6EEEB34A879D68D-0-wk-Fact-743DCAD12EC3A6011374EB34A8230DCA">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes share-based compensation expense related to restricted stock units and employee stock purchases under the ESPP for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:59%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;9.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;9.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;9.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;33.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;33.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;37.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Selling, general and administrative&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;60.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;59.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;59.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total share-based compensation expense included in net loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;102.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;101.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;106.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d37425896e2346-wk-Fact-8AF920AFA15751A2A4E484827F3AFA16"
      unitRef="usd">9000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d37425896e2365-wk-Fact-3E03D3B2542458E3AC3A61F3780C0E8B"
      unitRef="usd">9200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d37425896e2384-wk-Fact-995F17D324DDB478B94DEB34A7FE9852"
      unitRef="usd">9600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="d37425896e2400-wk-Fact-32CAA734830E5DB193A726D5AAD0EF03"
      unitRef="usd">33500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="d37425896e2419-wk-Fact-9D44A94B59C857E2924118C568A72CD8"
      unitRef="usd">33000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="d37425896e2438-wk-Fact-46541E1D85B760448189EB34A7FE7A30"
      unitRef="usd">37500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_dxcm_SellingGeneralAndAdministrativeMember"
      decimals="-5"
      id="d37425896e2459-wk-Fact-7B0D8A09FF785B91B3E19CED8C851F46"
      unitRef="usd">60200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_dxcm_SellingGeneralAndAdministrativeMember"
      decimals="-5"
      id="d37425896e2478-wk-Fact-007535EC3C4A588C84F66E0EF22965A4"
      unitRef="usd">59700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_dxcm_SellingGeneralAndAdministrativeMember"
      decimals="-5"
      id="d37425896e2497-wk-Fact-91C2E83A4CA93B549B8AEB34A80E6574"
      unitRef="usd">59100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37425896e2523-wk-Fact-E427ED85215AA224DF80CA56F0C97C52"
      unitRef="usd">102700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37425896e2542-wk-Fact-043FBC581574D1ED5455CA56F4356D16"
      unitRef="usd">101900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37425896e2561-wk-Fact-A2340A667760A58AD00DCA56F724D3B2"
      unitRef="usd">106200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-E46D2227CA197343E37DEB34A8798288-0-wk-Fact-7A47DEA6762E6EAF57CFEB34A81C38D3">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We estimate the fair value of ESPP purchase rights on the date of grant using the Black-Scholes option pricing model and the assumptions below for the specified reporting periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Risk free interest rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;1.72 - 2.55&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;1.55&#160;&#x2013;&#160;2.25&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.75&#160;&#x2013;&#160;1.12&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Expected volatility of DexCom common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.40 - 0.51&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.50&#160;&#x2013;&#160;0.67&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;0.33&#160;&#x2013;&#160;0.56&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Expected life (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      decimals="2"
      id="d37425896e2733-wk-Fact-A46B9D1F3DC51CCD2D97EB34A811D1B0"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="FD2018Q4QTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      decimals="2"
      id="d37425896e2748-wk-Fact-E4C0B701CC0AF3E1E52BEB34A817288F"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="FD2017Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      decimals="2"
      id="d37425896e2763-wk-Fact-BD3EB197660991E13585EB34A811C04C"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      id="d37425896e2822-wk-Fact-3F9E646D68C636836335EB34A814EE1E">P1Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="FD2018Q4QTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      id="d37425896e2836-wk-Fact-B27DBA6D4F64E0F00E75EB34A80E446A">P1Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="FD2017Q4YTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember"
      id="d37425896e2850-wk-Fact-32153104B55018405C6BEB34A8158C34">P1Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37425896e2865-wk-Fact-2A5270FAEF1D5C9E80AFCE9FF9956AC7"
      unitRef="usd">119300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-EDE4D99A6FD682620F32EB34A87A8DE5-0-wk-Fact-B98DB52E389D0DD725B1EB34A8209755">&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;"&gt;10. Business Segment and Geographic Information&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Reportable Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;An operating segment is identified as a component of a business that has discrete financial information available and for which the chief operating decision maker must decide the level of resource allocation. In addition, the guidance for segment reporting indicates certain quantitative materiality thresholds. None of the components of our business meet the definition of an operating segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;We currently consider our operations to be, and manage our business globally within, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;one&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; reportable segment, which is consistent with how our President and Chief Executive Officer, who is our chief operating decision maker, reviews our business, makes investment and resource allocation decisions, and assesses operating performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Disaggregation of Revenue &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;DexCom is domiciled in the United States. We sell our CGM systems through a direct sales force in the United States, Canada and some countries in Europe, and through distribution arrangements in the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;United States, and certain countries in Africa, Asia, Europe, Latin America, and the Middle East, as well as Australia, Canada, and New Zealand&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;. We disaggregate our revenue from contracts by geography and by major sales channel as we believe they best depict how the nature, amount and timing of revenues and cash flows are affected by economic factors. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Revenues by geographic region&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;During the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, no individual country outside the United States generated revenue that represented more than 10% of our total revenue. The following table sets forth revenues by our two primary geographical markets, the United States and outside of the United States, based on the geographic location to which we deliver the product:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.0234375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="21"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="20" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(Dollars in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Revenues:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,161.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;79&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;818.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;79&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;596.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Outside of the United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;314.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;213.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;122.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,476.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,031.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;718.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The majority of our long-lived assets are located in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Revenues by customer sales channel&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table sets forth revenues by major sales channel for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.0234375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="21"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="20" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(Dollars in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Revenues:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Distributor&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,011.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;69&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;652.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;63&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;538.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Direct&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;464.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;378.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;180.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,476.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,031.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;718.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="FD2019Q4YTD"
      decimals="INF"
      id="d37426741e573-wk-Fact-95CB2618983E036D9E04EB34A821842D"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-6474802CD379ECB54E71EB34A87AF2AA-0-wk-Fact-CAF5133436D951E618E5EB34A820265A">The following table sets forth revenues by our two primary geographical markets, the United States and outside of the United States, based on the geographic location to which we deliver the product:&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.0234375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="21"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="20" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(Dollars in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Revenues:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,161.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;79&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;818.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;79&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;596.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Outside of the United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;314.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;213.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;122.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,476.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,031.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;718.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d37426741e1082-wk-Fact-0529A0F449D25630B4FA8C2210724B24"
      unitRef="usd">1161500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US"
      decimals="2"
      id="d37426741e1096-wk-Fact-15A65B88B8D747AB268CEB34A8330684"
      unitRef="number">0.79</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d37426741e1116-wk-Fact-847E2EDCF7FD57EE8135965599D81A45"
      unitRef="usd">818400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US"
      decimals="2"
      id="d37426741e1131-wk-Fact-D3FFBF005BE968D5E9D9EB34A833F66E"
      unitRef="number">0.79</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d37426741e1151-wk-Fact-F29000C17B9338CADCACEB34A8338734"
      unitRef="usd">596200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2017Q4YTD_srt_StatementGeographicalAxis_country_US"
      decimals="2"
      id="d37426741e1165-wk-Fact-CC539047C07390B9A838EB34A83335D4"
      unitRef="number">0.83</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-5"
      id="d37426741e1181-wk-Fact-E6E649A906E95C96A9E863CA625D9876"
      unitRef="usd">314500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="2"
      id="d37426741e1200-wk-Fact-4794504DAFA11564DEAAEB34A833390A"
      unitRef="number">0.21</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-5"
      id="d37426741e1215-wk-Fact-117272D5CA54547FABC8D5FDCCCCFC74"
      unitRef="usd">213200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="2"
      id="d37426741e1235-wk-Fact-DDCAE03C4E45E3796062EB34A83348E7"
      unitRef="number">0.21</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-5"
      id="d37426741e1250-wk-Fact-A305D6DCE224D9C7C8C3EB34A8335913"
      unitRef="usd">122300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2017Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="2"
      id="d37426741e1269-wk-Fact-308A6FF6B2F45B378E8EEB34A8332E68"
      unitRef="number">0.17</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37426741e1290-wk-Fact-64400440AC62A8CA769BEB34A85294A0"
      unitRef="usd">1476000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2019Q4YTD"
      decimals="INF"
      id="d37426741e1304-wk-Fact-034D50E26A171F22FEC4EB34A8339404"
      unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37426741e1324-wk-Fact-D38A90028A2F0CC3FFCBEB34A7EE80E4"
      unitRef="usd">1031600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2018Q4YTD"
      decimals="INF"
      id="d37426741e1339-wk-Fact-91B80C5916C3992B2C57EB34A8334718"
      unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37426741e1359-wk-Fact-691FD3D368229313BD9DEB34A84333BF"
      unitRef="usd">718500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2017Q4YTD"
      decimals="INF"
      id="d37426741e1373-wk-Fact-A1C63F52C715EC12449AEB34A83304B0"
      unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-E63EF59377F57FDE659BEB34A87AF53A-0-wk-Fact-ECAE2BBCEE6FBB022C90EB34A8212BF6">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following table sets forth revenues by major sales channel for the &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.0234375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="21"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="20" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Twelve Months Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(Dollars in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Revenues:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Distributor&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,011.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;69&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;652.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;63&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;538.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Direct&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;464.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;378.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;180.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,476.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1,031.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;718.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember"
      decimals="-5"
      id="d37426741e1882-wk-Fact-2199CDA4F3005E8D805A721BD5846F6C"
      unitRef="usd">1011600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2019Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember"
      decimals="2"
      id="d37426741e1896-wk-Fact-8759A6C3631F8EB9A307EB34A833A3F0"
      unitRef="number">0.69</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember"
      decimals="-5"
      id="d37426741e1916-wk-Fact-320B097885D951D2B62CBA49A3FFBE73"
      unitRef="usd">652900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2018Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember"
      decimals="2"
      id="d37426741e1931-wk-Fact-B8590379B3A0FBCC7BAEEB34A8430818"
      unitRef="number">0.63</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember"
      decimals="-5"
      id="d37426741e1951-wk-Fact-32985E8D12DA82F2D183EB34A833B906"
      unitRef="usd">538000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2017Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelThroughIntermediaryMember"
      decimals="2"
      id="d37426741e1965-wk-Fact-9411A475BE792C6F4AD3EB34A8336733"
      unitRef="number">0.75</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember"
      decimals="-5"
      id="d37426741e1981-wk-Fact-BCF1290C6FA253269B8623CCA1C1BCEA"
      unitRef="usd">464400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2019Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember"
      decimals="2"
      id="d37426741e2000-wk-Fact-4327ECE5E3B6890BAF2FEB34A8339051"
      unitRef="number">0.31</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember"
      decimals="-5"
      id="d37426741e2015-wk-Fact-F1BECDBC82475C83AC225878DCF864FD"
      unitRef="usd">378700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2018Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember"
      decimals="2"
      id="d37426741e2035-wk-Fact-94B0378D4CFD5F1CBB3BEB34A83356D8"
      unitRef="number">0.37</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember"
      decimals="-5"
      id="d37426741e2050-wk-Fact-7CF9EFB6CE56887818A7EB34A83360D8"
      unitRef="usd">180500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2017Q4YTD_us-gaap_ContractWithCustomerSalesChannelAxis_us-gaap_SalesChannelDirectlyToConsumerMember"
      decimals="2"
      id="d37426741e2069-wk-Fact-0806E4AA1244C3E77280EB34A843792D"
      unitRef="number">0.25</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37426741e2090-wk-Fact-64400440AC62A8CA769BEB34A85294A0"
      unitRef="usd">1476000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d37426741e2104-wk-Fact-DE8825F124A33B1DEE1DEB34A833B2F5"
      unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37426741e2124-wk-Fact-D38A90028A2F0CC3FFCBEB34A7EE80E4"
      unitRef="usd">1031600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2018Q4YTD"
      decimals="2"
      id="d37426741e2139-wk-Fact-2D00262ECEA9DBFB6BEEEB34A833E60F"
      unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37426741e2159-wk-Fact-691FD3D368229313BD9DEB34A84333BF"
      unitRef="usd">718500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="FD2017Q4YTD"
      decimals="2"
      id="d37426741e2173-wk-Fact-6A3E02FE759DF572D676EB34A8431CC6"
      unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:QuarterlyFinancialInformationTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-26EDAAC837412722AE8FEB34A87AF34D-0-wk-Fact-1F02B5A3AF2642325175EB34A8275FC4">&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;"&gt;11. Quarterly Financial Information (Unaudited)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following is a summary of our quarterly results of operations for the years ended &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December 31,&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.046875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;For the Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions except per share data)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&#160;31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;September&#160;30&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;June&#160;30&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;March&#160;31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Year ended December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;462.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;396.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;336.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;280.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Gross profit &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;309.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;246.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;206.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;168.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total operating expenses &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;207.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;190.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;207.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;183.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Net income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;92.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;45.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(10.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(26.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Basic net income (loss) per share &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.01&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Diluted net income (loss) per share &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Year ended December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;338.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;266.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;242.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;184.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Gross profit &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;222.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;168.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;153.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;118.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total operating expenses &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;387.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;154.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;158.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;149.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Net income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(179.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;46.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;30.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(24.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Basic net income (loss) per share &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(2.03&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Diluted net income (loss) per share &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(2.03&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.52&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1) &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Basic and diluted earnings per share are computed independently for each of the quarters presented. Therefore, the sum of quarterly basic and diluted per share information may not equal annual basic and diluted earnings per share.&lt;/span&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-ADDBFA91D5E1310C51E7EB34A87A45C3-0-wk-Fact-1742CA2AE07F0492CD68EB34A826A29C">&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;The following is a summary of our quarterly results of operations for the years ended &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;December 31,&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.046875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;For the Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-style:italic;"&gt;(In millions except per share data)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&#160;31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;September&#160;30&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;June&#160;30&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;March&#160;31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Year ended December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;462.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;396.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;336.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;280.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Gross profit &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;309.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;246.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;206.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;168.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total operating expenses &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;207.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;190.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;207.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;183.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Net income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;92.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;45.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(10.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(26.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Basic net income (loss) per share &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.01&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Diluted net income (loss) per share &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;1.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Year ended December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;338.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;266.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;242.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;184.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Gross profit &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;222.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;168.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;153.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;118.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Total operating expenses &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;387.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;154.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;158.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;149.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Net income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(179.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;46.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;30.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(24.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Basic net income (loss) per share &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(2.03&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Diluted net income (loss) per share &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(2.03&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.52&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(0.28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:7pt"&gt;(1) &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Basic and diluted earnings per share are computed independently for each of the quarters presented. Therefore, the sum of quarterly basic and diluted per share information may not equal annual basic and diluted earnings per share.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4QTD"
      decimals="-5"
      id="d37428561e894-wk-Fact-C32A191D8E5691CB3A7CAF706098F79E"
      unitRef="usd">462800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d37428561e913-wk-Fact-F348F7E20F46E2AEBF08AF7060FB14FE"
      unitRef="usd">396300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q2QTD"
      decimals="-5"
      id="d37428561e933-wk-Fact-F9454993FB4FDAA69CD3AF7060F007D9"
      unitRef="usd">336400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q1QTD"
      decimals="-5"
      id="d37428561e952-wk-Fact-B704D960ECF351BC8A03AF70609F9471"
      unitRef="usd">280500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="FD2019Q4QTD"
      decimals="-5"
      id="d37428561e972-wk-Fact-5CEADA9A57C6DF3F91FDAF707BEBEF97"
      unitRef="usd">309300000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d37428561e991-wk-Fact-9851C42F7E3C0F7E52C2AF707C724E9A"
      unitRef="usd">246900000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2019Q2QTD"
      decimals="-5"
      id="d37428561e1010-wk-Fact-83758626A1FDC19008C7AF707BE7BA99"
      unitRef="usd">206500000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2019Q1QTD"
      decimals="-5"
      id="d37428561e1030-wk-Fact-C5B5BBF8F9D75F182CABAF707BF2B63D"
      unitRef="usd">168800000</us-gaap:GrossProfit>
    <us-gaap:OperatingExpenses
      contextRef="FD2019Q4QTD"
      decimals="-5"
      id="d37428561e1055-wk-Fact-75D7CD8747C9656A427CAF708FAD37F2"
      unitRef="usd">207800000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d37428561e1074-wk-Fact-D0FAD13B0294221FD500AF708FA17A73"
      unitRef="usd">190900000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="FD2019Q2QTD"
      decimals="-5"
      id="d37428561e1093-wk-Fact-46F71BCD559E3AE7B1A0AF708FA68BD8"
      unitRef="usd">207300000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="FD2019Q1QTD"
      decimals="-5"
      id="d37428561e1113-wk-Fact-9C75CB75C7D40861BACFAF708FB996A4"
      unitRef="usd">183200000</us-gaap:OperatingExpenses>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4QTD"
      decimals="-5"
      id="d37428561e1138-wk-Fact-CFBF2F29E076D53036DEAF70A5439989"
      unitRef="usd">92700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d37428561e1157-wk-Fact-9848FC188CE3A436E4A7AF70A5A36B88"
      unitRef="usd">45800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q2QTD"
      decimals="-5"
      id="d37428561e1176-wk-Fact-70C94A9280690D6835B0AF70A5971FB7"
      unitRef="usd">-10500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q1QTD"
      decimals="-5"
      id="d37428561e1197-wk-Fact-910F76DFCEF5A5C8872BAF70A53E0F6A"
      unitRef="usd">-26900000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2019Q4QTD"
      decimals="2"
      id="d37428561e1230-wk-Fact-390852B2FC4C148EB388AF70BE1AF5C5"
      unitRef="usdPerShare">1.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2019Q3QTD"
      decimals="2"
      id="d37428561e1249-wk-Fact-9F392EE649D7DCF640C2AF70BDC37647"
      unitRef="usdPerShare">0.50</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2019Q2QTD"
      decimals="2"
      id="d37428561e1269-wk-Fact-4E192321AABA61FC3B15AF70BDA911D7"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2019Q1QTD"
      decimals="2"
      id="d37428561e1289-wk-Fact-FE3E7B9F718E640461CCAF70BDCA445B"
      unitRef="usdPerShare">-0.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2019Q4QTD"
      decimals="2"
      id="d37428561e1317-wk-Fact-FC35D2700685C4E53212AF70D8E3BB62"
      unitRef="usdPerShare">1.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2019Q3QTD"
      decimals="2"
      id="d37428561e1336-wk-Fact-1AE429202B1019C42837AF70D8FBFB0B"
      unitRef="usdPerShare">0.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2019Q2QTD"
      decimals="2"
      id="d37428561e1356-wk-Fact-F9228ADEDB60EC481F6EAF70D8E67D09"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2019Q1QTD"
      decimals="2"
      id="d37428561e1376-wk-Fact-048623D6DED3B998F0FBAF70D8F020BA"
      unitRef="usdPerShare">-0.30</us-gaap:EarningsPerShareDiluted>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4QTD"
      decimals="-5"
      id="d37428561e1577-wk-Fact-5D8D1F61B24D3EAC7C19AF71122BFF6C"
      unitRef="usd">338000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q3QTD"
      decimals="-5"
      id="d37428561e1596-wk-Fact-CA5F790655241F2374B9AF7113999E36"
      unitRef="usd">266700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q2QTD"
      decimals="-5"
      id="d37428561e1616-wk-Fact-A9EBDF1028B7AE2945FEAF711519FDAA"
      unitRef="usd">242500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q1QTD"
      decimals="-5"
      id="d37428561e1635-wk-Fact-5389E2552BECA1014B3EAF7117D5E534"
      unitRef="usd">184400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="FD2018Q4QTD"
      decimals="-5"
      id="d37428561e1655-wk-Fact-C2A4A6BFECD040CCE04CAF7119228ED6"
      unitRef="usd">222800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2018Q3QTD"
      decimals="-5"
      id="d37428561e1674-wk-Fact-22BD2980D185A0E95256AF711AA0A700"
      unitRef="usd">168600000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2018Q2QTD"
      decimals="-5"
      id="d37428561e1693-wk-Fact-88AA07EAF63F87FC1475AF711D0BFD3F"
      unitRef="usd">153600000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2018Q1QTD"
      decimals="-5"
      id="d37428561e1713-wk-Fact-67F41AC134671AD14850AF711FA49367"
      unitRef="usd">118900000</us-gaap:GrossProfit>
    <us-gaap:OperatingExpenses
      contextRef="FD2018Q4QTD"
      decimals="-5"
      id="d37428561e1738-wk-Fact-929C2472CF1B52E00DD2AF71207CBDDF"
      unitRef="usd">387400000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="FD2018Q3QTD"
      decimals="-5"
      id="d37428561e1757-wk-Fact-E1BDD579ED81DA050AD0AF7121EC30F1"
      unitRef="usd">154700000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="FD2018Q2QTD"
      decimals="-5"
      id="d37428561e1776-wk-Fact-877160596068C5C264CDAF7124358BB9"
      unitRef="usd">158500000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="FD2018Q1QTD"
      decimals="-5"
      id="d37428561e1796-wk-Fact-E47CE328603EBC0D1A08AF7126CF55BA"
      unitRef="usd">149600000</us-gaap:OperatingExpenses>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q4QTD"
      decimals="-5"
      id="d37428561e1821-wk-Fact-228E3322AE224496B4C2AF7127A5880D"
      unitRef="usd">-179700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q3QTD"
      decimals="-5"
      id="d37428561e1841-wk-Fact-263112A10754A591127AAF71291C6FB9"
      unitRef="usd">46600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q2QTD"
      decimals="-5"
      id="d37428561e1860-wk-Fact-A8F184D9EB9EBFA93707AF712B8D2EB3"
      unitRef="usd">30200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q1QTD"
      decimals="-5"
      id="d37428561e1880-wk-Fact-0AFBF0B5C959F3FE0B79AF712E28C74B"
      unitRef="usd">-24200000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2018Q4QTD"
      decimals="2"
      id="d37428561e1913-wk-Fact-9B631464B7D468676E5AAF712EF00240"
      unitRef="usdPerShare">-2.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2018Q3QTD"
      decimals="2"
      id="d37428561e1933-wk-Fact-CF2F667FC4076727F977AF71306F6899"
      unitRef="usdPerShare">0.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2018Q2QTD"
      decimals="2"
      id="d37428561e1953-wk-Fact-0291485843EB190FDB1BAF71335EA507"
      unitRef="usdPerShare">0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2018Q1QTD"
      decimals="2"
      id="d37428561e1972-wk-Fact-1CF712C3F6D1FE9FBDA9AF7135529691"
      unitRef="usdPerShare">-0.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2018Q4QTD"
      decimals="2"
      id="d37428561e2000-wk-Fact-C5B326FB3FC21467E989AF7136A2FCE5"
      unitRef="usdPerShare">-2.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2018Q3QTD"
      decimals="2"
      id="d37428561e2020-wk-Fact-3810ADD528B8F23D85E1AF7139397B81"
      unitRef="usdPerShare">0.52</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2018Q2QTD"
      decimals="2"
      id="d37428561e2040-wk-Fact-3ABB046CA2AFF2A921D2AF713B2E0EB0"
      unitRef="usdPerShare">0.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2018Q1QTD"
      decimals="2"
      id="d37428561e2059-wk-Fact-2BA838386739F883C665AF713C9B08E3"
      unitRef="usdPerShare">-0.28</us-gaap:EarningsPerShareDiluted>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-778A2E8DE7641F8A70B1EB34A87A2EF6-0-wk-Fact-BC7BC6ED0274612CAE6BEB34A7FEA3E4">&lt;div style="line-height:120%;padding-bottom:2px;padding-top:2px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;"&gt;DexCom, Inc.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;"&gt;SCHEDULE II&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ffffff;"&gt;&#160;&#x2013; &lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;"&gt;VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:88%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2016&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;12.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Provision for doubtful accounts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Write-offs and adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(7.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Recoveries&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;11.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:88%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;11.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Provision for doubtful accounts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;3.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Write-offs and adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(8.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Recoveries&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;7.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:88%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;7.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Provision for doubtful accounts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Write-offs and adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;(3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Recoveries&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e1ede6;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;span&gt;5.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2016Q4"
      decimals="-5"
      id="d37429337e690-wk-Fact-C43F04A857B3CE8063CDEB34A821E4FD"
      unitRef="usd">12400000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37429337e705-wk-Fact-31E2C919F92B159B029CEB34A81200D6"
      unitRef="usd">5300000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37429337e725-wk-Fact-95C1290344FAA9991E9CEB34A843FB66"
      unitRef="usd">7000000.0</dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments>
    <us-gaap:ValuationAllowancesAndReservesRecoveries
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d37429337e746-wk-Fact-C751DDF1754E1A00DE42EB34A8336F56"
      unitRef="usd">700000</us-gaap:ValuationAllowancesAndReservesRecoveries>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2017Q4"
      decimals="-5"
      id="d37429337e771-wk-Fact-E93033BEAE2444EEF655EB34A833DA9B"
      unitRef="usd">11400000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2017Q4"
      decimals="-5"
      id="d37429337e844-wk-Fact-E93033BEAE2444EEF655EB34A833DA9B"
      unitRef="usd">11400000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37429337e859-wk-Fact-826EE0F8FB0BD4F4BA10EB34A8335E46"
      unitRef="usd">3600000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37429337e879-wk-Fact-005C8AE26AA9D145B580EB34A833AAE9"
      unitRef="usd">8300000</dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments>
    <us-gaap:ValuationAllowancesAndReservesRecoveries
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d37429337e900-wk-Fact-D11AEC1D7BA6453B0A06EB34A84327B3"
      unitRef="usd">500000</us-gaap:ValuationAllowancesAndReservesRecoveries>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37429337e925-wk-Fact-43C128D7D6BC16E4F687EB34A843042A"
      unitRef="usd">7200000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2018Q4"
      decimals="-5"
      id="d37429337e998-wk-Fact-43C128D7D6BC16E4F687EB34A843042A"
      unitRef="usd">7200000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37429337e1013-wk-Fact-7DA406F60E64DB890548EB34A81CF224"
      unitRef="usd">900000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37429337e1033-wk-Fact-6C71865AC4CA586AB116EB34A843F413"
      unitRef="usd">3000000.0</dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments>
    <us-gaap:ValuationAllowancesAndReservesRecoveries
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d37429337e1054-wk-Fact-B4720B22CE982B1F9179EB34A8435047"
      unitRef="usd">700000</us-gaap:ValuationAllowancesAndReservesRecoveries>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2019Q4"
      decimals="-5"
      id="d37429337e1079-wk-Fact-567C4B0102E7D0C446EAEB34A8432D01"
      unitRef="usd">5800000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6822048832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The carrying amounts of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2022:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Principal amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>400.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>400.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt discount</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(37.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(51.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net carrying amount of Senior Convertible Notes due 2022</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>358.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>342.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2023:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Principal amount</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>850.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>850.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt discount</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(140.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(171.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net carrying amount of Senior Convertible Notes due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>701.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>667.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total net carrying amount of senior convertible notes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,059.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,010.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Carrying value of equity component of convertible senior notes, net of debt issuance costs</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>70.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>70.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>171.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>171.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Remaining&#160;amortization&#160;period&#160;of&#160;debt discount&#160;on&#160;the&#160;liability&#160;component</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.5 years</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.5 years</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.0 years</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.0 years</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Schedule of Converted Value of Notes</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The amount by which the notes&#8217; if-converted value exceeds their principal amount is as of the dates indicated:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>486.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>125.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>372.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total by which the notes&#8217; if-converted value exceeds their principal amount</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>858.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>125.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;padding-left:0px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown. </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Interest expense recognized:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2022:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contractual coupon interest</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accretion of debt discount </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense recognized on 2022 Notes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2023:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contractual coupon interest</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accretion of debt discount </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest expense recognized on 2023 Notes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>40.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total interest expense recognized on senior notes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>58.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Effective interest rates:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)  </sup></span><span style="font-family:inherit;font-size:10pt;">The discount on the 2022 Notes is being amortized through May 15, 2022. Interest on the 2022 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.</span></div><div style="line-height:120%;padding-bottom:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)  </sup></span><span style="font-family:inherit;font-size:10pt;">The discount on the 2023 Notes is being amortized through December 1, 2023. Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Availability and Outstanding Borrowings on Credit Agreement</a></td>
<td class="text"><span style="font-family:inherit;font-size:10pt;">Information related to availability and outstanding borrowings on our Credit Agreement is as follows: </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:86%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Available principal amount </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>200.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Letters of credit sub-facility</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outstanding borrowings </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outstanding letters of credit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total available balance</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Disclosures include, but are not limited to, principal amount, amortized premium or discount, and amount of liability and equity components.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6995641312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Organization and Business</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Organization and Business</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DexCom, Inc. is a medical device company focused on the design, development and commercialization of CGM system(s) for use by people with diabetes and by healthcare providers. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;DexCom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Basis of Presentation and Principles of Consolidation</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Basis of Presentation and Principles of Consolidation</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div><span style="font-family:inherit;font-size:10pt;">The functional currencies of our international subsidiaries are generally the local currencies. We translate the financial statements of our foreign subsidiaries into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in </span><span style="font-family:inherit;font-size:10pt;">comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;"> and in </span><span style="font-family:inherit;font-size:10pt;">accumulated other comprehensive income</span><span style="font-family:inherit;font-size:10pt;"> in the equity section of our consolidated balance sheet. Gains and losses resulting from certain intercompany transactions as well as transactions with customers and vendors that are denominated in currencies other than the functional currency of each entity give rise to foreign exchange gains or losses that we record in </span><span style="font-family:inherit;font-size:10pt;">interest and other income, net</span> in our consolidated statements of operations<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Basis of Presentation and Principles of Consolidation</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The functional currencies of our international subsidiaries are generally the local currencies. We translate the financial statements of our foreign subsidiaries into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in </span><span style="font-family:inherit;font-size:10pt;">comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;"> and in </span><span style="font-family:inherit;font-size:10pt;">accumulated other comprehensive income</span><span style="font-family:inherit;font-size:10pt;"> in the equity section of our consolidated balance sheet. Gains and losses resulting from certain intercompany transactions as well as transactions with customers and vendors that are denominated in currencies other than the functional currency of each entity give rise to foreign exchange gains or losses that we record in </span><span style="font-family:inherit;font-size:10pt;">interest and other income, net</span><span style="font-family:inherit;font-size:10pt;"> in our consolidated statements of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Use of Estimates</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Use of Estimates</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles, or GAAP, requires us to make certain estimates and assumptions that affect the amounts reported in our financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include pharmacy rebates, transaction price, net accounts receivable, excess or obsolete inventories and the valuation of inventory, and accruals for litigation contingencies. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Fair Value Measurements</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The authoritative guidance establishes a fair value hierarchy that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities. In general, the authoritative guidance requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset or liability&#8217;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the measurement of its fair value. The three levels of input defined by the authoritative guidance are as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level&#160;1&#8212;Unadjusted quoted prices that are available in active markets for identical assets or liabilities.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level&#160;2&#8212;Inputs other than quoted prices included in Level&#160;1 that are observable, either directly or indirectly, through correlation with market data. These include quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data for substantially the full term of the assets or liabilities.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level&#160;3&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the determination of fair value. Level 3 assets and liabilities include those whose fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques and significant judgment or estimation.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We carry our marketable securities at fair value. We carry our other financial instruments, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, at cost, which approximates the related fair values due to the short-term maturities of these instruments. For more information see Note 3, &#8220;Fair Value Measurements.&#8221;</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Cash and Cash Equivalents</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We consider highly liquid investments with a maturity of </span><span style="font-family:inherit;font-size:10pt;"><span>90</span></span><span style="font-family:inherit;font-size:10pt;">&#160;days or less at the time of purchase to be cash equivalents.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Marketable Securities</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have classified our marketable securities with remaining maturity at purchase of more than three months and remaining maturities of one year or less as short-term marketable securities. We have also classified marketable securities with remaining maturities of greater than one year as short-term marketable securities based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We calculate realized gains or losses on our marketable securities using the specific identification method. We carry our marketable debt securities at fair value with unrealized gains and losses reported as a separate component of stockholders&#8217; equity in our consolidated balance sheets and included in </span><span style="font-family:inherit;font-size:10pt;">comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;">. Realized gains and losses on marketable debt securities are included in </span><span style="font-family:inherit;font-size:10pt;">interest and other income, net</span><span style="font-family:inherit;font-size:10pt;"> in our consolidated statements of operations. We carry our marketable equity securities at fair value with realized and unrealized gains and losses reported in income on equity investments in our consolidated statements of operations. </span></div>We invest in various types of debt securities, including debt securities in government-sponsored entities, corporate debt securities, U.S. Treasury securities and commercial paper. We do not generally intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivables and Allowance for Doubtful Accounts</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Accounts Receivable and Allowance for Doubtful Accounts</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable are generally recorded at the invoiced amount for Distributors and at net realizable value for Direct customers, which is determined using estimates of claim denials and historical reimbursement experience without regard to aging category. Accounts receivable are not interest bearing. We evaluate the creditworthiness of significant customers and generally do not require collateral from our customers. We maintain an allowance for doubtful accounts for potential credit losses. Uncollectable accounts are written off against the allowance after appropriate collection efforts have been exhausted and when it is deemed that a customer account is uncollectable.&#160;Generally, receivable balances greater than one year past due are deemed uncollectable.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk and Significant Customers</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Significant Customers</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position. </span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Inventory</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventory is valued at the lower of cost or net realizable value on a part-by-part basis that approximates first in, first out. We record adjustments to inventory for potentially excess, obsolete or scrapped goods in order to state inventory at net realizable value. Factors influencing these adjustments include inventories on hand and on order compared to estimated future usage and sales for existing and new products, as well as judgments regarding quality control testing data and assumptions about the likelihood of scrap and obsolescence. Once written down the adjustments are considered permanent and are not reversed until the related inventory is sold or disposed of.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our products require customized products and components that currently are available from a limited number of sources. We purchase certain components and materials from single sources due to quality considerations, costs or constraints resulting from regulatory requirements. </span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Property and Equipment</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property and equipment is stated at cost less accumulated depreciation. We calculate depreciation using the straight-line method over the estimated useful lives of the assets. Estimated useful lives are generally </span><span style="font-family:inherit;font-size:10pt;"><span>three years</span></span><span style="font-family:inherit;font-size:10pt;"> for computer software and hardware, four to </span><span style="font-family:inherit;font-size:10pt;"><span>fifteen years</span></span><span style="font-family:inherit;font-size:10pt;"> for machinery and equipment, and </span><span style="font-family:inherit;font-size:10pt;"><span>five years</span></span><span style="font-family:inherit;font-size:10pt;"> for furniture and fixtures. Leasehold improvements are amortized over the shorter of the estimated useful lives of the assets or the remaining lease term. We include the amortization of assets that are recorded under finance leases in depreciation expense.</span></div><span style="font-family:inherit;font-size:10pt;">We review property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the recoverability of the asset by comparing the carrying amount to the future undiscounted cash flows that we expect the asset to generate. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets and Other Long-Lived Assets</a></td>
<td class="text"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Goodwill</span></div></td></tr></table></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We record goodwill when the fair value of consideration transferred in a business combination exceeds the fair value of the identifiable assets acquired and liabilities assumed. Goodwill and other intangible assets that have indefinite useful lives are not amortized, but we test them annually for impairment in the fourth quarter of our fiscal year and whenever events or changes in circumstances indicate that it is more likely than not that the fair value is less than the carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate or operational performance of the business, and an adverse action or assessment by a regulator. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We perform our goodwill impairment analysis at the reporting unit level, which aligns with DexCom&#8217;s reporting structure and the availability of discrete financial information.&#160;We perform the first step of our annual impairment analysis by either comparing a reporting unit&#8217;s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit&#8217;s fair value from the last quantitative assessment to determine if there is potential impairment. We may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit&#8217;s estimated fair value was significantly in excess of the carrying value of its net assets and we do not believe there have been significant changes in the reporting unit&#8217;s operations that would significantly decrease its estimated fair value or significantly increase its net assets.&#160;If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections&#160;and/or use of a market approach by looking at market values of comparable companies. Key assumptions&#160;for these projections include revenue growth, future gross margin and operating margin growth, and weighted cost of capital and terminal growth rates. The revenue and margin growth are based on increased sales of new and existing products as we maintain investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements&#160;to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including the timing and probability of regulatory approvals for our products to be commercialized. We also consider DexCom&#8217;s market capitalization as a part of our analysis.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If the estimated fair value of a reporting unit exceeds the carrying amount of the net assets assigned to that unit, goodwill is not impaired and no further analysis is required. If the carrying value of the net assets assigned to a reporting unit exceeds the estimated fair value of the unit, we perform the second step of the impairment test. In this step we allocate the fair value of the reporting unit calculated in step one to all of the assets and liabilities of that unit, as if we had just acquired the reporting unit in a business combination. The excess of the fair value of the reporting unit over the total amount allocated to the assets and liabilities represents the implied fair value of goodwill. If the carrying amount of a reporting unit&#8217;s goodwill exceeds its implied fair value, we would record an impairment loss equal to the difference. We recorded </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> goodwill impairment charges for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The change in goodwill for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> consisted of translation adjustments on our foreign currency denominated goodwill. The change in goodwill for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;"> consisted of goodwill we recorded for acquisitions that were not significant, individually or in the aggregate, and translation adjustments on our foreign currency denominated goodwill. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Intangible Assets and Other Long-Lived Assets</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We amortize intangible assets with a finite life, such as acquired technology, customer relationships, trade names and trademarks, on a straight-line basis over their estimated useful lives, which range from </span><span style="font-family:inherit;font-size:10pt;">two</span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;">five</span><span style="font-family:inherit;font-size:10pt;"> years. We review intangible assets that have finite lives and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference. </span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Income Taxes</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We recognize deferred tax assets to the extent that we believe that these assets are more likely than not to be realized, which requires significant judgment. The realization of deferred tax assets is dependent, in part, upon future taxable income. In assessing whether our deferred tax assets will be realized, we consider all available evidence, both positive and negative. Such evidence includes historical earnings, future reversals of existing taxable temporary differences, estimates of future taxable income, and the feasibility of ongoing tax planning strategies. We have recorded a full valuation allowance on our net deferred tax asset balances for all periods presented because of the uncertainty related to utilization of our deferred tax assets.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We record uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than </span><span style="font-family:inherit;font-size:10pt;">50 percent</span><span style="font-family:inherit;font-size:10pt;"> likely to be realized upon ultimate settlement with the related tax authority.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We file federal and state income tax returns in the United States and income tax returns in various other foreign jurisdictions with varying statutes of limitations. Due to net operating losses incurred, our income tax returns from inception to date are subject to examination by taxing authorities. We recognize interest expense and penalties related to income tax matters, including unrecognized tax benefits, as a component of income tax expense. </span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Warranty Accrual</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Warranty Accrual</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Estimated warranty costs associated with a product are recorded at the time revenue is recognized. We estimate future warranty costs by analyzing historical warranty experience for the timing and amount of returned product, and expectations for future warranty activity based on changes and improvements to the product or process that are in place or will be in place in the future. We evaluate these estimates on at least a quarterly basis to determine the continued appropriateness of our assumptions.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Loss Contingencies</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Loss Contingencies</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If the potential loss from a claim or legal proceeding is considered probable and the amount can be reasonably estimated, we record a liability and an expense for the estimated loss and disclose it in our financial statements if it is significant. If we determine that a loss is possible and the range of the loss can be reasonably determined, then we disclose the range of the possible loss. Significant judgment is required in the determination of whether a potential loss is probable, reasonably possible, or remote as well as in the determination of whether a potential exposure is reasonably estimable. </span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:16%;"/><td style="width:14%;"/><td style="width:14%;"/><td style="width:14%;"/><td style="width:14%;"/><td style="width:14%;"/><td style="width:14%;"/></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Comprehensive Income (Loss)</span></div></td></tr></table></div></div><span style="font-family:inherit;font-size:10pt;">Comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;"> consists of two elements, </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">other comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;">. We report all components of </span><span style="font-family:inherit;font-size:10pt;">comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;">, including </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;">, in our financial statements in the period in which they are recognized. Total </span><span style="font-family:inherit;font-size:10pt;">comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;"> is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We report </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> and the components of </span><span style="font-family:inherit;font-size:10pt;">other comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;">, including foreign currency translation adjustments and unrealized gains and losses on marketable securities, net of their related tax effect to arrive at total </span><span style="font-family:inherit;font-size:10pt;">comprehensive income (loss)</span><span style="font-family:inherit;font-size:10pt;">.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Revenue Recognition</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We generate our revenue from the sale of our Reusable Hardware and disposable sensors, which we refer to in this section as &#8220;Components&#8221;. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We adopted ASC Topic 606 effective January 1, 2018 using the modified retrospective method. Our revenue recognition policies under ASC Topic 606 are explained below.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Policy elections and practical expedients taken</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We report revenue net of taxes collected from customers, which are subsequently remitted to governmental authorities;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We account for shipping and handling activities that are performed after a customer has obtained control of a good as fulfillment costs rather than as separate performance obligations;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We do not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If we expect, at contract inception, that the period between the transfer of control and corresponding payment from the customer will be one year or less, we do not adjust the amount of consideration for the effects of a significant financing component.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Contracts and performance obligations</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations. We also provide free-of-charge software, mobile applications and updates for our DexCom Share</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></span><span style="font-family:inherit;font-size:10pt;">remote monitoring system. The standalone selling prices of our free-of-charge software, mobile applications and updates are estimated based on an expected cost plus a margin approach.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Transaction price</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Transaction price for the Components reflects the net consideration to which we expect to be entitled. </span><span style="font-family:inherit;font-size:10pt;">Transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Variable consideration</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Rebates.</span><span style="font-family:inherit;font-size:10pt;"> We estimate reductions for rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Product Returns. </span><span style="font-family:inherit;font-size:10pt;">In accordance with the terms of their distribution agreements, most distributors do not have rights of return outside of our limited warranty. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. We generally provide a &#8220;</span><span style="font-family:inherit;font-size:10pt;"><span>30</span></span><span style="font-family:inherit;font-size:10pt;">-day money back guarantee&#8221; program whereby first-time end-user customers may return Reusable Hardware. Product returns have historically been immaterial.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue recognition</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The timing of revenue recognition is based on the satisfaction of performance obligations. Substantially all of the performance obligations associated with our Components are satisfied at a point in time, which typically occurs at shipment of our products. Terms of direct and distributor orders are generally</span><span style="font-family:inherit;font-size:10pt;color:#ee2724;"> </span><span style="font-family:inherit;font-size:10pt;">Freight on Board (FOB) shipping point for U.S. orders or Free Carrier (FCA) shipping point for international orders. For certain of our distributors, control transfers at delivery of the product to the customer. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In cases where our free-of-charge software, mobile applications and updates are deemed to be separate performance obligations, revenue is recognized over time on a ratable basis over the estimated life of the related hardware component. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our sales of Components include an assurance-type warranty.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Judgments and Estimates</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In determining how revenue should be recognized, a five-step process is used, which requires judgment and estimates that can have a significant impact on the amount and timing of revenue we report. These judgments and estimates include identifying performance obligations in the contract, determining whether the performance obligations are separate, allocating the transaction price to each separate performance obligation, determining the timing of revenue recognition for separate performance obligations and estimating the amount of variable consideration to include in the transaction price. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Contract balances</span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract balances represent amounts presented in the consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from </span><span style="font-family:inherit;font-size:10pt;"><span>30</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>90</span></span><span style="font-family:inherit;font-size:10pt;"> days. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> included unbilled accounts receivable of </span><span style="font-family:inherit;font-size:10pt;"><span>$3.6 million</span></span><span style="font-family:inherit;font-size:10pt;">. Unbilled accounts receivable consists of revenue recognized for Components we have delivered but not yet invoiced to customers. We expect to invoice and collect all unbilled accounts receivable within twelve months. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation. The table below shows revenue that we recognized as a result of changes in the contract liability balances in the periods shown.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenue recognized in the period from:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts included in contract liabilities at the beginning of the period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our performance obligations are generally satisfied within 12 months of the initial contract date. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, the deferred revenue balance related to performance obligations that will be satisfied after 12 months was </span><span style="font-family:inherit;font-size:10pt;"><span>$2.1 million</span></span><span style="font-family:inherit;font-size:10pt;">. and is included in other long-term liabilities on our consolidated balance sheets. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">, we had </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> deferred revenue balance related to performance obligations that will be satisfied after 12 months.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred cost of sales</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred cost of sales are associated with sales for which revenue recognition criteria are not met but product has shipped and released from inventory. Deferred cost of sales are included in prepaid and other current assets in our consolidated balance sheets. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Incentive compensation costs</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been </span><span style="font-family:inherit;font-size:10pt;"><span>one year</span></span><span style="font-family:inherit;font-size:10pt;"> or less. We record these costs in selling, general and administrative expense in our consolidated statement of operations. </span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_ProductShipmentCostsPolicyTextBlock', window );">Product Shipment Costs</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Product Shipment Costs</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We record the amounts we charge our customers for the shipping and handling of our products in revenue and we record the related costs as cost of sales in our statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Research and Development</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We expense costs of research and development as we incur them. Our research and development expenses primarily consist of engineering and research expenses related to our continuous glucose monitoring technology, clinical trials, regulatory expenses, quality assurance programs, materials and products for clinical trials. Research and development expenses primarily consist of employee compensation, including salary, fringe benefits, share-based compensation, and temporary employee expenses. We also incur significant expenses to operate our clinical trials that include clinical site reimbursement, clinical trial product, and associated travel expenses. Our research and development expenses also include fees for design services, contractors, and development materials.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our CGM systems include certain software that we develop. We expense software development costs as we incur them until technological feasibility has been established, at which time we capitalize development costs until the product is available for general release to customers. To date, our software has been available for general release concurrent with the establishment of technological feasibility and, accordingly, we have not capitalized any development costs. </span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Advertising Costs</span></div></td></tr></table></div></div>We expense advertising costs as we incur them to selling, general and administrative expenses.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Leases</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We determine if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The interest rate used to determine the present value of the future lease payments is our incremental borrowing rate, because the interest rate implicit in most of our leases is not readily determinable. Our incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in similar economic environments. The operating lease right-of-use asset also includes any lease payments made and excludes lease incentives. We have lease agreements with lease and non-lease components, which are generally accounted for separately. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Variable lease payments that do not depend on a rate or index, payments associated with non-lease components, and costs related to leases with terms of less than 12 months are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Share-Based Compensation</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized straight-line over the requisite service period of the individual grants, which typically equals the vesting period. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We value time-based Restricted Stock Units (&#8220;RSUs&#8221;) at the date of grant using the intrinsic value method. Certain RSUs granted to senior management vest based on the achievement of pre-established performance or market goals.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We estimate the fair value of performance/market-based RSUs at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We update our assessment of the probability that the specified performance criteria will be achieved each quarter and adjust our estimate of the fair value of the performance-based RSUs if necessary. The Monte Carlo methodology that we use to estimate the fair value of market-based RSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the market-based RSUs at the date of grant must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the performance of the specified market criteria. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If any of the assumptions used change significantly, share-based compensation expense may differ materially from what we have recorded in the current period.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We account for forfeitures as they occur by reversing any share-based compensation expense related to awards that will not vest. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Net Income (Loss) Per Share</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> per share attributable to common stockholders is calculated by dividing the </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted </span><span style="font-family:inherit;font-size:10pt;">net income (loss)</span><span style="font-family:inherit;font-size:10pt;"> per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Potentially dilutive common shares consist of shares issuable from stock options, unvested RSUs, warrants and the 2022 and 2023 Senior Convertible Notes. Potentially dilutive common share equivalents shares from outstanding stock options, warrants and unvested RSUs are determined using the average share price for each period under the treasury stock method. Potentially dilutive shares issuable upon conversion of our 2022 and 2023 Senior Convertible Notes are determined using the if-converted method. </span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Guidance</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:18%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:22%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Recent Accounting Guidance</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted Accounting Pronouncements</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</span><span style="font-family:inherit;font-size:10pt;"> (ASU 2016-02), which requires a lessee to recognize most leases on the consolidated balance sheet as lease liabilities with corresponding right-of-use assets. </span><span style="font-family:inherit;font-size:10pt;color:#252525;">We adopted ASU&#160;2016-02 utilizing the modified retrospective transition method at the beginning of the first quarter of 2019. </span><span style="font-family:inherit;font-size:10pt;">See Note 6, &#8220;Leases and Other Commitments&#8221; for more information on the impact of our adoption of ASU 2016-02 and related disclosures.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">In August 2017, the FASB issued ASU No. 2017-12, </span><span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Derivatives and Hedging </span><span style="font-family:inherit;font-size:10pt;color:#252525;">(ASU 2017-12), which is intended to more closely align hedge accounting with companies&#8217; risk management strategies, simplify the application of hedge accounting, and increase transparency regarding the scope and results of hedging programs. The guidance in this update is applied using a cumulative-effect adjustment to retained earnings at the beginning of the fiscal year of adoption. ASU 2017-12 is effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Our adoption of ASU 2017-12 at the beginning of the first quarter of 2019 did not have a significant impact on our consolidated financial statements. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments - </span><span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Credit Losses: Measurement of Credit Losses on Financial Instruments</span><span style="font-family:inherit;font-size:10pt;color:#252525;">, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available-for-sale debt securities. This update is effective for annual periods beginning after December 15, 2019, and interim periods within those periods, and early adoption is permitted. </span><span style="font-family:inherit;font-size:10pt;">W</span><span style="font-family:inherit;font-size:10pt;color:#252525;">e expect to adopt the standard on its effective date in the first quarter of 2020. We believe the adoption will modify the way we analyze financial instruments, but currently do not expect the adoption to have a material financial impact on our consolidated financial statements. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">In January 2017, the FASB issued ASU No. 2017-04, </span><span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Intangibles &#8211; Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment </span><span style="font-family:inherit;font-size:10pt;color:#252525;">(ASU 2017-04). This new guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit&#8217;s carrying amount over its fair value. ASU 2017-04 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We do not expect the adoption to have a material financial impact on our consolidated financial statements. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-13,&#160;</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement: Disclosure Framework </span><span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">&#8211;</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Changes to the Disclosure Requirements for Fair Value Measurement </span><span style="font-family:inherit;font-size:10pt;">(ASU 2018-13), which&#160;adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance,&#160;entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public business entities will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. ASU 2018-13 is effective for public business entities for fiscal years beginning after December&#160;15, 2019, including interim periods within those fiscal years, and early adoption is permitted.&#160;</span><span style="font-family:inherit;font-size:10pt;color:#252525;">We do not expect the adoption to have a material financial impact on our consolidated financial statements. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#252525;">In August 2018, the FASB issued ASU No. 2018-15, </span><span style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Intangibles - Goodwill and Other &#8211; Internal-Use Software: Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract</span><span style="font-family:inherit;font-size:10pt;color:#252525;"> (ASU 2018-15). This new guidance </span><span style="font-family:inherit;font-size:10pt;">requires a customer in a cloud computing arrangement to determine which implementation costs to capitalize as assets or expense as incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. </span><span style="font-family:inherit;font-size:10pt;color:#252525;">ASU 2018-15 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Application of this guidance can be applied either prospectively or retrospectively. We will adopt the new standard on January 1, 2020 on a prospective basis. We do not expect the adoption to have a material financial impact on our consolidated financial statements, however, the adoption of this standard will result in an increase in capitalized assets related to qualifying cloud computing arrangement implementation costs incurred after the adoption date.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In December 2019, the FASB issued&#160;ASU&#160;No. 2019-12, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Simplifying the Accounting for Income Taxes,</span><span style="font-family:inherit;font-size:10pt;"> which is intended to simplify various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years, and early adoption is permitted. </span><span style="font-family:inherit;font-size:10pt;color:#252525;">We are currently evaluating the impact that this guidance will have on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ProductShipmentCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Shipment Costs [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ProductShipmentCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6052-115624<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=116822174&amp;loc=d3e355033-122828<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=116822174&amp;loc=d3e355100-122828<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e32247-109318<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e32280-109318<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5033-111524<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6995675056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 101.1<span></span>
</td>
<td class="num">$ (127.1)<span></span>
</td>
<td class="num">$ (50.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">48.7<span></span>
</td>
<td class="nump">29.1<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">102.7<span></span>
</td>
<td class="nump">101.9<span></span>
</td>
<td class="nump">106.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Non-cash interest expense</a></td>
<td class="nump">49.6<span></span>
</td>
<td class="nump">17.9<span></span>
</td>
<td class="nump">9.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_RDexpensethroughissuanceofcommonstock', window );">Non-cash collaborative research and development fee through issuance of common stock</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">217.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized gain on equity investment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(36.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Realized (gain) loss on equity investment</a></td>
<td class="nump">4.2<span></span>
</td>
<td class="num">(44.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash income and expenses</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">7.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(60.0)<span></span>
</td>
<td class="num">(93.2)<span></span>
</td>
<td class="num">(31.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(49.1)<span></span>
</td>
<td class="num">(25.5)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid and other assets</a></td>
<td class="num">(7.2)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(6.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet', window );">Operating lease right-of-use assets and liabilities, net</a></td>
<td class="num">(2.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">109.0<span></span>
</td>
<td class="nump">56.2<span></span>
</td>
<td class="nump">21.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued payroll and related expenses</a></td>
<td class="nump">16.0<span></span>
</td>
<td class="nump">23.8<span></span>
</td>
<td class="nump">14.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability', window );">Deferred revenue, deferred rent and other liabilities</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">314.5<span></span>
</td>
<td class="nump">123.2<span></span>
</td>
<td class="nump">92.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchase of marketable securities</a></td>
<td class="num">(2,030.4)<span></span>
</td>
<td class="num">(452.5)<span></span>
</td>
<td class="num">(171.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from sale and maturity of marketable securities</a></td>
<td class="nump">1,196.4<span></span>
</td>
<td class="nump">392.1<span></span>
</td>
<td class="nump">93.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Purchase of other equity investments</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(180.0)<span></span>
</td>
<td class="num">(67.1)<span></span>
</td>
<td class="num">(66.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(11.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,015.2)<span></span>
</td>
<td class="num">(139.8)<span></span>
</td>
<td class="num">(144.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">11.9<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible debt, net of issuance costs</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">836.6<span></span>
</td>
<td class="nump">389.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from sale of warrants</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">183.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_PurchaseofConvertibleNoteHedge', window );">Purchase of convertible note hedge</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(218.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from short-term borrowings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">75.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Repayment of short-term borrowings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(75.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">10.7<span></span>
</td>
<td class="nump">710.4<span></span>
</td>
<td class="nump">399.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="num">(690.7)<span></span>
</td>
<td class="nump">695.6<span></span>
</td>
<td class="nump">347.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">1,137.1<span></span>
</td>
<td class="nump">441.5<span></span>
</td>
<td class="nump">94.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of period</a></td>
<td class="nump">446.4<span></span>
</td>
<td class="nump">1,137.1<span></span>
</td>
<td class="nump">441.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash, end of period:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">1,137.1<span></span>
</td>
<td class="nump">1,137.1<span></span>
</td>
<td class="nump">94.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Acquisition of property and equipment included in accounts payable and accrued liabilities</a></td>
<td class="nump">14.2<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the year for interest</a></td>
<td class="nump">10.4<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid during the year for income taxes</a></td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Operating Lease Assets and Liabilities, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PurchaseofConvertibleNoteHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of Convertible Note Hedge</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PurchaseofConvertibleNoteHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_RDexpensethroughissuanceofcommonstock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash R&amp;D expense through issuance of common stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_RDexpensethroughissuanceofcommonstock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherDeferredLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of investments, not including unrealized gains or losses on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, held at each balance sheet date and included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6833944592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 92.7<span></span>
</td>
<td class="nump">$ 45.8<span></span>
</td>
<td class="num">$ (10.5)<span></span>
</td>
<td class="num">$ (26.9)<span></span>
</td>
<td class="num">$ (179.7)<span></span>
</td>
<td class="nump">$ 46.6<span></span>
</td>
<td class="nump">$ 30.2<span></span>
</td>
<td class="num">$ (24.2)<span></span>
</td>
<td class="nump">$ 101.1<span></span>
</td>
<td class="num">$ (127.1)<span></span>
</td>
<td class="num">$ (50.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per share (USD per share)</a></td>
<td class="nump">$ 1.01<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.30)<span></span>
</td>
<td class="num">$ (2.03)<span></span>
</td>
<td class="nump">$ 0.53<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="nump">$ 1.11<span></span>
</td>
<td class="num">$ (1.44)<span></span>
</td>
<td class="num">$ (0.58)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per share (USD per share)</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.30)<span></span>
</td>
<td class="num">$ (2.03)<span></span>
</td>
<td class="nump">$ 0.52<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="nump">$ 1.10<span></span>
</td>
<td class="num">$ (1.44)<span></span>
</td>
<td class="num">$ (0.58)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91.1<span></span>
</td>
<td class="nump">88.2<span></span>
</td>
<td class="nump">86.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92.3<span></span>
</td>
<td class="nump">88.2<span></span>
</td>
<td class="nump">86.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options and employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">2023 Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Senior convertible notes | Senior convertible notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Senior convertible notes | Senior convertible notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1500-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6833885088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount', window );">Transfers between Level 1 and Level 2 securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_FairValueAssetsLevel3TransfersAmount', window );">Transfers in or out of Level 3 securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and intangible asset impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of outstanding hedge to currency risk</a></td>
<td class="nump">$ 8,000,000.0<span></span>
</td>
<td class="nump">60,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities | Designated as Hedging Instrument | Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgesLiabilities', window );">Recorded net exchange derivative instrument liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other Nonoperating Income (Expense) | Designated as Hedging Instrument | Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gains on forward exchange contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_FairValueAssetsLevel3TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Assets, Level 3 Transfers, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_FairValueAssetsLevel3TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgesLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum as of the balance sheet date of the (a) fair values of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and (b) the carrying amounts of the liabilities arising from financial instruments or contracts used to mitigate a specified risk (hedge), and which are expected to be extinguished or otherwise disposed of within a year or the normal operating cycle, if longer, net of the effects of master netting arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgesLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6833401904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (shares)</a></td>
<td class="nump">92,400,000<span></span>
</td>
<td class="nump">91,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (shares)</a></td>
<td class="nump">91,600,000<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock at cost (shares)</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6978990464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Contingencies</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">7. Contingencies</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Litigation</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span>On March 28, 2016, AgaMatrix, Inc., or AgaMatrix, filed a patent infringement lawsuit against us in the U.S. District Court for the District of Oregon, asserting that certain of our products infringe three patents held by AgaMatrix. (After filing suit, AgaMatrix reorganized its business and the Court granted AgaMatrix&#8217;s motion to substitute the newly created entity WaveForm Technologies, Inc., as the plaintiff following AgaMatrix&#8217;s transfer of the three asserted patents to WaveForm.) DexCom filed petitions for </span><span style="font-style:italic;">inter partes</span><span> review with the Patent Trial and Appeal Board, or PTAB, of the U.S. Patent and Trademark Office, challenging each of the three asserted patents as being unpatentable in view of prior art. The PTAB issued a Final Written Decision for each of the first two patents on February 28, 2018, where the PTAB found the majority of asserted claims from the first patent unpatentable and the remaining claims under review not unpatentable. The PTAB found all claims under review from the second patent not unpatentable. On September 12, 2018, the PTAB found all of the asserted claims in the third patent unpatentable. In October 2018, we filed in the District Court a motion for summary judgment that all remaining asserted claims are invalid. The District Court granted that motion and, on August 23, 2019, entered judgment in our favor. On September 6, 2019, WaveForm appealed the judgment. The appeal is pending and no hearing date has been set.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have also filed several lawsuits against AgaMatrix. We filed a patent infringement lawsuit against AgaMatrix in the United States District Court for the Central District of California, or C.D. Cal., in which a Final Judgment of non-infringement was entered by the C.D. Cal judge on February 23, 2018 and affirmed on appeal by the Federal Circuit on March 7, 2019. AgaMatrix was awarded attorneys&#8217; fees for this lawsuit.</span><span style="font-family:inherit;font-size:10pt;"> As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we have accrued an immaterial amount for those fees. </span><span style="font-family:inherit;font-size:10pt;">The fee decision is currently on appeal to the Federal Circuit. On September 15, 2017, we filed a patent infringement lawsuit against AgaMatrix in the United States District Court for the District of Delaware, asserting certain single-point blood glucose monitoring products of AgaMatrix infringe two patents held by us. In addition, on September 18, 2017, we filed a Complaint against AgaMatrix in the International Trade Commission, referred to as the ITC, requesting that the ITC institute an investigation and issue an order excluding certain products of AgaMatrix from importation into or sale in the United States based on AgaMatrix&#8217;s infringement of the same two patents asserted in the Delaware litigation. The investigation was terminated by the ITC on April 4, 2019 with a finding of non-infringement. The decision is currently on appeal.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Neither&#160;the outcome of these lawsuits nor the amount and range of potential loss associated with the lawsuits can be assessed at this time. Other than the attorneys&#8217; fees described above, as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> we have accrued </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> amounts for contingent losses associated with these suits.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters. </span><span style="font-family:inherit;font-size:10pt;">We do not expect that the resolution of these matters would, or will, have a material adverse effect or material impact on our financial position or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>74
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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MZ-!3 EYR8'*:&$YCU\(5,,$(HTO?!30+<:[^B9T[P,[),=DE-0Q#.31S+N_
MX>WI\65>M[ ^D?(:\Z]D!9T"KMEE\FOSL-EMF:RKNBJJNN#-CM\+?BM6J_?)
M]8??5=CUQN[M/S:^",H6?MV%_ )02P,$%     @ *HI-4)E<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M:/VG<?#]8%[RUNWK\J_BV)TW@0E61W?*W\KN:WW[V<T#2H/5//I?W;LK^_A
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M-*;55J3MHNN<=7YXG!3ZV':'L3VNAV?[X:0UU_&]A?]X>;+Y#U!+ P04
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ME@_E&6,&N4AWS?75O-=."P3/3$P3/B>JXZ@%P_W83)VIHQ?_ %!+ P04
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M#OY/;]KJ.'ZI87W^9L7M_U!+ P04    "  JBDU0YD0\\K !  #2 P  &
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MU09\V=3_QMH *&5WAR/4X0=;# 5-B,>W>';3F$U&L/W\@]CRC<M?4$L#!!0
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M^9>-_2\1'7@IJRL_0K7_8).AH'3AN/-G,XS98#ALQQ_$IF^<_0-02P,$%
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M;,"73?UOK V 4G8W.$(=?K#%4-"$>+S'LYO&;#*"[><?Q)9O7/X"4$L#!!0
M   ( "J*35"ZM=>GM@$  -(#   9    >&PO=V]R:W-H965T<R]S:&5E=#$V
M+GAM;'U386_<( S]*X@?4')<UMU.2:1>IVF35NG4:=MG+G$25 @ID$O[[V=(
MFF5;M"^ C=_SLS'9:.R3:P$\>=&J<SEMO>^/C+FR!2W<C>FAPYO:6"T\FK9A
MKK<@J@C2BO$DN65:R(X66?2=;9&9P2O9P=D2-V@M[.L)E!ESNJ-OCD?9M#XX
M6)'UHH%OX+_W9XL66U@JJ:%STG3$0IW3N]WQE(;X&/!#PNA69Q(JN1CS%(PO
M54Z3( @4E#XP"-RN< ]*!2*4\3QSTB5E *[/;^R?8NU8RT4XN#?JIZQ\F],#
M)1748E#^T8R?8:[G'25S\5_A"@K#@Q+,41KEXDK*P7FC9Q:4HL7+M,LN[N-T
MDQYFV#: SP"^  XQ#YL21>4?A1=%9LU([-3[7H0GWATY]J8,SMB*>(?B'7JO
M!=\?,G8-1'/,:8KAJYC=$L&0?4G!MU*<^#]PO@W?;RK<1_C^#X4?M@G238(T
M$J3_+7$C)DW^2L)6/=5@FSA-CI1FZ.(DK[S+P-[Q^":_PZ=I?Q"VD9TC%^/Q
M96/_:V,\H)3D!D>HQ0^V& IJ'X[O\6RG,9L,;_KY!['E&Q>_ %!+ P04
M"  JBDU0O<LAW+,!  #2 P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-RYX
M;6Q]4]MNU# 0_17+'U#O>@-4JR12MPB!!-*J"/KL32:)55^"[6S*WS-VTC1
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M$82IL$@)1<I; DH]$8#)4RQ209$*$/B]C3"!]F0I=E **#+?0@@T">@$G,H
MQ=370: \H /M^L (4!2^#@*5 1WL:Y;=4.1^GP$,Y8%&8]C]#%B[\%L-@@(A
MQW  ,.#NPH\9" KD#,,9P(#!LYLV * BU&XX!ACP>'&C@T"A=L-)P(#-BYMV
M0Z!0N^$P8,#I1>7K % 9R!S"<4# Z:6?.A 4B!W"<4# Z:4?.Q 4Z /"<4#
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M_?3.S?7TEJ>%5?W<IF3Y5Q2_ 5!+ P04    "  JBDU0$ 9S_10"  "<!@
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MA,:%XYT_FVG,)L-A/_\@MGSC\B]02P,$%     @ *HI-4-!Z%%(B P  '@X
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ML1 94%EJ-P4(&ML;L10)2#&U-V $&NNEA!5#0#'I2$D(*X:N4 QAQ=!G%(-
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MF&Y#R4GJ9:36O!GFS4:RJKVH.-UM*?D'4$L#!!0    ( "J*35"['(:.VP$
M &($   9    >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;'U466[;,!"]"L$#
MF-9BMS4D ;&#H 5:P$C1])N61@O"125I*[U]N<B*8@O],3FC]]XLG'$V2/6J
M6P"#WC@3.L>M,?V.$%VVP*E>R1Z$_5)+Q:FQIFJ([A70RI,X(_%ZO26<=@(7
MF?<=59')LV&=@*-"^LPY57_WP.20XPA?'<]=TQKG($76TP9^@OG5'Y6UR*12
M=1R$[J1 "NH</T2[0^KP'O#2P:!G=^0J.4GYZHQO58[7+B%@4!JG0.UQ@0,P
MYH1L&G]&33R%=,3Y_:K^Y&NWM9RHAH-DO[O*M#G^C%$%-3TS\RR'KS#6L\%H
M+/X[7(!9N,O$QB@ET_X7E6=M)!]5;"J<OH6S$_X<1OTK;9D0CX1X(D3;_Q*2
MD9"\$WPW2<C,E_I(#2TR)0>DPF/UU,U$M$ML,TOG]+WSWVRUVGHO11JE&;DX
MH1&S#YAXAHDF!+'J4XAX*<0^OJ/''P,<[A';9#E"LEA$XOG)/$*T619(%P52
M+Y!^Z,+FI@L!L_$8$8*LMC>%W&.BU9>;1,CL:3BHQD^Q1J4\"^.:,/-.B_(0
MNZ>]\>_M H5Y?Y<)V_>#JJ83&IVDL8/CG[>6TH!-<;VRV;5VX2>#06W<]9.]
MJS#VP3"R'S>:3'\KQ3]02P,$%     @ *HI-4"[#K=42!   /A0  !D   !X
M;"]W;W)K<VAE971S+W-H965T,S,N>&ULE9C;<J,X$(9?A>)^ (FSRW95["3C
M.&Q5:K9VYYK8LDT-( _@>/;M5QQ,H-5@DHL8Y.]O_5*WA,S\RK-?^8FQ0OF3
MQ&F^4$]%<9[I>KX[L23,-7YFJ?CFP+,D+,1M=M3S<\;"?25*8IT:AJ,G892J
MRWG5]I8MY_Q2Q%'*WC(EOR1)F/VW8C&_+E2BWAI^1,=343;HR_DY/+*_6?'/
M^2T3=WH;91\E+,TCGBH9.RS4!S(+J%D**N+?B%WSSK52#N6=\U_ES<M^H1JE
M(Q:S75&&",7'!UNS."XC"1^_FZ!JVV<I[%[?HC]7@Q>#>0]SMN;QSVA?G!:J
MIRI[=@@O<?&#7S>L&9"M*LWH _;!8H&73D0?.Q[GU7]E=\D+GC11A)4D_%-_
M1FGU>6WBWV2X@#8"V@I$WV,"LQ&8GP)K5& U FNJP&X$]E2!TPB<J0*W$;A3
M!5XC\*8*_$;@3Q40XY8YXU/BC$O:9)/)O=S232B0Z'5A597Z&!;A<I[QJY+5
MB^T<EFN:S(1*!"];J]JOOA35FHO6CZ5%G+G^449JF%7-T![C]IFMS)"6T(6%
MU@=%?:RHI*?]'M8R81&OSSQBC-]GGA"&&GWF668<LX]\Q\*0/K/!&#"L%XP!
M?6WO3L[K?<.!C!##QW-DXK5B5A',GE4+CV#A$:PJ@M7U0&U0;35C5TQ:,3[5
M0+FM9<BR-5@-,O2-&!KH[PFAJ*.!JGG&8KD^]/4=\>5H8#UM9,@T-%@7F"T+
M4EN9(@;10!V^8N:I"[$ P>RNL5Z&;3S#-I)AN)_43+E!?KK6#.!FC5!2\AX1
MZ)NA$3!-3S@&5L@S1E'-@"L?-P:H#4J9%L@R;HR"2MZB,T9@FK%@1+- GP'>
MI^WA>7;P/#M(GH'K5<VX7=,@Q\Z4'",0EF,<@SG&*"3'N#'0Y0:EI!SCQJ0<
M(YB\DK%82(KQ+H=2[.(I=J446W"SWM:,U]VLQ5+VNW]@!++"\^"V%B"0TTEE
MS[V'N_<0]V CVGJR>PHKYE6&$,,(-&C8QPW[B&$7CU F%CW,&=.?T&3H0$@0
M'[!6&\CI%CZ8MOM(,(KTS>*GQ@="$;,#AQHR<*HA7SC6D(%S#9$/-LBD65*1
M$%A(KPTT.FUC2-_NP$.:R$]IRQR*,?  (,X7IFU@AR'8%B--FWN_UNXBP2C2
M-SNPH1!D1S$'?N20@35._.F31@<6.34F3%H#C4W:?2081?IF!W83BNPFYL")
MD@XL<DJ_,&D#BYR:4R;-O#]I=Y%@%*G-ZIV?YPG+CM6+J%S9\4M:E /MM+8O
MNQYH^?,>M*_([(4@[5LR"^I769_AZS=K?X79,4ISY9T7!4^J7_X'S@LFG(L#
M@JJ<6+AO;V)V*,I+5UQG]1NM^J;@Y^9MG=Z^,ES^#U!+ P04    "  JBDU0
M)#'OD[ "  #="@  &0   'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6R55MN.
MVC 0_94H'T#B7&$%D8"H:J560ENU?39@(-HD3FT#V[^O[9AL+@,;7HCMG#D^
M<[ G,[]2]L9/A CKO<A+OK!/0E0OCL-W)U)@/J$5*>6; V4%%G+*C@ZO&,%[
M'53DCN>ZD5/@K+23N5[;L&1.SR+/2K)A%C\7!6;_5B2GUX6-[-O":W8\";7@
M)/,*'\E/(GY5&R9G3L.RSPI2\HR6%B.'A;U$+RF:J0"-^)V1*V^-+97*EM(W
M-?FV7]BN4D1RLA.* LO'A:Q)GBLFJ>.O(;6;/55@>WQC_Z*3E\EL,2=KFO_)
M]N*TL*>VM2<'?,[%*[U^)2:AT+9,]M_)A>02KI3(/78TY_K7VIVYH(5AD5(*
M_%X_LU(_KX;_%@8'>"; :P)0]## -P'^1T#P," P 4$OP*E3T=ZD6.!DSNC5
M8O7?6V%UBM!+(-W?J45MMGXG[>%R]9($OC]W+HK(8%8UQFMA4(-P)'NSA0=M
ML?(&X5YW@_40$?4TI$,(<F>P"A],U-<$?B?1 "8(0() $P0=@K#G5(V9:DQ9
MJPPF42]; !1/>I:D0U \N>-Z",H- ;D13!"!!-%XPV*0(!YA6(V)6FFZ/;?B
M@1%NRXC:+ AS1^H4E#H%I,8PP0PDF(TW"[GP171'V&5 W4S[MPD >9.X9]DG
MH*[B.Z4# 8K=.Q1@:5@B[PG?X'N-_#&^^8-LPZ%O(T"I <$GMJL7+B,(JB/3
M.Q3PU4;A$Z[!EQM%8UR+!KD&?<\^A:0/(5VM<!U!4"&Y4_L1?+_1] G'X!N.
M9F,<FXTY9R- J0$].F=.ZQM?$';4_1.W=O1<"O6I;*TV/=K24SU";WVE>C?=
M.WS0U(W?#\R.6<FM+16R ]%]PH%20:1"=R)/X4GVFLTD)P>AAK$<L[KAJB>"
M5J:9=)J.-OD/4$L#!!0    ( "J*35 I[E*3E@(  *0)   9    >&PO=V]R
M:W-H965T<R]S:&5E=#,U+GAM;)56ZV[;(!1^%<L/$!L,ME,ED=9FT29M4K5I
MVV^:D,2J;3P@2??V TPS7X[;[(\-^+N< QS,XB+DLSIRKH.7JJS5,CQJW=Q%
MD=H>><743#2\-E_V0E9,FZX\1*J1G.T<J2HC',=I5+&B#E<+-_8H5PMQTF51
M\T<9J%-5,?GGGI?BL@Q1^#KPK3@<M1V(5HN&'?AWKG\TC]+THJO*KJAXK0I1
M!Y+OE^$'=+=!J24XQ,^"7U2G'=A4GH1XMIW/NV48VXAXR;?:2C#S.O,'7I96
MR<3QVXN&5T]+[+9?U3<N>9/,$U/\092_BIT^+L,\#'9\STZE_B8NG[A/B(:!
MS_X+/_/2P&TDQF,K2N6>P?:DM*B\B@FE8B_MNZC=^^+U7VDP 7L"OA(0>9.0
M>$)R*X%X KF50#V!WDI(/2$=$*)VLMSLKYEFJX44ET"V&ZAA=I^BN]2L[]8.
MNN5TW\P"*#-Z7A$2+Z*S%?*8^Q:#>QC4QSR,,;B/6(\1:=*'?!Q#4#SO8S90
M,/^L(I/L-6,,9HR=0-(32&"!!!1(G #I1HG2P72TF,QA:H<93.JZ1= . J-L
ME@UFY"V=7J@$#)6,0B6$P (4%*"W3U8*"J1 !'2PO])1DIA.I)F!)AE@,EB1
M^Q:3=DQ03N+Y5#8Y:)2_O_3K_)V%[=G,09LYD,]@9VQ:#(J[":%\AG/8R *A
M\H\!JRF)B1,$W;Y'$%R2"-]04A[4G=AD-E'Y"*Y<-"Y=0N;#TVY<<SBC$SYP
MV2&@[NCH5"7_X0-7)Z* S^ADIJ.=CV-38$DZX047,@(JF>)A3A!HN!>BSK_)
MWE^^,GDH:A4\"6U^<^YGM!="<R,8STSP1W-ENG9*OM>VF9FV;.\-;4>+QM^)
MHNO%;/474$L#!!0    ( "J*35"%$RA-I@0  'D;   9    >&PO=V]R:W-H
M965T<R]S:&5E=#,V+GAM;)59ZVZC1AA]%8L' .9N1[:EKJM5*[52M%7;W\0>
MQ]:"\0*)MV]?+A/+S)PAPY\8R)GOQG<.W\#Z5E;?ZY/6S>)GD5_J371JFNM3
MDM3[DRZR.BZO^M+^YUA61=:TI]5K4E\KG1WZ146>T#2529&=+]%VW5][KK;K
M\JW)SQ?]7"WJMZ+(JO^^Z+R\;2(2?5SX=GX]-=V%9+N^9J_Z+]W\?7VNVK/D
M;N5P+O2E/I>71:6/F^@7\K23O%O0(_XYZUO]<+SH4GDIR^_=R>^'391V$>E<
M[YO.1-;^O.N=SO/.4AO'#V,TNOOL%CX>?UC_VB??)O.2U7I7YO^>#\UI$RVC
MQ4$?L[>\^5;>?M,F(1$M3/9_Z'>=M_ NDM;'OLSK_N]B_U8W96&LM*$4V<_A
M]WSI?V_&_L<RO(":!?2^@/#)!<PL8-:"9(BL3_77K,FVZZJ\+:KA;EVSKBG(
M$VN+N>\N]K7K_]=F6[=7W[=<\'7RWADRF"\#ACY@Z!BQ<Q&2W2%)&\ ]"@JC
MH/UZ-HI"8 ,,&F"] 3XR(*TT!HSJ,9<AC0<G0R( (R4.A,- . A$64X&C'QP
MPI;8AX ^!/"QM)(=,,L''R1=JIA8H;@P2M+8D[&$T4@G&F4WD'2\I+'"/A3T
MH4#&*\N)<C-FG,96878N3!#NRW@)HUFZT<@4&UA! ZOP=B<IIFT:T/ &-"I)
M>W?M'D"PU2KV$)AX=(0$-+X!A70^P4)!:$#O&]"CF]2.9 HR#@0+#G$5QVE[
M@PGJ>X+EA" ]L3O?@.S[;'<^@%&FO/<9:P\!XB.)QP06#")GM#_6 X($P6E_
MH B<QRN[+"Y,2N]MPHI @"2XW;\,[CDL&V05TORK,.4'N GIIUB&J"M##@L,
M)B!MBJ6%(FFQ.4!=:2&4V7.*08V25EX*4,^P C1(4H\)K!Z4A5. 8F6@2!EL
M"E!WU+"5<!(R#@0K D7CB-W[!A3B!8L&=<<,M_<-:#+=*<@X$"P]U)4>M^55
ML!.L)Q3IB=/R4WIBL@V6'(HEAP+)\8WV#&L$2V<,]U@!&%( ^^8S5P&DL@BQ
M8ZX $,5BSP.,80%@2 "XQX1GOS)# !@6 (8$P"G*YP(P"1D'@@6 H9' EPMF
M-YLQ$C#,2X9& J<<+C%!CX"Y8:)',(,9VB1X'JX,<X_-V"9PS#V.M@EV4?C4
M ]KL6(.?X1PSF ,&2\^,Q3'K^(R7!!RSCJ/7!$XYW*F=\F5LCQ( QF3L&0.X
MYV4!H+#T;(@X)A\7,ZJ"R<=#'JW\\T?K)&0<"*8P!Q26*X\)3#N^G%$.3#L>
M,F5S,#VC)G%A_B81F,,"<%AY"BLP^P0)KXK [!,A&V_Q^<9[$C(.!'-8  XK
MCS8+3#O!9Y3#\PHNZ!T<> DGJ;,!13#?ED1@"@M 8>5K,TP^H684!9-/H*G5
M*<KG4^LD9!P(IK  %%:>BDK,.CEC:I68=3)D:I5@( 4]@F"^'I&8P1(P6'FF
M5HFY)V=,K1)S3X9,K0:D)GID$C($DCQ\ ^D^2OV95:_G2[UX*9NF+/J/'L>R
M;'1K+HU;#IYT=KB?Y/K8=(>J/:Z&CT'#25->S8>NY/ZU;?L_4$L#!!0    (
M "J*35 7>.?Q>P(  -8(   9    >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM
M;)56VXZ;,!3\%<0'+)@[*X*4BZI6:J5HJVZ?'>($M 93VPG;OZ]M",O%8=,\
M@'V8,YXYP3XD#:%O+$>(&^\EKMC*S#FOGRV+93DJ(7LB-:K$DQ.A)>1B2L\6
MJRF"1Y548LNQ[< J85&9::)B>YHFY,)Q4:$]-=BE+"']NT&8-"L3F+? 2W'.
MN0Q8:5+#,_J)^*]Z3\7,ZEF.18DJ5I#*H.BT,M?@>0=\F: 0KP5JV&!L2"L'
M0M[DY-MQ9=I2$<(HXY("BML5;1'&DDGH^-.1FOV:,G$XOK%_4>:%F0-D:$OP
M[^+(\Y49F<81G> %\Q?2?$6=(=\T.O??T15A 9=*Q!H9P4Q=C>S"."D[%B&E
MA._MO:C4O>GX;VGZ!*=+</H$$"PFN%V"^Y'@+29X78(W2;!:*ZHV.\AAFE#2
M&+3]>VLHWR+P[(GJ9S*HBJV>B?(P$;VF7N@GUE42=9A-BW$&&- C+,'>+^'H
MEM@XLW1GO,!VC@C<,60WAP [UJMPM49=1> .C?J^GL#3$GB*P!M5*IA4JL6$
M"E,IC#VQNH08B?"U(GR-B' BHL4$"R*6$",1@59$,!/ASBH1?"KB4\0N>+16
MH59FJ*E5I">(M 31XZ],K"6(-0KB2:'BF<G(5K])N>)9N0)[ API K9^O]MS
M3=$]BCM'!GB\+D![)*R!HU$!)HX[T-"RLV18O^^!JUG*N4.AW_G ^P_#^GT+
M-!LW<J>&_=F[X.D,6X/#O43TK!HG,S)RJ;@\(P?1OCFO'=D<)O&-;-JJ:7S0
MM!W_!Z3GHF+&@7#1>E2#.!'"D9!I/PF9N?C(Z"<8G;@<AF),VT[;3CBINZ\(
MJ_^42?\!4$L#!!0    ( "J*35!L<FW[!P(  /,%   9    >&PO=V]R:W-H
M965T<R]S:&5E=#,X+GAM;(U4[8Z;,!!\%<0#Q'P'(D#JI:I:J96BJWK][< 2
MT!E,;2=<W[ZV(8B 5>4/]BZSXYD%;SI0]LYK &%]M*3CF5T+T1\0XD4-+>8[
MVD,GWU24M5C(D%T0[QG@4A>U!'F.$Z$6-YV=ISIW8GE*KX(T'9R8Q:]MB]G?
M%R!TR&S7OB=>FTLM5 +E:8\O\!/$K_[$9(1FEK)IH>,-[2P&569_<@_'1.$U
MX*V!@2_VEG)RIO1=!=_*S':4("!0",6 Y7*#(Q"BB*2,/Q.G/1^I"I?[._L7
M[5UZ.6,.1TI^-Z6H,SNVK1(J?"7BE0Y?8?(3VM9D_CO<@$BX4B+/*"CA^FD5
M5RYH.[%(*2W^&->FT^LP\=_+S 7>5.#-!6[PWP)_*O!7!6A4IJU^Q@+G*:.#
MQ<:/U6/U3[@'7S:S4$G=._U.NN4R>\N#.$C131%-F)<1XRTPWB/BN$5$_@Q!
M4L"LPC.J\'2]OU01AF8"WTC@:X+@P4:XLC%B0HWI1AMNZ.SBE9<MS/639 %[
MD!,8Y00;.9+#3! :"<+G&Q(9":(G&C)BXH73.-GV8XL* V?GF<7LC6+VVW8$
MCID@-A+$S[<C,1(D3[1CQ.R7']Z+G%4WDLW?$8?)+EII08OKI\;A#\PN3<>M
M,Q7R)NO[5E$J0#(Z.TE6RPD\!P0JH;9[N6?C'!H#0?MIQ*)YSN?_ %!+ P04
M    "  JBDU0(:0=IZD#  #%$0  &0   'AL+W=O<FMS:&5E=',O<VAE970S
M.2YX;6R5F%%OFS 0Q[\*XGV SV!(E41J.TV;M$G5IFW/-'$2-, 9D&;[]C/&
MS0AWSMA+ .?ON[/O^&%[>5;-C_8@9>?]JLJZ7?F'KCO>A6&[.<@J;P-UE+7^
M9Z>:*N_T8[,/VV,C\ZWI5)4A1)$(J[RH_?72M#TUZZ4Z=651RZ?&:T]5E3>_
M'V2ISBN?^:\-GXO]H>L;PO7RF._E%]E]/3XU^BF\6-D6E:S;0M5>(W<K_Y[=
M/?*X[V 4WPIY;D?W7C^49Z5^] \?MBL_ZB.2I=QTO8E<7U[DHRS+WI*.XZ<U
MZE]\]AW']Z_6WYG!Z\$\YZU\5.7W8ML=5G[F>UNYRT]E]UF=WTL[H,3W[.@_
MRA=9:GD?B?:Q465K?KW-J>U49:WH4*K\UW M:G,]6_NOW>@.8#O I0,3-SMP
MVX'_[6!F,QPB,T-]FW?Y>MFHL]<,V3KF?5&P.ZXG<],WFKDS_^G1MKKU91UG
M8AF^](:LYF'0P$C#+HI06[^X ,K% Z#N@E][>,02H#UP<A#<=.=7@TAI S%I
M(#8&XBL#V606!DUJ-/6M&!/214*X6$Q<#!HQ<L$%[4.0/@3VL8@F/@3R$=$N
M4M)%2KA@$Q<I'D9&^\A('QE.9^(PL" -+&:D<]!DXW2R*$@GA3FHDI&*19D(
M',7%(OH=BV;DWHKHQ S!6,DXYBA('*$X7G<VHT2L:.SG312P:33_4%V'0Z+A
MGL&,<K*B::K$-!XLT[E*G1'1*&%\1NU8T75$X*P*FCF,@@ZJBG@V$AC-'4:
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M]P<*1V6VCWHOW$1S!\6;;EBC_A\C_P=02P,$%     @ *HI-4.!EL4+G 0
M[ 0  !D   !X;"]W;W)K<VAE971S+W-H965T-#(N>&UL?531CIP@%/T5XWM%
M44=GHB9=FZ9-VF2R3=MG1J^C610+S+C]^P*ZQG5(7P0NYYQ[CB+9Q/B+: &D
M\]K30>1N*^5X0DA4+?1$>&R$0>TTC/=$JB6_(C%R(+4A]11AWS^@GG2#6V2F
M=N9%QFZ2=@.<N2-N?4_XWR>@;,K=P'TK/'?75NH"*K*17.$'R)_CF:L56E7J
MKH=!=&QP.#2Y^S$XE;'&&\"O#B:QF3LZR86Q%[WX6N>NKPT!A4IJ!:*&.Y1
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M!==*U!H[D3?FU]F=&RF*CD5)*=A[^\Q*\[QV_+<P/ "Z .@#R.*_ ;0+H*,
MOU5F4OW$)%LO:W%UZO9K54P7!7FBRLR=GC3>F?]4MHV:O:Q#$B_]BR;J,,\M
M!@88N$=L;$1$>XBO!/0J %4!)I[>J4AP HH24$.PN"-(1VFTF-!@2H-90.31
M42HV"B+P4ES, A6SL,5 ,!+38J+!,A]($(ZTM*!D"(I3;\*8$-42(EK(2$MH
M+4.!6,;8*))0C^!B(E1,A(@!G"!&">+Y=9*@!,F,.DGL1$-O_&D2Z_M%N(X4
MU9%:.F@2XP0DP!LWF.\%F>A],L.-#G1G!PQJL-L B.7'1,L0? <@@#BRF*#
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M3*KK80YQQ9@$1>>YJEVMGK4IH%!)/4W5G-O+;0/)^O'=PM/CF?\#4$L#!!0
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MC&%^$0 PIF,6BFYPEF @$4 D%NH-8,;C&;KXOHQ0]FUAS)$ V#+N"Q)-=$=
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MV]I&]KWCN3R>F.AP-ZLS/I*?A/TZ/[6\Y0XL^[(F35?2QFK)86T_HH<"9<)
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M'C;J.T9VH">QZ\@>:X]9(VK-;[*T:+>&;4526S$A!KT1M2=Y\%>*(5=B4Y'
M5 RW)\#PR] _B2F,M0)8DR36B,['5R<PW<S[2Q?]I<M>TG9WL;,H8!IQ$IM#
M$8.(PLZBP'(HSD_S1C1@*Z"8/1#R#A6WI@8D 84=1B'ST'%#FO(1PE7"F)G"
M)J. R9 < $7<F\(&H\!BA)@S$@4.-&PM"ED+00*(V/Y@6U' 5H)FJL"VH@;8
MBL:VHH&MA/CM:4JUQ ;PT$O:#@P;@ 9LQV ^-*+SULR%UK -:+# (#MG36U
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ME%(/,S7F0W,<)I)UMO&C\>]3_ -02P,$%     @ *HI-4 ?R2*!! P  P@T
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M*)R5V>9Z+]R,<8;BPS0^T3S#Z[]02P,$%     @ *HI-4!C_D,X[ @  %@<
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MIBV'DWKH:-&-MQ"9KL+B+U!+ P04    "  JBDU0^'T4WSH"  #:!P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6R-5>UNFS 4?17$ Q2;SU 1I#7M
MM$F;%'7J]MM);@*JP<QV0O?VLXU+0^)L_,%?YYQ[C_&UBY[Q5U$!2.^MH:U8
M^I64W7T0B&T%#1%WK(-6K>P9;XA40WX(1,>![ RIH4&(4!HTI&[]LC!S:UX6
M["AIW<*:>^+8-(3_>0#*^J6/_?>)Y_I023T1E$5'#O #Y$NWYFH4C"J[NH%6
MU*SU..R7_B=\_X1C33"(GS7TXJSO:2L;QE[UX.MNZ2.=$5#82BU!5'."%5"J
ME50>OZVH/\;4Q//^N_IG8UZ9V1 !*T9_U3M9+?V%[^U@3XY4/K/^"UA#B>]9
M]]_@!%3!=28JQI918;[>]B@D:ZR*2J4A;T-;MZ;MAY4LMS0W(;2$<"2$BW\2
M(DN(YA)B2XCG$A)+2#X(P_8.WLUF/A))RH*SWN/#>>B(/G;X/E&_:ZLGS=\Q
M:VH_A9H]E6D>%<%)"UG,PX ))YAXBEFY,,D4\^C"I%/,DP.3?>03*"^CH=!I
M*#0"T21(YA:(G *1$8@G HN++ =,9C"MP2!WB-@9(G:$R-T"B5,@F6\R=0JD
M5QED"%W\T@&3GID,W2$R9XALOLF%4V QWV3N%,@=)O'%F<RO3-XX;1BYZP<Y
M@MS8)WRC!/%\H]A]Z'$XPZH%S?'JK@Q\71H9NKHLHKG'!KN+ U]71X;B2R_Q
M?[T$9U>@?O6^$WZH6^%MF%2WJ;GS]HQ)4'+H3A54I1[:<4!A+W4W4WT^O#;#
M0++.OJ3!^)R7?P%02P,$%     @ *HI-4!W);N<X @  108  !D   !X;"]W
M;W)K<VAE971S+W-H965T-3@N>&UL?57;CILP%/P5Q/MB;G%(1) VB:I6:J5H
MJVV?'>($M 93VPG;OZ\OA"7&W1=L'V;&<P[V(>\I>^,5QL)[;TC+-WXE1+<&
M@)<5;A /:(=;^>9,68.$7+(+X!W#Z*1)#0%Q&$+0H+KUBUS'#JS(Z560NL4'
MYO%KTR#V=XL)[3=^Y-\#+_6E$BH BKQ#%_P3B]?NP.0*C"JGNL$MKVGK,7S>
M^,_1>@\57@-^U;CGD[FG,CE2^J86WTX;/U2&,,&E4 I(#C>\PX0H(6GCSZ#I
MCULJXG1^5_^B<Y>Y'!''.TI^UR=1;?S,]T[XC*Y$O-#^*Q[R6?C>D/QW?,-$
MPI43N4=)"==/K[QR09M!15IIT+L9ZU:/_:!_I[D)\4"(1T($/R4D R'Y(*2?
M$M*!D%H$8%+1M=DC@8J<T=YCYNMV2!VB:)W*ZI<JJ(NMW\GR<!F]%<MPD8.;
M$AHP6X.))YAH1 "I/FX1N[;8QC-Z_+C!;HZ R2-D/X=$X<KM(G$FFFB!9.HB
M@6Z!U"F0:H'TH5+0JI3!+#2F-2ZC51!9Z<Y13W$6V!D[M.(@=3M>.!TO'(Z7
MEF.#R:9>HC1868X=J%466)]Q;U!PBH+_.2G0:1C.#$=)9AF&\[*$J6UE-T<]
M13$,K).]=\#2++"/!9A<I@:SBVY4W"OIM17J3$ZB8R]\CM5EM.);V2--2_N0
M,0WV!V*7NN7>D0IYU?6%/%,JL#09!M)?)7OZN"#X+-1T*>?,=#:S$+0;FC88
M_QS%/U!+ P04    "  JBDU0'L;'(,4"  "&"@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970U.2YX;6R-EEUOFS 4AO\*XKX! X$D(I&2H&F3-JGJU.W:29P$
M%3"SG:3[]_-7*=@.RTW!YCVOG^.>V">_8?)&SP@Q[[VN&KKTSXRUBR"@^S.J
M(9W@%C7\RQ&3&C(^)*> M@3!@PRJJR *PS2H8=GXJUS./9-5CB^L*AOT3#QZ
MJ6M(_FY0A6]+'_@?$R_EZ<S$1+#*6WA"/Q%[;9\)'P6=RZ&L44-+W'@$'9?^
M&BP*$(L J?A5HAOMO7LBE1W&;V+P[;#T0T&$*K1GP@+RQQ5M454))\[Q1YOZ
MW9HBL/_^X?Y%)L^3V4&*MKCZ71[8>>G/?.^ CO!2L1=\^XIT0E/?T]E_1U=4
M<;D@X6OL<47E7V]_H0S7VH6CU/!=/<M&/F_J2Q;K,'= I .B+@"DHP&Q#H@_
M Y+1@$0')$9 H%*1>U- !E<YP3>/J']O"T45@47"=W\O)N5FRV]\>RB?O:ZR
M<)8'5V&D-1NEB7H:T"D"[MXM$;F6V$16>#1<8&LKTG@H*6P)".=NBMB9:"P-
MXD&B=PP2IT$B#9*^ 0B-G5*:3&H:J3$4V_\JBC'% '/JQ)PZ,(&!J31I;PE#
ML56*64\133(#U-:$DSN%D3I14P>J41J;U%H$3.8&K*WI@RA8E\_4#9LY83,'
MK%&DF\RQ:R:L2V/\X I; R:I&W;FA)W9Q0X2M\'<:3!_H-CG5A69Q3ZW\G@"
M5AF-V0Q(0>@^P<('*EZ+QF"U9$ ;]FI$T8X:#7'O'+C@@:K7HF%)FZ>F%HWD
M5(Q*AK3.LWL-(@?MU*2-'J&U14^1J2JTZA%@]S$/8@=P:@(KT;2W2FR>&%N'
M*)RD)J\MLG^J0>\RKA$YR4:'>GM\:9BXTWJS73.UCL1E;LQO1),E+_E/&]6A
M_8#D5#;4VV'&6P5YH1\Q9H@S\AKVO3-O"KM!A8Y,O&;\G:C.2 T8;G77%W2M
MY^H?4$L#!!0    ( "J*35")]47^M0(  'P*   9    >&PO=V]R:W-H965T
M<R]S:&5E=#8P+GAM;)56VX[:,!#]E2@?L(GMW%@!$E!5K=1*:*NVSR88$FT2
MI[:![=_7=K)9B(>(\D!L9V;.G/$<9>87+EYEP9CRWNJJD0N_4*I]#@*9%ZRF
M\HFWK-%O#ES45.FM. :R%8SNK5-=!3@,DZ"F9>,OY_9L*Y9S?E)5V;"M\.2I
MKJGXNV85ORQ\Y+\?O)3'0IF#8#EOZ9']8.IGNQ5Z%PQ1]F7-&EGRQA/LL/!7
MZ'F#K8.U^%6RB[Q:>X;*CO-7L_FZ7_BAR8A5+%<F!-6/,]NPJC*1=!Y_^J#^
M@&D<K]?OT3];\IK,CDJVX=7O<J^*A9_YWIX=Z*E2+_SRA?6$8M_KV7]C9U9I
M<Y.)QLAY)>V_EY^DXG4?1:=2T[?N63;V>>G>I+AW@QUP[X '!Y1,.I#>@7PX
M1)9\EYFE^HDJNIP+?O%$=ULM-4V!GHDN9FX.;>WL.\U6ZM/S,D7I/#B;0+W-
MNK/!5S9HL AT] $"0Q!K[+CC6X"-:Y$0&(& )(CU)S<D,CA ! :(;(#H)L!L
M5(7.)K4V34<#A>8' \4@4.P"X7 $U-DD5T"$8'P+U=4M=E(B))Q**@&32H"D
MT"BIQ$DJCM,)I!1$2@&D43.L4X?4'8@,A,@ "#*"<&U(EL @,Q!D!O3+G2Q1
M".LN?+QGT1WI(H!J--8N<LH9D2R;N#D$JGB%,( 6C]&PVR91- 4&"QH1 "P9
M@Q$';*KW$2Q]!&@?IW="P*)&\7_<)2Q!!&G0N4M7A 1'DYQA&2)(A\Y=INY=
MXBG)(UB0"%+DO>K <D.SQPN,8;WA\($"]T8W'35=8 Q+$T/2'']0L"M-#$$%
M5]_RFHFC'7NDE_-38V>NJ]-AM%K9:2/X,._FLN]4',M&>CNN]$1AO_L'SA73
MZ81/NHL+/0H.FXH=E%FF>BVZ>:C;*-[VLUXP#)S+?U!+ P04    "  JBDU0
M313L"=L"  !#"P  &0   'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q]EMV.
MFS 0A5\%<;\&V_RNDDA-JJJ56FFUU;;7WL1)T *FV$FV;U_;$,3:0W,1;'-F
M_,T 1U[=1/\FSYRKX+VI6[D.STIUCU$D]V?>,(E$QUM]YRCZABD][4^1['K.
M#C:HJ2,2QUG4L*H--RN[]M1O5N*BZJKE3WT@+TW#^K];7HO;.L3A?>&Y.IV5
M68@VJXZ=^$^N7KJG7L^B*<NA:G@K*]$&/3^NPT_X<8=S$V 5ORI^D[-Q8$IY
M%>+-3+X=UF%LB'C-]\JD8/IRY3M>UR:3YO@S)@VG/4W@?'S/_L46KXMY99+O
M1/V[.JCS.BS"X,"/[%*K9W'[RL>"TC 8J__.K[S6<D.B]]B+6MK_8'^12C1C
M%HW2L/?A6K7V>AOSW\/@ #(&D"D )_\-H&, =0*B@<R6^IDIMEGUXA;TP]/J
MF'DI\"/5S=R;1=L[>T]7*_7J=9/3>!5=3:)1LQTT9*8A'Q4[7Y'121)I@(F"
M@!3$QM,/%!A.0,$$U"9(/B1P(+>#)K6:UFHPR5'BE#*H\KDJ(S!* J(D  IU
M4 9-,=LDS1%V2'Q11M!"5U(0)050G'JWJ;=+7J"TG/\<KB$BF\.7,%4&4F4>
M%<XSARKSJ'",7!! 1% *H^0@2@XT*'50<J]<[+XS@"2#,0H0HP PW(X4WAZ9
M^Q467C_(8C]*$*0$0'('I/2[CAS-KO1@8Q@#Q[ KQ0!(X=I2[)'0U&>!9#19
M^I#P@DUB *AT@;"WTP.E!'EN">KB1238,S'QD1+/NHG_M$J4ND#$>U[) @ML
MOYCZ!IXLE0/;)@9\,W$M'/N>^*#KR=QZ !E%Q0(/[)T8,,_$]7'L>V'LLO@&
M^[#\J&''Q+YEYHEKY-BW0[ W@(RB!0/'L&UBP#<3US='4;I4^(CCJ_SN1+/3
MC#E>_F#]J6IE\"J4/AC9X\M1",5UPACI5&=]HITF-3\J,\SUN!^.=<-$B6X\
MLD;3N7GS#U!+ P04    "  JBDU0\[3O)C8#   G#0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970V,BYX;6R%EVUOFS 0Q[\*XGT! X:D2B(5T+1)FU1UVO::
M)DZ""C@#)^F^_?Q4"O:1O G8^=_Y=X?Q':LK[=[Z(R',>6_JME^[1\9.C[[?
M;X^D*7N/GDC+_]G3KBD9'W8'OS]UI-Q)HZ;VPR!(_*:L6G>SDG//W69%SZRN
M6O+<.?VY:<KN7T9J>EV[R/V8>*D.1R8F_,WJ5![(3\)^G9X[/O('+[NJ(6U?
MT=;IR'[M/J'' B7"0"I^5^3:C^X=$<HKI6]B\&VW=@-!1&JR9<)%R2\7DI.Z
M%IXXQU_MU!W6%(;C^P_O7V3P/)C7LB<YK?]4.W9<NPO7V9%]>:[9"[U^)3H@
M[#HZ^N_D0FHN%R1\C2VM>_GK;,\]HXWVPE&:\EU=JU9>K]K_AQEL$&J#<#!0
MR9DUB+1!]&D0WS2(M4%L&/@J%)F;HF3E9M71J].IQWLJQ2Y"CS'/_E9,RF3+
M_WAZ>CY[V:1QLO(OPI'69$H3CC1H4/C<^[!$""V1A99Y.%T@MQ5)-)44M@0%
M2Y@B @.-I(-H$F@*.XA!![%T$$\<+(Q,*0V6FE:%BKRE$:TM>@@3STAZH53I
M6(5F>#'(BP%> R53FL4$Q3-2GP,B[&$#%Q %W@QO O(F-B\.#%ZE24:K( ,V
ML3B0&5!A:V914Q U!5 -D"RU$X("S]@P.:1"(Q@%#*FB45@3Y 6(O "0C=<P
M6UC+8'-;YK8FLG A/S$,NP1AEP"L\1"S)9"3V$3) 17VC$=50*Z".6(4P.=H
M ##'YD$:6/O7V.'Y?4FA)<:[-G,DHYEC']FXH;D?M.@F[EU)H273],YN" 36
MD"<4 NG%)F]XGS>\\RIIYEN>IKQPM4$1P&O5U>@^;P0]Z]C$M54HP'-G&H+K
M&P(*'$Y-Y-A"?C"/8*VY?08#(EYZPAEBN,(AH,1ALR0CNS)%9@)S0(03LW 7
M@.H!H]DW#RYS"*ASR-H9B=4C1.:QE0.BP&HC !$:B12Q/^H6&](=9"?>.UMZ
M;IEHND:S0[?_%(INTYC/Q%> [$(_W:A/B!]E=ZC:WGFEC/>RLN/<4\H(9PP\
M3G?D7RW#H"9[)FY3?M^IUET-&#WISQ)_^#;:_ =02P,$%     @ *HI-4*W-
M*D=4 @  4@<  !D   !X;"]W;W)K<VAE971S+W-H965T-C,N>&UL?55=CYLP
M$/PKB/=BOD,B@G0DJEJIE4Y7M7UVR":@ TQM)[G^^]J&<,1V[R78R\SL[.*L
M\QNAKZP&X,Y;U_9LZ]:<#QN$6%5#AYE'!NC%FQ.A'>9B2\^(#13P49&Z%H6^
MGZ(.-[U;Y"KV3(N<7'C;]/!,'7;I.DS_EM"2V]8-W'O@I3G77 90D0_X##^
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M TI\3T?_G9U8)>%J)Y)CS:NN_^^MCYW@M?8BMU(7;\.U;/KK6?M_-X,-L#;
M%P.4WC4@VH!<#>*[!K$VB#]JD&B#Y&I ^O0.L??)7!6BF$];?O;:H1X.A2H[
M-$GDZUJKQ?[M]+_)?'9R]33/TG0:GI0CC5D,&#S"H LBE-XO%!BB6&#+'-\2
M+&U$2FXA*QN"HOP6\VACLC2#=TK 9)#> 1DYB'$,.XA!!W'O(+[9 36R.6#2
M'M,,D221^H.)$I H 8B,="QL3#Q*V0U)"I*D-DD6&200QE$=&4B2 0Z,^GC,
MK)3E]$[**$A$+2*4QD8TU"(RXEW:B'L[R<&=Y$#(1KTO<HL'4T(3F 9%L+8C
M@,@,68/4Y4J%:) Y"A\Y^@@"N!*3:P EX]I'>4 <3& [>4 88$H=+F"=HT\(
M'<%*1X#4L\R,%P)1!P\L= 0H/3.5#H&HHR01K'4$")DBDP<"80</+'<$Z)V:
MQ:]!XSJ) Z./+@$0#EQU +<$9/>$C+KJ -8RRC]>2AB6*;9EBA(S)1ID'!MQ
M9&8%PM$\CPS9KR <QC1QG)<85CT&5$]-U8,@QXO"L.8QH'EJJDV#;CH9B@+D
M^EB!>P,F )5YAFO0N/:2P'&V8KB!8* W4)<+N#?@Y!.U!\L> XK.S3->@VZ4
M%F6!]15GPQ".@MRL/  6QX'C:,-P&\% &\E=+QH6/Z:?R!XL?@R<Y#DVLV>#
MB*O\"=PA"'"0YXY3D\!*)>CCT1)8A 00H14M "*YR1..II.:M;M^5.R\-3\V
M0GW CU8OX^A#/XT:ZPLT60U#Y=7-,./^*-I=V73>"Q=R=NHGG"WG@LD]1H&L
MO;T<JR\/%=L*=9O)^W:8+8<'P0]Z;@XOP_O\/U!+ P04    "  JBDU0@09L
MC_(!  #;!   &0   'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q]5-N.FS 0
M_17D#XBY)>E&@+1)5+52*T5;M7UV8+AH;4QM)VS_OKX0EA"Z+]@S/N?,!8^3
MGHM760,H[XW15J:H5JK;82SS&AB1*]Y!JT]*+AA1VA05EIT 4E@2HSCT_0UF
MI&E1EEC?260)ORC:M' 2GKPP1L3?/5#>IRA -\=+4]7*.'"6=*2"'Z!^=B>A
M+3RJ% V#5C:\]024*7H.=L?8X"W@5P.]G.P]4\F9\U=C?"U2Y)N$@$*NC +1
MRQ4.0*D1TFG\&331&-(0I_N;^F=;NZ[E3"0<./W=%*I.T2?D%5"2"U4OO/\"
M0SUKY W%?X,K4 TWF>@8.:?2?KW\(A5G@XI.A9$WMS:M7?M!_T9;)H0#(1P)
MP>9#0C00HG="_"$A'@CQC(!=*;8W1Z)(E@C>>\+]W8Z82Q3L8MW]W#AML^V9
M;H_4WFNV?8H3?#5" V;O,.$$$XP(K-7'$.%2B'WX0 _O QP>$9OH'G)\A 3^
MTW(6T6*AD16(IEE$_Q&(%P5B*Q#?=6H]ZY3#K"VF=9C5K)L'A]E.,)$_*_91
M)@Q6FUFR>/*+&8C*CH_T<GYIE>G4Q#M.Z'-HKLC,O]>3ZP;M7<:-_7<BJJ:5
MWIDK?0'M-2DY5Z!S]%<ZO5J_-*-!H51FN]5[X>;-&8IWPU."Q_<L^P=02P,$
M%     @ *HI-4/1R;BQ7 P  % X  !D   !X;"]W;W)K<VAE971S+W-H965T
M-C8N>&ULC5=1;YLP$/XKB/>!#09,E41J$DV;M$E5IVW/-'$25, ,G*3[][,Q
MI6 ?67@(V/GN[OL.<V<OKKQY;4^,">>M+*IVZ9Z$J!]\O]V=6)FU'J]9)?\Y
M\*;,A!PV1[^M&Y;M.Z.R\ .$8K_,\LI=+;JYIV:UX&=1Y!5[:ISV7)99\W?-
M"GY=NMA]GWC.CR>A)OS5HLZ.[ <3/^NG1H[\P<L^+UG5YKQR&G98NH_X88M3
M9= A?N7LVHZ>'27EA?-7-?BZ7[I(,6(%VPGE(I.W"]NPHE">)(\_O5-WB*D,
MQ\_OWC]WXJ68EZQE&U[\SO?BM'2IZ^S9(3L7XIE?O[!>4.0ZO?IO[,(*"5=,
M9(P=+]KNU]F=6\'+WHND4F9O^IY7W?W:^W\W@PV"WB 8#'!\TR#L#<(/ W+3
M@/0&Q##PM90N-]M,9*M%PZ].HU]OG:E5A!^(S/Y.37;)[OZ3Z6GE[&65I/'"
MORA'/6:M,<$(@P>$+[T/(0(HQ#JPS(-I@(V-B,,I9&M#,$IA%B$H-.P<A!.A
M">R @ Y(YX!,'% C4QI#.TREI7HS02(P2 0$28T@&A./@F"*U&5D-;J?3 R2
MB2TR))QQD( .DOMS3D$'](Z<4RL=00*EXT[<UL:%!FY"/ 6)IQ9Q:@9:IU8@
MD+<-PR!O !?>X(T17 \0P!R;!0%9L3YA I&_&[D%D>DM 3,%#0," E, MH,%
M('\ &(+T 2"YQ1ZLE8\XN*, ]*#_5P  "*_Y.X!3]G"-Q7:1I2B<<0%766R7
M68J(F0 -4DMFX!NG'DY-_0 N05ZLDZ4O;*8"\AUXT4S+PW =QW8AIR@R96@0
M#L8ODA!O5&1['0 PCCT4IZ/+U '8))&7T!D=< O =@^@R-H?Q "]U".1*0/"
M48\0DSJ BZB7!C/4X>:#$X!Z8E)/[% T!*@#.$D]BDWJ$"[QYKH>AML>MOL>
M16;?ZT&3A9K&GKESVD XX&/90KCYCV4J VZ"&.J"5C'3H&3<;U-S@PB!; $:
M%(V_IHAXD<'9'VV-2]8<NV-'Z^SXN1)JASF:'8XVCX':6AOS:W7DZ;;<'V[T
M>>E[UASSJG5>N) ;]VY[?>!<,,D2>9+?21[1AD'!#D(])O*YT><4/1"\[L]@
M_G 07/T#4$L#!!0    ( "J*35!"PY<#"@(   $&   9    >&PO=V]R:W-H
M965T<R]S:&5E=#8W+GAM;'V4W8Z;,!"%7P7Q )A_LA$@;5A5K=1*T59MKQT8
M EJ#J>V$[=O7-@2QX#87L<><.?[&X$E'RMYX R"L]X[T/+,;(88C0KQLH,/<
MH0/T\DE-68>%#-D5\8$!KG121Y#ONC'J<-O;>:K7SBQ/Z4V0MH<SL_BMZS#[
M<P)"Q\SV[,?":WMMA%I >3K@*WP'\6,X,QFAQ:5J.^AY2WN+09W9S]ZQ2)1>
M"WZV,/+5W%*57"A]4\&7*K-=!00$2J$<L!SN4  ARDAB_)X][65+E;B>/]P_
MZ=IE+1?,H:#D5UN))K,/ME5!C6]$O-+Q,\SU1+8U%_\5[D"D7)'(/4I*N/ZW
MRAL7M)M=)$J'WZ>Q[?4XSOZ/-'."/R?X2X(7_C<AF!."30*:R'2I+UC@/&5T
MM-CTL@:LO@GO&,C#+-6B/CO]3%;+Y>H]/WANBN[*:-:<)HV_TO@?%<5>$0>+
M!$F A<(W4O@Z/UCO$#R9#0*C0: -P@]E>)LR)DVL-;W6; HM)L5AK7 \,T9H
MQ @-&)NS.H4[#._@JM\&)MS!^$YBAHF,,)$!)MC 1#N8\,D$$^U@ L<WP\1&
MF-@ $VY@XAV,D27>L7C_>DN)D24QL$0;EF3'DL0FF&0'D^Q@T.HRJN;X#;-K
MVW/K0H6\U_KVU90*D'ZN(T^ZD?UX"0C40DT3.6=35YH"08>YX:*EZ^=_ 5!+
M P04    "  JBDU0=5/;!7D"  "-"   &0   'AL+W=O<FMS:&5E=',O<VAE
M970V."YX;6R55MN.VC 0_94H'Y#$N8,"$A=5K=1*:*MNGPT8B-:)4]O ]N]K
M.R:;A&%%><"7G',\<\ S*:Z,OXD3(=)YKV@M9NY)RF;J^V)W(A46'FM(K9X<
M&*^P5$M^]$7#"=X;4D7], A2O\)E[<X+L[?A\X*=)2UKLN&..%<5YG^7A++K
MS$7N;>.E/)ZDWO#G18./Y">1OYH-5RN_4]F7%:E%R6J'D\/,7:#I&D6:8!"O
M);F*WMS1J6P9>].+;_N9&^B(""4[J26P&BYD12C52BJ./U;4[<[4Q/[\IO[%
M)*^2V6)!5HS^+O?R-'-SU]F3 SY3^<*N7XE-*'$=F_UW<B%4P74DZHP=H\)\
M.[NSD*RR*BJ4"K^W8UF;\6KU;S28$%I"V!%0^BDALH3H@Q!_2H@M(1X1_#85
MX\T:2SPO.+LZO/UY&ZS_16@:*_=W>M.8;9XI>X3:O<QSE!;^10M9S++%A#T,
MZA"^4N^."*$CEN$=/1P>L+I'I-$0LKZ'H& "1Q&!B49&(!HDFL$",2@0&X%X
M()"/G&HQB<'4-LK0RT;I0BCD34890ZC4"^&0$S#DY"YDA!X(I*! ^KQI&2B0
M/6%:BTE[B8ZL6+6(O(_PT&3P&9D',5(X\!P,/ >L2V"!"2@P>=XZ%,!7,WC"
M/ OJ9QI%7C(RT*+2 6ID&:24>0]R1@^J"0)L>Y0U6"T6*/P/X^"KCJ)GC(ON
M[E<:>./*!*"2R?A"KV'4N$CZO9I<$7XT_4XX.W:NI2YMO=VNIRY"7=-'^TO=
M:TVM_Y!I&_4/S(]E+9PMDZICF+I^8$P2%63@J?!.ZMV@6U!RD'J:J3EO&V2[
MD*RQS=_OWD#F_P!02P,$%     @ *HI-4-PYC;2' @  <PD  !D   !X;"]W
M;W)K<VAE971S+W-H965T-CDN>&ULC5;MKJ(P$'T5P@-<*%^B01.5;':3W<3<
MS>[^KEJ5W$+9MLK=M]^V(&(9C7^D'<Z<GIF1Z60-XQ_B1(AT/DM:B;E[DK*>
M>9[8G4B)Q1NK2:7>'!@OL51;?O1$S0G>&Z>2>H'O)UZ)B\I=9,:VX8N,G24M
M*K+ACCB7)>;_5H2R9NXB]VIX+XXGJ0W>(JOQD?PD\E>]X6KG]2S[HB25*%CE
M<'*8NTLTRU&H'0SB=T$:,5@[.I0M8Q]Z\VT_=WVMB%"RDYH"J\>%K FEFDGI
M^-N1NOV9VG&XOK)_,<&K8+98D#6C?XJ]/,W=U'7VY(#/5+ZSYBOI HI=IXO^
M.[D0JN!:B3ICQZ@PO\[N+"0K.Q8EI<2?[;.HS+/I^*]NL$/0.02]@SK[F4/8
M.80WA^2I0]0Y1#>'R&2K#<7D)L<2+S+.&H>WY:VQ_A>A6:2RO]-&DVSS3J5'
M*.MED:)IYETT48=9M9A@@(G0Y!ZS'F-0C_"4@EY& ,E8!2/W)+1.&$.">T0^
M1B!_"JL(P62$AB <!AI$,$$$$D2&(!IF,_"M;(XQ\<2.]05,_AQS)S8&Q<:
M6&2)'6/"U$K[^@5,_AQS)S8!Q28 P8/:3D""R>NU34&"%$B7%>8*PMBUA3"1
ME:XQ)HX36.P4%#L%#HDML1 FL<1"&.O3SR%,"HM%/MR$_'%UI_$#B@=]#+U>
M7P3VH"4*7J@P")K:S1  A58?R$'0@Z:)X'Z%PA?*#(%"^QL&07;' 4%VCKW!
MS5,2?C2WNG!V[%Q)W9P'UGYR6 ;ZYK+L:SU1F!OM1M..(S\P/Q:5<+9,JGO1
MW%X'QB11&OTWU6E.:@+J-Y0<I%Y.U)JW8T"[D:SN1AROG[,6_P%02P,$%
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MUXK;17!GM:*(X.$1O"Z"-XW@"=_]IF?\CBG[+R0@EI#I1YERX\ 2GOD)H=S
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MY/38M)<AOZ[ZXW]_T[#+\&K#'M^OK/\#4$L#!!0    ( "J*35#:ONRH#P0
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ME%G2JNA4DNA7<SVE]?7:ZM_"Z #>!O![@.[[LP"W#7 ? >+3 -$&B%<#O#;
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M^RPKE<Y>)VH:1Q7M[@^QVI?5K:_O\^8,I'DHLW-[O&/?SYB&_P-02P,$%
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MBC+0Z$J"G8Y(PGM(I4-\[]GL(C06&@J!\*[0T"P0&04B(1"M!-+$5SHE,;'
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M=[1OB,A10H6D(%<-/&!D-^4#7H ;'"[/M2P6K^GH^GYWT-K[[JOV&B<'@ZU
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M8(:UWH9N- >,PHH>N'(BR\@]00(>[ CYT'+^%)/EB/J0PW2W"6^@T[1:B6F
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M<7AF,.AVS&+2_8@65=YO"?$HX^N;?]O&)!N&2E=:;_VUZ.59;U5<DB$IR?
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ML\P>FT=&W>C K$ &AC56/L'1*82[R99OT4>_[GRQ$MMO[6JL*CR;.6&Q35W
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MV-\**RBWMJXK\%QU@B ;NVN0%+B"BD3"K)D$V ''QOJ]E!P 7">2N5BWQ5,
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M'J%1(E5@V\7R&>C3?8N.%M?VJDMR!E,[KY9'Z*T%3;UC0^0]<I[06NY>1ZT
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M^3K^ @L.BJ0DVW/-=0+!'B.H!0S\W#VLY?XNI]#0%#=(OW'U[<]AYF? RR4
M5+ZVMO_I)3PR/H>V&_+FQLR^ZT6,JSTCJ^+X%&UUA%&S59[Y#LX,&?%?)?.2
MJ@GCDC#<-)<X0WY"60!H4V?A@M(WRZ ="O4DKL9'R/L"*> A;68%JE3GDSE%
ML7MW!P-'L'[1H%V1@UHNN>0$"T"KK.110C&]V$/;PJT5N.('1F@BH=#!^R!2
M6\Q\CN'=Y;:8%UB 0>4CPC1-N&:?/!BXR\*Q*H1O'19+\/SN+LY6RNP,<[8K
M:MR&OC)#&+8O"9></]EI@ALZ4ONDI.9^$1\KF0A64FYY3QF#5MV#(5721D-
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MF9:Z"9X)C%$$?AX"N&%7&8:6;.TWQYT&%5!R;KG*"A>4>=;#"]!(38"_+NB
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M!6& B$IP',=4$10%2Z$FV$67KWMAZ"Y(T192QU*!%67JDB,[.K?11<6U19&
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M]/5;CI622,.42CB=B^=@,FIT@6@?% RF02X8]T]!5(DH?KH*[15(JD80#H;
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M>S21#Y5B@N$2V/TM;LJ+;W=VY)0_@M<TNUMQVQY)I%9N%WK))428[C=>5V+
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MJ%!BH?36*$O:]RO!F<]6^>;I<6IR,/F6PEC-L"EX^"C056)EU \BH(29K;%
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M;@/M[+D%59B3Z"^:9HF)<GHP7R[5 H16WM5G[51YC\[U@%VRBR$;GXJ* XF
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M4%^#+'X#TX^!P=BB+IA[-54$94Z44GUT8]5@:D_P+5_9)8T-6[ZZTD?R2L]
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M('&50;+5"TV@^@GK3O4YE8Z52TS"M!T$V_=_&NKUSGG'??6#6Z[PS['[9SB
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MSF!44+;)Q)2]*2?*6.V^(_>["DL$'5U(X,P6V=#BRMWT0KWH("5)H'332Y/
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MYFQT MF@(\3D/ 6OTW#\;:;OWRE28/$8\.Z8\^+C$K/YBMGS5F='0WGU"X'
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M9BTZB1#V]CU.2,5LS]N_.44_ 5!+ P04    "  JBDU0F$QW"KT%  ! ,0
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M+0*VKV6V[+^"\XWSS,7,L?0GS&R9!$9*'F5U+9>^]B4[XS57E6!=ZUH F"*
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M@'!,F/ H, $5]+L$GE?Q?NWM$!,34$$LH"BA.61_^_FY7<INCY?]DUU!3$Q
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M\^7V@&[/M]L#O#U?;P%Z"U]O 7K+ M?:Z&*;K[< O86OMP"]A:^W +V%K[<
MO86OMP"]A:^W +V%K[< O86OMP*]E:^W KV5K[<"O76!LQ)T6,+76X'>RM=;
M@=[*UUN!WLK76X'>RM=;@=[*UUN!WLK7.P"] U_O /0.?+T#T#OP]0Y [[#
M63<Z[.;K'8#>@:]W 'H'OMX!Z!WX>@>@=^#K'8#>@:]W!'I'OMX1Z!WY>D>@
M=^3K'8'>D:]W!'K'!>Y5HIN5?+TCT#OR]8Y [\C7.P*](U_O"/2.?+T-Z&U\
MO0WH;7R]#>AM?+T-Z&U\O0WH;7R]#>AM"SQK@AXVX>MM0&_CZVU ;^/K;4!O
MX^N=@-Z)KW<">B>^W@GHG?AZ)Z!WXNN=@-Z)KW>:Z%V.=9]W/X;^U!S*K4O^
M&?YES03N,GR<\^TSKE._W#]1>ABW9'=]O?G_Z3KU3X2;5I2GWU!+ P04
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M#T.^I8P^D&UB2Y2&OHRM#=3\3J$;MZ]Y[VQ(O^R0&[-]S_Y;4)XN1WKJZ7"
MN7+,R2EO"SHT:BZ\?/)O#7S;#;4+M/0A5T/J#CQ>CG27JY%-"X_YB#1MG8::
M3PW/K4_WP_YU83=_/_3"_Q4CFP_?>^O'RR% <DB0' HDAP;)84!R5" YSD%R
M7(#DX"N4("BB<A12.8JI' 55CJ(J1V&5H[C*46#E*+(*%%D%BJP"15:!(JM
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  JBDU0+^F;!.\    K @  $0
M            @ &9 0  9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  J
MBDU0F5R<(Q &  "<)P  $P              @ &W @  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( "J*35"ZK"2_: ,  ,$0   8
M  "  ?@(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  J
MBDU0)ZG/SAL$  #D$P  &               @ &6#   >&PO=V]R:W-H965T
M<R]S:&5E=#(N>&UL4$L! A0#%     @ *HI-4$U%!G%+ @  ) @  !@
M         ( !YQ   'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0
M   ( "J*35!^<_;EZ ,  $@1   8              "  6@3  !X;"]W;W)K
M<VAE971S+W-H965T-"YX;6Q02P$"% ,4    "  JBDU05X!H&&T"  #=!P
M&               @ &&%P  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L!
M A0#%     @ *HI-4!3S11J/!0  #QX  !@              ( !*1H  'AL
M+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( "J*35 #>#Z7$08
M &4A   8              "  >X?  !X;"]W;W)K<VAE971S+W-H965T-RYX
M;6Q02P$"% ,4    "  JBDU0YD0\\K !  #2 P  &               @ $U
M)@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ *HI-4#K2
M@HJU 0  T@,  !@              ( !&R@  'AL+W=O<FMS:&5E=',O<VAE
M970Y+GAM;%!+ 0(4 Q0    ( "J*35 RJ#F.LP$  -(#   9
M  "  08J  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @
M*HI-4,I0*C^T 0  T@,  !D              ( !\"L  'AL+W=O<FMS:&5E
M=',O<VAE970Q,2YX;6Q02P$"% ,4    "  JBDU0U^?D!;<!  #2 P  &0
M            @ ';+0  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4
M Q0    ( "J*35#L"?DCP $  #<$   9              "  <DO  !X;"]W
M;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ *HI-4.E=%\2T 0
MT@,  !D              ( !P#$  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX
M;6Q02P$"% ,4    "  JBDU03N'$A+4!  #2 P  &0              @ &K
M,P  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( "J*35"Z
MM=>GM@$  -(#   9              "  9<U  !X;"]W;W)K<VAE971S+W-H
M965T,38N>&UL4$L! A0#%     @ *HI-4+W+(=RS 0  T@,  !D
M     ( !A#<  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "J*35 O(VMDQ0$  #<$   9              "
M 7A"  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ *HI-
M4! &<_T4 @  G 8  !D              ( !=$0  'AL+W=O<FMS:&5E=',O
M<VAE970R,RYX;6Q02P$"% ,4    "  JBDU0S)*,+=X!   !!0  &0
M        @ &_1@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0
M   ( "J*35 #LAF7T@$  )P$   9              "  =1(  !X;"]W;W)K
M<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ *HI-4!($K$CM 0  9@4
M !D              ( !W4H  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q0
M2P$"% ,4    "  JBDU0(Q%8->H!  !F!0  &0              @ $!30
M>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( "J*35!GQ"OS
MQ0$  #<$   9              "  2)/  !X;"]W;W)K<VAE971S+W-H965T
M,C@N>&UL4$L! A0#%     @ *HI-4/-\XA6W 0  T@,  !D
M ( !'E$  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    "  J
MBDU0T'H44B(#   >#@  &0              @ $,4P  >&PO=V]R:W-H965T
M<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( "J*35"@,#TP;@(  #D)   9
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M970S-2YX;6Q02P$"% ,4    "  JBDU0A1,H3:8$  !Y&P  &0
M    @ $990  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (
M "J*35 7>.?Q>P(  -8(   9              "  ?9I  !X;"]W;W)K<VAE
M971S+W-H965T,S<N>&UL4$L! A0#%     @ *HI-4&QR;?L' @  \P4  !D
M             ( !J&P  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"
M% ,4    "  JBDU0(:0=IZD#  #%$0  &0              @ 'F;@  >&PO
M=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( "J*35"C](QM;@(
M  ((   9              "  <9R  !X;"]W;W)K<VAE971S+W-H965T-# N
M>&UL4$L! A0#%     @ *HI-4!CZ@:DJ @  /08  !D              ( !
M:W4  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    "  JBDU0
MX&6Q0N<!  #L!   &0              @ ',=P  >&PO=V]R:W-H965T<R]S
M:&5E=#0R+GAM;%!+ 0(4 Q0    ( "J*35",H 9D^@$  ($%   9
M      "  >IY  !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%
M  @ *HI-4!>2?MC) @  7PL  !D              ( !&WP  'AL+W=O<FMS
M:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    "  JBDU0TIT;$#T"   -!P
M&0              @ $;?P  >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+
M 0(4 Q0    ( "J*35!"IY>G*0(  !$&   9              "  8^!  !X
M;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ *HI-4#M%;U_S
M 0  2 4  !D              ( ![X,  'AL+W=O<FMS:&5E=',O<VAE970T
M-RYX;6Q02P$"% ,4    "  JBDU00Y$.;U\#  "8#P  &0
M@ $9A@  >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( "J*
M35!I$D>*+@(  (4&   9              "  :^)  !X;"]W;W)K<VAE971S
M+W-H965T-#DN>&UL4$L! A0#%     @ *HI-4 6_U@XR P  @PT  !D
M         ( !%(P  'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4
M    "  JBDU0U=/</<X&  "/*@  &0              @ %]CP  >&PO=V]R
M:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( "J*35 @W*E8' (  (D&
M   9              "  8*6  !X;"]W;W)K<VAE971S+W-H965T-3(N>&UL
M4$L! A0#%     @ *HI-4 ?R2*!! P  P@T  !D              ( !U9@
M 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    "  JBDU06#PT
MFXL#  #M#P  &0              @ %-G   >&PO=V]R:W-H965T<R]S:&5E
M=#4T+GAM;%!+ 0(4 Q0    ( "J*35!=:H%_#0(  ,\%   9
M  "  0^@  !X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @
M*HI-4!C_D,X[ @  %@<  !D              ( !4Z(  'AL+W=O<FMS:&5E
M=',O<VAE970U-BYX;6Q02P$"% ,4    "  JBDU0^'T4WSH"  #:!P  &0
M            @ '%I   >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4
M Q0    ( "J*35 =R6[G. (  $4&   9              "  3:G  !X;"]W
M;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ *HI-4![&QR#% @
MA@H  !D              ( !I:D  'AL+W=O<FMS:&5E=',O<VAE970U.2YX
M;6Q02P$"% ,4    "  JBDU0B?5%_K4"  !\"@  &0              @ &A
MK   >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( "J*35!-
M%.P)VP(  $,+   9              "  8VO  !X;"]W;W)K<VAE971S+W-H
M965T-C$N>&UL4$L! A0#%     @ *HI-4/.T[R8V P  )PT  !D
M     ( !G[(  'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "J*35!"PY<#"@(   $&   9              "
M 1;"  !X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @ *HI-
M4'53VP5Y @  C0@  !D              ( !5\0  'AL+W=O<FMS:&5E=',O
M<VAE970V."YX;6Q02P$"% ,4    "  JBDU0W#F-M(<"  !S"0  &0
M        @ $'QP  >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0
M   ( "J*35!_(IKPNP$  -(#   9              "  <7)  !X;"]W;W)K
M<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ *HI-4-1QZ\?# P  :Q$
M !D              ( !M\L  'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q0
M2P$"% ,4    "  JBDU0VK[LJ \$  !O$@  &0              @ &QSP
M>&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( "J*35!W)59S
M9@(  )\'   9              "  ??3  !X;"]W;W)K<VAE971S+W-H965T
M-S,N>&UL4$L! A0#%     @ *HI-4)XE,J#, 0  J 0  !D
M ( !E-8  'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4    "  J
MBDU0S@]4'!K!  "W!P, %               @ &7V   >&PO<VAA<F5D4W1R
M:6YG<RYX;6Q02P$"% ,4    "  JBDU0PSY[2&<"  !&#0  #0
M    @ 'CF0$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( "J*35"83'<*O04
M $ Q   /              "  76< 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    "  JBDU01'W]Q& "  !C+   &@              @ %?H@$ >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  JBDU0M 9O\1$"  !@
M*P  $P              @ 'WI $ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    4P!3 +<6   YIP$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6641539840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">3. Fair Value Measurements</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement date, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values of our Level 2 marketable securities portfolio balance provided by our investment managers.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes financial assets that we measured at fair value on a recurring basis as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, classified in accordance with the fair value hierarchy:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:49%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements Using</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>110.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>144.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>255.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. government agencies</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>676.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>676.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>248.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>248.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>162.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>162.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,087.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,087.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value on a recurring basis</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>110.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,232.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,342.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></span><span style="font-family:inherit;font-size:10pt;">Includes assets which are held pursuant to a deferred compensation plan for our executives, which consist mainly of mutual funds. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes financial assets that we measured at fair value on a recurring basis as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">, classified in accordance with the fair value hierarchy:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:49%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements Using</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>199.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>66.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>266.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity investment in Tandem Diabetes Care, Inc.</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. government agencies</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>173.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>173.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>210.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>210.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value on a recurring basis</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>237.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>277.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>514.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There were </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> transfers between Level 1 and Level 2 securities during the years ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">. There were </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> transfers into or out of Level 3 securities during the years ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments are not significant and we include them in other assets in our consolidated balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are often privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant adverse effect on the fair values.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value of Senior Convertible Notes</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fair value, based on trading prices (Level 1), of our Senior Convertible Notes were as follows as of the dates indicated:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements Using Level 1</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>890.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>540.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,260.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>859.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total fair value of outstanding senior convertible notes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,150.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,399.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For more information on the carrying values of our 2022 Notes and 2023 Notes, see Note 5, &#8220;Debt.&#8221;</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency and Derivative Financial Instruments</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">From time to time we engage in limited hedging transactions to reduce foreign currency risks. The fair values of these derivatives are based on quoted market prices, which are Level 1 inputs, and the derivative instruments are recorded in current assets or current liabilities in our balance sheets consistent with the nature of the instrument at period end. Derivative gains and losses are included in </span><span style="font-family:inherit;font-size:10pt;">interest and other income, net</span><span style="font-family:inherit;font-size:10pt;"> in our consolidated statement of operations.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, a notional amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$8.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> was outstanding to hedge currency risk relating to certain intercompany balances. The resulting impact from the hedging activity on our consolidated financial statements was not significant for the year ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">, a notional amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$60.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> was outstanding to hedge currency risk relating to certain intercompany balances. Derivative instrument gains on forward exchange contracts were </span><span style="font-family:inherit;font-size:10pt;"><span>$0.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the twelve months ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">. The fair value of the forward contract exchange derivative instrument liability was </span><span style="font-family:inherit;font-size:10pt;"><span>$0.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">. We entered into no foreign currency forward contracts during </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our foreign currency exposures vary but are primarily concentrated in the British Pound, the Euro, and the Canadian Dollar. We monitor the costs and the impact of foreign currency risks upon our financial results as part of our risk management program. We do not use derivative financial instruments for speculation or trading purposes or for activities other than risk management. We do not require and are not required to pledge collateral for these financial instruments and we do not carry any master netting arrangements to mitigate the credit risk. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</span></div><span style="font-family:inherit;font-size:10pt;">In accordance with authoritative guidance, we measure certain non-financial assets and liabilities at fair value on a non-recurring basis. These measurements are usually performed using the discounted cash flow method and Level 3 inputs. These include items such as non-financial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment. In general, non-financial assets, including goodwill, intangible assets, and property and equipment, are measured at fair value when there are indicators of impairment and are recorded at fair value only when any impairment is recognized. We recorded </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> significant impairment losses during the twelve months ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span>.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6981764336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Information (Unaudited) Quarterly Financial Information (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Quarterly Financial Information (Unaudited)</a></td>
<td class="text"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">11. Quarterly Financial Information (Unaudited)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following is a summary of our quarterly results of operations for the years ended </span><span style="font-family:inherit;font-size:10pt;">December 31,</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">For the Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions except per share data)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Year ended December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>462.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>396.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>336.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>280.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gross profit </span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>309.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>246.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>206.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>168.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating expenses </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>207.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>190.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>207.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>183.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(26.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic net income (loss) per share </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.01</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.50</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.12</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.30</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted net income (loss) per share </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.00</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.50</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.12</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.30</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Year ended December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>338.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>266.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>242.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>184.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gross profit </span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>222.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>168.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>153.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>118.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating expenses </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>387.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>154.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>158.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>149.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(179.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(24.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic net income (loss) per share </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.03</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.53</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.34</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.28</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted net income (loss) per share </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.03</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.52</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.34</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.28</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></span><span style="font-family:inherit;font-size:10pt;">Basic and diluted earnings per share are computed independently for each of the quarters presented. Therefore, the sum of quarterly basic and diluted per share information may not equal annual basic and diluted earnings per share.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6820991232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information - Summary (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Amount</a></td>
<td class="nump">$ 462.8<span></span>
</td>
<td class="nump">$ 396.3<span></span>
</td>
<td class="nump">$ 336.4<span></span>
</td>
<td class="nump">$ 280.5<span></span>
</td>
<td class="nump">$ 338.0<span></span>
</td>
<td class="nump">$ 266.7<span></span>
</td>
<td class="nump">$ 242.5<span></span>
</td>
<td class="nump">$ 184.4<span></span>
</td>
<td class="nump">$ 1,476.0<span></span>
</td>
<td class="nump">$ 1,031.6<span></span>
</td>
<td class="nump">$ 718.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">% of Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember', window );">Distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,011.6<span></span>
</td>
<td class="nump">$ 652.9<span></span>
</td>
<td class="nump">$ 538.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">% of Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69.00%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember', window );">Direct</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 464.4<span></span>
</td>
<td class="nump">$ 378.7<span></span>
</td>
<td class="nump">$ 180.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">% of Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,161.5<span></span>
</td>
<td class="nump">$ 818.4<span></span>
</td>
<td class="nump">$ 596.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">% of Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79.00%<span></span>
</td>
<td class="nump">79.00%<span></span>
</td>
<td class="nump">83.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Outside of the United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 314.5<span></span>
</td>
<td class="nump">$ 213.2<span></span>
</td>
<td class="nump">$ 122.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">% of Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_RevenuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_RevenuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6736408512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases And Other Commitments - Other Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 14.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from finance leases</a></td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from finance leases</a></td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">80.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for finance lease liabilities</a></td>
<td class="nump">$ 15.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term of operating leases</a></td>
<td class="text">6 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term of finance leases</a></td>
<td class="text">13 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate of operating leases (as a percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate of finance leases (as a percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6822643824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Availability and Outstanding Borrowings under Credit Agreement (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 19, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Total available balance</a></td>
<td class="nump">$ 195,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Letters of credit sub-facility</a></td>
<td class="nump">200,000,000.0<span></span>
</td>
<td class="nump">$ 200,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Outstanding borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Letters of credit sub-facility</a></td>
<td class="nump">10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Outstanding letters of credit</a></td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6836044928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>May 28, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized', window );">Stock authorized in ESPP (shares)</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum payroll deductions (as a percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_EmployeePurchasePriceFloorPercentage', window );">Employee purchase price floor (as a percent)</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock reserved for issuance (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_OptionsInMoneyNumber', window );">Options in-the-money</a></td>
<td class="nump">28,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_InMoneyOptionsMaximumExercisePrice', window );">In-the-money options, maximum exercise price (USD per share)</a></td>
<td class="nump">$ 218.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation costs related to unvested restricted stock units</a></td>
<td class="nump">$ 119.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dxcm_A401kPlanMember', window );">401(k) Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Maximum employee contribution (as a percent)</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer matching contribution (as a percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Employee contribution (as a percent)</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Total matching contributions</a></td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dxcm_EmployeeStockPurchasePlan2015Member', window );">Employee Stock Purchase Plan 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for Employee Stock Purchase Plan (shares)</a></td>
<td class="nump">150,408<span></span>
</td>
<td class="nump">189,904<span></span>
</td>
<td class="nump">122,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual term of stock options</a></td>
<td class="text">3 months 7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted-average exercise price of stock options (USD per share)</a></td>
<td class="nump">$ 10.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of stock options</a></td>
<td class="nump">$ 5.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of RSUs vested</a></td>
<td class="nump">$ 207.2<span></span>
</td>
<td class="nump">$ 120.9<span></span>
</td>
<td class="nump">$ 144.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EmployeePurchasePriceFloorPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee purchase price floor, percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EmployeePurchasePriceFloorPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan (ESPP), Number Of Shares Authorized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_InMoneyOptionsMaximumExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum exercise price for options to be considered in-the-money</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_InMoneyOptionsMaximumExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_OptionsInMoneyNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options that were in-the-money at the balance sheet date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_OptionsInMoneyNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dxcm_A401kPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dxcm_A401kPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dxcm_EmployeeStockPurchasePlan2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dxcm_EmployeeStockPurchasePlan2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6988469168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_UnusedExpiredFederalIncomeTaxCredits', window );">Tax credit carryforwards subject to expiration</a></td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance amount</a></td>
<td class="nump">332,200,000<span></span>
</td>
<td class="nump">$ 330,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital', window );">Tax benefits credited to additional paid-in capital</a></td>
<td class="nump">55,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_PossibleExtensionPeriodofTaxHoliday', window );">Possible extension period of tax holiday</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 438,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credit carryforwards</a></td>
<td class="nump">54,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration', window );">Research and development tax credit carryforwards subject to expiration</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">324,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credit carryforwards</a></td>
<td class="nump">52,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">124,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxHolidayAggregateDollarAmount', window );">Decrease in foreign taxes from tax holiday</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Benefits Credited to Additional Paid In Capital</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PossibleExtensionPeriodofTaxHoliday">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Possible Extension Period of Tax Holiday</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PossibleExtensionPeriodofTaxHoliday</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Credit Carryforwards, Research, Subject to Expiration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_UnusedExpiredFederalIncomeTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Federal income tax credits likely to expire unused as a result of limitations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_UnusedExpiredFederalIncomeTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxHolidayAggregateDollarAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxHolidayAggregateDollarAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6728006592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity - Share-based Compensation Expenses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense included in operating expenses</a></td>
<td class="nump">$ 102.7<span></span>
</td>
<td class="nump">$ 101.9<span></span>
</td>
<td class="nump">$ 106.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense included in operating expenses</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense included in operating expenses</a></td>
<td class="nump">33.5<span></span>
</td>
<td class="nump">33.0<span></span>
</td>
<td class="nump">37.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=dxcm_SellingGeneralAndAdministrativeMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense included in operating expenses</a></td>
<td class="nump">$ 60.2<span></span>
</td>
<td class="nump">$ 59.7<span></span>
</td>
<td class="nump">$ 59.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dxcm_SellingGeneralAndAdministrativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dxcm_SellingGeneralAndAdministrativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6984495376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Inventory (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 64.9<span></span>
</td>
<td class="nump">$ 30.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">11.1<span></span>
</td>
<td class="nump">11.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">43.8<span></span>
</td>
<td class="nump">28.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 119.8<span></span>
</td>
<td class="nump">$ 70.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6994813216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Other Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_FinancingLeaseObligation', window );">Finance lease obligations</a></td>
<td class="nump">$ 14.4<span></span>
</td>
<td class="nump">$ 7.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditNoncurrent', window );">Deferred rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">5.7<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Total other liabilities</a></td>
<td class="nump">$ 20.1<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_FinancingLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Lease Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_FinancingLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.26(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902458&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6815326592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income (Loss) before Income Taxes Subject to Taxes</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income (loss) before income taxes subject to taxes in the following jurisdictions is as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>119.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(28.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outside of the United States</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(98.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(61.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>104.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(126.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(48.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Significant components of the provision for income taxes are as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Federal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">State</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Federal</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">State</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total deferred income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Significant components of our deferred tax assets as of </span><span style="font-family:inherit;font-size:10pt;">December 31,</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> are shown below. A valuation allowance of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$332.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> has been established as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> to offset the deferred tax assets, as realization of such assets is uncertain. We maintain a deferred tax liability related to indefinite-lived intangible assets that is not netted against the deferred tax assets. Reversal of the taxable temporary difference for these intangible assets cannot serve as a source of income for realization of the deferred tax assets because the deferred tax liability will not reverse until the intangible assets are sold or written down due to impairment.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Net operating loss carryforwards</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>127.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>162.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Capitalized research and development expenses</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>57.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>62.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Tax credits</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>78.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>59.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Fixed and intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Accrued liabilities and reserves</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>62.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Convertible Debt</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total gross deferred tax assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>351.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>334.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: valuation allowance</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(332.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(330.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net deferred tax assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Fixed assets and acquired intangibles assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Convertible debt discount</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total deferred tax liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net deferred tax assets (liabilities)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation between Effective Tax Rate and Statutory Rate</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The reconciliation between our effective tax rate on income (loss) from continuing operations and the statutory rate is as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income taxes at statutory rates</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(26.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(17.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">State income tax, net of federal benefit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Permanent items</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Research and development credits</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign rate differential</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock and officers compensation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Rate change</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrecognized tax benefits</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Impact of adoption of ASU 2016-16</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Impact of Tax Cuts and Jobs Act of 2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>105.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in valuation allowance</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(51.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income taxes at effective rates</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Schedule of Unrecognized Tax Benefits</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the activity related to our gross unrecognized tax benefits:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at January&#160;1, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decreases related to prior year tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increases related to current year tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decrease related to Tax Cuts and Jobs Act of 2017</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decreases related to prior year tax positions </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increases related to current year tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decreases related to prior year tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increases related to current year tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6984495376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Fair Value Hierarchy for Financial Assets</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes financial assets that we measured at fair value on a recurring basis as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, classified in accordance with the fair value hierarchy:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:49%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements Using</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>110.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>144.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>255.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. government agencies</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>676.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>676.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>248.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>248.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>162.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>162.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,087.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,087.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value on a recurring basis</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>110.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,232.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,342.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;padding-left:42px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></span><span style="font-family:inherit;font-size:10pt;">Includes assets which are held pursuant to a deferred compensation plan for our executives, which consist mainly of mutual funds. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes financial assets that we measured at fair value on a recurring basis as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">, classified in accordance with the fair value hierarchy:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:49%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements Using</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>199.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>66.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>266.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity investment in Tandem Diabetes Care, Inc.</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. government agencies</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>173.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>173.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>210.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>210.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value on a recurring basis</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>237.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>277.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>514.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock', window );">Schedule of Fair Value of Senior Convertible Notes</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fair value, based on trading prices (Level 1), of our Senior Convertible Notes were as follows as of the dates indicated:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements Using Level 1</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>890.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>540.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,260.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>859.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total fair value of outstanding senior convertible notes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,150.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,399.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For more information on the carrying values of our 2022 Notes and 2023 Notes, see Note 5, &#8220;Debt.&#8221;</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about fair value of asset and liability not measured at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2E<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=SL7498357-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6806782256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity - Valuation Assumptions for Each Option Grant and Employee Stock Purchase Plan Purchase Rights (Details) - Employee Stock Purchase Plan<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (as a percent)</a></td>
<td class="nump">1.55%<span></span>
</td>
<td class="nump">1.72%<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility of the Company&#8217;s stock (as a percent)</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.33%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (as a percent)</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="nump">2.55%<span></span>
</td>
<td class="nump">1.12%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility of the Company&#8217;s stock (as a percent)</a></td>
<td class="nump">0.67%<span></span>
</td>
<td class="nump">0.51%<span></span>
</td>
<td class="nump">0.56%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dxcm_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dxcm_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6995291184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity - Intrinsic Value of Options Exercised and Fair Value of Options Vested (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised</a></td>
<td class="nump">$ 7.4<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="nump">$ 21.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6994728144">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCash</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCash</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCash</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6835218768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 127.4<span></span>
</td>
<td class="nump">$ 162.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Capitalized research and development expenses</a></td>
<td class="nump">57.1<span></span>
</td>
<td class="nump">62.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">78.6<span></span>
</td>
<td class="nump">59.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">10.9<span></span>
</td>
<td class="nump">12.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Fixed and intangible assets</a></td>
<td class="nump">14.0<span></span>
</td>
<td class="nump">16.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued liabilities and reserves</a></td>
<td class="nump">62.0<span></span>
</td>
<td class="nump">22.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DeferredTaxAssetsConvertibleDebt', window );">Convertible Debt</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets</a></td>
<td class="nump">351.7<span></span>
</td>
<td class="nump">334.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(332.2)<span></span>
</td>
<td class="num">(330.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Total net deferred tax assets</a></td>
<td class="nump">19.5<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesClassificationAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Fixed assets and acquired intangibles assets</a></td>
<td class="num">(19.6)<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount', window );">Convertible debt discount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(19.6)<span></span>
</td>
<td class="num">(3.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet', window );">Net deferred tax assets (liabilities)</a></td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DeferredTaxAssetsConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Convertible Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DeferredTaxAssetsConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets (Liabilities), Less Valuation Allowance, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Convertible Debt Discount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31931-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesClassificationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesClassificationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6822073920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Accounts Receivable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Accounts receivable</a></td>
<td class="nump">$ 292.1<span></span>
</td>
<td class="nump">$ 233.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Less allowance for doubtful accounts</a></td>
<td class="num">(5.8)<span></span>
</td>
<td class="num">(7.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Total accounts receivable, net</a></td>
<td class="nump">$ 286.3<span></span>
</td>
<td class="nump">$ 226.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118955202&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6985143488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details - Accrued Warranty (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward', window );"><strong>Movement in Standard Product Warranty Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Beginning balance</a></td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="nump">$ 8.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses', window );">Charges to costs and expenses</a></td>
<td class="nump">32.7<span></span>
</td>
<td class="nump">17.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPayments', window );">Costs incurred</a></td>
<td class="num">(32.1)<span></span>
</td>
<td class="num">(19.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Ending balance</a></td>
<td class="nump">$ 7.4<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Standard Product Warranty Accrual Charges To Costs And Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardProductWarrantyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6996271104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock', window );">Schedule of Intrinsic Value of Options Exercised and Fair Value of Options Vested</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The total intrinsic value of stock options exercised as of the date of exercise was as follows:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intrinsic value of options exercised</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Units Activity</a></td>
<td class="text">A summary of our RSU activity for the <span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> is as follows:</span><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:62%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions except weighted average grant date fair value)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted&#160;</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant&#160;Date</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair&#160;Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Intrinsic&#160;Value</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonvested at December 31, 2016</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>62.51</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.78</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>58.92</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>67.97</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonvested at December 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>70.68</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>154.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>66.07</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68.44</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68.56</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonvested at December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>69.19</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>319.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>144.37</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>69.45</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>83.45</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonvested at December 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>96.63</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>392.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock', window );">Schedule of Stock Options Reserved for Future Issuance</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shares of common stock reserved for future issuance were as follows as of the dated indicated:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:75%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options and awards under our plans:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options granted and outstanding</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unvested restricted stock units</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reserved for future grant</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Employee Stock Purchase Plan</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-Based Compensation Expenses</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes share-based compensation expense related to restricted stock units and employee stock purchases under the ESPP for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>37.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Selling, general and administrative</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>59.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>59.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total share-based compensation expense included in net loss</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>101.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>106.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Valuation Assumptions for Employee Stock Purchase Plan</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We estimate the fair value of ESPP purchase rights on the date of grant using the Black-Scholes option pricing model and the assumptions below for the specified reporting periods. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:62%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Risk free interest rate</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.72 - 2.55</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.55&#160;&#8211;&#160;2.25</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75&#160;&#8211;&#160;1.12</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividend yield</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected volatility of DexCom common stock</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.40 - 0.51</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.50&#160;&#8211;&#160;0.67</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.33&#160;&#8211;&#160;0.56</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected life (in years)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of intrinsic value of options exercised and fair value of options vested table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Shares Reserved For Future Issuance [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6977760816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Short-term Marketable Securities</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term marketable securities, consisting of equity securities and debt securities, were as follows as of the dates indicated:</span><span style="font-family:inherit;font-size:9pt;">&#160;&#160;</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gains</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Losses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Estimated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Market</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. government agencies</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>675.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>676.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>248.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>248.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate debt</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>163.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>162.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,086.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,087.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gains</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Losses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Estimated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Market</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity investment in Tandem Diabetes Care, Inc</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. government agencies</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>173.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>173.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>210.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>210.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total marketable securities </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>212.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>248.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsTextBlock', window );">Schedule of Reconciliation of Net Gain (Loss) Recognized on Equity Securities</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table reconciles the net gain recognized on equity securities during the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> to the unrealized gain recognized during those periods on equity securities still held at the reporting dates.</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended&#160;<br/>&#160;December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net gains and losses recognized during the period on equity securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>80.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Net gains and losses recognized during the period on equity securities sold during the period</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(44.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrealized gains recognized during the reporting period on equity securities still held at the reporting date</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts Receivable</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>292.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>233.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less allowance for doubtful accounts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total accounts receivable, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>286.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>226.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Raw materials</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Work-in-process</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished goods</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total inventory</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>119.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>70.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Building and land </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Furniture and fixtures</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Computer software and hardware</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Machinery and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>130.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>80.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leasehold improvements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>80.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Construction in progress </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>132.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>57.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>426.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>262.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less accumulated depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(105.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(79.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total property and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>321.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>183.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts payable trade</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued tax, audit, and legal fees</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued rebates </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>93.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued warranty</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other accrued liabilities </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total accounts payable and accrued liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>256.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>147.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Schedule of Accrued Warranty</a></td>
<td class="text">Reconciliations of our accrued warranty costs for the <span style="font-family:inherit;font-size:10pt;">twelve</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended </span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges to costs and expenses</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Costs incurred</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(32.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ending balance</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock', window );">Schedule of Other Long-Term Liabilities</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance lease obligations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred rent</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total other liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of realized and unrealized gain (loss) on investment in security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>96
<FILENAME>0001093557-20-000029-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001093557-20-000029-xbrl.zip
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M)'JB,,R=']*ES6-E:\)DZUB,X=@-D?7W\O&_(5!*V42#V044;#?V D$X&C8
M1:%P&<@3A*]_-:3Q!RO;QAS8\!G(R+>^UROE#*ALQZUK:$[? \VD<3>!;VLI
M<SF5MI]U&WH5=?VNJ8$'9SV=)'\/\9$)/1KN 1LOH/0WDB3/L>VQQP] [G0>
M69++89KC#*-LUH$.663=+JK^H-<>B"N1.]^2DDT)LBY?N?YU[H8%5.NVAKO=
M=!9UG=QQ:Y//@U,P0]"P)I<B.-[CYH\=9"%L9LG[E7P##T9W=!3[J]:!=72P
M4H;)0'J <ES(U"^#'&&Z$&- <^Z"@EH:&$+L<E@2-O"L?'"69QK#=1ITINX_
M(X]-FIH;\^SU\KD/E[QY*Q:=JGE>A]*6U"!U\3*J1M>% 0G,&Y;TUF:+O?!W
M@'Z$] 6C>JI+\*Y**E$TU80_LX R4*9W,VY60UAY>ZFTVL/8]# HR<BW&W"B
M;I<RS"?G>;FS/"/8H35D9^-34FX\:99W%1_-S#*A^L#UH%J5 [M5:%:^@/>#
M10+F6A8..TS]^07$X1,L8/_CC5!81?9%JJ<\S+]5MP1RSL4+'H(WYL9P+Z"A
MZQKWQ+)@4HCQ-%WU]@ZUX;YF<1\O$ID:_JKWR/[W($UNP3O3/>(B]*!?K54R
M@)<5@KQX53A<+^M>/1Z^%L*DT3RH#O!6:3#PDHJMGK@5%C6$,%2VURYY<[0M
M^*C6N/V>_)3&.[F\;07.,5?@GH\S!E.D&(3!6CL1,(*15[&A^FK+/VK95$-D
M  3P3."OJG/:TL3V/RGJEH8%5)M_-4DF$0##<W)6MINW3T@_=?MCJM_+OJ8C
MXS*T!:5&R+'TO:[!Q\I9!A.7Q]8,EM>\1&EKM'\!TD<+J'7 12"#: )$8][E
MJ@Z):/:Z+IT9A,VC.B'=3[3 [?(#0^46TR[)4FQM]+RN DQJR4?R0=OP>5X_
M\Q-D_Y=N/?BV&DIJ']-O&)RE/(NM#7-L?3X\&B8(%3#!4[Q%FC@DA#A8I#-$
MJS=2K2%L1SUN77C7?8V?MK"69U(A(.:5F$)O\YY^#B'F<-=V1Y)DC"R/Q$_"
M6">O_>43#3;7HFQ$[>)SJA+JKJ<!CV-V-J10$6)=)M'\ J=( =@6*\ OH>X;
M9$LRQIRT-V9Y#!U*^[C)&UH\(6JU[. 35T=AUN$V:O8,6,C#F97-=R773U*M
MY=8N8<FSGZO-Q*["OY6Q'AW_E2+,LAD.4# 7Z_@8\ A6+.JP#) (\->9=>3I
M$;!;#B"BL8+RT%\6GPK.#*FN@=6/\A25:Q-]*LHS;\FUQ+:Z,6NP6G@K>)04
M*SO;^-P_ST.YKT2J-W=<Y8M T*K9^9VYI4RB"2\6&.;(-+0-T"<^SYCR1BV7
M3 GD"Z@L<P0)WC5-I#36Z"AD7B9-]6E;!0>=1EHEYXZ?J+U,BEY#D#4&Z OK
M"I8YJGK<PK#"D//9\Y-EX3$U45<2E5E3"=.V004$SJN!*M?FP-A(_^?-E$#_
M2I+WKTK_GHI^)Z>'V/5)<Y8'_APRJ2A172Z]0=+\^EV]\'XEYC%!_VZQ3P<
MGD"XRN$CPY2Z2/LDH3I)VJTQ U3)U]^/P#L\R3<L+&S6XFVV?9M$+2N*<,BF
M[K?(2@S[]<VB%"DZ^S8G*RY9RLP:\Q E2*;T%0YI;N0LWC+=%NJNGMIZ+\]J
M6")CW?0R+8-O;NKM+)W@.H EU;)IS]"\6_9G4W>H=,9[@B-^+TV_Y-N^7/\C
M?0I".F WE#0]*L<S"GC/,2U$(RH1ME![:W8WPX3'M!ZF!<U50K4!?=L).98K
MB\V?R $#C9'("PL6R77UK*@0IY(*F:I [GOC#** 6<S3SPOVU@RR_SO;OX$'
MZND,A\!/JC^U^?@891[/F&M%*G1H5[Z[H3G2 T0SA@ER1K:KTA">D_&$Q.L-
MV.S:U"3^$/<'<*9 04!+QDLVX58-57NA%<T[WB@%#>_G::5+Y=$AF;>JH@<Q
M]P P)G,!A0CMH6DCM0WU#(>8";"!J7)UH":$#7\"!6TN(>.XS6#)7;FW$;^!
MGJE)3(J^!#:-+8&6<N]4[Y=U6Y;>$8@_<*^E))=/!%G^-O)V 64.\-UQ-G!!
M1XGM BK]+YZTE(:IO=VA"M26(]49@S:B+H&R@YVHWM!-$=\CLJ.9),2;:K#Q
MV%N13V&/Y6ZIV*EPQ_1IR\"RIY0[H:*I6OV&WD3V#3V5CRH*J=$&F@BHY4RY
MW*>-,9<LH'XAZ,,,F3*[0+YD'M.J9HPX'NZCN4W6(8Y#$R 'T'"K1*"SZ>=%
MAA+U)^;_W5EB#&&R7%.7>B624ZK&=UK]^B/Q35WZ-[KJB[;RV0+J5]ZPA<)W
M^MP9<%XB?U8 $OCNQ%6UW<OP-T);"L22S&__.2V%>VM?4YWDC5&SI^XWA1:%
M^FMW&J7PMDZ+OXB#;6-TEP#I\ )JF-'!_5%[#6FF>P [LT"]1^/7 &);B6MI
M8I7-%FVQFY5$']\:&DPER\DWPE?V:2)+1SYS+?N\PL>V]R7ZW7<B*S"F\)O7
MKDHKRDVE3PTX=<PNGM8)\"DE/R&+,IC@D3*[6\(*533$/M3W]ZV-MZ/9KTIO
M>-VHY :';<IV:? +L[WATO $]9&+4#+?#XA!YTEJ6%.]ZD!*A,H:#)MK18LW
M<LTI:6$N>[7/JF>)N=Q%<#!DU";6SYA59GO0!=/'55? P3MR$B&S;FQC#621
M^PV/ILA#H7+'7(-/]6>SQC4V2$(>4BKE0YHU#JI[R(-?.M0>T>$V$'ZJ$ZPX
M"#?+,3?<\98WRV1,4TJ2L"&I=7(!93S\F6O*@4^2GX7$#$7*']U=^<2\[''Y
MH]L)>6?DC?W71('J?['PANZI7L4H7H5,LK0$6G^?KH=I2MN@<7_UG:ICB,M%
M4F8NJ\D"?Q5G 3.%DE6Z-3!7% ;'Z6=0L;*N/?\VO@17OI"13=QOL*@1+#&_
M/&KG<SAM\"?EM#,N%1%!VSX@U8DH8&G5CQW)D=L$*@R,-=UC/=!TA\X!E5.7
MA[:S#6P/55^L:;FXYO>U2\#_2KW>S:%H3 1,#[STZ1R10^A80(WXJB*A"J2N
M%U K)%"*R@[J8ERC;:"XA\+59$@O&'*<L&1EN^:2S2GACABZSJ26R3_VGG+>
MSZFV-"G>::".(^NLK<D9":K-)_K# ^IDS1%XJ]I;-XIGWV2I/6!R,(B9BL;?
M^-1K18 EB>0XJ'L/'"'SQ@LQIK5$='-'JWDNGV-C.N2<2$3MKXA!=F0;!'&N
M4X-^Y>1;AI4454XP;_# HT &;SUPA@@[,Z<"U #M#7=Q,U3,T)C9'AC$GR$P
MQE:*_O7W=CP!/QJS2-994"1M[K\]&/&IB!9C,IL<%*,Q1Q@_(&5S&8KZ.OWO
MP+]_Z!X#_!->>N54!R0;6W2CM,4ON"GOO#S5JZCQHIG:KOV*'+6P</;3M=K<
MXGBAN(JU^75B]UHX7WUT:-;/O:!Q,#'W=F/YO1-7$>6]%,G!$X#-ZT /^TKQ
MTT52Y;O0UD(6?P&5QY 9_T98^1FH;>8^@9A\B;$;,H N$]$:?VBU4C:KG/KZ
M($JW\3E,F^NEY H;#F<HHA&#\!R,M;L]RWV#)\V<K0\-O;=-GAG*SHR/-?ZG
M+W3D]:4<N5D)I7JF/%/_]RWYIZHOGKVYHWN]J4<56?,7DMO5SZAKU-N07[P7
M4&=9(SQ%Y#20N( RQ.S37J,20.41. )"M^/1L50'D--NSK09:3-7$8T2M):=
M@L*2"CDVRZ"<( LMUA-BY9)U$[A-/1J7^^.%-599["@@*A&3AP&/R]2$8=AS
MOS:'%SG"&MZKD&/I['K=S@F@-N]C$;17),OX-D_6V-DXWY&^!XRP3B-M(4Y_
MS?^1/X8F6JQUL^I<&XNOD^9,3M^Z2I%,62$(1M9KG_$N\$8L5&O@"K57IWH[
M-57+*/*O'_1R>*8)Y, 9*9"GX$I)M7.)5[)T[10-0]F[JPF]].ZGM-FV 59D
M:&>S@]PW;>97481%TH/N=S1WVAA@0C.B=>'K6-,!B6H\G"($5N+/=C(PX90S
M55S7T^_"-)?!BM;43>MT]I1<@1+?2LKRLAFS@7[&V8(VQ6>>[JRUR&H*D':O
MZB0]%G]>'77E;35LBOB 992+GU0GD;(I ?AV"RC$E \KVQ%I31#K*Y3"Z2"5
M.UPN=UKIC27G<%?#.7-\W:K8D"^M.I=S@!QC! /RCJPIUU'B,79_X-N9D9:D
M3W\W@(%TQ@@/=F1=IVX'%;KEK]7)%$QKG;D8G4&U5YMHSH <.EOIW53IY/(S
MN/3CW?+@HJ+7(:0B^D%I7D5#86C7WB^!^=$.3?67?]?KXJX ^,?PT4">Y"6K
M!3_BT(I_SKM>2TA?0%E)^"'ON9@>'HGB1KPQ9@1'RXE9(<!5+U_(\NOW:H1*
MQW$;13H,K@R=U41X^!GG5@A'I2=6W0XWO8#W!TA8,5$V-Y6D=M60M8]I6W_N
MI5A)DP1,,^KNP>J-]75LWI!=3]5##_>,A&C6.B="%O4<ZW4YA2"X='C<>K"Y
M>GSPGY9# 8 [#]RG9BZAO4&4-H$U[*B:AD?5Q##FU7G"U-(JJ@<7CH3T$7N/
MCM5L!QO;=P+69R%7RZ368O?]+\$Q9*CFRE&B#V#5O'Y6:%N):W^3;RDE8K>H
MEJ[>%^+-FPR:;EQ6K3Y.::*]*;&&'66 V KQZ1E<&R*E4<6$HUG4,R!+<+0\
M3/,KV)%#-0$) L0LC&BV*R331J\2WM&V4OT8!(^+S#B9Q!0.E;G?J"+/K)DR
MNIJJ *T4G.N\:.*P6D:<1H.WY:)3(*.=F!EN!A=(TY.I&[.GFL[<%Y,\:,65
MHZ=&)M!GDBJZ+R<4__93U<S%A.F];^='JVWDH_=90MY5)/C3A!MXMKL .U(A
MEUS#_S+IR$12A^-NH.X#T>W%:_ QHP;4)+D1,R,_9)"EL/:7Y3.>:%;U-;G(
MC5*\307SC\HC22Q*=^M0 W-X\$WK5M;Y'(?_?'3&?\##"N4U7Q7B6])^I/4.
MW1I'N/,79H[X8R,HVM\TY#1+:B9)W87&OWF'3#?AX]:;'R.%N&=20ZN'*2QU
MN+='J^D#3038M__,N26.9 M94@MOL>Y]R0YM+B"58DQUK0NHM6XIP5YXI'.7
MP")\!_DJUZ;'R[@J7/.;MC@QFQJ'$3;B]2B-.I-&Q(;9F$,UE./37T([I1*S
M4^Y93=;GY'FV@CK?=G</;]%5()7XG#6->!Z=H8G:F>JDK=(M><UR$'3GA%Q^
MXH8HMT:C6&Q;N.6@9M>S&-Q:B)#1Y'<F,N7Q\)Y*&!!Z'"BMZ'9F/B:.%U[?
M/C)QY>3L6'$J*<XA3=>#('R,O(*Z"UEPO:Z%N0AG%8-G%TS?4B@-NR#L:3BE
M@L() /4%DC1 OZK\( OGH$F"F:GEE$*"_GA0P+;M<)* 9@4FW=!$RJURFW_X
MB>V_%N%O]&A,$T-C@E?H3Q&A IU!O=IC@OF<GO&-F<E;ZN4M"_9R2033AH@%
M0MI&V >RL7HR2\@:,X+>5J;&XSA/X>>4FI/]33[Q\KP+/LF*:O?3(J]X\EH1
MU>>L!52FHO0F*H?U="N?:%^ZL<0X.0$-$W6&B]0_A6"&7>3D[#$K] IX 744
M5&JV3.9*KHN7-5YY/JYH&[.NA5/E86B=R;YF1E#^D"!DS<BIMR7V/7;-*%T&
M(A/$_JJKO5R<!J]E?O>?'H'T9,A1UB$DKH,C%>@T+I:31S-RSZ*M'X%#_)7T
MPH&/9:"D%6/BY2FO/D%YX.WOK^L%UQ<B -#9U9%'^MQBB<?Z9IW,.S]B87L+
MS1K?$_\CI1Q5Z="S.VJ< #PT),6T!P#2 %5Q-364T<$9VP!)Z.Q4;%#SJ^QO
M##K.ID;DY?KD*?]BX57FL?[-?QSJ'=_[TT"Y=G^1W.(:I@-1P"N"A UN'<(]
M]T]3^$U;R9<*"C\6RXH"? Z+-@^Y>9(2[[']C2J[#ALY>:2>G +JSH>^2[A%
M39@^&+* VH8'29:^H*"%!YX$,G'XAI<@0XBF8\"CO)PKK)N:C:RQD6C<!K D
M%Y^9$.8A"AOZUCC^2V,?VU'=C28]'Y_OFCHRSNDXV!\R.'&B]NX?>K-*A8/&
MS$5!;B6_N]..J9UF3.6=@ZR$-BOANQ"Z1:31!R,[LOZ%PCGE5$^X3=Y]_0HC
MJ\E-7NPKLWYVZZEDC)=>2UPKIAS]UND_!W[EGULSVY'M'M7U&7B!UYA52)73
MU>K%L(]J#GQ4D"IC&I#"+: #I7( %?!TF*1S ($\+XNG$S882%_ ::BK$_TZ
M,#M>.^(8BE_Q\E3T%\KMD7#PPW1M7L,$N-=+W:H\%Z'>HD%Q^YTC7HB:XM47
M*4GM.*N"8(.RXOC=,$M]@<+KH*VXW3=R(LJ^WF8SR,MF5VJ=>PY<3/0T@L,=
MSYM>P.0B_7,(&-93L*8 I-$]D?0B;H#OSM8NTV%AAT]TG",5@_R1KOEQ,*#K
M'_.0_9S<V;!@W1JJ8^]45V5N9RBB_$/]&"%-MTE'ES!?!DRMWO-;B7/^P1:\
M+W &L;_;)+G?37JZZKWV80)K>#,^<P>MS7(!)5Q +:/DRCJRN=ZG2 W*&YI8
M\$X+2R$Q_[RS<(8.5B?@T2&Y9F$./P]>7%D3FU1UD/K.B?W.YC_=W>_*&MGB
M@5DEO(4WY12MCJ7X2,\7@?).X6_4 W0^T5BS'_HUX+>Y8T6RBFRW[A4QZ4*:
MHXAF^6X8CG,+\-W[2O<VQ=A46!+ _OW]V \N7@::>8#/#3&O5+!@!Z;& M.*
M6\TAFU 82 $PI^\\H,3_W/>!<:1IT(U@2M6G^_?$3IN/^87(9E/W4JJKPOQ"
M7_]5Y;31F/&<)Q5C,11WO@3<@S4(D!-61UN&:IR&$#O9Y2"W_VONN3&!WS!"
M/0P]XZ#IFOWE=%U/GV9_<GG,_/[IS&M)L>8L8&7U(RO/786Z@;.H^064ZC,2
M[&NX0F6N_1T?T2WN1@;FR^J"FTYX$F&UQA$\"Z U>&A&XC] LZ:4R><$6E^Y
M0V95+7I5#-' H4]#.!/Y*)IC>;[^:71=PV_BB3?,,W7]"?\%S@*7$K(3@]DC
M?HF= 1X=@91K/'9?HE%UT&%._0J^O*:?[-IL/O%E38N1E_AD;OUKM<>*2/@?
MQ(G\P2;]SUO[B*"6_D$S@0*[C$) ^G20&A-UY4-^C9U'V%MFBHP\/-+A0:NW
MGG*_W1X;ZE]?E^_M^T]L_K;KISTN$6;C(:RJ%/8!>6W$I5Z+GL"-@H8"!A"%
MR:[C&>/6PNZ'(7.&>Y;7?IIK;'R[S>:!*?:[BY%-S -@4EK3KF<41AC/'WC!
MMZXM8=KWNXOKBM=+;?#J2P!_+TZ/UM*I=N>T:W\>1HLC5+?@%/5/%"^?U#,Q
MX@-/% 4-%F.>0^9?]OT(6_&W[X]PSTT\Q0]P2\S;>O8LZ6_.E:!I ^B.@BRH
M3I$JK].6T;KS>>LU/I!GFXVMR,LGA:4YQI!ATK@6E% !SKQQZ)DF0LXS1:,T
M!_K)F[B#RV[)G# ^O5XNR4^)$_.CS2U?V"-.!R:&0"N=X5=$Z9Y&,EFM>\NL
M;:MH!:XB-O"%C&6\FVNEO8-S"=&0P<&")W!2![&&G#/;R,N=9Z8UK:6NDUM5
M5BJSF&:NK'54\\&'-=#Y0NZ6'B\CF7\6T2\EBF7US5&WW!_I6Q3"HVDY2&)V
M<I=HP@=KW[D!-W#+1$XZ(RI GXY[/Q%'#83CEA4_"IN<?VGWTM4=8T+=[I"I
MLVLO6NV&<RP1;ZM]6(K"7=+^R9/6\=CZT^0'M.&&;CX/=FAF9)W79M(<PS5;
M88XL"R!Y_T01".?SZ96DP?#-_5RSZ ),C?;97?GCA#P7@>5'#JF"=$69X19P
MV8J4ZNY7QPQLRNE)=0$==(9%<M9-Q%A@Q1TZ@TJR>M<XS@(B3-V36EO)];-I
MCJ,:4FJ0('R;J.GD&7#N"%A<DBW+)5Y7-0QDC&HP)@E#@U9'N%&NVQ]-9)L5
MUA29)/VW%2&1QH ES'4\Z:NX#J_5?R,>$KTZ;(>/U[&&T/>4 H7'R.D=[5.O
M5RB7="ZI6GRHYXWM^>VXL2+5DE=U!;J5CQ#0NCJLV]C/)#6$%OX'W[@E+YDO
MX5#5+SE3:X\=^#TUWR\BY[/9 LKW]D$%LS/9Y*#^1)+&]+C.L!H_K85(JK_A
M-7+E5:QZIR9,FX.S"]6XP$7@ BH,?D*"](4>F66)CV&&'P?:?*/.9C&8=YV[
M\E4_U:%J))BT*FSL-07CWQ!ZJJHV=-VG::X'DKS=W*W4Y=H_$;L!B O"M454
MSTK82K5OJ.E<=*EX7+)^9F,#+),Q,O,;SN)-J 399"43$?R18 J<U&;A(4FK
M3H@]YQ:<")A27-I6.<V6W+/)>SJ!&%0>A]G*9!"?%V@L.*H +9MW5KEXE%*Y
M'PF_B((5,E\P.[#&T9,K0MPX[0'HUK@Q"D:>E*WI#]W"[D934EK'#&'FL^72
M@J--(*ME 943O60RF>6)'Y_3K%E M11B6AGP)NRT0&J]Z<._(B^LV@;1+OL8
MQ_L?9GI.QVC&\\>3JR>&5AQU3E2:D8(L0MJ?7!)V/YXLK/ZGXI]7]0+4"=CS
M^^C1/L+MH'4!-4G3L3+>NWC^/)TO$2_[) M_$5\. RI.>@C,!^=D="%@$T5;
M-H"SG^"M9/$BF>CQL4TBG,UK5@B)MJVOR5.Q2_EK7Z"?TZ.DFT<MQNG3MI"O
M'(WX].L>GV[BS*B89G@6LL&OHN@);%;!1R/DTYXM ?+4XQW$51JL-/ 5%WI4
M_7"RD)SIBE\13,E4MMO8#CI_*_K&[G$U#K@]^O%+&_ 3,C0/%$F6T%XC-IXP
M5::.TUS45L\H:<L[%U!+9D&BX)3.BJ)NDZ"/^\+G$/4GKU5Q2#+&=8_#Z1&R
MHM'0TW">]P#O>I! _ 6N['!'!O\G>H(=9-QSV]A9,%^9X[/MZ-^][)\_5_7N
MV@MM1[$O1B3=:(K](_7F>/WAP7/\#9CT< 3Y-"ZM9\SU>^-32<CWLQ1 A8$!
M_+0^Z"FMIG=@5DT&$>NVJ8 5LZR5,86^@MA00J\&S^)-M<Q_*]1,0KZ[V5&S
M!*/HAK,NXI@O_D^,_%-"<[N#(+IFS9ON_5#%5)AZ!X6L2H+P67BR9,2BQ9RX
MFJ@ZTN^5\@!.(FA+J)B(1Q-S8SB(V,',5=Z/N8QXPJ:-<3+&VNB&,$F&UQIY
M*H (PK7-# '.ZFR#*%SYI4@5_XJ# 2F QFR92YQ^X7=SN(!:O.]%<F]R^PDP
M<BK)I7V3Y&-RKM&V?XJ2MFU[^;OMQAL2,RZ&<D>%J(GT:JZIKD^R[FS! 7B-
M.DK7*2[@$],PJQ-?GV&#.^]"10+FRH3I34#Z2S@-]HEX2&D\7=3R98)KW?OL
MXJ]-D)M2Z+13Y$-2%^5.>AY!#QN1X:V_4;=JV5PS6BN^SK=UVD$:U$80.[8.
M<3=J"VGV%$>Y?0>B5*YA+!-CE_F@<[A68K@@#,0*T.LH#O*;N7;YCX8$)?;@
MZ4*'K#)>WYG>IB#GFNIQ2WM)![[.06,^I&!.'95BKTI,:<ZTEE7!%*+J3^W]
M6NQ5WO)O3_ Q>;CNCI<'Q8.L<S*,%?Q)8"MU^GA79FW4'F)S+U:>&[!3U(:S
M'7+-\PQZR1[<5CUK_ZJ._B\&=F)>]=JCC@#X$3QI-J:&T>*?.,3=K.L"UGCY
MJ$]JJ(.N!TCW:"NHIB*:K<8$LLZO5Z1T;M+/? #M(QHV'3TG"PT(G&E7A U]
MZ'4=V;*Y(.1%=!Q/.KWN/@=.10JX^;:<XE26JS.TEX8^"?](N7^J6M9CG_SQ
MUH?$DSFCP3]_R?\B7^K_,O/8;OQ#UE7F.IP71=D!K/5:! VI$D0Z@S'-3^FR
MCT]D6#-*D'P*OY9J# 7MAD89.983:H%8R$33+$F6.\MEUO&M!?/+>/<GN>O3
M_CO_2C3K&%3@WW_!^>(K_#!>9Z@/&JDZX%KU6:H5[%-M[-]&?!'4802DX5?K
MBZ>>E?;/KJ.ZG$MUR':-B[9]&76)(NZ08P3GW?%<P(3J-O2)\,VQ<AEM3E4/
MOY!C,B3+9HWP]+Q'IZFQ<&75'A"0VJ0_F:RC67O,M75;=3SQ+2U*4:N=#MCE
MMGHX,;)H=J2;#>?+[3F97FNJPQ&.'2VOSUA W;8.)*X%^.MYT@:@!C]MK,!>
M;\!,2=1V"'G[>^F7Z]X YJZ5A-QYM)"U\I0F%+2FIVL\9;R<0AVK O;E6Y+I
MM4;-T5QS2KHP9+ F.C'I"3Z+MA.NFSPA>4)L6ZO_;2EBLMR%QY#U@F<0C777
M1T41W2'6P=MP>&Q[.]Q9;$BF/QH<V[,<_$'C[-% J9C^NH ZO_./L0VZ;IO0
M&)]3I&.W.%/6@*VR:MPR26/]]3&WO'+<XQ(&_/D=^Z/%_#/F^: CY.>27/2W
MHC]KKESP(1H=O=>54PLRIG)$Z'%Z"Y/-;%5F\];CG*CZ(#J;_?UC3RGY.M>*
M4B#_H\0&6E90M5\ZLH#*M>#^Q.!SS0;EHO+Z6+PP2>Q^-9&\NOO1J/^:#X^R
M4^^/O0_U7<8YX]J"*0S__OYKM280*:EK"C1L+Q$HASU;N4[P'5EWVBI:3TBD
MD+&:UG<;MN W?+KJ$+8NH'&\3K)($UD=';XE9RXXU/31(>=OXY9]*?RJCFB[
M;:GQJE7(BJ6POPHL4KV$23)\1O@&.$A]A-;&-'5#7V=:XY9J?H8"T^,JQG%.
MG/ZFHP^C.?,60LEB,5QQ$-)/=RL^SJ=MZ9MN\CEW7ULW..=;Z%^\?'SNRLF9
M4HT.854S^ .$^/,,^#\9;SA><;>BA2Q>BI?^,87854UBDHRU"%;LJ8.Z_J!9
M]+/QQDCKAN\"/^54$UNO"%^>ZF)U/AQ7E6P5?6,Y!O5=_,>D._*QUAO1*IV:
M4[ /-@VXP$N3F'D9)X$LG6&I#']SS!72UYC]1/6!]HE90N9-F^WD591;;.6-
M.HDX:._R)DQ$:M7D%?.R^Y2]2T!ZAL8O*4Y.^DG:Q[7_;!$DQ033A  8C!'[
M($VCWD;=JWV"5"SCG2E_3DRXAML$*V4G*P1H<]UP0U*FS@%I5B):XR1;0%G$
M7$&GQ79/?4J1CHPT!QV&E@3.&T[HL+WY,_/MZNF\BG>^-J4._0NH=7CI?28;
M+5A 98XYP=U2WKMZZG&0*6-.N<DD(Y[RR!RO1$@U(HN=N9-:28GHP+D-TO1@
MPFZ&#'US1A,,H5O'+$"OADS64V*7C&#L@VN^/S[G?CG)_8:M[@)/^@Y-CQNC
MO:&AM0\3T6+.,1 OP ]WZ RMU8$4ECR)[YW4SER1@$TKY-&IQ]5;QG4&(IT]
M)7/BZR%14QA)3E@18[.];S9@I_(4U#R4-N23?K0I71 H+N0_$V@]:2-XBR9C
M:$AG@%:?IT;#24^*";)N(1-&BG)ZEP*_!,Z4K>X;(H*7:T"'CH)P:VC_O63#
M/"OAE3WL(79*=H@[\V#_MHN;<PSLHR)0(.,=(O^*((5* >]1;Z'UV5AIL[=Y
M;57C:/W<'7">] \H@S?M$*M K]78-H(>U,,BUV9 [G#U#&PO>V<'5N0@1K<?
M/C!R#!S*G4V9MB&:P2G'!EP?9H8643P0N8W5K,$'?7?AU 1M \VP0^T]HME0
MH#*!6Q&-Y!4G-Y+DOH#'J;%R%GR0MIERQ5-I.)Z/,=;\=.';1JS O_/U1;?B
MO58R<N4[WS77"U:%VP'> )]EZN.@6:56N7QYE$.TU^'V;\TY\8?O-B*;T79K
MV^&(\T9VJ79Y-V?M+AXYR+H)2*^:D\$YG6'  DK?E.H)/:P;6P>U#4U7EVMV
MOP2?U<:OO,<B4M!A$&O:I.JSSO5E'RO<:))E..$1E$-U V)9>_3&\TBLSR*W
M-X\JSD:BM%&P$MD\!LX%]52>VN< B6E&>VMC,W !?Q;(XJVBVCZFH _ GS\=
M@:_)F'2;'_J:ME?!'7Z0\5#KP:HF[_AD+<NFLH(2=$+$<LZK+1XH'ZPVGJI[
MXO &]P."U R'CQTN4NW4UN&C%U##/D?@:+6];CBD0M"%V0TS087B9@84'PX3
MDB%?00@]1V/OW@;0Q2P!+Z.!'1(?58BK!RK'*$;'()[JM(>])F!->^G.6Q43
M34$:LZY8?8V)GLZ0+Y],F4S6[(+TP[057B=E 6=?KP^Y6%^*J&O+A&*]?0/L
MW*$[4_/Y=^16S9O]-.Y/0U[;%V0EJ)L]C_9^:'K9OZWBE2ZY*=&!03/0_0.
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MQR?.WAW'B8@C;"EVYKO2B7:PCZZG7MZN,BS7+!.J/^#,YF8S (.(QZH<- U
M(FX58;5G&6TK^)D)64MQ60@),D+E%\U<\JY;/Y2\SC[;Q WD,:*OQ;,1S^$(
M"^-X_[&IA@CEF9;N \[B.XD']^V;3=3![MNV4/:5?/:8'>M!M>9O']EF$YD8
M]?7E>UFLEY$92Y@U7'B5TIUF-U"'ZC[R*OD2)MB3<N&U*H_F(YM-QNG13:F,
M-CZ.ME]2$'$!":_-:QO7Z:=YL6DK!R^]:8+='_E2#X]/D0QJJ<-2_<G%W/)'
MB-4]3WA!XI3"O\J";8R0C4TR\HRY\A)B LN4SO2/@>M 9DK,!GP'JP[?RLK
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M4_D>/71S=2<.P]L*VW7PML%QLJ>NND]HAV! 2F(N+B3%)FA*-1Y)_J)MER8
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MMLJ3H["RNDQ5LX2Y"J03:TFWYXA"HF*/JAZY%@;=G):<*I")=! 7>$SI3+O
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M:2)FU@2T@[*.0+M!UT.R2E)JX(_W)+L"_)L;>4V57QI-%[+(9\ L9\O<Y/R
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MV21?*\)+QFRW(4D=VM5/7E COW>F"89\3HA'1;K48X)C&8A;!97P@\W\&]>
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M6+:_@&H6(*5T.1WL_S1D&R&?D1;X#<QUZ>P2:LU31OWWF4DW8J=(DCPY4>E
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M\9-P.<Q"^U=O"BZ<Y]!'.:Y<RQSZ[&@CIZ4P_5J9H\[H)J&D+0Z$3:(3<I$
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M4NBB#&3^VN[&#<LE>PY<T:^NI.ILQGEDP8VURG>(YW1T!)5BT0A7QP5T( \
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M9NI*JSM4)" >+US\KG9C:6()P>1Q507E'P3BGLYVFL4\=6+L0NKRS0$/<FL
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MH VI IK%6C@ U6UH VLF*9I2!&X"D4GSBY%LHHK?)Q',&E=ARE(>F4,I!M"
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MS9ME86*M/0EYL2G*LZRGB'D)^1@.)IE8/<57,6"3YW<!==@[.K* YPOP@"M
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MM(*1(A_+I B8C*CK&;VV3XW;0-OXN"ED796E0%[K'( .84;F:ZS+7 ,I8.H
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M _7WW08G/@E]P=?M8'<%/'X>O?+D -2[^H_2[?^JP3;6:Y5!MY6&&"!;3_4
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MQA+TU]E8FOB)HLS]HL*;4&K7!CXDI_%HNU/S;*]9H)/-+T\&>)$.0!R0I%&
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M@8;^+GP]^/=V6;3)I-_/DF_.@/2E-'T@@+@9[:P-6%6B[DV'BW=]YP$(W8$
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MD#+?A8L^ )UH.TO$06@6%/_8-B;B4 Q&I)DROK-Y?V>6-1Q"R.4D8Z.#AL"
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MLC?GG*TY2CM4X+G;\/SFBSEC^DP89S4)#-;G>^C9W?1(_LGGO8L/2^Z?\A+
M@T"@+UH[^PCIU5"U$^"KX#$FVA<F,@]5AE(P'X_]EYCK7>QAU%[GJ"-F $DV
M0PF?HUBGYG_PH78.F0";W!\=[;WHI\8KN*?7,=3QT:L/9[G]-63LS]1@OF+]
M&$CZG&@88[$IPG^X(!.Q-2@F.MMS!DWR H'@Q#_P"]F.AU)_1/R,O%X&+1^
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M84H4 +D\=O N]+=)1"7@T_R52591:5]SV1[.+#0D?CM#DV.,2B90>J9E>4.
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M;T!CVI6 6!*.;\X'(U5/#NF")T&.'8 \X?%PU@JSM /0\9!DC!KZ< -9L8@
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M9Y'?$T.56N/)^)@V.W*VPZ'<>1L@<%'1^<V,(]G"LVX#@SCA-1P=@).;%C8
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MKNJ&U%/]),%-;,.U<=V+!8Z72ZY*QNS#-OC_"(^_U>I7H-1WMH,3"*$=8<Q
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M9JC#![?H//7DX7[,4=2,FW83!=*_E<C@H]QQ8P=\E&*)8%;D-:I];+OLS9!
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MY6N-F/\PE<I?(;*DD-GJ9EYZG'<!TECJXZXV%B7-J9F+^R=<"_6,6C*E61V
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M9ZDF_5Y=YGF]CS_-[MZ,?V*S.+%JTZ-ULZSL>K& =9([GIUQE&F5O'J\2 -
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M2O_45.&Y_"\7S[\*%R!SD49D5U DPT(823*RTS8";)N8[+8U(:D6QJ:'V1:
M*!>]L0/("AB(#ULS;BKL/]>'HJ<7OGM0T_M4,\%[3V.84Y)GKFN;R'KEG(G5
M1 ;JA#PR"M]4P"6N)HR[*8L2."G(]435'E+A_&O$)L@<=.)*6FZKYS+\-]\P
MTV VU%%-)G. 7";3.9=U"FC[;1C%23'QR%'@M@Y+WV]I5KWQ?8/^\3_#X5_[
MF20UYA--%&[0#_EVA5-_/&>=B(21"G+0UA"&GSA:0["2Q&Y2& ,8/L>0?.":
M^'+D[FBXV7#YQ)O&WGB"ID-61)+6U/,,W@NOSRH[J$9^ MH@>PKM$IO6PB<*
M,MF_D"^"G%S6.I2K>(RX>41Q&8HH@[S$D9FLY BP  _Z/Z[[2()W47380M:^
M"I(YKP3>H'854[&]2G$8<(]6V8,),Z>G6AXAX_OQ?W*:6N:.@=T3W:_5%;T?
M"6>%R6V@.*Z++<\LH-NKGQ-5,Z\'!?M =TK=);U(\3+L-DKS$=FK'DQ,8QT
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M4:X\L;IM_%^ZMT'6!;5(;6]07W#F5H,<L:Q(G!S.QZQEZT-C$D]:&:F_Z1[
MKXF;Z-6?X>E/M39 E,,)\6E+[SLEHY8-^4Z^5;]'A_VN7PA;\L^$"F0CT /Y
M,?)6R$LRGT5MZ*U\W>XY)B;>(&-!. ]M"+6?D<ZY!T$UB8]&DSE^T(F)4-&J
MF='-N)6@<5;0:!C2"ZRK/0,:[5=X/_L2$L'A]IXPF3Z_@#$B+<,D)?5+[XH
M%7XEI(%32YE./V17J[*[BV ZOQY*[%!9@265FPO#F!FQK%T2G5_FCZ=TE"#4
MM<:VZ9/E$7!'!J+I<I)8PK;H=Y@R6?H57OZ%^=;/7B:&6JZID>0]&#F7<98:
MB462/0&:POJ4S2(F;=P"1'  R^XE9ZX@IU#([2$:?M&)K(G!V0"L$@?@/-TX
M0W##L3<I0*@R(Y4&4%>1&DZTM?8[FN8KX4)6<'4E#[N"9.7AE.EH2C2$:KKN
MOKL52>MD(YM;^F9K8U\G.!4LM62QO!^](;IFK&J]FL'D&B1]MX8A'GA0?H>/
MT;I;,;-# $<2F;V 7?&%[005R:-)E;*##)Z3'I1+3<7]XD*=.Z&N M0^]!;H
M9H+;(4%(_L"Q 30R^E+(5$OKNPQ"C<('O'I3/% 3-7K^2<'Z9+A\&Z7?I:5;
M:2[-O2\AV*S!;*0(\(U4GF!DH*M0>+N$"OV&PE,GBK!:$,,#)*;-U2WJX.9]
MZ,$ ,5>Q%^4A'LL)/TE=!XT*NQ";PO#':=Z92Y?@=?]O39?^=[/ZG*'Z988I
M#Z*/!B$W3]V9F@),I!/9E!5Y'3_T3Z<XT[=!-]B[J1MML[8%G1O<ZN?8: BT
MFG_(+TZ(^IIY?PF7"8,TQ/.S/?+ T!BV TU*GPL$NB65*:BK?]BFQV-64]YV
MBS4RFNBVO"4S<8,0%>O<3<_0GW8QX]R<36#"HI=LZE++RIMRFQ"5CI_^&@YV
M*F0V*4Y"FLD@]YC?2DED!FI?G<*D'A1US&>,&M\0 ZORQVT&R$0@G-^JP1/H
MB/Q ?>HF?(A?)1))"N06_GUI2K6F?W%,*\FJ?0]<KYW]:.#@0K'!BF^Y#7)7
M4K5<=AMB@ ,^4$'XDTH>?(3#932HBL00>=-EIRIQ$E.'Q)0X9ULKDN"9&EF/
M:<?:8GTE'@OX#QK<JT>YNG<J?1'/SA?.JPN;*>?\##UC"3,K?T3RZEHBWHAG
MW&!L0ALK@IXWM@/%W5G&82^@X.BG'Z80NME=$H:.F;[I3.ROW>B7F*:*)J.^
MGR'GNOYF5GUY!'\G4',WX(>YP3%E[R+O@SJV@K:IJ,@)XJAE)[+1-F-/O,!$
M<:S #_S,%&.T9B@F?CLFN?DB?0>&%NF*1&F[$)K!\BB-VO9S"[ 0<B2_Q>5J
M)56+DOYD]L3IR:B5;G9>@;DIE@]U-0YVN?Q?;O_Y798'V=21KP)>J0KSQQ#7
M%_#KIJ'MR>N@MAU5U:2@F:Y^?,MK4=:X#M01+AX:F",?$WLVTGFMC%O/&EV5
MP7-"NZG6".7<4'GVC_XQ!THL&#G!G N68K+'$:" NPP;)8B#;[ W010=A!66
MAK!0YL-YS T?/C4(X#E-G[0D?H)NO%9H--H<#,I)N/PH>C2G^X8C@:HU=40&
MG(S)J"*EN1%GW^Y<R8M5(<B'@$D:R[4,VM"M,GGO: #2TUDGI)^PO&48G(DZ
M@<P*[+J>RZF+D15&L(ND'(U><0W4U'YV--G^>,EWGE-?=.OI$+=W]+A5DB3\
MBF'.&>5*/P@I1RLTH(.26%=Q]VWV"G(D% S2L&'NG4@@;\>KRX!0\AO#X&+C
MVD:E/0\'KP<^<;)0O@E/DY](CV02X+HCXT5^\(.YP\/OQY%M.Q_!]]8#JV4/
M*A5'DOQBWN'U%.[#"3FG$D+G$-X7',KS?AU0V(AK7?R<QHXWO.(\[XMW0_IE
M2O8OAKDM6@T\'?=<2A+5TWD44\4O4!>0);NF+%*MAK2DQ-O/+JK6D-$ GHO4
M(W%/0GN6IM6YEZOF)0]&2GS1G#.7";K[XU>2"CT''.8NSQ>%@%?I9M-A(^C4
MN'"45>SBG,&*28:FRACRG>!PF9ID6\"MK)EB#%R\8Y17X75YFV_B7OW>Q&O4
M)(O+'5JBF.LY0Y\KR<,RV3#_VS?JB]'1L9]!X'6S_[E8?X*8OSC[=< _?UAT
ME' MGY\T=JUN5MRVK[XY?WIX?)J?5$3Z_.'[09U_RAH\:S<G[K77#!@R6/%S
MJE+U!HEDZ<G-%6N4?Z(W4-XC=5G[D@$Z%[<)P&21+TOQ(R^D$L\LM<BE&/99
M],?&FR[#:!R A3(WIIT9/F^4.+[]&^M4;>CTI=$W3VR>F:!+J;$8#LE4C.E*
M7LE=>E>NIM<LRD:0QL]Q%P_1;UU ;QTA;U=G3??#@_$S\P;3LM$N!G<MZEKU
MX<+ :<K6>CF11A6[ROU4#''MGO%)7MI4X1*R-.H1_('"1N[:)9XC2(F\J@2B
MSD=R+/1#C%T%X;LI3@,H4W2JN.@EQ10B\' ((-#R]H8NE]S:N#5_D,,DOJ_.
M#9$)3V<*_L"/?9D,2_%^[T (-5F&-?R8G4L&\.(?LS,3?D1^?HDSIH'S.DQC
M(I]>-48ZP7(TXEQ^$C6N#W"A\4G? AYZFPFN/%DL6A,]C!]I_O'CTHAW-90R
M^Z.6D&S6B,$:>X@?'%RPUOCN\"BE+^4U:C-P'?FXHV->G8C#>:+G3GF@U2%E
M&PH.!O*I8RJ8\J5C**$WV!?@T,J!R@RT64@(61=* @Z-.-#U/T$T7G[KY^<1
MT8#( RPI>G8:HOJF"7@-'T,%Y?CHO1VQN"H@94+GQTVTA>)7:$PJ,/4"X5(X
MCP%3F$-A$LR&J7&#)L I;7PM9(/AF85V.N67;&P:1AW\>[J%8@DQ02U>R99!
MQLE\TZ+VJR*_]_%*I$?_[ 7"E(\F3-\?]G=>'SSPU]4&J?>T\V'7[\(F*RTS
M[>S6>&*WG#M'/^K:]TO_O]M?_G,=.3L'(CL1SDHF92OD+)E/6V 84-X7H/6'
MR(9Q3Q76+X76*KV9\750X!.R==^BF7\'>ULTJ/!M_A9OA=</B[[K/5&6K_*.
MYUZ)_Z:3'!^VHB-!HT)+>W)@4^51#37_42.)=(J^'UHH[9Y;/0'/OGXU2^KG
MW&WB1[NQ#(ND0P'K/Q*"KN,S]7\$@J?ODO%0^35);6(0&/2JG/1V,KAPWB_7
M+9B;/^8P8L'*GX9[<""M)"DV$P^G[" '@<:I"GP<X"Z!TUG7 #L=+?$/Q;9"
M3HHEV'U3@07>S+$.2EP%1E"=E/?] PG.9^_J^\SP? X$/:CS2XZHGC'9+&QU
M*OI;N>6PQJH;E_PU-[V>IJ286S[JM<7=6_'-F<8YGQSG!WK-6=7,H#'O$V*U
M9+F0&)B7C#]^-$+:,^_#^+6?K 7,B.%<W_D5@FI?J5D09OTHJ<$=<BU_4S6C
M4_%%<%%E#JY^>/W<,*'2AA,H%=T,$61SHD0W1&:U*$)EM FQ@ZA)#@>:A"F6
MP,.E8F'F,DQ\J7MB)Y,H 5U(#'\L''V##7M.<"5"7DUE@Z$!;&.[L?18'^56
M#]BU\P\ OBDV&V$%M2?7F&&/#2NTQ$C:J%'^TO6#\-1X6S@!80D:O;CP536$
M*DBDV I1[I$)S][^WHAM(.&Y5V\=\+OY,F_PRY/_T?E1;>C+4!/@' K=!VFR
M:*CTC-I5W&%,PV0.Z[+4E*/SB>2??'&23^,OP]8IS@!/DEULKF(,HC7%J0/Q
MHDVXF;UAR["S,W.)3T^=&NU9%42\%-IC">G)PTZ3KX"V/$]E#<7("Q %)R=A
M^U$K8^4[_U10Q=2U8='!FFK\T9Q:AFW\2G$3_79F0.'?JJ8NKVI;[LD]BA,)
MD3:%74\.M5JPD?(T=8&E2R)G?U)!#3%K&;9BH N]^06D*<&F%"[#.HCI:,TA
M%?)?T2S!K(>(^+YPX#YOU#FS#A56^674OB5M^Y##S(Q-XFO5OA?LEQS:42WB
M]KS03Y-0J2PJ+Q#BRFT4G@ G2RU#M*%0640_>TN4$WI5*]#^E1,GR;'MIFCV
M*S0-7T OB$8G?1]3.UW+OC0WA/JB,R2;FGS3[A!QV[F,&G71ND-Q5/4LT;LX
M(QB)Y>Q !+@.KA,CVH"REYB9\I!Z\RR+\>U6ST@](:_40$#VAJ=NX+&1I^H<
M=7#+L*,O7]07\:Q69PJT WP3S>I/'1"-VLL<ZI6E%Q/>H(Y)YIS\++LY:J]0
M(VTS2K1!S,T)4'@S@;$6DH;V*[RI$N3:+R:,]$;IQ#+,;&J4?^_N5.M<KR@C
M_N?C9D!.<-E3F2SV^V5).*?6 !NX(08(8^!KJK@M]%/@L>8^AUC;WUH&'7L/
MQ8:>8J=XU[<,B%E#3;X//\:$% ]>[4$_IA[XSB1:E'S&C_L,M?RO?70IJD'D
M&N8R+(H^(I)B7R>[=EUE:S"DQER\L<*QH.L'SHQJR*1=8$4^"?OBO-2(0/@E
M<GVK<2.G1'YN.8VCO<4-864[_NZ!W=WD)E&GVTG9#<A1?ISLPX:2,9V848S8
MN#/6OK/YE^^\0HT<:L28*.<Z-8.50+Q,0.=(>M3_-,^M6M"B:C>Q"A"(_DC5
MN%-K[>OAKPFN[5B__L@!-\\!<0LO3(N+-E=S=J0$0Y- ]R5,PR\4\V$608*G
M$>NB"O);_6AI"LSELI:4!:()R5,R["K2ABZ=&L.>D11%]"_&>DX&WQJ>,WRV
MQVU8_8SN:K\>>$PJDD4K'Z-7D,R[KE-O.-)'0_D(5X@&PKLK.[)J1QB;%3["
MQD_$KO$M]6IAD4$^0# -T]G!?S<ZTB0U;\36S 2WCK^Z5C5M0AM:,DZQ=5B&
M&9$8_,*2&G6Y0V_I1^UZ%.I%K'"[GTNO@&+, KZ%)L7?57W['#&H\)68)087
MC_^SW>CNU'4R\]+2V7&_+P9'-=[@-:GGY]>3G2 M"?U6*R>;92A-5$\_?"[;
M)>_4,-I(,W[M'/L &0_.\UWG]'^\'FW)<?R$"5$/3/@I<&[X3L7':9.JAB%K
MAR*M6JRW_'B+SW@Q8#SA]6_"QM/JR2A VY@9[9R."I9B-Y!HI^Z^G^2-[P>7
M8726QU.HK;L$!8;-I>871R1(;(U(14&#CK[BRJG1B_1*C^UU66*EU6% 5E V
MY806>/P?][;_?VV4@ZHAO"%Z*RE1M6XE4"2.K<RB1K]2&9,*9-;*QRKK&8PN
M-=+5S#)(N A/1^I0["GO5 9 1?O?'Z-:3)J*6;C-4(IDSB0T*B$IV?SXD&/L
MUODYDZ_OWGVV/3W$B8%K47I'F7P&'%*IL?U'MJUZA.9O89XK?V2C=RA^!8U2
MEV%KZ>D+V&SV?J@!D!^"\IC1XP8W&ZDTIOA3>*>+K$G^F\*+NI*4=/@YT)7+
MD!RK4.L$[O/NB 55C?P "1.L+"=OE0=BF:3WR'3<.LA72KU5Z'D_MF;J.;0;
MNT+A#GK=0D5+BMS<?\USS__\/8 %VG*9&M-!2QU#3S@#G!<A[_B'K1UU_(>_
MNX8J"QW<L!(:CYEM@N41LQ"Z8+=:YFLK](%<)E6,U?L2U'P=1P.,NU1V(".E
MUL'/]CA0PCQ[9SJ$QL.8?B"]%9VDAS2 YU,E5L7F <U&LNN^T:\1!Y%SKW8\
MCXC5N,%>2QJ3M&0O"-)*5D #4OQ*LAU([YPWC'%)[&1D+,/6DZ,GL#!2:0=N
M:PMX&JT%/;#,GJ.806/=N$WU?63W"-W2":;.>)AWU2A!.&ITLP9$&F!BVUP9
M)@JL\B$M1;6-; \VUP)T6?T0&P'UR$,[]\T IU6"$$S:A46JX4?2U6%YT#!J
M0P7I$;0,<P>I'<CU,U>#N?S1-077F+@OA89EK=8AHD#Q/&0)?\U82:H4"[+1
M)B2:9+ZS/?RU:K-082AQ@(C2?X#\'##E-=L<JI*(<@K86E"IN-?5W60U_^89
MT%VB05<<$Y,4FI4DK:/ $?1^$)]*-GOZ!;=N>!ZU?YZFTAP"8H1\9Y5#$UC)
M)]G6-:F9K0WW?( C/C!PT2%GO6J$<Y8%C91' Y^@H,]+,[ZMX([B" E#(R?I
MZ/ B<J5H+#2*@AB,)<,C(\4[8?8.1!TR25G&F2CDK-L"$>6_0@T3/^;,P)6R
MDVK,8JY3D!I;^IIJ#W$E['*@@1NR6-<FU;$*[7/LM>(A3(0*WTL]TG9'AS_G
MF?%A7L?S#K:]=WRYT.LI>,LV5 E?D'^%?!]3/B W1$"U ):+7!&?$S>1R,?>
MN#0^2LJ2$V6-+Z"<<H41=',BYU#4@F]O8+<37H=B=9+:J05T\Q&F@POMMI)8
M00X3Y4NM^#@:':+?M>2NGFQU-"!.',GEW*88LX:)*$>@Y[7*"$H6]W#6X]VK
M"2^B$+I]LV37)V;! ;GOWKEY':7[#M1N>\4F'"YCY3N]*@ZY%I'XLQNKO$U9
MUP4X2VFSBTP\^1!(XXKH(CWT3O()\+%0$;Z=F;$@0)!/@9\$ZFC6(V5U('8#
M%<7BG,B.Z_EYH+X$LXFT8]ZCQ(JY<J;9)$R85F>]P;\I<R^\&$58AJWV[U-'
MH!;_W^@\(S^@N-RG< ;: L#KD)#G,OZ (,9H$0KAM^LH9B[3^#6.#,08Y+D,
MDZZID?AMD-@17."T^-J5[B\S%*M!9T_03 U7BU2=J7SV5CE<+)C3K"%[0R-@
MJ=CI 5#$6PK* BR[M8 ??(R>(T.?M"L^QYUG4M#)_'=7-<O1-LU!Q_[4(,OK
M:;2+@(;>'3IZ.FPZJ-!QF%[S);'YQW7R'V$A'^DEJ+AEV*J_H%.@ZV]%?A =
M9,H>@\W,9^1U4([<E33 =YGORG%48*6"-)&>8_L&WI60&4'$1)&-EL\0R[86
M2CK"!E15$\D:'=_PU^).0>.VFZ)_!!O=38X%N!.)-)4122!USHVGZT&"T"'5
M 8C#Q1T [R$LAQKGO/R:U8I;90IAQ'[WA;1:Z\8PF\;TBRSD!$9K+":H(NGE
MGOF%R:%#W*1DZO;_:/RSHU@]5VB9G(O8L1_B'6V@O:S[%4#CXM,Q+[II*KTQ
MA>Y[LFT5%"H^C=_$UB*I8]6R#5S]CRC5UGDJ"+U7>)&%KT(:]3#'HDHV^7:L
M<O=LIOOC&QP%8PU8]1BZ^8JO/@;")=N^4,R450I#N26I2+)SF Q;<F*H"0&I
M@=("X\2B3.OXC2A?3(8C9@U!4SJ'[%SJ?=W0*$3MJWY@RXP/K46X9K7Y_:2>
MA6N'*(ZKLP9([62HT3(*#X-J9 5L(&<9UK4=(.:0S2NC?P20-KP>INJ2=Y>8
MAJI=?;VN<N)[&>3#'^\TY>C&-)O<:XE)J)HO'Q;(;KRJ47%%VHYT?2BE:P.I
M15+>)$KG1,VK7=VH_%3,R&S\<V&&F$Y=@](4P]-4Z^I?W")J?<0:ISP&&#=1
M-N$UI"N$FINUV(IVY>)WW+3)0^$-I#E.]:%D&Y0!%DVT=.&UOXB,XN='&M0R
M1$\>38X'<O/*H;9.E]^A-Z4D9)CRSR9;&MMN8"$P*;R:A.P.9NN#:>W5"C>6
M,&'&#8W4)DT/SX2]^K?)5')Y5'NM2&% Y2)^ ?;<KQXE&T"]$N(:R$L6K\RE
M1B$-234!8.2-!+-P+.0EQ\:HK("KQ36??&M(KQ0'I<C-I#4SKW^,TG,71LZV
ML$ #N]ZGI,3 8=NRW-'O_61-=;@*H5V ] C034-923FYS6P=*!%HD[9T(%,1
MZ]J@.VM*Q8)4_%H*YLW$3Y0?,-^I-TZ*"?.?X8X;(%8!O4RNO=0LL*N0<=.A
MW67,_7W3FK[9QCFG=^.5ZI^60ONJ298\R@H&G[&IM ^%E;N25ZE??H5&3F/Z
MO!2*E.^?:?V13MFLS%1 A[QK64=:5#N%:LK:"FZ$)TC6.J[4^>@M"S5N@@T-
M4(E8V(S(F+P/J.&6:(#\UG%+905[M^K-'2CMD\*Q<BR*8Z#24C@,4JPAV0]<
M?U,MP6^XE@R/%=ML.*WB@]OOLQ_'U<7D!QG)6NU.0D6=H_G/?\12L&1[Y5U,
M5(Z5K 7LYM/U2=\EEJD.RD#)^2KI&@87V7B"EHW6)XDZKN!'OBQYI2[";U*L
M("UX1KP.(1"*>PPE>8(A!T$O.9([OO.6'_%U2+<,<5\\KWV*4J\+$UBNW''#
MZ+\6R?[_9+>FIX?YHQ*9[+.6J^OA':VM;:V%KDD$ H$T&OUUC^6#NSM_OV5Q
M[7Q^\$E)SJ9/]X_?^=:=QKF('S'O4MDW0U2Q@,[17<0:XD34\R=/>M2\T:FK
M?&J_4?+B?5-;36BRQO'6E_>N!=6?C"F )^XZ6?O;>[NJ;]^UOV]_NUN\\_PK
M?G!^\%^[DS:OWLS=V_G[M)00=PC=HXG5"WH(.AZH/H1^E_F0N;\FZ:WB9?9%
MN.;NHUUG@9?1PH+M:\_N,WCZMO%K@<W.P8=AWKACI^L#$J-#CR>'>1@$/TU8
M;1"86*>YZ@]=NT<M!SJ0.P]T_.="\ONU^SL>:1SSPMT[NL+CH*R&BID=C\='
MZ6G^92I\M]YX7\9?I[ZO6N.Q<\?8/T:KW2<S2_X'T>]:N;)ODB.^NV)I\V;$
M[2N:!HW_QPFH_[+3&EVVF>@5D-4$4E]Q%'HL\<6L)6EUR([%H"U ,X6ST*CP
MQ$-A<RLY4*!;%)V<O*U];J[V96B2-X/\UB=5NP=0(_RM-FK'@8/F*I.\#O+E
M9=@69#I&P1=R[E^J-(@<W'WV!=I4\/VAXVX!/%CO_KF?N>&'BDF=Q5Z>Y:<1
MB*;])XY/#Q15[MKU]/CMVF@/3DDOU):ZGZJ'U6)<QL#/_5D]&+0MW]3YW979
MYO80W;B*FH'2;%Y_E<N><I<_3I@;:^SWWQU\^ZYRVQ-6R@2]FWF;VIAXRQRZ
M V#YHXETQ88]M55?HB4Z>\9.-#;%AGJ12@>?W0[A,RIPFC8(TOT/8VN+2/O^
M,Z'O1F%EXS88W^ ).\+K7V8;V6L%Q5_>?R3,Y,\+_H@FYQX7QR]!V;O[:S1W
M5/J7F>]O.I_GEHVPU_SS3%3XI8W/G)Q79Y:O^W !I]]N[6^JYTDH-(P*+MWU
MOL8_NG+3P,/2[=6QJPT"U@0<UK"X=+D/>>CZQ6[7N(=QV2:3+AY/_K"K?_N'
MU^9;\&-_D&8/KD),W-KOH/;7D>_A=G^2>=]O$W9E7?]YR^F\QQ_=Q6(MJYU7
MG/(#'MU="U?/ \V5>2HJKX1;Y:@=[/3]P:H-'L[WK?_P_>?PW6N!770[S75&
M>KT(3XAQ(8OQP /F]U\GQ()#VX)?%?;N^9W0%O6H1#)R/J=N2]I4I6]TQ8U]
M^3OK$*/BW^_^=OS!HP?AY_<=-NKZOR&LDR'"#!9&/-+HFAQWLOY]);BGA2AN
M_\5JYO;-Q=CKT^]EJC'OYW 5>RG)S6E)LM/X,VFNW/R/%6_;KV^,N=B\H\G:
M;>/;AV8A0UM]"N^'W"GWV1-W.?.^3T/J_AWS+GG9YM>\+<MW.Q)Z Q[[E,?D
M^/L4[_0I^QC=><)R^UK+'8_][1Z.!F6;[W+U<&J)>K0Y.Y=VQR/FO,$Q[Y>1
M%Z]-W!'")E<M1:[2EEJLM\^$A>Q:H;%_B]0-_KA#D;YE:;W7T>@HV)/2Z+.G
MS#/*<B+N'<AU2M _; Y[]9N%_>U51J.Z?0<O_++;![:SS$+7^_4$Q6("7F4!
M<\V[Z4D2[.=?W[RTP(^;RY;QHU9$/5I_??TU\]QK&JN2#ZY"'MIWC-7O"79;
M/"_M8?V6^Z5V:XYVKM[)M.1T+7;?U:?6'XX5PNYFWAK]/"X;UVKS%K<VM::Y
M9A&*HL-+QB6:1U&!!QV.@+X&Z1W2N\[G$K;>S_PCYGR$Q_FSAL>-SI_]I?KF
M76\+&&R3Q1^POQ\>_:7_B'?X'?W#GQ '#''.GKHOK.H6SYVS-CN%CMA]..+G
M3?/"9+63CCH.O3C==5ZXWN8C((C3J?$S^=A#O !X748=-=)_HZT?%FKQ_HG#
M913P++O6^LP-R_^G)ID/P&?LG2D=X]:,#J-A9[8]C1NRP-9K&!P)]&L%4==/
MC'TQ&DUI[ZJVN;?T8M3CJB#A0LW%;T8EZ[6S?NXNL5>GA[X+?FH@ID;"Y!M(
M)B4Y-^2> $;R.5[G88+TU0S^A4$P'_1:>T(2\L%G$&K))L6>B1ZJ^ +PHV_W
M?)&TEXD= XTW^X?FWO>Y]_- M(]=1>DF[_T]GJSLGEWY$2Z!N82B?\;?VF6E
MA6:6TU)QT9ZGATX<<:-$>PYG^3MEW8T682<M90*0KC!<@Q^9X>=S$&0=H*>3
MHVF[HV]6$5U#=F8]9X2HWKT:OO#D5O<QN7%VT]B?+.>JF#5O>W#4YUK1UO\8
M"5OT3F&O6"CV7#GTG^T6VVH<BCY4/]GR\:]N\QZ]FR_W[P[?O<GGQ2T,QX_@
M\1[E538=HI'NT(X)[5LL,BVV#WKO&'K8=N$3UK\]XU';<\Z+UMQ00IOO4S-)
MR3AI?%?X^>  ';*'F GMH,^&B;&;0DDB7\@^W.GQ&:IN9<542'<Z*YA)"L:R
M6QY8WHI"63TC!!=:9ZSZ#V+\O6SXZUNC=>'-^#U;&'\A=BHW[:_,BOO8L._-
M2Y%>D5AZJ_Q&=Y#T82?;UKXCL#R=&5RT(GC/VU)WO=N7F;N\- )*]./!=7&D
MPN<\YS3%0 ;+Z:_O1ZZ:ZJ6\BSD[)=_85XOZKN?RLG"W_4/F(1)Y=ZJ/GU^3
MY[$R:> #N;=GY5>5!71*RH"L/;JY6-KW+T@=BL[,=0.V-O!7X8[GTJ(Y)^2F
MZ5;7*%EL^31B=^Y,]VBL9.9'_IIQZ0GY>48D27C71W@5/.U0[1;*_?=XZZW.
M-Q(DO%N"44OEAB$.[9RP\;#BX.6(JN@UWT2_YIUH\+LBZ0^6H&:%EZ)MKMF\
M>&:_K]A<2[LV7;0XJ'UI)_,C@-X@N72O/OX?"3TS 6=4@M"G+W44>*8&'W*0
M"%_D>P>416/OCK\[,>UW\&EKP]U):JQ7:G5 SD[V#LFUI/V=-LE4W:J>.QYD
M^.H=3WY2C \X%/G[36\14 -_GI-^W\CL5 M_I#J(EV&F*B$#"$EBY(QB:0[8
M-1!5@IP5[:D$3>9#BL2R*H#+C5/Q\)JH4 EG RE.DEM$?3R#U]I>/W2N%2R?
MS$2Y,DD4B0 7!+IU3<IR9_C*?F8)DW..,Y(5""9FHI*JR3 (4TT2=!O+"IDY
M*+]J,AIX5_F,Q T<J)VS<6CWZ@I.7$KH(67*#S<.+,C]$#,GC1NBG5J34YL?
MRNI/A7H9SW0/(W,PS_%S8W(B22J+59:0#="(*)$^-0JNH>I%-ACSY[.N=_.I
M^B2B.+<4W"#&\)$9RS!]EN5C:)[7XB+,BM=)ZJ!8@AH=F+1ZDDS*"XF\@8HK
M#R/CA'M0IA(S4VY?*.ZP*.H#98C:^ 'Z(3^L>C?*O@G<FN0S=,DK0"_)C]FE
MT1U94M,H:C1VU1B)X-X(X&\K]EVK(K'EV'Z5I<(4>IRD3@O".<=*Y%R1JYMI
M-V?5(E$GVN4(VG4(2Z-,@IQ9$#"7!-/5D!TL@7?,I[$=H0*@J2Y4+*23L1.]
M*T/ Q%M='\%/'[W$@O7X#X*JJ?QO>&YLE3)?Z\Z%PJ;BDEJ#754AH6$>9S$W
M&*O-AUB:S,I.)BPG24QID>+UR?N'!:D+^4,*+:;B\,M7K5#J,P@;0 B_]F@:
M=Z!$]@UOC(MN".V5[&A]J1I.>NYP\P8&Q9E@(#786@J2\@8U')^U#%MO,ZO:
M3CX!+L.X@AL,I,I<<6YXSP>RWQ U.N(E(.3!3<<)Z'T98N%"KR^7L:DV@;IN
M7&%_5Z:SLE-F@F)H6@"?*FD+S< "+K%L&=9Q6+5O9AD&IZQ0G /F4U1FTQ0M
MY3.*KDJ(VZ=6KB/QRS##;HGMS?$#2@994T)/+UG_GF*-&YNY4&+;GV"%U)BA
MK(&>$\JG<*N'R1J@=R-3]\OW&:/">PW1R[!J]F;(&*!V(G8+R00QGH;6!R8S
MR'[5XU *?C#>#S'F:\))7W2EM0V1_9+#S]5/Y4&,H%=WOCH2]1WILJ]5KHVC
M:8_CMMJ<:N8TT%\3=BGBW"H[X;3\7G W<L,8-+V?;%76'2N)0EUVP9&^FOGT
MQG85=4E[(.F@XLH?';] /2=R'+$;=(*/'KL"P^SX]X/&:CTUPB,GEF&9B+WT
M0Y#F4\L;F#.B$5/9',T';0C1+Q(7X#F4;5">&)\N6F,QZ,737&52_FP9IG-Q
MD;E*<4*NF>+OAW-#GH;.U.XI7&KO_GJ*]_3MEW4-=G8NQ<^*,B=JLNU:%R>J
M5N5ZD)7)\NV4OT)*BJN^+!6\1MY.7/)O 'YP\9H)R78_7E,0K0.+V-02G;9_
M@U+A/&C]^7E2DN 7TED9(8L#AWQ(?_<U)A6UO9FU_OWNMZF*>906P.@0Z3;!
MD3%HH_I8-Y4%J1@5)@D]7)XP4#XL[7.@ZYCV$+:,'S=V#@FB5>XI3_S^*<9Y
M;\;7B(C<\9TPS&;,N7F$XE?(3XS1@8PG/M\'!CRSI$*%89MJ73(0CA]BX<4"
M_>EE&)#U164,9:A9WQVX6B566G%+M@#O8[S%;<R40MNT8.[UM,HSE9:W1\.,
MO3C ](?0TR%+S-?,,:9T&39G6#9%,0**6V;_F6#DH.'*$K8^.0FB52H.#J*(
M%0HT^*D@FXU6Q$%64E?JJK#1&&/*+L YC8R)E&-(1:>68;?I@0.JK=Z/2$7=
M##C*L2X4%W*P.L:D^TM0EMQ&]0ZW6=6I>@UM!;@>_RXD=%.V0J5B;CGD[/'<
MQ9C',1Z;SF=;0REEIDDGWQ5+B09CA,)9A 7H5Y45*@P7)C0-V5[D,ZN2:XQL
M/XADV+1Y\7T%IH':L7.>K24BN- ["8U0M'C?9>#S/"^$(?O<;IERW@3_X-$.
M)G,MR_WIV >'("%N:TNC\)_4IBQ?PH<;Z+R PV\6W>A''B)^%6Q\M__=KQ9Q
MOJ=%-/)6,5W3B35NTN^@-&0=D[AAN\:W.*U?J\N4Q$;$YAT?GK^$+7Z*KRU^
M^NKAQ'^VT+?$UMW]K^71_V7K)UN>*E[8_]063GQM E>JM.81#345&8"M+)CA
MX1<:&(8@Y."YG9*P[<2OQK[Y$Y@NZ.1I[]]MQG_O]_SMF;PT^Q_C'[F92VQC
M22'9WOI")7>S%8]Q^F1\*>_G5:N]N?#IKS7$5?4C:2M'7%1#UNY%U155Q_XY
M>NDBWKR+O"LP<^O-5/1NR?C&I7LU;P2I<=9[PE"1+<<#<ATE+Q34IAQX.-GE
M5OE_IH>OQ'VFVWYKD5\F#:BTG*LH;_$FUM1HY&U,0PL-O?8T*:87O76&HCNX
M<$#A5_E%RG.Q&NLM\X@%74^_3$H;"O9/Y86<F+FF_Y;\F&Z'^;RI^,?FAI5Y
MC#\7!6XSRKUL5[(!X/7O-5=\T6JV.;<:JTZ(4W]$H[?0/(9V]"=XV]@L6ID%
M[8NL#BW+"_&6M;M\:$S/#MD+ZC6[XPLT5&O_/2"U#+/(>ZP(?6/!@-I<1($"
MQ4_A(OTV];!*4WR!MK?CLH:.^(5V&'F\8G>N\2T[3'C^,+='XU;I9L]=X0W5
M33B7$SL'*YV-JI2X?$3/ V]&-\5>N7'_?/9^FG4W,&]X]F6*9MJ;JHF9LR_G
MW4Y\=]G_I_1R0@E2RWJ-K^>]2[N+8Q+"-_%/N+4?<>?8[L;?$P%'1,;4CI.-
MU)'<=P*9"Q0&6'8MP]9TTU$$&S83U#K67ZOP'-]Q]^M?4.Z(M!VBB6L8ST/]
M;8;[<_]<7VK6LN%I .=1+*BETM7^($>OI+PUE1TX,H/8W'&I[!$&) E6U\.?
M_YU;NLB5_:XL4!E1_L/1DD#N &4,UP3$H[<(43YW2'1<*X@H<\2L]UTUFF+F
M^77_/]\VS3WY%BM;=?OB.G\)X4NF@IJE./?V.VZGH,&ZC<N$VVOK.MMW22[]
M.?N==OG;NWW'=P_'5>+M[FNK'"*RG];N_E:^L:.WQ8 ^1K+O.#)F*<8A>NQM
M]16'7X>_4# UTKHFKJ M>L1Y9PC'RM<./BXXQ(&_;;P4__%T%+^LW%$+YU=:
M!,2SMS,ZT<9%_*O#013; F[KYI+=C0,/D-AF<'-A6.E,L\PZ[Y/YJ8[JIH]!
MSPJ<U_591)R_IV=.":<,8G30-B2D[)YP&4;@C. /#Y$]P$@QOH.1UJ\(@C3*
M1=UG'E&&U:/L:&M*/E74A5XM-_LH&T4PY.X06L=(V(5LH/)\^4U70</<*H#>
M-5K>PIW/,&%7B3E#HW_'*E9.M&%-8AAZM:Q]3SJD[43W 99]#=3LNC88/\AR
M+3O]"3<58O:US'C.V"3HP;7DIV%3,CO[T%.?8DQ2NUB7>Y.O?J?H!%'>E_MD
MKJ^H/( =>>_O(.ZUW.-S^:+_WIPY@[]',[U;7BE7^B#>WG<A+^Y.<KE$:ZS9
MOKOIP+9208"WAT_97.^!G65_CWE?H.PD<%K\LP".[.@0^X"J>^7$?+K"7H))
M8[1,SN6<$1-$VE 5*E*JA4QAZ!4$WM4)[FAN0:_!Z"IV$9].+PENJ1S(OX+L
M!J($FXIV:@28-QPP-(2]<-&WV/ZW)5.I<.ZGE#@RT(TQ:()GH%?':HFI*6@#
MLC_4 (QNF/@4%TJ3RK( ANR<D.T*M73BM"&.>'[#M(G&#;9S5$A+*OF,;BF0
M*"%R/YD>$Z(WDH*681+DC46J?GES4W1%<H^4,Y(G2X08.XIM>9A;R'6*\TM^
M=%ZQ/?;?W/^:;384(#H"\1N062Y1N9\[I'G^T'W4?+*T1C/?%VL0DZ5;^\P]
ML6JLXYKA)Z3L&F0F7H;I>4MZ3<5>-QU$ZWTKNRJ\J\9(<5COPF'DNNCQ58?.
M1A6.S7F]7O)\,/'&$6XN/T34_!!*ND*H<HA*O7_P\<^='&/V=M)*6254!'H=
M!?&S\XE21A;C1:)B@Z\'\+GIR11EGYI >7C#95@T?K3(Y]5[LDUY=*$@PY&3
MI=K7U,],2 &"1M6QU7F=2L\VFNQJ+;BE<*V8+AQTHZE%/+23P<=FL=<-.)@Y
M<]5"@JP#TOV5C&78!4PNVW(0Y?L$2@D"/*N(ZO+V7K5=^;"Q?</!OGB.V<'D
MR'_[(E6*/["\P373(O[X+IJX*_]Y:=1HF#!#A!] '=08SV?4<V9CSXA_LFS.
MR&T5ZY[W[6@ V$7*@DA T#D\/+R$OZDXDP"N[##QH^=56K1>S9M@FN ^D8HZ
MEG ,FUI::M.UDIE#+?475L#IG+.<D;$N]B^O  H-2%2+I-N+9@?8UM,JF% ,
MA8OE/"A)2LPQ:BV$EF%\%\2#<_%>OAS#Z>M%,Y0]]8V#"V-$HQ@CV<#T_/:N
MIO+>>@V>J'ER;B5HBU/#UA65@&HTVZ3)-OFR#$.RMZB5)R9>-.K%9^L($VSA
MWNJ HB@?4VS(B %.E%O2(?#7EUE! +\@6OT81M-L@S;P*>?%(&N#N#CI*'@W
M9BGB<UIK<4L?M?$?SFOB!ZI8@V<[ANRD:K P9R2,$?E$2^Z%QF+G3B.UG*%%
M%XP;#"\B-<Q\D,:C44YOHN/$L<8G^EC[F 25[:!#<6@P$)FV\"DI8* NP'0N
M0!BPE"1V[JAU?8UIF%=K;/2>E^_1%E'CNI"W&'\[9)%?*R[R33;N-K&ED<W.
M3-0(AQ3F3W%06H<UV:O\0XNL+C4AJ>;D"]SI$52!4VWC#"EX@M:)64T*/PX$
MI[$1I& _(*VI A<5PDCSO+_Z<\HU\8P\\D4K\+$UJ%368PMYEC^_,XNEZ1OT
MY;_)*8Q^$RNOABGFH53Y.4J_2!OM/,-805P@IJACQX&1):K/9Q! A,@#;,XI
MC1%I<2YP-BK.0['/HFW$&UDG:GK*%7Y0I$20<CVM/2*>'/H42N25:(#.:3E?
MB\L(:Z:_^8>+@^>X<A\HB\]9AW*4S#E/W/_,D/R[^U<VI[RC<$_\[Q=UR ^U
M$HTI;Y:P?-%Z""-Y]X<C'$E*,\-P57L'5.LK\B34U!]6U=,F8;(&)V89V>?5
MK8[X:YC?GF$B1"-C?GWQ2.U3"B/H0B$\51$H%IA"B4?R.@O#NMA94O@:_A\D
M9UXK<?3WPM P0L=PW]@(Y'4T\Q@F=38VUKK1:&#.QD:<V4#I$?T2#\8^A8+%
MQITB7:CR-Q";2]E&\N(=(R%]"71MQ5$HJS+&A)K-WO9!F=$X]H%U0O*AR>T0
M9B/AJDLNHY;T9.#HD$V"7X#'X#SB5_A_/MFJUA7)#T*^XH+9+C5 MJ2PUTY?
MA\\ER$W)1I!<?(IE&JF6M+IJD%FIIBP/:$B^G:PKM$'OG+XN3%<<85M !PU_
MS!$>DR:Q(+I8(R6AUA0+)4E$VC&:-<6^6#"H> &?A;DP/QK8T2I4*QBE:N,8
M-!^H+%+9*9SZR*&@LYC()>J1^BL@*]!UXC<U:EU Q5608=CT5F(..59J"X/:
M'?ZE W^("HSQV=M!7Q(\>(!M"=ES6W/^^;M$=P!]5UE /4-/830P9X<FL"-C
M)P &5Y1Q":).T%/0JTCSO"4FMW@;'YZ%6 \0:8^!Z8,2@=9TXOCNYR;GV_7#
M8D8G4_..JH-OZ>OSVNF]'_A+]SK;\^=ET9 659QCWR'DK"-O2A K3<.*>$L1
M#Y=\O!V9&7OB=[&L$B6K!Q^\>[8T-)EZT1)H_UKEJ"@0EICD8^$?!7MR16<?
MP7N0.=1F#;X1T-+-,%08"=&_1(?,<5Z+H.T%//IJQ56@DEN;Q*-UEQ@KJU4N
MI.^OQW>\:%5]!'=D7*N!T&:V/D,)V-MVOG&KEV$T:]3E.K]$8AS36_8G^@[D
M)0]6]8F,*<XY6ERDK@H1@UR-TI+_JCBK+%0Y095'0:>;8KH!B=J%6<<Z\$Q)
MZ\(9 -\5[J!&YAY'I!'4[3O M&$;DE(Z\H,U 3J?C8#H98I?A[<,L!@&R=>>
MJ?YB-'2G/P++FU\!ON*K5430M*-D$Y0@?6J+TGOD"\]4:$SDYV-7DS"A6;.'
M7.=U24[17R^2S<L.<\X"79^&AL9I.JF]?WU[0_!0/J2L(,5)FDO! 77V7T/9
M%,78Y$B'?R#A@R%&.<GJUWIPN.;1U-6CT=>O%E>1\H?Y-@%+5C8[W@L\6_*G
M):%_+A"LW+9&JGH;6YJR5XYZ;?G?5U-H^_?_/2&=&>6XJ:PANFK=KDC0M"M?
MM):U L@Z 1%U2]=!OL? U5^+C1H2*LU<NBKNJ@ZP(BM]&O8\$?8_33*-^[O,
MZ\PJ5\KM?KP9_Z%Y</85Q1Z\;Q:)F_)/&K][(ZC85'C&[AE7O]2S"5DEJ9':
M?7Q7?&1S<43(\5+/AY^N.T3.&?PNMJT07[2HY.[_Z&E7J7M)J%\-G3H3!,_<
MN_$A5^-@ZR A^7RJM9/SROUGGSQM/5:U.R^S/.C9:=.[]ZC6'+&-NC34+L/Z
M]T'JZIIB9KD,*]&AX"@#C$;!G*'4-OTZ(@7$' /8J1+.S7&KEZT#M13$7)B]
M+UA>MD3^AN]-UF4^&YL.J:,[9@>M!3_^&?]S3>79\.\1+!VEYW]*SMH9G?OX
MK.V/N82/:S_FI#05N-Y__JU>HXF,3/RW":#R'O-K'9/),I,0>L;&BK)Z>MH8
MZ6RG0LGTUZ^1+UM?E40.9?6X=?%>8!UR?;VM<V>]P_%OT,Y*4\4IR47DZ[]Q
M9J17_ >UUC@[QY>9!>D?+SO>()%7G]YA95UYL_-OU%:3H>=:>TNUS\U(]AU_
MG):_CM90&I(0=@2S$)Q:XDRZ=F=R(VLL6^$BSFZM,]69?1'R<$/G'Z2N8&/_
M9E,D*LA\OR38_SZRZMW)J/[20V4UW8;!);4[C_W-_*Y.?W1U70NPS69K#9"3
M@)D.ZB\)\]HQ<?B0L7'4L$OR8.+UB(_-SL,%2PDB^IFV^K8T4I:#\7K^G/8?
MI_FUQ,M:G,=JM:*&[=6A\P!W(EBE'<]0D1Q_(#LP-Y Z__8J,#T%+,.X5CIX
M[_ZFW@"W\S_\!\E>M039FZKRLJMVN%,5SQ,39+LNQIYISIP--0AEO!ASJ!:L
M:THZ07G06;(&O ?%69(CI?ALA_WEOU=YN55R%9<+SMH%_WFHKS;8IBIW8G3C
M?\2$;[L7ODBV[GZ9$#S]O38]OKT=3Y/ C?:?WS1\[F5XITB'<&D9-EQI77%-
ML"Y\Y_D:#?2I]Y6Y:?",:C%N1^;%')][%E7#\4-1[Q]5SF[]C%QS4;5+1'8
MVH7\=GOW?I5EC^X3\HD*Z.+A\O[8RK#PHW[[3[Y9K:K<8%UH-S7@]V)):JQ_
M1--SC0/4(!N"-D@YZ2(#E2;YL))!]HX Y+(GT$$Q)AOA /E)8@,(,]1?2%_#
MG(AI0:W,UR)Z4,A9M^YT]EIRX'M'/RRW<*R\?;P=F.0%ER"@YQ,GL$:0$W\@
M0+FMSCT T+C51#>&$KN7*E,7_-SY;/WZH06F-JEBNG-34Z^&GU#5JWQUIFQZ
M3X7DK>"44Y#E\9:;=ZUDSY\3RN^-C&WDE-JQM'KL_FJSR7<V>^!K^UJ\U^ZO
M.)\^WOF3/VYS![BLBV=P]W<;S$B?^Q<QLVK]4S<>YQVOVA]0N6FG%VA-L0D'
MH8_QEUX>T;[\)\M_U^^7#":]5J:<S!QX5O]RM^/NH"I?35J@[&1,8&U0_)?.
M]?>]&_]6PS);CS+LDIC3R#10^$#.8HRFPA+J 8MD%>JH>,W)XFA3+"#"B6&5
M/60JU;B!.4^'O-';%3M27JN,& =;H <@YG4!Q3@E.']:RF<;0F$)P)5EV$E(
M'BFMF=?2V6.KMT#5IA(YV11G@#CK!EKQ$:OZV*8*C/(IVICRU_7/KZ0U& VH
M2(+GUKJJI0A?M/&@N#91;-0B@>N2^((NY&H1SH2>NB"X@5Q/)DR(#!0N4(J4
M:>0Q05T/%1T:MEZX!R*GG+-5&@HS*%UF!TV*J3<4P>@'TEHM"8415T<*]>*T
M-4(9XMI-*.?'I'&M5[5^;TF5?L!?!'%2,K'76=KYC\+90O#XS?:4*^-FRGQJ
MI.W:CQ!ZLI.SBKT)BF6M.%,^1=&A'0)R\\I&2(E^?0F?B%T(L_H!!_G&+0/B
M!D"0P?)E0EE<H\]#4F"X[5F,"?MV*^5QW/:.^0-POJ]:7XWQ&/JH8+FY:CS\
M&+1!_$F+)ZI?ABD,PM7LY&?/3T18 N,/ )7(;YAZ7@!Y*,S! HGN?=N,1=<9
M J'&QJE'<I^3IM"*EL#7D52BHP"3YN!W\9_'*Z>I-'P+M8MN2/Z-+J,.+V"T
MOR#U6>[R"(6G\H'"4MJ+[[@^GO6D6XR%J?@J#67=5[(W4^&,1@]]G:-LC7&)
MS*I#[2HE69"61(+G[VT5A)J#Y:>C302W)N0!DS)KY1WB151P0I+<7J'-8O!G
M0$-RD!"OC=IZJ754@6]L?@'5%]SQ+4>YHG=P(U?^M^ZN_BW)>XVS8UEJQJ9.
M2S*V6;K-BEI:38VGYBES9KA<61IP66,FSEA+%U/DJ4PQ"5EUTF4GJ?EN(IDO
ME"^0 K$=-5](34C>O%:).A]:X7?R  ?_BG-=YX?OK_=O]^?EON[OYT9W[0MT
M6L(?1;"(:YVJ?GBUSX%I>CG3NNU\+?,;^X!T^4I^':CI9D=TW;_V*-M;<792
MQ$ERO65@N(#1%[N_*SW(%,N(_L.9#@QVBKW>+T0H^S79@:'AYN^7,&D8!')%
MCYKQLW@GG/\-;CK56E$2]L(F5E0=<ZNE%A$49O(]DDP#^EN'2?F2K: +&1[^
M*ZYYC/&6G.011]=T^R;)-,=,B=>>:2FQ :V3W)R?IE_C%Q>+G;0$Z\ND8@[J
M77'(S+C\PJR<N6,-1D^9HSGV#RFFLI%27B?)NH1B[[<3P UK.%/120K4/.]O
MY)T:)8UC%?X-B3^82A=*NQV80FW0%?FP['3PW&*VQI8T:#F<^A!*%>'HE+7@
MKJ&C"S9JJ^H;)&X<V5K\2 N5B_=&T\R?SLO\*%[7R.:P&@OE7]JP#N19H<DK
MV91]Z#+V3*H'Z?0[;S,8>KZSOA> CB#+"B6KF7YDA%38B:,ATW*B[VCDEDI3
M4G A$9^F4W_4^T@]F_]'P^#T6FP;^<218FB%Z:.7>]ZC+S3L_4U9JZW4XW^!
MW2$ZE?>#B>@"/*U$]!-DK^@$0NBAWK-)'R_O3#&2/,#G08B?4N0!SL2;@[F1
MD6/$SX:R)GQS_78]&*T"\/I2V1SNI,#+'@AB%=25?[;BL=JJQ\**OP47V>',
M"DN%[<[B<66HY=8%-+(9&9,'>-C=MU2C.Y ^]<H'D2EZ$!E,JP$1I$'6Z7HG
M045]FI[->U[NEB,MHO@V#['"<O4#JX[67&RH?EK,SZE_SF[\W1IB[V]FJ@PB
M>9ID"1I\4ZE;%KH.D?;H_./T)&RLD8\!=#=:^8#,[CNVKBDC.F8H4W/C9?MP
M9D?.>5HE>6"GMG3IK;[A+P>G=/<Y,_V5S-ZO :=J,66R&DP?'453C.E.__F,
MZ2$K*?\ ]F)],52)S//1*-<Z1DK 2/'#R:ZUZ5S":M,H-ATV_O+G*0'Y@;3<
M9#RZBXBQ_=MI\0E<V#_R/23OD70YNM.Z'=U@_I-G]6++!*V)ESK]C+U4;Z>Q
M+FDR,-2Q">;B:T;"<E8(5S;_VJ1U0V!9KK>AIK!EPEO^V:ORT#:QN:!##Z\P
MJ;,:!:Y59^J^+X=LC9%GS.58]0D]O["![0.DAN!B^+@.?,S@L[88^>\D@0L.
M3/1F]!_@1B5K91,R*[[T=G;O#LFZ:K%!6KA-7 X]G>G$&N"5@&0DYC>"V.[V
M.7F<Z[:Q!@=FOP-CN +31&TH_BEL*">N\'!@QBU]4U*71J6,[RY4]I!#^BXP
MW_ YS9Z;H?S,DYN$&P@9F;P/A2V]$;;ML=*6E@OS^^\]:+L@L^RT77_3,<'X
M2N74%H*\MD1M(,>8W_@P*WU19?P<5W^4]9U$U0IQU;F3RN/5Y.U&2DW5$3IE
MAXIYSQQ4L4S3&IO.K4LMB<?V834OE@CLRW'FH#\F_R*$SCTC&9[<K7X>JDH^
M-DZW$%T0G[;M%C%RY6R--KDOAA_?FO50C W\,+<?9PLPBGS4=F52\"64":42
MQC5ZZ67)>O2?MC*V"WA?XL>L_NL@,OJ O8F5BNAZ>!&/(9^/6D$N4O9")=-Y
MHC3S<>UKFGC0?_*KO'CQ8 .:G/:3,>+(&UT[*P8)=-8B^BH02 &[H^\8J7G?
MOUI(Y208ONTPD/&'0*[3Q-FY/ING_#W 7LMHQDJR7UR!6AT2\&ER\+VV(K5Z
MAW DP^"FC':R0=\GMYDO>_H1K"%,R9$$,;,U/?"[F=PYEU?A//[ESBVTK*Q<
MVN+4*PI..V.KJQBG^Y4F\<H%/R2I55_=>.MQTMBE"3_'RC+PU0[,9!_<PLBW
M+P'E.L/:IFJ=72WUD=)X"8IP; $KI9*^E9DCPR.D_A"+'!$4S;[1#*Q)]PUG
M%"7(YU4@0JY>=\T4?KCB=K>MKO+YR=+I#8$OG="X="F0P@C5()[U#)8QSLU3
MPD:<??V+0$R834BO=6!20*/AC13/?J)=#S9=TD_@CX6C9:V"'A*^IG"&P4JH
MD-7^+HJI!SFRLRZ)US?<F9@?D$'/N 9.'H.],9G9L0N<G9QS!2I+ 2*:]43&
M>OP@S]G07D9>^3J$T3U0('4-7?4&URO,H807B-+NH-N* &A4C\D6KLO 747X
MGHG6QWQVAG9.,?>,HX?Y;'<P:8@^U^F"J R^0A'J"GJM1"9.N=8?9-S9J>L1
MN;(R56$14( &1.]352.ODZ<6)'5UBR'T#2=]VTMN5 .^/(E]LW8:3BM_XG8<
M V1?V]IA.K0"C!)<Z1)_@'=:F)YH PR"7BI(GB#ORT%B8%KVMWS]@";64@8U
M)\KQ'/L';:4*=9^:PXO$Y>"88P8E+^-4IC!8D9UJJ;XB!+C]@L4OU_Z- S*J
M!K842<%YO0.S$LSM ]'"5S\Z,&+!K)_U7:8>X+LED4.LW48?D((L,Y8JG=S'
M.HC0)'63<^\GO\KFC0KTGA'=Q ] 1NT>X_71K(VQ\>9-ER;)03MFT%"B&N1:
M\:B[$UVP[JQMH^S5K##SUQ0\M2"[N J&SK=8<^(8C_%N&1M^10C<QZ6UY/2K
M4V*[E[2)GXB0VTVE5T"0]1OMFK(GS*MZ2XFTF31C/5$W/GV8ZDKT3S(MP/+^
MJ,D]Q34,O<TWQ$KBMDMN$KGU*$G<'GNHC( WE6T<T?)JP<,UZ6+UGC^T-[)R
M-_)&%)VW\26##DQW%$2WI5MRH%9L@?U=U)=K\),3+@J:10ILWH*HD'4VI8[.
MO\N*!V.(]1%[&_)ME;,/.)+/S92[QH!E!Q "?Z9U(\ZXA*N_%;4;Y%?1V:O-
MU'-5XLY[!9JAZ%F"-2%=VA+=H[N88=1=9*]I'83UMV%?*)5:N#T;DA%\M&K6
MEX!68>])8(]HW3<?,>F\ESJ50)CML]QLG6QA8J2DR>BQ,_WP8";?I]OWUJ^]
M]8 0;SU[P'99^DT7/@;DW4Z#FAG=GEN_ $(C%_)GQ2P>KBI@>]\?[CQM[(*.
MDKR.3-N#5,*6WQK>D@^HY/]AD3).G_%8Q8K;J"RL\! >>TZ->4JRAK$'YL/K
MQH+!=L1(3I-\G$;%X0]?Z\F.I1]D48="W2*#JUC[KP*-K9JT9IQY8"_20 GZ
M"7>(N$ICF-I$C=XW\[.+YM7M%=__K_=F__\?UC'^7U!+ P04    "  JBDU0
M]3YJL!:\  !!T@  $P   &$R,#$Y8VAA<G1I=&5M-RYJ<&?4O'LX5&O8/[ZD
M4HG9.HEB=E$JH392PNJP2V775(H04UMR"@F1PZS.0LPN1:E,$I/0=' HI\EQ
M*M5@,"&&&>4P8889ULRL6?-=H_9^>]]WO]?U^_V^U_6[OM]QS1\SLYYG/??A
MN>_/Y[Z?1?%)T0W\LFO[SNV B@H J&!_@*(#V(I]^M][*2?YWYU#1?$:T)JA
M<G#*8U65I< 4+155+15%#8#'UCGM^P7 CY?*%-6ITZ:KS9@Y2QV[H/ 78(J*
MJNJ4J:K3IDV=BOT:@_T.3-6:-F?)VLW3Y^X[JK8T>-YOYZYES##8\JQR_OY&
M@:'YGZ?.SYRU0'NACNZRY48K5JZRL%QGM7Z#]=;?MVVWW[%SE^.!@T[.AUQ<
M/8]Y'??V\?4+"0T['1YQ)O+"Q4N78Z_$Q5]/OG$S)?76[;0'F0^SLJF/<AX_
M?U%06%3\\E5)575-;1WCS=MW3:SFEE;VI[;V'BZO]\O7OOZ!0>'HF$@\/@%+
MI$JY5 #5?T3_5[FT,+FF3)VJ.E5-*9?*E'#E!5I3IRU9.WW.YGUJ1X/G+OWM
MW(QY6ZYE/*N<:6"^7S#_SU.-LQ886O0L$RI%FY3L_YE@Y_\_2?:/8/\A5SLP
M6U4%,YZJ%@ "*+KB03SP?_T[TR ],FQ<VKAIVKQ]_^>_+5\Z,28(HQ:#_O(Z
M!1!&OW8?]Y73TS>T1,C?JP#.WX8J/4BZ1.1/."%,(.O!UT*?%,!.F-C]%G%\
MY-!#!P8J3.4W"H+FP]GU59$'DEK;38JO1.\,-BW.K3QND#3A>+S\YA_?ACG'
MS6I'XA2 :&^9*ZFDA3$V(DE#RN$P4R9L[(PLZ ]EUD&?(F3=I#H/?>96T;<S
MEA-;#D?)* ,L*=EU]C&..;NXE_Y6_S5=N\(HJ0(4!J&:@3@%0)0TUPO#N4<9
MB'/7:@50^8')5P"#-(.=8Z_!1Z*W&V0O@3D[7P/'_E*Q)&? ]57IRUF!EA1-
MF%)-^K5QR*BBL+2E8'?4SI;0>H=[IF?R"U>8F7T+,BHH2*OS/],T8'K\8O47
MF\0KF_XZ7SJ,CD=QD</PC6 %,'\D7JX N,$GH;?2^*?T!16&UW&(4?HJ; &U
M=: =Y"KL-WV0OIYZWJ?OL@\O;>:#:\LO^WAMNZZ3D;;.YVO\H3;#^$/W,E/6
MN1@<WSX[1(R?#X=O+6JEA=&U8&C;<T'G15W:E9&PQ*@=37G(ABQWPU$WOXHE
MI<U! 4<:0NL?%KV*"K!W3OGXKL?DB:M.K]N9>)7P3OF(]%O4.^003&:C<VGS
M9-[.%#QQJ^A-#IM;7./(9MBMZ*-(U#]#CN376L2-$5NY1N=L(,^P'%B-X3%3
M^/6VY\D3(V&@:@2CVN,W5MZ35EQ!8=;7C)Y$YX,O"DH65 ^9!(18A.0_E6W=
MOF0:/Y<E=K/=T[6H_+=1UO["EX:;PZCN;ISVS_-#M'XYW/;68BYWDZ><]<;J
MB[5PD_L$%&5[F[0*^9UG9R4$63)7'CV0,&K4E&=6"UZQIR66[8J"WCCQQ@9Q
M!%JDT-;8HZGPCF=4IE^[QXMCQ=H+$L]D#CI9%Z9UN>Y86EK@7[Z.._C)O7W'
M[^%.=9MM7]QTX27>WMSF0"990^F9DKW:,9RNR/;H??#Y2)A=$XMRDX7B/C!K
M#V4N G'JT@W!B7D4,EL2/WKLY01/]!IA#*YZ=SBTCX,H '&BRGL9G8\N"FG5
MY@:1R<A'DH$16[8_&OH-M#EX"4[E59/AO.AM8NN[',I^T'7TXLN)/O%;A#SH
MUX1Y:A1/!&;<-Y4-R=U8]32/V,=F-12]Q=YU^DLPK[BA '@<OI,V%TR*4 #Q
MI37XK3F[*51#TD7VS2P&G2V0ADCBGZ?JHPJ@#]^\UZ*KO32FTRXR@%],R:'5
M$!>)[$S83'G-<>:8FLCR*&EI1+-8>+P,&EZR#M)7 %2>QV%L;%>;W+X?$R=*
M*%?["N[;Y"Z.*6+[^_-;Y2Q7_73Z+V4^D3#-?;T">'2Q4WZF3Z@Z_RCIUXAZ
M]/*]DPK@\Y83D+G<^/U^'M4.6X0"R//#9AJ3]J+V8HMI'45H/GU8[,3:'1,U
M&.D'R^H60[7[\E&K49[DFE2<J\YC:BN !F9^Z$B,V<!'T./F5]_@$29AK$$!
M6&-R*0"41J(\LI@2X.8F.>,S1+IWK_20*$O(3B 0Y_")B:)R:"WR<545S*OU
M1H_O]J1A]G! ?T5MTL8P0TD5 $6H]WA2R]YB_/W[OO5-X[M&:*5\_IAW)BT1
M.1!,T?)3 (2B>ND8!7.LQ.B]D7"LDPW$["TCV8.W:.O=R"20 .V3QC\OGEP,
M@_Q&)-UK,1+@4424[N9P6Z2?1<>$E#AZ_Y$6@KS"@?S5OB_^:<5:H9E<K9"8
M4Y9,_6H_:/RQE<=1 &QX3*)/=YT4J^_5-^B>2GC+>) "6/9M/!Q*2NUH2*U%
M#7C6PU2X\ZU\SX9QRZ/1;MRY[,/-*,4_F?85W.+/O,[C(,'P$?3(>.[*X)%A
MB$H8M/71#=H=7H1&4[[*@C+ZU;GT7_"21#\/BE!L!%] !JO@7 _;L'N_*X .
ME@+ 5++&_ZP#&<)"X""XV0F;D-P/KI7&JUAUR4[(3A'9X;2<+K-XRVKVH6:<
MO(RN &AC^,1#Q+G^WNB?;'DL$ET!/D+V&%]T2+HKP_2+/LLU#AY!-\AQ@SYZ
M':/E:0K@+:3!&FDT+R'.\0=%\RL4P.O8.O W<)^3=HTK?>I@*OWJ$+F9-PKV
M'/[M<)0"2.][AH9YF=HJ  ;^,NXKSD\%7#?.5@ J1?*1*/^8R/YP=:Z&&WK>
MF7)UB-VQ7CXSA^W1@G/?/D9#)DY@QNOUC\/D"9%;0_OX3OLQ!9G#QTA'3M^W
M=274HYV</NIU;[^2KP\C![6A"<D+!="*/*[B1\;QH3 6&DD9D\[B-F&#)FP9
MHTI)L"R 1"!D0I:JB"5UMU( 9LP7[L<1<?G+(05@LL?NM@YZTWIP@CXF.1GR
M^5TG)I<K[]^M"Y0'P4_2*TK%)_CL@V4C85;-;Z <1F_DP4LMIJ6?'>!7*%6"
M1XN7*@?PR-5J8VJ%+O\(LDD!J.:Y[^H6IQ.SQU #T?(\TXRU"B"E2?]3%R1E
MB"S?+6/086_!&^3UT*30RO7?U\P)RK+U"E$ 4T"4WI1GPD]_PB 3!9@N#S__
MC*E:2M<'#5@#3DZ\BA@%\!'*0$-56/DL_;RHV7W24^#-0VYD1U3I[5]3>)P.
M1 1^S,.B#/\CN%6*=P7Z6[UL(:9(OGO70FS)% EZ\.S?D2?JX(V7$_(H2K;]
MUVF ?^.!_<KA,?:C<K^J]]0G(+,?L@;2XGV\;!D\%+II?7;6B@?_[]\K9[Y^
M*U<Q$J@:RH$\#?O:=.U&<8Q!M91V1:1GY2%4_2--,P[*\VV-K"L:%Y85JV<.
MI%JM)?HE3@U^:UCO.:UZ^Y5OKZ>= $+GL66)*!\R(-KV4PKQE1^BN.O(@CIF
MC?,:?L6J5M0@@OBZ)'&<_*@-=N.J)9!P[AYMT<X"\GEDWVJPS9H3'ZT2DL5W
M>.*C;J%[=1Q=)#R=D5&=Y]NE(73O2FQ'=L!O!2,]]N/[(T;<[VP/"#/[>/N+
MC]WRUDNO617OBB^18PO<#[N=V3[.F3+RYK>1Y2IFJ68I*LCK"/W=%($3!S9Y
M^M%<F#K^JVA(I@.'L/E#Q,!EC#V8M30[,7,=E-0+Z QTGI"(S-^(JF_DTG!8
M_ IJ$#,3%,"S R4!?-^T+Q<.FU"^Q=P_U'GY>;.H5&]79_[(K^F=EUKN3G&Z
M6G_"NRB"FCQ\0ZB?J@# =,KH4'1,5 )1KHY%[JTZT01I_S'$ORG:@$N[ ,TO
M,^$I "V_="V!5;R=?D1I-6F-T"/N4<6U/-B[.OW7QD!1@'.-KL?CI^Z0MT?_
M>#$-FO^MB.UT^JOJ\HP N[NF7.B\W8*(\Z,CW=Y#MP75W,!D06YM)/4<:5J$
ME.4$\P6C]5M8T:I"2F7DDT39E@[8KX.A/[_02A\O,*I1 #/?9OFG>BP3[+F=
M%T&N^BO"L[9"DQUM]&A JO_"][XOY4$.UWWE#C"PXZT"2/7OZ= CU2=MWZSV
MB/>7W[TL]H43!>S&$]\*'';KVI>F[-;MV)2DL71GF#JUC'[=W=36)'3@6$79
M=8=2=M1Q_]Q4W[[?',;V&@YQ2"B%?(?>'8Q7CP[0CY59( O+&TQ,;+RX9Z#C
M"B#6FG:^3",[(J$Z\G2A4'TOMK<J.>I$O;G5O_%UZU(]3XWN"#A*K]!^]LFG
MP7U9%_6,EV8;[AWX7.3 ([1'C7,$([6X"Z3538QX&SV93D0"5Q4YUH3.&VPW
M+>8N F<@#DMW^V\1])'1I;[J#]_-Z<*F3ULMY/BT&UTL6Z+Q)-<D*=?+7S-W
M7/R!>C8H"#').7S(=_I(I54XNVM>1$%(8(G&5VJVNP_[Q4#"]#LZ+\8*ZCOJ
M=YH,>2S:N;_[;7" 3:-K.7V??OG]U<F[C(KF?%X=_'G7:E,GMUO<[3L\7_WE
M,C/0(,[P^GK/V[T[,J_OX,VX;OV\9)A.@\,F+@W)SU"E^#OHKX(O-_1GP-/
MRR*F1K0!;"5S0=MH/+-$9[M%@O!8FXT]"=#%V!Y*(N-;7S=YP4#[GQ$AU:VD
M>?#-1]%6L%%FQ&/WXP[N^!JK=$-H1D1\5*)YG7:K;FP4YFE7Z(OM5D*5U@K
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M8X)<- DW$^H94?VB  AE#9C<:Q7 5H1*1>H:V/YFY("",9%M)J^O*M]^_(+
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ML^_JDGF?[[ RGN#CX*CYKMC.N>=5R&??]=V7Z:"]/6Q5\YWXJTOF+_^RTN[
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M/&A!A6\+1BJ[-B9OC1>&I@@Q2C@44, <TO)K/_M<%FH>DSJ4Z.43^/NR:%:
MYC>)/]EA5N;"A0Q@RI8)])?3$_RK(M$\\'/0A)M$%T - FWF=C.G0Y5."J#[
M*;I 4'RI (^+"-H.TV2+& ]]7.WN!% '7/T\2&_2%]++W(R-0P^9M Y*OW)'
M>SRWN9@>3]FONI:6Z4AH@OKUO!0 ::[0=@9ZL"=]?2J&Z<]70)5>K_A"[_&U
M<M"3-@.WC^_1H,SZ*!K[3U%( 3#JW1;:&&05YF>5:49OG?*B>D[F//1#LV:3
M\R/#Z8Q':DG&O6G2:EY-A?=%T3,%X#C52 &L9/,:(J6DF H";50V<% !&$5A
M6/W9\FT*X-'5_[FKN1O>8'(1/R=Z[3JJR=UU*X-CQN,L9]X_W[C5U_H\]9Y)
M/6/6A26;2CLWQSS6Y-Z7(R6,:@0((TP7Z84EXB26?<OI*RQIDNF'1:"%WB9P
MM&VC;C>,#BH CC$Z'Y6B]<0'@>X\<N-$PGJ&=MW++KW<B\(HL$=\MKHWU%PW
MY++ZA9>X-8>H5W)N=W_1.7"F(,?:X^VCQZMV!7QXA#HP0(?HZM<GOJ:J]:PW
M4JNY\6)V1:R6@]Z5CWRO%UDV7M%[#@L>7[(I7IBUT'YEXL&#+0G)>3UO7LVC
M#"WUQ^-*%( ?;,X".W3Q7SX,;Y+J/BUA5G_N':Q0?SL<=D^=DB,+W#3.G ]3
M&1/.J(0HR"0/T^2C]![B@#WBF+M, 612TR#NRDM8CAX1AW\)2E0 \=?ZB"*_
M4TQDE]"#*%XJ1HOD!>[>/=W8I+/Z5,$.:YS=!3" R3+$B%65/U&3@=26S5E[
MCCR4/S7X&ZD=- LT%N)^W,8>WTF4?8&JR##5R4$!V!,L,-[AB.TZ)F=PY!T#
M.4"VQI;@F )QG>-'%4".-DU<//R[+KU:TAL_P])L.M.FR7!OI28MH][B^9M*
MSZ05F67>*?:GYALDZMJ?GO5X)R#B9_<K )'Z,QX9'B=+CB39"HE7Z!I/[9;"
M4X<\;/Q[/"><BTH]AXA%D(^D(SW<:@S$X*UDT<"R[N6XUR=XEW_+P\_A1ERW
MV9SB.3:SM>;+C=&W1[,NU.ZK7K7ODDV@Y<&#\SW"C58%FKALZ^++U/L_B,XJ
MGQRY+MP>D-!S%YQ='QORQW3W6>NC/V8??^:@<S$W[J;+GFSU:=_N61&N;=X>
M_;;SK6O=>=\2$"]<_4PJ3P<%!K27N2NS^SNAY]]L(5X[6/T(W?X"@RKB/GR&
M'#?9:87&R(.VN9(\-,TB>7<CO5_[*$4Z3J9WX[K-G7Y\H0#.-O:Q&_ -K7\>
MCD++F:S)4T\_X.8F78=L'\:3U"/04+N- EB-_IGW)/5!>HE'.O:%'8:@\&?%
MXKR6GUIQ^3]AS0*5!R4>"0I@4SE(EIZ^ FT!9STO\4BL1.M9<G);)B+50E[E
M]?[;HSG-DR/9,F,"QD%]I"3BHPVUT1MD)UW:W'PX&NU-35TM=UR$:_ZJG%-W
M6,/<8=4BG]Z5AE>O_[9S_GC[/P 5CAW__-?;!\B&OG-Y$:D#'^]DD?3*IY%6
MBK E):^MZP2#KT/\W=?1*+P>5PVY)F'":XC2%Y7X]()]VZ!D^[%)1.3<@L6$
MF/)")L/$SOBEP<N+L$.=R9=WYUB1;:X! ?EU!])Q>PGS1R_%N,L6VG&2(L]@
MT&U>ZE70S7B?W%A$4P-[!V%,+*_36S$XOWB#R ;;*<OL-BL SV@U]"$+/)JZ
MO3'*UQ6BKFLD4Q?JH =_&]!=P7^(S0)KZ(.;Y1K'W?U:7<-*/?RLBB)CTAP"
MU#LYG6YMKH83Q6M=VJJ7M31?<WO(3DVN]O6=6_(V),S"2; Z><>5]MVGGJZF
M;<S3>JV2OK/M2!)P:+GWF5T,S6->F[Q\Q@RFXLU5B-_6RCU<=ALIGP;80U&Z
M@0+8#(_:^KWSM3:23\&((3*=C,'+_E49K^*F6"1=R[N>IU60=,WXXSN77Q,?
M>KD8>4UKFG?\YE\+#OPZ9[5AF^G\2I^'HUY[*]-TR@I3W]Z:\H?YF?WV9LG+
MW\[>;UAJ4^QT1#WN83\DFLD28IRS$8V9@1YNR6H*M0.YCE0>6IXY )-[_2W<
ME^Y<;++:WZ;QP^HUMW\A6#AU:#0W5!W:;;'NP8X/[Y\9,$X8DID^$]E\7^4)
M.);:V/2S%MH[&N"/R1A;[[:(03/!:Y9>H8DX,GQC4HOXO@9\G\O 3VVRH!-H
MIFB>ROVT/;%W%<"Q[U=AY$/W>=KV6+;,:(_R\0X?F5QM3+]P\^1Y-X2A/)CQ
MXR$<"Y48BT0<>LXZG(I$V2,"Y7]%&-#5ED^Q&(8&6D&,V[Y[]"]M094SH8GJ
MV*)\,>I%.Z0 3"G-I#"O']]UT85\O!C?C![<%OCC5,; 3X^B-%BR8O2&)L*P
MI6J,5I3885%V4^)&&QPL)D_6$$-CU-%SNN&@B(\GO,8$N:\L"_10JB<9SF2+
M>@+_[BSA8SVA:43P*L;B^^4T))*!"3G?Z\=G=$JMM%M+<N[ @I]()FS, X>6
M"/&OH4*K<Q4X/]V)6)(&;,0HT;]"F683PF/.7%XH8/&8-;)Z@A9XU4[3'P63
M#S6Q>T9J=B]PP&G4"L8J3[-U]Y3S;F&X)DZTD;D0\NJ$?WNO^P(R"10]+^:\
M8!66XC-R,ON)HADLNF"!&3-#!WG\SD>J5.DWC":1#TE)!HMENC#5M42>'4IL
M#^G)3L8SR*J#='6;,UQB7/K29E1CL\S&I]65<ZD"!ZM7S[$(V2E\3+R2:K>D
M7#BURT*(K[:=[KZ+,-6EG4B,B'4M?H&]GA99+B,SS!+#(W%#P]%@#V5&Q!B#
M^()*1C;WT,[KSV5Q*55_192TX]KH/6 ='N?C8=(LILTIS*HK!Z^4A>3Y%KN^
M;(DV?D#L<!M(H:):C]+[',^JVUI^:W?K^+TB4MS.'HPI*EEW@8'L%'&0J0DT
MJH$$W^>DO;T!"_QQ=G>P/7?-6PR@A4+&-TCV>_$0O@=:','9*CP8FX0N]NTR
M:D V=D/:G;!MA7;TYE278L'EU$?1^P3AM>!%1_?#?J"FS6[!2!W&E 7DMD_^
MZ]+VY.?Y/K>4/&TNN&4!+82+U7HFZCCQD<5#43S\)<Z<,+.YB(F@N1V7*":<
M5P S;1P%6ZL,=L"U/7A5HH_NNGPA\354T'>9M!Q^RD]+2C7-]^(2M*,7L!&]
M;D@G@K!->/R<C31@.)'JI_O^_C"KT[:XI7.TJS[</Y+FA@]?GGA?A#)845!]
M'K$;-Y:[,],'%*FQ(OM0VZ6HF_VHY;9_SD+\IW^389Q+2]U-*:5ULY$-818!
M:F0X>: ,8N41,:;KY+B] >K'96-;>_4A)L9UISG^="S"K^J?_R&B85OD9D4C
MA!#3L>1_QB) %9O%EPZK+U@KT9+&/T];=PZS0@&GKG5UE">YU^_Z?W_NL<&B
M]4[YG=)!R6IL?UH^"PL-4$//M@?Q_+6)-;B&M*=I9K$*H%\C&^HV=&'(1W']
MD0<M_CDUX?3WL8AS3RCC(S$D#8>X!Q$0-MZ;+C4D(GN4DOS>L%8!_!I@K@!4
MEJ()2*VC0Q(6?F+Q'N#25>\^ATZ6V72G4P*+PL-;7,&DTB%J3G#H;E7E).B4
M;5?169CT+NYSJQ&HYLX?RD=NL3P69R YN.U[CY_]# T[^K]X^].PII*U"QB.
MC8J*$!41&20J(@H"*B#(D+3:@$A#%&46HJ(R1(@(2,"0[00!$:*BHBBD$1&5
M(0X,RA2! "K*/,@@(8G(+ GC3K*S\VX\I[O/\YQ^KNO[?KSO#ZY+(6QJ5]6]
M[K6JZE[ULX>'_!?.3G<95*S#81S#O[PIT?VKX=8XE;IO4=%Z+4.I\M(%!8WS
MDY+W=KZ:UGG^4$0Q]]\5</_:X)#SGAYF7N@IA#HFCB3D_/M]LJ$H&T1;+L$U
M7A/+VR:9%Z3M-#]TXIJEPF]))@N<S3N65&U\^F[9<Q1*"<5,GS^+P<<]E<KG
M12]]E-9M>S<Z3&(\3WJ:3$<!\-3DE$BD'G;(1NXO\P:T"!F+AFO[6B$+J7S'
M19P*X#^A0&UAO +!2\(('@U2<>-U7@3\'!K7@C1WP=<T5K4,]85@WP&K#5=L
M;"]T).X'@XZ;U7(N]6ULAW?:951]?@0Z6QO7L@0%A0_6FDA755=AMW<>O^:]
M;SIE]C#<DM*O6OW9[@A8R6?00\FQU2["H.P:1KS/8GPLU4)X/H&/7DG$;A&,
MP3H@H'H5BZGNE^X[T&0:9/8K_(Y6J;4J 5_<<BR>8IVEV6TG2F22B;,KI/<!
M?R32"-*GB*0EJ)/=9F]U0*=X'&70C4<:/Z5Z=<:\3(TK0ZT 8V=']PO,QLIY
MC'B.(K1/,/&.HQBFH5'O*/=;,W9E8 =VR]O+B[2P;UA"JSE0JB>]7[$%!'A^
MEVOFKE!.\3D)?<JJ\(9VA E?AW<('J:O;(4(6BQ>&M&]=9JID%5'*]-6C0]C
M+!MV.]^]7$M'P(D=+].QCF4\J<X>L8A]8NI_!H6]\Z\C EM03UC_4G3AIC ?
M*.&\;Y(7&@E7S6_G2Q$!>FN060-\:9R6)D'K9F:FF4?GTR@). 3EU&"W?!B0
MH2J/X?I?]LZ >1)U&6I4BVRFQ<A@XO\\'75%#<(/B+0O@EU&][G1)GY/2M'P
M#0(:& 3=/JE,1]0NI30J#O.M39_2!TZ1K1=,$,P[11>FGW?6]%;#[+<8[E7_
M?Q!D^)^";'DY$=Z3@IM *%7FK3<6$S_5E0Q5+@\G'>@?A7-QQ^>@1VZ:0/>O
M(22XE*. GJ(/AR)1:[15AGIEA,1Z>^.*F-6'"&.7H*+5AVQ0YPE*2=CUX&HQ
MN;Y:?K)CS)'Z29KY/1B(@Q]+[8;TA72NL(Y.61%M1>!FBHB[;%D'L&840BMU
M*<6\ ]Y$7,,(:"D(LJOVI&9$6$UV#55H%0F1K,=<SDJ ",_W!$3OBN\G+%WG
M$3ZA-MK<Y8W0#S+UX^SXH_W-/PQDJ(_X[GE^&!'+F77R8XA?5V%&(\8XG5?*
M?D<:^T ;::S/ICGVWS4,O6B"0 ID(#U.(0B59Y,Z*M9"FBW4#>04.\&:Y#RB
M."G&-S.P>^(:)4"^,C1K!%[7"AWLLQ 2V$9+(6OA$^:\,84\/A6N77?81S#>
MD+*8M>;!J0B>\>.1D-&7,P05&.L#:8&.&>"@N^ [G0>L&3$0?-='6 @95X,.
MY^:0RWSY)#G0R%NH]8#W>=^!HI(VRCIN#UW#PSO \W')NJRYA$T/]K]X];*0
MX1*Y#6C(E&Y\W?JY*TJ&^EU<_K.R?_Y,U.B_EL3G2W Z&X"55),>4($74<F)
MO5NB62*MJT''S?G(M<_$S:P]$V2U<@D8*=2MB\)F7%@0RW,\?%BX% R-/IX]
M=,/T]9[L\H;2"Q$J!5%A%D_,QE<*!905R"O&YH_+7\KHL'++3\,XM6/U05HM
M=A&(S[0C+=]YM!?D\/ Q5G+"Q3V5)" D,CO 1R.9[4E-R1P1Y_7>^)S[I>Z4
MY8IMT4?_T8'G:&+,9[Y'5YJ]P?$VQZQG;<=?IA,?K"5]+CL]JZ'QX)Y!ON&9
M1R7&=GXA(:2@D)# EX[6A67Y@B>W>K5V3X#2W7#L18LC;^:DY,81W)[1^=7]
MGUED_@#SO\V_YNO[6^<]=BY:G/KS2-8=BK?$?S_!%HPR;G43JD'3X\;0#.YC
M1<%/QR8W%KY-'9R:K4[^U&*UH-'1BVTWU3K-$4QCTHE"W&,"=#]I%Y(OU'3A
M@JZMPK[UP <,DH>N+$($BM5*01H2"]^ZH'?SL: R8S1VK@=K%C#^T+<J'9F?
M+98D@;BSWF5Z8BQ.@C7^4BP] .MATK+>,%O*-!%5E<.=D-[I0L.Y9P>;SC*@
MVUWRTL07./'-W\7$V0^"E+BR_51E<O([>#T8^10<Y [&A2N>J^Z/J.DI=2#0
M,!J0:3Y(XS;2RARS.2.J(02@2H/'6'JTGBNA*U"<@A1JHMPNCT,V/'TC97+P
M8#6L5\YJA9TJI!EE^R[X\5@)?7*"6 91,#H;*4W ^4TD<A;@3K.N-0?BB,)/
MC)56-D+U:MX^=Y^A$DA\_IE0M7JV;UD35A[2%VY; ZPP493SZCAC6!"DYX6/
M+^J^C? (6%O NDKQ\UN<QD<K@,2:\VLZ7>=F9ZDZ305Y4=U]DQT\A9P+.?Z%
ME@X%Q>F6"<2 Y3=R3Q-TM._5+]E1E-='YTH/3-BUF:Y3V--F5&:M[<B5C$HU
M',K+FG1N'K=-WEOZMB U6JW+("_E_'V=C)K"_"6[BF WR7+ /?LK 5Z':^GD
M$+3[@Q1XC>QH'+^8C=$D1@&TLN.(GE049L!UZF[5CH$<YV)A9Q7]L@7MJI5I
M)-<HCH#F.[H&;=3X>EKB7 %RA9O%)(6/?3L%)G/->_CKL-7<OAA?U2S(2!!!
M@]=1N].MVLO6"1K?I<I?A@VIGV=]UA/B& IEA%##!WE$GU_ 7(P7"QS@QI_9
MV$S":I-327'79"ATQ=8N8LG,CQRND0*YKEJ]_=VMZD9\OJI]$ZZHE5WW6S,Z
MWID=8(_@2$ V>VM6;(3W#M/6,^&G6JL==O6HE'L=U+GCNO[5>_4[*9<IBXYS
MI5Y5KEI+!#X,KB-5T;;31U"1QL6CAV'-CO'"DV_H+D7M!?H&%IP#;7DS6R8,
M,]O6EQ6FZ[-+2[RNW@S>K"1'?-45-8S(CO3L=[B"P2M80P\RIX[(S8E697-6
MP.;0!>E-4Z#+J[8DN'0UU@(T\A54R5#O0BBG6TT5E;S43 UP7%ILV58N)UZ&
M6FF%YQEH'$JHPNJW4#<3*Q2%90J\=8?WOA;*CXP5K[":*EOB6WPAOKMO%S>S
M., [P_:#U6.;%=\&]4(_AZRY6W(JZU/*W50J@QAIFE=^N_/\[/D7WO6^_B\-
M\JZG'/HM995[=]SZ-;-!^IY5QV(RXSVW=(6W?#NO_6*T<3[ @V<G6\5P:=JJ
M^J&^>3N%T<IG':<Q@S)4&W#8?>F_*F\P!P/_-J,XJ!T^?RYT2CK/MO_\.7&!
MW^'.8430N]I-/KM[J(N%?7AA&G/O#Z7XG^20Q1U9Y/%7]G[@$3<W,2I#=?[D
MTD@$(P+EUY^'H<7'J+XS*J<,+4(G8$!<^_:O';2_^>'/X@A&I^XD[EF._5EK
MH$Z,^?.4Z'^>P*UK XPZ?L+<_"ZB)GRBPA\<EICOD?QJF,EEJ5'V=:*K&,I=
M-<?YF-A$+FO9R*'>[GVGCB^\4@EOJR@(\JMT\RQO2$$0H>1R#S$UZ?[3'B"8
MK#51I;4!&'=_"H5+L\IV"Y0("C5,D,366H_=FN!VM[W ,G'S O\2JU1*J,+-
M9XU*_!UMVMM%BRZZ?YO:?F"9P$:&NDR'+#!33A0J\$.;BX<=^<.-':Q=C67'
M!)VQQF=\;!C"T_(&GP6&EVOZ<XZ_UKNSQ<I)*]:09B( U=L(!=4GMK0?O:/C
M_WFKI]LU$12QYNRLQ[6<RW6G;V\'GVLU=C>G63G<MLZR",^(<+J>,7'XH0[Y
MP[#!F5:'Z5^,EG8QXE,G:C1R)*6??5T%/@G]EAI+M2\A/ X]5*2ETPEYYZ;M
M:#.M_DIF>G>8]*0%.J0<VR#(I@7]H6&0%6!U@M258M,QC>_NK(*W"8M8N>30
MV1+AHHY27H(WQJ&5LO4YN.DH(O3LJ@[[<H/.=PRZ!MF:%QC1^C#M:Z(!/*.Q
MXV3[(U9A65.X\J/**4^$ >R'->FB;,P*G,"7^SL,!&$ZLC "9X F!P>PV&A(
MC7P0TSA>R)>AV%0!HL<_1]R5H;A:(0CM<^:8G,NWY.+$Z[@EQ+$0JJL,=2_X
M+B%Q%ELK\*M28,F3ZVIEJ%5!9412M%"95Q=/71/(4+4Z@+QJV>[,+C*_FK6,
M8OF<[+:_Z82@(^:I^Q=_=3C[42"=^!3Z336JH^)&]W!)>-XU?W5=6H&C*JF:
ML+S0DK0VH,)<B+3&&L^CEG+MK4CHZNPVJW7]C8N]R!J_"X5%A9W'D]!+/+PP
MJT;/D:/J\((;PEUYFW:F_=(=YKUY'=ZU?4:_,5X57N8BZ 4^FX%7P$ ?98SD
M0N. ,Q-:7<I]@9ETK-C@!U=A5]4-S/9B/M)!>I^2#-4<<3<,><'?^7FL$2_I
M $@3SU0!TY;5883*&M'Y:I^.YIXG$LQ3^_^R6:&X"11FRP6,NHG5(_#J)BL=
M'@/]U1_& "L<(_*]AR+6O/9ZDN7[Y $Y^?<WJ:?>[.1L*GWLDE"?M*<TY"#U
MC<-U2?\::T%"XJ<HKAO.^.2"WFM299KY@PV\L?ST\.K(.YJ=^CFNA<O('U>/
MMF;KO8F46#0=8C=GN$X/_B@:?EHL*"JT'F/MK#S]QI^_$_I]A[G'QS"^ZT._
MM6]; XU=<Y:=._K*-2AG5UI:X7R0_LO=)4_G3W>7[\Z#V5@IL W :O3E9KWG
MIT?*I9_;<<-":^>";_SU6H_*6]]&&::6%PQ((V;\#A1K0=1T.!-!CO_P;<H_
M;?E'U'9K"\V'6A>.3>YNW)UC?\[X^E3;]:FD7S<IA=S\&FV#2O\:Y)<M+3T)
MCP:Q0I]XT0]/-#+Y4C0AS^/OX^>W_BIKSLUZ-Z_:G\)'% ,&>KPG/HRV>J?/
MOFSYVX?P;Z^JM[<1@2R:F"]Q_KEVX,:?U\!;U"^$MQLYG*.J0D[W?YY+P,7:
M?9</_'=UR _<G=#_=)OR^%/*7,27WT7D]O[B]\.N_T<U9N?.GR<#C__G@1:[
M0CEOS",J,UEH<?)G<X: M&BS/S2'HG;/M&[##P:I,6^V_*V6B=S7#+2_7Z=]
M:^,@<>4?(=U?<UD+@P[9K%X]S\M^?FGA&H<;Y$T.(2H92]T*5-I4*()RU;!:
MRF^MIG0,91_X0.C+EJ'DX6607A,2M7+N9 8O.*\_1^K969N^VTOJQ6XB1U1B
MEI8IG^*.1[ KMH.7^(G[[&B_"F;2&=^'D\G)->D*@LZXBF)PMQ"_!_PLD-@(
MYVAYS#!)M*VWFV-;@;=3],[1(X*)>*O=.1SR!3:LWO:CP'N?:_,/YK0B\'M;
M6'U"N?:1MH('K<'%):>D S&?R]D/ZVC :?IE+67P+8^9)$9?'#M3L0VLLV$)
M?CSCVYOB5A!&UJBO>?V\>Q3>V$+1)3X;F2O!7QRS\N)I*%JRJ:9%@EUIW/=0
M$,_:^/=.R+VD@?FDRZ=R&%84D&B4!=S/EE7I*J]2JW]KJ>DJO#SHW![^H"X5
MAB>.M!E.%$:?FW/N,'7<=["-R315W'>HW6C":((9G&^8GW\ZU>W<@M8_ST+\
MZ9IA:!O"F.+(9]11PB8<;UQ,O"7_\>O^=>5#<F 46&J4@@CC2T@BJ9% 1Z2)
MC7  PCTJI#E-\Y7A/9PV0&^R,5%Y(?*!2J#RN&@M3@7G>VN)MCSFY=P5^6*\
MK_>KHV&#K3,0_1M^\H]:0%E$W3\ ZSE\)U/9Y]7+_&2H33_JGL'A_2[CC%4Z
M4R:6.])3'_M-%K[5NCC'5&9.S@T?1F1LQ/R>I:'=_[%G^?^.1 ZGREE20OMK
MIX5^-/Q KD>JU%9X4*C2EQA.XD:&J;0-W#6YBUY5?<&0_BS ^?[ZCK '\28#
MZ2,?@^SPJ>X&INB7([MF4[!>A(#4F.3>GN*!QDLK&;5]*Y;L=&.+E6?DXF8<
MW(+QCY[!=\2QI@YGDK^G9V.T!Q?.]/MEEP-)0$$G&[N@'S87L!;5/ RJHA@G
ML@7Y$=>JCQO#&SZ>HSA2C#\+IETW)BZO5J7EN-(*LYT9A5=/*46%TLQ,3J9(
M3"5&H$*2^>M+E,.U9UGR0MS*?D&OUZWC(6MSZ1L^&Y^Q7G[@PZ@+.:K]Q5K/
MZ>&.(\];GXUEZV#M:X\6W?82 %=P2RGA LMW]?V<7^P$'UOW=E(./Q^-@!>Q
MRH2O065N.BT7Q%>GNC1>A=7=NST:2I[$A/.B]0E"4AQEQU-/$%\5D9IR/;P>
MO[R;3+37#\*I"(UG35X(<97CEESZ)>Q6Z)# US]=&=3M#S+LZZR=4_>[G"68
MJ)S0('NQ[P(DP>>D*\_L521= >J/NP^V3FQ\^4JH*38=:[(G9J5Q/ SS_-$[
MBSOK*?!:3$.V]^GW6J=)S#NZTQ@^X;L=9(=!1-[0.)DH0\77*48";8V- C]Q
MC RUPK<&H92F%1L GAK;<YP%Z1('AR2C_5A+Z?T!(:X&%X-9&08DL-9N"RI3
M$8Z0KE,W"V;SA,MX$KLVW@-N8Q)%62?_4E8=]VM15%9;Q<;FW(F8'YG2-*,K
M7*'2E< S/0=?$H&30D<&FZD"G@>6V3^!#(J;*;Y<&4H#/,Q;5)0'\,:C#:83
M(XU,O'<Z*C@YRCNV0"Z*@['Y@\F$)BNG$IW;%N7L\ZXEZ5F/>XXZ7F@R+#UA
MT?!%ALIW!FS@V&QO +\N& -#]0@KD*$. $)-BBHRVPNY3%A7TQBAO;B1ODL_
MWU.*X[N1:=G20V4V\_QE@M4L(D14==O08ZQ,N<QE >>\[9^0W:K3,8**!SK3
MWT?$CF;54:9)M.P/T6%["VN^W8VB*$:</1(YM]C^?+XT\_'?*P%Z8(+CST8X
MTJ4H^*+KY,\U70L9*@X:'3$G)I&-KL.E\-,0DF*(0WT%4_K'FPM6]<:,IU)2
MC]1M%.CZDHMOKW@]<^9 QOA;Z^+VT0M8DI\EI7'E6<+:L[0V&:JC8@W/4!UN
M$B.$NOC5F;HMXL'V:%I'1<X,M LSBG$3-V!Z)(; J?'AT$G)_M#Y<J]_GS)T
MN?UGC5U.JD,Z#?=-"F3\*QO^*[&*,[\[W?F/?,V\!1 CS8:Q"]4:3 DKE,%A
M<02_IW.Z)MHD14L*9'\#MA,'"-W/\<8. CPNPKD3/^A[#->H53Y%B)=NE*&^
M?0HIEI(_X&:>?, G">7@_= @M-9(ZM%/O_[T$:(>-S=^_[GDF",F)2+373QN
M9=\O]714]4S4>>$PE#?V(RW(J"FK%^LH+6]_NRK77V&MPY/>S*VZ)OK*;,PD
MPL.*[^%NWY%Z3&O4GQOC#U^8CJ@WIBQ6,*D/J=AZMF;Y:<(]KK_O"_.2G;4U
M'Y/TE\9GNZ%];J<ZMN8XG0W2ST-?$N)W?CH'*(%U)A]#P%ZF\;N3Y$].\COJ
M7[H(W,?6;+Y]Y-F)[??*3 ^X7[>..G?@R$CSLV4WHFKMTQ_A CG=*."S31G"
MF761L!'9.6$*@?&%2G;L"QQH%9D@0]T.GRI7F5_W%2ZF8) 9> B9@>O+C&2H
MAM?SDS.NAV\F7=>HS!):\YAPE(@:W35]4)K+\M_3RK.9@)=:S2\"6IR5Y@'^
MQUMYCA/P$FC^.WJBAFLXWG(0)T/99E83H#WS?RKM.")7BVM)8LMT78!WH88
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M?Y7ONWM4CM)A5EN(>)G(E^\WONZX8&>'MYTSN$>RAV+77#"Q?(1J*-Q<+KC
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M #J!$5"G7-936=VI+&Z$_"A,FQG!>;ZX@9,N"J=#"L6UT3)4T_OI,7V#?]S
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M8( =O,K8&E%FO3M\"-.C[R$9"DR66% "VZ @X2C;8A>31^1<PZPIVR#1P<0
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M<[^EN-&=XPN"D.3J4NRN<;"\HE!AV^S+NNT7(GP5S*]GCA\7IQ>= YK\O!N
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M#F>1CR$BT"=]0VH828$Y:2^]\%PBZ;+T$$42LQISG5OPXN6C7T9E*$P'YWT
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MVWL]"OAMS%XQG'YFL'O'.B@(.%<OT8<L4P]'1YHT@HC,9JG5P6@LO3@:EE3
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M1PV\7_&4.V3);<@M-5Z%)5]T6Y&9F=0%?N;&Y1#32G> ")')MB>FS [_H%;
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M%"5HS!1?;K/6./FAHZ.L;^^!LQ?S__-]NO\G_GM#=G7L_P)02P,$%     @
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M)6<T2DY9!0R%SG"THAP"YJKLK*P$1RL[H3?XO^TG.6%_[L?'!^P$K@=35$/
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M J  X(0B>IM:&5C37B37UQ6C/D4"?A2PC[F6;Z]BOY<S,A<3 _ZSPHWR)I#
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M%I"C'.0HIS$4@0R-( ,)9%"@ *+CLQ3@79;&6FGU(KFWI_PDKF>&]!2DB:(
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M2S"<K#YXK'NH[I=)E4,!KB35FCFM8$:'UQYT!Z/; O8L80^)JD:]=3[8?=0
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M:,;ZBD[?J*J ZRM8S[SU.GG,@.\I&%$*=U0KB9^17_;$O^\S&^=-%_V<N4]
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M)UK=MD[58"5<S6(QR[OZEIY R K11<[DC<SNWNE1$OY5]E71^"2%6P>11RB
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M9R6<DB_<6&.U4!:2M%!,UY/RJ>H-+V#DS%*"+ N:J$D 4^,XZ?(XVSU[=U&
M[D[/E4J]@+,C//AC"X3$SB-R^8B)5/X:+D[UJ*'2+:VO,A4EZJYF<(++QCKV
M/B:O_C TMJRHK<EKES\Z_=Z;\9).BU.D%YXCC[:,*I_.'9;>ON6RK.UEE/";
MGFZ/I[+%OET8+VZU]("C)S,/@RE;'?)#$Z9P>;ZV@.%2@>>3@JBE(U_P'=:.
M"]6C@\5H"A W7SM:&3XUK^G X5[;H'V^78-=4,C#QG+KD$J)#V]NZD<3B;88
M3WJ\T^[5KGG.3Z=QSFCZ4W:W'2?U6%=>+Y)XD[KJO:6]',N?*-RM8J%?RVA:
MZDOZ\%YU14VAEKRXEA#9,Y?>3EZ-ZDE81JWZ!#^G *GQCO-QY2..!\@YN86B
M,PVOP?CU"4R+@Q44'6OG^P^)&+4_?OAU6Z3D.T85/Z?1E$O7 "&1DR)<K Y2
MMQ&HW01CU?+',OA S8H"I\^XK[7W7G\*C5N\*Q&<FC=8U]I]+"0??IT8?F)P
MLA*YY^7#I(%CE[@<R0B'57VXLG!*4Y"5M^42*OT5]F2J%;;UY>W-'@8:<*F!
MY.RX^WGB;_>?RW6^^VQ3?E*)U-"V/1-!'#S5SY[(-B05F"R<2HI-$;GZZ=T;
MCWD*X&V@UYV_*]E1Y=P-EL4_R)MYU[J(0Q59!P9%;R)%RO2,32ZT;WN\(#"=
ML<_6:6+7Y^<XXZ1]OE$"0H$7#P:_8]JY:T\FVEJG+KQD.7[1OC/'JK_:2%9A
M1:XJ;(YW$X]H=%]R6"1WW*D]^[8.NW^)\EZTCZ_1+7 <+)=8WAHD^<D2D,QZ
M7U_A>KN.V6"^;?E.M3;2W2_7;*:4ZRMGPZAI[F.+STI6#6@8--^C:*>*;]78
M$M3J5LW@2K@'QF@M\55!CFL;PE=!,*CK8P%?^B'<'/T"BO\*!6C/&$SP[Y>+
M.A[QLMO/R*LQCO.9$CE%^Q#^H;;FH5S03]1"$I\9:XK:SHZ/C^X_7_(PU0IN
M8_)PTO+!3N?T%)B5&S'FF5=Z=I/U14.1&,*.L8&>U="F)T'R[T_XOBBMT]L5
M@N+L"WAW5U36AQLOLC(U=L=_+KCH\[CV\_C+=Y99P80W'SX8.8'L_S)%]-8P
MS/L:[/, XP,]]S A,$LCIA&/SLCJO"$;JVY94-H8*=,Q]+;T94=8^?8OOD:/
MPAN;92Y!K^-K7]6F36DW$0N#QMX6R.I?2DEY$F)MX+?R)C]IX=D@QRL* '6\
M\53]M 72#WW\>"A40,-S]("#>FJ:CPA'2$OJA<X EI;GR6* W2E9H>M=N=[]
M7J:UD9MV=VQG0SI7,@]4AP9N,AFO+X3E/ZZ5+=\9#C#WB:^YIK6&60R!D\BQ
M-M.X-R.JA)@K:WJ?T8 >W;*O,ICA27.0JP<F>F"F2!%,PKW2BD4^WI.)1$??
M:]XA,;?E%3)N.&N\O'#/\S!HJ?9T)!W2*6)%DVV;YV+6R;+GQKQ?5 5JNSUB
MY3B_M+7%VZ4V6E^1P4[G24%.%=R).>.%<N8<+9T8Z'!.#7H3='EO\CG&D![V
M%\@',T2W";RFO=7+Q);/21.O]N5V?-I" :ZIJY6ZK7QQ=TU/NSLN<CL^E.FX
M=*>FWW7^NW)Z<B];.AVQ:\IEJ4[7_!X\T FYMYHPP;H-5E6[#6(]'<U\']G?
M=/79[%?/*4WJENG]6XV:R\[NK:N+])ZK#\NBF1,E45/#+46.?7C3DZ>K7L<,
MW_\:WAEM^7S[XH$=T[U^\OPNNY+&;?%]=U-KWK^0)F])YX;+1LIMCT0H79<G
M^LE/6S-Y11$CG6\+',B^L!:O<@]RU",U.D1 TS2(2WET^UM(X0=5R02C+'F;
MQO*7%^DY)I7O3$F2U()X2#M&*.]XQM9$3R%[CKQ<6TQH55&??[_B-=.[&J*V
M/6@.TUHT>&*V=\5_*1C9(@(NJ,<[>U8,EZMH:XK9\M9^"G!0*W&VM6BXM7QA
MS0M<>N> :?42$<R]2X-ZCHWT'%.C )S,2SUF;TN71T>Z?.J7MR60<Q0H #=U
MF1Z")]?/?ES3*J,NU9<H0")(S35;G@NNVK.)GUNGQ<;60M-?CI6.63FV.]AO
MTS61%U0XTC@>7*HG&^J0EICI=O6^I(O[G6RW%!_M[5ZF9+'K".FN,7"HNK=I
M5K4ON_ );6\QJE[977>B+W*_\ZD4'Q_Y*<?BX@EY996@>_"YNEW*#U>M12<+
M]KHCZ3^^V_/HQ(B+UKUQD=()X6N1/5V>A;L?+Y-WN/=!UUIT>:_8.2=F;4JX
M[5E_Z4T#:UBLX JL2-# $%O2YK>:=2-_L, T<0R=AQ65,KB=J?[5EI^?N4]?
MF^%+XNLRKY,5!15/QP1-Y.XM1N[QO^9491=P-NG5V7=)HR/W0O[AAO5P^AJ*
MK+3I?N,LXECA4-S#H(G'&*' [2\#W?B#5-$M]QL],*:2KSHBO!LUFX?N7=D]
MY"KDYDN*3NK<-LY5XKNW5'(9J<!0U&U]S0\1RML/74T.]T_?8=T$E>0;%AB8
M\,,&G.AOS]]I<G_(8^N%; M1Q28)^TA&".3@]C-LMX*+50N659_Z<20D/9Y/
M]0MPY8IY+G\D.V\G@^53MY2*SQ\W.T\VZ9];X;M<P;^8]WH^O+ANM82XJ:&T
MNV K3GYOQ,U=6D9WP\_VW>:Z;I=72F2:K565F@CH=$G$RQGFA8!-]\ FI<2S
M(8:?>Y+FJU?):$U>GXFWY2WEK8/(ZJ%9ZC*U7%27 O#6MZQ0C=,S(6I" <I6
M@EJ/C;SHF?!]NI;V=2(X*)?L.%^QBJ]_WU,6')13GK'21CR.[%@-'AD;Z=K2
M?6K1I@NYC>CM$CCB8WUQF[7LATM1\0%3&@H:(K??L]5JF DUVAP 1/T,9IK#
MU7C.R;(47WO:$_=4ZXMKNX+9^YA#YX8;D#G).5PS[[*B/J>RE%\+Z(T+T/GD
MTJ%@]Z'E/GMT S+7*\AX;>>>'G5KGT?SE1,W@KVFTG"OVMS6QGPYA6Y(=VF2
M+V<>)O"=B+ZBY<AJD[KS[5AK^E6Q6S8NI\\?_GS^B>N!JCY'[[D0OR?(@R>%
MV^'9#Z!9D-/WN7HC4Z\!_)+,[#8YC@0SK;'M(Z[U[B?E:N!,1EOF%6:NKBE+
M0T(-F8 K5F'C^P9]OB_Q;0RG[1:F@A32,!I^N'<WYLEF6X=A66;<'C>O._8E
M*O1:/-@GA"J083C,($MZ;CK_!V'EA<@"(6TBTM%TK5&]9VQ63COV=!ET>O+M
M=EO(23.E)H4)VSUK2U]FNN\[YWQR.J3\^5W>7NVU=Z?%<AFY#A0<::( IRE
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M;$$V)::Z@@0@O<\-@'#W&(N%1^A3E56,J6,[IOD&,/SF"@6$M-\ 1HQ/71=
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M:IK=8Q,LP)/O8TE!6U61+P4:PP2 77?("J"8582+WXKNDK#\8$R;]UKBCQN
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MG!?127)B*XA1.[B[W1QT?WKX3TL8DCX$&$TK11K5'B4CGN\="E,J<9D#,RW
M#/@#CP1*"#<#\()8CNFB?'_0,$ Z=T=1P(JS*R>_S*TV+-3T7BT=TU_[H2K<
M9IZVH556T,"*B5L^<03N1<NB5B'^%4:[2\<\-P!2S!DVUO/R>W?#;P!S#5_:
MW3:&X4TS7!8>O?NIO/Y&WI[&6@4E* $+!2&UK!_QIM%E#7QX<\$+M0<I0S<
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MCGD27/R9ZO?O%H&J+306%G.=I:FD">6JNLEMR016Q?/HPY_T??^.Q4Z D^@
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M2'O5.]+2>V&,>;EY?3M)U8CVXP1C4-??:+$L&XEW;8+A ^T?7MX&V,TDV0T
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MH '%%4<\I' *V/LX2PW01]Q'GT&&_C^RB/IK>;"?M\$[:%-@3*<=PM"<1A\
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M8Y+?'9F4X;BN>J]80YE4Z,^JNCOLHY1$6V12XZ@Z7ZC<N@<8SET4&?)-Q1
MC 0BX.,@EC_8%BW ;@ED\^-[G]YSZNAC"\AWW$.Z)W5L[BH-OFF>S'"-WC>$
M-]>NG#GR>,N8IO7XH4W-7PW:6U49A]CF=Q1#ODY6OK.TLHZ;6\P(6,?T.Y;S
M,\T@M'>(ZXA87MZ=+UV3:I5\^.U3G;1O=T,,J&1/> "Q_^&_]&GX[R]<?Q!<
M/X*NUS%CU(^ZO;GP\+$#J?'J3ZL+9YSH/\^;E+\,$75[NZ[YUFA93*&0H$A.
M?8C//-7SQDP'PR5?I\Q2J._V[8/>HT-AA9M(;!Z, -W J;3T50LLOUPUYL0
M*>T9XY"3M^/H)$+^#C(DMQ2><OU1BRR1V;-8-HZ?:M/%(L:!-'>@4)N"?E1,
MYD@-XZG.\\W('S5A?AZU!U[&K[_8?B<W=PO\V.DGWS,('ZS3_;%?\)8EM<-T
M\IG3\HUN]-D'6%<4ZI*=2DD=0;7@TAY;3R>CVX?2K+OFR7Z0/9,A9]3]J[;,
M*_VLRT_.>4JD[*;VC1WJ'\ILM@5Y*48-GXZQ%7>W;GI6>^-+H7XOC-M5L>]&
M6,?2VZ=>:-"[NA4QCIV+?JHSCB_JDO91OG]B0X$.,.I\EAONW?\1H%3N(\4
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M$0>J:M!*QN D9M.K>W?I;Y07RTPPJO$]C4<B$>*%";[YHM=_&[%NKM.>0E:
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MR!6A^'JW-RXX?I6M?U+8<H/^8YJ%Y>Y)K5?RIXEG%:MLKPCD*U9L*^8(8L?
MQMIWSQP>3!H,^AX?+LK7<3ACO9PC^;SV/?Q5)Z<P646@$F_A_?6]''/==4[U
M,(6H%SB][U\>]!SBA]$MRR74A/+&==>Z?DL4.CUO/BJO%;1/\\CI-UM*W6(_
M[HDE?/BSLU6R07SN(U,M99\),.+Q4\=I7P[)06)C59OP<H2*E/WEQ^3D[>J+
M#O',_GCF(OERNLYS'NP:T"_#@]7!@U<@%!S(@Z&*L)#/UDGE&VULRRIR5@>5
M?O:OW6=&'P::YU?YH;LP0*XCYB,S 1=/.!>A$D9<'3D9WI$M'Y?:X=\7OW/7
ML<;$WOLG,T,,:@OF/A/V5=H968B(JN/HYRG,8!5.'JFW:*YV3"$$/RZO=U))
M$6\P.+/\W0H[2;X'!-3TW_V_1?;O.-O-A%"+V"DZZ:]@=UU1"XYSCG]6O(;G
M&<,/$?A0[;_Z],!1:#:$,5N@G[,[QR]/QY9)!4 9?C%S.V^0JC?0Q;QZF =+
MK\)^K[OC5X9:_C@$=%T@+H&%Y<--O>7_["_20GW,@Y59-_)@8S>&'-D?"7 R
M.UR;Q8,E'"6"06,\6+1QKSHEB9,G  9!7RA *VS!+?%@.[GGA!:]*-LU&NKK
M(-2+2 &N\KUHX)KXT@'(HK3T$Y%+:^GP#O(K(.HJC:\4^/\%YB.F[JU00.DY
M++@2RX,U:8\A"?M XU0L] U('LQ:Q*:* =&N6+0"T*6%6J+-)M=CYQ $B"B%
M+E$*@\A$) -%Y_SET1D]7"Q?Q[O*M]G .(BIH]5C>3A1"D@%A;@1]7=HG=%U
M(!RU1.(BCW+8##MRRQ(7\0'ZC[4<:/=BK* WP-Q1"9D&RHA7P6?0& <R_'"@
M6,H^'NQQ4!SA$G>$!QL&^=J64]!L99(/@Q34@K4R#]9Y%C'^FU_9(^D_*GO\
MG6X9K?+IEO$:W>+H5YH3T<QKT-(AU2NN3M3IU3.!'S$(4IGB(N)Z!P]6@641
M(0#+U1[%VOCB(.C*]F)\Y6?A!%%7^,H"(HI6QY[GGT,PAE%T(A(RB/5%$4P-
M'FS0Q O-T=5,X<%"A6S8J2"%!UNN\@16"N- --Y7+4B(!Y-[ 5$HHT'$+!=K
M=S2H'2P;7\N*W<PTY,&<VY<5>; =9I[\7)]A1 _J?ZLZ^\.%UK \V+"VPNWM
M.#I8QV_C5(I]4/$\2 48J,XJ[)H""9J56V #E[]H[$/Y(0L/4!ST:*D+]%VH
M1< I:)!QF]^98(UEH:&E%LJO0(Q?Y[EYG.M.Y6>\4, J%FH5S>;O'7^@'N'(
M(,Z%L''H1S<UL&,MK9[CL:DTAKG7UF:=S*>2@6CQ ?DRW3\81LH#5<6-+%B5
M15H*9_/AL;24V #TNT<2.4Z5L4?_3#Z"^*\ZW"CT>L$,=<_<,+*SANDX4B,^
MOS,G2#%",IC6EF6"R#!D^M[A:G)2&=N</[_7H<]%BLM+YDZB[M&&/>)_M._4
M2-^2UI.<F=,\-KM3]]JA#^C7A#%3]?=5P (WX.BK@!1_F_&FVYB%AUK?WO:>
M0)7*P'6RY<,&U =C/5U&^LQ_'MM@R'9Y %N1ND0\2L/\3%IM_XV WST85_!X
MKZR0G9:P6<RP[Q:F/2[>S/1+\;#MWKRV@ZXN_6Z?_&?T0E\F#3/;4U/:@PMV
MFL2Y1Q\W^&00E.6U\EOE>D1TS/FP;_KF%=]^W*C[L;2?;E]\]EVD$N>:&LOU
M7JGDH^*W$QJ2=:]8HO^S6^OV&JK[B!O1+J5JCI<KQ>^7SXE^.IZ76'.YZVVR
M_\3B:&GEHF1PO?'AW/8]R@84J6T/]M@^O<2N\[#;B/>NHJ@9[XG<<I!T57I3
M0=/[VOCUIL%/IPO\":J=45Y5PYB@^,BVC<8!N&>Y8QT$HW6R/44ZFN/^M'[N
MO,E@C4;.3;3=_> O068OAPHL&>O?N0E?O?YYR2%N%^>2>R==N2DOE^:?<60W
MW']#!XYM2JIS=)A+<?PU7Z9R[41_>G;JOJL_P_.S'N5]D+@)*"]H7B+7.Q#O
MVSG^]O@Y4HJC?]FXRUI">*A62%?D3]"A:4T<MH7K!:U5'DR'[V/9+>RF2@ZJ
MJX[ENU"LQK3C/%^E]0=<CFXBL /#[M#O+!0H5]8/M_6]6F+^./%J!NQQL>RZ
MEE^C=_$"!&[A7UH-;VEFEIZ#2VG'3]5;#.8DW1\NVDL,J+PGWW.PX-G%0Y"?
M<XG9)%VAM[3CFWN,0SO56L[#[&@?<"^1W3M_L>JV98SH\9VR[,.GSVG>X%PX
M=>6Q%"/1WD7QO^\4>TW''Q@\Y-<%'C !X<NT9@ ]MWG!CY-[HPLRH43J\LH6
MAAAHX>D*N0^(&<M>?X[G(G%<!HWQ5.*FESU0(D[D!/!;047PD\Q8W(!Q+G*5
MNA;^;D6R1YEJ?$^;"APW_!@UZ2,3FZ%M9D/9=+SOY4:WQ'*O7F6(.5KO,*]!
MT1,0/<.=<\;KNF1.PU*.GV,F-[NQUR$2 M^'1)VH)1^3/=I\1<?UACX'AL+W
M_ZRG*A5^_]]KMO]QX?-5$#O*A'PG4X#%7DMQJP_%CH(L1M5:1&><2XDVP:+_
M2NTV8!&YP"J_1=UKK\:-PLLIXZ./+80P%8?SG';OC7MP]82B3.#[5EB(H:HX
MRFE!5\H'<T+4F_U=A%6)'9V^-<\42*MRR$:-ET(&OGHXC*BKT?6O+>">*<;(
M*.KYN<G -)!EAD?[8?>'^]JP?X*DILJ$Y*B'(/XAC&1]YN[R@7,*\//^(>)$
MFEOU;RR*#EE6N&/P'#E=.PA)5V5Y@UH\6"U[C54(\F!%?V';+UA"A!90QT\^
M@0RG/)PMGYX .5'('=8GA0+0P-X&Q6E#)"<'V8ZE[>3![I;3C@3I\6!FNY*P
M4SP8]Y-)_X #-:5PY.]-<V0G9;EQBJU8CJYVS9HN_0%[*Q7-R:O%0QZA'<TJ
ME=4M]H'L/2*9!YNQXQM\>-$9H9ZH$ 1NBHB+8I-0-[@0_D)SS,8AY\37AW*\
MR"L03H7S:TOX=<%QTV8("OPW"/WHD #3#!B4&8=>8HD?&AK4PK!?#T=[*J(4
MNYQQD0?3]@&Z_A<D@_D[DL'^9R2#@)",Y*A9*';2(.R_AC&X%01%%<,>7<,P
MU2P[#F+ 9HD)U^4[CZ]P%.,C#>'80EKKE1'B/YXB>19,A9ZA"^U;C?SOCN]+
M_[\=WU/T%6NOL+_S8&U>29"+?\N#S8Z2]^DL(I8M)[N8I#A0I\[<A =#S.ED
M B6LD)!QD@T#=WL&_#[.)7$Q=;[0Z*G =&@%_%P F,2H_P(AF::6<2J(H3$6
M,#A>MV@E6&OC ZWP^CN^G=$ULEP&B4NKX^<1%&%SQ$.!7)#?K9&&I&%6H*42
M2>67@[?/67;DP9 U]=C%X0$4-"1-[;9_R?1$_>=,3R8_TY/X-ZMC@:6^^K'%
M*UISU]XR@SAG=HJPYN&B\42D1+E:6YJS^Q/EOC[S,F1>#R@TO(OQY)WLL?F8
M>QHH;SUZ^(M[..H)-]#SHTAH]O$?FH^,[CH^,.)\C;P-2L@6>6+S^-TRL.Q;
M(*96C[R3-0M9(]I3%IP&OH#6-/3#C\_"R53WT&U8 =9_Y(I7P"EPLS7Q;K$B
M4^7VT:3*&G=EH;DKOEE'SU@MQ0I6A?R*RG]Z>5CP9*5^V="\.X1MV*TB-<,;
MJB)"JG+NV89SABRU@"'Q -#>66@$W*OYDP?S7K7JV\>=F54"NWFP7-]2>&T9
M^3B+OWN>4F(^PYLTA&M/AQX_>D#APUPA\$*,Z;(G14G%;/RE?-=;3J)=J $=
M/M5:&VHU97/,M*Y^].[9J7W[F:Q'AAW=4>DWIH0?9KXZF7-]NZS%Y6,Z 61C
M!)H33:1($S4#22B^9'2%1&[E_/6TOC00^]93'<.&DRE$%,1_&&@ZA.)Q#M._
M@LU7,97UUE[:#67TJ>GO\]?KZBH<'YG9I685YV?GYEPN5MM#_W5DD]NUVPHF
M-J+R+M*S^J5HZ8<F1"U/ZR#?M(D'6E<.;'Y@('VM".:H,[NB-A%J5$6*(K>+
MN4\\'8UJ/!)?(GWE^I:=IBK3;'W.^YIS[?MS%SS"Q3?TFLC8:#<IY^V4;OUU
MKEDP\:)Q3%;WKJ:O:J*17 (FXX?8.X_S.&5]F5";/*:%=:_O463-PI3!MHX'
M&ZA<601U$:(21AU^RW;MK12.]82JZIN-R'V+8&E^J];S6'OG/9KDW8?*AAH#
M% S_!-GO&QGZ$S=.=3JVW.-IQU&21Z",I=EU/\QFJ=>?+E<<Q59XFY&Z4YZ!
MET=<S,ZH3BYX,)*>J"T<%1' T.=^UEMHW$ZNPVA<(DBUYS8W7+4JA>6I5[#K
M[K?J]_MLZXWB"D8CS%27@DN_DI2;-O=A2\1$W]*"YO'(Z9-N)*JH>1<'H1 Q
MDL/)!P][8-XLIP0%4!*C='DPX,Y*Z_E8C>*8Y9;RL2%O0[^#/_"Z6FX],_3C
MI71$3-$FI:'A&SU<MI((Z\LHD(),U! =8"NV)H8'VQU8L'5[[Q+,:44VF#O(
M7$NWR-908>\:MS[GF_.J F%*6UB?+[1\,2'J_FTYI8_%^X$JSFN5]Q46MWPW
M?LA/B5DG.S!^?V+!:O!S&B9I_G#,@UL'(:,2=--Q;J$E04/<H[:@/4A[^V#I
M=<C>-)868QEEPH!.A(B3PW.)?R]\<<ZZ%1Z3YK>$N6E-^?FU[02LK&=^OL98
MQK$%X^DBO6V[K+#!W%;T8W-E$MWMEL;D35BE:S(3[3:Y+=^^QS?EP,[F33@Y
MY@F11<R& [(?2$I4G;X?03?PV>136TZ]/%YLO7Q!Z!5-:[??:0'M>P7+CA/0
M1@S^2!3U+)JWIOM?WWSBXY"80N3C.*'/I7'5#NGQNY_@G/-C9>Y5SUPQN39[
M4E0F<O]B1&I EQ_)I(/H><T-<^W"E6>/+N2T/NAM#K-[:Z43N<=Z2U5#FIJG
MS[#)"'OZ\_G@8[IS+^&M]VZOID;&?86M?S8&P)$M>TFLH$TK.\@X\=  _@FA
M(YV/%<@SD&% @W1 BY^0A:5AQU!S" 2_!\,C1,X*W&SF*RLTA,^T;F"^\F!3
MVM:E=B(]6"D?\_ZYFZ6W*Y!.$Y+9Y=*?83:C&=\]#9')]SKS(S]*Y4FU1X\Z
MRQNMRVY%W \AQ-U7Y6 [_8Y4=+TX/I25L;SY4-O=VH2R7XLJR#^M9A[:>'<!
MKQ(?RS9W^ NY%S+ON*+FC2T3\,B;*N;'2\+E+?:4Z%H;:NVQ^'+JHKF)N<D)
M,[.K9AJ;#Z5O'I<7[VX_L+4P\]E)72GVC\9'":(&PV=.">ZXMTE=$'XJ&&E[
MOE#"LN_I^1.;6J68-.D1%N9?)O]BSM0EJ2GP!.=IALWS*87\$>;5 X]-'YS-
MHZ9?/*:GU.@]]&Q9//?:)ID=?I5[ITBQZOGR*EFOBV86#P6"U]W-=. *SX*9
M(LBVU-]/++B"S:B9*Q@FHJT_E1\S0./(*QSO%1TF2^.K:5T;O"==!T6YC<Q;
MTZB) TUF*Q- H=E??4CMJ%R@7Y5?%MY*CE-X;SR;&?[Y4(SZ/6Y!_<RAWWO;
M3\S_R%_^+?KC_/Z[J3?6^^YL*@YIUVDSV(6BTZ3Z_KP383;;(6)1#EE=SA,6
MI )?E0+\92%VJ]>B !,D5+QCI&C?<?SW GEK%SY5+#<:/AEAHS></)]^7V'B
MY]B1I[?]+XC>+DNP\-K2<#@SYF6RF)O4GB\OA8BJ:INV%7%I>=>5?31Z(KXW
MFJLODU/91=C?"T$)Q3%:ZA-&6]=EM8Y.&CU8GE$!^/T^QBK4Z,A,B8<\V)LU
M$+8FVH,OLNS(W&W89N(2WP5L0QTLD&H)?CTM'FZW.^OC0GU^8=[-K $]D_H2
MI<O?]EUUDCY_#NZ8TS,0%9=I4%63D!5\V-.JD?O,6?8C_-A99$J @[YV025^
M%_-R1%%WW8I>\;-_I0VPX,+\G$^K3<N'[[T7],8:T,-/E&[%I=>XW,G-DU[9
MZ-YN>252I'O7PW-5]+VD5WMU+D_U^^BR*R9"/82?L@T%/K1HE*%E?<QW(4<P
MTM13E?".Z,_='$<NK6MU)PU;'^3;!4(3*Q8E0D=$07B<[]=:$&9=;.]OV''J
M7_7FB$ )GUN\!.0N&T^$.LWE?]L4<_/Q3TZ[0?,N17PFW@F[\8CM>@R^-.Y4
M7F',IA"$M<!PZ5RFI%JEV/VG]PZ_>#QZW>I, C/X$?IG>HBQS@_\ZC#3]6CR
MJA45L>5W7@96FFC$.AA ^TRI'2(K_8U73&]FZJ^%.^3^&>Z0;- B\V GO%1Y
ML-]E9+#0L-L=6L>39E-8EM4(T!=!OARU-E]!D$V@MFO[,(J1XB!""JC="4H3
MEB# !3[G @, VBMG#65*V1!G@8998._&<4(UPTX7^&=,KXO&'080\W532:6H
MO\"P.1 >V$%T04SJ?898VBOL^(BM:U5$GOL_9<?(J7EHP*6O("M?]1G+T*O5
M_I[.!7[$>?W7*E9G (,A<;'C,Y1M/)A""1F]_2*6@"74IZZ%4)<0T),VAJ[5
M4.Y!,M!+'*"$?TZ.N;;*@_%@9^"9/-@2-(O@4J57R)Y)1Z8ETPOTEX> [&_?
M[@5[B"( 3OQ>X,#LT(I"D,XTZ1_CQ*&8'4!'WTP71W\0R7C3HLBQ)ASCC@(3
M& @84UMY,-H#6A3*'\X\L4SA4-MX,+B$N;4X1#K$.$$MQ:5\A0'Z,"=$G]6X
MM-:ID@>S 3W .NP8GVZ01=!L89M0!?FN5;XD ECK-%8$HG H1L-?G<;X^B!H
MBH1]^)VGU[03(6LY;UA$&(CHX6N(%HI[F(I RPA1#^SLA-YFC78[N/=_U+!R
MV/^B8<UM879[^EM%?:QP?BAG86Q=[Z?M[$?3V[K3H\/J="LG,BFW  9N=9PO
M_439&:BE8X./9]Q+OB09OS,?',+,D<7K%]4^V#WL)VR_;NB,D/JX!_#,YJ9=
MW;#6-LV#LI_5[% -IV!;N)1%_A11<KJ]P1(,W/$CH]IWH=:,5DGB$P6^=L&:
MR7E'C^NY3U@B7C-'2;K[S$OD&%K]D@^;3[UC?OIM]K.'*L_(-<>O.V]L_A6K
M(%2;Q:ZUV8UG)OFX-,9=W*$,O9X"31@P-1NKT]!_-80X]\@CM:%J!NSW'Q,"
MW3X^7,>#I61@;\[.U4UXV0JO68U?Z8W?*D_9IFXS7V>2TN3LO6>K>:O@@1/J
MN5/RDKFT(77D/CNN@G:I[WI[NQM#;8N&8H?8^W>$$K25M(R]!;L1WV<MN,]W
M]D=;QG_9K9)@L>>N4_['O/38;.FVZ(QTZQ?^*;$J,KFZC$XWZ;N9_B-W9PVD
MNU]+5C6=O*9[LL3H^.'3UW1N0N!<YU.(QPI?>P)W$)$D]VDLL@2ZQJFAP%@Z
MM[^:C&3$"/6&("9"H=G"B$R,6XL#AX(./B]@Y@>Z'[<J7#^]\Y=7"%(P?Z*B
M[G[?M,4Z=X&'V]":7.*-[?=',E1Z'T\A3IIL0BS-A0(*.8XWLRVG/ BBVRM*
MY)<SVG<@4 ]R6 6EC-H:\LE_,W3Q+Q>>*+[%'E:%-X=6H>>V430M-#6O>*1]
MT3_I/:7F$#+J=KST+ \FY?OBB,49BSZ-=S,WKS4J[=87]O%2G4]-^6Q<O>!A
M;G^Z64?=(6%+?5AGRK/(U.3U8E/U;GAU?;<DW^'4GM$+\-W1%\\KSN7);EDG
MVSWK1ZQC#R"D@X2D![3#WBI97KZ>)!R>Y;9/^,MBGG2=PJ[-1G.$$W=]9V,O
MU?;MVAM[2:&1_2W:;>H-/@7CAK$?NE?U7:KX95S;CH!U4_ZE>4Z&Y$T!.<E^
MIIXC,B-JAC[?=@3OS'J0CW@O>_)AH" /AH.\^?+9,?H7'DQVP*]'>V/U;/,P
M#]:DSZ*/\=_ $F)TA>,XR]_/G?&YUWY\/7OR1>.]*QWA,0,;U\4@9Q[HTQB4
M1=_J'>NDNB'>(,1$>'45(Y8*^$ -2X,@ LZ!Q3^6A=9N&]]F\;/O;C%9@!EM
M'G(R1%<K(@>+>+='_ZJ%$\NQ^DQYGZ_]Y:5?\_8X6^FNJSC+794VT^Z93K_;
MR[+?5HFGNDL8^PN?],%^<9BM_[KXD'+JIYWS;8,)E:/#J*/44W$\V-G5Z*&G
MFFS[A5>#U[?;3QUO&VP3WIW9^]5LPVV0N8*8!F9TMKW)NY='=OM3D)F^)=\H
M]W!>=EYV@FQ.7DZ:8(R9X*_$Z+MW7K^PNJ8KN,- 9WE4XLB%6+5M8C#=C1_"
MOH9-B;PERR6$Y5>?.G:17Z V,PAK];>5DYG-Q$?5/C9=&E)H?;N05E2I.EZ;
ME:ARF7 4O;]36LIM#RRO2NJ&2(Y.]X+5[0=XC/#&PW$-,H "30YTB'6T$\:+
MM:NNNKSJQOV*1S,#?XOF)V:\R,^.+#Z:D_<I/?#Z.WC$BXST2Y%W4[<+7#P<
M$Z"%#!YY='=DW#<S$MIZT=H^R3:9+PP/)3QJ?:TK^?QF&%WR$U<1Q.*XC*,$
M:.-1TA%C"'RL]C1MH:Z3WS'1F$UTF"8$"PV_]7!\)[$K+N&[O-4\RN,9Y.3\
M O[XB)T_ A-P6B:M#UL]RMA+UZ;7+]KX,$Z:-C\MW@I0WTM*(<[\>:1#KY[Q
M4&<G3MX^=\>9,_EF'/ZY3@/?0@BDI6G_'QS)I@,JC]WOFR74S3]=+%(V?[S=
M\>&U<V]7,R*C E<Q;T3U#L84;+GF&G-,''86)KQU'6.?%Q?7)=YUS^K)2.V3
M:_&V>6>>:(6+K^L7"GJ# >=)T<X5PA?=XZ381]??"'Z!77YD'0[F<,=G5CA!
M&QYM)G_BZYW ?1"<T^%2M?GH9H"+. HY(/ZY!G7&L-S']?["?$&5@$&$U\)E
MR?L:^VROC)4]^C(T?K=!HU6'\.>) 2**;8T9YDIP$P;&=[>N@E$;H2UD3*_Y
MZ%(UC\N,.92NQH,%W"38+I/];28,K\J\21CWM=:_M#7ZM8#TI^/ET@(/] 6#
M9A3VK]]FP8,5<&W)&7^>K1.2<&9X8O[>E)U*6O!AURU2Z]PYX5KLZQ&;#+YT
M,5 /_] )47?C7B&B9E@A(KTA%X"%M*[?#X64C*];[3%CMAW6GP:B0#GD.<>'
M"XD];]63K90W$O5)TB=OAN+(5QWI<-Q2%\>+L)'V3*^XJ(5CP +5ZZ"-JL-U
MJ,,%1RUUL2DM>_D3A613NM@+_/WOC6TK=]71PV@ZAM1N66';H4O9;D?\&_SE
M,(E_<EHO+!GX1_L8EN>+_G'4*ZD4#(N!^W76MF,I->^O9ZI&P0=<8DY)=__>
M*_E9-@]ZV]NP303,2$?QH0J;%KS<+/?S2_!2ZMDY7<K)ZA_1?T]:"N4G+9WA
M\).6=N&Q_T[2DC0H![2P1[O62BM4(_C*P $?+QJ3'WQ>)"V>5%S]JQ\O_W@K
MA0O9;P\>[* T'_>= XZ3@;(X72_FJB9NA@>3]P:I^O_]:2[F?SC-_6<,U! #
M_?,J=CR6MIT]"6'6<]#'5NQ7KOOI+G' %,#S8,C:L^3M$?8@ H%#S0"T^HHU
M%$3 3OB5"/ WR!1DDIN1*VLE77SA2 B;'6*9\6 [X780%A9[P?AE:@FA/,=$
M'HSTC @6R=IOGR0RK>F*S/$(L A]GE2^$!WX_YJH(HA1IW9Q.AU2H>6?'/*N
M9 +HT%=;840B_!V9\LL\&&<9P;VA[40B"(%&J1 IT%H&6G#Y;CS8343##(AE
MM]0&D267< !Y&4% #/CP45JU.#0^]"JF=V=+W1I#%.FLQY)1=/YA(N^W:&$H
MB@R4CH-RE/=I/K?1(G19CB= J ];*U7HM<3R:2&Q%M775.+?^#BA$6@D\N&2
M*R<)&)^G8&>XPP/0LW6E3W( NZ#_0K#YXS\)-F7_%\'F=0BC*X>VAY7H6))*
M>O<<MWQ-EJ@+'SBM)?/.3E9H>&';MP?G4969':XNGY+(LYF8PX1%%*%HTL_!
MO^:9;*'J51E8],%P9Z!#,QZAS/1]$;I"$:ZBIO:7:M\J"S_$=.] ,I^Q1#H#
MBQ\ 7ZD@?N86V#!LW&N(BV!QH 4K!D3\19D=(<L3Q^=1E8@>*G,,FO*UOI\>
M"9PJUI#IY]6D_GA:_+Q9$J'465/L6&'X0=V:$Z'C0G+'UX6I]H2);V/VBHSU
M_T2ZJ3X>9(K<V1Z?/*'2$,PQMT!07^J#V\N10W4?YCC(\HN'?P?T_B0X#J49
MLZ6[13H>!6BWV1ND_</*ICHJ5HCY8MH("T. !_U1+YL'4WO7U+/A=\RHVHWV
MZ@?>S;"KXY=U[L!R6"+!;-)(R1R'U)%X4#E_I"9WQ= L,HP[BBO<3.*6,\S4
MJ1()QU#7?GYBG0'S>R;V?.540Y0#QP*:L?TLNP']#W[V@!D=/N<!+/)S'OD+
M>@!H%.:G/E/XT9R2KDF_Z@]XX)2J_9[+>8*:-5X4^:*)M_&R[Q=5#LP:T,Y\
M2<\H7R=^5R&SYFGH?1? !9W8A:(/##S![#391_I0R<V"[1XSF+6F.] \U!=^
M[E-FO3SR.J0Z6)<'LYJ9;/3]LJ\63U;^-_-E_W9A2TU2Y6.S"[0%H P#&J^&
M"F_>M/0U7.Q0\@_3 ]X#XO)R90<[THU\Y0X*"U[YW6JUV^^:J=/4-DRB:DK1
MN&^22:'>D^P<?DVJR7=_1 Y9R1QSVLP8H7I-=A:3_49D?[GOX PBOT=J#4;#
M.)TPV2)#T"CX#='Q:(WT(2PFGF)X*3FW(KLW)S\Q^-*O;W+'H\3.R6R>*L@]
M=J0P[\0;RRO&;A=V-KX[TLD9J:(F4E1G*BO>+1]^*7I-9MD2+>I?<V7O_>XM
MZ\)NC';BD]0]ESVMYZQVOLS86" :*&*E99]GI7-NPQ5'ID *BD[XGK8A<(D'
MDT00 4>^6H$;CH70H,A:F!X)?*.$5U'B\4W+ 5CLUQ6PKR"*C:N<&5^RN.-N
MW:0QOPVC%>FD?B\_8$^^;'G6!DVAF\[^MV--Z'A\3?'CX8/N:5?O[SBUY"Q^
MX\_JU;@WSB[1CX[GM4NY(?" EX+ZS]7AD5GDS7#LU>:M;\)&+X48M*N-PG]+
M^08Z'M,1I@'^M+UR+A[BVX6=%NKK&L0!RSNEO<^BD;L$+TZ)N:K0NSNOVE4L
M?]G:J70J,6-+WL$\8<W+<1,M&D&N93X*W[;C;[E+%'$S'U7X[MZR,5CM@TQS
MRRL5%Z<;%HG;8F^,S__L[*C9K>E;]/DQ[G&;L>O5<^EOOYQM)MR6V57H9R%Q
MG3'5-)+F4D/%BP3?FGT@EG,?5Z^I&%7PJWASS,FW[5M+$Y_EQQ:G6R9O'G.-
M]#]@+RPG0-FBIEW&=L56X]7D[D2R]IV8]0]KF=IT.-R@8?U^T4UD88P]A"]<
MAA4JZGX(2,S)9\6#W;I_+,(LI05W7-(P!&KQ7*!H%8YJ^:P\C47[<#V\&+@U
M[$WFTB#?VT+CP5[R R\_(7?4E=95+G<*)5D3=A)1]:6GZ0W98]#QY-7B'G1^
M0H?=;35;I0_@O+-LC+QXA^''M-K[H2-/LUL=[VIW>%0;AYH3BQ$C/CN@5X<P
M?-7H:<82@S]'S;5M"=KT*X;PBQU_GX!/4)OAEX$(QR1@N]M&=\6M;A=T74PG
M/G\CMHG]@U 6\2^;I@A1[^G[B6;]P_0/WMC(S?L+.[_ [T_"[>.F#VJZ%28S
M7\1Q+54U+L?'A[%4- 5:=19W#;]Y-Q<\W[$WT$W8U,7,9%?H!X&)ZL_<?/V=
M_9O8<9\EDM+\\#>?Z\DT.Z_(J87J&#7%<=$7C2!HYK&*_1,EPB ZWHQ^,N+W
M%='+@]6% GA^;"&0B.QBH>E"D)DSDO]8Y5[A.3?$QHH^FE1-'_WN><.M[\,6
MSEZCE..7?-V<JN^Y64T(>,W,VX=/U/C2$D>%Z-V78Q59SC<;F-&)'K@R#WQX
M]/BFPA+HXM#K_<!IL,4.XY'6\&8$[^7E62N3_4FX:O%=6L.KM&>$^W<\GVU-
M$&R4;D55&5][\TT:E2?.GJ:E#:O1'R?1.^T"/MGN8!7DNN@$ZTH\,NV?DFMW
M=Z]Y7"C:7)S39[-1B+ZSA_)%^]B_:99P>LQOM* _FA%.C]..:"H@2BKB_BR;
MYUZ#>\]5/W^5&9^[42WOJ\OT6P&1*]D/,P>?C9EA\<>_3$F@@]X@C!:(>D"G
M@8D2_9/4GO',I8_9)X(8Y6(AY'N$7V;A/IO?(%?&SJ([/CV1XVQ,#[$0@IL"
MJI#32M_05/<UY%R(7R>2QH_#SPEAUYH"(6= AE<7;NUXE@<K05 @K O/XGO=
M*J\F#S;<-?CA3-IL^<'(U]G?OOZ>/'HFP)CT0+G!RU/TM_#LK=3&WNT!8RTI
M[&E]Z85/@9.2]L.^LWY?SK4@ T6VFZT.8>S73W [O+2*2A9T\Y?Q1S^UU%U*
MXD87(AI^/:&?F#;^>SZ&(8?@UR$&C&</#WK_P#8&"90LW75KMT4)?<EU+U<_
M^!PV A(55GM+]ZYW7SRW<3N#XF/G<*T<'Q9:U#<TSMI9H EOJSW-I&UASU0)
MFUYY]G7GV,B(5,Z*],9+TOVO=P 5Z)SK_7@N!GI.% .+KM4A[ZAFL(BXV= 7
M/%@/:VAMHTXC\"&*(%S7:Y'OYP"*P+(.JH>CPS_8'?S$-*$]3Y$;=S%EH+-/
M36A:/YXH+]$,%U7%XQO852^LSJE\4#^H]7S:C!SYT>:!KGK<G%4'WD^VK<HH
M/IDUF@IT0OC4!!@_?TGRX]/];1V.SA5W\ %:CD;QB?3'<:2/@ DBN5PDSKK@
M(D.9=MKW_UH%Z<T-S6B9W0RA/9'Z@$4RJLYO9:R%LXD$JJVNI=,\]>3'Z> M
M0OP<%+3/"@>HE_Y/,LAD$8Z!)@ZL&&^I[:8K@18&6%*QUR+:-FTNAY/[&$7]
MI<8!"N09IWU/_D.P:>G-&<'.)2PA5I-4D\!IM0@V\7]4W %('+>*0YP)%>*C
MYFH*BH8E!/"9&X2NPHMUGG-UL*,@'S\Z0 C,<0F:N I^K7(Z7^<P8CP. =S6
MT#C(RNE#S\%N'JU;,4\ )JTGL<P_$$XO,,3I5?F!EMPHT'\4^NC>737'_I3^
MCXWH )"4># EZYP-]74A[_@:RE@>+*+VZC\%! G_E8# >A4HX?!KY0'^C'YM
M6A\V3]".HX.:0TART^MP$20NT#2_PH-%KAULK>*@S1;(XE>B=^3UB';M(X%R
MW!"J4O%]7\IJNC['$#[.#Y@"Y_BI-,;\Y%?[(#2<023SNW3-(Z !<4)&H*]X
M,04QD9'T"7X5ZO\#\< CAU S/W!X=:2'G5)*]>FIO[;%UKM&;;-R9+FG]HB]
M<+&TQ.[#!@2CNU-P;YN9#N4'/\8F8.>#9SI54S^6."PPMFX=-?H>\3HVYM$Q
M:E90>NJ.7<GKNF^G,)-[XBOD.@DS$2\SWF;YR&0^EN(L-SZXTCG9GQ;0\=/L
MX9URL2@U6P4]E?2V"27U^\_I5"OGY82'_;C^R^<$.LTM-34EU661P3Q8557R
MPEA0S7OA8:.YN98H)=$.LXY8,U*_@/V-K@ ?[X"'D\5'WJ8-,,M%;4#GN)Y;
M'#&(G?!@>,#Q_DJ+ P8'K0A3Q !J#>A RQZZ6W0+X._<;OQ2>\Y#>]J(G4"!
M=]NQ".^I45#3>ALE"K__SZ!$>^R9)VV[XP?NV=9J%,KD'H?//MB$C*\*];P[
M)5_@_%)"R4#E[:J3PXQ8SZ9M<DVYM0;3QC_$L8I*5$E<^:6<AEBC5OW15T&9
M*N+;8\ZAQZ2\M3W=HENZQTZOG"UT45:V&7:14-"$ZYM6'Y^>SOU@=.^ZS8X;
M,LJ+%W(_+>X.FKYQJDGPJJ[HAE>[3SS]>FPW+/C)^C37%>_,TRV[C?:J7(&)
MP]8_$2GQ5<.G_;-GCGL39[0Z\8;LG3G)B0]9PF^(F@$5V8_OQH4/XTTO)4=F
M%.NU)!W'E.V\N D^V(QABYLQ>+!;[AYD]ZG]<2L*3HNI2,:$K2#*ZLT3^+$N
MFW(*H;G;,\7ZU"54EE;H+M1,L_%QA.HEJ>!/718$! $[AEVZ2H$'MBSPNW=+
M HAQ?DD4OA]C#V %6 YC1+Z[,$XO(P8HE,S9OQFH]$9+E_E9"?OTG+=]>^*G
MV*$-C^*5=G;A<7J[]*0XS1,A(N7R*3XI=T8J1@C#5NYNO\_)&4W?'#+12DXV
M:WW[*[NMVKC,2^S./(QK[/;;*##\IA'W]8F<B< 1M3L+<WMYL*$@K\#YR,;6
M^1%<>(OKTIZ7YHQ2IH;-;!XGLA!4[Y/I.>PP<[@L75>2=1Q#M/-,W)OR)O7C
MO.P;>Y'\$D'KJ;,[)^Z)V&\JK:L8OC^O.#<AXJY\;[:ATV8]XNWH1* YV_9W
M_;]/*V;*%9.:YCE6^IHIZ*RF6TN[+6VUBHVJG7,R6KJOGJ/V]5MT';<9?9:^
M:7 0"1.8?[]PZ#,F>7;*,IJ@<K*C.3(_(S-N M:V,I.7_8)PW%,V1N98UOM7
M'V!;8@W_P-JT[[VB(B?[72?W.7=45D=6*V0/]OG&VPD+3AEL\._OMO#DU)U6
MO5_OMML_H85YY+A-O)#2YTJU!3.=89_B18) V9S5W(7-W^LO6<.;P7,<X8L'
M3IKN"DKH\J$FSMVN>&P?.?(R_*R[UM9"Q*L7>[%;;L*,>V/LEE9)2 81Z8U=
M#7P#S3"%#C$'1S*%Z.JP5MQDG*]\]J ,D$<.B$0AQ-1<V\#?+?>UUJ6(/<_:
M.:E605:>5SDZ@/?^6=IUS2(A.D?^!JE![[+M96I*VFF9,BEL;( .#Y:F5OFX
MYMJU 3\3^1/2R ZF)?)[U-3PW8^1K]5EXR@!78%(#TS^]6/;E#_GOI%C"V,$
M'97,OYXF>RI\(8>@>E.DO7SI#0W?GN/%[KTX(1XB;N5V(^J+B:^O[A9:E5:X
MGG*?4MU$LNL=3[/:Q4'Z&^PM?-'CM.)U>^+E+@IT];T#C]Y.A/B,F6WG%P\K
ML:,C[E_F*\;DCEF<R 6=TX^\FWPW^4IF8J6&WWS DD@EC3Y6FRANC_.;WV)T
M3X<T6,FT$[#8?4XM^G!JNQ9>[?AQ%S/EZ([5H0CLL\QW;3:N;Q./,HSQE0$-
MGN[<^E.U39YI$1&1&3G?;Y,;F\V^-[_;:A 5TD%G;7^ ?S.9?(*ZH1JUK=(_
M\HP3@(F$?R?^ND.V^C%[<-C%]XZ:M+&Y7DR+I<45Z^Y^O2/:]GL\9#K-+ TM
MS<X4EECTF(E)?WKRXWMSO\YBML'$"_T7=P==K [%1^[0_2@H_FS[IC&-[S-.
MB9M=GMW]T?':,B%\2\E:WQ3!'?Z2&3Y<?;X,O(O%\5Y(4\.Y<D)1E"I2E,A:
M7RKH#K_T:YWO0L4IT!:KC"I?M*C;,,AT5+PU?]^/O43MH\$G-7'NMS,PB\EM
M1]3RA_&>R:?)5;$5SP/V'[B9;ON0.(CU-J5ZP>6\K/>,?##[]5@]^0A\L\[#
M2T*2"N^U6SL&W>:%*F6#/SM<)QPMIJP/C2OM^(4\;'9 6MQLW_73>=M-ZMDH
MC536W^IAQ *ILOHZQEYSCC'[C<Y0/7+LP^L(^\/.W#KC>\9J7BNU(U?+8H#3
M2U..52J_%R=M^@&V^>PHA2&OW%_CJF+78O5\==>5T(T:&;>7K4]FUUZ.W' \
M-8!!2MI*M_-2PK<0URW>^<"#Z?G8#* N/K3N.J.XE78.,IGW3<#4$'ZQ5A'_
MJGY%W_%;S%(M5!<,L'-<HHQXH0%C?LKN4A!7FUWD2^18<[V^P?FFT$X6.(%\
M:R$1UBN4I52U08R8EWCKU3._BRF*)7+W")<]+$^M?.[$R)U(?N$+6[VIG%EZ
M1NR.4"D'OYU< E@KN/!@CZT0,"V']4$&M,6!:9VH45ST&<:@ISO2;W*IG2'*
M@]7(K3LGLO=YW(=H^(9'\',[8GU]W4&20G;QOV>W,NRHI P7"OH-&ROTZM.]
M$6+YBM=\TE8CA^R<TYB\69"QQS3J3F)P__K\XD0966.+MIU:N3KCZ$=5+E4Y
M\8I%'Z(LN55+HP*O[G[+C_16"._=?C 2=1*FW3[YJ8.357E=5[)@5?_-)JKB
M?I6KU$<GPZ:^,GWSCF^P&=ZA+VA#&%\$&N'^1T#)DAO/MHE(5O-K')&0M$((
MKCKRH[8H!G$)[@@M1>^]"#,Z8LEL>@ULUZ,FA98W/KML^O]4]MX!36W;]G 4
M%3N*8*$% :4)B%*D1HX" E*D*$6(= $!Z9UM!:4%J0I"4*27" BA1T6Z&'H+
M$'H+$&I"^I=X[CWOG??N?;_[_>G>FV7VVFO--<9:<XRYM#N766SN[3O@%[*
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M^$Z*%VAQ-MCBZZCQE /KE#GF?;69%+DIKM9+>3WWB7FI/[*."56F \1,8!J
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M/:%/ F:0QS!<'&J,KARJ?B%45P&^4M<0;FW* -%>=\)(;[&4T^[;5,ISR#\
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MOSU+[@-$?GLM^08LVFG)?=*2;\^"YGN!PEVH[D"@\.N&ZO9NPZS#(?LD(?N
M0XZ21;MXR%$;@6/+FG@W$<<.9AV(A!U3L8,WLF'==M,A;#>]O?)_@V!XQYJ'
MP)IO'R1_ ZW912#W*0)YE-JQ<SZ/&AJ_KO/Y]DJ>2UB6YO^\\N,1H8R,OWT)
MXW RFQP&W\* /Y;#/_F$O\Z-OUO.+_Y#18Y2B7U+$_A$_O@M MMBQP/,39\B
M%7J/-X]3,J<8O_C!.(Q)^EAO=[CL4:?'CE3-$ZA9:;\5Y#PV;MV&&_LS,#GY
M+"70KA\^X$\'=G)H(VYIG^ZQ,<L:U;;OJ_\<5?0>EW,;V6?8DZ0'9H6V$OR6
MN1X-FQB5U'_Q_Y6DSBS+DPE)LYK'Q?_46P W / #F'!*G92K,/O1>^R1.!A/
M_/3''#]=^Q')KL@=B6?D*SD0;F*:8Y$BA6\S3Y(=X9MU!*VXMI&BQ[;=T/%L
MQ[.'%FE["L\Z'<\N\JQSA#S[]MA@ SUK=SR[R+/V$?+LV^O9#?!LQ[,=SQX:
MGMV:9WE=+R!R0,([_S8ZD/(N>\VV;40]&FV[ :KM.+?CW,/$MEO'$-XUY[Y5
M&*'3N1W"/4"%>]R1A UXMHO8[HVJ[7AV?>96E^KS]$RP+M7G1;B5P]FOR1V=
MFRPRA?K-?\1I9=_C 98YC2+_-F%";X]24JNASM-JRP9WQ,9<Z!%M<A&'>8B7
MVSU61*52X" *(^D49OKXU9^0JJL_8.S1X^=P2*Z#$#3+4FHOKN#EL/:1A>R#
MYI$<AGQ0Q?U4TI>9LD^G_3/E"^6U:>7X2-J6;D=2W;CP]5R,52O_:@!?DLYD
M<0. 7V^^0\.S0R'^$H(ASY.8%-UU<OR:<MQ"_DZ4.ZO<"70GT)U 'X1MON@$
MNA/H3J"?*]#S5PW6Y?.9MU^\J'QV;G#G!G>2N:U76UP"VAG,]R*3G<%\"[%\
M@<M;S9T'FSI3V9G*]RZ3^Y,2PE&O2P*&>LU.E#M1[D1Y6]0KG\GF+E&O6;N8
MLQ_&?AS FBZ4-:IX/YWB_!NK]>P[ZY>%%)HG65_G%;-\O67>'8I:6F8_3/_P
MHQGI/98__B<0UT^#\>-G<D>B^4(;19N+>#K+,]I 7M"9Q\$Y3Z);K61'.^%V
MI+$Z7GX37IY,2!I0TP=C[WCXQ7FX@=X=[](&2J>'M^/A)U3YZ_3PZ_*RM"$O
M?[_^+;DC:8P/"OK"JF1V/+!'X!T ?8^9PZ77Y? M5J/C^ZWX_NCQQRMS=H<_
MUF+G8^*^%[\ZXZ 8X,#*6K\2=#P^!NBLU]YZ'IWU6H.\CHG[GH"=CH@!-E5>
MG<NY3ZJM<SE?S^7LPH9OXWJ^][#A$2O<3KWMRX[>>^:RP]OO.U:^?]>.\U&Y
MJ59M6;>Z):Y\^W,2CW*23K"7I2(MUR0.DY2^?5C<L/L;V3;X>!-):Q6%%FGZ
M*CRXX[3Y1=72\6#'@X>E!Q<17,>#3[NT_<!Y<*_T8,>#1\F#+PSSWR<7'<E"
M6MU"O@^K8'4!IR[@M.\!I_WG^R[[YZ 9X(BU5*<3MF*)+@A]F,O:Y?GMHZ'H
M>/=U>+?+\SMR!NB.*1PY W1G"P\Y#>Y8P7A7VV ?U6:'VO:5=[LDY>.L,;/_
MO-R=\=YOA-'IX>ZPR.'S<*>'NP-_[SG&V?F!79VP]\WA[U^''P7C'?TRN_#R
M'2V47)$ ;W*>5U1)2L)1[#T$8ZRE#+_>^^E@05/])QF,PGCDD@R:LB+5]3Z*
MOY.!G?&FU1</BVM6T:RFI%80;4=:JIGDU1">0/-#Y>%ZIF[/CT"*R?68D/QS
M$BSSWF4^)JDS2U,8]N?0OPVCFA1WHO ,46@C?<6#*VF_(SGH!/+M,Z[-SJAT
M1N6 >;AV@]$^LG'9]B(.D@FYSJ$U/FVW=U^3. $*P%/L#5_R'J:PV*23BWV4
MBPU&LH(%%NSN&AYX.3G=GUN-ECR>;RF2)'_\!L@EM^.!]^]9.,4I]AZ73@?U
M9VD<YK.40+M^^( _'9B'^X39UJ2H=;J'ZB9LN_!.,IG.<I*6;=[QJK?,]=B6
MO#<+8;;QZ!VO]/P4#W6!S2T7^!AD^2UD^(6=R<W4-D5< <*ABQC>'($%>\\6
M>]6$#W7QMU7@G7R_>Q7^F?@9&2?1X&(R39,[=@/F.U[N%?,]-NGN5/MKJ_8]
MPN:=W+^NW.^1RN_<L@-1[-LN<!=C.W"+OKVSUL78#G#)76;'<:,L2W-<\0&
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MB!W2O.DIYDWO1&ND[5J#C9<JBFD"HEXH!)+]_.+B+E=9(KKCRF8?[:D%)A4
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M*3O! W*',6LV4QYPCK($41X,YY8P^\K9/,MG@R*&./!SOXH08NB7 "DI>,+
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M^3T@@E-J',$*94G,'/A3@?C9(^ZLT0TMQ"48"*BJ&^8IB0=9A3[""0842#/
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MVT)Z/*OLD0S*-'O<F:6I+[0T!3/=R6D=PO*-_8D_X*4MZ$--$G_Z\7-Y]./
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M8BUH6/RS!J&#%8U0=U*,?<8P-MU>RD@1:6TE$:]42"MEU$O.+A2A9T>+VVM
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M%1L=GI:V0-^F;U#O-'),,:?9G/T@%](Q06H9-?CIP&U\D2QHA%P'^PN3%*J
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MKA5-C[D0NW*;\6)TV)Z'VM809UE; ]U^4ENQ\+KN3^ @.CD>,(M1B)YAVH/
M%@[TFUWKJNS*=423(;2!(__N'<_73U-.BD#PC)*!8HY:F^;"6(D.NW,"Y_3X
M<7J'WK$3ESPGKV$H<41EM%4+A6D G51Y"\IQ%RYDRP8'K^!_[<'#( C66VB
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MLA^3"Q?3A>YL8<N<E'6T"L3J/*48NO@ 3XI5NLY^,Z*D:QQA+J/T]:[N/2'
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M E>HGS>IB@3"XCP"L+96[F.OFL$)2F;@)%??XY)01!$2MA1UVJCG2#<<[ZR
M[-&$FH;"Q%WX"TGT$0 GT7$48I0ASH,<%,P?^SJ_YNSG O="@$D1T'@1!&5>
M,, 2$(HPQ<4P%,Z[ZSN+;J'U:ENCPS W#Z1LS:(P22TE"%K; )W7RQD$3ND
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MQ=C/@^<\>,Z;/&==2!^+X<U/;JO"'"3:^!Y5M@@7^YL7YHV5%K$O1NLC/K,
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M9_YY;'C#<(( FGU^#O '/Y?GGOK',#>RSRXQ1LFYMT;\H7,=Q9IXS'Q>-EY
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M7C;;FL=;]-A2V4.1;G1.7'B)44.H<C0^T$FPNBJ6@^Q5,HV(!8^LL S/EHQ
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MHKQ5.CU$&[YT&#1(S!PPDXS6)5X]A;MWO7G6B=SO7+"0_3[6=:^9^ZKV;;3
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MB?,:1]X+"ZVC_L&?,?B(\G6#\U$Y#"U*TQI%ZSUQ-(0OS*M1"S+&=$VJTO^
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MXVSK%/@JMBSN@__<9H81]@V?<2BT)N[X*4_F[0SP5B9VIJ=KCFS6RH@R^YF
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MV4A9W(WU1$:_T]O\^#1Y+*+N?+G9[590J%:L:<I>\"SMQLF#N#M?7X:WO7]
M BDD1K,GMVP'_"YORK^:W(1!_(@'0.FLX^UVO)YT$*8JWW.A/?F1M?X4WCV.
M*J/^9+U0,M"1M'$>TD9),22W0JW>%X9L\XT&=@^3P"Z<)[J9<C&_2=N[I_L2
M+P6L%DJV\SIOW7U#8 1$$5_I?%2+0H7'17;QK!DOK ^M_8:M]?H2OYQ'F;;?
MS<-T#]-\+DE>*>;7O9"B\K,0^,MO%"@DB."QKR>$$G*+BDK[04D<OMJ_"9@A
M*3]Y& ?*#]WD2\Z$$Y,:3>@EA?G!D+7,P&P7K+^*YFG3^OM\JTMY9]5$9N%
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MFT_<'?S[/.GI&E&2;[DI:ZR&F\/&IQRNWC% 94S=DO,D=;& 8VLC(7N3"M.
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MW/];++Z17.CC'C"%AY'%#85K!8\P.&3?<48ARPC4Y:F[(QQLK+YGC?AIL6D
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M'"EPE#([:71#H^50T\WG9@M.Z;<V=-?8XQP:%R#4Y7'F.&@/ TZ/G-"Z.<K
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MBXW?%@"WY]20&<(DX@6>5!L4,J.3HE*R[L6X%N,Z:5RIL9U(4P2NPMG\)?'
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M$,5(A0E*3J?B2UY$C3'=>T#U=R.38?!,E&=8N'3ZFSREZ=X0SWB>#/;EFYM
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MOPYUC7G+Z(W0XMXJ4@4U$_QE]"X!' 12B91[KYJ>BK0D_E8-7-1 <K9OXSV
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M- 8$\J(T+@88.<UT/H:S)(,3G"QX&0+H3\#9 G4BN1J,#0@954K)QLV[VP&
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M\BXRH[]-NWDBN>7]-O:&]Y==@!9Z'5UK7TO5U6 93C)F/E$RJ:E[YRN>-=K
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M/SN-/""E"!,B 3!O#&7>CR="=*P$>!/1"H&^M1LPX^,/ES&:PI+QA^VC.KK
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M\/U"EX0^_^M7]\%J]52*J.GIW<I,%GZ4 -YPZMT_#_@,8,-;SRYZ56[#4!Z
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M'I7\,42N/+,9DR!ZC[EV,\-%QAI8.3A=#EB=,?&Y0W*CWAA9AIP#/A5?2S6
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M/!-U<(BI4ZFUF%/^.Y NC)8A^=1\[1I-)$HKD'5+2_K/#R:_UE,BX IKIY6
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M>8!++MGC((_IFI$1,"0:$(YF!^.$4'B]#!PK;=<0 HF*%"7Q.+7A($K>P5W
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MB@>#7G($()15?J5M-MZJW!PIBTM2HRV(1XS>\[QSNUIFV5O<9]@>DV:;X7D
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M6;J6_EFKP%EX!-#Q2U]/O(LLO.1QU$P;MQ1.7/DM=^;(.Z$V2OLS\\ \$FJ
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MXA/LV(8;=9NV7]D=U*HKZ1VA+SPBCW*2GX70<U--SG--9:3/6V*47.H\R#=
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M59KJJ^)_/S18P,NT;3DIBMQ!/O_N";/=+]=GX(G)UE9XG!(B:XJX4H S@#*
MVC"UOJG/; !5<:C$),X8"!ZFO51CL^CXXF\C/@XCKLVEV/Y6JE*0<6@<69*T
MU:HX,F<.1AI<UP#7;ZUVN8+PQY[];RCAU"BA.RA7@\@0@B&$HR*$?M<<C#2$
M8 @!#T8:U>CH#T9J0]\<C3SBH&BG7":BB8D:0.X&D*V=%#PU@#2 +.OA-( T
M@*P3(,L=L#2 -(#<&2"/2H<\C>CN1QZ;,K>/T.P+L-L![+IA,O+Y=A6MZQD2
M_6X7Z_,D<NKK_;):5@7\[B5K8D+BACG4%!R&.:RD#90L&KCUHARX\]RP$\-.
M##M9B;15T<S,<!/#30PW,=SD;;]7@2_;<!/#30PW,=P$LX ,-]E)FM .(Q\5
MS.D76W@.5DDH^H_9G$=,3.TH311ZN:M))/-'7.Z^%_"S*:>96>W6][D'G,]C
M+,&,RYW,3S3*M =.G='6FB<>)D?>W;0KS$BP=N-BVN]VGG" V)#NB9#N6ZO9
MW;X(S2-S+ZL;[0,$)WI>WQ#[J1![J]DKTX[!$+LA=D/LAT?LYX;8#;&_+K$?
M+3F_#L'N)+9:BF!KZHE\]4S7"F9ZBSY(P1+!71:'S EG\R3F;'2,;LMCCCR5
MS)HO$U%X!?VJ,KXUW&/ZZ2&Y!0UIO#II[![\@\$KYT,9>!MXOR*\^Z7*L1IX
M&W@?!+P[KYPQ8N!MX/UZ\#X?ENJ^?(#P/O04IBO/3V+N'ILWX B8AXF7G$B\
MQ&I:+9/$9$C7D.[!D:Y)8MKVO,@NB&%U\5ZR,H97&%YA<J ,KS"\8O\P.6%>
M85*H#*\PO,+PB@/+WJHAKSBIW"[W./VY)DIT>ME=[5?. #A0?ZDAC9,CC5?/
M_3I4TGA55!R4>6 HJQYI9X:R#&6=!F6]=L:;H2Q#62=!6:^>;%=3RMIK*MXR
M*2@_2+L%5^[3TWMD<TU90.<)%G!D\SZEN9H]/OZYFCT^_KF:/3[^N9[D'C];
MT:Q)9[3!2Q=@L&5VP2E$)*SAEAT,7^=(E\.#F$?;@H$^+21YC4+?A2=<"!:.
MV15W^&S$([ED':M1-[ML,U4,7[H00[T0=/6/7@R/=3 !XR9@<(OOA4&IWH''
M1!5/B8&GB*)R']8+*IWOC%3:+6MH<&%PL08791QWK[X6!C3U DV9IM<&-"<.
MFC+!-P.:$P=-[S#2:2L/,JU9C4O0[G%#;,RN_<7V[<#A[';*><RN[-C^T=C)
M)4GKB!?A9"=N=M_LOMG]TYRXV7VS^Z>\^\_3CP]"#0:MUQ;3!G/@7\;_2KQ[
MVP=K0S28'<#DIF$4GX'M,6,S._K*8QO3P 1W$GB4Q\5INCPKGU\M#\YN,^[J
M"F<U>IU.J7S]VF;_&@(P!/ 2 N@,RC4R-P1@". ("*#7'1CX&_B?*ORM=J=9
M)AAHX&_@?PSPMWJESL'7^(32X8?.WOS\1QA]A5<RQYYCCIQQD)4\Q'A8)?^M
M1K\U+%>6HG9%_0T^CQ&?W?/S<OWB##X-/G>.SWZK5^X8MT&G0>?NN2?PSE+E
M.PPZ#3IWC\Y^MUFJ#4/MT'E4P>.[$,P_9@O!XQ,-!C^;X.I)5^U&9]AKEFE.
M5%OV;D"U;U!9C:'5-Z RH*H25,-6MY1M;R!E(+5A:MU6NY1!;B!E(+5)GQJV
M#TOPG4; ZGV(0\(\5M^S1YY?-GO5N X.T'70L'IM$[8R^*PM/EN=5KF:Y :?
M!I\[QV>G:\)6!IUU1:?5-U$K \Z:@K/3+%,5K'[8/,*8E8A#Y^LT]%T>B?_X
MQZ!MG?]$YQ_C!W::CI?7<[:<?%;S8- V9UH,_$\5_OV^.=)KX'^R\.]:PU*I
M3 ;^!OY' /_VH&."K@;^)PO_MG6 )QK_295_TN_I7UD,R.&^KQ;R7V]:;^@S
M/,/1G]<,X<Z;<<$^\@7[$L[LX">V.I:BKV'AN?'TQTY?;I!:KI>X)HJ+]T@7
M>WI_ ?#60+[UY>LIDODCSI)'!G$^C]_\_-;"1@/)O 3=XN.?F/$.\'/+.?L8
MQER.M\WBD,53P$>^J.K8"^S \<C] E_,L-(4\P+VV8YB=G/38#?P)1M@VXEX
MZ@EV$00)7/R%ST.X8!Q&S&8N%T[DS6,O#/"Z,(E2A\V+Q_R%TSA<=AGZOCT*
M(YL>>S&). VN](/9PHNG[+_A1_^!O??&G-TZ'@\<P/W[]Y=46TO]>!-Q'S^^
M]V8>C*3Y% 4:JMLIU;4/FNJLUZ(Z?,>,Q]/098F 5\!KG7 V3V+.1K;P'$*X
MZ_D)OC_@,?-#(=B<1TQ,[8@S.XXC;Y1(,,N;9V%0<,H^20GTM11:].=Z\:AJ
M9[\,BZ6\&LM2G?Z=1OHA<WO"ST81M[^>V6,8TH^VO[ ?!)+6-%*SL9GG_NN-
MN.Q<#%OMR^[5Q66GU^NU+EJ_7)^W6KUW[RYZ5Y>=+MYCYZ:]:1E* #!W=X$@
ML>$6W>T%H(_*S_G'!V$TL_V"BF6U) U7QK&61BOYD]6">:FRZ@YR\;G@/^H_
M5B:<,;DTY-1[LYFGR5?@RKU9(?_7^2T_J-R0GP@@;:IEWQO8?6M0D<6ROI:]
M>L6.U545%U,OHQ^+M=QO[JX_L'-VQCY<?+SX]?K#]<<[%>6Y95<WMY>_W][>
M?/K(+CY>P?]?O/^?VYM;]ND=>W?S\>+CY<W%>W;YZ>/5S9V^YLOU[>_O[^B2
M3Y^OOUS@#[?/4Y9?.+,U<V'F/_.?^:^N_Q79P&/B=XFM#I8X[V!)QG8JZ7(I
M/^+E63^[.U3SW-!)4!=L@"[H^ D.@_2Z,0C/<(&?/M@!*"UXC>*=@EUYPDF$
M0#405;R+P/8?A$>- M^E:N9E&+A>K*\!(ROQ8[KD$VB 9&*)!JJHL>T% A7,
MA1VY9WX84E&AG)(:3^V8H;X8A#&;)V J/3 8>AQ&*/18Q"=P(]YSQ;]=AK-T
ME*"R>G#[;'7\'FB#@1K!B/L>'\,?_-N<.[$<F*Q[',,P^<3C-#JY*DD,[V^R
MNRD7_+$QCVW?)_,/-&RI)ML!7J*TYC$'H8FJ>%I$F?GV0DT5;<&8%&+Y.L;O
MZ9DP!K1SU9>9/@_+.4;%"PS+)KL!5(0SCJ6<.4SJ(4S@SP T2ISP^.&Q,8\>
M&";'>P&(U<D#$XDS9;9@N&KMUD\S^Z%!?UH_Z:\6GN\O?R=7<?G;.5BWR]_9
M,"#'F\/KEW^A+;E?^1K,=&^VYG+:37?EE2'ML>WK[V'YU$\(.B](>.X7W)0
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MIX;K)CQ0^KF:6(-&()5K]FN_9#ADG06RI9_^/_YAG7=_DJ[Z\D$:5!\GD0H
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MBZZT87X!Z"?<CLAO!D]7H):8BVQY%[X'=A1I43L>T-LE;6L]@!&?VO=>&.U
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M$"X"FD:68P)+F&WM K-;,'%$>BJ\I12;-)<&UPT5-HZ:BLO5WVH<<EWP\7J
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M;="CHJ^@HDY"6(%=,ON*0)C7ALC[5X!/;FYZKW !2VU"&AZ0NA^ZDQ\RKZ,
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MV]*<+ENU3VXGUN&%WM(O.4A\Y+$ZHB%WZ;]31J(O/P3V,,- BZUB_*C[DS6
MV^B&R2@&D9\!>IQQ/X1RB(X^E1](UI-.@0($*:>59BYI,H'.=U8*$,6[L[S=
M-,%7HI*.K"X]:@UU9B:KC5Z,44'VJ& 0A<0GF,F!R;&88OXW3X>5/K2! 1V/
MRQ 5L,$))DF-R36>>Y^40P!IG4R9WI9+':#BGIE*)IVB*:](HU4J\$P"%9TM
MWFQNJT3OU#1T\%A8K-=;FYFJ]M(G7),G]FT*O"U+!QEQ/#+G8DP@5H5&,=0@
M%Y<BZX47YIQOP&8=RI$!F2BU6&1GV<$U'=G/G;>BH>8YR@9@4((1.3*Y="ID
M>3N49(>*"Q?:8;CF3(!8Q1II"A[IO(? 9*Z_.3(_Q66?1L"/8?3L1B<AU-[H
M3$>*[@OB\FF,#%T=D4P^$Z1!8<H0;"[6ED#R5;KA']J-F$]EDU#0CZ:CK;J2
M%1V9Q25KH!5#ZR45.R<"20JOGX2A*\_*1:X\I$<2+?<\&.#ZL:BB2BC%X'/@
MJ$@*II;EQI;F%ZH'>NJ<@3S&(H^@T*MSYPCSD4%)+8D DT-JG/H /4S,DV$Z
M_#H SJ(S6@K'RK-TN"RO""-]2& ZNRM6\;[TV&G>-9R=-O"]KT#,TU"&%6D)
MY11H987#J9S:;RE_0Q,_3'(GQ#,:)8?PTTQFA;L ;:N?=&T.'XN$.P^.3P>0
MU9=Z@EEH+\<#EA,8<Y.%E7/E978^N:> M2R#,64_CM*1)9@HG\C)DEVE$#L$
M[G(34&+EG?UM^=!8#9E)WLJ0**/!QSCXHH-:']OY$]1?08>G$0:R^-F"-%L"
MS0A-!,H4OEUGU7DB4TB\8IHSOGX11KZ[\(C2]4!DNH>@(_UW=%S'=Q*_<)@"
MKRI:M_>ACQ2"Y>W2(^?%:G$ZQ2[+V58GU><^_R:?B)41Y0&XB7IA=M(K98[$
M112#R2"N1Y:^4\XD%(I\E(OX!GTQ 2GU,KWE5L4+4P\7W";/+>56'3@XG:[)
MG6'1X2&R;,!.Q_U4GH:TB&3V]A@4PT"?V\.!11S&'TC=(*>]256J.%W@8[@S
MI 7P;[;V/\@IP:.TUUNM<7Z':;V)4SFI7I)NKG0AYN G[4I9HT"6ZLN&DV.B
MQ&G3/,ELG'EVDPMB2ZUY%5N-(O251=E0F>DZ8Y=^*^96PR>5!$+&M*.YVX3R
M-#T9Q+9);Z5I%O.N#ZXRP!\J,*]]D@7/TH/$'^8/4 JHSHS-+^ FCY1&J<SB
MS80VWH)F,\!&MK"@PB(SC.='#^E9.9G1'B]0&!;.].F,?$VW^#CD:X^<YFRR
MJV>,=ZV'C"80R$QHHBN5<X#5*C Q5D_R@=LRWUM#!_UO^9=%N860*=U2=4(1
M^"1C1=TG;]^1IB\[*60^N,R4L2=8"3=>MTM*5R23"RO+9A$=R4SNN=*;5 53
MCHD00?$4!0#B3^ZDE@,F$=$FA.%717,-ILIM"&77/31T$4<O9\; #+AC"UG$
MY&+M5& 5\@E*%'24:=?D*B&V\2 C,FA6R7,12(XAV79IJ=0U^Y_F5Q?VXH+F
M5#I7^ I,74RQ4$YD5>ZA].,:J1S0S@:T#60T8=UR*0FP;KK2 L5_9-N-PE'O
M)>L[=P!Z*:54%P1"GT5*SLHM+KEMR!(,H/PMU0^RY2G_5!K&1,:J2"D>I]5/
M 61(DU4*D75SH_V2+A.9#)\>5"'TP<#&7IS/GU%L72<^*2BH-QU&\G+&<679
M&_+]Z;FJ(VD;%!+)OVP6+T)YCDQS<JETR5)^] .5="TRF/RCM'(1+3,P^3UM
M1:9RH-:05Q&4VT$6:2 6G7(<S5LH^.G8:8&EI^A[98 ZX4V /B!)A'(%;#S-
MFF=< )[03[1FB#D_VDV,5J_MJW!<K,OUJC-R*$#P"$-Q?=- SMJ!PO-''-^Y
M?DSD@T9/EIO? KV_J5A3F%9U 7P\IPB;EC]/I!>*7MQK?:\'DKY?<S;Y>BP9
MY9/S^(529Q/*5"IN+D/#SB69*1]B?@_R!85(M\)C\,4* 'D?F-3:&S(6+N#Y
M$C$R%6U).<U51@ [,Y+<A!9<G?4FD8U2+5N&]!*8A4APIR^+'KC\F4FTFXNI
M))N6Q5$UE36S6CE3)_*'ZG15HKP>FR9.K]=-R>7W57E[:<0Z%")?+6V'W'NE
M<U2Q^VPEM$XC/19SS=OUR?5ZQZ-[=8I'[\3U\![%YZ6N.H+G^@]!:BV5FM<D
MXH-2Z4NFRG$818^<RV> 021_/%:H%1#8/;#_*/J7LF7%>;V,.F21JAS5(\@S
MQT6F\A+?C>TXD=8NVC7Y6#60"VH*2F/P'_+Q![)M,Q]!ZD8'0J5S.^G)X>PB
M4G[(H6:KPY(H7Y96 =FG/@1*Z3?J-*%6P!2W5\DH:065A\P;JHQ\Z?_-FV[D
M2TTY26J/%<)0^LPZGCZBP\#>,XO_H&3WEC/N:!&6SF33H4AZ%1Z6I+3LW/3H
M(*+6S>BJU9EF5AE--4T$6IDQ*OW9A$<)9=FFDUMY73H8?._S_%MKTS3TX79[
M>>]SIT,;^0GI%Y/3':0)AI1SI/"2]VCXR8$N@0->42SJD[F]E1-PA I%(>"<
MJF=:T_)FG,RB@@\XNT&Z/T1VHX+C6E]3ME6Y"H1$65S65LD1?X[B927'!^ES
M62I/A.FF#YDW1A%_\4SKFO<_1TSF.J-H5?-Q,7E 1?9,8?^-%?2.NT#>VK*8
MSZN%9^!]#/!^JD#D(<$\W[&QH#JO 7YV,J7JUA5/S\Z;39B(G'^]L=$=B!6'
M8@_TJ//FG_/)&V;[\89?U!O5RSI=V"X%[?Y K?(_X=FG2)KM_I.TV7FL>.OF
MG\Y+W67>M=-W#8Y_\$]W05<L?!<<&G-,,-W[QZGG J>HPA/P6-/SE(PMJVSW
MX1;]5VHQ-@JGE?+9@Y?.?;"^Z>X=V';W\HCT5+#K ,\*Z5@1ZUB-E[2&/T(4
M]$\"!"CAV1G5FS?[?1K[/9#[?;Y)U=P7N]^LL@Y?.OGA!M_UVYN P2T^VI<_
M/(&'SA[P\-P6].H5^V$7>^,3+UB+?3$1 YH-/,> QH#FI:!9)Z%.22,QN%B#
MB^]4-H1A*)N!TS; 607.]_L&3CVP89B*82J&J;P"4WFV+;T:W.46=WG_,*)>
M;WZ^R]?.?24*VKAFY?!1U5)\5V+Z3V[_8\M0:K:$C2JF:S6ZY_UFJ\I)[W?_
M5.YE]7MXP)J#H=TCI=U6QVKV#>T:VJV"=H^./'=/@>?6H+E\7&"K61D2,R1F
M2"Q_1[?;;2Y7B#0D=E0D5NG$7P&1RWU *YECME';3+(J#'^_[VT\)/P:$;%?
M@NQ8G:9E1,0QD]BAB8A*-9;#$1$U33XK/<=?(SQO.8_"L1=O&5NI)U"'':N4
M 5M;#GD$C/# (=7O=YIE$@P-I RD-HG38;N4@F<@92"U86KM_GFIR(F!U $9
MV:_ F<I$S@]'GS\!T!TX'[/.K6:9S'S#QPP?R[O0RAB!A\/'3B21[Q&'YJ>T
MNI"J!O@62TD]=8#NR831PW++6=UVL]+@36VYZ#$[BH\5G6^M0;]:>-:306]@
M.@;/QX9GX+:5)D<9.!LX[U%%;@^JS;4URD/=;+,#0^1_&C0>.!J/E5>^M;J=
M4FXI(_L/&L_'A.'CX*['EI&#/9ZK]&#5$WM6RS(![YKQM@.'U%NK?5X*4\<C
M>0T(]P["7JO9-A@T&-QGYD][4 J#1K::B/F6YH&!D.%*FR3C>;]4UK21C#7"
MX 'B[J#86#W3>)9!IGJ@M"OJ?%A-2< 361"S" 85!A4&%085!A4&%0<6EZ[Q
M@IA%,+S"H,+PBB<7Y-CB[;_8PG-8L!QU9W,>,3&UHPW5H@_<&V<U+1-^KY=O
M[< 1]=9JEBH*9/R[!H.58;#5[&W3Q<M@T&!PZ^A[LV?J3=4+40>(HH.*6IT
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MZ1$Q=Z9!Z(>3AP9S8'D0RRR./-L7#7C2)(%GA=%#^O0&^RL!J,</S!8BB>S
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MF;-$E20&5,'3F2Q"HD\@J>8Y]_SL ?2\.G'=Y?7/FZ"DMYZIAG'DS4CFVY7
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MATRP**AM>$$$RX_+U]!_L4D4+H##1Q)P\$E@RE(T\0)Y,VJX.!0_1+#@QBW
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M=2'2+5*T2\M42CVYL;'6/&$%B]_GU5 E"PNY(62]"4^08R9U*V4.7^E2UZ-
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MPC95KEPS511Y94LCI10[5Q4)ZIM.*.RF#'Y)O["25NY9->M. VMJ:FY)'_4
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M@-IU#A8'-W$2M>$Z,+*CC 20"O1UC[[>@M3QXV@FB-@5QWYQ?@T[Y'N 31G
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M6>8!)NTZ!VGND]&8&U1@94=927 IM'0"^KI&'^#258==E'5>5W*'7=L'EVJ
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M_-9<YSZI3DYD;1,DR')VW9\"?-I9Y@$^[3H'O_M%BA/ZC7>5A] I >CK(GT
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M FCM!1L):!6 >T!?Q^@#T+KBOVOTZ$.=^N_YR8<L=[1/&UU1 L3:+LD'Q'I
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M =+<TL7>YWQI20"DV2[Q!Z3YWFJP%=+\#44H\4. F)WVC !B=I9Y #&[SD&
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M!4@/D-[V3K.X1TY/A)Q>ZX3W*)#>'D*[4TY/T+D_SV[/[#."^>@7!4GA\\.
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M[3@,@PA\::"O:_0=J2\-I *I0&H'2 4D5/ZT;LZ=W]R[.Y?[W;VX<&]:*A@
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M-1)S-0\BC-8X_&^&"7S= K^5@@-QX1^(F_H84?B+<4"6##)H?X31!7[0$PE
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MJL(!8ZJC8JZ8@9S1N2+AI-DBPG^G83R$(2_Q$?SBLH^5GR[A2<RL*UX'$V*
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M>=Y0+>P]":ZB*YXE*+S@X"7+L&S/D==XDVRFKT,_RO*T.YWL0\9 )5& )!\
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M\K7#OG7+%EVLE9*CBY9HRKS!MH+Q),GAK);^D FOQ6S?88D4^6;/ &AKIRU
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MJLBK]DIKEY?5MC$G5S;$]SF;HIUJV[=H;%ZO'MUSZ'&.HK25YW%W/;_5,OJ
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MJ8ZIV+;C86AGVHX@:+)IR)HC._+*X3XY1WYC_,#*:RYQXQWBH(K0[)%Z.TM
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M87RL4!HS/O<KT2*^7R]KJ0$XPNTQ9&N,L5H*@U*9I9RE=IU_CD7VY(KRXDD
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M*L2U-BE'1@*!U;W%2K5?9--9X_W& U&_E14&5R@Y&NBGB4,(0"L@!078<BN
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M)$P1 !GGR'!LTL;: R)3?:!HF,IE1%%$T8L"")RUY:6-Q"FR*B,IT-PH B6
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M=VJ!YYVAKU"-1@<6CA6)'5B,K#0H)' 1;4&=MSOQ&)+O6^[I2AWX"SQ)A9W
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MEF('9:S,K*Y932Y$0FM7FV)E%1=$G7Z\Q0JEC\03*>!#";T32AC$QXLA/21
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MUZ3="OD8A8[+OW5&4AU5>W^N_;VXA3]*,<@YU8"GP'0\6*1^L)R*'0%4)N#
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M$NBKE%-;6YE.EI+\)@>=2"12H/I"I*8<9R-M.4<Y7"JW(]5HM6IL)$QGC#[
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M4_RV*/\\'5!)<#KBO+3H&J!/2$*XJ)WY_-:BA^"3[6NPOX"@X QW3"G<8N.
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MXV.;(UE><=!AI$GX;__ (4^6XUH(]XNB1JTBFZ+1:4YV0 J,17+'.W"=VWM
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MYIH;E4/[<[8_W50@=W]UH/T\XWM[E+^K$_LY"Q$^,P3X7MNEBNDFLQ/#38+
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M,)XE<40Z-&8\0W%SHF6U=@EBJ':#<J@&HFZFE1AC4\+HM(NLRG<TA7@"_9A
M/Y-BB;DIAQ#0*VLA^] 2O/X>LP;H/6W][,A!KTJ41D$4Z2F&E"9-O+K+K(TP
MK[?@7#$,_=P[F5KU%*(9;"0O8",9,'# 0$=O&VW;D6,$49H$/OS+=X-8]]*F
MT;;G;281OTH/TD:X+#/9<1MW#R@XH." @J\*!3OMT\(P"NS8]'T]2G7?=$+=
ML10*N@GK$PJ^"D_9 ( #  X V'< M%H C%/;=UD*6K 1)"SUW%!O 3!*-HO&
M/;LST!B9%GOOFBL9_OY28ZJ9^OX8S^Y,9B.Z=XU^O35N[WXF.+"0PFE)\CD
M6?WIS&#',8<>'I>LK08F/WD$G^?CZ7+"*V61O+W.Q]=:5G+MFD\GVF)95LML
M7FMUH65 XY>\1'/EN)@M^+RB7DC:8@KOQ'(WQ;+4^ \^7M;Y#1;#$<\"YJGR
MJM9F63Z?WFG%I39;ULMLJET"%5;GVE'WK;M+YI%LUM^OL9K/%$XR-,82I6K5
M<C;+2KBHTBY5\2BUA/5U5FNW_"G&7;@5%V;O78SYF$0H<3Z:QD@#D/+V?MQ(
M&T]A,OEE#J//8;SC,0 +S))KMWE]#3/DW1E=*W'OT_'W\EX0ZKQ@A6'U-4K
MS]T1S!&3IRLO-'1QBHGM'?/I5/[Z_W[0/]!GF-E8?=ZRF-_S&1##%WZK_5;,
ML@UIYS:?U-?P)TQ=@C3@[S1;5/R3^F-CPA\:CTCC,C*<#[L=)N(=EO]?/W_8
M."_D^^_Y2=_OMN%E^[SL1>-@=C.6]U2(]![O[33L/A4S'@,N\/+0J=.G6P$J
M%\5T D]  5(C"5+[AS@ L)Q@I?U>P=#Z%A&UFQ+\IRZ'KY:#KOZ4U_#8,3SB
MX^>Y!K=,L6OB3Z_0(?X<-$-6$,WH:6C$>PZ'>+;=%RO$!A)X[R1@#B3P+DF
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MMVTQE:M@OH,SR&XQZ+IC#0*@10#FJ_@*P#:%Z8O?53(,80#P/+SS3@&8!&*
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MJ-6W?'I#N8WU]6FRM0_,]]_,"&VX1S%-RT9;M:9&%;HC1C\U;YEM)9DT==S
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MVL"['O#H(8S(CTR+8D>1AZA3Q[/&=ZK"*A_ZEU$R+CNA9,_];/T5Y-X)XC#
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MUMQR5I?'-*;?&#6;,]JZZI56*7Q;E^AS5&P"<$7>S3Q" @&CE* *,Z69I08
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MI Y5C;^M#7_X>Y3&/X)VJ]HL/*GYA^/_!+39ZH97"D*E"/M(0E.Z\D3I=^=
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M5+S(-M;*]((+<+([Z.J@:PE=N,JPD%H0 R31G%@"+/%>F RZ@J5$M=JPMQJ
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M$FP&/M^*4[P1G!*7C%,M]=EV?L]BBS?N<1<Q_-@5I6AT<;F%0YA5/$4:2\&
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MEY,:%[!Y'O=^%\DH3._B(>XA%?Y 5_5SEE4_"+ J#9@3I9&6%!M+J=1.8$F
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M<X$VQ.<$LE3RW=4O6; ]CQGLO/YL3T_9H[ ^. '#47/I,_&PE=+:AC)G>K$
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M;.4L"#M?/,LUJ]O"9 ];^)\9V7$:IGEPE, 'J96>4.0I,=1#H2TU5 C$J6"
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MA7L., 081U8((6/*%-%"D=@IU !X:5'RO!K=0YJUXG6TX_T\@]HKG.^M.#Y
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M(51$L:2:@N"GS4!UF%C1R^:F,44<;$A!PU"$Q%#!>*N_($7#MY#-_17H-K\
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MGCIU=X/_=%M#[QSDPCV:]OZW"-%/G;UN9^^O_AF,Y4D^@D?\]'':JG/5/;F
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ML]EA4<V^++R&P^[K\R,$UC-K[K&CG[ZW3@3L>I>ZZ"T3&9L88[&1A,2&@7+
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M?W8=?@U+G<=B@OT][-U.LW>+7WY\;'6_649:E^%E]N;I.&SQ%9S^Z<<W*]Z
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MG7,"R[F(,Z7%7<@'(,,?BP>HBY)X)_$^>?$&7;Y.O&$7HO:+=ZO*>^W@VR#
MHM^Y'V3#_I'4^(;$<7AE*K@B3$L+/;:&0F,LLI+/O=[00KU2CK3S+%+?&TRB
M#S^K^.]CU"<VI%YLQJ]!&=Q<MQ"C 1_"196IA4\&#5:2"D?S.:=E_ @MPT<7
MZ&'\Z+^SR;C?FUY'X@M@1S_6&#Q:E?@FQ#?_E"+5K<)Y98*X(P9H#@+$@?+8
M04>1GN.<(R'JFSF\!\[%W\C?$LX3SA/.7XAS5I[GVF*GH>2, 2FA@Y@*NCC/
M#2"F"3CGZ3Q_/9R?AZ=Q(8F=;^-AD.CA8'8?LQML]D<0\UA!<#..'QC$ZU7-
MV6-8K 1T+CJ@2V&=%FKRL33F_#I)H:1@C1L%=-FZV$@2TB2DKR*D&*\54LI:
M(:2M<N<MS_OAX"KK_# 8=>ZSWN2I:2>G;@@L<FX?V0$"E94AV$O'"+-,&(:9
MP SCA1U 7##_U]H!7S;; 5]>8@=\SB8W\" .O8I>?S'-+M_U[R9QP]_\!%?2
ME$^OL5 RQ4\6@;@<;J 1MUHQ2SPC#G@ '*>+0GQ"F'I5!.[O:DL(3 AL(@)I
MM4DMI!@"HBD-$D\ -6SA\Z;"X)56&$=%X/Y.L%8C\$@U3/%QW)K!J"@N>HVA
MP(\N84T5$^$^G!^*: <EP 1["L&RBLD)<H$+ 0L?D?75[,5O)[OLG)HU: +O
MW6BR'"V]+(%ZU"KD,@Z;KDY$OAM]"R_-JY*>'(V<UTP58]C#6V:]8;;'S-V"
MP/Y]@SM?5 :&($41!UXY#RTUT@F@O''2>RDI4X8_IK"M)G)_&,\7GI/7-.^P
M4GT^-L;_,)[],YN5\[K+3RK>]'$6UOCYNC?Z6-#=FE'V\L$H^YW+-J'LXA5/
M_6*>Y2-F>_&.%-TL)UG>1^9R+A=?XMSLI33-KH/9_O5ZGTG+J,P.6N&;EPM1
M#7P1 -]=O9;54KR?_J.7?_Q4(DJH]!11H*@S*BBZV@M*!<-6(@5BB55O\<;=
M"D.SK_$\_751(&@'T\OA>'HWV5#@:1VQ4BKF@ZF+& (>H_E2E;".5@H\M116
M4^2PD!98RQ'5<#X?'DA.Z;,<NO%[X(OJ0U=W]?SJ$NG&ND0HGJ[KBW>Q]N?0
M^F+!RB6_U,M'18]!<1INM/DE7^7_K"M>@*#;T;$V.)M..W/ Y@SZ<S;^.NG=
M7@>XOQ\59%XEYV?5NEKJ?O=>>_$POKR<FUQP40ZB^6*G*PRYMZY8<P6X&G7&
MMUELJ3?ZVIG.MV@P[<1X_*RHP>X%S2;7C,:C^.3X*CS\LMC5V75OU@F61J<?
M^'>2S;+.U6#4&UT.>L/.H-S:3N];;S#,;TW<_UCH_3WL_G5>[GUY/<BN*I<1
MS_)I?---[_=LTKFYF\[RO_6+(O5A;#4>+R/H6.-@YX2/+)I%A+=T@SQUXFV+
M#][F+_]Z-^B'"\KR+UVLL*PK#_=S$!M-3 /1A<T;C#K_NNN%I<_R+H.=J!=.
MPF)B0#B<[-GT.HCVM-L).E%>_YY?_^+>3.-?PB65M^<FRV9%O7P6[DM^5?D-
M7'/7#U'97G^[@,N[R21\Y/ ^'G[3L"63?,'SU<12_EPA>IMO<S@+>E^SAW?D
MZW#\)>S7?>?[8'8]"'NTIW;\I'+,.($9Y66JBZ1&HT"N4L2Q>LQ*!\C\/ _6
M/EK1,#[DN2(?KTI8+U"]39.V^:Y6==CW'_Q2B06K]GA09+^'XW&:C=[\%,1I
M4[;)RW772<E/\ZM[.T=A 'R^G4')#^"(.].Y'G_/-^Z7(/,Y&>0[:G*HNC^R
MR[L<'A^OKH+9,(F?,XZ?$M_Q/)S?ALOX-LB^3Q^(Q=O\R4 [N:6Q/"?6('SY
M<=-"QGK3:1;_7_G"\$M^;P/HN\^;\_D?"ZO_,>96B_M>K**]>(?\!7X<T,Y_
M7D]*5>]K=O%EDO5^O^A=A8MZUQM^[]U/HQ)R/5E=SV;5?PL]M9F';=#W>U^_
M3K*OO06I_AK.A:",-Y]&YUE% 2[]\<W@<C LVI#&8^*W0!_A4=X6-YPR_XA(
M'0YSJ)B?_]J9W@>$WDR7-F8O'+O!])P5P[,CHUQF:S_J;<<$+N[W<LA,QS?Q
MT+H;S2:#'',==S<)\'D[;\U2?'8_MMH=?+DKCN_2J3E=?,'.1/3HRN*7+L[>
M!U>EK@)(>V\[:CH(/Q?7^)<(\H[*$=Q[N^PF\]=!OQ^(S?6F@=6"/O(]WK?P
M7W47.P8/XR<4MZ!X2S16_E_6&X;?=UY'OC_]4@Z+DVXR%\.K29XY%I83^'O:
M^7+?^3K7>N_S*PA_N.G]5]1)\KV[O.Z-1MFPN/38#V<0/B>N[#X\R!6@VT'8
MZ$C+<;FCWBR8NF$M-_&.%7=A<!/9+U>,\DLH/%*7O>EU)P8*IKGCHG=U53@N
MPO=GX?*B!':NPB6.)W4WUSF0DCU?6^6&AA6$#5BQ()H(_;O)8-XI:6>QFQ7=
M2V[&>?>2+.]>LK-.T!R7[![^LK*OPFX.O7V^FN^QY-$X-S^^#?IWP5PJN.\^
MD,ALNK!U'E#E?*1.X8$N2"8WOX)>%Q2EJ*0$E7L\R?\ZZD#PIX4YDCNB%^\)
M(-_)X38'G@^TYOX(JL>H-S2!6\-9,IGJ^]*B5T$[V:+3&B.<"(",Q5PZHREQ
M'"X4#X^4JCCBC/(48DRBSDZA"RJ\HPM''&)4/>N(V_@]*XZXS[$1VC@HG-]S
MJ,[UY5E^O ;%>%(AH/SF?A_'!F<WO4F5D,+]#G_Y/;SM[9J-C$*WV.:Y$?GH
M4"Q:E\^;K55X;JD&!S.KT-V_1^-R&)3QHG?:[63<O[N<O7LRIK>E8KC%?:LS
M^#77L3>Z,D_:$1HDXNM@5%Q>[VXV7ORA\-CE?RD<BU)V 0H"S^E^+E,$-_I,
MR6XMU'C=/=F><=W6WO\M7?S++_X\FY^!<^V'UTF]\%;%@;V"-#2O'U7J?)=$
M9(.(I#YW240VB,AN7>U>I>&N?.FJY1.^JQ]LU-TGN7-SGI#T5,G)4EIP([HB
M'E]$5.[8/,  MC8I),UHF7E\X?A3'N0:7Q4W*4](/,^L_(;11,..F<0A)\,A
M#9.<1##-))C$(8T4CF9P2%-IHG5FS<.;L(C(O]N305H B+:O;VO MV"M;5]?
MPF5[UI=PV9[U)5RV9WUG@\NM5=Q3;Q3Y($WK2$+]>KW =AI@O&F'F],3Y(FB
M(0A$960Z15(!3XBTB#(,-/%*&(0@X(AHM-(4I)(F:<9%\O<_!K/K1:JD^^-R
M>!>7K8JZE?[GWA]/=[R:3F;_F8M:3+S_N9)<F+?]F">,_N=OG^JHFW\+&>S2
M.@<>-ZZ%7:/(J4E'[8FU6MP.Q++LK06I8E0+H87EA"N-F#!%,BO&@(DEB&,C
MG06"?\DFT6_4^_K,B(D=\/F2#M2/(,KE,="Y*K?[[/EKMJ _6S@G)>,$^ G"
MDI\$X0XY:SSWEG+G!,14,DJEM (J0@^C9(BC*QD"BBY)*L8Y<E(;50R(X1+"
M%GNO/0!4.\F$I4Y:N5 Q/&/NQ2K&[NA,*D92,9**D50,"&G)3QY) ("!7$N,
MA5'6J*4))/AJ<]-Z5 Q^=!4CZ$U=E%2,<^2D5JH8E>:>QE L >$&\/!?+0-T
MQ0+"F-J7>S%V1^<>*H98[<YYUBI&0[.#=E[CQV?JVE\A2M84'(OR*';,,2*5
M!,Q):B13T@F&C6*(6BDX>\60PJ*]^(?QZ+?IRO2\7<]D#$FMD87&'KUM/V%/
M&( (E U%")>$ F*55T%'9L0ZI98'J03J,.& Y[&UQXF*X%E.ICP#,+YJ@G53
M@ M+#1A"CCBRU"A**.%>:2,L]=:$?[SA!S)BM_+$'>;D1!#7:\UND)-TLKZ6
M[=IB .,2P-8:Y0 VQ!'J,)<,,+0X>8EP_#!>\M,X>;<5@70R-P#,Z60.P*[,
MSE(84,NL<0@1*PTWPN %L*F$^!7=RX<YF2%":^;,I)/Y%,%\M@!FLAQ^!X1B
MWC.-/*$:<^&$6P 8.28.XUP^V,D<^\NDD_G@>?J@L6[H76OV'^XU#GO=']_%
M=J![M5]ZZF[NUO;@5</BF^[//G'SW6['D4E3EEH/(P2 \*\R#"EA%&=R/C&4
M(DD4.*0GOY:<?\)9%QR,*5\B':^+A!1K/SH-'+Y]W7%Y 0-2%@UA8BEPB"G(
MH4?(.T,6RI0D8-=Z@V=5H^ITH4W*$6@&YG?2FUZ7*%*28-*EDBY5&V<B4DF@
M%DH"@(1"'AB#O3>%+A7K(8 [:&RG%ET*8-AEC>#5I$NUBR;/3Y?"I6-*0BV
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M"7T-01\NT6>HIEI[X:7EU$.!C-(%^CS2#*_4D6Y"7TU6+F2BUKA7\]#7M@R
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MBJG"SJ[8*,\/9JK-!8$02MTZ$_I:B;[*5!:$M$52  L%5<!)BBC+T:<44!R
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M]"2]01?Y9_*5^S"VU2Z[W+%:CUQ]?\15)/)ZIHPKN542Y3P%'^X"4&\P'-G
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M\'8/N!Q. _KST& $) _FP+M+"[:+OWX?78[MWM3O#QZK&$\4"Y(09IX@::Q
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MH2H>"7V$(R-'/7X]6,?WA*941[]KXF=;A[OK^%8G>CO:E!U*5R(%XR5G2!N
MSHB@D+7.@)=L39"48TIZT*+0F>K!:#$.8N78<KK;^,<W+7IY(@-C5(H1^<C&
MUWJR+6O'S2,54XYS'"F20N;(&6@/EEHCE\TC35PRFOP8ED&OGNZ!1]G\&FU3
MNT>=/7R^<D$++D)$/GEH9&($N90DB@$'C@GU3/188RAI$/3J[Z' *=;YJQN^
MUV&U[1U6;],GF*QR$[:18%NY'#O'0L(!42($8@*:JH@(2,.DYKR!;U./Q%TE
MS8!^9!@8I%*DN!<0N?5RT2=XL:MH%50B-F"&9 P<*2PM(B)Y%,%+-CS$R+J=
MH!V]Y=T:67&N)5-: BL\1\["CX@51MB21 PC7.B3C]<?MM-F0X)U!,KO]H2>
M2'[$</!6P&"VR@50\PDCPXU%+"@;M30>OON!:+!?3VWN\</A*;TJ]B.G=3T1
MTAS4V=L3F8Z!82EFW=P8^CZVT2M[46EGV<I2IYFTT%JO%<*1)\2T!>/$$$N-
M8$+2DS\(-#!WQ@"MV)[?^DZ*O]6+RYL[%F[OI]C-ER[%*ZDMC3Z"[Y$7L(30
M'EF&<[XH[P%<3XGO$<M=QB4?F#(CX78<[VT/OFPO6#E# DWP/BW 7TTF.<2H
MP(A*RQUQ###M$<-8QID?F"F#(U9T>><$#U:?R,33R](=%*:"4\W-3=*_S:87
M^3Q'>Z/TVN3:/LML*UFQ%*PFH!XE$!Y0U!H4)8POQUQ*W&E+U,DG/!J*&L-C
M=>1)I9O>V%6V"D2#M6Z@W9P'9**A\$,;!)-H"H01:OC);QP/ICY&0*N<%KF]
MZ#''3<W:N[3BU&]?.=M2JN+!,.Y@=A;&@845A4<I.8.<]#%HFF!2_9$FEN%7
MTH8%KQ11'H/P9NHGR]!>O=:TO;18-+5;MN<)/\XR^[-5/IN *!=OIHO8Q/DV
MG3/,"RHJL4B6:.1<T,BKH/*:/&!I?>3,:@_-^X$FK^'I=S2<'S/UF M>QX#A
MIU $[YIU@I86P3:@]NUR,<_74H#XVP./MA2LK*/<"&L0#XDBKRU#BH6$@A,F
M!B\MIB>?N>P$2#4XRB4MD=ET7U)M*56!5>6EX1(\-JX1-J E-542"6DC@(JY
M4#W65LM,!2? J&$A+K8A%$*=X;&3=[8.;Z;G]G.]L)-[C=FV!;2S<&4LQB'$
MA+QO5XK N%=,6"2E(Y%H;IQ+I^X G0"Y1D'Z"!E@VB4DD/IS$R_C=%Y_B0#E
M["KFT\UM=N0=9];WJZDR6GO"8-PYSCFR6BJ4<GZKQ&#<$<Y9$#W"%<I$YIP"
M^T:'O105W^<3J=,87MEF"NC,OTMIDVI?;W.]=A>N)&58! V&@L8*86@U"M@Z
ME*BGCH$K@DF/.%#YST*X49 NQ;&/3;3S97-]9PILX=3CAZLHL31>!Q12](B+
ME!!W+"$)XX90$82C/5QS5285S F0:!!H1T]KL/'L^#N;UT0OXZ+V=S='CGMV
M_<,"?K:.]MN4SX:^GLR^'N\,>Y;@P0G5]\")IO8@ZOH$Z_=_N/?D-E^H3[T5
M)9ES"2-)0>6P?+ -JT 0N(O2""QX\)UV?<;#[/\?INZBH JRX&0.7P]E0]U'
M9:N]=/_!*A 3HLUWJA%ED6<87!6; A+@F_C N69]3LN56;DZ'FMZ@UDRG\/!
M$+V+33T#_];GN3N^C*M_;TV'5]_\I9U>Q/<P3[U*,(=OC1(K*D@E,&4$$X92
M7N/1)N:0.^AA9PDSE'(O4J<C0>/T2CZ:#2U\U\R^U#!]O[C^-(_0O-L]V3._
MJ+_L.@G0O9+*1QQ4>VU:OA;">>.0,I$@T&E&D\BI3CV"(WZ *6)D LT*]DPI
MS0&-N%M,V$[#N^>J2!3VD<1\AEBCJ&-$6CN,F(HZ0$M)Z.-REV':6-WWF"6]
M@"M%A"[9A;?PHTOQ*KJ8*-<63"M*D&0PE9I 858./&\;8L#CY"/*"]%F)#R+
MA61<@B?] I1OR.N6<3K?Q9^G"U0).Q,T%<C!!Q@E8&WQ +\::KC5PFAM>MS%
M76:?K!!C!D.PV!;%/2J_33D/TLMZWI[->=?$JWIYM84N.\M6E@NI/&4HQJ00
M5RPA2AQ#1%BODU""\I,/,"_$G#' W$VB#5G)WK^,JV0FB\MFMKRXK.?S95Z@
MFR7?;KS--^R/=B]<42,<X7G691H:HHE#A!"<,^-SYSPTR?6@1ID=JI&I,2J:
MI13,XYOSWDYS'J7Y*K!IBWK94;*B(K& +?C_,3!XLTSY@!= &K4SEE*M1(^S
MN++,=D$A[3(\EL6.5[9[*+\#_;-3>2/QP_L]WTY!6WZ>S>VVI#7[5E6I* 1E
MGB 87!%QC?-M8EPAYBU,X5'(P$]_0ZH0PPJ 6_0H5=Z7 ]A6;N,ZM=>V$Q&;
MRE14&D5P@":R:%$BEB)BG4+:TF2#=C[TB3+3/Q6)AD2Q%%L>KW0]S@^YA3A=
MBE?8..4X@88+2Y#G(J(@88[77*:4N*0:]^"0^:DX-!*@QZ/33=;)[4O46\M5
MB8(AF'1 E'.!"(T142\U2A9[P;$)(O9PX0G^R1G4#\KC46>=F?+FRM0G,U3N
MQ:DN%58A>1<D^*B:)8LP]A2Y8"*27OB\NQMZK1>10G<Z'8UL(V%\_/GP+MG+
MXSPO!\V0VRJLE">>$<%0,,(C@9U&!,><%$ $DG(N -ECUYW\5 O=Q2 ^'@DW
M9XW9BWJ;JZD8C$+A /LD<)X.P#IE6AC$N-""66J#ZG$I$_FIULE'!O9X-&MU
M](WJOCWJO1?%GJZB,E(DRH-!@>3DU.#RH&A)0LE[HP(S/N$>.97)3[68/B*H
M!Z^I/Y2IGGZ?%V UL=OI?>H_G8*[3W4PF,[I:TG5JS.#7QN#^9ED9R\X5QP^
M*M,GB:7X*0RS@N@6C"]Y"K'5,EW/&*@G*JEPPLIJ&%"6!HMD(!I, @N#3('G
M9+-IX'HX #] P.-)Q$ -TS/%CHW;ZW8KXN/LS .03=Q^9>,6HNY94Z6=(#:*
MA'0B'-F((_A3@+]./"HB$TVFQ\'RXWJKO3GP\/3XZ-B62U,P\S&&^6N <GW)
MT^]VD66_?ILVMVH;[PZKL=+,)RFL0$82F*04C'\2I$>&)NQ4L#+V.51P5#]U
M</H5@_AH:J\U5+MMD.\L6W'-%&%!HR@PS"71!#!T%4/2B4@EAP$8>QQ"9S^W
M:AL S:.Q:./-,_O0:6,E@+,.2>*\7P+.D@Q)(!AB#$4P<TT 6YN+'BJ+_]R\
M&A+6HQ'LY@+BN#K\WAK$JV_"/A3;4DTEK7,D^^;**(T8I@'9)!T*+GFMDY(N
M]=CT/*ZS.CK)A@7VR([JZWIJI[ZGH_I$)16)*1CF09D[@Q&U$FQ48Q1B5F&;
MK&6ISSUE959L?WQ'=9B>.8;C\&8=C D#K%/>H)UELQ(P2@2)=+8QE,Q9ZQ5/
M2.2TTS%H)VF?O=-C.@.]NWF+,S 4F*7G4W!5WL?/RP:&V;P[BW86KEC2F--\
M70:Q\'+##!*<A)Q[&!JMM3=I&)_R"'/GX#P: \YC:*-[N:AW+9%M+E5A[X/1
M&(R/1 4* D %-]DB(IGCX#HSTL>V/^HNYI@:J#^,QYW _F:;QNY8;]A:L,I9
MB:B.%K0M42AF;:O!)$ 1&ARI Z.2]KCFZ*C[DV6FKAY('H,[-_GN?\N.!NA+
M<"VV9A';6;82!!K(I86WYE.4+A)$\DV:3&-+>0B$]8E2/.J9H#$9-!28Y?*H
M?%Y/N6_3OB3:6;;RSLCD,8R;G&B4>D$1@<D;)1(M#L10)X;)1/<3F#YCH'D,
M573/A&M7;?=;,-BSIHJ%$# %L%D@%M$H*1)$YJMC=: :!Y9<CPU#];.JJ7&@
M/3@>Y]W:TI^E>Z9;OKOE+S%</'5BHT.I2GA#E0+YI18:":T$ M^ KL]A.JR3
MZ1%T>MS#/D-Q8QP<BYU';)?!WJ;[2V-OIV.E[!OA;95T07D68'A9X?)]-A(%
MQBQT(3;*4N9IZJ&^RMCI/]"BYVETX=WP*)#.\\ETFN=0[X-MA2+I/)].V;Q!
MD"+7&#R4IT/^[RVE0%=JQP2PD7A+$;:&( QS'5(X2)K3X5'9*>Y\M"V=?]+<
M5H/UV0^:S*I+QO0G4R*O$@!OX4K/FBL1L7<X>.2HR"F5;422)@V*U.#$B"72
M]F!7H?C4D=A5'MMC\Q'\$>BNZ>J*5W_]L;'3N?7K5%_M;^LN#G]?KD*!QF'O
M*')4*BN O(R8#ZTB@45$W','_KR(T!^$V'CR^2B+<K+C>#B5WCKVZ+G++/.7
MV22;SW>I/NX",,^:>@Y?O81?IQ<K\[N#T3/6*ZL(,V300H!^]!RI8$ UBGRW
M)S61<9XP,R>O_T]Q3!RA8X[FUZS/ \&W1W,ECFM:CW:B<BWH>E-U44^70)0[
MN%_$!*IW]1QP)LY??5LT%L9>/;7-]1OHH/G>=XN.^-:*:^,D<1*!QVX0Y=@C
ME:0&BA.IA/.6N4[IL8\<T7,H@QZ?S#PAI(M-GC>'!SN-UR>>KG1PF 09D 7T
MD: L(<.=0=HZ;D/@EM*3-^-.IN\WW<_="^]27/JU ?G>-;.T=9_TWE.5T9X*
MV^8,=19)8QDB-%]@+J@+@H"K:$Z>.[W[:#8D/N5VRK_$Z3+>#)<&'(R_U8O+
M<_ H (3FU;?UDG4^C@S_A>WV] &U54YKCR5."!O'\NW"&!R2X)!5RCL=E8B^
M3Q:5(MPYN*\?[9:7P*\4M\YG<["Z?YW-0GN)>&R^U#[./X#AOG4=>E.AB@EN
M/('VT40MBAR\5DRE0XYC3HE@$53TR8><#D6507$J;J6L4TYULE%NGJV$U%AY
M'V'*I<!TFJ]L(BF@B*E)%@<9U>GW_]#3S! PE9MLYA'>E7<>7X*FF\S:0VF[
M4Y]N+5=%8+DW42.,90*22Y5S5!MDK/8Q>NYB[!$56MCX.*P7'U]H-2A>!T?
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MH&"2A$$%XXDQ\ \)$3G[GPM!G/P]K\<GU(%0GA*E=CC67:NHN+9>A93;GK>
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M%[YM+NQTG<PL7XI77TSK5'L[79SY5B> J?!N-JE]?2I2O++-%'Z=OXM->]_
MZ'VSCW#EN+N/5*?5@>_CESA=QO>WR3+;6R_;C*/S-]-\_65C_>)6N;VPDZPI
MQ\^C>4 ;\HC]M9G!C+EZ(E\^&>LO><R^N#Y?SA>SJ]B<E.!CZY/_7MIF$9O)
M]6J"J_,U;+=J]-/4+@-,R:';4\>6\D,V(YKKT?NOFS1C]]P'?QG#<A+?U'=)
M?J>YIR9UN@8&W5#\^!+L[I"UR9)_.)A8_^-?_A]02P,$%     @ *HI-4.@J
M-6$@80  WZD$ !4   !D>&-M+3(P,3DQ,C,Q7V1E9BYX;6SL?5EW&SF6YOO\
MBIR:YZS$OO3IFCE8JSS':7F\5,T\Q0F3(8F=%$,=)&VK?_T )(-:209CEZKR
MI&V)#"!POWL!7-P-__Z_?M[,?_F>%<M9OOC+G^"?P9]^R1:3?#I;7/WE3U\_
M_ZH^FW?O_O2__N=_^_?__NNO_U=_>O^+S2?KFVRQ^L446;K*IK_\F*VN?_G'
M-%O^\<MED=_\\H^\^&/V/?WUUVVC7S8_S&>+/_XM_O4M76:__%S._FTYN<YN
MTO?Y)%UMWGV]6MW^VV^__?CQX\\_OQ7S/^?%U6\( /S;OM7!)^)OOY:/_1H_
M^A6B7S'\\\_E]$^_! H7R\V[*[RD?#Q^.UWM&SQ\F/ZV_7+_Z+.N?^#-LU!*
M^=OFV_VCR]E+#X9.X6__]_?WGS>0_#I;+%?I8I+]Z7_^MU]^V2)7Y//L4W;Y
M2_SWZZ=WCSJ99C\G^<V?PY_?XM>_J<5J9F?S]6KV/?N<3=;%;#7+EC9;I;/Y
M,HQDT^%UD5W^Y4_3GY.;@!>4$&W1^A^5&J_N;K.__&DYN[F=!\!^JS=,G<XC
MD9^OLVQ5<7!'FG0U)#69Y.O%:ODQO4N_S3.UF(9/BG4V?3]+O\WFYT#;3N]=
M$_HIFV1A]H;1-"?K8%\=$A'1^T=:%.EB==>(@B,==37\=XOO86'-BP8#/]1%
M5T/^$!&*BT7](1_JHK,A9ZN_IK/%^WP9!32_6LS^*YM>+-Q_KF>KN[,7S-9>
MT!6Y%ZOKK&AEM3K14U<$?"SRVZQ8W875,4)X&Y6/^D14Z*TK0CY?Y\7J2U;<
M_)X6?X2/PKIX+PWJ>W@D?N3SXG/:9/5M\IJN2/\27UF'F,<-VQG>>CE;9,OE
MY^PJ,C\(PE^S_*I(;Z]GDW>+R[RXV6BD)P=[7C=]#OWL1;E9MWV2]GE]<Y-6
MWR";=-HG617G1YW.6B'#Y(ME/I]-XX'OX2P].>23#;L=WL>T"$!=9ZO9))W7
M'NN+O;0^\,^K\'?DZ_+BTJ3+:S_/?YR%[]$.NAUN?G-;9-?98AE6AW>+\'P6
MM9_:@S_>7:>D7 3M8#.+:H_^>0^=#OCS*I_\<9W/IUFQW*J8=0=^N*>V"%C-
M%E?98C([O=2]^'#[PSAWIZS4N*5A?L^*C^E5=GI(3QYLY?4V^[;:Z8I1VX_J
M\L5Z%>U2T32H\Z+(?X0?EE\705I,D4UG*W559-D9RGF+KVB-Y+CRY(OM='BW
M6&5%MERYG[=A)8K&&7=YF4U6FS5I^]6G,'GBQ,D6L[P(LA$XL9J%S?=#OJI\
MT.KXM2U"L]C9B?^>SM=97*4;T'M>7ZT1$?]4&>##YUI[^;F+S;$VK0VJL>SV
M*X75%.7G3[8T@._9/+_=Z=X;<\A^1:HPI@J-NQ_F^4)8H[-6R'"A=7Z793I;
M9)>SU<>@D"_#$,[7=\[NJ-_AAU6]F 55=[);"R]N-\JC^YD5D]DRFX9&/IT5
MC[_]>]@&LFE%'@XPE'XA/%>H&W?<+WF? L+%;+)1U\-W7Q>SU5)%C6!6V<?1
MQ;OZ!>'S=3B%ZS1(8=26@FJT.6/MM*2J&U8W;^L9B/C);NX%;F7%]VSJ\\*O
M5^LB>[=<KJ/AHG4\:KRT7UBJ:08UN^N7E+B^;N1-!6!OMJ 'L%TZN=ZRX*_1
M*QE/!KL>-UU\7!>3ZR"QL=_RYT^SJ^M5ZY.CX_&U O9^G_H]2Y=!1BOI:$<;
M=3>L_8=_FV5%&I"YN[CTLT684K-T'C#.*K.PI>Y[(+7AJ;F5SKLC\UR%Y*Q.
MNAMVM36T0M-6AKBU_'Y)?YX>T@N/MCV$AS::CT7^?1;-%Q79>V8W;0_=9I=9
M4633\,MVNH>E^?R(@-H=MDW._UX7L^4TZ*AQW_F0K>X]!)_7W_XCFZR^Y(_&
M>BYUC?IOF]AS5Y(*3=L>8@QR"7O)?+;1"72V^I%EB[W1,CP2[94;12)=K6-L
M4OS]?'+:>$W;I%=;, \V:'LX7Q?%/N H?+!3Y&I,@6H=M3+\]V$3R9:E;2DL
MCS>S525E[63#;H>W^<+DRZKNCK,[ZG;XOX=)4@1=_N)R\\CYVT'SGKLE\-R%
M\^R.NAW^YO<'01U-J3C17[?$5%LF*S9O9:@7Q54:5K?M*3;L&;.PUEW.)O'8
MN@U>GBVN/N;S615?=9V^>B?"I<4B>E,_9L7&ME51GEI\1>\DG[L"M-%W[T1V
M(:2#"^NG['NV6&?WT=.^R&_,=;JXRI;O%C$(HT@GJW)GN=L%:U7=N?H?R5
MQL7TKT4XN#S/R-!W9KU<!7VOZ ZU.J_O':IJ>U/]'ELAZ/^LTV*5%?.[O=WN
MP5;^=9&NI[-5-JWVU"E2NWA7CR"<%R'<I,\>B:HFI'7Z:H6(F+@X7<^S=[-[
MU\ BBLA\=GD79D8Y_T\1<&X_O0Z^HD35[.X@*6DQ*:G9_?B0H'UBZFRQ^FTZ
MN_EM]\QOZ?Q)O/.!U-<RFS6FS=(- 0]:MCVH\',,ZLT7OTZSRW0]7]4<XL%^
M.AQP?I/.%LW'^ZB;UH>[Z?W7F^SF6U;4'>M+?;0]T.O07S%9?\M^W4-3<[A'
M>CHXZ" TL\4LSLSWX=?=TW%<S?.JM^_,?JZRQ31L?_&=Y5OG^>0E$C?D7:;+
M;QL:U\M?K]+T]K>XI/R6S5?+\I/-(O,K@+NT]O^Q^SB)HYH^&Y7[.9FOISMM
M-;^Y7:\V"]'%Y=,S6@ @>[?*;O8$S--OV?PO?PJ#3=I^1:(Q$%!8J0DER!FO
M&))&&N2\D$X@^1C$>2P-D!<[SG6+8KEH7UPV)':SN1[!LMT7)6$6: 09T5)J
M83P 6.L=HHPAYJL@>C\;5#'Y)2^F6?&7/\&RY6[&GK7AQ#(00XM0/B+< T3A
M@\W"]6^3>;[,IG_YTZI89_<?AG-D6#/<?.-+#6O6-L&K%]&/L;+O%LLPGDV,
MY\_9L:7@^<,)MX(KQ3GR3BIHF:* E% @2T6/(GAD+W@NDD-)1-XRHAOAZEU.
M/J0WF7VDRYR4EOLF":4V0,(1<\03*HCW0.PHY (KF;RHUG4J.P=5RN>2TX1E
M1[G?&*&W* O#R, C<L8I N>R_OE1-7Z2/(N16F<((/3[(_W_ 4-/-TJHPDI3
M;)!!U#DAN.&X'+F12O?)TI=.,Z?X68<)>4?HM,Q77(>ONT:)#2.F2@!%=-C4
M%(1$ELH79[Z:_OXB7]%KYFL]=/I:JALJ-_KNY0Y.Z(D=OC7ACB&$,55<B+"V
M:H(PV>,L5'V%\WPI?(T*YWA8,^P4J*2UG&J:.*689L!C#;E7D*&@!NPH%I9J
M/6Y-=A2R4$D^&T/^SR!LHU25WZ2,#2-;C])IMIDV!]6YDVV2J/! ()'7VF-H
M%"?2W-,HX?BT]/;8EG<#4E^"\%*2YJ?/7T\*P]%V20!(,*@H8I8)JS0ACI6T
M<NKK"T1GZGUG M$F4'T)Q:Y8Z4DA>/1<@AQU"AJJI-?*<DHP*$^C0D%M:C,=
MOSJF-P&F+R8_.()NBV^4])]D^XF6B6 "6 BI(XPSK)A5RI:>%85M?4$@KTX0
MVH7JE9STU4T,2^GN3+_M/[$(!Z4->JXE=5@@Y3W8._"(!Z]%Z^C1=SD$\/="
M^^^_/<$\$/1'TUB*DY7<]Q$4S>,VVJR[WL^P3M1-[WP0)TN?=SN"XS7,NWWW
M\;C^^G$]RV+U8"4/OSU=Q<-'<=^9QOHBTWW\YGUY1I-NZRR\/Q*P<W8?B9*$
M6$<ITM)Q:BA17D+ML(4FK%. MQ:14XG^>POI,2H.A=B<V4-B++/<>:^LY) 3
M*A$K:==4PSYWHA=C9SKD9MX'8GU&O502KX]%/EU/5A?%YZSX/IMD!WP8AQY-
M&)96:!/.>PIY2Z'F')7D \[LV")=.F-OWBI0-?7C<UB^*6.S'>#RH!GVZ/,)
M9Q AA+5'T%+N**>.[F@R2AHW3D-_<Q8]YW5KX+P-QH_*Z#X2?K<4PK#5@[-B
M-Q!3EDXY'L-PO%4"N'12,>.LLM08"#PJ5SD#M&7C.8"VQ(.\*VSZ,FR45[;$
MPF&KA_>VZ+LO82 G0A$JM$ZH4P0C*#C62$$BH95DCR5!J+9,=!12T/7.WAUV
M@\M,'/=)3VR%UHGV2B&*#&?,4ZNQ V"O;!O-1Q[#VBIGJTI-8_3^>:1G5%K%
M:Q&:P5PR,<!P4R[LW2+0<55DRTK^F(/-$NX$H  $,#TAAB-""2LI=4ZI\2@I
MG?#ON3^F+:CZC) _?.M:O)WMB&B<;IP$X" P CB/L*):&>1 234!B(Y'0+HW
M8W4&6U_"LC=X_R,,/4R6'\=VE^</)TA03 F)7AQMB5.(V'+-M=ZQ^G%AK0=N
M]"<,C6'J;Z6X+;+)[-%E@2^N"?>/)< AA;"WUA#H*5(2@7+-<QS ^I;(UH,V
M^IS]M0'JB]7EK; 7B[@@;>J_WN^9^PWSB!!4ZR !7F.MPX8:E# N>#C/ UA2
MCX2J;[)J/92C/_'H!+I>X_V"_A.VML65N4Z+J^R8R>.EQQ/"N23,AC402JR\
M=02HDC)C4/WX'OIZA:(%H/H/E&ARO72WSO-*%T1W.X3*USOW6*+CX-'H?87B
M&Z<;)TAA:[TW%'$4CMB4"0HUY4 )J;&GE69V-Y3?VR@/'P\K%\PXWD4B0#A3
M<HZET9A3X$50\7<HB'#H[#,YXF@IC#89>K#(1:M8C;I\1??. :"TE>'0*"5
M C)'K'4[L"27NE*,S+ %+MJ2AAK>@?/ >SOV7:@Q(\)1#Q!PD$G&1#F%)=!0
MO'[O0&7.UC#TUD/OGT=Z7JUW8$BA&498]'HVC_<9G_0'/'XP(=YQ;;2V*B@!
MFGODPK%T2XW2"/19V:M%#T!E'N4M@M,7J_VZ"&BOBQA/[F<_XT^GW4"'&R4P
MG&D]4(H!SHQ15D)O2RHM8O45C\[R\;H4@=: ZL\O&),RLF(/0@67X(LM$J!)
M($@A:B1%RG'(O"KI0]K7M^=UEJ/7I2"T@U)O.=N5N?^4'N^"' OBF=, .A:+
M XG](N=-_?CTSA+RNN1Z,W3ZXO;F"I-X5^:[F]LB_[ZU5Y[D_)%6"9$LUB."
MFFEA@+><L/U6YT6#6EJMFVW[D(+VD'K-T2$>2"((HA!SZ96QR#M3VH<X$+BV
M3+#7*!,M0C7X"7)S6T:=P^.F84(P#M@A(L)A"ON@# FQIY;1!EM&_X>&YM;0
M5K'J+8E[,EG?K.?I*IL^=&B'G^?9[BH!=9,7J]U5) =I/")#;;TBD5QH3J@P
ME' L@_XM "D1]'",Y0 [E+:!4!U\Q?J0'9.U8\T2IS3'D##&*<=.,&E)J<)I
M:GW](,?^CS4=KE;G(]6_2_KS=9#L&&#W>UK\$3[Z-L\.!^+5=\<>2!-Z'B*P
M>\7[(_[5BBUC 2C(B (F*)38(L!I.1VUE9Q7LL,UI>.0C[1"JT3:L&H8:ZS
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MW?#^/,:=%XX*:8%W3EDKJ"NI IK5#^7L[DJ-=AG=&)/7DI]K=5!KL74JICA
MJ<(!".P!PJA^=45V-J<'4]\:P_(:<S*-DTY[Q$GT> 22*+!FOW 9XL>MP#5A
M6=7DS'H(O459&*42-P81:,FATT$>)^&68V\<I2SHLV'<6I4A)0H0T6<R1M,\
MSLI,J)['>1XZ8\J[ME@;C(B&,4&08@$$E>7(J?#U"Z?TGY_;(E_KH5-SJ5X6
MJP?+=/CMZ1(=/DH^I8NK0_:T1]\GD$C',;<,$!@6+RZ,P^68/6APMR4?OP;6
M!(G.N7=PFCYY(H%61$>!]II@0AEAFI=4:TWT2"\>J8G]4\XUPN#U\'!4*E"_
MK.N/9;\'^&[6-T>9]NB9!%M"O70D7FUO#+38[L_W6GHWHARDVJCG[=#>*=^V
ME\P>Y]O#9Q)/+'.$!35,$JLA)Q*69C,-J:QO26Q=C6F%;PUH'^8\Z=-)=O)*
MUD--$H809MB1()I8R/ ?H*5D&JU<KTZ!9L4_VBD34!N:89C_L#;X)EQBVK @
M^]-.$H00$1)1XXCBVK-8HKY$@6):/V&@]TL[VA&0%L'J2V0^%ODDRZ9+'Z!Z
M<"@[<7G#D5:)HM89B0RQGE$/-,+[M&SC!:^_E_=^=T==H6@/G6$6C@=COH^5
M_12SJ&#E=>-('PFQUGD$M+7*>(X8)'MGFY&&UC\J]W[-1SO+1GM8M1J+OAE0
M#)%>EK<TQ''Y+%VMBP<#/:A?M--Q(I6S "HC,78J*%S$@/)<9)42]>O)]W[E
MQ[G2,@B (UIR/A:S2=9PR=GVD6"IE/8^Z/C64FT99GOHP\1J<.OD^?[1\2XY
MM;#J+=8YP#6=9E.;%;/OFPIS'_(8+9 5>G:Y+B:;U-R-P'_*)O-TN9Q=SK+I
ME_SS*I_\<9W/ [>6VU#1(P+5WDL22KW"QBB*,$+.6TFE+E'4J$%4]?GVX($D
M;C P6]L%OV>+-([N-HSV.EUFFPER]!!5IYM$2"^T($0)Q#!FFCI8NCLL,([6
M%A4Q=E'I :[!][,OX2W+*,[ALV4V6<>)\*5(XZV?-KU;UMK?3O698,.4!XB*
M (L$BFEL=FJC@8#R^DJ3'+M(]8W=>.3K?HI<7&[6T,W$^5+,KJY.5 !IU'.T
MA5'- EL$@=X9:#U1)5Z6-?!\0O!VA*U-"%O:WSYET^SF-F)>KKF[03X\5&R&
M^3Y=QO4XC[6./Z?S[8H<G[JYR1<;:JIMA6V^,2'&. 6D8ERXH!/$LFP[>YI!
MG+$&/J/1FZ?'!>TP*^ ]P:>ULC-[2*@70L32X  1#DRL/U].1R0A;5 MX94:
MMMN"JGW[E%HN\\DL'B7NCQEA-U\LTTD<[O+#.N(6UMSK-*S$9UNISNL^B;F&
M&EFM(%=(,,$M)24:3I/ZUR[ T1N_!\2QOXS;_U@O5Y&RY9?\0*+HDVS41_?;
MGG"JM-%] @R(B:D<QPOB6>":=JY$CA#08%=\-<;U 7#L<PN\W\[W]T_<H[>=
M/^^6RW4V/76RK-Y1(F+VG ?$<P;()D0)B1(-HVR#@M&C-\+W@M@0WMXXTG01
M5;]_Q#L[PFRIZ/!]WC!1AGD@K%!8ND"CA=28_7KM50/Y>#7V]581ZDL>3#2[
M[D=Y47R:75VOW,^@WLV6Y<&@)&'W[5&#5:W^$NZ41()Z%L.,I00&BEV^A\$0
ML@9:TZNQE?<!W!!9JSZ=S.9AI]V%SNF\*/(?L\55V(;#-T=],>=TDP!)8GT/
M:V0X=1CK%'9[),(']?U[</0V]![PJGUL.V=,%YOSY9?\W6)29.GR<-QB2STG
MTA/#O49Q!B$JA42Z7)*Q\*Y!;M7HC>3#0#B,H4BGR]GR\VT8]O1B\?#JB.J>
ME\-=))PYZP!CU A/XG1R@N\1H U\=^B5&K];PVK([>KK8KW,IJ7P1]/H;'.@
M]%DU0V/M/A/.H0AK,X<<>TBYXV:_I8>I)G%]>1J]5;MO\!KM:OFSA7.U+C9#
M6Y0&AT]9P&2VM6]M;HC,+[\NBMV'D9CE=;[X6[J8[IU$QS:[3EZ88.X,H(XC
MP*(/'4E+RF,J<4 U2. 8O:5[5,C>RV)G5W]NB]X\2[Q],]=T(BD1E(23,%=!
M.%XK2!W4CA 5Y$#32D> /FBL<TVG4^%HIZPWA$,=T\,L%CO:5%SCZJNJ9\_2
M6M=T5N9-A6LZS\,B'?,UG6T4;N1!<P((:2 EM8 A#54)K0+$])DZV3COO#)K
MJQ1N/ ^8WK3-E@KV>1H.[U00 C#$5'EI--M1IV/&_CB3U=MA6+7*??40>FMR
M, S_ZQ1N[)G]P["]6>%&9ZC2(EYI0IGD"A+.;$E3]$_VR>Q&]?PJ,^=DX<;S
M(!G& E6CG)]UU'!KO/!8(P4!1[ZDRE+79V+M8)MZ8UB&87:S$F[,8H"@A98B
MH[!U3"E94LB)HN/>UINPK&HMMWH(O459&.76/@81:,G,UT'9-Q3'*!'&R JG
MC7!0P?(<['"#:W?Z+^=7F0G5R[Z=AT[+?&U4IM$:"X.*ZI'34&,"+!>D'#ER
MN,\KM$?$UWKH]*N*EPKJ9MAF711QU5I,/^2+R>Z7;P&D='(L<//,GA*-,)(&
M(.HE,#@H1I;=6\/$&-7XMNUZW2(VS&;?K-82X%0 P\,YAG/HX@O#+-Q2:"VB
MO6[VU62B,QY6K<%T'F3#",7717J3AX7QO[*IG2TG9TG'"VT3YR$5TFGF"92:
M2(QH>9BR6-,&[N&W)2;-L>M+7AZ.-)*P"QUU/V^#QGW,3W2\82(,P50ZQX+6
M'50JQ]U^T[46-)"4SC)1^I*45H'K+5+W7L.*"'TI$?J8WIWP)YYHF2C%"3-,
M:BRL02IF.I0*7R#7]GD5Z,@$I5WDAMF NB\"B)5ES%F-N7+(*FNU#KJ?4TX@
M+!VJ'[W=>P1).U[J%L'JTQGU96>E/^&"*A]+*"4><T!@6!PI4 ([O->^')'U
M%=;>,QWKLKT!'(,7C3!I4=S-%E=;5?KB\LMU]B0EKO+B<%:OB68(>(^\HUC2
M(/Y6"[/#R1&D1KC;=+M:=(G>X%+V*8L(Q\(J.QU<;16O=)-)GA6S_&228NU^
MDZ"Y,8M)V)2!A1PYY%AI=G:6R/J>\=Y3%EN7M [PZR& <>-./!2IN'MWHU=\
MS^;Y[<U6C;Q876>%NBJR35C80&_]$#.^8JI\_2C-@_44[E^[?]W[(]&7%5HE
M6AJ(O:6>8>\U]@(*BAG0P#&JH*E4"*C)^ ]%5IYHD0 '8J$3"WVT1WL/ $?;
M<5-#A:I?+*NEZ,I6L<^[P&34498Q[N3B4L7DR:NL0CS&B\\GQ$%C>5A\"2:<
M8V6HDCM ;%B%Z]_8U%&<96L,SMM'I[>"'?>C7&Y- ^G])P_+CYR,Q3JSIX1I
MSYU1#D@OJ&'<*V9V>#@*J!MW'$=#'C^MQ]$+=O^2J5'&@XQ;E(:RY<Z#..1;
MU>X!22<EYGC#!%EI+#7:.X@\E0)H#G8Z '94C#"ZI#-^/K/DM@A<33&I= 63
MB:>QK+A-B]5=#,HX<O7@2X\FEE+'-9)<(:"AQ=!+7E(B<*_W2@ZBI;0$3)<L
MOB]LO"?VZ8@/Q@R>U3Y1@69'H4'A/\4)HE;I'<V$$:#&J80T9V'>'UC_'((R
M*LUBI/+14G#BW[-B-K][/[O,/D]FV6)R)$_DZ/.Q,"<+HW24"4"88S;\7([7
M"=0K3RM<S=<^'_+V4:K-U8_IW693^[H($#Y01@*P^PWOP%9_5ON$20$5@D !
M3R3R$A+[ !U?7P4\WRLWR/[?)5J=<O_@2GYF#XE"09AC7DT B$$<ED2\EVAE
M]$@M#QWQ[5RI:(3AVY"/4>WUKTLL6A*'0X?5=Q'R6,?V[JBQX.P^$F8%$)90
M8Z@B1G$'I2E]!X#(/OT?)U2%SCB6]X-=ZS+Q^VR>+5?Y(BM!J2<6![I)0-"@
M=1@)P-@*R;D-FW%)';9X1/<[#RH9[<#7NG!\O0WX;&IDG2L/]RT3*C"QRKE-
MYJY5R'I&]@*NR(@N@>[,3=HZ2KVE.,7;/+85J>VZF"VNMK$=VTK5'[(?FZ^.
MN4*K=9!X)RW%F"HC/>%62:7V<AY-J2-;)EJ6D4[!:F=1^)0ML]#3M5I,'Q!?
M=6$XV#K18</3"@C!D8$< LGV"QS#"M0W-[<>!-K/XM 64KTM$%$V-^6ECRT"
M^X<2[2B'PK--2H1$#"E7(L0H:7#A>^O1FYU.]+J M+[#/R#P4W:UGD>X[_;:
MR/)+OHJU"\LOTL7TW2)&HH=.2DWE7,V@^1L3)&Q0ES&6G  5=D<>3FU[S*RJ
MGRS=>F!F[QI%[^CV+9$MBUM"L: !]+";2D2Q5 S)_;)*)*V??-+ZO1-CDZ4S
MH:MOW,I744+3N5]O;R??7S.W2;S[-L].JZ/U.DHXXP@:Q;1P2G$#D49["CWC
M]8WAK5\KT9EP= U:;;'X1Q;OL,BFZGM6I%?9_9;ZX%;6>!VK^Y[.US&)ZI!8
MG-U1HH@T7,9<'>,9A<P M?,IL*".H_KE%UJ_*J(SL>@:M(ZS =S-[3R_RS*=
M+4+[U<=YNHCA0X>O>F\];+_R"-XM5N$HN)Q--F6C+RZW%RDLRZM=IJ&13V?%
MXV__'M;HF)Q\+.B_1QI:2$-H\;BBTU@)/K^)V=I;V][]GJ?O[A_9:43J1UI,
MWU>H*]V\\T1[9</97GJ/B 72FWB7K_;,0P",PY6.PQTA-[G.INMYMKMA\1B9
MRT-TGBI<W=H[$@.-E<9(!Y&D2'-,)=[@&-8; 5Q]>U++Y:[[%)FG9]"!P.XS
MTZ-:E%0D\TB8Y/[[Q&"B'2!4A@W,2LR]UA@:8*C P"+;9XF=LXIJ#L#JO#E^
MG4;&Q3$=]'0]>2+1,6*(,&ZD"*<=S"GB?C=N*! EXXR(J(G]4\XUPN#U\'!4
M40O]LJX_EOT>X+M9WQQEVJ-GDD JMAAP3[%@CA,)PSDPCET2IG6#</1N@A#K
MH)ZW0WNG?-M>ZG:<;P^?23@U%CGNO/1<!OJ%<UN9-2#\Y$?D]V^%;PUH[RWM
M;+.+G[XCY-%S"46  >(0<D98[X(H&KO=\*TUSM6/[.FXCOAP*D\;./;JO:N%
MS3UUBVD\]U<J5-W%ZQ)"! RSU%DO*83,A#T2[I"-]2?L.)6SAE+RDC]Q',#^
M2W3;0WA4.ND;D-AA)/73_I:_C6'T9([NB\\G2E I'0E:H 5 A4TH[DC::6 <
M\-#55ZBZ*^\[*(OS]D'M2V!*DD\H:@\?2S99S!RHH'0J 8$(YT6RQ<43S'3]
M(,N.TG;&HZ<U@+%O@3BY2SV9+ I8C.,U")P"9QDQ"K- C9">0@?PR*]XJ\>8
M ]QMA,AKY_,H]8@AV-M2Z($B /X17WT\5^+)8XGC@2RAI'9$4\&<L+%TJQ?,
MAG%2+<:WA=>%-V\-A=H\*GW3F^W^XRXU. XC/$J/\ZU"T[#;6( 9XS%/3&!%
M---P2X4UB %4FY>=U2QN@Y?M(]/7TFHCUE&UB-$4W]:;,I51)K>&.[58K-/Y
MPR^7'[.BI'97??G(>MQ"[XD7R%KLJ16.*&&)!P27NBBPNE<'14L*?G?.Z_X!
M'UA0=X,O?D]7D^O9XNK1]UN"+BXW7YXOIM7[3@Q73!I+I*/800R@D&2/F>/U
MM[#N;@\9G9!V!O?X1;03V4R8M(@JS47<A3AT'.U1@MXV2##L[J*2URB49^(\
ML#2:?+GZE$WRJT6\IN5\P7O</G$0"DHP8IHY*91#VYL%-[0CV2"/N;L[3D8G
M8XT@;?\@X#Y__/AA'4'<&9^6:KVZSHL#\E*_LP0Q1[EQ"@N, %.!W&@DWU)*
M)*T?Q-!9(?D!A*<W?$?CH3J$X4Z+W6.Q_K:<%+--8'>\$J:+".03KTQ(T#QB
M232 G?'*4"Y8J2M#';3GVA+<>I;4"):_D7"A\8JYGW\QK\//\[PX>O-3Y;8)
MD)8K8A"A0@,F(6&2EW0P@T>45C66];!%.$=1.N+@.E^[EL3A'A/N#$<0,*
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MKD8B..V!VI< [4]9^NZY6>U]S-,]=>RLU$&B(37&,JHY( %?3PS=4\^5ZS/
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MZ_+4LF>_6=X''JZ_K(J[XZ70/O^]V-T7Y769_RM?7*[$Z?3&3%'*",5A3V2
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MPG!B>]X]:""0TAUL;G>;8KG+;PX4?PXBV'[\]+E%(Z$+ZS*C 5.8"XZ!Q I
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M):UX@(& 9PX2GE.Q?WA8;![#IG*)G'<7DH,'>&N&8U-TC1TTV.H0P O)&(+
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MZM (4"9S<J)H\G?%M_PYZ:WL4)OEF;10>N8(88H98JBAO'81PB]4]ZO+P;,
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M:^H\P=V/R@;/(QY15-W F.QTXT/P!F/SO[L<OB+F-LNRV"67<.IB!8_R7$"
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MO1B5YA=-G3]#EN?:D1M[)(U)C%"0H-3&> P8N&+?N"B$68A!4J-#%3?E.63
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MLN7J0(QO6NTW\_V?B),30#13(^O@I*&R/?]\T*"#O%3]3'_Z_1W<58]LH6
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M)92:0AEO<4.'Q&;I*B9U& #<6"7O44>Z3.4<"<SGI^"@H'/O7-EQ=#"(FWN
M,.G4U%A!C\7K )>NPCP?0>CT2.RS4<;%\9N1HCS0V,-PIBJ;)+^KZKS_N<_9
MM[S!W]HZHR87959_?]OF#PT5O65?FU3=S.P(@$T<.)X7.1$&'O1MQTFC=-S@
MZ4((7)$)CB5U&IXH>9JBW';%&.=,6E80T1'/@C7*.WKZ8U2FZ$CL;.+F]!E?
M7S3K5+:QBH>?[XIW8STMCC669XE/F8U4S.30</G781T]RRJ<>/6S[#74CEB?
M1I4,76>2ESG[X #$ /@.<&.,H!^3A(:%8S00\>UI4XTQSW"7=ANRTV62UHF
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M7X^-^B=<UI"V"^?BW&:N.<'F+P17UBSHB=S6T+-X;#'[Y6H;F[V.( 2)[<>
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M!KWE37%_*>M\6]V7Q3\[7:.<8X+](:="V(WR- '/RR;? )#2CAX )W2 &X#
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M$$,5PP?$Y>M$C).=WC,LLDKH5-'!_UA3'\::^L=93?72YX6HE+D3;#5;6>M
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MMHZW:R3VPL13H_?,_Y')LW+9#HM1>WJ3/6Z=]N&A*BLQX<T/-W);U783>6'
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MO0[5,^A/8>NAU%.V<TL20ED^I(**I+E%8!/1P(=QDH01]SW?%Q-IV1.O,<K
M*%F;:'$A3<M;F/5ZC.;(;RK':K(V!Z^C-.V1A-7ZUG'98IM7SX9Y&A S0P2O
M0\E,.5-8>0C-MM?$& 4A#6/B1XQZ8OY,DKBS"B#C.E6YJ;8L%^7DYK1M>CS^
MK,_EW<G$(3>K:<]@?[&^D*JLK^/=,^:-9E](/9:4B^*M*?F^;R ,N(_D*5Z7
M0( C/_&]SD02Q%J7JFE]L.424%/L/KS\=IGI9*O'HV)UVQ:%FI7LOIF<!#)S
M!?N,@J%J]1BFUB$GXZ _K4*/]W]<$>5,K&C[2N'ZC?IP_>4V:TK?<DMM<9#=
MU4CH <X]GD _AHP11B+:(DH"#VN=";")P[(,=0B;XZA2>YJUM?J80(VP;CM[
M)D2M-M5ZU/>EG3RCL1K*,56<Y:(XL;YS!ES\I0LO[G-+VQ^EQ[YD[4>+9.6J
MD)W0K4.:9_%TL))DD]W)PO\INTMSN;^X*W+A9O*8RGT>'[-C7NS<C9@EALP/
MQ& 5,!=YB9>$O,/$@A@8D7XC2"R+?X_12<_ .?<UNE[6N^*[(WY4W9[ZDI_E
M"$-:;R9Z$]5^]L"9U/M31#OTSCE\I\&_$LE787J,Z!N-X,IEWZROJL)O@6'E
M-ESB;7B?WF7X1UYN_  !+P0DCA+&(<+,\Q(:TX!$F/L<:2FYU@=;%F:)Q9%@
MG#\EG,L[%@Q0I":7UMC14S]E8NPTJ#HC84"81G&U#IT9!_UIJZGQ_NNJ "ND
M$&THBY$+,$RP%X6  TX [HP0 K3ZA&I^]'Q*T  :J06J1.FI@06.1NO!:_18
M583&N((F:#*V+E70!7]!%T9Q\)HR['YL[_IKU^L]KQ_%,W.;EIDT^UM]JG%#
M2,"P'Z$H"%GD^A SX'8F/1_'*CIAQ)!EU>C@-0<4G0Z@(Q&JZ8<9.H?59'8F
M];1EB$3GSP:>HAJ;87-7;.N!>#W*7@^KCV#-Q.X3,9<^UQ+M>JU J[#P@EP;
M)6]9\3;K2F'AX=(\7B /J1-A:2>KB]FAK)\W?#R*IRJ3SQ_Y>?J5C^E/^2W\
M/3WN>)H?ZX.^N"P?[N[EORH_Y>6_^#'+NN-=G](JV_B<>8 P#Y'$=P$((T)[
MW#% 6I>F+H_6=NU08'*N!2@G;U$Y1P'+^4M:.JDL(6Z%1Y>;>:PUQ&KCW^6!
MVDM[-? W7R5RY]P[Y\P]Y^M/Y_SW6A>=VL<K1WK9-$5PSOR\<NIG1KK:G^]U
MI+,SG\>P';N!6<!ZGIMU3"Q6Q,?34R+K0;9<EI2;++>R04_^+=]EAUV-.PJY
M3VD($7:!'X8>BGW8X"8@\#QOL2PY"JWE+-EA<7[FV7ZWGN0X+K(+)$?K05U-
M<NP\=?IGYA?/C2^%;J[<..FQ^1^8&Z?Q83,W&HC4HKGQG\5>?(S<#E$C3V+/
MC[! 2V$41&X8QU&/G "FM:UP#7AM%RH[T?O6PY+[3N0V$^ES>OC9MOPHV_YU
MJ\N@NO%?,(=:#/WZLNC)V?\I>?1Q^.;.I",?GO_!N70L(W-DTTG1TLJG7U]'
M_E4'N3PRX&X01PD!..8484@",26.X@YPC)-(.XTN W.N[+G/KS/G+_G!^9FE
MQW),6EPHC!K9</T17%\2E#XND/FLA.JUA+?L\[&B/+<P$2^EMS7$1KUOK\B8
M$L6'ZX$[9E&$/8 IHDGB 12B*(%N #R4A!PR0E2/4YHQ9E&D.GSUF>^7[EE>
M[D)E!>:&-,,H\RMY_<WZ]*R1JGG&M%_*+_6Y<Q0A[!+*8C=A+G)=$@>@,^*"
M0.M0N.9'6Q[2G5ZX/VL\FML]=7G25"GS%(V5H]?8L:LY7U[I+C&2L)6IB";X
M2W(QAH,1%PRWFX]B%( H%IKCQT$,PR@D+&[MA#!@6G<3Z7^Z9750NE31%%%J
MVF"7(SUY.*='>P^A\8MS+VXRG$[=.H1B O[+5^..8L+@Q9&M?3&; ## !#+(
M*0>^2R/2VA>#&D -7QFI:-6RO&C=6VC\SDA5YM5T:1G2]?0*?Z!OG]V$\3$]
MU@.<1>1+F;4!63//_#KDSH)?^A= CF)N[-6/K3&?<B8O96,,Q""@?B0TN3/F
M<8RG7/>H:&)&X6.O7/$XRS6$K[YD$WE<QQLUU8E7KA@<Q<FH:P4[2Y"$V(]#
MRBA!/(H\/_8Z2YC%6L=0QWR^Y;?D\;5W$VX&5*5++=/;9DHOIS\F::$T_@(E
M UHRA<!U",DD#X8N"!S%AL9L1/;.$%+UN4H/N_2X*W^_WXDD)*(:@KBU';J4
ML# (W2#Q@4]]'[A=X2027VB=2C)CT7XR;D$Z/4JG@2FO) W? ,U;20WQK#SO
MF)EBS3G'Z^PN-_=XG;GA>8=!YM<A;(9]>C[?,,Z8]HK..S%D>RN^+#<>) $+
M& ]1S,*8,Q(1UAJ*$41LU*J.^L?/M[(C,3DUJ+'+.QJD:2[QV.%K]#*/"E5V
MUWIZ0E36>_396X?.3''@TKK/6"Y4%>3M82N':AG+FC_?'IXO2W\J]GM>'.5^
MD@WU"6>1;#\6,A0 E](PZ5"(<9U6&<.T;<O:T\%U_M(!_D\G/US8T"%Q.RUP
M37TR'A(U\5HR&GK*9B$05M1/D]$!:;05FW7HIC7OBGF>\!$;OLL/#U4IAXMB
MV+AQ&?(1 *%//>[)G>4,H<Y.+*;&FZ:7K,@)QTIQX*9M0^=M?0I'^<4EZ;YN
M;9Y6SM?L)C_4/5:+ZZY7[E_*&O:8G==Z?"J.YJR2J#F8J[%<.6=H%MB2?$[&
MT$!N-''KT*,)^%_:MSN!"?5YH)'KV0GS0N1B/Z:^BSE/@BB$+3@<APR,$*)Y
M@*U O>:>6)G@=7 R-FO@5O+BS^STLTG? IQK28R\."[;L8>CA-2\1[7"=<W,
M2';(KO-*MC'; .)&Q$70]6,_X$Q,6(.NW(]IB-'F6W;\6JB7H@R;UY&,<Z3J
MLY3N(I?ZZI=Z3UUS^OKA( +<W1"3'^09;+DOZ%[\ZW+L&,AX<%0+7@M&1;<<
M)KEOL#H-V+:1_Y73C:[Z=HHMY.%6G_:$78/1UR3<1G!6)-96W'M)ENWQ.%&
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MOP;25]%DEJ@!KZ*4]C*78Y<[1L=D'1INR3>=I8V)#)I8T'@& 4,< \Z9%\"
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MU]-B>[+V]0427L[?%]5ZMX*,LAC!, &IRS"*DMAU.Q@IC6,R0N6T8YA']GJ
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M3CX7BH&:@)ZGWQX%E2?SC(8:B(@=*FK"L<+X:![9//2%<,,DY'/H$$(6I#1
MP,6T-P==HG36;;01XU/:4U?,D0U#E6F3G=7.P)CJK+8GRQ[]>HNFL]/:B<S:
MH4W3W7BKY>@T7J1?BN!BMUV76UY(;@^;^A_KLN259#>G7D$"7!<$:8 APRR@
M(,9I;Y-07VDC<YHEPPK4HQ&;E.5AO5-\ F(:B7)2-!]_:GK4XW(Z8$Z/S!YY
M.DO=&8W20[D=0J7)E^</.VAD2'XS\^XNK_NGT41_X'Q_D^TW^<O=5#\*0Y\
MC-R Q-0-(9_[=@"2&!"JMK>IS:QA,?M85)7S!*#J-J8^@F5W-1?A5G63\PBR
M/20[A&F/V,ES>7;'4WM [)!!$XZ]V \UQ)V"0-Z7V6VVK_*'K*TG7[^PX+.
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MOPZ*[?B,M7A2Z!^ "HL!;7^ZZL/^UV*?/;8?]0HD,6)Q&L$4 Q=P2SAQ>SL
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M<3V+@SWN(;Z%@B[W1)]>ME])\4O&U(*G_Y;RO%C^BU(H$EZK5JJG<(93R!@
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M6>H?__._];_#_W&UKK+_^=_^#U!+ P04    "  JBDU0.^S9"9BM   NE0@
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M'-%;!I%C4GF),0TH$2\EM14VTHB4N+_SLZ%J$ZGH6C%OW5FJM<',>0H$)18
M[8VEE;1,X$YI>/<B]U.+WH%.*'*8T_0P71Q];+-[%.9F4%[GL\]%3"0>\VY6
MI:JV'>\<V5W&&3/*<(V]#J\W8DP0LI*6 4M)"O/Z>E[8)><ZU$U7<^#K4EP.
M[I\DZW]E#MS=,$-8.DL45MQCXI&P&,A*6LYP2O1#?2-_1];%MTB_5J!_ZXNM
MT=H1JIB22"GB,(, 5-)*8&J%.39U,GGW+$WDF4Q[K6CB-)O+=].OH:=B2[;@
M[WA;B1&+W@"KM%<",8LDA"O/0+S78^CIMI4/*JL#1XU6&92(0"LEP$@*Q2E"
M7*]E%4:#DT7F]7*;6)L815L*Z&J%VHSXX^"OWX+!4 :X8H6QBZMU3=5=YM#^
MQEG RUD?Q-4.>TX(1QI54A,O\!D&A#9*AFT$:PKQSGGV1U'^^6X:5M-A/CN<
M:-M;9R1\,W1.: 2%I3'G&5>5W- P?L;;P%:9UACDG5,MS/_CV4T^^K4H1H=3
M;7OK3%I(G#):V2"HI1P*N)';(-7-/N\,J=88Y)U3;?>1X./',L4-)E JKBW&
MW$$F":TD\4:GD.?PJ-)N J@Z(<_AV)YF-[:[3M=WO!N#EA&A/=,4"2(@1<I8
M&(P8"XTVAM<Z(F\.J8=[^R]%>\AOOBU)]X$]9,8RRYWWRDH..:$R;$ JV:F&
M9W(SO&NB%%THX\BUIA8)UTZGB_)36 7'PWQ+MLEMCV8,2RNT49HHY"V%FG-4
M20(X2XDG[QFM6M%OT2B\'1 EGKVL!SC;FIUQY_,99Q AA+5',)A9CG+JZ%HF
MHZ0Y(S]1FDI?<B,9S*,/8E?Q3GFY'DB</8MIOB,-68U6&> R[.B8<599:@P$
M'E5OB0':GE%L;@/Z*]K"M<,CT;N\G-]?3F(!R>G(_>=B?!?G3'W_.0QD3YKC
M&JTSZA3!" J.-5*0R&#LDPV6!*6<6?4H*V+;:U%[B)^<:7'<>U,*UVB=::\4
MHLAPQCRU&CL *DRMT?S,2C\TRH2Z+#L:[0[S+,9L]\.HOZ7W\CHHM%:2Q:W-
M,NX$H  $,#TAAB-"":LD=4XE5N_J7YK@1K7_,LUB4T"W:5?OFL#-8)G@>/9^
M1_+$@_O(E"3$.DJ1EHY30XGR&T!E,$%/Y5M^6\MDV[AW-8T]34&JO@[&DXB'
M+\I/@TG^.2]O=TQF^QMGX66%P C@/,**:F60 Y74!*!:$1#]7RI;9,,KQ9,:
MA;S[\]DP]#"Y_[7+"'OY<(8$Q920F!!16^(4(K:R,*QW+.5:>,^L^VZ(E QQ
M=S-44$Y (<J]<RYZ>"P##BF$O;4F%@5%2B)0K>^. YCBENS9&M?5K',TN%W1
MY-=@++XO9K.+:9P(+ZZ>V)8;PW('@>IUD &OL=;!\ Q;'2XX,V%RK:1'(NEH
MOO<Y>]J@5BNP=T6Z906)L,<(R_'T>GU)80?%7GL\(YQ+PFR8>Z'$REM'@*HD
M,P:EW"Y)2LGS5@G5 ,@G.K?/Y]7+\#$?%M?3\;_RT<4TO@/S^]9*OK_Y4WWC
MM:&":(J10 0 P2W35%CFC.3,GC"-R6Y;O=)UC;#KPSK*+(?" ,X$DI(X["".
M47/":02]D2#%$=[[/5=[]#EH(Y:HDRYW_VN_V^,IIAK]'DKN:)DQP,*"#9#@
M@'$B +%A!5_*BR#WMMM]?VOI*-HFPRN<:P[T$Y/L8SZ8Q!7N>+(][R'C6A .
MC'<&0B<=(8#"2GZ(4(K_O'\I=_K!O40=G)B#OT_+9!:^[",+1J94C$@B3+ P
MP]L(D:DP8 2>B8N]'P1,AO\TQOXRP^+?-0VV7Y"37 IB4%C$!->(>(ZIQT(#
MH#50[*@Z*UN"F]:#G%Z_SP>S_.++9'R]S=FX\_D,A8TJX8PAZ2V1&#BIU'K,
M1@4)_K:[CU%PT3STW:TZ*XU]C&B$O\?S#\5TN#=E[JYFF8&&.X*4=Y(@$A.]
M<EY)BKD\ZW.0UDG6@@:ZXMIR0?FTF([*^T?+2BV^[6N:&2,L)X 9::T 4C-)
M-F\712KE\D"/[)D3<ZYA+73*NZ,8][J4DDIFF34> 8VXA]H)44GIH.JV)D+?
M\U@F<:T)_$]C/%=G1(]#QOXVH)]2 Z$P*5",H+8*AXT6QU6.]L 8"6L5.6IG
MQG@(R]H>_[<G!7/=+C(!/+6<8VDTYA1XX1&N4$ 4I5A+YV>2UZ;,\PQ&[6CC
MY/'BC=U, $I;"8R0$B !F2/6NK7<80+79[(Q;(\.1UQ-. SRDU.ML:L)4&-&
MA*,>(!"OIS,F8"4WT$E9YWM(M4:9<,35A,/0[HIE>A% &T^O]UY&>/I@1KSC
MVN@P^R..-/?(Z76&!*DT K5.TL^ .\?HMV@0V*YHXA?E=#R/!L T& W?XD_[
M[Z]L;Y1!8IT'2L5\F,8H*Z&WE906G2X_TMNC3V,@=W<9*I:YS\L-"#7N0;W:
M(@.:!($4HD92I!R'S*M*/J3]R3(?O3T2-8-P5PRJSYSG\G@7W@%!/',:0,<$
M-U)L)E=O4IR3/0K([8(Q:<AVQ93ET<]-,1F]N[TKUWEZ]Z];.UIE1#*!E82:
M:6& MYRPS?+LA4IQ$O0H K<+!C6'\EN^QNN!)((@"C&77AF+O%O7/0O;#9"4
MDO3P"I9OFD\-PGSR+?[[';=XZS?.D,+6>F]HV$JH(#T3M()28T]/5HSBW'Q)
MQR)^<I[M*Y6YNV%&, [O*")"<HE]V&0(L7FK&$TRI]Z2$^ (]==EUC$X=\4J
M-1PN;A>3&+GZ^,Y?^'F2+[4Y':G;HIR/_[7\?*N,._C7U%=DD@O-"16&DO#>
MASVQ *1"T$.4<E+<WVC?%@E[(L6<?,+<G5IW5[/,*<TQ)(QQRK$33%I2[9 T
MM?Y,BFZ><K(\'.73A"1\N@EO1DR_\-N@_#-\%&R2[3'1?\<J/"O'2I52P&'O
M(93(6@6JW-M:2TYJ7=<_+-CWT=73M3*VA1S4:)5)&^8U8XT5F""ME&3<5>-'
MFI[LT*W%C-M=:_Z5*.!FM-'9:<L#1G%+&T>])[)@2XLP'5)",:9>:0*DIYR!
MJJRZ@8B?+*5.BVQK5.W/#UL:@;DK&GTN!]-94-!#+M'Q]/KBZA4A9M'_,GO]
M5WM##9K\FHPI[(EA0"BJ+<#&,;*V![5U1IXC81LC5]$;O73%\-\__5I\S<OI
M[7+Q*.^*<JGT*+&ZSH,H^>S!LMKKJ#VBMXP;"B"R$"ICG;:$BRIB1%OJV,E<
M(!WP]33\*KK668?GXK=Y&=&Y'(3]39U3\9?/9R;F)C#88FMX6,N<@G@CFP]2
MG\KE^[WPL0FM=,>XU?N2/[V56X-Y.]IE#$%NK0,<.0B$!YA)7\D*@$A)U=[W
M>E0]86!SVMG/Q$.WSKM.MFJVS( PD!$%C+<<6P0X!1MD).<IL8=]G>/:V-2T
M W=7D]=KOK,#TB35:9XQ+0-N6 N+F5!8,EN=&FNK##F3\B.-\Z!H'>HN(\T>
M)Y#P7S^,7R:1J$&WPSK*$.4T[/.X9MAR&-YK+P,\,LS9.M[6.[/HZF8)\DJ@
M6FO(GY*'II@=RKC8)#,,AV_AEFK(L<= 25JY49W@\DPROK6M_AHL.P+M_LQK
M27-9IJ!D&A$*XI\*:N: K*3&1G9SW/X]<"P)]WZP;4\FK?V-,\%5C. *FR7B
M##,R+!&;=XP+F!)#67_'V75P1R](=P3\IR3=@33+.) $>P^XIL1*9I3$NI*,
M\([S2YPSHPY$NK,(MV>Q&(^B-/:;_/L;9Q08!I#&5FO% V[:J'4@JO;()<5/
M]G"9;-7,;QSM4W'L68;$51!=/HK&I![,=@8!'-I59E L:"40$5I"81S0"%:(
M $:[K:K9>DA:DQ39P[Z&D>\)%Q]B/I=AR4_7!IU?%67^>?#M>(+6ZS\S1%)H
MH<44 ZC"'DJY:JWP/'QR7K/FZ5C;BCKZ3N6X&+5)Y2?]9\1R@R1FD&$AO10>
MF<JEZB'"W9R5=;USZ2&C4[1R>F/TJ91'F:1/N\@X!$(8&PPPCJ6$%A#**@0D
M]9W>D^ZBN&B'E&P(\Z-/9G=GX'XE:?83ZV7;J6U:KYF,#@-K'9;.6VJ V603
MT]XBWNW=B+>Y$>I>#=U1<*]KNHEN,P<]5,@;1(G73B%LZ#HTP@#D=4ID?@^]
M/3TB89(>3L'"+2[K)KK-( >4.4 (DTI01[6LHGUC(@3<38FWIR;A]\?#(S31
M'0\;8UZFC;<*0@"!0I!) !0EE80,)?D?#TX^T869UR.N'8C]:2XJ+N/*_KYZ
M6#$C6/W* JV%D]+BL!74=+T%,$8R4RL<K)V]X9Y*W_'GST%Q.GS[GSOVAX=T
MDP%)O.'8(<DX!= A[$6%!@(RY=2U1W$D75/GL!+N*1KIRF_Q4+0WEA&?S5?A
MSS78N+MAYBT!DCKGH&6*6VH=,QM(>;VWL?]NX!/SKU$==,6XAT1 :C@L%F'$
M'XIY/GM?#);W@C:%@3[FPWS\M>[DF-!KQB!&&$,B/(Z)72U69IV)TU@H]=]%
M49K@:G<*ZI[(\>V;!D[<FU7IC=I+>MTN,D\05QP 2S#C@DBAG:L0$)*D+.=)
MWH_^YR5(YVNCJCEYCIPZM-S?.*.0( &1"+NC:,EXI36OI,8@J2IPCS)MGIB#
MC>OA=&O\Y> ^OC;QXN]P6"Z"9A]J%ATQ71[>;8895IP#RFW "#$&C8854@RC
M% =R4B[/[V$*;5U=W1,[O)NCQ7#^QZ LP\MY7PER?P29ZW65Q3 DI1SSGA&L
M!;(!E0J1>(LA@<#\;P+O)G K*NJ>M,MJ<6HVR^?1YGY>.^X(ZA[2888(%P)I
MAQS1X=V&RLF-I82@3;G;)/ZV&;K431<.[\5L/,UGLT_Y]3+7SG3T:UY<EX.[
MF_'P$9A-N;\/?ZE6X_J8W\4S^NEUC9CS;4TR0H5ES"#/D$*<4@5=C-@C"GL
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M8++8%3=8JWT6-FR$8Q-V79 #(K3VA%:R"RI37+\]M&43]?_\&*L%A-]BNC3
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M'0:+K]2U'/GR3M;%8CZ;#Z8Q!<WN./$=#3,$J&/ .1YVOU8;0A%U&VDA3CG
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M4;IYC1Q.*6L!#_?'OSF:M0OW"<.XES5';XI)T.1LY?$[63CWH_#[EZ,Z+(?
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M$+,\YA$TK+(@I#5)F=1ZN/"E$.+ES:T6@>YLCCH@6/EE?"RT'', &#:Q')N
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M0Y$V"%# -J:3P$G!"#V,E.J369NBB)-<KUQ-\FH84"IWTG!'JTP)R*17 H"
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MGU\/)K\-YM'F>"[(YZ 7';[VSQTXU&J?A=TY<%IJ"[SA@'E(J*SDY]Z?60:
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MY 6_H4R**_<X[K5MY:X<V6^U'RZDAR4V/M*8>( I9(8#9"6%VA&BD/2L7B6
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M\X>?"9P:BQQW7GHNX_Z%<SN\&Q#_Y"\D>+<3GF?0;;#,_^V5=;X!^://!8H
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M#4/+O%T46QN9=V1D\()3[+&EUF%-A54L$G2[7X&8!#F:]P2?@4>4>=TP8&#
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M+#0&,,M%M6_K4$ZN3GV36N[0M2B^IO+7GZ>3R]<9R+(I/QKB'DOR]F\H@0C
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M5!T.-Y'"46)^+'X4BTWQJ5C^F%\5;SY^.GN1G1D9E"9:.ZR$])2G7%;)*BV
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MQM-=;^G@_!GQE+N79W$H8)+H>)MO<9!-'2NFGSM;-%C9H#CU6(/WG&+O$EU
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M)#+8<P1"O3.")DZ!R8=W6>[Q@I'[ID$A%KVO7SNKNOH8B+=N88+E]_':)PQ
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M%1KQ4=(Q$OKTFX;^$=Y9Q3E/QDSR&V^8RZDE,1!1:$F$+!"2HO$Z61(RB8S
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M'/'$LD<S+?(;9@_#WK';9F_KU?WFWIO#@9#@.Y5 1&;WH9/_<>-$TV+[#88
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M=A^[]AS7]C NRCP>5B0$9SJ_C$-0J=V+7&O2[VM__M.KW=WMM_83^GOG[7H
M%T]4I ,0G&P$@J*#_7(<1&J&?QYEEWHRU'D'M/[.BTXPG)%D#'5YA4+6G<"0
MBJS*0WV@\POXY#"O+L!6Y%/1=)W@*H;;J32 ^<AU402J#';VMK>#3UF>X\!S
MD*5.T!OK M9TF&?9UTYPT@UV7F^_VM]X\>+U<WKB8?_OO>-/P2 --^?N".-\
MN?=\&U[[]TJGH>9[!F?PD\-87V1P]V[P>G=G=Z=CY^&LFDZ36.=F&NXHK0^S
MLD?'7SK!^8?^:?_=\6F_$\ VI\F /1]FX > #>%=+PLWJ<H*]NX4=GQ<P/+C
M;S/8EQ?TJP(O0H6AZ0ZD$JPX=.@&4Y67,5Z('Z-$C+(DR:Z*M_79*=4P 5V@
MDT3FXB_/MI_1W\54A>9O>=.VZ;K.^ ?SJKD$2U!&YH97<52.WSQ_!?=!.U]&
M^*7\QQ;]M/;S2]"2<:@261[0)\]N;==P&<SXT<B^V>:'?N=*BB;?WMF&_[5I
MG9V&^,E++7Z%MS>\PT/(XW<Y-=V3D^/!T3GJS.#X77#V^>3DXZ!_VO*:M&1;
M)%*/0[)>O_Q72):1YSN)UK-?U3)(TK7><'JA+D@E;?Z "\7C^?.?]G;?=@]Z
MI "-IA>E5F8!'".RE/RC NV$RN%0Q8\,KN".NG%)@=<4((*D=.&XE*.&C:JP
M+*PY.9$/K%6%2W  64IZ%2S;A-4QW"**61L7ND2-#K9L3AO33U4*QA;^BO 3
ML'(Y&CSXLT)W#H:)H\K@/\&@XJ,FBIPO]@(T/59&A8,)8>TR&'JQZ=X.;X(&
M?3K-8GP"WF6-G@SO"B8EAL\BWZ]@OZM81\N ]K<JQUD.\QZYG\$HX<H<US9B
M>^7N929I,WA7Y?@*DRP'TV_'<Q73'$^FX$:RC8>_1QJM'#ND10GN:9"HJZ(#
MC_B]BG,\K-KKX36M&PJV,45A]9_?/MZB;<>LE-)]*J7ALBNE<Y#5']9&F\%Y
M?7/C46PTTF%)VL>ZW1$*MU,*:@B^=["&WXB2Z=N+#N&G5M7@SI"M R*?5AKU
M"3^ =F!YE05KN^O!3"O<_N>X[=6H1*>^H77H+K!+,CQ,PH+ /LIU"J**MRFJ
M84$.=BGJ#(8-:C18VUE'Q21!*7I*)ZC2A#QSW.57X(O2)7%*(294.>1ISDB/
MH(,)G^*HXG2U%Q]Z+X;+OA</0'K#\0_NQNMN3%[#CX1M-E_<<&?8H0]RWQ\=
M\6W4'6Y6^/R.3E@_1@T@NQT]%*L'FKH'50R%I4!Y3,'7X&!:< 7W+G6*P:D8
M3O:@<Y0+4D5ZI*J$_!M4DYGW+-&I("L%W(S4H'NI#NG,D8J3*M?\4W"B^$+R
ME7+VG\S]T1F)V9/C84WA^5FT&=S^]<B?R7+Z=U:5_*K^FT[ACGGC=9="&R[O
M0?S9K[O+H R_Z]Q]<CKH]8/NT6%PTOW'?,3R<8K04AO4I3]QG^08*[Z#>]M-
M,.9( 6>*.(+KF1?HYM5/=D-P=B]!YY+ R?FX<=I4HU&<Q* ^"U:810S/5F 8
M$E5@0!-5=:XB35XL/Y-TNSE9!L58\9-(J2Z%_EQJX7\2)SN2JQ,U0T-]AVWP
MN7GFH>A1U"%!IQTP51R/L/LB3B\SVC<HQ#"LN)A6>$3*\@BW$/@<*L1(BL*L
M!NT(<DLJ/BR"N$]U&(]B/%1I.$:]Q<#491SA0\=PJKKD,Q[X-D45CO'Q$W=\
M4^#D8,J/!CU2ES [WL:$JU))"?@7T=Z&QV$4+9V)QW4USN F"G>21)EP0ET0
MC3,6:0;_+$I\%6^?TM/Q86]NN67O(3-3VPBO[3:^6Z[F,PH5OF08YV$UJ;^H
MG8N)^JKM:;DPTRAB$*A)5F$@#A<8OC)7V>.TLO[A1$]@O2@62/E=TJ42WL*8
M&*VW>X[-"L=%4?$1G!;9/>/^\U\/,LLXZEP7.K_$L"PZ^#BN#LX<O#6+8PX>
M=Q3KHD-QVPKV"#K[''$,IE4>PFRP+1&SL5:LLR?N)P5W]M\6)J*",VH/'6F6
M;E"0,O9WI>_L;SZ^;-E2&YFE"%D\W&G\4"-HXT E*&]W/(];1<1Z*9[@5@')
MIDC?)"Y)'<%>PB2P:"'<<G+X!8,"#\4S>,H:!XP3*2PP$B3D$0UUR$,%[ZVL
M.#]-F\3%Z>FT#08N+DHV?9@(8)/#1B"XA15H (3,?XYSMY4N],8PU^KK!H4[
MWZCD2LV*9[6?_P#2R"FT6VK"'Q&FP]I,@G:)](@R]XKU7@&:'Q<"%K%$3* *
M6=/'M#)6@<VM4#$K2CT!@W")2LUY$N4XSZJ+<2<85B6Y!? :H#?Q1T,]R]*(
M 0+P_Q2<#-# \#YXY4K7W:^N:\*F'J6NNS9_F^BPS$&#A,:E_O&CY9N@<83,
M=:@Q_R%.*2L/ZT2#5Q..M?ZZ&7R1*-L</LENC'JX#1.[%@33T)&X&6"[:.=N
MH%9D38?:<AX#)9LNT'8J,)6R&0Q&;3_V4]1TA7>=?=$V> ZF._&#,)YBP!$/
M"[#Y.7L#BJ*7:$7YT0\9AAHM *SWP26I\2SM)A,.#Q>YFOCASFQ*$".XRT4%
MYPI<8YNO.E*2\EGXS&Y19&',)L \_P@&T%V NEH>;[\A(X66?/W\TC&X;M@F
M)P1%&*KTJS_C8*C@B1FYFK]5<$44AS[&ZW,:XTR?E:2V*2ONG^V<S [12 Q_
MTYS_Q_,(:7,\@^55:,\?\#,R('"NR^GDB7OJ2N61G/+P3YCTE =J1!M_%J=@
MFW"8>$LP]90N" :^JT"6OB[=(,JJ(,'E8#[BS1/OF.F,&?GO9FS>P/C^X)CG
MYL3$+LD/S_Y-+Q4D64CB#2H%07??OTY-D(,<TYO9#?2VFN-\A 9VY_GS?X6%
M-7;]CA9V+5Y? A/[[-=3],<IB@#&IE1Q(NGY$ ^?*.TH9;!3$/$Y @M<N+W"
M$%V4,C"+!6YD]N[H$A1Y"A&P)[@@QD026I"20!BP4=ID.^&/X+1*4*P-TE=C
M90H(=/\;G*[3"QV\(T1ZL-8[__O-6GXEU'<7ZB61ZD%JPU)^^,G*%MDI5/(8
M9D%!8Q_%(D[H?,A(:/G6GGTZ;;@]HVG5%/X+G#X4U5&2*3**N1Z1PT78::V*
M"BW@I4HJ2@KC"2A/!7H6I_('7QS!01+!?8JCNEZ$M%6'4[H"@31#59B7P5<P
MEU[&BE['Y$G""HRQO>4TJ0KON:OM]$=LIR793W6_(DZIZ(=-@\-DS0L_R2^(
MO\ZQ8"(R 1X_'C3%PQ:YC."LP892T[&1^$;^@JP)B6N+[)-L]P\'Z%V-<6.'
MV13.0O._HQ<0QS77Q10+'%".<9\D./)N;S!PAQ4X9U"I(H6_T1R*X1$L""F&
M25P4XI)YKRW!]/D1Q(7-GPC^U*!05'3)YM'SUT:P_,[A@VMY *O=^0?LSLOE
MV)P+A%Q_TWD84P$>IF6*$M&:65Z2\=!IP? C$%?<:V@6/*'7?*)9X+6QO:@!
MR]WF11^!4:4K&7UX&5T2$3TS_A;[65B]R0%C%#539 ;Z4*L<H\\4Z2-1X\HP
MU,"UA.>;?TE$AWX4IXCYYT#LG6=F,<KG.VZT+8D7+*&=_^</AT7/O;0\V!W0
M*QBD@]5!*Z_SA&LTT<&&G=<>_, ?7&19)"='7.P:-L=:>+@+EH*R'5QSGF@'
MBWX5_BC$:]9-F;&> S<PKMV$_TS&P48 6P)&/L8!7U %9ZJL0-?-T,5/Z=_@
M%%#L9IPE,7U0N\CXT26YW=_ IT!> [3Z\-L_(M7]\ (Y?&("68 $8-%.R/ $
MZRH&D5!4"'(7\U,BJG$2,V#7B1SFR1(U(T ,0VPY6QFGHUR*%R3ND>4<'XDJ
MK"XR6&!U7<X !6Y>>/YE><A'*)3AT@JEB9!=O_JVX"XN ^9$2#'.A84R-73C
MM>X9P\)0;KGFY?8R;0:99@$#T[.6C-)UXOH8_+JE3L^VNLZ/S:N[ >P[4?EL
M 5_$.ZWO (!L),4([1C<^$"#,:%XF/RX5G5:R(\[P=4X#L?LE1:E2;2(:P(K
ME7!U'&%9))V%29XBL$6ZUPS%.22H.%Q>B>MH;WH'V*0\CB\6"]D-?Z]BYFH*
M>EGA*#B^='NUVCV+A12'*4( 3CD6!55/[ W9R9%\(3_2+Q^4_Y8[4<J9G'6,
MAAK IR31(W,7!R)%38ARPI#5>9P=)[ZYI-A-$@Z(O#\;"%T(*WR<)\UEKF#9
M6P:%Q+C-XX./@_==)-8YNQ'?]1C$8JD-U=)7I9R56?C5('3O4IQBP/<,O993
MKT*7C*-NJ*XF*B9FG*"H1J,XC$GAT@ <2IAI(&"@Q4B%F/@'!5V@FILYV'ND
M)Z2S31398>_MW2QUA(UWZV\A^H-6F8/RAN=G>?.@NMHEJ_*5YB[YJ"_@]-JS
M</3[V"@^ X>P;W0"IMY X48P3$(D'+"78(92C $29$"@]?AC&.L%_,<8+H"1
M7L!'X!)QV6W-M_.VUTK:5SCZFY#P<'(/SL;Q]&ZP4D_6QUDJ'#4.10J?\\G!
MG$HB?&QA'NO3R' =3:>A\'WJ'5MY@^#)2PJEXR;PG/1 J!=M\=?0&935GECA
MK6_VDU#7@@TPQ%+WL2\P<LK<"2Q@V62".4M0_%ZJTGI-UD/B]! 'V#RJJTX
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M"T,27LT ]AHQ7&J'_:ZWD5>4A@]N>2^7W?)V+13F?M/3<P!>[0-XTYF'P;&
M&PQKD'/)IUT+HZ\Q=1IX*S%K$?E(56YDHPUB_O:[<@D5(?'XT^&^WFU]FI72
M [=V ]B&4=S Q))3?<N^CX*Z^^G[J]<J>MU2F\AFI"?$)O!#<^PKP;G8[!I9
M60R+L$V&X67$"4>MC[U[C^#>R ZP;L^$[B#3L+_SL5,&9B>FA6%=F-'1F"LV
M7*G:.ZK:JV57M;A<1J=]5%4:CN]4MX%'HXLT_J=Q.*I4^O1B&K0HLC F1<IT
M -ZC$WETO84D!Q94(8T0BS=8GN7 ^X8JVKA9,58.8Y=+TV^!JB(Z%G]<W]>_
M9;%P5AOZ>,H>U7CGV^_(]L)R!B!Z3_(M*]?F@??;MV7?;[VQRB\T0GKO!9#,
M#OCB; ]'(OF8Z!X==+V3%YH'3G^X&AE.:&)\$[<:_'LI)'N9V_F]6 ;!GDN/
M7"?II_WSSZ<_W,'OE@W[[CN-1")T#RG90<H=FC&X8$[;9(;0HL7<T)=[]R)P
MW2_016?1M3T#VZ>_(:H<(0+8807]S3&W%I7TCK",@B=Y)B4W+];GC^BF9L$Q
M&&N#FB='\8J<39O>$W1^G<Y8BA>\)&"EY^H0;+F;-:%TIPX>?<K6APIV0[@;
M+?\[97(I!84*"%>W<TTI E<A^"8<!T=ZS-1<!-Q*V3MQ^4WZN#ZBQLZ%'Z,K
M']G *@_=,J.S>T G0^[L1+&;(>>5\ ?\*AUF32=?Q+;IR^",-^(W,IEV7W6?
MTW-/Z+FG_%R7>=??3!QU;6?=#HN:A2/VVI%3BM3AT7><>10+B&FQY)U3J3 T
MOIC!6A3X1J6D>/DA&)U"25C;=8]UDR#)':R:Q+ JG*XC/#WE7,!E;N\#>Y1T
MM+,\3"I':I495X2\M7"/CF27YL/1;G4<G)RVE-24^)OIAOE=;Y")MO"U<04-
M3GP3GH0^9'%3FWFOA3&?T&SB[$VPUEUO2;-SLBK-/)2-1RD@85JI?:&%.5A'
MS)*]GM"#68*^<AB;"*]]S!JR3G$9JPQH"/]9E=JCM5KG7@U(W8$SV9&:/?B;
M>K2G*4FU'9(7/:9A/7#:_[[T-:I#$0-D :RI0PKL8-(7%BE>]UK?:!V)0O$V
M"%7V8LP )IHK&T (X]CL%RK5HGJFR-VIMB5X>IM5#D:WOZ0,?S9ZR\L=XYWK
M+&LN1<QL9UP'+Z V6GJ!Q/I:>SJ>%>A?U,Y4/D5:X0Y=L R2I7<JFOGB>0/5
M+[N"X3K=#L^4_APX&D?35HRSJ[05A);K1%\JLCJ2PS$YHL+V'W.,Q,:>^BD2
M^W 0Y&QJN_.-U:4/0>-:M5 D&$O0L,$0S#!Q?./"F^Y]-.D=TN^,MN ,!!GD
MG.^M+"/Y"65Z4#LVM/A\L=S<3V^K/-X^6>4QWVI.WAI7^C*& T+9NG$'1K2Y
M[4%[7DAY2GJ.4YJ'FJ4")*M]4X\3S"U;/:;+X[[.[H"GDG.\Q-0)FIY=K2_W
M"$-XRWSP>OGD#EZ'W4_=]_W#X.3T^/!S[_QL6<]09]S0V.687:"-#:ZS*=F0
M8-36LGH)$[\4T+9<L%:.&CI(<R2%.6:YA: &1!$29"IAU8XD?M,R,:<!.>_P
M8ZT'S>K$'3,.^:8F9,@Y</8 ^&9M_;2M%\\L\CAJ4Y3-)QX_;NEG=GV B'_$
MN64F(Q3(J_*_AWM.Q07QJ[/L(H #$)<-K[B6>Z^-F!IUHF. :ICX:FA^J E/
MS>>@0*OB Z)=(F'.FN\8V"32<?7BY@$,X#-]LL$%T,QUSK XSY6QJ^"]N+3T
ML8F^N=_.(6/PX$?D%KC>-A#0:,8E;J#?M%U $C09<R]!7IYGWI:S3N2^M 1U
M)Y.&D7;^J**>9J^Q-;GRV%M3.;,RDY,YGV.3.?S#ZWKA"']=<\F\7N^/=ZZF
M*,028VDZ>"CIA\WQV&""J5^!"^ $W6Q3\1VB=6+DJ42V12IO:=5D$C+!4=D0
M"<40#!;)D]'&L%GPA(MB/JXB!:)6/]JD>5G3B_;EL+M?BO13TIM8AD8;K,.
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M7;"DXO#F\*?B& ]'E.PL2_U@HPVDAU[@@< R7>++>*2&*_KQAS:(P^4PB"A
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M>PIQE3&3OW0,6: AXJ<J6WPK@V5W])$JJA)X9T7TBI.X&,(P(RD&<?VX#7\
MO*3P&3@6!F$S$+0\HPRS4/B9.L' U4RY:YK,PCIX)YP([VAM#V%MZ4X]6=2@
MBVUT=G>"SYMGF^^1AF7GY?[;O>V= 'G"]>^;=J;?';[O>HV L,VXH4':>[%#
M'^R]W&D^EDL-D$DI*<=P18Y"Q0]]ODL/[9F'\C^#W9>[=+/=E\\[GLS&6(.'
MTXQO[-%:V/%UW2Q\A ER0Z6-@1U])PP8Y7)20^+07-&6Q;0K;23\+?<G,G\:
M&JCO$0]_ ]DB-I0R)QM#HAFA9S3WS(B)*OCY*+^#E%B"2JK&*[7IPBW;*&C,
MC0]Y?7?8Z\)"\VUPW==$&.RZ[.T-UM_2K,%;-U^[]3V&TG<*V29,43R_0H%]
MP P,N"FN#L^^>!=@4P6S"38#M_N=N@Q&52X,8ZKL&.+44'&;"51Q=DD**;]B
MMJUPK"?H(%(Q?S'-P>,0!BC64HM&(M!+A]BD#B',YF2HF"A\41'G"'8H<9Q0
M:I)52%: N%G#U2;=*NKWE<8CN9[0>*@+@5F)1PGQ]-:&$=&F[XVTYW XZIEK
M$7=[,S>GIVUW.9\=SI22<F^,E@YKU KM=HW6;),"(:AP7=7<KTU_-&H@SEU+
MJ$^:8@-KNHV9]CRPD)=QEE@,>&.?"M/P99R7E79]H>P&Q*X<'=I32%A&Q1YL
M8*ZUKM["R&;U^J&99@=<88+?M=NQNAE#Q06B/:IPJBW3$A<D,YL,45RH2^DE
M,_^JW$6#= (M44$4&LC*D<?#B@DUJ, %GKZ%E<>TG3LR0XSD-WNJT/$_JYR_
MQUFW\U5[^6;5,8AG@4AKXPZP1G0]W,W>Y,( 5!_8[RZ+F+K4]H.77TWS^!*U
MA%!Y.&,M75I@*'!M3+6?OU4Y=4M4/%O8"D93:R(24IB9;*'T</\)4KQU3PCE
MT[YWG(Z00$2;]X3!Z5)(5]%H4!M O+5]M)2K@@'8?_D6%.I,^*_]23-W]?NR
M4&/#B<J_LA(5<X_'-9AO^K+^!\QXKDM:"Y$-:MQ84CM=N$-M=W#CE^F,JPL3
MV2#?:S6$39'ZC%PWJ=A82;H+(B<,NH$@WU[W05KMW.@C%O"P;.] 9?0"J6WB
M OR16[>ZL8;ETOK&RV$-)J"DD9, =PH(S S;4:7TIKC?LWS6TF03U'J5*RGX
M)/8_[B:J4NZNC$(:9&%8Y50936Y22S=.:S:Y<-O=E;C##=?BM::H,V]_6H]7
MJK!-6K'M$#Y)1X4_L$9'33<V.V/.?"*U#U<OX:LK:@P5LZ9P5DE%EZQ\&TP_
M-YTA4=#PPL1QH=FVGC!H<31%Q5KF?3MYMO?7_%=(P$0^GQD2FG*O)RI.P\1K
MB$HLKAWAI&U=&^71M7(U%V^TB,M?A$U.&J>9 T+_],2>$>?DI[R";3K;&,'L
M!!.0PC$X^9[,&I^2JCIQ+@T7-?-MG)[@VZ/TQFF%#+'>6[EW,'1^2&R19XKY
M:2)5*AX+3K:K^HR$=[?)]B$MH>19Y&.;K<16&=OR6<-<I>I2Q0GJQ#EIMV0[
M/*I4Q#,W!R2%4SMI-#2Z85<8?S=B@1DRFQRRZ='PX-*OO))#>T81VCNX$-LM
MI?*WQXY%]YP;1(*#T"V#J)T*I/@P,(W]9NRA%Q5V%8Y),S,G.!$U7AI"09V,
M-CQETWB#S>#SE&K5J7U"I_:\V'=TS98M8&#%2(6DUOP&4PNVTKTK<+_8B4I>
M[T&CG[BSFVD?_=UD-G2$C&N-K%F&Q*$$A[:R;AP7AKKVU=(KT^Y$"O44(BKL
M^GHKDYFE!8^,PBEV#!2QA=_?>YSZ$5<>QBEY]TS%\\.A,5PI-\76 B0JA=/X
MA4\5BC6TX)N5A2,ILK^2=60?+LK"RG6D]7_3*'\4SKS'Z>W<:WGC0V[B!QGH
M@^;\#L&_QNZ?<*):6 -W$Q3DNZ?I>Q]TSP.X==W+?8UST3]W=C:>;V"F]79@
MF\<@2][1PQ*+]B@G,@L0>GM?4^,JX?&4YJJQC]'36+PRF-)_C)/VX!IL]]5]
MJ;#[WU-N0W6"WKOCA]Y5?]AF>I#Y/\G!F:"M1/X X1=7$GV7D?Z_6_]O.=ZG
M*VW50#&*YEW)QY+*1QTN];Q)I'%O9\MQELXKD7O##3U_]>[@X.7V_L'^J[V]
MO8.7AWN[KQDWU'W]:G^O_[/AA@Z6 ^;3/QR\>K$;G)P>'W[NG0?=WOG@;X/S
M?P2'W?/N3Z-1YI;@^Q<-YC' B:3<_"0N.(ACV/2I8=^5UE^360=)O684I"EG
M4VE39"GFF8 HT&ED0EFC.,?07E7 NX&^CQ1"BC"S'0NAH_?;$'/NZ5RT]D&/
M\S\Z8><4>-QY$YB9._=F+GB';$'E[<<]/Z 66.UCY2FZ)Q*BW9M)B%XM9@5Z
MM=M."_2'(WV;;WH?FS.I,8S_BZ',#_""/0S[IZYKP'?5K2!UXI*\Y_S)_F96
MR"5YM5.KM/$E%U(5/IF5C"75>/CYZ"SX7\'S)[JLR#IK(O^:7U9:%DZ3"I/6
M%?;)N8A+^*?,"/-BCJXCF7UZ4M#O!D<T+T]8#NP*>\WD\<59()[\8A\=]C#Q
M]?FD]T37&%.UMB/(H-03&QQWKQX,W.X.SLT!@#-S^"M1#H."SPP#['/WR4!&
M"+&:E>.Y1GQ(>IW6GL*(!@M4Z,!-T@K3Y81&$$0,:*9(NP($-[3:P>7)"R;N
M35RNIZV!3@V%;8%4Z%8T!Z9#]5GWQ$G:T<^ADIZ?/-'%/DZ#8ZK2^6N%/.'2
M '#W[;F#QV-9$P%$$4"3I1M<U6.A!!-/7SQY.?AK]^G*P0?,(+6( 2*_*: !
M:X_5)L'O\IMFQ0T#JLSII$C5M!AG3]\J_/7LB<K$&2Q\$1Q795,J L]$D !D
M)0%L+[.8JIX0JS0BX!ZW1T<)*JB#,]8\J*1P3=7)JH0"":#?45G!= +OGGU%
M1-)7F)4-_#=_C9Z.KW+@)]+IPZ#+", 8:L1W^MWE24"QU(AO4\ZF,B9[@X&,
M*<JSZ0;U4^:?$HJND/[I%FUOFWUPIS2X5P_\]+C<RO7&$+TBF0];H6;N'W6>
M^HYXOOU$=\3Q))[?#._BI+2%@:X%#%E)ZEQK&FK(X1Z+L*C8 .&:<!EZE"B)
M_D[()K'4^'$6#0L;?@[9^>O.$Y6=03H$=RKB],7(>ERC-J5J?@NR!'JO-%>P
M3%GS*V<[5G9H<DW<H!-\R; *B$N_?JM2*:="E^VO__/T#?+_/%$1 E/<*D,+
M#7-F+KA>D$!.B!W@UC(T>/HR=/A$9>@=^$*APJ#B5O 9/+7@4(,[%1D!\D_\
MNZ\V,(N,_AS:-KIL,^@&DRHIXVDR0W'AP@HL7J)Z52Z#Q8(.VPB'BVP&6-(2
MQ=0_#2-1>&20$J'*J^<(UN)-O1F\?BWY:W[H^M,7M],G*FYGYO!H-!6H*/+-
MK<2=U$I(C%+""@?QXB-7N%ES_*EJ";]I4V[@4)V@(XZ'B.G")Z"#9;SRIR]C
MYT]4QEQTJALA\(0RW,':25;$6.6W[AG'+(=OIO)%H+R?8Q,[(ZOVAIMB! =M
M1O##TY>8#S^7Q!SI"]4J,:E\L5!BXEM)S/G3EYC/3U1BK!WKF0/^*85]YCQP
M)UH<!^/HD$/LV0 !TXD,BB#"HKK(R1+:-7L5"AF:MQM;4MZ&?G!['KCW8OI0
MN+W'"L \17QK9*G%$,27S)B*".NB<XUL*Q3+X7 AA6=DM2@@0Z7C\&M:%\W5
MVFUUG.8D);7?<V%&IB;:F*KPJ[J@^QC)\;F<C/,BOD[WPPEX-A7LHRPXC<,L
ML,@(&A<Z6-^/!MYK)R$$V?QA;+*#K!K_"O8#5?R[^OABJD/,(C].W&E+YASC
M=GDU=1J=@M\^')7X+XI.BS20N%']>S7%73U"<[+V8KV&V"T\R"Y21]BB;5$>
MA6EP30<LT!KR<5Q64GZ_X,'Z&Q;[%]HO[0\)6IP%ZC*+(T<W(2%+>'VP>3@W
MZ44'<<?(JA&G3& G%$<Q@]#4HUR_<Z^7*\W!%1AF>-\+S1@&>#^D(QLI6L@L
M@-,G3$M<C ,$&H^TCN ,\2&[0OHARV3F24-M/8ADPS DF.R#1F:?/$OCT-V2
M !PIT5"@:R'*0R646R^)8 16PL(J#-[[!V88[><"[5ZSN:^G?M7(/C&2?M=\
MVTL>E&[VQ8O7W5?]7K?W<O^@^WROUWN^W>>RD5[W]<M7VS];V4COAU7S'UXV
M\G(_..M^[)\%I_V3X]-S9(I]Z*J1.U5GP'AOK,[87%5G>-49NU*= 3/WLU=G
MO'Z]^7SGQ>[V\Y?[K_9>[K[8?_!:C=?7U&HL:.'\%$H95K4:3R1F<"AD6[[F
M>*)1!'K5*W0 VPR- ?,^^1P_3<.I2B^>:HW.N9?> LFF4T/A3L*&%IFH$LN:
M##SY".'/4\E10_F[\@TDO6-F?6$IM7&BGV;I/PP^_41+/Q@,CG[ZM;=A<\M5
M\^3W?P.+8P+_%EZ1FIFX7C],GKP[8&7CK,RU+H,N4];\'&)1\#LKH>GAO(.3
MEI]',?1BY&H_0\IPIB%]JB4W3;U [UVX]_Z?P8F-!#5U!A*IES^5O?@ QO-)
MFXF:K_!AD:N@RI]')3SY^M^&!O#*<1>XB8:-?Y!>9@DBXB0Y22=';I:Q*O6]
MUR4B:&PO*[XKOKA$[]<0P:MQEFAN\1+^7L4%$X)C?Q[KD8@,/OF5'W#9UA97
M<XGM$2;UVC=/FV/&EP[SXB&_>.JFQ)9_4E#3^VUPI8H@+HKJ)P#6[KUZJO5N
MI 4M<OL,FX1E!OGV$RSL_JO=)[JP?=.PY8M5_&CL#(CQ@ !G5)B!>]H6"F&W
MLRV+390ZD-@EO*\Q(W*B^5FLR-E3+0H_]6NZ6]"OE.(H;.FW=!JC O"GON8'
M?WVB:XZ5-"56TAQ*.3[^.SB[7@)80&KE/-**E("L U,='V:HAPA..345.X0,
M)1ZC-$IB;-P'/WKZ G3ZMR<J0#::XU6!E3&2"9'8['AB@VVQK+VQIL9@AQ&E
M;8'R0KQ (*Q%6.(? \K_L1BJQXJ4G\<23]2,6IX2AT&EN7$7]T>LJ%,===.2
M[KY#K[T6-CQ*4&G@\F*]*(@R]A^$%4LB:1#H9<6P8I0B&$B4D&2%YG,($QZ6
MU ])_2#^D?ZLX]P9$/FC<$K"&(=L$TT1]=IAO[ON@K7!(E@V=S:O35,Q1G%&
M:(B;!6I0S%-PYB' ;;M8;F;,:V#G"(]GT_&LB*E-,J<7_ ZBA$K$GK'_C*>D
M7SO&1TNS= .6M:APQR(NT=0@Y-=[<8]#:MDL"4G+C]17-)9&C%8YSK/J8LR=
ML 0._RC??SGK%NZO<"&^4^%".U[]WXS5P);#O_[[+UOC<I+\^O\!4$L#!!0
M   ( "J*35 ?%@!<Z0H  *=*   ;    9'AC;3$R,S$R,#$Y97AH:6)I=#$P
M,SDN:'1M[5QK<]HX%_[<_@HMG7:2#O= FA#*3 "W96:;9 C=[#L[^T'8 K2U
M+:\LA]!?_YXCV6!N21/(-FWH3%M;UZ-SSG-N5E+_K7W>ZOWOPB(CY;GDXDOS
M]TZ+9'*%PM5!JU!H]]KD4^_S[Z22+Y9(3U(_Y(H+G[J%@G66(9F14D&M4!B/
MQ_GQ05[(8:'7+>!2E8(K1,CRCG(RC9=U;&J\?%$?,>K _R_JO^5RI"WLR&.^
M(K9D5#&'1"'WA^3*8>%74B*YW'1D2P03R8<C1<K%<I%<"?F57]-DA.+*90WK
M9L3[7-4+YA4V*\2[U?O"F33J#K\FH9JX['UF('R5&U"/NY-:CWLL)&=L3+K"
MH_Z)[@OY-U8K%0-U@M3#S$:=$I]Z,#<LO3MJ58XJQ4KUP_%A]:#=+AVU3UOE
MYO'A\=%IQ6IE&O4"A;]Z5O)/LK/+?98;,3Q+K50NOCY1[$;EJ,N'?DV?,+U_
M6>]?QY95E'-_Q"1?FJ%?QV:+OG =LX7#;"$I"J\6^0Z32 @L;OWYJ=/L]$BI
MF#\XKA=P;HKTM50O,>D^1,8S^K(QOV&*8[KO3BH"ZCB@,;F^4$IXM=)A<#-M
M4R(P#2D&VZ!L3&Y._!*',XV_WKY]^S=Y_^95Z;!XDASKGLOVJ?UU* 6()V<+
M5\C:JX'^LVJ_%I.*<I]P?R"DI^5*1C0D?<9\PFYL-W( 4 ,I/*)&/(0FC0[H
MMVD4,@*/>WS?D O=OE $5@&JJ$NH[T!GTCL6D>O /&(++V  +G[-W EL)KU!
MY!(^($'4=[D-;0X/;1=0[^2_7Y,VE^&64))IG'ZVSMKPMT=ZYZ3WR2*HANW.
M9:_;:7[I=<[/R*75_:/3LB[)Z<>N9>FA.*9I]:XLZXRTK3];YY])YZR5U^UO
MJ!><Z"=8NMNY//_2;5E-J_L1QW:_?"2M\^[%>?=4K[T9RU(<^B<*%1],3!,'
MK/NJ5CF",1OS+-/HH2Z=@M%VM.'>4R-&WKPZ*I<?I/3KY)"L_\ E,PU-4NED
M/TO88,!L5%D"X! #@@270D4<.L'7,W'-O#Z367 LI:/'/@^QIM2T 6Q;.!XB
M&_$ 6.>^$J0_T>CM,S5&0Y HI&_GR=[6SW49!8'+F=SX')IFX)+DH8BDS9I,
M#I%Z&0W!]<L@=ER/<(339FL;4O !KMR)J M&D"8*=$&EFL2#] G!J+M&_# L
MI6DXD+,PGXS]"2S!"E9>?;*ZUNGE@]F9U2R)>0'N!4 RI]J4M'FH).]'6A<N
MF;SF-HP\'4K&-+H6L9Z F[S3\*Z2/6BG"$;F9,GC0#TA9F.M,BJS4P6,3<8$
M4@(N&4$U0/GI_IG@0:PA4P0B(34"V^>*<?XGY=S9^5460X^N]>&\:VW 0."%
M5B ($6T!61M$_,:&QCXPD,SC(7"7QMST(@7V"P9?,Y_ZRG30A,4AKH(!IT;C
M//NS\48*!(/Y&[HA1EPVU.:PC_$L 3I9?S(O5[TXRFX =E&,P]J"S!3MNQ!U
M,M>-)?0^4\SH]S"@=O(>LV65$&_+\LAR$J @YU!.LN"8.VID!(T)G7*P,WXH
MZ*%SPZ\A'N<V=6.E@<@U\]T9%,HLH=]E U4KFDWO*?8X9RB6BO 'YI<6HO#X
M#.LI/KF#Y!6@V X&]/ :5["V?6NVVF8#[NL*1/A@;.0):=% ;_8-M'DLI!,2
M2(D@:HJ43H0<W(49I05E#T>@R,8A:: PZH.D0']#&[P1T_"1#+1^$1BPTPH)
M:.4I:.7>Z?BF.E[^]71\FBULHN)WZ=T6_.&<-+?C$)>E6WI@*07C*"Q>+/_[
M8*;VT&LR/W(5QTH)1!SH\6R&'O42XTYPKN6]P7[B86?AB3$@X!/CV%/[2\E"
MI8N>6,11.HV#"$>9_,W,D(PZM_C'IRG#.((MGB"_J ?>7R4<,34R2%G-0Y^&
M\!P(CN&%TK9+S<V!Y S7*KT["8D'NXP@G!A*$<(DR!)'%,,7E\&K0STZQ(A"
MD:N1@"8*1O74_C?BIEP-222D_$GV>'7:FDL\I^+A_K6 E,*9;H:] 9W,"]&)
M&!ES-0*YF7,X=#(M+3BH&?%SO-SCI76/(KUROORT,#?@$H2W"FW5'=2,1G=6
M!/D 'A-A8TB.40T$*'#H2/IP[ FYD,*);&#&GL#P!=A(?60 NX',( Q!^6<9
M%:02D@T@QO'M)/P'X$ZEL)\E224HYB9@QNR?)-A=O3'DZLA="LLDF !"#8@\
MM*NXAH,U+!1J&'G8O4?W'VH6]OK[LW/" 2%1E*R&=>^8$PSKW#[6RI%)%TQZ
M7*&>).1BO2 )!G5:N0]GQ<HX<:0(X+ \" S!4P8 EVV0N/"8#)%QP"J)1D2G
M/'HRWT\U3B 1TP0FLK%=RCV8.1-*^K@]/5$7EA(BLW&Y_GH_-H-.3+;"XR#E
MP)4P@I0.:4N$=AB?)TL8M4=H.#6/\1"V#DG7V]%U=:I=*+M9L'/PZX6RGWF(
M\J<^$]%&"9MU8[/ U'D"9O,!,@+]<VSD3:(&2 #;$R,'E#^,BZZ^8S+&96\Q
MYMKT>^9#&AE$\ HF#[P,SC3E1-A]_J-'%G T9'H7# ,62U%8-0'[&G]O"Y/D
M,*LMM.(J4G&<8[S0K,0R+=JG:R1Z!S#(<&J-7V,8^__@*T2A<$Q]>#B9]F51
M &:'.1@*35D12(ZUH%DE!T=J*8%7U!4;L"& PQ$92S1_OAX XG2SFY$$G.N8
MJ>S:L$9;NVLP)BB-Q(_,OHZD C'MSD)EA!0S.35W49+9Q0'K%A\*P!&D]&#<
M0'^^\RC<7U("Z)X@I>R&V5$<6N#Y_$@7G($^&]T5DVCDP]C*0NMXQ.&!HWT&
MPE%5@--\R'WJZO*#%ELR;*8QAC)0=]@G5#(RU87O2/(6OJ3?VV"DBYZ'Y<JV
MHI;58>)=X6/ZEL!(SES)D.7Z$,!]S=$!<+Q&W3%$Y)GXP%NY5/!8WY_G+&FF
M\=<E[$#!K2/:AHQ\,-'HWS]!+7O5?8Z?B=!M N4 -MI.+O8HB)A>9*H>ET^+
M1^W#:J78K%0.J]7R<<5<9&H>'1ZWCI<O,FT;3-N-2^8_I73.R%6G=V9=7A+\
M'G7^89M?)DV.PH'E"6(3IP1M3H2Q2:1&8-JQQ"P&$+#$^8!DF%^!EE#\4!D2
M?1O'6716YA/*U+G,HI'YBPSK+A;<Y^O7<F!][[1_J\A?:U]3:RY%WVGTX7MZ
M4Q_O1[GS=XKBB/U>*<MMZ<D"2SPJP:4;\D /1-*@+_B9%I.O')?RY?)1\5VQ
M]*Y:.3BJ'K\^Z0L)H1E> '-I$+):\I#F$2Z<2H%@"-#KO\\<9M9G/&;#4NEU
M*C^:[ZL>K.\KK^\JW3:M>,N\65>:W.EARIDUJ8]1G/D4K+QP:RS]'BM:NLD(
MHFRT8(5B_0!S=?<-L?NDAX_((XR@!Q"6U$;< <!MPX"L=&KQ^9ZK/J3N$GYG
M%/ <%.+N4LXOH V91G-2>R+"_:_.?%L9*2R0MHB&I"<C!MYVP_3Q.<#D5]:4
M'3J6T-&4D%^0INA_X\Q_8)JS?HM5E8H=UIZ;2SJC'MO!+G45;>>1=AYI!X[5
MX-@YI)U#>FS,]?#'?'>@FX'N#\3<A61X#P@6U9=&2B>D)?PP\IB<7H790>59
MJ,H.(<L(N<B2#]S'"VA/A"L[O[!UK<</8#NEGRG]]*<@J^:'G)\(:W9F?J?P
MCZ/PY[82J.\'I6>K\'/7P!9^N<J/OOCT7]T7^+%D;1'?CWY?Z2E=['N1O.C?
MV?2RKG^95./_4$L#!!0    ( "J*35#A+EW_:2D  .X+ 0 ;    9'AC;3$R
M,S$R,#$Y97AH:6)I=#$P-# N:'1M[5WI4^-(EO\\\U?D>G:VH4,<!JJ:.KHB
MC#%=S%9!+5!3N[$Q'V0K;6<C2QX=N-B_?M^1F4K),AAL4]#CB9AJ0%*>+U^^
M\_?>_]OQ>?OJ?[YTQ# ;A>++UZ-/IVW1V-K9^;;?WMDYOCH6'Z\^?Q('V[M-
M<97X4:HR%4=^N+/3.6N(QC#+QF]W=B:3R?9D?SM.!CM7%SO8U,%.&,>IW ZR
MH/'AS^_Q3Q_^_*?W0^D'\-\_O?^WK2UQ'/?RD8PRT4NDG\E Y*F*!N);(--K
MT11;6_;-=CR^3=1@F(F]W;U=\2U.KM6-;][(5!;*#YWO0]55V?L=_A4ZV]&]
MO>_&P>V']X&Z$6EV&\I?&_TXRK;Z_DB%MV^OU$BFXDQ.Q$4\\J-W]"Q5_R??
M-G?'V3L</7SYX;TO(G\$WZ;[[5>'OQSMO6F_>G7TZO7AWNO.Z_WC5A/^??WZ
M5;/SJO'A_8X/_Z>OS#^FYU!%<FLH<2YOFWN[?WV7R>_9EA^J0?269NCVOT?]
MO\>_U(U<14.9J*DOZ-<)=]&-PX"["&0O3GS<O+=Y%,@$!P*-=_[[X^G1Z95H
M[FX?[+[?P6_-T)T)=!/GUYE3&?M! !NXU8VS+!Z];;X>?[=_R^(Q_\&9;P_V
M7B;3"_Z0">_63;CQX7]__OGG?XA?_^,OS=>[[\RT'MALU^]=#Y(85FNK%X=Q
M\O8O??I?77]MF62^BH2*^G$RHF460S\572DC(;_WPCP ^NXG\4AD0Y7"GXA8
MX7G/SU,IX,<-M<G#A<=1G EH!4;EA\*/ GAHGD[B/ S@.]&+1V,)M*YN9'@+
MG26C?AX*U1?CO!NJ'OPM4&DOA$,8;)<W=IX]G&^_GH! KSZ>7AR+UN?.V3'\
M_TI<G8OSDY/3=D=\ZK0N.\N9V>]YFJG^+?])0>]1]O;@$-Y9>*XP =SO>V8A
M-AJ/(-+:M:0.DT"T@+,&R%T?V7#C0V-3P,A'?B")!&GS@8A5E,4"2#ON RE+
M\>;1[;]/\['YX ;.C^KYH=X/V*-W4QM8-' XSAH?LN'['6CAPZ/[_X^_[.^]
M"_Q;G,G?_"CWDUL/[I?F&T]T;VG*79E-\ #_[?SCF?C8.FN?M_]3?#H]Z8C3
ML\NO%_"'CFB??_[2.OL?L?%U^W*[M;WI"5],AG$(YR^>1+!>:=Y-5:"@=>SH
M,W04JKX4)RKRHQZ>[W:<C#7EX\>?56^H!GX$!]S^?:GT\0FF!NPL6( P/%J>
MX\Y_P^P]6(SV-H[\6(;^Q$_DRD9^)6'-%B'H1S#"69?9_MYJF.-=O/!" +V)
M4W$E6N*3N%R,\A_]]=OGSW-;VWQ93O]KB)\(F.FIS-FRH0\"J;[.S_M]U9/B
MD_3AC@Y(1OWL)[TAM[7?1'ZQ^UIL("-<Y@G%_A8[GJGP\0*  0,OLZ)%:7(G
M*DFSXIX0,/F:^;;R 6P4?]X\) :YN]1#71G&PERI$)5*L[V$(Q4%]T[WO)?%
M79GH^=)T#Y8ZW>HX%IKO!)Y)V&!+U2%.)<6Y:=IVR%P_(R'4?I -04"TBS1.
MY$CA2QL@\8:RQ\*E)Y9,WU]T-XN()F'<HPV#4>/H^C#>>(+J8S=7(3*=]*V8
M0?@Q;[MYT38%K[S>/]@%4OEG+B-XXSB!^7OB$B[C8R4'L2?:P+M PH^4OU2B
MH&Z/]'@6HH@9U'_GE)L_9LK-I4S9G/D'3WOOS0^9-G:[C&FO]H2:$2YR1)$]
M@2Q;'$B!LF'EW'Y)XM]A%F(#;JQ ]E54/"*VO+DMQ!7\<IZH 4C,(?^U>L'A
MZ]7K#.D"_UYEN!ZH-+>H0">R+Q.\]X%;(A^%;J'5YW65+TES7Z6L=313UM+W
M3B!3E?"E-)8)VD=$.DY4=!W*!#8ABF]84YC$R;79^](QH:VT-Q::5?Q!(GGC
MQDE\HT!#U7U-5#:$UX4:X0/)A( W@X^G7*%2%45X:K _?#?-@4*QYQ>PTNV9
M*WTZ/3&^%!/@93!43]3)O;PQN(ITE(I#A^> 3X3?!]'8+/)C[$C/27UJB=\$
MJE =\1G^?R:NU@K4K"&>G7_SQ-7'SD7GY/RBX^F3DP(1:+5>6W\LA<%![JG,
M#U/+=T=YE@._[L$Q1&I+L0&\E.'<,FVQN XMB!C>3\0@CID\;_PP][NA+'?)
M=QQT(]68N7N:X_6NX (GTPK?-GC':*G8[UU'\224P4 &_/783S(EF;@UU\?W
MD)L@S;,0F3YB?T+9S][NWF/OGKEAE1V:IXTY=M$T0VX%TU%S>UEWVUTGK>V/
MD1C@8V0VR>CQ8@1<_ZT0J,AI,,,&4?6)1)Y::A+I$!@]W XWDK8Z!9XF1M*/
MZ ))T90Y %DI8H[/;;B"ALBC4*9HF0<E*$W#6W@1KBOHH! Q^"LB?;3IENVL
M+^ "V7O,YN]JCE=_\SP%-5U::>'"2@L+$50JTC@F:2^!K8\C8#:W8ARGJ4*N
M4ZB2Q.%RH"KY7?9RXGO(=P(9 B6Q/;>.$H2KD1?WK6?N7:94(PL1L3Y,'AKG
M29K[;,,HZ!)[0E&7/+36/J_[1)<I$'J&U[F?97YOJ$\.&_.?8ANU@Y;IIM%Z
MK) -6_C\3]K^RSQIZ,94?85FOUX/N>'E6**/0J6/MU/!@3N!.QYH%DZ8)+J\
M9$%5&]G>[!\:8G64[K:Z4>@;":0CO.H+VS@V'4.7YPJVT_=_ZK%A-Y**9 U6
M/;6Q*XKY#_9\H8I!RS*((]0:TK&6K+%1<<<BB8UVZW*\R3PFD?_,5<*WAYZQ
MP,ENR,T'SC?-0&5.70E%B$9KCH' O1F9\3.CR;ND;EM#'_,S9"!  7BIVN69
M>A4=SL G6<4"!J;GX(_'H>I9>2U+<IKJ5B)#MK70V.#DARJCJ42!GP1Z@7EJ
M(O0G=-%GPS@?#(L_BB"6[ W7BXG+#Q,34QR@$J-P-U>8/N#.VU,BG<L?\'>W
MN0B]_6&9S>RR1)?QDL@PU$]_;>PVZ/=T[/?,[P\/2)FH(!O"CS"/+M"(3# Z
M(?3'J7QK?G"Y'$Z#A@/+D^$%@=U'OS;V,4PE"_"?Q#[5H^$N#II_?6=>JCYK
MOIG][&"W>%;3>,75RPIB69#>JPC2[N]:H73_Q +N'B^[LY.@>21]."YOARJ
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M2%I"6:#_.A#[?790H G?))&67#+%W<HGIN:P[-^!T_]"XCJ>TC3]FYM[W;8
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MJ0GMN*I:7^CR688WZRM>'44>(-/G5+'J\FU3[_]OWN']K]S@YDJK@IG8RM+
M-XB,.7Y/V_)^9T-OH,^\B:$JA HR.'(_IVZ2!=^END U?H5N'_2YDK$YD'X0
MD@^$RH6CL6@\)"Z'SA[B@PA/,G6V?D0J\0^%O'[U+PMY_?GTLMWY]*EUUCG_
M^@*J*[[Z,9#6%W*<2(2 ]S&X< FY6' *76/YJ1^)DSS$TP4/;&&QI-1M+4:!
M+O)54[NLCE5-AK%K2:=D+E,:X5;'K)3*JZ&%'9VFKK#L\"(_+:*X9O?[ J[
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M%\$%]19>A,W6#KYR[SNE&  K\&%@WV*>\#%- ? V<@.?B:!3* 6%4K U)[]
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MHXO# 7'Y0B8=0[*81\9'%Q,_0;CH$0L!54(NGD X!PL,"1,#/(B&(DZ"A"!
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M QJI5ZOU!R#R"$'<+[+?82PB=E%FEWP*NL@\T%:,ILP&W+:>5KM:F?59P,?
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M44F16311TF,^=&OR%@SH,T DL]+@Q@MI/&&D!SY^F0J8X;1IS3EXR_;L4N?
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M;Y*2! >+)>@$UD:5<X49\ 3)<L '?;>8)72D-'!=[!;2X-#XYKC"#XFZE@D
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M5L KG'JED;'LS"R$*.\<<5T.,?7N35#\1O]N)-_[)!'?K9,PJA>&;R>E'Z8
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MP=8K%/^30P1P%&\8C !^W4< =9D((/=-=$&X1$U=K-<]ZB61?36CZDH$X((
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MVPZWB\[C;+7M]$(V3Q3R.K'W(R2%ZJP[OS2UB0Z+M7= /".*DA0Q#]JP&9=
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MO0[O:L+(&2I,$9TJEA1^R_M6H5N7*E$X@FF=UZ8GFT]2DCN]5HP^D5N5#A-
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MIH0GNTF6(^TZ&D+=MBN_$O+@[I/(@UKUBO?^*21X(UE3HA#BY&[-70Z5^UH
M5BF64RR%N'K:<#@4&XH-MJ>D!PY!Y_8<[RX6P3Z98J5^SM(1!X^<@_&J7Z31
MFQ$5[@[(KKA2D$7<R<3_ 4Y/Y*-0O2[^FRS%D2@<A/Y_,31!0.%_B)W_86-B
M(;O_'HG"H"R^;X9Y")@ EYJX>*CJ1"I^*@/J7CRNU@@;:%HD)$0L)]F>!_:A
M?L]M]D/]RYW>IW]FCSDC.RI7^\SU]]Z>0N;WE*M*3)VT+$M>HGCKUC>?_2B
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MOK[*%DD_CPVVB3!;]3DB[F%<3BD0TJV@%7S[D-27S57QPZ]]R!8XB)S0R?\
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M9W=G)+YHIU^^MY6<:R-<U$'[0H_4S%5//)XPQ@._-YBL3?%G9>1 :Y1FU8P
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ME<$6[>RCP9,9$$$78(0/2AF?JTM)X@;J5'R8/#/P:&9JR*5NH6ZZT3T%Y2,
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M@KV QVXG"%G7GY%4N<,"Q]U/N$'D;46=NF3A)S]^%R\OVTZTUS&,DE@8'=1
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M)B7NW@$WJD&_N>?/C@K=;B)!IR]V?^I4?UJ4G=K^_131)C44K/MT^-^ZKOX
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M?X:<K\%(GBQ?[&24'8WD2Q[TI^3[=;Y^5#5M>\H-(P>Q)2*/Y@;)R=,1?:0
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MK'M_-=ZS_UPPFX"HD V*F<W)!"VYB!X2NK)G8/>6\2.YL#Z#TO3]68W_5P%
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M!\6IKR!<_D)%LZ8F>:H-LDVB"+H^CP"*+Z!F8WG=D>A;1"\;BY$SMW2A#NH
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M.,_W*1'K30I]&Y&H]):H_!-]!RQIWV_Y1Y7LQ;DCS?XARG*7=+R@@^G0=8]
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M%?$!]@18V1P=)!U!FJ=Y6NCJ8H!T9GI.E?R6G(GS!F[W*,[#YKBC=&9"R^B
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MD7\I;T'B:/Z_TD , &(T>=#P?BCTO1P2>X: -#^(+!7KX=W1J?PJ[?=&T/F
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M#\9B@OUZ8?K-=831QC3URV09M:*>O1_9GWG> -DCTF9L!AE(4-<2[1JMKFY
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MF0,,]$861(H AQ/#U8L7&00[\ ,REBTT4Z\,L_PX*.T7TB^? P1MGH3< 'S
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MV>I]YI.DG5JK>O>NB".'2"5TS'D$MLCW,DA@Q=BFQCBCFHOF%E_OX8S:TOE
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M_A58VO\XPA31DE72G+CG?;J17#!D5J*2W?G)4)\@646_3LB\3C8#8"P>+G"
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M$T\_6:7M3C1Q1:3#SQUQ61*2<79>F=55AKRB=,I_L],0E-X;UBM/8OO.0(W
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MSJ.[ 08Q!W=_]D-VGZ?? .W!MW"S++UK/&FS_ *1>D>2D1O\\IQTA*\[#@"
MVZ;G\I6*,-D-4")$G>"62SQZ=KVQQS+-+_MH5XA&R:WG!D"?GWZEN %&S*\^
M0-2#\AST<*$;9/B%+;.OZ_3_W7%M5Y]'-U$]A0F)/ DA5.IXB1=9_Y,;-T'*
M,H>VYXN?]?WSRDQ0..^:>G3TDADB2_G]Y[GWQN(-0.2\<3D:#8F@\KT!_E*N
M^YQ^RK7@EWG+7[]?B5S4?K(#RO[O4J_3?D3S@M"_BQN'6Z-7 <-'(82V25TL
M*D\V@=T_9\,+7[,1+5X>C(E!JKV"U&]T.764>#Z6^8-C&I/U%*C8,P(DUCK/
MW?Q"OLGL8(2\<+M.CJS4ZRXU@G7I7!1S/7;GGWG#"Y:B-?*@SE1C"-3Z/H#$
M5WR'?P/D@++4WX\/,U^M_3G#BN$0B2G0Y^[GA+)EI3YFVHK<0C#^Q&P.1A?3
MF1>UD$E<8]K#!]?ZX@<N)"KHRGMO*U@D^1()]\_G1KAXD4;O8'?8/6250U%2
M#H+SPC]FJEJ/B)XA"/6WM*V-D*R3-HKH2:R-6GP;'>),MP6F%Q#,523GKY-;
M$%$.A INE%VPVS6G=)R[):9T?#5MHY@M@\C>$AX]#QV8_S9[8>L%O%YJDF52
M7&\>"R2KJZS D?WD-H9=4;?> (=IZ[L7VY>1F_Y@6>Y\ Z?I#S_KP UPRF&9
M=9(9,.' JDOYS$!W@_*=@-/?$78?G>OC5=<7N% 8M2$I+'-2T"V=T(V3=Q-D
MSW 4?T/G>?K69:_OY6# :(G\]Q"\4 [SF*$!OQO S/D&" $C_QJ(5'PB7;=;
M6V[G;SRI)(TN+V?:S7Z._((B4^Z/F+7JV9F1"Q@UV+L!_+'2T_=93LZ/_F-Y
MF?^WK][ZNW0#N!S)'U3)^V,MTV8\+1)_E_0"W-4[N3(R+ 8G6&N\6=]? + H
M* NU['-JZ'BQ&PF'7G)MW #?5M]>!8P>A2#.]%KDV[M9<,M_ :G^!U#PU?1_
M/:OU7\_Z^G]D+86]GK(N!GY4_>54M"; ="C/@HK)@]CTI'"XUYPK;B6!VH"(
M6!0I*P\9=\L]_MT>!)\?(5^=5_/R59\FLTVI$>>L@3:@7(JB@H37/A2B:K-M
M-J.X=L-&WLP??X7 3M6V4A#/)OU0K6G>%IC'*JRGE>O,O6CWYV&_]L+KGPFE
M498M[7>7;S[?(WIUQY;8+8E&H9-_I%3?MO#[GD%!DSO/,[$L!/QQ;%LV7IR?
M[7Q[=-Z4Q^O)1J+5J_G0X*1E>M-_FG*2ORP:^_9-C72D#L5IQU%647=YJ8UO
M9Q!H,B-).YM_\^V_%#Y9SEW]Q[#-PUFEAMO/8+G+9PU;X P[5XF<4IZ5.$#1
M VZ01GY(E*B-$[LW 5_0UMU]J>S)E-5&A6%WKZ9(3QK=V;*J.PW/:N,):E@E
MM2/,">QUVH^HHZH._>BT Z\X.P%7K"N?.5I^NMZ7,J]R1#E/;4^\OEKU164&
M*4F7-X_\[YZQX@':N=^+0.@][SO?>\9>-'15?^DAE$M=CEF3[GXGRX:BUC*&
M1K!7\DO9DZE^NQ)46&U2(Z<\19+0SI-3II490"K'T*J0K>6@M1C#HT6V!"'?
M\]Q9#'A&MN=JC)!7;<0RZKQ_*1.OD8A,U#^4=<8Z']KVAPL1G]E^>"!QZKW,
MFM<A3"TO0#D'""=](V4]-'>'8.WYGGM*@W=Y\H(MJ+\JT:W9N34:;$I\W]"&
M%%ZN">AUI0[5L$^\M$[&FW.AMC+FDMH7J<(KYT$PM7M3OQZ/6-ID)P6Y& 1J
MV$1.4D6?JQ-E'I;[8#'<>X\R+B31DK*5G9(A/WS.FYN@S>7>7RM8]P*?/9!1
M6O(P5-J_SL$RISY/(KL^$F$N>%*V]"H,]7]1]MY136W=^O!.H;?0I$@)"!B0
MWKNAMP"A=Z1+%T)1$#0@7830.X86(%1!NFA00+ITI"E(KRH(*AZ/G^>\]WW?
M>^_OWC'NES_6V"-[K[G6VON967..//N9PA>R@9PA7]J'0K:W?^JV*5[,#D&F
M.H)N2E)]]<N@=@O)KJ86K $#P2=5(C?>A)+,Q1=.IS&;J]N&5W$"&8CY6B1U
M +1,Q%8?SE/Z-N2'>6+1\<<KM%@ 0,PWQLQ=%(!N3/4$WW\TKW,P_\C7=.'G
M-:S+4770AA3W\N9UACVQVJ]-WZN C[KC_7\J<-!K_ (* DS9]AU!NXN=38,;
M_/=:EAYG&6&]C^J"-JZ?= R%\%PYDJO[V@)Z]WL5?P1*<STPG76P^.@!4>.\
MS3#3XQ\OM7%AY.OW.T;ZC8C6X.N/!K5^>K:IGY%DP^<Z@SG2CDZX+GX2VNZ=
M(U7^RVF%J>J@#S)?.H;<9![OB]7.7__>]#O*_GL,S-4#L>JOC:#HRPK,WU8V
M3>=_C_?W_!X/;O#]^7M^D6L,NN,#]Q0XF,]R_P-G5W_C[/[?.(/\MV%Z@J)5
MVH9BI7$3R3[?;OX"+D&AOL.7 X?392XQM$J,#VS5-2X^$\G#J]S4JY%[6MQA
MGQ,H9J7MI%PNHS\!@[1+I9BM*U*QJY"_3M"OXQ7>B<#$Q*E].7#A4HS0H]*'
M(ZJ:B[VZM#>'%\>0L3)_?O^*>%/A; /P9H!01;^[,&,\#G=O7$M_'C8ZJ7KO
MQ1PH>)<L[5N:R81[$^/P@NC%GV\ ^CY1^D#D",<"3FM$XGG\.-\Z'JN(([E6
M]A#">TV'FZ0_^F6\NOK,F[;T7=7S \$FSD+S'.E*WQJ&$DJP!\*HJ!R"N/J$
MULT]N?>LM29;.^+Z\X )?K*%[*O+WY&@ Y)<P$.W+W(.HCL9XMU7,\4-3G;A
M8/XU3SB/)*^/6/Q&/$QD<[AKTF)+.#9"?:O@038M&'YMEQ]&:^KZ=M4,)FXZ
MD06"Y3V/'IWJOZX=BH0?@DGS=BJJR3<E<RT: :,*#;2V$'<0B^,A.4E$4W#X
M^W*^<O270%<8!\.D(M6;/A#K^8\'+1M_/.Y:5IY;:;=J/WH(N6I^5*@2^;!=
MP7!/YK:/!7&'2:VQQ<FZ_S0^%2+.?T4I%=KUV^V@>'+3VQ&,2-CV%K5<C1N6
M 9RMF<T,4))]\5E1K=X+R!!0"W6PJ4O<]X \""A*WET=U-[/>]I>7<];&X)5
MN]S!^FW5 _D+F)W_#TAH_0)6)[1_>C[]XWYM$$5%^(<7E^N3+\9]?7X!@G][
MZ&]L_\9=[==&X(O_BNE&,.X78!=@RON79RS_)^0Q_PVO?UFB^0W+LE_ \=^.
M4]IT+D'\?[O_Y5@[?Y]G^.,OL![_"ZQ#D']9^PNL_WD:300T1877A_N7BY,O
M1GW>_ (\1_Z+Y=Z@2XWMBYW7%4+>]#@F$MT@%P8^J2-PU;Z+7$[:-0F5Y[MO
M=ATBW5&UUDZ.#/;O[>@HVJXV9/JO;\0==V?0;IEI5R&X+;*--W?!RE#\U=#$
MFNBXWOS/^^NO7X%^S?^5/CYEH9/!>ENPZZ5E,C)R*YJ@>8+'.V^^80[J6F9O
MF(/@!;2KG!@1Z1(B93+9 Z!=6#%8,$#!>\U)P:"6!8!FV9J;3M ,D?-!+S&=
M8K$,CA1+*IX6VL]V=D3T69ZU\CB[Y65K@\&7 _(R_ NZX^)H&DW\W7Q(NG,5
M09^&(N%"B_KFV54X;X!+.=9)F:2L\5?5JW^((_^MA0Q]4*.*IOJG+FFXST]0
M%)I66E"!@S(4VDEA4PM".A2Z"P.FPY\HM-M*<6R"J'C<25Y1I6=-NGZZ;2HX
MU@/$#*(&J^IJ2&')!/J]!!!)W^#<(V@<)J%8E@Y.C]YG@"&9Z/&?H2#X7X>R
MP[AW0U6\]N"WO^V.PD'<@""<3M%O#4NTI';FI.W$^DEMS""H\>A]$ =TT-'E
MTM\3%OA+&162_<\)_\?<*1!A%/\4;O['0%QE_^UJ"N'(_W8A%07Z3BSP=_DM
M4$GF?>0-%JCQ:+]$I?5; *QQU(ZV1$*1T+VW<DRXEX!R,E(;,H<=M;/^X9->
M?[G\($BK\[RT>,MKG E=>2TE$WE+,O J>D#":RLD.W&!@.9<&[C\KK>IH?:F
MWW&99L5R1 \YSXY?V/)V8$\*QD]>8RMP\4:SL0_8U,>(WXH"*34C2V[YJN=G
M_]?X.E/!<>N(6ZOU]4;*^YV<<XCC6CKB3N?>H9*1MY)R\9P C5G8(OLTXU$J
M=!U!F_HQ^HXXCE7@6D[DD5"50;=W>+Q7LA6!AGI+J#9$*.QH@%M:.DLWRTH_
M48K[3=YP'@Q[GD=^\%D'U.LZLU1Q4IIL&Z;A5.3!9#6S,.:]M_#X$7N"PAY>
MAB!.3>0K]Z3OA:LU5&3L*CEPMP\K+O68-"Y]957SC:?&UTY\KL@0\6T[E1M*
MYS]*TT.D*YJX^)"T5YN/[=>'V,$[(UW"U'Z^#32"F\L<=?9,XEFWT)I3G30&
M%=)NA74H7PEZ,H%O^4K=:_P32N\:W8:S:>_KV3UJ0O9B!C=.3+BJ173I'>4Z
M:N9%B+.6F(AZ_C:;I7/?2A=NZ#X;$>QY]!XC5W1,&J->?93:\";FHT,U[\JZ
M+FJMQ&ZU?>FQM==G^5BA0YN[1C4$$9A:ZA8H3O[@6<K<1V,A\Z&V8,^ ]V^.
MK=MYY"H<KCV:'A/=']!IT"5:@=!R)IEU\J"EU,0,"THH-/E/&-VS^M[2I:P;
M]?.K-_S?=7<(/S6\1GRDT>?3)CWEN]L56-!_Z&CV+K_DB3&)4)J%+?3I,3B
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M*IN4)CLB<4IH_(V#?\\ C'\ SH[FEF6G?#;CU6$\4*PP%?7N6_MB@\*H_]%
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M&1R%&8:)/,]QF:,PL(Q8R7G0*F39?X=1XP";]3PF'(FEPN0&@Y-0D/>Z&U3
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M.OF82\P^6SJNG#UFBSK>I_4+N%=Y+\ "K@\7VF9[)9_+^.3(,=IE<K+,7GY
M9FE;MI^G8.^R/+Q V]""O8K5DI7^JM3K$:5^E*J+C(H'*C^M7)#;2!V[8!SI
M(N$B^JY<I*JZ!3%&44E1#X<G;+?S)G6X6W1<*_ YUSX=1;*=9_16W',,?RAT
M7!PS9)]A:_9>2*N'WRO/#T]R^5'4'1)PNT2\K\*&VXNET#V%>8FNA:6XYZ[Y
MJDSU]:"ZQ"9?$^8:]H^^;6S4Q>4UZ0I>/DC_QSR+H5$A7@[G<CTHNQ*FI4KI
M"O/E^B.;NHPZ%F8-*<SGX;2>#I%S%T]6Q>19M/9O=Z=-L#O)C61 H!0/Q,*P
MMC0:QAK\6"%&M#;)(O2D"*\*4J0+#63N>4-_G/:CVOF[W:"IH'6B:1BR+'=Z
M^*MQF5'U5':0N).BFG3:&3_BY\4[3<*'T)>.LMB+CC>WA>9:!&M=EW+^\!HP
M#;+A?H*9\JU?*6D(/C)<QLV,VS8A"G.H7VD6,!5XY$KU:)D$,1>M#*@<D3]>
M>MV5[L);^][[+N]D*3W/[]WXGW1_4*PFY9@A6)44\0L@T$,.D$ !($ &@+;7
M>'557U^XSH,^_44DE#6T"*8: 9')ODZFELZ#@=9?I9Y14B044OQE!(IC@*W)
M,-@TS6&A51QC$#M3Y+Q]W,6F)-WA<%,F9^KKN=F;)RY<YC%(:C3N=P];,) '
MVE\')OF0VA&:;C*,GWX!DJ2K7AJ2^8;.KE0F]D.*4 @6  !9@(JBYJ\<!L;2
MPT*XLICI!@9+SR)UW=6?%$/ZJV#@) !KB%3^M+Y/0@!_?[P!$!S8!^C_Z@0'
M@"2LKZHN2(E:^J^:D]JR:T(;&\44A41'%E]>]Z,VZQ(3F:J)%/C6/MW8UDO7
M"4OFHPFD)",O8GH==#+]_,AS(G!DI[(1)W0MIFBV=A]V&0X7=ZYY8LV44X *
M,LT/A?@,0F;XOQ<.Y7C,'5&6&6**B=EK;OD R:TX@2G_=TY\AE1YLWCQG)$J
MZ>RBF>7GDYLR/+KT3E!EJ*)^I  $M.-KT_ $M<UV%AD@\P1&->LDYY%!IG&2
M53B23:8#>9O(B'6]===*Y[* 0VRNAE-Y6I& [X,KC5T@$XMP@X+ 16>7]1&(
M)/:'6%WHUP%F&/15_2,Q;;DMV/XT>/=-$6C$V7P(J9B8CDUK9K4.G:61E$*&
M[N%0'K]OMR%X@'- ;61M6$&0=6SEX$$P(GR-LF%(Q#!JFLIG#?O#H*:0P $=
MU&3>S4/']<.O45'RFS$E9JD[R5+%)9IPP?^J-4PG9>B2@86J2E)2"3%E4#.!
M !R@#_52E\*B^9 "9/1,9U7"=_ LOY\)! G@(F. 9BA$NTJ6P(S[O0LN "!J
MY@RD4IQV%+]J5!#=8=;,$%6V%V0:S,-K#Z[\#3A)"U0?'UQ?&^I9V:^L:XX-
MRBYG@E&%&1G?^;8&"!L=(B&S #V7(E(4! 1/NG!"X5!L%7 &(8!Z4[2$<5#-
MWSN"IM;^'G!LOLLT"0"*G^AA]%@X%71G!H2J%=)0S(X'*<7MP.A0[K]1DLZ1
M! 7'^F"33BZY 5S* !3L9$\+/F&KVXE03'^ROP'ZUZL%_[>&O0SE-I2PQ?$9
MB^TYZ&MOU!VTZCG?,L?7%;M[O3\SNI>_^.&H4*FNMR/'H/4K,B4YN;C5C)$E
M]0J>%/(Y0?3 >?DX]5:W?2RK8=N<:?/''DQW[-> @*252QMU!SGR1-'A-[ZL
MNH%3?,RR)%(!7E#N]3N?7*D6A8:';AL][DN.U]I2_0J3VEX>EY]7;N=9>XVS
ML2CXE=P+RSMDEA18BWI1RJT+F7):_=3Q'.&:5?S^SGXZ6DZ"9NU91WJ1P\->
M#"+-M29>SB_\66WVQ9/=AA%QG0 ! *[J(B_65C+D^4>UULBQ=)I,F*^@AX0Q
MT?ZV#\RXMP<7L#_PW'?:=X;QVD**D)B5KS#[!S0$E(@L)L^^_?K.7$OB;3*M
MH#"9V>D7XB4O9Y; 1R+TA=SQ@J4F@C6#[ZMB?040!%%.8V.Y(XI&R(BC O.%
M7H3XN(C"*NY\NL.GQZ]+O,)!K'' CTX<:&M@MER<XZXV-2E=[3GEQIVPNHFZ
ML7OPN\Z#79=+/MZ.::B_<5=I<%9S*N3HLH*U_R51MJB>NIOO*M-&48+1)';0
M=%C%$\N)4/I!S^Q8R)Q;Z9=G!1GO7 5YWLX/*-$.M#N6%:HN]NR\5J/O>70M
M1_E&$8<%@C]<3GTL88L;A:9DX$J,(.PS=/3HA>;4W_"N36S\^N=43[1G1]U"
MHXK9#YJJ(Z$NC'(YMSOK&:B-(Q_A,2IEX.Q.CN-H.#[R_6BYJ+Y6WY.9$V3>
M:FU>Z]I31G-KPJK".M_*[(YH<9VAHXYA@&&^UW!R_[VG(:5!EY\1V%%E43'Z
MM"DW#^.\!!A1="-7I@49\QI 7_]O6/SW*P3_QX;V5F:]/3FZ-? RYR:;1X5C
M/5O5G&;A]U$%PQ;+:@--Q@,ED:02F21*"D>H7OG7VT?'CSJH";.U7T;VFN,]
M0Q2M5X*#9[E$8PFA10N4LN$AX0T907O\Q7W7/9BQGYM^-,IW68:%]-:BQ06Y
MG16?YR4<DYF&VT!O+(;>F)VG25("#Q-!B[$E,HS86O3QTZ7H8)$+UKK 5NL
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MT7;4:WTOX;25;MF$'N::#O,4/BVAMJ$Z?^RBRZ7"WAWGKLRKVIC:N9/ F3_
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M.>=C52_H4G[6%/M9O^5LG-6B2,-!MDC<?&))*^Z5(XN>5XH%MX># &A1-(>
M/PS[H&_H, 0>6"MNLSF?[XH4B+_Z$>OFK%6INZIBT)&O_UYB59[*</,-(4C,
MY647X(;Q>M'.R$<\<S<WR&_^E"F!TY8W;KO8T=-:W].DKF]3J]M!/;,>-1&S
MWU(]-?-, Y5LC9RG Y/0[][T#+;<^R$E]<G D\VP^LKFULOAGZ0+QSZC:B85
MM47/%/A2*W*+N,)$<@2<DM*HP$KP7A(JLEN'J?@!'I/HC[7"IA@J,6PGU3+C
MPDE(O*)[=9O9M8C%7*GD,<.BKCFM@VZ8AVD7GGP;J('&8%ZW@4[J[7BAEN23
MZ4$I9QFE3NLY9JXDI]?5S%ERH0(H @O0RNDT0T52!^#=</G]#?+!R5J]E*&O
M&(R[UE:)J=R73BD$-N*/P;\R:/ZH^D^#Z)-T!CSB[R-D?RX!V%.R#P1_9="-
MY>[A_T2(]'TYN67.4:\D6&.4\!<AFYU=*QCZA%;>D;932BKF2.X"L'N'3B]G
M^,\BR_&Q,!%CA#P>V<I",=9F'2'K5^*0(*)L,>RW>VM-^I3[_M HC+#M7V_/
M"10*F7;.F[.[<\SG\-%C235'R\S'2C7?F$=YGT#C/?Y$4(ZV:#>^4=\4;?S:
M'3P'C?=DYL%,,),\R_F$7$YER%-&YLN9'6:NSP@8] (@N/OA B _-1N!NW6I
M2I\_/28AEPZBL6 4<Q2G E0?J'C3BZTQZ*+CO'JNSI^2V5+VM=_EI?Q0JUJT
MO%EP=Y>Y(C\;*6WK5IAU7R#HS9<7$A_IZZ[#)U+PITV*7+8GJM1]HB?(//:K
MDH/TQ3MO;XD%>U ,TTOXJ1$&1<39ZBH3PISY$9;'9F[[NT$[;+/KF-RK0KP+
MZV8WTF_8T/#]\MA)&VP@GCUYJE=:9<L%,GDG5DH!878D@C"A^PS,+%]7YM:E
M"M3Q*/30CL/+UR/]^V23NNIM1Q4$\^\JO7I8K07 ((E$-S;&R+]9,6."0Q6)
M VJ;,I=Y7R_YM9O4M:8[SC[<=CUT@2],?K:74WL[YKG6IG4S(WEY65(6[:8[
M_#I?&+ARNQB*_IQRM>\(PC]=7YBD4UM$\2*\QJCJ*<6$6&$D@4?1>OA/^^M\
MR0C,Q]O'NJQQ67%O%<5U9:U M^@]I1Y'"!/#)VK>?+#3YQ2)ZK--<<D:X2(R
M8?ON=#?JJVFF5D&.&\,:+#([_"HVEP?MCDZA08P36;<:Y=943L^OC6J-6+SC
ML:OMO%Y0&FR<N%"IVK55"B9G/1H9+'EA"4);RW5#AJ9H>%H$*(^=-M?G/MXI
M:N(9,F>W^'[J<9!#/JHV-<B5D#3\/C$4>>,6)B>;0I@, "TBE6\7XT?->U2G
MN=U%8.OK/?4R3,8,Y][+"V3)KC9)+E;'\"[:(I)J3EOCDJX+?$!\8S1C%2!!
M/T\D=E</J-KJ%7<6KBM.3A&7BDXMK+UZDX^.Q56O\KU8+#*'7V?>6RBGSAF?
M'QHGA%&&3']KWE3KM_#)MZTU[*Q87PBN4%#KJ(4@"X+DC5F]=0J=QG3M2O.L
M>'C^^N;Q%\E7\#J]I]46UV";D6_GT\3.Y8)YM6\FMPXR?AH&!3&?AQMD3O7%
M9V?%0+GL"^U;$>9P,C8Z)+UKT+1^/;=R=(C]BYM57(>4?-.4#WIR<XKTW;]4
MK9L>Y$D\B7S4WS;^.G.$:41%W2H.:&\:N35*14-J%N5PU\]_NW.TW[U8K)9Z
MF"[W@??3Q1!8D.=;6%A>KG+(+]7[9#&$Z#;0#]NF+][+-X5;9Y:X$SN^[\RV
MWRJBFTD;E_169Q7,C*=K0 4M<5-]9'!X6TI'J*JUPLJ3(;4OU/!9K**\_"5%
MU1I^T:MRW21;H\0HO2H^]A+?.<T&^V>3']]X\(-(=3=UQUYGJ<4(R(-T59F^
M$<[-L+[S;6LPH@&/8XY\[*"8-AY#4=+E "/7Q4RNEYOO!A7[,->"J@2FF\2>
MEX9P(,P;VZ:W4P43=?N,DKQU*ZFLU[[>I'T0MKDX<&6DQ4E[BN\95U11MPY:
M2_+^#PY_[ Z]',V'# 5R\4(1:<UR$5V5HN::CW/]8VW7R_,AW=W]>@K+%:FY
MR%+ZO+V@\3SEH,1'@JP\SP5AY'< &'%%O=3&V>+R3=V[YD]LU#-U7 B8JSD2
MUGP6J=Z\&HTJI7QU)<OS]EZ7KI/33.KDF]@H0:?,=@@:Z^X06K+VLN@EC\JC
M2IU/^EF3.BA'U8("KARB,6VC:N/P0K'"6%U51/8@Z-ZU+%K(\.5L]N_[VHNB
MJNNE:%4EYF*)#WFYWY@Z@Z%PDUV3F=<!K-:XR_BV!)'1K&@[I?(FW@AOY5R#
M,'[5]B<_*X(?9:EK,U+?QP1_NU,=]+Y11 E3AJ(K#6%O<&RP.F[UGYK29Q55
MMN&+:\_#8RC6C?K6[+'*THZ *'5#JCM^E&A-3-@=G%F^R=I/EF*\2I"87765
MY?Y.@KFE8=S2ZXA'R\8?D5<%&+@?P@3>28:;4&G8CS0:N0ULDCZ*6UB_ *@K
MWQ=$YLV\,<F;J:X=U7),OV*3_#%?E)-0"':$O,&&W2J>J@9'OA.35.L(ZJN-
M]!31+@J<+YB3'=:(2QX.5S2HPQOB<M^?A=[#6W*F@AGY;)H).;JF!PI<]Z0)
MT7U?X,'G:N/24%EZGS>!SD"DPZ(H_HN:B>_( JE'UJJV*^"Q>\!/Q@[:L#RJ
MWYZ\*CW /U*H*IY83A?_PLD7GF"__3$_<M9*>5_QA6G68JUEKG,U>0K%(#,+
M_-[;?M94O.-Q@MX=HMFJ\Q77Z^MJ50R&K[,N@#Q32DX,N-_L"\U 2;MCNV%,
M3TS/.](\*&F7LJ,P^L2H<%)XNDX\B7'RYM*]\LHTQM+QEZM?J773/KW\$.WD
MS%TZ4T[<#OH"XWHM9.M\ QR,)U=U4N<)>E%F4J-7@AHAV,]9,&GY;BSJIL-'
M7?4Q^F%CHW'!050*&9<-T<]<7G8@4-E!D-*9'G[CT-7)"K^LNFBUX=[.=LF<
M&)]5!;R'*..G2[:QGIY:PXR>=J&P:Z9Z"O5[H6%Q5F6 N9S4CY^\<OG9UJ*3
MWV>;OLZ%PHZWT=S"A8]8S2B$'+6<#?&IFZ)G*@WS6A>L\3?>:-I?>R^/5%7I
MNN*MA5[)IR'=4.BLUFY6[.7;^6* WT\^[HW6';1]S7 +@Y<S_<"&/_Z,(Y@
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M_!TK="#0^W3^Z\+YS?J642]S:JDE]@O@41EH8;M)*CT6I'_P)XR'^O+_0'S
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M5J0,\R,X20WBQ'+]M\"&+A4@;=8&,I:\5*W#5UP22X#G6U8:\^.K<]M-HU^
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M 0!A,C Q.6-H87)T:71E;3<N:G!G4$L! A0#%     @ *HI-4#<85J12"@$
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M8FET,3 S-RYH=&U02P$"% ,4    "  JBDU0X&;^21)2   E)P( &P
M        @ ':+ H 9'AC;3$R,S$R,#$Y97AH:6)I=#$P,S@N:'1M4$L! A0#
M%     @ *HI-4!\6 %SI"@  ITH  !L              ( !)7\* &1X8VTQ
M,C,Q,C Q.65X:&EB:70Q,#,Y+FAT;5!+ 0(4 Q0    ( "J*35#A+EW_:2D
M .X+ 0 ;              "  4>*"@!D>&-M,3(S,3(P,3EE>&AI8FET,3 T
M,"YH=&U02P$"% ,4    "  JBDU0([B:2A H  #>B $ &P
M@ 'ILPH 9'AC;3$R,S$R,#$Y97AH:6)I=#$P-#$N:'1M4$L! A0#%     @
M*HI-4,N:)8ZS"P  $&@  !L              ( !,MP* &1X8VTQ,C,Q,C Q
M.65X:&EB:70Q,#0R+FAT;5!+ 0(4 Q0    ( "J*35 *V(L3T00  -$T   ;
M              "  1[H"@!D>&-M,3(S,3(P,3EE>&AI8FET,C$P,2YH=&U0
M2P$"% ,4    "  JBDU0RN?D#+($  !E'   &P              @ $H[0H
M9'AC;3$R,S$R,#$Y97AH:6)I=#(S,#$N:'1M4$L! A0#%     @ *HI-4([R
MG1$6"   O3   !L              ( !$_(* &1X8VTQ,C,Q,C Q.65X:&EB
M:70S,3 Q+FAT;5!+ 0(4 Q0    ( "J*35 XQ48"_@<  -<L   ;
M      "  6+Z"@!D>&-M,3(S,3(P,3EE>&AI8FET,S$P,BYH=&U02P$"% ,4
M    "  JBDU0SEH-X)<$   #%   &P              @ &9 @L 9'AC;3$R
M,S$R,#$Y97AH:6)I=#,R,#$N:'1M4$L! A0#%     @ *HI-4$B2$PZ(!
M>1,  !L              ( !:0<+ &1X8VTQ,C,Q,C Q.65X:&EB:70S,C R
M+FAT;5!+ 0(4 Q0    ( "J*35#R!IWM/1,  /QZ   :              "
M 2H,"P!D>&-M,3(S,3(P,3EE>&AI8FET-# T+FAT;5!+ 0(4 Q0    ( "J*
M35#B393Z,"D! %0Y 0 4              "  9\?"P!S:6YG;&5D87ED871A
=83 U+FIP9U!+!08     &  8 )L&   !20P    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6834027520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Senior convertible notes due 2022</div></th>
<th class="th"><div>Senior convertible notes due 2023</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>Senior convertible notes due 2022</div>
</th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>Senior convertible notes due 2023</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning of period (shares) at Dec. 31, 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2016</a></td>
<td class="nump">$ 283.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 905.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.0)<span></span>
</td>
<td class="num">$ (621.0)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for Employee Stock Purchase Plan (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for Employee Stock Purchase Plan</a></td>
<td class="nump">7.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">106.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible note issuance, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification', window );">Cumulative effect of adoption of new accounting pronouncement | Accounting Standards Update 2016-09</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(50.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Dec. 31, 2017</a></td>
<td class="nump">419.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">1,093.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(671.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for Employee Stock Purchase Plan (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for Employee Stock Purchase Plan</a></td>
<td class="nump">8.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">101.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible note issuance, net of issuance costs</a></td>
<td class="num">(218.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 171.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(218.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 171.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Issuance of common stock for collaborative research and development fee (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets', window );">Issuance of common stock for collaborative research and development fee</a></td>
<td class="nump">217.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Sale of warrants</a></td>
<td class="nump">$ 183.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (shares)</a></td>
<td class="num">(800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">$ (100.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(127.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(127.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Dec. 31, 2018</a></td>
<td class="nump">663.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">1,560.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="num">(798.9)<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for Employee Stock Purchase Plan (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for Employee Stock Purchase Plan</a></td>
<td class="nump">11.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">102.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification', window );">Cumulative effect of adoption of new accounting pronouncement | Accounting Standards Update 2016-02</a></td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Realization of tax benefit related to 2023 Note Hedge</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">101.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Dec. 31, 2019</a></td>
<td class="nump">$ 882.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 1,675.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="num">$ (695.7)<span></span>
</td>
<td class="num">$ (100.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 51<br> -URI http://asc.fasb.org/extlink&amp;oid=117331294&amp;loc=d3e34017-109320<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=51819886&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116855982&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109126253&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the quantification of the effect of adopting the new accounting standard or change in accounting principle expected by the entity to have a significant effect on the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201609Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201609Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6822048832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Revenue Recognized from Changes in Contract Liability Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Amounts included in contract liabilities at the beginning of the period</a></td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6832513392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Hierarchy of Financial Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 255.0<span></span>
</td>
<td class="nump">$ 266.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Equity investment in Tandem Diabetes Care, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available for sale:</a></td>
<td class="nump">1,087.1<span></span>
</td>
<td class="nump">210.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">1,342.8<span></span>
</td>
<td class="nump">514.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">110.1<span></span>
</td>
<td class="nump">199.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Equity investment in Tandem Diabetes Care, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available for sale:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">110.8<span></span>
</td>
<td class="nump">237.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">144.9<span></span>
</td>
<td class="nump">66.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Equity investment in Tandem Diabetes Care, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available for sale:</a></td>
<td class="nump">1,087.1<span></span>
</td>
<td class="nump">210.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">1,232.0<span></span>
</td>
<td class="nump">277.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Equity investment in Tandem Diabetes Care, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available for sale:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available for sale:</a></td>
<td class="nump">676.0<span></span>
</td>
<td class="nump">173.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available for sale:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available for sale:</a></td>
<td class="nump">676.0<span></span>
</td>
<td class="nump">173.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available for sale:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available for sale:</a></td>
<td class="nump">248.2<span></span>
</td>
<td class="nump">36.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available for sale:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available for sale:</a></td>
<td class="nump">248.2<span></span>
</td>
<td class="nump">36.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available for sale:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available for sale:</a></td>
<td class="nump">162.9<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available for sale:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available for sale:</a></td>
<td class="nump">162.9<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available for sale:</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26610-111562<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6829196960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 446.2<span></span>
</td>
<td class="nump">$ 1,137.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities', window );">Short-term marketable securities</a></td>
<td class="nump">1,087.1<span></span>
</td>
<td class="nump">248.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">286.3<span></span>
</td>
<td class="nump">226.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">119.8<span></span>
</td>
<td class="nump">70.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">30.0<span></span>
</td>
<td class="nump">16.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,969.4<span></span>
</td>
<td class="nump">1,699.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">321.3<span></span>
</td>
<td class="nump">183.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">71.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">18.6<span></span>
</td>
<td class="nump">18.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">14.2<span></span>
</td>
<td class="nump">14.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,395.0<span></span>
</td>
<td class="nump">1,916.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">256.4<span></span>
</td>
<td class="nump">147.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and related expenses</a></td>
<td class="nump">88.5<span></span>
</td>
<td class="nump">72.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current portion</a></td>
<td class="nump">13.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">360.2<span></span>
</td>
<td class="nump">222.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Long-term senior convertible notes</a></td>
<td class="nump">1,059.7<span></span>
</td>
<td class="nump">1,010.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">72.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">20.1<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,512.4<span></span>
</td>
<td class="nump">1,252.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValueOutstanding', window );">Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common stock, $0.001 par value, 200.0 million shares authorized; 92.4 million and 91.6 million shares issued and outstanding, respectively, at December 31, 2019; 91.1 million and 90.0 million shares issued and outstanding, respectively, at December 31, 2018</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,675.9<span></span>
</td>
<td class="nump">1,560.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(695.7)<span></span>
</td>
<td class="num">(798.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock at cost; 0.8 million shares at December 31, 2019</a></td>
<td class="num">(100.0)<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">882.6<span></span>
</td>
<td class="nump">663.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 2,395.0<span></span>
</td>
<td class="nump">$ 1,916.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale And Equity Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4428-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6644210192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:2px;padding-top:2px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">DexCom, Inc.</span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">SCHEDULE II</span><span style="font-family:inherit;font-size:10pt;color:#ffffff;">&#160;&#8211; </span><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">VALUATION AND QUALIFYING ACCOUNTS</span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">(In millions)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:9pt;">&#160;</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Allowance for doubtful accounts</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2016</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Provision for doubtful accounts</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Write-offs and adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recoveries</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Allowance for doubtful accounts</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Provision for doubtful accounts</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Write-offs and adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recoveries</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Allowance for doubtful accounts</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Provision for doubtful accounts</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Write-offs and adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recoveries</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6986788720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">8. Income Taxes</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income (loss) before income taxes subject to taxes in the following jurisdictions is as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>119.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(28.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Outside of the United States</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(98.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(61.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>104.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(126.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(48.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Significant components of the provision for income taxes are as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Federal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">State</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Federal</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">State</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total deferred income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had federal, state and foreign tax net operating loss carryforwards of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$438.8 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$324.1 million</span></span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>$124.1 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. The federal and state tax loss carryforwards will begin to expire in </span><span style="font-family:inherit;font-size:10pt;">2027</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2020</span><span style="font-family:inherit;font-size:10pt;">, respectively, unless previously utilized. The foreign net operating losses carry forward indefinitely. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we also had federal and state research and development tax credit carryforwards of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$54.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$52.7 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. </span><span style="font-family:inherit;font-size:10pt;"><span>$0.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> of the federal research and development tax credit will begin to expire in </span><span style="font-family:inherit;font-size:10pt;">2020</span><span style="font-family:inherit;font-size:10pt;">, unless previously utilized. The state research and development tax credit will carryforward indefinitely until utilized.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Utilization of net operating losses and credit carryforwards is subject to an annual limitation due to ownership change limitations provided by Section&#160;382 and 383 of the Internal Revenue Code of 1986, as amended, and similar state provisions. An ownership change limitation occurred as a result of the stock offering completed in February 2009. The limitation will likely result in approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$2.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> of U.S. income tax credits that will expire unused. The related deferred tax assets have been removed from the components of our deferred tax assets as summarized in the table below. We performed a Section 382 study on the remaining federal and state net operating losses and tax credit carryforwards and have determined that there is no annual limitation on them as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Significant components of our deferred tax assets as of </span><span style="font-family:inherit;font-size:10pt;">December 31,</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> are shown below. A valuation allowance of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$332.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> has been established as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> to offset the deferred tax assets, as realization of such assets is uncertain. We maintain a deferred tax liability related to indefinite-lived intangible assets that is not netted against the deferred tax assets. Reversal of the taxable temporary difference for these intangible assets cannot serve as a source of income for realization of the deferred tax assets because the deferred tax liability will not reverse until the intangible assets are sold or written down due to impairment.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Net operating loss carryforwards</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>127.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>162.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Capitalized research and development expenses</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>57.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>62.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Tax credits</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>78.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>59.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Fixed and intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Accrued liabilities and reserves</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>62.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Convertible Debt</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total gross deferred tax assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>351.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>334.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: valuation allowance</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(332.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(330.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net deferred tax assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Fixed assets and acquired intangibles assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Convertible debt discount</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total deferred tax liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net deferred tax assets (liabilities)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, and reliability of forecasting. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we have maintained a full valuation allowance on our deferred tax assets since inception based on our historical losses and the uncertainty of generating future taxable income to utilize our loss and credit carryforwards. A future release of our valuation allowance will result in a material tax benefit recognized in the quarter of the release.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, deferred tax assets for which any subsequently recognized tax benefits will be credited to additional paid-in capital rather than to income tax benefit totaled </span><span style="font-family:inherit;font-size:10pt;"><span>$55.7 million</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The reconciliation between our effective tax rate on income (loss) from continuing operations and the statutory rate is as follows:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended<br/>December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income taxes at statutory rates</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(26.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(17.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">State income tax, net of federal benefit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Permanent items</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Research and development credits</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(11.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign rate differential</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock and officers compensation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Rate change</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrecognized tax benefits</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Impact of adoption of ASU 2016-16</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Impact of Tax Cuts and Jobs Act of 2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>105.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in valuation allowance</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(51.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income taxes at effective rates</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the activity related to our gross unrecognized tax benefits:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at January&#160;1, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decreases related to prior year tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increases related to current year tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decrease related to Tax Cuts and Jobs Act of 2017</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decreases related to prior year tax positions </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increases related to current year tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decreases related to prior year tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increases related to current year tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due to the valuation allowance recorded against our deferred tax assets, </span><span style="font-family:inherit;font-size:10pt;"><span>none</span></span><span style="font-family:inherit;font-size:10pt;"> of the total unrecognized tax benefits as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> would reduce our annual effective tax rate if recognized. Interest and penalties are classified as a component of income tax expense and were not material for any period presented. Due to net operating losses incurred, tax years from 1999 and forward for federal and state purposes and from 2016 and forward for foreign jurisdictions remain open to examination by the major taxing jurisdictions to which we are subject. The IRS commenced an audit of our 2015 and 2016 federal income tax returns in February 2018. The audit closed in June 2019 with no significant changes to our unrecognized tax benefits. </span></div><span style="font-family:inherit;font-size:10pt;">We operate under a tax holiday in the Philippines, which is effective through December 31, 2023, and may be extended for another </span><span style="font-family:inherit;font-size:10pt;"><span>three years</span></span><span style="font-family:inherit;font-size:10pt;"> if certain additional requirements are satisfied. The tax holiday is conditional upon remaining in good standing, committing no violation of PEZA Rules and Regulations, pertinent circulars and directives. The impact of this tax holiday decreased foreign taxes by </span><span style="font-family:inherit;font-size:10pt;"><span>$0.2 million</span></span> in 2019.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6659509808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">Balance Sheet Details</a></td>
<td class="text"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#ffffff;font-weight:bold;">4. Balance Sheet Details</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Short-Term Marketable Securities</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term marketable securities, consisting of equity securities and debt securities, were as follows as of the dates indicated:</span><span style="font-family:inherit;font-size:9pt;">&#160;&#160;</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gains</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Losses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Estimated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Market</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. government agencies</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>675.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>676.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>248.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>248.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate debt</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>163.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>162.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,086.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,087.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gains</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Losses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Estimated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Market</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity investment in Tandem Diabetes Care, Inc</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. government agencies</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>173.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>173.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commercial paper</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>210.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>210.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total marketable securities </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>212.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>248.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, all of our debt securities had contractual maturities of less than </span><span style="font-family:inherit;font-size:10pt;"><span>twelve months</span></span><span style="font-family:inherit;font-size:10pt;">. Gross realized gains and losses on our debt securities for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> were not significant. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We periodically review our portfolio of debt securities to determine if any investment is other-than-temporarily impaired due to changes in credit risk or other potential valuation concerns. We believe that the investments we held at </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> were not other-than-temporarily impaired. Unrealized losses on available-for-sale debt securities at that date were not significant and were due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table reconciles the net gain recognized on equity securities during the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> to the unrealized gain recognized during those periods on equity securities still held at the reporting dates.</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended&#160;<br/>&#160;December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net gains and losses recognized during the period on equity securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>80.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Net gains and losses recognized during the period on equity securities sold during the period</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(44.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrealized gains recognized during the reporting period on equity securities still held at the reporting date</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:18px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Accounts Receivable</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>292.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>233.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less allowance for doubtful accounts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total accounts receivable, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>286.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>226.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Inventory</span><span style="font-family:inherit;font-size:9pt;color:#58a618;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Raw materials</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Work-in-process</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished goods</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total inventory</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>119.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>70.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, we recorded excess and obsolete inventory charges of </span><span style="font-family:inherit;font-size:10pt;"><span>$14.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> in cost of sales as a result of our ongoing assessment of sales demand, inventory on hand for each product and the continuous improvement and innovation of our products. During the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</span><span style="font-family:inherit;font-size:10pt;">, we recorded excess and obsolete inventory charges of </span><span style="font-family:inherit;font-size:10pt;"><span>$7.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> in cost of sales primarily as a result of the approval and launch of our G6 system and our ongoing assessment of sales demand and the continuous improvement and innovation of our products. </span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Property and Equipment</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Building and land </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Furniture and fixtures</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Computer software and hardware</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Machinery and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>130.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>80.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leasehold improvements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>80.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Construction in progress </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>132.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>57.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>426.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>262.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less accumulated depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(105.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(79.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total property and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>321.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>183.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Building and Land. </span><span style="font-family:inherit;font-size:10pt;">Although we do not legally own these premises, under previous lease accounting standards we were deemed the owner of the construction project during the construction period of our manufacturing facility in Mesa, Arizona under a build-to-suit lease arrangement. As a result of our adoption of ASC 842, we de-recognized the estimated fair value of the building shell that was included in &#8220;building and land&#8221; in our consolidated balance sheets as of December 31, 2018 and the related lease liability and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019. The </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> balance in &#8220;building and land&#8221; represents our finance lease right-of-use assets as a result of our adoption of ASC 842. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Depreciation expense related to property and equipment for the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$46.9 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$28.6 million</span></span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>$16.1 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> Loss on disposal of property and equipment during the </span><span style="font-family:inherit;font-size:10pt;">twelve months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> recorded in operating expenses was </span><span style="font-family:inherit;font-size:10pt;"><span>$10.5 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$5.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$11.0 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Accounts Payable and Accrued Liabilities</span><span style="font-family:inherit;font-size:9pt;color:#58a618;">&#160;</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts payable trade</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>75.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued tax, audit, and legal fees</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued rebates </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>93.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued warranty</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other accrued liabilities </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total accounts payable and accrued liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>256.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>147.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Restructuring Plan.</span><span style="font-family:inherit;font-size:10pt;"> In February 2019, our Board of Directors approved a restructuring plan that resulted in the transition of certain of our operations to the Philippines. We incurred total pre-tax charges and costs of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$8.0 million</span></span><span style="font-family:inherit;font-size:10pt;">, primarily for employee severance benefits under both ongoing and one-time benefit arrangements. We incurred most of these costs in the first half of 2019 and the restructuring activities have been substantially completed as of </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Accrued Warranty</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Warranty costs are reflected in our statements of operations as cost of sales. Reconciliations of our accrued warranty costs for the </span><span style="font-family:inherit;font-size:10pt;">twelve</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended </span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges to costs and expenses</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Costs incurred</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(32.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ending balance</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/><td style="width:20%;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#58a618;font-style:italic;font-weight:bold;">Other Long-Term Liabilities</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.89888776541962%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finance lease obligations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred rent</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e1ede6;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total other liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our adoption of ASC 842 during the first quarter of 2019 affected the balances of finance lease liabilities and deferred rent. See Note 6, &#8220;Leases And Other Commitments&#8221; for more information on leases.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6991677744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>105
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dxcm-12312019x10kasof1.htm": {
   "axisCustom": 4,
   "axisStandard": 26,
   "contextCount": 259,
   "dts": {
    "calculationLink": {
     "local": [
      "dxcm-20191231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dxcm-20191231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "dxcm-12312019x10kasof1.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dxcm-20191231_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-doc-2019-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dxcm-20191231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "dxcm-20191231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
      "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd",
      "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd"
     ]
    }
   },
   "elementCount": 671,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2019-01-31": 45,
    "http://www.dexcom.com/20191231": 4,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 54
   },
   "keyCustom": 64,
   "keyStandard": 457,
   "memberCustom": 18,
   "memberStandard": 47,
   "nsprefix": "dxcm",
   "nsuri": "http://www.dexcom.com/20191231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001000 - Document - Cover Page",
     "role": "http://www.dexcom.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103100 - Disclosure - Fair Value Measurements",
     "role": "http://www.dexcom.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104100 - Disclosure - Balance Sheet Details",
     "role": "http://www.dexcom.com/role/BalanceSheetDetails",
     "shortName": "Balance Sheet Details",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105100 - Disclosure - Debt Debt",
     "role": "http://www.dexcom.com/role/DebtDebt",
     "shortName": "Debt Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106100 - Disclosure - Leases And Other Commitments",
     "role": "http://www.dexcom.com/role/LeasesAndOtherCommitments",
     "shortName": "Leases And Other Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107100 - Disclosure - Contingencies",
     "role": "http://www.dexcom.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108100 - Disclosure - Income Taxes",
     "role": "http://www.dexcom.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109100 - Disclosure - Employee Benefit Plans and Stockholders' Equity",
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquity",
     "shortName": "Employee Benefit Plans and Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110100 - Disclosure - Business Segment and Geographic Information",
     "role": "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformation",
     "shortName": "Business Segment and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111100 - Disclosure - Quarterly Financial Information (Unaudited) Quarterly Financial Information (Unaudited)",
     "role": "http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedQuarterlyFinancialInformationUnaudited",
     "shortName": "Quarterly Financial Information (Unaudited) Quarterly Financial Information (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112100 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS",
     "role": "http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccounts",
     "shortName": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001000 - Statement - Consolidated Balance Sheets",
     "role": "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2201201 - Disclosure - Organization and Significant Accounting Policies (Policies)",
     "role": "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies",
     "shortName": "Organization and Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2301302 - Disclosure - Organization and Significant Accounting Policies (Tables)",
     "role": "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesTables",
     "shortName": "Organization and Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.dexcom.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Balance Sheet Details (Tables)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsTables",
     "shortName": "Balance Sheet Details (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Debt (Tables)",
     "role": "http://www.dexcom.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2306301 - Disclosure - Leases And Other Commitments (Tables)",
     "role": "http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables",
     "shortName": "Leases And Other Commitments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2308301 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.dexcom.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dxcm:ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309301 - Disclosure - Employee Benefit Plans and Stockholders' Equity (Tables)",
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityTables",
     "shortName": "Employee Benefit Plans and Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dxcm:ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310301 - Disclosure - Business Segment and Geographic Information (Tables)",
     "role": "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationTables",
     "shortName": "Business Segment and Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311301 - Disclosure - Quarterly Financial Information (Unaudited) (Tables)",
     "role": "http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedTables",
     "shortName": "Quarterly Financial Information (Unaudited) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001501 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dxcm:MaturityThresholdOfInvestmentsClassifiedToCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401403 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Organization and Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dxcm:MaturityThresholdOfInvestmentsClassifiedToCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401404 - Disclosure - Organization and Significant Accounting Policies - Revenues and Gross Accounts Receivable by Customer (Details)",
     "role": "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails",
     "shortName": "Organization and Significant Accounting Policies - Revenues and Gross Accounts Receivable by Customer (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD_srt_MajorCustomersAxis_dxcm_CustomerAMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401405 - Disclosure - Organization and Significant Accounting Policies - Revenue Recognized from Changes in Contract Liability Balances (Details)",
     "role": "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenueRecognizedFromChangesInContractLiabilityBalancesDetails",
     "shortName": "Organization and Significant Accounting Policies - Revenue Recognized from Changes in Contract Liability Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401406 - Disclosure - Organization and Significant Accounting Policies - Earnings Per Share (Details)",
     "role": "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails",
     "shortName": "Organization and Significant Accounting Policies - Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401407 - Disclosure - - Anti-Dilutive Securities (Details)",
     "role": "http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails",
     "shortName": "- Anti-Dilutive Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "dxcm:CollaborativeResearchAndDevelopmentFee",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Development and Other Agreements - Narrative (Details)",
     "role": "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails",
     "shortName": "Development and Other Agreements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "dxcm:DevelopmentAndOtherAgreementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "I2018Q4November20_dxcm_PaymentsUnderCollaborationAgreementsAxis_dxcm_CollaborativeArrangementInitialPaymentMember_srt_CounterpartyNameAxis_dxcm_VerilyLifeSciencesMember_us-gaap_TypeOfArrangementAxis_us-gaap_CollaborativeArrangementMember",
      "decimals": "-5",
      "lang": null,
      "name": "dxcm:CollaborativeArrangementUpfrontFee",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403402 - Disclosure - Fair Value Measurements - Fair Value Hierarchy of Financial Assets (Details)",
     "role": "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails",
     "shortName": "Fair Value Measurements - Fair Value Hierarchy of Financial Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403403 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConvertibleDebtFairValueDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403404 - Disclosure - Fair Value Measurements - Fair Value of Senior Convertible Notes (Details)",
     "role": "http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails",
     "shortName": "Fair Value Measurements - Fair Value of Senior Convertible Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConvertibleDebtFairValueDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2018Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:EquitySecuritiesFvNiCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404402 - Disclosure - Balance Sheet Details - Short-term Marketable Securities, Available-for-Sale (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails",
     "shortName": "Balance Sheet Details - Short-term Marketable Securities, Available-for-Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2018Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:EquitySecuritiesFvNiCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002000 - Statement - Consolidated Statements of Operations",
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTerm",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404403 - Disclosure - Balance Sheet Details - Narrative (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails",
     "shortName": "Balance Sheet Details - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtAndEquitySecuritiesGainLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404404 - Disclosure - Balance Sheet Details - Net Gain (Loss) Recognized on Equity Securities (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails",
     "shortName": "Balance Sheet Details - Net Gain (Loss) Recognized on Equity Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:DebtAndEquitySecuritiesRealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsReceivableGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404405 - Disclosure - Balance Sheet Details - Accounts Receivable (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails",
     "shortName": "Balance Sheet Details - Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsReceivableGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404406 - Disclosure - Balance Sheet Details - Inventory (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails",
     "shortName": "Balance Sheet Details - Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404407 - Disclosure - Balance Sheet Details - Property and Equipment (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails",
     "shortName": "Balance Sheet Details - Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404408 - Disclosure - Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails",
     "shortName": "Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2018Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:StandardProductWarrantyAccrual",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404409 - Disclosure - Balance Sheet Details - Accrued Warranty (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails",
     "shortName": "Balance Sheet Details - Accrued Warranty (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "lang": null,
      "name": "dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "dxcm:FinancingLeaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404410 - Disclosure - Balance Sheet Details - Other Liabilities (Details)",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails",
     "shortName": "Balance Sheet Details - Other Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "dxcm:FinancingLeaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConvertibleLongTermNotesPayable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Debt - Senior Convertible Notes (Details)",
     "role": "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
     "shortName": "Debt - Senior Convertible Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405403 - Disclosure - Debt - Conversion Value of Convertible Notes (Details)",
     "role": "http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails",
     "shortName": "Debt - Conversion Value of Convertible Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003000 - Statement - Consolidated Statements of Comprehensive Income (Loss)",
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfDebtDiscountPremium",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405404 - Disclosure - Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)",
     "role": "http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails",
     "shortName": "Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405405 - Disclosure - Debt - Narrative (Details)",
     "role": "http://www.dexcom.com/role/DebtNarrativeDetails",
     "shortName": "Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "D2018Q4November_us-gaap_DebtInstrumentAxis_dxcm_ConvertibleNotesDue2023Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405406 - Disclosure - Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)",
     "role": "http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails",
     "shortName": "Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Leases And Other Commitments - Narrative (Details)",
     "role": "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails",
     "shortName": "Leases And Other Commitments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "I2019Q1January1",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Leases And Other Commitments - Maturity of Lease Liabilities (Details)",
     "role": "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails",
     "shortName": "Leases And Other Commitments - Maturity of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406404 - Disclosure - Leases And Other Commitments - Lease Cost (Details)",
     "role": "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails",
     "shortName": "Leases And Other Commitments - Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406405 - Disclosure - Leases And Other Commitments - Other Information (Details)",
     "role": "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails",
     "shortName": "Leases And Other Commitments - Other Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:LegalMattersAndContingenciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407401 - Disclosure - Contingencies - Narrative (Details)",
     "role": "http://www.dexcom.com/role/ContingenciesNarrativeDetails",
     "shortName": "Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:LegalMattersAndContingenciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408402 - Disclosure - Income Taxes - Jurisdictions, Net Income (Loss) Subject to Income Taxes (Details)",
     "role": "http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails",
     "shortName": "Income Taxes - Jurisdictions, Net Income (Loss) Subject to Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Income Taxes - Components of Provision (Details)",
     "role": "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails",
     "shortName": "Income Taxes - Components of Provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004000 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "dxcm:UnusedExpiredFederalIncomeTaxCredits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "dxcm:UnusedExpiredFederalIncomeTaxCredits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "role": "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails",
     "shortName": "Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408406 - Disclosure - Income Taxes - Reconciliation between Effective Tax Rate and Statutory Rate (Details)",
     "role": "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails",
     "shortName": "Income Taxes - Reconciliation between Effective Tax Rate and Statutory Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2018Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408407 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)",
     "role": "http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2016Q4",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "dxcm:EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409402 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Narrative (Details)",
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails",
     "shortName": "Employee Benefit Plans and Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "dxcm:EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "dxcm:ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409403 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Intrinsic Value of Options Exercised and Fair Value of Options Vested (Details)",
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityIntrinsicValueOfOptionsExercisedAndFairValueOfOptionsVestedDetails",
     "shortName": "Employee Benefit Plans and Stockholders' Equity - Intrinsic Value of Options Exercised and Fair Value of Options Vested (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "dxcm:ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "dxcm:ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2018Q4",
      "decimals": "1",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Restricted Stock Units Activity (Details)",
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails",
     "shortName": "Employee Benefit Plans and Stockholders' Equity - Restricted Stock Units Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2016Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "dxcm:ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Stock Options Reserved for Future Issuance (Details)",
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails",
     "shortName": "Employee Benefit Plans and Stockholders' Equity - Stock Options Reserved for Future Issuance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "dxcm:ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409406 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Share-based Compensation Expenses (Details)",
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails",
     "shortName": "Employee Benefit Plans and Stockholders' Equity - Share-based Compensation Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2018Q4QTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409407 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Valuation Assumptions for Each Option Grant and Employee Stock Purchase Plan Purchase Rights (Details)",
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails",
     "shortName": "Employee Benefit Plans and Stockholders' Equity - Valuation Assumptions for Each Option Grant and Employee Stock Purchase Plan Purchase Rights (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2018Q4QTD_us-gaap_PlanNameAxis_dxcm_EmployeeStockPurchasePlanMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005000 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410402 - Disclosure - Business Segment and Geographic Information - Narrative (Details)",
     "role": "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationNarrativeDetails",
     "shortName": "Business Segment and Geographic Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410403 - Disclosure - Business Segment and Geographic Information - Summary (Details)",
     "role": "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails",
     "shortName": "Business Segment and Geographic Information - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "INF",
      "lang": null,
      "name": "dxcm:RevenuePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411402 - Disclosure - Quarterly Financial Information (Unaudited) - Summary (Details)",
     "role": "http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedSummaryDetails",
     "shortName": "Quarterly Financial Information (Unaudited) - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4QTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2018Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "2412401 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "role": "http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccountsDetails",
     "shortName": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2016Q4",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101100 - Disclosure - Organization and Significant Accounting Policies",
     "role": "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPolicies",
     "shortName": "Organization and Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dxcm:DevelopmentAndOtherAgreementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102100 - Disclosure - Development and Other Agreements",
     "role": "http://www.dexcom.com/role/DevelopmentAndOtherAgreements",
     "shortName": "Development and Other Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dxcm:DevelopmentAndOtherAgreementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2018Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - dxcm-12312019x10kasof1.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - dxcm-12312019x10kasof1.htm",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-12312019x10kasof1.htm",
      "contextRef": "FI2018Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 67,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2017-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dxcm_A401kPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "401(k) Plan [Member]",
        "label": "401(k) Plan [Member]",
        "terseLabel": "401(k) Plan"
       }
      }
     },
     "localname": "A401kPlanMember",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_AccruedTaxAuditAndLegalFees": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of accrued current tax, audit and legal fees.",
        "label": "Accrued Tax Audit And Legal Fees",
        "terseLabel": "Accrued tax, audit, and legal fees"
       }
      }
     },
     "localname": "AccruedTaxAuditAndLegalFees",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_AgaMatrixMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "AgaMatrix [Member]",
        "label": "AgaMatrix [Member]",
        "terseLabel": "AgaMatrix"
       }
      }
     },
     "localname": "AgaMatrixMember",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_AmortizationPeriodForIncentiveCompensationCosts": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortization Period For Incentive Compensation Costs",
        "label": "Amortization Period For Incentive Compensation Costs",
        "terseLabel": "Amortization period for incentive compensation costs"
       }
      }
     },
     "localname": "AmortizationPeriodForIncentiveCompensationCosts",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestones": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collaborative Arrangement, Development &amp; Regulatory Milestones",
        "label": "Collaborative Arrangement, Development &amp; Regulatory Milestones",
        "terseLabel": "Milestone payments due upon achievement of future development"
       }
      }
     },
     "localname": "CollaborativeArrangementDevelopmentRegulatoryMilestones",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collaborative Arrangement, Development &amp; Regulatory Milestones, Total Regulatory and Incentive Payments",
        "label": "Collaborative Arrangement, Development &amp; Regulatory Milestones, Total Regulatory and Incentive Payments",
        "terseLabel": "Additional milestones and incentive payments"
       }
      }
     },
     "localname": "CollaborativeArrangementDevelopmentRegulatoryMilestonesTotalRegulatoryandIncentivePayments",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_CollaborativeArrangementInitialPaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collaborative Arrangement, Initial Payment [Member]",
        "label": "Collaborative Arrangement, Initial Payment [Member]",
        "terseLabel": "Collaborative Arrangement, Initial Payment"
       }
      }
     },
     "localname": "CollaborativeArrangementInitialPaymentMember",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_CollaborativeArrangementMilestonePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collaborative Arrangement, Milestone Payments [Member]",
        "label": "Collaborative Arrangement, Milestone Payments [Member]",
        "terseLabel": "Collaborative Arrangement, Milestone Payments"
       }
      }
     },
     "localname": "CollaborativeArrangementMilestonePaymentsMember",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_CollaborativeArrangementUpfrontFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collaborative Arrangement, Upfront Fee",
        "label": "Collaborative Arrangement, Upfront Fee",
        "terseLabel": "Initial payment on collaborative agreement"
       }
      }
     },
     "localname": "CollaborativeArrangementUpfrontFee",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_CollaborativeResearchAndDevelopmentFee": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collaborative Research and Development Fee",
        "label": "Collaborative Research And Development Fee",
        "terseLabel": "Collaborative research and development fee"
       }
      }
     },
     "localname": "CollaborativeResearchAndDevelopmentFee",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations",
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_ContractPaymentTermsNumberofDays": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract Payment Terms, Number of Days",
        "label": "Contract Payment Terms, Number of Days",
        "terseLabel": "Customer contract payment terms"
       }
      }
     },
     "localname": "ContractPaymentTermsNumberofDays",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dxcm_ConvertibleNotesDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Convertible Notes Due 2022 [Member]",
        "label": "Convertible Notes Due 2022 [Member]",
        "terseLabel": "Senior convertible notes due 2022"
       }
      }
     },
     "localname": "ConvertibleNotesDue2022Member",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_ConvertibleNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Convertible Notes Due 2023 [Member]",
        "label": "Convertible Notes Due 2023 [Member]",
        "terseLabel": "Senior convertible notes due 2023"
       }
      }
     },
     "localname": "ConvertibleNotesDue2023Member",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_CustomerAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer A [Member]",
        "label": "Customer A [Member]",
        "terseLabel": "Distributor A"
       }
      }
     },
     "localname": "CustomerAMember",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_CustomerBMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer B [Member]",
        "label": "Customer B [Member]",
        "terseLabel": "Distributor B"
       }
      }
     },
     "localname": "CustomerBMember",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_CustomerCMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer C [Member]",
        "label": "Customer C [Member]",
        "terseLabel": "Distributor C"
       }
      }
     },
     "localname": "CustomerCMember",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_DebtInstrumentConversionTermAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument Conversion Term [Axis]",
        "label": "Debt Instrument Conversion Term [Axis]",
        "terseLabel": "Debt Instrument Conversion Term [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentConversionTermAxis",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_DebtInstrumentConversionTermDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Debt Instrument Conversion Term [Axis]",
        "label": "Debt Instrument Conversion Term [Domain]",
        "terseLabel": "Debt Instrument Conversion Term [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentConversionTermDomain",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_DebtInstrumentConversionTermOneMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument Conversion Term One [Member]",
        "label": "Debt Instrument Conversion Term One [Member]",
        "terseLabel": "Debt Instrument Conversion Term One"
       }
      }
     },
     "localname": "DebtInstrumentConversionTermOneMember",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_DebtInstrumentConversionTermTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument Conversion Term Two [Member]",
        "label": "Debt Instrument Conversion Term Two [Member]",
        "terseLabel": "Debt Instrument Conversion Term Two"
       }
      }
     },
     "localname": "DebtInstrumentConversionTermTwoMember",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares1",
        "label": "Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares",
        "terseLabel": "Stock issued upon conversion of senior notes (shares)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dxcm_DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Terms Of Conversion Feature, Conversion Amount",
        "label": "Debt Instrument, Convertible, Terms Of Conversion Feature, Conversion Amount",
        "terseLabel": "Conversion amount"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleTermsOfConversionFeatureConversionAmount",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_DebtInstrumentCovenantRepurchasePricePercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Covenant Repurchase Price, Percentage",
        "label": "Debt Instrument, Covenant Repurchase Price, Percentage",
        "terseLabel": "Holder's repurchase price percentage in event of fundamental change (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentCovenantRepurchasePricePercentage",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock",
        "label": "Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock",
        "terseLabel": "Proportion of conversion price (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale And Equity Securities",
        "label": "Debt Securities, Available-For-Sale And Equity Securities",
        "terseLabel": "Short-term marketable securities",
        "verboseLabel": "Estimated Market Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecurities",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale And Equity Securities, Amortized Cost",
        "label": "Debt Securities, Available-For-Sale And Equity Securities, Amortized Cost",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecuritiesAmortizedCost",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale And Equity Securities, Unrealized Gain",
        "label": "Debt Securities, Available-For-Sale And Equity Securities, Unrealized Gain",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedGain",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale And Equity Securities, Unrealized Loss",
        "label": "Debt Securities, Available-For-Sale And Equity Securities, Unrealized Loss",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecuritiesUnrealizedLoss",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_DeferredTaxAssetsConvertibleDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Tax Assets, Convertible Debt",
        "label": "Deferred Tax Assets, Convertible Debt",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "DeferredTaxAssetsConvertibleDebt",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Tax Assets (Liabilities), Less Valuation Allowance, Net",
        "label": "Deferred Tax Assets (Liabilities), Less Valuation Allowance, Net",
        "totalLabel": "Net deferred tax assets (liabilities)"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Benefits Credited to Additional Paid In Capital",
        "label": "Deferred Tax Assets, Tax Benefits Credited to Additional Paid In Capital",
        "terseLabel": "Tax benefits credited to additional paid-in capital"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_DeferredTaxLiabilitiesConvertibleDebtDiscount": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Convertible Debt Discount",
        "label": "Deferred Tax Liabilities, Convertible Debt Discount",
        "negatedTerseLabel": "Convertible debt discount"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesConvertibleDebtDiscount",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_DevelopmentAgreementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Development Agreements [Line Items]",
        "label": "Development Agreements [Line Items]",
        "terseLabel": "Development Agreements [Line Items]"
       }
      }
     },
     "localname": "DevelopmentAgreementsLineItems",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_DevelopmentAgreementsTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Development Agreements [Table]",
        "label": "Development Agreements [Table]",
        "terseLabel": "Development Agreements [Table]"
       }
      }
     },
     "localname": "DevelopmentAgreementsTable",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_DevelopmentAndOtherAgreementsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Development And Other Agreements [Text Block]",
        "label": "Development And Other Agreements [Text Block]",
        "terseLabel": "Development and Other Agreements"
       }
      }
     },
     "localname": "DevelopmentAndOtherAgreementsTextBlock",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dxcm_EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Impact of Adoption of ASU 2016-16",
        "label": "Effective Income Tax Reconciliation, Impact of Adoption of ASU 2016-16",
        "terseLabel": "Impact of adoption of ASU 2016-16"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_EffectiveIncomeTaxReconciliationImpactofTCJA": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Impact of TCJA",
        "label": "Effective Income Tax Reconciliation, Impact of TCJA",
        "terseLabel": "Impact of Tax Cuts and Jobs Act of 2017"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationImpactofTCJA",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_EffectiveIncomeTaxReconciliationPermanentItems": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Permanent Items",
        "label": "Effective Income Tax Reconciliation, Permanent Items",
        "terseLabel": "Permanent items"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationPermanentItems",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Unrecognized tax benefits",
        "label": "Effective Income Tax Reconciliation, Unrecognized tax benefits",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_EmployeePurchasePriceFloorPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Employee purchase price floor, percentage",
        "label": "Employee Purchase Price Floor Percentage",
        "terseLabel": "Employee purchase price floor (as a percent)"
       }
      }
     },
     "localname": "EmployeePurchasePriceFloorPercentage",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dxcm_EmployeeStockPurchasePlan2015Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Employee Stock Purchase Plan 2015",
        "label": "Employee Stock Purchase Plan 2015 [Member]",
        "terseLabel": "Employee Stock Purchase Plan 2015"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlan2015Member",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Employee Stock Purchase Plan (ESPP), Number Of Shares Authorized",
        "label": "Employee Stock Purchase Plan (ESPP), Number Of Shares Authorized",
        "terseLabel": "Stock authorized in ESPP (shares)"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dxcm_EmployeeStockPurchasePlanEsppSharesInEspp": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Employee Stock Purchase Plan ESPP Shares In ESPP",
        "label": "Employee Stock Purchase Plan Espp Shares In Espp",
        "terseLabel": "Employee Stock Purchase Plan (shares)"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanEsppSharesInEspp",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dxcm_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Member]",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_FairValueAssetsLevel3TransfersAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair Value, Assets, Level 3 Transfers, Amount",
        "label": "Fair Value, Assets, Level 3 Transfers, Amount",
        "terseLabel": "Transfers in or out of Level 3 securities"
       }
      }
     },
     "localname": "FairValueAssetsLevel3TransfersAmount",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_FinanceLeaseShortTermLeasesPaymentsDue": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetailsCalc2": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finance Lease, Short Term Leases, Payments Due",
        "label": "Finance Lease, Short Term Leases, Payments Due",
        "terseLabel": "Less: Short-term leases not recorded as a liability"
       }
      }
     },
     "localname": "FinanceLeaseShortTermLeasesPaymentsDue",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetailsCalc2": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finance Leases, Liability, Less Payments Due On Short Term Leases Not Recorded As A Liability",
        "label": "Finance Leases, Liability, Less Payments Due On Short Term Leases Not Recorded As A Liability",
        "terseLabel": "Present value of future payments"
       }
      }
     },
     "localname": "FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_FinancialStatementDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial Statement Details [Line Items]",
        "label": "Financial Statement Details [Line Items]",
        "terseLabel": "Financial Statement Details [Line Items]"
       }
      }
     },
     "localname": "FinancialStatementDetailsLineItems",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_FinancialStatementDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial Statement Details [Table]",
        "label": "Financial Statement Details [Table]",
        "terseLabel": "Financial Statement Details [Table]"
       }
      }
     },
     "localname": "FinancialStatementDetailsTable",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_FinancingLeaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financing Lease Obligation",
        "label": "Financing Lease Obligation",
        "terseLabel": "Finance lease obligations"
       }
      }
     },
     "localname": "FinancingLeaseObligation",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_InMoneyOptionsMaximumExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum exercise price for options to be considered in-the-money",
        "label": "In Money Options Maximum Exercise Price",
        "terseLabel": "In-the-money options, maximum exercise price (USD per share)"
       }
      }
     },
     "localname": "InMoneyOptionsMaximumExercisePrice",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase (Decrease) in Operating Lease Assets and Liabilities, Net",
        "label": "Increase (Decrease) in Operating Lease Assets and Liabilities, Net",
        "negatedLabel": "Operating lease right-of-use assets and liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Leased Buildings - Mesa, Arizona Expiring March 2028 [Member]",
        "label": "Leased Buildings - Mesa, Arizona Expiring March 2028 [Member]",
        "terseLabel": "Leased Buildings - Mesa, Arizona Expiring March 2028"
       }
      }
     },
     "localname": "LeasedBuildingsMesaArizonaExpiringMarch2028Member",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_LesseeFutureLeaseCostLeaseNotyetCommenced": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Future Lease Cost, Lease Not yet Commenced",
        "label": "Lessee, Future Lease Cost, Lease Not yet Commenced",
        "terseLabel": "Minimum lease payments for leases not yet commenced"
       }
      }
     },
     "localname": "LesseeFutureLeaseCostLeaseNotyetCommenced",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Leasing Arrangements, Operating Leases, Number Of Renewal Terms",
        "label": "Lessee Leasing Arrangements, Operating Leases, Number Of Renewal Terms",
        "terseLabel": "Number of renewal terms"
       }
      }
     },
     "localname": "LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dxcm_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Operating Lease, Remaining Lease Term",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease terms"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dxcm_LesseeOperatingLeasesLeaseCostAmortization": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Operating Leases, Lease Cost, Amortization",
        "label": "Lessee, Operating Leases, Lease Cost, Amortization",
        "terseLabel": "Amortization of operating lease right-of-use asset"
       }
      }
     },
     "localname": "LesseeOperatingLeasesLeaseCostAmortization",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_LesseeOperatingLeasesShortTermLeasePaymentsDue": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetailsCalc2": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Operating Leases, Short Term Lease Payments Due",
        "label": "Lessee, Operating Leases, Short Term Lease Payments Due",
        "terseLabel": "Less: Short-term leases not recorded as a liability"
       }
      }
     },
     "localname": "LesseeOperatingLeasesShortTermLeasePaymentsDue",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line of Credit Facility, Maximum Borrowing Capacity, Option to Increase, Amount",
        "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Option To Increase, Amount",
        "terseLabel": "Option to increase revolving line of credit"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line of Credit Facility, Maturity, Conditional Restrictions, Value of Unrestricted Cash on Hand Threshold",
        "label": "Line of Credit Facility, Maturity, Conditional Restrictions, Value of Unrestricted Cash on Hand Threshold",
        "terseLabel": "Value of unrestricted cash on hand threshold"
       }
      }
     },
     "localname": "LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Patents Allegedly Infringed, Determined Patentable, Number",
        "label": "Loss Contingency, Patents Allegedly Infringed, Determined Patentable, Number",
        "terseLabel": "Number of patents allegedly infringed upon by entity that are not unpatentable"
       }
      }
     },
     "localname": "LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Patents Allegedly Infringed, Number Transferred To New Plaintiff",
        "label": "Loss Contingency, Patents Allegedly Infringed, Number Transferred To New Plaintiff",
        "terseLabel": "Number of patent infringement claims transferred to new plaintiff"
       }
      }
     },
     "localname": "LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maturity Threshold Of Investments Classified To Cash Equivalents",
        "label": "Maturity Threshold Of Investments Classified To Cash Equivalents",
        "terseLabel": "Maturity threshold of investments classified to cash equivalents"
       }
      }
     },
     "localname": "MaturityThresholdOfInvestmentsClassifiedToCashEquivalents",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dxcm_NameOfDefendantAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name Of Defendant [Axis]",
        "label": "Name Of Defendant [Axis]",
        "terseLabel": "Name Of Defendant [Axis]"
       }
      }
     },
     "localname": "NameOfDefendantAxis",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_NameOfDefendantDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Name Of Defendant [Axis]",
        "label": "Name Of Defendant [Domain]",
        "terseLabel": "Name Of Defendant [Domain]"
       }
      }
     },
     "localname": "NameOfDefendantDomain",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_NameOfPlaintiffAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name Of Plaintiff [Axis]",
        "label": "Name Of Plaintiff [Axis]",
        "terseLabel": "Name Of Plaintiff [Axis]"
       }
      }
     },
     "localname": "NameOfPlaintiffAxis",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_NameOfPlaintiffDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Name Of Plaintiff [Axis]",
        "label": "Name Of Plaintiff [Domain]",
        "terseLabel": "Name Of Plaintiff [Domain]"
       }
      }
     },
     "localname": "NameOfPlaintiffDomain",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_NumberofFinancingLeases": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Financing Leases",
        "label": "Number of Financing Leases",
        "terseLabel": "Number of financing leases"
       }
      }
     },
     "localname": "NumberofFinancingLeases",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dxcm_OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetailsCalc2": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Lease, Liability, Less Payments Due On Short Term Leases Not Recorded As A Liability",
        "label": "Operating Lease, Liability, Less Payments Due On Short Term Leases Not Recorded As A Liability",
        "terseLabel": "Present value of future payments"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_OptionsInMoneyNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options that were in-the-money at the balance sheet date",
        "label": "Options In Money Number",
        "terseLabel": "Options in-the-money"
       }
      }
     },
     "localname": "OptionsInMoneyNumber",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Organization And Summary Of Significant Accounting Policies [Line Items]",
        "label": "Organization And Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Organization And Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Organization And Summary Of Significant Accounting Policies [Table]",
        "label": "Organization And Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Organization And Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "OrganizationAndSummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_PaymentsUnderCollaborationAgreementsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payments Under Collaboration Agreements [Axis]",
        "label": "Payments Under Collaboration Agreements [Axis]",
        "terseLabel": "Payments Under Collaboration Agreements [Axis]"
       }
      }
     },
     "localname": "PaymentsUnderCollaborationAgreementsAxis",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_PaymentsUnderCollaborationAgreementsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Payments Under Collaboration Agreements [Axis]",
        "label": "Payments Under Collaboration Agreements [Domain]",
        "terseLabel": "Payments Under Collaboration Agreements [Domain]"
       }
      }
     },
     "localname": "PaymentsUnderCollaborationAgreementsDomain",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_PharmacyRebates": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharmacy Rebates",
        "label": "Pharmacy Rebates",
        "terseLabel": "Accrued rebates"
       }
      }
     },
     "localname": "PharmacyRebates",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_PossibleExtensionPeriodofTaxHoliday": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Possible Extension Period of Tax Holiday",
        "label": "Possible Extension Period of Tax Holiday",
        "terseLabel": "Possible extension period of tax holiday"
       }
      }
     },
     "localname": "PossibleExtensionPeriodofTaxHoliday",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dxcm_PotentialFutureCommonStockIssuableSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Potential Future Common Stock Issuable, Shares, New Issues",
        "label": "Potential Future Common Stock Issuable, Shares, New Issues",
        "terseLabel": "Potential future common stock issuable (shares)"
       }
      }
     },
     "localname": "PotentialFutureCommonStockIssuableSharesNewIssues",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dxcm_ProductShipmentCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product Shipment Costs [Policy Text Block]",
        "label": "Product Shipment Costs [Policy Text Block]",
        "terseLabel": "Product Shipment Costs"
       }
      }
     },
     "localname": "ProductShipmentCostsPolicyTextBlock",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dxcm_PurchaseofConvertibleNoteHedge": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchase of Convertible Note Hedge",
        "label": "Purchase of Convertible Note Hedge",
        "negatedTerseLabel": "Purchase of convertible note hedge"
       }
      }
     },
     "localname": "PurchaseofConvertibleNoteHedge",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_RDexpensethroughissuanceofcommonstock": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Non-cash R&amp;D expense through issuance of common stock",
        "label": "R&amp;D expense through issuance of common stock",
        "terseLabel": "Non-cash collaborative research and development fee through issuance of common stock"
       }
      }
     },
     "localname": "RDexpensethroughissuanceofcommonstock",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_ReceiverProductComponentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Receiver Product Component [Member]",
        "label": "Receiver Product Component [Member]",
        "terseLabel": "Receiver Product Component"
       }
      }
     },
     "localname": "ReceiverProductComponentMember",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Recorded Unconditional Purchase Obligation Due Within One Year, Maximum Term",
        "label": "Recorded Unconditional Purchase Obligation Due Within One Year Maximum Term",
        "terseLabel": "Term of purchase obligations"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dxcm_RevenuePercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue, Percentage",
        "label": "Revenue, Percentage",
        "terseLabel": "% of Total"
       }
      }
     },
     "localname": "RevenuePercentage",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dxcm_RevenueRecognitionSalesReturnsCoveragePeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue Recognition, Sales Returns, Coverage Period",
        "label": "Revenue Recognition, Sales Returns, Coverage Period",
        "terseLabel": "Sales return period"
       }
      }
     },
     "localname": "RevenueRecognitionSalesReturnsCoveragePeriod",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the write-offs and adjustments in a given period to allowances and reserves for doubtful accounts",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction, Write-offs and Adjustments",
        "negatedTerseLabel": "Write-offs and adjustments"
       }
      }
     },
     "localname": "SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of intrinsic value of options exercised and fair value of options vested table.",
        "label": "Schedule Of Intrinsic Value Of Options Exercised Table [Table Text Block]",
        "terseLabel": "Schedule of Intrinsic Value of Options Exercised and Fair Value of Options Vested"
       }
      }
     },
     "localname": "ScheduleOfIntrinsicValueOfOptionsExercisedTableTableTextBlock",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dxcm_ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Shares Reserved For Future Issuance [Table Text Block]",
        "label": "Schedule Of Shares Reserved For Future Issuance Table [Table Text Block]",
        "terseLabel": "Schedule of Stock Options Reserved for Future Issuance"
       }
      }
     },
     "localname": "ScheduleOfSharesReservedForFutureIssuanceTableTableTextBlock",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dxcm_SellingGeneralAndAdministrativeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The allocation of expenses to selling, general and administrative",
        "label": "Selling General And Administrative [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeMember",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Standard Product Warranty Accrual Charges To Costs And Expenses",
        "label": "Standard Product Warranty Accrual Charges To Costs And Expenses",
        "terseLabel": "Charges to costs and expenses"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualChargesToCostsAndExpenses",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_StockOptionsReservedForFutureGrant": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of stock options and awards reserved for future grant",
        "label": "Stock Options Reserved For Future Grant",
        "terseLabel": "Reserved for future grant (shares)"
       }
      }
     },
     "localname": "StockOptionsReservedForFutureGrant",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dxcm_TaxCreditCarryforwardsResearchSubjecttoExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Credit Carryforwards, Research, Subject to Expiration",
        "label": "Tax Credit Carryforwards, Research, Subject to Expiration",
        "terseLabel": "Research and development tax credit carryforwards subject to expiration"
       }
      }
     },
     "localname": "TaxCreditCarryforwardsResearchSubjecttoExpiration",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Decrease Resulting from Tax Cuts And Jobs Act Of 2017",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Tax Cuts And Jobs Act Of 2017",
        "negatedTerseLabel": "Decrease related to Tax Cuts and Jobs Act of 2017"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_UnusedExpiredFederalIncomeTaxCredits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Federal income tax credits likely to expire unused as a result of limitations",
        "label": "Unused Expired Federal Income Tax Credits",
        "terseLabel": "Tax credit carryforwards subject to expiration"
       }
      }
     },
     "localname": "UnusedExpiredFederalIncomeTaxCredits",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_VerilyLifeSciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Verily Life Sciences  [Member]",
        "label": "Verily Life Sciences [Member]",
        "terseLabel": "Verily Life Sciences"
       }
      }
     },
     "localname": "VerilyLifeSciencesMember",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_WaveFormTechnologiesInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "WaveForm Technologies, Inc. [Member]",
        "label": "WaveForm Technologies, Inc. [Member]",
        "terseLabel": "WaveForm Technologies, Inc."
       }
      }
     },
     "localname": "WaveFormTechnologiesInc.Member",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_WeightedAverageSharePriceConsecutiveDaysEvaluated": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted Average Share Price, Consecutive Days Evaluated",
        "label": "Weighted Average Share Price, Consecutive Days Evaluated",
        "terseLabel": "Consecutive days used to calculate volume weighted average trading price"
       }
      }
     },
     "localname": "WeightedAverageSharePriceConsecutiveDaysEvaluated",
     "nsuri": "http://www.dexcom.com/20191231",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Condensed Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_CondensedFinancialStatementsCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Condensed Financial Statements, Captions [Line Items]",
        "terseLabel": "Condensed Financial Statements, Captions [Line Items]"
       }
      }
     },
     "localname": "CondensedFinancialStatementsCaptionsLineItems",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r55",
      "r116",
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r163",
      "r251",
      "r256",
      "r449"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r160",
      "r251",
      "r254",
      "r446",
      "r447"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": {
     "auth_ref": [
      "r457",
      "r469",
      "r472"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of property.",
        "label": "Name of Property [Axis]",
        "terseLabel": "Name of Property [Axis]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the property, for example, but not limited to, ABC Shopping Center.",
        "label": "Name of Property [Domain]",
        "terseLabel": "Name of Property [Domain]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfCondensedFinancialStatementsTable": {
     "auth_ref": [
      "r121",
      "r348",
      "r467",
      "r471",
      "r473",
      "r474"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.",
        "label": "Condensed Financial Statements [Table]",
        "terseLabel": "Condensed Financial Statements [Table]"
       }
      }
     },
     "localname": "ScheduleOfCondensedFinancialStatementsTable",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r122",
      "r468"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r162",
      "r251",
      "r255",
      "r448",
      "r452",
      "r456",
      "r465",
      "r466"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201609Member": {
     "auth_ref": [
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2016-09 Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.",
        "label": "Accounting Standards Update 2016-09 [Member]",
        "terseLabel": "Accounting Standards Update 2016-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201609Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued liabilities",
        "totalLabel": "Total accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r7",
      "r36"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable trade"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGross": {
     "auth_ref": [
      "r165"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts Receivable, before Allowance for Credit Loss",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Gross Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNet": {
     "auth_ref": [
      "r19",
      "r434"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "totalLabel": "Total accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r3",
      "r19",
      "r165",
      "r166",
      "r252"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r34",
      "r205"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r58",
      "r59",
      "r60"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r57",
      "r60",
      "r61",
      "r355"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash investing and financing transactions:"
       }
      }
     },
     "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "Balance Sheet Details"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by new accounting pronouncement.",
        "label": "Adjustments for New Accounting Pronouncements [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": {
     "auth_ref": [
      "r238",
      "r244",
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.",
        "label": "Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature",
        "terseLabel": "Realization of tax benefit related to 2023 Note Hedge"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r229"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "terseLabel": "Equity component of convertible note issuance, net of issuance costs"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r266",
      "r268",
      "r305",
      "r306"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r228",
      "r238",
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "terseLabel": "Sale of warrants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r268",
      "r290",
      "r304"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "verboseLabel": "Share-based compensation expense included in operating expenses"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r168",
      "r180",
      "r182",
      "r183"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "negatedTerseLabel": "Less allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r81",
      "r102",
      "r384"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Non-cash interest expense",
        "verboseLabel": "Accretion of debt discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r74",
      "r102",
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r157",
      "r418",
      "r435"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r54"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r176"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r177"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r174",
      "r188"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale [Abstract]",
        "terseLabel": "Debt securities, available for sale:"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r172",
      "r175",
      "r188"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Debt securities, available for sale:",
        "verboseLabel": "Estimated Market Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r269",
      "r292"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r363",
      "r366"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building and land"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r1",
      "r31",
      "r104"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r10",
      "r105",
      "r111"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r97",
      "r104",
      "r110"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period",
        "totalLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash, end of period:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r97",
      "r382"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price of warrants or rights (USD per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CollaborativeArrangementMember": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaborative Arrangement [Member]",
        "terseLabel": "Collaborative Arrangement"
       }
      }
     },
     "localname": "CollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r45",
      "r212",
      "r423",
      "r442"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r111",
      "r223",
      "r453",
      "r454"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Loss Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "totalLabel": "Total (shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r18",
      "r238"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValueOutstanding": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.",
        "label": "Common Stock, Value, Outstanding",
        "terseLabel": "Common stock, $0.001 par value, 200.0 million shares authorized; 92.4 million and 91.6 million shares issued and outstanding, respectively, at December 31, 2019; 91.1 million and 90.0 million shares issued and outstanding, respectively, at December 31, 2018"
       }
      }
     },
     "localname": "CommonStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r259",
      "r260",
      "r265",
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "terseLabel": "Employee Benefit Plans and Stockholders' Equity"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r64",
      "r66",
      "r67"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer software and hardware"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r146",
      "r147",
      "r379",
      "r380"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r146",
      "r147",
      "r379",
      "r380",
      "r451"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r142",
      "r432"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk and Significant Customers"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r146",
      "r147",
      "r379",
      "r380"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk (as a percent)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r148",
      "r379",
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r111",
      "r353",
      "r357",
      "r358"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress",
        "verboseLabel": "Construction in Progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails",
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of contract balances and changes in contract balances.",
        "label": "Contract with Customer, Asset and Liability [Table Text Block]",
        "terseLabel": "Schedule of Revenue Recognized as a Result of Changes in Contract Liability Balances"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r247",
      "r248",
      "r252"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r247",
      "r248",
      "r252"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenue that will be satisfied after 12 months"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r253"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Amounts included in contract liabilities at the beginning of the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenueRecognizedFromChangesInContractLiabilityBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "verboseLabel": "Total fair value of outstanding senior convertible notes"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.",
        "label": "Convertible Debt Securities [Member]",
        "terseLabel": "Senior convertible notes"
       }
      }
     },
     "localname": "ConvertibleDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Disclosures include, but are not limited to, principal amount, amortized premium or discount, and amount of liability and equity components.",
        "label": "Convertible Debt [Table Text Block]",
        "terseLabel": "Schedule of Converted Value of Notes"
       }
      }
     },
     "localname": "ConvertibleDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertibleLongTermNotesPayable": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.",
        "label": "Convertible Notes Payable, Noncurrent",
        "terseLabel": "Long-term senior convertible notes",
        "totalLabel": "Net carrying amount of Senior Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleLongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r261",
      "r263",
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.",
        "label": "Cumulative Effect of New Accounting Principle in Period of Adoption",
        "terseLabel": "Cumulative-effect adjustment"
       }
      }
     },
     "localname": "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r338",
      "r342"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r340"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r338",
      "r342"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current income taxes"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r338",
      "r342"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtAndEquitySecuritiesGainLoss": {
     "auth_ref": [
      "r73",
      "r75"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in debt and equity securities.",
        "label": "Debt and Equity Securities, Gain (Loss)",
        "terseLabel": "Income (loss) from equity investments",
        "totalLabel": "Net gains and losses recognized during the period on equity securities"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtAndEquitySecuritiesRealizedGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndEquitySecuritiesGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment in debt and equity securities.",
        "label": "Debt and Equity Securities, Realized Gain (Loss)",
        "negatedTerseLabel": "Less: Net gains and losses recognized during the period on equity securities sold during the period"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndEquitySecuritiesGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in debt and equity securities.",
        "label": "Debt and Equity Securities, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized gains recognized during the reporting period on equity securities still held at the reporting date"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r107",
      "r109"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Stock counterparties to acquire with warrants purchased (shares)"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r419",
      "r421",
      "r433"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "auth_ref": [
      "r230"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.",
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "terseLabel": "Carrying value of equity component of convertible senior notes, net of debt issuance costs"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Conversion price of convertible notes (USD per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r42",
      "r239",
      "r240",
      "r242"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Conversion ratio"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only.",
        "label": "Debt Instrument, Convertible, If-converted Value in Excess of Principal",
        "terseLabel": "Total by which the notes\u2019 if-converted value exceeds their principal amount"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Remaining amortization period for discount on the liability component of convertible debt which may be settled in cash upon conversion, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Convertible, Remaining Discount Amortization Period",
        "terseLabel": "Remaining amortization period of debt discount on the liability component"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Number of trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Proportion of applicable conversion price (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r385",
      "r387"
     ],
     "calculation": {
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ConvertibleLongTermNotesPayable",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r41",
      "r235",
      "r385"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate on convertible notes (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r43",
      "r117",
      "r239",
      "r241",
      "r242",
      "r243",
      "r384",
      "r385",
      "r387",
      "r431"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r384",
      "r387"
     ],
     "calculation": {
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ConvertibleLongTermNotesPayable",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedTerseLabel": "Unamortized debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleGainLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Gain (Loss) [Abstract]",
        "terseLabel": "Net gain recognized on equity securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleGainLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Schedule of Short-term Marketable Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTerm": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period between issuance and maturity of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Debt Securities, Available-for-sale, Term",
        "terseLabel": "Maximum contractual maturities of debt securities held"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTerm",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r339",
      "r342"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r339",
      "r342"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r102",
      "r115",
      "r339",
      "r342"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredRentCreditNoncurrent": {
     "auth_ref": [
      "r46",
      "r388"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.",
        "label": "Deferred Rent Credit, Noncurrent",
        "terseLabel": "Deferred rent"
       }
      }
     },
     "localname": "DeferredRentCreditNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r339",
      "r342"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetDomain": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the deferred tax asset for which a valuation reserve exists.",
        "label": "Deferred Tax Asset [Domain]",
        "terseLabel": "Deferred Tax Asset [Domain]"
       }
      }
     },
     "localname": "DeferredTaxAssetDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Fixed and intangible assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r330"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total gross deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r332"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Total net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Deferred Tax Assets, Net, Classification [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r311",
      "r336",
      "r337"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r334",
      "r336",
      "r337"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r334",
      "r336",
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research and development tax credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r311",
      "r336",
      "r337"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
     "auth_ref": [
      "r312",
      "r336",
      "r337"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Other",
        "terseLabel": "Capitalized research and development expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r311",
      "r336",
      "r337"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued liabilities and reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r331"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Less: valuation allowance",
        "terseLabel": "Valuation allowance amount"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails",
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r318",
      "r332"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "dxcm_DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesClassificationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Deferred Tax Liabilities, Net, Classification [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesClassificationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r312",
      "r336",
      "r337"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedTerseLabel": "Fixed assets and acquired intangibles assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Total matching contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Employee contribution (as a percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Employer matching contribution (as a percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Maximum employee contribution (as a percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r102",
      "r203"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r102",
      "r155"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r364",
      "r365",
      "r367",
      "r368"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgesLiabilities": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum as of the balance sheet date of the (a) fair values of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and (b) the carrying amounts of the liabilities arising from financial instruments or contracts used to mitigate a specified risk (hedge), and which are expected to be extinguished or otherwise disposed of within a year or the normal operating cycle, if longer, net of the effects of master netting arrangements.",
        "label": "Derivative Instruments and Hedges, Liabilities",
        "terseLabel": "Recorded net exchange derivative instrument liability"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgesLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r360",
      "r361"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount of outstanding hedge to currency risk"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r72",
      "r124",
      "r127",
      "r129",
      "r130",
      "r131",
      "r135",
      "r427",
      "r444"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income (loss) per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails",
      "http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedSummaryDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r72",
      "r124",
      "r127",
      "r129",
      "r130",
      "r131",
      "r135",
      "r427",
      "r444"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income (loss) per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails",
      "http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedSummaryDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r111",
      "r132",
      "r133",
      "r134"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r382"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity": {
     "auth_ref": [
      "r370"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of the liability for the conversion option reclassified to stockholders' equity when the embedded option no longer required separation from the host instrument.",
        "label": "Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity",
        "terseLabel": "Recognized additional paid-in capital from cash conversion option"
       }
      }
     },
     "localname": "EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued payroll and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation costs related to unvested restricted stock units"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options and employee stock purchase plan",
        "verboseLabel": "Options outstanding to purchase common stock"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r76",
      "r77",
      "r102"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "negatedTerseLabel": "Realized (gain) loss on equity investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r378"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Estimated Market Value"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.",
        "label": "Equity Securities, FV-NI, Cost",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGain": {
     "auth_ref": [
      "r179"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss) [Abstract]",
        "terseLabel": "Equity investment in Tandem Diabetes Care, Inc"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedLoss": {
     "auth_ref": [
      "r179"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Loss",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r371",
      "r372",
      "r373",
      "r376"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount": {
     "auth_ref": [
      "r373"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.",
        "label": "Fair Value, Assets, Level 1 to Level 2 Transfers, Amount",
        "terseLabel": "Transfers between Level 1 and Level 2 securities"
       }
      }
     },
     "localname": "FairValueAssetsLevel1ToLevel2TransfersAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r371",
      "r372"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value Hierarchy for Financial Assets"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r261",
      "r262",
      "r263",
      "r372",
      "r410"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information about fair value of asset and liability not measured at fair value.",
        "label": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Senior Convertible Notes"
       }
      }
     },
     "localname": "FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r261",
      "r262",
      "r263",
      "r372",
      "r411"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r261",
      "r262",
      "r263",
      "r372",
      "r412"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r261",
      "r262",
      "r263",
      "r372",
      "r413"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r392",
      "r398",
      "r408"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r394",
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r391",
      "r407"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetailsCalc2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance lease liability",
        "totalLabel": "Revised present value of future lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r391"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "negatedTerseLabel": "Less: Current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturity of Finance Lease Liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r391"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetailsCalc2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total future lease cost"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due after fifth fiscal year following latest fiscal year.",
        "label": "Finance Lease, Liability, Payments, Due after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in next fiscal year following latest fiscal year.",
        "label": "Finance Lease, Liability, Payments, Due Next Twelve Months",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fifth fiscal year following latest fiscal year.",
        "label": "Finance Lease, Liability, Payments, Due Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fourth fiscal year following latest fiscal year.",
        "label": "Finance Lease, Liability, Payments, Due Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in third fiscal year following latest fiscal year.",
        "label": "Finance Lease, Liability, Payments, Due Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in second fiscal year following latest fiscal year.",
        "label": "Finance Lease, Liability, Payments, Due Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetailsCalc2": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: Amount representing interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r393",
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r390"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under finance lease.",
        "label": "Finance Lease, Right-of-Use Asset",
        "terseLabel": "Finance lease right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r392",
      "r398",
      "r408"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r405",
      "r408"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate of finance leases (as a percent)"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r404",
      "r408"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term of finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r181",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Useful life of finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Exchange Forward"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of entity's patents that another entity has allegedly infringed.",
        "label": "Gain Contingency, Patents Allegedly Infringed upon, Number",
        "terseLabel": "Number of patents allegedly infringed upon by counterparty"
       }
      }
     },
     "localname": "GainContingencyPatentsAllegedlyInfringedUponNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.",
        "label": "Gain (Loss) on Derivative Instruments, Net, Pretax",
        "terseLabel": "Gains on forward exchange contract"
       }
      }
     },
     "localname": "GainLossOnDerivativeInstrumentsNetPretax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestmentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of realized and unrealized gain (loss) on investment in security.",
        "label": "Gain (Loss) on Securities [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Net Gain (Loss) Recognized on Equity Securities"
       }
      }
     },
     "localname": "GainLossOnInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "terseLabel": "Gain (loss) on disposal of machinery and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r199",
      "r200"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Goodwill and intangible asset impairment"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r111",
      "r201",
      "r202"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets and Other Long-Lived Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations",
      "http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r362",
      "r369"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r70",
      "r124",
      "r416",
      "r425",
      "r445"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Outside of the United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]",
        "verboseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]",
        "verboseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r156",
      "r344"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense",
        "totalLabel": "Income taxes at effective rates"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations",
      "http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails",
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Amount [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxHolidayAggregateDollarAmount": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction.",
        "label": "Income Tax Holiday, Aggregate Dollar Amount",
        "terseLabel": "Decrease in foreign taxes from tax holiday"
       }
      }
     },
     "localname": "IncomeTaxHolidayAggregateDollarAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r68",
      "r111",
      "r316",
      "r317",
      "r328",
      "r329",
      "r333",
      "r345",
      "r455"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r315",
      "r319",
      "r320"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r314",
      "r319",
      "r320"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "terseLabel": "Rate change"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r113",
      "r319",
      "r320"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Foreign rate differential"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r114",
      "r319",
      "r320"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income taxes at statutory rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r319",
      "r320"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount",
        "terseLabel": "Stock and officers compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r319"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r114",
      "r319",
      "r320"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income tax, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r319",
      "r320"
     ],
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "negatedTerseLabel": "Research and development credits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r99",
      "r106"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid during the year for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued payroll and related expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherDeferredLiability": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred obligations classified as other.",
        "label": "Increase (Decrease) in Other Deferred Liability",
        "terseLabel": "Deferred revenue, deferred rent and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherDeferredLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r128",
      "r133"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive potential common stock outstanding (shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r69",
      "r154",
      "r383",
      "r386",
      "r428"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r81",
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Total interest expense recognized on senior notes"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r83"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Contractual coupon interest"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.",
        "label": "Interest Income and Interest Expense Disclosure [Table Text Block]",
        "terseLabel": "Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes"
       }
      }
     },
     "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r96",
      "r98",
      "r106"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid during the year for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r23",
      "r198"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r2",
      "r52",
      "r194"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r9",
      "r53",
      "r111",
      "r136",
      "r195",
      "r197"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r25",
      "r198"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r24",
      "r198"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r196"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Equity investment in Tandem Diabetes Care, Inc."
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Operating Leases, Rent Expense",
        "terseLabel": "Rent expense"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r406",
      "r408"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Components of Lease Expense and Other Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases And Other Commitments"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturity of Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetailsCalc2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due",
        "totalLabel": "Total future lease cost"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetailsCalc2": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: Amount representing interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases And Other Commitments"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Outstanding letters of credit"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r22",
      "r422",
      "r440"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r15",
      "r421",
      "r433"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Outstanding borrowings"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Letters of credit sub-facility",
        "verboseLabel": "Maximum borrowing capacity of revolving credit agreement"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Total available balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r37",
      "r117"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Unused capacity fee (as a percent)"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r45",
      "r212"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Loss contingency accrual"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r15",
      "r231",
      "r421",
      "r437"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Total net carrying amount of senior convertible notes"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r43",
      "r227"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r220",
      "r221"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyPatentsAllegedlyInfringedNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of another entity's patents that the entity has allegedly infringed.",
        "label": "Loss Contingency, Patents Allegedly Infringed, Number",
        "terseLabel": "Number of patents allegedly infringed upon by entity"
       }
      }
     },
     "localname": "LossContingencyPatentsAllegedlyInfringedNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and Equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesGainLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Marketable Securities, Gain (Loss) [Abstract]",
        "terseLabel": "Total marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesGainLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard Product Warranty Accrual [Roll Forward]",
        "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardProductWarrantyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r139",
      "r152"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Organization and Business"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r97",
      "r100",
      "r103"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r62",
      "r65",
      "r71",
      "r103",
      "r133",
      "r426",
      "r443"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss",
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations",
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails",
      "http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the quantification of the effect of adopting the new accounting standard or change in accounting principle expected by the entity to have a significant effect on the entity's financial statements.",
        "label": "New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification",
        "terseLabel": "Cumulative effect of adoption of new accounting pronouncement"
       }
      }
     },
     "localname": "NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Guidance"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Outside of the United States"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "auth_ref": [
      "r107",
      "r108",
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired",
        "terseLabel": "Acquisition of property and equipment included in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "terseLabel": "Total operating expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations",
      "http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r399",
      "r408"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r391"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetailsCalc2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease liability",
        "totalLabel": "Revised present value of future lease payments"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r391"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "negatedLabel": "Less: Current portion",
        "terseLabel": "Operating lease liabilities, current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r391"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, net of current portion",
        "verboseLabel": "Long-term portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r395",
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r390"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r405",
      "r408"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate of operating leases (as a percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r404",
      "r408"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term of operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r334"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r359"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization and Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r39"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of other assets.",
        "label": "Other Assets, Fair Value Disclosure",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r351",
      "r352",
      "r354"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "verboseLabel": "Foreign currency translation gain (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of income taxes:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r63",
      "r66",
      "r351",
      "r352",
      "r354"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Total other comprehensive income (loss), net"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss",
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r56",
      "r58"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Unrealized gain (loss) on marketable debt securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities",
        "totalLabel": "Total other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash income and expenses"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Interest and other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Nonoperating Income (Expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherSundryLiabilitiesNoncurrent": {
     "auth_ref": [
      "r16",
      "r420",
      "r436"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.",
        "label": "Other Sundry Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r84",
      "r86",
      "r173"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-sale",
        "negatedLabel": "Purchase of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherInvestments": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investments classified as other.",
        "label": "Payments to Acquire Other Investments",
        "negatedTerseLabel": "Purchase of other equity investments"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r269",
      "r292"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock issued (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock outstanding (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValueOutstanding": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.",
        "label": "Preferred Stock, Value, Outstanding",
        "terseLabel": "Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively"
       }
      }
     },
     "localname": "PreferredStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r4",
      "r29",
      "r30"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from issuance of convertible debt, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Net proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "terseLabel": "Proceeds from sale of warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Proceeds from short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r92",
      "r95",
      "r121"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r84",
      "r85",
      "r173"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from sale and maturity of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r222"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.",
        "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments",
        "negatedLabel": "Costs incurred"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r34",
      "r206"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property, Plant and Equipment, Type [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails",
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r33",
      "r204"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r11",
      "r12",
      "r206",
      "r441"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r32",
      "r111",
      "r206"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r11",
      "r206"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r11",
      "r204"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property, Plant and Equipment, Type [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails",
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "Quarterly Financial Information (Unaudited)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedQuarterlyFinancialInformationUnaudited"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r111",
      "r167",
      "r169",
      "r170",
      "r171"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivables and Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear": {
     "auth_ref": [
      "r211"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the recorded unconditional purchase obligation maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Recorded Unconditional Purchase Obligation Due in Next Twelve Months",
        "terseLabel": "Purchase obligations"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueWithinOneYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-term Lines of Credit",
        "negatedTerseLabel": "Repayment of short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r310",
      "r458"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r111",
      "r310"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r110",
      "r417",
      "r438"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Unvested restricted stock units",
        "verboseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r102",
      "r208",
      "r209",
      "r210"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring charges and costs"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r21",
      "r244",
      "r439"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit",
        "verboseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r250",
      "r251"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "verboseLabel": "Amount"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations",
      "http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r112",
      "r258"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Revenue from External Customers by Geographic Areas"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r403",
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for finance lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r403",
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred directly to consumer.",
        "label": "Sales Channel, Directly to Consumer [Member]",
        "terseLabel": "Direct"
       }
      }
     },
     "localname": "SalesChannelDirectlyToConsumerMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred through intermediary.",
        "label": "Sales Channel, Through Intermediary [Member]",
        "terseLabel": "Distributor"
       }
      }
     },
     "localname": "SalesChannelThroughIntermediaryMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Accounts Receivable"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "verboseLabel": "Schedule of Outstanding Anti-Dilutive Securities Excluded in Diluted Net Income (Loss) per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Basic and Diluted Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation between Effective Tax Rate and Statutory Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r268",
      "r289",
      "r304"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r268",
      "r289",
      "r304"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Share-Based Compensation Expenses"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income (Loss) before Income Taxes Subject to Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r9",
      "r26",
      "r27",
      "r28"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "auth_ref": [
      "r37",
      "r117"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "terseLabel": "Schedule of Availability and Outstanding Borrowings on Credit Agreement"
       }
      }
     },
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock Units Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, classified as other.",
        "label": "Schedule of Other Assets and Other Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Long-Term Liabilities"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Schedule of Accrued Warranty"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r34",
      "r206"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Information [Table Text Block]",
        "terseLabel": "Schedule of Quarterly Financial Information"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r153",
      "r157",
      "r158",
      "r159",
      "r201"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r269",
      "r292"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Valuation Assumptions for Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r148",
      "r379",
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Schedules of Percentage of Total Revenues and Accounts Receivable by Customer"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segment and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r80",
      "r193"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Senior Notes [Abstract]",
        "terseLabel": "Senior Convertible Notes"
       }
      }
     },
     "localname": "SeniorLongtermNotesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r278"
     ],
     "calculation": {
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of period (shares)",
        "periodStartLabel": "Nonvested at beginning of period (shares)",
        "terseLabel": "Unvested restricted stock units (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at end of period (USD per share)",
        "periodStartLabel": "Nonvested at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r282"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of RSUs vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility of the Company\u2019s stock (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Maximum payroll deductions (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Stock reserved for issuance (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise price of stock options (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r282"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityIntrinsicValueOfOptionsExercisedAndFairValueOfOptionsVestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r274",
      "r292"
     ],
     "calculation": {
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "verboseLabel": "Stock options granted and outstanding (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r267",
      "r272"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r111",
      "r269",
      "r273"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Closing stock price (USD per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r284",
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r292"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of stock options"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual term of stock options"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r400",
      "r408"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short-term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrual": {
     "auth_ref": [
      "r224"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.",
        "label": "Standard Product Warranty Accrual",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Accrued warranty"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails",
      "http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "auth_ref": [
      "r111",
      "r223"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.",
        "label": "Standard Product Warranty, Policy [Policy Text Block]",
        "terseLabel": "Warranty Accrual"
       }
      }
     },
     "localname": "StandardProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "verboseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r49",
      "r238"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.",
        "label": "Stock Issued During Period, Shares, Employee Benefit Plan",
        "verboseLabel": "Issuance of common stock under equity incentive plans (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeBenefitPlan",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r17",
      "r18",
      "r238",
      "r244"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock for Employee Stock Purchase Plan (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r17",
      "r18",
      "r238",
      "r244"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "verboseLabel": "Issuance of common stock in connection with acquisition, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.",
        "label": "Stock Issued During Period, Shares, Purchase of Assets",
        "terseLabel": "Issuance of common stock for collaborative research and development fee (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.",
        "label": "Stock Issued During Period, Value, Employee Benefit Plan",
        "terseLabel": "Issuance of common stock under equity incentive plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeBenefitPlan",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r17",
      "r18",
      "r238",
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock for Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.",
        "label": "Stock Issued During Period, Value, Purchase of Assets",
        "terseLabel": "Issuance of common stock for collaborative research and development fee"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValuePurchaseOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r349",
      "r350",
      "r356"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r322",
      "r327",
      "r329"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r48",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r48",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock at cost (shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r18",
      "r238",
      "r244"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Purchases of treasury stock (shares)",
        "terseLabel": "Purchases of treasury stock (shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r48",
      "r245",
      "r246"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock at cost; 0.8 million shares at December 31, 2019"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r238",
      "r244",
      "r245"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States. The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009. As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right. All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification. For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.",
        "label": "Type of Adoption [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Government Corporations and Agencies Securities [Member]",
        "terseLabel": "U.S. government agencies"
       }
      }
     },
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ConvertibleLongTermNotesPayable",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "negatedTerseLabel": "Unamortized debt issuance costs"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnbilledContractsReceivable": {
     "auth_ref": [
      "r50",
      "r415"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.",
        "label": "Unbilled Contracts Receivable",
        "terseLabel": "Unbilled accounts receivable"
       }
      }
     },
     "localname": "UnbilledContractsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of investments, not including unrealized gains or losses on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, held at each balance sheet date and included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Investments",
        "negatedTerseLabel": "Unrealized gain on equity investment"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r313",
      "r324"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r325"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Decreases related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense": {
     "auth_ref": [
      "r321"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties Expense",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r326"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increases related to current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r140",
      "r141",
      "r143",
      "r144",
      "r149",
      "r150",
      "r151"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceByDeferredTaxAssetAxis": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of deferred tax consequences attributable to deductible temporary differences.",
        "label": "Valuation Allowance by Deferred Tax Asset [Axis]",
        "terseLabel": "Valuation Allowance by Deferred Tax Asset [Axis]"
       }
      }
     },
     "localname": "ValuationAllowanceByDeferredTaxAssetAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesRecoveries": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from recovery of amount previously written off or reestablishment of reserve previously utilized.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery",
        "terseLabel": "Recoveries"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesRecoveries",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r401",
      "r408"
     ],
     "calculation": {
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "2023 Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r126",
      "r131"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used to compute diluted net income (loss) per share (shares)",
        "verboseLabel": "Diluted weighted average shares outstanding (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r125",
      "r131"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Shares used to compute basic net income (loss) per share (shares)",
        "verboseLabel": "Basic weighted average shares outstanding (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsOfOperations",
      "http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(i)(4))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1500-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=118952077&loc=d3e1280-108306"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "http://asc.fasb.org/topic&trid=2126967"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9054-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5033-111524"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5074-111524"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26610-111562"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26853-111562"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=116654751&loc=SL75117546-209714"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919244-210447"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919253-210447"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919258-210447"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919230-210447"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118942338&loc=SL82898722-210454"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922888-210455"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922895-210455"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922900-210455"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118942371&loc=SL82922954-210456"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=77896938&loc=d3e25383-109308"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14394-108349"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14453-108349"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14472-108349"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12021-110248"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12053-110248"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1),(c)(5)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4724-112606"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=51819886&loc=SL6014347-161799"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031898-161870"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031898-161870"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031898-161870"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "http://asc.fasb.org/topic&trid=2127225"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79507997-165333"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79507997-165333"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508013-165333"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508013-165333"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508029-165333"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508029-165333"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508043-165333"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508043-165333"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508057-165333"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508057-165333"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=SL37586934-109318"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32059-109318"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32123-109318"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32247-109318"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32280-109318"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31931-109318"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "51",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117331294&loc=d3e34017-109320"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "30",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=d3e5283-111683"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3A-02)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355033-122828"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3A-03)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355100-122828"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "15",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=35708913&loc=d3e50896-113970"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL7498357-110258"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13531-108611"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=77902458&loc=d3e39927-112707"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=119364159&loc=SL77916155-209984"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918638-209977"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918666-209980"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=118261985&loc=d3e55302-109406"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.6(a)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62652-112803"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117420044&loc=d3e19393-158473"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6052-115624"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28)",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r459": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.26(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r461": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r462": {
   "Name": "Forms 10-K, 20-F, 40-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d-1"
  },
  "r463": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r464": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r465": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r466": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r467": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "04"
  },
  "r468": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r469": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(m)",
   "Publisher": "SEC",
   "Section": "4",
   "Subparagraph": "(1)(iii)",
   "Subsection": "08"
  },
  "r471": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "5",
   "Subparagraph": "Schedule I",
   "Subsection": "04"
  },
  "r472": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "5",
   "Subparagraph": "Schedule III",
   "Subsection": "04"
  },
  "r473": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "7",
   "Subparagraph": "Schedule II",
   "Subsection": "05"
  },
  "r474": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "9",
   "Subsection": "06"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(c)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e7018-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3151-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837544912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Feb. 28, 2018 </div>
<div>number_patents</div>
</th>
<th class="th">
<div>Sep. 15, 2017 </div>
<div>number_patents</div>
</th>
<th class="th">
<div>Mar. 28, 2016 </div>
<div>number_patents</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Loss contingency accrual | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_NameOfDefendantAxis=dxcm_AgaMatrixMember', window );">AgaMatrix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber', window );">Number of patents allegedly infringed upon by counterparty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_NameOfPlaintiffAxis=dxcm_AgaMatrixMember', window );">AgaMatrix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber', window );">Number of patents allegedly infringed upon by entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_NameOfPlaintiffAxis=dxcm_WaveFormTechnologiesInc.Member', window );">WaveForm Technologies, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber', window );">Number of patents allegedly infringed upon by entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber', window );">Number of patents allegedly infringed upon by entity that are not unpatentable</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff', window );">Number of patent infringement claims transferred to new plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Patents Allegedly Infringed, Determined Patentable, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LossContingencyPatentsAllegedlyInfringedDeterminedPatentableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Patents Allegedly Infringed, Number Transferred To New Plaintiff</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LossContingencyPatentsAllegedlyInfringedNumberTransferredToNewPlaintiff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of entity's patents that another entity has allegedly infringed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of another entity's patents that the entity has allegedly infringed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPatentsAllegedlyInfringedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_NameOfDefendantAxis=dxcm_AgaMatrixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_NameOfDefendantAxis=dxcm_AgaMatrixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_NameOfPlaintiffAxis=dxcm_AgaMatrixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_NameOfPlaintiffAxis=dxcm_AgaMatrixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_NameOfPlaintiffAxis=dxcm_WaveFormTechnologiesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_NameOfPlaintiffAxis=dxcm_WaveFormTechnologiesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3.a.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>259</ContextCount>
  <ElementCount>521</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>67</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001000 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001501 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002000 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003000 - Statement - Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004000 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005000 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101100 - Disclosure - Organization and Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationAndSignificantAccountingPolicies</Role>
      <ShortName>Organization and Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2102100 - Disclosure - Development and Other Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DevelopmentAndOtherAgreements</Role>
      <ShortName>Development and Other Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2103100 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2104100 - Disclosure - Balance Sheet Details</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetails</Role>
      <ShortName>Balance Sheet Details</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2105100 - Disclosure - Debt Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DebtDebt</Role>
      <ShortName>Debt Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2106100 - Disclosure - Leases And Other Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesAndOtherCommitments</Role>
      <ShortName>Leases And Other Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2107100 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2108100 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2109100 - Disclosure - Employee Benefit Plans and Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquity</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2110100 - Disclosure - Business Segment and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentAndGeographicInformation</Role>
      <ShortName>Business Segment and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2111100 - Disclosure - Quarterly Financial Information (Unaudited) Quarterly Financial Information (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedQuarterlyFinancialInformationUnaudited</Role>
      <ShortName>Quarterly Financial Information (Unaudited) Quarterly Financial Information (Unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2112100 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccounts</Role>
      <ShortName>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2201201 - Disclosure - Organization and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Organization and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/OrganizationAndSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2301302 - Disclosure - Organization and Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesTables</Role>
      <ShortName>Organization and Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/OrganizationAndSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/FairValueMeasurements</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Balance Sheet Details (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsTables</Role>
      <ShortName>Balance Sheet Details (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/BalanceSheetDetails</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/DebtDebt</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2306301 - Disclosure - Leases And Other Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesAndOtherCommitmentsTables</Role>
      <ShortName>Leases And Other Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/LeasesAndOtherCommitments</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2308301 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/IncomeTaxes</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2309301 - Disclosure - Employee Benefit Plans and Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityTables</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquity</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2310301 - Disclosure - Business Segment and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationTables</Role>
      <ShortName>Business Segment and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/BusinessSegmentAndGeographicInformation</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2311301 - Disclosure - Quarterly Financial Information (Unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedTables</Role>
      <ShortName>Quarterly Financial Information (Unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedQuarterlyFinancialInformationUnaudited</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2401403 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2401404 - Disclosure - Organization and Significant Accounting Policies - Revenues and Gross Accounts Receivable by Customer (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenuesAndGrossAccountsReceivableByCustomerDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Revenues and Gross Accounts Receivable by Customer (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2401405 - Disclosure - Organization and Significant Accounting Policies - Revenue Recognized from Changes in Contract Liability Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesRevenueRecognizedFromChangesInContractLiabilityBalancesDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Revenue Recognized from Changes in Contract Liability Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2401406 - Disclosure - Organization and Significant Accounting Policies - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesEarningsPerShareDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2401407 - Disclosure - - Anti-Dilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/AntiDilutiveSecuritiesDetails</Role>
      <ShortName>- Anti-Dilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Development and Other Agreements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DevelopmentAndOtherAgreementsNarrativeDetails</Role>
      <ShortName>Development and Other Agreements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2403402 - Disclosure - Fair Value Measurements - Fair Value Hierarchy of Financial Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyOfFinancialAssetsDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value Hierarchy of Financial Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2403403 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2403404 - Disclosure - Fair Value Measurements - Fair Value of Senior Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsFairValueOfSeniorConvertibleNotesDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value of Senior Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2404402 - Disclosure - Balance Sheet Details - Short-term Marketable Securities, Available-for-Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetails</Role>
      <ShortName>Balance Sheet Details - Short-term Marketable Securities, Available-for-Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2404403 - Disclosure - Balance Sheet Details - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails</Role>
      <ShortName>Balance Sheet Details - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2404404 - Disclosure - Balance Sheet Details - Net Gain (Loss) Recognized on Equity Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsNetGainLossRecognizedOnEquitySecuritiesDetails</Role>
      <ShortName>Balance Sheet Details - Net Gain (Loss) Recognized on Equity Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2404405 - Disclosure - Balance Sheet Details - Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsAccountsReceivableDetails</Role>
      <ShortName>Balance Sheet Details - Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2404406 - Disclosure - Balance Sheet Details - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails</Role>
      <ShortName>Balance Sheet Details - Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2404407 - Disclosure - Balance Sheet Details - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails</Role>
      <ShortName>Balance Sheet Details - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2404408 - Disclosure - Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2404409 - Disclosure - Balance Sheet Details - Accrued Warranty (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsAccruedWarrantyDetails</Role>
      <ShortName>Balance Sheet Details - Accrued Warranty (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2404410 - Disclosure - Balance Sheet Details - Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsOtherLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Details - Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Debt - Senior Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails</Role>
      <ShortName>Debt - Senior Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2405403 - Disclosure - Debt - Conversion Value of Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/DebtConversionValueOfConvertibleNotesDetails</Role>
      <ShortName>Debt - Conversion Value of Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2405404 - Disclosure - Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/DebtComponentsOfInterestExpenseAndEffectiveInterestRatesOfSeniorConvertibleNotesDetails</Role>
      <ShortName>Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2405405 - Disclosure - Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2405406 - Disclosure - Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DebtAvailabilityAndOutstandingBorrowingsUnderCreditAgreementDetails</Role>
      <ShortName>Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Leases And Other Commitments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesAndOtherCommitmentsNarrativeDetails</Role>
      <ShortName>Leases And Other Commitments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Leases And Other Commitments - Maturity of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesAndOtherCommitmentsMaturityOfLeaseLiabilitiesDetails</Role>
      <ShortName>Leases And Other Commitments - Maturity of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2406404 - Disclosure - Leases And Other Commitments - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesAndOtherCommitmentsLeaseCostDetails</Role>
      <ShortName>Leases And Other Commitments - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2406405 - Disclosure - Leases And Other Commitments - Other Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesAndOtherCommitmentsOtherInformationDetails</Role>
      <ShortName>Leases And Other Commitments - Other Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2407401 - Disclosure - Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ContingenciesNarrativeDetails</Role>
      <ShortName>Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2408402 - Disclosure - Income Taxes - Jurisdictions, Net Income (Loss) Subject to Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesJurisdictionsNetIncomeLossSubjectToIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Jurisdictions, Net Income (Loss) Subject to Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Income Taxes - Components of Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesComponentsOfProvisionDetails</Role>
      <ShortName>Income Taxes - Components of Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2408406 - Disclosure - Income Taxes - Reconciliation between Effective Tax Rate and Statutory Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateAndStatutoryRateDetails</Role>
      <ShortName>Income Taxes - Reconciliation between Effective Tax Rate and Statutory Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2408407 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2409402 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityNarrativeDetails</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2409403 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Intrinsic Value of Options Exercised and Fair Value of Options Vested (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityIntrinsicValueOfOptionsExercisedAndFairValueOfOptionsVestedDetails</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity - Intrinsic Value of Options Exercised and Fair Value of Options Vested (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity - Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Stock Options Reserved for Future Issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityStockOptionsReservedForFutureIssuanceDetails</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity - Stock Options Reserved for Future Issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Share-based Compensation Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityShareBasedCompensationExpensesDetails</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity - Share-based Compensation Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2409407 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Valuation Assumptions for Each Option Grant and Employee Stock Purchase Plan Purchase Rights (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansAndStockholdersEquityValuationAssumptionsForEachOptionGrantAndEmployeeStockPurchasePlanPurchaseRightsDetails</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity - Valuation Assumptions for Each Option Grant and Employee Stock Purchase Plan Purchase Rights (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2410402 - Disclosure - Business Segment and Geographic Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationNarrativeDetails</Role>
      <ShortName>Business Segment and Geographic Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - Business Segment and Geographic Information - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationSummaryDetails</Role>
      <ShortName>Business Segment and Geographic Information - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2411402 - Disclosure - Quarterly Financial Information (Unaudited) - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedSummaryDetails</Role>
      <ShortName>Quarterly Financial Information (Unaudited) - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/QuarterlyFinancialInformationUnauditedTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2412401 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccountsDetails</Role>
      <ShortName>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/ScheduleIiValuationAndQualifyingAccounts</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="dxcm-12312019x10kasof1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - dxcm-12312019x10kasof1.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - dxcm-12312019x10kasof1.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="dxcm-12312019x10kasof1.htm">dxcm-12312019x10kasof1.htm</File>
    <File>dxcm-20191231.xsd</File>
    <File>dxcm-20191231_cal.xml</File>
    <File>dxcm-20191231_def.xml</File>
    <File>dxcm-20191231_lab.xml</File>
    <File>dxcm-20191231_pre.xml</File>
    <File>dxcm12312019exhibit1036.htm</File>
    <File>dxcm12312019exhibit1037.htm</File>
    <File>dxcm12312019exhibit1038.htm</File>
    <File>dxcm12312019exhibit1039.htm</File>
    <File>dxcm12312019exhibit1040.htm</File>
    <File>dxcm12312019exhibit1041.htm</File>
    <File>dxcm12312019exhibit1042.htm</File>
    <File>dxcm12312019exhibit2101.htm</File>
    <File>dxcm12312019exhibit2301.htm</File>
    <File>dxcm12312019exhibit3101.htm</File>
    <File>dxcm12312019exhibit3102.htm</File>
    <File>dxcm12312019exhibit3201.htm</File>
    <File>dxcm12312019exhibit3202.htm</File>
    <File>dxcm12312019exhibit404.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>a2019chartitem5.jpg</File>
    <File>a2019chartitem7.jpg</File>
    <File>dexcomgreenstandalone.jpg</File>
    <File>singledaydataa05.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2017-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837567856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases And Other Commitments - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>renewal_term </div>
<div>finance_lease</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 71.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">86.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease liability</a></td>
<td class="nump">15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.5<span></span>
</td>
<td class="nump">$ 11.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_LesseeOperatingLeasesLeaseCostAmortization', window );">Amortization of operating lease right-of-use asset</a></td>
<td class="nump">9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear', window );">Purchase obligations</a></td>
<td class="nump">$ 165.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm', window );">Term of purchase obligations</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member', window );">Leased Buildings - Mesa, Arizona Expiring March 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_NumberofFinancingLeases', window );">Number of financing leases | finance_lease</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms', window );">Number of renewal terms | renewal_term</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease terms</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dxcm_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease terms</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings | Accounting Standards Update 2016-02</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Cumulative-effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Leasing Arrangements, Operating Leases, Number Of Renewal Terms</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LesseeOperatingLeasesLeaseCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Leases, Lease Cost, Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LesseeOperatingLeasesLeaseCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_NumberofFinancingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Financing Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_NumberofFinancingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recorded Unconditional Purchase Obligation Due Within One Year, Maximum Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the recorded unconditional purchase obligation maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77896938&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=dxcm_LeasedBuildingsMesaArizonaExpiringMarch2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
